<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37188781</PMID><DateCompleted><Year>2023</Year><Month>09</Month><Day>21</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1546-170X</ISSN><JournalIssue CitedMedium="Internet"><Volume>29</Volume><Issue>5</Issue><PubDate><Year>2023</Year><Month>May</Month></PubDate></JournalIssue><Title>Nature medicine</Title><ISOAbbreviation>Nat Med</ISOAbbreviation></Journal><ArticleTitle>Resilience to autosomal dominant Alzheimer's disease in a Reelin-COLBOS heterozygous man.</ArticleTitle><Pagination><StartPage>1243</StartPage><EndPage>1252</EndPage><MedlinePgn>1243-1252</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41591-023-02318-3</ELocationID><Abstract><AbstractText>We characterized the world's second case with ascertained extreme resilience to autosomal dominant Alzheimer's disease (ADAD). Side-by-side comparisons of this male case and the previously reported female case with ADAD homozygote for the APOE3 Christchurch (APOECh) variant allowed us to discern common features. The male remained cognitively intact until 67 years of age despite carrying a PSEN1-E280A mutation. Like the APOECh carrier, he had extremely elevated amyloid plaque burden and limited entorhinal Tau tangle burden. He did not carry the APOECh variant but was heterozygous for a rare variant in RELN (H3447R, termed COLBOS after the Colombia-Boston biomarker research study), a ligand that like apolipoprotein E binds to the VLDLr and APOEr2 receptors. RELN-COLBOS is a gain-of-function variant showing stronger ability to activate its canonical protein target Dab1 and reduce human Tau phosphorylation in a knockin mouse. A genetic variant in a case protected from ADAD suggests a role for RELN signaling in resilience to dementia.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Lopera</LastName><ForeName>Francisco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Neuroscience Group of Antioquia, Medicine School, University of Antioquia, Medell&#xed;n, Colombia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medicine School, University of Antioquia, Medell&#xed;n, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Marino</LastName><ForeName>Claudia</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-2332-2163</Identifier><AffiliationInfo><Affiliation>Schepens Eye Research Institute of Mass Eye and Ear and Department of Ophthalmology at Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Chandrahas</LastName><ForeName>Anita S</ForeName><Initials>AS</Initials><AffiliationInfo><Affiliation>Schepens Eye Research Institute of Mass Eye and Ear and Department of Ophthalmology at Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>O'Hare</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Schepens Eye Research Institute of Mass Eye and Ear and Department of Ophthalmology at Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Villalba-Moreno</LastName><ForeName>Nelson David</ForeName><Initials>ND</Initials><AffiliationInfo><Affiliation>Institute of Neuropathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aguillon</LastName><ForeName>David</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0003-2283-536X</Identifier><AffiliationInfo><Affiliation>Neuroscience Group of Antioquia, Medicine School, University of Antioquia, Medell&#xed;n, Colombia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medicine School, University of Antioquia, Medell&#xed;n, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baena</LastName><ForeName>Ana</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Neuroscience Group of Antioquia, Medicine School, University of Antioquia, Medell&#xed;n, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sanchez</LastName><ForeName>Justin S</ForeName><Initials>JS</Initials><Identifier Source="ORCID">0000-0003-4421-3078</Identifier><AffiliationInfo><Affiliation>Department of Neurology at Harvard Medical School, Massachusetts General Hospital, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vila-Castelar</LastName><ForeName>Clara</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-8779-1487</Identifier><AffiliationInfo><Affiliation>Department of Psychiatry at Harvard Medical School, Massachusetts General Hospital, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ramirez Gomez</LastName><ForeName>Liliana</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Neurology at Harvard Medical School, Massachusetts General Hospital, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chmielewska</LastName><ForeName>Natalia</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Schepens Eye Research Institute of Mass Eye and Ear and Department of Ophthalmology at Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oliveira</LastName><ForeName>Gabriel M</ForeName><Initials>GM</Initials><AffiliationInfo><Affiliation>Schepens Eye Research Institute of Mass Eye and Ear and Department of Ophthalmology at Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychiatry at Harvard Medical School, Massachusetts General Hospital, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Littau</LastName><ForeName>Jessica Lisa</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>Institute of Neuropathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hartmann</LastName><ForeName>Kristin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Institute of Neuropathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Kyungeun</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Institute of Neuropathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Krasemann</LastName><ForeName>Susanne</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-8795-818X</Identifier><AffiliationInfo><Affiliation>Institute of Neuropathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Glatzel</LastName><ForeName>Markus</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-7720-8817</Identifier><AffiliationInfo><Affiliation>Institute of Neuropathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schoemaker</LastName><ForeName>Dorothee</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Schepens Eye Research Institute of Mass Eye and Ear and Department of Ophthalmology at Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychiatry at Harvard Medical School, Massachusetts General Hospital, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gonzalez-Buendia</LastName><ForeName>Lucia</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Schepens Eye Research Institute of Mass Eye and Ear and Department of Ophthalmology at Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Delgado-Tirado</LastName><ForeName>Santiago</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Schepens Eye Research Institute of Mass Eye and Ear and Department of Ophthalmology at Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arevalo-Alquichire</LastName><ForeName>Said</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-3366-7384</Identifier><AffiliationInfo><Affiliation>Schepens Eye Research Institute of Mass Eye and Ear and Department of Ophthalmology at Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saez-Torres</LastName><ForeName>Kahira L</ForeName><Initials>KL</Initials><AffiliationInfo><Affiliation>Schepens Eye Research Institute of Mass Eye and Ear and Department of Ophthalmology at Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Amarnani</LastName><ForeName>Dhanesh</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Schepens Eye Research Institute of Mass Eye and Ear and Department of Ophthalmology at Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Leo A</ForeName><Initials>LA</Initials><Identifier Source="ORCID">0000-0001-9106-6416</Identifier><AffiliationInfo><Affiliation>Schepens Eye Research Institute of Mass Eye and Ear and Department of Ophthalmology at Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mazzarino</LastName><ForeName>Randall C</ForeName><Initials>RC</Initials><Identifier Source="ORCID">0000-0001-7954-3283</Identifier><AffiliationInfo><Affiliation>Schepens Eye Research Institute of Mass Eye and Ear and Department of Ophthalmology at Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gordon</LastName><ForeName>Harper</ForeName><Initials>H</Initials><Identifier Source="ORCID">0009-0005-9561-5706</Identifier><AffiliationInfo><Affiliation>Schepens Eye Research Institute of Mass Eye and Ear and Department of Ophthalmology at Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bocanegra</LastName><ForeName>Yamile</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0003-3064-2509</Identifier><AffiliationInfo><Affiliation>Neuroscience Group of Antioquia, Medicine School, University of Antioquia, Medell&#xed;n, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Villegas</LastName><ForeName>Andres</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Neuroscience Group of Antioquia, Medicine School, University of Antioquia, Medell&#xed;n, Colombia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medicine School, University of Antioquia, Medell&#xed;n, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gai</LastName><ForeName>Xiaowu</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Center for Personalized Medicine, Department of Pathology and Laboratory Medicine, Children's Hospital Los Angeles, Los Angeles, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathology, Keck School of Medicine of University of Southern California, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bootwalla</LastName><ForeName>Moiz</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center for Personalized Medicine, Department of Pathology and Laboratory Medicine, Children's Hospital Los Angeles, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ji</LastName><ForeName>Jianling</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-4941-3538</Identifier><AffiliationInfo><Affiliation>Center for Personalized Medicine, Department of Pathology and Laboratory Medicine, Children's Hospital Los Angeles, Los Angeles, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathology, Keck School of Medicine of University of Southern California, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shen</LastName><ForeName>Lishuang</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Center for Personalized Medicine, Department of Pathology and Laboratory Medicine, Children's Hospital Los Angeles, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kosik</LastName><ForeName>Kenneth S</ForeName><Initials>KS</Initials><Identifier Source="ORCID">0000-0003-3224-5179</Identifier><AffiliationInfo><Affiliation>Neuroscience Research Institute, Department of Molecular Cellular Developmental Biology, University of California, Santa Barbara, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Su</LastName><ForeName>Yi</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0002-1946-8063</Identifier><AffiliationInfo><Affiliation>The Banner Alzheimer's Institute, Phoenix, AZ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Yinghua</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>The Banner Alzheimer's Institute, Phoenix, AZ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schultz</LastName><ForeName>Aaron</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neurology at Harvard Medical School, Massachusetts General Hospital, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sperling</LastName><ForeName>Reisa A</ForeName><Initials>RA</Initials><Identifier Source="ORCID">0000-0003-1535-6133</Identifier><AffiliationInfo><Affiliation>Department of Neurology at Harvard Medical School, Brigham and Women's Hospital, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Johnson</LastName><ForeName>Keith</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Neurology at Harvard Medical School, Brigham and Women's Hospital, Boston, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Radiology at Harvard Medical School, Massachusetts General Hospital, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reiman</LastName><ForeName>Eric M</ForeName><Initials>EM</Initials><Identifier Source="ORCID">0000-0002-0705-3696</Identifier><AffiliationInfo><Affiliation>The Banner Alzheimer's Institute, Phoenix, AZ, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Arizona, Tucson, AZ, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Arizona State University, Tucson, AZ, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neurogenomics Division, Translational Genomics Research Institute, Phoenix, AZ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sepulveda-Falla</LastName><ForeName>Diego</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0003-0176-2042</Identifier><AffiliationInfo><Affiliation>Institute of Neuropathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. d.sepulveda-falla@uke.uni-hamburg.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arboleda-Velasquez</LastName><ForeName>Joseph F</ForeName><Initials>JF</Initials><Identifier Source="ORCID">0000-0002-3192-9117</Identifier><AffiliationInfo><Affiliation>Schepens Eye Research Institute of Mass Eye and Ear and Department of Ophthalmology at Harvard Medical School, Boston, MA, USA. joseph_arboleda@meei.harvard.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Quiroz</LastName><ForeName>Yakeel T</ForeName><Initials>YT</Initials><Identifier Source="ORCID">0000-0001-9714-8244</Identifier><AffiliationInfo><Affiliation>Neuroscience Group of Antioquia, Medicine School, University of Antioquia, Medell&#xed;n, Colombia. yquiroz@mgh.harvard.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology at Harvard Medical School, Massachusetts General Hospital, Boston, MA, USA. yquiroz@mgh.harvard.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychiatry at Harvard Medical School, Massachusetts General Hospital, Boston, MA, USA. yquiroz@mgh.harvard.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 AG058468</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG054671</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K99 AG073452</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>RF1 AG077627</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 EY027739</GrantID><Acronym>EY</Acronym><Agency>NEI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UH3 NS100121</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>RF1 NS110048</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AG072980</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>DP5 OD019833</GrantID><Acronym>OD</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>RF1 AG041705</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>05</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Nat Med</MedlineTA><NlmUniqueID>9502015</NlmUniqueID><ISSNLinking>1078-8956</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C103773">Dab1 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D009419">Nerve Tissue Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.21.-</RegistryNumber><NameOfSubstance UI="C000717127">RELN protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Nature. 2023 May;617(7962):660-661. doi: 10.1038/d41586-023-01610-z.</RefSource><PMID Version="1">37188948</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006579" MajorTopicYN="N">Heterozygote</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009419" MajorTopicYN="N">Nerve Tissue Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>None of the authors were precluded from accessing data in the study; they accept responsibility to submit the manuscript for publication. J.F.A.-V. and L.A.K. are cofounders of Epoch Biotech, a company developing resilient case-inspired therapeutics. Y.T.Q., J.F.A.-V. and F.L. serve as consultants for Biogen. K.S.K. consults with Expansion Therapeutics, ADRx Pharma and Herophilus, and serves on the board of directors of the Tau Consortium. E.M.R. is a compensated scientific advisor to Alzheon, Aural Analytics, Denali, Retromer Therapeutics and Vaxxinity, and a cofounder and advisor to ALZpath, which was not involved in this study. The other authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>10</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>3</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>24</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>16</Day><Hour>1</Hour><Minute>9</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>15</Day><Hour>23</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>5</Month><Day>15</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37188781</ArticleId><ArticleId IdType="pmc">PMC10202812</ArticleId><ArticleId IdType="doi">10.1038/s41591-023-02318-3</ArticleId><ArticleId IdType="pii">10.1038/s41591-023-02318-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Acosta-Baena N, et al. Pre-dementia clinical stages in presenilin 1 E280A familial early-onset Alzheimer&#x2019;s disease: a retrospective cohort study. Lancet Neurol. 2011;10:213&#x2013;220. doi: 10.1016/S1474-4422(10)70323-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(10)70323-9</ArticleId><ArticleId IdType="pubmed">21296022</ArticleId></ArticleIdList></Reference><Reference><Citation>Arboleda-Velasquez JF, et al. Resistance to autosomal dominant Alzheimer&#x2019;s disease in an APOE3 Christchurch homozygote: a case report. Nat. Med. 2019;25:1680&#x2013;1683. doi: 10.1038/s41591-019-0611-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-019-0611-3</ArticleId><ArticleId IdType="pmc">PMC6898984</ArticleId><ArticleId IdType="pubmed">31686034</ArticleId></ArticleIdList></Reference><Reference><Citation>Quiroz YT, et al. Association between amyloid and tau accumulation in young adults with autosomal dominant Alzheimer disease. JAMA Neurol. 2018;75:548&#x2013;556. doi: 10.1001/jamaneurol.2017.4907.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2017.4907</ArticleId><ArticleId IdType="pmc">PMC5885174</ArticleId><ArticleId IdType="pubmed">29435558</ArticleId></ArticleIdList></Reference><Reference><Citation>Hiesberger T, et al. Direct binding of Reelin to VLDL receptor and ApoE receptor 2 induces tyrosine phosphorylation of disabled-1 and modulates tau phosphorylation. Neuron. 1999;24:481&#x2013;489. doi: 10.1016/S0896-6273(00)80861-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0896-6273(00)80861-2</ArticleId><ArticleId IdType="pubmed">10571241</ArticleId></ArticleIdList></Reference><Reference><Citation>Dunham I, et al. An integrated encyclopedia of DNA elements in the human genome. Nature. 2012;489:57&#x2013;74. doi: 10.1038/nature11247.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature11247</ArticleId><ArticleId IdType="pmc">PMC3439153</ArticleId><ArticleId IdType="pubmed">22955616</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwenk JM, et al. The Human Plasma Proteome draft of 2017: building on the Human Plasma PeptideAtlas from mass spectrometry and complementary assays. J. Proteome Res. 2017;16:4299&#x2013;4310. doi: 10.1021/acs.jproteome.7b00467.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jproteome.7b00467</ArticleId><ArticleId IdType="pmc">PMC5864247</ArticleId><ArticleId IdType="pubmed">28938075</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Arcangelo G, et al. Reelin is a ligand for lipoprotein receptors. Neuron. 1999;24:471&#x2013;479. doi: 10.1016/S0896-6273(00)80860-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0896-6273(00)80860-0</ArticleId><ArticleId IdType="pubmed">10571240</ArticleId></ArticleIdList></Reference><Reference><Citation>Lane-Donovan C, Herz J. ApoE, ApoE receptors, and the synapse in Alzheimer&#x2019;s disease. Trends Endocrinol. Metab. 2017;28:273&#x2013;284. doi: 10.1016/j.tem.2016.12.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tem.2016.12.001</ArticleId><ArticleId IdType="pmc">PMC5366078</ArticleId><ArticleId IdType="pubmed">28057414</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheldon M, et al. Scrambler and yotari disrupt the disabled gene and produce a reeler-like phenotype in mice. Nature. 1997;389:730&#x2013;733. doi: 10.1038/39601.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/39601</ArticleId><ArticleId IdType="pubmed">9338784</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakano Y, et al. The extremely conserved C-terminal region of Reelin is not necessary for secretion but is required for efficient activation of downstream signaling. J. Biol. Chem. 2007;282:20544&#x2013;20552. doi: 10.1074/jbc.M702300200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M702300200</ArticleId><ArticleId IdType="pubmed">17504759</ArticleId></ArticleIdList></Reference><Reference><Citation>Kohno T, et al. Reelin-Nrp1 interaction regulates neocortical dendrite development in a context-specific manner. J. Neurosci. 2020;40:8248&#x2013;8261. doi: 10.1523/JNEUROSCI.1907-20.2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1907-20.2020</ArticleId><ArticleId IdType="pmc">PMC7577592</ArticleId><ArticleId IdType="pubmed">33009002</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahley RW, Ji ZS. Remnant lipoprotein metabolism: key pathways involving cell-surface heparan sulfate proteoglycans and apolipoprotein E. J. Lipid Res. 1999;40:1&#x2013;16. doi: 10.1016/S0022-2275(20)33334-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-2275(20)33334-4</ArticleId><ArticleId IdType="pubmed">9869645</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Donato V, et al. An attractive Reelin gradient establishes synaptic lamination in the vertebrate visual system. Neuron. 2018;97:1049&#x2013;1062. doi: 10.1016/j.neuron.2018.01.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2018.01.030</ArticleId><ArticleId IdType="pubmed">29429939</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Arcangelo G, et al. A protein related to extracellular matrix proteins deleted in the mouse mutant reeler. Nature. 1995;374:719&#x2013;723. doi: 10.1038/374719a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/374719a0</ArticleId><ArticleId IdType="pubmed">7715726</ArticleId></ArticleIdList></Reference><Reference><Citation>Wasser CR, Herz J. Reelin: neurodevelopmental architect and homeostatic regulator of excitatory synapses. J. Biol. Chem. 2017;292:1330&#x2013;1338. doi: 10.1074/jbc.R116.766782.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.R116.766782</ArticleId><ArticleId IdType="pmc">PMC5270476</ArticleId><ArticleId IdType="pubmed">27994051</ArticleId></ArticleIdList></Reference><Reference><Citation>Utsunomiya-Tate N, et al. Reelin molecules assemble together to form a large protein complex, which is inhibited by the function-blocking CR-50 antibody. Proc. Natl Acad. Sci. USA. 2000;97:9729&#x2013;9734. doi: 10.1073/pnas.160272497.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.160272497</ArticleId><ArticleId IdType="pmc">PMC16933</ArticleId><ArticleId IdType="pubmed">10920200</ArticleId></ArticleIdList></Reference><Reference><Citation>Shifman S, et al. Genome-wide association identifies a common variant in the reelin gene that increases the risk of schizophrenia only in women. PLoS Genet. 2008;4:e28. doi: 10.1371/journal.pgen.0040028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.0040028</ArticleId><ArticleId IdType="pmc">PMC2242812</ArticleId><ArticleId IdType="pubmed">18282107</ArticleId></ArticleIdList></Reference><Reference><Citation>Ober C, Loisel DA, Gilad Y. Sex-specific genetic architecture of human disease. Nat. Rev. Genet. 2008;9:911&#x2013;922. doi: 10.1038/nrg2415.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrg2415</ArticleId><ArticleId IdType="pmc">PMC2694620</ArticleId><ArticleId IdType="pubmed">19002143</ArticleId></ArticleIdList></Reference><Reference><Citation>Goes FS, et al. Sex-specific association of the reelin gene with bipolar disorder. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2010;153B:549&#x2013;553. doi: 10.1002/ajmg.b.31018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ajmg.b.31018</ArticleId><ArticleId IdType="pmc">PMC3032172</ArticleId><ArticleId IdType="pubmed">19691043</ArticleId></ArticleIdList></Reference><Reference><Citation>Seripa D, et al. The RELN locus in Alzheimer&#x2019;s disease. J. Alzheimers Dis. 2008;14:335&#x2013;344. doi: 10.3233/JAD-2008-14308.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-2008-14308</ArticleId><ArticleId IdType="pubmed">18599960</ArticleId></ArticleIdList></Reference><Reference><Citation>Feh&#xe9;r &#xc1;, Juh&#xe1;sz A, P&#xe1;k&#xe1;ski M, K&#xe1;lm&#xe1;n J, Janka Z. Genetic analysis of the RELN gene: gender specific association with Alzheimer&#x2019;s disease. Psychiatry Res. 2015;230:716&#x2013;718. doi: 10.1016/j.psychres.2015.09.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.psychres.2015.09.021</ArticleId><ArticleId IdType="pubmed">26384575</ArticleId></ArticleIdList></Reference><Reference><Citation>Kelemenova S, Ostatnikova D. Neuroendocrine pathways altered in autism. Special role of reelin. Neuro. Endocrinol. Lett. 2009;30:429&#x2013;436.</Citation><ArticleIdList><ArticleId IdType="pubmed">20010491</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewis J, et al. Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein. Nat. Genet. 2000;25:402&#x2013;405. doi: 10.1038/78078.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/78078</ArticleId><ArticleId IdType="pubmed">10932182</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu N-N, Tan M-S, Yu J-T, Xie A-M, Tan L. The role of Reelin signaling in Alzheimer&#x2019;s disease. Mol. Neurobiol. 2016;53:5692&#x2013;5700. doi: 10.1007/s12035-015-9459-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-015-9459-9</ArticleId><ArticleId IdType="pubmed">26491027</ArticleId></ArticleIdList></Reference><Reference><Citation>Sepulveda-Falla D, et al. Distinct tau neuropathology and cellular profiles of an APOE3 Christchurch homozygote protected against autosomal dominant Alzheimer&#x2019;s dementia. Acta Neuropathol. 2022;144:589&#x2013;601. doi: 10.1007/s00401-022-02467-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-022-02467-8</ArticleId><ArticleId IdType="pmc">PMC9381462</ArticleId><ArticleId IdType="pubmed">35838824</ArticleId></ArticleIdList></Reference><Reference><Citation>Braak H, Braak E. Evolution of the neuropathology of Alzheimer&#x2019;s disease. Acta Neurol. Scand. Suppl. 1996;165:3&#x2013;12. doi: 10.1111/j.1600-0404.1996.tb05866.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-0404.1996.tb05866.x</ArticleId><ArticleId IdType="pubmed">8740983</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xf3;mez-Isla T, et al. Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer&#x2019;s disease. J. Neurosci. 1996;16:4491&#x2013;4500. doi: 10.1523/JNEUROSCI.16-14-04491.1996.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.16-14-04491.1996</ArticleId><ArticleId IdType="pmc">PMC6578866</ArticleId><ArticleId IdType="pubmed">8699259</ArticleId></ArticleIdList></Reference><Reference><Citation>Kramer PL, et al. Alzheimer disease pathology in cognitively healthy elderly: a genome-wide study. Neurobiol. Aging. 2011;32:2113&#x2013;2122. doi: 10.1016/j.neurobiolaging.2010.01.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2010.01.010</ArticleId><ArticleId IdType="pmc">PMC2990809</ArticleId><ArticleId IdType="pubmed">20452100</ArticleId></ArticleIdList></Reference><Reference><Citation>Bracher-Smith M, et al. Whole genome analysis in APOE4 homozygotes identifies the DAB1-RELN pathway in Alzheimer&#x2019;s disease pathogenesis. Neurobiol. Aging. 2022;119:67&#x2013;76. doi: 10.1016/j.neurobiolaging.2022.07.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2022.07.009</ArticleId><ArticleId IdType="pmc">PMC9548409</ArticleId><ArticleId IdType="pubmed">35977442</ArticleId></ArticleIdList></Reference><Reference><Citation>Lalazar A, et al. Site-specific mutagenesis of human apolipoprotein E. Receptor binding activity of variants with single amino acid substitutions. J. Biochem. 1988;263:3542&#x2013;3545.</Citation><ArticleIdList><ArticleId IdType="pubmed">2831187</ArticleId></ArticleIdList></Reference><Reference><Citation>Desikan RS, et al. Automated MRI measures identify individuals with mild cognitive impairment and Alzheimer&#x2019;s disease. Brain. 2009;132:2048&#x2013;2057. doi: 10.1093/brain/awp123.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awp123</ArticleId><ArticleId IdType="pmc">PMC2714061</ArticleId><ArticleId IdType="pubmed">19460794</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson KA, et al. Tau positron emission tomographic imaging in aging and early Alzheimer disease. Ann. Neurol. 2016;79:110&#x2013;119. doi: 10.1002/ana.24546.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.24546</ArticleId><ArticleId IdType="pmc">PMC4738026</ArticleId><ArticleId IdType="pubmed">26505746</ArticleId></ArticleIdList></Reference><Reference><Citation>Schneider CA, Rasband WS, Eliceiri KW. NIH Image to ImageJ: 25 years of image analysis. Nat. Methods. 2012;9:671&#x2013;675. doi: 10.1038/nmeth.2089.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.2089</ArticleId><ArticleId IdType="pmc">PMC5554542</ArticleId><ArticleId IdType="pubmed">22930834</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37188873</PMID><DateCompleted><Year>2023</Year><Month>06</Month><Day>08</Day></DateCompleted><DateRevised><Year>2023</Year><Month>06</Month><Day>19</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1546-1726</ISSN><JournalIssue CitedMedium="Internet"><Volume>26</Volume><Issue>6</Issue><PubDate><Year>2023</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Nature neuroscience</Title><ISOAbbreviation>Nat Neurosci</ISOAbbreviation></Journal><ArticleTitle>Early alterations in the MCH system link aberrant neuronal activity and sleep disturbances in a mouse model of Alzheimer's disease.</ArticleTitle><Pagination><StartPage>1021</StartPage><EndPage>1031</EndPage><MedlinePgn>1021-1031</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41593-023-01325-4</ELocationID><Abstract><AbstractText>Early Alzheimer's disease (AD) is associated with hippocampal hyperactivity and decreased sleep quality. Here we show that homeostatic mechanisms transiently counteract the increased excitatory drive to CA1 neurons in App<sup>NL-G-F</sup> mice, but that this mechanism fails in older mice. Spatial transcriptomics analysis identifies Pmch as part of the adaptive response in App<sup>NL-G-F</sup> mice. Pmch encodes melanin-concentrating hormone (MCH), which is produced in sleep-active lateral hypothalamic neurons that project to CA1 and modulate memory. We show that MCH downregulates synaptic transmission, modulates firing rate homeostasis in hippocampal neurons and reverses the increased excitatory drive to CA1 neurons in App<sup>NL-G-F</sup> mice. App<sup>NL-G-F</sup> mice spend less time in rapid eye movement (REM) sleep. App<sup>NL-G-F</sup> mice and individuals with AD show progressive changes in morphology of CA1-projecting MCH axons. Our findings identify the MCH system as vulnerable in early AD and suggest that impaired MCH-system function contributes to aberrant excitatory drive and sleep defects, which can compromise hippocampus-dependent functions.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Calafate</LastName><ForeName>Sara</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-1276-3211</Identifier><AffiliationInfo><Affiliation>VIB Center for Brain &amp; Disease Research, Leuven, Belgium. sara.calafate@kuleuven.be.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>KU Leuven, Department of Neurosciences, Leuven Brain Institute, Leuven, Belgium. sara.calafate@kuleuven.be.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal. sara.calafate@kuleuven.be.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>ICVS/3B's - PT Government Associate Laboratory, Braga/Guimar&#xe3;es, Portugal. sara.calafate@kuleuven.be.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>&#xd6;zturan</LastName><ForeName>G&#xf6;khan</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>VIB Center for Brain &amp; Disease Research, Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>KU Leuven, Department of Neurosciences, Leuven Brain Institute, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thrupp</LastName><ForeName>Nicola</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>VIB Center for Brain &amp; Disease Research, Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>KU Leuven, Department of Neurosciences, Leuven Brain Institute, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vanderlinden</LastName><ForeName>Jeroen</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>VIB Center for Brain &amp; Disease Research, Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>KU Leuven, Department of Neurosciences, Leuven Brain Institute, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Santa-Marinha</LastName><ForeName>Lu&#xed;sa</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>ICVS/3B's - PT Government Associate Laboratory, Braga/Guimar&#xe3;es, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morais-Ribeiro</LastName><ForeName>Rafaela</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>ICVS/3B's - PT Government Associate Laboratory, Braga/Guimar&#xe3;es, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ruggiero</LastName><ForeName>Antonella</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Physiology and Pharmacology, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bozic</LastName><ForeName>Ivan</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Zentrum f&#xfc;r Experimentelle Neurologie, Department of Neurology, Inselspital University Hospital Bern, University of Bern, Bern, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rusterholz</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Zentrum f&#xfc;r Experimentelle Neurologie, Department of Neurology, Inselspital University Hospital Bern, University of Bern, Bern, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Research, University of Bern, Bern, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lorente-Echeverr&#xed;a</LastName><ForeName>Blanca</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>VIB Center for Brain &amp; Disease Research, Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>KU Leuven, Department of Neurosciences, Leuven Brain Institute, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dias</LastName><ForeName>Marcelo</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-1844-8631</Identifier><AffiliationInfo><Affiliation>Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>ICVS/3B's - PT Government Associate Laboratory, Braga/Guimar&#xe3;es, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Wei-Ting</ForeName><Initials>WT</Initials><AffiliationInfo><Affiliation>VIB Center for Brain &amp; Disease Research, Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>KU Leuven, Department of Neurosciences, Leuven Brain Institute, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fiers</LastName><ForeName>Mark</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>VIB Center for Brain &amp; Disease Research, Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>KU Leuven, Department of Neurosciences, Leuven Brain Institute, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>Ashley</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>VIB Center for Brain &amp; Disease Research, Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>KU Leuven, Department of Neurosciences, Leuven Brain Institute, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vlaeminck</LastName><ForeName>Ine</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0001-8934-6179</Identifier><AffiliationInfo><Affiliation>VIB Center for Brain &amp; Disease Research, Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>KU Leuven, Department of Neurosciences, Leuven Brain Institute, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Creemers</LastName><ForeName>Eline</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>VIB Center for Brain &amp; Disease Research, Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>KU Leuven, Department of Neurosciences, Leuven Brain Institute, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Craessaerts</LastName><ForeName>Katleen</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>VIB Center for Brain &amp; Disease Research, Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>KU Leuven, Department of Neurosciences, Leuven Brain Institute, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vandenbempt</LastName><ForeName>Joris</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>VIB Center for Brain &amp; Disease Research, Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>KU Leuven, Department of Neurosciences, Leuven Brain Institute, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Boekholdt</LastName><ForeName>Luuk</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0001-5809-8379</Identifier><AffiliationInfo><Affiliation>VIB Center for Brain &amp; Disease Research, Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>KU Leuven, Department of Neurosciences, Leuven Brain Institute, Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>KU Leuven, Department of Otorhinolaryngology, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Poovathingal</LastName><ForeName>Suresh</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>VIB Center for Brain &amp; Disease Research, Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>KU Leuven, Department of Neurosciences, Leuven Brain Institute, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Davie</LastName><ForeName>Kristofer</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0003-2182-1249</Identifier><AffiliationInfo><Affiliation>VIB Center for Brain &amp; Disease Research, Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>KU Leuven, Department of Neurosciences, Leuven Brain Institute, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thal</LastName><ForeName>Dietmar Rudolf</ForeName><Initials>DR</Initials><Identifier Source="ORCID">0000-0002-1036-1075</Identifier><AffiliationInfo><Affiliation>Department of Imaging and Pathology, Laboratory of Neuropathology, and Leuven Brain Institute, KU-Leuven, O&amp;N IV, Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathology, UZ Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wierda</LastName><ForeName>Keimpe</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>VIB Center for Brain &amp; Disease Research, Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>KU Leuven, Department of Neurosciences, Leuven Brain Institute, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oliveira</LastName><ForeName>Tiago Gil</ForeName><Initials>TG</Initials><Identifier Source="ORCID">0000-0003-0509-0562</Identifier><AffiliationInfo><Affiliation>Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>ICVS/3B's - PT Government Associate Laboratory, Braga/Guimar&#xe3;es, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Slutsky</LastName><ForeName>Inna</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0002-0700-2266</Identifier><AffiliationInfo><Affiliation>Department of Physiology and Pharmacology, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Adamantidis</LastName><ForeName>Antoine</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-2531-5175</Identifier><AffiliationInfo><Affiliation>Zentrum f&#xfc;r Experimentelle Neurologie, Department of Neurology, Inselspital University Hospital Bern, University of Bern, Bern, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Research, University of Bern, Bern, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Strooper</LastName><ForeName>Bart</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0001-5455-5819</Identifier><AffiliationInfo><Affiliation>VIB Center for Brain &amp; Disease Research, Leuven, Belgium. bart.destrooper@kuleuven.be.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>KU Leuven, Department of Neurosciences, Leuven Brain Institute, Leuven, Belgium. bart.destrooper@kuleuven.be.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>UK Dementia Research Institute (UK DRI@UCL) at University College London, London, UK. bart.destrooper@kuleuven.be.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Wit</LastName><ForeName>Joris</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-1120-1089</Identifier><AffiliationInfo><Affiliation>VIB Center for Brain &amp; Disease Research, Leuven, Belgium. joris.dewit@kuleuven.be.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>KU Leuven, Department of Neurosciences, Leuven Brain Institute, Leuven, Belgium. joris.dewit@kuleuven.be.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>05</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Nat Neurosci</MedlineTA><NlmUniqueID>9809671</NlmUniqueID><ISSNLinking>1097-6256</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>67382-96-1</RegistryNumber><NameOfSubstance UI="C019463">melanin-concentrating hormone</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007028">Hypothalamic Hormones</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010907">Pituitary Hormones</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007028" MajorTopicYN="Y">Hypothalamic Hormones</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009474" MajorTopicYN="N">Neurons</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010907" MajorTopicYN="N">Pituitary Hormones</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012890" MajorTopicYN="N">Sleep</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>D.R.T. received speaker honorarium from Biogen (USA), travel reimbursement from UCB (Belgium) and collaborated with GE HealthCare (United Kingdom), Novartis Pharma Basel (Switzerland), Probiodrug (Germany) and Janssen Pharmaceutical Companies (Belgium). T.G.O. is a scientific advisor board member and shareholder of Ceracuity (USA) and collaborated with Biogen (USA). B.D.S. is or has been consultant for Eisai, AbbVie, K5/Muna; co-founder of Augustine Tx; and founder and shareholder of K5/Muna. J.d.W. is co-founder and scientific advisory board member of Augustine Tx. All other authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>10</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>4</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>8</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>16</Day><Hour>1</Hour><Minute>8</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>15</Day><Hour>23</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>5</Month><Day>15</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37188873</ArticleId><ArticleId IdType="pmc">PMC10244178</ArticleId><ArticleId IdType="doi">10.1038/s41593-023-01325-4</ArticleId><ArticleId IdType="pii">10.1038/s41593-023-01325-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Busche MA, et al. Clusters of hyperactive neurons near amyloid plaques in a mouse model of Alzheimer&#x2019;s disease. Science. 2008;321:1686&#x2013;1689. doi: 10.1126/science.1162844.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1162844</ArticleId><ArticleId IdType="pubmed">18802001</ArticleId></ArticleIdList></Reference><Reference><Citation>Dickerson BC, et al. Increased hippocampal activation in mild cognitive impairment compared to normal aging and AD. Neurology. 2005;65:404&#x2013;411. doi: 10.1212/01.wnl.0000171450.97464.49.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000171450.97464.49</ArticleId><ArticleId IdType="pmc">PMC4335677</ArticleId><ArticleId IdType="pubmed">16087905</ArticleId></ArticleIdList></Reference><Reference><Citation>Baker J, Libretto T, Henley W, Zeman A. A longitudinal study of epileptic seizures in Alzheimer&#x2019;s disease. Front. Neurol. 2019;10:1266. doi: 10.3389/fneur.2019.01266.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2019.01266</ArticleId><ArticleId IdType="pmc">PMC6904279</ArticleId><ArticleId IdType="pubmed">31866927</ArticleId></ArticleIdList></Reference><Reference><Citation>Zarhin D, et al. Disrupted neural correlates of anesthesia and sleep reveal early circuit dysfunctions in Alzheimer models. Cell Rep. 2022;38:110268. doi: 10.1016/j.celrep.2021.110268.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2021.110268</ArticleId><ArticleId IdType="pmc">PMC8789564</ArticleId><ArticleId IdType="pubmed">35045289</ArticleId></ArticleIdList></Reference><Reference><Citation>Lam AD, et al. Silent hippocampal seizures and spikes identified by foramen ovale electrodes in Alzheimer&#x2019;s disease. Nat. Med. 2017;23:678&#x2013;680. doi: 10.1038/nm.4330.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.4330</ArticleId><ArticleId IdType="pmc">PMC5461182</ArticleId><ArticleId IdType="pubmed">28459436</ArticleId></ArticleIdList></Reference><Reference><Citation>Mander BA. Local sleep and Alzheimer&#x2019;s disease pathophysiology. Front. Neurosci. 2020;14:525970. doi: 10.3389/fnins.2020.525970.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2020.525970</ArticleId><ArticleId IdType="pmc">PMC7538792</ArticleId><ArticleId IdType="pubmed">33071726</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakazono T, et al. Impaired in vivo gamma oscillations in the medial entorhinal cortex of knock-in Alzheimer model. Front. Syst. Neurosci. 2017;11:48. doi: 10.3389/fnsys.2017.00048.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnsys.2017.00048</ArticleId><ArticleId IdType="pmc">PMC5491963</ArticleId><ArticleId IdType="pubmed">28713250</ArticleId></ArticleIdList></Reference><Reference><Citation>Musiek, E. S. et al. Targeting sleep and circadian function in the prevention of Alzheimer disease. JAMA Neurol.10.1001/jamaneurol.2022.1732 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10437079</ArticleId><ArticleId IdType="pubmed">35816332</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis GW. Homeostatic control of neural activity: from phenomenology to molecular design. Annu. Rev. Neurosci. 2006;29:307&#x2013;323. doi: 10.1146/annurev.neuro.28.061604.135751.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.neuro.28.061604.135751</ArticleId><ArticleId IdType="pubmed">16776588</ArticleId></ArticleIdList></Reference><Reference><Citation>Styr, B. &amp; Slutsky, I. Imbalance between firing homeostasis and synaptic plasticity drives early-phase Alzheimer&#x2019;s disease. Nat. Neurosci. 10.1038/s41593-018-0080-x (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6533171</ArticleId><ArticleId IdType="pubmed">29403035</ArticleId></ArticleIdList></Reference><Reference><Citation>De Vivo L, et al. Ultrastructural evidence for synaptic scaling across the wake/sleep cycle. Science. 2017;355:507&#x2013;510. doi: 10.1126/science.aah5982.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aah5982</ArticleId><ArticleId IdType="pmc">PMC5313037</ArticleId><ArticleId IdType="pubmed">28154076</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Z-W, Faraguna U, Cirelli C, Tononi G, Gao X-B. Direct eidence for wake-related increases and sleep-related decreases in synaptic strength in rodent cortex. J. Neurosci. 2010;30:8671&#x2013;8675. doi: 10.1523/JNEUROSCI.1409-10.2010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1409-10.2010</ArticleId><ArticleId IdType="pmc">PMC2903226</ArticleId><ArticleId IdType="pubmed">20573912</ArticleId></ArticleIdList></Reference><Reference><Citation>Bridi MCD, et al. Daily oscillation of the excitation&#x2013;inhibition balance in visual cortical circuits. Neuron. 2020;105:621&#x2013;629. doi: 10.1016/j.neuron.2019.11.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2019.11.011</ArticleId><ArticleId IdType="pmc">PMC9520672</ArticleId><ArticleId IdType="pubmed">31831331</ArticleId></ArticleIdList></Reference><Reference><Citation>Diering GH, et al. Homer1a drives homeostatic scaling-down of excitatory synapses during sleep. Science. 2017;355:511&#x2013;515. doi: 10.1126/science.aai8355.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aai8355</ArticleId><ArticleId IdType="pmc">PMC5382711</ArticleId><ArticleId IdType="pubmed">28154077</ArticleId></ArticleIdList></Reference><Reference><Citation>Vyazovskiy VV, Cirelli C, Pfister-Genskow M, Faraguna U, Tononi G. Molecular and electrophysiological evidence for net synaptic potentiation in wake and depression in sleep. Nat. Neurosci. 2008;11:200&#x2013;208. doi: 10.1038/nn2035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn2035</ArticleId><ArticleId IdType="pubmed">18204445</ArticleId></ArticleIdList></Reference><Reference><Citation>Grosmark AD, Mizuseki K, Pastalkova E, Diba K, Buzs&#xe1;ki G. REM sleep reorganizes hippocampal excitability. Neuron. 2012;75:1001&#x2013;1007. doi: 10.1016/j.neuron.2012.08.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2012.08.015</ArticleId><ArticleId IdType="pmc">PMC3608095</ArticleId><ArticleId IdType="pubmed">22998869</ArticleId></ArticleIdList></Reference><Reference><Citation>Torrado Pacheco, A., Bottorff, J., Gao, Y. &amp; Turrigiano, G. G. Sleep promotes downward firing rate homeostasis. Neuron10.1016/j.neuron.2020.11.001 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7864886</ArticleId><ArticleId IdType="pubmed">33232655</ArticleId></ArticleIdList></Reference><Reference><Citation>Jego, S. et al. Optogenetic identification of a rapid eye movement sleep modulatory circuit in the hypothalamus. Nat. Neurosci. 10.1038/nn.3522 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4974078</ArticleId><ArticleId IdType="pubmed">24056699</ArticleId></ArticleIdList></Reference><Reference><Citation>Verret L, et al. A role of melanin-concentrating hormone producing neurons in the central regulation of paradoxical sleep. BMC Neurosci. 2003;4:19. doi: 10.1186/1471-2202-4-19.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2202-4-19</ArticleId><ArticleId IdType="pmc">PMC201018</ArticleId><ArticleId IdType="pubmed">12964948</ArticleId></ArticleIdList></Reference><Reference><Citation>Izawa S, et al. REM sleep-active MCH neurons are involved in forgetting hippocampusdependent memories. Science. 2019;365:1308&#x2013;1313. doi: 10.1126/science.aax9238.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aax9238</ArticleId><ArticleId IdType="pmc">PMC7378274</ArticleId><ArticleId IdType="pubmed">31604241</ArticleId></ArticleIdList></Reference><Reference><Citation>Palop JJ, et al. Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer&#x2019;s disease. Neuron. 2007;55:697&#x2013;711. doi: 10.1016/j.neuron.2007.07.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2007.07.025</ArticleId><ArticleId IdType="pmc">PMC8055171</ArticleId><ArticleId IdType="pubmed">17785178</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson ECB, et al. Behavioral and neural network abnormalities in human APP transgenic mice resemble those of App knock-in mice and are modulated by familial Alzheimer&#x2019;s disease mutations but not by inhibition of BACE1. Mol. Neurodegener. 2020;15:53. doi: 10.1186/s13024-020-00393-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-020-00393-5</ArticleId><ArticleId IdType="pmc">PMC7489007</ArticleId><ArticleId IdType="pubmed">32921309</ArticleId></ArticleIdList></Reference><Reference><Citation>Turrigiano GG, Leslie KR, Desai NS, Rutherford LC, Nelson SB. Activity-dependent scaling of quantal amplitude in neocortical neurons. Nature. 1998;391:892&#x2013;896. doi: 10.1038/36103.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/36103</ArticleId><ArticleId IdType="pubmed">9495341</ArticleId></ArticleIdList></Reference><Reference><Citation>Turrigiano GG. The dialectic of Hebb and homeostasis. Philos. Trans. R. Soc. Lond. B Biol. Sci. 2017;372:20160258. doi: 10.1098/rstb.2016.0258.</Citation><ArticleIdList><ArticleId IdType="doi">10.1098/rstb.2016.0258</ArticleId><ArticleId IdType="pmc">PMC5247594</ArticleId><ArticleId IdType="pubmed">28093556</ArticleId></ArticleIdList></Reference><Reference><Citation>Keck T, et al. Integrating Hebbian and homeostatic plasticity: the current state of the field and future research directions. Philos. Trans. R. Soc. Lond. B Biol. Sci. 2017;372:20160158. doi: 10.1098/rstb.2016.0158.</Citation><ArticleIdList><ArticleId IdType="doi">10.1098/rstb.2016.0158</ArticleId><ArticleId IdType="pmc">PMC5247590</ArticleId><ArticleId IdType="pubmed">28093552</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen WT, et al. Spatial transcriptomics and in situ sequencing to study Alzheimer&#x2019;s disease. Cell. 2020;182:976&#x2013;991. doi: 10.1016/j.cell.2020.06.038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.06.038</ArticleId><ArticleId IdType="pubmed">32702314</ArticleId></ArticleIdList></Reference><Reference><Citation>Schaukowitch K, et al. An intrinsic transcriptional program underlying synaptic scaling during activity suppression. Cell Rep. 2017;18:1512&#x2013;1526. doi: 10.1016/j.celrep.2017.01.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2017.01.033</ArticleId><ArticleId IdType="pmc">PMC5524384</ArticleId><ArticleId IdType="pubmed">28178527</ArticleId></ArticleIdList></Reference><Reference><Citation>Oostrum, M. van, et al. Surface proteome dynamics during neuronal development and synaptic plasticity. Nat. Commun.11, 4990 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7536423</ArticleId><ArticleId IdType="pubmed">33020478</ArticleId></ArticleIdList></Reference><Reference><Citation>Butko MT, et al. In vivo quantitative proteomics of somatosensory cortical synapses shows which protein levels are modulated by sensory deprivation. Proc. Natl Acad. Sci. USA. 2013;110:E726&#x2013;E735. doi: 10.1073/pnas.1300424110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1300424110</ArticleId><ArticleId IdType="pmc">PMC3581967</ArticleId><ArticleId IdType="pubmed">23382246</ArticleId></ArticleIdList></Reference><Reference><Citation>Hrvatin S, et al. Single-cell analysis of experience-dependent transcriptomic states in the mouse visual cortex. Nat. Neurosci. 2018;21:120&#x2013;129. doi: 10.1038/s41593-017-0029-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-017-0029-5</ArticleId><ArticleId IdType="pmc">PMC5742025</ArticleId><ArticleId IdType="pubmed">29230054</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu AKY, et al. APCCdh1 mediates EphA4-dependent downregulation of AMPA receptors in homeostatic plasticity. Nat. Neurosci. 2011;14:181&#x2013;191. doi: 10.1038/nn.2715.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.2715</ArticleId><ArticleId IdType="pubmed">21186356</ArticleId></ArticleIdList></Reference><Reference><Citation>Diniz GB, Bittencourt JC. The melanin-concentrating hormone as an integrative peptide driving motivated behaviors. Front. Syst. Neurosci. 2017;11:32. doi: 10.3389/fnsys.2017.00032.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnsys.2017.00032</ArticleId><ArticleId IdType="pmc">PMC5447028</ArticleId><ArticleId IdType="pubmed">28611599</ArticleId></ArticleIdList></Reference><Reference><Citation>Bittencourt JC, et al. The melanin-concentrating hormone system of the rat brain: an immuno- and hybridization histochemical characterization. J. Comp. Neurol. 1992;319:218&#x2013;245. doi: 10.1002/cne.903190204.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cne.903190204</ArticleId><ArticleId IdType="pubmed">1522246</ArticleId></ArticleIdList></Reference><Reference><Citation>Pachoud B, et al. Major impairments of glutamatergic transmission and long-term synaptic plasticity in the hippocampus of mice lacking the melanin-concentrating hormone receptor-1. J. Neurophysiol. 2010;104:1417&#x2013;1425. doi: 10.1152/jn.01052.2009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/jn.01052.2009</ArticleId><ArticleId IdType="pmc">PMC4073994</ArticleId><ArticleId IdType="pubmed">20592115</ArticleId></ArticleIdList></Reference><Reference><Citation>Adamantidis A, et al. Disrupting the melanin-concentrating hormone receptor 1 in mice leads to cognitive deficits and alterations of NMDA receptor function. Eur. J. Neurosci. 2005;21:2837&#x2013;2844. doi: 10.1111/j.1460-9568.2005.04100.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1460-9568.2005.04100.x</ArticleId><ArticleId IdType="pubmed">15926931</ArticleId></ArticleIdList></Reference><Reference><Citation>Monzon ME, et al. Melanin-concentrating hormone modifies memory retention in rats. Peptides. 1999;20:1517&#x2013;1519. doi: 10.1016/S0196-9781(99)00164-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0196-9781(99)00164-3</ArticleId><ArticleId IdType="pubmed">10698129</ArticleId></ArticleIdList></Reference><Reference><Citation>Varas M, P&#xe9;rez M, Monz&#xf3;n ME, de Barioglio SR. Melanin-concentrating hormone, hippocampal nitric oxide levels and memory retention. Peptides. 2002;23:2213&#x2013;2221. doi: 10.1016/S0196-9781(02)00252-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0196-9781(02)00252-8</ArticleId><ArticleId IdType="pubmed">12535701</ArticleId></ArticleIdList></Reference><Reference><Citation>Kosse C, Burdakov D. Natural hypothalamic circuit dynamics underlying object memorization. Nat. Commun. 2019;10:2505. doi: 10.1038/s41467-019-10484-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-10484-7</ArticleId><ArticleId IdType="pmc">PMC6555780</ArticleId><ArticleId IdType="pubmed">31175285</ArticleId></ArticleIdList></Reference><Reference><Citation>Monz&#xf3;n ME, De Barioglio SR. Response to novelty after i.c.v. injection of melanin-concentrating hormone (MCH) in rats. Physiol. Behav. 1999;67:813&#x2013;817. doi: 10.1016/S0031-9384(99)00117-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0031-9384(99)00117-1</ArticleId><ArticleId IdType="pubmed">10604856</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeisel A, et al. Molecular architecture of the mouse nervous system. Cell. 2018;174:999&#x2013;1014. doi: 10.1016/j.cell.2018.06.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2018.06.021</ArticleId><ArticleId IdType="pmc">PMC6086934</ArticleId><ArticleId IdType="pubmed">30096314</ArticleId></ArticleIdList></Reference><Reference><Citation>Slomowitz E, et al. Interplay between population firing stability and single neuron dynamics in hippocampal networks. Elife. 2015;4:e04378. doi: 10.7554/eLife.04378.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.04378</ArticleId><ArticleId IdType="pmc">PMC4311497</ArticleId><ArticleId IdType="pubmed">25556699</ArticleId></ArticleIdList></Reference><Reference><Citation>Styr B, et al. Mitochondrial regulation of the hippocampal firing rate set point and seizure susceptibility. Neuron. 2019;102:1009&#x2013;1024. doi: 10.1016/j.neuron.2019.03.045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2019.03.045</ArticleId><ArticleId IdType="pmc">PMC6559804</ArticleId><ArticleId IdType="pubmed">31047779</ArticleId></ArticleIdList></Reference><Reference><Citation>Lisman J, Cooper K, Sehgal M, Silva AJ. Memory formation depends on both synapse-specific modifications of synaptic strength and cell-specific increases in excitability. Nat. Neurosci. 2018;21:309&#x2013;314. doi: 10.1038/s41593-018-0076-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-018-0076-6</ArticleId><ArticleId IdType="pmc">PMC5915620</ArticleId><ArticleId IdType="pubmed">29434376</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y, et al. Activity-induced Nr4a1 regulates spine density and distribution pattern of excitatory synapses in pyramidal neurons. Neuron. 2014;83:431&#x2013;443. doi: 10.1016/j.neuron.2014.05.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2014.05.027</ArticleId><ArticleId IdType="pubmed">24976215</ArticleId></ArticleIdList></Reference><Reference><Citation>Spiegel I, et al. Npas4 regulates excitatory&#x2013;inhibitory balance within neural circuits through cell-type-specific gene programs. Cell. 2014;157:1216&#x2013;1229. doi: 10.1016/j.cell.2014.03.058.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2014.03.058</ArticleId><ArticleId IdType="pmc">PMC4089405</ArticleId><ArticleId IdType="pubmed">24855953</ArticleId></ArticleIdList></Reference><Reference><Citation>Shepherd JD, et al. Arc/Arg3.1 mediates homeostatic synaptic scaling of AMPA receptors. Neuron. 2006;52:475&#x2013;484. doi: 10.1016/j.neuron.2006.08.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2006.08.034</ArticleId><ArticleId IdType="pmc">PMC1764219</ArticleId><ArticleId IdType="pubmed">17088213</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C, Magee JC, Bazan NG. Cyclooxygenase-2 regulates prostaglandin E2 signaling in hippocampal long-term synaptic plasticity. J. Neurophysiol. 2002;87:2851&#x2013;2857. doi: 10.1152/jn.2002.87.6.2851.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/jn.2002.87.6.2851</ArticleId><ArticleId IdType="pubmed">12037188</ArticleId></ArticleIdList></Reference><Reference><Citation>Leal G, Afonso PM, Salazar IL, Duarte CB. Regulation of hippocampal synaptic plasticity by BDNF. Brain Res. 2015;1621:82&#x2013;101. doi: 10.1016/j.brainres.2014.10.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2014.10.019</ArticleId><ArticleId IdType="pubmed">25451089</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon R, et al. Prokineticin-2 upregulation during neuronal injury mediates a compensatory protective response against dopaminergic neuronal degeneration. Nat. Commun. 2016;7:12932. doi: 10.1038/ncomms12932.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms12932</ArticleId><ArticleId IdType="pmc">PMC5059486</ArticleId><ArticleId IdType="pubmed">27703142</ArticleId></ArticleIdList></Reference><Reference><Citation>Pr&#xf6;schel C, et al. Epilepsy-causing sequence variations in SIK1 disrupt synaptic activity response gene expression and affect neuronal morphology. Eur. J. Hum. Genet. 2017;25:216&#x2013;221. doi: 10.1038/ejhg.2016.145.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ejhg.2016.145</ArticleId><ArticleId IdType="pmc">PMC5255945</ArticleId><ArticleId IdType="pubmed">27966542</ArticleId></ArticleIdList></Reference><Reference><Citation>Thongrong S, et al. Sprouty2 and -4 hypomorphism promotes neuronal survival and astrocytosis in a mouse model of kainic acid induced neuronal damage. Hippocampus. 2016;26:658&#x2013;667. doi: 10.1002/hipo.22549.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hipo.22549</ArticleId><ArticleId IdType="pmc">PMC4949526</ArticleId><ArticleId IdType="pubmed">26540287</ArticleId></ArticleIdList></Reference><Reference><Citation>Strauss KI, Marini AM. Cyclooxygenase-2 inhibition protects cultured cerebellar granule neurons from glutamate-mediated cell death. J. Neurotrauma. 2002;19:627&#x2013;638. doi: 10.1089/089771502753754091.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/089771502753754091</ArticleId><ArticleId IdType="pmc">PMC1456322</ArticleId><ArticleId IdType="pubmed">12042097</ArticleId></ArticleIdList></Reference><Reference><Citation>Laezza F, Wilding TJ, Sequeira S, Craig AM, Huettner JE. The BTB/kelch protein, KRIP6, modulates the interaction of PICK1 with GluR6 kainate receptors. Neuropharmacology. 2008;55:1131&#x2013;1139. doi: 10.1016/j.neuropharm.2008.07.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuropharm.2008.07.021</ArticleId><ArticleId IdType="pmc">PMC2685165</ArticleId><ArticleId IdType="pubmed">18692513</ArticleId></ArticleIdList></Reference><Reference><Citation>Hassani OK, Lee MG, Jones BE. Melanin-concentrating hormone neurons discharge in a reciprocal manner to orexin neurons across the sleep&#x2013;wake cycle. Proc. Natl Acad. Sci. USA. 2009;106:2418&#x2013;2422. doi: 10.1073/pnas.0811400106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0811400106</ArticleId><ArticleId IdType="pmc">PMC2650171</ArticleId><ArticleId IdType="pubmed">19188611</ArticleId></ArticleIdList></Reference><Reference><Citation>Adamantidis AR, Zhang F, Aravanis AM, Deisseroth K, De Lecea L. Neural substrates of awakening probed with optogenetic control of hypocretin neurons. Nature. 2007;450:420&#x2013;424. doi: 10.1038/nature06310.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature06310</ArticleId><ArticleId IdType="pmc">PMC6744371</ArticleId><ArticleId IdType="pubmed">17943086</ArticleId></ArticleIdList></Reference><Reference><Citation>Konadhode RR, et al. Optogenetic stimulation of MCH neurons increases sleep. J. Neurosci. 2013;33:10257&#x2013;10263. doi: 10.1523/JNEUROSCI.1225-13.2013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1225-13.2013</ArticleId><ArticleId IdType="pmc">PMC3685832</ArticleId><ArticleId IdType="pubmed">23785141</ArticleId></ArticleIdList></Reference><Reference><Citation>Vetrivelan R, et al. Melanin-concentrating hormone neurons specifically promote rapid eye movement sleep in mice. Neuroscience. 2016;336:102&#x2013;113. doi: 10.1016/j.neuroscience.2016.08.046.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2016.08.046</ArticleId><ArticleId IdType="pmc">PMC5056843</ArticleId><ArticleId IdType="pubmed">27595887</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsunematsu T, et al. Optogenetic manipulation of activity and temporally controlled cell-specific ablation reveal a role for MCH neurons in sleep/wake. Regulation. 2014;34:6896&#x2013;6909.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4019803</ArticleId><ArticleId IdType="pubmed">24828644</ArticleId></ArticleIdList></Reference><Reference><Citation>Maezono, S. E. B. et al. Progressive changes in sleep and its relations to amyloid-&#x3b2; distribution and learning in single App knock-in mice. eneuro 7, 10.1523/ENEURO.0093-20.2020 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7196722</ArticleId><ArticleId IdType="pubmed">32321771</ArticleId></ArticleIdList></Reference><Reference><Citation>Tobler I, Borb&#xe9;ly AA. Sleep EEG in the rat as a function of prior waking. Electroencephalogr. Clin. Neurophysiol. 1986;64:74&#x2013;76. doi: 10.1016/0013-4694(86)90044-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0013-4694(86)90044-1</ArticleId><ArticleId IdType="pubmed">2424723</ArticleId></ArticleIdList></Reference><Reference><Citation>Sabetghadam A, et al. Melanin-concentrating hormone and orexin systems in rat nucleus incertus: dual innervation, bidirectional effects on neuron activity, and differential influences on arousal and feeding. Neuropharmacology. 2018;139:238&#x2013;256. doi: 10.1016/j.neuropharm.2018.07.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuropharm.2018.07.004</ArticleId><ArticleId IdType="pubmed">29981758</ArticleId></ArticleIdList></Reference><Reference><Citation>Phinney AL, et al. Cerebral amyloid induces aberrant axonal sprouting and ectopic terminal formation in amyloid precursor protein transgenic mice. J. Neurosci. 1999;19:8552&#x2013;8559. doi: 10.1523/JNEUROSCI.19-19-08552.1999.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.19-19-08552.1999</ArticleId><ArticleId IdType="pmc">PMC6783025</ArticleId><ArticleId IdType="pubmed">10493755</ArticleId></ArticleIdList></Reference><Reference><Citation>Blanco-Centurion C, et al. Dynamic network activation of hypothalamic MCH neurons in REM sleep and exploratory behavior. J. Neurosci. 2019;39:4986&#x2013;4998. doi: 10.1523/JNEUROSCI.0305-19.2019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.0305-19.2019</ArticleId><ArticleId IdType="pmc">PMC6670248</ArticleId><ArticleId IdType="pubmed">31036764</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris, J., Concetti, C., Peleg-Raibstein, D. &amp; Burdakov, D. A role for MCH neuron firing in hippocampal plasticity and learning. Preprint at bioRxiv10.1101/2022.12.01.518339 (2022).</Citation></Reference><Reference><Citation>Alhassen W, et al. Regulation of brain primary cilia length by MCH signaling: evidence from pharmacological, genetic, optogenetic and chemogenic manipulations. Mol. Neurobiol. 2022;59:245&#x2013;265. doi: 10.1007/s12035-021-02511-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-021-02511-w</ArticleId><ArticleId IdType="pmc">PMC9083846</ArticleId><ArticleId IdType="pubmed">34665407</ArticleId></ArticleIdList></Reference><Reference><Citation>Sears RM, et al. Regulation of nucleus accumbens activity by the hypothalamic neuropeptide melanin-concentrating hormone. J. Neurosci. 2010;30:8263&#x2013;8273. doi: 10.1523/JNEUROSCI.5858-09.2010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.5858-09.2010</ArticleId><ArticleId IdType="pmc">PMC2907886</ArticleId><ArticleId IdType="pubmed">20554878</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao XB, Van Den Pol AN. Melanin concentrating hormone depresses synaptic activity of glutamate and GABA neurons from rat lateral hypothalamus. J. Physiol. 2001;533:237&#x2013;252. doi: 10.1111/j.1469-7793.2001.0237b.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1469-7793.2001.0237b.x</ArticleId><ArticleId IdType="pmc">PMC2278620</ArticleId><ArticleId IdType="pubmed">11351031</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu JJ, Tsien RW, Pang ZP. Hypothalamic melanin-concentrating hormone regulates hippocampus-dorsolateral septum activity. Nat. Neurosci. 2022;25:61&#x2013;71. doi: 10.1038/s41593-021-00984-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-021-00984-5</ArticleId><ArticleId IdType="pmc">PMC8741735</ArticleId><ArticleId IdType="pubmed">34980924</ArticleId></ArticleIdList></Reference><Reference><Citation>Klinzing JG, Niethard N, Born J. Mechanisms of systems memory consolidation during sleep. Nat. Neurosci. 2019;22:1598&#x2013;1610. doi: 10.1038/s41593-019-0467-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-019-0467-3</ArticleId><ArticleId IdType="pubmed">31451802</ArticleId></ArticleIdList></Reference><Reference><Citation>Pase MP, et al. Author response: sleep architecture and the risk of incident dementia in the community. Neurology. 2018;90:487. doi: 10.1212/WNL.0000000000005047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000005047</ArticleId><ArticleId IdType="pubmed">29507137</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan P, et al. PLD3 affects axonal spheroids and network defects in Alzheimer&#x2019;s disease. Nature. 2022;612:328&#x2013;337. doi: 10.1038/s41586-022-05491-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-05491-6</ArticleId><ArticleId IdType="pmc">PMC9729106</ArticleId><ArticleId IdType="pubmed">36450991</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah, D. et al. Astrocyte calcium dysfunction causes early network hyperactivity in Alzheimer&#x2019;s disease. Cell Rep. 40, 111280 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9433881</ArticleId><ArticleId IdType="pubmed">36001964</ArticleId></ArticleIdList></Reference><Reference><Citation>Frere S, Slutsky I. Alzheimer&#x2019;s disease: from firing instability to homeostasis network collapse. Neuron. 2018;97:32&#x2013;58. doi: 10.1016/j.neuron.2017.11.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2017.11.028</ArticleId><ArticleId IdType="pubmed">29301104</ArticleId></ArticleIdList></Reference><Reference><Citation>Oh ST, et al. Nasal cavity administration of melanin-concentrating hormone improves memory impairment in memory-impaired and Alzheimer&#x2019;s disease mouse models. Mol. Neurobiol. 2019;56:8076&#x2013;8086. doi: 10.1007/s12035-019-01662-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-019-01662-1</ArticleId><ArticleId IdType="pubmed">31183806</ArticleId></ArticleIdList></Reference><Reference><Citation>Takase K, et al. Meta-analysis of melanin-concentrating hormone signaling-deficient mice on behavioral and metabolic phenotypes. PLoS ONE. 2014;9:e99961. doi: 10.1371/journal.pone.0099961.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0099961</ArticleId><ArticleId IdType="pmc">PMC4055708</ArticleId><ArticleId IdType="pubmed">24924345</ArticleId></ArticleIdList></Reference><Reference><Citation>Thannickal TC, Lai YY, Siegel JM. Hypocretin (orexin) cell loss in Parkinson&#x2019;s disease. Brain. 2007;130:1586&#x2013;1595. doi: 10.1093/brain/awm097.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awm097</ArticleId><ArticleId IdType="pmc">PMC8762453</ArticleId><ArticleId IdType="pubmed">17491094</ArticleId></ArticleIdList></Reference><Reference><Citation>Severinsen JE, et al. Association analyses suggest GPR24 as a shared susceptibility gene for bipolar affective disorder and schizophrenia. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2006;141:524&#x2013;533. doi: 10.1002/ajmg.b.30335.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ajmg.b.30335</ArticleId><ArticleId IdType="pubmed">16741940</ArticleId></ArticleIdList></Reference><Reference><Citation>Mullins N, et al. Genome-wide association study of more than 40,000 bipolar disorder cases provides new insights into the underlying biology. Nat. Genet. 2021;53:817&#x2013;829. doi: 10.1038/s41588-021-00857-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-021-00857-4</ArticleId><ArticleId IdType="pmc">PMC8192451</ArticleId><ArticleId IdType="pubmed">34002096</ArticleId></ArticleIdList></Reference><Reference><Citation>Saito T, et al. Single App knock-in mouse models of Alzheimer&#x2019;s disease. Nat. Neurosci. 2014;17:661&#x2013;663. doi: 10.1038/nn.3697.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3697</ArticleId><ArticleId IdType="pubmed">24728269</ArticleId></ArticleIdList></Reference><Reference><Citation>Butler A, Hoffman P, Smibert P, Papalexi E, Satija R. Integrating single-cell transcriptomic data across different conditions, technologies, and species. Nat. Biotechnol. 2018;36:411&#x2013;420. doi: 10.1038/nbt.4096.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt.4096</ArticleId><ArticleId IdType="pmc">PMC6700744</ArticleId><ArticleId IdType="pubmed">29608179</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson MD, McCarthy DJ, Smyth GK. edgeR: A Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 2009;26:139&#x2013;140. doi: 10.1093/bioinformatics/btp616.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btp616</ArticleId><ArticleId IdType="pmc">PMC2796818</ArticleId><ArticleId IdType="pubmed">19910308</ArticleId></ArticleIdList></Reference><Reference><Citation>Eden E, Navon R, Steinfeld I, Lipson D, Yakhini Z. GOrilla: a tool for discovery and visualization of enriched GO terms in ranked gene lists. BMC Bioinformatics. 2009;10:48. doi: 10.1186/1471-2105-10-48.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2105-10-48</ArticleId><ArticleId IdType="pmc">PMC2644678</ArticleId><ArticleId IdType="pubmed">19192299</ArticleId></ArticleIdList></Reference><Reference><Citation>Koopmans F, et al. SynGO: an evidence-based, expert-curated knowledge base for the synapse. Neuron. 2019;103:217&#x2013;234. doi: 10.1016/j.neuron.2019.05.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2019.05.002</ArticleId><ArticleId IdType="pmc">PMC6764089</ArticleId><ArticleId IdType="pubmed">31171447</ArticleId></ArticleIdList></Reference><Reference><Citation>Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 1991;82:239&#x2013;259. doi: 10.1007/BF00308809.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF00308809</ArticleId><ArticleId IdType="pubmed">1759558</ArticleId></ArticleIdList></Reference><Reference><Citation>Thal DR, et al. Sequence of A&#x3b2;-protein deposition in the human medial temporal lobe. J. Neuropathol. Exp. Neurol. 2000;59:733&#x2013;748. doi: 10.1093/jnen/59.8.733.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jnen/59.8.733</ArticleId><ArticleId IdType="pubmed">10952063</ArticleId></ArticleIdList></Reference><Reference><Citation>Hyman BT, et al. National Institute on Aging-Alzheimer&#x2019;s Association guidelines for the neuropathologic assessment of Alzheimer&#x2019;s disease. Alzheimers Dement. 2012;8:1&#x2013;13. doi: 10.1016/j.jalz.2011.10.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2011.10.007</ArticleId><ArticleId IdType="pmc">PMC3266529</ArticleId><ArticleId IdType="pubmed">22265587</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding G, et al. REV-ERB in GABAergic neurons controls diurnal hepatic insulin sensitivity. Nature. 2021;592:763&#x2013;767. doi: 10.1038/s41586-021-03358-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03358-w</ArticleId><ArticleId IdType="pmc">PMC8085086</ArticleId><ArticleId IdType="pubmed">33762728</ArticleId></ArticleIdList></Reference><Reference><Citation>Verret L, et al. A role of melanin-concentrating hormone producing neurons in the central regulation of paradoxical sleep. BMC Neurosci. 2003;4:19. doi: 10.1186/1471-2202-4-19.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2202-4-19</ArticleId><ArticleId IdType="pmc">PMC201018</ArticleId><ArticleId IdType="pubmed">12964948</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberson ED, et al. Amyloid-&#x3b2;/Fyn-induced synaptic, network, and cognitive impairments depend on tau levels in multiple mouse models of Alzheimer&#x2019;s disease. J. Neurosci. 2011;31:700&#x2013;711. doi: 10.1523/JNEUROSCI.4152-10.2011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.4152-10.2011</ArticleId><ArticleId IdType="pmc">PMC3325794</ArticleId><ArticleId IdType="pubmed">21228179</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37195665</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>19</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>30</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2574-3805</ISSN><JournalIssue CitedMedium="Internet"><Volume>6</Volume><Issue>5</Issue><PubDate><Year>2023</Year><Month>May</Month><Day>01</Day></PubDate></JournalIssue><Title>JAMA network open</Title><ISOAbbreviation>JAMA Netw Open</ISOAbbreviation></Journal><ArticleTitle>Genetic Associations Between Modifiable Risk Factors and Alzheimer Disease.</ArticleTitle><Pagination><StartPage>e2313734</StartPage><MedlinePgn>e2313734</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e2313734</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1001/jamanetworkopen.2023.13734</ELocationID><Abstract><AbstractText Label="IMPORTANCE">An estimated 40% of dementia is potentially preventable by modifying 12 risk factors throughout the life course. However, robust evidence for most of these risk factors is lacking. Effective interventions should target risk factors in the causal pathway to dementia.</AbstractText><AbstractText Label="OBJECTIVE">To comprehensively disentangle potentially causal aspects of modifiable risk factors for Alzheimer disease (AD) to inspire new drug targeting and improved prevention.</AbstractText><AbstractText Label="DESIGN, SETTING, AND PARTICIPANTS">This genetic association study was conducted using 2-sample univariable and multivariable mendelian randomization. Independent genetic variants associated with modifiable risk factors were selected as instrumental variables from genomic consortia. Outcome data for AD were obtained from the European Alzheimer &amp; Dementia Biobank (EADB), generated on August 31, 2021. Main analyses were conducted using the EADB clinically diagnosed end point data. All analyses were performed between April 12 and October 27, 2022.</AbstractText><AbstractText Label="EXPOSURES">Genetically determined modifiable risk factors.</AbstractText><AbstractText Label="MAIN OUTCOMES AND MEASURES">Odds ratios (ORs) and 95% CIs for AD were calculated per 1-unit change of genetically determined risk factors.</AbstractText><AbstractText Label="RESULTS">The EADB-diagnosed cohort included 39&#x202f;106 participants with clinically diagnosed AD and 401&#x202f;577 control participants without AD. The mean age ranged from 72 to 83 years for participants with AD and 51 to 80 years for control participants. Among participants with AD, 54% to 75% were female, and among control participants, 48% to 60% were female. Genetically determined high-density lipoprotein (HDL) cholesterol concentrations were associated with increased odds of AD (OR per 1-SD increase, 1.10 [95% CI, 1.05-1.16]). Genetically determined high systolic blood pressure was associated with increased risk of AD after adjusting for diastolic blood pressure (OR per 10-mm Hg increase, 1.22 [95% CI, 1.02-1.46]). In a second analysis to minimize bias due to sample overlap, the entire UK Biobank was excluded from the EADB consortium; odds for AD were similar for HDL cholesterol (OR per 1-SD unit increase, 1.08 [95% CI, 1.02-1.15]) and systolic blood pressure after adjusting for diastolic blood pressure (OR per 10-mm Hg increase, 1.23 [95% CI, 1.01-1.50]).</AbstractText><AbstractText Label="CONCLUSIONS AND RELEVANCE">This genetic association study found novel genetic associations between high HDL cholesterol concentrations and high systolic blood pressure with higher risk of AD. These findings may inspire new drug targeting and improved prevention implementation.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><CollectiveName>European Alzheimer&#x2019;s &amp; Dementia Biobank Mendelian Randomization (EADB-MR) Collaboration</CollectiveName></Author><Author ValidYN="Y"><LastName>Luo</LastName><ForeName>Jiao</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Clinical Biochemistry, Copenhagen University Hospital-Rigshospitalet, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thomassen</LastName><ForeName>Jesper Qvist</ForeName><Initials>JQ</Initials><AffiliationInfo><Affiliation>Department of Clinical Biochemistry, Copenhagen University Hospital-Rigshospitalet, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bellenguez</LastName><ForeName>C&#xe9;line</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Univ. Lille, Inserm, CHU Lille, Institut Pasteur Lille, U1167-RID-AGE-Facteurs de risque et d&#xe9;terminants mol&#xe9;culaires des maladies li&#xe9;es au vieillissement, Lille, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grenier-Boley</LastName><ForeName>Benjamin</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Univ. Lille, Inserm, CHU Lille, Institut Pasteur Lille, U1167-RID-AGE-Facteurs de risque et d&#xe9;terminants mol&#xe9;culaires des maladies li&#xe9;es au vieillissement, Lille, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Rojas</LastName><ForeName>Itziar</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Research Center and Memory clinic Fundaci&#xf3; ACE, Institut Catal&#xe0; de Neuroci&#xe8;ncies Aplicades, Universitat Internacional de Catalunya, Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Network Center for Biomedical Research in Neurodegenerative Diseases, National Institute of Health Carlos III, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Castillo</LastName><ForeName>Atahualpa</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Psychological Medicine and Clinical Neuroscience, School of Medicine, Cardiff University, Wales, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Parveen</LastName><ForeName>Kayenat</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Division of Neurogenetics and Molecular Psychiatry, Department of Psychiatry and Psychotherapy, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurodegenerative diseases and Geriatric Psychiatry, University Hospital Bonn, Medical Faculty, Bonn, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>K&#xfc;&#xe7;&#xfc;kali</LastName><ForeName>Fahri</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Complex Genetics of Alzheimer's Disease Group, VIB Center for Molecular Neurology, Antwerp, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nicolas</LastName><ForeName>Aude</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Univ. Lille, Inserm, CHU Lille, Institut Pasteur Lille, U1167-RID-AGE-Facteurs de risque et d&#xe9;terminants mol&#xe9;culaires des maladies li&#xe9;es au vieillissement, Lille, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peters</LastName><ForeName>Oliver</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>German Center for Neurodegenerative Diseases, Berlin, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Psychiatry and Psychotherapy, Charit&#xe9;-Universit&#xe4;tsmedizin Berlin, corporate member of Freie Universit&#xe4;t Berlin, Humboldt-Universit&#xe4;t zu Berlin, and Berlin Institute of Health, Institute of Psychiatry and Psychotherapy, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schneider</LastName><ForeName>Anja</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>German Center for Neurodegenerative Diseases, Bonn, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department for Neurodegenerative Diseases and Geriatric Psychiatry, University Hospital Bonn, Bonn, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dichgans</LastName><ForeName>Martin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute for Stroke and Dementia Research, University Hospital, LMU Munich, Munich, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>German Center for Neurodegenerative Diseases, Munich, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Munich Cluster for Systems Neurology, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rujescu</LastName><ForeName>Dan</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Comprehensive Centre for Clinical Neurosciences and Mental Health, Medical University of Vienna, Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scherbaum</LastName><ForeName>Norbert</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>LVR-Hospital Essen, Department of Psychiatry and Psychotherapy, Medical Faculty, University of Duisburg-Essen, Essen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>J&#xfc;rgen</LastName><ForeName>Deckert</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, Psychosomatics and Psychotherapy, Center of Mental Health, University Hospital of W&#xfc;rzburg, W&#xfc;rzburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Riedel-Heller</LastName><ForeName>Steffi</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Institute of Social Medicine, Occupational Health and Public Health (ISAP), University of Leipzig, Leipzig, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hausner</LastName><ForeName>Lucrezia</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Geriatric Psychiatry, Central Institute for Mental Health Mannheim, Faculty Mannheim, University of Heidelberg, Heidelberg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Porcel</LastName><ForeName>Laura Molina</ForeName><Initials>LM</Initials><AffiliationInfo><Affiliation>Neurological Tissue Bank, Biobanc Hospital Clinic, Instituto de Investigaciones Biom&#xe9;dicas August Pi i Sunyer, Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Alzheimer's Disease and Other Cognitive Disorders Unit, Neurology Department, Hospital Clinic, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>D&#xfc;zel</LastName><ForeName>Emrah</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>German Center for Neurodegenerative Diseases, Magdeburg, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Cognitive Neurology and Dementia Research, Otto-von-Guericke University, Magdeburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grimmer</LastName><ForeName>Timo</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Technical University of Munich, School of Medicine, Klinikum rechts der Isar, Department of Psychiatry and Psychotherapy, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wiltfang</LastName><ForeName>Jens</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Psychiatry and Psychotherapy, University Medical Center Goettingen, Goettingen, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>German Center for Neurodegenerative Diseases, Goettingen, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical Science Department, Instituto de Biomedicina, Aveiro, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Heilmann-Heimbach</LastName><ForeName>Stefanie</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Institute of Human Genetics, University of Bonn, School of Medicine and University Hospital Bonn, Bonn, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moebus</LastName><ForeName>Susanne</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Institute for Urban Public Health, University Hospital of University Duisburg-Essen, Essen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tegos</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>First Department of Neurology, Medical School, Aristotle University of Thessaloniki, Thessaloniki, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scarmeas</LastName><ForeName>Nikolaos</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>First Department of Neurology, Aiginition Hospital, National and Kapodistrian University of Athens, Medical School, Athens, Greece.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Taub Institute for Research in Alzheimer's Disease and the Aging Brain, The Gertrude H. Sergievsky Center, Department of Neurology, Columbia University, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Clarimon</LastName><ForeName>Jordi</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Network Center for Biomedical Research in Neurodegenerative Diseases, National Institute of Health Carlos III, Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, II B Sant Pau, Hospital de la Santa Creu i Sant Pau, Universitat Aut&#xf2;noma de Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moreno</LastName><ForeName>Fermin</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Network Center for Biomedical Research in Neurodegenerative Diseases, National Institute of Health Carlos III, Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Hospital Universitario Donostia, San Sebastian, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neurosciences Area, Instituto Biodonostia, San Sebastian, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>P&#xe9;rez-Tur</LastName><ForeName>Jordi</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Network Center for Biomedical Research in Neurodegenerative Diseases, National Institute of Health Carlos III, Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Unitat de Gen&#xe8;tica Molecular, Institut de Biomedicina de Val&#xe8;ncia, Consejo Superior de Investigaciones Cient&#xed;ficas, Valencia, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Unidad Mixta de Neurologia Gen&#xe8;tica, Instituto de Investigaci&#xf3;n Sanitaria La Fe, Valencia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bullido</LastName><ForeName>Mar&#xed;a J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Network Center for Biomedical Research in Neurodegenerative Diseases, National Institute of Health Carlos III, Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centro de Biolog&#xed;a Molecular Severo Ochoa, UAM-CSIC, Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Instituto de Investigacion Sanitaria Hospital la Paz, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pastor</LastName><ForeName>Pau</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Unit of Neurodegenerative Diseases, Department of Neurology, University Hospital Germans Trias i Pujol and The Germans Trias i Pujol Research Institute (IGTP) Badalona, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>S&#xe1;nchez-Valle</LastName><ForeName>Raquel</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Alzheimer's Disease and Other Cognitive Disorders Unit, Service of Neurology, Hospital Cl&#xed;nic of Barcelona, Institut d'Investigacions Biom&#xe8;diques August Pi i Sunyer, University of Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>&#xc1;lvarez</LastName><ForeName>Victoria</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Laboratorio de Gen&#xe9;tica, Hospital Universitario Central de Asturias, Oviedo, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Instituto de Investigaci&#xf3;n Sanitaria del Principado de Asturias, Asturias, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boada</LastName><ForeName>Merc&#xe8;</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Research Center and Memory clinic Fundaci&#xf3; ACE, Institut Catal&#xe0; de Neuroci&#xe8;ncies Aplicades, Universitat Internacional de Catalunya, Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Network Center for Biomedical Research in Neurodegenerative Diseases, National Institute of Health Carlos III, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garc&#xed;a-Gonz&#xe1;lez</LastName><ForeName>Pablo</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Research Center and Memory clinic Fundaci&#xf3; ACE, Institut Catal&#xe0; de Neuroci&#xe8;ncies Aplicades, Universitat Internacional de Catalunya, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Puerta</LastName><ForeName>Raquel</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Research Center and Memory clinic Fundaci&#xf3; ACE, Institut Catal&#xe0; de Neuroci&#xe8;ncies Aplicades, Universitat Internacional de Catalunya, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mir</LastName><ForeName>Pablo</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Network Center for Biomedical Research in Neurodegenerative Diseases, National Institute of Health Carlos III, Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Unidad de Trastornos del Movimiento, Servicio de Neurolog&#xed;a y Neurofisiolog&#xed;a, Instituto de Biomedicina de Sevilla, Hospital Universitario Virgen del Roc&#xed;o, Consejo Superior de Investigaciones Cient&#xed;ficas, Universidad de Sevilla, Seville, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Real</LastName><ForeName>Luis M</ForeName><Initials>LM</Initials><AffiliationInfo><Affiliation>Unidad Cl&#xed;nica de Enfermedades Infecciosas y Microbiolog&#xed;a, Hospital Universitario de Valme, Sevilla, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Depatamento de Especialidades Quir&#xfa;rgicas, Bioqu&#xed;mica e Inmunolog&#xed;a, Facultad de Medicina, Universidad de M&#xe1;laga, M&#xe1;laga, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pi&#xf1;ol-Ripoll</LastName><ForeName>Gerard</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Unitat Trastorns Cognitius, Hospital Universitari Santa Maria de Lleida, Lleida, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institut de Recerca Biomedica de Lleida, Lleida, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garc&#xed;a-Alberca</LastName><ForeName>Jose Mar&#xed;a</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Network Center for Biomedical Research in Neurodegenerative Diseases, National Institute of Health Carlos III, Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Alzheimer Research Center &amp; Memory Clinic, Instituto Andaluz de Neurociencia, M&#xe1;laga, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Royo</LastName><ForeName>Jose Lu&#xed;s</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>Depatamento de Especialidades Quir&#xfa;rgicas, Bioqu&#xed;mica e Inmunolog&#xed;a, Facultad de Medicina, Universidad de M&#xe1;laga, M&#xe1;laga, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rodriguez-Rodriguez</LastName><ForeName>Eloy</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Network Center for Biomedical Research in Neurodegenerative Diseases, National Institute of Health Carlos III, Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neurology Service, Marqu&#xe9;s de Valdecilla University Hospital, University of Cantabria and IDIVAL, Santander, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Soininen</LastName><ForeName>Hilkka</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Institute of Clinical Medicine, Neurology, University of Eastern Finland, Kuopio, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kuulasmaa</LastName><ForeName>Teemu</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Institute of Biomedicine, University of Eastern Finland, Kuopio, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Mendon&#xe7;a</LastName><ForeName>Alexandre</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, University of Lisbon, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mehrabian</LastName><ForeName>Shima</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Clinic of Neurology, UH "Alexandrovska," Medical University-Sofia, Sofia, Bulgaria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hort</LastName><ForeName>Jakub</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Memory Clinic, Department of Neurology, Charles University, Second Faculty of Medicine and Motol University Hospital, Prague, Czech Republic.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>International Clinical Research Center, St Anne's University Hospital Brno, Brno, Czech Republic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vyhnalek</LastName><ForeName>Martin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Memory Clinic, Department of Neurology, Charles University, Second Faculty of Medicine and Motol University Hospital, Prague, Czech Republic.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>International Clinical Research Center, St Anne's University Hospital Brno, Brno, Czech Republic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van der Lee</LastName><ForeName>Sven</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Genomics of Neurodegenerative Diseases and Aging, Human Genetics, Vrije Universiteit Amsterdam, Amsterdam UMC, locatie VUmc, Amsterdam, the Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Alzheimer Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC, locatie VUmc, Amsterdam, the Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Amsterdam Neuroscience, Neurodegeneration, Amsterdam, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Graff</LastName><ForeName>Caroline</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Unit for Hereditary Dementias, Theme Aging, Karolinska University Hospital-Solna, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Papenberg</LastName><ForeName>Goran</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Aging Research Center, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet and Stockholm University, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Giedraitis</LastName><ForeName>Vilmantas</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Public Health and Caring Sciences/ and Geriatrics, Uppsala University, Uppsala, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boland</LastName><ForeName>Anne</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Universit&#xe9; Paris-Saclay, CEA, Centre National de Recherche en G&#xe9;nomique Humaine, Evry, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bacq-Daian</LastName><ForeName>Delphine</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Universit&#xe9; Paris-Saclay, CEA, Centre National de Recherche en G&#xe9;nomique Humaine, Evry, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Deleuze</LastName><ForeName>Jean-Fran&#xe7;ois</ForeName><Initials>JF</Initials><AffiliationInfo><Affiliation>Universit&#xe9; Paris-Saclay, CEA, Centre National de Recherche en G&#xe9;nomique Humaine, Evry, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nicolas</LastName><ForeName>Gael</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Normandie Univ, Universit&#xe9; de Rouen Normandie, Inserm U1245 and CHU Rouen, Department of Genetics and Centre national de r&#xe9;f&#xe9;rence pour les malades Alzheimer jeunes, Rouen, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dufouil</LastName><ForeName>Carole</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Inserm, Bordeaux Population Health Research Center, UMR 1219, University of Bordeaux, ISPED, CIC 1401-EC, Bordeaux, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CHU de Bordeaux, Pole sant&#xe9; publique, Bordeaux, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pasquier</LastName><ForeName>Florence</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>University of Lille, Inserm, CHU Lille, UMR1172, Resources and Research Memory Center of Distalz, Licend, Lille, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hanon</LastName><ForeName>Olivier</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Universit&#xe9; de Paris, EA 4468, Assistance Publique - H&#xf4;pitaux de Paris, H&#xf4;pital Broca, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Debette</LastName><ForeName>St&#xe9;phanie</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>University Bordeaux, Inserm, Bordeaux Population Health Research Center, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Bordeaux University Hospital, Bordeaux, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gr&#xfc;nblatt</LastName><ForeName>Edna</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Child and Adolescent Psychiatry and Psychotherapy, Psychiatric University Hospital Zurich, University of Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neuroscience Center Zurich, University of Zurich and ETH Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Zurich Center for Integrative Human Physiology, University of Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Popp</LastName><ForeName>Julius</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Old Age Psychiatry, Department of Psychiatry, Lausanne University Hospital, Lausanne, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Geriatric Psychiatry, University Hospital of Psychiatry Z&#xfc;rich, Z&#xfc;rich, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychiatry, Psychotherapy and Psychosomatics, University of Z&#xfc;rich, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Benussi</LastName><ForeName>Luisa</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Molecular Markers Laboratory, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Galimberti</LastName><ForeName>Daniela</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Neurodegenerative Diseases Unit, Fondazione IRCCS Ca' Granda, Ospedale Policlinico, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical, Surgical and Dental Sciences, University of Milan, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arosio</LastName><ForeName>Beatrice</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Geriatric Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mecocci</LastName><ForeName>Patrizia</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Institute of Gerontology and Geriatrics, Department of Medicine and Surgery, University of Perugia, Perugia, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Clinical Geriatrics, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Solfrizzi</LastName><ForeName>Vincenzo</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Interdisciplinary Department of Medicine, Geriatric Medicine and Memory Unit, University of Bari Aldo Moro, Bari, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Parnetti</LastName><ForeName>Lucilla</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Centre for Memory Disturbances, Lab of Clinical Neurochemistry, Section of Neurology, University of Perugia, Perugia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Squassina</LastName><ForeName>Alessio</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Section of Neuroscience and Clinical Pharmacology, University of Cagliari, Cagliari, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tremolizzo</LastName><ForeName>Lucio</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Neurology Unit, Hospital San Gerardo, Monza and University of Milano-Bicocca, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Borroni</LastName><ForeName>Barbara</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Centre for Neurodegenerative Disorders, Neurology Unit, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nacmias</LastName><ForeName>Benedetta</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Neuroscience, Psychology, Drug Research and Child Health University of Florence, Florence, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>IRCCS Fondazione Don Carlo Gnocchi, Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sorbi</LastName><ForeName>Sandro</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neuroscience, Psychology, Drug Research and Child Health University of Florence, Florence, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>IRCCS Fondazione Don Carlo Gnocchi, Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Caffarra</LastName><ForeName>Paolo</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Unit of Neurology, University of Parma, Parma, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seripa</LastName><ForeName>Davide</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Laboratory for Advanced Hematological Diagnostics, Department of Hematology and Stem Cell Transplant, Vito Fazzi Hospital, Lecce, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rainero</LastName><ForeName>Innocenzo</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Neuroscience Rita Levi Montalcini, University of Torino, Torino, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Daniele</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neuroscience, Universit&#xe0; Cattolica del Sacro Cuore, Rome, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neurology Unit, IRCCS Fondazione Policlinico Universitario A. Gemelli, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Masullo</LastName><ForeName>Carlo</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Institute of Neurology, Universit&#xe0; Cattolica del Sacro Cuore, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spalletta</LastName><ForeName>Gianfranco</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Laboratory of Neuropsychiatry, IRCCS Santa Lucia Foundation, Rome, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychiatry and Behavioral Sciences, Baylor College of Medicine, Houston, Texas.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Williams</LastName><ForeName>Julie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>UK Dementia Research Institute at Cardiff, School of Medicine, Cardiff University, Cardiff, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Amouyel</LastName><ForeName>Philippe</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Univ. Lille, Inserm, CHU Lille, Institut Pasteur Lille, U1167-RID-AGE-Facteurs de risque et d&#xe9;terminants mol&#xe9;culaires des maladies li&#xe9;es au vieillissement, Lille, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jessen</LastName><ForeName>Frank</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Division of Neurogenetics and Molecular Psychiatry, Department of Psychiatry and Psychotherapy, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>German Center for Neurodegenerative Diseases, Bonn, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Cluster of Excellence Cellular Stress Responses in Aging-Associated Diseases, University of Cologne, Cologne, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kehoe</LastName><ForeName>Patrick</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsolaki</LastName><ForeName>Magda</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>First Department of Neurology, Medical School, Aristotle University of Thessaloniki, Thessaloniki, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rossi</LastName><ForeName>Giacomina</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Unit of Neurology V - Neuropathology, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>S&#xe1;nchez-Juan</LastName><ForeName>Pascual</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Network Center for Biomedical Research in Neurodegenerative Diseases, National Institute of Health Carlos III, Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Alzheimer's Centre Reina Sofia-CIEN Foundation-ISCIII, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sleegers</LastName><ForeName>Kristel</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Complex Genetics of Alzheimer's Disease Group, VIB Center for Molecular Neurology, Antwerp, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ingelsson</LastName><ForeName>Martin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Universit&#xe9; Paris-Saclay, CEA, Centre National de Recherche en G&#xe9;nomique Humaine, Evry, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Krembil Brain Institute, University Health Network, Toronto, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine and Tanz Centre for Research in Neurodegenerative Diseases, University of Toronto, Toronto, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Andreassen</LastName><ForeName>Ole A</ForeName><Initials>OA</Initials><AffiliationInfo><Affiliation>NORMENT Centre, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Clinical Medicine, University of Oslo, Oslo, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hiltunen</LastName><ForeName>Mikko</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute of Biomedicine, University of Eastern Finland, Kuopio, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van Duijn</LastName><ForeName>Cornelia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, ErasmusMC, Rotterdam, the Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Nuffield Department of Population Health, Oxford University, Oxford, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sims</LastName><ForeName>Rebecca</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Division of Psychological Medicine and Clinical Neuroscience, School of Medicine, Cardiff University, Wales, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van der Flier</LastName><ForeName>Wiesje</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Alzheimer Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC, locatie VUmc, Amsterdam, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ruiz</LastName><ForeName>Agust&#xed;n</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Research Center and Memory clinic Fundaci&#xf3; ACE, Institut Catal&#xe0; de Neuroci&#xe8;ncies Aplicades, Universitat Internacional de Catalunya, Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Network Center for Biomedical Research in Neurodegenerative Diseases, National Institute of Health Carlos III, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ramirez</LastName><ForeName>Alfredo</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Neurogenetics and Molecular Psychiatry, Department of Psychiatry and Psychotherapy, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurodegenerative diseases and Geriatric Psychiatry, University Hospital Bonn, Medical Faculty, Bonn, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>German Center for Neurodegenerative Diseases, Bonn, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Cluster of Excellence Cellular Stress Responses in Aging-Associated Diseases, University of Cologne, Cologne, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychiatry and Glenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases, San Antonio, Texas.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lambert</LastName><ForeName>Jean-Charles</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Univ. Lille, Inserm, CHU Lille, Institut Pasteur Lille, U1167-RID-AGE-Facteurs de risque et d&#xe9;terminants mol&#xe9;culaires des maladies li&#xe9;es au vieillissement, Lille, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Frikke-Schmidt</LastName><ForeName>Ruth</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Clinical Biochemistry, Copenhagen University Hospital-Rigshospitalet, Copenhagen, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>MR/L010305/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>05</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JAMA Netw Open</MedlineTA><NlmUniqueID>101729235</NlmUniqueID><ISSNLinking>2574-3805</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008076">Cholesterol, HDL</NameOfSubstance></Chemical><Chemical><RegistryNumber>102568-44-5</RegistryNumber><NameOfSubstance UI="C063819">ethyl 4-azidophenyl-1,4-dithiobutyrimidate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="ErratumIn"><RefSource>JAMA Netw Open. 2023 Jun 1;6(6):e2321189. doi: 10.1001/jamanetworkopen.2023.21189.</RefSource><PMID Version="1">37273211</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008076" MajorTopicYN="N">Cholesterol, HDL</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015984" MajorTopicYN="N">Causality</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement><b>Conflict of Interest Disclosures:</b> Dr Schneider reported receiving personal fees from Biogen and Eisai outside the submitted work. Dr Rujescu reported receiving personal fees from Janssen, Gerot Lannacher, Pharmgenetix, Angelina, AC Immune, Roche, and Rovi outside the submitted work. Dr Deckert reported receiving grants from Vogel Foundation during the conduct of the study and grants from Vogel Foundation outside the submitted work. Dr Molina-Porcel reported receiving personal fees from Biogen outside the submitted work. Dr D&#xfc;zel reported receiving grants from German Federal Ministry of Education and Research (BMBF), and Human Brain Project; personal fees from Roche, Biogen, and Lilly; and serving as cofounder of and owning stock in Neotiv outside the submitted work. Dr Grimmer reported receiving personal fees from AbbVie, Alector, Anavex, Biogen, Eli Lilly, Functional Neuromodulation, Grifols, Iqvia, Medical Tribune, Noselab, Novo Nordisk, NuiCare, Orphanzyme, Roche Diagnostics, Roche, Schwabe, UCB, and Vivoryon and grants from Biogen and Roche Diagnostics outside the submitted work. Dr Wiltfang reported receiving grants from BMBF during the conduct of the study and personal fees from Abbott, Biogen, Boehringer-Ingelheim, Immungenetics, Janssen, Lilly, Merck Sharp &amp; Dohme, Pfizer, Roche, Actelion, Amgen, Beejing Yibai Science and Technology, and Roboscreen outside the submitted work; in addition, Dr Wiltfang has a patent for PCT/EP 2011 001724 issued and a patent for PCT/EP 2015 052945 issued. Dr Heilmann-Heimbach reported receiving personal fees from Life &amp; Brain outside the submitted work. Dr Scarmeas reported receiving grants from Alzheimer&#x2019;s Association, National Strategic Reference Framework, Excellence Grant, and Greek Ministry of Health during the conduct of the study and grants from Novo Nordisk and personal fees from Albert Einstein College of Medicine outside the submitted work. Dr Moreno reported receiving grants from Tau Consortium and Instituto de Salud Carlos III outside the submitted work. Dr Boada reported serving on advisory boards for Grifols, Roche, Lilly, Araclon Biotech, Merck, Zambon, Biogen, Novo Nordisk, Bioiberica, Eisai, Servier, and Schwabe Pharma outside the submitted work. Dr Soininen reported receiving personal fees from Novo Nordisk outside the submitted work. Dr Hort reported owing stock in Alzheon and receiving personal fees from Schwabe outside the submitted work. Dr Graff reported receiving grants from the Swedish Medical Research Council, Swedish Demensfonden, Swedish Alzheimer Foundation, Swedish Brain Foundation, Region Stockholm County ALF Project, and Karolinska Institutet StratNeuro during the conduct of the study. Dr Popp reported receiving grants from the Swiss National Research Foundation and Synapsis Foundation Switzerland during the conduct of the study and personal fees from OM Pharma Switzerland, Dr Schwabe Pharma Switzerland, and Roche outside the submitted work. Dr Spalletta reported receiving grants from the Italian Ministry of Health during the conduct of the study. Dr Amouyel reported receiving personal fees from Fondation Alzheimer and Genoscreen Biotech outside the submitted work. Dr Ingelsson reported receiving personal fees from BioArctic outside the submitted work. Dr Andreassen reported receiving grants from KG Jebsen Stiftelsen, South East Norway Health Authority, Research Council of Norway, and European Union Horizon 2020 during the conduct of the study and personal fees from HealthLytix, Lundbeck, and Sunovion outside the submitted work. Dr van der Flier reported receiving grants from Netherlands Organisation for Health Research and Development and European Alzheimer&#x2019;s Disease DNA Biobank during the conduct of the study; grants from Alzheimer Nederland, Hersenstichting, CardioVascular Onderzoek Nederland, Health~Holland, Topsector Life Sciences &amp; Health, Alzheimer &amp; Neuropsychiatrie Foundation, Philips, Biogen MA, Novartis-NL, Life-MI, Avid Radiopharmaceuticals, Roche BV, Fujifilm, Combinostics, Gieskes-Strijbis, Dioraphte, Edwin Bouw, Equilibrio, and Pasman; personal fees from Boehringer Ingelheim, Biogen, Danone, Eisai, WebMD Neurology (Medscape), and Springer Healthcare; performing contract research for Biogen and Boehringer Ingelheim; is consultant to Oxford Health Policy Forum CIC, Roche, and Biogen MA; serving on advisory boards for Biogen and Roche; and serving as associate editor of <i>Alzheimer, Research and Therapy</i> (in 2020-2021) and <i>Brain </i>outside the submitted work<i>.</i> Dr Ramirez reported receiving grants from BMBF during the conduct of the study. No other disclosures were reported.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>19</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>17</Day><Hour>13</Hour><Minute>10</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>17</Day><Hour>11</Hour><Minute>32</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>5</Month><Day>17</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37195665</ArticleId><ArticleId IdType="pmc">PMC10193187</ArticleId><ArticleId IdType="doi">10.1001/jamanetworkopen.2023.13734</ArticleId><ArticleId IdType="pii">2805006</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Livingston G, Huntley J, Sommerlad A, et al. . Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet. 2020;396(10248):413-446. doi:10.1016/S0140-6736(20)30367-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30367-6</ArticleId><ArticleId IdType="pmc">PMC7392084</ArticleId><ArticleId IdType="pubmed">32738937</ArticleId></ArticleIdList></Reference><Reference><Citation>Guidelines WHO; Approved by the Guidelines Review Committee . Risk Reduction of Cognitive Decline and Dementia: WHO Guidelines. World Health Organization; 2019.</Citation><ArticleIdList><ArticleId IdType="pubmed">31219687</ArticleId></ArticleIdList></Reference><Reference><Citation>Chowdhary N, Barbui C, Anstey KJ, et al. . Reducing the risk of cognitive decline and dementia: WHO recommendations. Front Neurol. 2022;12:765584. doi:10.3389/fneur.2021.765584</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2021.765584</ArticleId><ArticleId IdType="pmc">PMC8784726</ArticleId><ArticleId IdType="pubmed">35082745</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh-Manoux A, Dugravot A, Shipley M, et al. . Obesity trajectories and risk of dementia: 28 years of follow-up in the Whitehall II Study. Alzheimers Dement. 2018;14(2):178-186. doi:10.1016/j.jalz.2017.06.2637</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2017.06.2637</ArticleId><ArticleId IdType="pmc">PMC5805839</ArticleId><ArticleId IdType="pubmed">28943197</ArticleId></ArticleIdList></Reference><Reference><Citation>Abell JG, Kivim&#xe4;ki M, Dugravot A, et al. . Association between systolic blood pressure and dementia in the Whitehall II cohort study: role of age, duration, and threshold used to define hypertension. Eur Heart J. 2018;39(33):3119-3125. doi:10.1093/eurheartj/ehy288</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehy288</ArticleId><ArticleId IdType="pmc">PMC6122131</ArticleId><ArticleId IdType="pubmed">29901708</ArticleId></ArticleIdList></Reference><Reference><Citation>Richmond RC, Davey Smith G. Mendelian randomization: concepts and scope. Cold Spring Harb Perspect Med. 2022;12(1):a040501. doi:10.1101/cshperspect.a040501</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a040501</ArticleId><ArticleId IdType="pmc">PMC8725623</ArticleId><ArticleId IdType="pubmed">34426474</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellenguez C, K&#xfc;&#xe7;&#xfc;kali F, Jansen IE, et al. ; EADB; GR@ACE; DEGESCO; EADI; GERAD; Demgene; FinnGen; ADGC; CHARGE . New insights into the genetic etiology of Alzheimer&#x2019;s disease and related dementias. Nat Genet. 2022;54(4):412-436. doi:10.1038/s41588-022-01024-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-022-01024-z</ArticleId><ArticleId IdType="pmc">PMC9005347</ArticleId><ArticleId IdType="pubmed">35379992</ArticleId></ArticleIdList></Reference><Reference><Citation>Okbay A, Wu Y, Wang N, et al. ; 23andMe Research Team; Social Science Genetic Association Consortium . Polygenic prediction of educational attainment within and between families from genome-wide association analyses in 3 million individuals. Nat Genet. 2022;54(4):437-449. doi:10.1038/s41588-022-01016-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-022-01016-z</ArticleId><ArticleId IdType="pmc">PMC9005349</ArticleId><ArticleId IdType="pubmed">35361970</ArticleId></ArticleIdList></Reference><Reference><Citation>Richardson TG, Sanderson E, Palmer TM, et al. . Evaluating the relationship between circulating lipoprotein lipids and apolipoproteins with risk of coronary heart disease: a multivariable mendelian randomisation analysis. PLoS Med. 2020;17(3):e1003062. doi:10.1371/journal.pmed.1003062</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1003062</ArticleId><ArticleId IdType="pmc">PMC7089422</ArticleId><ArticleId IdType="pubmed">32203549</ArticleId></ArticleIdList></Reference><Reference><Citation>Yengo L, Sidorenko J, Kemper KE, et al. ; GIANT Consortium . Meta-analysis of genome-wide association studies for height and body mass index in ~700000 individuals of European ancestry. Hum Mol Genet. 2018;27(20):3641-3649. doi:10.1093/hmg/ddy271</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddy271</ArticleId><ArticleId IdType="pmc">PMC6488973</ArticleId><ArticleId IdType="pubmed">30124842</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu M, Jiang Y, Wedow R, et al. ; 23andMe Research Team; HUNT All-In Psychiatry . Association studies of up to 1.2 million individuals yield new insights into the genetic etiology of tobacco and alcohol use. Nat Genet. 2019;51(2):237-244. doi:10.1038/s41588-018-0307-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-018-0307-5</ArticleId><ArticleId IdType="pmc">PMC6358542</ArticleId><ArticleId IdType="pubmed">30643251</ArticleId></ArticleIdList></Reference><Reference><Citation>Evangelou E, Warren HR, Mosen-Ansorena D, et al. ; Million Veteran Program . Genetic analysis of over 1 million people identifies 535 new loci associated with blood pressure traits. Nat Genet. 2018;50(10):1412-1425. doi:10.1038/s41588-018-0205-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-018-0205-x</ArticleId><ArticleId IdType="pmc">PMC6284793</ArticleId><ArticleId IdType="pubmed">30224653</ArticleId></ArticleIdList></Reference><Reference><Citation>Vujkovic M, Keaton JM, Lynch JA, et al. ; HPAP Consortium; Regeneron Genetics Center; VA Million Veteran Program . Discovery of 318 new risk loci for type 2 diabetes and related vascular outcomes among 1.4 million participants in a multi-ancestry meta-analysis. Nat Genet. 2020;52(7):680-691. doi:10.1038/s41588-020-0637-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-020-0637-y</ArticleId><ArticleId IdType="pmc">PMC7343592</ArticleId><ArticleId IdType="pubmed">32541925</ArticleId></ArticleIdList></Reference><Reference><Citation>Burgess S. Sample size and power calculations in mendelian randomization with a single instrumental variable and a binary outcome. Int J Epidemiol. 2014;43(3):922-929. doi:10.1093/ije/dyu005</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyu005</ArticleId><ArticleId IdType="pmc">PMC4052137</ArticleId><ArticleId IdType="pubmed">24608958</ArticleId></ArticleIdList></Reference><Reference><Citation>Benjamini Y, Drai D, Elmer G, Kafkafi N, Golani I. Controlling the false discovery rate in behavior genetics research. Behav Brain Res. 2001;125(1-2):279-284. doi:10.1016/S0166-4328(01)00297-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0166-4328(01)00297-2</ArticleId><ArticleId IdType="pubmed">11682119</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowden J, Davey Smith G, Haycock PC, Burgess S. Consistent estimation in mendelian randomization with some invalid instruments using a weighted median estimator. Genet Epidemiol. 2016;40(4):304-314. doi:10.1002/gepi.21965</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/gepi.21965</ArticleId><ArticleId IdType="pmc">PMC4849733</ArticleId><ArticleId IdType="pubmed">27061298</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowden J, Davey Smith G, Burgess S. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int J Epidemiol. 2015;44(2):512-525. doi:10.1093/ije/dyv080</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyv080</ArticleId><ArticleId IdType="pmc">PMC4469799</ArticleId><ArticleId IdType="pubmed">26050253</ArticleId></ArticleIdList></Reference><Reference><Citation>Verbanck M, Chen CY, Neale B, Do R. Detection of widespread horizontal pleiotropy in causal relationships inferred from mendelian randomization between complex traits and diseases. Nat Genet. 2018;50(5):693-698. doi:10.1038/s41588-018-0099-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-018-0099-7</ArticleId><ArticleId IdType="pmc">PMC6083837</ArticleId><ArticleId IdType="pubmed">29686387</ArticleId></ArticleIdList></Reference><Reference><Citation>Burgess S, Thompson SG. Multivariable mendelian randomization: the use of pleiotropic genetic variants to estimate causal effects. Am J Epidemiol. 2015;181(4):251-260. doi:10.1093/aje/kwu283</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/aje/kwu283</ArticleId><ArticleId IdType="pmc">PMC4325677</ArticleId><ArticleId IdType="pubmed">25632051</ArticleId></ArticleIdList></Reference><Reference><Citation>Morrison J, Knoblauch N, Marcus JH, Stephens M, He X. Mendelian randomization accounting for correlated and uncorrelated pleiotropic effects using genome-wide summary statistics. Nat Genet. 2020;52(7):740-747. doi:10.1038/s41588-020-0631-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-020-0631-4</ArticleId><ArticleId IdType="pmc">PMC7343608</ArticleId><ArticleId IdType="pubmed">32451458</ArticleId></ArticleIdList></Reference><Reference><Citation>Mounier N, Kutalik Z. Bias correction for inverse variance weighting mendelian randomization. bioRxiv. Preprint posted online September 20, 2022. doi:10.1101/2021.03.26.437168</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.03.26.437168</ArticleId><ArticleId IdType="pubmed">37036286</ArticleId></ArticleIdList></Reference><Reference><Citation>Nordestgaard LT, Christoffersen M, Lauridsen BK, et al. . Long-term benefits and harms associated with genetic cholesteryl ester transfer protein deficiency in the general population. JAMA Cardiol. 2022;7(1):55-64. doi:10.1001/jamacardio.2021.3728</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2021.3728</ArticleId><ArticleId IdType="pmc">PMC8495609</ArticleId><ArticleId IdType="pubmed">34613338</ArticleId></ArticleIdList></Reference><Reference><Citation>Peloso GM, van der Lee SJ, Destefano AL, Seshardi S; International Genomics of Alzheimer&#x2019;s Project (IGAP) . Genetically elevated high-density lipoprotein cholesterol through the cholesteryl ester transfer protein gene does not associate with risk of Alzheimer&#x2019;s disease. Alzheimers Dement (Amst). 2018;10:595-598. doi:10.1016/j.dadm.2018.08.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dadm.2018.08.008</ArticleId><ArticleId IdType="pmc">PMC6215982</ArticleId><ArticleId IdType="pubmed">30422133</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrews SJ, Goate A, Anstey KJ. Association between alcohol consumption and Alzheimer&#x2019;s disease: a mendelian randomization study. Alzheimers Dement. 2020;16(2):345-353. doi:10.1016/j.jalz.2019.09.086</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2019.09.086</ArticleId><ArticleId IdType="pmc">PMC7057166</ArticleId><ArticleId IdType="pubmed">31786126</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang SY, Yang YX, Zhang YR, et al. . Investigating causal relations between circulating metabolites and Alzheimer&#x2019;s disease: a mendelian randomization study. J Alzheimers Dis. 2022;87(1):463-477. doi:10.3233/JAD-220050</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-220050</ArticleId><ArticleId IdType="pubmed">35275550</ArticleId></ArticleIdList></Reference><Reference><Citation>Kjeldsen EW, Thomassen JQ, Juul Rasmussen I, Nordestgaard BG, Tybj&#xe6;rg-Hansen A, Frikke-Schmidt R. Plasma high-density lipoprotein cholesterol and risk of dementia: observational and genetic studies. Cardiovasc Res. 2022;118(5):1330-1343. doi:10.1093/cvr/cvab164</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cvr/cvab164</ArticleId><ArticleId IdType="pubmed">33964140</ArticleId></ArticleIdList></Reference><Reference><Citation>Larsson SC, Traylor M, Malik R, Dichgans M, Burgess S, Markus HS; CoSTREAM Consortium, on behalf of the International Genomics of Alzheimer&#x2019;s Project . Modifiable pathways in Alzheimer&#x2019;s disease: mendelian randomisation analysis. BMJ. 2017;359:j5375. doi:10.1136/bmj.j5375</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.j5375</ArticleId><ArticleId IdType="pmc">PMC5717765</ArticleId><ArticleId IdType="pubmed">29212772</ArticleId></ArticleIdList></Reference><Reference><Citation>&#xd8;stergaard SD, Mukherjee S, Sharp SJ, et al. ; Alzheimer&#x2019;s Disease Genetics Consortium; GERAD1 Consortium; EPIC-InterAct Consortium . Associations between potentially modifiable risk factors and Alzheimer disease: a mendelian randomization study. PLoS Med. 2015;12(6):e1001841. doi:10.1371/journal.pmed.1001841</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1001841</ArticleId><ArticleId IdType="pmc">PMC4469461</ArticleId><ArticleId IdType="pubmed">26079503</ArticleId></ArticleIdList></Reference><Reference><Citation>Proitsi P, Lupton MK, Velayudhan L, et al. ; Alzheimer&#x2019;s Disease Neuroimaging Initiative; GERAD1 Consortium . Genetic predisposition to increased blood cholesterol and triglyceride lipid levels and risk of Alzheimer disease: a mendelian randomization analysis. PLoS Med. 2014;11(9):e1001713. doi:10.1371/journal.pmed.1001713</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1001713</ArticleId><ArticleId IdType="pmc">PMC4165594</ArticleId><ArticleId IdType="pubmed">25226301</ArticleId></ArticleIdList></Reference><Reference><Citation>Lord J, Jermy B, Green R, et al. . Mendelian randomization identifies blood metabolites previously linked to midlife cognition as causal candidates in Alzheimer&#x2019;s disease. Proc Natl Acad Sci U S A. 2021;118(16):e2009808118. doi:10.1073/pnas.2009808118</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2009808118</ArticleId><ArticleId IdType="pmc">PMC8072203</ArticleId><ArticleId IdType="pubmed">33879569</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Q, Xu F, Wang L, Zhang WD, Sun CQ, Deng HW. Detecting potential causal relationship between multiple risk factors and Alzheimer&#x2019;s disease using multivariable mendelian randomization. Aging (Albany NY). 2020;12(21):21747-21757. doi:10.18632/aging.103983</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/aging.103983</ArticleId><ArticleId IdType="pmc">PMC7695397</ArticleId><ArticleId IdType="pubmed">33177243</ArticleId></ArticleIdList></Reference><Reference><Citation>Koch S, Donarski N, Goetze K, et al. . Characterization of four lipoprotein classes in human cerebrospinal fluid. J Lipid Res. 2001;42(7):1143-1151. doi:10.1016/S0022-2275(20)31605-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-2275(20)31605-9</ArticleId><ArticleId IdType="pubmed">11441143</ArticleId></ArticleIdList></Reference><Reference><Citation>Hubin E, Verghese PB, van Nuland N, Broersen K. Apolipoprotein E associated with reconstituted high-density lipoprotein-like particles is protected from aggregation. FEBS Lett. 2019;593(11):1144-1153. doi:10.1002/1873-3468.13428</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1873-3468.13428</ArticleId><ArticleId IdType="pmc">PMC6617784</ArticleId><ArticleId IdType="pubmed">31058310</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinez AE, Weissberger G, Kuklenyik Z, et al. . The small HDL particle hypothesis of Alzheimer&#x2019;s disease. Alzheimers Dement. 2023;19(2):391-404. doi:10.1002/alz.12649</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alz.12649</ArticleId><ArticleId IdType="pmc">PMC10563117</ArticleId><ArticleId IdType="pubmed">35416404</ArticleId></ArticleIdList></Reference><Reference><Citation>Zanoni P, Khetarpal SA, Larach DB, et al. ; CHD Exome+ Consortium; CARDIoGRAM Exome Consortium; Global Lipids Genetics Consortium . Rare variant in scavenger receptor BI raises HDL cholesterol and increases risk of coronary heart disease. Science. 2016;351(6278):1166-1171. doi:10.1126/science.aad3517</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aad3517</ArticleId><ArticleId IdType="pmc">PMC4889017</ArticleId><ArticleId IdType="pubmed">26965621</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuller LH, Snitz BE, Hughes TM, et al. . Low untreated systolic blood pressure over 18 years is associated with survival free of dementia age 90. Alzheimers Dement. 2022;18(11):2176-2187. doi:10.1002/alz.12493</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alz.12493</ArticleId><ArticleId IdType="pmc">PMC9787390</ArticleId><ArticleId IdType="pubmed">35089640</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiu C, von Strauss E, Fastbom J, Winblad B, Fratiglioni L. Low blood pressure and risk of dementia in the Kungsholmen project: a 6-year follow-up study. Arch Neurol. 2003;60(2):223-228. doi:10.1001/archneur.60.2.223</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneur.60.2.223</ArticleId><ArticleId IdType="pubmed">12580707</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker KA, Sharrett AR, Wu A, et al. . Association of midlife to late-life blood pressure patterns with incident dementia. JAMA. 2019;322(6):535-545. doi:10.1001/jama.2019.10575</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2019.10575</ArticleId><ArticleId IdType="pmc">PMC6692677</ArticleId><ArticleId IdType="pubmed">31408138</ArticleId></ArticleIdList></Reference><Reference><Citation>Hughes D, Judge C, Murphy R, et al. . Association of blood pressure lowering with incident dementia or cognitive impairment: a systematic review and meta-analysis. JAMA. 2020;323(19):1934-1944. doi:10.1001/jama.2020.4249</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.4249</ArticleId><ArticleId IdType="pmc">PMC7237983</ArticleId><ArticleId IdType="pubmed">32427305</ArticleId></ArticleIdList></Reference><Reference><Citation>Peters R, Xu Y, Fitzgerald O, et al. ; Dementia Risk Reduction (DIRECT) Collaboration . Blood pressure lowering and prevention of dementia: an individual patient data meta-analysis. Eur Heart J. 2022;43(48):4980-4990. doi:10.1093/eurheartj/ehac584</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehac584</ArticleId><ArticleId IdType="pubmed">36282295</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrews SJ, Fulton-Howard B, O&#x2019;Reilly P, Marcora E, Goate AM; Collaborators of the Alzheimer&#x2019;s Disease Genetics Consortium . Causal associations between modifiable risk factors and the Alzheimer&#x2019;s phenome. Ann Neurol. 2021;89(1):54-65. doi:10.1002/ana.25918</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.25918</ArticleId><ArticleId IdType="pmc">PMC8088901</ArticleId><ArticleId IdType="pubmed">32996171</ArticleId></ArticleIdList></Reference><Reference><Citation>Sproviero W, Winchester L, Newby D, et al. . High blood pressure and risk of dementia: a two-sample mendelian randomization study in the UK Biobank. Biol Psychiatry. 2021;89(8):817-824. doi:10.1016/j.biopsych.2020.12.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopsych.2020.12.015</ArticleId><ArticleId IdType="pubmed">33766239</ArticleId></ArticleIdList></Reference><Reference><Citation>Li C, Zhu Y, Ma Y, Hua R, Zhong B, Xie W. Association of cumulative blood pressure with cognitive decline, dementia, and mortality. J Am Coll Cardiol. 2022;79(14):1321-1335. doi:10.1016/j.jacc.2022.01.045</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2022.01.045</ArticleId><ArticleId IdType="pubmed">35393012</ArticleId></ArticleIdList></Reference><Reference><Citation>Brenowitz WD, Zimmerman SC, Filshtein TJ, et al. . Extension of mendelian randomization to identify earliest manifestations of Alzheimer disease: association of genetic risk score for Alzheimer disease with lower body mass index by age 50 years. Am J Epidemiol. 2021;190(10):2163-2171. doi:10.1093/aje/kwab103</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/aje/kwab103</ArticleId><ArticleId IdType="pmc">PMC8576370</ArticleId><ArticleId IdType="pubmed">33843952</ArticleId></ArticleIdList></Reference><Reference><Citation>Nordestgaard AT, Nordestgaard BG, Frikke-Schmidt R, Juul Rasmussen I, Bojesen SE. Self-reported and genetically predicted coffee consumption and smoking in dementia: a mendelian randomization study. Atherosclerosis. 2022;348:36-43. doi:10.1016/j.atherosclerosis.2022.03.022</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.atherosclerosis.2022.03.022</ArticleId><ArticleId IdType="pubmed">35405480</ArticleId></ArticleIdList></Reference><Reference><Citation>Larsson SC, Burgess S. Appraising the causal role of smoking in multiple diseases: a systematic review and meta-analysis of mendelian randomization studies. EBioMedicine. 2022;82:104154. doi:10.1016/j.ebiom.2022.104154</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2022.104154</ArticleId><ArticleId IdType="pmc">PMC9278068</ArticleId><ArticleId IdType="pubmed">35816897</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu H, Hu Y, Zhang Y, et al. . Mendelian randomization highlights significant difference and genetic heterogeneity in clinically diagnosed Alzheimer&#x2019;s disease GWAS and self-report proxy phenotype GWAX. Alzheimers Res Ther. 2022;14(1):17. doi:10.1186/s13195-022-00963-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13195-022-00963-3</ArticleId><ArticleId IdType="pmc">PMC8800228</ArticleId><ArticleId IdType="pubmed">35090530</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37192625</PMID><DateCompleted><Year>2023</Year><Month>11</Month><Day>22</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>30</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1097-4199</ISSN><JournalIssue CitedMedium="Internet"><Volume>111</Volume><Issue>14</Issue><PubDate><Year>2023</Year><Month>Jul</Month><Day>19</Day></PubDate></JournalIssue><Title>Neuron</Title><ISOAbbreviation>Neuron</ISOAbbreviation></Journal><ArticleTitle>Synaptic oligomeric tau in Alzheimer's disease - A potential culprit in the spread of tau pathology through the brain.</ArticleTitle><Pagination><StartPage>2170</StartPage><EndPage>2183.e6</EndPage><MedlinePgn>2170-2183.e6</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.neuron.2023.04.020</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0896-6273(23)00305-7</ELocationID><Abstract><AbstractText>In Alzheimer's disease, fibrillar tau pathology accumulates and spreads through the brain and synapses are lost. Evidence from mouse models indicates that tau spreads trans-synaptically from pre- to postsynapses and that oligomeric tau is synaptotoxic, but data on synaptic tau in human brain are scarce. Here we used sub-diffraction-limit microscopy to study synaptic tau accumulation in postmortem temporal and occipital cortices of human Alzheimer's and control donors. Oligomeric tau is present in pre- and postsynaptic terminals, even in areas without abundant fibrillar tau deposition. Furthermore, there is a higher proportion of oligomeric tau compared with phosphorylated or misfolded tau found at synaptic terminals. These data suggest that accumulation of oligomeric tau in synapses is an early event in pathogenesis and that tau pathology may progress through the brain via trans-synaptic spread in human disease. Thus, specifically reducing oligomeric tau at synapses may be a promising therapeutic strategy for Alzheimer's disease.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 The Author(s). Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Colom-Cadena</LastName><ForeName>Mart&#xed;</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>The University of Edinburgh Centre for Discovery Brain Sciences and UK Dementia Research Institute, Edinburgh, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Davies</LastName><ForeName>Caitlin</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>The University of Edinburgh Centre for Discovery Brain Sciences and UK Dementia Research Institute, Edinburgh, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sirisi</LastName><ForeName>S&#xf2;nia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Memory Unit, Department of Neurology, Institut d'Investigacions Biom&#xe8;diques Sant Pau - Hospital de Sant Pau, Universitat Aut&#xf2;noma de Barcelona, Barcelona, Spain; Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red en Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Ji-Eun</ForeName><Initials>JE</Initials><AffiliationInfo><Affiliation>EaStCHEM School of Chemistry, The University of Edinburgh, Edinburgh, UK; IRR Chemistry Hub, Institute for Regeneration and Repair, The University of Edinburgh, EH16 4 UU Edinburgh, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Simzer</LastName><ForeName>Elizabeth M</ForeName><Initials>EM</Initials><AffiliationInfo><Affiliation>The University of Edinburgh Centre for Discovery Brain Sciences and UK Dementia Research Institute, Edinburgh, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tzioras</LastName><ForeName>Makis</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>The University of Edinburgh Centre for Discovery Brain Sciences and UK Dementia Research Institute, Edinburgh, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Querol-Vilaseca</LastName><ForeName>Marta</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Memory Unit, Department of Neurology, Institut d'Investigacions Biom&#xe8;diques Sant Pau - Hospital de Sant Pau, Universitat Aut&#xf2;noma de Barcelona, Barcelona, Spain; Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red en Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>S&#xe1;nchez-Aced</LastName><ForeName>&#xc9;rika</ForeName><Initials>&#xc9;</Initials><AffiliationInfo><Affiliation>Memory Unit, Department of Neurology, Institut d'Investigacions Biom&#xe8;diques Sant Pau - Hospital de Sant Pau, Universitat Aut&#xf2;noma de Barcelona, Barcelona, Spain; Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red en Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>Ya Yin</ForeName><Initials>YY</Initials><AffiliationInfo><Affiliation>The University of Edinburgh Centre for Discovery Brain Sciences and UK Dementia Research Institute, Edinburgh, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Holt</LastName><ForeName>Kristjan</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>The University of Edinburgh Centre for Discovery Brain Sciences and UK Dementia Research Institute, Edinburgh, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McGeachan</LastName><ForeName>Robert I</ForeName><Initials>RI</Initials><AffiliationInfo><Affiliation>The University of Edinburgh Centre for Discovery Brain Sciences and UK Dementia Research Institute, Edinburgh, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rose</LastName><ForeName>Jamie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>The University of Edinburgh Centre for Discovery Brain Sciences and UK Dementia Research Institute, Edinburgh, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tulloch</LastName><ForeName>Jane</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>The University of Edinburgh Centre for Discovery Brain Sciences and UK Dementia Research Institute, Edinburgh, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wilkins</LastName><ForeName>Lewis</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>The University of Edinburgh Centre for Discovery Brain Sciences and UK Dementia Research Institute, Edinburgh, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smith</LastName><ForeName>Colin</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Centre for Clinical Brain Sciences and Sudden Death Brain Bank, The University of Edinburgh, Edinburgh, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Andrian</LastName><ForeName>Teodora</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Nanoscopy for Nanomedicine Lab, Institute of Bioengineering of Catalonia (IBEC Barcelona Institute of Science and Technology), Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Belbin</LastName><ForeName>Olivia</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Memory Unit, Department of Neurology, Institut d'Investigacions Biom&#xe8;diques Sant Pau - Hospital de Sant Pau, Universitat Aut&#xf2;noma de Barcelona, Barcelona, Spain; Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red en Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pujals</LastName><ForeName>S&#xed;lvia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Biological Chemistry, Institute for Advanced Chemistry of Catalonia (IQAC-CSIC), Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Horrocks</LastName><ForeName>Mathew H</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>EaStCHEM School of Chemistry, The University of Edinburgh, Edinburgh, UK; IRR Chemistry Hub, Institute for Regeneration and Repair, The University of Edinburgh, EH16 4 UU Edinburgh, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lle&#xf3;</LastName><ForeName>Alberto</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Memory Unit, Department of Neurology, Institut d'Investigacions Biom&#xe8;diques Sant Pau - Hospital de Sant Pau, Universitat Aut&#xf2;noma de Barcelona, Barcelona, Spain; Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red en Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain. Electronic address: alleo@santpau.cat.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spires-Jones</LastName><ForeName>Tara L</ForeName><Initials>TL</Initials><AffiliationInfo><Affiliation>The University of Edinburgh Centre for Discovery Brain Sciences and UK Dementia Research Institute, Edinburgh, UK. Electronic address: Tara.spires-jones@ed.ac.uk.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>MR/V00610X/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>05</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Neuron</MedlineTA><NlmUniqueID>8809320</NlmUniqueID><ISSNLinking>0896-6273</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016229">Amyloid beta-Peptides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016875">tau Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Nat Rev Neurosci. 2023 Jul;24(7):393. doi: 10.1038/s41583-023-00714-9.</RefSource><PMID Version="1">37237104</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Nat Rev Neurol. 2023 Jul;19(7):385. doi: 10.1038/s41582-023-00831-0.</RefSource><PMID Version="1">37258722</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016229" MajorTopicYN="N">Amyloid beta-Peptides</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017729" MajorTopicYN="N">Presynaptic Terminals</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013569" MajorTopicYN="N">Synapses</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016875" MajorTopicYN="Y">tau Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Alzheimer</Keyword><Keyword MajorTopicYN="N">synapse</Keyword><Keyword MajorTopicYN="N">tau</Keyword></KeywordList><CoiStatement>Declaration of interests T.S.-J. is on the Scientific Advisory Board of Cognition Therapeutics and has received honoraria for talks for industry collaborators. They did not have any involvement in or influence over the current paper. T.S.-J. is also a member of the Neuron Editorial Advisory Board.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>8</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>3</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>4</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>10</Month><Day>23</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>17</Day><Hour>1</Hour><Minute>7</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>16</Day><Hour>18</Hour><Minute>42</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37192625</ArticleId><ArticleId IdType="doi">10.1016/j.neuron.2023.04.020</ArticleId><ArticleId IdType="pii">S0896-6273(23)00305-7</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37202517</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>22</Day></DateCompleted><DateRevised><Year>2024</Year><Month>03</Month><Day>30</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2662-8465</ISSN><JournalIssue CitedMedium="Internet"><Volume>3</Volume><Issue>5</Issue><PubDate><Year>2023</Year><Month>May</Month></PubDate></JournalIssue><Title>Nature aging</Title><ISOAbbreviation>Nat Aging</ISOAbbreviation></Journal><ArticleTitle>Blood biomarkers for Alzheimer's disease in clinical practice and trials.</ArticleTitle><Pagination><StartPage>506</StartPage><EndPage>519</EndPage><MedlinePgn>506-519</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s43587-023-00403-3</ELocationID><Abstract><AbstractText>Blood-based biomarkers hold great promise to revolutionize the diagnostic and prognostic work-up of Alzheimer's disease (AD) in clinical practice. This is very timely, considering the recent development of anti-amyloid-&#x3b2; (A&#x3b2;) immunotherapies. Several assays for measuring phosphorylated tau (p-tau) in plasma exhibit high diagnostic accuracy in distinguishing AD from all other neurodegenerative diseases in patients with cognitive impairment. Prognostic models based on plasma p-tau levels can also predict future development of AD dementia in patients with mild cognitive complaints. The use of such high-performing plasma p-tau assays in the clinical practice of specialist memory clinics would reduce the need for more costly investigations involving cerebrospinal fluid samples or positron emission tomography. Indeed, blood-based biomarkers already facilitate identification of individuals with pre-symptomatic AD in the context of clinical trials. Longitudinal measurements of such biomarkers will also improve the detection of relevant disease-modifying effects of new drugs or lifestyle interventions.</AbstractText><CopyrightInformation>&#xa9; 2023. Springer Nature America, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hansson</LastName><ForeName>Oskar</ForeName><Initials>O</Initials><Identifier Source="ORCID">0000-0001-8467-7286</Identifier><AffiliationInfo><Affiliation>Clinical Memory Research Unit, Department of Clinical Sciences Malm&#xf6;, Faculty of Medicine, Lund University, Lund, Sweden. oskar.hansson@med.lu.se.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Memory Clinic, Sk&#xe5;ne University Hospital, Lund, Sweden. oskar.hansson@med.lu.se.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blennow</LastName><ForeName>Kaj</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0002-1890-4193</Identifier><AffiliationInfo><Affiliation>Department of Psychiatry and Neurochemistry, the Sahlgrenska Academy at the University of Gothenburg, M&#xf6;lndal, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, M&#xf6;lndal, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zetterberg</LastName><ForeName>Henrik</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Psychiatry and Neurochemistry, the Sahlgrenska Academy at the University of Gothenburg, M&#xf6;lndal, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, M&#xf6;lndal, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurodegenerative Disease, UCL Institute of Neurology, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>UK Dementia Research Institute at UCL, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hong Kong Center for 27 Neurodegenerative Diseases, Hong Kong, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Wisconsin Alzheimer's Disease Research Center, University of Wisconsin School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dage</LastName><ForeName>Jeffrey</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-2192-1699</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Indiana University School of Medicine, Indianapolis, IN, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Indiana Alzheimer's Disease Research Center, Indiana University School of Medicine, Indianapolis, IN, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Stark Neurosciences Research Institute, Indiana University School of Medicine, Indianapolis, IN, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 AG068398</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>05</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Nat Aging</MedlineTA><NlmUniqueID>101773306</NlmUniqueID><ISSNLinking>2662-8465</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016229">Amyloid beta-Peptides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014057" MajorTopicYN="N">Tomography, X-Ray Computed</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016229" MajorTopicYN="N">Amyloid beta-Peptides</DescriptorName><QualifierName UI="Q000134" MajorTopicYN="N">cerebrospinal fluid</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D060825" MajorTopicYN="Y">Cognitive Dysfunction</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>O.H. has acquired research support (for the institution) from ADx, Avid Radiopharmaceuticals, Biogen, Eli Lilly, Eisai, Fujirebio, GE Healthcare, Pfizer and Roche. In the past 2 years, he has received consultancy and/or speaker fees from AC Immune, Amylyx, ALZpath, BioArctic, Biogen, Cerveau, Eisai, Fujirebio, Genentech, Novartis, Roche and Siemens. K.B. has served as a consultant on advisory boards or on data-monitoring committees for Abcam, Axon, BioArctic, Biogen, JOMDD&#x2013;Shimadzu, Julius Clinical, Lilly, MagQu, Novartis, Ono Pharma, Pharmatrophix, Prothena, Roche Diagnostics and Siemens Healthineers and is a cofounder of Brain Biomarker Solutions in Gothenburg (BBS), which is a part of the GU Ventures Incubator Program, outside the work presented in this paper. H.Z. has served on scientific advisory boards and/or as a consultant for AbbVie, Acumen, Alector, Alzinova, ALZpath, Annexon, Apellis, Artery Therapeutics, AZTherapies, CogRx, Denali, Eisai, NervGen, Novo Nordisk, Passage Bio, Pinteon Therapeutics, Prothena, Red Abbey Labs, reMYND, Roche, Samumed, Siemens Healthineers, Triplet Therapeutics and Wave; has given lectures in symposia sponsored by Cellectricon, Fujirebio, AlzeCure, Biogen and Roche; and is a cofounder of Brain Biomarker Solutions in Gothenburg (BBS), which is a part of the GU Ventures Incubator Program (outside the work presented in this paper). J.D. is an inventor on patents or patent applications of Eli Lilly relating to the assays, methods, reagents and/or compositions of matter related to measurement of p-tau217. J.D. has served as a consultant for AbbVie, Genotix Biotechnologies, Gates Ventures, Karuna Therapeutics, ALZpath and Cognito Therapeutics and received research support from ADx NeuroSciences, Fujirebio, ALZpath, Roche Diagnostics and Eli Lilly in the past 2 years. J.D. has received speaker fees from Eli Lilly.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>11</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>3</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>22</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>19</Day><Hour>1</Hour><Minute>5</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>18</Day><Hour>23</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>3</Month><Day>29</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37202517</ArticleId><ArticleId IdType="mid">NIHMS1977292</ArticleId><ArticleId IdType="pmc">PMC10979350</ArticleId><ArticleId IdType="doi">10.1038/s43587-023-00403-3</ArticleId><ArticleId IdType="pii">10.1038/s43587-023-00403-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>DeTure MA &amp; Dickson DW The neuropathological diagnosis of Alzheimer&#x2019;s disease. Mol. Neurodegener 14, 32 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6679484</ArticleId><ArticleId IdType="pubmed">31375134</ArticleId></ArticleIdList></Reference><Reference><Citation>Hansson O Biomarkers for neurodegenerative diseases. Nat. Med 27, 954&#x2013;963 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34083813</ArticleId></ArticleIdList></Reference><Reference><Citation>Pichet Binette A et al. Amyloid-associated increases in soluble tau relate to tau aggregation rates and cognitive decline in early Alzheimer&#x2019;s disease. Nat. Commun 13, 6635 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9636262</ArticleId><ArticleId IdType="pubmed">36333294</ArticleId></ArticleIdList></Reference><Reference><Citation>Vogel JW et al. Four distinct trajectories of tau deposition identified in Alzheimer&#x2019;s disease. Nat. Med 27, 871&#x2013;881 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8686688</ArticleId><ArticleId IdType="pubmed">33927414</ArticleId></ArticleIdList></Reference><Reference><Citation>Budd Haeberlein S et al. Two randomized phase 3 studies of aducanumab in early Alzheimer&#x2019;s disease. J. Prev. Alzheimers Dis 9, 197&#x2013;210 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35542991</ArticleId></ArticleIdList></Reference><Reference><Citation>Mintun MA et al. Donanemab in early Alzheimer&#x2019;s disease. N. Engl. J. Med 384, 1691&#x2013;1704 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33720637</ArticleId></ArticleIdList></Reference><Reference><Citation>van Dyck CH et al. Lecanemab in early Alzheimer&#x2019;s disease. N. Engl. J. Med 388, 9&#x2013;21 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">36449413</ArticleId></ArticleIdList></Reference><Reference><Citation>Jansen WJ et al. Prevalence estimates of amyloid abnormality across the Alzheimer disease clinical spectrum. JAMA Neurol. 79, 228&#x2013;243 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35099509</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith R, Wibom M, Pawlik D, Englund E &amp; Hansson O Correlation of in vivo [18F]flortaucipir with postmortem Alzheimer disease tau pathology. JAMA Neurol. 76, 310&#x2013;317 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6439731</ArticleId><ArticleId IdType="pubmed">30508025</ArticleId></ArticleIdList></Reference><Reference><Citation>Fleisher AS et al. Positron emission tomography imaging with [18F]flortaucipir and postmortem assessment of Alzheimer disease neuropathologic changes. JAMA Neurol. 77, 829&#x2013;839 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7186920</ArticleId><ArticleId IdType="pubmed">32338734</ArticleId></ArticleIdList></Reference><Reference><Citation>Ossenkoppele R et al. Discriminative accuracy of [18F]flortaucipir positron emission tomography for Alzheimer disease vs other neurodegenerative disorders. JAMA 320, 1151&#x2013;1162 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6233630</ArticleId><ArticleId IdType="pubmed">30326496</ArticleId></ArticleIdList></Reference><Reference><Citation>Ossenkoppele R &amp; Hansson O Towards clinical application of tau PET tracers for diagnosing dementia due to Alzheimer&#x2019;s disease. Alzheimers Dement. 17, 1998&#x2013;2008 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33984177</ArticleId></ArticleIdList></Reference><Reference><Citation>Ossenkoppele R et al. Amyloid and tau PET-positive cognitively unimpaired individuals are at high risk for future cognitive decline. Nat. Med 28, 2381&#x2013;2387 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9671808</ArticleId><ArticleId IdType="pubmed">36357681</ArticleId></ArticleIdList></Reference><Reference><Citation>Jack CR Jr. et al. NIA-AA Research Framework: toward a biological definition of Alzheimer&#x2019;s disease. Alzheimers Dement. 14, 535&#x2013;562 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5958625</ArticleId><ArticleId IdType="pubmed">29653606</ArticleId></ArticleIdList></Reference><Reference><Citation>Janelidze S et al. CSF A&#x3b2;42/A&#x3b2;40 and A&#x3b2;42/A&#x3b2;38 ratios: better diagnostic markers of Alzheimer disease. Ann. Clin. Transl. Neurol 3, 154&#x2013;165 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4774260</ArticleId><ArticleId IdType="pubmed">27042676</ArticleId></ArticleIdList></Reference><Reference><Citation>Hansson O et al. CSF biomarkers of Alzheimer&#x2019;s disease concord with amyloid-&#x3b2; PET and predict clinical progression: a study of fully automated immunoassays in BioFINDER and ADNI cohorts. Alzheimers Dement. 14, 1470&#x2013;1481 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6119541</ArticleId><ArticleId IdType="pubmed">29499171</ArticleId></ArticleIdList></Reference><Reference><Citation>Mattsson-Carlgren N et al. Cerebrospinal fluid biomarkers in autopsy-confirmed Alzheimer disease and frontotemporal lobar degeneration. Neurology 98, e1137&#x2013;e1150 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8935438</ArticleId><ArticleId IdType="pubmed">35173015</ArticleId></ArticleIdList></Reference><Reference><Citation>Gobom J et al. Validation of the LUMIPULSE automated immunoassay for the measurement of core AD biomarkers in cerebrospinal fluid. Clin. Chem. Lab. Med 60, 207&#x2013;219 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">34773730</ArticleId></ArticleIdList></Reference><Reference><Citation>Palmqvist S et al. Detailed comparison of amyloid PET and CSF biomarkers for identifying early Alzheimer disease. Neurology 85, 1240&#x2013;1249 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4607601</ArticleId><ArticleId IdType="pubmed">26354982</ArticleId></ArticleIdList></Reference><Reference><Citation>Blennow K &amp; Zetterberg H Biomarkers for Alzheimer&#x2019;s disease: current status and prospects for the future. J. Intern. Med 284, 643&#x2013;663 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">30051512</ArticleId></ArticleIdList></Reference><Reference><Citation>Janelidze S et al. Cerebrospinal fluid p-tau217 performs better than p-tau181 as a biomarker of Alzheimer&#x2019;s disease. Nat. Commun 11, 1683 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7125218</ArticleId><ArticleId IdType="pubmed">32246036</ArticleId></ArticleIdList></Reference><Reference><Citation>Leuzy A et al. Comparing the clinical utility and diagnostic performance of CSF p-Tau181, p-Tau217, and p-Tau231 assays. Neurology 97, e1681&#x2013;e1694 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8605616</ArticleId><ArticleId IdType="pubmed">34493616</ArticleId></ArticleIdList></Reference><Reference><Citation>Karikari TK et al. Head-to-head comparison of clinical performance of CSF phospho-tau T181 and T217 biomarkers for Alzheimer&#x2019;s disease diagnosis. Alzheimers Dement. 17, 755&#x2013;767 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8246793</ArticleId><ArticleId IdType="pubmed">33252199</ArticleId></ArticleIdList></Reference><Reference><Citation>Suarez-Calvet M et al. Novel tau biomarkers phosphorylated at T181, T217 or T231 rise in the initial stages of the preclinical Alzheimer&#x2019;s continuum when only subtle changes in A&#x3b2; pathology are detected. EMBO Mol. Med 12, e12921 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7721364</ArticleId><ArticleId IdType="pubmed">33169916</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanes J et al. Evaluation of a novel immunoassay to detect p-tau Thr217 in the CSF to distinguish Alzheimer disease from other dementias. Neurology 95, e3026&#x2013;e3035 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7734919</ArticleId><ArticleId IdType="pubmed">32973122</ArticleId></ArticleIdList></Reference><Reference><Citation>Mielke MM et al. Comparison of CSF phosphorylated tau 181 and 217 for cognitive decline. Alzheimers Dement. 18, 602&#x2013;611 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8789950</ArticleId><ArticleId IdType="pubmed">34310832</ArticleId></ArticleIdList></Reference><Reference><Citation>Mattsson-Carlgren N et al. The implications of different approaches to define AT(N) in Alzheimer disease. Neurology 94, e2233&#x2013;e2244 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7357296</ArticleId><ArticleId IdType="pubmed">32398359</ArticleId></ArticleIdList></Reference><Reference><Citation>Schindler SE et al. High-precision plasma &#x3b2;-amyloid 42/40 predicts current and future brain amyloidosis. Neurology 93, e1647&#x2013;e1659 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6946467</ArticleId><ArticleId IdType="pubmed">31371569</ArticleId></ArticleIdList></Reference><Reference><Citation>Palmqvist S, Mattsson N, Hansson O &amp; Alzheimer&#x2019;s Disease Neuroimaging Initiative. Cerebrospinal fluid analysis detects cerebral amyloid-&#x3b2; accumulation earlier than positron emission tomography. Brain 139, 1226&#x2013;1236 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4806222</ArticleId><ArticleId IdType="pubmed">26936941</ArticleId></ArticleIdList></Reference><Reference><Citation>Palmqvist S et al. Cerebrospinal fluid and plasma biomarker trajectories with increasing amyloid deposition in Alzheimer&#x2019;s disease. EMBO Mol. Med 11, e11170 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6895602</ArticleId><ArticleId IdType="pubmed">31709776</ArticleId></ArticleIdList></Reference><Reference><Citation>Mattsson-Carlgren N et al. A&#x3b2; deposition is associated with increases in soluble and phosphorylated tau that precede a positive tau PET in Alzheimer&#x2019;s disease. Sci. Adv 6, eaaz2387 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7159908</ArticleId><ArticleId IdType="pubmed">32426454</ArticleId></ArticleIdList></Reference><Reference><Citation>Janelidze S et al. Associations of plasma phospho-tau217 levels with tau positron emission tomography in early Alzheimer disease. JAMA Neurol. 78, 149&#x2013;156 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7653537</ArticleId><ArticleId IdType="pubmed">33165506</ArticleId></ArticleIdList></Reference><Reference><Citation>Groot C et al. Phospho-tau with subthreshold tau-PET predicts increased tau accumulation rates in amyloid-positive individuals. Brain 10.1093/brain/awac329 (2022).</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awac329</ArticleId><ArticleId IdType="pmc">PMC10115173</ArticleId><ArticleId IdType="pubmed">36084009</ArticleId></ArticleIdList></Reference><Reference><Citation>Bastiaansen AEM et al. Autoimmune encephalitis resembling dementia syndromes. Neurol. Neuroimmunol. Neuroinflamm 8, e1039 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8362342</ArticleId><ArticleId IdType="pubmed">34341093</ArticleId></ArticleIdList></Reference><Reference><Citation>Riemenschneider M et al. Phospho-tau/total tau ratio in cerebrospinal fluid discriminates Creutzfeldt&#x2013;Jakob disease from other dementias. Mol. Psychiatry 8, 343&#x2013;347 (2003).</Citation><ArticleIdList><ArticleId IdType="pubmed">12660807</ArticleId></ArticleIdList></Reference><Reference><Citation>Hesse C et al. Transient increase in total tau but not phospho-tau in human cerebrospinal fluid after acute stroke. Neurosci. Lett 297, 187&#x2013;190 (2001).</Citation><ArticleIdList><ArticleId IdType="pubmed">11137759</ArticleId></ArticleIdList></Reference><Reference><Citation>Ost M et al. Initial CSF total tau correlates with 1-year outcome in patients with traumatic brain injury. Neurology 67, 1600&#x2013;1604 (2006).</Citation><ArticleIdList><ArticleId IdType="pubmed">17101890</ArticleId></ArticleIdList></Reference><Reference><Citation>Khalil M et al. Neurofilaments as biomarkers in neurological disorders. Nat. Rev. Neurol 14, 577&#x2013;589 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">30171200</ArticleId></ArticleIdList></Reference><Reference><Citation>Preische O et al. Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer&#x2019;s disease. Nat. Med 25, 277&#x2013;283 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6367005</ArticleId><ArticleId IdType="pubmed">30664784</ArticleId></ArticleIdList></Reference><Reference><Citation>Salvado G et al. Optimal combinations of CSF biomarkers for predicting cognitive decline and clinical conversion in cognitively unimpaired participants and mild cognitive impairment patients: a multi-cohort study. Alzheimers Dement. 10.1002/alz.12907 (2023).</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alz.12907</ArticleId><ArticleId IdType="pmc">PMC10350470</ArticleId><ArticleId IdType="pubmed">36648169</ArticleId></ArticleIdList></Reference><Reference><Citation>Salvad&#xf3; G et al. Specific associations between plasma biomarkers and postmortem amyloid plaque and tau tangle loads. EMBO Mol. Med 10.15252/emmm.202217123 (2023).</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/emmm.202217123</ArticleId><ArticleId IdType="pmc">PMC10165361</ArticleId><ArticleId IdType="pubmed">36912178</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakamura A et al. High performance plasma amyloid-&#x3b2; biomarkers for Alzheimer&#x2019;s disease. Nature 554, 249&#x2013;254 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">29420472</ArticleId></ArticleIdList></Reference><Reference><Citation>Ovod V et al. Amyloid &#x3b2; concentrations and stable isotope labeling kinetics of human plasma specific to central nervous system amyloidosis. Alzheimers Dement. 13, 841&#x2013;849 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5567785</ArticleId><ArticleId IdType="pubmed">28734653</ArticleId></ArticleIdList></Reference><Reference><Citation>Janelidze S et al. Plasma &#x3b2;-amyloid in Alzheimer&#x2019;s disease and vascular disease. Sci. Rep 6, 26801 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4886210</ArticleId><ArticleId IdType="pubmed">27241045</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y et al. Validation of plasma amyloid-&#x3b2; 42/40 for detecting Alzheimer disease amyloid plaques. Neurology 98, e688&#x2013;e699 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8865895</ArticleId><ArticleId IdType="pubmed">34906975</ArticleId></ArticleIdList></Reference><Reference><Citation>Palmqvist S et al. Performance of fully automated plasma assays as screening tests for Alzheimer disease-related &#x3b2;-amyloid status. JAMA Neurol. 76, 1060&#x2013;1069 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6593637</ArticleId><ArticleId IdType="pubmed">31233127</ArticleId></ArticleIdList></Reference><Reference><Citation>West T et al. A blood-based diagnostic test incorporating plasma A&#x3b2;42/40 ratio, ApoE proteotype, and age accurately identifies brain amyloid status: findings from a multi cohort validity analysis. Mol. Neurodegener 16, 30 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8088704</ArticleId><ArticleId IdType="pubmed">33933117</ArticleId></ArticleIdList></Reference><Reference><Citation>Janelidze S et al. Head-to-head comparison of 8 plasma amyloid-&#x3b2; 42/40 assays in Alzheimer disease. JAMA Neurol. 78, 1375&#x2013;1382 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8453354</ArticleId><ArticleId IdType="pubmed">34542571</ArticleId></ArticleIdList></Reference><Reference><Citation>Roher AE et al. Amyloid &#x3b2; peptides in human plasma and tissues and their significance for Alzheimer&#x2019;s disease. Alzheimers Dement. 5, 18&#x2013;29 (2009).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2663406</ArticleId><ArticleId IdType="pubmed">19118806</ArticleId></ArticleIdList></Reference><Reference><Citation>Mielke MM et al. Plasma phospho-tau181 increases with Alzheimer&#x2019;s disease clinical severity and is associated with tau- and amyloid-positron emission tomography. Alzheimers Dement. 14, 989&#x2013;997 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6097897</ArticleId><ArticleId IdType="pubmed">29626426</ArticleId></ArticleIdList></Reference><Reference><Citation>Janelidze S et al. Plasma p-tau181 in Alzheimer&#x2019;s disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer&#x2019;s dementia. Nat. Med 26, 379&#x2013;386 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32123385</ArticleId></ArticleIdList></Reference><Reference><Citation>Karikari TK et al. Blood phosphorylated tau 181 as a biomarker for Alzheimer&#x2019;s disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts. Lancet Neurol. 19, 422&#x2013;433 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32333900</ArticleId></ArticleIdList></Reference><Reference><Citation>Thijssen EH et al. Diagnostic value of plasma phosphorylated tau181 in Alzheimer&#x2019;s disease and frontotemporal lobar degeneration. Nat. Med 26, 387&#x2013;397 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7101073</ArticleId><ArticleId IdType="pubmed">32123386</ArticleId></ArticleIdList></Reference><Reference><Citation>Palmqvist S et al. Discriminative accuracy of plasma phospho-tau217 for Alzheimer disease vs other neurodegenerative disorders. JAMA 324, 772&#x2013;781 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7388060</ArticleId><ArticleId IdType="pubmed">32722745</ArticleId></ArticleIdList></Reference><Reference><Citation>Barthelemy NR, Horie K, Sato C &amp; Bateman RJ Blood plasma phosphorylated-tau isoforms track CNS change in Alzheimer&#x2019;s disease. J. Exp. Med 217, e20200861 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7596823</ArticleId><ArticleId IdType="pubmed">32725127</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashton NJ et al. Plasma p-tau231: a new biomarker for incipient Alzheimer&#x2019;s disease pathology. Acta Neuropathol. 141, 709&#x2013;724 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8043944</ArticleId><ArticleId IdType="pubmed">33585983</ArticleId></ArticleIdList></Reference><Reference><Citation>Janelidze S et al. Head-to-head comparison of 10 plasma phospho-tau assays in prodromal Alzheimer&#x2019;s disease. Brain 10.1093/brain/awac333 (2022).</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awac333</ArticleId><ArticleId IdType="pmc">PMC10115176</ArticleId><ArticleId IdType="pubmed">36087307</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashton NJ et al. Plasma and CSF biomarkers in a memory clinic: head-to-head comparison of phosphorylated tau immunoassays. Alzheimers Dement. 10.1002/alz.12841 (2022).</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alz.12841</ArticleId><ArticleId IdType="pmc">PMC10762642</ArticleId><ArticleId IdType="pubmed">36370462</ArticleId></ArticleIdList></Reference><Reference><Citation>Mielke MM et al. Comparison of plasma phosphorylated tau species with amyloid and tau positron emission tomography, neurodegeneration, vascular pathology, and cognitive outcomes. JAMA Neurol. 78, 1108&#x2013;1117 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8314178</ArticleId><ArticleId IdType="pubmed">34309632</ArticleId></ArticleIdList></Reference><Reference><Citation>Bayoumy S et al. Clinical and analytical comparison of six Simoa assays for plasma p-tau isoforms p-tau181, p-tau217, and p-tau231. Alzheimers Res. Ther 13, 198 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8645090</ArticleId><ArticleId IdType="pubmed">34863295</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashton NJ et al. Differential roles of A&#x3b2;42/40, p-tau231 and p-tau217 for Alzheimer&#x2019;s trial selection and disease monitoring. Nat. Med 28, 2555&#x2013;2562 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9800279</ArticleId><ArticleId IdType="pubmed">36456833</ArticleId></ArticleIdList></Reference><Reference><Citation>Mila-Aloma M et al. Plasma p-tau231 and p-tau217 as state markers of amyloid-&#x3b2; pathology in preclinical Alzheimer&#x2019;s disease. Nat. Med 28, 1797&#x2013;1801 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9499867</ArticleId><ArticleId IdType="pubmed">35953717</ArticleId></ArticleIdList></Reference><Reference><Citation>Therriault J et al. Association of phosphorylated tau biomarkers with amyloid positron emission tomography vs tau positron emission tomography. JAMA Neurol. 80, 188&#x2013;199 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9856704</ArticleId><ArticleId IdType="pubmed">36508198</ArticleId></ArticleIdList></Reference><Reference><Citation>Mattsson-Carlgren N et al. Soluble p-tau217 reflects amyloid and tau pathology and mediates the association of amyloid with tau. EMBO Mol. Med 13, e14022 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8185545</ArticleId><ArticleId IdType="pubmed">33949133</ArticleId></ArticleIdList></Reference><Reference><Citation>Sato C et al. Tau kinetics in neurons and the human central nervous system. Neuron 98, 861&#x2013;864 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6192252</ArticleId><ArticleId IdType="pubmed">29772204</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaeser SA et al. CSF p-tau increase in response to A&#x3b2;-type and Danish-type cerebral amyloidosis and in the absence of neurofibrillary tangles. Acta Neuropathol. 143, 287&#x2013;290 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8742811</ArticleId><ArticleId IdType="pubmed">34961894</ArticleId></ArticleIdList></Reference><Reference><Citation>Horie K, Barthelemy NR, Sato C &amp; Bateman RJ CSF tau microtubule binding region identifies tau tangle and clinical stages of Alzheimer&#x2019;s disease. Brain 144, 515&#x2013;527 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7940175</ArticleId><ArticleId IdType="pubmed">33283854</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashton NJ et al. A multicentre validation study of the diagnostic value of plasma neurofilament light. Nat. Commun 12, 3400 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8185001</ArticleId><ArticleId IdType="pubmed">34099648</ArticleId></ArticleIdList></Reference><Reference><Citation>Gisslen M et al. Plasma concentration of the neurofilament light protein (NfL) is a biomarker of CNS injury in HIV infection: a cross-sectional study. EBioMedicine 3, 135&#x2013;140 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4739412</ArticleId><ArticleId IdType="pubmed">26870824</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodrigues FB et al. Mutant huntingtin and neurofilament light have distinct longitudinal dynamics in Huntington&#x2019;s disease. Sci. Transl. Med 12, eabc2888 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7611886</ArticleId><ArticleId IdType="pubmed">33328328</ArticleId></ArticleIdList></Reference><Reference><Citation>Verberk IMW et al. Combination of plasma amyloid &#x3b2;(1&#x2013;42/1&#x2013;40) and glial fibrillary acidic protein strongly associates with cerebral amyloid pathology. Alzheimers Res. Ther 12, 118 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7523295</ArticleId><ArticleId IdType="pubmed">32988409</ArticleId></ArticleIdList></Reference><Reference><Citation>Pereira JB et al. Plasma GFAP is an early marker of amyloid-&#x3b2; but not tau pathology in Alzheimer&#x2019;s disease. Brain 144, 3505&#x2013;3516 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8677538</ArticleId><ArticleId IdType="pubmed">34259835</ArticleId></ArticleIdList></Reference><Reference><Citation>Benedet AL et al. Differences between plasma and cerebrospinal fluid glial fibrillary acidic protein levels across the Alzheimer disease continuum. JAMA Neurol. 78, 1471&#x2013;1483 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8524356</ArticleId><ArticleId IdType="pubmed">34661615</ArticleId></ArticleIdList></Reference><Reference><Citation>Verberk IMW et al. Serum markers glial fibrillary acidic protein and neurofilament light for prognosis and monitoring in cognitively normal older people: a prospective memory clinic-based cohort study. Lancet Healthy Longev. 2, e87&#x2013;e95 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">36098162</ArticleId></ArticleIdList></Reference><Reference><Citation>Cicognola C et al. Plasma glial fibrillary acidic protein detects Alzheimer pathology and predicts future conversion to Alzheimer dementia in patients with mild cognitive impairment. Alzheimers Res. Ther 13, 68 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8005231</ArticleId><ArticleId IdType="pubmed">33773595</ArticleId></ArticleIdList></Reference><Reference><Citation>Heller C et al. Plasma glial fibrillary acidic protein is raised in progranulin-associated frontotemporal dementia. J. Neurol. Neurosurg. Psychiatry 91, 263&#x2013;270 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">31937580</ArticleId></ArticleIdList></Reference><Reference><Citation>Brum WS et al. A two-step workflow based on plasma p-tau217 to screen for A&#x3b2; pathology with further confirmatory testing only in uncertain cases. Nat. Aging (in the press).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10501903</ArticleId><ArticleId IdType="pubmed">37653254</ArticleId></ArticleIdList></Reference><Reference><Citation>Janelidze S et al. Detecting amyloid positivity in early Alzheimer&#x2019;s disease using combinations of plasma A&#x3b2;42/A&#x3b2;40 and p-tau. Alzheimers Dement. 18, 283&#x2013;293 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">34151519</ArticleId></ArticleIdList></Reference><Reference><Citation>Palmqvist S et al. An accurate fully automated panel of plasma biomarkers for Alzheimer&#x2019;s disease. Alzheimers Dement. 10.1002/alz.12751 (2022).</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alz.12751</ArticleId><ArticleId IdType="pmc">PMC9918613</ArticleId><ArticleId IdType="pubmed">35950735</ArticleId></ArticleIdList></Reference><Reference><Citation>Karikari TK et al. Blood phospho-tau in Alzheimer disease: analysis, interpretation, and clinical utility. Nat. Rev. Neurol 18, 400&#x2013;418 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35585226</ArticleId></ArticleIdList></Reference><Reference><Citation>Teunissen CE et al. Blood-based biomarkers for Alzheimer&#x2019;s disease: towards clinical implementation. Lancet Neurol. 21, 66&#x2013;77 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">34838239</ArticleId></ArticleIdList></Reference><Reference><Citation>Leuzy A et al. Blood-based biomarkers for Alzheimer&#x2019;s disease. EMBO Mol. Med 14, e14408 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8749476</ArticleId><ArticleId IdType="pubmed">34859598</ArticleId></ArticleIdList></Reference><Reference><Citation>Cullen NC et al. Test&#x2013;retest variability of plasma biomarkers in Alzheimer&#x2019;s disease and its effects on clinical prediction models. Alzheimers Dement. 19, 797&#x2013;806 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9747985</ArticleId><ArticleId IdType="pubmed">35699240</ArticleId></ArticleIdList></Reference><Reference><Citation>Mielke MM et al. Performance of plasma phosphorylated tau 181 and 217 in the community. Nat. Med 28, 1398&#x2013;1405 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9329262</ArticleId><ArticleId IdType="pubmed">35618838</ArticleId></ArticleIdList></Reference><Reference><Citation>Janelidze S, Barth&#xe9;lemy NR, He Y, Bateman RJ &amp; Hansson O Mitigating the associations of kidney dysfunction with blood biomarkers of Alzheimer disease by using a phosphorylated tau to total tau ratio. JAMA Neurol. 10.1001/jamaneurol.2023.0199 (2023).</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2023.0199</ArticleId><ArticleId IdType="pmc">PMC10061310</ArticleId><ArticleId IdType="pubmed">36987840</ArticleId></ArticleIdList></Reference><Reference><Citation>Rabe C et al. Clinical performance and robustness evaluation of plasma amyloid-&#x3b2;42/40 prescreening. Alzheimers Dement. 10.1002/alz.12801 (2022).</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alz.12801</ArticleId><ArticleId IdType="pubmed">36150024</ArticleId></ArticleIdList></Reference><Reference><Citation>Hansson O et al. The Alzheimer&#x2019;s Association appropriate use recommendations for blood biomarkers in Alzheimer&#x2019;s disease. Alzheimers Dement. 18, 2669&#x2013;2686 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10087669</ArticleId><ArticleId IdType="pubmed">35908251</ArticleId></ArticleIdList></Reference><Reference><Citation>Mank A et al. Identifying relevant outcomes in the progression of Alzheimer&#x2019;s disease; what do patients and care partners want to know about prognosis? Alzheimers Dement. 7, e12189 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8377775</ArticleId><ArticleId IdType="pubmed">34458555</ArticleId></ArticleIdList></Reference><Reference><Citation>Karikari TK et al. Diagnostic performance and prediction of clinical progression of plasma phospho-tau181 in the Alzheimer&#x2019;s Disease Neuroimaging Initiative. Mol. Psychiatry 26, 429&#x2013;442 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33106600</ArticleId></ArticleIdList></Reference><Reference><Citation>Palmqvist S et al. Prediction of future Alzheimer&#x2019;s disease dementia using plasma phospho-tau combined with other accessible measures. Nat. Med 27, 1034&#x2013;1042 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34031605</ArticleId></ArticleIdList></Reference><Reference><Citation>Cullen N et al. Individualized prognosis of cognitive decline and dementia in mild cognitive impairment based on plasma biomarker combinations. Nat. Aging 1, 114&#x2013;123 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">37117993</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith R et al. Tau-PET is superior to phospho-tau when predicting cognitive decline in symptomatic AD patients. Alzheimers Dement. 10.1002/alz.12875 (2022).</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alz.12875</ArticleId><ArticleId IdType="pmc">PMC10264552</ArticleId><ArticleId IdType="pubmed">36516028</ArticleId></ArticleIdList></Reference><Reference><Citation>Schindler SE et al. Using Alzheimer&#x2019;s disease blood tests to accelerate clinical trial enrollment. Alzheimers Dement. 10.1002/alz.12754 (2022).</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alz.12754</ArticleId><ArticleId IdType="pmc">PMC9902574</ArticleId><ArticleId IdType="pubmed">35934777</ArticleId></ArticleIdList></Reference><Reference><Citation>Cullen N et al. Plasma amyloid-&#x3b2;42/40 and apolipoprotein E for amyloid PET pre-screening in secondary prevention trials of Alzheimer&#x2019;s disease. Brain Commun. 5, fcad015 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10012324</ArticleId><ArticleId IdType="pubmed">36926368</ArticleId></ArticleIdList></Reference><Reference><Citation>Insel PS et al. Determining clinically meaningful decline in preclinical Alzheimer disease. Neurology 93, e322&#x2013;e333 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6669933</ArticleId><ArticleId IdType="pubmed">31289148</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Kall LM et al. Association of &#x3b2;-amyloid level, clinical progression, and longitudinal cognitive change in normal older individuals. Neurology 96, e662&#x2013;e670 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7884996</ArticleId><ArticleId IdType="pubmed">33184233</ArticleId></ArticleIdList></Reference><Reference><Citation>Donohue MC et al. Association between elevated brain amyloid and subsequent cognitive decline among cognitively normal persons. JAMA 317, 2305&#x2013;2316 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5736301</ArticleId><ArticleId IdType="pubmed">28609533</ArticleId></ArticleIdList></Reference><Reference><Citation>Mattsson-Carlgren N et al. Prediction of longitudinal cognitive decline in preclinical Alzheimer disease using plasma biomarkers. JAMA Neurol. 10.1001/jamaneurol.2022.5272 (2023).</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2022.5272</ArticleId><ArticleId IdType="pmc">PMC10087054</ArticleId><ArticleId IdType="pubmed">36745413</ArticleId></ArticleIdList></Reference><Reference><Citation>Ossenkoppele R et al. Accuracy of tau positron emission tomography as a prognostic marker in preclinical and prodromal Alzheimer disease: a head-to-head comparison against amyloid positron emission tomography and magnetic resonance imaging. JAMA Neurol. 78, 961&#x2013;971 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8240013</ArticleId><ArticleId IdType="pubmed">34180956</ArticleId></ArticleIdList></Reference><Reference><Citation>Leuzy A et al. Biomarker-based prediction of longitudinal tau positron emission tomography in Alzheimer disease. JAMA Neurol. 79, 149&#x2013;158 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8689441</ArticleId><ArticleId IdType="pubmed">34928318</ArticleId></ArticleIdList></Reference><Reference><Citation>Bradford A, Kunik ME, Schulz P, Williams SP &amp; Singh H Missed and delayed diagnosis of dementia in primary care: prevalence and contributing factors. Alzheimer Dis. Assoc. Disord 23, 306&#x2013;314 (2009).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2787842</ArticleId><ArticleId IdType="pubmed">19568149</ArticleId></ArticleIdList></Reference><Reference><Citation>US Food and Drug Administration. Surrogate Endpoint Resources for Drug and Biologic Development
https://www.fda.gov/drugs/development-resources/surrogate-endpoint-resources-drug-and-biologic-development (2018).</Citation></Reference><Reference><Citation>Ning L &amp; Wang B Neurofilament light chain in blood as a diagnostic and predictive biomarker for multiple sclerosis: a systematic review and meta-analysis. PLoS ONE 17, e0274565 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9473405</ArticleId><ArticleId IdType="pubmed">36103562</ArticleId></ArticleIdList></Reference><Reference><Citation>Zetterberg H et al. Association of cerebrospinal fluid neurofilament light concentration with Alzheimer disease progression. JAMA Neurol. 73, 60&#x2013;67 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5624219</ArticleId><ArticleId IdType="pubmed">26524180</ArticleId></ArticleIdList></Reference><Reference><Citation>Mattsson N, Andreasson U, Zetterberg H, Blennow K &amp; Alzheimer&#x2019;s Disease Neuroimaging I Association of plasma neurofilament light with neurodegeneration in patients with Alzheimer disease. JAMA Neurol. 74, 557&#x2013;566 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5822204</ArticleId><ArticleId IdType="pubmed">28346578</ArticleId></ArticleIdList></Reference><Reference><Citation>Disanto G et al. Serum neurofilament light: a biomarker of neuronal damage in multiple sclerosis. Ann. Neurol 81, 857&#x2013;870 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5519945</ArticleId><ArticleId IdType="pubmed">28512753</ArticleId></ArticleIdList></Reference><Reference><Citation>Benatar M et al. Validation of serum neurofilaments as prognostic and potential pharmacodynamic biomarkers for ALS. Neurology 95, e59&#x2013;e69 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7371380</ArticleId><ArticleId IdType="pubmed">32385188</ArticleId></ArticleIdList></Reference><Reference><Citation>Staffaroni AM et al. Temporal order of clinical and biomarker changes in familial frontotemporal dementia. Nat. Med 28, 2194&#x2013;2206 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9951811</ArticleId><ArticleId IdType="pubmed">36138153</ArticleId></ArticleIdList></Reference><Reference><Citation>Delcoigne B et al. Blood neurofilament light levels segregate treatment effects in multiple sclerosis. Neurology 94, e1201&#x2013;e1212 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7387108</ArticleId><ArticleId IdType="pubmed">32047070</ArticleId></ArticleIdList></Reference><Reference><Citation>Olsson B et al. NfL is a marker of treatment response in children with SMA treated with nusinersen. J. Neurol 266, 2129&#x2013;2136 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6687695</ArticleId><ArticleId IdType="pubmed">31123861</ArticleId></ArticleIdList></Reference><Reference><Citation>Salloway S et al. A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer&#x2019;s disease. Nat. Med 27, 1187&#x2013;1196 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8988051</ArticleId><ArticleId IdType="pubmed">34155411</ArticleId></ArticleIdList></Reference><Reference><Citation>Swanson CJ et al. A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer&#x2019;s disease with lecanemab, an anti-A&#x3b2; protofibril antibody. Alzheimers Res. Ther 13, 80 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8053280</ArticleId><ArticleId IdType="pubmed">33865446</ArticleId></ArticleIdList></Reference><Reference><Citation>Pontecorvo MJ et al. Association of donanemab treatment with exploratory plasma biomarkers in early symptomatic Alzheimer disease: a secondary analysis of the TRAILBLAZER-ALZ randomized clinical trial. JAMA Neurol. 79, 1250&#x2013;1259 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9577883</ArticleId><ArticleId IdType="pubmed">36251300</ArticleId></ArticleIdList></Reference><Reference><Citation>Buchhave P et al. Cerebrospinal fluid levels of &#x3b2;-amyloid 1&#x2013;42, but not of tau, are fully changed already 5 to 10 years before the onset of Alzheimer dementia. Arch. Gen. Psychiatry 69, 98&#x2013;106 (2012).</Citation><ArticleIdList><ArticleId IdType="pubmed">22213792</ArticleId></ArticleIdList></Reference><Reference><Citation>Samgard K et al. Cerebrospinal fluid total tau as a marker of Alzheimer&#x2019;s disease intensity. Int. J. Geriatr. Psychiatry 25, 403&#x2013;410 (2010).</Citation><ArticleIdList><ArticleId IdType="pubmed">19650161</ArticleId></ArticleIdList></Reference><Reference><Citation>Mattsson-Carlgren N et al. Longitudinal plasma p-tau217 is increased in early stages of Alzheimer&#x2019;s disease. Brain 143, 3234&#x2013;3241 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7719022</ArticleId><ArticleId IdType="pubmed">33068398</ArticleId></ArticleIdList></Reference><Reference><Citation>Hansson O et al. Plasma phosphorylated tau181 and neurodegeneration in Alzheimer&#x2019;s disease. Ann. Clin. Transl. Neurol 8, 259&#x2013;265 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7818141</ArticleId><ArticleId IdType="pubmed">33249783</ArticleId></ArticleIdList></Reference><Reference><Citation>Moscoso A et al. Time course of phosphorylated-tau181 in blood across the Alzheimer&#x2019;s disease spectrum. Brain 144, 325&#x2013;339 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7880671</ArticleId><ArticleId IdType="pubmed">33257949</ArticleId></ArticleIdList></Reference><Reference><Citation>Portelius E et al. Ex vivo 18O-labeling mass spectrometry identifies a peripheral amyloid &#x3b2; clearance pathway. Mol. Neurodegener 12, 18 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5317049</ArticleId><ArticleId IdType="pubmed">28219449</ArticleId></ArticleIdList></Reference><Reference><Citation>Yanamandra K et al. Anti-tau antibody administration increases plasma tau in transgenic mice and patients with tauopathy. Sci. Transl. Med 9 eaal2029 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5727571</ArticleId><ArticleId IdType="pubmed">28424326</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuhlmann J et al. CSF A&#x3b2;1&#x2013;42&#x2014;an excellent but complicated Alzheimer&#x2019;s biomarker&#x2014;a route to standardisation. Clin. Chim. Acta 467, 27&#x2013;33 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">27216941</ArticleId></ArticleIdList></Reference><Reference><Citation>Boulo S et al. First amyloid &#x3b2;1&#x2013;42 certified reference material for re-calibrating commercial immunoassays. Alzheimers Dement. 16, 1493&#x2013;1503 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7984389</ArticleId><ArticleId IdType="pubmed">32755010</ArticleId></ArticleIdList></Reference><Reference><Citation>Pannee J et al. The global Alzheimer&#x2019;s Association round robin study on plasma amyloid &#x3b2; methods. Alzheimers Dement. 13, e12242 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8515356</ArticleId><ArticleId IdType="pubmed">34692980</ArticleId></ArticleIdList></Reference><Reference><Citation>Andreasson U et al. Commutability of the certified reference materials for the standardization of &#x3b2;-amyloid 1&#x2013;42 assay in human cerebrospinal fluid: lessons for tau and &#x3b2;-amyloid 1&#x2013;40 measurements. Clin. Chem. Lab. Med 56, 2058&#x2013;2066 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">29949507</ArticleId></ArticleIdList></Reference><Reference><Citation>Hansson O et al. The Alzheimer&#x2019;s Association international guidelines for handling of cerebrospinal fluid for routine clinical measurements of amyloid &#x3b2; and tau. Alzheimers Dement. 17, 1575&#x2013;1582 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33788410</ArticleId></ArticleIdList></Reference><Reference><Citation>Rozga M, Bittner T, Batrla R &amp; Karl J Preanalytical sample handling recommendations for Alzheimer&#x2019;s disease plasma biomarkers. Alzheimers Dement. 11, 291&#x2013;300 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6446057</ArticleId><ArticleId IdType="pubmed">30984815</ArticleId></ArticleIdList></Reference><Reference><Citation>Verberk IMW et al. Characterization of pre-analytical sample handling effects on a panel of Alzheimer&#x2019;s disease-related blood-based biomarkers: results from the Standardization of Alzheimer&#x2019;s Blood Biomarkers (SABB) working group. Alzheimers Dement. 18, 1484&#x2013;1497 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9148379</ArticleId><ArticleId IdType="pubmed">34845818</ArticleId></ArticleIdList></Reference><Reference><Citation>Winston CN et al. Evaluation of blood-based plasma biomarkers as potential markers of amyloid burden in preclinical Alzheimer&#x2019;s disease. J. Alzheimers Dis 92, 95&#x2013;107 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11191492</ArticleId><ArticleId IdType="pubmed">36710683</ArticleId></ArticleIdList></Reference><Reference><Citation>Leuzy A et al. Robustness of CSF A&#x3b2;42/40 and A&#x3b2;42/p-tau181 measured using fully automated immunoassays to detect AD-related outcomes. Alzheimers Dement. 10.1002/alz.12897 (2023).</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alz.12897</ArticleId><ArticleId IdType="pubmed">36681387</ArticleId></ArticleIdList></Reference><Reference><Citation>Benedet AL et al. The accuracy and robustness of plasma biomarker models for amyloid PET positivity. Alzheimers Res. Ther 14, 26 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8819863</ArticleId><ArticleId IdType="pubmed">35130933</ArticleId></ArticleIdList></Reference><Reference><Citation>Hampel H et al. Developing the ATX(N) classification for use across the Alzheimer disease continuum. Nat. Rev. Neurol 17, 580&#x2013;589 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34239130</ArticleId></ArticleIdList></Reference><Reference><Citation>Simren J et al. Establishment of reference values for plasma neurofilament light based on healthy individuals aged 5&#x2013;90 years. Brain Commun. 4, fcac174 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9297091</ArticleId><ArticleId IdType="pubmed">35865350</ArticleId></ArticleIdList></Reference><Reference><Citation>Syrjanen JA et al. Associations of amyloid and neurodegeneration plasma biomarkers with comorbidities. Alzheimers Dement. 18, 1128&#x2013;1140 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8957642</ArticleId><ArticleId IdType="pubmed">34569696</ArticleId></ArticleIdList></Reference><Reference><Citation>Pichet Binette A et al. Confounding factors of Alzheimer&#x2019;s disease plasma biomarkers and their impact on clinical performance. Alzheimers Dement. 10.1002/alz.12787 (2022).</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alz.12787</ArticleId><ArticleId IdType="pmc">PMC10499000</ArticleId><ArticleId IdType="pubmed">36152307</ArticleId></ArticleIdList></Reference><Reference><Citation>Sullivan GM &amp; Feinn R Using effect size&#x2014;or why the P value is not enough. J. Grad. Med. Educ 4, 279&#x2013;282 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3444174</ArticleId><ArticleId IdType="pubmed">23997866</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim E, Miyamura J &amp; Chen JJ Racial/ethnic-specific reference intervals for common laboratory tests: a comparison among Asians, Blacks, Hispanics, and white. Hawaii J. Med. Public Health 74, 302&#x2013;310 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4578165</ArticleId><ArticleId IdType="pubmed">26468426</ArticleId></ArticleIdList></Reference><Reference><Citation>Brickman AM et al. Plasma p-tau181, p-tau217, and other blood-based Alzheimer&#x2019;s disease biomarkers in a multi-ethnic, community study. Alzheimers Dement. 17, 1353&#x2013;1364 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8451860</ArticleId><ArticleId IdType="pubmed">33580742</ArticleId></ArticleIdList></Reference><Reference><Citation>Windon C et al. Comparison of plasma and CSF biomarkers across ethnoracial groups in the ADNI. Alzheimers Dement. 14, e12315 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9057320</ArticleId><ArticleId IdType="pubmed">35510092</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu Y et al. Assessment of a plasma amyloid probability score to estimate amyloid positron emission tomography findings among adults with cognitive impairment. JAMA Netw. Open 5, e228392 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9024390</ArticleId><ArticleId IdType="pubmed">35446396</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37202518</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>22</Day></DateCompleted><DateRevised><Year>2024</Year><Month>06</Month><Day>27</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2662-8465</ISSN><JournalIssue CitedMedium="Internet"><Volume>3</Volume><Issue>5</Issue><PubDate><Year>2023</Year><Month>May</Month></PubDate></JournalIssue><Title>Nature aging</Title><ISOAbbreviation>Nat Aging</ISOAbbreviation></Journal><ArticleTitle>Detection and treatment of Alzheimer's disease in its preclinical stage.</ArticleTitle><Pagination><StartPage>520</StartPage><EndPage>531</EndPage><MedlinePgn>520-531</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s43587-023-00410-4</ELocationID><Abstract><AbstractText>Longitudinal multimodal biomarker studies reveal that the continuum of Alzheimer's disease (AD) includes a long latent phase, referred to as preclinical AD, which precedes the onset of symptoms by decades. Treatment during the preclinical AD phase offers an optimal opportunity for slowing the progression of disease. However, trial design in this population is complex. In this Review, we discuss the recent advances in accurate plasma measurements, new recruitment approaches, sensitive cognitive instruments and self-reported outcomes that have facilitated the successful launch of multiple phase 3 trials for preclinical AD. The recent success of anti-amyloid immunotherapy trials in symptomatic AD has increased the enthusiasm for testing this strategy at the earliest feasible stage. We provide an outlook for standard screening of amyloid accumulation at the preclinical stage in clinically normal individuals, during which effective therapy to delay or prevent cognitive decline can be initiated.</AbstractText><CopyrightInformation>&#xa9; 2023. Springer Nature America, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rafii</LastName><ForeName>Michael S</ForeName><Initials>MS</Initials><Identifier Source="ORCID">0000-0003-2640-2094</Identifier><AffiliationInfo><Affiliation>Alzheimer's Therapeutic Research Institute, Keck School of Medicine University of Southern California, Los Angeles, CA, USA. mrafii@usc.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aisen</LastName><ForeName>Paul S</ForeName><Initials>PS</Initials><AffiliationInfo><Affiliation>Alzheimer's Therapeutic Research Institute, Keck School of Medicine University of Southern California, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R33 AG066543</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R61 AG066543</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U24 AG057437</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>05</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Nat Aging</MedlineTA><NlmUniqueID>101773306</NlmUniqueID><ISSNLinking>2662-8465</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016229">Amyloid beta-Peptides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D058227">Amyloidogenic Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016229" MajorTopicYN="N">Amyloid beta-Peptides</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060825" MajorTopicYN="Y">Cognitive Dysfunction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058227" MajorTopicYN="N">Amyloidogenic Proteins</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>11</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>3</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>22</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>19</Day><Hour>1</Hour><Minute>4</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>18</Day><Hour>23</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>5</Month><Day>22</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37202518</ArticleId><ArticleId IdType="mid">NIHMS1991750</ArticleId><ArticleId IdType="pmc">PMC11110912</ArticleId><ArticleId IdType="doi">10.1038/s43587-023-00410-4</ArticleId><ArticleId IdType="pii">10.1038/s43587-023-00410-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Knopman DS et al. Alzheimer disease. Nat. Rev. Dis. Primers 7, 33 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8574196</ArticleId><ArticleId IdType="pubmed">33986301</ArticleId></ArticleIdList></Reference><Reference><Citation>Aisen PS et al. On the path to 2025: understanding the Alzheimer&#x2019;s disease continuum. Alzheimers Res. Ther 9, 60 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5549378</ArticleId><ArticleId IdType="pubmed">28793924</ArticleId></ArticleIdList></Reference><Reference><Citation>Jack CR Jr et al. Tracking pathophysiological processes in Alzheimer&#x2019;s disease: an updated hypothetical model of dynamic biomarkers. Lancet Neurol. 12, 207&#x2013;216 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3622225</ArticleId><ArticleId IdType="pubmed">23332364</ArticleId></ArticleIdList></Reference><Reference><Citation>Raskin J, Cummings J, Hardy J, Schuh K &amp; Dean RA Neurobiology of Alzheimer&#x2019;s disease: integrated molecular, physiological, anatomical, biomarker, and cognitive dimensions. Curr. Alzheimer Res 12, 712&#x2013;722 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5384474</ArticleId><ArticleId IdType="pubmed">26412218</ArticleId></ArticleIdList></Reference><Reference><Citation>Jack CR Jr et al. Hypothetical model of dynamic biomarkers of the Alzheimer&#x2019;s pathological cascade. Lancet Neurol. 9, 119&#x2013;128 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2819840</ArticleId><ArticleId IdType="pubmed">20083042</ArticleId></ArticleIdList></Reference><Reference><Citation>Bateman RJ et al. Clinical and biomarker changes in dominantly inherited Alzheimer&#x2019;s disease. N. Engl. J. Med 367, 795&#x2013;804 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3474597</ArticleId><ArticleId IdType="pubmed">22784036</ArticleId></ArticleIdList></Reference><Reference><Citation>Fortea J. et al. Clinical and biomarker changes of Alzheimer&#x2019;s disease in adults with Down syndrome: a cross-sectional study. Lancet 395, 1988&#x2013;1997 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7322523</ArticleId><ArticleId IdType="pubmed">32593336</ArticleId></ArticleIdList></Reference><Reference><Citation>Dubois B. et al. Advancing research diagnostic criteria for Alzheimer&#x2019;s disease: the IWG-2 criteria. Lancet Neurol. 13, 614&#x2013;629 (2014).</Citation><ArticleIdList><ArticleId IdType="pubmed">24849862</ArticleId></ArticleIdList></Reference><Reference><Citation>Donohue MC et al. Association between elevated brain amyloid and subsequent cognitive decline among cognitively normal persons. JAMA 317, 2305&#x2013;2316 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5736301</ArticleId><ArticleId IdType="pubmed">28609533</ArticleId></ArticleIdList></Reference><Reference><Citation>Ossenkoppele R. et al. Amyloid and tau PET-positive cognitively unimpaired individuals are at high risk for future cognitive decline. Nat. Med 28, 2381&#x2013;2387 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9671808</ArticleId><ArticleId IdType="pubmed">36357681</ArticleId></ArticleIdList></Reference><Reference><Citation>Aisen PS, Jimenez-Maggiora GA, Rafii MS, Walter S &amp; Raman R Early-stage Alzheimer disease: getting trial-ready. Nat. Rev. Neurol 18, 389&#x2013;399 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8978175</ArticleId><ArticleId IdType="pubmed">35379951</ArticleId></ArticleIdList></Reference><Reference><Citation>US Department of Health and Human Services, Food and Drug Administration. Guidance for Industry: Early Alzheimer&#x2019;s Disease: Developing Drugs for Treatment
https://www.fda.gov/regulatory-information/search-fda-guidance-documents/alzheimers-disease-developing-drugs-treatment-guidance-industy (2018).</Citation></Reference><Reference><Citation>Rowe CC et al. Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging. Neurobiol. Aging 31, 1275&#x2013;1283 (2010).</Citation><ArticleIdList><ArticleId IdType="pubmed">20472326</ArticleId></ArticleIdList></Reference><Reference><Citation>Mintun MA et al. [11C]PIB in a nondemented population: potential antecedent marker of Alzheimer disease. Neurology 67, 446&#x2013;452 (2006).</Citation><ArticleIdList><ArticleId IdType="pubmed">16894106</ArticleId></ArticleIdList></Reference><Reference><Citation>Jack CR Jr et al. 11C PiB and structural MRI provide complementary information in imaging of Alzheimer&#x2019;s disease and amnestic mild cognitive impairment. Brain 131, 665&#x2013;680 (2008).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2730157</ArticleId><ArticleId IdType="pubmed">18263627</ArticleId></ArticleIdList></Reference><Reference><Citation>De Meyer G. et al. Diagnosis-independent Alzheimer disease biomarker signature in cognitively normal elderly people. Arch. Neurol 67, 949&#x2013;956 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2963067</ArticleId><ArticleId IdType="pubmed">20697045</ArticleId></ArticleIdList></Reference><Reference><Citation>Arriagada PV, Marzloff K &amp; Hyman BT Distribution of Alzheimer-type pathologic changes in nondemented elderly individuals matches the pattern in Alzheimer&#x2019;s disease. Neurology 42, 1681&#x2013;1688 (1992).</Citation><ArticleIdList><ArticleId IdType="pubmed">1307688</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris JC et al. Cerebral amyloid deposition and diffuse plaques in &#x201c;normal&#x201d; aging: evidence for presymptomatic and very mild Alzheimer&#x2019;s disease. Neurology 46, 707&#x2013;719 (1996).</Citation><ArticleIdList><ArticleId IdType="pubmed">8618671</ArticleId></ArticleIdList></Reference><Reference><Citation>Villemagne VL et al. A&#x3b2; deposits in older non-demented individuals with cognitive decline are indicative of preclinical Alzheimer&#x2019;s disease. Neuropsychologia 46, 1688&#x2013;1697 (2008).</Citation><ArticleIdList><ArticleId IdType="pubmed">18343463</ArticleId></ArticleIdList></Reference><Reference><Citation>Stonnington CM et al. Fibrillar amyloid correlates of preclinical cognitive decline. Alzheimers Dement. 10, e1&#x2013;e8 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3713087</ArticleId><ArticleId IdType="pubmed">23583233</ArticleId></ArticleIdList></Reference><Reference><Citation>Moonis M. et al. Familial Alzheimer disease: decreases in CSF A&#x3b2;42 levels precede cognitive decline. Neurology 65, 323&#x2013;325 (2005).</Citation><ArticleIdList><ArticleId IdType="pubmed">16043812</ArticleId></ArticleIdList></Reference><Reference><Citation>Klunk WE et al. Amyloid deposition begins in the striatum of presenilin-1 mutation carriers from two unrelated pedigrees. J. Neurosci 27, 6174&#x2013;6184 (2007).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3265970</ArticleId><ArticleId IdType="pubmed">17553989</ArticleId></ArticleIdList></Reference><Reference><Citation>Ringman JM et al. Biochemical markers in persons with preclinical familial Alzheimer disease. Neurology 71, 85&#x2013;92 (2008).</Citation><ArticleIdList><ArticleId IdType="pubmed">18509095</ArticleId></ArticleIdList></Reference><Reference><Citation>Reiman EM et al. Fibrillar amyloid-&#x3b2; burden in cognitively normal people at 3 levels of genetic risk for Alzheimer&#x2019;s disease. Proc. Natl Acad. Sci. USA 106, 6820&#x2013;6825 (2009).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2665196</ArticleId><ArticleId IdType="pubmed">19346482</ArticleId></ArticleIdList></Reference><Reference><Citation>Boerwinkle AH et al. Comparison of amyloid burden in individuals with Down syndrome versus autosomal dominant Alzheimer&#x2019;s disease: a cross-sectional study. Lancet Neurol. 22, 55&#x2013;65 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9979840</ArticleId><ArticleId IdType="pubmed">36517172</ArticleId></ArticleIdList></Reference><Reference><Citation>Pike KE et al. &#x3b2;-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer&#x2019;s disease. Brain 130, 2837&#x2013;2844 (2007).</Citation><ArticleIdList><ArticleId IdType="pubmed">17928318</ArticleId></ArticleIdList></Reference><Reference><Citation>Wirth M. et al. The effect of amyloid &#x3b2; on cognitive decline is modulated by neural integrity in cognitively normal elderly. Alzheimers Dement. 9, 687&#x2013;698 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3823816</ArticleId><ArticleId IdType="pubmed">23474040</ArticleId></ArticleIdList></Reference><Reference><Citation>Mormino EC et al. Synergistic effect of &#x3b2;-amyloid and neurodegeneration on cognitive decline in clinically normal individuals. JAMA Neurol. 71, 1379&#x2013;1385 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4293023</ArticleId><ArticleId IdType="pubmed">25222039</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim YY et al. Effect of amyloid on memory and non-memory decline from preclinical to clinical Alzheimer&#x2019;s disease. Brain 137, 221&#x2013;231 (2014).</Citation><ArticleIdList><ArticleId IdType="pubmed">24176981</ArticleId></ArticleIdList></Reference><Reference><Citation>Landau SM et al. Amyloid deposition, hypometabolism, and longitudinal cognitive decline. Ann. Neurol 72, 578&#x2013;586 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3786871</ArticleId><ArticleId IdType="pubmed">23109153</ArticleId></ArticleIdList></Reference><Reference><Citation>Storandt M, Mintun MA, Head D &amp; Morris JC Cognitive decline and brain volume loss as signatures of cerebral amyloid-&#x3b2; peptide deposition identified with Pittsburgh compound B: cognitive decline associated with A&#x3b2; deposition. Arch. Neurol 66, 1476&#x2013;1481 (2009).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2796577</ArticleId><ArticleId IdType="pubmed">20008651</ArticleId></ArticleIdList></Reference><Reference><Citation>Pietrzak RH et al. Trajectories of memory decline in preclinical Alzheimer&#x2019;s disease: results from the Australian Imaging, Biomarkers and Lifestyle Flagship Study of Ageing. Neurobiol. Aging 36, 1231&#x2013;1238 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">25585532</ArticleId></ArticleIdList></Reference><Reference><Citation>Jicha GA et al. Preclinical AD Workgroup staging: pathological correlates and potential challenges. Neurobiol. Aging 33, 622.e1&#x2013;622.e16 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3245887</ArticleId><ArticleId IdType="pubmed">21507528</ArticleId></ArticleIdList></Reference><Reference><Citation>Vos SJ et al. Preclinical Alzheimer&#x2019;s disease and its outcome: a longitudinal cohort study. Lancet Neurol. 12, 957&#x2013;965 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3904678</ArticleId><ArticleId IdType="pubmed">24012374</ArticleId></ArticleIdList></Reference><Reference><Citation>Knopman DS et al. Short-term clinical outcomes for stages of NIA-AA preclinical Alzheimer disease. Neurology 78, 1576&#x2013;1582 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3348848</ArticleId><ArticleId IdType="pubmed">22551733</ArticleId></ArticleIdList></Reference><Reference><Citation>Toledo JB et al. CSF Apo-E levels associate with cognitive decline and MRI changes. Acta Neuropathol. 127, 621&#x2013;632 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3988233</ArticleId><ArticleId IdType="pubmed">24385135</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryman DC et al. Symptom onset in autosomal dominant Alzheimer disease: a systematic review and meta-analysis. Neurology 83, 253&#x2013;260 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4117367</ArticleId><ArticleId IdType="pubmed">24928124</ArticleId></ArticleIdList></Reference><Reference><Citation>de Graaf G, Buckley F &amp; Skotko BG Estimation of the number of people with Down syndrome in the United States. Genet. Med 19, 439&#x2013;447 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">27608174</ArticleId></ArticleIdList></Reference><Reference><Citation>Rafii MS, Wishnek H &amp; Brewer JB The Down Syndrome Biomarker Initiative (DSBI) pilot: proof of concept for deep phenotyping of Alzheimer&#x2019;s disease biomarkers in Down syndrome. Front. Behav. Neurosci 9, 239 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4568340</ArticleId><ArticleId IdType="pubmed">26441570</ArticleId></ArticleIdList></Reference><Reference><Citation>Neale N, Padilla C, Fonseca LM, Holland T &amp; Zaman S Neuroimaging and other modalities to assess Alzheimer&#x2019;s disease in Down syndrome. NeuroImage Clin. 17, 263&#x2013;271 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5683343</ArticleId><ArticleId IdType="pubmed">29159043</ArticleId></ArticleIdList></Reference><Reference><Citation>Handen BL, Cohen AD &amp; Channamalappa U Imaging brain amyloid in nondemented young adults with Down syndrome using Pittsburgh compound B. Alzheimers Dement. 8, 496&#x2013;501 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3532743</ArticleId><ArticleId IdType="pubmed">23102120</ArticleId></ArticleIdList></Reference><Reference><Citation>Annus T, Wilson LR &amp; Hong YT The pattern of amyloid accumulation in the brains of adults with Down syndrome. Alzheimers Dement. 12, 538&#x2013;545 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4867786</ArticleId><ArticleId IdType="pubmed">26362596</ArticleId></ArticleIdList></Reference><Reference><Citation>Lao PJ, Betthauser TJ &amp; Hillmer AT The effects of normal aging on amyloid-&#x3b2; deposition in nondemented adults with Down syndrome as imaged by carbon 11-labeled Pittsburgh compound B. Alzheimers Dement. 12, 380&#x2013;390 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4677061</ArticleId><ArticleId IdType="pubmed">26079411</ArticleId></ArticleIdList></Reference><Reference><Citation>Fortea J. et al. Plasma and CSF biomarkers for the diagnosis of Alzheimer&#x2019;s disease in adults with Down syndrome: a cross-sectional study. Lancet Neurol. 17, 860&#x2013;869 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">30172624</ArticleId></ArticleIdList></Reference><Reference><Citation>Fleisher AS, Chen K &amp; Quiroz YT Associations between biomarkers and age in the presenilin 1 E280A autosomal dominant Alzheimer disease kindred: a cross-sectional study. JAMA Neurol. 72, 316&#x2013;324 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4355261</ArticleId><ArticleId IdType="pubmed">25580592</ArticleId></ArticleIdList></Reference><Reference><Citation>Rafii MS et al. A randomized, double-blind, placebo-controlled, phase II study of oral ELND005 (scyllo-inositol) in young adults with Down syndrome without dementia. J. Alzheimers Dis 58, 401&#x2013;411 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5777855</ArticleId><ArticleId IdType="pubmed">28453471</ArticleId></ArticleIdList></Reference><Reference><Citation>Rafii MS et al. Safety, tolerability, and immunogenicity of the ACI-24 vaccine in adults with Down syndrome: a phase 1b randomized clinical trial. JAMA Neurol. 79, 565&#x2013;574 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9086937</ArticleId><ArticleId IdType="pubmed">35532913</ArticleId></ArticleIdList></Reference><Reference><Citation>Rafii MS Alzheimer&#x2019;s disease in Down syndrome: progress in the design and conduct of drug prevention trials. CNS Drugs 34, 785&#x2013;794 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7395870</ArticleId><ArticleId IdType="pubmed">32506291</ArticleId></ArticleIdList></Reference><Reference><Citation>Jack CR Jr et al. A/T/N: an unbiased descriptive classification scheme for Alzheimer disease biomarkers. Neurology 87, 539&#x2013;547 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4970664</ArticleId><ArticleId IdType="pubmed">27371494</ArticleId></ArticleIdList></Reference><Reference><Citation>Knopman DS et al. The National Institute on Aging and the Alzheimer&#x2019;s Association Research Framework for Alzheimer&#x2019;s disease: perspectives from the Research Roundtable. Alzheimers Dement. 14, 563&#x2013;575 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6747694</ArticleId><ArticleId IdType="pubmed">29653607</ArticleId></ArticleIdList></Reference><Reference><Citation>Strikwerda-Brown C. et al. Association of elevated amyloid and tau positron emission tomography signal with near-term development of Alzheimer disease symptoms in older adults without cognitive impairment. JAMA Neurol. 79, 975&#x2013;985 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9339146</ArticleId><ArticleId IdType="pubmed">35907254</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Flier WM &amp; Scheltens P The ATN framework&#x2014;moving preclinical Alzheimer disease to clinical relevance. JAMA Neurol. 79, 968&#x2013;970 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">36214803</ArticleId></ArticleIdList></Reference><Reference><Citation>Soldan A. et al. ATN profiles among cognitively normal individuals and longitudinal cognitive outcomes. Neurology 92, e1567&#x2013;e1579 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6448449</ArticleId><ArticleId IdType="pubmed">30842300</ArticleId></ArticleIdList></Reference><Reference><Citation>Vos SJB &amp; Duara R The prognostic value of ATN Alzheimer biomarker profiles in cognitively normal individuals. Neurology 92, 643&#x2013;644 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">30842299</ArticleId></ArticleIdList></Reference><Reference><Citation>Delmotte K. et al. Prognostic value of amyloid/tau/neurodegeneration (ATN) classification based on diagnostic cerebrospinal fluid samples for Alzheimer&#x2019;s disease. Alzheimers Res. Ther 13, 84 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8059197</ArticleId><ArticleId IdType="pubmed">33879243</ArticleId></ArticleIdList></Reference><Reference><Citation>Allegri RF et al. Prognostic value of ATN Alzheimer biomarkers: 60-month follow-up results from the Argentine Alzheimer&#x2019;s Disease Neuroimaging Initiative. Alzheimers Dement. 12, e12026 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7243942</ArticleId><ArticleId IdType="pubmed">32490138</ArticleId></ArticleIdList></Reference><Reference><Citation>Selvackadunco S. et al. Comparison of clinical and neuropathological diagnoses of neurodegenerative diseases in two centres from the Brains for Dementia Research (BDR) cohort. J. Neural Transm. 126, 327&#x2013;337 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6449484</ArticleId><ArticleId IdType="pubmed">30730007</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris JC et al. Pittsburgh compound B imaging and prediction of progression from cognitive normality to symptomatic Alzheimer disease. Arch. Neurol 66, 1469&#x2013;1475 (2009).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2798814</ArticleId><ArticleId IdType="pubmed">20008650</ArticleId></ArticleIdList></Reference><Reference><Citation>Vemuri P. et al. MRI and CSF biomarkers in normal, MCI, and AD subjects: predicting future clinical change. Neurology 73, 294&#x2013;301 (2009).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2715214</ArticleId><ArticleId IdType="pubmed">19636049</ArticleId></ArticleIdList></Reference><Reference><Citation>Fagan AM et al. Decreased cerebrospinal fluid A&#x3b2;42 correlates with brain atrophy in cognitively normal elderly. Ann. Neurol 65, 176&#x2013;183 (2009).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2763631</ArticleId><ArticleId IdType="pubmed">19260027</ArticleId></ArticleIdList></Reference><Reference><Citation>Lowe VJ et al. Association of hypometabolism and amyloid levels in aging, normal subjects. Neurology 82, 1959&#x2013;1967 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4105262</ArticleId><ArticleId IdType="pubmed">24793183</ArticleId></ArticleIdList></Reference><Reference><Citation>Nettiksimmons J. et al. Subtypes based on cerebrospinal fluid and magnetic resonance imaging markers in normal elderly predict cognitive decline. Neurobiol. Aging 31, 1419&#x2013;1428 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2902683</ArticleId><ArticleId IdType="pubmed">20542598</ArticleId></ArticleIdList></Reference><Reference><Citation>Pankratz VS et al. Predicting the risk of mild cognitive impairment in the Mayo Clinic Study of Aging. Neurology 84, 1433&#x2013;1442 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4395890</ArticleId><ArticleId IdType="pubmed">25788555</ArticleId></ArticleIdList></Reference><Reference><Citation>Stomrud E. et al. Correlation of longitudinal cerebrospinal fluid biomarkers with cognitive decline in healthy older adults. Arch. Neurol 67, 217&#x2013;223 (2010).</Citation><ArticleIdList><ArticleId IdType="pubmed">20142530</ArticleId></ArticleIdList></Reference><Reference><Citation>Sutphen CL et al. Longitudinal cerebrospinal fluid biomarker changes in preclinical Alzheimer disease during middle age. JAMA Neurol. 72, 1029&#x2013;1042 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4570860</ArticleId><ArticleId IdType="pubmed">26147946</ArticleId></ArticleIdList></Reference><Reference><Citation>Dumurgier J. et al. Alzheimer&#x2019;s disease biomarkers and future decline in cognitive normal older adults. J. Alzheimers Dis 60, 1451&#x2013;1459 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5773095</ArticleId><ArticleId IdType="pubmed">29036824</ArticleId></ArticleIdList></Reference><Reference><Citation>Farrell ME et al. Defining the lowest threshold for amyloid-PET to predict future cognitive decline and amyloid accumulation. Neurology 96, e619&#x2013;e631 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7905788</ArticleId><ArticleId IdType="pubmed">33199430</ArticleId></ArticleIdList></Reference><Reference><Citation>Campbell MR et al. P-tau/A&#x3b2;42 and A&#x3b2;42/40 ratios in CSF are equally predictive of amyloid PET status. Alzheimers Dement. 13, e12190 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8129859</ArticleId><ArticleId IdType="pubmed">34027020</ArticleId></ArticleIdList></Reference><Reference><Citation>Schindler SE et al. Predicting symptom onset in sporadic Alzheimer disease with amyloid PET. Neurology 97, e1823&#x2013;e1834 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8610624</ArticleId><ArticleId IdType="pubmed">34504028</ArticleId></ArticleIdList></Reference><Reference><Citation>Bourgeat P. et al. &#x3b2;-amyloid burden in the temporal neocortex is related to hippocampal atrophy in elderly subjects without dementia. Neurology 74, 121&#x2013;127 (2010).</Citation><ArticleIdList><ArticleId IdType="pubmed">20065247</ArticleId></ArticleIdList></Reference><Reference><Citation>Oh H. et al. &#x3b2;-amyloid affects frontal and posterior brain networks in normal aging. NeuroImage 54, 1887&#x2013;1895 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3038633</ArticleId><ArticleId IdType="pubmed">20965254</ArticleId></ArticleIdList></Reference><Reference><Citation>Dickerson BC et al. The cortical signature of Alzheimer&#x2019;s disease: regionally specific cortical thinning relates to symptom severity in very mild to mild AD dementia and is detectable in asymptomatic amyloid-positive individuals. Cereb. Cortex 19, 497&#x2013;510 (2009).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2638813</ArticleId><ArticleId IdType="pubmed">18632739</ArticleId></ArticleIdList></Reference><Reference><Citation>Sperling RA et al. Amyloid deposition is associated with impaired default network function in older persons without dementia. Neuron 63, 178&#x2013;188 (2009).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2738994</ArticleId><ArticleId IdType="pubmed">19640477</ArticleId></ArticleIdList></Reference><Reference><Citation>Hedden T. et al. Disruption of functional connectivity in clinically normal older adults harboring amyloid burden. J. Neurosci 29, 12686&#x2013;12694 (2009).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2808119</ArticleId><ArticleId IdType="pubmed">19812343</ArticleId></ArticleIdList></Reference><Reference><Citation>Mormino EC et al. Relationships between &#x3b2;-amyloid and functional connectivity in different components of the default mode network in aging. Cereb. Cortex 21, 2399&#x2013;2407 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3169663</ArticleId><ArticleId IdType="pubmed">21383234</ArticleId></ArticleIdList></Reference><Reference><Citation>Rentz DM et al. Face&#x2013;name associative memory performance is related to amyloid burden in normal elderly. Neuropsychologia 49, 2776&#x2013;2783 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3137730</ArticleId><ArticleId IdType="pubmed">21689670</ArticleId></ArticleIdList></Reference><Reference><Citation>Chetelat G. et al. Independent contribution of temporal &#x3b2;-amyloid deposition to memory decline in the pre-dementia phase of Alzheimer&#x2019;s disease. Brain 134, 798&#x2013;807 (2011).</Citation><ArticleIdList><ArticleId IdType="pubmed">21310725</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakamura A. et al. High performance plasma amyloid-&#x3b2; biomarkers for Alzheimer&#x2019;s disease. Nature 554, 249&#x2013;254 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">29420472</ArticleId></ArticleIdList></Reference><Reference><Citation>Schindler SE et al. High-precision plasma &#x3b2;-amyloid 42/40 predicts current and future brain amyloidosis. Neurology 93, e1647&#x2013;e1659 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6946467</ArticleId><ArticleId IdType="pubmed">31371569</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y et al. Validation of plasma amyloid-&#x3b2; 42/40 for detecting Alzheimer disease amyloid plaques. Neurology 98, e688&#x2013;e699 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8865895</ArticleId><ArticleId IdType="pubmed">34906975</ArticleId></ArticleIdList></Reference><Reference><Citation>Fandos N. et al. Plasma amyloid &#x3b2; 42/40 ratios as biomarkers for amyloid &#x3b2; cerebral deposition in cognitively normal individuals. Alzheimers Dement. 8, 179&#x2013;187 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5602863</ArticleId><ArticleId IdType="pubmed">28948206</ArticleId></ArticleIdList></Reference><Reference><Citation>Mattsson N, Cullen NC, Andreasson U, Zetterberg H &amp; Blennow K. Association between longitudinal plasma neurofilament light and neurodegeneration in patients with Alzheimer disease. JAMA Neurol. 76, 791&#x2013;799 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6583067</ArticleId><ArticleId IdType="pubmed">31009028</ArticleId></ArticleIdList></Reference><Reference><Citation>Mielke MM et al. Plasma phospho-tau181 increases with Alzheimer&#x2019;s disease clinical severity and is associated with tau- and amyloid-positron emission tomography. Alzheimers Dement. 14, 989&#x2013;997 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6097897</ArticleId><ArticleId IdType="pubmed">29626426</ArticleId></ArticleIdList></Reference><Reference><Citation>Janelidze S. et al. Plasma p-tau181 in Alzheimer&#x2019;s disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer&#x2019;s dementia. Nat. Med 26, 379&#x2013;386 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32123385</ArticleId></ArticleIdList></Reference><Reference><Citation>Palmqvist S. et al. Performance of fully automated plasma assays as screening tests for Alzheimer disease-related &#x3b2;-amyloid status. JAMA Neurol. 76, 1060&#x2013;1069 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6593637</ArticleId><ArticleId IdType="pubmed">31233127</ArticleId></ArticleIdList></Reference><Reference><Citation>Cullen NC et al. Plasma biomarkers of Alzheimer&#x2019;s disease improve prediction of cognitive decline in cognitively unimpaired elderly populations. Nat. Commun 12, 3555 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8196018</ArticleId><ArticleId IdType="pubmed">34117234</ArticleId></ArticleIdList></Reference><Reference><Citation>Ossenkoppele R. et al. Accuracy of tau positron emission tomography as a prognostic marker in preclinical and prodromal Alzheimer disease: a head-to-head comparison against amyloid positron emission tomography and magnetic resonance imaging. JAMA Neurol. 78, 961&#x2013;971 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8240013</ArticleId><ArticleId IdType="pubmed">34180956</ArticleId></ArticleIdList></Reference><Reference><Citation>Rafii MS et al. The AHEAD 3-45 Study: design of a prevention trial for Alzheimer&#x2019;s disease. Alzheimers Dement. 10.1002/alz.12748 (2022).</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alz.12748</ArticleId><ArticleId IdType="pmc">PMC9929028</ArticleId><ArticleId IdType="pubmed">35971310</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson KA et al. Tau positron emission tomographic imaging in aging and early Alzheimer disease. Ann. Neurol 79, 110&#x2013;119 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4738026</ArticleId><ArticleId IdType="pubmed">26505746</ArticleId></ArticleIdList></Reference><Reference><Citation>Insel PS et al. Tau positron emission tomography in preclinical Alzheimer&#x2019;s disease. Brain 146, 700&#x2013;711 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10169284</ArticleId><ArticleId IdType="pubmed">35962782</ArticleId></ArticleIdList></Reference><Reference><Citation>Mattsson-Carlgren N. et al. Prediction of longitudinal cognitive decline in preclinical Alzheimer disease using plasma biomarkers. JAMA Neurol. 80, 360&#x2013;369 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10087054</ArticleId><ArticleId IdType="pubmed">36745413</ArticleId></ArticleIdList></Reference><Reference><Citation>Mosconi L. et al. Hippocampal hypometabolism predicts cognitive decline from normal aging. Neurobiol. Aging 29, 676&#x2013;692 (2008).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2430185</ArticleId><ArticleId IdType="pubmed">17222480</ArticleId></ArticleIdList></Reference><Reference><Citation>Kennedy AM et al. Deficits in cerebral glucose metabolism demonstrated by positron emission tomography in individuals at risk of familial Alzheimer&#x2019;s disease. Neurosci. Lett 186, 17&#x2013;20 (1995).</Citation><ArticleIdList><ArticleId IdType="pubmed">7783942</ArticleId></ArticleIdList></Reference><Reference><Citation>de Leon MJ et al. Prediction of cognitive decline in normal elderly subjects with 2-[18F]fluoro-2-deoxy-d-glucose/positron-emission tomography (FDG/PET). Proc. Natl Acad. Sci. USA 98, 10966&#x2013;10971 (2001).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC58582</ArticleId><ArticleId IdType="pubmed">11526211</ArticleId></ArticleIdList></Reference><Reference><Citation>Jagust WJ et al. Brain imaging evidence of preclinical Alzheimer&#x2019;s disease in normal aging. Ann. Neurol 59, 673&#x2013;681 (2006).</Citation><ArticleIdList><ArticleId IdType="pubmed">16470518</ArticleId></ArticleIdList></Reference><Reference><Citation>Serrano ME, Kim E, Petrinovic MM, Turkheimer F &amp; Cash D Imaging synaptic density: the next holy grail of neuroscience? Front. Neurosci 16, 796129 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8990757</ArticleId><ArticleId IdType="pubmed">35401097</ArticleId></ArticleIdList></Reference><Reference><Citation>Mecca AP et al. In vivo measurement of widespread synaptic loss in Alzheimer&#x2019;s disease with SV2A PET. Alzheimers Dement. 16, 974&#x2013;982 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7383876</ArticleId><ArticleId IdType="pubmed">32400950</ArticleId></ArticleIdList></Reference><Reference><Citation>Arvidsson R&#xe5;destig M. et al. Cerebrospinal fluid biomarkers of axonal and synaptic degeneration in a population-based sample. Alzheimers Res. Ther 15, 44 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9983206</ArticleId><ArticleId IdType="pubmed">36869347</ArticleId></ArticleIdList></Reference><Reference><Citation>Zetterberg H. et al. Association of cerebrospinal fluid neurofilament light concentration with Alzheimer disease progression. JAMA Neurol. 73, 60&#x2013;67 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5624219</ArticleId><ArticleId IdType="pubmed">26524180</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferreira PCL et al. Plasma biomarkers identify older adults at risk of Alzheimer&#x2019;s disease and related dementias in a real-world population-based cohort. Alzheimers Dement. 10.1002/alz.12986 (2023).</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alz.12986</ArticleId><ArticleId IdType="pmc">PMC10480336</ArticleId><ArticleId IdType="pubmed">36876954</ArticleId></ArticleIdList></Reference><Reference><Citation>Pettigrew C. et al. Progressive medial temporal lobe atrophy during preclinical Alzheimer&#x2019;s disease. NeuroImage Clin. 16, 439&#x2013;446 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5577409</ArticleId><ArticleId IdType="pubmed">28879085</ArticleId></ArticleIdList></Reference><Reference><Citation>Pettigrew C. et al. Cortical thickness in relation to clinical symptom onset in preclinical AD. NeuroImage Clin. 12, 116&#x2013;122 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4932610</ArticleId><ArticleId IdType="pubmed">27408796</ArticleId></ArticleIdList></Reference><Reference><Citation>Mueller SG et al. Hippocampal atrophy patterns in mild cognitive impairment and Alzheimer&#x2019;s disease. Hum. Brain Mapp 31, 1339&#x2013;1347 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2943433</ArticleId><ArticleId IdType="pubmed">20839293</ArticleId></ArticleIdList></Reference><Reference><Citation>McRae-McKee K. et al. Combining hippocampal volume metrics to better understand Alzheimer&#x2019;s disease progression in at-risk individuals. Sci. Rep 9, 7499 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6522521</ArticleId><ArticleId IdType="pubmed">31097733</ArticleId></ArticleIdList></Reference><Reference><Citation>Elias MF et al. The preclinical phase of Alzheimer disease: a 22-year prospective study of the Framingham Cohort. Arch. Neurol 57, 808&#x2013;813 (2000).</Citation><ArticleIdList><ArticleId IdType="pubmed">10867777</ArticleId></ArticleIdList></Reference><Reference><Citation>Saxton J. et al. Preclinical Alzheimer disease: neuropsychological test performance 1.5 to 8 years prior to onset. Neurology 63, 2341&#x2013;2347 (2004).</Citation><ArticleIdList><ArticleId IdType="pubmed">15623697</ArticleId></ArticleIdList></Reference><Reference><Citation>Donohue MC et al. The preclinical Alzheimer cognitive composite: measuring amyloid-related decline. JAMA Neurol. 71, 961&#x2013;970 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4439182</ArticleId><ArticleId IdType="pubmed">24886908</ArticleId></ArticleIdList></Reference><Reference><Citation>Bransby L. et al. Sensitivity of a Preclinical Alzheimer&#x2019;s Cognitive Composite (PACC) to amyloid &#x3b2; load in preclinical Alzheimer&#x2019;s disease. J. Clin. Exp. Neuropsychol 41, 591&#x2013;600 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">30924399</ArticleId></ArticleIdList></Reference><Reference><Citation>Papp KV et al. Sensitivity of the Preclinical Alzheimer&#x2019;s Cognitive Composite (PACC), PACC5, and Repeatable Battery for Neuropsychological Status (RBANS) to amyloid status in preclinical Alzheimer&#x2019;s disease&#x2014;Atabecestat Phase 2b/3 EARLY Clinical Trial. J. Prev. Alzheimers Dis 9, 255&#x2013;261 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35542998</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayutyanont N. et al. The Alzheimer&#x2019;s Prevention Initiative Composite Cognitive Test score: sample size estimates for the evaluation of preclinical Alzheimer&#x2019;s disease treatments in presenilin 1 E280A mutation carriers. J. Clin. Psychiatry 75, 652&#x2013;660 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4331113</ArticleId><ArticleId IdType="pubmed">24816373</ArticleId></ArticleIdList></Reference><Reference><Citation>Langbaum JB et al. The Alzheimer&#x2019;s Prevention Initiative Composite Cognitive Test: a practical measure for tracking cognitive decline in preclinical Alzheimer&#x2019;s disease. Alzheimers Res. Ther 12, 66 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7254761</ArticleId><ArticleId IdType="pubmed">32460855</ArticleId></ArticleIdList></Reference><Reference><Citation>Amariglio RE et al. Tracking early decline in cognitive function in older individuals at risk for Alzheimer disease dementia: the Alzheimer&#x2019;s Disease Cooperative Study Cognitive Function Instrument. JAMA Neurol. 72, 446&#x2013;454 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4397164</ArticleId><ArticleId IdType="pubmed">25706191</ArticleId></ArticleIdList></Reference><Reference><Citation>Li C. et al. The utility of the Cognitive Function Instrument (CFI) to detect cognitive decline in non-demented older adults. J. Alzheimers Dis 60, 427&#x2013;437 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6417419</ArticleId><ArticleId IdType="pubmed">28854503</ArticleId></ArticleIdList></Reference><Reference><Citation>Galasko D. et al. ADCS Prevention Instrument Project: assessment of instrumental activities of daily living for community-dwelling elderly individuals in dementia prevention clinical trials. Alzheimer Dis. Assoc. Disord 20, S152&#x2013;S169 (2006).</Citation><ArticleIdList><ArticleId IdType="pubmed">17135809</ArticleId></ArticleIdList></Reference><Reference><Citation>Marshall GA et al. Measuring instrumental activities of daily living in non-demented elderly: a comparison of the new performance-based Harvard Automated Phone Task with other functional assessments. Alzheimers Res. Ther 11, 4 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6329044</ArticleId><ArticleId IdType="pubmed">30630529</ArticleId></ArticleIdList></Reference><Reference><Citation>Weintraub S. et al. Measuring cognition and function in the preclinical stage of Alzheimer&#x2019;s disease. Alzheimers Dement. 4, 64&#x2013;75 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6021264</ArticleId><ArticleId IdType="pubmed">29955653</ArticleId></ArticleIdList></Reference><Reference><Citation>Barnes DE &amp; Yaffe K The projected effect of risk factor reduction on Alzheimer&#x2019;s disease prevalence. Lancet Neurol. 10, 819&#x2013;828 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3647614</ArticleId><ArticleId IdType="pubmed">21775213</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding J. et al. Antihypertensive medications and risk for incident dementia and Alzheimer&#x2019;s disease: a meta-analysis of individual participant data from prospective cohort studies. Lancet Neurol. 19, 61&#x2013;70 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7391421</ArticleId><ArticleId IdType="pubmed">31706889</ArticleId></ArticleIdList></Reference><Reference><Citation>Marinelli JP et al. Association between hearing loss and development of dementia using formal behavioural audiometric testing within the Mayo Clinic Study of Aging (MCSA): a prospective population-based study. Lancet Healthy Longev. 3, e817&#x2013;e824 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9831680</ArticleId><ArticleId IdType="pubmed">36410368</ArticleId></ArticleIdList></Reference><Reference><Citation>Middleton LE, Barnes DE, Lui LY &amp; Yaffe K Physical activity over the life course and its association with cognitive performance and impairment in old age. J. Am. Geriatr. Soc 58, 1322&#x2013;1326 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3662219</ArticleId><ArticleId IdType="pubmed">20609030</ArticleId></ArticleIdList></Reference><Reference><Citation>Yiannopoulou KG, Anastasiou AI, Zachariou V &amp; Pelidou SH Reasons for failed trials of disease-modifying treatments for Alzheimer disease and their contribution in recent research. Biomedicines 7, 97 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6966425</ArticleId><ArticleId IdType="pubmed">31835422</ArticleId></ArticleIdList></Reference><Reference><Citation>Arndt JW et al. Structural and kinetic basis for the selectivity of aducanumab for aggregated forms of amyloid-&#x3b2;. Sci. Rep 8, 6412 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5913127</ArticleId><ArticleId IdType="pubmed">29686315</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrero J. et al. First-in-human, double-blind, placebo-controlled, single-dose escalation study of aducanumab (BIIB037) in mild-to-moderate Alzheimer&#x2019;s disease. Alzheimers Dement. 2, 169&#x2013;176 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5651340</ArticleId><ArticleId IdType="pubmed">29067304</ArticleId></ArticleIdList></Reference><Reference><Citation>Sevigny J. et al. The antibody aducanumab reduces A&#x3b2; plaques in Alzheimer&#x2019;s disease. Nature 537, 50&#x2013;56 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">27582220</ArticleId></ArticleIdList></Reference><Reference><Citation>Budd Haeberlein S. et al. Two randomized phase 3 studies of aducanumab in early Alzheimer&#x2019;s disease. J. Prev. Alzheimers Dis. 9, 197&#x2013;210 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35542991</ArticleId></ArticleIdList></Reference><Reference><Citation>Ostrowitzki S. et al. Mechanism of amyloid removal in patients with Alzheimer disease treated with gantenerumab. Arch. Neurol 69, 198&#x2013;207 (2012).</Citation><ArticleIdList><ArticleId IdType="pubmed">21987394</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein G. et al. Gantenerumab reduces amyloid-&#x3b2; plaques in patients with prodromal to moderate Alzheimer&#x2019;s disease: a PET substudy interim analysis. Alzheimers Res. Ther 11, 101 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6909550</ArticleId><ArticleId IdType="pubmed">31831056</ArticleId></ArticleIdList></Reference><Reference><Citation>Doody R. Clinical Trial in Alzheimer&#x2019;s Disease (CTAD) meeting, November 29 (2022).</Citation></Reference><Reference><Citation>Salloway S. et al. A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer&#x2019;s disease. Nat. Med 27, 1187&#x2013;1196 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8988051</ArticleId><ArticleId IdType="pubmed">34155411</ArticleId></ArticleIdList></Reference><Reference><Citation>Lowe SL et al. Donanemab (LY3002813) phase 1b study in Alzheimer&#x2019;s disease: rapid and sustained reduction of brain amyloid measured by florbetapir F18 imaging. J. Prev. Alzheimers Dis 8, 414&#x2013;424 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34585215</ArticleId></ArticleIdList></Reference><Reference><Citation>Mintun MA et al. Donanemab in early Alzheimer&#x2019;s disease. N. Engl. J. Med 384, 1691&#x2013;1704 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33720637</ArticleId></ArticleIdList></Reference><Reference><Citation>Swanson CJ et al. A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer&#x2019;s disease with lecanemab, an anti-A&#x3b2; protofibril antibody. Alzheimers Res. Ther 13, 80 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8053280</ArticleId><ArticleId IdType="pubmed">33865446</ArticleId></ArticleIdList></Reference><Reference><Citation>van Dyck CH et al. Lecanemab in early Alzheimer&#x2019;s disease. N. Engl. J. Med 388, 9&#x2013;21 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">36449413</ArticleId></ArticleIdList></Reference><Reference><Citation>Sperling RA et al. Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: recommendations from the Alzheimer&#x2019;s Association Research Roundtable Workgroup. Alzheimers Dement. 7, 367&#x2013;385 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3693547</ArticleId><ArticleId IdType="pubmed">21784348</ArticleId></ArticleIdList></Reference><Reference><Citation>Barakos J. et al. Detection and management of amyloid-related imaging abnormalities in patients with Alzheimer&#x2019;s disease treated with anti-amyloid &#x3b2; therapy. J. Prev. Alzheimers Dis 9, 211&#x2013;220 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35542992</ArticleId></ArticleIdList></Reference><Reference><Citation>Piazza F. et al. Anti-amyloid &#x3b2; autoantibodies in cerebral amyloid angiopathy-related inflammation: implications for amyloid-modifying therapies. Ann. Neurol 73, 449&#x2013;458 (2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">23625526</ArticleId></ArticleIdList></Reference><Reference><Citation>Salloway S. et al. Amyloid-related imaging abnormalities in 2 phase 3 studies evaluating aducanumab in patients with early Alzheimer disease. JAMA Neurol. 79, 13&#x2013;21 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8609465</ArticleId><ArticleId IdType="pubmed">34807243</ArticleId></ArticleIdList></Reference><Reference><Citation>Doody RS et al. Phase 3 trials of solanezumab for mild-to-moderate Alzheimer&#x2019;s disease. N. Engl. J. Med 370, 311&#x2013;321 (2014).</Citation><ArticleIdList><ArticleId IdType="pubmed">24450890</ArticleId></ArticleIdList></Reference><Reference><Citation>Honig LS et al. Trial of solanezumab for mild dementia due to Alzheimer&#x2019;s disease. N. Engl. J. Med 378, 321&#x2013;330 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">29365294</ArticleId></ArticleIdList></Reference><Reference><Citation>Lilly. Lilly provides update on A4 study of solanezumab for preclinical Alzheimer&#x2019;s disease. investory.lilly.com, https://investor.lilly.com/news-releases/news-release-details/lilly-provides-update-a4-study-solanezumab-preclinical#:~:text=INDIANAPOLIS%2C%20March%208%2C%202023%20%2FPRNewswire%2F%20--%20Eli%20Lilly,known%20as%20the%20preclinical%20stage%20of%20AD%201 (8
March
2023).</Citation></Reference><Reference><Citation>Vassar R. et al. &#x3b2;-secretase cleavage of Alzheimer&#x2019;s amyloid precursor protein by the transmembrane aspartic protease BACE. Science 286, 735&#x2013;741 (1999).</Citation><ArticleIdList><ArticleId IdType="pubmed">10531052</ArticleId></ArticleIdList></Reference><Reference><Citation>Jonsson T. et al. A mutation in APP protects against Alzheimer&#x2019;s disease and age-related cognitive decline. Nature 488, 96&#x2013;99 (2012).</Citation><ArticleIdList><ArticleId IdType="pubmed">22801501</ArticleId></ArticleIdList></Reference><Reference><Citation>Egan MF et al. Randomized trial of verubecestat for prodromal Alzheimer&#x2019;s disease. N. Engl. J. Med 380, 1408&#x2013;1420 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6776078</ArticleId><ArticleId IdType="pubmed">30970186</ArticleId></ArticleIdList></Reference><Reference><Citation>Henley D. et al. Preliminary results of a trial of atabecestat in preclinical Alzheimer&#x2019;s disease. N. Engl. J. Med 380, 1483&#x2013;1485 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">30970197</ArticleId></ArticleIdList></Reference><Reference><Citation>Wessels AM et al. Efficacy and safety of lanabecestat for treatment of early and mild Alzheimer disease: the AMARANTH and DAYBREAK-ALZ randomized clinical trials. JAMA Neurol. 77, 199&#x2013;209 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6902191</ArticleId><ArticleId IdType="pubmed">31764959</ArticleId></ArticleIdList></Reference><Reference><Citation>Sperling R. et al. Findings of efficacy, safety, and biomarker outcomes of atabecestat in preclinical Alzheimer disease: a truncated randomized phase 2b/3 clinical trial. JAMA Neurol. 78, 293&#x2013;301 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7816119</ArticleId><ArticleId IdType="pubmed">33464300</ArticleId></ArticleIdList></Reference><Reference><Citation>McDade E. et al. The case for low-level BACE1 inhibition for the prevention of Alzheimer disease. Nat. Rev. Neurol 17, 703&#x2013;714 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34548654</ArticleId></ArticleIdList></Reference><Reference><Citation>Congdon EE &amp; Sigurdsson EM Tau-targeting therapies for Alzheimer disease. Nat. Rev. Neurol 14, 399&#x2013;415 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6463489</ArticleId><ArticleId IdType="pubmed">29895964</ArticleId></ArticleIdList></Reference><Reference><Citation>Langbaum JB et al. Recommendations to address key recruitment challenges of Alzheimer&#x2019;s disease clinical trials. Alzheimers Dement. 19, 696&#x2013;707 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9911558</ArticleId><ArticleId IdType="pubmed">35946590</ArticleId></ArticleIdList></Reference><Reference><Citation>Indorewalla KK, O&#x2019;Connor MK, Budson AE, Guess DiTerlizzi C &amp; Jackson J Modifiable barriers for recruitment and retention of older adults participants from underrepresented minorities in Alzheimer&#x2019;s disease research. J. Alzheimers Dis 80, 927&#x2013;940 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8150544</ArticleId><ArticleId IdType="pubmed">33612540</ArticleId></ArticleIdList></Reference><Reference><Citation>Aisen PS et al. The Trial-Ready Cohort for Preclinical/Prodromal Alzheimer&#x2019;s Disease (TRC-PAD) project: an overview. J. Prev. Alzheimer&#x2019;s Dis 7, 208&#x2013;212 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7735207</ArticleId><ArticleId IdType="pubmed">32920621</ArticleId></ArticleIdList></Reference><Reference><Citation>Aisen PS et al. The Trial-Ready Cohort for Preclinical/Prodromal Alzheimer&#x2019;s Disease (TRC-PAD) project: an overview. J. Prev. Alzheimers Dis 7, 208&#x2013;212 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7735207</ArticleId><ArticleId IdType="pubmed">32920621</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37202516</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>22</Day></DateCompleted><DateRevised><Year>2023</Year><Month>06</Month><Day>26</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2662-8465</ISSN><JournalIssue CitedMedium="Internet"><Volume>3</Volume><Issue>5</Issue><PubDate><Year>2023</Year><Month>May</Month></PubDate></JournalIssue><Title>Nature aging</Title><ISOAbbreviation>Nat Aging</ISOAbbreviation></Journal><ArticleTitle>Clinical relevance of animal models in aging-related dementia research.</ArticleTitle><Pagination><StartPage>481</StartPage><EndPage>493</EndPage><MedlinePgn>481-493</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s43587-023-00402-4</ELocationID><Abstract><AbstractText>Alzheimer's disease (AD) and other, less prevalent dementias are complex age-related disorders that exhibit multiple etiologies. Over the past decades, animal models have provided pathomechanistic insight and evaluated countless therapeutics; however, their value is increasingly being questioned due to the long history of drug failures. In this Perspective, we dispute this criticism. First, the utility of the models is limited by their design, as neither the etiology of AD nor whether interventions should occur at a cellular or network level is fully understood. Second, we highlight unmet challenges shared between animals and humans, including impeded drug transport across the blood-brain barrier, limiting effective treatment development. Third, alternative human-derived models also suffer from the limitations mentioned above and can only act as complementary resources. Finally, age being the strongest AD risk factor should be better incorporated into the experimental design, with computational modeling expected to enhance the value of animal models.</AbstractText><CopyrightInformation>&#xa9; 2023. Springer Nature America, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Padmanabhan</LastName><ForeName>Pranesh</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0001-5569-8731</Identifier><AffiliationInfo><Affiliation>Clem Jones Centre for Ageing Dementia Research, Queensland Brain Institute, the University of Queensland, Brisbane, Queensland, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>G&#xf6;tz</LastName><ForeName>J&#xfc;rgen</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0001-8501-7896</Identifier><AffiliationInfo><Affiliation>Clem Jones Centre for Ageing Dementia Research, Queensland Brain Institute, the University of Queensland, Brisbane, Queensland, Australia. j.goetz@uq.edu.au.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>05</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Nat Aging</MedlineTA><NlmUniqueID>101773306</NlmUniqueID><ISSNLinking>2662-8465</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000092522" MajorTopicYN="Y">Clinical Relevance</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000375" MajorTopicYN="N">Aging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D023421" MajorTopicYN="N">Models, Animal</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>10</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>3</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>22</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>19</Day><Hour>1</Hour><Minute>4</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>18</Day><Hour>23</Hour><Minute>21</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37202516</ArticleId><ArticleId IdType="doi">10.1038/s43587-023-00402-4</ArticleId><ArticleId IdType="pii">10.1038/s43587-023-00402-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Alzheimer&#x2019;s Association. 2020 Alzheimer&#x2019;s disease facts and figures. Alzheimers Dement. 16, 391&#x2013;460 (2020).</Citation></Reference><Reference><Citation>Sengupta, U. &amp; Kayed, R. Amyloid &#x3b2;, tau, and &#x3b1;-synuclein aggregates in the pathogenesis, prognosis, and therapeutics for neurodegenerative diseases. Prog. Neurobiol. 214, 102270 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35447272</ArticleId><ArticleId IdType="doi">10.1016/j.pneurobio.2022.102270</ArticleId></ArticleIdList></Reference><Reference><Citation>Jellinger, K. A. &amp; Attems, J. Challenges of multimorbidity of the aging brain: a critical update. J. Neural Transm. 122, 505&#x2013;521 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">25091618</ArticleId><ArticleId IdType="doi">10.1007/s00702-014-1288-x</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanne, J. H. Aduhelm: approval of Alzheimer&#x2019;s drug was highly unorthodox, finds report. BMJ 380, 6 (2023).</Citation></Reference><Reference><Citation>van Dyck, C. H. et al. Lecanemab in early Alzheimer&#x2019;s disease. N. Engl. J. Med. 388, 9&#x2013;21 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">36449413</ArticleId><ArticleId IdType="doi">10.1056/NEJMoa2212948</ArticleId></ArticleIdList></Reference><Reference><Citation>Perry, R. J. &amp; Hodges, J. R. Attention and executive deficits in Alzheimer&#x2019;s disease. A critical review. Brain 122, 383&#x2013;404 (1999).</Citation><ArticleIdList><ArticleId IdType="pubmed">10094249</ArticleId><ArticleId IdType="doi">10.1093/brain/122.3.383</ArticleId></ArticleIdList></Reference><Reference><Citation>Polanco, J. C. et al. Amyloid-&#x3b2; and tau complexity&#x2014;towards improved biomarkers and targeted therapies. Nat. Rev. Neurol. 14, 22&#x2013;39 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">29242522</ArticleId><ArticleId IdType="doi">10.1038/nrneurol.2017.162</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xf6;tz, J. &amp; Ittner, L. M. Animal models of Alzheimer&#x2019;s disease and frontotemporal dementia. Nat. Rev. Neurosci. 9, 532&#x2013;544 (2008).</Citation><ArticleIdList><ArticleId IdType="pubmed">18568014</ArticleId><ArticleId IdType="doi">10.1038/nrn2420</ArticleId></ArticleIdList></Reference><Reference><Citation>Dujardin, S., Colin, M. &amp; Buee, L. Invited review: animal models of tauopathies and their implications for research/translation into the clinic. Neuropathol. Appl. Neurobiol. 41, 59&#x2013;80 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">25428793</ArticleId><ArticleId IdType="doi">10.1111/nan.12200</ArticleId></ArticleIdList></Reference><Reference><Citation>Jankowsky, J. L. &amp; Zheng, H. Practical considerations for choosing a mouse model of Alzheimer&#x2019;s disease. Mol. Neurodegener. 12, 89 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">29273078</ArticleId><ArticleId IdType="pmc">5741956</ArticleId><ArticleId IdType="doi">10.1186/s13024-017-0231-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Schenk, D. et al. Immunization with amyloid-&#x3b2; attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature 400, 173&#x2013;177 (1999).</Citation><ArticleIdList><ArticleId IdType="pubmed">10408445</ArticleId><ArticleId IdType="doi">10.1038/22124</ArticleId></ArticleIdList></Reference><Reference><Citation>Bard, F. et al. Peripherally administered antibodies against amyloid &#x3b2;-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease. Nat. Med. 6, 916&#x2013;919 (2000).</Citation><ArticleIdList><ArticleId IdType="pubmed">10932230</ArticleId><ArticleId IdType="doi">10.1038/78682</ArticleId></ArticleIdList></Reference><Reference><Citation>de la Torre, J. C. &amp; Mussivand, T. Can disturbed brain microcirculation cause Alzheimer&#x2019;s disease? Neurol. Res. 15, 146&#x2013;153 (1993).</Citation><ArticleIdList><ArticleId IdType="pubmed">8103579</ArticleId><ArticleId IdType="doi">10.1080/01616412.1993.11740127</ArticleId></ArticleIdList></Reference><Reference><Citation>Grimm, A. &amp; Eckert, A. Brain aging and neurodegeneration: from a mitochondrial point of view. J. Neurochem. 143, 418&#x2013;431 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28397282</ArticleId><ArticleId IdType="pmc">5724505</ArticleId><ArticleId IdType="doi">10.1111/jnc.14037</ArticleId></ArticleIdList></Reference><Reference><Citation>Heneka, M. T. et al. Neuroinflammation in Alzheimer&#x2019;s disease. Lancet Neurol. 14, 388&#x2013;405 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">25792098</ArticleId><ArticleId IdType="pmc">5909703</ArticleId><ArticleId IdType="doi">10.1016/S1474-4422(15)70016-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Wirths, O. &amp; Zampar, S. Neuron loss in Alzheimer&#x2019;s disease: translation in transgenic mouse models. Int. J. Mol. Sci. 21, 8144 (2020).</Citation></Reference><Reference><Citation>Eimer, W. A. &amp; Vassar, R. Neuron loss in the 5XFAD mouse model of Alzheimer&#x2019;s disease correlates with intraneuronal A&#x3b2;<sub>42</sub> accumulation and caspase-3 activation. Mol. Neurodegener. 8, 2 (2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">23316765</ArticleId><ArticleId IdType="pmc">3552866</ArticleId><ArticleId IdType="doi">10.1186/1750-1326-8-2</ArticleId></ArticleIdList></Reference><Reference><Citation>van Eersel, J. et al. Early-onset axonal pathology in a novel P301S-tau transgenic mouse model of frontotemporal lobar degeneration. Neuropathol. Appl. Neurobiol. 41, 906&#x2013;925 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">25763777</ArticleId><ArticleId IdType="doi">10.1111/nan.12233</ArticleId></ArticleIdList></Reference><Reference><Citation>Hatch, R. J., Wei, Y., Xia, D. &amp; G&#xf6;tz, J. Hyperphosphorylated tau causes reduced hippocampal CA1 excitability by relocating the axon initial segment. Acta Neuropathol. 133, 717&#x2013;730 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28091722</ArticleId><ArticleId IdType="pmc">5389999</ArticleId><ArticleId IdType="doi">10.1007/s00401-017-1674-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Roy, D. S. et al. Memory retrieval by activating engram cells in mouse models of early Alzheimer&#x2019;s disease. Nature 531, 508&#x2013;512 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">26982728</ArticleId><ArticleId IdType="pmc">4847731</ArticleId><ArticleId IdType="doi">10.1038/nature17172</ArticleId></ArticleIdList></Reference><Reference><Citation>Oh, H., Razlighi, Q. R. &amp; Stern, Y. Multiple pathways of reserve simultaneously present in cognitively normal older adults. Neurology 90, e197&#x2013;e205 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">29273689</ArticleId><ArticleId IdType="pmc">5772159</ArticleId><ArticleId IdType="doi">10.1212/WNL.0000000000004829</ArticleId></ArticleIdList></Reference><Reference><Citation>Stern, Y., Barnes, C. A., Grady, C., Jones, R. N. &amp; Raz, N. Brain reserve, cognitive reserve, compensation, and maintenance: operationalization, validity, and mechanisms of cognitive resilience. Neurobiol. Aging 83, 124&#x2013;129 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">31732015</ArticleId><ArticleId IdType="pmc">6859943</ArticleId><ArticleId IdType="doi">10.1016/j.neurobiolaging.2019.03.022</ArticleId></ArticleIdList></Reference><Reference><Citation>Ammassari-Teule, M. Neural compensation in presymptomatic hAPP mouse models of Alzheimer&#x2019;s disease. Learn. Mem. 27, 390&#x2013;394 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32817305</ArticleId><ArticleId IdType="pmc">7433654</ArticleId><ArticleId IdType="doi">10.1101/lm.050401.119</ArticleId></ArticleIdList></Reference><Reference><Citation>Morrone, C. D., Lai, A. Y., Bishay, J., Hill, M. E. &amp; McLaurin, J. Parvalbumin neuroplasticity compensates for somatostatin impairment, maintaining cognitive function in Alzheimer&#x2019;s disease. Transl. Neurodegener. 11, 26 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35501886</ArticleId><ArticleId IdType="pmc">9063209</ArticleId><ArticleId IdType="doi">10.1186/s40035-022-00300-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Probst, A. et al. Axonopathy and amyotrophy in mice transgenic for human four-repeat tau protein. Acta Neuropathol. 99, 469&#x2013;481 (2000).</Citation><ArticleIdList><ArticleId IdType="pubmed">10805089</ArticleId><ArticleId IdType="doi">10.1007/s004010051148</ArticleId></ArticleIdList></Reference><Reference><Citation>Allen, B. et al. Abundant tau filaments and nonapoptotic neurodegeneration in transgenic mice expressing human P301S tau protein. J. Neurosci. 22, 9340&#x2013;9351 (2002).</Citation><ArticleIdList><ArticleId IdType="pubmed">12417659</ArticleId><ArticleId IdType="pmc">6758022</ArticleId><ArticleId IdType="doi">10.1523/JNEUROSCI.22-21-09340.2002</ArticleId></ArticleIdList></Reference><Reference><Citation>Santacruz, K. et al. Tau suppression in a neurodegenerative mouse model improves memory function. Science 309, 476&#x2013;481 (2005).</Citation><ArticleIdList><ArticleId IdType="pubmed">16020737</ArticleId><ArticleId IdType="pmc">1574647</ArticleId><ArticleId IdType="doi">10.1126/science.1113694</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xf6;tz, J., Bodea, L. G. &amp; Goedert, M. Rodent models for Alzheimer disease. Nat. Rev. Neurosci. 19, 583&#x2013;598 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">30194347</ArticleId><ArticleId IdType="doi">10.1038/s41583-018-0054-8</ArticleId></ArticleIdList></Reference><Reference><Citation>Saito, T. et al. Single App knock-in mouse models of Alzheimer&#x2019;s disease. Nat. Neurosci. 17, 661&#x2013;663 (2014).</Citation><ArticleIdList><ArticleId IdType="pubmed">24728269</ArticleId><ArticleId IdType="doi">10.1038/nn.3697</ArticleId></ArticleIdList></Reference><Reference><Citation>Sato, K. et al. A third-generation mouse model of Alzheimer&#x2019;s disease shows early and increased cored plaque pathology composed of wild-type human amyloid &#x3b2; peptide. J. Biol. Chem. 297, 101004 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34329683</ArticleId><ArticleId IdType="pmc">8397900</ArticleId><ArticleId IdType="doi">10.1016/j.jbc.2021.101004</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia, D., Gutmann, J. M. &amp; G&#xf6;tz, J. Mobility and subcellular localization of endogenous, gene-edited tau differs from that of over-expressed human wild-type and P301L mutant tau. Sci. Rep. 6, 29074 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">27378256</ArticleId><ArticleId IdType="pmc">4932628</ArticleId><ArticleId IdType="doi">10.1038/srep29074</ArticleId></ArticleIdList></Reference><Reference><Citation>Bjorkhem, I. et al. Cholesterol homeostasis in human brain: turnover of 24S-hydroxycholesterol and evidence for a cerebral origin of most of this oxysterol in the circulation. J. Lipid Res. 39, 1594&#x2013;1600 (1998).</Citation><ArticleIdList><ArticleId IdType="pubmed">9717719</ArticleId><ArticleId IdType="doi">10.1016/S0022-2275(20)32188-X</ArticleId></ArticleIdList></Reference><Reference><Citation>Huynh, T. V. et al. Lack of hepatic ApoE does not influence early A&#x3b2; deposition: observations from a new APOE knock-in model. Mol. Neurodegener. 14, 37 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">31623648</ArticleId><ArticleId IdType="pmc">6796484</ArticleId><ArticleId IdType="doi">10.1186/s13024-019-0337-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Barisano, G. et al. A &#x2018;multi-omics&#x2019; analysis of blood&#x2013;brain barrier and synaptic dysfunction in APOE4 mice. J. Exp. Med. 219, e20221137 (2022).</Citation></Reference><Reference><Citation>Shi, Y. et al. ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy. Nature 549, 523&#x2013;527 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28959956</ArticleId><ArticleId IdType="pmc">5641217</ArticleId><ArticleId IdType="doi">10.1038/nature24016</ArticleId></ArticleIdList></Reference><Reference><Citation>Bales, K. R. et al. Human APOE isoform-dependent effects on brain &#x3b2;-amyloid levels in PDAPP transgenic mice. J. Neurosci. 29, 6771&#x2013;6779 (2009).</Citation><ArticleIdList><ArticleId IdType="pubmed">19474305</ArticleId><ArticleId IdType="pmc">6665579</ArticleId><ArticleId IdType="doi">10.1523/JNEUROSCI.0887-09.2009</ArticleId></ArticleIdList></Reference><Reference><Citation>Castellano, J. M. et al. Human ApoE isoforms differentially regulate brain amyloid-&#x3b2; peptide clearance. Sci. Transl. Med. 3, 89ra57 (2011).</Citation><ArticleIdList><ArticleId IdType="pubmed">21715678</ArticleId><ArticleId IdType="pmc">3192364</ArticleId><ArticleId IdType="doi">10.1126/scitranslmed.3002156</ArticleId></ArticleIdList></Reference><Reference><Citation>Hou, J., Chen, Y., Grajales-Reyes, G. &amp; Colonna, M. TREM2 dependent and independent functions of microglia in Alzheimer&#x2019;s disease. Mol. Neurodegener. 17, 84 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">36564824</ArticleId><ArticleId IdType="pmc">9783481</ArticleId><ArticleId IdType="doi">10.1186/s13024-022-00588-y</ArticleId></ArticleIdList></Reference><Reference><Citation>Fitz, N. F. et al. Trem2 deficiency differentially affects phenotype and transcriptome of human APOE3 and APOE4 mice. Mol. Neurodegener. 15, 41 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32703241</ArticleId><ArticleId IdType="pmc">7379780</ArticleId><ArticleId IdType="doi">10.1186/s13024-020-00394-4</ArticleId></ArticleIdList></Reference><Reference><Citation>Humpel, C. Organotypic brain slice cultures: a review. Neuroscience 305, 86&#x2013;98 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">26254240</ArticleId><ArticleId IdType="doi">10.1016/j.neuroscience.2015.07.086</ArticleId></ArticleIdList></Reference><Reference><Citation>Fath, T., Ke, Y. D., Gunning, P., G&#xf6;tz, J. &amp; Ittner, L. M. Primary support cultures of hippocampal and substantia nigra neurons. Nat. Protoc. 4, 78&#x2013;85 (2009).</Citation><ArticleIdList><ArticleId IdType="pubmed">19131959</ArticleId><ArticleId IdType="doi">10.1038/nprot.2008.199</ArticleId></ArticleIdList></Reference><Reference><Citation>Pir, G. J., Choudhary, B. &amp; Mandelkow, E. Caenorhabditis elegans models of tauopathy. FASEB J. 31, 5137&#x2013;5148 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">29191965</ArticleId><ArticleId IdType="doi">10.1096/fj.201701007</ArticleId></ArticleIdList></Reference><Reference><Citation>Griffin, E. F., Caldwell, K. A. &amp; Caldwell, G. A. Genetic and pharmacological discovery for Alzheimer&#x2019;s disease using Caenorhabditis elegans. ACS Chem. Neurosci. 8, 2596&#x2013;2606 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">29022701</ArticleId><ArticleId IdType="doi">10.1021/acschemneuro.7b00361</ArticleId></ArticleIdList></Reference><Reference><Citation>Asadzadeh, J. et al. Retromer deficiency in tauopathy models enhances the truncation and toxicity of tau. Nat. Commun. 13, 5049 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">36030267</ArticleId><ArticleId IdType="pmc">9420134</ArticleId><ArticleId IdType="doi">10.1038/s41467-022-32683-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Saleem, S. &amp; Kannan, R. R. Zebrafish: an emerging real-time model system to study Alzheimer&#x2019;s disease and neurospecific drug discovery. Cell Death Discov. 4, 45 (2018).</Citation></Reference><Reference><Citation>Pang, K. et al. An App knock-in rat model for Alzheimer&#x2019;s disease exhibiting A&#x3b2; and tau pathologies, neuronal death and cognitive impairments. Cell Res. 32, 157&#x2013;175 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">34789895</ArticleId><ArticleId IdType="doi">10.1038/s41422-021-00582-x</ArticleId></ArticleIdList></Reference><Reference><Citation>Hurley, M. J. et al. Genome sequencing variations in the Octodon degus, an unconventional natural model of aging and Alzheimer&#x2019;s disease. Front. Aging Neurosci. 14, 894994 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35860672</ArticleId><ArticleId IdType="pmc">9291219</ArticleId><ArticleId IdType="doi">10.3389/fnagi.2022.894994</ArticleId></ArticleIdList></Reference><Reference><Citation>Reid, S. J. et al. Alzheimer&#x2019;s disease markers in the aged sheep (Ovis aries). Neurobiol. Aging 58, 112&#x2013;119 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28728117</ArticleId><ArticleId IdType="doi">10.1016/j.neurobiolaging.2017.06.020</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan, S. et al. A huntingtin knockin pig model recapitulates features of selective neurodegeneration in Huntington&#x2019;s disease. Cell 173, 989&#x2013;1002 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">29606351</ArticleId><ArticleId IdType="pmc">5935586</ArticleId><ArticleId IdType="doi">10.1016/j.cell.2018.03.005</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee, S. E. et al. Production of transgenic pig as an Alzheimer&#x2019;s disease model using a multi-cistronic vector system. PLoS ONE 12, e0177933 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28586343</ArticleId><ArticleId IdType="pmc">5460854</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0177933</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker, L. C. &amp; Jucker, M. The exceptional vulnerability of humans to Alzheimer&#x2019;s disease. Trends Mol. Med. 23, 534&#x2013;545 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28483344</ArticleId><ArticleId IdType="pmc">5521004</ArticleId><ArticleId IdType="doi">10.1016/j.molmed.2017.04.001</ArticleId></ArticleIdList></Reference><Reference><Citation>Haque, R. U. &amp; Levey, A. I. Alzheimer&#x2019;s disease: a clinical perspective and future nonhuman primate research opportunities. Proc. Natl Acad. Sci. USA 116, 26224&#x2013;26229 (2019).</Citation></Reference><Reference><Citation>Paspalas, C. D. et al. The aged rhesus macaque manifests Braak stage III/IV Alzheimer&#x2019;s-like pathology. Alzheimers Dement. 14, 680&#x2013;691 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">29241829</ArticleId><ArticleId IdType="doi">10.1016/j.jalz.2017.11.005</ArticleId></ArticleIdList></Reference><Reference><Citation>Sasaguri, H. et al. Recent advances in the modeling of Alzheimer&#x2019;s disease. Front. Neurosci. 16, 807473 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35431779</ArticleId><ArticleId IdType="pmc">9009508</ArticleId><ArticleId IdType="doi">10.3389/fnins.2022.807473</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshimatsu, S. et al. Multimodal analyses of a non-human primate model harboring mutant amyloid precursor protein transgenes driven by the human EF1&#x3b1; promoter. Neurosci. Res. 185, 49&#x2013;61 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">36075457</ArticleId><ArticleId IdType="doi">10.1016/j.neures.2022.08.008</ArticleId></ArticleIdList></Reference><Reference><Citation>Seita, Y. et al. Generation of transgenic cynomolgus monkeys overexpressing the gene for amyloid-&#x3b2; precursor protein. J. Alzheimers Dis. 75, 45&#x2013;60 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32250299</ArticleId><ArticleId IdType="pmc">7306892</ArticleId><ArticleId IdType="doi">10.3233/JAD-191081</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang, M. et al. Neurological manifestations of autosomal dominant familial Alzheimer&#x2019;s disease: a comparison of the published literature with the Dominantly Inherited Alzheimer Network observational study (DIAN-OBS). Lancet Neurol. 15, 1317&#x2013;1325 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">27777020</ArticleId><ArticleId IdType="pmc">5116769</ArticleId><ArticleId IdType="doi">10.1016/S1474-4422(16)30229-0</ArticleId></ArticleIdList></Reference><Reference><Citation>Lear, A. et al. Understanding them to understand ourselves: the importance of NHP research for translational neuroscience. Curr. Res. Neurobiol. 3, 100049 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">36518342</ArticleId><ArticleId IdType="pmc">9743051</ArticleId><ArticleId IdType="doi">10.1016/j.crneur.2022.100049</ArticleId></ArticleIdList></Reference><Reference><Citation>Kennedy, M. E. et al. The BACE1 inhibitor verubecestat (MK-8931) reduces CNS &#x3b2;-amyloid in animal models and in Alzheimer&#x2019;s disease patients. Sci. Transl. Med. 8, 363ra150 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">27807285</ArticleId><ArticleId IdType="doi">10.1126/scitranslmed.aad9704</ArticleId></ArticleIdList></Reference><Reference><Citation>Amin, N. D. &amp; Pasca, S. P. Building models of brain disorders with three-dimensional organoids. Neuron 100, 389&#x2013;405 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">30359604</ArticleId><ArticleId IdType="doi">10.1016/j.neuron.2018.10.007</ArticleId></ArticleIdList></Reference><Reference><Citation>Park, J. et al. A 3D human triculture system modeling neurodegeneration and neuroinflammation in Alzheimer&#x2019;s disease. Nat. Neurosci. 21, 941&#x2013;951 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">29950669</ArticleId><ArticleId IdType="pmc">6800152</ArticleId><ArticleId IdType="doi">10.1038/s41593-018-0175-4</ArticleId></ArticleIdList></Reference><Reference><Citation>Fair, S. R. et al. Electrophysiological maturation of cerebral organoids correlates with dynamic morphological and cellular development. Stem Cell Rep. 15, 855&#x2013;868 (2020).</Citation></Reference><Reference><Citation>Sun, X. Y. et al. Generation of vascularized brain organoids to study neurovascular interactions. eLife 11, e76707 (2022).</Citation></Reference><Reference><Citation>Shin, N. et al. Vascularization of iNSC spheroid in a 3D spheroid-on-a-chip platform enhances neural maturation. Biotechnol. Bioeng. 119, 566&#x2013;574 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">34716703</ArticleId><ArticleId IdType="doi">10.1002/bit.27978</ArticleId></ArticleIdList></Reference><Reference><Citation>Duque, A., Arellano, J. I. &amp; Rakic, P. An assessment of the existence of adult neurogenesis in humans and value of its rodent models for neuropsychiatric diseases. Mol. Psychiatry 27, 377&#x2013;382 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">34667259</ArticleId><ArticleId IdType="doi">10.1038/s41380-021-01314-8</ArticleId></ArticleIdList></Reference><Reference><Citation>Sloan, S. A. et al. Human astrocyte maturation captured in 3D cerebral cortical spheroids derived from pluripotent stem cells. Neuron 95, 779&#x2013;790 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28817799</ArticleId><ArticleId IdType="pmc">5890820</ArticleId><ArticleId IdType="doi">10.1016/j.neuron.2017.07.035</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Otin, C. &amp; Kroemer, G. Hallmarks of health. Cell 184, 33&#x2013;63 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33340459</ArticleId><ArticleId IdType="doi">10.1016/j.cell.2020.11.034</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Otin, C., Blasco, M. A., Partridge, L., Serrano, M. &amp; Kroemer, G. Hallmarks of aging: an expanding universe. Cell 186, 243&#x2013;278 (2022).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.11.001</ArticleId></ArticleIdList></Reference><Reference><Citation>Turturro, A., Duffy, P., Hass, B., Kodell, R. &amp; Hart, R. Survival characteristics and age-adjusted disease incidences in C57BL/6 mice fed a commonly used cereal-based diet modulated by dietary restriction. J. Gerontol. A Biol. Sci. Med. Sci. 57, B379&#x2013;B389 (2002).</Citation><ArticleIdList><ArticleId IdType="pubmed">12403793</ArticleId><ArticleId IdType="doi">10.1093/gerona/57.11.B379</ArticleId></ArticleIdList></Reference><Reference><Citation>Blackmore, D. G. et al. Multimodal analysis of aged wild-type mice exposed to repeated scanning ultrasound treatments demonstrates long-term safety. Theranostics 8, 6233&#x2013;6247 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">30613294</ArticleId><ArticleId IdType="pmc">6299703</ArticleId><ArticleId IdType="doi">10.7150/thno.27941</ArticleId></ArticleIdList></Reference><Reference><Citation>van Praag, H., Shubert, T., Zhao, C. &amp; Gage, F. H. Exercise enhances learning and hippocampal neurogenesis in aged mice. J. Neurosci. 25, 8680&#x2013;8685 (2005).</Citation><ArticleIdList><ArticleId IdType="pubmed">16177036</ArticleId><ArticleId IdType="pmc">1360197</ArticleId><ArticleId IdType="doi">10.1523/JNEUROSCI.1731-05.2005</ArticleId></ArticleIdList></Reference><Reference><Citation>Blackmore, D. G. et al. Low-intensity ultrasound restores long-term potentiation and memory in senescent mice through pleiotropic mechanisms including NMDAR signaling. Mol. Psychiatry 26, 6975&#x2013;6991 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34040151</ArticleId><ArticleId IdType="pmc">8760044</ArticleId><ArticleId IdType="doi">10.1038/s41380-021-01129-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Nisbet, R. M. et al. Combined effects of scanning ultrasound and a tau-specific single chain antibody in a tau transgenic mouse model. Brain 140, 1220&#x2013;1230 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28379300</ArticleId><ArticleId IdType="pmc">5405237</ArticleId><ArticleId IdType="doi">10.1093/brain/awx052</ArticleId></ArticleIdList></Reference><Reference><Citation>Pandit, R., Leinenga, G. &amp; G&#xf6;tz, J. Repeated ultrasound treatment of tau transgenic mice clears neuronal tau by autophagy and improves behavioral functions. Theranostics 9, 3754&#x2013;3767 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">31281511</ArticleId><ArticleId IdType="pmc">6587352</ArticleId><ArticleId IdType="doi">10.7150/thno.34388</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu, G. et al. TAPPing into the potential of inducible tau/APP transgenic mice. Neuropathol. Appl. Neurobiol. 48, e12791 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35067965</ArticleId><ArticleId IdType="doi">10.1111/nan.12791</ArticleId></ArticleIdList></Reference><Reference><Citation>Beckmann, N., Gerard, C., Abramowski, D., Cannet, C. &amp; Staufenbiel, M. Noninvasive magnetic resonance imaging detection of cerebral amyloid angiopathy-related microvascular alterations using superparamagnetic iron oxide particles in APP transgenic mouse models of Alzheimer&#x2019;s disease: application to passive A&#x3b2; immunotherapy. J. Neurosci. 31, 1023&#x2013;1031 (2011).</Citation><ArticleIdList><ArticleId IdType="pubmed">21248127</ArticleId><ArticleId IdType="pmc">6632947</ArticleId><ArticleId IdType="doi">10.1523/JNEUROSCI.4936-10.2011</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewis, J. et al. Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein. Nat. Genet. 25, 402&#x2013;405 (2000).</Citation><ArticleIdList><ArticleId IdType="pubmed">10932182</ArticleId><ArticleId IdType="doi">10.1038/78078</ArticleId></ArticleIdList></Reference><Reference><Citation>Coninx, E. et al. Hippocampal and cortical tissue-specific epigenetic clocks indicate an increased epigenetic age in a mouse model for Alzheimer&#x2019;s disease. Aging 12, 20817&#x2013;20834 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">33082299</ArticleId><ArticleId IdType="pmc">7655172</ArticleId><ArticleId IdType="doi">10.18632/aging.104056</ArticleId></ArticleIdList></Reference><Reference><Citation>Gamache, J. et al. Factors other than hTau overexpression that contribute to tauopathy-like phenotype in rTg4510 mice. Nat. Commun. 10, 2479 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">31171783</ArticleId><ArticleId IdType="pmc">6554306</ArticleId><ArticleId IdType="doi">10.1038/s41467-019-10428-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Polanco, J. C., Hand, G. R., Briner, A., Li, C. &amp; G&#xf6;tz, J. Exosomes induce endolysosomal permeabilization as a gateway by which exosomal tau seeds escape into the cytosol. Acta Neuropathol. 141, 235&#x2013;256 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33417012</ArticleId><ArticleId IdType="pmc">7847444</ArticleId><ArticleId IdType="doi">10.1007/s00401-020-02254-3</ArticleId></ArticleIdList></Reference><Reference><Citation>Thal, D. R. et al. Estimation of amyloid distribution by [<sup>18</sup>F]flutemetamol PET predicts the neuropathological phase of amyloid &#x3b2;-protein deposition. Acta Neuropathol. 136, 557&#x2013;567 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">30123935</ArticleId><ArticleId IdType="pmc">6132944</ArticleId><ArticleId IdType="doi">10.1007/s00401-018-1897-9</ArticleId></ArticleIdList></Reference><Reference><Citation>Braak, H. &amp; Braak, E. Staging of Alzheimer&#x2019;s disease-related neurofibrillary changes. Neurobiol. Aging 16, 271&#x2013;278 (1995).</Citation><ArticleIdList><ArticleId IdType="pubmed">7566337</ArticleId><ArticleId IdType="doi">10.1016/0197-4580(95)00021-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Jucker, M. &amp; Walker, L. C. Self-propagation of pathogenic protein aggregates in neurodegenerative diseases. Nature 501, 45&#x2013;51 (2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">24005412</ArticleId><ArticleId IdType="pmc">3963807</ArticleId><ArticleId IdType="doi">10.1038/nature12481</ArticleId></ArticleIdList></Reference><Reference><Citation>de Calignon, A. et al. Propagation of tau pathology in a model of early Alzheimer&#x2019;s disease. Neuron 73, 685&#x2013;697 (2012).</Citation><ArticleIdList><ArticleId IdType="pubmed">22365544</ArticleId><ArticleId IdType="pmc">3292759</ArticleId><ArticleId IdType="doi">10.1016/j.neuron.2011.11.033</ArticleId></ArticleIdList></Reference><Reference><Citation>Asai, H. et al. Depletion of microglia and inhibition of exosome synthesis halt tau propagation. Nat. Neurosci. 18, 1584&#x2013;1593 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">26436904</ArticleId><ArticleId IdType="pmc">4694577</ArticleId><ArticleId IdType="doi">10.1038/nn.4132</ArticleId></ArticleIdList></Reference><Reference><Citation>Clavaguera, F. et al. Brain homogenates from human tauopathies induce tau inclusions in mouse brain. Proc. Natl Acad. Sci. USA 110, 9535&#x2013;9540 (2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">23690619</ArticleId><ArticleId IdType="pmc">3677441</ArticleId><ArticleId IdType="doi">10.1073/pnas.1301175110</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed, Z. et al. A novel in vivo model of tau propagation with rapid and progressive neurofibrillary tangle pathology: the pattern of spread is determined by connectivity, not proximity. Acta Neuropathol. 127, 667&#x2013;683 (2014).</Citation><ArticleIdList><ArticleId IdType="pubmed">24531916</ArticleId><ArticleId IdType="pmc">4252866</ArticleId><ArticleId IdType="doi">10.1007/s00401-014-1254-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferris, S. H. et al. Positron emission tomography in the study of aging and senile dementia. Neurobiol. Aging 1, 127&#x2013;131 (1980).</Citation><ArticleIdList><ArticleId IdType="pubmed">24279935</ArticleId><ArticleId IdType="doi">10.1016/0197-4580(80)90005-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Palop, J. J. &amp; Mucke, L. Network abnormalities and interneuron dysfunction in Alzheimer disease. Nat. Rev. Neurosci. 17, 777&#x2013;792 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">27829687</ArticleId><ArticleId IdType="pmc">8162106</ArticleId><ArticleId IdType="doi">10.1038/nrn.2016.141</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheline, Y. I. et al. APOE4 allele disrupts resting state fMRI connectivity in the absence of amyloid plaques or decreased CSF A&#x3b2;<sub>42</sub>. J. Neurosci. 30, 17035&#x2013;17040 (2010).</Citation><ArticleIdList><ArticleId IdType="pubmed">21159973</ArticleId><ArticleId IdType="pmc">3023180</ArticleId><ArticleId IdType="doi">10.1523/JNEUROSCI.3987-10.2010</ArticleId></ArticleIdList></Reference><Reference><Citation>Palmqvist, S. et al. Earliest accumulation of &#x3b2;-amyloid occurs within the default-mode network and concurrently affects brain connectivity. Nat. Commun. 8, 1214 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">29089479</ArticleId><ArticleId IdType="pmc">5663717</ArticleId><ArticleId IdType="doi">10.1038/s41467-017-01150-x</ArticleId></ArticleIdList></Reference><Reference><Citation>Zott, B., Busche, M. A., Sperling, R. A. &amp; Konnerth, A. What happens with the circuit in Alzheimer&#x2019;s disease in mice and humans? Annu. Rev. Neurosci. 41, 277&#x2013;297 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">29986165</ArticleId><ArticleId IdType="pmc">6571139</ArticleId><ArticleId IdType="doi">10.1146/annurev-neuro-080317-061725</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu, H. et al. Rat brains also have a default mode network. Proc. Natl Acad. Sci. USA 109, 3979&#x2013;3984 (2012).</Citation><ArticleIdList><ArticleId IdType="pubmed">22355129</ArticleId><ArticleId IdType="pmc">3309754</ArticleId><ArticleId IdType="doi">10.1073/pnas.1200506109</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitesell, J. D. et al. Regional, layer, and cell-type-specific connectivity of the mouse default mode network. Neuron 109, 545&#x2013;559 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33290731</ArticleId><ArticleId IdType="pmc">8150331</ArticleId><ArticleId IdType="doi">10.1016/j.neuron.2020.11.011</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou, Y. et al. Abnormal connectivity in the posterior cingulate and hippocampus in early Alzheimer&#x2019;s disease and mild cognitive impairment. Alzheimers Dement. 4, 265&#x2013;270 (2008).</Citation><ArticleIdList><ArticleId IdType="pubmed">18631977</ArticleId><ArticleId IdType="doi">10.1016/j.jalz.2008.04.006</ArticleId></ArticleIdList></Reference><Reference><Citation>Quiroz, Y. T. et al. Hippocampal hyperactivation in presymptomatic familial Alzheimer&#x2019;s disease. Ann. Neurol. 68, 865&#x2013;875 (2010).</Citation><ArticleIdList><ArticleId IdType="pubmed">21194156</ArticleId><ArticleId IdType="pmc">3175143</ArticleId><ArticleId IdType="doi">10.1002/ana.22105</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Brien, J. L. et al. Longitudinal fMRI in elderly reveals loss of hippocampal activation with clinical decline. Neurology 74, 1969&#x2013;1976 (2010).</Citation><ArticleIdList><ArticleId IdType="pubmed">20463288</ArticleId><ArticleId IdType="pmc">2905893</ArticleId><ArticleId IdType="doi">10.1212/WNL.0b013e3181e3966e</ArticleId></ArticleIdList></Reference><Reference><Citation>Busche, M. A. et al. Critical role of soluble amyloid-&#x3b2; for early hippocampal hyperactivity in a mouse model of Alzheimer&#x2019;s disease. Proc. Natl Acad. Sci. USA 109, 8740&#x2013;8745 (2012).</Citation><ArticleIdList><ArticleId IdType="pubmed">22592800</ArticleId><ArticleId IdType="pmc">3365221</ArticleId><ArticleId IdType="doi">10.1073/pnas.1206171109</ArticleId></ArticleIdList></Reference><Reference><Citation>Palop, J. J. et al. Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer&#x2019;s disease. Neuron 55, 697&#x2013;711 (2007).</Citation><ArticleIdList><ArticleId IdType="pubmed">17785178</ArticleId><ArticleId IdType="pmc">8055171</ArticleId><ArticleId IdType="doi">10.1016/j.neuron.2007.07.025</ArticleId></ArticleIdList></Reference><Reference><Citation>Padmanabhan, P., Kneynsberg, A. &amp; G&#xf6;tz, J. Super-resolution microscopy: a closer look at synaptic dysfunction in Alzheimer disease. Nat. Rev. Neurosci. 22, 723&#x2013;740 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34725519</ArticleId><ArticleId IdType="doi">10.1038/s41583-021-00531-y</ArticleId></ArticleIdList></Reference><Reference><Citation>Tzioras, M., McGeachan, R. I., Durrant, C. S. &amp; Spires-Jones, T. L. Synaptic degeneration in Alzheimer disease. Nat. Rev. Neurol. 19, 19&#x2013;38 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">36513730</ArticleId><ArticleId IdType="doi">10.1038/s41582-022-00749-z</ArticleId></ArticleIdList></Reference><Reference><Citation>Sweeney, M. D., Zhao, Z., Montagne, A., Nelson, A. R. &amp; Zlokovic, B. V. Blood&#x2013;brain barrier: from physiology to disease and back. Physiol. Rev. 99, 21&#x2013;78 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">30280653</ArticleId><ArticleId IdType="doi">10.1152/physrev.00050.2017</ArticleId></ArticleIdList></Reference><Reference><Citation>Pardridge, W. M. Tyrosine hydroxylase replacement in experimental Parkinson&#x2019;s disease with transvascular gene therapy. NeuroRx 2, 129&#x2013;138 (2005).</Citation><ArticleIdList><ArticleId IdType="pubmed">15717064</ArticleId><ArticleId IdType="pmc">539333</ArticleId><ArticleId IdType="doi">10.1602/neurorx.2.1.129</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuwelt, E. et al. Strategies to advance translational research into brain barriers. Lancet Neurol. 7, 84&#x2013;96 (2008).</Citation><ArticleIdList><ArticleId IdType="pubmed">18093565</ArticleId><ArticleId IdType="doi">10.1016/S1474-4422(07)70326-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Golde, T. E. Open questions for Alzheimer&#x2019;s disease immunotherapy. Alzheimers Res. Ther. 6, 3 (2014).</Citation><ArticleIdList><ArticleId IdType="pubmed">24393284</ArticleId><ArticleId IdType="pmc">4056616</ArticleId><ArticleId IdType="doi">10.1186/alzrt233</ArticleId></ArticleIdList></Reference><Reference><Citation>Budd Haeberlein, S. et al. Two randomized phase 3 studies of aducanumab in early Alzheimer&#x2019;s disease. J. Prev. Alzheimers Dis. 9, 197&#x2013;210 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35542991</ArticleId></ArticleIdList></Reference><Reference><Citation>Schneider, L. A resurrection of aducanumab for Alzheimer&#x2019;s disease. Lancet Neurol. 19, 111&#x2013;112 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">31978357</ArticleId><ArticleId IdType="doi">10.1016/S1474-4422(19)30480-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayton, S. Ventricular enlargement caused by aducanumab. Nat. Rev. Neurol. 18, 383&#x2013;384 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35440813</ArticleId><ArticleId IdType="doi">10.1038/s41582-022-00660-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Leinenga, G., Koh, W. K. &amp; G&#xf6;tz, J. A comparative study of the effects of aducanumab and scanning ultrasound on amyloid plaques and behavior in the APP23 mouse model of Alzheimer disease. Alzheimers Res. Ther. 13, 76 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33836798</ArticleId><ArticleId IdType="pmc">8035770</ArticleId><ArticleId IdType="doi">10.1186/s13195-021-00809-4</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun, T. et al. Focused ultrasound with anti-pGlu3 A&#x3b2; enhances efficacy in Alzheimer&#x2019;s disease-like mice via recruitment of peripheral immune cells. J. Control. Release 336, 443&#x2013;456 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34186148</ArticleId><ArticleId IdType="pmc">8373822</ArticleId><ArticleId IdType="doi">10.1016/j.jconrel.2021.06.037</ArticleId></ArticleIdList></Reference><Reference><Citation>Kovacs, Z. I. et al. Disrupting the blood&#x2013;brain barrier by focused ultrasound induces sterile inflammation. Proc. Natl Acad. Sci. USA 114, E75&#x2013;E84 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">27994152</ArticleId><ArticleId IdType="doi">10.1073/pnas.1614777114</ArticleId></ArticleIdList></Reference><Reference><Citation>McMahon, D. &amp; Hynynen, K. Acute inflammatory response following increased blood&#x2013;brain barrier permeability induced by focused ultrasound is dependent on microbubble dose. Theranostics 7, 3989&#x2013;4000 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">29109793</ArticleId><ArticleId IdType="pmc">5667420</ArticleId><ArticleId IdType="doi">10.7150/thno.21630</ArticleId></ArticleIdList></Reference><Reference><Citation>Clausznitzer, D. et al. Quantitative systems pharmacology model for Alzheimer disease indicates targeting sphingolipid dysregulation as potential treatment option. CPT Pharmacometrics Syst. Pharmacol. 7, 759&#x2013;770 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">30207429</ArticleId><ArticleId IdType="pmc">6263662</ArticleId><ArticleId IdType="doi">10.1002/psp4.12351</ArticleId></ArticleIdList></Reference><Reference><Citation>Madrasi, K. et al. Systematic in silico analysis of clinically tested drugs for reducing amyloid-&#x3b2; plaque accumulation in Alzheimer&#x2019;s disease. Alzheimers Dement. 17, 1487&#x2013;1498 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33938131</ArticleId><ArticleId IdType="pmc">8478725</ArticleId><ArticleId IdType="doi">10.1002/alz.12312</ArticleId></ArticleIdList></Reference><Reference><Citation>Vogel, J. W. et al. Four distinct trajectories of tau deposition identified in Alzheimer&#x2019;s disease. Nat. Med. 27, 871&#x2013;881 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33927414</ArticleId><ArticleId IdType="pmc">8686688</ArticleId><ArticleId IdType="doi">10.1038/s41591-021-01309-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Cornblath, E. J. et al. Computational modeling of tau pathology spread reveals patterns of regional vulnerability and the impact of a genetic risk factor. Sci. Adv. 7, eabg6677 (2021).</Citation></Reference><Reference><Citation>Meisl, G. et al. In vivo rate-determining steps of tau seed accumulation in Alzheimer&#x2019;s disease. Sci. Adv. 7, eabh1448 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34714685</ArticleId><ArticleId IdType="pmc">8555892</ArticleId><ArticleId IdType="doi">10.1126/sciadv.abh1448</ArticleId></ArticleIdList></Reference><Reference><Citation>Kunze, T., Hunold, A., Haueisen, J., Jirsa, V. &amp; Spiegler, A. Transcranial direct current stimulation changes resting state functional connectivity: a large-scale brain network modeling study. NeuroImage 140, 174&#x2013;187 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">26883068</ArticleId><ArticleId IdType="doi">10.1016/j.neuroimage.2016.02.015</ArticleId></ArticleIdList></Reference><Reference><Citation>Geerts, H. et al. A combined PBPK and QSP model for modeling amyloid aggregation in Alzheimer&#x2019;s disease. CPT Pharmacometrics Syst. Pharmacol. https://doi.org/10.1002/psp4.12912 (2023).</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/psp4.12912</ArticleId><ArticleId IdType="pubmed">36632701</ArticleId><ArticleId IdType="pmc">10088087</ArticleId></ArticleIdList></Reference><Reference><Citation>Taubes, A. et al. Experimental and real-world evidence supporting the computational repurposing of bumetanide for APOE4-related Alzheimer&#x2019;s disease. Nat. Aging 1, 932&#x2013;947 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">36172600</ArticleId><ArticleId IdType="pmc">9514594</ArticleId><ArticleId IdType="doi">10.1038/s43587-021-00122-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Haeno, H. et al. Computational modeling of pancreatic cancer reveals kinetics of metastasis suggesting optimum treatment strategies. Cell 148, 362&#x2013;375 (2012).</Citation><ArticleIdList><ArticleId IdType="pubmed">22265421</ArticleId><ArticleId IdType="pmc">3289413</ArticleId><ArticleId IdType="doi">10.1016/j.cell.2011.11.060</ArticleId></ArticleIdList></Reference><Reference><Citation>Padmanabhan, P., Desikan, R. &amp; Dixit, N. M. Modeling how antibody responses may determine the efficacy of COVID-19 vaccines. Nat. Comput. Sci. 2, 123&#x2013;131 (2022).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s43588-022-00198-0</ArticleId></ArticleIdList></Reference><Reference><Citation>Suberbielle, E. et al. Physiologic brain activity causes DNA double-strand breaks in neurons, with exacerbation by amyloid-&#x3b2;. Nat. Neurosci. 16, 613&#x2013;621 (2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">23525040</ArticleId><ArticleId IdType="pmc">3637871</ArticleId><ArticleId IdType="doi">10.1038/nn.3356</ArticleId></ArticleIdList></Reference><Reference><Citation>Thadathil, N. et al. DNA double-strand break accumulation in Alzheimer&#x2019;s disease: evidence from experimental models and postmortem human brains. Mol. Neurobiol. 58, 118&#x2013;131 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">32895786</ArticleId><ArticleId IdType="doi">10.1007/s12035-020-02109-8</ArticleId></ArticleIdList></Reference><Reference><Citation>Rolyan, H. et al. Telomere shortening reduces Alzheimer&#x2019;s disease amyloid pathology in mice. Brain 134, 2044&#x2013;2056 (2011).</Citation><ArticleIdList><ArticleId IdType="pubmed">21672962</ArticleId><ArticleId IdType="doi">10.1093/brain/awr133</ArticleId></ArticleIdList></Reference><Reference><Citation>Shu, L. et al. Genome-wide alteration of 5-hydroxymenthylcytosine in a mouse model of Alzheimer&#x2019;s disease. BMC Genomics 17, 381 (2016).</Citation></Reference><Reference><Citation>Cadena-del-Castillo, C. et al. Age-dependent increment of hydroxymethylation in the brain cortex in the triple-transgenic mouse model of Alzheimer&#x2019;s disease. J. Alzheimers Dis. 41, 845&#x2013;854 (2014).</Citation><ArticleIdList><ArticleId IdType="pubmed">24685633</ArticleId><ArticleId IdType="doi">10.3233/JAD-132285</ArticleId></ArticleIdList></Reference><Reference><Citation>Trishina, E. et al. Defects in mitochondrial dynamics and metabolomic signatures of evolving energetic stress in mouse models of familial Alzheimer&#x2019;s disease. PLoS ONE 7, e32737 (2012).</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0032737</ArticleId></ArticleIdList></Reference><Reference><Citation>David, D. C. et al. Proteomic and functional analysis reveal a mitochondrial dysfunction in P301L tau transgenic mice. J. Biol. Chem. 280, 23802&#x2013;23814 (2005).</Citation><ArticleIdList><ArticleId IdType="pubmed">15831501</ArticleId><ArticleId IdType="doi">10.1074/jbc.M500356200</ArticleId></ArticleIdList></Reference><Reference><Citation>Ittner, L. M. et al. Parkinsonism and impaired axonal transport in a mouse model of frontotemporal dementia. Proc. Natl Acad. Sci. USA 105, 15997&#x2013;16002 (2008).</Citation><ArticleIdList><ArticleId IdType="pubmed">18832465</ArticleId><ArticleId IdType="pmc">2572931</ArticleId><ArticleId IdType="doi">10.1073/pnas.0808084105</ArticleId></ArticleIdList></Reference><Reference><Citation>Duboff, B., G&#xf6;tz, J. &amp; Feany, M. B. Tau promotes neurodegeneration via DRP1 mislocalization in vivo. Neuron 75, 618&#x2013;632 (2012).</Citation><ArticleIdList><ArticleId IdType="pubmed">22920254</ArticleId><ArticleId IdType="pmc">3428596</ArticleId><ArticleId IdType="doi">10.1016/j.neuron.2012.06.026</ArticleId></ArticleIdList></Reference><Reference><Citation>Cummins, N., Tweedie, A., Zuryn, S., Bertran-Gonzalez, J. &amp; G&#xf6;tz, J. Disease-associated tau impairs mitophagy by inhibiting parkin translocation to mitochondria. EMBO J. 38, e99360 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">30538104</ArticleId><ArticleId IdType="pmc">6356067</ArticleId><ArticleId IdType="doi">10.15252/embj.201899360</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans, H. T., Benetatos, J., van Roijen, M., Bodea, L. G. &amp; G&#xf6;tz, J. Decreased synthesis of ribosomal proteins in tauopathy revealed by non-canonical amino acid labelling. EMBO J. 38, e101174 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">31268600</ArticleId><ArticleId IdType="pmc">6600635</ArticleId><ArticleId IdType="doi">10.15252/embj.2018101174</ArticleId></ArticleIdList></Reference><Reference><Citation>Saito, T. &amp; Saido, T. C. Neuroinflammation in mouse models of Alzheimer&#x2019;s disease. Clin. Exp. Neuroimmunol. 9, 211&#x2013;218 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">30546389</ArticleId><ArticleId IdType="pmc">6282739</ArticleId><ArticleId IdType="doi">10.1111/cen3.12475</ArticleId></ArticleIdList></Reference><Reference><Citation>Reinitz, F. et al. Inhibiting USP16 rescues stem cell aging and memory in an Alzheimer&#x2019;s model. eLife 11, e66037 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35311644</ArticleId><ArticleId IdType="pmc">9122497</ArticleId><ArticleId IdType="doi">10.7554/eLife.66037</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu, W. H. et al. Macroautophagy&#x2014;a novel &#x3b2;-amyloid peptide-generating pathway activated in Alzheimer&#x2019;s disease. J. Cell Biol. 171, 87&#x2013;98 (2005).</Citation><ArticleIdList><ArticleId IdType="pubmed">16203860</ArticleId><ArticleId IdType="pmc">2171227</ArticleId><ArticleId IdType="doi">10.1083/jcb.200505082</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun, J. et al. Fecal microbiota transplantation alleviated Alzheimer&#x2019;s disease-like pathogenesis in APP/PS1 transgenic mice. Transl. Psychiatry 9, 189 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">31383855</ArticleId><ArticleId IdType="pmc">6683152</ArticleId><ArticleId IdType="doi">10.1038/s41398-019-0525-3</ArticleId></ArticleIdList></Reference><Reference><Citation>Dodiya, H. B. et al. Gut microbiota-driven brain A&#x3b2; amyloidosis in mice requires microglia. J. Exp. Med. 219, e20200895 (2022).</Citation></Reference><Reference><Citation>Seo, D. O. et al. ApoE isoform- and microbiota-dependent progression of neurodegeneration in a mouse model of tauopathy. Science 379, eadd1236 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">36634180</ArticleId><ArticleId IdType="doi">10.1126/science.add1236</ArticleId></ArticleIdList></Reference><Reference><Citation>Heneka, M. T. et al. NLRP3 is activated in Alzheimer&#x2019;s disease and contributes to pathology in APP/PS1 mice. Nature 493, 674&#x2013;678 (2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">23254930</ArticleId><ArticleId IdType="doi">10.1038/nature11729</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang, S. et al. Proteopathic tau primes and activates interleukin-1&#x3b2; via myeloid-cell-specific MyD88- and NLRP3&#x2013;ASC&#x2013;inflammasome pathway. Cell Rep. 36, 109720 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34551296</ArticleId><ArticleId IdType="pmc">8491766</ArticleId><ArticleId IdType="doi">10.1016/j.celrep.2021.109720</ArticleId></ArticleIdList></Reference><Reference><Citation>Lafay-Chebassier, C. et al. mTOR/p70S6k signalling alteration by A&#x3b2; exposure as well as in APP-PS1 transgenic models and in patients with Alzheimer&#x2019;s disease. J. Neurochem. 94, 215&#x2013;225 (2005).</Citation><ArticleIdList><ArticleId IdType="pubmed">15953364</ArticleId><ArticleId IdType="doi">10.1111/j.1471-4159.2005.03187.x</ArticleId></ArticleIdList></Reference><Reference><Citation>Caccamo, A., Majumder, S., Richardson, A., Strong, R. &amp; Oddo, S. Molecular interplay between mammalian target of rapamycin (mTOR), amyloid-&#x3b2;, and tau: effects on cognitive impairments. J. Biol. Chem. 285, 13107&#x2013;13120 (2010).</Citation><ArticleIdList><ArticleId IdType="pubmed">20178983</ArticleId><ArticleId IdType="pmc">2857107</ArticleId><ArticleId IdType="doi">10.1074/jbc.M110.100420</ArticleId></ArticleIdList></Reference><Reference><Citation>Dorigatti, A. O. et al. Brain cellular senescence in mouse models of Alzheimer&#x2019;s disease. Geroscience 44, 1157&#x2013;1168 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35249206</ArticleId><ArticleId IdType="pmc">9135905</ArticleId><ArticleId IdType="doi">10.1007/s11357-022-00531-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, P. et al. Senolytic therapy alleviates A&#x3b2;-associated oligodendrocyte progenitor cell senescence and cognitive deficits in an Alzheimer&#x2019;s disease model. Nat. Neurosci. 22, 719&#x2013;728 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">30936558</ArticleId><ArticleId IdType="pmc">6605052</ArticleId><ArticleId IdType="doi">10.1038/s41593-019-0372-9</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37202515</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>22</Day></DateCompleted><DateRevised><Year>2023</Year><Month>06</Month><Day>26</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2662-8465</ISSN><JournalIssue CitedMedium="Internet"><Volume>3</Volume><Issue>5</Issue><PubDate><Year>2023</Year><Month>May</Month></PubDate></JournalIssue><Title>Nature aging</Title><ISOAbbreviation>Nat Aging</ISOAbbreviation></Journal><ArticleTitle>Towards a future where Alzheimer's disease pathology is stopped before the onset of dementia.</ArticleTitle><Pagination><StartPage>494</StartPage><EndPage>505</EndPage><MedlinePgn>494-505</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s43587-023-00404-2</ELocationID><Abstract><AbstractText>Alzheimer's disease (AD) is a major healthcare challenge with no curative treatment at present. To address this challenge, we need a paradigm shift, where we focus on pre-dementia stages of AD. In this Perspective, we outline a strategy to move towards a future with personalized medicine for AD by preparing for and investing in effective and patient-orchestrated diagnosis, prediction and prevention of the dementia stage. While focusing on AD, this Perspective also discusses studies that do not specify the cause of dementia. Future personalized prevention strategies encompass multiple components, including tailored combinations of disease-modifying interventions and lifestyle. By empowering the public and patients to be more actively engaged in the management of their health and disease and by developing improved strategies for diagnosis, prediction and prevention, we can pave the way for a future with personalized medicine, in which AD pathology is stopped to prevent or delay the onset of dementia.</AbstractText><CopyrightInformation>&#xa9; 2023. Springer Nature America, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>van der Flier</LastName><ForeName>Wiesje M</ForeName><Initials>WM</Initials><Identifier Source="ORCID">0000-0001-8766-6224</Identifier><AffiliationInfo><Affiliation>Alzheimer Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC location VUmc, Amsterdam, the Netherlands. wm.vdflier@amsterdamumc.nl.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Amsterdam Neuroscience, Neurodegeneration, Amsterdam, the Netherlands. wm.vdflier@amsterdamumc.nl.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Epidemiology and Data Science, Vrije Universiteit Amsterdam, Amsterdam UMC location VUmc, Amsterdam, the Netherlands. wm.vdflier@amsterdamumc.nl.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Vugt</LastName><ForeName>Marjolein E</ForeName><Initials>ME</Initials><AffiliationInfo><Affiliation>Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Alzheimer Centre Limburg, Maastricht University, Maastricht, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smets</LastName><ForeName>Ellen M A</ForeName><Initials>EMA</Initials><Identifier Source="ORCID">0000-0002-8145-8595</Identifier><AffiliationInfo><Affiliation>Medical Psychology, Amsterdam UMC location AMC, Amsterdam, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blom</LastName><ForeName>Marco</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Alzheimer Nederland, Amersfoort, Utrecht, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Teunissen</LastName><ForeName>Charlotte E</ForeName><Initials>CE</Initials><Identifier Source="ORCID">0000-0002-4061-0837</Identifier><AffiliationInfo><Affiliation>Amsterdam Neuroscience, Neurodegeneration, Amsterdam, the Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neurochemistry Laboratory, Clinical Chemistry, Vrije Universiteit Amsterdam, Amsterdam UMC location VUmc, Amsterdam, the Netherlands.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>05</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Nat Aging</MedlineTA><NlmUniqueID>101773306</NlmUniqueID><ISSNLinking>2662-8465</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057285" MajorTopicYN="N">Precision Medicine</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>12</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>3</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>22</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>19</Day><Hour>1</Hour><Minute>4</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>18</Day><Hour>23</Hour><Minute>21</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37202515</ArticleId><ArticleId IdType="doi">10.1038/s43587-023-00404-2</ArticleId><ArticleId IdType="pii">10.1038/s43587-023-00404-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>WHO. Global Status Report on the Public Health Response to Dementia. Report No. ISBN 978-92-4-003324-5 (World Health Organization, 2021).</Citation></Reference><Reference><Citation>Gustavsson, A. et al. Global estimates on the number of persons across the Alzheimer&#x2019;s disease continuum. Alzheimers Dement. 19, 658&#x2013;670 (2022).</Citation></Reference><Reference><Citation>Jack, C. R. Jr. et al. Prevalence of biologically vs clinically defined Alzheimer spectrum entities using the National Institute on Aging-Alzheimer&#x2019;s Association research framework. JAMA Neurol. 76, 1174&#x2013;1183 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">31305929</ArticleId><ArticleId IdType="pmc">6632154</ArticleId><ArticleId IdType="doi">10.1001/jamaneurol.2019.1971</ArticleId></ArticleIdList></Reference><Reference><Citation>Knopman, D. S., Petersen, R. C. &amp; Jack, C. R. Jr. A brief history of &#x201c;Alzheimer disease&#x201d;: multiple meanings separated by a common name. Neurology 92, 1053&#x2013;1059 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">31028129</ArticleId><ArticleId IdType="pmc">6556090</ArticleId><ArticleId IdType="doi">10.1212/WNL.0000000000007583</ArticleId></ArticleIdList></Reference><Reference><Citation>Jack, C. R. Jr. et al. NIA-AA research framework: toward a biological definition of Alzheimer&#x2019;s disease. Alzheimers Dement. 14, 535&#x2013;562 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">29653606</ArticleId><ArticleId IdType="pmc">5958625</ArticleId><ArticleId IdType="doi">10.1016/j.jalz.2018.02.018</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Flier, W. M. &amp; Scheltens, P. The ATN framework&#x2014;moving preclinical Alzheimer disease to clinical relevance. JAMA Neurol. 79, 968&#x2013;970 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">36214803</ArticleId><ArticleId IdType="doi">10.1001/jamaneurol.2022.2967</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Roest, H. G. et al. Subjective needs of people with dementia: a review of the literature. Int. Psychogeriatr. 19, 559&#x2013;592 (2007).</Citation><ArticleIdList><ArticleId IdType="pubmed">17201993</ArticleId><ArticleId IdType="doi">10.1017/S1041610206004716</ArticleId></ArticleIdList></Reference><Reference><Citation>Wimo, A., Guerchet, M., Ali, G. C., Wu, Y. T. &amp; Prina, M. World Alzheimer Report 2015: the Global Impact of Dementia (Alzheimer&#x2019;s Disease International, 2015).</Citation></Reference><Reference><Citation>Brookmeyer, R., Gray, S. &amp; Kawas, C. Projections of Alzheimer&#x2019;s disease in the United States and the public health impact of delaying disease onset. Am. J. Public Health 88, 1337&#x2013;1342 (1998).</Citation><ArticleIdList><ArticleId IdType="pubmed">9736873</ArticleId><ArticleId IdType="pmc">1509089</ArticleId><ArticleId IdType="doi">10.2105/AJPH.88.9.1337</ArticleId></ArticleIdList></Reference><Reference><Citation>Bateman, R. J. et al. Clinical and biomarker changes in dominantly inherited Alzheimer&#x2019;s disease. N. Engl. J. Med. 367, 795&#x2013;804 (2012).</Citation><ArticleIdList><ArticleId IdType="pubmed">22784036</ArticleId><ArticleId IdType="pmc">3474597</ArticleId><ArticleId IdType="doi">10.1056/NEJMoa1202753</ArticleId></ArticleIdList></Reference><Reference><Citation>Jansen, W. J. et al. Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis. JAMA 313, 1924&#x2013;1938 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">25988462</ArticleId><ArticleId IdType="pmc">4486209</ArticleId><ArticleId IdType="doi">10.1001/jama.2015.4668</ArticleId></ArticleIdList></Reference><Reference><Citation>Weldring, T. &amp; Smith, S. M. Patient-reported outcomes (PROs) and patient-reported outcome measures (PROMs). Health Serv. Insights 6, 61&#x2013;68 (2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">25114561</ArticleId><ArticleId IdType="pmc">4089835</ArticleId></ArticleIdList></Reference><Reference><Citation>Hofman, C. S. et al. Comparing the health state preferences of older persons, informal caregivers and healthcare professionals: a vignette study. PLoS ONE 10, e0119197 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">25739034</ArticleId><ArticleId IdType="pmc">4349801</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0119197</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. Global Action Plan on the Public Health Response to Dementia 2017&#x2013;2025. Report No. ISBN 978-92-4-151348-7 (World Health Organization, 2017).</Citation></Reference><Reference><Citation>van Dyck, C. H. et al. Lecanemab in early Alzheimer&#x2019;s disease. N. Engl. J. Med. 388, 9&#x2013;21 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">36449413</ArticleId><ArticleId IdType="doi">10.1056/NEJMoa2212948</ArticleId></ArticleIdList></Reference><Reference><Citation>Budd Haeberlein, S. et al. Two randomized phase 3 studies of aducanumab in early Alzheimer&#x2019;s disease. J. Prev. Alzheimers Dis. 9, 197&#x2013;210 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35542991</ArticleId></ArticleIdList></Reference><Reference><Citation>Cummings, J. et al. Alzheimer&#x2019;s disease drug development pipeline: 2022. Alzheimers Dement. 8, e12295 (2022).</Citation></Reference><Reference><Citation>van Bokhoven, P. et al. The Alzheimer&#x2019;s disease drug development landscape. Alzheimers Res. Ther. 13, 186 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34763720</ArticleId><ArticleId IdType="pmc">8582156</ArticleId><ArticleId IdType="doi">10.1186/s13195-021-00927-z</ArticleId></ArticleIdList></Reference><Reference><Citation>Livingston, G. et al. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet 396, 413&#x2013;446 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32738937</ArticleId><ArticleId IdType="pmc">7392084</ArticleId><ArticleId IdType="doi">10.1016/S0140-6736(20)30367-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu, Y. T. et al. The changing prevalence and incidence of dementia over time&#x2014;current evidence. Nat. Rev. Neurol. 13, 327&#x2013;339 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28497805</ArticleId><ArticleId IdType="doi">10.1038/nrneurol.2017.63</ArticleId></ArticleIdList></Reference><Reference><Citation>Stephan, B. C. M. et al. Secular trends in dementia prevalence and incidence worldwide: a systematic review. J. Alzheimers Dis. 66, 653&#x2013;680 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">30347617</ArticleId><ArticleId IdType="doi">10.3233/JAD-180375</ArticleId></ArticleIdList></Reference><Reference><Citation>Grodstein, F., Leurgans, S. E., Capuano, A. W., Schneider, J. A. &amp; Bennett, D. A. Trends in postmortem neurodegenerative and cerebrovascular neuropathologies over 25 years. JAMA Neurol. 20, e225416 (2023).</Citation></Reference><Reference><Citation>Ngandu, T. et al. A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial. Lancet 385, 2255&#x2013;2263 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">25771249</ArticleId><ArticleId IdType="doi">10.1016/S0140-6736(15)60461-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Kivipelto, M. et al. World-Wide FINGERS Network: a global approach to risk reduction and prevention of dementia. Alzheimers Dement. 16, 1078&#x2013;1094 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32627328</ArticleId><ArticleId IdType="pmc">9527644</ArticleId><ArticleId IdType="doi">10.1002/alz.12123</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomon, A. et al. Effect of the apolipoprotein E genotype on cognitive change during a multidomain lifestyle intervention: a subgroup analysis of a randomized clinical trial. JAMA Neurol. 75, 462&#x2013;470 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">29356827</ArticleId><ArticleId IdType="pmc">5885273</ArticleId><ArticleId IdType="doi">10.1001/jamaneurol.2017.4365</ArticleId></ArticleIdList></Reference><Reference><Citation>Muller, S. et al. Relationship between physical activity, cognition, and Alzheimer pathology in autosomal dominant Alzheimer&#x2019;s disease. Alzheimers Dement. 14, 1427&#x2013;1437 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">30266303</ArticleId><ArticleId IdType="pmc">6322213</ArticleId><ArticleId IdType="doi">10.1016/j.jalz.2018.06.3059</ArticleId></ArticleIdList></Reference><Reference><Citation>Stern, Y. et al. Mechanisms underlying resilience in ageing. Nat. Rev. Neurosci. 20, 246 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">30814677</ArticleId><ArticleId IdType="doi">10.1038/s41583-019-0138-0</ArticleId></ArticleIdList></Reference><Reference><Citation>Steyaert, J. et al. Putting primary prevention of dementia on everybody&#x2019;s agenda. Aging Ment. Health 25, 1376&#x2013;1380 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">32590910</ArticleId><ArticleId IdType="doi">10.1080/13607863.2020.1783514</ArticleId></ArticleIdList></Reference><Reference><Citation>Fargo, K. N., Carrillo, M. C., Weiner, M. W., Potter, W. Z. &amp; Khachaturian, Z. The crisis in recruitment for clinical trials in Alzheimer&#x2019;s and dementia: an action plan for solutions. Alzheimers Dement. 12, 1113&#x2013;1115 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">27836052</ArticleId><ArticleId IdType="doi">10.1016/j.jalz.2016.10.001</ArticleId></ArticleIdList></Reference><Reference><Citation>Grill, J. D., Sperling, R. A. &amp; Raman, R. What should the goals be for diverse recruitment in Alzheimer clinical trials? JAMA Neurol. 79, 1097&#x2013;1098 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35969392</ArticleId><ArticleId IdType="doi">10.1001/jamaneurol.2022.2274</ArticleId></ArticleIdList></Reference><Reference><Citation>Weiner, M. W. et al. Increasing participant diversity in AD research: plans for digital screening, blood testing, and a community-engaged approach in the Alzheimer&#x2019;s Disease Neuroimaging Initiative 4. Alzheimers Dement. 19, 307&#x2013;317 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">36209495</ArticleId><ArticleId IdType="doi">10.1002/alz.12797</ArticleId></ArticleIdList></Reference><Reference><Citation>Aisen, P. et al. Registries and cohorts to accelerate early phase Alzheimer&#x2019;s trials. A report from the E.U./U.S. clinical trials in Alzheimer&#x2019;s Disease Task Force. J. Prev. Alzheimers Dis. 3, 68&#x2013;74 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">29210442</ArticleId></ArticleIdList></Reference><Reference><Citation>Weiner, M. W. et al. The Brain Health registry: an internet-based platform for recruitment, assessment, and longitudinal monitoring of participants for neuroscience studies. Alzheimers Dement. 14, 1063&#x2013;1076 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">29754989</ArticleId><ArticleId IdType="pmc">6126911</ArticleId><ArticleId IdType="doi">10.1016/j.jalz.2018.02.021</ArticleId></ArticleIdList></Reference><Reference><Citation>Zwan, M. D. et al. Dutch Brain Research registry for study participant recruitment: design and first results. Alzheimers Dement. 7, e12132 (2021).</Citation></Reference><Reference><Citation>van Maurik, I. S. et al. Development and usability of ADappt: web-based tool to support clinicians, patients, and caregivers in the diagnosis of mild cognitive impairment and Alzheimer disease. JMIR Form. Res. 3, e13417 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">31287061</ArticleId><ArticleId IdType="pmc">6643768</ArticleId><ArticleId IdType="doi">10.2196/13417</ArticleId></ArticleIdList></Reference><Reference><Citation>Franzen, S. et al. Neuropsychological assessment in the multicultural memory clinic: development and feasibility of the TULIPA battery. Clin. Neuropsychol. 37, 60&#x2013;80 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">35225154</ArticleId><ArticleId IdType="doi">10.1080/13854046.2022.2043447</ArticleId></ArticleIdList></Reference><Reference><Citation>Festari, C. et al. European consensus for the diagnosis of MCI and mild dementia: preparatory phase. Alzheimers Dement. https://doi.org/10.1002/alz.12798 (2022).</Citation></Reference><Reference><Citation>Ashton, N. J. et al. The validation status of blood biomarkers of amyloid and phospho-tau assessed with the 5-phase development framework for AD biomarkers. Eur. J. Nucl. Med. Mol. Imaging 48, 2140&#x2013;2156 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33677733</ArticleId><ArticleId IdType="pmc">8175325</ArticleId><ArticleId IdType="doi">10.1007/s00259-021-05253-y</ArticleId></ArticleIdList></Reference><Reference><Citation>Leuzy, A. et al. 2020 update on the clinical validity of cerebrospinal fluid amyloid, tau, and phospho-tau as biomarkers for Alzheimer&#x2019;s disease in the context of a structured 5-phase development framework. Eur. J. Nucl. Med. Mol. Imaging 48, 2121&#x2013;2139 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33674895</ArticleId><ArticleId IdType="pmc">8175301</ArticleId><ArticleId IdType="doi">10.1007/s00259-021-05258-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Teunissen, C. E. et al. Blood-based biomarkers for Alzheimer&#x2019;s disease: towards clinical implementation. Lancet Neurol. 21, 66&#x2013;77 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">34838239</ArticleId><ArticleId IdType="doi">10.1016/S1474-4422(21)00361-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Pontecorvo, M. J. et al. Association of donanemab treatment with exploratory plasma biomarkers in early symptomatic Alzheimer disease: a secondary analysis of the TRAILBLAZER-ALZ randomized clinical trial. JAMA Neurol. 79, 1250&#x2013;1259 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">36251300</ArticleId><ArticleId IdType="pmc">9577883</ArticleId><ArticleId IdType="doi">10.1001/jamaneurol.2022.3392</ArticleId></ArticleIdList></Reference><Reference><Citation>Hansson, O. et al. The Alzheimer&#x2019;s Association appropriate use recommendations for blood biomarkers in Alzheimer&#x2019;s disease. Alzheimers Dement. 18, 2669&#x2013;2686 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35908251</ArticleId><ArticleId IdType="pmc">10087669</ArticleId><ArticleId IdType="doi">10.1002/alz.12756</ArticleId></ArticleIdList></Reference><Reference><Citation>Tijms, B. M. et al. Pathophysiological subtypes of Alzheimer&#x2019;s disease based on cerebrospinal fluid proteomics. Brain 143, 3776&#x2013;3792 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">33439986</ArticleId><ArticleId IdType="pmc">7805814</ArticleId><ArticleId IdType="doi">10.1093/brain/awaa325</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellenguez, C. et al. New insights into the genetic etiology of Alzheimer&#x2019;s disease and related dementias. Nat. Genet. 54, 412&#x2013;436 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35379992</ArticleId><ArticleId IdType="pmc">9005347</ArticleId><ArticleId IdType="doi">10.1038/s41588-022-01024-z</ArticleId></ArticleIdList></Reference><Reference><Citation>Jansen, I. E. et al. Genome-wide meta-analysis for Alzheimer&#x2019;s disease cerebrospinal fluid biomarkers. Acta Neuropathol. 144, 821&#x2013;842 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">36066633</ArticleId><ArticleId IdType="pmc">9547780</ArticleId><ArticleId IdType="doi">10.1007/s00401-022-02454-z</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Lee, S. J. et al. The effect of APOE and other common genetic variants on the onset of Alzheimer&#x2019;s disease and dementia: a community-based cohort study. Lancet Neurol. 17, 434&#x2013;444 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">29555425</ArticleId><ArticleId IdType="doi">10.1016/S1474-4422(18)30053-X</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Lee, S. J. et al. A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer&#x2019;s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity. Acta Neuropathol. 138, 237&#x2013;250 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">31131421</ArticleId><ArticleId IdType="pmc">6660501</ArticleId><ArticleId IdType="doi">10.1007/s00401-019-02026-8</ArticleId></ArticleIdList></Reference><Reference><Citation>Jonsson, T. et al. A mutation in APP protects against Alzheimer&#x2019;s disease and age-related cognitive decline. Nature 488, 96&#x2013;99 (2012).</Citation><ArticleIdList><ArticleId IdType="pubmed">22801501</ArticleId><ArticleId IdType="doi">10.1038/nature11283</ArticleId></ArticleIdList></Reference><Reference><Citation>Ebenau, J. L. et al. Risk of dementia in APOE &#x3b5;4 carriers is mitigated by a polygenic risk score. Alzheimers Dement. 13, e12229 (2021).</Citation></Reference><Reference><Citation>Guerreiro, R. et al. TREM2 variants in Alzheimer&#x2019;s disease. N. Engl. J. Med. 368, 117&#x2013;127 (2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">23150934</ArticleId><ArticleId IdType="doi">10.1056/NEJMoa1211851</ArticleId></ArticleIdList></Reference><Reference><Citation>Jonsson, T. et al. Variant of TREM2 associated with the risk of Alzheimer&#x2019;s disease. N. Engl. J. Med. 368, 107&#x2013;116 (2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">23150908</ArticleId><ArticleId IdType="doi">10.1056/NEJMoa1211103</ArticleId></ArticleIdList></Reference><Reference><Citation>Holstege, H. et al. Characterization of pathogenic SORL1 genetic variants for association with Alzheimer&#x2019;s disease: a clinical interpretation strategy. Eur. J. Hum. Genet. 25, 973&#x2013;981 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28537274</ArticleId><ArticleId IdType="pmc">5567154</ArticleId><ArticleId IdType="doi">10.1038/ejhg.2017.87</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohman, F., Hassenstab, J., Berron, D., Scholl, M. &amp; Papp, K. V. Current advances in digital cognitive assessment for preclinical Alzheimer&#x2019;s disease. Alzheimers Dement. 13, e12217 (2021).</Citation></Reference><Reference><Citation>Chan, J. Y. C., Yau, S. T. Y., Kwok, T. C. Y. &amp; Tsoi, K. K. F. Diagnostic performance of digital cognitive tests for the identification of MCI and dementia: a systematic review. Ageing Res. Rev. 72, 101506 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34744026</ArticleId><ArticleId IdType="doi">10.1016/j.arr.2021.101506</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhodius-Meester, H. F. M. et al. cCOG: a web-based cognitive test tool for detecting neurodegenerative disorders. Alzheimers Dement. 12, e12083 (2020).</Citation></Reference><Reference><Citation>Jutten, R. J. et al. Detecting functional decline from normal aging to dementia: development and validation of a short version of the Amsterdam IADL Questionnaire. Alzheimers Dement. 8, 26&#x2013;35 (2017).</Citation></Reference><Reference><Citation>Piau, A., Wild, K., Mattek, N. &amp; Kaye, J. Current state of digital biomarker technologies for real-life, home-based monitoring of cognitive function for mild cognitive impairment to mild Alzheimer disease and implications for clinical care: systematic review. J. Med. Internet Res. 21, e12785 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">31471958</ArticleId><ArticleId IdType="pmc">6743264</ArticleId><ArticleId IdType="doi">10.2196/12785</ArticleId></ArticleIdList></Reference><Reference><Citation>Tavabi, N. et al. Cognitive digital biomarkers from automated transcription of spoken language. J. Prev. Alzheimers Dis. 9, 791&#x2013;800 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">36281684</ArticleId></ArticleIdList></Reference><Reference><Citation>Lam, K. H. et al. Smartphone-derived keystroke dynamics are sensitive to relevant changes in multiple sclerosis. Eur. J. Neurol. 29, 522&#x2013;534 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">34719076</ArticleId><ArticleId IdType="doi">10.1111/ene.15162</ArticleId></ArticleIdList></Reference><Reference><Citation>van Gils, A. M. et al. Assessing the views of professionals, patients, and care partners concerning the use of computer tools in memory clinics: international survey study. JMIR Form. Res. 5, e31053 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34870612</ArticleId><ArticleId IdType="pmc">8686488</ArticleId><ArticleId IdType="doi">10.2196/31053</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaye, J. et al. Using digital tools to advance Alzheimer&#x2019;s drug trials during a pandemic: the EU/US CTAD Task Force. J. Prev. Alzheimers Dis. 8, 513&#x2013;519 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34585227</ArticleId><ArticleId IdType="pmc">8244451</ArticleId></ArticleIdList></Reference><Reference><Citation>Kunneman, M. et al. Patients&#x2019; and caregivers&#x2019; views on conversations and shared decision making in diagnostic testing for Alzheimer&#x2019;s disease: the ABIDE project. Alzheimers Dement. 3, 314&#x2013;322 (2017).</Citation></Reference><Reference><Citation>Fruijtier, A. D. et al. ABIDE Delphi study: topics to discuss in diagnostic consultations in memory clinics. Alzheimers Res. Ther. 11, 77 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">31472676</ArticleId><ArticleId IdType="pmc">6717649</ArticleId><ArticleId IdType="doi">10.1186/s13195-019-0531-y</ArticleId></ArticleIdList></Reference><Reference><Citation>Licher, S. et al. Development and validation of a dementia risk prediction model in the general population: an analysis of three longitudinal studies. Am. J. Psychiatry 176, 543&#x2013;551 (2019).</Citation></Reference><Reference><Citation>Exalto, L. G. et al. Midlife risk score for the prediction of dementia four decades later. Alzheimers Dement. 10, 562&#x2013;570 (2014).</Citation><ArticleIdList><ArticleId IdType="pubmed">24035147</ArticleId><ArticleId IdType="doi">10.1016/j.jalz.2013.05.1772</ArticleId></ArticleIdList></Reference><Reference><Citation>Kivipelto, M. et al. Risk score for the prediction of dementia risk in 20 years among middle aged people: a longitudinal, population-based study. Lancet Neurol. 5, 735&#x2013;741 (2006).</Citation><ArticleIdList><ArticleId IdType="pubmed">16914401</ArticleId><ArticleId IdType="doi">10.1016/S1474-4422(06)70537-3</ArticleId></ArticleIdList></Reference><Reference><Citation>van Maurik, I. S. et al. Biomarker-based prognosis for people with mild cognitive impairment (ABIDE): a modelling study. Lancet Neurol. 18, 1034&#x2013;1044 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">31526625</ArticleId><ArticleId IdType="doi">10.1016/S1474-4422(19)30283-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Karikari, T. K. et al. Blood phosphorylated tau 181 as a biomarker for Alzheimer&#x2019;s disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts. Lancet Neurol. 19, 422&#x2013;433 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32333900</ArticleId><ArticleId IdType="doi">10.1016/S1474-4422(20)30071-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Strikwerda-Brown, C. et al. Association of elevated amyloid and tau positron emission tomography signal with near-term development of Alzheimer disease symptoms in older adults without cognitive impairment. JAMA Neurol. 79, 975&#x2013;985 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35907254</ArticleId><ArticleId IdType="doi">10.1001/jamaneurol.2022.2379</ArticleId></ArticleIdList></Reference><Reference><Citation>Ossenkoppele, R. et al. Amyloid and tau PET-positive cognitively unimpaired individuals are at high risk for future cognitive decline. Nat. Med. 28, 2381&#x2013;2387 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">36357681</ArticleId><ArticleId IdType="pmc">9671808</ArticleId><ArticleId IdType="doi">10.1038/s41591-022-02049-x</ArticleId></ArticleIdList></Reference><Reference><Citation>Mank, A. et al. Identifying relevant outcomes in the progression of Alzheimer&#x2019;s disease; what do patients and care partners want to know about prognosis? Alzheimers Dement. 7, e12189 (2021).</Citation></Reference><Reference><Citation>van der Schaar, J. et al. Considerations regarding a diagnosis of Alzheimer&#x2019;s disease before dementia: a systematic review. Alzheimers Res. Ther. 14, 31 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35144684</ArticleId><ArticleId IdType="pmc">8829985</ArticleId><ArticleId IdType="doi">10.1186/s13195-022-00971-3</ArticleId></ArticleIdList></Reference><Reference><Citation>Kunneman, M., Montori, V. M., Castaneda-Guarderas, A. &amp; Hess, E. P. What is shared decision making? (and what it is not). Acad. Emerg. Med. 23, 1320&#x2013;1324 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">27770514</ArticleId><ArticleId IdType="doi">10.1111/acem.13065</ArticleId></ArticleIdList></Reference><Reference><Citation>Visser, L. N. C. et al. Clinician&#x2013;patient communication during the diagnostic workup: the ABIDE project. Alzheimers Dement. 11, 520&#x2013;528 (2019).</Citation></Reference><Reference><Citation>Visser, L. N. C. et al. Clinicians&#x2019; communication with patients receiving a MCI diagnosis: the ABIDE project. PLoS ONE 15, e0227282 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">31961882</ArticleId><ArticleId IdType="pmc">6974141</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0227282</ArticleId></ArticleIdList></Reference><Reference><Citation>Vanderschaeghe, G., Schaeverbeke, J., Vandenberghe, R. &amp; Dierickx, K. Amnestic MCI patients&#x2019; perspectives toward disclosure of amyloid PET results in a research context. Neuroethics 10, 281&#x2013;297 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28725289</ArticleId><ArticleId IdType="pmc">5486502</ArticleId><ArticleId IdType="doi">10.1007/s12152-017-9313-z</ArticleId></ArticleIdList></Reference><Reference><Citation>Fruijtier, A. D. et al. Identifying best practices for disclosure of amyloid imaging results: a randomized controlled trial. Alzheimers Dement. 19, 285&#x2013;295 (2022).</Citation></Reference><Reference><Citation>Ketchum, F. B. et al. Moving beyond disclosure: stages of care in preclinical Alzheimer&#x2019;s disease biomarker testing. Alzheimers Dement. 18, 1969&#x2013;1979 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35213786</ArticleId><ArticleId IdType="pmc">9402800</ArticleId><ArticleId IdType="doi">10.1002/alz.12620</ArticleId></ArticleIdList></Reference><Reference><Citation>Grill, J. D. et al. Communicating mild cognitive impairment diagnoses with and without amyloid imaging. Alzheimers Res. Ther. 9, 35 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28472970</ArticleId><ArticleId IdType="pmc">5418690</ArticleId><ArticleId IdType="doi">10.1186/s13195-017-0261-y</ArticleId></ArticleIdList></Reference><Reference><Citation>Lingler, J. H. et al. Development of a standardized approach to disclosing amyloid imaging research results in mild cognitive impairment. J. Alzheimers Dis. 52, 17&#x2013;24 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">27060950</ArticleId><ArticleId IdType="pmc">4860948</ArticleId><ArticleId IdType="doi">10.3233/JAD-150985</ArticleId></ArticleIdList></Reference><Reference><Citation>Babapour Mofrad, R. et al. Cerebrospinal fluid collection: an informative animation video for patients and caregivers. Alzheimers Dement. 11, 435&#x2013;438 (2019).</Citation></Reference><Reference><Citation>Gruters, A. A. A. et al. An exploratory study of the development and pilot testing of an interactive visual tool of neuropsychological test results in memory clinics. J. Alzheimers Dis. 79, 1157&#x2013;1170 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33386807</ArticleId><ArticleId IdType="pmc">7990417</ArticleId><ArticleId IdType="doi">10.3233/JAD-201128</ArticleId></ArticleIdList></Reference><Reference><Citation>van Gils, A. M. et al. Development and design of a diagnostic report to support communication in dementia: co-creation with patients and care partners. Alzheimers Dement. 14, e12333 (2022).</Citation></Reference><Reference><Citation>Altomare, D. et al. Brain Health Services: organization, structure, and challenges for implementation. A user manual for Brain Health Services&#x2014;part 1 of 6. Alzheimers Res. Ther. 13, 168 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34635163</ArticleId><ArticleId IdType="pmc">8507194</ArticleId><ArticleId IdType="doi">10.1186/s13195-021-00827-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Visser, L. N. C. et al. Dementia risk communication. A user manual for Brain Health Services&#x2014;part 3 of 6. Alzheimers Res. Ther. 13, 170 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34635169</ArticleId><ArticleId IdType="pmc">8507171</ArticleId><ArticleId IdType="doi">10.1186/s13195-021-00840-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Jessen, F. et al. A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer&#x2019;s disease. Alzheimers Dement. 10, 844&#x2013;852 (2014).</Citation><ArticleIdList><ArticleId IdType="pubmed">24798886</ArticleId><ArticleId IdType="pmc">4317324</ArticleId><ArticleId IdType="doi">10.1016/j.jalz.2014.01.001</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37202514</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>22</Day></DateCompleted><DateRevised><Year>2024</Year><Month>05</Month><Day>02</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2662-8465</ISSN><JournalIssue CitedMedium="Internet"><Volume>3</Volume><Issue>5</Issue><PubDate><Year>2023</Year><Month>May</Month></PubDate></JournalIssue><Title>Nature aging</Title><ISOAbbreviation>Nat Aging</ISOAbbreviation></Journal><ArticleTitle>The role of cerebrospinal fluid and other biomarker modalities in the Alzheimer's disease diagnostic revolution.</ArticleTitle><Pagination><StartPage>460</StartPage><EndPage>462</EndPage><MedlinePgn>460-462</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s43587-023-00400-6</ELocationID><Abstract><AbstractText>A major transformation in dementia diagnosis and care appears imminent and will depend on three major types of biomarkers: molecular imaging, blood-based biomarkers, and cerebrospinal fluid biomarkers. Each modality has unique strengths and limitations that suggest its optimal uses in research, clinical trials, and clinical diagnosis.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Schindler</LastName><ForeName>Suzanne E</ForeName><Initials>SE</Initials><Identifier Source="ORCID">0000-0002-1680-1465</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Washington University in St Louis, St Louis, MO, USA. schindler.s.e@wustl.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Charles F. and Joanne Knight Alzheimer Disease Research Center, St Louis, MO, USA. schindler.s.e@wustl.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Atri</LastName><ForeName>Alireza</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Banner Sun Health Research Institute, Banner Health, Sun City, AZ, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Brain/Mind Medicine, Department of Neurology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P01 AG026276</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AG072980</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG070941</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Nat Aging</MedlineTA><NlmUniqueID>101773306</NlmUniqueID><ISSNLinking>2662-8465</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016229">Amyloid beta-Peptides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016875">tau Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016229" MajorTopicYN="N">Amyloid beta-Peptides</DescriptorName><QualifierName UI="Q000134" MajorTopicYN="N">cerebrospinal fluid</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016875" MajorTopicYN="N">tau Proteins</DescriptorName><QualifierName UI="Q000134" MajorTopicYN="N">cerebrospinal fluid</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000134" MajorTopicYN="N">cerebrospinal fluid</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>22</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>19</Day><Hour>1</Hour><Minute>5</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>18</Day><Hour>23</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>5</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37202514</ArticleId><ArticleId IdType="mid">NIHMS1945322</ArticleId><ArticleId IdType="pmc">PMC10720501</ArticleId><ArticleId IdType="doi">10.1038/s43587-023-00400-6</ArticleId><ArticleId IdType="pii">10.1038/s43587-023-00400-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Mintun MA, et al. Donanemab in Early Alzheimer's Disease. N Engl J Med 384, 1691&#x2013;1704 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33720637</ArticleId></ArticleIdList></Reference><Reference><Citation>van Dyck CH, et al. Lecanemab in Early Alzheimer's Disease. N Engl J Med (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">37099355</ArticleId></ArticleIdList></Reference><Reference><Citation>Angioni D., et al. Blood Biomarkers from Research Use to Clinical Practice: What Must Be Done? A Report from the EU/US CTAD Task Force. J Prev Alzheimers Dis 9, 569&#x2013;579 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9683846</ArticleId><ArticleId IdType="pubmed">36281661</ArticleId></ArticleIdList></Reference><Reference><Citation>Teunissen CE, et al. Blood-based biomarkers for Alzheimer's disease: towards clinical implementation. The Lancet. Neurology (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34838239</ArticleId></ArticleIdList></Reference><Reference><Citation>Janelidze S., et al. Head-to-head comparison of 10 plasma phospho-tau assays in prodromal Alzheimer's disease. Brain (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10115176</ArticleId><ArticleId IdType="pubmed">36087307</ArticleId></ArticleIdList></Reference><Reference><Citation>Janelidze S., et al. Head-to-Head Comparison of 8 Plasma Amyloid-beta 42/40 Assays in Alzheimer Disease. JAMA Neurol (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8453354</ArticleId><ArticleId IdType="pubmed">34542571</ArticleId></ArticleIdList></Reference><Reference><Citation>Karikari TK Blood Tests for Alzheimer's Disease: Increasing Efforts to Expand and Diversify Research Participation Is Critical for Widespread Validation and Acceptance. Journal of Alzheimer's disease : JAD (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9741736</ArticleId><ArticleId IdType="pubmed">35491788</ArticleId></ArticleIdList></Reference><Reference><Citation>Hansson O., et al. The Alzheimer's Association appropriate use recommendations for blood biomarkers in Alzheimer's disease. Alzheimer's &amp; dementia : the journal of the Alzheimer's Association (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10087669</ArticleId><ArticleId IdType="pubmed">35908251</ArticleId></ArticleIdList></Reference><Reference><Citation>Schindler SE Fluid Biomarkers in Dementia Diagnosis. CONTINUUM: Lifelong Learning in Neurology 28, 822&#x2013;833 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35678404</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellomo G., et al. alpha-Synuclein Seed Amplification Assays for Diagnosing Synucleinopathies: The Way Forward. Neurology 99, 195&#x2013;205 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35914941</ArticleId></ArticleIdList></Reference><Reference><Citation>Bridel C., et al. Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology: A Systematic Review and Meta-analysis. JAMA Neurol (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6580449</ArticleId><ArticleId IdType="pubmed">31206160</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaw LM, et al. Appropriate use criteria for lumbar puncture and cerebrospinal fluid testing in the diagnosis of Alzheimer's disease. Alzheimer's &amp; dementia : the journal of the Alzheimer's Association 14, 1505&#x2013;1521 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10013957</ArticleId><ArticleId IdType="pubmed">30316776</ArticleId></ArticleIdList></Reference><Reference><Citation>Barthelemy NR, et al. A soluble phosphorylated tau signature links tau, amyloid and the evolution of stages of dominantly inherited Alzheimer's disease. Nat Med 26, 398&#x2013;407 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7309367</ArticleId><ArticleId IdType="pubmed">32161412</ArticleId></ArticleIdList></Reference><Reference><Citation>Horie K, Barthelemy NR, Sato C &amp; Bateman RJ CSF tau microtubule binding region identifies tau tangle and clinical stages of Alzheimer's disease. Brain 144, 515&#x2013;527 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7940175</ArticleId><ArticleId IdType="pubmed">33283854</ArticleId></ArticleIdList></Reference><Reference><Citation>Horie K., et al. CSF tau microtubule-binding region identifies pathological changes in primary tauopathies. Nat Med 28, 2547&#x2013;2554 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9800273</ArticleId><ArticleId IdType="pubmed">36424467</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37198197</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>19</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>30</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2041-1723</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>May</Month><Day>17</Day></PubDate></JournalIssue><Title>Nature communications</Title><ISOAbbreviation>Nat Commun</ISOAbbreviation></Journal><ArticleTitle>The in-tissue molecular architecture of &#x3b2;-amyloid pathology in the mammalian brain.</ArticleTitle><Pagination><StartPage>2833</StartPage><MedlinePgn>2833</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">2833</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41467-023-38495-5</ELocationID><Abstract><AbstractText>Amyloid plaques composed of A&#x3b2; fibrils are a hallmark of Alzheimer's disease (AD). However, the molecular architecture of amyloid plaques in the context of fresh mammalian brain tissue is unknown. Here, using cryogenic correlated light and electron tomography we report the in situ molecular architecture of A&#x3b2; fibrils in the App<sup>NL-G-F</sup> familial&#xa0;AD mouse model containing the Arctic mutation and an atomic model of ex vivo purified Arctic A&#x3b2; fibrils. We show that in-tissue A&#x3b2; fibrils are arranged in a lattice or parallel bundles, and are interdigitated by subcellular compartments, extracellular vesicles, extracellular droplets and extracellular multilamellar bodies. The Arctic A&#x3b2; fibril differs significantly from an&#xa0;earlier App<sup>NL-F</sup> fibril structure, indicating a striking effect of the Arctic mutation. These structural data also revealed an ensemble of additional fibrillar species, including thin protofilament-like rods and branched fibrils. Together, these results provide a structural model for the dense network architecture that characterises &#x3b2;-amyloid plaque pathology.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Leistner</LastName><ForeName>Conny</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Astbury Centre for Structural Molecular Biology, School of Biomedical Sciences, Faculty of Biological Sciences, University of Leeds, Leeds, LS2 9JT, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wilkinson</LastName><ForeName>Martin</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-5490-613X</Identifier><AffiliationInfo><Affiliation>Astbury Centre for Structural Molecular Biology, School of Molecular and Cellular Biology, Faculty of Biological Sciences, University of Leeds, Leeds, LS2 9JT, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Burgess</LastName><ForeName>Ailidh</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-9643-3163</Identifier><AffiliationInfo><Affiliation>Astbury Centre for Structural Molecular Biology, School of Biomedical Sciences, Faculty of Biological Sciences, University of Leeds, Leeds, LS2 9JT, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Francis Crick Institute, 1 Midland Road, London, NW1 1AT, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lovatt</LastName><ForeName>Megan</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-7171-0494</Identifier><AffiliationInfo><Affiliation>Astbury Centre for Structural Molecular Biology, School of Biomedical Sciences, Faculty of Biological Sciences, University of Leeds, Leeds, LS2 9JT, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goodbody</LastName><ForeName>Stanley</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Astbury Centre for Structural Molecular Biology, School of Biomedical Sciences, Faculty of Biological Sciences, University of Leeds, Leeds, LS2 9JT, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Yong</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0002-8389-4120</Identifier><AffiliationInfo><Affiliation>Astbury Centre for Structural Molecular Biology, School of Molecular and Cellular Biology, Faculty of Biological Sciences, University of Leeds, Leeds, LS2 9JT, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>AstraZeneca, 1 Francis Crick Avenue, Cambridge, CB2 0AA, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Deuchars</LastName><ForeName>Susan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Astbury Centre for Structural Molecular Biology, School of Biomedical Sciences, Faculty of Biological Sciences, University of Leeds, Leeds, LS2 9JT, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Radford</LastName><ForeName>Sheena E</ForeName><Initials>SE</Initials><Identifier Source="ORCID">0000-0002-3079-8039</Identifier><AffiliationInfo><Affiliation>Astbury Centre for Structural Molecular Biology, School of Molecular and Cellular Biology, Faculty of Biological Sciences, University of Leeds, Leeds, LS2 9JT, UK. s.e.radford@leeds.ac.uk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ranson</LastName><ForeName>Neil A</ForeName><Initials>NA</Initials><Identifier Source="ORCID">0000-0002-3640-5275</Identifier><AffiliationInfo><Affiliation>Astbury Centre for Structural Molecular Biology, School of Molecular and Cellular Biology, Faculty of Biological Sciences, University of Leeds, Leeds, LS2 9JT, UK. n.a.ranson@leeds.ac.uk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Frank</LastName><ForeName>Ren&#xe9; A W</ForeName><Initials>RAW</Initials><Identifier Source="ORCID">0000-0001-9724-9547</Identifier><AffiliationInfo><Affiliation>Astbury Centre for Structural Molecular Biology, School of Biomedical Sciences, Faculty of Biological Sciences, University of Leeds, Leeds, LS2 9JT, UK. r.frank@leeds.ac.uk.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>108466/Z/15/Z</GrantID><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>221524/Z/20/Z</GrantID><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>BB/M012573/1</GrantID><Acronym>BB_</Acronym><Agency>Biotechnology and Biological Sciences Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>204963</GrantID><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>204963/Z/16/Z</GrantID><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>208395/Z/17/Z</GrantID><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MR/T011149/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>05</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nat Commun</MedlineTA><NlmUniqueID>101528555</NlmUniqueID><ISSNLinking>2041-1723</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016229">Amyloid beta-Peptides</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016229" MajorTopicYN="Y">Amyloid beta-Peptides</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058225" MajorTopicYN="N">Plaque, Amyloid</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008322" MajorTopicYN="N">Mammals</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>11</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>5</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>19</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>18</Day><Hour>1</Hour><Minute>7</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>17</Day><Hour>23</Hour><Minute>17</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>5</Month><Day>17</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37198197</ArticleId><ArticleId IdType="pmc">PMC10192217</ArticleId><ArticleId IdType="doi">10.1038/s41467-023-38495-5</ArticleId><ArticleId IdType="pii">10.1038/s41467-023-38495-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Long JM, Holtzman DM. Alzheimer disease: an update on pathobiology and treatment strategies. Cell. 2019;179:312&#x2013;339. doi: 10.1016/j.cell.2019.09.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2019.09.001</ArticleId><ArticleId IdType="pmc">PMC6778042</ArticleId><ArticleId IdType="pubmed">31564456</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardy JA, Higgins GA. Alzheimer&#x2019;s disease: the amyloid cascade hypothesis. Science. 1992;256:184&#x2013;185. doi: 10.1126/science.1566067.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1566067</ArticleId><ArticleId IdType="pubmed">1566067</ArticleId></ArticleIdList></Reference><Reference><Citation>Haass C, Kaether C, Thinakaran G, Sisodia S. Trafficking and proteolytic processing of APP. Cold Spring Harb. Perspect. Med. 2012;2:a006270. doi: 10.1101/cshperspect.a006270.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a006270</ArticleId><ArticleId IdType="pmc">PMC3331683</ArticleId><ArticleId IdType="pubmed">22553493</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker LC, Jucker M. Neurodegenerative diseases: expanding the prion concept. Annu. Rev. Neurosci. 2015;38:1&#x2013;17. doi: 10.1146/annurev-neuro-071714-033828.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-neuro-071714-033828</ArticleId><ArticleId IdType="pmc">PMC4803040</ArticleId><ArticleId IdType="pubmed">25840008</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwatsubo T, et al. Visualization of A&#x3b2;42(43) and A&#x3b2;40 in senile plaques with end-specific A&#x3b2; monoclonals: evidence that an initially deposited species is A&#x3b2;42(43) Neuron. 1994;13:45&#x2013;53. doi: 10.1016/0896-6273(94)90458-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0896-6273(94)90458-8</ArticleId><ArticleId IdType="pubmed">8043280</ArticleId></ArticleIdList></Reference><Reference><Citation>Duyckaerts C, Delatour B, Potier M-C. Classification and basic pathology of Alzheimer disease. Acta Neuropathol. 2009;118:5&#x2013;36. doi: 10.1007/s00401-009-0532-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-009-0532-1</ArticleId><ArticleId IdType="pubmed">19381658</ArticleId></ArticleIdList></Reference><Reference><Citation>Kidd M. Alzheimer&#x2019;s disease &#x2014; an electron microscopical study. Brain. 1964;87:307&#x2013;320. doi: 10.1093/brain/87.2.307.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/87.2.307</ArticleId><ArticleId IdType="pubmed">14188276</ArticleId></ArticleIdList></Reference><Reference><Citation>Terry RD, Gonatas NK, Weiss M. Ultrastructural studies in Alzheimer&#x2019;s presenile dementia. Am. J. Pathol. 1964;44:269&#x2013;297.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1906996</ArticleId><ArticleId IdType="pubmed">14119171</ArticleId></ArticleIdList></Reference><Reference><Citation>Dikranian K, Kim J, Stewart FR, Levy MA, Holtzman DM. Ultrastructural studies in APP/PS1 mice expressing human ApoE isoforms: implications for Alzheimer&#x2019;s disease. Int. J. Clin. Exp. Pathol. 2012;5:482&#x2013;495.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3430100</ArticleId><ArticleId IdType="pubmed">22949930</ArticleId></ArticleIdList></Reference><Reference><Citation>Nystr&#xf6;m S, et al. Evidence for age-dependent in vivo conformational rearrangement within A&#x3b2; amyloid deposits. ACS Chem. Biol. 2013;8:1128&#x2013;1133. doi: 10.1021/cb4000376.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/cb4000376</ArticleId><ArticleId IdType="pubmed">23521783</ArticleId></ArticleIdList></Reference><Reference><Citation>Rasmussen J, et al. Amyloid polymorphisms constitute distinct clouds of conformational variants in different etiological subtypes of Alzheimer&#x2019;s disease. Proc. Natl Acad. Sci. USA. 2017;114:13018&#x2013;13023. doi: 10.1073/pnas.1713215114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1713215114</ArticleId><ArticleId IdType="pmc">PMC5724274</ArticleId><ArticleId IdType="pubmed">29158413</ArticleId></ArticleIdList></Reference><Reference><Citation>Eisenberg DS, Sawaya MR. Structural studies of amyloid proteins at the molecular level. Annu. Rev. Biochem. 2017;86:69&#x2013;95. doi: 10.1146/annurev-biochem-061516-045104.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-biochem-061516-045104</ArticleId><ArticleId IdType="pubmed">28125289</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y, et al. Cryo-EM structures of amyloid-&#x3b2; 42 filaments from human brains. Science. 2022;375:167&#x2013;172. doi: 10.1126/science.abm7285.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abm7285</ArticleId><ArticleId IdType="pmc">PMC7612234</ArticleId><ArticleId IdType="pubmed">35025654</ArticleId></ArticleIdList></Reference><Reference><Citation>Stern, A. M. et al. Abundant A&#x3b2; fibrils in ultracentrifugal supernatants of aqueous extracts from Alzheimer&#x2019;s disease brains. Neuron 10.1016/j.neuron.2023.04.007 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10330525</ArticleId><ArticleId IdType="pubmed">37167969</ArticleId></ArticleIdList></Reference><Reference><Citation>Kollmer, M. et al. Cryo-EM structure and polymorphism of &#x3b2; amyloid fibrils purified from Alzheimer&#x2019;s brain tissue. Nat. Commun.10, 4760 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6820800</ArticleId><ArticleId IdType="pubmed">31664019</ArticleId></ArticleIdList></Reference><Reference><Citation>Saito T, et al. Single App knock-in mouse models of Alzheimer&#x2019;s disease. Nat. Neurosci. 2014;17:661&#x2013;663. doi: 10.1038/nn.3697.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3697</ArticleId><ArticleId IdType="pubmed">24728269</ArticleId></ArticleIdList></Reference><Reference><Citation>Nilsberth C, et al. The &#x201c;Arctic&#x201d; APP mutation (E693G) causes Alzheimer&#x2019;s disease by enhanced A&#x3b2; protofibril formation. Nat. Neurosci. 2001;4:887&#x2013;893. doi: 10.1038/nn0901-887.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn0901-887</ArticleId><ArticleId IdType="pubmed">11528419</ArticleId></ArticleIdList></Reference><Reference><Citation>Sasaguri H, et al. Recent advances in the modeling of Alzheimer&#x2019;s disease. Front. Neurosci. 2022;16:807473. doi: 10.3389/fnins.2022.807473.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2022.807473</ArticleId><ArticleId IdType="pmc">PMC9009508</ArticleId><ArticleId IdType="pubmed">35431779</ArticleId></ArticleIdList></Reference><Reference><Citation>Klunk WE, et al. Imaging A&#x3b2; plaques in living transgenic mice with multiphoton microscopy and methoxy-X04, a systemically administered Congo Red derivative. J. Neuropathol. Exp. Neurol. 2002;61:797&#x2013;805. doi: 10.1093/jnen/61.9.797.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jnen/61.9.797</ArticleId><ArticleId IdType="pubmed">12230326</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Amoudi A, et al. Cryo&#x2010;electron microscopy of vitreous sections. EMBO J. 2004;23:3583&#x2013;3588. doi: 10.1038/sj.emboj.7600366.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.emboj.7600366</ArticleId><ArticleId IdType="pmc">PMC517607</ArticleId><ArticleId IdType="pubmed">15318169</ArticleId></ArticleIdList></Reference><Reference><Citation>Dubochet J, et al. Cryo-electron microscopy of vitrified specimens. Q. Rev. Biophys. 1988;21:129&#x2013;228. doi: 10.1017/S0033583500004297.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0033583500004297</ArticleId><ArticleId IdType="pubmed">3043536</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuber B, Nikonenko I, Klauser P, Muller D, Dubochet J. The mammalian central nervous synaptic cleft contains a high density of periodically organized complexes. Proc. Natl Acad. Sci. USA. 2005;102:19192&#x2013;19197. doi: 10.1073/pnas.0509527102.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0509527102</ArticleId><ArticleId IdType="pmc">PMC1323199</ArticleId><ArticleId IdType="pubmed">16354833</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicholson C, Tao L. Hindered diffusion of high molecular weight compounds in brain extracellular microenvironment measured with integrative optical imaging. Biophys. J. 1993;65:2277&#x2013;2290. doi: 10.1016/S0006-3495(93)81324-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0006-3495(93)81324-9</ArticleId><ArticleId IdType="pmc">PMC1225970</ArticleId><ArticleId IdType="pubmed">7508761</ArticleId></ArticleIdList></Reference><Reference><Citation>Han S, et al. Amyloid plaque structure and cell surface interactions of &#x3b2;-amyloid fibrils revealed by electron tomography. Sci. Rep. 2017;7:43577. doi: 10.1038/srep43577.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep43577</ArticleId><ArticleId IdType="pmc">PMC5327471</ArticleId><ArticleId IdType="pubmed">28240273</ArticleId></ArticleIdList></Reference><Reference><Citation>Nixon RA, et al. Extensive involvement of autophagy in Alzheimer disease: an immuno-electron microscopy study. J. Neuropathol. Exp. Neurol. 2005;64:113&#x2013;122. doi: 10.1093/jnen/64.2.113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jnen/64.2.113</ArticleId><ArticleId IdType="pubmed">15751225</ArticleId></ArticleIdList></Reference><Reference><Citation>Klumpe S, et al. A modular platform for automated cryo-FIB workflows. Elife. 2021;10:e70506. doi: 10.7554/eLife.70506.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.70506</ArticleId><ArticleId IdType="pmc">PMC8769651</ArticleId><ArticleId IdType="pubmed">34951584</ArticleId></ArticleIdList></Reference><Reference><Citation>Peukes, J. et al. The molecular infrastructure of glutamatergic synapses in the mammalian forebrain. Preprint at bioRxiv10.1101/2021.02.19.432002 (2021).</Citation></Reference><Reference><Citation>Zhu F, et al. Architecture of the mouse brain synaptome. Neuron. 2018;99:781&#x2013;799. doi: 10.1016/j.neuron.2018.07.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2018.07.007</ArticleId><ArticleId IdType="pmc">PMC6117470</ArticleId><ArticleId IdType="pubmed">30078578</ArticleId></ArticleIdList></Reference><Reference><Citation>Broadhead MJ, et al. PSD95 nanoclusters are postsynaptic building blocks in hippocampus circuits. Sci. Rep. 2016;6:1&#x2013;14. doi: 10.1038/srep24626.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep24626</ArticleId><ArticleId IdType="pmc">PMC4842999</ArticleId><ArticleId IdType="pubmed">27109929</ArticleId></ArticleIdList></Reference><Reference><Citation>Enzlein T, et al. Computational analysis of Alzheimer amyloid plaque composition in 2D- and elastically reconstructed 3D-MALDI MS images. Anal. Chem. 2020;92:14484&#x2013;14493. doi: 10.1021/acs.analchem.0c02585.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.analchem.0c02585</ArticleId><ArticleId IdType="pubmed">33138378</ArticleId></ArticleIdList></Reference><Reference><Citation>Henderson R, Unwin PN. Three-dimensional model of purple membrane obtained by electron microscopy. Nature. 1975;257:28&#x2013;32. doi: 10.1038/257028a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/257028a0</ArticleId><ArticleId IdType="pubmed">1161000</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J-H, et al. Faulty autolysosome acidification in Alzheimer&#x2019;s disease mouse models induces autophagic build-up of A&#x3b2; in neurons, yielding senile plaques. Nat. Neurosci. 2022;25:688&#x2013;701. doi: 10.1038/s41593-022-01084-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-022-01084-8</ArticleId><ArticleId IdType="pmc">PMC9174056</ArticleId><ArticleId IdType="pubmed">35654956</ArticleId></ArticleIdList></Reference><Reference><Citation>Strooper BD, Karran E. The cellular phase of Alzheimer&#x2019;s disease. Cell. 2016;164:603&#x2013;615. doi: 10.1016/j.cell.2015.12.056.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2015.12.056</ArticleId><ArticleId IdType="pubmed">26871627</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang, Y. et al. Cryo-EM structures of amyloid-&#x3b2; filaments with the Arctic mutation (E22G) from human and mouse brains. Acta Neuropathol.10.1007/s00401-022-02533-1 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9925504</ArticleId><ArticleId IdType="pubmed">36611124</ArticleId></ArticleIdList></Reference><Reference><Citation>Sch&#xf6;ll M, et al. Low PiB PET retention in presence of pathologic CSF biomarkers in Arctic APP mutation carriers. Neurology. 2012;79:229&#x2013;236. doi: 10.1212/WNL.0b013e31825fdf18.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e31825fdf18</ArticleId><ArticleId IdType="pubmed">22700814</ArticleId></ArticleIdList></Reference><Reference><Citation>Meier SR, et al. 11C-PiB and 124I-antibody PET provide differing estimates of brain amyloid-&#x3b2; after therapeutic intervention. J. Nucl. Med. 2022;63:302&#x2013;309. doi: 10.2967/jnumed.121.262083.</Citation><ArticleIdList><ArticleId IdType="doi">10.2967/jnumed.121.262083</ArticleId><ArticleId IdType="pmc">PMC8805773</ArticleId><ArticleId IdType="pubmed">34088777</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeong JS, Ansaloni A, Mezzenga R, Lashuel HA, Dietler G. Novel mechanistic insight into the molecular basis of amyloid polymorphism and secondary nucleation during amyloid formation. J. Mol. Biol. 2013;425:1765&#x2013;1781. doi: 10.1016/j.jmb.2013.02.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2013.02.005</ArticleId><ArticleId IdType="pubmed">23415897</ArticleId></ArticleIdList></Reference><Reference><Citation>Nirmalraj PN, et al. Complete aggregation pathway of amyloid &#x3b2; (1-40) and (1-42) resolved on an atomically clean interface. Sci. Adv. 2020;6:eaaz6014. doi: 10.1126/sciadv.aaz6014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.aaz6014</ArticleId><ArticleId IdType="pmc">PMC7141833</ArticleId><ArticleId IdType="pubmed">32285004</ArticleId></ArticleIdList></Reference><Reference><Citation>T&#xf6;rnquist M, et al. Ultrastructural evidence for self-replication of Alzheimer-associated A&#x3b2;42 amyloid along the sides of fibrils. Proc. Natl Acad. Sci. USA. 2020;117:11265&#x2013;11273. doi: 10.1073/pnas.1918481117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1918481117</ArticleId><ArticleId IdType="pmc">PMC7260961</ArticleId><ArticleId IdType="pubmed">32439711</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen SIA, et al. Proliferation of amyloid-&#x3b2;42 aggregates occurs through a secondary nucleation mechanism. Proc. Natl Acad. Sci. USA. 2013;110:9758&#x2013;9763. doi: 10.1073/pnas.1218402110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1218402110</ArticleId><ArticleId IdType="pmc">PMC3683769</ArticleId><ArticleId IdType="pubmed">23703910</ArticleId></ArticleIdList></Reference><Reference><Citation>van Dyck, C. H. et al. Lecanemab in early Alzheimer&#x2019;s disease. N. Engl. J. Med.10.1056/nejmoa2212948 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Ting, J. T. et al. Preparation of acute brain slices using an optimized N-methyl-D-glucamine protective recovery method. J. Vis. Exp.26, 53825 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5931343</ArticleId><ArticleId IdType="pubmed">29553547</ArticleId></ArticleIdList></Reference><Reference><Citation>Pierson J, et al. Improving the technique of vitreous cryo-sectioning for cryo-electron tomography: electrostatic charging for section attachment and implementation of an anti-contamination glove box. J. Struct. Biol. 2010;169:219&#x2013;225. doi: 10.1016/j.jsb.2009.10.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jsb.2009.10.001</ArticleId><ArticleId IdType="pubmed">19822214</ArticleId></ArticleIdList></Reference><Reference><Citation>Studer D, Klein A, Iacovache I, Gnaegi H, Zuber B. A new tool based on two micromanipulators facilitates the handling of ultrathin cryosection ribbons. J. Struct. Biol. 2014;185:125&#x2013;128. doi: 10.1016/j.jsb.2013.11.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jsb.2013.11.005</ArticleId><ArticleId IdType="pubmed">24269483</ArticleId></ArticleIdList></Reference><Reference><Citation>Schindelin J, et al. Fiji: an open-source platform for biological-image analysis. Nat. Methods. 2012;9:676&#x2013;682. doi: 10.1038/nmeth.2019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.2019</ArticleId><ArticleId IdType="pmc">PMC3855844</ArticleId><ArticleId IdType="pubmed">22743772</ArticleId></ArticleIdList></Reference><Reference><Citation>Schorb M, Briggs JAG. Correlated cryo-fluorescence and cryo-electron microscopy with high spatial precision and improved sensitivity. Ultramicroscopy. 2014;143:24&#x2013;32. doi: 10.1016/j.ultramic.2013.10.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ultramic.2013.10.015</ArticleId><ArticleId IdType="pmc">PMC5472196</ArticleId><ArticleId IdType="pubmed">24275379</ArticleId></ArticleIdList></Reference><Reference><Citation>Kukulski W, et al. Correlated fluorescence and 3D electron microscopy with high sensitivity and spatial precision. J. Cell Biol. 2011;192:111&#x2013;119. doi: 10.1083/jcb.201009037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.201009037</ArticleId><ArticleId IdType="pmc">PMC3019550</ArticleId><ArticleId IdType="pubmed">21200030</ArticleId></ArticleIdList></Reference><Reference><Citation>Hagen WJH, Wan W, Briggs JAG. Implementation of a cryo-electron tomography tilt-scheme optimized for high resolution subtomogram averaging. J. Struct. Biol. 2017;197:191&#x2013;198. doi: 10.1016/j.jsb.2016.06.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jsb.2016.06.007</ArticleId><ArticleId IdType="pmc">PMC5287356</ArticleId><ArticleId IdType="pubmed">27313000</ArticleId></ArticleIdList></Reference><Reference><Citation>Mastronarde DN. Automated electron microscope tomography using robust prediction of specimen movements. J. Struct. Biol. 2005;152:36&#x2013;51. doi: 10.1016/j.jsb.2005.07.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jsb.2005.07.007</ArticleId><ArticleId IdType="pubmed">16182563</ArticleId></ArticleIdList></Reference><Reference><Citation>Fukuda Y, Laugks U, Lu&#x10d;i&#x107; V, Baumeister W, Danev R. Electron cryotomography of vitrified cells with a Volta phase plate. J. Struct. Biol. 2015;190:143&#x2013;154. doi: 10.1016/j.jsb.2015.03.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jsb.2015.03.004</ArticleId><ArticleId IdType="pubmed">25770733</ArticleId></ArticleIdList></Reference><Reference><Citation>Kremer JR, Mastronarde DN, McIntosh JR. Computer visualization of three-dimensional image data using IMOD. J. Struct. Biol. 1996;116:71&#x2013;76. doi: 10.1006/jsbi.1996.0013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/jsbi.1996.0013</ArticleId><ArticleId IdType="pubmed">8742726</ArticleId></ArticleIdList></Reference><Reference><Citation>Casta&#xf1;o-D&#xed;ez D, Kudryashev M, Arheit M, Stahlberg H. Dynamo: a flexible, user-friendly development tool for subtomogram averaging of cryo-EM data in high-performance computing environments. J. Struct. Biol. 2012;178:139&#x2013;151. doi: 10.1016/j.jsb.2011.12.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jsb.2011.12.017</ArticleId><ArticleId IdType="pubmed">22245546</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y-T. Isotropic reconstruction for electron tomography with deep learning. Nat. Commun. 2022;13:6482. doi: 10.1038/s41467-022-33957-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-33957-8</ArticleId><ArticleId IdType="pmc">PMC9617606</ArticleId><ArticleId IdType="pubmed">36309499</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang K. Gctf: real-time CTF determination and correction. J. Struct. Biol. 2016;193:1&#x2013;12. doi: 10.1016/j.jsb.2015.11.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jsb.2015.11.003</ArticleId><ArticleId IdType="pmc">PMC4711343</ArticleId><ArticleId IdType="pubmed">26592709</ArticleId></ArticleIdList></Reference><Reference><Citation>Han H-M, Zuber B, Dubochet J. Compression and crevasses in vitreous sections under different cutting conditions. J. Microsc. 2008;230:167&#x2013;171. doi: 10.1111/j.1365-2818.2008.01972.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2818.2008.01972.x</ArticleId><ArticleId IdType="pubmed">18445144</ArticleId></ArticleIdList></Reference><Reference><Citation>Kimanius D, Dong L, Sharov G, Nakane T, Scheres SHW. New tools for automated cryo-EM single-particle analysis in RELION-4.0. Biochem. J. 2021;478:4169&#x2013;4185. doi: 10.1042/BCJ20210708.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BCJ20210708</ArticleId><ArticleId IdType="pmc">PMC8786306</ArticleId><ArticleId IdType="pubmed">34783343</ArticleId></ArticleIdList></Reference><Reference><Citation>Rohou A, Grigorieff N. CTFFIND4: fast and accurate defocus estimation from electron micrographs. J. Struct. Biol. 2015;192:216&#x2013;221. doi: 10.1016/j.jsb.2015.08.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jsb.2015.08.008</ArticleId><ArticleId IdType="pmc">PMC6760662</ArticleId><ArticleId IdType="pubmed">26278980</ArticleId></ArticleIdList></Reference><Reference><Citation>Wagner T, et al. Two particle-picking procedures for filamentous proteins: SPHIRE-crYOLO filament mode and SPHIRE-STRIPER. Acta Crystallogr. D. 2020;76:613&#x2013;620. doi: 10.1107/S2059798320007342.</Citation><ArticleIdList><ArticleId IdType="doi">10.1107/S2059798320007342</ArticleId><ArticleId IdType="pmc">PMC7336381</ArticleId><ArticleId IdType="pubmed">32627734</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheres SHW. Amyloid structure determination in RELION&#x2010;3.1. Acta Crystallogr. D. 2020;76:94&#x2013;101. doi: 10.1107/S2059798319016577.</Citation><ArticleIdList><ArticleId IdType="doi">10.1107/S2059798319016577</ArticleId><ArticleId IdType="pmc">PMC7008511</ArticleId><ArticleId IdType="pubmed">32038040</ArticleId></ArticleIdList></Reference><Reference><Citation>Emsley P, Lohkamp B, Scott WG, Cowtan K. Features and development of Coot. Acta Crystallogr. D Biol. Crystallogr. 2010;66:486&#x2013;501. doi: 10.1107/S0907444910007493.</Citation><ArticleIdList><ArticleId IdType="doi">10.1107/S0907444910007493</ArticleId><ArticleId IdType="pmc">PMC2852313</ArticleId><ArticleId IdType="pubmed">20383002</ArticleId></ArticleIdList></Reference><Reference><Citation>Adams PD, et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr. D Biol. Crystallogr. 2010;66:213&#x2013;221. doi: 10.1107/S0907444909052925.</Citation><ArticleIdList><ArticleId IdType="doi">10.1107/S0907444909052925</ArticleId><ArticleId IdType="pmc">PMC2815670</ArticleId><ArticleId IdType="pubmed">20124702</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams CJ, et al. MolProbity: more and better reference data for improved all&#x2010;atom structure validation. Protein Sci. 2018;27:293&#x2013;315. doi: 10.1002/pro.3330.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pro.3330</ArticleId><ArticleId IdType="pmc">PMC5734394</ArticleId><ArticleId IdType="pubmed">29067766</ArticleId></ArticleIdList></Reference><Reference><Citation>Goddard TD, et al. UCSF ChimeraX: meeting modern challenges in visualization and analysis. Protein Sci. 2018;27:14&#x2013;25. doi: 10.1002/pro.3235.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pro.3235</ArticleId><ArticleId IdType="pmc">PMC5734306</ArticleId><ArticleId IdType="pubmed">28710774</ArticleId></ArticleIdList></Reference><Reference><Citation>Pettersen EF, et al. UCSF ChimeraX: structure visualization for researchers, educators, and developers. Protein Sci. 2021;30:70&#x2013;82. doi: 10.1002/pro.3943.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pro.3943</ArticleId><ArticleId IdType="pmc">PMC7737788</ArticleId><ArticleId IdType="pubmed">32881101</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37202513</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>22</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>30</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2662-8465</ISSN><JournalIssue CitedMedium="Internet"><Volume>3</Volume><Issue>5</Issue><PubDate><Year>2023</Year><Month>May</Month></PubDate></JournalIssue><Title>Nature aging</Title><ISOAbbreviation>Nat Aging</ISOAbbreviation></Journal><ArticleTitle>Social participation and risk of developing dementia.</ArticleTitle><Pagination><StartPage>532</StartPage><EndPage>545</EndPage><MedlinePgn>532-545</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s43587-023-00387-0</ELocationID><Abstract><AbstractText>The increasing number of people with dementia globally illustrates the urgent need to reduce dementia's scale and impact. Lifetime social participation may affect dementia risk by increasing cognitive reserve, and through brain maintenance by reducing stress and improving cerebrovascular health. It may therefore have important implications for individual behavior and public health policy aimed at reducing dementia burden. Observational study evidence indicates that greater social participation in midlife and late life is associated with 30-50% lower subsequent dementia risk, although some of this may not be causal. Social participation interventions have led to improved cognition but, partly due to short follow-up and small numbers of participants, no reduction in risk of dementia. We summarize the evidence linking social participation with dementia, discuss potential mechanisms by which social participation is likely to reduce and mitigate the impact of neuropathology in the brain, and consider the implications for future clinical and policy dementia prevention interventions.</AbstractText><CopyrightInformation>&#xa9; 2023. Springer Nature America, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sommerlad</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-8895-7055</Identifier><AffiliationInfo><Affiliation>Division of Psychiatry, University College London, London, UK. a.sommerlad@ucl.ac.uk.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Camden and Islington NHS Foundation Trust, London, UK. a.sommerlad@ucl.ac.uk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kivim&#xe4;ki</LastName><ForeName>Mika</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-4699-5627</Identifier><AffiliationInfo><Affiliation>Division of Psychiatry, University College London, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Public Health, University of Helsinki, Helsinki, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Larson</LastName><ForeName>Eric B</ForeName><Initials>EB</Initials><AffiliationInfo><Affiliation>University of Washington Schools of Medicine and Public Health, Seattle, WA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>R&#xf6;hr</LastName><ForeName>Susanne</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>School of Psychology, Massey University, Manawatu, New Zealand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Global Brain Health Institute (GBHI), Trinity College Dublin, Dublin, Ireland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Social Medicine, Occupational Health and Public Health (ISAP), Medical Faculty, University of Leipzig, Leipzig, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shirai</LastName><ForeName>Kokoro</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Social Medicine, Graduate School of Medicine, Osaka University, Osaka, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Singh-Manoux</LastName><ForeName>Archana</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-1244-5037</Identifier><AffiliationInfo><Affiliation>Division of Psychiatry, University College London, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Universit&#xe9; Paris Cit&#xe9;, Inserm, U1153, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Livingston</LastName><ForeName>Gill</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0001-6741-5516</Identifier><AffiliationInfo><Affiliation>Division of Psychiatry, University College London, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Camden and Islington NHS Foundation Trust, London, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>MR/R024227/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MRC S011676/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>R024227/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>R01 AG056477</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>MR/S011676/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>RF1 AG062553</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>05</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Nat Aging</MedlineTA><NlmUniqueID>101773306</NlmUniqueID><ISSNLinking>2662-8465</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003704" MajorTopicYN="Y">Dementia</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058992" MajorTopicYN="N">Social Participation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003071" MajorTopicYN="N">Cognition</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058245" MajorTopicYN="Y">Cognitive Reserve</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064887" MajorTopicYN="N">Observational Studies as Topic</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>9</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>2</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>22</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>19</Day><Hour>1</Hour><Minute>4</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>18</Day><Hour>23</Hour><Minute>21</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37202513</ArticleId><ArticleId IdType="doi">10.1038/s43587-023-00387-0</ArticleId><ArticleId IdType="pii">10.1038/s43587-023-00387-0</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Patterson, C. World Alzheimer report 2018 (Alzheimer&#x2019;s Disease International, 2018).</Citation></Reference><Reference><Citation>Alzheimer&#x2019;s Research UK. Dementia Attitudes Monitor: Shaping Breakthroughs in Public Understanding of Dementia and Attitudes to Research (2021).</Citation></Reference><Reference><Citation>Velandia, P. P. Global and regional spending on dementia care from 2000&#x2013;2019 and expected future health spending scenarios from 2020&#x2013;2050: an economic modelling exercise. EClinicalMedicine 45, 101337 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35299657</ArticleId><ArticleId IdType="doi">10.1016/j.eclinm.2022.101337</ArticleId><ArticleId IdType="pmc">8921543</ArticleId></ArticleIdList></Reference><Reference><Citation>Seshadri, S. &amp; Wolf, P. A. Lifetime risk of stroke and dementia: current concepts, and estimates from the Framingham Study. Lancet Neurol. 6, 1106&#x2013;1114 (2007).</Citation><ArticleIdList><ArticleId IdType="pubmed">18031707</ArticleId><ArticleId IdType="doi">10.1016/S1474-4422(07)70291-0</ArticleId></ArticleIdList></Reference><Reference><Citation>Zissimopoulos, J., Crimmins, E. &amp; Clair, P. S. The value of delaying Alzheimer&#x2019;s disease onset. Forum Health Econ. Policy 18, 25&#x2013;39 (2014).</Citation><ArticleIdList><ArticleId IdType="pubmed">27134606</ArticleId><ArticleId IdType="doi">10.1515/fhep-2014-0013</ArticleId><ArticleId IdType="pmc">4851168</ArticleId></ArticleIdList></Reference><Reference><Citation>R&#xf6;hr, S., Pabst, A., Luck, T. &amp; Riedel-Heller, S. G. Is dementia incidence declining in high-income countries? A systematic review and meta-analysis. Clin. Epidemiol. 10, 1233&#x2013;1247 (2018).</Citation></Reference><Reference><Citation>Langa, K. M. et al. A comparison of the prevalence of dementia in the United States in 2000 and 2012. JAMA Intern. Med. 177, 51&#x2013;58 (2016).</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2016.6807</ArticleId></ArticleIdList></Reference><Reference><Citation>Matthews, F. et al. A two decade dementia incidence comparison from the Cognitive Function and Ageing Studies I and II. Nat. Commun. 7, 11398 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">27092707</ArticleId><ArticleId IdType="doi">10.1038/ncomms11398</ArticleId><ArticleId IdType="pmc">4838896</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu, Y.-T. et al. The changing prevalence and incidence of dementia over time&#x2014;current evidence. Nat. Rev. Neurol. 13, 327&#x2013;339 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28497805</ArticleId><ArticleId IdType="doi">10.1038/nrneurol.2017.63</ArticleId></ArticleIdList></Reference><Reference><Citation>Sreeramareddy, C. T. &amp; Aye, S. N. Changes in adult smoking behaviours in ten global adult tobacco survey (GATS) countries during 2008&#x2013;2018&#x2014;a test of &#x2018;hardening&#x2019;hypothesis&#x2019;. BMC Public Health 21, 1209 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34167508</ArticleId><ArticleId IdType="doi">10.1186/s12889-021-11201-0</ArticleId><ArticleId IdType="pmc">8223378</ArticleId></ArticleIdList></Reference><Reference><Citation>Mosterd, A. et al. Trends in the prevalence of hypertension, antihypertensive therapy, and left ventricular hypertrophy from 1950 to 1989. N. Engl. J. Med. 340, 1221&#x2013;1227 (1999).</Citation><ArticleIdList><ArticleId IdType="pubmed">10210704</ArticleId><ArticleId IdType="doi">10.1056/NEJM199904223401601</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang, M., Wang, D., Coresh, J. &amp; Selvin, E. Trends in diabetes treatment and control in US adults, 1999&#x2013;2018. N. Engl. J. Med. 384, 2219&#x2013;2228 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34107181</ArticleId><ArticleId IdType="doi">10.1056/NEJMsa2032271</ArticleId><ArticleId IdType="pmc">8385648</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiyohara, Y. Epidemiology of dementia: the Hisayama study. Nihon Rinsho 72, 601&#x2013;606 (2014).</Citation><ArticleIdList><ArticleId IdType="pubmed">24796086</ArticleId></ArticleIdList></Reference><Reference><Citation>Livingston, G. et al. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet 396, 413&#x2013;446 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32738937</ArticleId><ArticleId IdType="doi">10.1016/S0140-6736(20)30367-6</ArticleId><ArticleId IdType="pmc">7392084</ArticleId></ArticleIdList></Reference><Reference><Citation>Mukadam, N., Sommerlad, A., Huntley, J. &amp; Livingston, G. Population attributable fractions for risk factors for dementia in low-income and middle-income countries: an analysis using cross-sectional survey data. Lancet Glob. Health 7, e596&#x2013;e603 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">31000129</ArticleId><ArticleId IdType="doi">10.1016/S2214-109X(19)30074-9</ArticleId></ArticleIdList></Reference><Reference><Citation>Suemoto, C. K. et al. Risk factors for dementia in Brazil: differences by region and race. Alzheimers Dement. https://doi.org/10.1002/alz.12820 (2022).</Citation></Reference><Reference><Citation>Surkalim, D. L. et al. The prevalence of loneliness across 113 countries: systematic review and meta-analysis. BMJ 376, e067068 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35140066</ArticleId><ArticleId IdType="doi">10.1136/bmj-2021-067068</ArticleId><ArticleId IdType="pmc">8826180</ArticleId></ArticleIdList></Reference><Reference><Citation>Serrat, R., Scharf, T., Villar, F. &amp; G&#xf3;mez, C. Fifty-five years of research into older people&#x2019;s civic participation: recent trends, future directions. Gerontologist 60, e38&#x2013;e51 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">30889249</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. Risk Reduction of Cognitive Decline and Dementia: WHO Guidelines (2019).</Citation></Reference><Reference><Citation>Ang, S. Life course social connectedness: age-cohort trends in social participation. Adv. Life Course Res. 39, 13&#x2013;22 (2019).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.alcr.2019.02.002</ArticleId></ArticleIdList></Reference><Reference><Citation>Dahlberg, L., Agahi, N. &amp; Lennartsson, C. Lonelier than ever? Loneliness of older people over two decades. Arch. Gerontol. Geriatrics 75, 96&#x2013;103 (2018).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.archger.2017.11.004</ArticleId></ArticleIdList></Reference><Reference><Citation>Sommerlad, A. et al. Social relationships and depression during the COVID-19 lockdown: longitudinal analysis of the COVID-19 Social Study. Psychol. Med. 52, 3381&#x2013;3390 (2022).</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0033291721000039</ArticleId></ArticleIdList></Reference><Reference><Citation>Su&#xe1;rez-Gonz&#xe1;lez, A., Rajagopalan, J., Livingston, G. &amp; Alladi, S. The effect of COVID-19 isolation measures on the cognition and mental health of people living with dementia: a rapid systematic review of one year of quantitative evidence. EClinicalMedicine 39, 101047 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34386758</ArticleId><ArticleId IdType="doi">10.1016/j.eclinm.2021.101047</ArticleId><ArticleId IdType="pmc">8342894</ArticleId></ArticleIdList></Reference><Reference><Citation>Levasseur, M. et al. Scoping study of definitions of social participation: update and co-construction of an interdisciplinary consensual definition. Age Ageing 51, afab215 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35134843</ArticleId><ArticleId IdType="doi">10.1093/ageing/afab215</ArticleId></ArticleIdList></Reference><Reference><Citation>Berkman, L. F. &amp; Syme, S. L. Social networks, host resistance, and mortality: a nine-year follow-up study of Alameda County residents. Am. J. Epidemiol. 109, 186&#x2013;204 (1979).</Citation><ArticleIdList><ArticleId IdType="pubmed">425958</ArticleId><ArticleId IdType="doi">10.1093/oxfordjournals.aje.a112674</ArticleId></ArticleIdList></Reference><Reference><Citation>Russell, D., Peplau, L. A. &amp; Cutrona, C. E. The revised UCLA Loneliness Scale: concurrent and discriminant validity evidence. J. Pers. Soc. Psychol. 39, 472&#x2013;480 (1980).</Citation><ArticleIdList><ArticleId IdType="pubmed">7431205</ArticleId><ArticleId IdType="doi">10.1037/0022-3514.39.3.472</ArticleId></ArticleIdList></Reference><Reference><Citation>Yates, L. A., Ziser, S., Spector, A. &amp; Orrell, M. Cognitive leisure activities and future risk of cognitive impairment and dementia: systematic review and meta-analysis. Int. Psychogeriatr. 28, 1791&#x2013;1806 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">27502691</ArticleId><ArticleId IdType="doi">10.1017/S1041610216001137</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou, Z., Wang, P. &amp; Fang, Y. Social engagement and its change are associated with dementia risk among Chinese older adults: a longitudinal study. Sci. Rep. 8, 1551 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">29367696</ArticleId><ArticleId IdType="doi">10.1038/s41598-017-17879-w</ArticleId><ArticleId IdType="pmc">5784173</ArticleId></ArticleIdList></Reference><Reference><Citation>Fancourt, D., Steptoe, A. &amp; Cadar, D. Community engagement and dementia risk: time-to-event analyses from a national cohort study. J. Epidemiol. Community Health 74, 71&#x2013;77 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">31662344</ArticleId><ArticleId IdType="doi">10.1136/jech-2019-213029</ArticleId></ArticleIdList></Reference><Reference><Citation>Duffner, L. et al. The role of cognitive and social leisure activities in dementia risk: assessing longitudinal associations of modifiable and on-modifiable risk factors. Epidemiol. Psychiatr. Sci. 31, e5 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35499392</ArticleId><ArticleId IdType="doi">10.1017/S204579602100069X</ArticleId><ArticleId IdType="pmc">8786616</ArticleId></ArticleIdList></Reference><Reference><Citation>Amieva, H. et al. Prodromal Alzheimer&#x2019;s disease: successive emergence of the clinical symptoms. Ann. Neurol. 64, 492&#x2013;498 (2008).</Citation><ArticleIdList><ArticleId IdType="pubmed">19067364</ArticleId><ArticleId IdType="doi">10.1002/ana.21509</ArticleId></ArticleIdList></Reference><Reference><Citation>Jack, C. R. Jr. et al. Hypothetical model of dynamic biomarkers of the Alzheimer&#x2019;s pathological cascade. Lancet Neurol. 9, 119&#x2013;128 (2010).</Citation><ArticleIdList><ArticleId IdType="pubmed">20083042</ArticleId><ArticleId IdType="doi">10.1016/S1474-4422(09)70299-6</ArticleId><ArticleId IdType="pmc">2819840</ArticleId></ArticleIdList></Reference><Reference><Citation>Almeida-Meza, P., Steptoe, A. &amp; Cadar, D. Is engagement in intellectual and social leisure activities protective against dementia risk? Evidence from the English longitudinal study of ageing. J. Alzheimer&#x2019;s Dis. 80, 555&#x2013;565 (2021).</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-200952</ArticleId></ArticleIdList></Reference><Reference><Citation>Nemoto, Y. et al. An additive effect of leading role in the organization between social participation and dementia onset among Japanese older adults: the AGES cohort study. BMC Geriatr. 17, 297 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">29284406</ArticleId><ArticleId IdType="doi">10.1186/s12877-017-0688-9</ArticleId><ArticleId IdType="pmc">5747184</ArticleId></ArticleIdList></Reference><Reference><Citation>Sommerlad, A. et al. Leisure activity participation and risk of dementia: an 18-year follow-up of the Whitehall II Study. Neurology 95, e2803&#x2013;e2815 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">33115773</ArticleId><ArticleId IdType="doi">10.1212/WNL.0000000000010966</ArticleId><ArticleId IdType="pmc">7734721</ArticleId></ArticleIdList></Reference><Reference><Citation>Floud, S. et al. Cognitive and social activities and long-term dementia risk: the prospective UK Million Women Study. Lancet Public Health 6, e116&#x2013;e123 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33516288</ArticleId><ArticleId IdType="doi">10.1016/S2468-2667(20)30284-X</ArticleId><ArticleId IdType="pmc">7848753</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuiper, J. S. et al. Social relationships and risk of dementia: a systematic review and meta-analysis of longitudinal cohort studies. Ageing Res. Rev. 22, 39&#x2013;57 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">25956016</ArticleId><ArticleId IdType="doi">10.1016/j.arr.2015.04.006</ArticleId></ArticleIdList></Reference><Reference><Citation>Penninkilampi, R., Casey, A.-N., Singh, M. F. &amp; Brodaty, H. The association between social engagement, loneliness, and risk of dementia: a systematic review and meta-analysis. J. Alzheimer&#x2019;s Dis. 66, 1619&#x2013;1633 (2018).</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-180439</ArticleId></ArticleIdList></Reference><Reference><Citation>Sommerlad, A., Ruegger, J., Singh-Manoux, A., Lewis, G. &amp; Livingston, G. Marriage and risk of dementia: systematic review and meta-analysis of observational studies. J. Neurol. Neurosurg. Psychiatry 89, 231&#x2013;238 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">29183957</ArticleId><ArticleId IdType="doi">10.1136/jnnp-2017-316274</ArticleId></ArticleIdList></Reference><Reference><Citation>Sundstr&#xf6;m, A., Westerlund, O., Mousavi-Nasab, H., Adolfsson, R. &amp; Nilsson, L.-G. The relationship between marital and parental status and the risk of dementia. Int. Psychogeriatr. 26, 749&#x2013;757 (2014).</Citation><ArticleIdList><ArticleId IdType="pubmed">24451183</ArticleId><ArticleId IdType="doi">10.1017/S1041610213002652</ArticleId></ArticleIdList></Reference><Reference><Citation>Sommerlad, A., Sabia, S., Singh-Manoux, A., Lewis, G. &amp; Livingston, G. Association of social contact with dementia and cognition: 28-year follow-up of the Whitehall II cohort study. PLoS Med. 16, e1002862 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">31374073</ArticleId><ArticleId IdType="doi">10.1371/journal.pmed.1002862</ArticleId><ArticleId IdType="pmc">6677303</ArticleId></ArticleIdList></Reference><Reference><Citation>Elovainio, M. et al. Association of social isolation, loneliness and genetic risk with incidence of dementia: UK Biobank Cohort Study. BMJ Open 12, e053936 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35197341</ArticleId><ArticleId IdType="doi">10.1136/bmjopen-2021-053936</ArticleId><ArticleId IdType="pmc">8867309</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen, C. et al. Associations of social isolation and loneliness with later dementia. Neurology 99, e164&#x2013;e175 (2022).</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000200583</ArticleId></ArticleIdList></Reference><Reference><Citation>Lara, E. et al. Does loneliness contribute to mild cognitive impairment and dementia? A systematic review and meta-analysis of longitudinal studies. Ageing Res. Rev. 52, 7&#x2013;16 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">30914351</ArticleId><ArticleId IdType="doi">10.1016/j.arr.2019.03.002</ArticleId></ArticleIdList></Reference><Reference><Citation>Akhter&#x2010;Khan, S. C. et al. Associations of loneliness with risk of Alzheimer&#x2019;s disease dementia in the Framingham Heart Study. Alzheimer&#x2019;s Dement. 17, 1619&#x2013;1627 (2021).</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alz.12327</ArticleId></ArticleIdList></Reference><Reference><Citation>Sutin, A. R., Stephan, Y., Luchetti, M. &amp; Terracciano, A. Loneliness and risk of dementia. J. Gerontol. B Psychol. Sci. Soc. Sci. 75, 1414&#x2013;1422 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">30365023</ArticleId><ArticleId IdType="doi">10.1093/geronb/gby112</ArticleId></ArticleIdList></Reference><Reference><Citation>Salinas, J. et al. Association of loneliness with 10-year dementia risk and early markers of vulnerability for neurocognitive decline. Neurology 98, e1337&#x2013;e1348 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35131906</ArticleId><ArticleId IdType="doi">10.1212/WNL.0000000000200039</ArticleId><ArticleId IdType="pmc">8967424</ArticleId></ArticleIdList></Reference><Reference><Citation>Freak-Poli, R. et al. Loneliness, not social support, is associated with cognitive decline and dementia across two longitudinal population-based cohorts. J. Alzheimer&#x2019;s Dis. 85, 295&#x2013;308 (2022).</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-210330</ArticleId></ArticleIdList></Reference><Reference><Citation>Shibata, M. et al. Emotional loneliness is associated with a risk of dementia in a general Japanese older population: the Hisayama study. J. Gerontol. B Psychol. Sci. Soc. Sci. 76, 1756&#x2013;1766 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33170218</ArticleId><ArticleId IdType="doi">10.1093/geronb/gbaa196</ArticleId></ArticleIdList></Reference><Reference><Citation>Akhter-Khan, S. et al. Associations of loneliness with risk of Alzheimer&#x2019;s disease dementia in the Framingham Heart Study. Alzheimers Dement. 17, 1619&#x2013;1627 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33760348</ArticleId><ArticleId IdType="doi">10.1002/alz.12327</ArticleId><ArticleId IdType="pmc">8460688</ArticleId></ArticleIdList></Reference><Reference><Citation>Oh, D. J. et al. Association of low emotional and tangible support with risk of dementia among adults 60 years and older in South Korea. JAMA Netw. Open 5, e2226260&#x2013;e2226260 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35951325</ArticleId><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.26260</ArticleId><ArticleId IdType="pmc">9372780</ArticleId></ArticleIdList></Reference><Reference><Citation>Gardener, H. et al. Social connectivity is related to mild cognitive impairment and dementia. J. Alzheimer&#x2019;s Dis. 84, 1811&#x2013;1820 (2021).</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-210519</ArticleId></ArticleIdList></Reference><Reference><Citation>Weuve, J. et al. Guidelines for reporting methodological challenges and evaluating potential bias in dementia research. Alzheimer&#x2019;s Dement. 11, 1098&#x2013;1109 (2015).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2015.06.1885</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuiper, J. S. et al. Social relationships and cognitive decline: a systematic review and meta-analysis of longitudinal cohort studies. Int. J. Epidemiol. 45, 1169&#x2013;1206 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">27272181</ArticleId></ArticleIdList></Reference><Reference><Citation>Piolatto, M. et al. The effect of social relationships on cognitive decline in older adults: an updated systematic review and meta-analysis of longitudinal cohort studies. BMC Public Health 22, 278 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35148704</ArticleId><ArticleId IdType="doi">10.1186/s12889-022-12567-5</ArticleId><ArticleId IdType="pmc">8831686</ArticleId></ArticleIdList></Reference><Reference><Citation>Kelly, M. E. et al. The impact of social activities, social networks, social support and social relationships on the cognitive functioning of healthy older adults: a systematic review. Syst. Rev. 6, 259 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">29258596</ArticleId><ArticleId IdType="doi">10.1186/s13643-017-0632-2</ArticleId><ArticleId IdType="pmc">5735742</ArticleId></ArticleIdList></Reference><Reference><Citation>R&#xf6;hr, S. et al. Changes in social network size are associated with cognitive changes in the oldest-old. Front. Psychiatry 11, 330 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32431627</ArticleId><ArticleId IdType="doi">10.3389/fpsyt.2020.00330</ArticleId><ArticleId IdType="pmc">7212889</ArticleId></ArticleIdList></Reference><Reference><Citation>Saito, T. et al. Association between intra-individual changes in social network diversity and global cognition in older adults: does closeness to network members make a difference? J. Psychosom. Res. 151, 110658 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34741873</ArticleId><ArticleId IdType="doi">10.1016/j.jpsychores.2021.110658</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts, B. A., Fuhrer, R., Marmot, M. &amp; Richards, M. Does retirement influence cognitive performance? The Whitehall II Study. J. Epidemiol. Community Health 65, 958&#x2013;963 (2011).</Citation><ArticleIdList><ArticleId IdType="pubmed">20940172</ArticleId><ArticleId IdType="doi">10.1136/jech.2010.111849</ArticleId></ArticleIdList></Reference><Reference><Citation>Meng, A., Nex&#xf8;, M. A. &amp; Borg, V. The impact of retirement on age related cognitive decline&#x2014;a systematic review. BMC Geriatr. 17, 160 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28732489</ArticleId><ArticleId IdType="doi">10.1186/s12877-017-0556-7</ArticleId><ArticleId IdType="pmc">5520232</ArticleId></ArticleIdList></Reference><Reference><Citation>Xue, B. et al. Effect of retirement on cognitive function: the Whitehall II cohort study. Eur. J. Epidemiol. 33, 989&#x2013;1001 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">29280030</ArticleId><ArticleId IdType="doi">10.1007/s10654-017-0347-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Rohwedder, S. &amp; Willis, R. J. Mental retirement. J. Econ. Perspect. 24, 119&#x2013;138 (2010).</Citation><ArticleIdList><ArticleId IdType="pubmed">20975927</ArticleId><ArticleId IdType="doi">10.1257/jep.24.1.119</ArticleId><ArticleId IdType="pmc">2958696</ArticleId></ArticleIdList></Reference><Reference><Citation>Clouston, S. A. &amp; Denier, N. Mental retirement and health selection: analyses from the US Health and Retirement Study. Soc. Sci. Med. 178, 78&#x2013;86 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28213301</ArticleId><ArticleId IdType="doi">10.1016/j.socscimed.2017.01.019</ArticleId><ArticleId IdType="pmc">5400287</ArticleId></ArticleIdList></Reference><Reference><Citation>Boss, L., Kang, D.-H. &amp; Branson, S. Loneliness and cognitive function in the older adult: a systematic review. Int. Psychogeriatr. 27, 541&#x2013;553 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">25554219</ArticleId><ArticleId IdType="doi">10.1017/S1041610214002749</ArticleId></ArticleIdList></Reference><Reference><Citation>Schnittger, R. I., Wherton, J., Prendergast, D. &amp; Lawlor, B. A. Risk factors and mediating pathways of loneliness and social support in community-dwelling older adults. Aging Ment. Health 16, 335&#x2013;346 (2012).</Citation><ArticleIdList><ArticleId IdType="pubmed">22129431</ArticleId><ArticleId IdType="doi">10.1080/13607863.2011.629092</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen, L.-X. et al. Social isolation, social interaction, and Alzheimer&#x2019;s disease: a Mendelian randomization study. J. Alzheimer&#x2019;s Dis. 80, 665&#x2013;672 (2021).</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-201442</ArticleId></ArticleIdList></Reference><Reference><Citation>Kivim&#xe4;ki, M. et al. IPD-Work consortium: pre-defined meta-analyses of individual-participant data strengthen evidence base for a link between psychosocial factors and health. Scand. J. Work Environ. Health 41, 312&#x2013;321 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">25654401</ArticleId><ArticleId IdType="doi">10.5271/sjweh.3485</ArticleId></ArticleIdList></Reference><Reference><Citation>Fry, A. et al. Comparison of sociodemographic and health-related characteristics of UK Biobank participants with those of the general population. Am. J. Epidemiol. 186, 1026&#x2013;1034 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28641372</ArticleId><ArticleId IdType="doi">10.1093/aje/kwx246</ArticleId><ArticleId IdType="pmc">5860371</ArticleId></ArticleIdList></Reference><Reference><Citation>Brayne, C. &amp; Moffitt, T. E. The limitations of large-scale volunteer databases to address inequalities and global challenges in health and aging. Nat. Aging 2, 775&#x2013;783 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">37118500</ArticleId><ArticleId IdType="doi">10.1038/s43587-022-00277-x</ArticleId></ArticleIdList></Reference><Reference><Citation>Verghese, J. et al. Leisure activities and the risk of dementia in the elderly. N. Engl. J. Med. 348, 2508&#x2013;2516 (2003).</Citation><ArticleIdList><ArticleId IdType="pubmed">12815136</ArticleId><ArticleId IdType="doi">10.1056/NEJMoa022252</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma&#x2019;u, E., Cullum, S., Cheung, G., Livingston, G. &amp; Mukadam, N. Differences in the potential for dementia prevention between major ethnic groups within one country: a cross-sectional analysis of population attributable fraction of potentially modifiable risk factors in New Zealand. Lancet Reg. Health West. Pac. 13, 100191 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34527984</ArticleId><ArticleId IdType="doi">10.1016/j.lanwpc.2021.100191</ArticleId><ArticleId IdType="pmc">8358157</ArticleId></ArticleIdList></Reference><Reference><Citation>Dekhtyar, S. et al. Genetic risk of dementia mitigated by cognitive reserve: a cohort study. Ann. Neurol. 86, 68&#x2013;78 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">31066941</ArticleId><ArticleId IdType="doi">10.1002/ana.25501</ArticleId><ArticleId IdType="pmc">6618249</ArticleId></ArticleIdList></Reference><Reference><Citation>Stern, Y. et al. Whitepaper: Defining and investigating cognitive reserve, brain reserve, and brain maintenance. Alzheimer&#x2019;s Dement. 16, 1305&#x2013;1311 (2020).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2018.07.219</ArticleId></ArticleIdList></Reference><Reference><Citation>Alvares Pereira, G., Silva Nunes, M. V., Alzola, P. &amp; Contador, I. Cognitive reserve and brain maintenance in aging and dementia: an integrative review. Appl. Neuropsychol. Adult 29, 1615&#x2013;1625 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">33492168</ArticleId><ArticleId IdType="doi">10.1080/23279095.2021.1872079</ArticleId></ArticleIdList></Reference><Reference><Citation>Grande, G., Qiu, C. &amp; Fratiglioni, L. Prevention of dementia in an ageing world: evidence and biological rationale. Ageing Res. Rev. 64, 101045 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32171784</ArticleId><ArticleId IdType="doi">10.1016/j.arr.2020.101045</ArticleId></ArticleIdList></Reference><Reference><Citation>Fratiglioni, L., Marseglia, A. &amp; Dekhtyar, S. Ageing without dementia: can stimulating psychosocial and lifestyle experiences make a difference? Lancet Neurol. 19, 533&#x2013;543 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32470425</ArticleId><ArticleId IdType="doi">10.1016/S1474-4422(20)30039-9</ArticleId></ArticleIdList></Reference><Reference><Citation>Turkstra, L. S. Conversation-based assessment of social cognition in adults with traumatic brain injury. Brain Inj. 22, 397&#x2013;409 (2008).</Citation><ArticleIdList><ArticleId IdType="pubmed">18415720</ArticleId><ArticleId IdType="doi">10.1080/02699050802027059</ArticleId></ArticleIdList></Reference><Reference><Citation>Lanooij, S. D., Eisel, U. L., Drinkenburg, W. H., van der Zee, E. A. &amp; Kas, M. J. Influencing cognitive performance via social interactions: a novel therapeutic approach for brain disorders based on neuroanatomical mapping? Mol. Psychiatry 28, 28&#x2013;33 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35858991</ArticleId><ArticleId IdType="doi">10.1038/s41380-022-01698-1</ArticleId><ArticleId IdType="pmc">9812764</ArticleId></ArticleIdList></Reference><Reference><Citation>Scarmeas, N. &amp; Stern, Y. Cognitive reserve and lifestyle. J. Clin. Exp. Neuropsychol. 25, 625&#x2013;633 (2003).</Citation><ArticleIdList><ArticleId IdType="pubmed">12815500</ArticleId><ArticleId IdType="doi">10.1076/jcen.25.5.625.14576</ArticleId><ArticleId IdType="pmc">3024591</ArticleId></ArticleIdList></Reference><Reference><Citation>Bennett, D. A., Schneider, J. A., Tang, Y., Arnold, S. E. &amp; Wilson, R. S. The effect of social networks on the relation between Alzheimer&#x2019;s disease pathology and level of cognitive function in old people: a longitudinal cohort study. Lancet Neurol. 5, 406&#x2013;412 (2006).</Citation><ArticleIdList><ArticleId IdType="pubmed">16632311</ArticleId><ArticleId IdType="doi">10.1016/S1474-4422(06)70417-3</ArticleId></ArticleIdList></Reference><Reference><Citation>Marseglia, A., Wang, H.-X., Rizzuto, D., Fratiglioni, L. &amp; Xu, W. Participating in mental, social, and physical leisure activities and having a rich social network reduce the incidence of diabetes-related dementia in a cohort of Swedish older adults. Diabetes Care 42, 232&#x2013;239 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">30523030</ArticleId><ArticleId IdType="doi">10.2337/dc18-1428</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Velpen, I. F. et al. Social health is associated with structural brain changes in older adults: the Rotterdam Study. Biol. Psychiatry Cogn. Neurosci. Neuroimaging 7, 659&#x2013;668 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">33549803</ArticleId></ArticleIdList></Reference><Reference><Citation>Maguire, E. A. et al. Navigation-related structural change in the hippocampi of taxi drivers. Proc. Natl Acad. Sci. USA 97, 4398&#x2013;4403 (2000).</Citation><ArticleIdList><ArticleId IdType="pubmed">10716738</ArticleId><ArticleId IdType="doi">10.1073/pnas.070039597</ArticleId><ArticleId IdType="pmc">18253</ArticleId></ArticleIdList></Reference><Reference><Citation>Kivim&#xe4;ki, M. et al. Cognitive stimulation in the workplace, plasma proteins, and risk of dementia: three analyses of population cohort studies. BMJ 374, n1804 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34407988</ArticleId><ArticleId IdType="doi">10.1136/bmj.n1804</ArticleId><ArticleId IdType="pmc">8372196</ArticleId></ArticleIdList></Reference><Reference><Citation>Elovainio, M. et al. Contribution of risk factors to excess mortality in isolated and lonely individuals: an analysis of data from the UK Biobank cohort study. Lancet Public Health 2, e260&#x2013;e266 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28626828</ArticleId><ArticleId IdType="doi">10.1016/S2468-2667(17)30075-0</ArticleId><ArticleId IdType="pmc">5463031</ArticleId></ArticleIdList></Reference><Reference><Citation>Kelly, S., Olanrewaju, O., Cowan, A., Brayne, C. &amp; Lafortune, L. Alcohol and older people: a systematic review of barriers, facilitators and context of drinking in older people and implications for intervention design. PLoS ONE 13, e0191189 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">29370214</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0191189</ArticleId><ArticleId IdType="pmc">5784942</ArticleId></ArticleIdList></Reference><Reference><Citation>Holt-Lunstad, J., Smith, T. B., Baker, M., Harris, T. &amp; Stephenson, D. Loneliness and social isolation as risk factors for mortality: a meta-analytic review. Perspect. Psychol. Sci. 10, 227&#x2013;237 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">25910392</ArticleId><ArticleId IdType="doi">10.1177/1745691614568352</ArticleId></ArticleIdList></Reference><Reference><Citation>Larson, E. B. et al. Exercise is associated with reduced risk for incident dementia among persons 65 years of age and older. Ann. Intern. Med. 144, 73&#x2013;81 (2006).</Citation><ArticleIdList><ArticleId IdType="pubmed">16418406</ArticleId><ArticleId IdType="doi">10.7326/0003-4819-144-2-200601170-00004</ArticleId></ArticleIdList></Reference><Reference><Citation>Barberger-Gateau, P. et al. Dietary patterns and risk of dementia The Three-City cohort study. Neurology 69, 1921&#x2013;1930 (2007).</Citation><ArticleIdList><ArticleId IdType="pubmed">17998483</ArticleId><ArticleId IdType="doi">10.1212/01.wnl.0000278116.37320.52</ArticleId></ArticleIdList></Reference><Reference><Citation>Del Brutto, O. H., Mera, R. M., Recalde, B. Y., Rumbea, D. A. &amp; Del Brutto, V. J. High social risk influence progression of white matter hyperintensities of presumed vascular origin: a prospective study in community-dwelling older adults. Stroke 53, 2577&#x2013;2584 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35506386</ArticleId><ArticleId IdType="doi">10.1161/STROKEAHA.122.038561</ArticleId></ArticleIdList></Reference><Reference><Citation>Cacioppo, J. T., Cacioppo, S., Capitanio, J. P. &amp; Cole, S. W. The neuroendocrinology of social isolation. Annu. Rev. Psychol. 66, 733&#x2013;767 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">25148851</ArticleId><ArticleId IdType="doi">10.1146/annurev-psych-010814-015240</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothman, S. M. &amp; Mattson, M. P. Adverse stress, hippocampal networks, and Alzheimer&#x2019;s disease. Neuromolecular Med. 12, 56&#x2013;70 (2010).</Citation><ArticleIdList><ArticleId IdType="pubmed">19943124</ArticleId><ArticleId IdType="doi">10.1007/s12017-009-8107-9</ArticleId></ArticleIdList></Reference><Reference><Citation>Johansson, L. et al. Common psychosocial stressors in middle-aged women related to longstanding distress and increased risk of Alzheimer&#x2019;s disease: a 38-year longitudinal population study. BMJ Open 3, e003142 (2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">24080094</ArticleId><ArticleId IdType="doi">10.1136/bmjopen-2013-003142</ArticleId><ArticleId IdType="pmc">3787482</ArticleId></ArticleIdList></Reference><Reference><Citation>Stafford, M., Gardner, M., Kumari, M., Kuh, D. &amp; Ben-Shlomo, Y. Social isolation and diurnal cortisol patterns in an ageing cohort. Psychoneuroendocrinology 38, 2737&#x2013;2745 (2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">23920224</ArticleId><ArticleId IdType="doi">10.1016/j.psyneuen.2013.07.002</ArticleId><ArticleId IdType="pmc">3820041</ArticleId></ArticleIdList></Reference><Reference><Citation>Friedler, B., Crapser, J. &amp; McCullough, L. One is the deadliest number: the detrimental effects of social isolation on cerebrovascular diseases and cognition. Acta Neuropathol. 129, 493&#x2013;509 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">25537401</ArticleId><ArticleId IdType="doi">10.1007/s00401-014-1377-9</ArticleId></ArticleIdList></Reference><Reference><Citation>Carroll, J. E., Roux, A. V. D., Fitzpatrick, A. L. &amp; Seeman, T. Low social support is associated with shorter leukocyte telomere length in late life: multi-ethnic study of atherosclerosis (MESA). Psychosom. Med. 75, 171&#x2013;177 (2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">23370895</ArticleId><ArticleId IdType="doi">10.1097/PSY.0b013e31828233bf</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitchell, A. M., Kowalsky, J. M., Epel, E. S., Lin, J. &amp; Christian, L. M. Childhood adversity, social support, and telomere length among perinatal women. Psychoneuroendocrinology 87, 43&#x2013;52 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">29035711</ArticleId><ArticleId IdType="doi">10.1016/j.psyneuen.2017.10.003</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilson, S. J. et al. Loneliness and telomere length: immune and parasympathetic function in associations with accelerated aging. Ann. Behav. Med. 53, 541&#x2013;550 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">30107521</ArticleId><ArticleId IdType="doi">10.1093/abm/kay064</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith, K. J., Gavey, S., RIddell, N. E., Kontari, P. &amp; Victor, C. The association between loneliness, social isolation and inflammation: a systematic review and meta-analysis. Neurosci. Biobehav. Rev. 112, 519&#x2013;541 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32092313</ArticleId><ArticleId IdType="doi">10.1016/j.neubiorev.2020.02.002</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker, K. A. et al. Systemic inflammation during midlife and cognitive change over 20 years: the ARIC study. Neurology 92, e1256&#x2013;e1267 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">30760633</ArticleId><ArticleId IdType="pmc">6511107</ArticleId></ArticleIdList></Reference><Reference><Citation>Sweeney, M. D., Zhao, Z., Montagne, A., Nelson, A. R. &amp; Zlokovic, B. V. Blood&#x2013;brain barrier: from physiology to disease and back. Physiol. Rev. 99, 21&#x2013;78 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">30280653</ArticleId><ArticleId IdType="doi">10.1152/physrev.00050.2017</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker, K. A. et al. Large-scale plasma proteomic analysis identifies proteins and pathways associated with dementia risk. Nat. Aging 1, 473&#x2013;489 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">37118015</ArticleId><ArticleId IdType="doi">10.1038/s43587-021-00064-0</ArticleId><ArticleId IdType="pmc">10154040</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindbohm, J. V. et al. Immune system wide biomarker analyses provide causal evidence for autoimmunity in dementia causing diseases. Nat. Aging 2, 956&#x2013;972 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">37118290</ArticleId><ArticleId IdType="doi">10.1038/s43587-022-00293-x</ArticleId><ArticleId IdType="pmc">10154235</ArticleId></ArticleIdList></Reference><Reference><Citation>Sipil&#xe4;, P. N. et al. Hospital-treated infectious diseases and the risk of dementia: a large, multicohort, observational study with a replication cohort. Lancet Infect. Dis. 21, 1557&#x2013;1567 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34166620</ArticleId><ArticleId IdType="doi">10.1016/S1473-3099(21)00144-4</ArticleId><ArticleId IdType="pmc">8592915</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun, J. et al. Hospital-treated infections in early-and mid-life and risk of Alzheimer&#x2019;s disease, Parkinson&#x2019;s disease, and amyotrophic lateral sclerosis: a nationwide nested case-control study in Sweden. PLoS Med. 19, e1004092 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">36107840</ArticleId><ArticleId IdType="doi">10.1371/journal.pmed.1004092</ArticleId><ArticleId IdType="pmc">9477309</ArticleId></ArticleIdList></Reference><Reference><Citation>Bu, F., Philip, K. &amp; Fancourt, D. Social isolation and loneliness as risk factors for hospital admissions for respiratory disease among older adults. Thorax 75, 597&#x2013;599 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32317268</ArticleId><ArticleId IdType="doi">10.1136/thoraxjnl-2019-214445</ArticleId></ArticleIdList></Reference><Reference><Citation>Scharf, I. et al. Social isolation causes downregulation of immune and stress response genes and behavioural changes in a social insect. Mol. Ecol. 30, 2378&#x2013;2389 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33772940</ArticleId><ArticleId IdType="doi">10.1111/mec.15902</ArticleId></ArticleIdList></Reference><Reference><Citation>Elovainio, M. et al. Association of social isolation and loneliness with future risk of hospital-treated infections: a prospective multicohort study. Lancet Public Health 8, e109&#x2013;e118 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">36669514</ArticleId><ArticleId IdType="doi">10.1016/S2468-2667(22)00253-5</ArticleId><ArticleId IdType="pmc">9879771</ArticleId></ArticleIdList></Reference><Reference><Citation>Byers, A. L. &amp; Yaffe, K. Depression and risk of developing dementia. Nat. Rev. Neurol. 7, 323&#x2013;331 (2011).</Citation><ArticleIdList><ArticleId IdType="pubmed">21537355</ArticleId><ArticleId IdType="doi">10.1038/nrneurol.2011.60</ArticleId><ArticleId IdType="pmc">3327554</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh-Manoux, A. et al. Trajectories of depressive symptoms before diagnosis of dementia: a 28-year follow-up study. JAMA Psychiatry 74, 712&#x2013;718 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28514478</ArticleId><ArticleId IdType="doi">10.1001/jamapsychiatry.2017.0660</ArticleId><ArticleId IdType="pmc">5710246</ArticleId></ArticleIdList></Reference><Reference><Citation>Young, S. N. The neurobiology of human social behaviour: an important but neglected topic. J. Psychiatry Neurosci. 33, 391&#x2013;392 (2008).</Citation><ArticleIdList><ArticleId IdType="pubmed">18787656</ArticleId><ArticleId IdType="pmc">2527715</ArticleId></ArticleIdList></Reference><Reference><Citation>Watts, D. J., Dodds, P. S. &amp; Newman, M. E. Identity and search in social networks. Science 296, 1302&#x2013;1305 (2002).</Citation><ArticleIdList><ArticleId IdType="pubmed">12016312</ArticleId><ArticleId IdType="doi">10.1126/science.1070120</ArticleId></ArticleIdList></Reference><Reference><Citation>Leary, M. R., Herbst, K. C. &amp; McCrary, F. Finding pleasure in solitary activities: desire for aloneness or disinterest in social contact? Pers. Individ. Dif. 35, 59&#x2013;68 (2003).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0191-8869(02)00141-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Chevallier, C., Kohls, G., Troiani, V., Brodkin, E. S. &amp; Schultz, R. T. The social motivation theory of autism. Trends Cogn. Sci. 16, 231&#x2013;239 (2012).</Citation><ArticleIdList><ArticleId IdType="pubmed">22425667</ArticleId><ArticleId IdType="doi">10.1016/j.tics.2012.02.007</ArticleId><ArticleId IdType="pmc">3329932</ArticleId></ArticleIdList></Reference><Reference><Citation>Livingston, J. D. &amp; Boyd, J. E. Correlates and consequences of internalized stigma for people living with mental illness: a systematic review and meta-analysis. Soc. Sci. Med. 71, 2150&#x2013;2161 (2010).</Citation><ArticleIdList><ArticleId IdType="pubmed">21051128</ArticleId><ArticleId IdType="doi">10.1016/j.socscimed.2010.09.030</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen, W. G., Mohs, R. C. &amp; Davis, K. L. A new rating scale for Alzheimer&#x2019;s disease. Am. J. Psychiatry 141, 1356&#x2013;1364 (1984).</Citation><ArticleIdList><ArticleId IdType="pubmed">6496779</ArticleId><ArticleId IdType="doi">10.1176/ajp.141.11.1356</ArticleId></ArticleIdList></Reference><Reference><Citation>Pitkala, K. H., Routasalo, P., Kautiainen, H., Sintonen, H. &amp; Tilvis, R. S. Effects of socially stimulating group intervention on lonely, older people&#x2019;s cognition: a randomized, controlled trial. Am. J. Geriatr. Psychiatry 19, 654&#x2013;663 (2011).</Citation><ArticleIdList><ArticleId IdType="pubmed">21709611</ArticleId><ArticleId IdType="doi">10.1097/JGP.0b013e3181f7d8b0</ArticleId></ArticleIdList></Reference><Reference><Citation>Mortimer, J. A. et al. Changes in brain volume and cognition in a randomized trial of exercise and social interaction in a community-based sample of non-demented Chinese elders. J. Alzheimer&#x2019;s Dis. 30, 757&#x2013;766 (2012).</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-2012-120079</ArticleId></ArticleIdList></Reference><Reference><Citation>Park, D. C. et al. The impact of sustained engagement on cognitive function in older adults: the Synapse Project. Psychological Sci. 25, 103&#x2013;112 (2014).</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0956797613499592</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Rourke, H. M., Collins, L. &amp; Sidani, S. Interventions to address social connectedness and loneliness for older adults: a scoping review. BMC Geriatr. 18, 214 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">30219034</ArticleId><ArticleId IdType="doi">10.1186/s12877-018-0897-x</ArticleId><ArticleId IdType="pmc">6139173</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen-Mansfield, J. &amp; Perach, R. Interventions for alleviating loneliness among older persons: a critical review. Am. J. Health Promot. 29, e109&#x2013;e125 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">24575725</ArticleId><ArticleId IdType="doi">10.4278/ajhp.130418-LIT-182</ArticleId></ArticleIdList></Reference><Reference><Citation>Hafdi, M., Hoevenaar-Blom, M. P. &amp; Richard, E. Multi&#x2010;domain interventions for the prevention of dementia and cognitive decline. Cochrane Database Syst. Rev. 11, CD013572 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34748207</ArticleId></ArticleIdList></Reference><Reference><Citation>Ngandu, T. et al. A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial. Lancet 385, 2255&#x2013;2263 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">25771249</ArticleId><ArticleId IdType="doi">10.1016/S0140-6736(15)60461-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee, K. S. et al. Effects of a multidomain lifestyle modification on cognitive function in older adults: an eighteen-month community-based cluster randomized controlled trial. Psychother. Psychosom. 83, 270&#x2013;278 (2014).</Citation><ArticleIdList><ArticleId IdType="pubmed">25116574</ArticleId><ArticleId IdType="doi">10.1159/000360820</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenberg, A. et al. Multidomain lifestyle intervention benefits a large elderly population at risk for cognitive decline and dementia regardless of baseline characteristics: the FINGER trial. Alzheimer&#x2019;s Dement. 14, 263&#x2013;270 (2018).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2017.09.006</ArticleId></ArticleIdList></Reference><Reference><Citation>Park, H. K. et al. South Korean study to prevent cognitive impairment and protect brain health through lifestyle intervention in at-risk elderly people: protocol of a multicenter, randomized controlled feasibility trial. J. Clin. Neurol. 16, 292&#x2013;303 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32319247</ArticleId><ArticleId IdType="doi">10.3988/jcn.2020.16.2.292</ArticleId><ArticleId IdType="pmc">7174118</ArticleId></ArticleIdList></Reference><Reference><Citation>Moon, S. Y. et al. Facility-based and home-based multidomain interventions including cognitive training, exercise, diet, vascular risk management, and motivation for older adults: a randomized controlled feasibility trial. Aging 13, 15898&#x2013;15916 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34148030</ArticleId><ArticleId IdType="doi">10.18632/aging.203213</ArticleId><ArticleId IdType="pmc">8266338</ArticleId></ArticleIdList></Reference><Reference><Citation>Moon, S. Y. et al. Impact of a multidomain lifestyle intervention on regional spontaneous brain activity. Front. Aging Neurosci. 14, 926077 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35966769</ArticleId><ArticleId IdType="doi">10.3389/fnagi.2022.926077</ArticleId><ArticleId IdType="pmc">9366741</ArticleId></ArticleIdList></Reference><Reference><Citation>Z&#xfc;lke, A. et al. AgeWell.de&#x2014;study protocol of a pragmatic multi-center cluster-randomized controlled prevention trial against cognitive decline in older primary care patients. BMC Geriatr. 19, 203 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">31370792</ArticleId><ArticleId IdType="doi">10.1186/s12877-019-1212-1</ArticleId><ArticleId IdType="pmc">6670136</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang, Y. et al. MIND China (China) World&#x2010;wide FINGERS network: the first global network of multidomain dementia prevention trials. Alzheimer&#x2019;s Dement. 16, e046957 (2020).</Citation></Reference><Reference><Citation>Baker, L. D. et al. US POINTER (USA) World&#x2010;wide FINGERS network: the first global network of multidomain dementia prevention trials. Alzheimer&#x2019;s Dement. 16, e046951 (2020).</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alz.046951</ArticleId></ArticleIdList></Reference><Reference><Citation>Ingram, J., Hand, C. J. &amp; Maciejewski, G. Social isolation during COVID&#x2010;19 lockdown impairs cognitive function. Appl. Cogn. Psychol. 35, 935&#x2013;947 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34230768</ArticleId><ArticleId IdType="doi">10.1002/acp.3821</ArticleId><ArticleId IdType="pmc">8250848</ArticleId></ArticleIdList></Reference><Reference><Citation>Menze, I., Mueller, P., Mueller, N. G. &amp; Schmicker, M. Age-related cognitive effects of the COVID-19 pandemic restrictions and associated mental health changes in Germans. Sci. Rep. 12, 8172 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35581297</ArticleId><ArticleId IdType="doi">10.1038/s41598-022-11283-9</ArticleId><ArticleId IdType="pmc">9112263</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen, F., Min, C., Lu, Y. &amp; Chu, Y. The effect of cognition and affect on preventive behaviors during the COVID-19 pandemic: a cross-sectional study in China. BMC Public Health 21, 722 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33853555</ArticleId><ArticleId IdType="doi">10.1186/s12889-021-10784-y</ArticleId><ArticleId IdType="pmc">8045573</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu, E., Xie, Y. &amp; Al-Aly, Z. Long-term neurologic outcomes of COVID-19. Nat. Med. 28, 2406&#x2013;2415 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">36138154</ArticleId><ArticleId IdType="doi">10.1038/s41591-022-02001-z</ArticleId><ArticleId IdType="pmc">9671811</ArticleId></ArticleIdList></Reference><Reference><Citation>Karr, J. E., Graham, R. B., Hofer, S. M. &amp; Muniz-Terrera, G. When does cognitive decline begin? A systematic review of change point studies on accelerated decline in cognitive and neurological outcomes preceding mild cognitive impairment, dementia, and death. Psychol. Aging 33, 195&#x2013;218 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">29658744</ArticleId><ArticleId IdType="doi">10.1037/pag0000236</ArticleId><ArticleId IdType="pmc">5906105</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu, J. C., Hl&#xe1;vka, J. P., Joe, E., Richmond, F. J. &amp; Lakdawalla, D. N. Impact of non&#x2010;binding FDA guidances on primary endpoint selection in Alzheimer&#x2019;s disease trials. Alzheimer&#x2019;s Dement. 8, e12280 (2022).</Citation></Reference><Reference><Citation>AGE Platform Europe. The Right to Adequate Housing of Older Persons; Age Platform Europe Contribution (2022).</Citation></Reference><Reference><Citation>World Health Organization. Global Age-Friendly Cities: A Guide (World Health Organization, 2007).</Citation></Reference><Reference><Citation>Holt-Lunstad, J., Smith, T. B. &amp; Layton, J. B. Social relationships and mortality risk: a meta-analytic review. PLoS Med. 7, e1000316 (2010).</Citation><ArticleIdList><ArticleId IdType="pubmed">20668659</ArticleId><ArticleId IdType="doi">10.1371/journal.pmed.1000316</ArticleId><ArticleId IdType="pmc">2910600</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. Optimizing Brain Health Across the Life Course: WHO Position Paper (2022).</Citation></Reference><Reference><Citation>National Academies of Sciences, E. &amp; Medicine. Evidence-Based Practice for Public Health Emergency Preparedness and Response (National Academies Press, 2020).</Citation></Reference><Reference><Citation>R&#xf6;hr, S. et al. Social factors and the prevalence of social isolation in a population-based adult cohort. Soc. Psychiatry Psychiatr. Epidemiol 57, 1959&#x2013;1968 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34533607</ArticleId><ArticleId IdType="doi">10.1007/s00127-021-02174-x</ArticleId><ArticleId IdType="pmc">8445781</ArticleId></ArticleIdList></Reference><Reference><Citation>Valenzuela, M. J. &amp; Sachdev, P. Brain reserve and dementia: a systematic review. Psychol. Med. 36, 441&#x2013;454 (2006).</Citation><ArticleIdList><ArticleId IdType="pubmed">16207391</ArticleId><ArticleId IdType="doi">10.1017/S0033291705006264</ArticleId></ArticleIdList></Reference><Reference><Citation>Berkman, L. F., Glass, T., Brissette, I. &amp; Seeman, T. E. From social integration to health: Durkheim in the new millennium. Soc. Sci. Med. 51, 843&#x2013;857 (2000).</Citation><ArticleIdList><ArticleId IdType="pubmed">10972429</ArticleId><ArticleId IdType="doi">10.1016/S0277-9536(00)00065-4</ArticleId></ArticleIdList></Reference><Reference><Citation>Leedahl, S. N., Sellon, A. &amp; Chapin, R. K. Assessment of multiple constructs of social integration for older adults living in nursing homes. J. Gerontol. Soc. Work 61, 526&#x2013;548 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">29543577</ArticleId><ArticleId IdType="doi">10.1080/01634372.2018.1451938</ArticleId></ArticleIdList></Reference><Reference><Citation>Zavaleta, D., Samuel, K. &amp; Mills, C. Social Isolation: A Conceptual and Measurement Proposal. OPHI Working Papers 67. Report no. 1907194541 (2014).</Citation></Reference><Reference><Citation>Perlman, D. &amp; Peplau, L. A. in Preventing the Harmful Consequences of Severe and Persistent Loneliness vol. 13 (eds. L. A. Peplau &amp; S. Goldston) 13&#x2013;46 (US Government Printing Office, 1984).</Citation></Reference><Reference><Citation>Stringhini, S. et al. Socioeconomic status, structural and functional measures of social support, and mortality: The British Whitehall II Cohort Study, 1985&#x2013;2009. Am. J. Epidemiol. 175, 1275&#x2013;1283 (2012).</Citation><ArticleIdList><ArticleId IdType="pubmed">22534202</ArticleId><ArticleId IdType="doi">10.1093/aje/kwr461</ArticleId><ArticleId IdType="pmc">3372313</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37202512</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>22</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>30</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2662-8465</ISSN><JournalIssue CitedMedium="Internet"><Volume>3</Volume><Issue>5</Issue><PubDate><Year>2023</Year><Month>May</Month></PubDate></JournalIssue><Title>Nature aging</Title><ISOAbbreviation>Nat Aging</ISOAbbreviation></Journal><ArticleTitle>A WHO blueprint for action to reshape dementia research.</ArticleTitle><Pagination><StartPage>469</StartPage><EndPage>471</EndPage><MedlinePgn>469-471</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s43587-023-00381-6</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cataldi</LastName><ForeName>Rodrigo</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Brain Health Unit, Department of Mental Health and Substance Use, World Health Organization, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sachdev</LastName><ForeName>Perminder S</ForeName><Initials>PS</Initials><Identifier Source="ORCID">0000-0002-9595-3220</Identifier><AffiliationInfo><Affiliation>Centre for Healthy Brain Ageing, University of New South Wales, Sydney, New South Wales, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chowdhary</LastName><ForeName>Neerja</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Brain Health Unit, Department of Mental Health and Substance Use, World Health Organization, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seeher</LastName><ForeName>Katrin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Brain Health Unit, Department of Mental Health and Substance Use, World Health Organization, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bentvelzen</LastName><ForeName>Adam</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Centre for Healthy Brain Ageing, University of New South Wales, Sydney, New South Wales, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moorthy</LastName><ForeName>Vasee</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Science Division, World Health Organization, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dua</LastName><ForeName>Tarun</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-4269-7657</Identifier><AffiliationInfo><Affiliation>Brain Health Unit, Department of Mental Health and Substance Use, World Health Organization, Geneva, Switzerland. duat@who.int.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>001</GrantID><Acronym>WHO_</Acronym><Agency>World Health Organization</Agency><Country>International</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Nat Aging</MedlineTA><NlmUniqueID>101773306</NlmUniqueID><ISSNLinking>2662-8465</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003704" MajorTopicYN="Y">Dementia</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014944" MajorTopicYN="N">World Health Organization</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>22</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>19</Day><Hour>1</Hour><Minute>5</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>18</Day><Hour>23</Hour><Minute>21</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37202512</ArticleId><ArticleId IdType="doi">10.1038/s43587-023-00381-6</ArticleId><ArticleId IdType="pii">10.1038/s43587-023-00381-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>WHO. Global Status Report on the Public Health Response to Dementia (WHO, 2021).</Citation></Reference><Reference><Citation>RDD/10495. G8 dementia summit declaration. gov.uk, https://www.gov.uk/government/publications/g8-dementia-summit-agreements/g8-dementia-summit-declaration (11 December 2013).</Citation></Reference><Reference><Citation>WHO. Global Action Plan on the Public Health Response to Dementia 2017&#x2013;2025 (WHO, 2017).</Citation></Reference><Reference><Citation>G20 Okayama Health Ministers&#x2019; meeting. Okayama Declarations of the G20 Health Ministers 19&#x2013;20 October 2019. mhlw.go.jp, https://www.mhlw.go.jp/seisakunitsuite/bunya/hokabunya/kokusai/g20/health/jp/img/G20Okayama_HM_EN.pdf (accessed 21 November 2022).</Citation></Reference><Reference><Citation>Wright, T. &amp; O&#x2019;Connor, S. J. Public Ment. Health 17, 157&#x2013;167 (2018).</Citation><ArticleIdList><ArticleId IdType="doi">10.1108/JPMH-02-2018-0012</ArticleId><ArticleId IdType="pubmed">30581491</ArticleId><ArticleId IdType="pmc">6290892</ArticleId></ArticleIdList></Reference><Reference><Citation>Gauthier, S. et al. World Alzheimer Report 2022: Life After Diagnosis: Navigating Treatment, Care And Support (Alzheimer&#x2019;s Disease International, 2022).</Citation></Reference><Reference><Citation>WHO. A Blueprint for Dementia Research (WHO, 2022).</Citation></Reference><Reference><Citation>WHO. Global observatory on health research and development. who.int, https://www.who.int/observatories/global-observatory-on-health-research-and-development (accessed 21 November 2022).</Citation></Reference><Reference><Citation>Tenopir, C. et al. PLoS ONE 6, e21101 (2011).</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0021101</ArticleId><ArticleId IdType="pubmed">21738610</ArticleId><ArticleId IdType="pmc">3126798</ArticleId></ArticleIdList></Reference><Reference><Citation>Andreou, M. et al. AMRC Open Res. 4, 18 (2022).</Citation><ArticleIdList><ArticleId IdType="doi">10.12688/amrcopenres.13072.1</ArticleId></ArticleIdList></Reference><Reference><Citation>The Lancet Digital Health. Lancet Digit. Health 3, e684 (2021).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2589-7500(21)00238-7</ArticleId><ArticleId IdType="pubmed">34711372</ArticleId></ArticleIdList></Reference><Reference><Citation>ITU. Measuring Digital Development: Facts and Figures 2021 (ITU, 2021).</Citation></Reference><Reference><Citation>Anstey, K. J., Ee, N., Eramudugolla, R., Jagger, C. &amp; Peters, R. J. Alzheimers Dis. 70, S165&#x2013;S186 (2019).</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-190181</ArticleId><ArticleId IdType="pubmed">31306123</ArticleId><ArticleId IdType="pmc">6700718</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37202511</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>22</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>30</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2662-8465</ISSN><JournalIssue CitedMedium="Internet"><Volume>3</Volume><Issue>5</Issue><PubDate><Year>2023</Year><Month>May</Month></PubDate></JournalIssue><Title>Nature aging</Title><ISOAbbreviation>Nat Aging</ISOAbbreviation></Journal><ArticleTitle>Sex and gender considerations in dementia: a call for global research.</ArticleTitle><Pagination><StartPage>463</StartPage><EndPage>465</EndPage><MedlinePgn>463-465</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s43587-023-00374-5</ELocationID><Abstract><AbstractText>Studies have identified sex and/or gender differences in Alzheimer&#x2019;s disease, but few have examined other dementias. We highlight sex and gender differences in other dementias, discuss sociocultural factors and provide a framework for future global studies.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Vila-Castelar</LastName><ForeName>Clara</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Udeh-Momoh</LastName><ForeName>Chinedu</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Ageing Epidemiology (AGE) Research Unit, School of Public Health, Imperial College London, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurobiology, Care Sciences and Society (NVS), Division of Clinical Geriatrics, Karolinska Institute, Stockholm, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Global Brain Health Institute (GBHI), University of California, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aggarwal</LastName><ForeName>Neelum T</ForeName><Initials>NT</Initials><AffiliationInfo><Affiliation>Department of Neurological Sciences, Rush University Medical Center, Chicago, IL, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, IL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mielke</LastName><ForeName>Michelle M</ForeName><Initials>MM</Initials><Identifier Source="ORCID">0000-0001-7177-1185</Identifier><AffiliationInfo><Affiliation>Department of Epidemiology and Prevention, Wake Forest University School of Medicine, Winston-Salem, NC, USA. mmielke@wakehealth.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>RF1 AG079397</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K99 AG073452</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U54 AG044170</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P50 AG044170</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>RF1 AG055151</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AG072947</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>RF1 AG077386</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Nat Aging</MedlineTA><NlmUniqueID>101773306</NlmUniqueID><ISSNLinking>2662-8465</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005783" MajorTopicYN="N">Gender Identity</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>Competing interests. M.M.M. has served on scientific advisory boards and/or has consulted for Biogen, LabCorp, Lilly, Merck, PeerView Institute, Siemens Healthineers, and Sunbird Bio unrelated to the current manuscript. The other authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>22</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>19</Day><Hour>1</Hour><Minute>4</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>18</Day><Hour>23</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>11</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37202511</ArticleId><ArticleId IdType="mid">NIHMS1912947</ArticleId><ArticleId IdType="pmc">PMC10331726</ArticleId><ArticleId IdType="doi">10.1038/s43587-023-00374-5</ArticleId><ArticleId IdType="pii">10.1038/s43587-023-00374-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Mielke MM et al. Alzheimers Dement. 18, 2707&#x2013;2724 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9547039</ArticleId><ArticleId IdType="pubmed">35394117</ArticleId></ArticleIdList></Reference><Reference><Citation>Udeh-Momoh C &amp; Watermeyer T. Ageing Res. Rev 71, 101459 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34508876</ArticleId></ArticleIdList></Reference><Reference><Citation>Kane JPM et al. Alzheimers Res. Ther 10, 19 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Jurado-Coronel JC et al. Front. Neuroendocrinol 50, 18&#x2013;30 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">28974386</ArticleId></ArticleIdList></Reference><Reference><Citation>Pengo M. et al. Neurol. Sci 43, 5281&#x2013;5287 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9385756</ArticleId><ArticleId IdType="pubmed">35672480</ArticleId></ArticleIdList></Reference><Reference><Citation>Ill&#xe1;n-Gala I. et al. Alzheimers Dement. 17, 1329&#x2013;1341 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8364861</ArticleId><ArticleId IdType="pubmed">33590953</ArticleId></ArticleIdList></Reference><Reference><Citation>Curtis AF et al. Neurology 89, 1633&#x2013;1642 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5634668</ArticleId><ArticleId IdType="pubmed">28916533</ArticleId></ArticleIdList></Reference><Reference><Citation>de Boer SCM et al. J. Alzheimers Dis 84, 1153&#x2013;1161 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Gannon O, Robison L, Custozzo A &amp; Zuloaga K Neurochem. Internatl 127, 38&#x2013;55 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">30471324</ArticleId></ArticleIdList></Reference><Reference><Citation>Huo N. et al. Neurology 98, e623&#x2013;e632 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8829960</ArticleId><ArticleId IdType="pubmed">34987078</ArticleId></ArticleIdList></Reference><Reference><Citation>Mayeda ER Am. J. Epidemiol 188, 1224&#x2013;1227 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6601521</ArticleId><ArticleId IdType="pubmed">30824902</ArticleId></ArticleIdList></Reference><Reference><Citation>Barnes LL, Lamar M &amp; Schneider JA Brain Res. 1719, 11&#x2013;16 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6636678</ArticleId><ArticleId IdType="pubmed">31128096</ArticleId></ArticleIdList></Reference><Reference><Citation>Liesinger AM et al. Acta Neuropathol. 136, 873&#x2013;885 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6280837</ArticleId><ArticleId IdType="pubmed">30219939</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramaniapillai S. et al. Front. Neuroendocrinol 60, 100879 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33137359</ArticleId></ArticleIdList></Reference><Reference><Citation>Huque H. et al. J. Alzheimers Dis 10.3233/JAD-220724 (2022).</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-220724</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37202520</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>22</Day></DateCompleted><DateRevised><Year>2023</Year><Month>06</Month><Day>26</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2662-8465</ISSN><JournalIssue CitedMedium="Internet"><Volume>3</Volume><Issue>5</Issue><PubDate><Year>2023</Year><Month>May</Month></PubDate></JournalIssue><Title>Nature aging</Title><ISOAbbreviation>Nat Aging</ISOAbbreviation></Journal><ArticleTitle>Equity across the life course matters for brain health.</ArticleTitle><Pagination><StartPage>466</StartPage><EndPage>468</EndPage><MedlinePgn>466-468</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s43587-023-00413-1</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lock</LastName><ForeName>Sarah Lenz</ForeName><Initials>SL</Initials><Identifier Source="ORCID">0009-0002-2876-6705</Identifier><AffiliationInfo><Affiliation>The Global Council on Brain Health, . Slock@aarp.org.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>AARP, . Slock@aarp.org.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chura</LastName><ForeName>Lindsay R</ForeName><Initials>LR</Initials><AffiliationInfo><Affiliation>The Global Council on Brain Health, . LChura@aarp.org.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>AARP, . LChura@aarp.org.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dilworth-Anderson</LastName><ForeName>Peggye</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>The Global Council on Brain Health.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peterson</LastName><ForeName>Jonathan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Getter Peterson Consulting Group.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Nat Aging</MedlineTA><NlmUniqueID>101773306</NlmUniqueID><ISSNLinking>2662-8465</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000069576" MajorTopicYN="Y">Health Equity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006257" MajorTopicYN="N">Head</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>22</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>19</Day><Hour>1</Hour><Minute>4</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>18</Day><Hour>23</Hour><Minute>21</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37202520</ArticleId><ArticleId IdType="doi">10.1038/s43587-023-00413-1</ArticleId><ArticleId IdType="pii">10.1038/s43587-023-00413-1</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Global Council on Brain Health. How to Sustain Brain Healthy Behaviors: Applying Lessons of Public Health and Science to Drive Change (GCBH, 2022).</Citation></Reference><Reference><Citation>Dilworth-Anderson, P. &amp; Moon, H. Generations Today 42, 1 (2021).</Citation></Reference><Reference><Citation>Global Council on Brain Health. Engage Your Brain: GCBH Recommendations on Cognitively Stimulating Activities (GCBH, 2017).</Citation></Reference><Reference><Citation>Livingston, G. et al. Lancet 396, 413&#x2013;446 (2020).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30367-6</ArticleId><ArticleId IdType="pubmed">32738937</ArticleId><ArticleId IdType="pmc">7392084</ArticleId></ArticleIdList></Reference><Reference><Citation>Global Council on Brain Health. Choose brain-healthy habits. aarp.org, https://www.aarp.org/content/dam/aarp/health/brain_health/2022-09/gcbh-behavior-change-infographic-english.doi.10.26419-2Fpia.00106.008.pdf (accessed 28 March 2023).</Citation></Reference><Reference><Citation>Mahoney, D. F., Cloutterbuck, J., Neary, S. &amp; Zhan, L. Gerontologist 45, 783&#x2013;792 (2005).</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geront/45.6.783</ArticleId><ArticleId IdType="pubmed">16326660</ArticleId></ArticleIdList></Reference><Reference><Citation>Cipriani, G. &amp; Borin, G. Int. J. Soc. Psychiatry 61, 198&#x2013;204 (2015).</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0020764014560357</ArticleId><ArticleId IdType="pubmed">25431401</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee, S., Kim, D. &amp; Lee, H. Int. J. Environ. Res. Public Health 19, 8865 (2022).</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph19148865</ArticleId><ArticleId IdType="pubmed">35886711</ArticleId><ArticleId IdType="pmc">9321249</ArticleId></ArticleIdList></Reference><Reference><Citation>Centers for Disease Control and Prevention. Healthy aging &amp; the built environment. cdc.gov, https://www.cdc.gov/healthyplaces/healthtopics/healthyaging.htm (accessed 3 March 2023).</Citation></Reference><Reference><Citation>Centers for Disease Control and Prevention. Built environment: NCCDPHP&#x2019;s program successes. cdc.gov, https://www.cdc.gov/chronicdisease/healthequity/sdoh-and-chronic-disease/nccdphp-and-social-determinants-of-health/built-environment.htm (accessed 3 March 2023).</Citation></Reference><Reference><Citation>World Health Organization. Social determinants of health. who.int, https://www.who.int/health-topics/social-determinants-of-health#tab=tab_1 (accessed 3 March 2023).</Citation></Reference><Reference><Citation>Wouters, O. J. et al. Lancet 397, 1023&#x2013;1034 (2021).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)00306-8</ArticleId><ArticleId IdType="pubmed">33587887</ArticleId><ArticleId IdType="pmc">7906643</ArticleId></ArticleIdList></Reference><Reference><Citation>Aranda, M. P. et al. J. Am. Geriatr. Soc. 69, 1774&#x2013;1783 (2021).</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jgs.17345</ArticleId><ArticleId IdType="pubmed">34245588</ArticleId><ArticleId IdType="pmc">8608182</ArticleId></ArticleIdList></Reference><Reference><Citation>Global Council on Brain Health. Resource library. aarp.org, https://www.aarp.org/health/brain-health/global-council-on-brain-health/resource-library/ (accessed 4 March 2023).</Citation></Reference><Reference><Citation>US Department of Health and Human Services. National plan to address Alzheimer&#x2019;s disease. A 2021 update. aspe.hhs.gov, https://aspe.hhs.gov/reports/national-plan-2021-update (2021).</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37231161</PMID><DateCompleted><Year>2023</Year><Month>07</Month><Day>17</Day></DateCompleted><DateRevised><Year>2025</Year><Month>04</Month><Day>22</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1476-4679</ISSN><JournalIssue CitedMedium="Internet"><Volume>25</Volume><Issue>7</Issue><PubDate><Year>2023</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Nature cell biology</Title><ISOAbbreviation>Nat Cell Biol</ISOAbbreviation></Journal><ArticleTitle>Autophagy enables microglia to engage amyloid plaques and prevents microglial senescence.</ArticleTitle><Pagination><StartPage>963</StartPage><EndPage>974</EndPage><MedlinePgn>963-974</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41556-023-01158-0</ELocationID><Abstract><AbstractText>Dysfunctional autophagy has been implicated in the pathogenesis of Alzheimer's disease (AD). Previous evidence suggested disruptions of multiple stages of the autophagy-lysosomal pathway in affected neurons. However, whether and how deregulated autophagy in microglia, a cell type with an important link to AD, contributes to AD progression remains elusive. Here we report that autophagy is activated in microglia, particularly of disease-associated microglia surrounding amyloid plaques in AD mouse models. Inhibition of microglial autophagy causes disengagement of microglia from amyloid plaques, suppression of disease-associated microglia, and aggravation of neuropathology in AD mice. Mechanistically, autophagy deficiency promotes senescence-associated microglia as evidenced by reduced proliferation, increased Cdkn1a/p21<sup>Cip1</sup>, dystrophic morphologies and senescence-associated secretory phenotype. Pharmacological treatment removes autophagy-deficient senescent microglia and alleviates neuropathology in AD mice. Our study demonstrates the protective role of microglial autophagy in regulating the homeostasis of amyloid plaques and preventing senescence; removal of senescent microglia is a promising therapeutic strategy.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s), under exclusive licence to Springer Nature Limited.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Choi</LastName><ForeName>Insup</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Neurology and Neuroscience, Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Minghui</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-9171-4962</Identifier><AffiliationInfo><Affiliation>Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Mount Sinai Center for Transformative Disease Modeling, Icahn School of Medicine at Mount Sinai, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yoo</LastName><ForeName>Seungyeul</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Sema4, Stamford, CT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Peng</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Mount Sinai Center for Transformative Disease Modeling, Icahn School of Medicine at Mount Sinai, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seegobin</LastName><ForeName>Steven P</ForeName><Initials>SP</Initials><Identifier Source="ORCID">0000-0002-4514-9293</Identifier><AffiliationInfo><Affiliation>Department of Neurology and Neuroscience, Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Xianting</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Neurology and Neuroscience, Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Han</LastName><ForeName>Xian</ForeName><Initials>X</Initials><Identifier Source="ORCID">0000-0002-3802-6420</Identifier><AffiliationInfo><Affiliation>Departments of Structural Biology and Developmental Neurobiology, Saint Jude Children's Research Hospital, Memphis, TN, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Integrated Biomedical Sciences Program, University of Tennessee Health Science Center, Memphis, TN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Qian</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Mount Sinai Center for Transformative Disease Modeling, Icahn School of Medicine at Mount Sinai, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peng</LastName><ForeName>Junmin</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-0472-7648</Identifier><AffiliationInfo><Affiliation>Departments of Structural Biology and Developmental Neurobiology, Saint Jude Children's Research Hospital, Memphis, TN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Bin</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Mount Sinai Center for Transformative Disease Modeling, Icahn School of Medicine at Mount Sinai, New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yue</LastName><ForeName>Zhenyu</ForeName><Initials>Z</Initials><Identifier Source="ORCID">0000-0001-8730-8515</Identifier><AffiliationInfo><Affiliation>Department of Neurology and Neuroscience, Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA. zhenyu.yue@mssm.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>RF1 AG068581</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K01 AG078442</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AG066514</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS060123</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG072520</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 AG046170</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG057907</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>05</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nat Cell Biol</MedlineTA><NlmUniqueID>100890575</NlmUniqueID><ISSNLinking>1465-7392</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017628" MajorTopicYN="Y">Microglia</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058225" MajorTopicYN="N">Plaque, Amyloid</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001343" MajorTopicYN="N">Autophagy</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009474" MajorTopicYN="N">Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>Competing interests. S.Y. is an employee of Sema4, a for-profit organization that promotes personalized patient care through information-driven insights. All other authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>4</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>4</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>7</Month><Day>17</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>26</Day><Hour>1</Hour><Minute>5</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>25</Day><Hour>23</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>3</Month><Day>19</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37231161</ArticleId><ArticleId IdType="mid">NIHMS1967634</ArticleId><ArticleId IdType="pmc">PMC10950302</ArticleId><ArticleId IdType="doi">10.1038/s41556-023-01158-0</ArticleId><ArticleId IdType="pii">10.1038/s41556-023-01158-0</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Yamamoto A &amp; Yue Z Autophagy and its normal and pathogenic states in the brain. Annu. Rev. Neurosci. 37, 55&#x2013;78 (2014).</Citation><ArticleIdList><ArticleId IdType="pubmed">24821313</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Acker ZP, Bretou M &amp; Annaert W Endo-lysosomal dysregulations and late-onset Alzheimer&#x2019;s disease: impact of genetic risk factors. Mol. Neurodegener. 14, 20 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6547588</ArticleId><ArticleId IdType="pubmed">31159836</ArticleId></ArticleIdList></Reference><Reference><Citation>Pickford F et al. The autophagy-related protein beclin 1 shows reduced expression in early Alzheimer disease and regulates amyloid &#x3b2; accumulation in mice. J. Clin. Invest. 118, 2190&#x2013;2199 (2008).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2391284</ArticleId><ArticleId IdType="pubmed">18497889</ArticleId></ArticleIdList></Reference><Reference><Citation>Lachance V et al. Autophagy protein NRBF2 has reduced expression in Alzheimer&#x2019;s brains and modulates memory and amyloid-&#x3b2; homeostasis in mice. Mol. Neurodegener. 14, 43 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6882183</ArticleId><ArticleId IdType="pubmed">31775806</ArticleId></ArticleIdList></Reference><Reference><Citation>Nixon RA et al. Extensive involvement of autophagy in Alzheimer disease: an immuno-electron microscopy study. J. Neuropathol. Exp. Neurol. 64, 113&#x2013;122 (2005).</Citation><ArticleIdList><ArticleId IdType="pubmed">15751225</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee JH et al. Faulty autolysosome acidification in Alzheimer&#x2019;s disease mouse models induces autophagic build-up of A&#x3b2; in neurons, yielding senile plaques. Nat. Neurosci. 25, 688&#x2013;701 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9174056</ArticleId><ArticleId IdType="pubmed">35654956</ArticleId></ArticleIdList></Reference><Reference><Citation>Tammineni P, Ye X, Feng T, Aikal D &amp; Cai Q Impaired retrograde transport of axonal autophagosomes contributes to autophagic stress in Alzheimer&#x2019;s disease neurons. eLife 6, e21776 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5235353</ArticleId><ArticleId IdType="pubmed">28085665</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Y, Propson NE, Du S, Xiong W &amp; Zheng H Autophagy deficiency modulates microglial lipid homeostasis and aggravates tau pathology and spreading. Proc. Natl Acad. Sci. USA 118, e2023418118 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8271658</ArticleId><ArticleId IdType="pubmed">34187889</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi I et al. Microglia clear neuron-released alpha-synuclein via selective autophagy and prevent neurodegeneration. Nat. Commun. 11, 1386 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7069981</ArticleId><ArticleId IdType="pubmed">32170061</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho MH et al. Autophagy in microglia degrades extracellular beta-amyloid fibrils and regulates the NLRP3 inflammasome. Autophagy 10, 1761&#x2013;1775 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4198361</ArticleId><ArticleId IdType="pubmed">25126727</ArticleId></ArticleIdList></Reference><Reference><Citation>Ulland TK et al. TREM2 maintains microglial metabolic fitness in Alzheimer&#x2019;s disease. Cell 170, 649&#x2013;663 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5573224</ArticleId><ArticleId IdType="pubmed">28802038</ArticleId></ArticleIdList></Reference><Reference><Citation>Heckmann BL et al. LC3-associated endocytosis facilitates beta-amyloid clearance and mitigates neurodegeneration in murine alzheimer&#x2019;s disease. Cell 178, 536&#x2013;551 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6689199</ArticleId><ArticleId IdType="pubmed">31257024</ArticleId></ArticleIdList></Reference><Reference><Citation>Berglund R et al. Microglial autophagy-associated phagocytosis is essential for recovery from neuroinflammation. Sci. Immunol. 5, eabb5077 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">33067381</ArticleId></ArticleIdList></Reference><Reference><Citation>Srinivasan K et al. Alzheimer&#x2019;s patient microglia exhibit enhanced aging and unique transcriptional activation. Cell Rep. 31, 107843 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7422733</ArticleId><ArticleId IdType="pubmed">32610143</ArticleId></ArticleIdList></Reference><Reference><Citation>Olah M et al. Single cell RNA sequencing of human microglia uncovers a subset associated with Alzheimer&#x2019;s disease. Nat. Commun. 11, 6129 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7704703</ArticleId><ArticleId IdType="pubmed">33257666</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerrits E et al. Distinct amyloid-beta and tau-associated microglia profiles in Alzheimer&#x2019;s disease. Acta Neuropathol. 141, 681&#x2013;696 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8043951</ArticleId><ArticleId IdType="pubmed">33609158</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen AT et al. APOE and TREM2 regulate amyloid-responsive microglia in Alzheimer&#x2019;s disease. Acta Neuropathol. 140, 477&#x2013;493 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7520051</ArticleId><ArticleId IdType="pubmed">32840654</ArticleId></ArticleIdList></Reference><Reference><Citation>Sobue A et al. Microglial gene signature reveals loss of homeostatic microglia associated with neurodegeneration of Alzheimer&#x2019;s disease. Acta Neuropathol. Commun. 9, 1 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7786928</ArticleId><ArticleId IdType="pubmed">33402227</ArticleId></ArticleIdList></Reference><Reference><Citation>Krasemann S et al. The TREM2-APOE pathway drives the transcriptional phenotype of dysfunctional microglia in neurodegenerative diseases. Immunity 47, 566&#x2013;581 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5719893</ArticleId><ArticleId IdType="pubmed">28930663</ArticleId></ArticleIdList></Reference><Reference><Citation>Keren-Shaul H et al. A Unique microglia type associated with restricting development of alzheimer&#x2019;s disease. Cell 169, 1276&#x2013;1290 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28602351</ArticleId></ArticleIdList></Reference><Reference><Citation>Oakley H et al. Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer&#x2019;s disease mutations: potential factors in amyloid plaque formation. J. Neurosci. 26, 10129&#x2013;10140 (2006).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6674618</ArticleId><ArticleId IdType="pubmed">17021169</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J, Kundu M, Viollet B &amp; Guan KL AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat. Cell Biol. 13, 132&#x2013;141 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3987946</ArticleId><ArticleId IdType="pubmed">21258367</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizushima N, Yamamoto A, Matsui M, Yoshimori T &amp; Ohsumi Y In vivo analysis of autophagy in response to nutrient starvation using transgenic mice expressing a fluorescent autophagosome marker. Mol. Biol. Cell 15, 1101&#x2013;1111 (2004).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC363084</ArticleId><ArticleId IdType="pubmed">14699058</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizushima N et al. A protein conjugation system essential for autophagy. Nature 395, 395&#x2013;398 (1998).</Citation><ArticleIdList><ArticleId IdType="pubmed">9759731</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan P et al. TREM2 haplodeficiency in mice and humans impairs the microglia barrier function leading to decreased amyloid compaction and severe axonal dystrophy. Neuron 90, 724&#x2013;739 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4898967</ArticleId><ArticleId IdType="pubmed">27196974</ArticleId></ArticleIdList></Reference><Reference><Citation>Spangenberg E et al. Sustained microglial depletion with CSF1R inhibitor impairs parenchymal plaque development in an Alzheimer&#x2019;s disease model. Nat. Commun. 10, 3758 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6704256</ArticleId><ArticleId IdType="pubmed">31434879</ArticleId></ArticleIdList></Reference><Reference><Citation>Shankar GM et al. Amyloid-&#x3b2; protein dimers isolated directly from Alzheimer&#x2019;s brains impair synaptic plasticity and memory. Nat. Med. 14, 837&#x2013;842 (2008).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2772133</ArticleId><ArticleId IdType="pubmed">18568035</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y et al. TREM2-mediated early microglial response limits diffusion and toxicity of amyloid plaques. J. Exp. Med. 213, 667&#x2013;675 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4854736</ArticleId><ArticleId IdType="pubmed">27091843</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Hove H et al. A single-cell atlas of mouse brain macrophages reveals unique transcriptional identities shaped by ontogeny and tissue environment. Nat. Neurosci. 22, 1021&#x2013;1035 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">31061494</ArticleId></ArticleIdList></Reference><Reference><Citation>Liberzon A et al. The molecular signatures database (MSigDB) hallmark gene set collection. Cell Syst. 1, 417&#x2013;425 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4707969</ArticleId><ArticleId IdType="pubmed">26771021</ArticleId></ArticleIdList></Reference><Reference><Citation>Hammond TR et al. Single-cell RNA sequencing of microglia throughout the mouse lifespan and in the injured brain reveals complex cell-state changes. Immunity 50, 253&#x2013;271 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6655561</ArticleId><ArticleId IdType="pubmed">30471926</ArticleId></ArticleIdList></Reference><Reference><Citation>Olah M et al. A transcriptomic atlas of aged human microglia. Nat. Commun. 9, 539 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5803269</ArticleId><ArticleId IdType="pubmed">29416036</ArticleId></ArticleIdList></Reference><Reference><Citation>Sankowski R et al. Mapping microglia states in the human brain through the integration of high-dimensional techniques. Nat. Neurosci. 22, 2098&#x2013;2110 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">31740814</ArticleId></ArticleIdList></Reference><Reference><Citation>Shahidehpour RK et al. Dystrophic microglia are associated with neurodegenerative disease and not healthy aging in the human brain. Neurobiol. Aging 99, 19&#x2013;27 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8293930</ArticleId><ArticleId IdType="pubmed">33422891</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu P et al. The landscape of human tissue and cell type specific expression and co-regulation of senescence genes. Mol. Neurodegener. 17, 5 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8744330</ArticleId><ArticleId IdType="pubmed">35000600</ArticleId></ArticleIdList></Reference><Reference><Citation>Chatsirisupachai K, Palmer D, Ferreira S &amp; de Magalhaes JP A human tissue-specific transcriptomic analysis reveals a complex relationship between aging, cancer, and cellular senescence. Aging Cell 18, e13041 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6826163</ArticleId><ArticleId IdType="pubmed">31560156</ArticleId></ArticleIdList></Reference><Reference><Citation>Avelar RA et al. A multidimensional systems biology analysis of cellular senescence in aging and disease. Genome Biol. 21, 91 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7333371</ArticleId><ArticleId IdType="pubmed">32264951</ArticleId></ArticleIdList></Reference><Reference><Citation>Fuger P et al. Microglia turnover with aging and in an Alzheimer&#x2019;s model via long-term in vivo single-cell imaging. Nat. Neurosci. 20, 1371&#x2013;1376 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28846081</ArticleId></ArticleIdList></Reference><Reference><Citation>Bertolo A, Baur M, Guerrero J, Potzel T &amp; Stoyanov J Autofluorescence is a reliable in vitro marker of cellular senescence in human mesenchymal stromal cells. Sci. Rep. 9, 2074 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6376004</ArticleId><ArticleId IdType="pubmed">30765770</ArticleId></ArticleIdList></Reference><Reference><Citation>Streit WJ, Xue QS, Tischer J &amp; Bechmann I Microglial pathology. Acta Neuropathol. Commun. 2, 142 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4180960</ArticleId><ArticleId IdType="pubmed">25257319</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang P et al. Senolytic therapy alleviates A&#x3b2;-associated oligodendrocyte progenitor cell senescence and cognitive deficits in an Alzheimer&#x2019;s disease model. Nat. Neurosci. 22, 719&#x2013;728 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6605052</ArticleId><ArticleId IdType="pubmed">30936558</ArticleId></ArticleIdList></Reference><Reference><Citation>Bjorkoy G et al. p62/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtin-induced cell death. J. Cell Biol. 171, 603&#x2013;614 (2005).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2171557</ArticleId><ArticleId IdType="pubmed">16286508</ArticleId></ArticleIdList></Reference><Reference><Citation>Pankiv S et al. p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy. J. Biol. Chem. 282, 24131&#x2013;24145 (2007).</Citation><ArticleIdList><ArticleId IdType="pubmed">17580304</ArticleId></ArticleIdList></Reference><Reference><Citation>Itakura E, Kishi C, Inoue K &amp; Mizushima N Beclin 1 forms two distinct phosphatidylinositol 3-kinase complexes with mammalian Atg14 and UVRAG. Mol. Biol. Cell 19, 5360&#x2013;5372 (2008).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2592660</ArticleId><ArticleId IdType="pubmed">18843052</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhong Y et al. Distinct regulation of autophagic activity by Atg14L and Rubicon associated with Beclin 1-phosphatidylinositol-3-kinase complex. Nat. Cell Biol. 11, 468&#x2013;476 (2009).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2664389</ArticleId><ArticleId IdType="pubmed">19270693</ArticleId></ArticleIdList></Reference><Reference><Citation>Basisty N et al. A proteomic atlas of senescence-associated secretomes for aging biomarker development. PLoS Biol. 18, e3000599 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6964821</ArticleId><ArticleId IdType="pubmed">31945054</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai B et al. Proteomic landscape of Alzheimer&#x2019;s disease: novel insights into pathogenesis and biomarker discovery. Mol. Neurodegener. 16, 55 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8359598</ArticleId><ArticleId IdType="pubmed">34384464</ArticleId></ArticleIdList></Reference><Reference><Citation>Aman Y et al. Autophagy in healthy aging and disease. Nat. Aging 1, 634&#x2013;650 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8659158</ArticleId><ArticleId IdType="pubmed">34901876</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao S, Casey AE, Sargeant TJ &amp; Makinen VP Genetic variation within endolysosomal system is associated with late-onset Alzheimer&#x2019;s disease. Brain 141, 2711&#x2013;2720 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">30124770</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen H et al. A review of APOE genotype-dependent autophagic flux regulation in alzheimer&#x2019;s disease. J. Alzheimers Dis. 84, 535&#x2013;555 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34569952</ArticleId></ArticleIdList></Reference><Reference><Citation>Bussian TJ et al. Clearance of senescent glial cells prevents tau-dependent pathology and cognitive decline. Nature 562, 578&#x2013;582 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6206507</ArticleId><ArticleId IdType="pubmed">30232451</ArticleId></ArticleIdList></Reference><Reference><Citation>Saez-Atienzar S &amp; Masliah E Cellular senescence and Alzheimer disease: the egg and the chicken scenario. Nat. Rev. Neurosci. 21, 433&#x2013;444 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32601397</ArticleId></ArticleIdList></Reference><Reference><Citation>Kenkhuis B et al. Iron loading is a prominent feature of activated microglia in Alzheimer&#x2019;s disease patients. Acta Neuropathol. Commun. 9, 27 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7887813</ArticleId><ArticleId IdType="pubmed">33597025</ArticleId></ArticleIdList></Reference><Reference><Citation>Streit WJ, Braak H, Xue QS &amp; Bechmann I Dystrophic (senescent) rather than activated microglial cells are associated with tau pathology and likely precede neurodegeneration in Alzheimer&#x2019;s disease. Acta Neuropathol. 118, 475&#x2013;485 (2009).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2737117</ArticleId><ArticleId IdType="pubmed">19513731</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu C et al. SIRT1 is downregulated by autophagy in senescence and ageing. Nat. Cell Biol. 22, 1170&#x2013;1179 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7805578</ArticleId><ArticleId IdType="pubmed">32989246</ArticleId></ArticleIdList></Reference><Reference><Citation>Dou Z et al. Autophagy mediates degradation of nuclear lamina. Nature 527, 105&#x2013;109 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4824414</ArticleId><ArticleId IdType="pubmed">26524528</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia-Prat L et al. Autophagy maintains stemness by preventing senescence. Nature 529, 37&#x2013;42 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">26738589</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang HT, Lee KB, Kim SY, Choi HR &amp; Park SC Autophagy impairment induces premature senescence in primary human fibroblasts. PLoS ONE 6, e23367 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3152578</ArticleId><ArticleId IdType="pubmed">21858089</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinez J et al. Molecular characterization of LC3-associated phagocytosis reveals distinct roles for Rubicon, NOX2 and autophagy proteins. Nat. Cell Biol. 17, 893&#x2013;906 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4612372</ArticleId><ArticleId IdType="pubmed">26098576</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzales MM et al. Senolytic therapy to modulate the progression of Alzheimer&#x2019;s disease (SToMP-AD): a pilot clinical trial. J. Prev. Alzheimers Dis. 9, 22&#x2013;29 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8612719</ArticleId><ArticleId IdType="pubmed">35098970</ArticleId></ArticleIdList></Reference><Reference><Citation>Hernandez-Silva D et al. Senescence-independent anti-inflammatory activity of the senolytic drugs dasatinib, navitoclax, and venetoclax in zebrafish models of chronic inflammation. Int. J. Mol. Sci. 23, 10468 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9499634</ArticleId><ArticleId IdType="pubmed">36142384</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan A et al. Neuroprotective effect of quercetin against the detrimental effects of LPS in the adult mouse brain. Front. Pharm. 9, 1383 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6297180</ArticleId><ArticleId IdType="pubmed">30618732</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryu KY et al. Dasatinib regulates LPS-induced microglial and astrocytic neuroinflammatory responses by inhibiting AKT/STAT3 signaling. J. Neuroinflamm. 16, 190 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6815018</ArticleId><ArticleId IdType="pubmed">31655606</ArticleId></ArticleIdList></Reference><Reference><Citation>Veremeyko T, Starossom SC, Weiner HL &amp; Ponomarev ED Detection of microRNAs in microglia by real-time PCR in normal CNS and during neuroinflammation. J. Vis. Exp. 23, 4097 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3476396</ArticleId><ArticleId IdType="pubmed">22872097</ArticleId></ArticleIdList></Reference><Reference><Citation>Butovsky O et al. Identification of a unique TGF-beta-dependent molecular and functional signature in microglia. Nat. Neurosci. 17, 131&#x2013;143 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4066672</ArticleId><ArticleId IdType="pubmed">24316888</ArticleId></ArticleIdList></Reference><Reference><Citation>Butler A, Hoffman P, Smibert P, Papalexi E &amp; Satija R Integrating single-cell transcriptomic data across different conditions, technologies, and species. Nat. Biotechnol. 36, 411 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6700744</ArticleId><ArticleId IdType="pubmed">29608179</ArticleId></ArticleIdList></Reference><Reference><Citation>Mukherjee S et al. Molecular estimation of neurodegeneration pseudotime in older brains. Nat. Commun. 11, 5781 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7666177</ArticleId><ArticleId IdType="pubmed">33188183</ArticleId></ArticleIdList></Reference><Reference><Citation>Trapnell C et al. The dynamics and regulators of cell fate decisions are revealed by pseudotemporal ordering of single cells. Nat. Biotechnol. 32, 381&#x2013;386 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4122333</ArticleId><ArticleId IdType="pubmed">24658644</ArticleId></ArticleIdList></Reference><Reference><Citation>Goedhart J &amp; Luijsterburg MS VolcaNoseR is a web app for creating, exploring, labeling and sharing volcano plots. Sci. Rep. 10, 20560 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7689420</ArticleId><ArticleId IdType="pubmed">33239692</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim D, Paggi JM, Park C, Bennett C &amp; Salzberg SL Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype. Nat. Biotechnol. 37, 907&#x2013;915 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7605509</ArticleId><ArticleId IdType="pubmed">31375807</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao Y, Smyth GK &amp; Shi W featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics 30, 923&#x2013;930 (2014).</Citation><ArticleIdList><ArticleId IdType="pubmed">24227677</ArticleId></ArticleIdList></Reference><Reference><Citation>Love MI, Huber W &amp; Anders S Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4302049</ArticleId><ArticleId IdType="pubmed">25516281</ArticleId></ArticleIdList></Reference><Reference><Citation>Pagala VR et al. Quantitative protein analysis by mass spectrometry. Methods Mol. Biol. 1278, 281&#x2013;305 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">25859956</ArticleId></ArticleIdList></Reference><Reference><Citation>Edgar R, Domrachev M &amp; Lash AE Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res. 30, 207&#x2013;210 (2002).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC99122</ArticleId><ArticleId IdType="pubmed">11752295</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37248300</PMID><DateCompleted><Year>2023</Year><Month>07</Month><Day>23</Day></DateCompleted><DateRevised><Year>2023</Year><Month>07</Month><Day>26</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1546-170X</ISSN><JournalIssue CitedMedium="Internet"><Volume>29</Volume><Issue>7</Issue><PubDate><Year>2023</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Nature medicine</Title><ISOAbbreviation>Nat Med</ISOAbbreviation></Journal><ArticleTitle>Astrocyte reactivity influences amyloid-&#x3b2; effects on tau pathology in preclinical Alzheimer's disease.</ArticleTitle><Pagination><StartPage>1775</StartPage><EndPage>1781</EndPage><MedlinePgn>1775-1781</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41591-023-02380-x</ELocationID><Abstract><AbstractText>An unresolved question for the understanding of Alzheimer's disease (AD) pathophysiology is why a significant percentage of amyloid-&#x3b2; (A&#x3b2;)-positive cognitively unimpaired (CU) individuals do not develop detectable downstream tau pathology and, consequently, clinical deterioration. In vitro evidence suggests that reactive astrocytes unleash A&#x3b2; effects in pathological tau phosphorylation. Here, in a biomarker study across three cohorts (n&#x2009;=&#x2009;1,016), we tested whether astrocyte reactivity modulates the association of A&#x3b2; with tau phosphorylation in CU individuals. We found that A&#x3b2; was associated with increased plasma phosphorylated tau only in individuals positive for astrocyte reactivity (Ast<sup>+</sup>). Cross-sectional and longitudinal tau-positron emission tomography analyses revealed an AD-like pattern of tau tangle accumulation as a function of A&#x3b2; only in CU Ast<sup>+</sup> individuals. Our findings suggest astrocyte reactivity as an important upstream event linking A&#x3b2; with initial tau pathology, which may have implications for the biological definition of preclinical AD and for selecting CU individuals for clinical trials.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bellaver</LastName><ForeName>Bruna</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0002-2212-3373</Identifier><AffiliationInfo><Affiliation>Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Graduate Program in Biological Sciences-Biochemistry, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Povala</LastName><ForeName>Guilherme</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-2023-6569</Identifier><AffiliationInfo><Affiliation>Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ferreira</LastName><ForeName>Pamela C L</ForeName><Initials>PCL</Initials><Identifier Source="ORCID">0000-0003-2134-9829</Identifier><AffiliationInfo><Affiliation>Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ferrari-Souza</LastName><ForeName>Jo&#xe3;o Pedro</ForeName><Initials>JP</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Graduate Program in Biological Sciences-Biochemistry, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leffa</LastName><ForeName>Douglas T</ForeName><Initials>DT</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lussier</LastName><ForeName>Firoza Z</ForeName><Initials>FZ</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Benedet</LastName><ForeName>Andr&#xe9;a L</ForeName><Initials>AL</Initials><AffiliationInfo><Affiliation>Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy at the University of Gothenburg, M&#xf6;lndal, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ashton</LastName><ForeName>Nicholas J</ForeName><Initials>NJ</Initials><AffiliationInfo><Affiliation>Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy at the University of Gothenburg, M&#xf6;lndal, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Age-Related Medicine, Stavanger University Hospital, Stavanger, Norway.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Old Age Psychiatry, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Triana-Baltzer</LastName><ForeName>Gallen</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Neuroscience Biomarkers, Janssen Research and Development, La Jolla, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kolb</LastName><ForeName>Hartmuth C</ForeName><Initials>HC</Initials><AffiliationInfo><Affiliation>Neuroscience Biomarkers, Janssen Research and Development, La Jolla, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tissot</LastName><ForeName>C&#xe9;cile</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0003-2711-3833</Identifier><AffiliationInfo><Affiliation>Translational Neuroimaging Laboratory, McGill University Research Centre for Studies in Aging, Alzheimer's Disease Research Unit, Douglas Research Institute, Le Centre int&#xe9;gr&#xe9; universitaire de sant&#xe9; et de services sociaux (CIUSSS) de l'Ouest-de-l'&#xce;le-de-Montr&#xe9;al; Department of Neurology and Neurosurgery, Psychiatry and Pharmacology and Therapeutics, McGill University, Montreal, Quebec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Therriault</LastName><ForeName>Joseph</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-7826-4781</Identifier><AffiliationInfo><Affiliation>Translational Neuroimaging Laboratory, McGill University Research Centre for Studies in Aging, Alzheimer's Disease Research Unit, Douglas Research Institute, Le Centre int&#xe9;gr&#xe9; universitaire de sant&#xe9; et de services sociaux (CIUSSS) de l'Ouest-de-l'&#xce;le-de-Montr&#xe9;al; Department of Neurology and Neurosurgery, Psychiatry and Pharmacology and Therapeutics, McGill University, Montreal, Quebec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Servaes</LastName><ForeName>Stijn</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Translational Neuroimaging Laboratory, McGill University Research Centre for Studies in Aging, Alzheimer's Disease Research Unit, Douglas Research Institute, Le Centre int&#xe9;gr&#xe9; universitaire de sant&#xe9; et de services sociaux (CIUSSS) de l'Ouest-de-l'&#xce;le-de-Montr&#xe9;al; Department of Neurology and Neurosurgery, Psychiatry and Pharmacology and Therapeutics, McGill University, Montreal, Quebec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stevenson</LastName><ForeName>Jenna</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Translational Neuroimaging Laboratory, McGill University Research Centre for Studies in Aging, Alzheimer's Disease Research Unit, Douglas Research Institute, Le Centre int&#xe9;gr&#xe9; universitaire de sant&#xe9; et de services sociaux (CIUSSS) de l'Ouest-de-l'&#xce;le-de-Montr&#xe9;al; Department of Neurology and Neurosurgery, Psychiatry and Pharmacology and Therapeutics, McGill University, Montreal, Quebec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rahmouni</LastName><ForeName>Nesrine</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Translational Neuroimaging Laboratory, McGill University Research Centre for Studies in Aging, Alzheimer's Disease Research Unit, Douglas Research Institute, Le Centre int&#xe9;gr&#xe9; universitaire de sant&#xe9; et de services sociaux (CIUSSS) de l'Ouest-de-l'&#xce;le-de-Montr&#xe9;al; Department of Neurology and Neurosurgery, Psychiatry and Pharmacology and Therapeutics, McGill University, Montreal, Quebec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lopez</LastName><ForeName>Oscar L</ForeName><Initials>OL</Initials><Identifier Source="ORCID">0000-0002-8546-8256</Identifier><AffiliationInfo><Affiliation>Department of Neurology, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tudorascu</LastName><ForeName>Dana L</ForeName><Initials>DL</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biostatistics, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Villemagne</LastName><ForeName>Victor L</ForeName><Initials>VL</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ikonomovic</LastName><ForeName>Milos D</ForeName><Initials>MD</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Geriatric Research Education and Clinical Center, VA Pittsburgh HS, Pittsburgh, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gauthier</LastName><ForeName>Serge</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Translational Neuroimaging Laboratory, McGill University Research Centre for Studies in Aging, Alzheimer's Disease Research Unit, Douglas Research Institute, Le Centre int&#xe9;gr&#xe9; universitaire de sant&#xe9; et de services sociaux (CIUSSS) de l'Ouest-de-l'&#xce;le-de-Montr&#xe9;al; Department of Neurology and Neurosurgery, Psychiatry and Pharmacology and Therapeutics, McGill University, Montreal, Quebec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zimmer</LastName><ForeName>Eduardo R</ForeName><Initials>ER</Initials><AffiliationInfo><Affiliation>Graduate Program in Biological Sciences-Biochemistry, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pharmacology, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Graduate Program in Biological Sciences: Pharmacology and Therapeutics, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Brain Institute, PUCRS, Porto Alegre, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zetterberg</LastName><ForeName>Henrik</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0003-3930-4354</Identifier><AffiliationInfo><Affiliation>Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy at the University of Gothenburg, M&#xf6;lndal, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, M&#xf6;lndal, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>UK Dementia Research Institute at UCL, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hong Kong Center for Neurodegenerative Diseases, Hong Kong, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Wisconsin Alzheimer's Disease Research Center, University of Wisconsin School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blennow</LastName><ForeName>Kaj</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0002-1890-4193</Identifier><AffiliationInfo><Affiliation>Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy at the University of Gothenburg, M&#xf6;lndal, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, M&#xf6;lndal, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aizenstein</LastName><ForeName>Howard J</ForeName><Initials>HJ</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Bioengineering, University of Pittsburgh, Pittsburgh, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Klunk</LastName><ForeName>William E</ForeName><Initials>WE</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Snitz</LastName><ForeName>Beth E</ForeName><Initials>BE</Initials><AffiliationInfo><Affiliation>Department of Neurology, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maki</LastName><ForeName>Pauline</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, University of Illinois, Chicago, IL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thurston</LastName><ForeName>Rebecca C</ForeName><Initials>RC</Initials><Identifier Source="ORCID">0000-0001-6580-1202</Identifier><AffiliationInfo><Affiliation>Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychology, University of Pittsburgh, Pittsburgh, PA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Epidemiology, University of Pittsburgh School of Public Health, Pittsburgh, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cohen</LastName><ForeName>Ann D</ForeName><Initials>AD</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ganguli</LastName><ForeName>Mary</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Epidemiology, University of Pittsburgh School of Public Health, Pittsburgh, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Karikari</LastName><ForeName>Thomas K</ForeName><Initials>TK</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy at the University of Gothenburg, M&#xf6;lndal, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rosa-Neto</LastName><ForeName>Pedro</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0001-9116-1376</Identifier><AffiliationInfo><Affiliation>Translational Neuroimaging Laboratory, McGill University Research Centre for Studies in Aging, Alzheimer's Disease Research Unit, Douglas Research Institute, Le Centre int&#xe9;gr&#xe9; universitaire de sant&#xe9; et de services sociaux (CIUSSS) de l'Ouest-de-l'&#xce;le-de-Montr&#xe9;al; Department of Neurology and Neurosurgery, Psychiatry and Pharmacology and Therapeutics, McGill University, Montreal, Quebec, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Brain Imaging Centre, Montreal Neurological Institute-Hospital, Montreal, Quebec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pascoal</LastName><ForeName>Tharick A</ForeName><Initials>TA</Initials><Identifier Source="ORCID">0000-0001-9057-8014</Identifier><AffiliationInfo><Affiliation>Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA, USA. pascoalt@upmc.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA. pascoalt@upmc.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 AG075336</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG052521</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG052528</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R37 AG023651</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG053504</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AG066468</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG073267</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>RF1 AG052525</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HL105647</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P01 AG014449</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>RF1 AG025516</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG052446</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>RF1 AG053504</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K24 HL123565</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P01 AG025204</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>05</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Nat Med</MedlineTA><NlmUniqueID>9502015</NlmUniqueID><ISSNLinking>1078-8956</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016229">Amyloid beta-Peptides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016875">tau Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C545487">APP protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C054369">MAPT protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="UpdateOf"><RefSource>Res Sq. 2023 Feb 01:rs.3.rs-2507179. doi: 10.21203/rs.3.rs-2507179/v1.</RefSource><PMID Version="1">36778243</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016229" MajorTopicYN="N">Amyloid beta-Peptides</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001253" MajorTopicYN="N">Astrocytes</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060825" MajorTopicYN="Y">Cognitive Dysfunction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D049268" MajorTopicYN="N">Positron-Emission Tomography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016875" MajorTopicYN="N">tau Proteins</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>H.C.K. and G.T.-B. are employees and stockholders of Johnson &amp; Johnson. H.Z. has served on scientific advisory boards and/or as a consultant for Abbvie, Acumen, Alector, Alzinova, ALZPath, Annexon, Apellis, Artery Therapeutics, AZTherapies, CogRx, Denali, Eisai, Nervgen, Novo Nordisk, Optoceutics, Passage Bio, Pinteon Therapeutics, Prothena, Red Abbey Labs, reMYND, Roche, Samumed, Siemens Healthineers, Triplet Therapeutics and Wave; has given lectures in symposia sponsored by Cellectricon, Fujirebio, Alzecure, Biogen and Roche and is a cofounder of Brain Biomarker Solutions in Gothenburg AB (BBS), which is a part of the GU Ventures Incubator Program (outside submitted work). K.B. has served as a consultant, at advisory boards, or at data monitoring committees for Abcam, Axon, Biogen, JOMDD/Shimadzu, Julius Clinical, Lilly, MagQu, Novartis, Prothena, Roche Diagnostics and Siemens Healthineers and is a cofounder of Brain Biomarker Solutions in Gothenburg AB (BBS), which is a part of the GU Ventures Incubator Program, all unrelated to the work presented in this paper. S.G. has served as a scientific advisor to Cerveau Therapeutics. E.R.Z. serves on the scientific advisory board of Next Innovative Therapeutics (Nintx). P.R.-N. has served on scientific advisory boards and/or as a consultant for Eisai, Novo Nordisk and Roche. N.J.A. has given lectures in symposia sponsored by Lilly and Quanterix. M.D.I. has received research funding from GE Healthcare and Avid Radiopharmaceuticals. R.C.T. serves as a consultant, advisor and/or on the medical advisory board of Happify Health, Astellas Pharma, Bayer and Hello Therapeutics. GE Healthcare holds a license agreement with the University of Pittsburgh based on the PiB PET technology described in this paper. W.E.K. is a co-inventor of PiB and, as such, has a financial interest in this license agreement. GE Healthcare provided no grant support for this study and had no role in the design or interpretation of results or preparation of this paper. The other authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>1</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>5</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>7</Month><Day>21</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>30</Day><Hour>1</Hour><Minute>6</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>29</Day><Hour>23</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>5</Month><Day>29</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37248300</ArticleId><ArticleId IdType="pmc">PMC10353939</ArticleId><ArticleId IdType="doi">10.1038/s41591-023-02380-x</ArticleId><ArticleId IdType="pii">10.1038/s41591-023-02380-x</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Jack CR, Jr, et al. Tracking pathophysiological processes in Alzheimer&#x2019;s disease: an updated hypothetical model of dynamic biomarkers. Lancet Neurol. 2013;12:207&#x2013;216.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3622225</ArticleId><ArticleId IdType="pubmed">23332364</ArticleId></ArticleIdList></Reference><Reference><Citation>Hansson O. Biomarkers for neurodegenerative diseases. Nat. Med. 2021;27:954&#x2013;963.</Citation><ArticleIdList><ArticleId IdType="pubmed">34083813</ArticleId></ArticleIdList></Reference><Reference><Citation>Mil&#xe0;-Alom&#xe0; M, et al. Plasma p-tau231 and p-tau217 as state markers of amyloid-&#x3b2; pathology in preclinical Alzheimer&#x2019;s disease. Nat. Med. 2022;28:1797&#x2013;1801.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9499867</ArticleId><ArticleId IdType="pubmed">35953717</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanseeuw BJ, et al. Association of amyloid and tau with cognition in preclinical Alzheimer disease: a longitudinal study. JAMA Neurol. 2019;76:915&#x2013;924.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6547132</ArticleId><ArticleId IdType="pubmed">31157827</ArticleId></ArticleIdList></Reference><Reference><Citation>Ossenkoppele R, et al. Accuracy of tau positron emission tomography as a prognostic marker in preclinical and prodromal Alzheimer disease: a head-to-head comparison against amyloid positron emission tomography and magnetic resonance imaging. JAMA Neurol. 2021;78:961&#x2013;971.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8240013</ArticleId><ArticleId IdType="pubmed">34180956</ArticleId></ArticleIdList></Reference><Reference><Citation>Ossenkoppele R, et al. Amyloid and tau PET-positive cognitively unimpaired individuals are at high risk for future cognitive decline. Nat. Med. 2022;28:2381&#x2013;2387.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9671808</ArticleId><ArticleId IdType="pubmed">36357681</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts RO, et al. Prevalence and outcomes of amyloid positivity among persons without dementia in a longitudinal, population-based setting. JAMA Neurol. 2018;75:970&#x2013;979.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6142936</ArticleId><ArticleId IdType="pubmed">29710225</ArticleId></ArticleIdList></Reference><Reference><Citation>Josephs KA, Weigand SD, Whitwell JL. Characterizing amyloid-positive individuals with normal tau PET levels after 5 years: an ADNI study. Neurology. 2022;98:e2282&#x2013;e2292.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9162162</ArticleId><ArticleId IdType="pubmed">35314506</ArticleId></ArticleIdList></Reference><Reference><Citation>Nordberg A. Dementia in 2014. Towards early diagnosis in Alzheimer disease. Nat. Rev. Neurol. 2015;11:69&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pubmed">25623789</ArticleId></ArticleIdList></Reference><Reference><Citation>Sperling RA, et al. Toward defining the preclinical stages of Alzheimer&#x2019;s disease: recommendations from the National Institute on Aging-Alzheimer&#x2019;s Association workgroups on diagnostic guidelines for Alzheimer&#x2019;s disease. Alzheimers Dement. 2011;7:280&#x2013;292.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3220946</ArticleId><ArticleId IdType="pubmed">21514248</ArticleId></ArticleIdList></Reference><Reference><Citation>Pike CJ, Cummings BJ, Cotman CW. Early association of reactive astrocytes with senile plaques in Alzheimer&#x2019;s disease. Exp. Neurol. 1995;132:172&#x2013;179.</Citation><ArticleIdList><ArticleId IdType="pubmed">7789457</ArticleId></ArticleIdList></Reference><Reference><Citation>Beach TG, Walker R, McGeer EG. Patterns of gliosis in Alzheimer&#x2019;s disease and aging cerebrum. Glia. 1989;2:420&#x2013;436.</Citation><ArticleIdList><ArticleId IdType="pubmed">2531723</ArticleId></ArticleIdList></Reference><Reference><Citation>Escartin C, et al. Reactive astrocyte nomenclature, definitions, and future directions. Nat. Neurosci. 2021;24:312&#x2013;325.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8007081</ArticleId><ArticleId IdType="pubmed">33589835</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar A, Fontana IC, Nordberg A. Reactive astrogliosis: a friend or foe in the pathogenesis of Alzheimer&#x2019;s disease. J. Neurochem. 2023;164:309&#x2013;324.</Citation><ArticleIdList><ArticleId IdType="pubmed">34931315</ArticleId></ArticleIdList></Reference><Reference><Citation>Wruck W, Adjaye J. Meta-analysis of human prefrontal cortex reveals activation of GFAP and decline of synaptic transmission in the aging brain. Acta Neuropathol. Commun. 2020;8:26.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7059712</ArticleId><ArticleId IdType="pubmed">32138778</ArticleId></ArticleIdList></Reference><Reference><Citation>Garwood CJ, Pooler AM, Atherton J, Hanger DP, Noble W. Astrocytes are important mediators of A&#x3b2;-induced neurotoxicity and tau phosphorylation in primary culture. Cell Death Dis. 2011;2:e167.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3168992</ArticleId><ArticleId IdType="pubmed">21633390</ArticleId></ArticleIdList></Reference><Reference><Citation>Mann CN, et al. Astrocytic &#x3b1;2-Na+/K+ ATPase inhibition suppresses astrocyte reactivity and reduces neurodegeneration in a tauopathy mouse model. Sci. Transl. Med. 2022;14:eabm4107.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9161722</ArticleId><ArticleId IdType="pubmed">35171651</ArticleId></ArticleIdList></Reference><Reference><Citation>Litvinchuk A, et al. Complement C3aR inactivation attenuates tau pathology and reverses an immune network deregulated in tauopathy models and Alzheimer&#x2019;s disease. Neuron. 2018;100:1337&#x2013;1353.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6309202</ArticleId><ArticleId IdType="pubmed">30415998</ArticleId></ArticleIdList></Reference><Reference><Citation>de Calignon A, et al. Propagation of tau pathology in a model of early Alzheimer&#x2019;s disease. Neuron. 2012;73:685&#x2013;697.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3292759</ArticleId><ArticleId IdType="pubmed">22365544</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang P, Ye Y. Filamentous recombinant human tau activates primary astrocytes via an integrin receptor complex. Nat. Commun. 2021;12:95.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7782792</ArticleId><ArticleId IdType="pubmed">33398028</ArticleId></ArticleIdList></Reference><Reference><Citation>Benedet AL, et al. Differences between plasma and cerebrospinal fluid glial fibrillary acidic protein levels across the Alzheimer disease continuum. JAMA Neurol. 2021;78:1471&#x2013;1483.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8524356</ArticleId><ArticleId IdType="pubmed">34661615</ArticleId></ArticleIdList></Reference><Reference><Citation>Chatterjee P, et al. Plasma glial fibrillary acidic protein is elevated in cognitively normal older adults at risk of Alzheimer&#x2019;s disease. Transl. Psychiatry. 2021;11:27.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7801513</ArticleId><ArticleId IdType="pubmed">33431793</ArticleId></ArticleIdList></Reference><Reference><Citation>Pereira JB, et al. Plasma GFAP is an early marker of amyloid-&#x3b2; but not tau pathology in Alzheimer&#x2019;s disease. Brain. 2021;144:3505&#x2013;3516.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8677538</ArticleId><ArticleId IdType="pubmed">34259835</ArticleId></ArticleIdList></Reference><Reference><Citation>Chatterjee P, et al. Plasma glial fibrillary acidic protein is associated with 18F-SMBT-1 PET: two putative astrocyte reactivity biomarkers for Alzheimer&#x2019;s disease. J. Alzheimers Dis. 2023;92:615&#x2013;628.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10041433</ArticleId><ArticleId IdType="pubmed">36776057</ArticleId></ArticleIdList></Reference><Reference><Citation>Palmqvist S, et al. Earliest accumulation of &#x3b2;-amyloid occurs within the default-mode network and concurrently affects brain connectivity. Nat. Commun. 2017;8:1214.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5663717</ArticleId><ArticleId IdType="pubmed">29089479</ArticleId></ArticleIdList></Reference><Reference><Citation>Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 1991;82:239&#x2013;259.</Citation><ArticleIdList><ArticleId IdType="pubmed">1759558</ArticleId></ArticleIdList></Reference><Reference><Citation>Jack CR, Jr, et al. NIA-AA research framework: toward a biological definition of Alzheimer&#x2019;s disease. Alzheimers Dement. 2018;14:535&#x2013;562.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5958625</ArticleId><ArticleId IdType="pubmed">29653606</ArticleId></ArticleIdList></Reference><Reference><Citation>Johansson C, et al. Plasma biomarker profiles in autosomal dominant Alzheimer&#x2019;s disease. Brain. 2023;146:1132&#x2013;1140.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9976964</ArticleId><ArticleId IdType="pubmed">36626935</ArticleId></ArticleIdList></Reference><Reference><Citation>Verberk IMW, et al. Serum markers glial fibrillary acidic protein and neurofilament light for prognosis and monitoring in cognitively normal older people: a prospective memory clinic-based cohort study. Lancet Healthy Longev. 2021;2:e87&#x2013;e95.</Citation><ArticleIdList><ArticleId IdType="pubmed">36098162</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen X-N, et al. Plasma glial fibrillary acidic protein in the Alzheimer disease continuum: relationship to other biomarkers, differential diagnosis, and prediction of clinical progression. Clin. Chem. 2023;69:411&#x2013;421.</Citation><ArticleIdList><ArticleId IdType="pubmed">36861369</ArticleId></ArticleIdList></Reference><Reference><Citation>Buckley RF, et al. Sex differences in the association of global amyloid and regional tau deposition measured by positron emission tomography in clinically normal older adults. JAMA Neurol. 2019;76:542&#x2013;551.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6515599</ArticleId><ArticleId IdType="pubmed">30715078</ArticleId></ArticleIdList></Reference><Reference><Citation>Palta P, et al. Sex differences in in vivo tau neuropathology in a multiethnic sample of late middle-aged adults. Neurobiol. Aging. 2021;103:109&#x2013;116.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8178209</ArticleId><ArticleId IdType="pubmed">33894641</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsiknia AA, et al. Sex differences in plasma p-tau181 associations with Alzheimer&#x2019;s disease biomarkers, cognitive decline, and clinical progression. Mol. Psychiatry. 2022;27:4314&#x2013;4322.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9718670</ArticleId><ArticleId IdType="pubmed">35768637</ArticleId></ArticleIdList></Reference><Reference><Citation>van Dyck CH, et al. Lecanemab in early Alzheimer&#x2019;s disease. N. Engl. J. Med. 2023;388:9&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pubmed">36449413</ArticleId></ArticleIdList></Reference><Reference><Citation>Ganguli M, et al. Prevalence of mild cognitive impairment by multiple classifications: the Monongahela-Youghiogheny Healthy Aging Team (MYHAT) project. Am. J. Geriatr. Psychiatry. 2010;18:674&#x2013;683.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2906673</ArticleId><ArticleId IdType="pubmed">20220597</ArticleId></ArticleIdList></Reference><Reference><Citation>Bambs C, et al. Low prevalence of &#x201c;ideal cardiovascular health&#x201d; in a community-based population: the heart strategies concentrating on risk evaluation (Heart SCORE) study. Circulation. 2011;123:850&#x2013;857.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3061396</ArticleId><ArticleId IdType="pubmed">21321154</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen AD, et al. Connectomics in brain aging and dementia&#x2014;the background and design of a study of a connectome related to human disease. Front. Aging Neurosci. 2021;13:669490.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8530182</ArticleId><ArticleId IdType="pubmed">34690734</ArticleId></ArticleIdList></Reference><Reference><Citation>Aizenstein HJ, et al. Frequent amyloid deposition without significant cognitive impairment among the elderly. Arch. Neurol. 2008;65:1509&#x2013;1517.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2636844</ArticleId><ArticleId IdType="pubmed">19001171</ArticleId></ArticleIdList></Reference><Reference><Citation>Thurston RC, et al. Menopausal vasomotor symptoms and white matter hyperintensities in midlife women. Neurology. 2023;100:e133&#x2013;e141.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9841446</ArticleId><ArticleId IdType="pubmed">36224031</ArticleId></ArticleIdList></Reference><Reference><Citation>Karikari TK, et al. Blood phosphorylated tau 181 as a biomarker for Alzheimer&#x2019;s disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts. Lancet Neurol. 2020;19:422&#x2013;433.</Citation><ArticleIdList><ArticleId IdType="pubmed">32333900</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashton NJ, et al. Plasma p-tau231: a new biomarker for incipient Alzheimer&#x2019;s disease pathology. Acta Neuropathol. 2021;141:709&#x2013;724.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8043944</ArticleId><ArticleId IdType="pubmed">33585983</ArticleId></ArticleIdList></Reference><Reference><Citation>Triana-Baltzer G, et al. Development and validation of a high-sensitivity assay for measuring p217+tau in plasma. Alzheimers Dement. (Amst.) 2021;13:e12204.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8158165</ArticleId><ArticleId IdType="pubmed">34095436</ArticleId></ArticleIdList></Reference><Reference><Citation>Ossenkoppele R, et al. Prevalence of amyloid PET positivity in dementia syndromes: a meta-analysis. JAMA. 2015;313:1939&#x2013;1949.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4517678</ArticleId><ArticleId IdType="pubmed">25988463</ArticleId></ArticleIdList></Reference><Reference><Citation>Jack CR, Jr., et al. Defining imaging biomarker cut points for brain aging and Alzheimer&#x2019;s disease. Alzheimers Dement. 2017;13:205&#x2013;216.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5344738</ArticleId><ArticleId IdType="pubmed">27697430</ArticleId></ArticleIdList></Reference><Reference><Citation>Gr&#xe4;sbeck R. The evolution of the reference value concept. Clin. Chem. Lab. Med. 2004;42:692&#x2013;697.</Citation><ArticleIdList><ArticleId IdType="pubmed">15327001</ArticleId></ArticleIdList></Reference><Reference><Citation>Jensen CS, et al. Exercise as a potential modulator of inflammation in patients with Alzheimer&#x2019;s disease measured in cerebrospinal fluid and plasma. Exp. Gerontol. 2019;121:91&#x2013;98.</Citation><ArticleIdList><ArticleId IdType="pubmed">30980923</ArticleId></ArticleIdList></Reference><Reference><Citation>Therriault J, et al. Determining amyloid-&#x3b2; positivity using (18)F-AZD4694 PET imaging. J. Nucl. Med. 2021;62:247&#x2013;252.</Citation><ArticleIdList><ArticleId IdType="pubmed">32737243</ArticleId></ArticleIdList></Reference><Reference><Citation>Pascoal TA, et al. 18F-MK-6240 PET for early and late detection of neurofibrillary tangles. Brain. 2020;143:2818&#x2013;2830.</Citation><ArticleIdList><ArticleId IdType="pubmed">32671408</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen AD, et al. Classification of amyloid-positivity in controls: comparison of visual read and quantitative approaches. Neuroimage. 2013;71:207&#x2013;215.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3605888</ArticleId><ArticleId IdType="pubmed">23353602</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathotaarachchi S, et al. VoxelStats: a MATLAB package for multi-modal voxel-wise brain image analysis. Front. Neuroinform. 2016;10:20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4908129</ArticleId><ArticleId IdType="pubmed">27378902</ArticleId></ArticleIdList></Reference><Reference><Citation>Worsley KJ, Taylor JE, Tomaiuolo F, Lerch J. Unified univariate and multivariate random field theory. Neuroimage. 2004;23:S189&#x2013;S195.</Citation><ArticleIdList><ArticleId IdType="pubmed">15501088</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37248224</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>31</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>30</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2041-1723</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>May</Month><Day>29</Day></PubDate></JournalIssue><Title>Nature communications</Title><ISOAbbreviation>Nat Commun</ISOAbbreviation></Journal><ArticleTitle>Multi-omic approach characterises the neuroprotective role of retromer in regulating lysosomal health.</ArticleTitle><Pagination><StartPage>3086</StartPage><MedlinePgn>3086</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">3086</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41467-023-38719-8</ELocationID><Abstract><AbstractText>Retromer controls cellular homeostasis through regulating integral membrane protein sorting and transport and by controlling maturation of the endo-lysosomal network. Retromer dysfunction, which is linked to neurodegenerative disorders including Parkinson's and Alzheimer's diseases, manifests in complex cellular phenotypes, though the precise nature of this dysfunction, and its relation to neurodegeneration, remain unclear. Here, we perform an integrated multi-omics approach to provide precise insight into the impact of Retromer dysfunction on endo-lysosomal health and homeostasis within a human neuroglioma cell model. We quantify widespread changes to the lysosomal proteome, indicative of broad lysosomal dysfunction and inefficient autophagic lysosome reformation, coupled with a reconfigured cell surface proteome and secretome reflective of increased lysosomal exocytosis. Through this global proteomic approach and parallel transcriptomic analysis, we provide a holistic view of Retromer function in regulating lysosomal homeostasis and emphasise its role in neuroprotection.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Daly</LastName><ForeName>James L</ForeName><Initials>JL</Initials><Identifier Source="ORCID">0000-0002-4551-1256</Identifier><AffiliationInfo><Affiliation>School of Biochemistry, Biomedical Sciences Building, University Walk, University of Bristol, Bristol, BS8 1TD, UK. james.l.daly@kcl.ac.uk.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Infectious Diseases, School of Immunology and Microbial Sciences, Guy's Hospital, King's College London, SE1 9RT, London, UK. james.l.daly@kcl.ac.uk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Danson</LastName><ForeName>Chris M</ForeName><Initials>CM</Initials><AffiliationInfo><Affiliation>School of Biochemistry, Biomedical Sciences Building, University Walk, University of Bristol, Bristol, BS8 1TD, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lewis</LastName><ForeName>Philip A</ForeName><Initials>PA</Initials><Identifier Source="ORCID">0000-0002-2868-2459</Identifier><AffiliationInfo><Affiliation>Bristol Proteomics Facility, School of Biochemistry, Biomedical Sciences Building, University Walk, University of Bristol, BS8 1TD, Bristol, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Lu</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Neurosciences, Case Western Reserve University, Cleveland, OH, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Riccardo</LastName><ForeName>Sara</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Telethon Institute of Genetics and Medicine, Armenise/Harvard Laboratory of Integrative Genomics, Pozzuoli, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Next Generation Diagnostic srl, Pozzuoli, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Di Filippo</LastName><ForeName>Lucio</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Telethon Institute of Genetics and Medicine, Armenise/Harvard Laboratory of Integrative Genomics, Pozzuoli, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Next Generation Diagnostic srl, Pozzuoli, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cacchiarelli</LastName><ForeName>Davide</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-9621-6716</Identifier><AffiliationInfo><Affiliation>Telethon Institute of Genetics and Medicine, Armenise/Harvard Laboratory of Integrative Genomics, Pozzuoli, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Translational Medicine, University of Naples "Federico II", Naples, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School for Advanced Studies, University of Naples "Federico II", Naples, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Daehoon</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Neurosciences, Case Western Reserve University, Cleveland, OH, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cross</LastName><ForeName>Stephen J</ForeName><Initials>SJ</Initials><Identifier Source="ORCID">0000-0003-3565-0479</Identifier><AffiliationInfo><Affiliation>Wolfson Bioimaging Facility, Faculty of Biomedical Sciences, University of Bristol, Bristol, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Heesom</LastName><ForeName>Kate J</ForeName><Initials>KJ</Initials><Identifier Source="ORCID">0000-0002-5418-5392</Identifier><AffiliationInfo><Affiliation>Bristol Proteomics Facility, School of Biochemistry, Biomedical Sciences Building, University Walk, University of Bristol, BS8 1TD, Bristol, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xiong</LastName><ForeName>Wen-Cheng</ForeName><Initials>WC</Initials><Identifier Source="ORCID">0000-0001-9071-7598</Identifier><AffiliationInfo><Affiliation>Department of Neurosciences, Case Western Reserve University, Cleveland, OH, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ballabio</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-1381-4604</Identifier><AffiliationInfo><Affiliation>Telethon Institute of Genetics and Medicine, Armenise/Harvard Laboratory of Integrative Genomics, Pozzuoli, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Translational Medicine, University of Naples "Federico II", Naples, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School for Advanced Studies, University of Naples "Federico II", Naples, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Molecular and Human Genetics and Neurological Research Institute, Baylor College of Medicine, Houston, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Edgar</LastName><ForeName>James R</ForeName><Initials>JR</Initials><Identifier Source="ORCID">0000-0001-7903-8199</Identifier><AffiliationInfo><Affiliation>Department of Pathology, Cambridge University, Tennis Court Road, Cambridge, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cullen</LastName><ForeName>Peter J</ForeName><Initials>PJ</Initials><Identifier Source="ORCID">0000-0002-9070-8349</Identifier><AffiliationInfo><Affiliation>School of Biochemistry, Biomedical Sciences Building, University Walk, University of Bristol, Bristol, BS8 1TD, UK. pete.cullen@bristol.ac.uk.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>MR/L007363/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>RF1 AG045781</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>MR/P018807/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MR/K018299/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>104568/Z/14/Z</GrantID><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>203959/Z/16/Z</GrantID><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>225128/Z/22/Z</GrantID><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>220260/Z/20/Z</GrantID><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>05</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nat Commun</MedlineTA><NlmUniqueID>101528555</NlmUniqueID><ISSNLinking>2041-1723</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D020543">Proteome</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000066829" MajorTopicYN="Y">Neuroprotection</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000095028" MajorTopicYN="Y">Multiomics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020543" MajorTopicYN="N">Proteome</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D040901" MajorTopicYN="N">Proteomics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011992" MajorTopicYN="N">Endosomes</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D021381" MajorTopicYN="N">Protein Transport</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008247" MajorTopicYN="N">Lysosomes</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>A.B. is cofounder of CASMA Therapeutics and Advisory board member of Avilar Therapeutics and Coave Therapeutics. D.C. and A.B. are founders, shareholders, and consultants of Next Generation Diagnostic srl. S.R .and L.D.F. are employees of Next Generation Diagnostic srl. The remaining authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>9</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>5</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>31</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>30</Day><Hour>1</Hour><Minute>6</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>29</Day><Hour>23</Hour><Minute>14</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>5</Month><Day>29</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37248224</ArticleId><ArticleId IdType="pmc">PMC10227043</ArticleId><ArticleId IdType="doi">10.1038/s41467-023-38719-8</ArticleId><ArticleId IdType="pii">10.1038/s41467-023-38719-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Cullen PJ, Steinberg F. To degrade or not to degrade: mechanisms and significance of endocytic recycling. Nat. Rev. Mol. Cell Biol. 2018;19:679&#x2013;696. doi: 10.1038/s41580-018-0053-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41580-018-0053-7</ArticleId><ArticleId IdType="pubmed">30194414</ArticleId></ArticleIdList></Reference><Reference><Citation>Seaman MNJ, McCaffery JM, Emr SD. A membrane coat complex essential for endosome-to-Golgi retrograde transport in yeast. J. Cell Biol. 1998;142:665&#x2013;681. doi: 10.1083/jcb.142.3.665.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.142.3.665</ArticleId><ArticleId IdType="pmc">PMC2148169</ArticleId><ArticleId IdType="pubmed">9700157</ArticleId></ArticleIdList></Reference><Reference><Citation>Kvainickas A, et al. Retromer and TBC1D5 maintain late endosomal RAB7 domains to enable amino acid-induced mTORC1 signaling. J. Cell Biol. 2019;218:3019&#x2013;3038. doi: 10.1083/jcb.201812110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.201812110</ArticleId><ArticleId IdType="pmc">PMC6719456</ArticleId><ArticleId IdType="pubmed">31431476</ArticleId></ArticleIdList></Reference><Reference><Citation>Jimenez&#x2010;Orgaz, A. et al. Control of RAB7 activity and localization through the retromer&#x2010;TBC1D5 complex enables RAB7&#x2010;dependent mitophagy. EMBO J. 37, 235&#x2013;254 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5770787</ArticleId><ArticleId IdType="pubmed">29158324</ArticleId></ArticleIdList></Reference><Reference><Citation>Seaman MNJJ, Harbour ME, Tattersall D, Read E, Bright N. Membrane recruitment of the cargo-selective retromer subcomplex is catalysed by the small GTPase Rab7 and inhibited by the Rab-GAP TBC1D5. J. Cell Sci. 2009;122:2371&#x2013;2382. doi: 10.1242/jcs.048686.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.048686</ArticleId><ArticleId IdType="pmc">PMC2704877</ArticleId><ArticleId IdType="pubmed">19531583</ArticleId></ArticleIdList></Reference><Reference><Citation>Carosi JM, et al. Retromer regulates the lysosomal clearance of MAPT/tau. Autophagy. 2020;00:1&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8496733</ArticleId><ArticleId IdType="pubmed">32960680</ArticleId></ArticleIdList></Reference><Reference><Citation>Bi F, Li F, Huang C, Zhou H. Pathogenic mutation in VPS35 impairs its protection against MPP(+) cytotoxicity. Int. J. Biol. Sci. 2013;9:149&#x2013;155. doi: 10.7150/ijbs.5617.</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/ijbs.5617</ArticleId><ArticleId IdType="pmc">PMC3572397</ArticleId><ArticleId IdType="pubmed">23411763</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang FL, et al. VPS35 in dopamine neurons is required for endosome-to- golgi retrieval of Lamp2a, a receptor of chaperone- mediated autophagy that is critical for &#x3b1;-synuclein degradation and prevention of pathogenesis of Parkinson&#x2019;s disease. J. Neurosci. 2015;35:10613&#x2013;10628. doi: 10.1523/JNEUROSCI.0042-15.2015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.0042-15.2015</ArticleId><ArticleId IdType="pmc">PMC4510296</ArticleId><ArticleId IdType="pubmed">26203154</ArticleId></ArticleIdList></Reference><Reference><Citation>Sullivan CP, et al. Retromer disruption promotes amyloidogenic APP processing. Neurobiol. Dis. 2011;43:338&#x2013;345. doi: 10.1016/j.nbd.2011.04.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2011.04.002</ArticleId><ArticleId IdType="pmc">PMC3114192</ArticleId><ArticleId IdType="pubmed">21515373</ArticleId></ArticleIdList></Reference><Reference><Citation>Simoes S, et al. Tau and other proteins found in Alzheimer&#x2019;s disease spinal fluid are linked to retromer-mediated endosomal traffic in mice and humans. Sci. Transl. Med. 2020;12:eaba6334. doi: 10.1126/scitranslmed.aba6334.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.aba6334</ArticleId><ArticleId IdType="pmc">PMC7901670</ArticleId><ArticleId IdType="pubmed">33239387</ArticleId></ArticleIdList></Reference><Reference><Citation>Small SA, et al. Model-guided microarray implicates the retromer complex in Alzheimer&#x2019;s disease. Ann. Neurol. 2005;58:909&#x2013;919. doi: 10.1002/ana.20667.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.20667</ArticleId><ArticleId IdType="pubmed">16315276</ArticleId></ArticleIdList></Reference><Reference><Citation>Zimprich A, et al. A mutation in VPS35, encoding a subunit of the retromer complex, causes late-onset Parkinson disease. Am. J. Hum. Genet. 2011;89:168&#x2013;175. doi: 10.1016/j.ajhg.2011.06.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajhg.2011.06.008</ArticleId><ArticleId IdType="pmc">PMC3135812</ArticleId><ArticleId IdType="pubmed">21763483</ArticleId></ArticleIdList></Reference><Reference><Citation>Muhammad A, et al. Retromer deficiency observed in Alzheimer&#x2019;s disease causes hippocampal dysfunction, neurodegeneration, and Abeta accumulation. Proc. Natl. Acad. Sci. USA. 2008;105:7327&#x2013;7332. doi: 10.1073/pnas.0802545105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0802545105</ArticleId><ArticleId IdType="pmc">PMC2386077</ArticleId><ArticleId IdType="pubmed">18480253</ArticleId></ArticleIdList></Reference><Reference><Citation>Wen L, et al. VPS35 haploinsufficiency increases Alzheimer&#x2019;s disease neuropathology. J. Cell Biol. 2011;195:765&#x2013;779. doi: 10.1083/jcb.201105109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.201105109</ArticleId><ArticleId IdType="pmc">PMC3257571</ArticleId><ArticleId IdType="pubmed">22105352</ArticleId></ArticleIdList></Reference><Reference><Citation>Vilari&#xf1;o-G&#xfc;ell C, et al. VPS35 mutations in parkinson disease. Am. J. Hum. Genet. 2011;89:162&#x2013;167. doi: 10.1016/j.ajhg.2011.06.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajhg.2011.06.001</ArticleId><ArticleId IdType="pmc">PMC3135796</ArticleId><ArticleId IdType="pubmed">21763482</ArticleId></ArticleIdList></Reference><Reference><Citation>Rovelet-Lecrux A, et al. De novo deleterious genetic variations target a biological network centered on A&#x3b2; peptide in early-onset Alzheimer disease. Mol. Psychiatry. 2015;20:1046&#x2013;1056. doi: 10.1038/mp.2015.100.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/mp.2015.100</ArticleId><ArticleId IdType="pubmed">26194182</ArticleId></ArticleIdList></Reference><Reference><Citation>Sargent D, et al. Neuronal VPS35 deletion induces spinal cord motor neuron degeneration and early post-natal lethality. Brain Commun. 2021;3:fcab208. doi: 10.1093/braincomms/fcab208.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/braincomms/fcab208</ArticleId><ArticleId IdType="pmc">PMC8445400</ArticleId><ArticleId IdType="pubmed">34704029</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans AJ, Daly JL, Anuar ANK, Simonetti B, Cullen PJ. Acute inactivation of retromer and ESCPE-1 leads to time-resolved defects in endosomal cargo sorting. J. Cell Sci. 2020;133:jcs246033. doi: 10.1242/jcs.246033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.246033</ArticleId><ArticleId IdType="pmc">PMC7420817</ArticleId><ArticleId IdType="pubmed">32747499</ArticleId></ArticleIdList></Reference><Reference><Citation>Simonetti B, Danson CM, Heesom KJ, Cullen PJ. Sequence-dependent cargo recognition by SNX-BARs mediates retromer-independent transport of CI-MPR. J. Cell Biol. 2017;216:3695&#x2013;3712. doi: 10.1083/jcb.201703015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.201703015</ArticleId><ArticleId IdType="pmc">PMC5674890</ArticleId><ArticleId IdType="pubmed">28935633</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang CL, et al. VPS35 regulates developing mouse hippocampal neuronal morphogenesis by promoting retrograde trafficking of BACE1. Biol. Open. 2012;1:1248&#x2013;1257. doi: 10.1242/bio.20122451.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/bio.20122451</ArticleId><ArticleId IdType="pmc">PMC3522886</ArticleId><ArticleId IdType="pubmed">23259059</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang FL, et al. Coupling of terminal differentiation deficit with neurodegenerative pathology in Vps35-deficient pyramidal neurons. Cell Death Differ. 2020;27:2099&#x2013;2116. doi: 10.1038/s41418-019-0487-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41418-019-0487-2</ArticleId><ArticleId IdType="pmc">PMC7308361</ArticleId><ArticleId IdType="pubmed">31907392</ArticleId></ArticleIdList></Reference><Reference><Citation>Cataldo AM, et al. Endocytic pathway abnormalities precede amyloid &#x3b2; deposition in sporadic Alzheimer&#x2019;s disease and down syndrome: differential effects of APOE genotype and presenilin mutations. Am. J. Pathol. 2000;157:277&#x2013;286. doi: 10.1016/S0002-9440(10)64538-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0002-9440(10)64538-5</ArticleId><ArticleId IdType="pmc">PMC1850219</ArticleId><ArticleId IdType="pubmed">10880397</ArticleId></ArticleIdList></Reference><Reference><Citation>Crews L, et al. Selective molecular alterations in the autophagy pathway in patients with Lewy body disease and in models of &#x3b1;-synucleinopathy. PLoS ONE. 2010;5:e9313. doi: 10.1371/journal.pone.0009313.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0009313</ArticleId><ArticleId IdType="pmc">PMC2824828</ArticleId><ArticleId IdType="pubmed">20174468</ArticleId></ArticleIdList></Reference><Reference><Citation>Shahmoradian SH, et al. Lewy pathology in Parkinson&#x2019;s disease consists of crowded organelles and lipid membranes. Nat. Neurosci. 2019;22:1099&#x2013;1109. doi: 10.1038/s41593-019-0423-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-019-0423-2</ArticleId><ArticleId IdType="pubmed">31235907</ArticleId></ArticleIdList></Reference><Reference><Citation>Abu-Remaileh M, et al. Lysosomal metabolomics reveals V-ATPase- and mTOR-dependent regulation of amino acid efflux from lysosomes. Science. 2017;358:807&#x2013;813. doi: 10.1126/science.aan6298.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aan6298</ArticleId><ArticleId IdType="pmc">PMC5704967</ArticleId><ArticleId IdType="pubmed">29074583</ArticleId></ArticleIdList></Reference><Reference><Citation>Curnock R, Calcagni A, Ballabio A, Cullen PJ. TFEB controls retromer expression in response to nutrient availability. J. Cell Biol. 2019;218:3954&#x2013;3966. doi: 10.1083/jcb.201903006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.201903006</ArticleId><ArticleId IdType="pmc">PMC6891082</ArticleId><ArticleId IdType="pubmed">31694921</ArticleId></ArticleIdList></Reference><Reference><Citation>Pu J, et al. BORC, a multisubunit complex that regulates lysosome positioning. Dev. Cell. 2015;33:176&#x2013;188. doi: 10.1016/j.devcel.2015.02.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.devcel.2015.02.011</ArticleId><ArticleId IdType="pmc">PMC4788105</ArticleId><ArticleId IdType="pubmed">25898167</ArticleId></ArticleIdList></Reference><Reference><Citation>Bar-Peled L, Sabatini DM. Regulation of mTORC1 by amino acids. Trends Cell Biol. 2014;24:400&#x2013;406. doi: 10.1016/j.tcb.2014.03.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tcb.2014.03.003</ArticleId><ArticleId IdType="pmc">PMC4074565</ArticleId><ArticleId IdType="pubmed">24698685</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui Y, et al. Retromer has a selective function in cargo sorting via endosome transport carriers. J. Cell Biol. 2019;218:615&#x2013;631. doi: 10.1083/jcb.201806153.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.201806153</ArticleId><ArticleId IdType="pmc">PMC6363445</ArticleId><ArticleId IdType="pubmed">30559172</ArticleId></ArticleIdList></Reference><Reference><Citation>Gegg ME, Schapira AHV. The role of glucocerebrosidase in Parkinson disease pathogenesis. FEBS J. 2018;285:3591&#x2013;3603. doi: 10.1111/febs.14393.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/febs.14393</ArticleId><ArticleId IdType="pubmed">29385658</ArticleId></ArticleIdList></Reference><Reference><Citation>Gieselmann V. Lysosomal storage diseases. Biochim. Biophys. Acta&#x2014;Mol. Basis Dis. 1995;1270:103&#x2013;136. doi: 10.1016/0925-4439(94)00075-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0925-4439(94)00075-2</ArticleId><ArticleId IdType="pubmed">7727535</ArticleId></ArticleIdList></Reference><Reference><Citation>Zerial M, McBride H. Rab proteins as membrane organizers. Nat. Rev. Mol. Cell Biol. 2001;2:107&#x2013;117. doi: 10.1038/35052055.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/35052055</ArticleId><ArticleId IdType="pubmed">11252952</ArticleId></ArticleIdList></Reference><Reference><Citation>Egami Y, Araki N. Rab20 regulates phagosome maturation in RAW264 macrophages during Fc gamma receptor-mediated phagocytosis. PLoS ONE. 2012;7:e35663. doi: 10.1371/journal.pone.0035663.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0035663</ArticleId><ArticleId IdType="pmc">PMC3335809</ArticleId><ArticleId IdType="pubmed">22545127</ArticleId></ArticleIdList></Reference><Reference><Citation>Jean S, Cox S, Nassari S, Kiger AA. Starvation-induced MTMR13 and RAB21 activity regulates VAMP8 to promote autophagosome&#x2013;lysosome fusion. EMBO Rep. 2015;16:297. doi: 10.15252/embr.201439464.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embr.201439464</ArticleId><ArticleId IdType="pmc">PMC4364869</ArticleId><ArticleId IdType="pubmed">25648148</ArticleId></ArticleIdList></Reference><Reference><Citation>Kasmapour B, Gronow A, Bleck CKE, Hong W, Gutierrez MG. Size-dependent mechanism of cargo sorting during lysosome-phagosome fusion is controlled by Rab34. Proc. Natl. Acad. Sci. USA. 2012;109:20485&#x2013;20490. doi: 10.1073/pnas.1206811109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1206811109</ArticleId><ArticleId IdType="pmc">PMC3528610</ArticleId><ArticleId IdType="pubmed">23197834</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilson GR, et al. Mutations in RAB39B cause x-linked intellectual disability and early-onset parkinson disease with &#x3b1;-synuclein pathology. Am. J. Hum. Genet. 2014;95:729&#x2013;735. doi: 10.1016/j.ajhg.2014.10.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajhg.2014.10.015</ArticleId><ArticleId IdType="pmc">PMC4259921</ArticleId><ArticleId IdType="pubmed">25434005</ArticleId></ArticleIdList></Reference><Reference><Citation>Gon&#xe7;alves SA, et al. shRNA-based screen identifies endocytic recycling pathway components that act as genetic modifiers of alpha-synuclein aggregation, secretion and toxicity. PLOS Genet. 2016;12:e1005995. doi: 10.1371/journal.pgen.1005995.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1005995</ArticleId><ArticleId IdType="pmc">PMC4849646</ArticleId><ArticleId IdType="pubmed">27123591</ArticleId></ArticleIdList></Reference><Reference><Citation>Hashimoto Y, Shirane M, Nakayama KI. TMEM55B contributes to lysosomal homeostasis and amino acid&#x2013;induced mTORC1 activation. Genes Cells. 2018;23:418&#x2013;434. doi: 10.1111/gtc.12583.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/gtc.12583</ArticleId><ArticleId IdType="pubmed">29644770</ArticleId></ArticleIdList></Reference><Reference><Citation>Willett R, et al. TFEB regulates lysosomal positioning by modulating TMEM55B expression and JIP4 recruitment to lysosomes. Nat. Commun. 2017;8:1&#x2013;17. doi: 10.1038/s41467-017-01871-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-017-01871-z</ArticleId><ArticleId IdType="pmc">PMC5691037</ArticleId><ArticleId IdType="pubmed">29146937</ArticleId></ArticleIdList></Reference><Reference><Citation>Dai L, et al. Cholesterol metabolism in neurodegenerative diseases: molecular mechanisms and therapeutic targets. Mol. Neurobiol. 2021;58:2183&#x2013;2201. doi: 10.1007/s12035-020-02232-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-020-02232-6</ArticleId><ArticleId IdType="pubmed">33411241</ArticleId></ArticleIdList></Reference><Reference><Citation>Graves AR, Curran PK, Smith CL, Mindell JA. The Cl-/H+ antiporter ClC-7 is the primary chloride permeation pathway in lysosomes. Nature. 2008;453:788&#x2013;792. doi: 10.1038/nature06907.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature06907</ArticleId><ArticleId IdType="pubmed">18449189</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu M, et al. Parkinson&#x2019;s disease-risk protein TMEM175 is a proton-activated proton channel in lysosomes. Cell. 2022;185:2292&#x2013;2308.e20. doi: 10.1016/j.cell.2022.05.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.05.021</ArticleId><ArticleId IdType="pmc">PMC9236176</ArticleId><ArticleId IdType="pubmed">35750034</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Brien RJ, Wong PC. Amyloid precursor protein processing and Alzheimer&#x2019;s disease. Annu. Rev. Neurosci. 2011;34:185&#x2013;204. doi: 10.1146/annurev-neuro-061010-113613.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-neuro-061010-113613</ArticleId><ArticleId IdType="pmc">PMC3174086</ArticleId><ArticleId IdType="pubmed">21456963</ArticleId></ArticleIdList></Reference><Reference><Citation>Qureshi YH, et al. The neuronal retromer can regulate both neuronal and microglial phenotypes of Alzheimer&#x2019;s disease. Cell Rep. 2022;38:110262. doi: 10.1016/j.celrep.2021.110262.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2021.110262</ArticleId><ArticleId IdType="pmc">PMC8830374</ArticleId><ArticleId IdType="pubmed">35045281</ArticleId></ArticleIdList></Reference><Reference><Citation>Nixon RA. Amyloid precursor protein and endosomal&#x2013;lysosomal dysfunction in Alzheimer&#x2019;s disease: inseparable partners in a multifactorial disease. FASEB J. 2017;31:2729. doi: 10.1096/fj.201700359.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.201700359</ArticleId><ArticleId IdType="pmc">PMC6137496</ArticleId><ArticleId IdType="pubmed">28663518</ArticleId></ArticleIdList></Reference><Reference><Citation>Steinberg F, et al. A global analysis of SNX27-retromer assembly and cargo specificity reveals a function in glucose and metal ion transport. Nat. Cell Biol. 2013;15:461&#x2013;471. doi: 10.1038/ncb2721.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncb2721</ArticleId><ArticleId IdType="pmc">PMC4052425</ArticleId><ArticleId IdType="pubmed">23563491</ArticleId></ArticleIdList></Reference><Reference><Citation>Li B, et al. The retromer complex safeguards against neural progenitor-derived tumorigenesis by regulating notch receptor trafficking. Elife. 2018;7:e38181. doi: 10.7554/eLife.38181.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.38181</ArticleId><ArticleId IdType="pmc">PMC6140715</ArticleId><ArticleId IdType="pubmed">30176986</ArticleId></ArticleIdList></Reference><Reference><Citation>Curnock R, Cullen PJ. Mammalian copper homeostasis requires retromer-dependent recycling of the high-affinity copper transporter 1. J. Cell Sci. 2020;133:jcs249201. doi: 10.1242/jcs.249201.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.249201</ArticleId><ArticleId IdType="pmc">PMC7473646</ArticleId><ArticleId IdType="pubmed">32843536</ArticleId></ArticleIdList></Reference><Reference><Citation>Kvainickas A, et al. Retromer- and WASH-dependent sorting of nutrient transporters requires a multivalent interaction network with ANKRD50. J. Cell Sci. 2017;130:382&#x2013;395.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5278674</ArticleId><ArticleId IdType="pubmed">27909246</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakamura F, Kalb RG, Strittmatter SM. Molecular basis of semaphorin-mediated axon guidance. J Neurobiol. 2000;44:219&#x2013;229. doi: 10.1002/1097-4695(200008)44:2&lt;219::AID-NEU11&gt;3.0.CO;2-W.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1097-4695(200008)44:2&lt;219::AID-NEU11&gt;3.0.CO;2-W</ArticleId><ArticleId IdType="pubmed">10934324</ArticleId></ArticleIdList></Reference><Reference><Citation>Giniger E. Notch signaling and neural connectivity. Curr. Opin. Genet. Dev. 2012;22:339. doi: 10.1016/j.gde.2012.04.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gde.2012.04.003</ArticleId><ArticleId IdType="pmc">PMC3426662</ArticleId><ArticleId IdType="pubmed">22608692</ArticleId></ArticleIdList></Reference><Reference><Citation>Ivakine EA, et al. Neto2 is a KCC2 interacting protein required for neuronal Cl- regulation in hippocampal neurons. Proc. Natl. Acad. Sci. USA. 2013;110:3561&#x2013;3566. doi: 10.1073/pnas.1212907110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1212907110</ArticleId><ArticleId IdType="pmc">PMC3587235</ArticleId><ArticleId IdType="pubmed">23401525</ArticleId></ArticleIdList></Reference><Reference><Citation>Vernon CG, Swanson GT. Neto2 assembles with kainate receptors in DRG neurons during development and modulates neurite outgrowth in adult sensory neurons. J. Neurosci. 2017;37:3352. doi: 10.1523/JNEUROSCI.2978-16.2017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.2978-16.2017</ArticleId><ArticleId IdType="pmc">PMC5373122</ArticleId><ArticleId IdType="pubmed">28235897</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahadevan V, et al. Neto2-null mice have impaired GABAergic inhibition and are susceptible to seizures. Front. Cell. Neurosci. 2015;9:368. doi: 10.3389/fncel.2015.00368.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2015.00368</ArticleId><ArticleId IdType="pmc">PMC4585209</ArticleId><ArticleId IdType="pubmed">26441539</ArticleId></ArticleIdList></Reference><Reference><Citation>del Puerto A, et al. Kidins220 deficiency causes ventriculomegaly via SNX27-retromer-dependent AQP4 degradation. Mol. Psychiatry. 2021;26:6411&#x2013;6426. doi: 10.1038/s41380-021-01127-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41380-021-01127-9</ArticleId><ArticleId IdType="pmc">PMC8760065</ArticleId><ArticleId IdType="pubmed">34002021</ArticleId></ArticleIdList></Reference><Reference><Citation>Sebasti&#xe1;n-Serrano &#xc1;, et al. Differential regulation of Kidins220 isoforms in Huntington&#x2019;s disease. Brain Pathol. 2020;30:120&#x2013;136. doi: 10.1111/bpa.12761.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bpa.12761</ArticleId><ArticleId IdType="pmc">PMC8018008</ArticleId><ArticleId IdType="pubmed">31264746</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Q, S&#xfc;dhof TC. Cleavage of amyloid-&#x3b2; precursor protein and amyloid-&#x3b2; precursor-like protein by BACE 1. J. Biol. Chem. 2004;279:10542&#x2013;10550. doi: 10.1074/jbc.M310001200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M310001200</ArticleId><ArticleId IdType="pubmed">14699153</ArticleId></ArticleIdList></Reference><Reference><Citation>Fotinopoulou A, et al. BRI2 interacts with amyloid precursor protein (APP) and regulates amyloid &#x3b2; (A&#x3b2;) production. J. Biol. Chem. 2005;280:30768&#x2013;30772. doi: 10.1074/jbc.C500231200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.C500231200</ArticleId><ArticleId IdType="pubmed">16027166</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsuda S, et al. The familial dementia BRI2 gene binds the Alzheimer gene amyloid-&#x3b2; precursor protein and inhibits amyloid-&#x3b2; production. J. Biol. Chem. 2005;280:28912&#x2013;28916. doi: 10.1074/jbc.C500217200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.C500217200</ArticleId><ArticleId IdType="pubmed">15983050</ArticleId></ArticleIdList></Reference><Reference><Citation>Medina DL, et al. Transcriptional activation of lysosomal exocytosis promotes cellular clearance. Dev. Cell. 2011;21:421&#x2013;430. doi: 10.1016/j.devcel.2011.07.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.devcel.2011.07.016</ArticleId><ArticleId IdType="pmc">PMC3173716</ArticleId><ArticleId IdType="pubmed">21889421</ArticleId></ArticleIdList></Reference><Reference><Citation>Alvarez-Erviti L, et al. Lysosomal dysfunction increases exosome-mediated alpha-synuclein release and transmission. Neurobiol. Dis. 2011;42:360&#x2013;367. doi: 10.1016/j.nbd.2011.01.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2011.01.029</ArticleId><ArticleId IdType="pmc">PMC3107939</ArticleId><ArticleId IdType="pubmed">21303699</ArticleId></ArticleIdList></Reference><Reference><Citation>Miranda AM, et al. Neuronal lysosomal dysfunction releases exosomes harboring APP C-terminal fragments and unique lipid signatures. Nat. Commun. 2018;9:1&#x2013;16. doi: 10.1038/s41467-017-02533-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-017-02533-w</ArticleId><ArticleId IdType="pmc">PMC5773483</ArticleId><ArticleId IdType="pubmed">29348617</ArticleId></ArticleIdList></Reference><Reference><Citation>Ballabio A, Bonifacino JS. Lysosomes as dynamic regulators of cell and organismal homeostasis. Nat. Rev. Mol. Cell Biol. 2020;21:101&#x2013;118. doi: 10.1038/s41580-019-0185-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41580-019-0185-4</ArticleId><ArticleId IdType="pubmed">31768005</ArticleId></ArticleIdList></Reference><Reference><Citation>Follett J, et al. The Vps35 D620N mutation linked to Parkinson&#x2019;s disease disrupts the cargo sorting function of retromer. Traffic. 2014;15:230&#x2013;244. doi: 10.1111/tra.12136.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/tra.12136</ArticleId><ArticleId IdType="pubmed">24152121</ArticleId></ArticleIdList></Reference><Reference><Citation>Bugarcic A, et al. Vps26A and Vps26B subunits define distinct retromer complexes. Traffic. 2011;12:1759&#x2013;1773. doi: 10.1111/j.1600-0854.2011.01284.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-0854.2011.01284.x</ArticleId><ArticleId IdType="pubmed">21920005</ArticleId></ArticleIdList></Reference><Reference><Citation>Rojas R, et al. Regulation of retromer recruitment to endosomes by sequential action of Rab5 and Rab7. J. Cell Biol. 2008;183:513&#x2013;526. doi: 10.1083/jcb.200804048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.200804048</ArticleId><ArticleId IdType="pmc">PMC2575791</ArticleId><ArticleId IdType="pubmed">18981234</ArticleId></ArticleIdList></Reference><Reference><Citation>Hata S, et al. Alcadein cleavages by amyloid &#x3b2;-precursor protein (APP) &#x3b1;- and &#x3b3;-secretases generate small peptides, p3-Alcs, indicating Alzheimer disease-related &#x3b3;-secretase dysfunction. J. Biol. Chem. 2009;284:36024&#x2013;36033. doi: 10.1074/jbc.M109.057497.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M109.057497</ArticleId><ArticleId IdType="pmc">PMC2794718</ArticleId><ArticleId IdType="pubmed">19864413</ArticleId></ArticleIdList></Reference><Reference><Citation>Walsh RB, et al. Opposing functions for retromer and Rab11 in extracellular vesicle traffic at presynaptic terminals. J. Cell Biol. 2021;220:e202012034. doi: 10.1083/jcb.202012034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.202012034</ArticleId><ArticleId IdType="pmc">PMC8144913</ArticleId><ArticleId IdType="pubmed">34019080</ArticleId></ArticleIdList></Reference><Reference><Citation>Sardiello M, et al. A gene network regulating lysosomal biogenesis and function. Science. 2009;325:473&#x2013;477. doi: 10.1126/science.1174447.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1174447</ArticleId><ArticleId IdType="pubmed">19556463</ArticleId></ArticleIdList></Reference><Reference><Citation>Settembre C, et al. A lysosome-to-nucleus signalling mechanism senses and regulates the lysosome via mTOR and TFEB. EMBO J. 2012;31:1095&#x2013;1108. doi: 10.1038/emboj.2012.32.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emboj.2012.32</ArticleId><ArticleId IdType="pmc">PMC3298007</ArticleId><ArticleId IdType="pubmed">22343943</ArticleId></ArticleIdList></Reference><Reference><Citation>Palmieri M, et al. Characterization of the CLEAR network reveals an integrated control of cellular clearance pathways. Hum. Mol. Genet. 2011;20:3852&#x2013;3866. doi: 10.1093/hmg/ddr306.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddr306</ArticleId><ArticleId IdType="pubmed">21752829</ArticleId></ArticleIdList></Reference><Reference><Citation>Pe&#xf1;a-Llopis S, et al. Regulation of TFEB and V-ATPases by mTORC1. EMBO J. 2011;30:3242&#x2013;3258. doi: 10.1038/emboj.2011.257.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emboj.2011.257</ArticleId><ArticleId IdType="pmc">PMC3160667</ArticleId><ArticleId IdType="pubmed">21804531</ArticleId></ArticleIdList></Reference><Reference><Citation>Mansueto G, et al. Transcription factor EB controls metabolic flexibility during exercise. Cell Metab. 2017;25:182&#x2013;196. doi: 10.1016/j.cmet.2016.11.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2016.11.003</ArticleId><ArticleId IdType="pmc">PMC5241227</ArticleId><ArticleId IdType="pubmed">28011087</ArticleId></ArticleIdList></Reference><Reference><Citation>Seaman MNJ. Identification of a novel conserved sorting motif required for retromer-mediated endosome-to-TGN retrieval. J. Cell Sci. 2007;120:2378&#x2013;2389. doi: 10.1242/jcs.009654.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.009654</ArticleId><ArticleId IdType="pubmed">17606993</ArticleId></ArticleIdList></Reference><Reference><Citation>Lucas M, et al. Structural mechanism for cargo recognition by the retromer complex. Cell. 2016;167:1623&#x2013;1635.e14. doi: 10.1016/j.cell.2016.10.056.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2016.10.056</ArticleId><ArticleId IdType="pmc">PMC5147500</ArticleId><ArticleId IdType="pubmed">27889239</ArticleId></ArticleIdList></Reference><Reference><Citation>Ostrowski M, et al. Rab27a and Rab27b control different steps of the exosome secretion pathway. Nat. Cell Biol. 2010;12:19&#x2013;30. doi: 10.1038/ncb2000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncb2000</ArticleId><ArticleId IdType="pubmed">19966785</ArticleId></ArticleIdList></Reference><Reference><Citation>Joshi CS, Mora A, Felder PA, Mysorekar IU. NRF2 promotes urothelial cell response to bacterial infection by regulating reactive oxygen species and RAB27B expression. Cell Rep. 2021;37:109856. doi: 10.1016/j.celrep.2021.109856.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2021.109856</ArticleId><ArticleId IdType="pubmed">34686330</ArticleId></ArticleIdList></Reference><Reference><Citation>Underwood R, et al. The GTPase Rab27b regulates the release, autophagic clearance, and toxicity of alpha-synuclein. J. Biol. Chem. 2020;295:8005&#x2013;8016. doi: 10.1074/jbc.RA120.013337.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.RA120.013337</ArticleId><ArticleId IdType="pmc">PMC7278354</ArticleId><ArticleId IdType="pubmed">32350025</ArticleId></ArticleIdList></Reference><Reference><Citation>Underwood, R., Wang, B., Pathak, A., Volpicelli-Daley, L. &amp; Yacoubian, T. A. Rab27 GTPases regulate alpha-synuclein uptake, cell-to-cell transmission, and toxicity. bioRxiv 2020.11.17.387449. 10.1101/2020.11.17.387449 (2020).</Citation></Reference><Reference><Citation>Jia D, et al. Structural and mechanistic insights into regulation of the retromer coat by TBC1d5. Nat. Commun. 2016;7:1&#x2013;11. doi: 10.1038/ncomms13305.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms13305</ArticleId><ArticleId IdType="pmc">PMC5105194</ArticleId><ArticleId IdType="pubmed">27827364</ArticleId></ArticleIdList></Reference><Reference><Citation>Hesketh G, et al. VARP is recruited on to endosomes by direct interaction with retromer, where together they function in export to the cell surface. Dev. Cell. 2014;29:591&#x2013;606. doi: 10.1016/j.devcel.2014.04.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.devcel.2014.04.010</ArticleId><ArticleId IdType="pmc">PMC4059916</ArticleId><ArticleId IdType="pubmed">24856514</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu L, et al. Termination of autophagy and reformation of lysosomes regulated by mTOR. Nature. 2010;465:942&#x2013;946. doi: 10.1038/nature09076.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature09076</ArticleId><ArticleId IdType="pmc">PMC2920749</ArticleId><ArticleId IdType="pubmed">20526321</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu K, et al. BLOC1S1/GCN5L1/BORCS1 is a critical mediator for the initiation of autolysosomal tubulation. Autophagy. 2021;17:3707&#x2013;3724. doi: 10.1080/15548627.2021.1894759.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2021.1894759</ArticleId><ArticleId IdType="pmc">PMC8632325</ArticleId><ArticleId IdType="pubmed">33629936</ArticleId></ArticleIdList></Reference><Reference><Citation>McGrath MJ, et al. Defective lysosome reformation during autophagy causes skeletal muscle disease. J. Clin. Invest. 2021;131:e135124. doi: 10.1172/JCI135124.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI135124</ArticleId><ArticleId IdType="pmc">PMC7773396</ArticleId><ArticleId IdType="pubmed">33119550</ArticleId></ArticleIdList></Reference><Reference><Citation>Mecozzi VJ, et al. Pharmacological chaperones stabilize retromer to limit APP processing. Nat. Chem. Biol. 2014;10:443&#x2013;449. doi: 10.1038/nchembio.1508.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nchembio.1508</ArticleId><ArticleId IdType="pmc">PMC4076047</ArticleId><ArticleId IdType="pubmed">24747528</ArticleId></ArticleIdList></Reference><Reference><Citation>Muzio L, et al. Retromer stabilization results in neuroprotection in a model of Amyotrophic Lateral Sclerosis. Nat. Commun. 2020;11:1&#x2013;17. doi: 10.1038/s41467-020-17524-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-17524-7</ArticleId><ArticleId IdType="pmc">PMC7395176</ArticleId><ArticleId IdType="pubmed">32737286</ArticleId></ArticleIdList></Reference><Reference><Citation>Luzio JP, Pryor PR, Bright NA. Lysosomes: Fusion and function. Nat. Rev. Mol. Cell Biol. 2007;8:622&#x2013;632. doi: 10.1038/nrm2217.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrm2217</ArticleId><ArticleId IdType="pubmed">17637737</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y, Yu L. Recent progress in autophagic lysosome reformation. Traffic. 2017;18:358&#x2013;361. doi: 10.1111/tra.12484.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/tra.12484</ArticleId><ArticleId IdType="pubmed">28371052</ArticleId></ArticleIdList></Reference><Reference><Citation>Zavodszky E, et al. Mutation in VPS35 associated with Parkinson&#x2019;s disease impairs WASH complex association and inhibits autophagy. Nat. Commun. 2014;5:3828. doi: 10.1038/ncomms4828.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms4828</ArticleId><ArticleId IdType="pmc">PMC4024763</ArticleId><ArticleId IdType="pubmed">24819384</ArticleId></ArticleIdList></Reference><Reference><Citation>Pu J, Keren-Kaplan T, Bonifacino JS. A Ragulator-BORC interaction controls lysosome positioning in response to amino acid availability. J. Cell Biol. 2017;216:4183&#x2013;4197. doi: 10.1083/jcb.201703094.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.201703094</ArticleId><ArticleId IdType="pmc">PMC5716277</ArticleId><ArticleId IdType="pubmed">28993468</ArticleId></ArticleIdList></Reference><Reference><Citation>Yordanov TE, et al. Biogenesis of lysosome-related organelles complex-1 (BORC) regulates late endosomal/lysosomal size through PIKfyve-dependent phosphatidylinositol-3,5-bisphosphate. Traffic. 2019;20:674&#x2013;696.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6771566</ArticleId><ArticleId IdType="pubmed">31314175</ArticleId></ArticleIdList></Reference><Reference><Citation>Rong Y, et al. Clathrin and phosphatidylinositol-4,5-bisphosphate regulate autophagic lysosome reformation. Nat. Cell Biol. 2012;14:924&#x2013;934. doi: 10.1038/ncb2557.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncb2557</ArticleId><ArticleId IdType="pubmed">22885770</ArticleId></ArticleIdList></Reference><Reference><Citation>Du W, et al. Kinesin 1 drives autolysosome tubulation. Dev. Cell. 2016;37:326&#x2013;336. doi: 10.1016/j.devcel.2016.04.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.devcel.2016.04.014</ArticleId><ArticleId IdType="pubmed">27219061</ArticleId></ArticleIdList></Reference><Reference><Citation>Dai A, Yu L, Wang HW. WHAMM initiates autolysosome tubulation by promoting actin polymerization on autolysosomes. Nat. Commun. 2019;10:3699. doi: 10.1038/s41467-019-11694-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-11694-9</ArticleId><ArticleId IdType="pmc">PMC6697732</ArticleId><ArticleId IdType="pubmed">31420534</ArticleId></ArticleIdList></Reference><Reference><Citation>B&#xe9;cot A, Volgers C, van Niel G. Transmissible endosomal intoxication: a balance between exosomes and lysosomes at the basis of intercellular amyloid propagation. Biomedicines. 2020;8:272. doi: 10.3390/biomedicines8080272.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines8080272</ArticleId><ArticleId IdType="pmc">PMC7459801</ArticleId><ArticleId IdType="pubmed">32759666</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang FL, et al. VPS35 deficiency or mutation causes dopaminergic neuronal loss by impairing mitochondrial fusion and function. Cell Rep. 2015;12:1631&#x2013;1643. doi: 10.1016/j.celrep.2015.08.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2015.08.001</ArticleId><ArticleId IdType="pmc">PMC4565770</ArticleId><ArticleId IdType="pubmed">26321632</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian Y, et al. VPS35-deficiency results in an impaired AMPA receptor trafficking and decreased dendritic spine maturation. Mol. Brain. 2015;8:1&#x2013;12. doi: 10.1186/s13041-015-0156-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13041-015-0156-4</ArticleId><ArticleId IdType="pmc">PMC4628247</ArticleId><ArticleId IdType="pubmed">26521016</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao L, et al. pHluorin-BACE1-mCherry acts as a reporter for the intracellular distribution of active BACE1 in vitro and in vivo. Cells. 2019;8:474. doi: 10.3390/cells8050474.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells8050474</ArticleId><ArticleId IdType="pmc">PMC6562731</ArticleId><ArticleId IdType="pubmed">31108937</ArticleId></ArticleIdList></Reference><Reference><Citation>Costes SV, et al. Automatic and quantitative measurement of protein-protein colocalization in live cells. Biophys. J. 2004;86:3993&#x2013;4003. doi: 10.1529/biophysj.103.038422.</Citation><ArticleIdList><ArticleId IdType="doi">10.1529/biophysj.103.038422</ArticleId><ArticleId IdType="pmc">PMC1304300</ArticleId><ArticleId IdType="pubmed">15189895</ArticleId></ArticleIdList></Reference><Reference><Citation>Brenes A, Hukelmann J, Bensaddek D, Lamond AI. Multibatch TMT reveals false positives, batch effects and missing values. Mol. Cell. Proteomics. 2019;18:1967&#x2013;1980. doi: 10.1074/mcp.RA119.001472.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/mcp.RA119.001472</ArticleId><ArticleId IdType="pmc">PMC6773557</ArticleId><ArticleId IdType="pubmed">31332098</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong Y, et al. A comparison of mRNA sequencing with random primed and 3&#x2032;-directed libraries. Sci. Reports. 2017;7:1&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5676863</ArticleId><ArticleId IdType="pubmed">29116112</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobin A, et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2013;29:15&#x2013;21. doi: 10.1093/bioinformatics/bts635.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/bts635</ArticleId><ArticleId IdType="pmc">PMC3530905</ArticleId><ArticleId IdType="pubmed">23104886</ArticleId></ArticleIdList></Reference><Reference><Citation>Anders S, Pyl PT, Huber W. HTSeq&#x2014;a Python framework to work with high-throughput sequencing data. Bioinformatics. 2015;31:166&#x2013;169. doi: 10.1093/bioinformatics/btu638.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btu638</ArticleId><ArticleId IdType="pmc">PMC4287950</ArticleId><ArticleId IdType="pubmed">25260700</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson MD, McCarthy DJ, Smyth GK. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 2010;26:139&#x2013;140. doi: 10.1093/bioinformatics/btp616.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btp616</ArticleId><ArticleId IdType="pmc">PMC2796818</ArticleId><ArticleId IdType="pubmed">19910308</ArticleId></ArticleIdList></Reference><Reference><Citation>Mootha VK, et al. PGC-1&#x3b1;-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat. Genet. 2003;34:267&#x2013;273. doi: 10.1038/ng1180.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng1180</ArticleId><ArticleId IdType="pubmed">12808457</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanian A, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA. 2005;102:15545&#x2013;15550. doi: 10.1073/pnas.0506580102.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0506580102</ArticleId><ArticleId IdType="pmc">PMC1239896</ArticleId><ArticleId IdType="pubmed">16199517</ArticleId></ArticleIdList></Reference><Reference><Citation>Merico D, Isserlin R, Stueker O, Emili A, Bader GD. Enrichment map: a network-based method for gene-set enrichment visualization and interpretation. PLoS ONE. 2010;5:e13984. doi: 10.1371/journal.pone.0013984.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0013984</ArticleId><ArticleId IdType="pmc">PMC2981572</ArticleId><ArticleId IdType="pubmed">21085593</ArticleId></ArticleIdList></Reference><Reference><Citation>Durinck S, Spellman PT, Birney E, Huber W. Mapping identifiers for the integration of genomic datasets with the R/Bioconductor package biomaRt. Nat. Protoc. 2009;4:1184&#x2013;1191. doi: 10.1038/nprot.2009.97.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nprot.2009.97</ArticleId><ArticleId IdType="pmc">PMC3159387</ArticleId><ArticleId IdType="pubmed">19617889</ArticleId></ArticleIdList></Reference><Reference><Citation>Goedhart J, Luijsterburg MS. VolcaNoseR is a web app for creating, exploring, labeling and sharing volcano plots. Sci. Rep. 2020;10:1&#x2013;5. doi: 10.1038/s41598-020-76603-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-76603-3</ArticleId><ArticleId IdType="pmc">PMC7689420</ArticleId><ArticleId IdType="pubmed">33239692</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y, et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat. Commun. 2019;10:1&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6447622</ArticleId><ArticleId IdType="pubmed">30944313</ArticleId></ArticleIdList></Reference><Reference><Citation>Mi H, et al. Protocol Update for large-scale genome and gene function analysis with the PANTHER classification system (v.14.0) Nat. Protoc. 2019;14:703&#x2013;721. doi: 10.1038/s41596-019-0128-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41596-019-0128-8</ArticleId><ArticleId IdType="pmc">PMC6519457</ArticleId><ArticleId IdType="pubmed">30804569</ArticleId></ArticleIdList></Reference><Reference><Citation>Perez-Riverol Y, et al. The PRIDE database resources in 2022: a hub for mass spectrometry-based proteomics evidences. Nucleic Acids Res. 2022;50:D543&#x2013;D552. doi: 10.1093/nar/gkab1038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkab1038</ArticleId><ArticleId IdType="pmc">PMC8728295</ArticleId><ArticleId IdType="pubmed">34723319</ArticleId></ArticleIdList></Reference><Reference><Citation>Edgar R, Domrachev M, Lash AE. Gene expression omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res. 2002;30:207&#x2013;210. doi: 10.1093/nar/30.1.207.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/30.1.207</ArticleId><ArticleId IdType="pmc">PMC99122</ArticleId><ArticleId IdType="pubmed">11752295</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37264161</PMID><DateCompleted><Year>2023</Year><Month>06</Month><Day>08</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1546-1726</ISSN><JournalIssue CitedMedium="Internet"><Volume>26</Volume><Issue>6</Issue><PubDate><Year>2023</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Nature neuroscience</Title><ISOAbbreviation>Nat Neurosci</ISOAbbreviation></Journal><ArticleTitle>Single-nucleus multiregion transcriptomic analysis of brain vasculature in Alzheimer's disease.</ArticleTitle><Pagination><StartPage>970</StartPage><EndPage>982</EndPage><MedlinePgn>970-982</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41593-023-01334-3</ELocationID><Abstract><AbstractText>Cerebrovascular dysregulation is a hallmark of Alzheimer's disease (AD), but the changes that occur in specific cell types have not been fully characterized. Here, we profile single-nucleus transcriptomes in the human cerebrovasculature in six brain regions from 220 individuals with AD and 208 age-matched controls. We annotate 22,514 cerebrovascular cells, including 11 subtypes of endothelial, pericyte, smooth muscle, perivascular fibroblast and ependymal cells. We identify 2,676 differentially expressed genes in AD, including downregulation of PDGFRB in pericytes, and of ABCB1 and ATP10A in endothelial cells, and validate the downregulation of SLC6A1 and upregulation of APOD, INSR and COL4A1 in postmortem AD brain tissues. We detect vasculature, glial and neuronal coexpressed gene modules, suggesting coordinated neurovascular unit dysregulation in AD. Integration with AD genetics reveals 125 AD differentially expressed genes directly linked to AD-associated genetic variants. Lastly, we show that APOE4 genotype-associated differences are significantly enriched among AD-associated genes in capillary and venule endothelial cells, as well as subsets of pericytes and fibroblasts.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s), under exclusive licence to Springer Nature America, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Na</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>MIT Computer Science and Artificial Intelligence Laboratory, Cambridge, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Broad Institute of MIT and Harvard, Cambridge, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Akay</LastName><ForeName>Leyla Anne</ForeName><Initials>LA</Initials><Identifier Source="ORCID">0000-0002-5944-2466</Identifier><AffiliationInfo><Affiliation>MIT Computer Science and Artificial Intelligence Laboratory, Cambridge, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Broad Institute of MIT and Harvard, Cambridge, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Picower Institute for Learning and Memory, Massachusetts Institute of Technology, Cambridge, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Murdock</LastName><ForeName>Mitchell H</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>Picower Institute for Learning and Memory, Massachusetts Institute of Technology, Cambridge, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Yongjin</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>MIT Computer Science and Artificial Intelligence Laboratory, Cambridge, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Broad Institute of MIT and Harvard, Cambridge, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathology and Laboratory Medicine, Department of Statistics, University of British Columbia, Vancouver, British Columbia, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Molecular Oncology, BC Cancer, Vancouver, British Columbia, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Galiana-Melendez</LastName><ForeName>Fabiola</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Picower Institute for Learning and Memory, Massachusetts Institute of Technology, Cambridge, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bubnys</LastName><ForeName>Adele</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Picower Institute for Learning and Memory, Massachusetts Institute of Technology, Cambridge, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Galani</LastName><ForeName>Kyriaki</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>MIT Computer Science and Artificial Intelligence Laboratory, Cambridge, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Broad Institute of MIT and Harvard, Cambridge, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mathys</LastName><ForeName>Hansruedi</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Picower Institute for Learning and Memory, Massachusetts Institute of Technology, Cambridge, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurobiology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Xueqiao</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Picower Institute for Learning and Memory, Massachusetts Institute of Technology, Cambridge, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ng</LastName><ForeName>Ayesha P</ForeName><Initials>AP</Initials><Identifier Source="ORCID">0000-0001-8283-4436</Identifier><AffiliationInfo><Affiliation>Picower Institute for Learning and Memory, Massachusetts Institute of Technology, Cambridge, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bennett</LastName><ForeName>David A</ForeName><Initials>DA</Initials><AffiliationInfo><Affiliation>Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, IL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsai</LastName><ForeName>Li-Huei</ForeName><Initials>LH</Initials><Identifier Source="ORCID">0000-0003-1262-0592</Identifier><AffiliationInfo><Affiliation>Broad Institute of MIT and Harvard, Cambridge, MA, USA. lhtsai@mit.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Picower Institute for Learning and Memory, Massachusetts Institute of Technology, Cambridge, MA, USA. lhtsai@mit.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge, MA, USA. lhtsai@mit.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kellis</LastName><ForeName>Manolis</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-7113-9630</Identifier><AffiliationInfo><Affiliation>MIT Computer Science and Artificial Intelligence Laboratory, Cambridge, MA, USA. manoli@mit.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Broad Institute of MIT and Harvard, Cambridge, MA, USA. manoli@mit.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 AG074003</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>RF1 AG062377</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AG010161</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS127187</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>RF1 AG057473</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG062335</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 MH119509</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG015819</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AG072975</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 DA053631</GrantID><Acronym>DA</Acronym><Agency>NIDA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>RF1 AG054012</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 AG046152</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG058002</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HG008155</GrantID><Acronym>HG</Acronym><Agency>NHGRI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 AG061356</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UG3 NS115064</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG017917</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UH3 NS115064</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 NS110453</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R56 AG067151</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG015473</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG067151</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 MH109978</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>06</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Nat Neurosci</MedlineTA><NlmUniqueID>9809671</NlmUniqueID><ISSNLinking>1097-6256</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="ErratumIn"><RefSource>Nat Neurosci. 2023 Dec;26(12):2251. doi: 10.1038/s41593-023-01507-0.</RefSource><PMID Version="1">37907809</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D059467" MajorTopicYN="N">Transcriptome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D042783" MajorTopicYN="N">Endothelial Cells</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020869" MajorTopicYN="N">Gene Expression Profiling</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>Competing Interests. The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>2</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>4</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>8</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>2</Day><Hour>1</Hour><Minute>7</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>1</Day><Hour>23</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>12</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37264161</ArticleId><ArticleId IdType="mid">NIHMS1916467</ArticleId><ArticleId IdType="pmc">PMC10464935</ArticleId><ArticleId IdType="doi">10.1038/s41593-023-01334-3</ArticleId><ArticleId IdType="pii">10.1038/s41593-023-01334-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Sweeney MD, Kisler K, Montagne A, Toga AW &amp; Zlokovic BV The role of brain vasculature in neurodegenerative disorders. Nat. Neurosci. 21, 1318&#x2013;1331 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6198802</ArticleId><ArticleId IdType="pubmed">30250261</ArticleId></ArticleIdList></Reference><Reference><Citation>Sweeney MD, Sagare AP &amp; Zlokovic BV Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders. Nat. Rev. Neurol. 14, 133&#x2013;150 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5829048</ArticleId><ArticleId IdType="pubmed">29377008</ArticleId></ArticleIdList></Reference><Reference><Citation>Vanlandewijck M et al. A molecular atlas of cell types and zonation in the brain vasculature. Nature 554, 475&#x2013;480 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">29443965</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia FJ et al. Single-cell dissection of the human brain vasculature. Nature 603, 893&#x2013;899 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9680899</ArticleId><ArticleId IdType="pubmed">35158371</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang AC et al. A human brain vascular atlas reveals diverse mediators of Alzheimer&#x2019;s risk. Nature 603, 885&#x2013;892 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9635042</ArticleId><ArticleId IdType="pubmed">35165441</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilhelm I, Ny&#xfa;l-T&#xf3;th &#xc1;, Suciu M, Hermenean A &amp; Krizbai IA Heterogeneity of the blood-brain barrier. Tissue Barriers 4, e1143544 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4836475</ArticleId><ArticleId IdType="pubmed">27141424</ArticleId></ArticleIdList></Reference><Reference><Citation>Tran KA et al. Endothelial &#x3b2;-Catenin Signaling Is Required for Maintaining Adult Blood-Brain Barrier Integrity and Central Nervous System Homeostasis. Circulation 133, 177&#x2013;186 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4814374</ArticleId><ArticleId IdType="pubmed">26538583</ArticleId></ArticleIdList></Reference><Reference><Citation>Slater SC et al. MicroRNA-532&#x2013;5p Regulates Pericyte Function by Targeting the Transcription Regulator BACH1 and Angiopoietin-1. Mol. Ther. 26, 2823&#x2013;2837 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6277430</ArticleId><ArticleId IdType="pubmed">30274787</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X et al. High-resolution mapping of brain vasculature and its impairment in the hippocampus of Alzheimer&#x2019;s disease mice. Natl Sci Rev 6, 1223&#x2013;1238 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8291402</ArticleId><ArticleId IdType="pubmed">34692000</ArticleId></ArticleIdList></Reference><Reference><Citation>Lau S-F, Cao H, Fu AKY &amp; Ip NY Single-nucleus transcriptome analysis reveals dysregulation of angiogenic endothelial cells and neuroprotective glia in Alzheimer&#x2019;s disease. Proc. Natl. Acad. Sci. U. S. A. 117, 25800&#x2013;25809 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7568283</ArticleId><ArticleId IdType="pubmed">32989152</ArticleId></ArticleIdList></Reference><Reference><Citation>Velmeshev D et al. Single-cell genomics identifies cell type&#x2013;specific molecular changes in autism. Science vol. 364 685&#x2013;689 Preprint at 10.1126/science.aav8130 (2019).</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aav8130</ArticleId><ArticleId IdType="pmc">PMC7678724</ArticleId><ArticleId IdType="pubmed">31097668</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruzicka WB et al. Single-cell dissection of schizophrenia reveals neurodevelopmental-synaptic axis and transcriptional resilience. bioRxiv (2020) doi:10.1101/2020.11.06.20225342.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.11.06.20225342</ArticleId></ArticleIdList></Reference><Reference><Citation>Montagne A et al. Blood-brain barrier breakdown in the aging human hippocampus. Neuron 85, 296&#x2013;302 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4350773</ArticleId><ArticleId IdType="pubmed">25611508</ArticleId></ArticleIdList></Reference><Reference><Citation>Elali A &amp; Rivest S The role of ABCB1 and ABCA1 in beta-amyloid clearance at the neurovascular unit in Alzheimer&#x2019;s disease. Front. Physiol. 4, 45 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3595512</ArticleId><ArticleId IdType="pubmed">23494712</ArticleId></ArticleIdList></Reference><Reference><Citation>van Assema DME et al. Blood-brain barrier P-glycoprotein function in Alzheimer&#x2019;s disease. Brain 135, 181&#x2013;189 (2012).</Citation><ArticleIdList><ArticleId IdType="pubmed">22120145</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamilton NB, Attwell D &amp; Hall CN Pericyte-mediated regulation of capillary diameter: a component of neurovascular coupling in health and disease. Front. Neuroenergetics 2, (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2912025</ArticleId><ArticleId IdType="pubmed">20725515</ArticleId></ArticleIdList></Reference><Reference><Citation>Nortley R et al. Amyloid &#x3b2; oligomers constrict human capillaries in Alzheimer&#x2019;s disease via signaling to pericytes. Science 365, (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6658218</ArticleId><ArticleId IdType="pubmed">31221773</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang F et al. RNAscope: a novel in situ RNA analysis platform for formalin-fixed, paraffin-embedded tissues. J. Mol. Diagn. 14, 22&#x2013;29 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3338343</ArticleId><ArticleId IdType="pubmed">22166544</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhatia S, Kim WS, Shepherd CE &amp; Halliday GM Apolipoprotein D Upregulation in Alzheimer&#x2019;s Disease but Not Frontotemporal Dementia. J. Mol. Neurosci. 67, 125&#x2013;132 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6344390</ArticleId><ArticleId IdType="pubmed">30467822</ArticleId></ArticleIdList></Reference><Reference><Citation>Leng K et al. Molecular characterization of selectively vulnerable neurons in Alzheimer&#x2019;s disease. Nat. Neurosci. 24, 276&#x2013;287 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7854528</ArticleId><ArticleId IdType="pubmed">33432193</ArticleId></ArticleIdList></Reference><Reference><Citation>Szklarczyk D et al. The STRING database in 2021: customizable protein-protein networks, and functional characterization of user-uploaded gene/measurement sets. Nucleic Acids Res. 49, D605&#x2013;D612 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7779004</ArticleId><ArticleId IdType="pubmed">33237311</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim K-J et al. STAT3 activation in endothelial cells is important for tumor metastasis via increased cell adhesion molecule expression. Oncogene 36, 5445&#x2013;5459 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28534515</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei D et al. Stat3 activation regulates the expression of vascular endothelial growth factor and human pancreatic cancer angiogenesis and metastasis. Oncogene 22, 319&#x2013;329 (2003).</Citation><ArticleIdList><ArticleId IdType="pubmed">12545153</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang B et al. A dynamic H3K27ac signature identifies VEGFA-stimulated endothelial enhancers and requires EP300 activity. Genome Res. 23, 917&#x2013;927 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3668360</ArticleId><ArticleId IdType="pubmed">23547170</ArticleId></ArticleIdList></Reference><Reference><Citation>Marconcini L et al. c-fos-induced growth factor/vascular endothelial growth factor D induces angiogenesis in vivo and in vitro. Proc. Natl. Acad. Sci. U. S. A. 96, 9671&#x2013;9676 (1999).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC22268</ArticleId><ArticleId IdType="pubmed">10449752</ArticleId></ArticleIdList></Reference><Reference><Citation>Battle TE, Lynch RA &amp; Frank DA Signal transducer and activator of transcription 1 activation in endothelial cells is a negative regulator of angiogenesis. Cancer Res. 66, 3649&#x2013;3657 (2006).</Citation><ArticleIdList><ArticleId IdType="pubmed">16585190</ArticleId></ArticleIdList></Reference><Reference><Citation>Paneni F et al. Deletion of the activated protein-1 transcription factor JunD induces oxidative stress and accelerates age-related endothelial dysfunction. Circulation 127, 1229&#x2013;40, e1&#x2013;21 (2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">23410942</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang N et al. c-Jun triggers apoptosis in human vascular endothelial cells. Circ. Res. 85, 387&#x2013;393 (1999).</Citation><ArticleIdList><ArticleId IdType="pubmed">10473668</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahamud MR et al. GATA2 controls lymphatic endothelial cell junctional integrity and lymphovenous valve morphogenesis through. Development 146, (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6857586</ArticleId><ArticleId IdType="pubmed">31582413</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen MB et al. Brain Endothelial Cells Are Exquisite Sensors of Age-Related Circulatory Cues. Cell Rep. 30, 4418&#x2013;4432.e4 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7292569</ArticleId><ArticleId IdType="pubmed">32234477</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao L et al. Pharmacologically reversible zonation-dependent endothelial cell transcriptomic changes with neurodegenerative disease associations in the aged brain. Nat. Commun. 11, 4413 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7474063</ArticleId><ArticleId IdType="pubmed">32887883</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohnesorge N et al. Erk5 activation elicits a vasoprotective endothelial phenotype via induction of Kruppel-like factor 4 (KLF4). J. Biol. Chem. 285, 26199&#x2013;26210 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2924030</ArticleId><ArticleId IdType="pubmed">20551324</ArticleId></ArticleIdList></Reference><Reference><Citation>Pugacheva EM et al. CTCF mediates chromatin looping via N-terminal domain-dependent cohesin retention. Proc. Natl. Acad. Sci. U. S. A. 117, 2020&#x2013;2031 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6995019</ArticleId><ArticleId IdType="pubmed">31937660</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu L, Nirwane A &amp; Yao Y Basement membrane and blood-brain barrier. Stroke Vasc Neurol 4, 78&#x2013;82 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6613871</ArticleId><ArticleId IdType="pubmed">31338215</ArticleId></ArticleIdList></Reference><Reference><Citation>McMillin MA et al. TGF&#x3b2;1 exacerbates blood-brain barrier permeability in a mouse model of hepatic encephalopathy via upregulation of MMP9 and downregulation of claudin-5. Lab. Invest. 95, 903&#x2013;913 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5040071</ArticleId><ArticleId IdType="pubmed">26006017</ArticleId></ArticleIdList></Reference><Reference><Citation>Rustenhoven J et al. TGF-beta1 regulates human brain pericyte inflammatory processes involved in neurovasculature function. J. Neuroinflammation 13, 37 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4751726</ArticleId><ArticleId IdType="pubmed">26867675</ArticleId></ArticleIdList></Reference><Reference><Citation>Kashima R &amp; Hata A The role of TGF-&#x3b2; superfamily signaling in neurological disorders. Acta Biochim. Biophys. Sin. 50, 106&#x2013;120 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5846707</ArticleId><ArticleId IdType="pubmed">29190314</ArticleId></ArticleIdList></Reference><Reference><Citation>van Cruijsen H, Giaccone G &amp; Hoekman K Epidermal growth factor receptor and angiogenesis: Opportunities for combined anticancer strategies. Int. J. Cancer 117, 883&#x2013;888 (2005).</Citation><ArticleIdList><ArticleId IdType="pubmed">16152621</ArticleId></ArticleIdList></Reference><Reference><Citation>Jansen IE et al. Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer&#x2019;s disease risk. Nat. Genet. 51, 404&#x2013;413 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6836675</ArticleId><ArticleId IdType="pubmed">30617256</ArticleId></ArticleIdList></Reference><Reference><Citation>Kunkle BW et al. Genetic meta-analysis of diagnosed Alzheimer&#x2019;s disease identifies new risk loci and implicates A&#x3b2;, tau, immunity and lipid processing. Nat. Genet. 51, 414&#x2013;430 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6463297</ArticleId><ArticleId IdType="pubmed">30820047</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang S et al. Potential Novel Genes for Late-Onset Alzheimer&#x2019;s Disease in East-Asian Descent Identified by APOE-Stratified Genome-Wide Association Study. J. Alzheimers. Dis. 82, 1451&#x2013;1460 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8461686</ArticleId><ArticleId IdType="pubmed">34151794</ArticleId></ArticleIdList></Reference><Reference><Citation>Pallej&#xe0; A, Horn H, Eliasson S &amp; Jensen LJ DistiLD Database: diseases and traits in linkage disequilibrium blocks. Nucleic Acids Res. 40, D1036&#x2013;40 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3245128</ArticleId><ArticleId IdType="pubmed">22058129</ArticleId></ArticleIdList></Reference><Reference><Citation>Buniello A et al. The NHGRI-EBI GWAS Catalog of published genome-wide association studies, targeted arrays and summary statistics 2019. Nucleic Acids Res. 47, D1005&#x2013;D1012 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6323933</ArticleId><ArticleId IdType="pubmed">30445434</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang T-Y, Yamauchi Y, Hasan MT &amp; Chang C Cellular cholesterol homeostasis and Alzheimer&#x2019;s disease. J. Lipid Res. 58, 2239&#x2013;2254 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5711498</ArticleId><ArticleId IdType="pubmed">28298292</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Y et al. Nuclear receptor ROR&#x3b1; regulates pathologic retinal angiogenesis by modulating SOCS3-dependent inflammation. Proc. Natl. Acad. Sci. U. S. A. 112, 10401&#x2013;10406 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4547221</ArticleId><ArticleId IdType="pubmed">26243880</ArticleId></ArticleIdList></Reference><Reference><Citation>Saint-Pol J et al. Brain pericytes ABCA1 expression mediates cholesterol efflux but not cellular amyloid-&#x3b2; peptide accumulation. J. Alzheimers. Dis. 30, 489&#x2013;503 (2012).</Citation><ArticleIdList><ArticleId IdType="pubmed">22433669</ArticleId></ArticleIdList></Reference><Reference><Citation>Robert J, Osto E &amp; von Eckardstein A The Endothelium Is Both a Target and a Barrier of HDL&#x2019;s Protective Functions. Cells 10, (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8146309</ArticleId><ArticleId IdType="pubmed">33924941</ArticleId></ArticleIdList></Reference><Reference><Citation>Husemann J &amp; Silverstein SC Expression of scavenger receptor class B, type I, by astrocytes and vascular smooth muscle cells in normal adult mouse and human brain and in Alzheimer&#x2019;s disease brain. Am. J. Pathol. 158, 825&#x2013;832 (2001).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1850374</ArticleId><ArticleId IdType="pubmed">11238031</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothaug M, Becker-Pauly C &amp; Rose-John S The role of interleukin-6 signaling in nervous tissue. Biochim. Biophys. Acta 1863, 1218&#x2013;1227 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">27016501</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi JM, Rotimi OO, O&#x2019;Carroll SJ &amp; Nicholson LFB IL-6 stimulates a concentration-dependent increase in MCP-1 in immortalised human brain endothelial cells. F1000Res. 5, 270 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4900293</ArticleId><ArticleId IdType="pubmed">27347374</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei G et al. Ets1 and Ets2 are required for endothelial cell survival during embryonic angiogenesis. Blood 114, 1123&#x2013;1130 (2009).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2721789</ArticleId><ArticleId IdType="pubmed">19411629</ArticleId></ArticleIdList></Reference><Reference><Citation>Park R et al. Yap is required for ependymal integrity and is suppressed in LPA-induced hydrocephalus. Nat. Commun. 7, 10329 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4729961</ArticleId><ArticleId IdType="pubmed">26754915</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie C et al. Yap1 protein regulates vascular smooth muscle cell phenotypic switch by interaction with myocardin. J. Biol. Chem. 287, 14598&#x2013;14605 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3340286</ArticleId><ArticleId IdType="pubmed">22411986</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen T et al. YAP1 plays a key role of the conversion of normal fibroblasts into cancer-associated fibroblasts that contribute to prostate cancer progression. J. Exp. Clin. Cancer Res. 39, 1&#x2013;16 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7027236</ArticleId><ArticleId IdType="pubmed">32066485</ArticleId></ArticleIdList></Reference><Reference><Citation>Go G-W &amp; Mani A Low-density lipoprotein receptor (LDLR) family orchestrates cholesterol homeostasis. Yale J. Biol. Med. 85, 19&#x2013;28 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3313535</ArticleId><ArticleId IdType="pubmed">22461740</ArticleId></ArticleIdList></Reference><Reference><Citation>Thambisetty M, Beason-Held L, An Y, Kraut MA &amp; Resnick SM APOE epsilon4 genotype and longitudinal changes in cerebral blood flow in normal aging. Arch. Neurol. 67, 93&#x2013;98 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2856443</ArticleId><ArticleId IdType="pubmed">20065135</ArticleId></ArticleIdList></Reference><Reference><Citation>Leaston J et al. Neurovascular imaging with QUTE-CE MRI in APOE4 rats reveals early vascular abnormalities. PLoS One 16, e0256749 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8396782</ArticleId><ArticleId IdType="pubmed">34449808</ArticleId></ArticleIdList></Reference><Reference><Citation>Montagne A et al. APOE4 leads to blood-brain barrier dysfunction predicting cognitive decline. Nature 581, 71&#x2013;76 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7250000</ArticleId><ArticleId IdType="pubmed">32376954</ArticleId></ArticleIdList></Reference><Reference><Citation>Bennett DA et al. Religious Orders Study and Rush Memory and Aging Project. J. Alzheimers. Dis. 64, S161&#x2013;S189 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6380522</ArticleId><ArticleId IdType="pubmed">29865057</ArticleId></ArticleIdList></Reference><Reference><Citation>Bennett DA et al. Natural history of mild cognitive impairment in older persons. Neurology 59, 198&#x2013;205 (2002).</Citation><ArticleIdList><ArticleId IdType="pubmed">12136057</ArticleId></ArticleIdList></Reference><Reference><Citation>Bennett DA et al. Apolipoprotein E epsilon4 allele, AD pathology, and the clinical expression of Alzheimer&#x2019;s disease. Neurology 60, 246&#x2013;252 (2003).</Citation><ArticleIdList><ArticleId IdType="pubmed">12552039</ArticleId></ArticleIdList></Reference><Reference><Citation>Bennett DA et al. Neuropathology of older persons without cognitive impairment from two community-based studies. Neurology 66, 1837&#x2013;1844 (2006).</Citation><ArticleIdList><ArticleId IdType="pubmed">16801647</ArticleId></ArticleIdList></Reference><Reference><Citation>Bennett DA, Schneider JA, Wilson RS, Bienias JL &amp; Arnold SE Neurofibrillary tangles mediate the association of amyloid load with clinical Alzheimer disease and level of cognitive function. Arch. Neurol. 61, 378&#x2013;384 (2004).</Citation><ArticleIdList><ArticleId IdType="pubmed">15023815</ArticleId></ArticleIdList></Reference><Reference><Citation>Bennett DA et al. Decision rules guiding the clinical diagnosis of Alzheimer&#x2019;s disease in two community-based cohort studies compared to standard practice in a clinic-based cohort study. Neuroepidemiology 27, 169&#x2013;176 (2006).</Citation><ArticleIdList><ArticleId IdType="pubmed">17035694</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathys H et al. Single-cell transcriptomic analysis of Alzheimer&#x2019;s disease. Nature 570, 332&#x2013;337 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6865822</ArticleId><ArticleId IdType="pubmed">31042697</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng GXY et al. Massively parallel digital transcriptional profiling of single cells. Nat. Commun. 8, 14049 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5241818</ArticleId><ArticleId IdType="pubmed">28091601</ArticleId></ArticleIdList></Reference><Reference><Citation>Hao Y et al. Integrated analysis of multimodal single-cell data. Cell 184, 3573&#x2013;3587.e29 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8238499</ArticleId><ArticleId IdType="pubmed">34062119</ArticleId></ArticleIdList></Reference><Reference><Citation>Korsunsky I et al. Fast, sensitive and accurate integration of single-cell data with Harmony. Nat. Methods 16, 1289&#x2013;1296 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6884693</ArticleId><ArticleId IdType="pubmed">31740819</ArticleId></ArticleIdList></Reference><Reference><Citation>McGinnis CS, Murrow LM &amp; Gartner ZJ DoubletFinder: Doublet Detection in Single-Cell RNA Sequencing Data Using Artificial Nearest Neighbors. Cell Syst 8, 329&#x2013;337.e4 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6853612</ArticleId><ArticleId IdType="pubmed">30954475</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang D et al. Comprehensive functional genomic resource and integrative model for the human brain. Science 362, (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6413328</ArticleId><ArticleId IdType="pubmed">30545857</ArticleId></ArticleIdList></Reference><Reference><Citation>Finak G et al. MAST: a flexible statistical framework for assessing transcriptional changes and characterizing heterogeneity in single-cell RNA sequencing data. Genome Biol. 16, 278 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4676162</ArticleId><ArticleId IdType="pubmed">26653891</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson MD, McCarthy DJ &amp; Smyth GK edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26, 139&#x2013;140 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2796818</ArticleId><ArticleId IdType="pubmed">19910308</ArticleId></ArticleIdList></Reference><Reference><Citation>Bankhead P et al. QuPath: Open source software for digital pathology image analysis. Sci. Rep. 7, 16878 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5715110</ArticleId><ArticleId IdType="pubmed">29203879</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen EY et al. Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool. BMC Bioinformatics 14, 128 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3637064</ArticleId><ArticleId IdType="pubmed">23586463</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Z et al. Gene Set Knowledge Discovery with Enrichr. Curr Protoc 1, e90 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8152575</ArticleId><ArticleId IdType="pubmed">33780170</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuleshov MV et al. Enrichr: a comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Res. 44, W90&#x2013;7 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4987924</ArticleId><ArticleId IdType="pubmed">27141961</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashburner M et al. Gene Ontology: tool for the unification of biology. Nat. Genet. 25, 25&#x2013;29 (2000).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3037419</ArticleId><ArticleId IdType="pubmed">10802651</ArticleId></ArticleIdList></Reference><Reference><Citation>The Gene Ontology Consortium. The Gene Ontology Resource: 20 years and still GOing strong. Nucleic Acids Res. 47, D330&#x2013;D338 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6323945</ArticleId><ArticleId IdType="pubmed">30395331</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin S et al. Inference and analysis of cell-cell communication using CellChat. Nat. Commun. 12, 1&#x2013;20 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7889871</ArticleId><ArticleId IdType="pubmed">33597522</ArticleId></ArticleIdList></Reference><Reference><Citation>Efremova M, Vento-Tormo M, Teichmann SA &amp; Vento-Tormo R CellPhoneDB: inferring cell-cell communication from combined expression of multi-subunit ligand-receptor complexes. Nat. Protoc. 15, 1484&#x2013;1506 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32103204</ArticleId></ArticleIdList></Reference><Reference><Citation>Shao X et al. CellTalkDB: a manually curated database of ligand-receptor interactions in humans and mice. Brief. Bioinform. 22, (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33147626</ArticleId></ArticleIdList></Reference><Reference><Citation>Cabello-Aguilar S et al. SingleCellSignalR: inference of intercellular networks from single-cell transcriptomics. Nucleic Acids Res. 48, e55&#x2013;e55 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7261168</ArticleId><ArticleId IdType="pubmed">32196115</ArticleId></ArticleIdList></Reference><Reference><Citation>Park YP &amp; Kellis M CoCoA-diff: counterfactual inference for single-cell gene expression analysis. Genome Biol. 22, 228 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8369635</ArticleId><ArticleId IdType="pubmed">34404460</ArticleId></ArticleIdList></Reference><Reference><Citation>Barber RF &amp; Cand&#xe8;s EJ Controlling the false discovery rate via knockoffs. aos 43, 2055&#x2013;2085 (2015).</Citation></Reference><Reference><Citation>Wang Y &amp; Blei DM The Blessings of Multiple Causes. J. Am. Stat. Assoc. 114, 1574&#x2013;1596 (2019).</Citation></Reference><Reference><Citation>Zhu Z, Fan Y, Kong Y, Lv J &amp; Sun F DeepLINK: Deep learning inference using knockoffs with applications to genomics. Proc. Natl. Acad. Sci. U. S. A. 118, (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8433583</ArticleId><ArticleId IdType="pubmed">34480002</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang T, Li Y &amp; Motsinger-Reif AA Knockoff boosted tree for model-free variable selection. Bioinformatics 37, 976&#x2013;983 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8128453</ArticleId><ArticleId IdType="pubmed">32966559</ArticleId></ArticleIdList></Reference><Reference><Citation>Candes E, Fan Y, Janson L &amp; Lv J Panning for gold:&#x2019;model-X&#x2019;knockoffs for high dimensional controlled variable selection. Journal of the Royal (2018).</Citation></Reference><Reference><Citation>Kaul A, Bhattacharyya S &amp; Ay F Identifying statistically significant chromatin contacts from Hi-C data with FitHiC2. Nat. Protoc. 15, 991&#x2013;1012 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7451401</ArticleId><ArticleId IdType="pubmed">31980751</ArticleId></ArticleIdList></Reference><Reference><Citation>Lalonde S et al. Integrative analysis of vascular endothelial cell genomic features identifies AIDA as a coronary artery disease candidate gene. Genome Biol. 20, 133 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6613242</ArticleId><ArticleId IdType="pubmed">31287004</ArticleId></ArticleIdList></Reference><Reference><Citation>Niskanen H et al. Endothelial cell differentiation is encompassed by changes in long range interactions between inactive chromatin regions. Nucleic Acids Res. 46, 1724&#x2013;1740 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5829566</ArticleId><ArticleId IdType="pubmed">29216379</ArticleId></ArticleIdList></Reference><Reference><Citation>Mumbach MR et al. Enhancer connectome in primary human cells identifies target genes of disease-associated DNA elements. Nat. Genet. 49, 1602&#x2013;1612 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5805393</ArticleId><ArticleId IdType="pubmed">28945252</ArticleId></ArticleIdList></Reference><Reference><Citation>Boix CA, James BT, Park YP, Meuleman W &amp; Kellis M Regulatory genomic circuitry of human disease loci by integrative epigenomics. Nature 590, 300&#x2013;307 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7875769</ArticleId><ArticleId IdType="pubmed">33536621</ArticleId></ArticleIdList></Reference><Reference><Citation>Consortium GTEx. The GTEx Consortium atlas of genetic regulatory effects across human tissues. Science 369, 1318&#x2013;1330 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7737656</ArticleId><ArticleId IdType="pubmed">32913098</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37262162</PMID><DateCompleted><Year>2023</Year><Month>06</Month><Day>14</Day></DateCompleted><DateRevised><Year>2025</Year><Month>04</Month><Day>12</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1095-9203</ISSN><JournalIssue CitedMedium="Internet"><Volume>380</Volume><Issue>6648</Issue><PubDate><Year>2023</Year><Month>Jun</Month><Day>02</Day></PubDate></JournalIssue><Title>Science (New York, N.Y.)</Title><ISOAbbreviation>Science</ISOAbbreviation></Journal><ArticleTitle>Heart-brain connections: Phenotypic and genetic insights from magnetic resonance images.</ArticleTitle><Pagination><StartPage>abn6598</StartPage><MedlinePgn>abn6598</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1126/science.abn6598</ELocationID><Abstract><AbstractText>Cardiovascular health interacts with cognitive and mental health in complex ways, yet little is known about the phenotypic and genetic links of heart-brain systems. We quantified heart-brain connections using multiorgan magnetic resonance imaging (MRI) data from more than 40,000 subjects. Heart MRI traits displayed numerous association patterns with brain gray matter morphometry, white matter microstructure, and functional networks. We identified 80 associated genomic loci (<i>P</i> &lt; 6.09 &#xd7; 10<sup>-10</sup>) for heart MRI traits, which shared genetic influences with cardiovascular and brain diseases. Genetic correlations were observed between heart MRI traits and brain-related traits and disorders. Mendelian randomization suggests that heart conditions may causally contribute to brain disorders. Our results advance a multiorgan perspective on human health by revealing heart-brain connections and shared genetic influences.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Bingxin</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0002-0979-7891</Identifier><AffiliationInfo><Affiliation>Department of Statistics and Data Science, University of Pennsylvania, Philadelphia, PA 19104, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Statistics, Purdue University, West Lafayette, IN 47907, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Tengfei</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0001-6142-3865</Identifier><AffiliationInfo><Affiliation>Department of Radiology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Biomedical Research Imaging Center, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fan</LastName><ForeName>Zirui</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Statistics and Data Science, University of Pennsylvania, Philadelphia, PA 19104, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Statistics, Purdue University, West Lafayette, IN 47907, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Yue</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0002-0470-7244</Identifier><AffiliationInfo><Affiliation>Department of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shu</LastName><ForeName>Juan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Statistics, Purdue University, West Lafayette, IN 47907, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Xiaochen</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Statistics, Purdue University, West Lafayette, IN 47907, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Xifeng</ForeName><Initials>X</Initials><Identifier Source="ORCID">0000-0002-2078-6691</Identifier><AffiliationInfo><Affiliation>Department of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luo</LastName><ForeName>Tianyou</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tang</LastName><ForeName>Jiarui</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xiong</LastName><ForeName>Di</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Zhenyi</ForeName><Initials>Z</Initials><Identifier Source="ORCID">0009-0001-4180-7877</Identifier><AffiliationInfo><Affiliation>Department of Statistics, Purdue University, West Lafayette, IN 47907, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Bingxuan</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0002-9193-5308</Identifier><AffiliationInfo><Affiliation>Department of Computer Science, Purdue University, West Lafayette, IN 47907, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Jie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shan</LastName><ForeName>Yue</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tomlinson</LastName><ForeName>Chalmer</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0003-4322-930X</Identifier><AffiliationInfo><Affiliation>Department of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Ziliang</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Yun</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0002-9275-4189</Identifier><AffiliationInfo><Affiliation>Department of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stein</LastName><ForeName>Jason L</ForeName><Initials>JL</Initials><Identifier Source="ORCID">0000-0003-4829-0513</Identifier><AffiliationInfo><Affiliation>Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>UNC Neuroscience Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Hongtu</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0002-6781-2690</Identifier><AffiliationInfo><Affiliation>Biomedical Research Imaging Center, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Computer Science, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Statistics and Operations Research, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P50 HD103573</GrantID><Acronym>HD</Acronym><Agency>NICHD NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 MH086633</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 MH116527</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R56 AG079291</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>06</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Science</MedlineTA><NlmUniqueID>0404511</NlmUniqueID><ISSNLinking>0036-8075</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Nat Rev Cardiol. 2023 Aug;20(8):513. doi: 10.1038/s41569-023-00905-y.</RefSource><PMID Version="1">37337022</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Nat Cardiovasc Res. 2023 Jul;2(7):602. doi: 10.1038/s44161-023-00304-z.</RefSource><PMID Version="1">39195925</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="Y">Brain</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D066128" MajorTopicYN="N">Gray Matter</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006321" MajorTopicYN="Y">Heart</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008279" MajorTopicYN="N">Magnetic Resonance Imaging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D066127" MajorTopicYN="N">White Matter</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002318" MajorTopicYN="Y">Cardiovascular Diseases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001927" MajorTopicYN="Y">Brain Diseases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D056426" MajorTopicYN="N">Genetic Loci</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="N">Genetic Predisposition to Disease</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement><b>Competing interests:</b> Chalmer Tomlinson is currently an employee at Janssen R&amp;D of Johnson &amp; Johnson, Raritan, NJ, USA. The remaining authors declare that no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>5</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>1</Day><Hour>23</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>1</Day><Hour>14</Hour><Minute>4</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>4</Month><Day>11</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37262162</ArticleId><ArticleId IdType="mid">NIHMS2065441</ArticleId><ArticleId IdType="pmc">PMC11987082</ArticleId><ArticleId IdType="doi">10.1126/science.abn6598</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Gardener H, Wright CB, Rundek T, Sacco RL, Brain health and shared risk factors for dementia and stroke. Nat. Rev. Neurol. 11, 651&#x2013;657 (2015). doi: 10.1038/nrneurol.2015.195</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2015.195</ArticleId><ArticleId IdType="pubmed">26481296</ArticleId></ArticleIdList></Reference><Reference><Citation>Broce IJ et al., Dissecting the genetic relationship between cardiovascular risk factors and Alzheimer&#x2019;s disease. Acta Neuropathol. 137, 209&#x2013;226 (2019). doi: 10.1007/s00401-018-1928-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-018-1928-6</ArticleId><ArticleId IdType="pmc">PMC6358498</ArticleId><ArticleId IdType="pubmed">30413934</ArticleId></ArticleIdList></Reference><Reference><Citation>Papadopoulos A et al., Left ventricular hypertrophy and cerebral small vessel disease: A systematic review and meta-analysis. J. Stroke 22, 206&#x2013;224 (2020). doi: 10.5853/jos.2019.03335</Citation><ArticleIdList><ArticleId IdType="doi">10.5853/jos.2019.03335</ArticleId><ArticleId IdType="pmc">PMC7341009</ArticleId><ArticleId IdType="pubmed">32635685</ArticleId></ArticleIdList></Reference><Reference><Citation>Abete P et al., Cognitive impairment and cardiovascular diseases in the elderly. A heart-brain continuum hypothesis. Ageing Res. Rev. 18, 41&#x2013;52 (2014). doi: 10.1016/j.arr.2014.07.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arr.2014.07.003</ArticleId><ArticleId IdType="pubmed">25107566</ArticleId></ArticleIdList></Reference><Reference><Citation>Moroni F et al., Cardiovascular disease and brain health: Focus on white matter hyperintensities. Int. J. Cardiol. Heart Vasc. 19, 63&#x2013;69 (2018). doi: 10.1016/j.ijcha.2018.04.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcha.2018.04.006</ArticleId><ArticleId IdType="pmc">PMC6016077</ArticleId><ArticleId IdType="pubmed">29946567</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwok CS, Loke YK, Hale R, Potter JF, Myint PK, Atrial fibrillation and incidence of dementia: A systematic review and meta-analysis. Neurology 76, 914&#x2013;922 (2011). doi: 10.1212/WNL.0b013e31820f2e38</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e31820f2e38</ArticleId><ArticleId IdType="pubmed">21383328</ArticleId></ArticleIdList></Reference><Reference><Citation>Kobayashi A, Iguchi M, Shimizu S, Uchiyama S, Silent cerebral infarcts and cerebral white matter lesions in patients with nonvalvular atrial fibrillation. J. Stroke Cerebrovasc. Dis. 21, 310&#x2013;317 (2012). doi: 10.1016/j.jstrokecerebrovasdis.2010.09.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jstrokecerebrovasdis.2010.09.004</ArticleId><ArticleId IdType="pubmed">21111632</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim D et al., Risk of dementia in stroke-free patients diagnosed with atrial fibrillation: Data from a population-based cohort. Eur. Heart J. 40, 2313&#x2013;2323 (2019). doi: 10.1093/eurheartj/ehz386</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehz386</ArticleId><ArticleId IdType="pubmed">31212315</ArticleId></ArticleIdList></Reference><Reference><Citation>Vogels RL, Scheltens P, Schroeder-Tanka JM, Weinstein HC, Cognitive impairment in heart failure: A systematic review of the literature. Eur. J. Heart Fail. 9, 440&#x2013;449 (2007). doi: 10.1016/j.ejheart.2006.11.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejheart.2006.11.001</ArticleId><ArticleId IdType="pubmed">17174152</ArticleId></ArticleIdList></Reference><Reference><Citation>Meng L, Hou W, Chui J, Han R, Gelb AW, Cardiac output and cerebral blood flow: The integrated regulation of brain perfusion in adult humans. Anesthesiology 123, 1198&#x2013;1208 (2015). doi: 10.1097/ALN.0000000000000872</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000000872</ArticleId><ArticleId IdType="pubmed">26402848</ArticleId></ArticleIdList></Reference><Reference><Citation>Levine GN et al., Psychological health, well-being, and the mind-heart-body connection: A scientific statement from the American Heart Association. Circulation 143, e763&#x2013;e783 (2021). doi: 10.1161/CIR.0000000000000947</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIR.0000000000000947</ArticleId><ArticleId IdType="pubmed">33486973</ArticleId></ArticleIdList></Reference><Reference><Citation>Krantz DS, Burg MM, Current perspective on mental stress-induced myocardial ischemia. Psychosom. Med. 76, 168&#x2013;170 (2014). doi: 10.1097/PSY.0000000000000054</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PSY.0000000000000054</ArticleId><ArticleId IdType="pmc">PMC8607301</ArticleId><ArticleId IdType="pubmed">24677165</ArticleId></ArticleIdList></Reference><Reference><Citation>Abisse SS, Lampert R, Burg M, Soufer R, Shusterman V, Cardiac repolarization instability during psychological stress in patients with ventricular arrhythmias. J. Electrocardiol. 44, 678&#x2013;683 (2011). doi: 10.1016/j.jelectrocard.2011.07.019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jelectrocard.2011.07.019</ArticleId><ArticleId IdType="pmc">PMC3200452</ArticleId><ArticleId IdType="pubmed">21920534</ArticleId></ArticleIdList></Reference><Reference><Citation>Jindal R, MacKenzie EM, Baker GB, Yeragani VK, Cardiac risk and schizophrenia. J. Psychiatry Neurosci. 30, 393&#x2013;395 (2005).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1277021</ArticleId><ArticleId IdType="pubmed">16327872</ArticleId></ArticleIdList></Reference><Reference><Citation>Nielsen RE, Banner J, Jensen SE, Cardiovascular disease in patients with severe mental illness. Nat. Rev. Cardiol. 18, 136&#x2013;145 (2021). doi: 10.1038/s41569-020-00463-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41569-020-00463-7</ArticleId><ArticleId IdType="pubmed">33128044</ArticleId></ArticleIdList></Reference><Reference><Citation>Tawakol A et al., Relation between resting amygdalar activity and cardiovascular events: A longitudinal and cohort study. Lancet 389, 834&#x2013;845 (2017). doi: 10.1016/S0140-6736(16)31714-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(16)31714-7</ArticleId><ArticleId IdType="pmc">PMC7864285</ArticleId><ArticleId IdType="pubmed">28088338</ArticleId></ArticleIdList></Reference><Reference><Citation>Verrier RL, Pang TD, Nearing BD, Schachter SC, The Epileptic Heart: Concept and clinical evidence. Epilepsy Behav. 105, 106946 (2020). doi: 10.1016/j.yebeh.2020.106946</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yebeh.2020.106946</ArticleId><ArticleId IdType="pubmed">32109857</ArticleId></ArticleIdList></Reference><Reference><Citation>Hinterdobler J et al., Acute mental stress drives vascular inflammation and promotes plaque destabilization in mouse atherosclerosis. Eur. Heart J. 42, 4077&#x2013;4088 (2021). doi: 10.1093/eurheartj/ehab371</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehab371</ArticleId><ArticleId IdType="pmc">PMC8516477</ArticleId><ArticleId IdType="pubmed">34279021</ArticleId></ArticleIdList></Reference><Reference><Citation>S. R. Cox et al., Associations between vascular risk factors and brain MRI indices in UK Biobank. Eur. Heart J. 40, 2290&#x2013;2300 (2019). doi: 10.1093/eurheartj/ehz100</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehz100</ArticleId><ArticleId IdType="pmc">PMC6642726</ArticleId><ArticleId IdType="pubmed">30854560</ArticleId></ArticleIdList></Reference><Reference><Citation>Jensen MT et al., Changes in cardiac morphology and function in individuals with diabetes mellitus: The UK Biobank cardiovascular magnetic resonance substudy. Circ. Cardiovasc. Imaging 12, e009476 (2019). doi: 10.1161/CIRCIMAGING.119.009476</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCIMAGING.119.009476</ArticleId><ArticleId IdType="pmc">PMC7099857</ArticleId><ArticleId IdType="pubmed">31522551</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramaniapillai S et al., Sex- and age-specific associations between cardiometabolic risk and white matter brain age in the UK Biobank cohort. Hum. Brain Mapp. 43, 3759&#x2013;3774 (2022). doi: 10.1002/hbm.25882</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hbm.25882</ArticleId><ArticleId IdType="pmc">PMC9294301</ArticleId><ArticleId IdType="pubmed">35460147</ArticleId></ArticleIdList></Reference><Reference><Citation>de Lange AG et al., Multimodal brain-age prediction and cardiovascular risk: The Whitehall II MRI sub-study. Neuroimage 222, 117292 (2020). doi: 10.1016/j.neuroimage.2020.117292</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroimage.2020.117292</ArticleId><ArticleId IdType="pmc">PMC8121758</ArticleId><ArticleId IdType="pubmed">32835819</ArticleId></ArticleIdList></Reference><Reference><Citation>Babo-Rebelo M, Richter CG, Tallon-Baudry C, Neural responses to heartbeats in the default network encode the self in spontaneous thoughts. J. Neurosci. 36, 7829&#x2013;7840 (2016). doi: 10.1523/JNEUROSCI.0262-16.2016</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.0262-16.2016</ArticleId><ArticleId IdType="pmc">PMC4961773</ArticleId><ArticleId IdType="pubmed">27466329</ArticleId></ArticleIdList></Reference><Reference><Citation>Markovic SJ et al., Investigating the link between later-life brain volume and cardiorespiratory fitness after mild traumatic brain injury exposure. Gerontology 69, 201&#x2013;211 (2023). doi: 10.1159/000526297</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000526297</ArticleId><ArticleId IdType="pubmed">36174542</ArticleId></ArticleIdList></Reference><Reference><Citation>Raimondo F et al., Brain-heart interactions reveal consciousness in noncommunicating patients. Ann. Neurol. 82, 578&#x2013;591 (2017). doi: 10.1002/ana.25045</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.25045</ArticleId><ArticleId IdType="pubmed">28892566</ArticleId></ArticleIdList></Reference><Reference><Citation>Petersen SE et al., UK Biobank&#x2019;s cardiovascular magnetic resonance protocol. J. Cardiovasc. Magn. Reson. 18, 8 (2016). doi: 10.1186/s12968-016-0227-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12968-016-0227-4</ArticleId><ArticleId IdType="pmc">PMC4736703</ArticleId><ArticleId IdType="pubmed">26830817</ArticleId></ArticleIdList></Reference><Reference><Citation>Littlejohns TJ, Sudlow C, Allen NE, Collins R, Opportunities for cardiovascular research. Eur. Heart J. 40, 1158&#x2013;1166 (2019). doi: 10.1093/eurheartj/ehx254</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehx254</ArticleId><ArticleId IdType="pmc">PMC6451771</ArticleId><ArticleId IdType="pubmed">28531320</ArticleId></ArticleIdList></Reference><Reference><Citation>Raisi-Estabragh Z, Harvey NC, Neubauer S, Petersen SE, Cardiovascular magnetic resonance imaging in the UK Biobank: A major international health research resource. Eur. Heart J. Cardiovasc. Imaging 22, 251&#x2013;258 (2021). doi: 10.1093/ehjci/jeaa297</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ehjci/jeaa297</ArticleId><ArticleId IdType="pmc">PMC7899275</ArticleId><ArticleId IdType="pubmed">33164079</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller KL et al., Multimodal population brain imaging in the UK Biobank prospective epidemiological study. Nat. Neurosci. 19, 1523&#x2013;1536 (2016). doi: 10.1038/nn.4393</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.4393</ArticleId><ArticleId IdType="pmc">PMC5086094</ArticleId><ArticleId IdType="pubmed">27643430</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee MH, Smyser CD, Shimony JS, Resting-state fMRI: A review of methods and clinical applications. AJNR Am. J. Neuroradiol. 34, 1866&#x2013;1872 (2013). doi: 10.3174/ajnr.A3263</Citation><ArticleIdList><ArticleId IdType="doi">10.3174/ajnr.A3263</ArticleId><ArticleId IdType="pmc">PMC4035703</ArticleId><ArticleId IdType="pubmed">22936095</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson PM et al., ENIGMA and global neuroscience: A decade of large-scale studies of the brain in health and disease across more than 40 countries. Transl. Psychiatry 10, 100 (2020). doi: 10.1038/s41398-020-0705-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41398-020-0705-1</ArticleId><ArticleId IdType="pmc">PMC7083923</ArticleId><ArticleId IdType="pubmed">32198361</ArticleId></ArticleIdList></Reference><Reference><Citation>Frisoni GB, Fox NC, Jack CR Jr., Scheltens P, Thompson PM, The clinical use of structural MRI in Alzheimer disease. Nat. Rev. Neurol. 6, 67&#x2013;77 (2010). doi: 10.1038/nrneurol.2009.215</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2009.215</ArticleId><ArticleId IdType="pmc">PMC2938772</ArticleId><ArticleId IdType="pubmed">20139996</ArticleId></ArticleIdList></Reference><Reference><Citation>Colclough GL et al., The heritability of multi-modal connectivity in human brain activity. eLife 6, e20178 (2017). doi: 10.7554/eLife.20178</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.20178</ArticleId><ArticleId IdType="pmc">PMC5621837</ArticleId><ArticleId IdType="pubmed">28745584</ArticleId></ArticleIdList></Reference><Reference><Citation>C. A. Busjahn et al., Heritability of left ventricular and papillary muscle heart size: A twin study with cardiac magnetic resonance imaging. Eur. Heart J. 30, 1643&#x2013;1647 (2009). doi: 10.1093/eurheartj/ehp142</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehp142</ArticleId><ArticleId IdType="pubmed">19406865</ArticleId></ArticleIdList></Reference><Reference><Citation>Chien K-L, Hsu H-C, Su T-C, Chen M-F, Lee Y-T, Heritability and major gene effects on left ventricular mass in the Chinese population: A family study. BMC Cardiovasc. Disord. 6, 37 (2006). doi: 10.1186/1471-2261-6-37</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2261-6-37</ArticleId><ArticleId IdType="pmc">PMC1579230</ArticleId><ArticleId IdType="pubmed">16945138</ArticleId></ArticleIdList></Reference><Reference><Citation>Jansen AG, Mous SE, White T, Posthuma D, Polderman TJ, What twin studies tell us about the heritability of brain development, morphology, and function: A review. Neuropsychol. Rev. 25, 27&#x2013;46 (2015). doi: 10.1007/s11065-015-9278-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11065-015-9278-9</ArticleId><ArticleId IdType="pmc">PMC4412550</ArticleId><ArticleId IdType="pubmed">25672928</ArticleId></ArticleIdList></Reference><Reference><Citation>Foo H et al., Genetic influence on ageing-related changes in resting-state brain functional networks in healthy adults: A systematic review. Neurosci. Biobehav. Rev. 113, 98&#x2013;110 (2020). doi: 10.1016/j.neubiorev.2020.03.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neubiorev.2020.03.011</ArticleId><ArticleId IdType="pubmed">32169413</ArticleId></ArticleIdList></Reference><Reference><Citation>Aung N et al., Genome-wide analysis of left ventricular image-derived phenotypes identifies fourteen loci associated with cardiac morphogenesis and heart failure development. Circulation 140, 1318&#x2013;1330 (2019). doi: 10.1161/CIRCULATIONAHA.119.041161 pmid:</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.119.041161</ArticleId><ArticleId IdType="pmc">PMC6791514</ArticleId><ArticleId IdType="pubmed">31554410</ArticleId></ArticleIdList></Reference><Reference><Citation>C&#xf3;rdova-Palomera A et al., Cardiac imaging of aortic valve area from 34,287 UK Biobank participants reveals novel genetic associations and shared genetic comorbidity with multiple disease phenotypes. Circ. Genom. Precis. Med. 13, e003014 (2020). doi: 10.1161/CIRCGEN.120.003014</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCGEN.120.003014</ArticleId><ArticleId IdType="pubmed">33125279</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyer HV et al., Genetic and functional insights into the fractal structure of the heart. Nature 584, 589&#x2013;594 (2020). doi: 10.1038/s41586-020-2635-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2635-8</ArticleId><ArticleId IdType="pmc">PMC7116759</ArticleId><ArticleId IdType="pubmed">32814899</ArticleId></ArticleIdList></Reference><Reference><Citation>Pirruccello JP et al., Analysis of cardiac magnetic resonance imaging in 36,000 individuals yields genetic insights into dilated cardiomyopathy. Nat. Commun. 11, 2254 (2020). doi: 10.1038/s41467-020-15823-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-15823-7</ArticleId><ArticleId IdType="pmc">PMC7206184</ArticleId><ArticleId IdType="pubmed">32382064</ArticleId></ArticleIdList></Reference><Reference><Citation>Pirruccello JP et al., Genetic analysis of right heart structure and function in 40,000 people. Nat. Genet. 54, 792&#x2013;803 (2022). doi: 10.1038/s41588-022-01090-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-022-01090-3</ArticleId><ArticleId IdType="pmc">PMC10313645</ArticleId><ArticleId IdType="pubmed">35697867</ArticleId></ArticleIdList></Reference><Reference><Citation>Thanaj M et al., Genetic and environmental determinants of diastolic heart function. Nat. Cardiovasc. Res. 1, 361&#x2013;371 (2022). doi: 10.1038/s44161-022-00048-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s44161-022-00048-2</ArticleId><ArticleId IdType="pmc">PMC7612636</ArticleId><ArticleId IdType="pubmed">35479509</ArticleId></ArticleIdList></Reference><Reference><Citation>Elliott LT et al., Genome-wide association studies of brain imaging phenotypes in UK Biobank. Nature 562, 210&#x2013;216 (2018). doi: 10.1038/s41586-018-0571-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-018-0571-7</ArticleId><ArticleId IdType="pmc">PMC6786974</ArticleId><ArticleId IdType="pubmed">30305740</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao B et al., Genome-wide association analysis of 19,629 individuals identifies variants influencing regional brain volumes and refines their genetic co-architecture with cognitive and mental health traits. Nat. Genet. 51, 1637&#x2013;1644 (2019). doi: 10.1038/s41588-019-0516-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-019-0516-6</ArticleId><ArticleId IdType="pmc">PMC6858580</ArticleId><ArticleId IdType="pubmed">31676860</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith SM et al., An expanded set of genome-wide association studies of brain imaging phenotypes in UK Biobank. Nat. Neurosci. 24, 737&#x2013;745 (2021). doi: 10.1038/s41593-021-00826-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-021-00826-4</ArticleId><ArticleId IdType="pmc">PMC7610742</ArticleId><ArticleId IdType="pubmed">33875891</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao B et al., Common genetic variation influencing human white matter microstructure. Science 372, eabf3736 (2021). doi: 10.1126/science.abf3736</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abf3736</ArticleId><ArticleId IdType="pmc">PMC8370718</ArticleId><ArticleId IdType="pubmed">34140357</ArticleId></ArticleIdList></Reference><Reference><Citation>Grasby KL et al., The genetic architecture of the human cerebral cortex. Science 367, eaay6690 (2020). doi: 10.1126/science.aay6690</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aay6690</ArticleId><ArticleId IdType="pmc">PMC7295264</ArticleId><ArticleId IdType="pubmed">32193296</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao B et al., Genetic influences on the intrinsic and extrinsic functional organizations of the cerebral cortex. medRxiv, 2021.2007. 2027.21261187 (2021). doi: 10.1101/2021.07.27.21261187</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.07.27.21261187</ArticleId></ArticleIdList></Reference><Reference><Citation>Hofer E et al., Genetic correlations and genome-wide associations of cortical structure in general population samples of 22,824 adults. Nat. Commun. 11, 4796 (2020). doi: 10.1038/s41467-020-18367-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-18367-y</ArticleId><ArticleId IdType="pmc">PMC7508833</ArticleId><ArticleId IdType="pubmed">32963231</ArticleId></ArticleIdList></Reference><Reference><Citation>Satizabal CL et al., Genetic architecture of subcortical brain structures in 38,851 individuals. Nat. Genet. 51, 1624&#x2013;1636 (2019). doi: 10.1038/s41588-019-0511-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-019-0511-y</ArticleId><ArticleId IdType="pmc">PMC7055269</ArticleId><ArticleId IdType="pubmed">31636452</ArticleId></ArticleIdList></Reference><Reference><Citation>Psaty BM et al., Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium: Design of prospective meta-analyses of genome-wide association studies from 5 cohorts. Circ. Cardiovasc. Genet. 2, 73&#x2013;80 (2009). doi: 10.1161/CIRCGENETICS.108.829747</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCGENETICS.108.829747</ArticleId><ArticleId IdType="pmc">PMC2875693</ArticleId><ArticleId IdType="pubmed">20031568</ArticleId></ArticleIdList></Reference><Reference><Citation>Mascarell Mari&#x10d;i&#x107; L et al., The IMAGEN study: A decade of imaging genetics in adolescents. Mol. Psychiatry 25, 2648&#x2013;2671 (2020). doi: 10.1038/s41380-020-0822-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41380-020-0822-5</ArticleId><ArticleId IdType="pmc">PMC7577859</ArticleId><ArticleId IdType="pubmed">32601453</ArticleId></ArticleIdList></Reference><Reference><Citation>Littlejohns TJ et al., The UK Biobank imaging enhancement of 100,000 participants: Rationale, data collection, management and future directions. Nat. Commun. 11, 2624 (2020). doi: 10.1038/s41467-020-15948-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-15948-9</ArticleId><ArticleId IdType="pmc">PMC7250878</ArticleId><ArticleId IdType="pubmed">32457287</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai W et al., A population-based phenome-wide association study of cardiac and aortic structure and function. Nat. Med. 26, 1654&#x2013;1662 (2020). doi: 10.1038/s41591-020-1009-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-1009-y</ArticleId><ArticleId IdType="pmc">PMC7613250</ArticleId><ArticleId IdType="pubmed">32839619</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai W et al., Automated cardiovascular magnetic resonance image analysis with fully convolutional networks. J. Cardiovasc. Magn. Reson. 20, 65 (2018). doi: 10.1186/s12968-018-0471-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12968-018-0471-x</ArticleId><ArticleId IdType="pmc">PMC6138894</ArticleId><ArticleId IdType="pubmed">30217194</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai W, Suzuki H, Qin C, Tarroni G, Oktay O, Matthews PM, Rueckert D, &#x201c;Recurrent neural networks for aortic image sequence segmentation with sparse annotations,&#x201d; in: Frangi A, Schnabel J, Davatzikos C, Alberola-L&#xf3;pez C, Fichtinger G, Eds. Medical Image Computing and Computer Assisted Intervention &#x2013; MICCAI 2018 (Springer, 2018), vol. 11073 of MICCAI 2018 Lecture Notes in Computer Science, pp. 586&#x2013;594.</Citation></Reference><Reference><Citation>Cerqueira MD et al., Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 105, 539&#x2013;542 (2002). doi: 10.1161/hc0402.102975</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/hc0402.102975</ArticleId><ArticleId IdType="pubmed">11815441</ArticleId></ArticleIdList></Reference><Reference><Citation>Supplementary materials are available online.</Citation></Reference><Reference><Citation>Alfaro-Almagro F et al., Image processing and Quality Control for the first 10,000 brain imaging datasets from UK Biobank. Neuroimage 166, 400&#x2013;424 (2018). doi: 10.1016/j.neuroimage.2017.10.034</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroimage.2017.10.034</ArticleId><ArticleId IdType="pmc">PMC5770339</ArticleId><ArticleId IdType="pubmed">29079522</ArticleId></ArticleIdList></Reference><Reference><Citation>Avants BB et al., A reproducible evaluation of ANTs similarity metric performance in brain image registration. Neuroimage 54, 2033&#x2013;2044 (2011). doi: 10.1016/j.neuroimage.2010.09.025</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroimage.2010.09.025</ArticleId><ArticleId IdType="pmc">PMC3065962</ArticleId><ArticleId IdType="pubmed">20851191</ArticleId></ArticleIdList></Reference><Reference><Citation>Mori S et al., Stereotaxic white matter atlas based on diffusion tensor imaging in an ICBM template. Neuroimage 40, 570&#x2013;582 (2008). doi: 10.1016/j.neuroimage.2007.12.035</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroimage.2007.12.035</ArticleId><ArticleId IdType="pmc">PMC2478641</ArticleId><ArticleId IdType="pubmed">18255316</ArticleId></ArticleIdList></Reference><Reference><Citation>Glasser MF et al., A multi-modal parcellation of human cerebral cortex. Nature 536, 171&#x2013;178 (2016). doi: 10.1038/nature18933</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature18933</ArticleId><ArticleId IdType="pmc">PMC4990127</ArticleId><ArticleId IdType="pubmed">27437579</ArticleId></ArticleIdList></Reference><Reference><Citation>Ji JL et al., Mapping the human brain&#x2019;s cortical-subcortical functional network organization. Neuroimage 185, 35&#x2013;57 (2019). doi: 10.1016/j.neuroimage.2018.10.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroimage.2018.10.006</ArticleId><ArticleId IdType="pmc">PMC6289683</ArticleId><ArticleId IdType="pubmed">30291974</ArticleId></ArticleIdList></Reference><Reference><Citation>Bennett IJ, Madden DJ, Vaidya CJ, Howard DV, Howard JH Jr., Age-related differences in multiple measures of white matter integrity: A diffusion tensor imaging study of healthy aging. Hum. Brain Mapp. 31, 378&#x2013;390 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2826569</ArticleId><ArticleId IdType="pubmed">19662658</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith SM et al., A positive-negative mode of population covariation links brain connectivity, demographics and behavior. Nat. Neurosci. 18, 1565&#x2013;1567 (2015). doi: 10.1038/nn.4125</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.4125</ArticleId><ArticleId IdType="pmc">PMC4625579</ArticleId><ArticleId IdType="pubmed">26414616</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang J, Lee SH, Goddard ME, Visscher PM, GCTA: A tool for genome-wide complex trait analysis. Am. J. Hum. Genet. 88, 76&#x2013;82 (2011). doi: 10.1016/j.ajhg.2010.11.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajhg.2010.11.011</ArticleId><ArticleId IdType="pmc">PMC3014363</ArticleId><ArticleId IdType="pubmed">21167468</ArticleId></ArticleIdList></Reference><Reference><Citation>Bulik-Sullivan BK et al., LD Score regression distinguishes confounding from polygenicity in genome-wide association studies. Nat. Genet. 47, 291&#x2013;295 (2015). doi: 10.1038/ng.3211</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.3211</ArticleId><ArticleId IdType="pmc">PMC4495769</ArticleId><ArticleId IdType="pubmed">25642630</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanai M et al., Genetic analysis of quantitative traits in the Japanese population links cell types to complex human diseases. Nat. Genet. 50, 390&#x2013;400 (2018). doi: 10.1038/s41588-018-0047-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-018-0047-6</ArticleId><ArticleId IdType="pubmed">29403010</ArticleId></ArticleIdList></Reference><Reference><Citation>Mak TSH, Porsch RM, Choi SW, Zhou X, Sham PC, Polygenic scores via penalized regression on summary statistics. Genet. Epidemiol. 41, 469&#x2013;480 (2017). doi: 10.1002/gepi.22050</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/gepi.22050</ArticleId><ArticleId IdType="pubmed">28480976</ArticleId></ArticleIdList></Reference><Reference><Citation>Buniello A et al., The NHGRI-EBI GWAS Catalog of published genome-wide association studies, targeted arrays and summary statistics 2019. Nucleic Acids Res. 47 (D1), D1005&#x2013;D1012 (2019). doi: 10.1093/nar/gky1120</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gky1120</ArticleId><ArticleId IdType="pmc">PMC6323933</ArticleId><ArticleId IdType="pubmed">30445434</ArticleId></ArticleIdList></Reference><Reference><Citation>Giambartolomei C et al., Bayesian test for colocalisation between pairs of genetic association studies using summary statistics. PLOS Genet. 10, e1004383 (2014). doi: 10.1371/journal.pgen.1004383</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1004383</ArticleId><ArticleId IdType="pmc">PMC4022491</ArticleId><ArticleId IdType="pubmed">24830394</ArticleId></ArticleIdList></Reference><Reference><Citation>Kibinge NK, Relton CL, Gaunt TR, Richardson TG, Characterizing the causal pathway for genetic variants associated with neurological phenotypes using human brain-derived proteome data. Am. J. Hum. Genet. 106, 885&#x2013;892 (2020). doi: 10.1016/j.ajhg.2020.04.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajhg.2020.04.007</ArticleId><ArticleId IdType="pmc">PMC7273531</ArticleId><ArticleId IdType="pubmed">32413284</ArticleId></ArticleIdList></Reference><Reference><Citation>de Klein N et al., Brain expression quantitative trait locus and network analyses reveal downstream effects and putative drivers for brain-related diseases. Nat. Genet. 55, 377&#x2013;388 (2023). doi: 10.1038/s41588-023-01300-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-023-01300-6</ArticleId><ArticleId IdType="pmc">PMC10011140</ArticleId><ArticleId IdType="pubmed">36823318</ArticleId></ArticleIdList></Reference><Reference><Citation>V&#xf5;sa U et al., Large-scale cis- and trans-eQTL analyses identify thousands of genetic loci and polygenic scores that regulate blood gene expression. Nat. Genet. 53, 1300&#x2013;1310 (2021). doi: 10.1038/s41588-021-00913-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-021-00913-z</ArticleId><ArticleId IdType="pmc">PMC8432599</ArticleId><ArticleId IdType="pubmed">34475573</ArticleId></ArticleIdList></Reference><Reference><Citation>Nelson CP et al., Association analyses based on false discovery rate implicate new loci for coronary artery disease. Nat. Genet. 49, 1385&#x2013;1391 (2017). doi: 10.1038/ng.3913</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.3913</ArticleId><ArticleId IdType="pubmed">28714975</ArticleId></ArticleIdList></Reference><Reference><Citation>Roselli C et al., Multi-ethnic genome-wide association study for atrial fibrillation. Nat. Genet. 50, 1225&#x2013;1233 (2018). doi: 10.1038/s41588-018-0133-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-018-0133-9</ArticleId><ArticleId IdType="pmc">PMC6136836</ArticleId><ArticleId IdType="pubmed">29892015</ArticleId></ArticleIdList></Reference><Reference><Citation>Takeuchi F et al., Interethnic analyses of blood pressure loci in populations of East Asian and European descent. Nat. Commun. 9, 5052 (2018). doi: 10.1038/s41467-018-07345-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-018-07345-0</ArticleId><ArticleId IdType="pmc">PMC6261994</ArticleId><ArticleId IdType="pubmed">30487518</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones GT et al., Meta-analysis of genome-wide association studies for abdominal aortic aneurysm identifies four new disease-specific risk loci. Circ. Res. 120, 341&#x2013;353 (2017). doi: 10.1161/CIRCRESAHA.116.308765</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.116.308765</ArticleId><ArticleId IdType="pmc">PMC5253231</ArticleId><ArticleId IdType="pubmed">27899403</ArticleId></ArticleIdList></Reference><Reference><Citation>Dina C et al., Genetic association analyses highlight biological pathways underlying mitral valve prolapse. Nat. Genet. 47, 1206&#x2013;1211 (2015). doi: 10.1038/ng.3383</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.3383</ArticleId><ArticleId IdType="pmc">PMC4773907</ArticleId><ArticleId IdType="pubmed">26301497</ArticleId></ArticleIdList></Reference><Reference><Citation>Villard E et al., A genome-wide association study identifies two loci associated with heart failure due to dilated cardiomyopathy. Eur. Heart J. 32, 1065&#x2013;1076 (2011). doi: 10.1093/eurheartj/ehr105</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehr105</ArticleId><ArticleId IdType="pmc">PMC3086901</ArticleId><ArticleId IdType="pubmed">21459883</ArticleId></ArticleIdList></Reference><Reference><Citation>Malik R et al., Multiancestry genome-wide association study of 520,000 subjects identifies 32 loci associated with stroke and stroke subtypes. Nat. Genet. 50, 524&#x2013;537 (2018). doi: 10.1038/s41588-018-0058-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-018-0058-3</ArticleId><ArticleId IdType="pmc">PMC5968830</ArticleId><ArticleId IdType="pubmed">29531354</ArticleId></ArticleIdList></Reference><Reference><Citation>Foroud T et al., Genome-wide association study of intracranial aneurysm identifies a new association on chromosome 7. Stroke 45, 3194&#x2013;3199 (2014). doi: 10.1161/STROKEAHA.114.006096</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.114.006096</ArticleId><ArticleId IdType="pmc">PMC4213281</ArticleId><ArticleId IdType="pubmed">25256182</ArticleId></ArticleIdList></Reference><Reference><Citation>Duan L et al., Novel susceptibility loci for moyamoya disease revealed by a genome-wide association study. Stroke 49, 11&#x2013;18 (2018). doi: 10.1161/STROKEAHA.117.017430</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.117.017430</ArticleId><ArticleId IdType="pubmed">29273593</ArticleId></ArticleIdList></Reference><Reference><Citation>Tischfield MA et al., Cerebral vein malformations result from loss of Twist1 expression and BMP signaling from skull progenitor cells and dura. Dev. Cell 42, 445&#x2013;461.e5 (2017). doi: 10.1016/j.devcel.2017.07.027</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.devcel.2017.07.027</ArticleId><ArticleId IdType="pmc">PMC5595652</ArticleId><ArticleId IdType="pubmed">28844842</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Souza Y, Elharram A, Soon-Shiong R, Andrew RD, Bennett BM, Characterization of Aldh2 (&#x2212;/&#x2212;) mice as an age-related model of cognitive impairment and Alzheimer&#x2019;s disease. Mol. Brain 8, 27 (2015). doi: 10.1186/s13041-015-0117-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13041-015-0117-y</ArticleId><ArticleId IdType="pmc">PMC4409701</ArticleId><ArticleId IdType="pubmed">25910195</ArticleId></ArticleIdList></Reference><Reference><Citation>Sim&#xf3;n-S&#xe1;nchez J et al., Genome-wide association study reveals genetic risk underlying Parkinson&#x2019;s disease. Nat. Genet. 41, 1308&#x2013;1312 (2009). doi: 10.1038/ng.487</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.487</ArticleId><ArticleId IdType="pmc">PMC2787725</ArticleId><ArticleId IdType="pubmed">19915575</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamboh MI et al., Genome-wide association study of Alzheimer&#x2019;s disease. Transl. Psychiatry 2, e117 (2012). doi: 10.1038/tp.2012.45</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/tp.2012.45</ArticleId><ArticleId IdType="pmc">PMC3365264</ArticleId><ArticleId IdType="pubmed">22832961</ArticleId></ArticleIdList></Reference><Reference><Citation>Nelson PT et al., ABCC9 gene polymorphism is associated with hippocampal sclerosis of aging pathology. Acta Neuropathol. 127, 825&#x2013;843 (2014). doi: 10.1007/s00401-014-1282-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-014-1282-2</ArticleId><ArticleId IdType="pmc">PMC4113197</ArticleId><ArticleId IdType="pubmed">24770881</ArticleId></ArticleIdList></Reference><Reference><Citation>Pardi&#xf1;as AF et al., Common schizophrenia alleles are enriched in mutation-intolerant genes and in regions under strong background selection. Nat. Genet. 50, 381&#x2013;389 (2018). doi: 10.1038/s41588-018-0059-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-018-0059-2</ArticleId><ArticleId IdType="pmc">PMC5918692</ArticleId><ArticleId IdType="pubmed">29483656</ArticleId></ArticleIdList></Reference><Reference><Citation>Hou L et al., Genome-wide association study of 40,000 individuals identifies two novel loci associated with bipolar disorder. Hum. Mol. Genet. 25, 3383&#x2013;3394 (2016). doi: 10.1093/hmg/ddw181</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddw181</ArticleId><ArticleId IdType="pmc">PMC5179929</ArticleId><ArticleId IdType="pubmed">27329760</ArticleId></ArticleIdList></Reference><Reference><Citation>Wade TD et al., Genetic variants associated with disordered eating. Int. J. Eat. Disord. 46, 594&#x2013;608 (2013). doi: 10.1002/eat.22133</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eat.22133</ArticleId><ArticleId IdType="pmc">PMC3775874</ArticleId><ArticleId IdType="pubmed">23568457</ArticleId></ArticleIdList></Reference><Reference><Citation>Raisi-Estabragh Z et al., Associations of cognitive performance with cardiovascular magnetic resonance phenotypes in the UK Biobank. Eur. Heart J. Cardiovasc. Imaging 23, 663&#x2013;672 (2022). doi: 10.1093/ehjci/jeab075</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ehjci/jeab075</ArticleId><ArticleId IdType="pmc">PMC9016359</ArticleId><ArticleId IdType="pubmed">33987659</ArticleId></ArticleIdList></Reference><Reference><Citation>Gottesman RF et al., Associations between midlife vascular risk factors and 25-year incident dementia in the Atherosclerosis Risk in Communities (ARIC) cohort. JAMA Neurol. 74, 1246&#x2013;1254 (2017). doi: 10.1001/jamaneurol.2017.1658</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2017.1658</ArticleId><ArticleId IdType="pmc">PMC5710244</ArticleId><ArticleId IdType="pubmed">28783817</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccarino V et al., Brain-heart connections in stress and cardiovascular disease: Implications for the cardiac patient. Atherosclerosis 328, 74&#x2013;82 (2021). doi: 10.1016/j.atherosclerosis.2021.05.020</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.atherosclerosis.2021.05.020</ArticleId><ArticleId IdType="pmc">PMC8254768</ArticleId><ArticleId IdType="pubmed">34102426</ArticleId></ArticleIdList></Reference><Reference><Citation>Barrett JC et al., Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes. Nat. Genet. 41, 703&#x2013;707 (2009). doi: 10.1038/ng.381</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.381</ArticleId><ArticleId IdType="pmc">PMC2889014</ArticleId><ArticleId IdType="pubmed">19430480</ArticleId></ArticleIdList></Reference><Reference><Citation>Cousminer DL et al., First genome-wide association study of latent autoimmune diabetes in adults reveals novel insights linking immune and metabolic diabetes. Diabetes Care 41, 2396&#x2013;2403 (2018). doi: 10.2337/dc18-1032</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc18-1032</ArticleId><ArticleId IdType="pmc">PMC6196829</ArticleId><ArticleId IdType="pubmed">30254083</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahajan A et al., Multi-ancestry genetic study of type 2 diabetes highlights the power of diverse populations for discovery and translation. Nat. Genet. 54, 560&#x2013;572 (2022). doi: 10.1038/s41588-022-01058-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-022-01058-3</ArticleId><ArticleId IdType="pmc">PMC9179018</ArticleId><ArticleId IdType="pubmed">35551307</ArticleId></ArticleIdList></Reference><Reference><Citation>Demenais F et al., Multiancestry association study identifies new asthma risk loci that colocalize with immune-cell enhancer marks. Nat. Genet. 50, 42&#x2013;53 (2018). doi: 10.1038/s41588-017-0014-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-017-0014-7</ArticleId><ArticleId IdType="pmc">PMC5901974</ArticleId><ArticleId IdType="pubmed">29273806</ArticleId></ArticleIdList></Reference><Reference><Citation>Noth I et al., Genetic variants associated with idiopathic pulmonary fibrosis susceptibility and mortality: A genome-wide association study. Lancet Respir. Med. 1, 309&#x2013;317 (2013). doi: 10.1016/S2213-2600(13)70045-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(13)70045-6</ArticleId><ArticleId IdType="pmc">PMC3894577</ArticleId><ArticleId IdType="pubmed">24429156</ArticleId></ArticleIdList></Reference><Reference><Citation>Fingerlin TE et al., Genome-wide association study identifies multiple susceptibility loci for pulmonary fibrosis. Nat. Genet. 45, 613&#x2013;620 (2013). doi: 10.1038/ng.2609</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.2609</ArticleId><ArticleId IdType="pmc">PMC3677861</ArticleId><ArticleId IdType="pubmed">23583980</ArticleId></ArticleIdList></Reference><Reference><Citation>Bulik-Sullivan B et al., An atlas of genetic correlations across human diseases and traits. Nat. Genet. 47, 1236&#x2013;1241 (2015). doi: 10.1038/ng.3406</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.3406</ArticleId><ArticleId IdType="pmc">PMC4797329</ArticleId><ArticleId IdType="pubmed">26414676</ArticleId></ArticleIdList></Reference><Reference><Citation>Burgess S, Dudbridge F, Thompson SG, Combining information on multiple instrumental variables in Mendelian randomization: Comparison of allele score and summarized data methods. Stat. Med. 35, 1880&#x2013;1906 (2016). doi: 10.1002/sim.6835</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.6835</ArticleId><ArticleId IdType="pmc">PMC4832315</ArticleId><ArticleId IdType="pubmed">26661904</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurki MI et al., FinnGen provides genetic insights from a well-phenotyped isolated population. Nature 613, 508&#x2013;518 (2023). doi: 10.1038/s41586-022-05473-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-05473-8</ArticleId><ArticleId IdType="pmc">PMC9849126</ArticleId><ArticleId IdType="pubmed">36653562</ArticleId></ArticleIdList></Reference><Reference><Citation>Sullivan PF et al., Psychiatric genomics: An update and an agenda. Am. J. Psychiatry 175, 15&#x2013;27 (2018). doi: 10.1176/appi.ajp.2017.17030283</Citation><ArticleIdList><ArticleId IdType="doi">10.1176/appi.ajp.2017.17030283</ArticleId><ArticleId IdType="pmc">PMC5756100</ArticleId><ArticleId IdType="pubmed">28969442</ArticleId></ArticleIdList></Reference><Reference><Citation>Cross-Disorder Group of the Psychiatric Genomics Consortium, Identification of risk loci with shared effects on five major psychiatric disorders: A genome-wide analysis. Lancet 381, 1371&#x2013;1379 (2013). doi: 10.1016/S0140-6736(12)62129-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(12)62129-1</ArticleId><ArticleId IdType="pmc">PMC3714010</ArticleId><ArticleId IdType="pubmed">23453885</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhar AK, Barton DA, Depression and the link with cardiovascular disease. Front. Psychiatry 7, 33 (2016). doi: 10.3389/fpsyt.2016.00033</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyt.2016.00033</ArticleId><ArticleId IdType="pmc">PMC4800172</ArticleId><ArticleId IdType="pubmed">27047396</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu HL et al., Association between depression and clinical outcomes in patients with hypertrophic cardiomyopathy. J. Am. Heart Assoc. 10, e019071 (2021). doi: 10.1161/JAHA.120.019071</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.120.019071</ArticleId><ArticleId IdType="pmc">PMC8174176</ArticleId><ArticleId IdType="pubmed">33834850</ArticleId></ArticleIdList></Reference><Reference><Citation>Morgan JF, O&#x2019;Donoghue AC, McKenna WJ, Schmidt MM, Psychiatric disorders in hypertrophic cardiomyopathy. Gen. Hosp. Psychiatry 30, 49&#x2013;54 (2008). doi: 10.1016/j.genhosppsych.2007.09.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.genhosppsych.2007.09.005</ArticleId><ArticleId IdType="pubmed">18164940</ArticleId></ArticleIdList></Reference><Reference><Citation>Cuspidi C, Tadic M, Obstructive sleep apnea and left ventricular strain: Useful tool or fancy gadget? J. Clin. Hypertens. (Greenwich) 22, 120&#x2013;122 (2020). doi: 10.1111/jch.13787</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jch.13787</ArticleId><ArticleId IdType="pmc">PMC8030089</ArticleId><ArticleId IdType="pubmed">31891443</ArticleId></ArticleIdList></Reference><Reference><Citation>de Leeuw CA, Mooij JM, Heskes T, Posthuma D, MAGMA: Generalized gene-set analysis of GWAS data. PLOS Comput. Biol. 11, e1004219 (2015). doi: 10.1371/journal.pcbi.1004219</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pcbi.1004219</ArticleId><ArticleId IdType="pmc">PMC4401657</ArticleId><ArticleId IdType="pubmed">25885710</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe K, Taskesen E, van Bochoven A, Posthuma D, Functional mapping and annotation of genetic associations with FUMA. Nat. Commun. 8, 1826 (2017). doi: 10.1038/s41467-017-01261-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-017-01261-5</ArticleId><ArticleId IdType="pmc">PMC5705698</ArticleId><ArticleId IdType="pubmed">29184056</ArticleId></ArticleIdList></Reference><Reference><Citation>Lek M et al., Analysis of protein-coding genetic variation in 60,706 humans. Nature 536, 285&#x2013;291 (2016). doi: 10.1038/nature19057</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature19057</ArticleId><ArticleId IdType="pmc">PMC5018207</ArticleId><ArticleId IdType="pubmed">27535533</ArticleId></ArticleIdList></Reference><Reference><Citation>Finucane HK et al., Partitioning heritability by functional annotation using genome-wide association summary statistics. Nat. Genet. 47, 1228&#x2013;1235 (2015). doi: 10.1038/ng.3404</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.3404</ArticleId><ArticleId IdType="pmc">PMC4626285</ArticleId><ArticleId IdType="pubmed">26414678</ArticleId></ArticleIdList></Reference><Reference><Citation>Kundaje A et al., Integrative analysis of 111 reference human epigenomes. Nature 518, 317&#x2013;330 (2015). doi: 10.1038/nature14248 pmid:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature14248</ArticleId><ArticleId IdType="pmc">PMC4530010</ArticleId><ArticleId IdType="pubmed">25693563</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Q et al., A Bayesian framework that integrates multiomics data and gene networks predicts risk genes from schizophrenia GWAS data. Nat. Neurosci. 22, 691&#x2013;699 (2019). doi: 10.1038/s41593-019-0382-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-019-0382-7</ArticleId><ArticleId IdType="pmc">PMC6646046</ArticleId><ArticleId IdType="pubmed">30988527</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo X-J, Liu B, Ma Q-L, Peng J, Mitochondrial aldehyde dehydrogenase, a potential drug target for protection of heart and brain from ischemia/reperfusion injury. Curr. Drug Targets 15, 948&#x2013;955 (2014). doi: 10.2174/1389450115666140828142401 pmid:</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1389450115666140828142401</ArticleId><ArticleId IdType="pubmed">25163552</ArticleId></ArticleIdList></Reference><Reference><Citation>Pang J, Wang J, Zhang Y, Xu F, Chen Y, Targeting acetaldehyde dehydrogenase 2 (ALDH2) in heart failure-Recent insights and perspectives. Biochim. Biophys. Acta Mol. Basis Dis. 1863, 1933&#x2013;1941 (2017). doi: 10.1016/j.b badis.2016.10.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.b</ArticleId><ArticleId IdType="pubmed">27742538</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C-H, Ferreira JCB, Gross ER, Mochly-Rosen D, Targeting aldehyde dehydrogenase 2: New therapeutic opportunities. Physiol. Rev. 94, 1&#x2013;34 (2014). doi: 10.1152/physrev.00017.2013</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physrev.00017.2013</ArticleId><ArticleId IdType="pmc">PMC3929114</ArticleId><ArticleId IdType="pubmed">24382882</ArticleId></ArticleIdList></Reference><Reference><Citation>Ballinger EC, Ananth M, Talmage DA, Role LW, Basal forebrain cholinergic circuits and signaling in cognition and cognitive decline. Neuron 91, 1199&#x2013;1218 (2016). doi: 10.1016/j.neuron.2016.09.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2016.09.006</ArticleId><ArticleId IdType="pmc">PMC5036520</ArticleId><ArticleId IdType="pubmed">27657448</ArticleId></ArticleIdList></Reference><Reference><Citation>Geula C et al., Basal forebrain cholinergic system in the dementias: Vulnerability, resilience, and resistance. J. Neurochem. 158, 1394&#x2013;1411 (2021). doi: 10.1111/jnc.15471</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.15471</ArticleId><ArticleId IdType="pmc">PMC8458251</ArticleId><ArticleId IdType="pubmed">34272732</ArticleId></ArticleIdList></Reference><Reference><Citation>Iturria-Medina Y, Sotero RC, Toussaint PJ, Mateos-P&#xe9;rez JM, Evans AC; Alzheimer&#x2019;s Disease Neuroimaging Initiative, Early role of vascular dysregulation on late-onset Alzheimer&#x2019;s disease based on multifactorial data-driven analysis. Nat. Commun. 7, 11934 (2016). doi: 10.1038/ncomms11934</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms11934</ArticleId><ArticleId IdType="pmc">PMC4919512</ArticleId><ArticleId IdType="pubmed">27327500</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmitz TW, Nathan Spreng R; Alzheimer&#x2019;s Disease Neuroimaging Initiative, Basal forebrain degeneration precedes and predicts the cortical spread of Alzheimer&#x2019;s pathology. Nat. Commun. 7, 13249 (2016). doi: 10.1038/ncomms13249</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms13249</ArticleId><ArticleId IdType="pmc">PMC5097157</ArticleId><ArticleId IdType="pubmed">27811848</ArticleId></ArticleIdList></Reference><Reference><Citation>Huffman JC, Stern TA, Neuropsychiatric consequences of cardiovascular medications. Dialogues Clin. Neurosci. 9, 29&#x2013;45 (2007). doi: 10.31887/DCNS.2007.9.1/jchuffman</Citation><ArticleIdList><ArticleId IdType="doi">10.31887/DCNS.2007.9.1/jchuffman</ArticleId><ArticleId IdType="pmc">PMC3181843</ArticleId><ArticleId IdType="pubmed">17506224</ArticleId></ArticleIdList></Reference><Reference><Citation>Stuhec M, Keuschler J, Serra-Mestres J, Isetta M, Effects of different antihypertensive medication groups on cognitive function in older patients: A systematic review. Eur. Psychiatry 46, 1&#x2013;15 (2017). doi: 10.1016/j.eurpsy.2017.07.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eurpsy.2017.07.015</ArticleId><ArticleId IdType="pubmed">28992530</ArticleId></ArticleIdList></Reference><Reference><Citation>Ou Y-N et al., Blood pressure and risks of cognitive impairment and dementia: A systematic review and meta-analysis of 209 prospective studies. Hypertension 76, 217&#x2013;225 (2020). doi: 10.1161/HYPERTENSIONAHA.120.14993</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/HYPERTENSIONAHA.120.14993</ArticleId><ArticleId IdType="pubmed">32450739</ArticleId></ArticleIdList></Reference><Reference><Citation>Colbourne L, Harrison PJ, Brain-penetrant calcium channel blockers are associated with a reduced incidence of neuropsychiatric disorders. Mol. Psychiatry 27, 3904&#x2013;3912 (2022). doi: 10.1038/s41380-022-01615-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41380-022-01615-6</ArticleId><ArticleId IdType="pmc">PMC9708561</ArticleId><ArticleId IdType="pubmed">35618884</ArticleId></ArticleIdList></Reference><Reference><Citation>de Simone G, Galderisi M, Allometric normalization of cardiac measures: Producing better, but imperfect, accuracy. J. Am. Soc. Echocardiogr. 27, 1275&#x2013;1278 (2014). doi: 10.1016/j.echo.2014.10.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.echo.2014.10.006</ArticleId><ArticleId IdType="pubmed">25479898</ArticleId></ArticleIdList></Reference><Reference><Citation>Alexander AL, Lee JE, Lazar M, Field AS, Diffusion tensor imaging of the brain. Neurotherapeutics 4, 316&#x2013;329 (2007). doi: 10.1016/j.nurt.2007.05.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nurt.2007.05.011</ArticleId><ArticleId IdType="pmc">PMC2041910</ArticleId><ArticleId IdType="pubmed">17599699</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferreira LK, Busatto GF, Resting-state functional connectivity in normal brain aging. Neurosci. Biobehav. Rev. 37, 384&#x2013;400 (2013). doi: 10.1016/j.neubiorev.2013.01.017</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neubiorev.2013.01.017</ArticleId><ArticleId IdType="pubmed">23333262</ArticleId></ArticleIdList></Reference><Reference><Citation>Fry A et al., Comparison of sociodemographic and health-related characteristics of UK Biobank participants with those of the general population. Am. J. Epidemiol. 186, 1026&#x2013;1034 (2017). doi: 10.1093/aje/kwx246</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/aje/kwx246</ArticleId><ArticleId IdType="pmc">PMC5860371</ArticleId><ArticleId IdType="pubmed">28641372</ArticleId></ArticleIdList></Reference><Reference><Citation>Laird AR, Large, open datasets for human connectomics research: Considerations for reproducible and responsible data use. Neuroimage 244, 118579 (2021). doi: 10.1016/j.neuroimage.2021.118579</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroimage.2021.118579</ArticleId><ArticleId IdType="pubmed">34536537</ArticleId></ArticleIdList></Reference><Reference><Citation>McCracken C et al., Multiorgan imaging demonstrates the heart-brain-liver axis in UK Biobank participants. Nat. Commun. 13, 7839 (2022). doi: 10.1038/s41467-022-35321-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-35321-2</ArticleId><ArticleId IdType="pmc">PMC9772225</ArticleId><ArticleId IdType="pubmed">36543768</ArticleId></ArticleIdList></Reference><Reference><Citation>Carabotti M, Scirocco A, Maselli MA, Severi C, The gut-brain axis: Interactions between enteric microbiota, central and enteric nervous systems. Ann. Gastroenterol. 28, 203&#x2013;209 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4367209</ArticleId><ArticleId IdType="pubmed">25830558</ArticleId></ArticleIdList></Reference><Reference><Citation>Barberio B, Zamani M, Black CJ, Savarino EV, Ford AC, Prevalence of symptoms of anxiety and depression in patients with inflammatory bowel disease: A systematic review and meta-analysis. Lancet Gastroenterol. Hepatol. 6, 359&#x2013;370 (2021). doi: 10.1016/S2468-1253(21)00014-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2468-1253(21)00014-5</ArticleId><ArticleId IdType="pubmed">33721557</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang L et al., A resource-efficient tool for mixed model association analysis of large-scale data. Nat. Genet. 51, 1749&#x2013;1755 (2019). doi: 10.1038/s41588-019-0530-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-019-0530-8</ArticleId><ArticleId IdType="pubmed">31768069</ArticleId></ArticleIdList></Reference><Reference><Citation>Analysis code for: Zhao B
et al., Heart-brain connections: phenotypic and genetic insights from magnetic resonance images, Zenodo;  (2023); https://zenodo.org/record/7799207.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11987082</ArticleId><ArticleId IdType="pubmed">37262162</ArticleId></ArticleIdList></Reference><Reference><Citation>GWAS summary statistics for: Zhao B
et al., Heart-brain connections: phenotypic and genetic insights from magnetic resonance images, Zenodo;  (2023); https://zenodo.org/record/7239166.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11987082</ArticleId><ArticleId IdType="pubmed">37262162</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37256596</PMID><DateCompleted><Year>2023</Year><Month>08</Month><Day>03</Day></DateCompleted><DateRevised><Year>2023</Year><Month>08</Month><Day>03</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2168-6238</ISSN><JournalIssue CitedMedium="Internet"><Volume>80</Volume><Issue>8</Issue><PubDate><Year>2023</Year><Month>Aug</Month><Day>01</Day></PubDate></JournalIssue><Title>JAMA psychiatry</Title><ISOAbbreviation>JAMA Psychiatry</ISOAbbreviation></Journal><ArticleTitle>Does Microglial Activation Lead to Cognitive Changes After COVID-19 Infection?</ArticleTitle><Pagination><StartPage>767</StartPage><MedlinePgn>767</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1001/jamapsychiatry.2023.0664</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gerhard</LastName><ForeName>Alexander</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Neuroscience and Experimental Psychology, Wolfson Molecular Imaging Centre, University of Manchester, Manchester, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Geriatric Medicine, Klinikum Hochsauerland GmbH Springufer 7, Arnsberg, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Nuclear Medicine, Center for Translational Neuro- and Behavioral Sciences, University Hospital Essen, Essen, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016421">Editorial</PublicationType><PublicationType UI="D016420">Comment</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JAMA Psychiatry</MedlineTA><NlmUniqueID>101589550</NlmUniqueID><ISSNLinking>2168-622X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentOn"><RefSource>JAMA Psychiatry. 2023 Aug 1;80(8):787-795. doi: 10.1001/jamapsychiatry.2023.1321.</RefSource><PMID Version="1">37256580</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017628" MajorTopicYN="N">Microglia</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060825" MajorTopicYN="Y">Cognitive Dysfunction</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003071" MajorTopicYN="N">Cognition</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>3</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>31</Day><Hour>13</Hour><Minute>12</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>31</Day><Hour>11</Hour><Minute>34</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37256596</ArticleId><ArticleId IdType="doi">10.1001/jamapsychiatry.2023.0664</ArticleId><ArticleId IdType="pii">2805370</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37223890</PMID><DateCompleted><Year>2023</Year><Month>08</Month><Day>03</Day></DateCompleted><DateRevised><Year>2024</Year><Month>05</Month><Day>25</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2168-6238</ISSN><JournalIssue CitedMedium="Internet"><Volume>80</Volume><Issue>8</Issue><PubDate><Year>2023</Year><Month>Aug</Month><Day>01</Day></PubDate></JournalIssue><Title>JAMA psychiatry</Title><ISOAbbreviation>JAMA Psychiatry</ISOAbbreviation></Journal><ArticleTitle>COVID-19 and Risk for Mental Disorders Among Adults in Denmark.</ArticleTitle><Pagination><StartPage>778</StartPage><EndPage>786</EndPage><MedlinePgn>778-786</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1001/jamapsychiatry.2023.1265</ELocationID><Abstract><AbstractText Label="IMPORTANCE">Psychiatric outcomes after COVID-19 have been of high concern during the pandemic; however, studies on a nationwide level are lacking.</AbstractText><AbstractText Label="OBJECTIVE">To estimate the risk of mental disorders and use of psychotropic medication among individuals with COVID-19 compared with individuals not tested, individuals with SARS-CoV-2-negative test results, and those hospitalized for non-COVID-19 infections.</AbstractText><AbstractText Label="DESIGN, SETTING, AND PARTICIPANTS">This nationwide cohort study used Danish registries to identify all individuals who were alive, 18 years or older, and residing in Denmark between January 1 and March 1, 2020 (N&#x2009;=&#x2009;4&#x202f;152&#x202f;792), excluding individuals with a mental disorder history (n&#x2009;=&#x2009;616&#x202f;546), with follow-up until December 31, 2021.</AbstractText><AbstractText Label="EXPOSURES">Results of SARS-CoV-2 polymerase chain reaction (PCR) testing (negative, positive, and never tested) and COVID-19 hospitalization.</AbstractText><AbstractText Label="MAIN OUTCOMES AND MEASURES">Risk of new-onset mental disorders (International Statistical Classification of Diseases and Related Health Problems, Tenth Revision, codes F00-F99) and redeemed psychotropic medication (Anatomical Therapeutic Chemical classification codes N05-N06) was estimated through survival analysis using a Cox proportional hazards model, with a hierarchical time-varying exposure, reporting hazard rate ratios (HRR) with 95% CIs. All outcomes were adjusted for age, sex, parental history of mental illness, Charlson Comorbidity Index, educational level, income, and job status.</AbstractText><AbstractText Label="RESULTS">A total of 526&#x202f;749 individuals had positive test results for SARS-CoV-2 (50.2% men; mean [SD] age, 41.18 [17.06] years), while 3&#x202f;124&#x202f;933 had negative test results (50.6% women; mean [SD] age, 49.36 [19.00] years), and 501&#x202f;110 had no tests performed (54.6% men; mean [SD] age, 60.71 [19.78] years). Follow-up time was 1.83 years for 93.4% of the population. The risk of mental disorders was increased in individuals with positive (HRR, 1.24 [95% CI, 1.17-1.31]) and negative (HRR, 1.42 [95% CI, 1.38-1.46]) test results for SARS-CoV-2 compared with those never tested. Compared with individuals with negative test results, the risk of new-onset mental disorders in SARS-CoV-2-positive individuals was lower in the group aged 18 to 29 years (HRR, 0.75 [95% CI, 0.69-0.81]), whereas individuals 70 years or older had an increased risk (HRR, 1.25 [95% CI, 1.05-1.50]). A similar pattern was seen regarding psychotropic medication use, with a decreased risk in the group aged 18 to 29 years (HRR, 0.81 [95% CI, 0.76-0.85]) and elevated risk in those 70 years or older (HRR, 1.57 [95% CI, 1.45-1.70]). The risk for new-onset mental disorders was substantially elevated in hospitalized patients with COVID-19 compared with the general population (HRR, 2.54 [95% CI, 2.06-3.14]); however, no significant difference in risk was seen when compared with hospitalization for non-COVID-19 respiratory tract infections (HRR, 1.03 [95% CI, 0.82-1.29]).</AbstractText><AbstractText Label="CONCLUSION AND RELEVANCE">In this Danish nationwide cohort study, overall risk of new-onset mental disorders in SARS-CoV-2-positive individuals did not exceed the risk among individuals with negative test results (except for those aged &#x2265;70 years). However, when hospitalized, patients with COVID-19 had markedly increased risk compared with the general population, but comparable to risk among patients hospitalized for non-COVID-19 infections. Future studies should include even longer follow-up time and preferentially include immunological biomarkers to further investigate the impact of infection severity on postinfectious mental disorder sequelae.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Nersesjan</LastName><ForeName>Vardan</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Biological and Precision Psychiatry, Copenhagen Research Center for Mental Health, Mental Health Centre Copenhagen, Copenhagen University Hospital, Copenhagen, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Christensen</LastName><ForeName>Rune H B</ForeName><Initials>RHB</Initials><AffiliationInfo><Affiliation>Biological and Precision Psychiatry, Copenhagen Research Center for Mental Health, Mental Health Centre Copenhagen, Copenhagen University Hospital, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kondziella</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Neurology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Benros</LastName><ForeName>Michael E</ForeName><Initials>ME</Initials><AffiliationInfo><Affiliation>Biological and Precision Psychiatry, Copenhagen Research Center for Mental Health, Mental Health Centre Copenhagen, Copenhagen University Hospital, Copenhagen, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JAMA Psychiatry</MedlineTA><NlmUniqueID>101589550</NlmUniqueID><ISSNLinking>2168-622X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001523" MajorTopicYN="Y">Mental Disorders</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003718" MajorTopicYN="N" Type="Geographic">Denmark</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><CoiStatement><b>Conflict of Interest Disclosures:</b> Dr Nersesjan reported receiving grants from Mental Health services of the Capital Region of Denmark during the conduct of the study. Dr Kondziella reported receiving personal fees from John Wiley &amp; Sons, Inc, for serving as associate editor for <i>Acta Neurologica Scandinavica</i> outside the submitted work. Dr Benros reported receiving unrestricted charitable grants from research fund of the Mental Health Services of the Capital Region of Denmark, the Novo Nordisk Foundation, and the Lundbeck Foundation during the conduct of the study. No other disclosures were reported.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>3</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>24</Day><Hour>13</Hour><Minute>9</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>24</Day><Hour>11</Hour><Minute>58</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>5</Month><Day>24</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37223890</ArticleId><ArticleId IdType="pmc">PMC10209831</ArticleId><ArticleId IdType="doi">10.1001/jamapsychiatry.2023.1265</ArticleId><ArticleId IdType="pii">2804861</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Subramanian A, Nirantharakumar K, Hughes S, et al. . Symptoms and risk factors for long COVID in non-hospitalized adults. Nat Med. 2022;28(8):1706-1714. doi:10.1038/s41591-022-01909-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01909-w</ArticleId><ArticleId IdType="pmc">PMC9388369</ArticleId><ArticleId IdType="pubmed">35879616</ArticleId></ArticleIdList></Reference><Reference><Citation>Nersesjan V, Fonsmark L, Christensen RHB, et al. . Neuropsychiatric and cognitive outcomes in patients 6 months after COVID-19 requiring hospitalization compared with matched control patients hospitalized for non&#x2013;COVID-19 illness. JAMA Psychiatry. 2022;79(5):486-497. doi:10.1001/jamapsychiatry.2022.0284</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapsychiatry.2022.0284</ArticleId><ArticleId IdType="pmc">PMC8943626</ArticleId><ArticleId IdType="pubmed">35319743</ArticleId></ArticleIdList></Reference><Reference><Citation>Nersesjan V, Amiri M, Lebech AM, et al. . Central and peripheral nervous system complications of COVID-19: a prospective tertiary center cohort with 3-month follow-up. J Neurol. 2021;268(9):3086-3104. doi:10.1007/s00415-020-10380-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-020-10380-x</ArticleId><ArticleId IdType="pmc">PMC7803470</ArticleId><ArticleId IdType="pubmed">33438076</ArticleId></ArticleIdList></Reference><Reference><Citation>Badenoch JB, Rengasamy ER, Watson C, et al. . Persistent neuropsychiatric symptoms after COVID-19: a systematic review and meta-analysis. Brain Commun. 2021;4(1):fcab297. doi:10.1093/braincomms/fcab297</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/braincomms/fcab297</ArticleId><ArticleId IdType="pmc">PMC8833580</ArticleId><ArticleId IdType="pubmed">35169700</ArticleId></ArticleIdList></Reference><Reference><Citation>Spudich S, Nath A. Nervous system consequences of COVID-19. Science. 2022;375(6578):267-269. doi:10.1126/science.abm2052</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abm2052</ArticleId><ArticleId IdType="pubmed">35050660</ArticleId></ArticleIdList></Reference><Reference><Citation>K&#xf6;hler-Forsberg O, Petersen L, Gasse C, et al. . A Nationwide study in Denmark of the association between treated infections and the subsequent risk of treated mental disorders in children and adolescents. JAMA Psychiatry. 2019;76(3):271-279. doi:10.1001/jamapsychiatry.2018.3428</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapsychiatry.2018.3428</ArticleId><ArticleId IdType="pmc">PMC6439826</ArticleId><ArticleId IdType="pubmed">30516814</ArticleId></ArticleIdList></Reference><Reference><Citation>Benros ME, Nielsen PR, Nordentoft M, Eaton WW, Dalton SO, Mortensen PB. Autoimmune diseases and severe infections as risk factors for schizophrenia: a 30-year population-based register study. Am J Psychiatry. 2011;168(12):1303-1310. doi:10.1176/appi.ajp.2011.11030516</Citation><ArticleIdList><ArticleId IdType="doi">10.1176/appi.ajp.2011.11030516</ArticleId><ArticleId IdType="pubmed">22193673</ArticleId></ArticleIdList></Reference><Reference><Citation>Benros ME, Waltoft BL, Nordentoft M, et al. . Autoimmune diseases and severe infections as risk factors for mood disorders: a nationwide study. JAMA Psychiatry. 2013;70(8):812-820. doi:10.1001/jamapsychiatry.2013.1111</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapsychiatry.2013.1111</ArticleId><ArticleId IdType="pubmed">23760347</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, Geddes JR, Husain M, Luciano S, Harrison PJ. 6-month neurological and psychiatric outcomes in 236&#x2009;379 survivors of COVID-19: a retrospective cohort study using electronic health records. Lancet Psychiatry. 2021;8(5):416-427. doi:10.1016/S2215-0366(21)00084-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(21)00084-5</ArticleId><ArticleId IdType="pmc">PMC8023694</ArticleId><ArticleId IdType="pubmed">33836148</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y, Xu E, Al-Aly Z. Risks of mental health outcomes in people with COVID-19: cohort study. BMJ. 2022;376:e068993. doi:10.1136/bmj-2021-068993</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2021-068993</ArticleId><ArticleId IdType="pmc">PMC8847881</ArticleId><ArticleId IdType="pubmed">35172971</ArticleId></ArticleIdList></Reference><Reference><Citation>Clift AK, Ranger TA, Patone M, et al. . Neuropsychiatric ramifications of severe COVID-19 and other severe acute respiratory infections. JAMA Psychiatry. 2022;79(7):690-698. doi:10.1001/jamapsychiatry.2022.1067</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapsychiatry.2022.1067</ArticleId><ArticleId IdType="pmc">PMC9096686</ArticleId><ArticleId IdType="pubmed">35544272</ArticleId></ArticleIdList></Reference><Reference><Citation>Abel KM, Carr MJ, Ashcroft DM, et al. . Association of SARS-CoV-2 infection with psychological distress, psychotropic prescribing, fatigue, and sleep problems among UK primary care patients. JAMA Netw Open. 2021;4(11):e2134803. doi:10.1001/jamanetworkopen.2021.34803</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.34803</ArticleId><ArticleId IdType="pmc">PMC8596199</ArticleId><ArticleId IdType="pubmed">34783824</ArticleId></ArticleIdList></Reference><Reference><Citation>Lund LC, Hallas J, Nielsen H, et al. . Post-acute effects of SARS-CoV-2 infection in individuals not requiring hospital admission: a Danish population-based cohort study. Lancet Infect Dis. 2021;21(10):1373-1382. doi:10.1016/S1473-3099(21)00211-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00211-5</ArticleId><ArticleId IdType="pmc">PMC8110209</ArticleId><ArticleId IdType="pubmed">33984263</ArticleId></ArticleIdList></Reference><Reference><Citation>Haut ER, Pronovost PJ. Surveillance bias in outcomes reporting. JAMA. 2011;305(23):2462-2463. doi:10.1001/jama.2011.822</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2011.822</ArticleId><ArticleId IdType="pubmed">21673300</ArticleId></ArticleIdList></Reference><Reference><Citation>Frank L. Epidemiology. The epidemiologist&#x2019;s dream: Denmark. Science. 2003;301(5630):163. doi:10.1126/science.301.5630.163</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.301.5630.163</ArticleId><ArticleId IdType="pubmed">12855788</ArticleId></ArticleIdList></Reference><Reference><Citation>Pedersen CB, G&#xf8;tzsche H, M&#xf8;ller JO, Mortensen PB. The Danish Civil Registration System: a cohort of eight million persons. Dan Med Bull. 2006;53(4):441-449.</Citation><ArticleIdList><ArticleId IdType="pubmed">17150149</ArticleId></ArticleIdList></Reference><Reference><Citation>Mors O, Perto GP, Mortensen PB. The Danish Psychiatric Central Research Register. Scand J Public Health. 2011;39(7)(suppl):54-57. doi:10.1177/1403494810395825</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1403494810395825</ArticleId><ArticleId IdType="pubmed">21775352</ArticleId></ArticleIdList></Reference><Reference><Citation>Voldstedlund M, Haarh M, M&#xf8;lbak K; MiBa Board of Representatives . The Danish Microbiology Database (MIBA) 2010 to 2013. Euro Surveill. 2014;19(1):20667. doi:10.2807/1560-7917.ES2014.19.1.20667</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.ES2014.19.1.20667</ArticleId><ArticleId IdType="pubmed">24434175</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersen TF, Madsen M, J&#xf8;rgensen J, Mellemkjoer L, Olsen JH. The Danish National Hospital Register: a valuable source of data for modern health sciences. Dan Med Bull. 1999;46(3):263-268.</Citation><ArticleIdList><ArticleId IdType="pubmed">10421985</ArticleId></ArticleIdList></Reference><Reference><Citation>Kildemoes HW, S&#xf8;rensen HT, Hallas J. The Danish National Prescription Registry. Scand J Public Health. 2011;39(7)(suppl):38-41. doi:10.1177/1403494810394717</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1403494810394717</ArticleId><ArticleId IdType="pubmed">21775349</ArticleId></ArticleIdList></Reference><Reference><Citation>Petersson F, Baadsgaard M, Thygesen LC. Danish registers on personal labour market affiliation. Scand J Public Health. 2011;39(7)(suppl):95-98. doi:10.1177/1403494811408483</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1403494811408483</ArticleId><ArticleId IdType="pubmed">21775363</ArticleId></ArticleIdList></Reference><Reference><Citation>Blichert-Hansen L, Nielsson MS, Nielsen RB, Christiansen CF, N&#xf8;rgaard M. Validity of the coding for intensive care admission, mechanical ventilation, and acute dialysis in the Danish National Patient Registry: a short report. Clin Epidemiol. 2013;5:9-12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3555432</ArticleId><ArticleId IdType="pubmed">23359787</ArticleId></ArticleIdList></Reference><Reference><Citation>Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373-383. doi:10.1016/0021-9681(87)90171-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0021-9681(87)90171-8</ArticleId><ArticleId IdType="pubmed">3558716</ArticleId></ArticleIdList></Reference><Reference><Citation>Lund LC, St&#xf8;vring H, Potteg&#xe5;rd A, Andersen M, Hallas J. Cox regression using a calendar time scale was unbiased in simulations of COVID-19 vaccine effectiveness &amp; safety. J Clin Epidemiol. Published online February 16, 2023. doi:10.1016/j.jclinepi.2023.02.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2023.02.012</ArticleId><ArticleId IdType="pmc">PMC9933854</ArticleId><ArticleId IdType="pubmed">36806733</ArticleId></ArticleIdList></Reference><Reference><Citation>Centers for Disease Control and Prevention . Estimated COVID-19 burden. Updated August 12, 2022. Accessed December 22, 2022. https://www.cdc.gov/coronavirus/2019-ncov/cases-updates/burden.html</Citation></Reference><Reference><Citation>Wu SL, Mertens AN, Crider YS, et al. . Substantial underestimation of SARS-CoV-2 infection in the United States. Nat Commun. 2020;11(1):4507. doi:10.1038/s41467-020-18272-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-18272-4</ArticleId><ArticleId IdType="pmc">PMC7481226</ArticleId><ArticleId IdType="pubmed">32908126</ArticleId></ArticleIdList></Reference><Reference><Citation>Potteg&#xe5;rd A, Kristensen KB, Reilev M, et al. . Existing data sources in clinical epidemiology: the Danish COVID-19 cohort. Clin Epidemiol. 2020;12:875-881. doi:10.2147/CLEP.S257519</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/CLEP.S257519</ArticleId><ArticleId IdType="pmc">PMC7429185</ArticleId><ArticleId IdType="pubmed">32848476</ArticleId></ArticleIdList></Reference><Reference><Citation>Umberson D, Montez JK. Social relationships and health: a flashpoint for health policy. J Health Soc Behav. 2010;51(suppl):S54-S66. doi:10.1177/0022146510383501</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0022146510383501</ArticleId><ArticleId IdType="pmc">PMC3150158</ArticleId><ArticleId IdType="pubmed">20943583</ArticleId></ArticleIdList></Reference><Reference><Citation>Campochiaro C, Dagna L. The conundrum of interleukin-6 blockade in COVID-19. Lancet Rheumatol. 2020;2(10):e579-e580. doi:10.1016/S2665-9913(20)30287-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2665-9913(20)30287-3</ArticleId><ArticleId IdType="pmc">PMC7428300</ArticleId><ArticleId IdType="pubmed">32838322</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A, Sehgal K, Gupta A, et al. . Post-acute COVID-19 syndrome. Nat Med. 2021;27(4):601-615. doi:10.1038/s41591-021-01283-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Gustine JN, Jones D. Immunopathology of Hyperinflammation in COVID-19. Am J Pathol. 2021;191(1):4-17. doi:10.1016/j.ajpath.2020.08.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajpath.2020.08.009</ArticleId><ArticleId IdType="pmc">PMC7484812</ArticleId><ArticleId IdType="pubmed">32919977</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryabkova VA, Churilov LP, Shoenfeld Y. Influenza infection, SARS, MERS and COVID-19: cytokine storm: the common denominator and the lessons to be learned. Clin Immunol. 2021;223:108652. doi:10.1016/j.clim.2020.108652</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clim.2020.108652</ArticleId><ArticleId IdType="pmc">PMC7832378</ArticleId><ArticleId IdType="pubmed">33333256</ArticleId></ArticleIdList></Reference><Reference><Citation>Bartley CM, Johns C, Ngo TT, et al. . Anti&#x2013;SARS-CoV-2 and autoantibody profiles in the cerebrospinal fluid of 3 teenaged patients with COVID-19 and subacute neuropsychiatric symptoms. JAMA Neurol. 2021;78(12):1503-1509. doi:10.1001/jamaneurol.2021.3821</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2021.3821</ArticleId><ArticleId IdType="pmc">PMC8546622</ArticleId><ArticleId IdType="pubmed">34694339</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith S, Rahman O. Post Intensive Care Syndrome. StatPearls; 2022.</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewis A, Frontera J, Placantonakis DG, et al. . Cerebrospinal fluid in COVID-19: a systematic review of the literature. J Neurol Sci. 2021;421:117316. doi:10.1016/j.jns.2021.117316</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2021.117316</ArticleId><ArticleId IdType="pmc">PMC7833669</ArticleId><ArticleId IdType="pubmed">33561753</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37256580</PMID><DateCompleted><Year>2023</Year><Month>08</Month><Day>04</Day></DateCompleted><DateRevised><Year>2023</Year><Month>08</Month><Day>04</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2168-6238</ISSN><JournalIssue CitedMedium="Internet"><Volume>80</Volume><Issue>8</Issue><PubDate><Year>2023</Year><Month>Aug</Month><Day>01</Day></PubDate></JournalIssue><Title>JAMA psychiatry</Title><ISOAbbreviation>JAMA Psychiatry</ISOAbbreviation></Journal><ArticleTitle>Neuroinflammation After COVID-19 With Persistent Depressive and Cognitive Symptoms.</ArticleTitle><Pagination><StartPage>787</StartPage><EndPage>795</EndPage><MedlinePgn>787-795</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1001/jamapsychiatry.2023.1321</ELocationID><Abstract><AbstractText Label="IMPORTANCE">Persistent depressive symptoms, often accompanied by cognitive symptoms, commonly occur after COVID-19 illness (hereinafter termed COVID-DC, DC for depressive and/or cognitive symptoms). In patients with COVID-DC, gliosis, an inflammatory change, was suspected, but measurements of gliosis had not been studied in the brain for this condition.</AbstractText><AbstractText Label="OBJECTIVE">To determine whether translocator protein total distribution volume (TSPO VT), a marker of gliosis that is quantifiable with positron emission tomography (PET), is elevated in the dorsal putamen, ventral striatum, prefrontal cortex, anterior cingulate cortex, and hippocampus of persons with COVID-DC.</AbstractText><AbstractText Label="DESIGN, SETTING, AND PARTICIPANTS">This case-control study conducted at a tertiary care psychiatric hospital in Canada from April 1, 2021, to June 30, 2022, compared TSPO VT of specific brain regions in 20 participants with COVID-DC with that in 20 healthy controls. The TSPO VT was measured with fluorine F 18-labeled N-(2-(2-fluoroethoxy)benzyl)-N-(4-phenoxypyridin-3-yl)acetamide ([18F]FEPPA) PET.</AbstractText><AbstractText Label="MAIN OUTCOMES AND MEASURES">The TSPO VT was measured in the dorsal putamen, ventral striatum, prefrontal cortex, anterior cingulate cortex, and hippocampus. Symptoms were measured with neuropsychological and psychological tests, prioritizing outcomes related to striatal function.</AbstractText><AbstractText Label="RESULTS">The study population included 40 participants (mean [SD] age, 32.9 [12.3] years). The TSPO VT across the regions of interest was greater in persons with COVID-DC (mean [SD] age, 32.7 [11.4] years; 12 [60%] women) compared with healthy control participants (mean [SD] age, 33.3 [13.9] years; 11 [55%] women): mean (SD) difference, 1.51 (4.47); 95% CI, 0.04-2.98; 1.51 divided by 9.20 (17%). The difference was most prominent in the ventral striatum (mean [SD] difference, 1.97 [4.88]; 95% CI, 0.36-3.58; 1.97 divided by 8.87 [22%]) and dorsal putamen (mean difference, 1.70 [4.25]; 95% CI, 0.34-3.06; 1.70 divided by 8.37 [20%]). Motor speed on the finger-tapping test negatively correlated with dorsal putamen TSPO VT (r, -0.53; 95% CI, -0.79 to -0.09), and the 10 persons with the slowest speed among those with COVID-DC had higher dorsal putamen TSPO VT than healthy persons by 2.3 (2.30 divided by 8.37 [27%]; SD, 2.46; 95% CI, 0.92-3.68).</AbstractText><AbstractText Label="CONCLUSIONS AND RELEVANCE">In this case-control study, TSPO VT was higher in patients with COVID-DC. Greater TSPO VT is evidence for an inflammatory change of elevated gliosis in the brain of an individual with COVID-DC. Gliosis may be consequent to inflammation, injury, or both, particularly in the ventral striatum and dorsal putamen, which may explain some persistent depressive and cognitive symptoms, including slowed motor speed, low motivation or energy, and anhedonia, after initially mild to moderate COVID-19 illness.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Braga</LastName><ForeName>Joeffre</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Brain Health Imaging Centre, Campbell Family Mental Health Research Institute, The Centre for Addiction and Mental Health, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Azrieli Centre for Neuro-Radiochemistry, Campbell Family Mental Health Research Institute, The Centre for Addiction and Mental Health Toronto, Ontario, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pharmacology and Toxicology, University of Toronto, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lepra</LastName><ForeName>Mariel</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Brain Health Imaging Centre, Campbell Family Mental Health Research Institute, The Centre for Addiction and Mental Health, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Azrieli Centre for Neuro-Radiochemistry, Campbell Family Mental Health Research Institute, The Centre for Addiction and Mental Health Toronto, Ontario, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pharmacology and Toxicology, University of Toronto, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kish</LastName><ForeName>Stephen J</ForeName><Initials>SJ</Initials><AffiliationInfo><Affiliation>Brain Health Imaging Centre, Campbell Family Mental Health Research Institute, The Centre for Addiction and Mental Health, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Azrieli Centre for Neuro-Radiochemistry, Campbell Family Mental Health Research Institute, The Centre for Addiction and Mental Health Toronto, Ontario, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pharmacology and Toxicology, University of Toronto, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rusjan</LastName><ForeName>Pablo M</ForeName><Initials>PM</Initials><AffiliationInfo><Affiliation>Douglas Research Centre, McGill University, Montreal, Quebec, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychiatry, McGill University, Montreal, Quebec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nasser</LastName><ForeName>Zahra</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Brain Health Imaging Centre, Campbell Family Mental Health Research Institute, The Centre for Addiction and Mental Health, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Verhoeff</LastName><ForeName>Natasha</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Brain Health Imaging Centre, Campbell Family Mental Health Research Institute, The Centre for Addiction and Mental Health, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vasdev</LastName><ForeName>Neil</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Brain Health Imaging Centre, Campbell Family Mental Health Research Institute, The Centre for Addiction and Mental Health, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Azrieli Centre for Neuro-Radiochemistry, Campbell Family Mental Health Research Institute, The Centre for Addiction and Mental Health Toronto, Ontario, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bagby</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Azrieli Centre for Neuro-Radiochemistry, Campbell Family Mental Health Research Institute, The Centre for Addiction and Mental Health Toronto, Ontario, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychology, University of Toronto, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boileau</LastName><ForeName>Isabelle</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Brain Health Imaging Centre, Campbell Family Mental Health Research Institute, The Centre for Addiction and Mental Health, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Azrieli Centre for Neuro-Radiochemistry, Campbell Family Mental Health Research Institute, The Centre for Addiction and Mental Health Toronto, Ontario, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pharmacology and Toxicology, University of Toronto, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Husain</LastName><ForeName>M Ishrat</ForeName><Initials>MI</Initials><AffiliationInfo><Affiliation>Brain Health Imaging Centre, Campbell Family Mental Health Research Institute, The Centre for Addiction and Mental Health, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Azrieli Centre for Neuro-Radiochemistry, Campbell Family Mental Health Research Institute, The Centre for Addiction and Mental Health Toronto, Ontario, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pharmacology and Toxicology, University of Toronto, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kolla</LastName><ForeName>Nathan</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Brain Health Imaging Centre, Campbell Family Mental Health Research Institute, The Centre for Addiction and Mental Health, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Azrieli Centre for Neuro-Radiochemistry, Campbell Family Mental Health Research Institute, The Centre for Addiction and Mental Health Toronto, Ontario, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pharmacology and Toxicology, University of Toronto, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Waypoint Centre for Mental Health Care, Penetanguishene, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garcia</LastName><ForeName>Armando</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Brain Health Imaging Centre, Campbell Family Mental Health Research Institute, The Centre for Addiction and Mental Health, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Azrieli Centre for Neuro-Radiochemistry, Campbell Family Mental Health Research Institute, The Centre for Addiction and Mental Health Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chao</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, Institute of Mental Health, University of British Columbia, Vancouver, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mizrahi</LastName><ForeName>Romina</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Douglas Research Centre, McGill University, Montreal, Quebec, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychiatry, McGill University, Montreal, Quebec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Faiz</LastName><ForeName>Khunsa</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Diagnostic Radiology, Hamilton Health Sciences, McMaster University, Hamilton, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vieira</LastName><ForeName>Erica L</ForeName><Initials>EL</Initials><AffiliationInfo><Affiliation>Brain Health Imaging Centre, Campbell Family Mental Health Research Institute, The Centre for Addiction and Mental Health, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Azrieli Centre for Neuro-Radiochemistry, Campbell Family Mental Health Research Institute, The Centre for Addiction and Mental Health Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meyer</LastName><ForeName>Jeffrey H</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Brain Health Imaging Centre, Campbell Family Mental Health Research Institute, The Centre for Addiction and Mental Health, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Azrieli Centre for Neuro-Radiochemistry, Campbell Family Mental Health Research Institute, The Centre for Addiction and Mental Health Toronto, Ontario, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pharmacology and Toxicology, University of Toronto, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>CIHR</Agency><Country>Canada</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016420">Comment</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JAMA Psychiatry</MedlineTA><NlmUniqueID>101589550</NlmUniqueID><ISSNLinking>2168-622X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C499229">TSPO protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018079">Receptors, GABA</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>JAMA Psychiatry. 2023 Aug 1;80(8):767. doi: 10.1001/jamapsychiatry.2023.0664.</RefSource><PMID Version="1">37256596</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000090862" MajorTopicYN="Y">Neuroinflammatory Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017628" MajorTopicYN="N">Microglia</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005911" MajorTopicYN="N">Gliosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D049268" MajorTopicYN="N">Positron-Emission Tomography</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003071" MajorTopicYN="N">Cognition</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018079" MajorTopicYN="N">Receptors, GABA</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><CoiStatement><b>Conflict of Interest Disclosures:</b> Drs Vasdev, Boileau, and Meyer reported receiving salary support from their respective Canada Research Chair awards. Dr Husain reported receiving grants from Compass Pathways; holding stock options for advisory board services from Mindset Pharma; serving as a consultant for Psyched Therapeutics and Wake Network outside the submitted work; and receiving salary support from an Academic Scholars Award from the Department of Psychiatry, University of Toronto. Dr Kolla reported receiving salary support from a Waypoint/University of Toronto Research Chair in Forensic Mental Health Science. Prof Meyer reported receiving grants from Sanofi outside the submitted work; potentially receiving contracts, which may include salary support, from Bristol Myers Squibb and AbbVie; holding stock in Moderna; being an inventor on patents for a dietary supplement to prevent postpartum sadness; and being an inventor on submitted patents for some blood markers to predict inflammation in psychiatric illness; in addition, there is an agreement in development with Exceltis to distribute the dietary supplement, which may lead to funding. No other disclosures were reported.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>3</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>31</Day><Hour>13</Hour><Minute>11</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>31</Day><Hour>11</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>5</Month><Day>31</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37256580</ArticleId><ArticleId IdType="pmc">PMC10233457</ArticleId><ArticleId IdType="doi">10.1001/jamapsychiatry.2023.1321</ArticleId><ArticleId IdType="pii">2805366</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>World Health Organization. WHO Coronavirus (COVID-19) Dashboard. Updated September 14, 2022. Accessed September 15, 2022, 2022. https://covid19.who.int/?mapFilter=cases</Citation></Reference><Reference><Citation>Office for National Statistics (United Kingdom). Self-reported long COVID after infection with the Omicron variant in the UK: 6 May 2022. Accessed April 13, 2023. https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/selfreportedlongcovidafterinfectionwiththeomicronvariant/6may2022</Citation></Reference><Reference><Citation>Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72&#x2009;314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020;323(13):1239-1242. doi:10.1001/jama.2020.2648</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.2648</ArticleId><ArticleId IdType="pubmed">32091533</ArticleId></ArticleIdList></Reference><Reference><Citation>National Institutes of Health . Clinical spectrum of SARS-CoV-2 infection. Accessed August 3, 2022. https://www.covid19treatmentguidelines.nih.gov/overview/clinical-spectrum/#:~:text=Patients%20with%20COVID%2D19%20are,may%20experience%20rapid%20clinical%20deterioration.</Citation></Reference><Reference><Citation>Varatharaj A, Thomas N, Ellul MA, et al. ; CoroNerve Study Group . Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study. Lancet Psychiatry. 2020;7(10):875-882. doi:10.1016/S2215-0366(20)30287-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(20)30287-X</ArticleId><ArticleId IdType="pmc">PMC7316461</ArticleId><ArticleId IdType="pubmed">32593341</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, Assaf GS, McCorkell L, et al. . Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021;38:101019. doi:10.1016/j.eclinm.2021.101019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamontagne SJ, Winters MF, Pizzagalli DA, Olmstead MC. Post-acute sequelae of COVID-19: evidence of mood and cognitive impairment. Brain Behav Immun Health. 2021;17:100347. doi:10.1016/j.bbih.2021.100347</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbih.2021.100347</ArticleId><ArticleId IdType="pmc">PMC8437695</ArticleId><ArticleId IdType="pubmed">34549199</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao N, Li W, Zhang SF, et al. . Network analysis of depressive symptoms among residents of Wuhan in the later stage of the COVID-19 pandemic. Front Psychiatry. 2021;12:735973. doi:10.3389/fpsyt.2021.735973</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyt.2021.735973</ArticleId><ArticleId IdType="pmc">PMC8514718</ArticleId><ArticleId IdType="pubmed">34658968</ArticleId></ArticleIdList></Reference><Reference><Citation>Block ML, Zecca L, Hong JS. Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat Rev Neurosci. 2007;8(1):57-69. doi:10.1038/nrn2038</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn2038</ArticleId><ArticleId IdType="pubmed">17180163</ArticleId></ArticleIdList></Reference><Reference><Citation>Dantzer R, O&#x2019;Connor JC, Freund GG, Johnson RW, Kelley KW. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci. 2008;9(1):46-56. doi:10.1038/nrn2297</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn2297</ArticleId><ArticleId IdType="pmc">PMC2919277</ArticleId><ArticleId IdType="pubmed">18073775</ArticleId></ArticleIdList></Reference><Reference><Citation>Boldrini M, Canoll PD, Klein RS. How COVID-19 affects the brain. JAMA Psychiatry. 2021;78(6):682-683. doi:10.1001/jamapsychiatry.2021.0500</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapsychiatry.2021.0500</ArticleId><ArticleId IdType="pmc">PMC9894299</ArticleId><ArticleId IdType="pubmed">33769431</ArticleId></ArticleIdList></Reference><Reference><Citation>Cosentino G, Todisco M, Hota N, et al. . Neuropathological findings from COVID-19 patients with neurological symptoms argue against a direct brain invasion of SARS-CoV-2: a critical systematic review. Eur J Neurol. 2021;28(11):3856-3865. doi:10.1111/ene.15045</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.15045</ArticleId><ArticleId IdType="pmc">PMC8444743</ArticleId><ArticleId IdType="pubmed">34339563</ArticleId></ArticleIdList></Reference><Reference><Citation>Matschke J, L&#xfc;tgehetmann M, Hagel C, et al. . Neuropathology of patients with COVID-19 in Germany: a post-mortem case series. Lancet Neurol. 2020;19(11):919-929. doi:10.1016/S1474-4422(20)30308-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(20)30308-2</ArticleId><ArticleId IdType="pmc">PMC7535629</ArticleId><ArticleId IdType="pubmed">33031735</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyer JH, Cervenka S, Kim M-J, Kreisl WC, Henter ID, Innis RB. Neuroinflammation in psychiatric disorders: PET imaging and promising new targets. Lancet Psychiatry. 2020;7(12):1064-1074. doi:10.1016/S2215-0366(20)30255-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(20)30255-8</ArticleId><ArticleId IdType="pmc">PMC7893630</ArticleId><ArticleId IdType="pubmed">33098761</ArticleId></ArticleIdList></Reference><Reference><Citation>Rusjan PM, Wilson AA, Bloomfield PM, et al. . Quantitation of translocator protein binding in human brain with the novel radioligand [18F]-FEPPA and positron emission tomography. J Cereb Blood Flow Metab. 2011;31(8):1807-1816. doi:10.1038/jcbfm.2011.55</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/jcbfm.2011.55</ArticleId><ArticleId IdType="pmc">PMC3170950</ArticleId><ArticleId IdType="pubmed">21522163</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilson AA, Garcia A, Parkes J, et al. . Radiosynthesis and initial evaluation of [18F]-FEPPA for PET imaging of peripheral benzodiazepine receptors. Nucl Med Biol. 2008;35(3):305-314.</Citation><ArticleIdList><ArticleId IdType="pubmed">18355686</ArticleId></ArticleIdList></Reference><Reference><Citation>Suridjan I, Pollock BG, Verhoeff NP, et al. . In-vivo imaging of grey and white matter neuroinflammation in Alzheimer&#x2019;s disease: a positron emission tomography study with a novel radioligand, [18F]-FEPPA. Mol Psychiatry. 2015;20(12):1579-1587. doi:10.1038/mp.2015.1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/mp.2015.1</ArticleId><ArticleId IdType="pmc">PMC8026116</ArticleId><ArticleId IdType="pubmed">25707397</ArticleId></ArticleIdList></Reference><Reference><Citation>Liljeholm M, O&#x2019;Doherty JP. Contributions of the striatum to learning, motivation, and performance: an associative account. Trends Cogn Sci. 2012;16(9):467-475. doi:10.1016/j.tics.2012.07.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tics.2012.07.007</ArticleId><ArticleId IdType="pmc">PMC3449003</ArticleId><ArticleId IdType="pubmed">22890090</ArticleId></ArticleIdList></Reference><Reference><Citation>Haber S. Neuroanatomy of reward: a view from the ventral striatum. In: Gottfried J, ed. Neurobiology of Sensation and Reward. CRC Press/Taylor and Francis; 2011.</Citation><ArticleIdList><ArticleId IdType="pubmed">22593898</ArticleId></ArticleIdList></Reference><Reference><Citation>Ressler KJ, Mayberg HS. Targeting abnormal neural circuits in mood and anxiety disorders: from the laboratory to the clinic. Nat Neurosci. 2007;10(9):1116-1124. doi:10.1038/nn1944</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn1944</ArticleId><ArticleId IdType="pmc">PMC2444035</ArticleId><ArticleId IdType="pubmed">17726478</ArticleId></ArticleIdList></Reference><Reference><Citation>First MB, Williams JBW, Karg RS, Spitzer RL. Structured Clinical Interview for DSM-5&#x2014;Research Version (SCID-5-RV). American Psychiatric Association; 2015.</Citation></Reference><Reference><Citation>World Health Organization. Clinical management of COVID-19: interim guidance, 27 May 2020. 2020. Accessed April 13, 2023. https://apps.who.int/iris/handle/10665/332196</Citation></Reference><Reference><Citation>Rusjan PM, Wilson AA, Bloomfield PM, et al. . Quantitation of translocator protein binding in human brain with the novel radioligand [18F]-FEPPA and positron emission tomography. J Cereb Blood Flow Metab. 2011;31(8):1807-1816. doi:10.1038/jcbfm.2011.55</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/jcbfm.2011.55</ArticleId><ArticleId IdType="pmc">PMC3170950</ArticleId><ArticleId IdType="pubmed">21522163</ArticleId></ArticleIdList></Reference><Reference><Citation>Spreen O, Strauss E. A Compendium of Neuropsychological Tests: Administration, Norms, Commentary. 2nd ed. Oxford University Press; 1998.</Citation></Reference><Reference><Citation>Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23(1):56-62. doi:10.1136/jnnp.23.1.56</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.23.1.56</ArticleId><ArticleId IdType="pmc">PMC495331</ArticleId><ArticleId IdType="pubmed">14399272</ArticleId></ArticleIdList></Reference><Reference><Citation>Broadbent DE, Cooper PF, FitzGerald P, Parkes KR. The Cognitive Failures Questionnaire (CFQ) and its correlates. Br J Clin Psychol. 1982;21(1):1-16.</Citation><ArticleIdList><ArticleId IdType="pubmed">7126941</ArticleId></ArticleIdList></Reference><Reference><Citation>Setiawan E, Attwells S, Wilson AA, et al. . Association of translocator protein total distribution volume with duration of untreated major depressive disorder: a cross-sectional study. Lancet Psychiatry. 2018;5(4):339-347. doi:10.1016/S2215-0366(18)30048-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(18)30048-8</ArticleId><ArticleId IdType="pubmed">29496589</ArticleId></ArticleIdList></Reference><Reference><Citation>Scott G, Mahmud M, Owen DR, Johnson MR. Microglial positron emission tomography (PET) imaging in epilepsy: applications, opportunities and pitfalls. Seizure. 2017;44:42-47. doi:10.1016/j.seizure.2016.10.023</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.seizure.2016.10.023</ArticleId><ArticleId IdType="pubmed">27884611</ArticleId></ArticleIdList></Reference><Reference><Citation>Kreisl WC, Lyoo CH, McGwier M, et al. ; Biomarkers Consortium PET Radioligand Project Team . In vivo radioligand binding to translocator protein correlates with severity of Alzheimer&#x2019;s disease. Brain. 2013;136(pt 7):2228-2238. doi:10.1093/brain/awt145</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awt145</ArticleId><ArticleId IdType="pmc">PMC3692038</ArticleId><ArticleId IdType="pubmed">23775979</ArticleId></ArticleIdList></Reference><Reference><Citation>Attwells S, Setiawan E, Wilson AA, et al. . Inflammation in the neurocircuitry of obsessive-compulsive disorder. JAMA Psychiatry. 2017;74(8):833-840. doi:10.1001/jamapsychiatry.2017.1567</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapsychiatry.2017.1567</ArticleId><ArticleId IdType="pmc">PMC5710556</ArticleId><ArticleId IdType="pubmed">28636705</ArticleId></ArticleIdList></Reference><Reference><Citation>Boutin H, Pinborg LH. TSPO imaging in stroke: from animal models to human subjects. Clin Transl Imaging. 2015;3:423-435. doi:10.1007/s40336-015-0146-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40336-015-0146-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen R, Wang K, Yu J, et al. . The spatial and cell-type distribution of SARS-CoV-2 receptor ACE2 in the human and mouse brains. Front Neurol. 2021;11:573095. doi:10.3389/fneur.2020.573095</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2020.573095</ArticleId><ArticleId IdType="pmc">PMC7855591</ArticleId><ArticleId IdType="pubmed">33551947</ArticleId></ArticleIdList></Reference><Reference><Citation>Hern&#xe1;ndez VS, Zetter MA, Guerra EC, et al. . ACE2 expression in rat brain: implications for COVID-19 associated neurological manifestations. Exp Neurol. 2021;345:113837. doi:10.1016/j.expneurol.2021.113837</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2021.113837</ArticleId><ArticleId IdType="pmc">PMC8361001</ArticleId><ArticleId IdType="pubmed">34400158</ArticleId></ArticleIdList></Reference><Reference><Citation>Richards EM, Zanotti-Fregonara P, Fujita M, et al. . PET radioligand binding to translocator protein (TSPO) is increased in unmedicated depressed subjects. EJNMMI Res. 2018;8(1):57. doi:10.1186/s13550-018-0401-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13550-018-0401-9</ArticleId><ArticleId IdType="pmc">PMC6029989</ArticleId><ArticleId IdType="pubmed">29971587</ArticleId></ArticleIdList></Reference><Reference><Citation>Betlazar C, Middleton RJ, Banati R, Liu GJ. The translocator protein (TSPO) in mitochondrial bioenergetics and immune processes. Cells. 2020;9(2):512. doi:10.3390/cells9020512</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells9020512</ArticleId><ArticleId IdType="pmc">PMC7072813</ArticleId><ArticleId IdType="pubmed">32102369</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhattacharya A. Recent advances in CNS P2X7 physiology and pharmacology: focus on neuropsychiatric disorders. Front Pharmacol. 2018;9:30. doi:10.3389/fphar.2018.00030</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2018.00030</ArticleId><ArticleId IdType="pmc">PMC5799703</ArticleId><ArticleId IdType="pubmed">29449810</ArticleId></ArticleIdList></Reference><Reference><Citation>Visser D, Golla SSV, Verfaillie SCJ, et al. . Long COVID is associated with extensive in-vivo neuroinflammation on [18F]DPA-714 PET. medRxiv. Preprint posted online June 24, 2022. doi:10.1101/2022.06.02.22275916</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.06.02.22275916</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolburg H, Noell S, Mack A, Wolburg-Buchholz K, Fallier-Becker P. Brain endothelial cells and the glio-vascular complex. Cell Tissue Res. 2009;335(1):75-96. doi:10.1007/s00441-008-0658-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00441-008-0658-9</ArticleId><ArticleId IdType="pubmed">18633647</ArticleId></ArticleIdList></Reference><Reference><Citation>Leenders KL, Perani D, Lammertsma AA, et al. . Cerebral blood flow, blood volume and oxygen utilization: normal values and effect of age. Brain. 1990;113(Pt 1):27-47. doi:10.1093/brain/113.1.27</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/113.1.27</ArticleId><ArticleId IdType="pubmed">2302536</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37291336</PMID><DateCompleted><Year>2023</Year><Month>07</Month><Day>07</Day></DateCompleted><DateRevised><Year>2024</Year><Month>07</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1546-1726</ISSN><JournalIssue CitedMedium="Internet"><Volume>26</Volume><Issue>7</Issue><PubDate><Year>2023</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Nature neuroscience</Title><ISOAbbreviation>Nat Neurosci</ISOAbbreviation></Journal><ArticleTitle>Identification of a protective microglial state mediated by miR-155 and interferon-&#x3b3; signaling in a mouse model of Alzheimer's disease.</ArticleTitle><Pagination><StartPage>1196</StartPage><EndPage>1207</EndPage><MedlinePgn>1196-1207</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41593-023-01355-y</ELocationID><Abstract><AbstractText>Microglia play a critical role in brain homeostasis and disease progression. In neurodegenerative conditions, microglia acquire the neurodegenerative phenotype (MGnD), whose function is poorly understood. MicroRNA-155 (miR-155), enriched in immune cells, critically regulates MGnD. However, its role in Alzheimer's disease (AD) pathogenesis remains unclear. Here, we report that microglial deletion of miR-155 induces a pre-MGnD activation state via interferon-&#x3b3; (IFN-&#x3b3;) signaling, and blocking IFN-&#x3b3; signaling attenuates MGnD induction and microglial phagocytosis. Single-cell RNA-sequencing analysis of microglia from an AD mouse model identifies Stat1 and Clec2d as pre-MGnD markers. This phenotypic transition enhances amyloid plaque compaction, reduces dystrophic neurites, attenuates plaque-associated synaptic degradation and improves cognition. Our study demonstrates a miR-155-mediated regulatory mechanism of MGnD and the beneficial role of IFN-&#x3b3;-responsive pre-MGnD in restricting neurodegenerative pathology and preserving cognitive function in an AD mouse model, highlighting miR-155 and IFN-&#x3b3; as potential therapeutic targets for AD.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s), under exclusive licence to Springer Nature America, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Yin</LastName><ForeName>Zhuoran</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Evergrande Center for Immunologic Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Herron</LastName><ForeName>Shawn</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Silveira</LastName><ForeName>Sebastian</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kleemann</LastName><ForeName>Kilian</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0002-2753-6804</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Computing, University of Portsmouth, Portsmouth, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gauthier</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mallah</LastName><ForeName>Dania</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cheng</LastName><ForeName>Yiran</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0001-5589-2024</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Margeta</LastName><ForeName>Milica A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Ophthalmology, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pitts</LastName><ForeName>Kristen M</ForeName><Initials>KM</Initials><Identifier Source="ORCID">0000-0001-7049-0883</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Ophthalmology, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barry</LastName><ForeName>Jen-Li</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Subramanian</LastName><ForeName>Ayshwarya</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-4134-7612</Identifier><AffiliationInfo><Affiliation>Klarman Cell Observatory, Broad Institute of MIT and Harvard, Cambridge, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>ARCND, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shorey</LastName><ForeName>Hannah</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brandao</LastName><ForeName>Wesley</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Durao</LastName><ForeName>Ana</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Delpech</LastName><ForeName>Jean-Christophe</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Department of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratoire NutriNeuro, UMR 1286, Bordeaux INP, INRAE, University of Bordeaux, Bordeaux, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Madore</LastName><ForeName>Charlotte</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratoire NutriNeuro, UMR 1286, Bordeaux INP, INRAE, University of Bordeaux, Bordeaux, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jedrychowski</LastName><ForeName>Mark</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Cancer Biology, Dana-Farber Cancer Institute and Department of Cell Biology, Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ajay</LastName><ForeName>Amrendra K</ForeName><Initials>AK</Initials><Identifier Source="ORCID">0000-0003-2790-5726</Identifier><AffiliationInfo><Affiliation>Department of Medicine, Division of Renal Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Murugaiyan</LastName><ForeName>Gopal</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hersh</LastName><ForeName>Samuel W</ForeName><Initials>SW</Initials><AffiliationInfo><Affiliation>Department of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ikezu</LastName><ForeName>Seiko</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neuroscience, Mayo Clinic Florida, Jacksonville, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ikezu</LastName><ForeName>Tsuneya</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-3979-8596</Identifier><AffiliationInfo><Affiliation>Department of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, MA, USA. ikezu.tsuneya@mayo.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neuroscience, Mayo Clinic Florida, Jacksonville, FL, USA. ikezu.tsuneya@mayo.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Butovsky</LastName><ForeName>Oleg</ForeName><Initials>O</Initials><Identifier Source="ORCID">0000-0003-0186-8867</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. obutovsky@rics.bwh.harvard.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Evergrande Center for Immunologic Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. obutovsky@rics.bwh.harvard.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 AG067763</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R21 NS101673</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K12 EY016335</GrantID><Acronym>EY</Acronym><Agency>NEI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 EY027921</GrantID><Acronym>EY</Acronym><Agency>NEI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R41 AG073059</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 GM008541</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG072719</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R21 NS104609</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG051812</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 GM132668</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>RF1 AG054199</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG066429</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG075509</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS088137</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R21 AG076982</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG080992</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>F31 AG071106</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG054672</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K08 EY030160</GrantID><Acronym>EY</Acronym><Agency>NEI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG079859</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>06</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Nat Neurosci</MedlineTA><NlmUniqueID>9809671</NlmUniqueID><ISSNLinking>1097-6256</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>82115-62-6</RegistryNumber><NameOfSubstance UI="D007371">Interferon-gamma</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D035683">MicroRNAs</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016229">Amyloid beta-Peptides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C532623">Mirn155 microRNA, mouse</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007371" MajorTopicYN="N">Interferon-gamma</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017628" MajorTopicYN="N">Microglia</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D035683" MajorTopicYN="Y">MicroRNAs</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016229" MajorTopicYN="N">Amyloid beta-Peptides</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058225" MajorTopicYN="N">Plaque, Amyloid</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>Competing Interests. O.B. is an inventor of a patent for use of miR-155 inhibitors for treatment of neurodegenerative diseases. O.B.: collaboration with GSK, Regulus Therapeutics; research funding from Sanofi, GSK, honoraria for lectures, consultancy: Camp4, Ono Pharma USA. T.I. consults Takeda. The remaining authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>4</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>5</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>7</Month><Day>7</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>9</Day><Hour>1</Hour><Minute>9</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>8</Day><Hour>23</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>7</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37291336</ArticleId><ArticleId IdType="mid">NIHMS1934469</ArticleId><ArticleId IdType="pmc">PMC10619638</ArticleId><ArticleId IdType="doi">10.1038/s41593-023-01355-y</ArticleId><ArticleId IdType="pii">10.1038/s41593-023-01355-y</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Efthymiou AG &amp; Goate AM Late onset Alzheimer&#x2019;s disease genetics implicates microglial pathways in disease risk. Mol Neurodegener 12, 43 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5446752</ArticleId><ArticleId IdType="pubmed">28549481</ArticleId></ArticleIdList></Reference><Reference><Citation>Lambert JC, et al. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer&#x2019;s disease. Nat Genet 45, 1452&#x2013;1458 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3896259</ArticleId><ArticleId IdType="pubmed">24162737</ArticleId></ArticleIdList></Reference><Reference><Citation>Kunkle BW, et al. Genetic meta-analysis of diagnosed Alzheimer&#x2019;s disease identifies new risk loci and implicates Abeta, tau, immunity and lipid processing. Nat Genet 51, 414&#x2013;430 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6463297</ArticleId><ArticleId IdType="pubmed">30820047</ArticleId></ArticleIdList></Reference><Reference><Citation>Colonna M &amp; Butovsky O Microglia Function in the Central Nervous System During Health and Neurodegeneration. Annu Rev Immunol 35, 441&#x2013;468 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8167938</ArticleId><ArticleId IdType="pubmed">28226226</ArticleId></ArticleIdList></Reference><Reference><Citation>Heneka MT, et al. Neuroinflammation in Alzheimer&#x2019;s disease. Lancet Neurol 14, 388&#x2013;405 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5909703</ArticleId><ArticleId IdType="pubmed">25792098</ArticleId></ArticleIdList></Reference><Reference><Citation>Butovsky O, et al. Identification of a unique TGF-beta-dependent molecular and functional signature in microglia. Nat Neurosci 17, 131&#x2013;143 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4066672</ArticleId><ArticleId IdType="pubmed">24316888</ArticleId></ArticleIdList></Reference><Reference><Citation>Krasemann S, et al. The TREM2-APOE Pathway Drives the Transcriptional Phenotype of Dysfunctional Microglia in Neurodegenerative Diseases. Immunity 47, 566&#x2013;581 e569 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5719893</ArticleId><ArticleId IdType="pubmed">28930663</ArticleId></ArticleIdList></Reference><Reference><Citation>Keren-Shaul H, et al. A Unique Microglia Type Associated with Restricting Development of Alzheimer&#x2019;s Disease. Cell 169, 1276&#x2013;1290 e1217 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28602351</ArticleId></ArticleIdList></Reference><Reference><Citation>Gosselin D, et al. Environment drives selection and function of enhancers controlling tissue-specific macrophage identities. Cell 159, 1327&#x2013;1340 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4364385</ArticleId><ArticleId IdType="pubmed">25480297</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, et al. TREM2 lipid sensing sustains the microglial response in an Alzheimer&#x2019;s disease model. Cell 160, 1061&#x2013;1071 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4477963</ArticleId><ArticleId IdType="pubmed">25728668</ArticleId></ArticleIdList></Reference><Reference><Citation>Butovsky O &amp; Weiner HL Microglial signatures and their role in health and disease. Nat Rev Neurosci 19, 622&#x2013;635 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7255106</ArticleId><ArticleId IdType="pubmed">30206328</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, et al. TREM2-mediated early microglial response limits diffusion and toxicity of amyloid plaques. J Exp Med 213, 667&#x2013;675 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4854736</ArticleId><ArticleId IdType="pubmed">27091843</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan P, et al. TREM2 Haplodeficiency in Mice and Humans Impairs the Microglia Barrier Function Leading to Decreased Amyloid Compaction and Severe Axonal Dystrophy. Neuron 90, 724&#x2013;739 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4898967</ArticleId><ArticleId IdType="pubmed">27196974</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng Q, et al. TREM2-activating antibodies abrogate the negative pleiotropic effects of the Alzheimer&#x2019;s disease variant Trem2R47H on murine myeloid cell function. Journal of Biological Chemistry 293, 12620&#x2013;12633 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6093249</ArticleId><ArticleId IdType="pubmed">29599291</ArticleId></ArticleIdList></Reference><Reference><Citation>Cignarella F, et al. TREM2 activation on microglia promotes myelin debris clearance and remyelination in a model of multiple sclerosis. Acta neuropathologica 140, 513&#x2013;534 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7498497</ArticleId><ArticleId IdType="pubmed">32772264</ArticleId></ArticleIdList></Reference><Reference><Citation>Ellwanger DC, et al. Prior activation state shapes the microglia response to antihuman TREM2 in a mouse model of Alzheimer&#x2019;s disease. Proceedings of the National Academy of Sciences 118, e2017742118 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7826333</ArticleId><ArticleId IdType="pubmed">33446504</ArticleId></ArticleIdList></Reference><Reference><Citation>Fassler M, Rappaport MS, Cu&#xf1;o CB &amp; George J Engagement of TREM2 by a novel monoclonal antibody induces activation of microglia and improves cognitive function in Alzheimer&#x2019;s disease models. Journal of Neuroinflammation 18, 1&#x2013;18 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7796541</ArticleId><ArticleId IdType="pubmed">33422057</ArticleId></ArticleIdList></Reference><Reference><Citation>Schlepckow K, et al. Enhancing protective microglial activities with a dual function TREM 2 antibody to the stalk region. EMBO molecular medicine 12, e11227 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7136959</ArticleId><ArticleId IdType="pubmed">32154671</ArticleId></ArticleIdList></Reference><Reference><Citation>Jain N, Lewis CA, Ulrich JD &amp; Holtzman DM Chronic TREM2 activation exacerbates A&#x3b2;-associated tau seeding and spreading. Journal of Experimental Medicine 220 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9559604</ArticleId><ArticleId IdType="pubmed">36219197</ArticleId></ArticleIdList></Reference><Reference><Citation>Clayton K, et al. Plaque associated microglia hyper-secrete extracellular vesicles and accelerate tau propagation in a humanized APP mouse model. Mol Neurodegener 16, 18 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7986521</ArticleId><ArticleId IdType="pubmed">33752701</ArticleId></ArticleIdList></Reference><Reference><Citation>Schafer DP, et al. Microglia sculpt postnatal neural circuits in an activity and complement-dependent manner. Neuron 74, 691&#x2013;705 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3528177</ArticleId><ArticleId IdType="pubmed">22632727</ArticleId></ArticleIdList></Reference><Reference><Citation>Stevens B, et al. The classical complement cascade mediates CNS synapse elimination. Cell 131, 1164&#x2013;1178 (2007).</Citation><ArticleIdList><ArticleId IdType="pubmed">18083105</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong S, et al. Complement and microglia mediate early synapse loss in Alzheimer mouse models. Science 352, 712&#x2013;716 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5094372</ArticleId><ArticleId IdType="pubmed">27033548</ArticleId></ArticleIdList></Reference><Reference><Citation>Faraoni I, Antonetti FR, Cardone J &amp; Bonmassar E miR-155 gene: a typical multifunctional microRNA. Biochim Biophys Acta 1792, 497&#x2013;505 (2009).</Citation><ArticleIdList><ArticleId IdType="pubmed">19268705</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Connell RM, Taganov KD, Boldin MP, Cheng G &amp; Baltimore D MicroRNA-155 is induced during the macrophage inflammatory response. Proc Natl Acad Sci U S A 104, 1604&#x2013;1609 (2007).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1780072</ArticleId><ArticleId IdType="pubmed">17242365</ArticleId></ArticleIdList></Reference><Reference><Citation>Butovsky O, et al. Targeting miR-155 restores abnormal microglia and attenuates disease in SOD1 mice. Ann Neurol 77, 1085 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4432483</ArticleId><ArticleId IdType="pubmed">25381879</ArticleId></ArticleIdList></Reference><Reference><Citation>Koval ED, et al. Method for widespread microRNA-155 inhibition prolongs survival in ALS-model mice. Hum Mol Genet 22, 4127&#x2013;4135 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3781640</ArticleId><ArticleId IdType="pubmed">23740943</ArticleId></ArticleIdList></Reference><Reference><Citation>Readhead B, et al. miR155 regulation of behavior, neuropathology, and cortical transcriptomics in Alzheimer&#x2019;s disease. Acta Neuropathol 140, 295&#x2013;315 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8414561</ArticleId><ArticleId IdType="pubmed">32666270</ArticleId></ArticleIdList></Reference><Reference><Citation>Aloi MS, et al. The pro-inflammatory microRNA miR-155 influences fibrillar beta-Amyloid1 &#x2212;42 catabolism by microglia. Glia 69, 1736&#x2013;1748 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9098129</ArticleId><ArticleId IdType="pubmed">33694209</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu R, et al. miR-155 promotes T follicular helper cell accumulation during chronic, low-grade inflammation. Immunity 41, 605&#x2013;619 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4657560</ArticleId><ArticleId IdType="pubmed">25367574</ArticleId></ArticleIdList></Reference><Reference><Citation>Parkhurst CN, et al. Microglia promote learning-dependent synapse formation through brain-derived neurotrophic factor. Cell 155, 1596&#x2013;1609 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4033691</ArticleId><ArticleId IdType="pubmed">24360280</ArticleId></ArticleIdList></Reference><Reference><Citation>Radde R, et al. Abeta42-driven cerebral amyloidosis in transgenic mice reveals early and robust pathology. EMBO Rep 7, 940&#x2013;946 (2006).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1559665</ArticleId><ArticleId IdType="pubmed">16906128</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldmann T, et al. Origin, fate and dynamics of macrophages at central nervous system interfaces. Nat Immunol 17, 797&#x2013;805 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4968048</ArticleId><ArticleId IdType="pubmed">27135602</ArticleId></ArticleIdList></Reference><Reference><Citation>Roy ER, et al. Type I interferon response drives neuroinflammation and synapse loss in Alzheimer disease. J Clin Invest 130, 1912&#x2013;1930 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7108898</ArticleId><ArticleId IdType="pubmed">31917687</ArticleId></ArticleIdList></Reference><Reference><Citation>Sala Frigerio C, et al. The Major Risk Factors for Alzheimer&#x2019;s Disease: Age, Sex, and Genes Modulate the Microglia Response to Abeta Plaques. Cell Rep 27, 1293&#x2013;1306 e1296 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7340153</ArticleId><ArticleId IdType="pubmed">31018141</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai JJ, Cruz FM &amp; Rock KL Immune Sensing of Cell Death through Recognition of Histone Sequences by C-Type Lectin-Receptor-2d Causes Inflammation and Tissue Injury. Immunity 52, 123&#x2013;135 e126 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6962543</ArticleId><ArticleId IdType="pubmed">31859049</ArticleId></ArticleIdList></Reference><Reference><Citation>Gracias DT, et al. The microRNA miR-155 controls CD8+ T cell responses by regulating interferon signaling. Nature immunology 14, 593&#x2013;602 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3664306</ArticleId><ArticleId IdType="pubmed">23603793</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H, Gade P, Xiao W &amp; Kalvakolanu DV The interferon signaling network and transcription factor C/EBP-&#x3b2;. Cellular &amp; molecular immunology 4, 407 (2007).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2782719</ArticleId><ArticleId IdType="pubmed">18163952</ArticleId></ArticleIdList></Reference><Reference><Citation>He M, Xu Z, Ding T, Kuang D-M &amp; Zheng L MicroRNA-155 regulates inflammatory cytokine production in tumor-associated macrophages via targeting C/EBP&#x3b2;. Cellular &amp; molecular immunology 6, 343&#x2013;352 (2009).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4003217</ArticleId><ArticleId IdType="pubmed">19887047</ArticleId></ArticleIdList></Reference><Reference><Citation>Prencipe G, et al. Neutralization of IFN-gamma reverts clinical and laboratory features in a mouse model of macrophage activation syndrome. J Allergy Clin Immunol 141, 1439&#x2013;1449 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">28807602</ArticleId></ArticleIdList></Reference><Reference><Citation>Parhizkar S, et al. Loss of TREM2 function increases amyloid seeding but reduces plaque-associated ApoE. Nat Neurosci 22, 191&#x2013;204 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6417433</ArticleId><ArticleId IdType="pubmed">30617257</ArticleId></ArticleIdList></Reference><Reference><Citation>Serneels L, et al. gamma-Secretase heterogeneity in the Aph1 subunit: relevance for Alzheimer&#x2019;s disease. Science 324, 639&#x2013;642 (2009).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2740474</ArticleId><ArticleId IdType="pubmed">19299585</ArticleId></ArticleIdList></Reference><Reference><Citation>Hammond TR, et al. Single-cell RNA sequencing of microglia throughout the mouse lifespan and in the injured brain reveals complex cell-state changes. Immunity 50, 253&#x2013;271. e256 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6655561</ArticleId><ArticleId IdType="pubmed">30471926</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerrits E, et al. Distinct amyloid-beta and tau-associated microglia profiles in Alzheimer&#x2019;s disease. Acta Neuropathol 141, 681&#x2013;696 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8043951</ArticleId><ArticleId IdType="pubmed">33609158</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathys H, et al. Single-cell transcriptomic analysis of Alzheimer&#x2019;s disease. Nature 570, 332&#x2013;337 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6865822</ArticleId><ArticleId IdType="pubmed">31042697</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y, et al. Human and mouse single-nucleus transcriptomics reveal TREM2-dependent and TREM2-independent cellular responses in Alzheimer&#x2019;s disease. Nat Med 26, 131&#x2013;142 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6980793</ArticleId><ArticleId IdType="pubmed">31932797</ArticleId></ArticleIdList></Reference><Reference><Citation>Sierksma A, et al. Deregulation of neuronal miRNAs induced by amyloid-beta or TAU pathology. Mol Neurodegener 13, 54 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6186090</ArticleId><ArticleId IdType="pubmed">30314521</ArticleId></ArticleIdList></Reference><Reference><Citation>Culpan D, Kehoe PG &amp; Love S Tumour necrosis factor-alpha (TNF-alpha) and miRNA expression in frontal and temporal neocortex in Alzheimer&#x2019;s disease and the effect of TNF-alpha on miRNA expression in vitro. Int J Mol Epidemiol Genet 2, 156&#x2013;162 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3110390</ArticleId><ArticleId IdType="pubmed">21686130</ArticleId></ArticleIdList></Reference><Reference><Citation>Patrick E, et al. Dissecting the role of non-coding RNAs in the accumulation of amyloid and tau neuropathologies in Alzheimer&#x2019;s disease. Mol Neurodegener 12, 51 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5494142</ArticleId><ArticleId IdType="pubmed">28668092</ArticleId></ArticleIdList></Reference><Reference><Citation>Lau P, et al. Alteration of the microRNA network during the progression of Alzheimer&#x2019;s disease. EMBO Mol Med 5, 1613&#x2013;1634 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3799583</ArticleId><ArticleId IdType="pubmed">24014289</ArticleId></ArticleIdList></Reference><Reference><Citation>Landgraf P, et al. A mammalian microRNA expression atlas based on small RNA library sequencing. Cell 129, 1401&#x2013;1414 (2007).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2681231</ArticleId><ArticleId IdType="pubmed">17604727</ArticleId></ArticleIdList></Reference><Reference><Citation>Korotkov A, et al. Increased expression of miR142 and miR155 in glial and immune cells after traumatic brain injury may contribute to neuroinflammation via astrocyte activation. Brain Pathology 30, 897&#x2013;912 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7540383</ArticleId><ArticleId IdType="pubmed">32460356</ArticleId></ArticleIdList></Reference><Reference><Citation>Parkhurst CN, et al. Microglia promote learning-dependent synapse formation through brain-derived neurotrophic factor. Cell 155, 1596&#x2013;1609 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4033691</ArticleId><ArticleId IdType="pubmed">24360280</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee SH, et al. Identifying the initiating events of anti-Listeria responses using mice with conditional loss of IFN-gamma receptor subunit 1 (IFNGR1). J Immunol 191, 4223&#x2013;4234 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3874833</ArticleId><ArticleId IdType="pubmed">24048899</ArticleId></ArticleIdList></Reference><Reference><Citation>Radde R, et al. Abeta42-driven cerebral amyloidosis in transgenic mice reveals early and robust pathology. EMBO Rep 7, 940&#x2013;946 (2006).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1559665</ArticleId><ArticleId IdType="pubmed">16906128</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu R, et al. miR-155 promotes T follicular helper cell accumulation during chronic, low-grade inflammation. Immunity 41, 605&#x2013;619 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4657560</ArticleId><ArticleId IdType="pubmed">25367574</ArticleId></ArticleIdList></Reference><Reference><Citation>Butovsky O, et al. Identification of a unique TGF-beta-dependent molecular and functional signature in microglia. Nat Neurosci 17, 131&#x2013;143 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4066672</ArticleId><ArticleId IdType="pubmed">24316888</ArticleId></ArticleIdList></Reference><Reference><Citation>Krasemann S, et al. The TREM2-APOE Pathway Drives the Transcriptional Phenotype of Dysfunctional Microglia in Neurodegenerative Diseases. Immunity 47, 566&#x2013;581 e569 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5719893</ArticleId><ArticleId IdType="pubmed">28930663</ArticleId></ArticleIdList></Reference><Reference><Citation>Picelli S, et al. Smart-seq2 for sensitive full-length transcriptome profiling in single cells. Nat Methods 10, 1096&#x2013;1098 (2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">24056875</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia-Alonso L, Holland CH, Ibrahim MM, Turei D &amp; Saez-Rodriguez J Benchmark and integration of resources for the estimation of human transcription factor activities. Genome Res 29, 1363&#x2013;1375 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6673718</ArticleId><ArticleId IdType="pubmed">31340985</ArticleId></ArticleIdList></Reference><Reference><Citation>Hao Y, et al. Integrated analysis of multimodal single-cell data. Cell 184, 3573&#x2013;3587 e3529 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8238499</ArticleId><ArticleId IdType="pubmed">34062119</ArticleId></ArticleIdList></Reference><Reference><Citation>Germain PL, Lun A, Garcia Meixide C, Macnair W &amp; Robinson MD Doublet identification in single-cell sequencing data using scDblFinder. F1000Res 10, 979 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9204188</ArticleId><ArticleId IdType="pubmed">35814628</ArticleId></ArticleIdList></Reference><Reference><Citation>Zappia L &amp; Oshlack A Clustering trees: a visualization for evaluating clusterings at multiple resolutions. Gigascience 7 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6057528</ArticleId><ArticleId IdType="pubmed">30010766</ArticleId></ArticleIdList></Reference><Reference><Citation>Korsunsky I, et al. Fast, sensitive and accurate integration of single-cell data with Harmony. Nat Methods 16, 1289&#x2013;1296 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6884693</ArticleId><ArticleId IdType="pubmed">31740819</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanian Ae.a. Obesity-instructed TREM2high macrophages identified by comparative analysis of diabetic mouse and human kidney at single cell resolution. bioRxiv (2021).</Citation></Reference><Reference><Citation>Gabriely G, et al. Myeloid cell subsets that express latency-associated peptide promote cancer growth by modulating T cells. iScience 24, 103347 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8602030</ArticleId><ArticleId IdType="pubmed">34820606</ArticleId></ArticleIdList></Reference><Reference><Citation>Mantri M, et al. Spatiotemporal single-cell RNA sequencing of developing chicken hearts identifies interplay between cellular differentiation and morphogenesis. Nat Commun 12, 1771 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7979764</ArticleId><ArticleId IdType="pubmed">33741943</ArticleId></ArticleIdList></Reference><Reference><Citation>Mootha VK, et al. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 34, 267&#x2013;273 (2003).</Citation><ArticleIdList><ArticleId IdType="pubmed">12808457</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanian A, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 102, 15545&#x2013;15550 (2005).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1239896</ArticleId><ArticleId IdType="pubmed">16199517</ArticleId></ArticleIdList></Reference><Reference><Citation>Griffiths-Jones S, Grocock RJ, van Dongen S, Bateman A &amp; Enright AJ miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res 34, D140&#x2013;144 (2006).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1347474</ArticleId><ArticleId IdType="pubmed">16381832</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolf A, Bauer B, Abner EL, Ashkenazy-Frolinger T &amp; Hartz AM A Comprehensive Behavioral Test Battery to Assess Learning and Memory in 129S6/Tg2576 Mice. PLoS One 11, e0147733 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4726499</ArticleId><ArticleId IdType="pubmed">26808326</ArticleId></ArticleIdList></Reference><Reference><Citation>Lalonde R The neurobiological basis of spontaneous alternation. Neurosci Biobehav Rev 26, 91&#x2013;104 (2002).</Citation><ArticleIdList><ArticleId IdType="pubmed">11835987</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37315112</PMID><DateCompleted><Year>2023</Year><Month>06</Month><Day>16</Day></DateCompleted><DateRevised><Year>2024</Year><Month>02</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1946-6242</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><Issue>700</Issue><PubDate><Year>2023</Year><Month>Jun</Month><Day>14</Day></PubDate></JournalIssue><Title>Science translational medicine</Title><ISOAbbreviation>Sci Transl Med</ISOAbbreviation></Journal><ArticleTitle>Gut microbiome composition may be an indicator of preclinical Alzheimer's disease.</ArticleTitle><Pagination><StartPage>eabo2984</StartPage><MedlinePgn>eabo2984</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1126/scitranslmed.abo2984</ELocationID><Abstract><AbstractText>Alzheimer's disease (AD) pathology is thought to progress from normal cognition through preclinical disease and ultimately to symptomatic AD with cognitive impairment. Recent work suggests that the gut microbiome of symptomatic patients with AD has an altered taxonomic composition compared with that of healthy, cognitively normal control individuals. However, knowledge about changes in the gut microbiome before the onset of symptomatic AD is limited. In this cross-sectional study that accounted for clinical covariates and dietary intake, we compared the taxonomic composition and gut microbial function in a cohort of 164 cognitively normal individuals, 49 of whom showed biomarker evidence of early preclinical AD. Gut microbial taxonomic profiles of individuals with preclinical AD were distinct from those of individuals without evidence of preclinical AD. The change in gut microbiome composition correlated with &#x3b2;-amyloid (A&#x3b2;) and tau pathological biomarkers but not with biomarkers of neurodegeneration, suggesting that the gut microbiome may change early in the disease process. We identified specific gut bacterial taxa associated with preclinical AD. Inclusion of these microbiome features improved the accuracy, sensitivity, and specificity of machine learning classifiers for predicting preclinical AD status when tested on a subset of the cohort (65 of the 164 participants). Gut microbiome correlates of preclinical AD neuropathology may improve our understanding of AD etiology and may help to identify gut-derived markers of AD risk.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ferreiro</LastName><ForeName>Aura L</ForeName><Initials>AL</Initials><Identifier Source="ORCID">0000-0003-4022-2460</Identifier><AffiliationInfo><Affiliation>Edison Family Center for Genome Sciences and Systems Biology, Washington University School of Medicine, St.&#xa0;Louis, MO 63110, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Engineering, Washington University in St.&#xa0;Louis, St.&#xa0;Louis, MO 63130, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathology and Immunology, Division of Laboratory and Genomic Medicine, Washington University School of Medicine, St.&#xa0;Louis, MO 63110, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Choi</LastName><ForeName>JooHee</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-6368-2470</Identifier><AffiliationInfo><Affiliation>Edison Family Center for Genome Sciences and Systems Biology, Washington University School of Medicine, St.&#xa0;Louis, MO 63110, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ryou</LastName><ForeName>Jian</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-1466-4521</Identifier><AffiliationInfo><Affiliation>Edison Family Center for Genome Sciences and Systems Biology, Washington University School of Medicine, St.&#xa0;Louis, MO 63110, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Newcomer</LastName><ForeName>Erin P</ForeName><Initials>EP</Initials><Identifier Source="ORCID">0000-0002-2028-0359</Identifier><AffiliationInfo><Affiliation>Edison Family Center for Genome Sciences and Systems Biology, Washington University School of Medicine, St.&#xa0;Louis, MO 63110, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Engineering, Washington University in St.&#xa0;Louis, St.&#xa0;Louis, MO 63130, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thompson</LastName><ForeName>Regina</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0003-4176-2581</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Washington University School of Medicine, St.&#xa0;Louis, MO 63110, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bollinger</LastName><ForeName>Rebecca M</ForeName><Initials>RM</Initials><Identifier Source="ORCID">0000-0002-1931-8372</Identifier><AffiliationInfo><Affiliation>Program in Occupational Therapy, Washington University School of Medicine, St.&#xa0;Louis, MO 63110, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hall-Moore</LastName><ForeName>Carla</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Division of Gastroenterology, Hepatology, and Nutrition, Department of Pediatrics, Washington University School of Medicine, St.&#xa0;Louis, MO 63110, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ndao</LastName><ForeName>I Malick</ForeName><Initials>IM</Initials><AffiliationInfo><Affiliation>Division of Gastroenterology, Hepatology, and Nutrition, Department of Pediatrics, Washington University School of Medicine, St.&#xa0;Louis, MO 63110, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sax</LastName><ForeName>Laurie</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-9439-4746</Identifier><AffiliationInfo><Affiliation>Division of Gastroenterology, Hepatology, and Nutrition, Department of Pediatrics, Washington University School of Medicine, St.&#xa0;Louis, MO 63110, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Benzinger</LastName><ForeName>Tammie L S</ForeName><Initials>TLS</Initials><Identifier Source="ORCID">0000-0002-8114-0552</Identifier><AffiliationInfo><Affiliation>Department of Radiology, Washington University School of Medicine, St.&#xa0;Louis, MO 63110, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Charles F.&#xa0;and Joanne Knight Alzheimer's Disease Research Center, Washington University School of Medicine, St.&#xa0;Louis, MO 63110, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stark</LastName><ForeName>Susan L</ForeName><Initials>SL</Initials><AffiliationInfo><Affiliation>Department of Neurology, Washington University School of Medicine, St.&#xa0;Louis, MO 63110, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Program in Occupational Therapy, Washington University School of Medicine, St.&#xa0;Louis, MO 63110, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Charles F.&#xa0;and Joanne Knight Alzheimer's Disease Research Center, Washington University School of Medicine, St.&#xa0;Louis, MO 63110, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Holtzman</LastName><ForeName>David M</ForeName><Initials>DM</Initials><Identifier Source="ORCID">0000-0002-3400-0856</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Washington University School of Medicine, St.&#xa0;Louis, MO 63110, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Charles F.&#xa0;and Joanne Knight Alzheimer's Disease Research Center, Washington University School of Medicine, St.&#xa0;Louis, MO 63110, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hope Center for Neurological Disorders, Washington University School of Medicine, St.&#xa0;Louis, MO 63110, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fagan</LastName><ForeName>Anne M</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Department of Neurology, Washington University School of Medicine, St.&#xa0;Louis, MO 63110, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Charles F.&#xa0;and Joanne Knight Alzheimer's Disease Research Center, Washington University School of Medicine, St.&#xa0;Louis, MO 63110, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hope Center for Neurological Disorders, Washington University School of Medicine, St.&#xa0;Louis, MO 63110, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schindler</LastName><ForeName>Suzanne E</ForeName><Initials>SE</Initials><Identifier Source="ORCID">0000-0002-1680-1465</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Washington University School of Medicine, St.&#xa0;Louis, MO 63110, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Charles F.&#xa0;and Joanne Knight Alzheimer's Disease Research Center, Washington University School of Medicine, St.&#xa0;Louis, MO 63110, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cruchaga</LastName><ForeName>Carlos</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-0276-2899</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Washington University School of Medicine, St.&#xa0;Louis, MO 63110, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hope Center for Neurological Disorders, Washington University School of Medicine, St.&#xa0;Louis, MO 63110, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NeuroGenomics and Informatics, Washington University School of Medicine, St.&#xa0;Louis, MO 63110, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychiatry, Washington University School of Medicine, St.&#xa0;Louis, MO 63110, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Butt</LastName><ForeName>Omar H</ForeName><Initials>OH</Initials><Identifier Source="ORCID">0000-0003-2252-3673</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Washington University School of Medicine, St.&#xa0;Louis, MO 63110, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morris</LastName><ForeName>John C</ForeName><Initials>JC</Initials><Identifier Source="ORCID">0000-0001-9820-5618</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Washington University School of Medicine, St.&#xa0;Louis, MO 63110, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Charles F.&#xa0;and Joanne Knight Alzheimer's Disease Research Center, Washington University School of Medicine, St.&#xa0;Louis, MO 63110, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tarr</LastName><ForeName>Phillip I</ForeName><Initials>PI</Initials><Identifier Source="ORCID">0000-0003-4078-7517</Identifier><AffiliationInfo><Affiliation>Division of Gastroenterology, Hepatology, and Nutrition, Department of Pediatrics, Washington University School of Medicine, St.&#xa0;Louis, MO 63110, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Molecular Microbiology, Washington University School of Medicine, St.&#xa0;Louis, MO 63110, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ances</LastName><ForeName>Beau M</ForeName><Initials>BM</Initials><Identifier Source="ORCID">0000-0003-3862-7397</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Engineering, Washington University in St.&#xa0;Louis, St.&#xa0;Louis, MO 63130, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Washington University School of Medicine, St.&#xa0;Louis, MO 63110, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Radiology, Washington University School of Medicine, St.&#xa0;Louis, MO 63110, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Charles F.&#xa0;and Joanne Knight Alzheimer's Disease Research Center, Washington University School of Medicine, St.&#xa0;Louis, MO 63110, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hope Center for Neurological Disorders, Washington University School of Medicine, St.&#xa0;Louis, MO 63110, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Molecular Microbiology, Washington University School of Medicine, St.&#xa0;Louis, MO 63110, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dantas</LastName><ForeName>Gautam</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0003-0455-8370</Identifier><AffiliationInfo><Affiliation>Edison Family Center for Genome Sciences and Systems Biology, Washington University School of Medicine, St.&#xa0;Louis, MO 63110, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Engineering, Washington University in St.&#xa0;Louis, St.&#xa0;Louis, MO 63130, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathology and Immunology, Division of Laboratory and Genomic Medicine, Washington University School of Medicine, St.&#xa0;Louis, MO 63110, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Molecular Microbiology, Washington University School of Medicine, St.&#xa0;Louis, MO 63110, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatrics, Washington University School of Medicine, St.&#xa0;Louis, MO 63110, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P01 AG003991</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P01 AG026276</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG057680</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>S10 OD025214</GrantID><Acronym>OD</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 DK052574</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>06</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Sci Transl Med</MedlineTA><NlmUniqueID>101505086</NlmUniqueID><ISSNLinking>1946-6234</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016229">Amyloid beta-Peptides</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Nat Rev Neurol. 2023 Aug;19(8):458. doi: 10.1038/s41582-023-00848-5.</RefSource><PMID Version="1">37402802</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069196" MajorTopicYN="Y">Gastrointestinal Microbiome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064307" MajorTopicYN="Y">Microbiota</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016229" MajorTopicYN="N">Amyloid beta-Peptides</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>G.D. is a co-founder, holder of equity in, a consultant to, and a member of the Scientific Advisory Board of Viosera Therapeutics, which is developing combination antimicrobial therapy against bacterial pathogens. G.D. is a co-inventor on a patent assigned to Viosera Therapeutics. G.D. is a consultant to and a member of the Scientific Advisory Board of Pluton Biosciences and has consulted for SNIPR Technologies Ltd. in the last 5 years. P.I.T. is a holder of equity in, a consultant to, and a member of the Scientific Advisory Board of MediBeacon Inc. and is a co-inventor on patents assigned to MediBeacon; Chair of the Scientific Advisory Board of the AGA Center for Microbiome Research and Education (a paid position); a consultant to Temple University on waterborne enteric infections; a recipient of royalties from UpToDate; and an unpaid member of the Data Safety Monitoring Board of Inmunova. D.M.H. co-founded and is on the Scientific Advisory Board of C2N Diagnostics and consults for Genentech, Denali, Cajal Neurosciences, C2N Diagnostics, and Asteroid. Washington University receives research grants to the laboratory of D.M.H. from NextCure, Eli Lilly, Novartis, Ionis, and Denali. T.L.S.B. receives research funding from Siemens as well as technical support and materials from Avid Radiopharmaceuticals, Cerveau, and Life Molecular Imaging. T.L.S.B. also receives paid and unpaid consulting and has advisory roles for Siemens, Eli Lilly, Roche, Life Molecular Imaging, Biogen, and Eisai. A.M.F. was a member of the scientific advisory boards for Roche Diagnostics, Genentech, and Diadem and also previously consulted for DiamiR and Siemens Healthcare Diagnostics Inc. S.E.S. has analyzed data provided by C2N Diagnostics to Washington University and has served on a Scientific Advisory Board for Eisai. C.C. has received research support from GlaxoSmithKline and Eisai and is a member of the advisory board of Vivid Genomics and Circular Genomics and owns stocks. J.C.M. is a member of the Barcelona Brain Research Foundation Scientific Advisory Board, the Native Alzheimer Disease-Related Resource Center in Minority Aging Research External Advisory Board, the Cure Alzheimer&#x2019;s Fund Research Strategy Council, and the Longer Life Foundation Board of Governors. J.C.M. was previously a member of the Diverse VCID (Vascular Contributions to Cognitive Impairment and Dementia) Observational Study Monitoring Board.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>16</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>14</Day><Hour>19</Hour><Minute>10</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>14</Day><Hour>14</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>11</Month><Day>27</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37315112</ArticleId><ArticleId IdType="mid">NIHMS1945399</ArticleId><ArticleId IdType="pmc">PMC10680783</ArticleId><ArticleId IdType="doi">10.1126/scitranslmed.abo2984</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Shreiner AB, Kao JY, Young VB, The gut microbiome in health and in disease. Curr. Opin. Gastroenterol 31, 69&#x2013;75 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4290017</ArticleId><ArticleId IdType="pubmed">25394236</ArticleId></ArticleIdList></Reference><Reference><Citation>Valdes AM, Walter J, Segal E, Spector TD, Role of the gut microbiota in nutrition and health. BMJ 361, k2179 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6000740</ArticleId><ArticleId IdType="pubmed">29899036</ArticleId></ArticleIdList></Reference><Reference><Citation>Hooper LV, Littman DR, Macpherson AJ, Interactions between the microbiota and the immune system. Science 336, 1268&#x2013;1273 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4420145</ArticleId><ArticleId IdType="pubmed">22674334</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruiz L, Delgado S, Ruas-Madiedo P, S&#xe1;nchez B, Margolles A, Bifidobacteria and their molecular communication with the immune system. Front. Microbiol 8, 2345 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5722804</ArticleId><ArticleId IdType="pubmed">29255450</ArticleId></ArticleIdList></Reference><Reference><Citation>Haran JP, Bhattarai SK, Foley SE, Dutta P, Ward DV, Bucci V, McCormick BA, Gilbert J, Faith J, Alzheimer&#x2019;s disease microbiome is associated with dysregulation of the anti-inflammatory P-glycoprotein pathway. MBio 10, (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6509190</ArticleId><ArticleId IdType="pubmed">31064831</ArticleId></ArticleIdList></Reference><Reference><Citation>Vogt NM, Kerby RL, Dill-McFarland KA, Harding SJ, Merluzzi AP, Johnson SC, Carlsson CM, Asthana S, Zetterberg H, Blennow K, Bendlin BB, Rey FE, Gut microbiome alterations in Alzheimer&#x2019;s disease. Sci. Rep 7, 13537 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5648830</ArticleId><ArticleId IdType="pubmed">29051531</ArticleId></ArticleIdList></Reference><Reference><Citation>Belizario JE, Faintuch J, Microbiome and gut dysbiosis. Exp. Suppl 109, 459&#x2013;476 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">30535609</ArticleId></ArticleIdList></Reference><Reference><Citation>Pellegrini C, Antonioli L, Colucci R, Blandizzi C, Fornai M, Interplay among gut microbiota, intestinal mucosal barrier and enteric neuro-immune system: A common path to neurodegenerative diseases? Acta Neuropathol. 136, 345&#x2013;361 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">29797112</ArticleId></ArticleIdList></Reference><Reference><Citation>Shim YS, Morris JC, Biomarkers predicting Alzheimer&#x2019;s disease in cognitively normal aging. J. Clin. Neurol 7, 60&#x2013;68 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3131540</ArticleId><ArticleId IdType="pubmed">21779293</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris JC, The Clinical Dementia Rating (CDR): Current version and scoring rules. Neurology 43, 2412&#x2013;2414 (1993).</Citation><ArticleIdList><ArticleId IdType="pubmed">8232972</ArticleId></ArticleIdList></Reference><Reference><Citation>Rizzetto L, Fava F, Tuohy KM, Selmi C, Connecting the immune system, systemic chronic inflammation and the gut microbiome: The role of sex. J. Autoimmun 92, 12&#x2013;34 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">29861127</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang R, Miller RG, Gascon R, Champion S, Katz J, Lancero M, Narvaez A, Honrada R, Ruvalcaba D, McGrath MS, Circulating endotoxin and systemic immune activation in sporadic amyotrophic lateral sclerosis (sALS). J. Neuroimmunol 206, 121&#x2013;124 (2009).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2995297</ArticleId><ArticleId IdType="pubmed">19013651</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanchez-Ramos J, Song S, Sava V, Catlow B, Lin X, Mori T, Cao C, Arendash GW, Granulocyte colony stimulating factor decreases brain amyloid burden and reverses cognitive impairment in Alzheimer&#x2019;s mice. Neuroscience 163, 55&#x2013;72 (2009).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5966834</ArticleId><ArticleId IdType="pubmed">19500657</ArticleId></ArticleIdList></Reference><Reference><Citation>Sochocka M, Donskow-&#x141;ysoniewska K, Diniz BS, Kurpas D, Brzozowska E, Leszek J, The gut microbiome alterations and inflammation-driven pathogenesis of alzheimer&#x2019;s disease-a critical review. Mol. Neurobiol 56, 1841&#x2013;1851 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6394610</ArticleId><ArticleId IdType="pubmed">29936690</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim MS, Kim Y, Choi H, Kim W, Park S, Lee D, Kim DK, Kim HJ, Choi H, Hyun DW, Lee JY, Choi EY, Lee DS, Bae JW, Mook-Jung I, Transfer of a healthy microbiota reduces amyloid and tau pathology in an Alzheimer&#x2019;s disease animal model. Gut 69, 283&#x2013;294 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">31471351</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren Z, Li A, Jiang J, Zhou L, Yu Z, Lu H, Xie H, Chen X, Shao L, Zhang R, Xu S, Zhang H, Cui G, Chen X, Sun R, Wen H, Lerut JP, Kan Q, Li L, Zheng S, Gut microbiome analysis as a tool towards targeted non-invasive biomarkers for early hepatocellular carcinoma. Gut 68, 1014&#x2013;1023 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6580753</ArticleId><ArticleId IdType="pubmed">30045880</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas AM, Manghi P, Asnicar F, Pasolli E, Armanini F, Zolfo M, Beghini F, Manara S, Karcher N, Pozzi C, Gandini S, Serrano D, Tarallo S, Francavilla A, Gallo G, Trompetto M, Ferrero G, Mizutani S, Shiroma H, Shiba S, Shibata T, Yachida S, Yamada T, Wirbel J, Schrotz-King P, Ulrich CM, Brenner H, Arumugam M, Bork P, Zeller G, Cordero F, Dias-Neto E, Setubal JC, Tett A, Pardini B, Rescigno M, Waldron L, Naccarati A, Segata N, Metagenomic analysis of colorectal cancer datasets identifies cross-cohort microbial diagnostic signatures and a link with choline degradation. Nat. Med 25, 667&#x2013;678 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9533319</ArticleId><ArticleId IdType="pubmed">30936548</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu Q, Hou Q, Huang S, Ou Q, Huo D, V&#xe1;zquez-Baeza Y, Cen C, Cantu V, Estaki M, Chang H, Belda-Ferre P, Kim HC, Chen K, Knight R, Zhang J, Compositional and genetic alterations in Graves&#x2019; disease gut microbiome reveal specific diagnostic biomarkers. ISME J. 15, 3399&#x2013;3411 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8528855</ArticleId><ArticleId IdType="pubmed">34079079</ArticleId></ArticleIdList></Reference><Reference><Citation>Masi AC, Embleton ND, Lamb CA, Young G, Granger CL, Najera J, Smith DP, Hoffman KL, Petrosino JF, Bode L, Berrington JE, Stewart CJ, Human milk oligosaccharide DSLNT and gut microbiome in preterm infants predicts necrotising enterocolitis. Gut 70, 2273&#x2013;2282 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9231288</ArticleId><ArticleId IdType="pubmed">33328245</ArticleId></ArticleIdList></Reference><Reference><Citation>Jack CR Jr., Bennett DA, Blennow K, Carrillo MC, Feldman HH, Frisoni GB, Hampel H, Jagust WJ, Johnson KA, Knopman DS, Petersen RC, Scheltens P, Sperling RA, Dubois B, A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers. Neurology 87, 539&#x2013;547 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4970664</ArticleId><ArticleId IdType="pubmed">27371494</ArticleId></ArticleIdList></Reference><Reference><Citation>Puurunen MK, Vockley J, Searle SL, Sacharow SJ, Phillips III JA, Denney WS, Goodlett BD, Wagner DA, Blankstein L, Castillo MJ, Charbonneau MR, Isabella VM, Sethuraman VV, Riese RJ, Kurtz CB, Brennan AM, Safety and pharmacodynamics of an engineered E. coli Nissle for the treatment of phenylketonuria: A first-in-human phase 1/2a study. Metabolism 3, 1125&#x2013;1132 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34294923</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang T, Kuang W, Chen W, Xu W, Zhang L, Li Y, Li H, Peng Y, Chen Y, Wang B, Xiao J, Li H, Yan C, du Y, Tang M, He Z, Chen H, Li W, Lin H, Shi S, Bi J, Zhou H, Cheng Y, Gao X, Guan Y, Huang Q, Chen K, Xin X, Ding J, Geng M, Xiao S, A phase II randomized trial of sodium oligomannate in Alzheimer&#x2019;s dementia. Alzheimer&#x2019;s Res. Ther 12, 110 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7489025</ArticleId><ArticleId IdType="pubmed">32928279</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo J, Weng H, Morris JC, Xiong C, Minimizing the sample sizes of clinical trials on preclinical and early symptomatic stage of alzheimer disease. J. Prev Alzheimers Dis 5, 110&#x2013;119 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6429951</ArticleId><ArticleId IdType="pubmed">29616704</ArticleId></ArticleIdList></Reference><Reference><Citation>Babulal GM, Ghoshal N, Head D, Vernon EK, Holtzman DM, Benzinger TLS, Fagan AM, Morris JC, Roe CM, Mood changes in cognitively normal older adults are linked to alzheimer disease biomarker levels. Am. J. Geriatr. Psychiatry 24, 1095&#x2013;1104 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5069099</ArticleId><ArticleId IdType="pubmed">27426238</ArticleId></ArticleIdList></Reference><Reference><Citation>Cairns NJ, Perrin RJ, Franklin EE, Carter D, Vincent B, Xie M, Bateman RJ, Benzinger T, Friedrichsen K, Brooks WS, Halliday GM, McLean C, Ghetti B, Morris JC; the Alzheimer Disease Neuroimaging Initiative; Dominantly Inherited Alzheimer Network, Neuropathologic assessment of participants in two multi-center longitudinal observational studies: The Alzheimer Disease Neuroimaging Initiative (ADNI) and the Dominantly Inherited Alzheimer Network (DIAN). Neuropathology 35, 390&#x2013;400 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4521391</ArticleId><ArticleId IdType="pubmed">25964057</ArticleId></ArticleIdList></Reference><Reference><Citation>Day GS, Cruchaga C, Wingo T, Schindler SE, Coble D, Morris JC, Association of acquired and heritable factors with intergenerational differences in age at symptomatic onset of alzheimer disease between offspring and parents with dementia. JAMA Netw. Open 2, e1913491 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6806434</ArticleId><ArticleId IdType="pubmed">31617930</ArticleId></ArticleIdList></Reference><Reference><Citation>Bollinger RM, Keleman A, Thompson R, Westerhaus E, Fagan AM, Benzinger TLS, Schindler SE, Xiong C, Balota D, Morris JC, Ances BM, Stark SL, Falls: A marker of preclinical Alzheimer disease: A cohort study protocol. BMJ Open 11, e050820 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8444237</ArticleId><ArticleId IdType="pubmed">34526343</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris JC, Schindler SE, McCue LM, Moulder KL, Benzinger TLS, Cruchaga C, Fagan AM, Grant E, Gordon BA, Holtzman DM, Xiong C, Assessment of racial disparities in biomarkers for Alzheimer disease. JAMA Neurol. 76, 264&#x2013;273 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6439726</ArticleId><ArticleId IdType="pubmed">30615028</ArticleId></ArticleIdList></Reference><Reference><Citation>Villeneuve S, Rabinovici GD, Cohn-Sheehy BI, Madison C, Ayakta N, Ghosh PM, La Joie R, Arthur-Bentil SK, Vogel JW, Marks SM, Lehmann M, Rosen HJ, Reed B, Olichney J, Boxer AL, Miller BL, Borys E, Jin LW, Huang EJ, Grinberg LT, DeCarli C, Seeley WW, Jagust W, Existing Pittsburgh Compound-B positron emission tomography thresholds are too high: Statistical and pathological evaluation. Brain 138 (Pt. 7), 2020&#x2013;2033 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4806716</ArticleId><ArticleId IdType="pubmed">25953778</ArticleId></ArticleIdList></Reference><Reference><Citation>Schindler S, Li Y, Buckles VD, Gordon BA, Benzinger TLS, Wang G, Coble D, Klunk WE, Fagan AM, Holtzman DM, Bateman RJ, Morris JC, Xiong C, Predicting symptom onset in sporadic alzheimer disease with Amyloid PET. Neurology 97, e1823&#x2013;e1834 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8610624</ArticleId><ArticleId IdType="pubmed">34504028</ArticleId></ArticleIdList></Reference><Reference><Citation>Dumurgier J, Schraen S, Gabelle A, Vercruysse O, Bombois S, Laplanche JL, Peoc&#x2019;h K, Sablonni&#xe8;re B, Kastanenka KV, Delaby C, Pasquier F, Touchon J, Hugon J, Paquet C, Lehmann S, Cerebrospinal fluid amyloid-&#x3b2; 42/40 ratio in clinical setting of memory centers: A multicentric study. Alzheimer&#x2019;s Res. Ther 7, 30 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4450486</ArticleId><ArticleId IdType="pubmed">26034513</ArticleId></ArticleIdList></Reference><Reference><Citation>Volluz KE, Schindler SE, Henson RL, Xiong C, Gordon BA, Benzinger TLS, Holtzman DM, Morris JC, Fagan AM, Correspondence of CSF biomarkers measured by Lumipulse assays with amyloid PET. Alzheimers Dement. 17 (S5), e051085 (2021).</Citation></Reference><Reference><Citation>Singh RK, Chang HW, Yan D, Lee KM, Ucmak D, Wong K, Abrouk M, Farahnik B, Nakamura M, Zhu TH, Bhutani T, Liao W, Influence of diet on the gut microbiome and implications for human health. J. Transl. Med 15, 73 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5385025</ArticleId><ArticleId IdType="pubmed">28388917</ArticleId></ArticleIdList></Reference><Reference><Citation>David LA, Maurice CF, Carmody RN, Gootenberg DB, Button JE, Wolfe BE, Ling AV, Devlin AS, Varma Y, Fischbach MA, Biddinger SB, Dutton RJ, Turnbaugh PJ, Diet rapidly and reproducibly alters the human gut microbiome. Nature 505, 559&#x2013;563 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3957428</ArticleId><ArticleId IdType="pubmed">24336217</ArticleId></ArticleIdList></Reference><Reference><Citation>Beghini F, McIver LJ, Blanco-M&#xed;guez A, Dubois L, Asnicar F, Maharjan S, Mailyan A, Manghi P, Scholz M, Thomas AM, Valles-Colomer M, Weingart G, Zhang Y, Zolfo M, Huttenhower C, Franzosa EA, Segata N, Integrating taxonomic, functional, and strain-level profiling of diverse microbial communities with bioBakery 3. eLife 10, (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8096432</ArticleId><ArticleId IdType="pubmed">33944776</ArticleId></ArticleIdList></Reference><Reference><Citation>Lozupone C, Knight R, UniFrac: A new phylogenetic method for comparing microbial communities. Appl. Environ. Microbiol 71, 8228&#x2013;8235 (2005).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1317376</ArticleId><ArticleId IdType="pubmed">16332807</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson MJ, Willis TJ, Canonical analysis of principal coordinates: A useful method of constrained ordination for ecology. Ecology 84, 511&#x2013;525 (2003).</Citation></Reference><Reference><Citation>Klunk WE, Engler H, Nordberg A, Wang Y, Blomqvist G, Holt DP, Bergstr&#xf6;m M, Savitcheva I, Huang GF, Estrada S, Aus&#xe9;n B, Debnath ML, Barletta J, Price JC, Sandell J, Lopresti BJ, Wall A, Koivisto P, Antoni G, Mathis CA, L&#xe5;ngstr&#xf6;m B, Imaging brain amyloid in Alzheimer&#x2019;s disease with Pittsburgh Compound-B. Ann. Neurol 55, 306&#x2013;319 (2004).</Citation><ArticleIdList><ArticleId IdType="pubmed">14991808</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson KA, Minoshima S, Bohnen NI, Donohoe KJ, Foster NL, Herscovitch P, Karlawish JH, Rowe CC, Carrillo MC, Hartley DM, Hedrick S, Pappas V, Thies WH; Alzheimer&#x2019;s Association; Society of Nuclear Medicine and Molecular Imaging; Amyloid Imaging Taskforce, Appropriate use criteria for amyloid PET: A report of the amyloid imaging task force, the society of nuclear medicine and molecular imaging, and the alzheimer&#x2019;s association. Alzheimers Dement. 9, e-1&#x2013;16 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3733252</ArticleId><ArticleId IdType="pubmed">23360977</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Y, Flores S, Hornbeck RC, Speidel B, Vlassenko AG, Gordon BA, Koeppe RA, Klunk WE, Xiong C, Morris JC, Benzinger TLS, Utilizing the Centiloid scale in cross-sectional and longitudinal PiB PET studies. Neuroimage Clin. 19, 406&#x2013;416 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6051499</ArticleId><ArticleId IdType="pubmed">30035025</ArticleId></ArticleIdList></Reference><Reference><Citation>Craig-Schapiro R, Fagan AM, Holtzman DM, Biomarkers of Alzheimer&#x2019;s disease. Neurobiol. Dis 35, 128&#x2013;140 (2009).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2747727</ArticleId><ArticleId IdType="pubmed">19010417</ArticleId></ArticleIdList></Reference><Reference><Citation>Vlassenko AG, McCue L, Jasielec MS, Su Y, Gordon BA, Xiong C, Holtzman DM, Benzinger TLS, Morris JC, Fagan AM, Imaging and cerebrospinal fluid biomarkers in early preclinical alzheimer disease. Ann. Neurol 80, 379&#x2013;387 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5016232</ArticleId><ArticleId IdType="pubmed">27398953</ArticleId></ArticleIdList></Reference><Reference><Citation>Mishra S, Gordon BA, Su Y, Christensen J, Friedrichsen K, Jackson K, Hornbeck R, Balota DA, Cairns NJ, Morris JC, Ances BM, Benzinger TLS, AV-1451 PET imaging of tau pathology in preclinical Alzheimer disease: Defining a summary measure. Neuroimage 161, 171&#x2013;178 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5696044</ArticleId><ArticleId IdType="pubmed">28756238</ArticleId></ArticleIdList></Reference><Reference><Citation>Fagan AM, Roe CM, Xiong C, Mintun MA, Morris JC, Holtzman DM, Cerebrospinal fluid tau/beta-amyloid(42) ratio as a prediction of cognitive decline in nondemented older adults. Arch. Neurol 64, 343&#x2013;349 (2007).</Citation><ArticleIdList><ArticleId IdType="pubmed">17210801</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L, Benzinger TL, Hassenstab J, Blazey T, Owen C, Liu J, Fagan AM, Morris JC, Ances BM, Spatially distinct atrophy is linked to &#x3b2;-amyloid and tau in preclinical Alzheimer disease. Neurology 84, 1254&#x2013;1260 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4366088</ArticleId><ArticleId IdType="pubmed">25716355</ArticleId></ArticleIdList></Reference><Reference><Citation>Cruchaga C, del-Aguila JL, Saef B, Black K, Fernandez MV, Budde J, Ibanez L, Deming Y, Kapoor M, Tosto G, Mayeux RP, Holtzman DM, Fagan AM, Morris JC, Bateman RJ, Goate AM; Dominantly Inherited Alzheimer Network (DIAN); Disease Neuroimaging Initiative (ADNI); NIA-LOAD family study, Harari O, Polygenic risk score of sporadic late-onset Alzheimer&#x2019;s disease reveals a shared architecture with the familial and early-onset forms. Alzheimers Dement. 14, 205&#x2013;214 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5803427</ArticleId><ArticleId IdType="pubmed">28943286</ArticleId></ArticleIdList></Reference><Reference><Citation>Jack CR Jr., Wiste HJ, Therneau TM, Weigand SD, Knopman DS, Mielke MM, Lowe VJ, Vemuri P, Machulda MM, Schwarz CG, Gunter JL, Senjem ML, Graff-Radford J, Jones DT, Roberts RO, Rocca WA, Petersen RC, Associations of Amyloid, Tau, and neurodegeneration biomarker profiles with rates of memory decline among individuals without dementia. JAMA 321, 2316&#x2013;2325 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6582267</ArticleId><ArticleId IdType="pubmed">31211344</ArticleId></ArticleIdList></Reference><Reference><Citation>Weigand AJ, Edwards L, Thomas KR, Bangen KJ, Bondi MW; for the Alzheimer&#x2019;s Disease Neuroimaging Initiative, Comprehensive characterization of elevated tau PET signal in the absence of amyloid-beta. Brain Commun. 4, fcac272 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9651027</ArticleId><ArticleId IdType="pubmed">36382220</ArticleId></ArticleIdList></Reference><Reference><Citation>Jack CR Jr., Knopman DS, Jagust WJ, Shaw LM, Aisen PS, Weiner MW, Petersen RC, Trojanowski JQ, Hypothetical model of dynamic biomarkers of the Alzheimer&#x2019;s pathological cascade. Lancet Neurol. 9, 119&#x2013;128 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2819840</ArticleId><ArticleId IdType="pubmed">20083042</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris JC, Roe CM, Grant EA, Head D, Storandt M, Goate AM, Fagan AM, Holtzman DM, Mintun MA, Pittsburgh compound B imaging and prediction of progression from cognitive normality to symptomatic Alzheimer disease. Arch. Neurol 66, 1469&#x2013;1475 (2009).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2798814</ArticleId><ArticleId IdType="pubmed">20008650</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts RO, Aakre JA, Kremers WK, Vassilaki M, Knopman DS, Mielke MM, Alhurani R, Geda YE, Machulda MM, Coloma P, Schauble B, Lowe VJ, Jack CR Jr., Petersen RC, Prevalence and outcomes of amyloid positivity among persons without dementia in a longitudinal, population-based setting. JAMA Neurol. 75, 970&#x2013;979 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6142936</ArticleId><ArticleId IdType="pubmed">29710225</ArticleId></ArticleIdList></Reference><Reference><Citation>Kursa MB, Rudnicki WR, Feature selection with the Boruta package. J. Stat. Softw 36, 1&#x2013;13 (2010).</Citation></Reference><Reference><Citation>Brown GC, Living too long: The current focus of medical research on increasing the quantity, rather than the quality, of life is damaging our health and harming the economy. EMBO Rep. 16, 137&#x2013;141 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4328740</ArticleId><ArticleId IdType="pubmed">25525070</ArticleId></ArticleIdList></Reference><Reference><Citation>Jack CR Jr., Bennett DA, Blennow K, Carrillo MC, Dunn B, Haeberlein SB, Holtzman DM, Jagust W, Jessen F, Karlawish J, Liu E, Molinuevo JL, Montine T, Phelps C, Rankin KP, Rowe CC, Scheltens P, Siemers E, Snyder HM, Sperling R; Contributors, Elliott C, Masliah E, Ryan L, Silverberg N, NIA-AA Research Framework: Toward a biological definition of Alzheimer&#x2019;s disease. Alzheimers Dement. 14, 535&#x2013;562 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5958625</ArticleId><ArticleId IdType="pubmed">29653606</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobs HIL, Becker JA, Kwong K, Engels-Dom&#xed;nguez N, Prokopiou PC, Papp KV, Properzi M, Hampton OL, d&#x2019;Oleire Uquillas F, Sanchez JS, Rentz DM, el Fakhri G, Normandin MD, Price JC, Bennett DA, Sperling RA, Johnson KA, In vivo and neuropathology data support locus coeruleus integrity as indicator of Alzheimer&#x2019;s disease pathology and cognitive decline. Sci. Transl. Med 13, eabj2511 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8641759</ArticleId><ArticleId IdType="pubmed">34550726</ArticleId></ArticleIdList></Reference><Reference><Citation>Serena C, Ceperuelo-Mallafr&#xe9; V, Keiran N, Queipo-Ortu&#xf1;o MI, Bernal R, Gomez-Huelgas R, Urpi-Sarda M, Sabater M, P&#xe9;rez-Brocal V, Andr&#xe9;s-Lacueva C, Moya A, Tinahones FJ, Fern&#xe1;ndez-Real JM, Vendrell J, Fern&#xe1;ndez-Veledo S, Elevated circulating levels of succinate in human obesity are linked to specific gut microbiota. ISME J. 12, 1642&#x2013;1657 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6018807</ArticleId><ArticleId IdType="pubmed">29434314</ArticleId></ArticleIdList></Reference><Reference><Citation>Macias-Ceja DC, Ortiz-Masi&#xe1; D, Salvador P, Gisbert-Ferr&#xe1;ndiz L, Hern&#xe1;ndez C, Hausmann M, Rogler G, Esplugues JV, Hinojosa J, Al&#xf3;s R, Navarro F, Cosin-Roger J, Calatayud S, Barrachina MD, Succinate receptor mediates intestinal inflammation and fibrosis. Mucosal Immunol. 12, 178&#x2013;187 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">30279517</ArticleId></ArticleIdList></Reference><Reference><Citation>Tannahill GM, Curtis AM, Adamik J, Palsson-McDermott EM, McGettrick AF, Goel G, Frezza C, Bernard NJ, Kelly B, Foley NH, Zheng L, Gardet A, Tong Z, Jany SS, Corr SC, Haneklaus M, Caffrey BE, Pierce K, Walmsley S, Beasley FC, Cummins E, Nizet V, Whyte M, Taylor CT, Lin H, Masters SL, Gottlieb E, Kelly VP, Clish C, Auron PE, Xavier RJ, O&#x2019;Neill LAJ, Succinate is an inflammatory signal that induces IL-1&#x3b2; through HIF-1&#x3b1;. Nature 496, 238&#x2013;242 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4031686</ArticleId><ArticleId IdType="pubmed">23535595</ArticleId></ArticleIdList></Reference><Reference><Citation>Fremder M, Kim SW, Khamaysi A, Shimshilashvili L, Eini-Rider H, Park IS, Hadad U, Cheon JH, Ohana E, A transepithelial pathway delivers succinate to macrophages, thus perpetuating their pro-inflammatory metabolic state. Cell Rep. 36, 109521 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34380041</ArticleId></ArticleIdList></Reference><Reference><Citation>Banerjee A, Herring CA, Chen B, Kim H, Simmons AJ, Southard-Smith AN, Allaman MM, White JR, Macedonia MC, Mckinley ET, Ramirez-Solano MA, Scoville EA, Liu Q, Wilson KT, Coffey RJ, Washington MK, Goettel JA, Lau KS, Succinate produced by intestinal microbes promotes specification of tuft cells to suppress ileal inflammation. Gastroenterology 159, 2101&#x2013;2115.e5 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7725941</ArticleId><ArticleId IdType="pubmed">32828819</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-Veledo S, Vendrell J, Gut microbiota-derived succinate: Friend or foe in human metabolic diseases? Rev. Endocr. Metab. Disord 20, 439&#x2013;447 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6938788</ArticleId><ArticleId IdType="pubmed">31654259</ArticleId></ArticleIdList></Reference><Reference><Citation>Kowalski K, Mulak A, Brain-gut-microbiota axis in Alzheimer&#x2019;s disease. J. Neurogastroenterol. Motil 25, 48&#x2013;60 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6326209</ArticleId><ArticleId IdType="pubmed">30646475</ArticleId></ArticleIdList></Reference><Reference><Citation>Killingsworth J, Sawmiller D, Shytle RD, Propionate and Alzheimer&#x2019;s disease. Front. Aging Neurosci 12, 580001 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7831739</ArticleId><ArticleId IdType="pubmed">33505301</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho L, Ono K, Tsuji M, Mazzola P, Singh R, Pasinetti GM, Protective roles of intestinal microbiota derived short chain fatty acids in Alzheimer&#x2019;s disease-type beta-amyloid neuropathological mechanisms. Expert Rev. Neurother 18, 83&#x2013;90 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5958896</ArticleId><ArticleId IdType="pubmed">29095058</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng H, Xu P, Jiang Q, Xu Q, Zheng Y, Yan J, Ji H, Ning J, Zhang X, Li C, Zhang L, Li Y, Li X, Song W, Gao H, Depletion of acetate-producing bacteria from the gut microbiota facilitates cognitive impairment through the gut-brain neural mechanism in diabetic mice. Microbiome 9, 145 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8235853</ArticleId><ArticleId IdType="pubmed">34172092</ArticleId></ArticleIdList></Reference><Reference><Citation>Marizzoni M, Cattaneo A, Mirabelli P, Festari C, Lopizzo N, Nicolosi V, Mombelli E, Mazzelli M, Luongo D, Naviglio D, Coppola L, Salvatore M, Frisoni GB, Short-chain fatty acids and lipopolysaccharide as mediators between gut dysbiosis and amyloid pathology in Alzheimer&#x2019;s disease. J. Alzheimers Dis 78, 683&#x2013;697 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">33074224</ArticleId></ArticleIdList></Reference><Reference><Citation>Abell GCJ, Conlon MA, McOrist AL, Methanogenic archaea in adult human faecal samples are inversely related to butyrate concentration. Microb. Ecol. Health Dis 18, 154&#x2013;160 (2006).</Citation></Reference><Reference><Citation>Liu Q, Xi Y, Wang Q, Liu J, Li P, Meng X, Liu K, Chen W, Liu X, Liu Z, Mannan oligosaccharide attenuates cognitive and behavioral disorders in the 5xFAD Alzheimer&#x2019;s disease mouse model via regulating the gut microbiota-brain axis. Brain Behav. Immun 95, 330&#x2013;343 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33839232</ArticleId></ArticleIdList></Reference><Reference><Citation>Vacca M, Celano G, Calabrese FM, Portincasa P, Gobbetti M, de Angelis M, The controversial role of human gut lachnospiraceae. Microorganisms 8, (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7232163</ArticleId><ArticleId IdType="pubmed">32326636</ArticleId></ArticleIdList></Reference><Reference><Citation>Lam YY, Ha CWY, Campbell CR, Mitchell AJ, Dinudom A, Oscarsson J, Cook DI, Hunt NH, Caterson ID, Holmes AJ, Storlien LH, Increased gut permeability and microbiota change associate with mesenteric fat inflammation and metabolic dysfunction in diet-induced obese mice. PLOS ONE 7, e34233 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3311621</ArticleId><ArticleId IdType="pubmed">22457829</ArticleId></ArticleIdList></Reference><Reference><Citation>Asnicar F, Berry SE, Valdes AM, Nguyen LH, Piccinno G, Drew DA, Leeming E, Gibson R, le Roy C, Khatib HA, Francis L, Mazidi M, Mompeo O, Valles-Colomer M, Tett A, Beghini F, Dubois L, Bazzani D, Thomas AM, Mirzayi C, Khleborodova A, Oh S, Hine R, Bonnett C, Capdevila J, Danzanvilliers S, Giordano F, Geistlinger L, Waldron L, Davies R, Hadjigeorgiou G, Wolf J, Ordov&#xe1;s JM, Gardner C, Franks PW, Chan AT, Huttenhower C, Spector TD, Segata N, Microbiome connections with host metabolism and habitual diet from 1,098 deeply phenotyped individuals. Nat. Med 27, 321&#x2013;332 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8353542</ArticleId><ArticleId IdType="pubmed">33432175</ArticleId></ArticleIdList></Reference><Reference><Citation>Sokol H, Pigneur B, Watterlot L, Lakhdari O, Berm&#xfa;dez-Humar&#xe1;n LG, Gratadoux JJ, Blugeon S, Bridonneau C, Furet JP, Corthier G, Grangette C, Vasquez N, Pochart P, Trugnan G, Thomas G, Blotti&#xe8;re HM, Dor&#xe9; J, Marteau P, Seksik P, Langella P, Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc. Natl. Acad. Sci. U.S.A 105, 16731&#x2013;16736 (2008).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2575488</ArticleId><ArticleId IdType="pubmed">18936492</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng D, Liwinski T, Elinav E, Interaction between microbiota and immunity in health and disease. Cell Res. 30, 492&#x2013;506 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7264227</ArticleId><ArticleId IdType="pubmed">32433595</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan Y, Nguyen LH, Franzosa EA, Huttenhower C, Strain-level epidemiology of microbial communities and the human microbiome. Genome Med. 12, 71 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7427293</ArticleId><ArticleId IdType="pubmed">32791981</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Siles M, Duncan SH, Garcia-Gil LJ, Martinez-Medina M, Faecalibacterium prausnitzii: From microbiology to diagnostics and prognostics. ISME J. 11, 841&#x2013;852 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5364359</ArticleId><ArticleId IdType="pubmed">28045459</ArticleId></ArticleIdList></Reference><Reference><Citation>Fitzgerald CB, Shkoporov AN, Sutton TDS, Chaplin AV, Velayudhan V, Ross RP, Hill C, Comparative analysis of Faecalibacterium prausnitzii genomes shows a high level of genome plasticity and warrants separation into new species-level taxa. BMC Genomics 19, 931 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6295017</ArticleId><ArticleId IdType="pubmed">30547746</ArticleId></ArticleIdList></Reference><Reference><Citation>Ueda A, Shinkai S, Shiroma H, Taniguchi Y, Tsuchida S, Kariya T, Kawahara T, Kobayashi Y, Kohda N, Ushida K, Kitamura A, Yamada T, Identification of Faecalibacterium prausnitzii strains for gut microbiome-based intervention in Alzheimer&#x2019;s-type dementia. Cell Rep. Med 2, 100398 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8484692</ArticleId><ArticleId IdType="pubmed">34622235</ArticleId></ArticleIdList></Reference><Reference><Citation>Wetterstrand K, DNA sequencing costs: Data from the NHGRI Genome Sequence Program (GSP) (2020); www.genome.gov/sequencingcostsdata [accessed
17 October 2021].</Citation></Reference><Reference><Citation>Cullen NC, Leuzy A, Janelidze S, Palmqvist S, Svenningsson AL, Stomrud E, Dage JL, Mattsson-Carlgren N, Hansson O, Plasma biomarkers of Alzheimer&#x2019;s disease improve prediction of cognitive decline in cognitively unimpaired elderly populations. Nat. Commun 12, 3555 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8196018</ArticleId><ArticleId IdType="pubmed">34117234</ArticleId></ArticleIdList></Reference><Reference><Citation>Gallach M, Lette MM, Abdel-Wahab M, Giammarile F, Pellet O, Paez D, Addressing global inequities in positron emission tomography-computed tomography (PET-CT) for cancer management: A statistical model to guide strategic planning. Med. Sci. Monit 26, e926544 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7476356</ArticleId><ArticleId IdType="pubmed">32848125</ArticleId></ArticleIdList></Reference><Reference><Citation>McDonald D, Hyde E, Debelius JW, Morton JT, Gonzalez A, Ackermann G, Aksenov AA, Behsaz B, Brennan C, Chen Y, DeRight Goldasich L, Dorrestein PC, Dunn RR, Fahimipour AK, Gaffney J, Gilbert JA, Gogul G, Green JL, Hugenholtz P, Humphrey G, Huttenhower C, Jackson MA, Janssen S, Jeste DV, Jiang L, Kelley ST, Knights D, Kosciolek T, Ladau J, Leach J, Marotz C, Meleshko D, Melnik AV, Metcalf JL, Mohimani H, Montassier E, Navas-Molina J, Nguyen TT, Peddada S, Pevzner P, Pollard KS, Rahnavard G, Robbins-Pianka A, Sangwan N, Shorenstein J, Smarr L, Song SJ, Spector T, Swafford AD, Thackray VG, Thompson LR, Tripathi A, V&#xe1;zquez-Baeza Y, Vrbanac A, Wischmeyer P, Wolfe E, Zhu Q; The American Gut Consortium, Knight R, American Gut: An open platform for citizen science microbiome research. mSystems 3, e00031&#x2013;18 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5954204</ArticleId><ArticleId IdType="pubmed">29795809</ArticleId></ArticleIdList></Reference><Reference><Citation>Seo D-O, O&#x2019;Donnell D, Jain N, Ulrich JD, Herz J, Li Y, Lemieux M, Cheng J, Hu H, Serrano JR, Bao X, Franke E, Karlsson M, Meier M, Deng S, Desai C, Dodiya H, Lelwala-Guruge J, Handley SA, Kipnis J, Sisodia SS, Gordon JI, Holtzman DM, ApoE isoform&#x2013; and microbiota-dependent progression of neurodegeneration in a mouse model of tauopathy. Science 379, eadd1236 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9901565</ArticleId><ArticleId IdType="pubmed">36634180</ArticleId></ArticleIdList></Reference><Reference><Citation>Hadjichrysanthou C, Evans S, Bajaj S, Siakallis LC, McRae-McKee K, de Wolf F, Anderson RM; Alzheimer&#x2019;s Disease Neuroimaging Initiative, The dynamics of biomarkers across the clinical spectrum of Alzheimer&#x2019;s disease. Alzheimers Res. Ther 12, 74 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7293779</ArticleId><ArticleId IdType="pubmed">32534594</ArticleId></ArticleIdList></Reference><Reference><Citation>Lozupone CA, Stombaugh JI, Gordon JI, Jansson JK, Knight R, Diversity, stability and resilience of the human gut microbiota. Nature 489, 220&#x2013;230 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3577372</ArticleId><ArticleId IdType="pubmed">22972295</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta RS, Abu-Ali GS, Drew DA, Lloyd-Price J, Subramanian A, Lochhead P, Joshi AD, Ivey KL, Khalili H, Brown GT, DuLong C, Song M, Nguyen LH, Mallick H, Rimm EB, Izard J, Huttenhower C, Chan AT, Stability of the human faecal microbiome in a cohort of adult men. Nat. Microbiol 3, 347&#x2013;355 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6016839</ArticleId><ArticleId IdType="pubmed">29335554</ArticleId></ArticleIdList></Reference><Reference><Citation>Davenport ER, Mizrahi-Man O, Michelini K, Barreiro LB, Ober C, Gilad Y, Seasonal variation in human gut microbiome composition. PLOS ONE 9, e90731 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3949691</ArticleId><ArticleId IdType="pubmed">24618913</ArticleId></ArticleIdList></Reference><Reference><Citation>Koliada A, Moseiko V, Romanenko M, Piven L, Lushchak O, Kryzhanovska N, Guryanov V, Vaiserman A, Seasonal variation in gut microbiota composition: Cross-sectional evidence from Ukrainian population. BMC Microbiol. 20, 100 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7175530</ArticleId><ArticleId IdType="pubmed">32316935</ArticleId></ArticleIdList></Reference><Reference><Citation>Fassarella M, Blaak EE, Penders J, Nauta A, Smidt H, Zoetendal EG, Gut microbiome stability and resilience: Elucidating the response to perturbations in order to modulate gut health. Gut 70, 595&#x2013;605 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33051190</ArticleId></ArticleIdList></Reference><Reference><Citation>Joshi AD, Pontecorvo MJ, Clark CM, Carpenter AP, Jennings DL, Sadowsky CH, Adler LP, Kovnat KD, Seibyl JP, Arora A, Saha K, Burns JD, Lowrey MJ, Mintun MA, Skovronsky DM; Florbetapir F 18 Study Investigators, Performance characteristics of amyloid PET with florbetapir F 18 in patients with alzheimer&#x2019;s disease and cognitively normal subjects. J. Nucl. Med 53, 378&#x2013;384 (2012).</Citation><ArticleIdList><ArticleId IdType="pubmed">22331215</ArticleId></ArticleIdList></Reference><Reference><Citation>McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr., Kawas CH, Klunk WE, Koroshetz WJ, Manly JJ, Mayeux R, Mohs RC, Morris JC, Rossor MN, Scheltens P, Carrillo MC, Thies B, Weintraub S, Phelps CH, The diagnosis of dementia due to Alzheimer&#x2019;s disease: Recommendations from the National Institute on Aging-Alzheimer&#x2019;s Association workgroups on diagnostic guidelines for Alzheimer&#x2019;s disease. Alzheimers Dement. 7, 263&#x2013;269 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3312024</ArticleId><ArticleId IdType="pubmed">21514250</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris JC, Clinical dementia rating: A reliable and valid diagnostic and staging measure for dementia of the Alzheimer type. Int. Psychogeriatr 9 (Suppl 1), 173&#x2013;176(1997).</Citation><ArticleIdList><ArticleId IdType="pubmed">9447441</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris JC, Weintraub S, Chui HC, Cummings J, Decarli C, Ferris S, Foster NL, Galasko D, Graff-Radford N, Peskind ER, Beekly D, Ramos EM, Kukull WA, The Uniform Data Set (UDS): Clinical and cognitive variables and descriptive data from Alzheimer Disease Centers. Alzheimer Dis. Assoc. Disord 20, 210&#x2013;216 (2006).</Citation><ArticleIdList><ArticleId IdType="pubmed">17132964</ArticleId></ArticleIdList></Reference><Reference><Citation>Weintraub S, Salmon D, Mercaldo N, Ferris S, Graff-Radford NR, Chui H, Cummings J, DeCarli C, Foster NL, Galasko D, Peskind E, Dietrich W, Beekly DL, Kukull WA, Morris JC, The Alzheimer&#x2019;s Disease Centers&#x2019; Uniform Data Set (UDS): The neuropsychologic test battery. Alzheimer Dis. Assoc. Disord 23, 91&#x2013;101 (2009).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2743984</ArticleId><ArticleId IdType="pubmed">19474567</ArticleId></ArticleIdList></Reference><Reference><Citation>Cruchaga C, Kauwe JS, Harari O, Jin SC, Cai Y, Karch CM, Benitez BA, Jeng AT, Skorupa T, Carrell D, Bertelsen S, Bailey M, McKean D, Shulman JM, de Jager PL, Chibnik L, Bennett DA, Arnold SE, Harold D, Sims R, Gerrish A, Williams J, van Deerlin V, Lee VM, Shaw LM, Trojanowski JQ, Haines JL, Mayeux R, Pericak-Vance MA, Farrer LA, Schellenberg GD, Peskind ER, Galasko D, Fagan AM, Holtzman DM, Morris JC; GERAD Consortium; Alzheimer&#x2019;s Disease Neuroimaging Initiative (ADNI); Alzheimer Disease Genetic Consortium (ADGC), Goate AM, GWAS of cerebrospinal fluid tau levels identifies risk variants for Alzheimer&#x2019;s disease. Neuron 78, 256&#x2013;268 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3664945</ArticleId><ArticleId IdType="pubmed">23562540</ArticleId></ArticleIdList></Reference><Reference><Citation>Kunkle BW, Grenier-Boley B, Sims R, Bis JC, Damotte V, Naj AC, Boland A, Vronskaya M, van der Lee SJ, Amlie-Wolf A, Bellenguez C, Frizatti A, Chouraki V, Martin ER, Sleegers K, Badarinarayan N, Jakobsdottir J, Hamilton-Nelson KL, Moreno-Grau S, Olaso R, Raybould R, Chen Y, Kuzma AB, Hiltunen M, Morgan T, Ahmad S, Vardarajan BN, Epelbaum J, Hoffmann P, Boada M, Beecham GW, Garnier J-G, Harold D, Fitzpatrick AL, Valladares O, Moutet M-L, Gerrish A, Smith AV, Qu L, Bacq D, Denning N, Jian X, Zhao Y, Zompo MD, Fox NC, Choi S-H, Mateo I, Hughes JT, Adams HH, Malamon J, Sanchez-Garcia F, Patel Y, Brody JA, Dombroski BA, Naranjo MCD, Daniilidou M, Eiriksdottir G, Mukherjee S, Wallon D, Uphill J, Aspelund T, Cantwell LB, Garzia F, Galimberti D, Hofer E, Butkiewicz M, Fin B, Scarpini E, Sarnowski C, Bush WS, Meslage S, Kornhuber J, White CC, Song Y, Barber RC, Engelborghs S, Sordon S, Voijnovic D, Adams PM, Vandenberghe R, Mayhaus M, Cupples LA, Albert MS, De Deyn PP, Gu W, Himali JJ, Beekly D, Squassina A, Hartmann AM, Orellana A, Blacker D, Rodriguez-Rodriguez E, Lovestone S, Garcia ME, Doody RS, Munoz-Fernadez C, Sussams R, Lin H, Fairchild TJ, Benito YA, Holmes C, Karamuji&#x107;-&#x10c;omi&#x107; H, Frosch MP, Thonberg H, Maier W, Roshchupkin G, Ghetti B, Giedraitis V, Kawalia A, Li S, Huebinger RM, Kilander L, Moebus S, Hern&#xe1;ndez I, Kamboh MI, Brundin RM, Turton J, Yang Q, Katz MJ, Concari L, Lord J, Beiser AS, Keene CD, Helisalmi S, Kloszewska I, Kukull WA, Koivisto AM, Lynch A, Tarraga L, Larson EB, Haapasalo A, Lawlor B, Mosley TH, Lipton RB, Solfrizzi V, Gill M, Longstreth WT Jr., Montine TJ, Frisardi V, Diez-Fairen M, Rivadeneira F, Petersen RC, Deramecourt V, Alvarez I, Salani F, Ciaramella A, Boerwinkle E, Reiman EM, Fievet N, Rotter JI, Reisch JS, Hanon O, Cupidi C, Uitterlinden AGA, Royall DR, Dufouil C, Maletta RG, de Rojas I, Sano M, Brice A, Cecchetti R, St George-Hyslop P, Ritchie K, Tsolaki M, Tsuang DW, Dubois B, Craig D, Wu C-K, Soininen H, Avramidou D, Albin RL, Fratiglioni L, Germanou A, Apostolova LG, Keller L, Koutroumani M, Arnold SE, Panza F, Gkatzima O, Asthana S, Hannequin D, Whitehead P, Atwood CS, Caffarra P, Hampel H, Quintela I, Carracedo &#xc1;, Lannfelt L, Rubinsztein DC, Barnes LL, Pasquier F, Fr&#xf6;lich L, Barral S, Guinness BM, Beach TG, Johnston JA, Becker JT, Passmore P, Bigio EH, Schott JM, Bird TD, Warren JD, Boeve BF, Lupton MK, Bowen JD, Proitsi P, Boxer A, Powell JF, Burke JR, Kauwe JSK, Burns JM, Mancuso M, Buxbaum JD, Bonuccelli U, Cairns NJ, Quillin AM, Cao C, Livingston G, Carlson CS, Bass NJ, Carlsson CM, Hardy J, Carney RM, Bras J, Carrasquillo MM, Guerreiro R, Allen M, Chui HC, Fisher E, Masullo C, Crocco EA, De Carli C, Bisceglio G, Dick M, Ma L, Duara R, Graff-Radford NR, Evans DA, Hodges A, Faber KM, Scherer M, Fallon KB, Riemenschneider M, Fardo DW, Heun R, Farlow MR, K&#xf6;lsch H, Ferris S, Leber M, Foroud TM, Heuser I, Galasko DR, Giegling I, Gearing M, H&#xfc;ll M, Geschwind DH, Gilbert JR, Morris J, Green RC, Mayo K, Growdon JH, Feulner T, Hamilton RL, Harrell LE, Drichel D, Honig LS, Cushion TD, Huentelman MJ, Hollingworth P, Hulette CM, Hyman BT, Marshall R, Jarvik GP, Meggy A, Abner E, Menzies GE, Jin L-W, Leonenko G, Real LM, Jun GR, Baldwin CT, Grozeva D, Karydas A, Russo G, Kaye JA, Kim R, Jessen F, Kowall NW, Vellas B, Kramer JH, Vardy E, La Ferla FM, J&#xf6;ckel K-H, Lah JJ, Dichgans M, Leverenz JB, Mann D, Levey AI, Pickering-Brown S, Lieberman AP, Klopp N, Lunetta KL, Wichmann H-E, Lyketsos CG, Morgan K, Marson DC, Brown K, Martiniuk F, Medway C, Mash DC, N&#xf6;then MM, Masliah E, Hooper NM, McCormick WC, Daniele A, McCurry SM, Bayer A, McDavid AN, Gallacher J, McKee AC, van den Bussche H, Mesulam M, Brayne C, Miller BL, Riedel-Heller S, Miller CA, Miller JW, Al-Chalabi A, Morris JC, Shaw CE, Myers AJ, Wiltfang J, O&#x2019;Bryant S, Olichney JM, Alvarez V, Parisi JE, Singleton AB, Paulson HL, Collinge J, Perry WR, Mead S, Peskind E, Cribbs DH, Rossor M, Pierce A, Ryan NS, Poon WW, Nacmias B, Potter H, Sorbi S, Quinn JF, Sacchinelli E, Raj A, Spalletta G, Raskind M, Caltagirone C, Boss&#xf9; P, Orfei MD, Reisberg B, Clarke R, Reitz C, Smith AD, Ringman JM, Warden D, Roberson ED, Wilcock G, Rogaeva E, Bruni AC, Rosen HJ, Gallo M, Rosenberg RN, Ben-Shlomo Y, Sager MA, Mecocci P, Saykin AJ, Pastor P, Cuccaro ML, Vance JM, Schneider JA, Schneider LS, Slifer S, Seeley WW, Smith AG, Sonnen JA, Spina S, Stern RA, Swerdlow RH, Tang M, Tanzi RE, Trojanowski JQ, Troncoso JC, Van Deerlin VM, Van Eldik LJ, Vinters HV, Vonsattel JP, Weintraub S, Welsh-Bohmer KA, Wilhelmsen KC, Williamson J, Wingo TS, Woltjer RL, Wright CB, Yu C-E, Yu L, Saba Y, Pilotto A, Bullido MJ, Peters O, Crane PK, Bennett D, Bosco P, Coto E, Boccardi V, De Jager PL, Lleo A, Warner N, Lopez OL, Ingelsson M, Deloukas P, Cruchaga C, Graff C, Gwilliam R, Fornage M, Goate AM, Sanchez-Juan P, Kehoe PG, Amin N, Ertekin-Taner N, Berr C, Debette S, Love S, Launer LJ, Younkin SG, Dartigues JF, Corcoran C, Ikram MA, Dickson DW, Nicolas G, Campion D, Tschanz JA, Schmidt H, Hakonarson H, Clarimon J, Munger R, Schmidt R, Farrer LA, Van Broeckhoven C, O&#x2019;Donovan MC, De Stefano AL, Jones L, Haines JL, Deleuze J-F, Owen MJ, Gudnason V, Mayeux R, Escott-Price V, Psaty BM, Ramirez A, Wang L-S, Ruiz A, van Duijn CM, Holmans PA, Seshadri S, Williams J, Amouyel P, Schellenberg GD, Lambert J-C, Pericak-Vance MA; Alzheimer Disease Genetics Consortium (ADGC); The European Alzheimer&#x2019;s Disease Initiative (EADI); Cohorts for Heart, Aging Research in Genomic Epidemiology Consortium (CHARGE); Genetic, Environmental Risk in AD/Defining Genetic, Polygenic, Environmental Risk for Alzheimer&#x2019;s Disease Consortium (GERAD/PERADES), Genetic meta-analysis of diagnosed Alzheimer&#x2019;s disease identifies new risk loci and implicates A&#x3b2;, tau, immunity and lipid processing. Nat. Genet 51, 414&#x2013;430 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6463297</ArticleId><ArticleId IdType="pubmed">30820047</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi SW, O&#x2019;Reilly PF, PRSice-2: Polygenic Risk Score software for biobank-scale data. Gigascience 8, giz082 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6629542</ArticleId><ArticleId IdType="pubmed">31307061</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Y, Blazey TM, Snyder AZ, Raichle ME, Marcus DS, Ances BM, Bateman RJ, Cairns NJ, Aldea P, Cash L, Christensen JJ, Friedrichsen K, Hornbeck RC, Farrar AM, Owen CJ, Mayeux R, Brickman AM, Klunk W, Price JC, Thompson PM, Ghetti B, Saykin AJ, Sperling RA, Johnson KA, Schofield PR, Buckles V, Morris JC, Benzinger TLS; Dominantly Inherited Alzheimer Network, Partial volume correction in quantitative amyloid imaging. Neuroimage 107, 55&#x2013;64 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4300252</ArticleId><ArticleId IdType="pubmed">25485714</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Y, D&#x2019;Angelo GM, Vlassenko AG, Zhou G, Snyder AZ, Marcus DS, Blazey TM, Christensen JJ, Vora S, Morris JC, Mintun MA, Benzinger TLS, Quantitative analysis of PiB-PET with FreeSurfer ROIs. PLOS ONE 8, e73377 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3819320</ArticleId><ArticleId IdType="pubmed">24223109</ArticleId></ArticleIdList></Reference><Reference><Citation>Baumann-Dudenhoeffer AM, D&#x2019;Souza AW, Tarr PI, Warner BB, Dantas G, Infant diet and maternal gestational weight gain predict early metabolic maturation of gut microbiomes. Nat. Med 24, 1822&#x2013;1829 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6294307</ArticleId><ArticleId IdType="pubmed">30374198</ArticleId></ArticleIdList></Reference><Reference><Citation>Gasparrini AJ, Wang B, Sun X, Kennedy EA, Hernandez-Leyva A, Ndao IM, Tarr PI, Warner BB, Dantas G, Persistent metagenomic signatures of early-life hospitalization and antibiotic treatment in the infant gut microbiota and resistome. Nat. Microbiol 4, 2285&#x2013;2297 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6879825</ArticleId><ArticleId IdType="pubmed">31501537</ArticleId></ArticleIdList></Reference><Reference><Citation>Baym M, Kryazhimskiy S, Lieberman TD, Chung H, Desai MM, Kishony R, Inexpensive multiplexed library preparation for megabase-sized genomes. PLOS ONE 10, e0128036 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4441430</ArticleId><ArticleId IdType="pubmed">26000737</ArticleId></ArticleIdList></Reference><Reference><Citation>Bolger AM, Lohse M, Usadel B, Trimmomatic: A flexible trimmer for Illumina sequence data. Bioinformatics 30, 2114&#x2013;2120 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4103590</ArticleId><ArticleId IdType="pubmed">24695404</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmieder R, Edwards R, Fast identification and removal of sequence contamination from genomic and metagenomic datasets. PLOS ONE 6, e17288 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3052304</ArticleId><ArticleId IdType="pubmed">21408061</ArticleId></ArticleIdList></Reference><Reference><Citation>McMurdie PJ, Holmes S, phyloseq: An R package for reproducible interactive analysis and graphics of microbiome census data. PLOS ONE 8, e61217 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3632530</ArticleId><ArticleId IdType="pubmed">23630581</ArticleId></ArticleIdList></Reference><Reference><Citation>Letunic I, Bork P, Interactive Tree Of Life (iTOL) v5: An online tool for phylogenetic tree display and annotation. Nucleic Acids Res. 49, W293&#x2013;W296 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8265157</ArticleId><ArticleId IdType="pubmed">33885785</ArticleId></ArticleIdList></Reference><Reference><Citation>Bray JR, Curtis JT, An ordination of the upland forest communities of southern Wisconsin. Ecol. Monogr 27, 325&#x2013;349 (1957).</Citation></Reference><Reference><Citation>Wei T, Simko V, Levy M, Xie Y, Jin Y, Zemla J, Freidank M, Cai J, Protivinsky T, R package &#x201c;corrplot&#x201d;: Visualization of a correlation matrix (2017). p. R package version 0.84.</Citation></Reference><Reference><Citation>Mallick H, Rahnavard A, McIver LJ, Ma S, Zhang Y, Nguyen LH, Tickle TL, Weingart G, Ren B, Schwager EH, Chatterjee S, Thompson KN, Wilkinson JE, Subramanian A, Lu Y, Waldron L, Paulson JN, Franzosa EA, Bravo HC, Huttenhower C, Multivariable association discovery in population-scale meta-omics studies. PLOS Comput. Biol 17, e1009442 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8714082</ArticleId><ArticleId IdType="pubmed">34784344</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37289866</PMID><DateCompleted><Year>2023</Year><Month>06</Month><Day>14</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>08</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1095-9203</ISSN><JournalIssue CitedMedium="Internet"><Volume>380</Volume><Issue>6649</Issue><PubDate><Year>2023</Year><Month>Jun</Month><Day>09</Day></PubDate></JournalIssue><Title>Science (New York, N.Y.)</Title><ISOAbbreviation>Science</ISOAbbreviation></Journal><ArticleTitle>Taurine deficiency as a driver of aging.</ArticleTitle><Pagination><StartPage>eabn9257</StartPage><MedlinePgn>eabn9257</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1126/science.abn9257</ELocationID><Abstract><AbstractText>Aging is associated with changes in circulating levels of various molecules, some of which remain undefined. We find that concentrations of circulating taurine decline with aging in mice, monkeys, and humans. A reversal of this decline through taurine supplementation increased the health span (the period of healthy living) and life span in mice and health span in monkeys. Mechanistically, taurine reduced cellular senescence, protected against telomerase deficiency, suppressed mitochondrial dysfunction, decreased DNA damage, and attenuated inflammaging. In humans, lower taurine concentrations correlated with several age-related diseases and taurine concentrations increased after acute endurance exercise. Thus, taurine deficiency may be a driver of aging because its reversal increases health span in worms, rodents, and primates and life span in worms and rodents. Clinical trials in humans seem warranted to test whether taurine deficiency might drive aging in humans.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Singh</LastName><ForeName>Parminder</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-2851-6805</Identifier><AffiliationInfo><Affiliation>Metabolic Research Laboratories, National Institute of Immunology, New Delhi, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Gollapalli</LastName><ForeName>Kishore</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0002-9546-2472</Identifier><AffiliationInfo><Affiliation>Vagelos College of Physicians and Surgeons, Columbia University, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Mangiola</LastName><ForeName>Stefano</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-7474-836X</Identifier><AffiliationInfo><Affiliation>The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Biology, University of Melbourne, Melbourne, VIC, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Cancer Medicine, La Trobe University, Bundoora, VIC, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Olivia Newton-John Cancer Research Institute, Heidelberg, VIC, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Schranner</LastName><ForeName>Daniela</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0003-2316-318X</Identifier><AffiliationInfo><Affiliation>Exercise Biology Group, Technical University of Munich, Munich, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Computational Biology, Helmholtz Zentrum M&#xfc;nchen, Neuherberg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Yusuf</LastName><ForeName>Mohd Aslam</ForeName><Initials>MA</Initials><Identifier Source="ORCID">0000-0003-2779-9919</Identifier><AffiliationInfo><Affiliation>Department of Bioengineering, Integral University, Lucknow, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Chamoli</LastName><ForeName>Manish</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-0339-7894</Identifier><AffiliationInfo><Affiliation>Buck Institute for Research on Aging, Novato, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shi</LastName><ForeName>Sting L</ForeName><Initials>SL</Initials><Identifier Source="ORCID">0000-0003-0264-7011</Identifier><AffiliationInfo><Affiliation>Vagelos College of Physicians and Surgeons, Columbia University, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lopes Bastos</LastName><ForeName>Bruno</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0002-0517-9455</Identifier><AffiliationInfo><Affiliation>Institute for Research on Cancer and Aging of Nice (IRCAN), Nice, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nair</LastName><ForeName>Tripti</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-5380-4622</Identifier><AffiliationInfo><Affiliation>Molecular Aging Laboratory, National Institute of Immunology, New Delhi, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Riermeier</LastName><ForeName>Annett</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Exercise Biology Group, Technical University of Munich, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vayndorf</LastName><ForeName>Elena M</ForeName><Initials>EM</Initials><Identifier Source="ORCID">0000-0001-9416-3350</Identifier><AffiliationInfo><Affiliation>Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Judy Z</ForeName><Initials>JZ</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nilakhe</LastName><ForeName>Aishwarya</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-6669-5330</Identifier><AffiliationInfo><Affiliation>Metabolic Research Laboratories, National Institute of Immunology, New Delhi, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nguyen</LastName><ForeName>Christina Q</ForeName><Initials>CQ</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Muir</LastName><ForeName>Michael</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-5596-3443</Identifier><AffiliationInfo><Affiliation>Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kiflezghi</LastName><ForeName>Michael G</ForeName><Initials>MG</Initials><Identifier Source="ORCID">0000-0003-3318-3686</Identifier><AffiliationInfo><Affiliation>Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Foulger</LastName><ForeName>Anna</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-4135-9741</Identifier><AffiliationInfo><Affiliation>Buck Institute for Research on Aging, Novato, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Junker</LastName><ForeName>Alex</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-1746-7160</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Columbia University, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Devine</LastName><ForeName>Jack</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurology, Columbia University, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sharan</LastName><ForeName>Kunal</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0003-2139-2544</Identifier><AffiliationInfo><Affiliation>Mouse Genetics Project, Wellcome Sanger Institute, Cambridge, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chinta</LastName><ForeName>Shankar J</ForeName><Initials>SJ</Initials><Identifier Source="ORCID">0000-0001-6386-6790</Identifier><AffiliationInfo><Affiliation>Buck Institute for Research on Aging, Novato, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rajput</LastName><ForeName>Swati</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-2079-965X</Identifier><AffiliationInfo><Affiliation>Division of Endocrinology, CSIR-Central Drug Research Institute, Lucknow, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rane</LastName><ForeName>Anand</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-5886-5291</Identifier><AffiliationInfo><Affiliation>Buck Institute for Research on Aging, Novato, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baumert</LastName><ForeName>Philipp</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-5463-1954</Identifier><AffiliationInfo><Affiliation>Exercise Biology Group, Technical University of Munich, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sch&#xf6;nfelder</LastName><ForeName>Martin</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-3003-3378</Identifier><AffiliationInfo><Affiliation>Exercise Biology Group, Technical University of Munich, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Iavarone</LastName><ForeName>Francescopaolo</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0002-8855-1848</Identifier><AffiliationInfo><Affiliation>Telethon Institute of Genetics and Medicine (TIGEM), Pozzuoli, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>di Lorenzo</LastName><ForeName>Giorgia</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0001-8659-5268</Identifier><AffiliationInfo><Affiliation>Telethon Institute of Genetics and Medicine (TIGEM), Pozzuoli, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kumari</LastName><ForeName>Swati</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-0607-8098</Identifier><AffiliationInfo><Affiliation>Metabolic Research Laboratories, National Institute of Immunology, New Delhi, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gupta</LastName><ForeName>Alka</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-8126-3475</Identifier><AffiliationInfo><Affiliation>Metabolic Research Laboratories, National Institute of Immunology, New Delhi, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sarkar</LastName><ForeName>Rajesh</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0001-7779-031X</Identifier><AffiliationInfo><Affiliation>Metabolic Research Laboratories, National Institute of Immunology, New Delhi, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khyriem</LastName><ForeName>Costerwell</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0003-2078-2532</Identifier><AffiliationInfo><Affiliation>Harry Perkins Institute of Medical Research, Perth, WA, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Curtin Medical School, Curtin University, Perth, WA, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chawla</LastName><ForeName>Amanpreet S</ForeName><Initials>AS</Initials><AffiliationInfo><Affiliation>Immunobiology Laboratory, National Institute of Immunology, New Delhi, India.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>MRC-Protein Phosphorylation and Ubiquitination Unit, University of Dundee, Dundee, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sharma</LastName><ForeName>Ankur</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-6862-136X</Identifier><AffiliationInfo><Affiliation>Harry Perkins Institute of Medical Research, Perth, WA, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Curtin Medical School, Curtin University, Perth, WA, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sarper</LastName><ForeName>Nazan</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0003-1599-774X</Identifier><AffiliationInfo><Affiliation>Pediatrics and Pediatric Hematology, Kocaeli University Hospital, Kocaeli, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chattopadhyay</LastName><ForeName>Naibedya</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0003-2473-0246</Identifier><AffiliationInfo><Affiliation>Division of Endocrinology, CSIR-Central Drug Research Institute, Lucknow, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Biswal</LastName><ForeName>Bichitra K</ForeName><Initials>BK</Initials><Identifier Source="ORCID">0000-0002-5927-3244</Identifier><AffiliationInfo><Affiliation>Metabolic Research Laboratories, National Institute of Immunology, New Delhi, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Settembre</LastName><ForeName>Carmine</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-5829-8589</Identifier><AffiliationInfo><Affiliation>Telethon Institute of Genetics and Medicine (TIGEM), Pozzuoli, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Medicine and Surgery, Federico II University, Naples, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nagarajan</LastName><ForeName>Perumal</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0003-4557-4633</Identifier><AffiliationInfo><Affiliation>Primate Research Facility, National Institute of Immunology, New Delhi, India.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Small Animal Research Facility, National Institute of Immunology, New Delhi, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Targoff</LastName><ForeName>Kimara L</ForeName><Initials>KL</Initials><Identifier Source="ORCID">0000-0002-6066-6002</Identifier><AffiliationInfo><Affiliation>Division of Cardiology, Department of Pediatrics, Columbia University, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Picard</LastName><ForeName>Martin</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-2835-0478</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Columbia University, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gupta</LastName><ForeName>Sarika</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-3054-0337</Identifier><AffiliationInfo><Affiliation>Metabolic Research Laboratories, National Institute of Immunology, New Delhi, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Velagapudi</LastName><ForeName>Vidya</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Institute for Molecular Medicine Finland FIMM, University of Helsinki, Helsinki, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Papenfuss</LastName><ForeName>Anthony T</ForeName><Initials>AT</Initials><Identifier Source="ORCID">0000-0002-1102-8506</Identifier><AffiliationInfo><Affiliation>The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Biology, University of Melbourne, Melbourne, VIC, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kaya</LastName><ForeName>Alaattin</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-6132-5197</Identifier><AffiliationInfo><Affiliation>Department of Biology, Virginia Commonwealth University, Richmond, VA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ferreira</LastName><ForeName>Miguel Godinho</ForeName><Initials>MG</Initials><Identifier Source="ORCID">0000-0002-8363-7183</Identifier><AffiliationInfo><Affiliation>Institute for Research on Cancer and Aging of Nice (IRCAN), Nice, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kennedy</LastName><ForeName>Brian K</ForeName><Initials>BK</Initials><Identifier Source="ORCID">0000-0002-5754-1874</Identifier><AffiliationInfo><Affiliation>Healthy Longevity Translational Research Program, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Healthy Longevity, National University Health System, Singapore, Singapore.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Departments of Biochemistry and Physiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Andersen</LastName><ForeName>Julie K</ForeName><Initials>JK</Initials><AffiliationInfo><Affiliation>Buck Institute for Research on Aging, Novato, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lithgow</LastName><ForeName>Gordon J</ForeName><Initials>GJ</Initials><Identifier Source="ORCID">0000-0002-8953-3043</Identifier><AffiliationInfo><Affiliation>Buck Institute for Research on Aging, Novato, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ali</LastName><ForeName>Abdullah Mahmood</ForeName><Initials>AM</Initials><Identifier Source="ORCID">0000-0002-4007-6769</Identifier><AffiliationInfo><Affiliation>Department of Medicine, Columbia University Irving Medical Center, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mukhopadhyay</LastName><ForeName>Arnab</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-5266-7849</Identifier><AffiliationInfo><Affiliation>Molecular Aging Laboratory, National Institute of Immunology, New Delhi, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Palotie</LastName><ForeName>Aarno</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Institute for Molecular Medicine Finland FIMM, University of Helsinki, Helsinki, Finland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Broad Institute of Harvard and MIT, Cambridge, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Analytic and Translational Genetics Unit, Massachusetts General Hospital, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kastenm&#xfc;ller</LastName><ForeName>Gabi</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-2368-7322</Identifier><AffiliationInfo><Affiliation>Institute of Computational Biology, Helmholtz Zentrum M&#xfc;nchen, Neuherberg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kaeberlein</LastName><ForeName>Matt</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-1311-3421</Identifier><AffiliationInfo><Affiliation>Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wackerhage</LastName><ForeName>Henning</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Exercise Biology Group, Technical University of Munich, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pal</LastName><ForeName>Bhupinder</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0002-3684-4331</Identifier><AffiliationInfo><Affiliation>The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Biology, University of Melbourne, Melbourne, VIC, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Cancer Medicine, La Trobe University, Bundoora, VIC, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Olivia Newton-John Cancer Research Institute, Heidelberg, VIC, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yadav</LastName><ForeName>Vijay K</ForeName><Initials>VK</Initials><Identifier Source="ORCID">0000-0003-2345-2846</Identifier><AffiliationInfo><Affiliation>Metabolic Research Laboratories, National Institute of Immunology, New Delhi, India.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Vagelos College of Physicians and Surgeons, Columbia University, New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Mouse Genetics Project, Wellcome Sanger Institute, Cambridge, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Genetics and Development, Columbia University, New York, NY, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>T32 AG066574</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HL162989</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HD107574</GrantID><Acronym>HD</Acronym><Agency>NICHD NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HL170188</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HL131438</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>P30 AG013280</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>06</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Science</MedlineTA><NlmUniqueID>0404511</NlmUniqueID><ISSNLinking>0036-8075</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>1EQV5MLY3D</RegistryNumber><NameOfSubstance UI="D013654">Taurine</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.7.49</RegistryNumber><NameOfSubstance UI="D019098">Telomerase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Nat Aging. 2023 Jul;3(7):758-759. doi: 10.1038/s43587-023-00465-3.</RefSource><PMID Version="1">37414989</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000375" MajorTopicYN="Y">Aging</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016922" MajorTopicYN="N">Cellular Senescence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000882" MajorTopicYN="N">Haplorhini</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008136" MajorTopicYN="N">Longevity</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013654" MajorTopicYN="Y">Taurine</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000172" MajorTopicYN="N">deficiency</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019587" MajorTopicYN="N">Dietary Supplements</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004249" MajorTopicYN="N">DNA Damage</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019098" MajorTopicYN="N">Telomerase</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><CoiStatement><b>Competing interests:</b> Columbia University has filed provisional patent applications for which VKY is an inventor. The remaining authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>12</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>8</Day><Hour>19</Hour><Minute>14</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>8</Day><Hour>14</Hour><Minute>4</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>12</Month><Day>9</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37289866</ArticleId><ArticleId IdType="mid">NIHMS1908473</ArticleId><ArticleId IdType="pmc">PMC10630957</ArticleId><ArticleId IdType="doi">10.1126/science.abn9257</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>D. o. E. a. S. A.
United Nations, Population Division, World populations ageing 2019, highlights. https://www.un.org/en/development/desa/population/publications/pdf/ageing/WorldPopulationAgeing2019-Highlights.pdf, (2019).</Citation></Reference><Reference><Citation>Mkrtchyan GV et al., ARDD 2020: from aging mechanisms to interventions. Aging (Albany NY) 12, 24484&#x2013;24503 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7803558</ArticleId><ArticleId IdType="pubmed">33378272</ArticleId></ArticleIdList></Reference><Reference><Citation>Gems D, Partridge L, Genetics of longevity in model organisms: debates and paradigm shifts. Annu Rev Physiol 75, 621&#x2013;644 (2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">23190075</ArticleId></ArticleIdList></Reference><Reference><Citation>Campisi J. et al., From discoveries in ageing research to therapeutics for healthy ageing. Nature 571, 183&#x2013;192 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7205183</ArticleId><ArticleId IdType="pubmed">31292558</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyer K, Yankner BA, Slowing Down Aging. Cell Metab 26, 592&#x2013;593 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28978424</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan H, Finkel T, Key proteins and pathways that regulate lifespan. J Biol Chem 292, 6452&#x2013;6460 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5399099</ArticleId><ArticleId IdType="pubmed">28264931</ArticleId></ArticleIdList></Reference><Reference><Citation>Haigis MC, Yankner BA, The aging stress response. Mol Cell 40, 333&#x2013;344 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2987618</ArticleId><ArticleId IdType="pubmed">20965426</ArticleId></ArticleIdList></Reference><Reference><Citation>Rando TA, Chang HY, Aging, rejuvenation, and epigenetic reprogramming: resetting the aging clock. Cell 148, 46&#x2013;57 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3336960</ArticleId><ArticleId IdType="pubmed">22265401</ArticleId></ArticleIdList></Reference><Reference><Citation>Blackburn EH, Greider CW, Szostak JW, Telomeres and telomerase: the path from maize, Tetrahymena and yeast to human cancer and aging. Nat Med 12, 1133&#x2013;1138 (2006).</Citation><ArticleIdList><ArticleId IdType="pubmed">17024208</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamming DW, Ye L, Sabatini DM, Baur JA, Rapalogs and mTOR inhibitors as anti-aging therapeutics. J Clin Invest 123, 980&#x2013;989 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3582126</ArticleId><ArticleId IdType="pubmed">23454761</ArticleId></ArticleIdList></Reference><Reference><Citation>Cabral WA et al., Genetic reduction of mTOR extends lifespan in a mouse model of Hutchinson-Gilford Progeria syndrome. Aging Cell 20, e13457 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8441492</ArticleId><ArticleId IdType="pubmed">34453483</ArticleId></ArticleIdList></Reference><Reference><Citation>Niedernhofer LJ, Robbins PD, Senotherapeutics for healthy ageing. Nat Rev Drug Discov 17, 377 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">29651106</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Otin C, Blasco MA, Partridge L, Serrano M, Kroemer G, The hallmarks of aging. Cell 153, 1194&#x2013;1217 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3836174</ArticleId><ArticleId IdType="pubmed">23746838</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirkwood TB, Understanding the odd science of aging. Cell 120, 437&#x2013;447 (2005).</Citation><ArticleIdList><ArticleId IdType="pubmed">15734677</ArticleId></ArticleIdList></Reference><Reference><Citation>Imai SI, Guarente L, It takes two to tango: NAD(+) and sirtuins in aging/longevity control. NPJ Aging Mech Dis 2, 16017 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5514996</ArticleId><ArticleId IdType="pubmed">28721271</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y. et al., The starvation hormone, fibroblast growth factor-21, extends lifespan in mice. Elife 1, e00065 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3466591</ArticleId><ArticleId IdType="pubmed">23066506</ArticleId></ArticleIdList></Reference><Reference><Citation>Asadi Shahmirzadi A. et al., Alpha-Ketoglutarate, an Endogenous Metabolite, Extends Lifespan and Compresses Morbidity in Aging Mice. Cell Metab 32, 447&#x2013;456 e446 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8508957</ArticleId><ArticleId IdType="pubmed">32877690</ArticleId></ArticleIdList></Reference><Reference><Citation>Ripps H, Shen W, Review: taurine: a &#x201c;very essential&#x201d; amino acid. Mol Vis 18, 2673&#x2013;2686 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3501277</ArticleId><ArticleId IdType="pubmed">23170060</ArticleId></ArticleIdList></Reference><Reference><Citation>Spriet LL, Whitfield J, Taurine and skeletal muscle function. Curr Opin Clin Nutr Metab Care 18, 96&#x2013;101 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">25415270</ArticleId></ArticleIdList></Reference><Reference><Citation>Lambert IH, Kristensen DM, Holm JB, Mortensen OH, Physiological role of taurine--from organism to organelle. Acta Physiol (Oxf) 213, 191&#x2013;212 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">25142161</ArticleId></ArticleIdList></Reference><Reference><Citation>Hebert A. et al., New insights into sulfur metabolism in yeasts as revealed by studies of Yarrowia lipolytica. Appl Environ Microbiol 79, 1200&#x2013;1211 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3568587</ArticleId><ArticleId IdType="pubmed">23220962</ArticleId></ArticleIdList></Reference><Reference><Citation>Tiedemann L. FG, Einige neue Bestandtheile der Galle des Ochsen. . Ann. Physik. Chem. 9, 326&#x2013;337 (1827).</Citation></Reference><Reference><Citation>Warskulat U. et al., Phenotype of the taurine transporter knockout mouse. Methods Enzymol 428, 439&#x2013;458 (2007).</Citation><ArticleIdList><ArticleId IdType="pubmed">17875433</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobsen JG, Smith LH, Biochemistry and physiology of taurine and taurine derivatives. Physiol Rev 48, 424&#x2013;511 (1968).</Citation><ArticleIdList><ArticleId IdType="pubmed">4297098</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayes KC, Carey RE, Schmidt SY, Retinal degeneration associated with taurine deficiency in the cat. Science 188, 949&#x2013;951 (1975).</Citation><ArticleIdList><ArticleId IdType="pubmed">1138364</ArticleId></ArticleIdList></Reference><Reference><Citation>Preising MN et al., Biallelic mutation of human SLC6A6 encoding the taurine transporter TAUT is linked to early retinal degeneration. FASEB J 33, 11507&#x2013;11527 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">31345061</ArticleId></ArticleIdList></Reference><Reference><Citation>Eppler B, Dawson R Jr., Dietary taurine manipulations in aged male Fischer 344 rat tissue: taurine concentration, taurine biosynthesis, and oxidative markers. Biochem Pharmacol 62, 29&#x2013;39 (2001).</Citation><ArticleIdList><ArticleId IdType="pubmed">11377394</ArticleId></ArticleIdList></Reference><Reference><Citation>Stuerenburg HJ, Stangneth B, Schoser BG, Age related profiles of free amino acids in human skeletal muscle. Neuro Endocrinol Lett 27, 133&#x2013;136 (2006).</Citation><ArticleIdList><ArticleId IdType="pubmed">16648814</ArticleId></ArticleIdList></Reference><Reference><Citation>Suarez LM, Munoz MD, Martin Del Rio R, Solis JM, Taurine content in different brain structures during ageing: effect on hippocampal synaptic plasticity. Amino Acids 48, 1199&#x2013;1208 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">26803657</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshimura T. et al., Age-related decline in the taurine content of the skin in rodents. Amino Acids 53, 429&#x2013;434 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7979616</ArticleId><ArticleId IdType="pubmed">33608821</ArticleId></ArticleIdList></Reference><Reference><Citation>Carneiro EM et al., Taurine supplementation modulates glucose homeostasis and islet function. J Nutr Biochem 20, 503&#x2013;511 (2009).</Citation><ArticleIdList><ArticleId IdType="pubmed">18708284</ArticleId></ArticleIdList></Reference><Reference><Citation>Fukuda K, Nishi Y, Usui T, Free amino acid concentrations in plasma, erythrocytes, granulocytes, and lymphocytes in umbilical cord blood, children, and adults. J Pediatr Gastroenterol Nutr 3, 432&#x2013;439 (1984).</Citation><ArticleIdList><ArticleId IdType="pubmed">6737189</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeevanandam M, Young DH, Ramias L, Schiller WR, Effect of major trauma on plasma free amino acid concentrations in geriatric patients. Am J Clin Nutr 51, 1040&#x2013;1045 (1990).</Citation><ArticleIdList><ArticleId IdType="pubmed">2349917</ArticleId></ArticleIdList></Reference><Reference><Citation>Ames BN, Prolonging healthy aging: Longevity vitamins and proteins. Proc Natl Acad Sci U S A 115, 10836&#x2013;10844 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6205492</ArticleId><ArticleId IdType="pubmed">30322941</ArticleId></ArticleIdList></Reference><Reference><Citation>Ito T. et al., Tissue depletion of taurine accelerates skeletal muscle senescence and leads to early death in mice. PLoS One 9, e107409 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4167997</ArticleId><ArticleId IdType="pubmed">25229346</ArticleId></ArticleIdList></Reference><Reference><Citation>Yilmaz LS et al., Modeling tissue-relevant Caenorhabditis elegans metabolism at network, pathway, reaction, and metabolite levels. Mol Syst Biol 16, e9649 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7537831</ArticleId><ArticleId IdType="pubmed">33022146</ArticleId></ArticleIdList></Reference><Reference><Citation>Wan QL et al., Metabolomic signature associated with reproduction-regulated aging in Caenorhabditis elegans. Aging (Albany NY) 9, 447&#x2013;474 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5361674</ArticleId><ArticleId IdType="pubmed">28177875</ArticleId></ArticleIdList></Reference><Reference><Citation>McCormick MA et al., A Comprehensive Analysis of Replicative Lifespan in 4,698 Single-Gene Deletion Strains Uncovers Conserved Mechanisms of Aging. Cell Metab 22, 895&#x2013;906 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4862740</ArticleId><ArticleId IdType="pubmed">26456335</ArticleId></ArticleIdList></Reference><Reference><Citation>Coleman ST, Fang TK, Rovinsky SA, Turano FJ, Moye-Rowley WS, Expression of a glutamate decarboxylase homologue is required for normal oxidative stress tolerance in Saccharomyces cerevisiae. J Biol Chem 276, 244&#x2013;250 (2001).</Citation><ArticleIdList><ArticleId IdType="pubmed">11031268</ArticleId></ArticleIdList></Reference><Reference><Citation>Olshansky SJ, From Lifespan to Healthspan. JAMA 320, 1323&#x2013;1324 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">30242384</ArticleId></ArticleIdList></Reference><Reference><Citation>Shoji H, Takao K, Hattori S, Miyakawa T, Age-related changes in behavior in C57BL/6J mice from young adulthood to middle age. Mol Brain 9, 11 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4730600</ArticleId><ArticleId IdType="pubmed">26822304</ArticleId></ArticleIdList></Reference><Reference><Citation>Steru L, Chermat R, Thierry B, Simon P, The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology (Berl) 85, 367&#x2013;370 (1985).</Citation><ArticleIdList><ArticleId IdType="pubmed">3923523</ArticleId></ArticleIdList></Reference><Reference><Citation>Bourin M, Hascoet M, The mouse light/dark box test. Eur J Pharmacol 463, 55&#x2013;65 (2003).</Citation><ArticleIdList><ArticleId IdType="pubmed">12600702</ArticleId></ArticleIdList></Reference><Reference><Citation>Pavlopoulos E. et al., Molecular mechanism for age-related memory loss: the histone-binding protein RbAp48. Sci Transl Med 5, 200ra115 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4940031</ArticleId><ArticleId IdType="pubmed">23986399</ArticleId></ArticleIdList></Reference><Reference><Citation>Dey N. et al., Regulators of gut motility revealed by a gnotobiotic model of diet-microbiome interactions related to travel. Cell 163, 95&#x2013;107 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4583712</ArticleId><ArticleId IdType="pubmed">26406373</ArticleId></ArticleIdList></Reference><Reference><Citation>Yano JM et al., Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis. Cell 161, 264&#x2013;276 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4393509</ArticleId><ArticleId IdType="pubmed">25860609</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho RH, Sieburg HB, Muller-Sieburg CE, A new mechanism for the aging of hematopoietic stem cells: aging changes the clonal composition of the stem cell compartment but not individual stem cells. Blood 111, 5553&#x2013;5561 (2008).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2424153</ArticleId><ArticleId IdType="pubmed">18413859</ArticleId></ArticleIdList></Reference><Reference><Citation>Mangiola S, Molania R, Dong R, Doyle MA, Papenfuss AT, tidybulk: an R tidy framework for modular transcriptomic data analysis. Genome Biol 22, 42 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7821481</ArticleId><ArticleId IdType="pubmed">33482892</ArticleId></ArticleIdList></Reference><Reference><Citation>Chinta SJ et al., Cellular Senescence Is Induced by the Environmental Neurotoxin Paraquat and Contributes to Neuropathology Linked to Parkinson's Disease. Cell Rep 22, 930&#x2013;940 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5806534</ArticleId><ArticleId IdType="pubmed">29386135</ArticleId></ArticleIdList></Reference><Reference><Citation>Yi JS et al., Low-dose dasatinib rescues cardiac function in Noonan syndrome. JCI Insight 1, e90220 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5135272</ArticleId><ArticleId IdType="pubmed">27942593</ArticleId></ArticleIdList></Reference><Reference><Citation>McEachern MJ, Krauskopf A, Blackburn EH, Telomeres and their control. Annu Rev Genet 34, 331&#x2013;358 (2000).</Citation><ArticleIdList><ArticleId IdType="pubmed">11092831</ArticleId></ArticleIdList></Reference><Reference><Citation>Henriques CM, Carneiro MC, Tenente IM, Jacinto A, Ferreira MG, Telomerase is required for zebrafish lifespan. PLoS Genet 9, e1003214 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3547866</ArticleId><ArticleId IdType="pubmed">23349637</ArticleId></ArticleIdList></Reference><Reference><Citation>Maslov AY et al., DNA damage in normally and prematurely aged mice. Aging Cell 12, 467&#x2013;477 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3655155</ArticleId><ArticleId IdType="pubmed">23496256</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamilton ML et al., Does oxidative damage to DNA increase with age? Proc Natl Acad Sci U S A 98, 10469&#x2013;10474 (2001).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC56984</ArticleId><ArticleId IdType="pubmed">11517304</ArticleId></ArticleIdList></Reference><Reference><Citation>Marioni RE et al., DNA methylation age of blood predicts all-cause mortality in later life. Genome Biol 16, 25 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4350614</ArticleId><ArticleId IdType="pubmed">25633388</ArticleId></ArticleIdList></Reference><Reference><Citation>Michalak EM, Burr ML, Bannister AJ, Dawson MA, The roles of DNA, RNA and histone methylation in ageing and cancer. Nat Rev Mol Cell Biol 20, 573&#x2013;589 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">31270442</ArticleId></ArticleIdList></Reference><Reference><Citation>Bettedi L, Foukas LC, Growth factor, energy and nutrient sensing signalling pathways in metabolic ageing. Biogerontology 18, 913&#x2013;929 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5684302</ArticleId><ArticleId IdType="pubmed">28795262</ArticleId></ArticleIdList></Reference><Reference><Citation>Bitto A. et al., Transient rapamycin treatment can increase lifespan and healthspan in middle-aged mice. Elife 5, (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4996648</ArticleId><ArticleId IdType="pubmed">27549339</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrucci L, Fabbri E, Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty. Nat Rev Cardiol 15, 505&#x2013;522 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6146930</ArticleId><ArticleId IdType="pubmed">30065258</ArticleId></ArticleIdList></Reference><Reference><Citation>Oh J, Lee YD, Wagers AJ, Stem cell aging: mechanisms, regulators and therapeutic opportunities. Nat Med 20, 870&#x2013;880 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4160113</ArticleId><ArticleId IdType="pubmed">25100532</ArticleId></ArticleIdList></Reference><Reference><Citation>Barker N. et al., Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature 449, 1003&#x2013;1007 (2007).</Citation><ArticleIdList><ArticleId IdType="pubmed">17934449</ArticleId></ArticleIdList></Reference><Reference><Citation>Kauppila TES, Kauppila JHK, Larsson NG, Mammalian Mitochondria and Aging: An Update. Cell Metab 25, 57&#x2013;71 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28094012</ArticleId></ArticleIdList></Reference><Reference><Citation>Wenz T, Rossi SG, Rotundo RL, Spiegelman BM, Moraes CT, Increased muscle PGC-1alpha expression protects from sarcopenia and metabolic disease during aging. Proc Natl Acad Sci U S A 106, 20405&#x2013;20410 (2009).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2787152</ArticleId><ArticleId IdType="pubmed">19918075</ArticleId></ArticleIdList></Reference><Reference><Citation>Suzuki T, Suzuki T, Wada T, Saigo K, Watanabe K, Taurine as a constituent of mitochondrial tRNAs: new insights into the functions of taurine and human mitochondrial diseases. EMBO J 21, 6581&#x2013;6589 (2002).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC136959</ArticleId><ArticleId IdType="pubmed">12456664</ArticleId></ArticleIdList></Reference><Reference><Citation>Pierce-Shimomura JT et al., Genetic analysis of crawling and swimming locomotory patterns in C. elegans. Proc Natl Acad Sci U S A 105, 20982&#x2013;20987 (2008).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2634943</ArticleId><ArticleId IdType="pubmed">19074276</ArticleId></ArticleIdList></Reference><Reference><Citation>Pietzner M. et al., Plasma metabolites to profile pathways in noncommunicable disease multimorbidity. Nat Med 27, 471&#x2013;479 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8127079</ArticleId><ArticleId IdType="pubmed">33707775</ArticleId></ArticleIdList></Reference><Reference><Citation>Warburton DE, Nicol CW, Bredin SS, Prescribing exercise as preventive therapy. CMAJ 174, 961&#x2013;974 (2006).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1405860</ArticleId><ArticleId IdType="pubmed">16567757</ArticleId></ArticleIdList></Reference><Reference><Citation>Pedersen BK, Saltin B, Exercise as medicine - evidence for prescribing exercise as therapy in 26 different chronic diseases. Scand J Med Sci Sports 25 Suppl 3, 1&#x2013;72 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">26606383</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergstrom J, Furst P, Noree LO, Vinnars E, Intracellular free amino acid concentration in human muscle tissue. J Appl Physiol 36, 693&#x2013;697 (1974).</Citation><ArticleIdList><ArticleId IdType="pubmed">4829908</ArticleId></ArticleIdList></Reference><Reference><Citation>Wright CE, Tallan HH, Lin YY, Gaull GE, Taurine: biological update. Annu Rev Biochem 55, 427&#x2013;453 (1986).</Citation><ArticleIdList><ArticleId IdType="pubmed">3527049</ArticleId></ArticleIdList></Reference><Reference><Citation>Lambert IH, Regulation of the cellular content of the organic osmolyte taurine in mammalian cells. Neurochem Res 29, 27&#x2013;63 (2004).</Citation><ArticleIdList><ArticleId IdType="pubmed">14992263</ArticleId></ArticleIdList></Reference><Reference><Citation>Holopainen I, Kontro P, Taurine and hypotaurine transport by a single system in cultured neuroblastoma cells. Acta Physiol Scand 122, 381&#x2013;386 (1984).</Citation><ArticleIdList><ArticleId IdType="pubmed">6516887</ArticleId></ArticleIdList></Reference><Reference><Citation>Takahashi K. et al., Taurine transporter in primary cultured neonatal rat heart cells: a comparison between cardiac myocytes and nonmyocytes. Biochem Pharmacol 65, 1181&#x2013;1187 (2003).</Citation><ArticleIdList><ArticleId IdType="pubmed">12663053</ArticleId></ArticleIdList></Reference><Reference><Citation>Oja SS, Lehtinen I, Lahdesmaki P, Taurine transport rates between plasma and tissues in adult and 7-day-old mice. Q J Exp Physiol Cogn Med Sci 61, 133&#x2013;143 (1976).</Citation><ArticleIdList><ArticleId IdType="pubmed">1047457</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee G, Lee H, Hong J, Lee SH, Jung BH, Quantitative profiling of bile acids in rat bile using ultrahigh-performance liquid chromatography-orbitrap mass spectrometry: Alteration of the bile acid composition with aging. J Chromatogr B Analyt Technol Biomed Life Sci 1031, 37&#x2013;49 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">27450898</ArticleId></ArticleIdList></Reference><Reference><Citation>Calvani R. et al., Fecal and urinary NMR-based metabolomics unveil an aging signature in mice. Exp Gerontol 49, 5&#x2013;11 (2014).</Citation><ArticleIdList><ArticleId IdType="pubmed">24184118</ArticleId></ArticleIdList></Reference><Reference><Citation>Barua M, Liu Y, Quinn MR, Taurine chloramine inhibits inducible nitric oxide synthase and TNF-alpha gene expression in activated alveolar macrophages: decreased NF-kappaB activation and IkappaB kinase activity. J Immunol 167, 2275&#x2013;2281 (2001).</Citation><ArticleIdList><ArticleId IdType="pubmed">11490015</ArticleId></ArticleIdList></Reference><Reference><Citation>DiNicolantonio JJ, JH OK, McCarty MF, Boosting endogenous production of vasoprotective hydrogen sulfide via supplementation with taurine and N-acetylcysteine: a novel way to promote cardiovascular health. Open Heart 4, e000600 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5471864</ArticleId><ArticleId IdType="pubmed">28674632</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi X, Yao D, Chen C, Identification of N-acetyltaurine as a novel metabolite of ethanol through metabolomics-guided biochemical analysis. J Biol Chem 287, 6336&#x2013;6349 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3307278</ArticleId><ArticleId IdType="pubmed">22228769</ArticleId></ArticleIdList></Reference><Reference><Citation>Ito T. et al., Cardiac and skeletal muscle abnormality in taurine transporter-knockout mice. J Biomed Sci 17 Suppl 1, S20 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2994367</ArticleId><ArticleId IdType="pubmed">20804595</ArticleId></ArticleIdList></Reference><Reference><Citation>Roman-Garcia P. et al., Vitamin B(1)(2)-dependent taurine synthesis regulates growth and bone mass. J Clin Invest 124, 2988&#x2013;3002 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4071367</ArticleId><ArticleId IdType="pubmed">24911144</ArticleId></ArticleIdList></Reference><Reference><Citation>de Magalhaes JP, Church GM, Genomes optimize reproduction: aging as a consequence of the developmental program. Physiology (Bethesda) 20, 252&#x2013;259 (2005).</Citation><ArticleIdList><ArticleId IdType="pubmed">16024513</ArticleId></ArticleIdList></Reference><Reference><Citation>Shindyapina AV et al., Rapamycin treatment during development extends lifespan and healthspan. bioRxiv, 2022.2002.2018.481092 (2022).</Citation></Reference><Reference><Citation>Ansar M. et al., Taurine treatment of retinal degeneration and cardiomyopathy in a consanguineous family with SLC6A6 taurine transporter deficiency. Hum Mol Genet 29, 618&#x2013;623 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7068170</ArticleId><ArticleId IdType="pubmed">31903486</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan L, Miao P, The effects of taurine supplementation on obesity, blood pressure and lipid profile: A meta-analysis of randomized controlled trials. Eur J Pharmacol 885, 173533 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32871172</ArticleId></ArticleIdList></Reference><Reference><Citation>Brennan AM et al., Plasma Metabolite Profiles in Response to Chronic Exercise. Med Sci Sports Exerc 50, 1480&#x2013;1486 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6027642</ArticleId><ArticleId IdType="pubmed">29509640</ArticleId></ArticleIdList></Reference><Reference><Citation>Cuisinier C. et al., Role of taurine in osmoregulation during endurance exercise. Eur J Appl Physiol 87, 489&#x2013;495 (2002).</Citation><ArticleIdList><ArticleId IdType="pubmed">12355187</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharan K, Lewis K, Furukawa T, Yadav VK, Regulation of bone mass through pineal-derived melatonin-MT2 receptor pathway. J Pineal Res 63, (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5575491</ArticleId><ArticleId IdType="pubmed">28512916</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh P. et al., Maternal vitamin B12 in mice positively regulates bone, but not muscle mass and strength in post-weaning and mature offspring. Am J Physiol Regul Integr Comp Physiol, (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8285619</ArticleId><ArticleId IdType="pubmed">33759575</ArticleId></ArticleIdList></Reference><Reference><Citation>Yadav VK, Lakshmi G, Medhamurthy R, Prostaglandin F2alpha-mediated activation of apoptotic signaling cascades in the corpus luteum during apoptosis: involvement of caspase-activated DNase. J Biol Chem 280, 10357&#x2013;10367 (2005).</Citation><ArticleIdList><ArticleId IdType="pubmed">15623530</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee MB et al., A system to identify inhibitors of mTOR signaling using high-resolution growth analysis in Saccharomyces cerevisiae. Geroscience 39, 419&#x2013;428 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5636783</ArticleId><ArticleId IdType="pubmed">28707282</ArticleId></ArticleIdList></Reference><Reference><Citation>Steffen KK, Kennedy BK, Kaeberlein M, Measuring replicative life span in the budding yeast. J Vis Exp, (2009).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2797481</ArticleId><ArticleId IdType="pubmed">19556967</ArticleId></ArticleIdList></Reference><Reference><Citation>Beaupere C. et al., Genetic screen identifies adaptive aneuploidy as a key mediator of ER stress resistance in yeast. Proc Natl Acad Sci U S A 115, 9586&#x2013;9591 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6156608</ArticleId><ArticleId IdType="pubmed">30185560</ArticleId></ArticleIdList></Reference><Reference><Citation>Murakami CJ, Wall V, Basisty N, Kaeberlein M, Composition and acidification of the culture medium influences chronological aging similarly in vineyard and laboratory yeast. PLoS One 6, e24530 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3176285</ArticleId><ArticleId IdType="pubmed">21949725</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee MB et al., Pterocarpus marsupium extract extends replicative lifespan in budding yeast. Geroscience 43, 2595&#x2013;2609 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8599564</ArticleId><ArticleId IdType="pubmed">34297314</ArticleId></ArticleIdList></Reference><Reference><Citation>Olsen B, Murakami CJ, Kaeberlein M, YODA: software to facilitate high-throughput analysis of chronological life span, growth rate, and survival in budding yeast. BMC bioinformatics 11, 141 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2850362</ArticleId><ArticleId IdType="pubmed">20298554</ArticleId></ArticleIdList></Reference><Reference><Citation>Aartsma-Rus A, van Putten M, Assessing functional performance in the mdx mouse model. J Vis Exp, (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4158772</ArticleId><ArticleId IdType="pubmed">24747372</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen JJ et al., Maintenance of serotonin in the intestinal mucosa and ganglia of mice that lack the high-affinity serotonin transporter: Abnormal intestinal motility and the expression of cation transporters. J Neurosci 21, 6348&#x2013;6361 (2001).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6763151</ArticleId><ArticleId IdType="pubmed">11487658</ArticleId></ArticleIdList></Reference><Reference><Citation>Mayorga AJ, Lucki I, Limitations on the use of the C57BL/6 mouse in the tail suspension test. Psychopharmacology (Berl) 155, 110&#x2013;112 (2001).</Citation><ArticleIdList><ArticleId IdType="pubmed">11374330</ArticleId></ArticleIdList></Reference><Reference><Citation>Oh CM et al., Regulation of systemic energy homeostasis by serotonin in adipose tissues. Nat Commun 6, 6794 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4403443</ArticleId><ArticleId IdType="pubmed">25864946</ArticleId></ArticleIdList></Reference><Reference><Citation>Parfitt AM et al., Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 2, 595&#x2013;610 (1987).</Citation><ArticleIdList><ArticleId IdType="pubmed">3455637</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewis KE, Sharan K, Takumi T, Yadav VK, Skeletal Site-specific Changes in Bone Mass in a Genetic Mouse Model for Human 15q11&#x2013;13 Duplication Seen in Autism. Sci Rep 7, 9902 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5575059</ArticleId><ArticleId IdType="pubmed">28851986</ArticleId></ArticleIdList></Reference><Reference><Citation>Hildebrand T, Laib A, Muller R, Dequeker J, Ruegsegger P, Direct three-dimensional morphometric analysis of human cancellous bone: microstructural data from spine, femur, iliac crest, and calcaneus. J Bone Miner Res 14, 1167&#x2013;1174 (1999).</Citation><ArticleIdList><ArticleId IdType="pubmed">10404017</ArticleId></ArticleIdList></Reference><Reference><Citation>Feldkamp LA, Goldstein SA, Parfitt AM, Jesion G, Kleerekoper M, The direct examination of three-dimensional bone architecture in vitro by computed tomography. J Bone Miner Res 4, 3&#x2013;11 (1989).</Citation><ArticleIdList><ArticleId IdType="pubmed">2718776</ArticleId></ArticleIdList></Reference><Reference><Citation>Gundersen HJ, Boyce RW, Nyengaard JR, Odgaard A, The Conneulor: unbiased estimation of connectivity using physical disectors under projection. Bone 14, 217&#x2013;222 (1993).</Citation><ArticleIdList><ArticleId IdType="pubmed">8363860</ArticleId></ArticleIdList></Reference><Reference><Citation>Debacq-Chainiaux F, Erusalimsky JD, Campisi J, Toussaint O, Protocols to detect senescence-associated beta-galactosidase (SA-betagal) activity, a biomarker of senescent cells in culture and in vivo. Nat Protoc 4, 1798&#x2013;1806 (2009).</Citation><ArticleIdList><ArticleId IdType="pubmed">20010931</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Park C, Bennett C, Thornton M, Kim D, Rapid and accurate alignment of nucleotide conversion sequencing reads with HISAT-3N. Genome Res, (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8256862</ArticleId><ArticleId IdType="pubmed">34103331</ArticleId></ArticleIdList></Reference><Reference><Citation>Putri GH, Anders S, Pyl PT, Pimanda JE, Zanini F, Analysing high-throughput sequencing data in Python with HTSeq 2.0. Bioinformatics 38, 2943&#x2013;2945 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9113351</ArticleId><ArticleId IdType="pubmed">35561197</ArticleId></ArticleIdList></Reference><Reference><Citation>Wickham H, Welcome to the Tidyverse. . Journal of Open Source Software 4, 1686, (2019).</Citation></Reference><Reference><Citation>Robinson MD, McCarthy DJ, Smyth GK, edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26, 139&#x2013;140 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2796818</ArticleId><ArticleId IdType="pubmed">19910308</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson MD, Oshlack A, A scaling normalization method for differential expression analysis of RNA-seq data. Genome Biol 11, R25 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2864565</ArticleId><ArticleId IdType="pubmed">20196867</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou X, Lindsay H, Robinson MD, Robustly detecting differential expression in RNA sequencing data using observation weights. Nucleic Acids Res 42, e91 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4066750</ArticleId><ArticleId IdType="pubmed">24753412</ArticleId></ArticleIdList></Reference><Reference><Citation>McCarthy DJ, Smyth GK, Testing significance relative to a fold-change threshold is a TREAT. Bioinformatics 25, 765&#x2013;771 (2009).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2654802</ArticleId><ArticleId IdType="pubmed">19176553</ArticleId></ArticleIdList></Reference><Reference><Citation>Mangiola S, Thomas EA, Modrak M, Vehtari A, Papenfuss AT, Probabilistic outlier identification for RNA sequencing generalized linear models. NAR Genom Bioinform 3, lqab005 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7936652</ArticleId><ArticleId IdType="pubmed">33709073</ArticleId></ArticleIdList></Reference><Reference><Citation>Wickham H, ggplot2: Elegant Graphics for Data Analysis. . Springer International Publishing, (2016).</Citation></Reference><Reference><Citation>Mangiola SP, A. T. , tidyHeatmap: an R package for modular heatmap production based on tidy principles. Journal of Open Source Software 5, 2472 (2020). (2020).</Citation></Reference><Reference><Citation>Gu Z, Eils R, Schlesner M, Complex heatmaps reveal patterns and correlations in multidimensional genomic data. Bioinformatics 32, 2847&#x2013;2849 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">27207943</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu G, Wang LG, Han Y, He QY, clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS 16, 284&#x2013;287 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3339379</ArticleId><ArticleId IdType="pubmed">22455463</ArticleId></ArticleIdList></Reference><Reference><Citation>Hernandez-Segura A. et al., Unmasking Transcriptional Heterogeneity in Senescent Cells. Curr Biol 27, 2652&#x2013;2660 e2654 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5788810</ArticleId><ArticleId IdType="pubmed">28844647</ArticleId></ArticleIdList></Reference><Reference><Citation>Hochberg Y, Benjamini Y, More powerful procedures for multiple significance testing. Stat Med 9, 811&#x2013;818 (1990).</Citation><ArticleIdList><ArticleId IdType="pubmed">2218183</ArticleId></ArticleIdList></Reference><Reference><Citation>Verlaan S. et al., Nutritional status, body composition, and quality of life in community-dwelling sarcopenic and non-sarcopenic older adults: A case-control study. Clin Nutr 36, 267&#x2013;274 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">26689868</ArticleId></ArticleIdList></Reference><Reference><Citation>Rausser S. et al., Mitochondrial phenotypes in purified human immune cell subtypes and cell mixtures. Elife 10, (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8612706</ArticleId><ArticleId IdType="pubmed">34698636</ArticleId></ArticleIdList></Reference><Reference><Citation>Anand N. et al., Dysregulated iron metabolism in C. elegans catp-6/ATP13A2 mutant impairs mitochondrial function. Neurobiol Dis 139, 104786 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7150649</ArticleId><ArticleId IdType="pubmed">32032734</ArticleId></ArticleIdList></Reference><Reference><Citation>Vanharanta M, Voutilainen S, Rissanen TH, Adlercreutz H, Salonen JT, Risk of cardiovascular disease-related and all-cause death according to serum concentrations of enterolactone: Kuopio Ischaemic Heart Disease Risk Factor Study. Arch Intern Med 163, 1099&#x2013;1104 (2003).</Citation><ArticleIdList><ArticleId IdType="pubmed">12742810</ArticleId></ArticleIdList></Reference><Reference><Citation>Kolho KL, Pessia A, Jaakkola T, de Vos WM, Velagapudi V, Faecal and Serum Metabolomics in Paediatric Inflammatory Bowel Disease. J Crohns Colitis 11, 321&#x2013;334 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">27609529</ArticleId></ArticleIdList></Reference><Reference><Citation>Buzkova J. et al., Metabolomes of mitochondrial diseases and inclusion body myositis patients: treatment targets and biomarkers. EMBO Mol Med 10, (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6284386</ArticleId><ArticleId IdType="pubmed">30373890</ArticleId></ArticleIdList></Reference><Reference><Citation>Day N. et al., EPIC-Norfolk: study design and characteristics of the cohort. European Prospective Investigation of Cancer. Br J Cancer 80 Suppl 1, 95&#x2013;103 (1999).</Citation><ArticleIdList><ArticleId IdType="pubmed">10466767</ArticleId></ArticleIdList></Reference><Reference><Citation>Schranner D. et al., Physiological extremes of the human blood metabolome: A metabolomics analysis of highly glycolytic, oxidative, and anabolic athletes. Physiol Rep 9, e14885 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8215680</ArticleId><ArticleId IdType="pubmed">34152092</ArticleId></ArticleIdList></Reference><Reference><Citation>Percie du Sert N. et al., The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research. Br J Pharmacol 177, 3617&#x2013;3624 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7393194</ArticleId><ArticleId IdType="pubmed">32662519</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37289872</PMID><DateCompleted><Year>2023</Year><Month>06</Month><Day>14</Day></DateCompleted><DateRevised><Year>2023</Year><Month>11</Month><Day>22</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1095-9203</ISSN><JournalIssue CitedMedium="Internet"><Volume>380</Volume><Issue>6649</Issue><PubDate><Year>2023</Year><Month>Jun</Month><Day>09</Day></PubDate></JournalIssue><Title>Science (New York, N.Y.)</Title><ISOAbbreviation>Science</ISOAbbreviation></Journal><ArticleTitle>Taurine linked with healthy aging.</ArticleTitle><Pagination><StartPage>1010</StartPage><EndPage>1011</EndPage><MedlinePgn>1010-1011</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1126/science.adi3025</ELocationID><Abstract><AbstractText>Reversing age-associated taurine loss improves mouse longevity and monkey health.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>McGaunn</LastName><ForeName>Joseph</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Physiology and Institute for Diabetes, Obesity, and Metabolism, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baur</LastName><ForeName>Joseph A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Department of Physiology and Institute for Diabetes, Obesity, and Metabolism, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>T32 GM007170</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>06</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Science</MedlineTA><NlmUniqueID>0404511</NlmUniqueID><ISSNLinking>0036-8075</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>1EQV5MLY3D</RegistryNumber><NameOfSubstance UI="D013654">Taurine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000073656" MajorTopicYN="Y">Healthy Aging</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008136" MajorTopicYN="N">Longevity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013654" MajorTopicYN="Y">Taurine</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000172" MajorTopicYN="N">deficiency</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000882" MajorTopicYN="N">Haplorhini</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>12</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>8</Day><Hour>19</Hour><Minute>14</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>8</Day><Hour>14</Hour><Minute>4</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37289872</ArticleId><ArticleId IdType="doi">10.1126/science.adi3025</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">37333365</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>23</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2692-8205</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2023</Year><Month>Jun</Month><Day>05</Day></PubDate></JournalIssue><Title>bioRxiv : the preprint server for biology</Title><ISOAbbreviation>bioRxiv</ISOAbbreviation></Journal><ArticleTitle>Early Alzheimer's disease pathology in human cortex is associated with a transient phase of distinct cell states.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2023.06.03.543569</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1101/2023.06.03.543569</ELocationID><Abstract><AbstractText>Cellular perturbations underlying Alzheimer's disease are primarily studied in human postmortem samples and model organisms. Here we generated a single-nucleus atlas from a rare cohort of cortical biopsies from living individuals with varying degrees of Alzheimer's disease pathology. We next performed a systematic cross-disease and cross-species integrative analysis to identify a set of cell states that are specific to early AD pathology. These changes-which we refer to as the Early Cortical Amyloid Response-were prominent in neurons, wherein we identified a transient state of hyperactivity preceding loss of excitatory neurons, which correlated with the selective loss of layer 1 inhibitory neurons. Microglia overexpressing neuroinflammatory-related processes also expanded as AD pathological burden increased. Lastly, both oligodendrocytes and pyramidal neurons upregulated genes associated with amyloid beta production and processing during this early hyperactive phase. Our integrative analysis provides an organizing framework for targeting circuit dysfunction, neuroinflammation, and amyloid production early in AD pathogenesis.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gazestani</LastName><ForeName>Vahid</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Broad Institute of MIT and Harvard, Cambridge, MA 02142 USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kamath</LastName><ForeName>Tushar</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Broad Institute of MIT and Harvard, Cambridge, MA 02142 USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Harvard Graduate Program in Biophysics and Harvard/MIT MD-PhD Program, Harvard University, Cambridge, MA 02139 USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nadaf</LastName><ForeName>Naeem M</ForeName><Initials>NM</Initials><AffiliationInfo><Affiliation>Broad Institute of MIT and Harvard, Cambridge, MA 02142 USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Burris</LastName><ForeName>S J</ForeName><Initials>SJ</Initials><AffiliationInfo><Affiliation>Broad Institute of MIT and Harvard, Cambridge, MA 02142 USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rooney</LastName><ForeName>Brendan</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Program in Neuroscience, Harvard Medical School, Boston, MA 02115 USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Junkkari</LastName><ForeName>Antti</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Institute of Clinical Medicine, Unit of Pathology, Faculty of Health Sciences, University of Eastern Finland, Kuopio, Finland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurosurgery, Kuopio University Hospital, Kuopio, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vanderburg</LastName><ForeName>Charles</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Broad Institute of MIT and Harvard, Cambridge, MA 02142 USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rauramaa</LastName><ForeName>Tuomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Institute of Clinical Medicine, Unit of Pathology, Faculty of Health Sciences, University of Eastern Finland, Kuopio, Finland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathology, Kuopio University Hospital, Kuopio, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Therrien</LastName><ForeName>Martine</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Broad Institute of MIT and Harvard, Cambridge, MA 02142 USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tegtmeyer</LastName><ForeName>Matthew</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Broad Institute of MIT and Harvard, Cambridge, MA 02142 USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Herukka</LastName><ForeName>Sanna-Kaisa</ForeName><Initials>SK</Initials><AffiliationInfo><Affiliation>Institute of Clinical Medicine, Unit of Pathology, Faculty of Health Sciences, University of Eastern Finland, Kuopio, Finland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Kuopio University Hospital, Kuopio, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abdulraouf</LastName><ForeName>Abdulraouf</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Broad Institute of MIT and Harvard, Cambridge, MA 02142 USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marsh</LastName><ForeName>Samuel</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>F.M. Kirby Neurobiology Center, Boston Children's Hospital, Boston, MA 02115 USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Malm</LastName><ForeName>Tarja</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>A.I. Virtanen Institute for Molecular Sciences, Faculty of Health Sciences, University of Eastern Finland, Kuopio, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hiltunen</LastName><ForeName>Mikko</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute of Biomedicine, Faculty of Health Sciences, University of Eastern Finland, Kuopio, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nehme</LastName><ForeName>Ralda</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Broad Institute of MIT and Harvard, Cambridge, MA 02142 USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stevens</LastName><ForeName>Beth</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Broad Institute of MIT and Harvard, Cambridge, MA 02142 USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>F.M. Kirby Neurobiology Center, Boston Children's Hospital, Boston, MA 02115 USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Howard Hughes Medical Institute (HHMI), Boston, MA 02115 USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leinonen</LastName><ForeName>Ville</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Institute of Clinical Medicine, Unit of Pathology, Faculty of Health Sciences, University of Eastern Finland, Kuopio, Finland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurosurgery, Kuopio University Hospital, Kuopio, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Macosko</LastName><ForeName>Evan Z</ForeName><Initials>EZ</Initials><AffiliationInfo><Affiliation>Broad Institute of MIT and Harvard, Cambridge, MA 02142 USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Massachusetts General Hospital, Department of Psychiatry, Boston, MA 02114 USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>F30 AG069446</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 GM007753</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 GM144273</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D000076942">Preprint</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>06</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>bioRxiv</MedlineTA><NlmUniqueID>101680187</NlmUniqueID><ISSNLinking>2692-8205</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="UpdateIn"><RefSource>Cell. 2023 Sep 28;186(20):4438-4453.e23. doi: 10.1016/j.cell.2023.08.005.</RefSource><PMID Version="1">37774681</PMID></CommentsCorrections></CommentsCorrectionsList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>19</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>19</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>19</Day><Hour>2</Hour><Minute>48</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>6</Month><Day>16</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37333365</ArticleId><ArticleId IdType="pmc">PMC10274680</ArticleId><ArticleId IdType="doi">10.1101/2023.06.03.543569</ArticleId><ArticleId IdType="pii">2023.06.03.543569</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>De Strooper B., and Karran E. (2016). The Cellular Phase of Alzheimer&#x2019;s Disease. Cell 164, 603&#x2013;615.</Citation><ArticleIdList><ArticleId IdType="pubmed">26871627</ArticleId></ArticleIdList></Reference><Reference><Citation>Long J.M., and Holtzman D.M. (2019). Alzheimer Disease: An Update on Pathobiology and Treatment Strategies. Cell 179, 312&#x2013;339.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6778042</ArticleId><ArticleId IdType="pubmed">31564456</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathys H., Davila-Velderrain J., Peng Z., Gao F., Mohammadi S., Young J.Z., Menon M., He L., Abdurrob F., Jiang X., et al. (2019). Single-cell transcriptomic analysis of Alzheimer&#x2019;s disease. Nature 570, 332&#x2013;337.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6865822</ArticleId><ArticleId IdType="pubmed">31042697</ArticleId></ArticleIdList></Reference><Reference><Citation>Leng K., Li E., Eser R., Piergies A., Sit R., Tan M., Neff N., Li S.H., Rodriguez R.D., Suemoto C.K., et al. (2021). Molecular characterization of selectively vulnerable neurons in Alzheimer&#x2019;s disease. Nat. Neurosci. 24, 276&#x2013;287.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7854528</ArticleId><ArticleId IdType="pubmed">33432193</ArticleId></ArticleIdList></Reference><Reference><Citation>Lau S.-F., Cao H., Fu A.K.Y., and Ip N.Y. (2020). Single-nucleus transcriptome analysis reveals dysregulation of angiogenic endothelial cells and neuroprotective glia in Alzheimer&#x2019;s disease. Proc. Natl. Acad. Sci. U. S. A. 117, 25800&#x2013;25809.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7568283</ArticleId><ArticleId IdType="pubmed">32989152</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerrits E., Brouwer N., Kooistra S.M., Woodbury M.E., Vermeiren Y., Lambourne M., Mulder J., Kummer M., M&#xf6;ller T., Biber K., et al. (2021). Distinct amyloid-&#x3b2; and tau-associated microglia profiles in Alzheimer&#x2019;s disease. Acta Neuropathol. 141, 681&#x2013;696.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8043951</ArticleId><ArticleId IdType="pubmed">33609158</ArticleId></ArticleIdList></Reference><Reference><Citation>Otero-Garcia M., Mahajani S.U., Wakhloo D., Tang W., Xue Y.-Q., Morabito S., Pan J., Oberhauser J., Madira A.E., Shakouri T., et al. (2022). Molecular signatures underlying neurofibrillary tangle susceptibility in Alzheimer&#x2019;s disease. Neuron 110, 2929&#x2013;2948.e8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9509477</ArticleId><ArticleId IdType="pubmed">35882228</ArticleId></ArticleIdList></Reference><Reference><Citation>Marinaro F., Haneklaus M., Zhang Z., Strano A., Evans L., Handfield L.-F., Ryan N.S., Fox N.C., Hemberg M., Ramanathan S., et al. (2020). Molecular and cellular pathology of monogenic Alzheimer&#x2019;s disease at single cell resolution. bioRxiv, 2020.07.14.202317. 10.1101/2020.07.14.202317.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.07.14.202317</ArticleId></ArticleIdList></Reference><Reference><Citation>Kramvis I., Mansvelder H.D., and Meredith R.M. (2018). Neuronal life after death: electrophysiologic recordings from neurons in adult human brain tissue obtained through surgical resection or postmortem. Handb. Clin. Neurol. 150, 319&#x2013;333.</Citation><ArticleIdList><ArticleId IdType="pubmed">29496151</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo L., Rezvanian A., Kukreja L., Hoveydai R., Bigio E.H., Mesulam M.-M., El Khoury J., and Geula C. (2016). Postmortem Adult Human Microglia Proliferate in Culture to High Passage and Maintain Their Response to Amyloid-&#x3b2;. J. Alzheimers. Dis. 54, 1157&#x2013;1167.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5075451</ArticleId><ArticleId IdType="pubmed">27567845</ArticleId></ArticleIdList></Reference><Reference><Citation>De Groot C.J., Montagne L., Janssen I., Ravid R., Van Der Valk P., and Veerhuis R. (2000). Isolation and characterization of adult microglial cells and oligodendrocytes derived from postmortem human brain tissue. Brain Res. Brain Res. Protoc. 5, 85&#x2013;94.</Citation><ArticleIdList><ArticleId IdType="pubmed">10719269</ArticleId></ArticleIdList></Reference><Reference><Citation>Dachet F., Brown J.B., Valyi-Nagy T., Narayan K.D., Serafini A., Boley N., Gingeras T.R., Celniker S.E., Mohapatra G., and Loeb J.A. (2021). Selective time-dependent changes in activity and cell-specific gene expression in human postmortem brain. Sci. Rep. 11, 6078.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7988150</ArticleId><ArticleId IdType="pubmed">33758256</ArticleId></ArticleIdList></Reference><Reference><Citation>Luikku A.J., Hall A., Nerg O., Koivisto A.M., Hiltunen M., Helisalmi S., Herukka S.-K., Junkkari A., Sutela A., Kojoukhova M., et al. (2019). Predicting Development of Alzheimer&#x2019;s Disease in Patients with Shunted Idiopathic Normal Pressure Hydrocephalus. J. Alzheimers. Dis. 71, 1233&#x2013;1243.</Citation><ArticleIdList><ArticleId IdType="pubmed">31498122</ArticleId></ArticleIdList></Reference><Reference><Citation>Leinonen V., Koivisto A.M., Alafuzoff I., Pyykk&#xf6; O.T., Rummukainen J., von Und Zu Fraunberg, M., J&#xe4;&#xe4;skel&#xe4;inen J.E., Soininen H., Rinne J., and Savolainen S. (2012). Cortical brain biopsy in long-term prognostication of 468 patients with possible normal pressure hydrocephalus. Neurodegener. Dis. 10, 166&#x2013;169.</Citation><ArticleIdList><ArticleId IdType="pubmed">22343771</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamilton R., Patel S., Lee E.B., Jackson E.M., Lopinto J., Arnold S.E., Clark C.M., Basil A., Shaw L.M., Xie S.X., et al. (2010). Lack of shunt response in suspected idiopathic normal pressure hydrocephalus with Alzheimer disease pathology. Ann. Neurol. 68, 535&#x2013;540.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2964442</ArticleId><ArticleId IdType="pubmed">20687117</ArticleId></ArticleIdList></Reference><Reference><Citation>Seeburger J.L., Holder D.J., Combrinck M., Joachim C., Laterza O., Tanen M., Dallob A., Chappell D., Snyder K., Flynn M., et al. (2015). Cerebrospinal fluid biomarkers distinguish postmortem-confirmed Alzheimer&#x2019;s disease from other dementias and healthy controls in the OPTIMA cohort. J. Alzheimers. Dis. 44, 525&#x2013;539.</Citation><ArticleIdList><ArticleId IdType="pubmed">25391385</ArticleId></ArticleIdList></Reference><Reference><Citation>Strozyk D., Blennow K., White L.R., and Launer L.J. (2003). CSF Abeta 42 levels correlate with amyloid-neuropathology in a population-based autopsy study. Neurology 60, 652&#x2013;656.</Citation><ArticleIdList><ArticleId IdType="pubmed">12601108</ArticleId></ArticleIdList></Reference><Reference><Citation>Welch J.D., Kozareva V., Ferreira A., Vanderburg C., Martin C., and Macosko E.Z. (2019). Single-Cell Multi-omic Integration Compares and Contrasts Features of Brain Cell Identity. Cell 177, 1873&#x2013;1887.e17.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6716797</ArticleId><ArticleId IdType="pubmed">31178122</ArticleId></ArticleIdList></Reference><Reference><Citation>Marsh S.E., Walker A.J., Kamath T., Dissing-Olesen L., Hammond T.R., de Soysa T.Y., Young A.M.H., Murphy S., Abdulraouf A., Nadaf N., et al. (2022). Dissection of artifactual and confounding glial signatures by single-cell sequencing of mouse and human brain. Nat. Neurosci. 25, 306&#x2013;316.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11645269</ArticleId><ArticleId IdType="pubmed">35260865</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y.E., Pan L., Zuo Y., Li X., and Hong W. (2017). Detecting Activated Cell Populations Using Single-Cell RNA-Seq. Neuron 96, 313&#x2013;329.e6.</Citation><ArticleIdList><ArticleId IdType="pubmed">29024657</ArticleId></ArticleIdList></Reference><Reference><Citation>Bakken T.E., Jorstad N.L., Hu Q., Lake B.B., Tian W., Kalmbach B.E., Crow M., Hodge R.D., Krienen F.M., Sorensen S.A., et al. (2021). Comparative cellular analysis of motor cortex in human, marmoset and mouse. Nature 598, 111&#x2013;119.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8494640</ArticleId><ArticleId IdType="pubmed">34616062</ArticleId></ArticleIdList></Reference><Reference><Citation>Habib N., McCabe C., Medina S., Varshavsky M., Kitsberg D., Dvir-Szternfeld R., Green G., Dionne D., Nguyen L., Marshall J.L., et al. (2020). Disease-associated astrocytes in Alzheimer&#x2019;s disease and aging. Nat. Neurosci. 23, 701&#x2013;706.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9262034</ArticleId><ArticleId IdType="pubmed">32341542</ArticleId></ArticleIdList></Reference><Reference><Citation>Tyssowski K.M., DeStefino N.R., Cho J.-H., Dunn C.J., Poston R.G., Carty C.E., Jones R.D., Chang S.M., Romeo P., Wurzelmann M.K., et al. (2018). Different Neuronal Activity Patterns Induce Different Gene Expression Programs. Neuron 98, 530&#x2013;546.e11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5934296</ArticleId><ArticleId IdType="pubmed">29681534</ArticleId></ArticleIdList></Reference><Reference><Citation>Ibrahim L.A., Huang S., Fernandez-Otero M., Sherer M., Qiu Y., Vemuri S., Xu Q., Machold R., Pouchelon G., Rudy B., et al. (2021). Bottom-up inputs are required for establishment of top-down connectivity onto cortical layer 1 neurogliaform cells. Neuron 109, 3473&#x2013;3485.e5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9316418</ArticleId><ArticleId IdType="pubmed">34478630</ArticleId></ArticleIdList></Reference><Reference><Citation>Malina K.C.-K., Tsivourakis E., Kushinsky D., Apelblat D., Shtiglitz S., Zohar E., Sokoletsky M., Tasaka G.-I., Mizrahi A., Lampl I., et al. (2021). NDNF interneurons in layer 1 gain-modulate whole cortical columns according to an animal&#x2019;s behavioral state. Neuron. 10.1016/j.neuron.2021.05.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2021.05.001</ArticleId><ArticleId IdType="pubmed">34038743</ArticleId></ArticleIdList></Reference><Reference><Citation>West A.E., and Greenberg M.E. (2011). Neuronal activity-regulated gene transcription in synapse development and cognitive function. Cold Spring Harb. Perspect. Biol. 3. 10.1101/cshperspect.a005744.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a005744</ArticleId><ArticleId IdType="pmc">PMC3098681</ArticleId><ArticleId IdType="pubmed">21555405</ArticleId></ArticleIdList></Reference><Reference><Citation>Turrigiano G.G. (2008). The self-tuning neuron: synaptic scaling of excitatory synapses. Cell 135, 422&#x2013;435.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2834419</ArticleId><ArticleId IdType="pubmed">18984155</ArticleId></ArticleIdList></Reference><Reference><Citation>Verderio C., Pozzi D., Pravettoni E., Inverardi F., Schenk U., Coco S., Proux-Gillardeaux V., Galli T., Rossetto O., Frassoni C., et al. (2004). SNAP-25 modulation of calcium dynamics underlies differences in GABAergic and glutamatergic responsiveness to depolarization. Neuron 41, 599&#x2013;610.</Citation><ArticleIdList><ArticleId IdType="pubmed">14980208</ArticleId></ArticleIdList></Reference><Reference><Citation>Pozzi D., Condliffe S., Bozzi Y., Chikhladze M., Grumelli C., Proux-Gillardeaux V., Takahashi M., Franceschetti S., Verderio C., and Matteoli M. (2008). Activity-dependent phosphorylation of Ser187 is required for SNAP-25-negative modulation of neuronal voltage-gated calcium channels. Proc. Natl. Acad. Sci. U. S. A. 105, 323&#x2013;328.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2224210</ArticleId><ArticleId IdType="pubmed">18162553</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim S.H., and Ryan T.A. (2010). CDK5 serves as a major control point in neurotransmitter release. Neuron 67, 797&#x2013;809.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2939042</ArticleId><ArticleId IdType="pubmed">20826311</ArticleId></ArticleIdList></Reference><Reference><Citation>Cirrito J.R., Yamada K.A., Finn M.B., Sloviter R.S., Bales K.R., May P.C., Schoepp D.D., Paul S.M., Mennerick S., and Holtzman D.M. (2005). Synaptic activity regulates interstitial fluid amyloid-beta levels in vivo. Neuron 48, 913&#x2013;922.</Citation><ArticleIdList><ArticleId IdType="pubmed">16364896</ArticleId></ArticleIdList></Reference><Reference><Citation>Li S., and Selkoe D.J. (2020). A mechanistic hypothesis for the impairment of synaptic plasticity by soluble <mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" display="inline"><mml:mi mathvariant="normal">A</mml:mi><mml:mi mathvariant="normal">&#x3b2;</mml:mi></mml:math> oligomers from Alzheimer&#x2019;s brain. J. Neurochem. 154, 583&#x2013;597.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7487043</ArticleId><ArticleId IdType="pubmed">32180217</ArticleId></ArticleIdList></Reference><Reference><Citation>Zott B., Simon M.M., Hong W., Unger F., Chen-Engerer H.-J., Frosch M.P., Sakmann B., Walsh D.M., and Konnerth A. (2019). A vicious cycle of &#x3b2; amyloid-dependent neuronal hyperactivation. Science 365, 559&#x2013;565.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6690382</ArticleId><ArticleId IdType="pubmed">31395777</ArticleId></ArticleIdList></Reference><Reference><Citation>Ioannou M.S., Jackson J., Sheu S.-H., Chang C.-L., Weigel A.V., Liu H., Pasolli H.A., Xu C.S., Pang S., Matthies D., et al. (2019). Neuron-Astrocyte Metabolic Coupling Protects against Activity-Induced Fatty Acid Toxicity. Cell 177, 1522&#x2013;1535.e14.</Citation><ArticleIdList><ArticleId IdType="pubmed">31130380</ArticleId></ArticleIdList></Reference><Reference><Citation>Wightman D.P., Jansen I.E., Savage J.E., Shadrin A.A., Bahrami S., Holland D., Rongve A., B&#xf8;rte S., Winsvold B.S., Drange O.K., et al. (2021). A genome-wide association study with 1,126,563 individuals identifies new risk loci for Alzheimer&#x2019;s disease. Nat. Genet. 53, 1276&#x2013;1282.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10243600</ArticleId><ArticleId IdType="pubmed">34493870</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellenguez C., K&#xfc;&#xe7;&#xfc;kali F., Jansen I.E., Kleineidam L., Moreno-Grau S., Amin N., Naj A.C., Campos-Martin R., Grenier-Boley B., Andrade V., et al. (2022). New insights into the genetic etiology of Alzheimer&#x2019;s disease and related dementias. Nat. Genet. 54, 412&#x2013;436.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9005347</ArticleId><ArticleId IdType="pubmed">35379992</ArticleId></ArticleIdList></Reference><Reference><Citation>Jansen I.E., Savage J.E., Watanabe K., Bryois J., Williams D.M., Steinberg S., Sealock J., Karlsson I.K., H&#xe4;gg S., Athanasiu L., et al. (2019). Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer&#x2019;s disease risk. Nat. Genet. 51, 404&#x2013;413.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6836675</ArticleId><ArticleId IdType="pubmed">30617256</ArticleId></ArticleIdList></Reference><Reference><Citation>Mich J.K., Graybuck L.T., Hess E.E., Mahoney J.T., Kojima Y., Ding Y., Somasundaram S., Miller J.A., Kalmbach B.E., Radaelli C., et al. (2021). Functional enhancer elements drive subclass-selective expression from mouse to primate neocortex. Cell Rep. 34, 108754.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8163032</ArticleId><ArticleId IdType="pubmed">33789096</ArticleId></ArticleIdList></Reference><Reference><Citation>Keren-Shaul H., Spinrad A., Weiner A., Matcovitch-Natan O., Dvir-Szternfeld R., Ulland T.K., David E., Baruch K., Lara-Astaiso D., Toth B., et al. (2017). A Unique Microglia Type Associated with Restricting Development of Alzheimer&#x2019;s Disease. Cell 169, 1276&#x2013;1290.e17.</Citation><ArticleIdList><ArticleId IdType="pubmed">28602351</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Q., Cheng Z., Zhou L., Darmanis S., Neff N.F., Okamoto J., Gulati G., Bennett M.L., Sun L.O., Clarke L.E., et al. (2019). Developmental Heterogeneity of Microglia and Brain Myeloid Cells Revealed by Deep Single-Cell RNA Sequencing. Neuron 101, 207&#x2013;223.e10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6336504</ArticleId><ArticleId IdType="pubmed">30606613</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopes K. de P., Snijders G.J.L., Humphrey J., Allan A., Sneeboer M.A.M., Navarro E., Schilder B.M., Vialle R.A., Parks M., Missall R., et al. (2022). Genetic analysis of the human microglial transcriptome across brain regions, aging and disease pathologies. Nat. Genet. 54, 4&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9245609</ArticleId><ArticleId IdType="pubmed">34992268</ArticleId></ArticleIdList></Reference><Reference><Citation>de Leeuw C.A., Mooij J.M., Heskes T., and Posthuma D. (2015). MAGMA: generalized gene-set analysis of GWAS data. PLoS Comput. Biol. 11, e1004219.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4401657</ArticleId><ArticleId IdType="pubmed">25885710</ArticleId></ArticleIdList></Reference><Reference><Citation>Gomez-Nicola D., Valle-Argos B., and Nieto-Sampedro M. (2010). Blockade of IL-15 activity inhibits microglial activation through the NFkappaB, p38, and ERK1/2 pathways, reducing cytokine and chemokine release. Glia 58, 264&#x2013;276.</Citation><ArticleIdList><ArticleId IdType="pubmed">19610094</ArticleId></ArticleIdList></Reference><Reference><Citation>Matejuk A., and Ransohoff R.M. (2020). Crosstalk Between Astrocytes and Microglia: An Overview. Frontiers in Immunology 11. 10.3389/fimmu.2020.01416.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.01416</ArticleId><ArticleId IdType="pmc">PMC7378357</ArticleId><ArticleId IdType="pubmed">32765501</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi S.X., Li Y.-J., Shi K., Wood K., Ducruet A.F., and Liu Q. (2020). IL (Interleukin)-15 Bridges Astrocyte-Microglia Crosstalk and Exacerbates Brain Injury Following Intracerebral Hemorrhage. Stroke 51, 967&#x2013;974.</Citation><ArticleIdList><ArticleId IdType="pubmed">32019481</ArticleId></ArticleIdList></Reference><Reference><Citation>Supek F., Bo&#x161;njak M., &#x160;kunca N., and &#x160;muc T. (2011). REVIGO summarizes and visualizes long lists of gene ontology terms. PLoS One 6, e21800.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3138752</ArticleId><ArticleId IdType="pubmed">21789182</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamath T., Abdulraouf A., Burris S.J., Langlieb J., Gazestani V., Nadaf N.M., Balderrama K., Vanderburg C., and Macosko E.Z. (2022). Single-cell genomic profiling of human dopamine neurons identifies a population that selectively degenerates in Parkinson&#x2019;s disease. Nat. Neurosci. 25, 588&#x2013;595.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9076534</ArticleId><ArticleId IdType="pubmed">35513515</ArticleId></ArticleIdList></Reference><Reference><Citation>Smaji&#x107; S., Prada-Medina C.A., Landoulsi Z., Ghelfi J., Delcambre S., Dietrich C., Jarazo J., Henck J., Balachandran S., Pachchek S., et al. (2022). Single-cell sequencing of human midbrain reveals glial activation and a Parkinson-specific neuronal state. Brain 145, 964&#x2013;978.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9050543</ArticleId><ArticleId IdType="pubmed">34919646</ArticleId></ArticleIdList></Reference><Reference><Citation>Velmeshev D., Schirmer L., Jung D., Haeussler M., Perez Y., Mayer S., Bhaduri A., Goyal N., Rowitch D.H., and Kriegstein A.R. (2019). Single-cell genomics identifies cell type-specific molecular changes in autism. Science 364, 685&#x2013;689.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7678724</ArticleId><ArticleId IdType="pubmed">31097668</ArticleId></ArticleIdList></Reference><Reference><Citation>J&#xe4;kel S., Agirre E., Mendanha Falc&#xe3;o A., van Bruggen D., Lee K.W., Knuesel I., Malhotra D., Ffrench-Constant C., Williams A., and Castelo-Branco G. (2019). Altered human oligodendrocyte heterogeneity in multiple sclerosis. Nature 566, 543&#x2013;547.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6544546</ArticleId><ArticleId IdType="pubmed">30747918</ArticleId></ArticleIdList></Reference><Reference><Citation>Abs E., Poorthuis R.B., Apelblat D., Muhammad K., Pardi M.B., Enke L., Kushinsky D., Pu D.-L., Eizinger M.F., Conzelmann K.-K., et al. (2018). Learning-Related Plasticity in Dendrite-Targeting Layer 1 Interneurons. Neuron 100, 684&#x2013;699.e6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6226614</ArticleId><ArticleId IdType="pubmed">30269988</ArticleId></ArticleIdList></Reference><Reference><Citation>Mercier M.S., Magloire V., Cornford J.H., and Kullmann D.M. (2022). Long-term potentiation in neurogliaform interneurons modulates excitation-inhibition balance in the temporoammonic pathway. J. Physiol. 600, 4001&#x2013;4017.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9540908</ArticleId><ArticleId IdType="pubmed">35876215</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah D., Gsell W., Wahis J., Luckett E.S., Jamoulle T., Vermaercke B., Preman P., Moechars D., Hendrickx V., Jaspers T., et al. (2022). Astrocyte calcium dysfunction causes early network hyperactivity in Alzheimer&#x2019;s disease. Cell Rep. 40, 111280.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9433881</ArticleId><ArticleId IdType="pubmed">36001964</ArticleId></ArticleIdList></Reference><Reference><Citation>Busche M.A., Eichhoff G., Adelsberger H., Abramowski D., Wiederhold K.-H., Haass C., Staufenbiel M., Konnerth A., and Garaschuk O. (2008). Clusters of hyperactive neurons near amyloid plaques in a mouse model of Alzheimer&#x2019;s disease. Science 321, 1686&#x2013;1689.</Citation><ArticleIdList><ArticleId IdType="pubmed">18802001</ArticleId></ArticleIdList></Reference><Reference><Citation>Tarasoff-Conway J.M., Carare R.O., Osorio R.S., Glodzik L., Butler T., Fieremans E., Axel L., Rusinek H., Nicholson C., Zlokovic B.V., et al. (2015). Clearance systems in the brain&#x2014;implications for Alzheimer disease. Nature Reviews Neurology 11, 457&#x2013;470. 10.1038/nrneurol.2015.119.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2015.119</ArticleId><ArticleId IdType="pmc">PMC4694579</ArticleId><ArticleId IdType="pubmed">26195256</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi I., Zhang Y., Seegobin S.P., Pruvost M., Wang Q., Purtell K., Zhang B., and Yue Z. (2020). Microglia clear neuron-released &#x3b1;-synuclein via selective autophagy and prevent neurodegeneration. Nat. Commun. 11, 1386.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7069981</ArticleId><ArticleId IdType="pubmed">32170061</ArticleId></ArticleIdList></Reference><Reference><Citation>Wyss-Coray T., Lin C., Yan F., Yu G.Q., Rohde M., McConlogue L., Masliah E., and Mucke L. (2001). TGF-beta1 promotes microglial amyloid-beta clearance and reduces plaque burden in transgenic mice. Nat. Med. 7, 612&#x2013;618.</Citation><ArticleIdList><ArticleId IdType="pubmed">11329064</ArticleId></ArticleIdList></Reference><Reference><Citation>Brionne T.C., Tesseur I., Masliah E., and Wyss-Coray T. (2003). Loss of TGF-beta 1 leads to increased neuronal cell death and microgliosis in mouse brain. Neuron 40, 1133&#x2013;1145.</Citation><ArticleIdList><ArticleId IdType="pubmed">14687548</ArticleId></ArticleIdList></Reference><Reference><Citation>Dolan M.-J., Therrien M., Jereb S., Kamath T., Atkeson T., Marsh S.E., Goeva A., Lojek N.M., Murphy S., White C.M., et al. (2022). A resource for generating and manipulating human microglial states in vitro. bioRxiv, 2022.05.02.490100. 10.1101/2022.05.02.490100.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.05.02.490100</ArticleId></ArticleIdList></Reference><Reference><Citation>Bateman R.J., Xiong C., Benzinger T.L.S., Fagan A.M., Goate A., Fox N.C., Marcus D.S., Cairns N.J., Xie X., Blazey T.M., et al. (2012). Clinical and biomarker changes in dominantly inherited Alzheimer&#x2019;s disease. N. Engl. J. Med. 367, 795&#x2013;804.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3474597</ArticleId><ArticleId IdType="pubmed">22784036</ArticleId></ArticleIdList></Reference><Reference><Citation>Veeraraghavalu K., Zhang C., Zhang X., Tanzi R.E., and Sisodia S.S. (2014). Age-dependent, non-cell-autonomous deposition of amyloid from synthesis of &#x3b2;-amyloid by cells other than excitatory neurons. J. Neurosci. 34, 3668&#x2013;3673.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3942582</ArticleId><ArticleId IdType="pubmed">24599465</ArticleId></ArticleIdList></Reference><Reference><Citation>Skaper S.D., Evans N.A., Evans N.A., Rosin C., Facci L., and Richardson J.C. (2009). Oligodendrocytes are a novel source of amyloid peptide generation. Neurochem. Res. 34, 2243&#x2013;2250.</Citation><ArticleIdList><ArticleId IdType="pubmed">19557514</ArticleId></ArticleIdList></Reference><Reference><Citation>Braak H., and Braak E. (1996). Development of Alzheimer-related neurofibrillary changes in the neocortex inversely recapitulates cortical myelogenesis. Acta Neuropathol. 92, 197&#x2013;201.</Citation><ArticleIdList><ArticleId IdType="pubmed">8841666</ArticleId></ArticleIdList></Reference><Reference><Citation>Bartzokis G., Lu P.H., and Mintz J. (2007). Human brain myelination and amyloid beta deposition in Alzheimer&#x2019;s disease. Alzheimers. Dement. 3, 122&#x2013;125.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2442864</ArticleId><ArticleId IdType="pubmed">18596894</ArticleId></ArticleIdList></Reference><Reference><Citation>Collins-Praino L.E., Francis Y.I., Griffith E.Y., Wiegman A.F., Urbach J., Lawton A., Honig L.S., Cortes E., Vonsattel J.P.G., Canoll P.D., et al. (2014). Soluble amyloid beta levels are elevated in the white matter of Alzheimer&#x2019;s patients, independent of cortical plaque severity. Acta Neuropathol Commun 2, 83.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4147157</ArticleId><ArticleId IdType="pubmed">25129614</ArticleId></ArticleIdList></Reference><Reference><Citation>Junkkari A., Luikku A.J., Danner N., Jyrkk&#xe4;nen H.K., Rauramaa T., Korhonen V.E., Koivisto A.M., Nerg O., Kojoukhova M., Huttunen T.J., et al. (2019). The Kuopio idiopathic normal pressure hydrocephalus protocol: initial outcome of 175 patients. Fluids Barriers CNS 16, 21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6657079</ArticleId><ArticleId IdType="pubmed">31340831</ArticleId></ArticleIdList></Reference><Reference><Citation>Sepp&#xe4;l&#xe4; T.T., Nerg O., Koivisto A.M., Rummukainen J., Puli L., Zetterberg H., Pyykk&#xf6; O.T., Helisalmi S., Alafuzoff I., Hiltunen M., et al. (2012). CSF biomarkers for Alzheimer disease correlate with cortical brain biopsy findings. Neurology 78, 1568&#x2013;1575.</Citation><ArticleIdList><ArticleId IdType="pubmed">22517093</ArticleId></ArticleIdList></Reference><Reference><Citation>Leinonen V., Koivisto A.M., Savolainen S., Rummukainen J., Sutela A., Vanninen R., J&#xe4;&#xe4;skel&#xe4;inen J.E., Soininen H., and Alafuzoff I. (2012). Post-mortem findings in 10 patients with presumed normal-pressure hydrocephalus and review of the literature. Neuropathol. Appl. Neurobiol. 38, 72&#x2013;86.</Citation><ArticleIdList><ArticleId IdType="pubmed">21696417</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans A.C., Janke A.L., Collins D.L., and Baillet S. (2012). Brain templates and atlases. Neuroimage 62, 911&#x2013;922.</Citation><ArticleIdList><ArticleId IdType="pubmed">22248580</ArticleId></ArticleIdList></Reference><Reference><Citation>Eickhoff S.B., Stephan K.E., Mohlberg H., Grefkes C., Fink G.R., Amunts K., and Zilles K. (2005). A new SPM toolbox for combining probabilistic cytoarchitectonic maps and functional imaging data. Neuroimage 25, 1325&#x2013;1335.</Citation><ArticleIdList><ArticleId IdType="pubmed">15850749</ArticleId></ArticleIdList></Reference><Reference><Citation>Amunts K., Mohlberg H., Bludau S., and Zilles K. (2020). Julich-Brain: A 3D probabilistic atlas of the human brain&#x2019;s cytoarchitecture. Science 369, 988&#x2013;992. 10.1126/science.abb4588.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abb4588</ArticleId><ArticleId IdType="pubmed">32732281</ArticleId></ArticleIdList></Reference><Reference><Citation>Kubo Y., Kazui H., Yoshida T., Kito Y., Kimura N., Tokunaga H., Ogino A., Miyake H., Ishikawa M., and Takeda M. (2008). Validation of grading scale for evaluating symptoms of idiopathic normal-pressure hydrocephalus. Dement. Geriatr. Cogn. Disord. 25, 37&#x2013;45.</Citation><ArticleIdList><ArticleId IdType="pubmed">18025828</ArticleId></ArticleIdList></Reference><Reference><Citation>Fleming S.J., Chaffin M.D., Arduini A., Akkad A.-D., Banks E., Marioni J.C., Philippakis A.A., Ellinor P.T., and Babadi M. (2019). Unsupervised removal of systematic background noise from droplet-based single-cell experiments using CellBender. bioRxiv. 10.1101/791699.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/791699</ArticleId><ArticleId IdType="pubmed">37550580</ArticleId></ArticleIdList></Reference><Reference><Citation>Hammond T.R., Dufort C., Dissing-Olesen L., Giera S., Young A., Wysoker A., Walker A.J., Gergits F., Segel M., Nemesh J., et al. (2019). Single-Cell RNA Sequencing of Microglia throughout the Mouse Lifespan and in the Injured Brain Reveals Complex Cell-State Changes. Immunity 50, 253&#x2013;271.e6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6655561</ArticleId><ArticleId IdType="pubmed">30471926</ArticleId></ArticleIdList></Reference><Reference><Citation>Blake J.A., Baldarelli R., Kadin J.A., Richardson J.E., Smith C.L., Bult C.J., and Mouse Genome Database Group (2021). Mouse Genome Database (MGD): Knowledgebase for mouse-human comparative biology. Nucleic Acids Res. 49, D981&#x2013;D987.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7779030</ArticleId><ArticleId IdType="pubmed">33231642</ArticleId></ArticleIdList></Reference><Reference><Citation>Stuart T., Butler A., Hoffman P., Hafemeister C., Papalexi E., Mauck W.M. 3rd, Hao Y., Stoeckius M., Smibert P., and Satija R. (2019). Comprehensive Integration of Single-Cell Data. Cell 177, 1888&#x2013;1902.e21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6687398</ArticleId><ArticleId IdType="pubmed">31178118</ArticleId></ArticleIdList></Reference><Reference><Citation>Baglaenko Y., Brenner M., Loh P., and Raychaudhuri S. (2019). Fast, sensitive and accurate integration of single-cell data with Harmony. Nature.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6884693</ArticleId><ArticleId IdType="pubmed">31740819</ArticleId></ArticleIdList></Reference><Reference><Citation>van Dijk D., Sharma R., Nainys J., Yim K., Kathail P., Carr A.J., Burdziak C., Moon K.R., Chaffer C.L., Pattabiraman D., et al. (2018). Recovering Gene Interactions from Single-Cell Data Using Data Diffusion. Cell 174, 716&#x2013;729.e27.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6771278</ArticleId><ArticleId IdType="pubmed">29961576</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y., Song W.M., Andhey P.S., Swain A., Levy T., Miller K.R., Poliani P.L., Cominelli M., Grover S., Gilfillan S., et al. (2020). Human and mouse single-nucleus transcriptomics reveal TREM2-dependent and TREM2-independent cellular responses in Alzheimer&#x2019;s disease. Nat. Med. 26, 131&#x2013;142.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6980793</ArticleId><ArticleId IdType="pubmed">31932797</ArticleId></ArticleIdList></Reference><Reference><Citation>Fonseka C.Y., Rao D.A., Teslovich N.C., Korsunsky I., Hannes S.K., Slowikowski K., Gurish M.F., Donlin L.T., Lederer J.A., Weinblatt M.E., et al. (2018). Mixed-effects association of single cells identifies an expanded effector CD4+ T cell subset in rheumatoid arthritis. Sci. Transl. Med. 10. 10.1126/scitranslmed.aaq0305.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.aaq0305</ArticleId><ArticleId IdType="pmc">PMC6448773</ArticleId><ArticleId IdType="pubmed">30333237</ArticleId></ArticleIdList></Reference><Reference><Citation>Zimmerman K.D., Espeland M.A., and Langefeld C.D. (2021). A practical solution to pseudoreplication bias in single-cell studies. Nat. Commun. 12, 738.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7854630</ArticleId><ArticleId IdType="pubmed">33531494</ArticleId></ArticleIdList></Reference><Reference><Citation>Law C.W., Chen Y., Shi W., and Smyth G.K. (2014). voom: Precision weights unlock linear model analysis tools for RNA-seq read counts. Genome Biol. 15, R29.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4053721</ArticleId><ArticleId IdType="pubmed">24485249</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen E.Y., Tan C.M., Kou Y., Duan Q., Wang Z., Meirelles G.V., Clark N.R., and Ma&#x2019;ayan A. (2013). Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool. BMC Bioinformatics 14, 128.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3637064</ArticleId><ArticleId IdType="pubmed">23586463</ArticleId></ArticleIdList></Reference><Reference><Citation>Korotkevich G., Sukhov V., Budin N., Shpak B., Artyomov M.N., and Sergushichev A. Fast gene set enrichment analysis. 10.1101/060012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/060012</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding J., Adiconis X., Simmons S.K., Kowalczyk M.S., Hession C.C., Marjanovic N.D., Hughes T.K., Wadsworth M.H., Burks T., Nguyen L.T., et al. (2020). Systematic comparison of single-cell and single-nucleus RNA-sequencing methods. Nat. Biotechnol. 38, 737&#x2013;746.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7289686</ArticleId><ArticleId IdType="pubmed">32341560</ArticleId></ArticleIdList></Reference><Reference><Citation>Langfelder P., and Horvath S. (2008). WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics 9, 559.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2631488</ArticleId><ArticleId IdType="pubmed">19114008</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalls M.A., Blauwendraat C., Vallerga C.L., Heilbron K., Bandres-Ciga S., Chang D., Tan M., Kia D.A., Noyce A.J., Xue A., et al. (2019). Identification of novel risk loci, causal insights, and heritable risk for Parkinson&#x2019;s disease: a meta-analysis of genome-wide association studies. Lancet Neurol. 18, 1091&#x2013;1102.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8422160</ArticleId><ArticleId IdType="pubmed">31701892</ArticleId></ArticleIdList></Reference><Reference><Citation>Grove J., Ripke S., Als T.D., Mattheisen M., Walters R.K., Won H., Pallesen J., Agerbo E., Andreassen O.A., Anney R., et al. (2019). Identification of common genetic risk variants for autism spectrum disorder. Nat. Genet. 51, 431&#x2013;444.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6454898</ArticleId><ArticleId IdType="pubmed">30804558</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe K., Mirkov M.U., de Leeuw C.A., van den Heuvel M.P., and Posthuma D. (2019). Genetic mapping of cell type specificity for complex traits. Nat. Commun. 10, 1&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6642112</ArticleId><ArticleId IdType="pubmed">31324783</ArticleId></ArticleIdList></Reference><Reference><Citation>Garc&#xed;a-Le&#xf3;n J.A., Garc&#xed;a-D&#xed;az B., Eggermont K., C&#xe1;ceres-Palomo L., Neyrinck K., Madeiro da Costa R., D&#xe1;vila J.C., Baron-Van Evercooren A., Guti&#xe9;rrez A., and Verfaillie C.M. (2020). Generation of oligodendrocytes and establishment of an all-human myelinating platform from human pluripotent stem cells. Nat. Protoc. 15, 3716&#x2013;3744.</Citation><ArticleIdList><ArticleId IdType="pubmed">33097924</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandopulle M.S., Prestil R., Grunseich C., Wang C., Gan L., and Ward M.E. (2018). Transcription Factor-Mediated Differentiation of Human iPSCs into Neurons. Curr. Protoc. Cell Biol. 79, e51.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6993937</ArticleId><ArticleId IdType="pubmed">29924488</ArticleId></ArticleIdList></Reference><Reference><Citation>Nehme R., Zuccaro E., Ghosh S.D., Li C., Sherwood J.L., Pietilainen O., Barrett L.E., Limone F., Worringer K.A., Kommineni S., et al. (2018). Combining NGN2 Programming with Developmental Patterning Generates Human Excitatory Neurons with NMDAR-Mediated Synaptic Transmission. Cell Rep. 23, 2509&#x2013;2523.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6003669</ArticleId><ArticleId IdType="pubmed">29791859</ArticleId></ArticleIdList></Reference><Reference><Citation>Busskamp V., Lewis N.E., Guye P., Ng A.H.M., Shipman S.L., Byrne S.M., Sanjana N.E., Murn J., Li Y., Li S., et al. (2014). Rapid neurogenesis through transcriptional activation in human stem cells. Mol. Syst. Biol. 10, 760.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4299601</ArticleId><ArticleId IdType="pubmed">25403753</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y., Pak C., Han Y., Ahlenius H., Zhang Z., Chanda S., Marro S., Patzke C., Acuna C., Covy J., et al. (2013). Rapid single-step induction of functional neurons from human pluripotent stem cells. Neuron 78, 785&#x2013;798.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3751803</ArticleId><ArticleId IdType="pubmed">23764284</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Giorgio F.P., Boulting G.L., Bobrowicz S., and Eggan K.C. (2008). Human embryonic stem cell-derived motor neurons are sensitive to the toxic effect of glial cells carrying an ALS-causing mutation. Cell Stem Cell 3, 637&#x2013;648.</Citation><ArticleIdList><ArticleId IdType="pubmed">19041780</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37385246</PMID><DateCompleted><Year>2023</Year><Month>09</Month><Day>11</Day></DateCompleted><DateRevised><Year>2023</Year><Month>09</Month><Day>12</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1097-4199</ISSN><JournalIssue CitedMedium="Internet"><Volume>111</Volume><Issue>17</Issue><PubDate><Year>2023</Year><Month>Sep</Month><Day>06</Day></PubDate></JournalIssue><Title>Neuron</Title><ISOAbbreviation>Neuron</ISOAbbreviation></Journal><ArticleTitle>Increased G3BP2-Tau interaction in tauopathies is a natural defense against Tau aggregation.</ArticleTitle><Pagination><StartPage>2660</StartPage><EndPage>2674.e9</EndPage><MedlinePgn>2660-2674.e9</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.neuron.2023.05.033</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0896-6273(23)00434-8</ELocationID><Abstract><AbstractText>Many RNA-binding proteins (RBPs), particularly those associated with RNA granules, promote pathological protein aggregation in neurodegenerative diseases. Here, we demonstrate that G3BP2, a core component of stress granules, directly interacts with Tau and inhibits Tau aggregation. In the human brain, the interaction of G3BP2 and Tau is dramatically increased in multiple tauopathies, and it is independent of neurofibrillary tangle (NFT) formation in Alzheimer's disease (AD). Surprisingly, Tau pathology is significantly elevated upon loss of G3BP2 in human neurons and brain organoids. Moreover, we found that G3BP2 masks the microtubule-binding region (MTBR) of Tau, thereby inhibiting Tau aggregation. Our study defines a novel role for RBPs as a line of defense against Tau aggregation in tauopathies.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 The Authors. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Congwei</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Roche Pharma Research and Early Development, Roche Innovation Center Basel, 4070 Basel, Switzerland. Electronic address: congwei.wang@roche.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Terrigno</LastName><ForeName>Marco</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Roche Pharma Research and Early Development, Roche Innovation Center Basel, 4070 Basel, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Juan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>School of Life Sciences, University of Science and Technology of China, 230026 Anhui, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Distler</LastName><ForeName>Tania</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Roche Pharma Research and Early Development, Roche Innovation Center Basel, 4070 Basel, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pandya</LastName><ForeName>Nikhil J</ForeName><Initials>NJ</Initials><AffiliationInfo><Affiliation>Roche Pharma Research and Early Development, Roche Innovation Center Basel, 4070 Basel, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ebeling</LastName><ForeName>Martin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Roche Pharma Research and Early Development, Roche Innovation Center Basel, 4070 Basel, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tyanova</LastName><ForeName>Stefka</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Roche Pharma Research and Early Development, Roche Innovation Center Basel, 4070 Basel, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hoozemans</LastName><ForeName>Jeroen J M</ForeName><Initials>JJM</Initials><AffiliationInfo><Affiliation>Department of Pathology, Amsterdam Neuroscience, Amsterdam University Medical Centers, 1081 HV Amsterdam, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dijkstra</LastName><ForeName>Anke A</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>Department of Pathology, Amsterdam Neuroscience, Amsterdam University Medical Centers, 1081 HV Amsterdam, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fuchs</LastName><ForeName>Luisa</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Roche Pharma Research and Early Development, Roche Innovation Center Basel, 4070 Basel, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xiang</LastName><ForeName>Shengqi</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>School of Life Sciences, University of Science and Technology of China, 230026 Anhui, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bonni</LastName><ForeName>Azad</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Roche Pharma Research and Early Development, Roche Innovation Center Basel, 4070 Basel, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gr&#xfc;ninger</LastName><ForeName>Fiona</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Roche Pharma Research and Early Development, Roche Innovation Center Basel, 4070 Basel, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jagasia</LastName><ForeName>Ravi</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Roche Pharma Research and Early Development, Roche Innovation Center Basel, 4070 Basel, Switzerland. Electronic address: ravi.jagasia@roche.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>06</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Neuron</MedlineTA><NlmUniqueID>8809320</NlmUniqueID><ISSNLinking>0896-6273</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016875">tau Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016601">RNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C574606">G3BP2 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D048868">Adaptor Proteins, Signal Transducing</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Neuron. 2023 Sep 6;111(17):2617-2619. doi: 10.1016/j.neuron.2023.08.001.</RefSource><PMID Version="1">37678165</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016875" MajorTopicYN="N">tau Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D024801" MajorTopicYN="Y">Tauopathies</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009474" MajorTopicYN="N">Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016601" MajorTopicYN="N">RNA-Binding Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D048868" MajorTopicYN="N">Adaptor Proteins, Signal Transducing</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Alzheimer&#x2019;s disease</Keyword><Keyword MajorTopicYN="N">G3BP2</Keyword><Keyword MajorTopicYN="N">RBP</Keyword><Keyword MajorTopicYN="N">Tau aggregation</Keyword><Keyword MajorTopicYN="N">tauopathies</Keyword></KeywordList><CoiStatement>Declaration of interests C.W., M.T., N.J.P., T.D., M.E., S.T., L.F., A.B., R.J., and F.G. are employed by F. Hoffmann-La Roche. Parts of the work in this study have been filed in the patent PCT/EP2023/056281.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>8</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>2</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>5</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>11</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>30</Day><Hour>1</Hour><Minute>6</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>29</Day><Hour>18</Hour><Minute>41</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37385246</ArticleId><ArticleId IdType="doi">10.1016/j.neuron.2023.05.033</ArticleId><ArticleId IdType="pii">S0896-6273(23)00434-8</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">37398209</PMID><DateRevised><Year>2023</Year><Month>10</Month><Day>09</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2692-8205</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2023</Year><Month>Jun</Month><Day>16</Day></PubDate></JournalIssue><Title>bioRxiv : the preprint server for biology</Title><ISOAbbreviation>bioRxiv</ISOAbbreviation></Journal><ArticleTitle>A MICROGLIAL ACTIVITY STATE BIOMARKER PANEL DIFFERENTIATES FTD-GRANULIN AND ALZHEIMER'S DISEASE PATIENTS FROM CONTROLS.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2023.06.15.545187</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1101/2023.06.15.545187</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">With the emergence of microglia-modulating therapies there is an urgent need for reliable biomarkers to evaluate microglial activation states.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">Using mouse models and human induced pluripotent stem cell-derived microglia (hiMGL), which were genetically modified to yield the most opposite homeostatic ( <i>TREM2-</i> knockout) and disease-associated ( <i>GRN</i> -knockout) states, we identified microglia activity-dependent markers. Non-targeted mass spectrometry was used to identify changes in microglial and cerebrospinal (CSF) proteome of <i>Grn</i> - and <i>Trem2</i> -knockout mice. Additionally, we analyzed the proteome of <i>GRN</i> - and <i>TREM2</i> -knockout hiMGL and their conditioned media. Candidate marker proteins were tested in two independent patient cohorts, the ALLFTD cohort with 11 <i>GRN</i> mutation carriers and 12 non-carriers, as well as the proteomic data set available from the European Medical Information Framework Alzheimer's Disease Multimodal Biomarker Discovery (EMIF-AD MBD).</AbstractText><AbstractText Label="FINDINGS" NlmCategory="UNASSIGNED">We identified proteomic changes between the opposite activation states in mouse microglia and cerebrospinal fluid (CSF), as well as in hiMGL cell lysates and conditioned media. For further verification, we analyzed the CSF proteome of heterozygous <i>GRN</i> mutation carriers suffering from frontotemporal dementia (FTD). We identified a panel of six proteins (FABP3, MDH1, GDI1, CAPG, CD44, GPNMB) as potential indicators for microglial activation. Moreover, we confirmed three of these proteins (FABP3, GDI1, MDH1) to be significantly elevated in the CSF of AD patients. In AD, these markers differentiated amyloid-positive cases with mild cognitive impairment (MCI) from amyloid-negative individuals.</AbstractText><AbstractText Label="INTERPRETATION" NlmCategory="UNASSIGNED">The identified candidate proteins reflect microglia activity and may be relevant for monitoring the microglial response in clinical practice and clinical trials modulating microglial activity and amyloid deposition. Moreover, the finding that three of these markers differentiate amyloid-positive from amyloid-negative MCI cases in the AD cohort suggests that these marker proteins associate with a very early immune response to seeded amyloid. This is consistent with our previous findings in the DIAN (Dominantly Inherited Alzheimer's Disease Network) cohort, where soluble TREM2 increases as early as 21 years before symptom onset. Moreover, in mouse models for amyloidogenesis, seeding of amyloid is limited by physiologically active microglia further supporting their early protective role. The biological functions of some of our main candidates (FABP3, CD44, GPNMB) also further emphasize that lipid dysmetabolism may be a common feature of neurodegenerative disorders.</AbstractText><AbstractText Label="FUNDING" NlmCategory="UNASSIGNED">This work was supported by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) under Germany's Excellence Strategy within the framework of the Munich Cluster for Systems Neurology (EXC 2145 SyNergy - ID 390857198 to CH, SFL and DP) and a Koselleck Project HA1737/16-1 (to CH).</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pes&#xe4;maa</LastName><ForeName>Ida</ForeName><Initials>I</Initials><Identifier Source="ORCID">0009-0007-3902-3137</Identifier></Author><Author ValidYN="Y"><LastName>M&#xfc;ller</LastName><ForeName>Stephan A</ForeName><Initials>SA</Initials><Identifier Source="ORCID">0000-0003-3414-307X</Identifier></Author><Author ValidYN="Y"><LastName>Robinson</LastName><ForeName>Sophie</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-1261-1370</Identifier></Author><Author ValidYN="Y"><LastName>Darcher</LastName><ForeName>Alana</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Paquet</LastName><ForeName>Dominik</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0003-2065-1639</Identifier></Author><Author ValidYN="Y"><LastName>Zetterberg</LastName><ForeName>Henrik</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Lichtenthaler</LastName><ForeName>Stefan F</ForeName><Initials>SF</Initials><Identifier Source="ORCID">0000-0003-2211-2575</Identifier></Author><Author ValidYN="Y"><LastName>Haass</LastName><ForeName>Christian</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-4869-1627</Identifier></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D000076942">Preprint</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>06</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>bioRxiv</MedlineTA><NlmUniqueID>101680187</NlmUniqueID><ISSNLinking>2692-8205</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="UpdateIn"><RefSource>Mol Neurodegener. 2023 Sep 29;18(1):70. doi: 10.1186/s13024-023-00657-w.</RefSource><PMID Version="1">37775827</PMID></CommentsCorrections></CommentsCorrectionsList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>7</Month><Day>3</Day><Hour>13</Hour><Minute>6</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>7</Month><Day>3</Day><Hour>13</Hour><Minute>5</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>7</Month><Day>3</Day><Hour>11</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>6</Month><Day>30</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37398209</ArticleId><ArticleId IdType="pmc">PMC10312678</ArticleId><ArticleId IdType="doi">10.1101/2023.06.15.545187</ArticleId><ArticleId IdType="pii">2023.06.15.545187</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37406134</PMID><DateCompleted><Year>2023</Year><Month>07</Month><Day>07</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1946-6242</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><Issue>703</Issue><PubDate><Year>2023</Year><Month>Jul</Month><Day>05</Day></PubDate></JournalIssue><Title>Science translational medicine</Title><ISOAbbreviation>Sci Transl Med</ISOAbbreviation></Journal><ArticleTitle>Proteomics of brain, CSF, and plasma identifies molecular signatures for distinguishing sporadic and genetic Alzheimer's disease.</ArticleTitle><Pagination><StartPage>eabq5923</StartPage><MedlinePgn>eabq5923</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1126/scitranslmed.abq5923</ELocationID><Abstract><AbstractText>Proteomic studies for Alzheimer's disease (AD) are instrumental in identifying AD pathways but often focus on single tissues and sporadic AD cases. Here, we present a proteomic study analyzing 1305 proteins in brain tissue, cerebrospinal fluid (CSF), and plasma from patients with sporadic AD, <i>TREM2</i> risk variant carriers, patients with autosomal dominant AD (ADAD), and healthy individuals. We identified 8 brain, 40 CSF, and 9 plasma proteins that were altered in individuals with sporadic AD, and we replicated these findings in several external datasets. We identified a proteomic signature that differentiated <i>TREM2</i> variant carriers from both individuals with sporadic AD and healthy individuals. The proteins associated with sporadic AD were also altered in patients with ADAD, but with a greater effect size. Brain-derived proteins associated with ADAD were also replicated in additional CSF samples. Enrichment analyses highlighted several pathways, including those implicated in AD (calcineurin and Apo E), Parkinson's disease (&#x3b1;-synuclein and LRRK2), and innate immune responses (SHC1, ERK-1, and SPP1). Our findings suggest that combined proteomics across brain tissue, CSF, and plasma can be used to identify markers for sporadic and genetically defined AD.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sung</LastName><ForeName>Yun Ju</ForeName><Initials>YJ</Initials><Identifier Source="ORCID">0000-0002-8021-4070</Identifier><AffiliationInfo><Affiliation>Department of Psychiatry, Washington University School of Medicine, St.&#xa0;Louis, MO 63108, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NeuroGenomics and Informatics Center, Washington University School of Medicine, St.&#xa0;Louis, MO 63108, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Biostatistics, Washington University School of Medicine, St.&#xa0;Louis, MO 63108, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Chengran</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0003-4577-5590</Identifier><AffiliationInfo><Affiliation>Department of Psychiatry, Washington University School of Medicine, St.&#xa0;Louis, MO 63108, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NeuroGenomics and Informatics Center, Washington University School of Medicine, St.&#xa0;Louis, MO 63108, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Norton</LastName><ForeName>Joanne</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, Washington University School of Medicine, St.&#xa0;Louis, MO 63108, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NeuroGenomics and Informatics Center, Washington University School of Medicine, St.&#xa0;Louis, MO 63108, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Johnson</LastName><ForeName>Matt</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, Washington University School of Medicine, St.&#xa0;Louis, MO 63108, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NeuroGenomics and Informatics Center, Washington University School of Medicine, St.&#xa0;Louis, MO 63108, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fagan</LastName><ForeName>Anne</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Charles F.&#xa0;and Joanne Knight Alzheimer Disease Research Center, Washington University School of Medicine, St.&#xa0;Louis, MO 63108, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Washington University School of Medicine, St.&#xa0;Louis, MO 63108, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bateman</LastName><ForeName>Randall J</ForeName><Initials>RJ</Initials><Identifier Source="ORCID">0000-0002-7729-1702</Identifier><AffiliationInfo><Affiliation>Charles F.&#xa0;and Joanne Knight Alzheimer Disease Research Center, Washington University School of Medicine, St.&#xa0;Louis, MO 63108, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Washington University School of Medicine, St.&#xa0;Louis, MO 63108, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perrin</LastName><ForeName>Richard J</ForeName><Initials>RJ</Initials><Identifier Source="ORCID">0000-0002-3443-7716</Identifier><AffiliationInfo><Affiliation>Charles F.&#xa0;and Joanne Knight Alzheimer Disease Research Center, Washington University School of Medicine, St.&#xa0;Louis, MO 63108, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Washington University School of Medicine, St.&#xa0;Louis, MO 63108, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathology and Immunology, Washington University School of Medicine, St.&#xa0;Louis, MO 63108, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morris</LastName><ForeName>John C</ForeName><Initials>JC</Initials><Identifier Source="ORCID">0000-0001-9820-5618</Identifier><AffiliationInfo><Affiliation>Charles F.&#xa0;and Joanne Knight Alzheimer Disease Research Center, Washington University School of Medicine, St.&#xa0;Louis, MO 63108, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Washington University School of Medicine, St.&#xa0;Louis, MO 63108, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathology and Immunology, Washington University School of Medicine, St.&#xa0;Louis, MO 63108, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Farlow</LastName><ForeName>Martin R</ForeName><Initials>MR</Initials><Identifier Source="ORCID">0000-0001-7897-5471</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Indiana University School of Medicine, Indianapolis, IN 46202, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chhatwal</LastName><ForeName>Jasmeer P</ForeName><Initials>JP</Initials><Identifier Source="ORCID">0000-0002-7792-1698</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02115, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schofield</LastName><ForeName>Peter R</ForeName><Initials>PR</Initials><Identifier Source="ORCID">0000-0003-2967-9662</Identifier><AffiliationInfo><Affiliation>Neuroscience Research Australia, Randwick, NSW 2031, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Biomedical Sciences, University of New South Wales, Sydney, NSW 2052, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chui</LastName><ForeName>Helena</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Southern California, Los Angeles, CA 90089, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Fengxian</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0002-7677-5406</Identifier><AffiliationInfo><Affiliation>Department of Psychiatry, Washington University School of Medicine, St.&#xa0;Louis, MO 63108, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NeuroGenomics and Informatics Center, Washington University School of Medicine, St.&#xa0;Louis, MO 63108, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Novotny</LastName><ForeName>Brenna</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0003-4732-1736</Identifier><AffiliationInfo><Affiliation>Department of Psychiatry, Washington University School of Medicine, St.&#xa0;Louis, MO 63108, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eteleeb</LastName><ForeName>Abdallah</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-9045-250X</Identifier><AffiliationInfo><Affiliation>Department of Psychiatry, Washington University School of Medicine, St.&#xa0;Louis, MO 63108, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Karch</LastName><ForeName>Celeste</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-6854-5547</Identifier><AffiliationInfo><Affiliation>Department of Psychiatry, Washington University School of Medicine, St.&#xa0;Louis, MO 63108, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NeuroGenomics and Informatics Center, Washington University School of Medicine, St.&#xa0;Louis, MO 63108, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schindler</LastName><ForeName>Suzanne E</ForeName><Initials>SE</Initials><Identifier Source="ORCID">0000-0002-1680-1465</Identifier><AffiliationInfo><Affiliation>Charles F.&#xa0;and Joanne Knight Alzheimer Disease Research Center, Washington University School of Medicine, St.&#xa0;Louis, MO 63108, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Washington University School of Medicine, St.&#xa0;Louis, MO 63108, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rhinn</LastName><ForeName>Herve</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Leal Therapeutics, 17 Briden St., Office 329, Worcester, MA 01605, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Johnson</LastName><ForeName>Erik C B</ForeName><Initials>ECB</Initials><Identifier Source="ORCID">0000-0002-0604-2944</Identifier><AffiliationInfo><Affiliation>Goizueta Alzheimer's Disease Research Center, Emory University School of Medicine, Atlanta, GA 30329, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oh</LastName><ForeName>Hamilton Se-Hwee</ForeName><Initials>HS</Initials><Identifier Source="ORCID">0000-0001-8192-7593</Identifier><AffiliationInfo><Affiliation>Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA 94304, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rutledge</LastName><ForeName>Jarod Evert</ForeName><Initials>JE</Initials><Identifier Source="ORCID">0000-0001-7790-2801</Identifier><AffiliationInfo><Affiliation>Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA 94304, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dammer</LastName><ForeName>Eric B</ForeName><Initials>EB</Initials><Identifier Source="ORCID">0000-0003-2947-7606</Identifier><AffiliationInfo><Affiliation>Goizueta Alzheimer's Disease Research Center, Emory University School of Medicine, Atlanta, GA 30329, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seyfried</LastName><ForeName>Nicholas T</ForeName><Initials>NT</Initials><Identifier Source="ORCID">0000-0002-8694-9211</Identifier><AffiliationInfo><Affiliation>Goizueta Alzheimer's Disease Research Center, Emory University School of Medicine, Atlanta, GA 30329, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biochemistry, Emory School of Medicine, Atlanta, GA 30329, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wyss-Coray</LastName><ForeName>Tony</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0001-5893-0831</Identifier><AffiliationInfo><Affiliation>Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA 94304, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Harari</LastName><ForeName>Oscar</ForeName><Initials>O</Initials><Identifier Source="ORCID">0000-0002-2635-6975</Identifier><AffiliationInfo><Affiliation>Department of Psychiatry, Washington University School of Medicine, St.&#xa0;Louis, MO 63108, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cruchaga</LastName><ForeName>Carlos</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-0276-2899</Identifier><AffiliationInfo><Affiliation>Department of Psychiatry, Washington University School of Medicine, St.&#xa0;Louis, MO 63108, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NeuroGenomics and Informatics Center, Washington University School of Medicine, St.&#xa0;Louis, MO 63108, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Charles F.&#xa0;and Joanne Knight Alzheimer Disease Research Center, Washington University School of Medicine, St.&#xa0;Louis, MO 63108, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P30 AG066444</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>RF1 AG053303</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 AG024904</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P01 AG003991</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>RF1 AG074007</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>RF1 AG044546</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U19 AG032438</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 AG058922</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG044546</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P01 AG026276</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>RF1 AG058501</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>07</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Sci Transl Med</MedlineTA><NlmUniqueID>101505086</NlmUniqueID><ISSNLinking>1946-6234</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016875">tau Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016229">Amyloid beta-Peptides</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D040901" MajorTopicYN="N">Proteomics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007113" MajorTopicYN="N">Immunity, Innate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006579" MajorTopicYN="N">Heterozygote</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016875" MajorTopicYN="N">tau Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016229" MajorTopicYN="N">Amyloid beta-Peptides</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><CoiStatement><b>Competing interests:</b> CC has received research support from: GSK and EISAI. The funders of the study had no role in the collection, analysis, or interpretation of data; in the writing of the report; or in the decision to submit the paper for publication. CC is a member of the advisory board of Vivid Genomics and Circular Genomics and owns stocks. Dr. Fagan has received research funding from the National Institute on Aging of the National Institutes of Health, Biogen, Centene, Fujirebio and Roche Diagnostics. She is a member of the scientific advisory boards for Roche Diagnostics and Genentech and also consults for Diadem, DiamiR and Siemens Healthcare Diagnostics Inc. There are no conflicts. Dr. Seyfried is co-founder of Emtherapro Corp. There are no conflicts.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>7</Month><Day>7</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>7</Month><Day>5</Day><Hour>19</Hour><Minute>12</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>7</Month><Day>5</Day><Hour>14</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>1</Month><Day>22</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37406134</ArticleId><ArticleId IdType="mid">NIHMS1951625</ArticleId><ArticleId IdType="pmc">PMC10803068</ArticleId><ArticleId IdType="doi">10.1126/scitranslmed.abq5923</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>A. s. Association, 2020 Alzheimer&#x2019;s disease facts and figures. Alzheimers Dementia, (2020); published online EpubMar 10 (10.1002/alz.12068).</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alz.12068</ArticleId><ArticleId IdType="pubmed">32157811</ArticleId></ArticleIdList></Reference><Reference><Citation>McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM, Clinical diagnosis of Alzheimer&#x2019;s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer&#x2019;s Disease. Neurology 34, 939&#x2013;944 (1984); published online EpubJul (10.1212/wnl.34.7.939).</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/wnl.34.7.939</ArticleId><ArticleId IdType="pubmed">6610841</ArticleId></ArticleIdList></Reference><Reference><Citation>Bateman RJ, Xiong C, Benzinger TL, Fagan AM, Goate A, Fox NC, Marcus DS, Cairns NJ, Xie X, Blazey TM, Holtzman DM, Santacruz A, Buckles V, Oliver A, Moulder K, Aisen PS, Ghetti B, Klunk WE, McDade E, Martins RN, Masters CL, Mayeux R, Ringman JM, Rossor MN, Schofield PR, Sperling RA, Salloway S, Morris JC, N. Dominantly Inherited Alzheimer, Clinical and biomarker changes in dominantly inherited Alzheimer&#x2019;s disease. N Engl J Med 367, 795&#x2013;804 (2012); published online EpubAug 30 (10.1056/NEJMoa1202753).</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1202753</ArticleId><ArticleId IdType="pmc">PMC3474597</ArticleId><ArticleId IdType="pubmed">22784036</ArticleId></ArticleIdList></Reference><Reference><Citation>Ulrich JD, Holtzman DM, TREM2 Function in Alzheimer&#x2019;s Disease and Neurodegeneration. ACS Chem Neurosci 7, 420&#x2013;427 (2016); published online EpubApr 20 (10.1021/acschemneuro.5b00313).</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschemneuro.5b00313</ArticleId><ArticleId IdType="pubmed">26854967</ArticleId></ArticleIdList></Reference><Reference><Citation>Guerreiro R, Wojtas A, Bras J, Carrasquillo M, Rogaeva E, Majounie E, Cruchaga C, Sassi C, Kauwe JS, Younkin S, Hazrati L, Collinge J, Pocock J, Lashley T, Williams J, Lambert JC, Amouyel P, Goate A, Rademakers R, Morgan K, Powell J, St George-Hyslop P, Singleton A, Hardy J, Alzheimer Genetic Analysis G, TREM2 variants in Alzheimer&#x2019;s disease. N Engl J Med 368, 117&#x2013;127 (2013); published online EpubJan 10 (10.1056/NEJMoa1211851).</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1211851</ArticleId><ArticleId IdType="pmc">PMC3631573</ArticleId><ArticleId IdType="pubmed">23150934</ArticleId></ArticleIdList></Reference><Reference><Citation>Benitez BA, Cooper B, Pastor P, Jin SC, Lorenzo E, Cervantes S, Cruchaga C, TREM2 is associated with the risk of Alzheimer&#x2019;s disease in Spanish population. Neurobiol Aging 34, 1711 e1715&#x2013;1717 (2013); published online EpubJun (10.1016/j.neurobiolaging.2012.12.018).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2012.12.018</ArticleId><ArticleId IdType="pmc">PMC3596468</ArticleId><ArticleId IdType="pubmed">23391427</ArticleId></ArticleIdList></Reference><Reference><Citation>Olsson B, Lautner R, Andreasson U, Ohrfelt A, Portelius E, Bjerke M, Holtta M, Rosen C, Olsson C, Strobel G, Wu E, Dakin K, Petzold M, Blennow K, Zetterberg H, CSF and blood biomarkers for the diagnosis of Alzheimer&#x2019;s disease: a systematic review and meta-analysis. Lancet Neurol 15, 673&#x2013;684 (2016); published online EpubJun (10.1016/S1474-4422(16)00070-3).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(16)00070-3</ArticleId><ArticleId IdType="pubmed">27068280</ArticleId></ArticleIdList></Reference><Reference><Citation>Schindler SE, Bollinger JG, Ovod V, Mawuenyega KG, Li Y, Gordon BA, Holtzman DM, Morris JC, Benzinger TLS, Xiong C, Fagan AM, Bateman RJ, High-precision plasma beta-amyloid 42/40 predicts current and future brain amyloidosis. Neurology 93, e1647&#x2013;e1659 (2019); published online EpubOct 22 (10.1212/WNL.0000000000008081).</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000008081</ArticleId><ArticleId IdType="pmc">PMC6946467</ArticleId><ArticleId IdType="pubmed">31371569</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Schindler SE, Bollinger JG, Ovod V, Mawuenyega KG, Weiner MW, Leslie SM, Masters CL, Fowler CJ, Trojanowski JQ, Korecka M, Martins RN, Janelidze S, Hansson O, Bateman RJ, Validation of Plasma Amyloid-beta 42/40 for Detecting Alzheimer Disease Amyloid Plaques. Neurology, (2021); published online EpubDec 14 (10.1212/WNL.0000000000013211).</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000013211</ArticleId><ArticleId IdType="pmc">PMC8865895</ArticleId><ArticleId IdType="pubmed">34906975</ArticleId></ArticleIdList></Reference><Reference><Citation>Fagan AM, Roe CM, Xiong C, Mintun MA, Morris JC, Holtzman DM, Cerebrospinal fluid tau/beta-amyloid(42) ratio as a prediction of cognitive decline in nondemented older adults. Arch Neurol 64, 343&#x2013;349 (2007); published online EpubMar (10.1001/archneur.64.3.noc60123).</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneur.64.3.noc60123</ArticleId><ArticleId IdType="pubmed">17210801</ArticleId></ArticleIdList></Reference><Reference><Citation>Gold L, Ayers D, Bertino J, Bock C, Bock A, Brody EN, Carter J, Dalby AB, Eaton BE, Fitzwater T, Flather D, Forbes A, Foreman T, Fowler C, Gawande B, Goss M, Gunn M, Gupta S, Halladay D, Heil J, Heilig J, Hicke B, Husar G, Janjic N, Jarvis T, Jennings S, Katilius E, Keeney TR, Kim N, Koch TH, Kraemer S, Kroiss L, Le N, Levine D, Lindsey W, Lollo B, Mayfield W, Mehan M, Mehler R, Nelson SK, Nelson M, Nieuwlandt D, Nikrad M, Ochsner U, Ostroff RM, Otis M, Parker T, Pietrasiewicz S, Resnicow DI, Rohloff J, Sanders G, Sattin S, Schneider D, Singer B, Stanton M, Sterkel A, Stewart A, Stratford S, Vaught JD, Vrkljan M, Walker JJ, Watrobka M, Waugh S, Weiss A, Wilcox SK, Wolfson A, Wolk SK, Zhang C, Zichi D, Aptamer-based multiplexed proteomic technology for biomarker discovery. PLoS One 5, e15004 (2010); published online EpubDec 7 (10.1371/journal.pone.0015004).</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0015004</ArticleId><ArticleId IdType="pmc">PMC3000457</ArticleId><ArticleId IdType="pubmed">21165148</ArticleId></ArticleIdList></Reference><Reference><Citation>Leek JT, Johnson WE, Parker HS, Jaffe AE, Storey JD, The sva package for removing batch effects and other unwanted variation in high-throughput experiments. Bioinformatics 28, 882&#x2013;883 (2012); published online EpubMar 15 (10.1093/bioinformatics/bts034).</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/bts034</ArticleId><ArticleId IdType="pmc">PMC3307112</ArticleId><ArticleId IdType="pubmed">22257669</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris JC, The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology 43, 2412&#x2013;2414 (1993); published online EpubNov (</Citation><ArticleIdList><ArticleId IdType="pubmed">8232972</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson ECB, Dammer EB, Duong DM, Ping L, Zhou M, Yin L, Higginbotham LA, Guajardo A, White B, Troncoso JC, Thambisetty M, Montine TJ, Lee EB, Trojanowski JQ, Beach TG, Reiman EM, Haroutunian V, Wang M, Schadt E, Zhang B, Dickson DW, Ertekin-Taner N, Golde TE, Petyuk VA, De Jager PL, Bennett DA, Wingo TS, Rangaraju S, Hajjar I, Shulman JM, Lah JJ, Levey AI, Seyfried NT, Large-scale proteomic analysis of Alzheimer&#x2019;s disease brain and cerebrospinal fluid reveals early changes in energy metabolism associated with microglia and astrocyte activation. Nat Med 26, 769&#x2013;780 (2020); published online EpubMay (10.1038/s41591-020-0815-6).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-0815-6</ArticleId><ArticleId IdType="pmc">PMC7405761</ArticleId><ArticleId IdType="pubmed">32284590</ArticleId></ArticleIdList></Reference><Reference><Citation>Higginbotham L, Ping L, Dammer EB, Duong DM, Zhou M, Gearing M, Hurst C, Glass JD, Factor SA, Johnson ECB, Hajjar I, Lah JJ, Levey AI, Seyfried NT, Integrated proteomics reveals brain-based cerebrospinal fluid biomarkers in asymptomatic and symptomatic Alzheimer&#x2019;s disease. Sci Adv 6, (2020); published online EpubOct (10.1126/sciadv.aaz9360).</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.aaz9360</ArticleId><ArticleId IdType="pmc">PMC7577712</ArticleId><ArticleId IdType="pubmed">33087358</ArticleId></ArticleIdList></Reference><Reference><Citation>Wingo AP, Fan W, Duong DM, Gerasimov ES, Dammer EB, Liu Y, Harerimana NV, White B, Thambisetty M, Troncoso JC, Kim N, Schneider JA, Hajjar IM, Lah JJ, Bennett DA, Seyfried NT, Levey AI, Wingo TS, Shared proteomic effects of cerebral atherosclerosis and Alzheimer&#x2019;s disease on the human brain. Nat Neurosci 23, 696&#x2013;700 (2020); published online EpubJun (10.1038/s41593-020-0635-5).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-020-0635-5</ArticleId><ArticleId IdType="pmc">PMC7269838</ArticleId><ArticleId IdType="pubmed">32424284</ArticleId></ArticleIdList></Reference><Reference><Citation>Whelan CD, Mattsson N, Nagle MW, Vijayaraghavan S, Hyde C, Janelidze S, Stomrud E, Lee J, Fitz L, Samad TA, Ramaswamy G, Margolin RA, Malarstig A, Hansson O, Multiplex proteomics identifies novel CSF and plasma biomarkers of early Alzheimer&#x2019;s disease. Acta Neuropathol Commun 7, 169 (2019); published online EpubNov 6 (10.1186/s40478-019-0795-2).</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-019-0795-2</ArticleId><ArticleId IdType="pmc">PMC6836495</ArticleId><ArticleId IdType="pubmed">31694701</ArticleId></ArticleIdList></Reference><Reference><Citation>Sattlecker M, Kiddle SJ, Newhouse S, Proitsi P, Nelson S, Williams S, Johnston C, Killick R, Simmons A, Westman E, Hodges A, Soininen H, Kloszewska I, Mecocci P, Tsolaki M, Vellas B, Lovestone S, AddNeuroMed C, Dobson RJ, Alzheimer&#x2019;s disease biomarker discovery using SOMAscan multiplexed protein technology. Alzheimers Dement 10, 724&#x2013;734 (2014); published online EpubNov (10.1016/j.jalz.2013.09.016).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2013.09.016</ArticleId><ArticleId IdType="pubmed">24768341</ArticleId></ArticleIdList></Reference><Reference><Citation>Vlassenko AG, McCue L, Jasielec MS, Su Y, Gordon BA, Xiong C, Holtzman DM, Benzinger TL, Morris JC, Fagan AM, Imaging and cerebrospinal fluid biomarkers in early preclinical alzheimer disease. Ann Neurol 80, 379&#x2013;387 (2016); published online EpubSep (10.1002/ana.24719).</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.24719</ArticleId><ArticleId IdType="pmc">PMC5016232</ArticleId><ArticleId IdType="pubmed">27398953</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo T, Shaw LM, Trojanowski JQ, Jagust WJ, Landau SM, I. Alzheimer&#x2019;s Disease Neuroimaging, Association of CSF Abeta, amyloid PET, and cognition in cognitively unimpaired elderly adults. Neurology 95, e2075&#x2013;e2085 (2020); published online EpubOct 13 (10.1212/WNL.0000000000010596).</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000010596</ArticleId><ArticleId IdType="pmc">PMC7713747</ArticleId><ArticleId IdType="pubmed">32759202</ArticleId></ArticleIdList></Reference><Reference><Citation>Jack CR Jr., Bennett DA, Blennow K, Carrillo MC, Feldman HH, Frisoni GB, Hampel H, Jagust WJ, Johnson KA, Knopman DS, Petersen RC, Scheltens P, Sperling RA, Dubois B, A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers. Neurology 87, 539&#x2013;547 (2016); published online EpubAug 2 (10.1212/WNL.0000000000002923).</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000002923</ArticleId><ArticleId IdType="pmc">PMC4970664</ArticleId><ArticleId IdType="pubmed">27371494</ArticleId></ArticleIdList></Reference><Reference><Citation>Timsina J, Gomez-Fonseca D, Wang L, Do A, Western D, Alvarez I, Aguilar M, Pastor P, Henson RL, Herries E, Xiong C, Schindler SE, Fagan AM, Bateman RJ, Farlow M, Morris JC, Perrin R, Moulder K, Hassenstab J, Chhatwal J, Mori H, I. Alzheimer&#x2019;s Disease Neuroimaging, C. Dominantly Inherited Alzheimer Network, Sung YJ, Cruchaga C, Comparative Analysis of Alzheimer&#x2019;s Disease Cerebrospinal Fluid Biomarkers Measurement by Multiplex SOMAscan Platform and Immunoassay-Based Approach. J Alzheimers Dis 89, 193&#x2013;207 (2022)10.3233/JAD-220399).</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-220399</ArticleId><ArticleId IdType="pmc">PMC9562128</ArticleId><ArticleId IdType="pubmed">35871346</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen EY, Tan CM, Kou Y, Duan Q, Wang Z, Meirelles GV, Clark NR, Ma&#x2019;ayan A, Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool. BMC Bioinformatics 14, 128 (2013); published online EpubApr 15 (10.1186/1471-2105-14-128).</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2105-14-128</ArticleId><ArticleId IdType="pmc">PMC3637064</ArticleId><ArticleId IdType="pubmed">23586463</ArticleId></ArticleIdList></Reference><Reference><Citation>Plagman A, Hoscheidt S, McLimans KE, Klinedinst B, Pappas C, Anantharam V, Kanthasamy A, Willette AA, I. Alzheimer&#x2019;s Disease Neuroimaging, Cholecystokinin and Alzheimer&#x2019;s disease: a biomarker of metabolic function, neural integrity, and cognitive performance. Neurobiol Aging 76, 201&#x2013;207 (2019); published online EpubApr (10.1016/j.neurobiolaging.2019.01.002).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2019.01.002</ArticleId><ArticleId IdType="pmc">PMC6425756</ArticleId><ArticleId IdType="pubmed">30739077</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu H, Liu B, Li L, Lemere CA, Microglia Do Not Take Up Soluble Amyloid-beta Peptides, But Partially Degrade Them by Secreting Insulin-degrading Enzyme. Neuroscience 443, 30&#x2013;43 (2020); published online EpubSep 1 (10.1016/j.neuroscience.2020.07.020).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2020.07.020</ArticleId><ArticleId IdType="pmc">PMC7484427</ArticleId><ArticleId IdType="pubmed">32697980</ArticleId></ArticleIdList></Reference><Reference><Citation>Dammer EB, Ping L, Duong DM, Modeste ES, Seyfried NT, Lah JJ, Levey AI, Johnson ECB, Multi-Platform Proteomic Analysis of Alzheimer&#x2019;s Disease Cerebrospinal Fluid and Plasma Reveals Network Biomarkers Associated with Proteostasis and the Matrisome. bioRxiv, 2022.2006.2020.494087 (2022)10.1101/2022.06.20.494087).</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.06.20.494087</ArticleId><ArticleId IdType="pmc">PMC9670630</ArticleId><ArticleId IdType="pubmed">36384809</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheltens P, De Strooper B, Kivipelto M, Holstege H, Chetelat G, Teunissen CE, Cummings J, van der Flier WM, Alzheimer&#x2019;s disease. Lancet 397, 1577&#x2013;1590 (2021); published online EpubApr 24 (10.1016/S0140-6736(20)32205-4).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32205-4</ArticleId><ArticleId IdType="pmc">PMC8354300</ArticleId><ArticleId IdType="pubmed">33667416</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakamura A, Kaneko N, Villemagne VL, Kato T, Doecke J, Dore V, Fowler C, Li QX, Martins R, Rowe C, Tomita T, Matsuzaki K, Ishii K, Ishii K, Arahata Y, Iwamoto S, Ito K, Tanaka K, Masters CL, Yanagisawa K, High performance plasma amyloid-beta biomarkers for Alzheimer&#x2019;s disease. Nature 554, 249&#x2013;254 (2018); published online EpubFeb 8 (10.1038/nature25456).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature25456</ArticleId><ArticleId IdType="pubmed">29420472</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Ghose U, Buckley NJ, Engelborghs S, Sleegers K, Frisoni GB, Wallin A, Lleo A, Popp J, Martinez-Lage P, Legido-Quigley C, Barkhof F, Zetterberg H, Visser PJ, Bertram L, Lovestone S, Nevado-Holgado AJ, Shi L, Predicting AT(N) pathologies in Alzheimer&#x2019;s disease from blood-based proteomic data using neural networks. Front Aging Neurosci 14, 1040001 (2022)10.3389/fnagi.2022.1040001).</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2022.1040001</ArticleId><ArticleId IdType="pmc">PMC9746615</ArticleId><ArticleId IdType="pubmed">36523958</ArticleId></ArticleIdList></Reference><Reference><Citation>Palmqvist S, Tideman P, Cullen N, Zetterberg H, Blennow K, I. Alzheimer&#x2019;s Disease Neuroimaging, Dage JL, Stomrud E, Janelidze S, Mattsson-Carlgren N, Hansson O, Prediction of future Alzheimer&#x2019;s disease dementia using plasma phospho-tau combined with other accessible measures. Nat Med 27, 1034&#x2013;1042 (2021); published online EpubJun (10.1038/s41591-021-01348-z).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01348-z</ArticleId><ArticleId IdType="pubmed">34031605</ArticleId></ArticleIdList></Reference><Reference><Citation>Cruchaga C, Kauwe JS, Nowotny P, Bales K, Pickering EH, Mayo K, Bertelsen S, Hinrichs A, I. Alzheimer&#x2019;s Disease Neuroimaging, Fagan AM, Holtzman DM, Morris JC, Goate AM, Cerebrospinal fluid APOE levels: an endophenotype for genetic studies for Alzheimer&#x2019;s disease. Hum Mol Genet 21, 4558&#x2013;4571 (2012); published online EpubOct 15 (10.1093/hmg/dds296).</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/dds296</ArticleId><ArticleId IdType="pmc">PMC3459471</ArticleId><ArticleId IdType="pubmed">22821396</ArticleId></ArticleIdList></Reference><Reference><Citation>Castellano JM, Kim J, Stewart FR, Jiang H, DeMattos RB, Patterson BW, Fagan AM, Morris JC, Mawuenyega KG, Cruchaga C, Goate AM, Bales KR, Paul SM, Bateman RJ, Holtzman DM, Human apoE isoforms differentially regulate brain amyloid-beta peptide clearance. Sci Transl Med 3, 89ra57 (2011); published online EpubJun 29 (10.1126/scitranslmed.3002156).</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.3002156</ArticleId><ArticleId IdType="pmc">PMC3192364</ArticleId><ArticleId IdType="pubmed">21715678</ArticleId></ArticleIdList></Reference><Reference><Citation>Cruchaga C, Kauwe JS, Mayo K, Spiegel N, Bertelsen S, Nowotny P, Shah AR, Abraham R, Hollingworth P, Harold D, Owen MM, Williams J, Lovestone S, Peskind ER, Li G, Leverenz JB, Galasko D, I. Alzheimer&#x2019;s Disease Neuroimaging, Morris JC, Fagan AM, Holtzman DM, Goate AM, SNPs associated with cerebrospinal fluid phospho-tau levels influence rate of decline in Alzheimer&#x2019;s disease. PLoS Genet 6, (2010); published online EpubSep (10.1371/journal.pgen.1001101).</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1001101</ArticleId><ArticleId IdType="pmc">PMC2940763</ArticleId><ArticleId IdType="pubmed">20862329</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao WQ, Ravindranath L, Mohamed AS, Zohar O, Chen GH, Lyketsos CG, Etcheberrigaray R, Alkon DL, MAP kinase signaling cascade dysfunction specific to Alzheimer&#x2019;s disease in fibroblasts. Neurobiol Dis 11, 166&#x2013;183 (2002); published online EpubOct (10.1006/nbdi.2002.0520).</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/nbdi.2002.0520</ArticleId><ArticleId IdType="pubmed">12460556</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang C, Farias FHG, Ibanez L, Suhy A, Sadler B, Fernandez MV, Wang F, Bradley JL, Eiffert B, Bahena JA, Budde JP, Li Z, Dube U, Sung YJ, Mihindukulasuriya KA, Morris JC, Fagan AM, Perrin RJ, Benitez BA, Rhinn H, Harari O, Cruchaga C, Genomic atlas of the proteome from brain, CSF and plasma prioritizes proteins implicated in neurological disorders. Nat Neurosci, (2021); published online EpubJul (10.1038/s41593-021-00886-6).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-021-00886-6</ArticleId><ArticleId IdType="pmc">PMC8521603</ArticleId><ArticleId IdType="pubmed">34239129</ArticleId></ArticleIdList></Reference><Reference><Citation>Ringman JM, Monsell S, Ng DW, Zhou Y, Nguyen A, Coppola G, Van Berlo V, Mendez MF, Tung S, Weintraub S, Mesulam MM, Bigio EH, Gitelman DR, Fisher-Hubbard AO, Albin RL, Vinters HV, Neuropathology of Autosomal Dominant Alzheimer Disease in the National Alzheimer Coordinating Center Database. J Neuropathol Exp Neurol 75, 284&#x2013;290 (2016); published online EpubMar (10.1093/jnen/nlv028).</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jnen/nlv028</ArticleId><ArticleId IdType="pmc">PMC4934612</ArticleId><ArticleId IdType="pubmed">26888304</ArticleId></ArticleIdList></Reference><Reference><Citation>Zimprich A, Biskup S, Leitner P, Lichtner P, Farrer M, Lincoln S, Kachergus J, Hulihan M, Uitti RJ, Calne DB, Stoessl AJ, Pfeiffer RF, Patenge N, Carbajal IC, Vieregge P, Asmus F, Muller-Myhsok B, Dickson DW, Meitinger T, Strom TM, Wszolek ZK, Gasser T, Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron 44, 601&#x2013;607 (2004); published online EpubNov 18 (10.1016/j.neuron.2004.11.005).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2004.11.005</ArticleId><ArticleId IdType="pubmed">15541309</ArticleId></ArticleIdList></Reference><Reference><Citation>Tolosa E, Vila M, Klein C, Rascol O, LRRK2 in Parkinson disease: challenges of clinical trials. Nat Rev Neurol 16, 97&#x2013;107 (2020); published online EpubFeb (10.1038/s41582-019-0301-2).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-019-0301-2</ArticleId><ArticleId IdType="pubmed">31980808</ArticleId></ArticleIdList></Reference><Reference><Citation>Thrupp N, Sala Frigerio C, Wolfs L, Skene NG, Fattorelli N, Poovathingal S, Fourne Y, Matthews PM, Theys T, Mancuso R, de Strooper B, Fiers M, Single-Nucleus RNA-Seq Is Not Suitable for Detection of Microglial Activation Genes in Humans. Cell Rep 32, 108189 (2020); published online EpubSep 29 (10.1016/j.celrep.2020.108189).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2020.108189</ArticleId><ArticleId IdType="pmc">PMC7527779</ArticleId><ArticleId IdType="pubmed">32997994</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma G, Liu M, Du K, Zhong X, Gong S, Jiao L, Wei M, Differential Expression of mRNAs in the Brain Tissues of Patients with Alzheimer&#x2019;s Disease Based on GEO Expression Profile and Its Clinical Significance. Biomed Res Int 2019, 8179145 (2019)10.1155/2019/8179145).</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2019/8179145</ArticleId><ArticleId IdType="pmc">PMC6413412</ArticleId><ArticleId IdType="pubmed">30918899</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan XD, Zhu YG, Lin N, Zhang J, Ye QY, Huang HP, Chen XC, Microglial phagocytosis induced by fibrillar beta-amyloid is attenuated by oligomeric beta-amyloid: implications for Alzheimer&#x2019;s disease. Mol Neurodegener 6, 45 (2011); published online EpubJun 30 (10.1186/1750-1326-6-45).</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1750-1326-6-45</ArticleId><ArticleId IdType="pmc">PMC3149591</ArticleId><ArticleId IdType="pubmed">21718498</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Z, Xiong Z, Manor LC, Cao H, Li T, Integrative computational evaluation of genetic markers for Alzheimer&#x2019;s disease. Saudi J Biol Sci 25, 996&#x2013;1002 (2018); published online EpubJul (10.1016/j.sjbs.2018.05.019).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.sjbs.2018.05.019</ArticleId><ArticleId IdType="pmc">PMC6088103</ArticleId><ArticleId IdType="pubmed">30108454</ArticleId></ArticleIdList></Reference><Reference><Citation>Da Mesquita S, Papadopoulos Z, Dykstra T, Brase L, Farias FG, Wall M, Jiang H, Kodira CD, de Lima KA, Herz J, Louveau A, Goldman DH, Salvador AF, Onengut-Gumuscu S, Farber E, Dabhi N, Kennedy T, Milam MG, Baker W, Smirnov I, Rich SS, N. Dominantly Inherited Alzheimer, Benitez BA, Karch CM, Perrin RJ, Farlow M, Chhatwal JP, Holtzman DM, Cruchaga C, Harari O, Kipnis J, Meningeal lymphatics affect microglia responses and anti-Abeta immunotherapy. Nature 593, 255&#x2013;260 (2021); published online EpubMay (10.1038/s41586-021-03489-0).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03489-0</ArticleId><ArticleId IdType="pmc">PMC8817786</ArticleId><ArticleId IdType="pubmed">33911285</ArticleId></ArticleIdList></Reference><Reference><Citation>Scafidi J, Hammond TR, Scafidi S, Ritter J, Jablonska B, Roncal M, Szigeti-Buck K, Coman D, Huang Y, McCarter RJ Jr., Hyder F, Horvath TL, Gallo V, Intranasal epidermal growth factor treatment rescues neonatal brain injury. Nature 506, 230&#x2013;234 (2014); published online EpubFeb 13 (10.1038/nature12880).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature12880</ArticleId><ArticleId IdType="pmc">PMC4106485</ArticleId><ArticleId IdType="pubmed">24390343</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L, Chiang HC, Wu W, Liang B, Xie Z, Yao X, Ma W, Du S, Zhong Y, Epidermal growth factor receptor is a preferred target for treating amyloid-beta-induced memory loss. Proc Natl Acad Sci U S A 109, 16743&#x2013;16748 (2012); published online EpubOct 9 (10.1073/pnas.1208011109).</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1208011109</ArticleId><ArticleId IdType="pmc">PMC3478595</ArticleId><ArticleId IdType="pubmed">23019586</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas R, Zuchowska P, Morris AW, Marottoli FM, Sunny S, Deaton R, Gann PH, Tai LM, Epidermal growth factor prevents APOE4 and amyloid-beta-induced cognitive and cerebrovascular deficits in female mice. Acta Neuropathol Commun 4, 111 (2016); published online EpubOct 27 (10.1186/s40478-016-0387-3).</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-016-0387-3</ArticleId><ArticleId IdType="pmc">PMC5084423</ArticleId><ArticleId IdType="pubmed">27788676</ArticleId></ArticleIdList></Reference><Reference><Citation>Aerqin Q, Wang ZT, Wu KM, He XY, Dong Q, Yu JT, Omics-based biomarkers discovery for Alzheimer&#x2019;s disease. Cell Mol Life Sci 79, 585 (2022); published online EpubNov 8 (10.1007/s00018-022-04614-6).</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-022-04614-6</ArticleId><ArticleId IdType="pmc">PMC11803048</ArticleId><ArticleId IdType="pubmed">36348101</ArticleId></ArticleIdList></Reference><Reference><Citation>Berg L, McKeel DW Jr., Miller JP, Storandt M, Rubin EH, Morris JC, Baty J, Coats M, Norton J, Goate AM, Price JL, Gearing M, Mirra SS, Saunders AM, Clinicopathologic studies in cognitively healthy aging and Alzheimer&#x2019;s disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype. Arch Neurol 55, 326&#x2013;335 (1998); published online EpubMar (</Citation><ArticleIdList><ArticleId IdType="pubmed">9520006</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37402372</PMID><DateCompleted><Year>2023</Year><Month>09</Month><Day>26</Day></DateCompleted><DateRevised><Year>2023</Year><Month>10</Month><Day>03</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1097-4199</ISSN><JournalIssue CitedMedium="Internet"><Volume>111</Volume><Issue>18</Issue><PubDate><Year>2023</Year><Month>Sep</Month><Day>20</Day></PubDate></JournalIssue><Title>Neuron</Title><ISOAbbreviation>Neuron</ISOAbbreviation></Journal><ArticleTitle>Hepatic soluble epoxide hydrolase activity regulates cerebral A&#x3b2; metabolism and the pathogenesis of Alzheimer's disease in mice.</ArticleTitle><Pagination><StartPage>2847</StartPage><EndPage>2862.e10</EndPage><MedlinePgn>2847-2862.e10</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.neuron.2023.06.002</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0896-6273(23)00437-3</ELocationID><Abstract><AbstractText>Alzheimer's disease (AD) is caused by a complex interaction between genetic and environmental factors. However, how the role of peripheral organ changes in response to environmental stimuli during aging in AD pathogenesis remains unknown. Hepatic soluble epoxide hydrolase (sEH) activity increases with age. Hepatic sEH manipulation bidirectionally attenuates brain amyloid-&#x3b2; (A&#x3b2;) burden, tauopathy, and cognitive deficits in AD mouse models. Moreover, hepatic sEH manipulation bidirectionally regulates the plasma level of 14,15-epoxyeicosatrienoic acid (-EET), which rapidly crosses the blood-brain barrier and modulates brain A&#x3b2; metabolism through multiple pathways. A balance between the brain levels of 14,15-EET and A&#x3b2; is essential for preventing A&#x3b2; deposition. In AD models, 14,15-EET infusion mimicked the neuroprotective effects of hepatic&#xa0;sEH ablation at biological and behavioral levels. These results highlight the liver's key role in AD pathology,&#xa0;and targeting the liver-brain axis in response to environmental stimuli may constitute a promising therapeutic approach for AD prevention.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Yu</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>School of Psychology, Shenzhen University, Shenzhen 518060, China; Research Center for Brain Health, Pazhou Lab, Guangzhou 510330, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dong</LastName><ForeName>Jing-Hua</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Research Center for Brain Health, Pazhou Lab, Guangzhou 510330, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dai</LastName><ForeName>Yong-Feng</ForeName><Initials>YF</Initials><AffiliationInfo><Affiliation>Research Center for Brain Health, Pazhou Lab, Guangzhou 510330, China; School of Biology and Biological Engineering, South China University of Technology, Guangzhou 510006, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Min-Zhen</ForeName><Initials>MZ</Initials><AffiliationInfo><Affiliation>Research Center for Brain Health, Pazhou Lab, Guangzhou 510330, China; School of Automation Science and Engineering, South China University of Technology, Guangzhou 510640, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Meng-Yao</ForeName><Initials>MY</Initials><AffiliationInfo><Affiliation>Research Center for Brain Health, Pazhou Lab, Guangzhou 510330, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Yuan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>School of Psychology, Shenzhen University, Shenzhen 518060, China; Research Center for Brain Health, Pazhou Lab, Guangzhou 510330, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pan</LastName><ForeName>Yi-Da</ForeName><Initials>YD</Initials><AffiliationInfo><Affiliation>Research Center for Brain Health, Pazhou Lab, Guangzhou 510330, China; School of Biology and Biological Engineering, South China University of Technology, Guangzhou 510006, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yuan</LastName><ForeName>Xin-Rui</ForeName><Initials>XR</Initials><AffiliationInfo><Affiliation>Research Center for Brain Health, Pazhou Lab, Guangzhou 510330, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guo</LastName><ForeName>Zhi-Xin</ForeName><Initials>ZX</Initials><AffiliationInfo><Affiliation>Research Center for Brain Health, Pazhou Lab, Guangzhou 510330, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Chen-Xi</ForeName><Initials>CX</Initials><AffiliationInfo><Affiliation>Research Center for Brain Health, Pazhou Lab, Guangzhou 510330, China; School of Automation Science and Engineering, South China University of Technology, Guangzhou 510640, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Yuan-Qing</ForeName><Initials>YQ</Initials><AffiliationInfo><Affiliation>School of Automation Science and Engineering, South China University of Technology, Guangzhou 510640, China; Research Center for Brain-Computer Interface, Pazhou Lab, Guangzhou 510330, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Xin-Hong</ForeName><Initials>XH</Initials><AffiliationInfo><Affiliation>School of Psychology, Shenzhen University, Shenzhen 518060, China; Research Center for Brain Health, Pazhou Lab, Guangzhou 510330, China; School of Biology and Biological Engineering, South China University of Technology, Guangzhou 510006, China. Electronic address: zhuxh527@126.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>07</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Neuron</MedlineTA><NlmUniqueID>8809320</NlmUniqueID><ISSNLinking>0896-6273</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016229">Amyloid beta-Peptides</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.3.2.-</RegistryNumber><NameOfSubstance UI="D004851">Epoxide Hydrolases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.3.2.10</RegistryNumber><NameOfSubstance UI="C518648">Ephx2 protein, mouse</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Neuron. 2023 Sep 20;111(18):2775-2777. doi: 10.1016/j.neuron.2023.08.019.</RefSource><PMID Version="1">37734320</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016229" MajorTopicYN="N">Amyloid beta-Peptides</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004851" MajorTopicYN="N">Epoxide Hydrolases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">14,15-epoxyeicosatrienoic acid</Keyword><Keyword MajorTopicYN="N">Alzheimer&#x2019;s disease</Keyword><Keyword MajorTopicYN="N">apolipoprotein E</Keyword><Keyword MajorTopicYN="N">liver</Keyword><Keyword MajorTopicYN="N">soluble epoxide hydrolase</Keyword></KeywordList><CoiStatement>Declaration of interests The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>11</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>5</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>6</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>25</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>7</Month><Day>5</Day><Hour>1</Hour><Minute>6</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>7</Month><Day>4</Day><Hour>18</Hour><Minute>42</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37402372</ArticleId><ArticleId IdType="doi">10.1016/j.neuron.2023.06.002</ArticleId><ArticleId IdType="pii">S0896-6273(23)00437-3</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37421950</PMID><DateCompleted><Year>2023</Year><Month>08</Month><Day>07</Day></DateCompleted><DateRevised><Year>2024</Year><Month>08</Month><Day>04</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1097-4172</ISSN><JournalIssue CitedMedium="Internet"><Volume>186</Volume><Issue>16</Issue><PubDate><Year>2023</Year><Month>Aug</Month><Day>03</Day></PubDate></JournalIssue><Title>Cell</Title><ISOAbbreviation>Cell</ISOAbbreviation></Journal><ArticleTitle>Development of an &#x3b1;-synuclein positron emission tomography tracer for imaging synucleinopathies.</ArticleTitle><Pagination><StartPage>3350</StartPage><EndPage>3367.e19</EndPage><MedlinePgn>3350-3367.e19</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.cell.2023.06.004</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0092-8674(23)00644-X</ELocationID><Abstract><AbstractText>Synucleinopathies are characterized by the accumulation of &#x3b1;-synuclein (&#x3b1;-Syn) aggregates in the brain. Positron emission tomography (PET) imaging of synucleinopathies requires radiopharmaceuticals that selectively bind &#x3b1;-Syn deposits. We report the identification of a brain permeable and rapid washout PET tracer [<sup>18</sup>F]-F0502B, which shows high binding affinity for &#x3b1;-Syn, but not for A&#x3b2; or Tau fibrils, and preferential binding to &#x3b1;-Syn aggregates in the brain sections. Employing several cycles of counter screenings with in&#xa0;vitro fibrils, intraneuronal aggregates, and neurodegenerative disease brain sections from several mice models and human subjects, [<sup>18</sup>F]-F0502B images &#x3b1;-Syn deposits in the brains of mouse and non-human primate PD models. We further determined the atomic structure of the &#x3b1;-Syn fibril-F0502B complex by cryo-EM and revealed parallel diagonal stacking of F0502B on the fibril surface through an intense noncovalent bonding network via inter-ligand interactions. Therefore, [<sup>18</sup>F]-F0502B is a promising lead compound for imaging aggregated &#x3b1;-Syn in synucleinopathies.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Xiang</LastName><ForeName>Jie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA 30322, USA; Department of Neurobiology, Fourth Military Medical University, Xi'an, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tao</LastName><ForeName>Youqi</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders, Ministry of Education, Shanghai Jiao Tong University, Shanghai, China; Zhangjiang Institute for Advanced Study, Shanghai Jiao Tong University, Shanghai 200240, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xia</LastName><ForeName>Yiyuan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA 30322, USA; Department of Pathophysiology, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China; Institute of Biomedical Sciences, School of Medicine, JiangHan University, #8, Sanjiaohu Rd., Wuhan 430056, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luo</LastName><ForeName>Shilin</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA 30322, USA; Department of Pharmacy, the Second Xiangya Hospital, Central South University, Changsha, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Qinyue</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders, Ministry of Education, Shanghai Jiao Tong University, Shanghai, China; Zhangjiang Institute for Advanced Study, Shanghai Jiao Tong University, Shanghai 200240, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Bowei</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Shenzhen Institute of Advanced Technology, University of Chinese Academy of Science, Shenzhen, Guangdong 518055, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Xiaoqian</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science &amp; Technology, Wuhan 430022, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Yunpeng</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Interdisciplinary Research Center on Biology and Chemistry, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, Shanghai 201210, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xia</LastName><ForeName>Wencheng</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Interdisciplinary Research Center on Biology and Chemistry, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, Shanghai 201210, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Mingming</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Interdisciplinary Research Center on Biology and Chemistry, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, Shanghai 201210, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kang</LastName><ForeName>Seong Su</ForeName><Initials>SS</Initials><AffiliationInfo><Affiliation>Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA 30322, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ahn</LastName><ForeName>Eun-Hee</ForeName><Initials>EH</Initials><AffiliationInfo><Affiliation>Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA 30322, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Xia</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA 30322, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xie</LastName><ForeName>Fang</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Nuclear Medicine &amp; PET Center, Huashan Hospital, Fudan University, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guan</LastName><ForeName>Yihui</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Nuclear Medicine &amp; PET Center, Huashan Hospital, Fudan University, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Jenny J</ForeName><Initials>JJ</Initials><AffiliationInfo><Affiliation>Department of Chemistry, Georgia State University, Atlanta, GA 30303, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bu</LastName><ForeName>Lihong</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>PET-CT/MRI Center, Renmin Hospital of Wuhan University, Wuhan 430060, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Shengxi</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurobiology, Fourth Military Medical University, Xi'an, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Xiaochuan</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Pathophysiology, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cao</LastName><ForeName>Xuebing</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science &amp; Technology, Wuhan 430022, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Cong</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Interdisciplinary Research Center on Biology and Chemistry, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, Shanghai 201210, China; State Key Laboratory of Chemical Biology, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, Shanghai 200032, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Zhentao</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Neurology, Renmin Hospital of Wuhan University, Wuhan 430060, China. Electronic address: zhentaozhang@whu.edu.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Dan</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders, Ministry of Education, Shanghai Jiao Tong University, Shanghai, China; Zhangjiang Institute for Advanced Study, Shanghai Jiao Tong University, Shanghai 200240, China. Electronic address: lidan2017@sjtu.edu.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ye</LastName><ForeName>Keqiang</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA 30322, USA; Faculty of Life and Health Sciences, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, Guangdong 518055, China. Electronic address: kq.ye@siat.ac.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>RF1 AG051538</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>07</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cell</MedlineTA><NlmUniqueID>0413066</NlmUniqueID><ISSNLinking>0092-8674</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051844">alpha-Synuclein</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Cell. 2023 Aug 3;186(16):3327-3329. doi: 10.1016/j.cell.2023.06.018.</RefSource><PMID Version="1">37541192</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051844" MajorTopicYN="N">alpha-Synuclein</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000080874" MajorTopicYN="Y">Synucleinopathies</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="Y">Neurodegenerative Diseases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D049268" MajorTopicYN="N">Positron-Emission Tomography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Lewy body</Keyword><Keyword MajorTopicYN="N">PET tracer</Keyword><Keyword MajorTopicYN="N">cryoelectron microscopy</Keyword><Keyword MajorTopicYN="N">protein aggregation</Keyword><Keyword MajorTopicYN="N">synucleinopathies</Keyword></KeywordList><CoiStatement>Declaration of interests K.Y. is a co-founder of Shanghai Braegen Pharmaceuticals, Inc. that licensed the PET tracer patent from Emory University. No data are sponsored by the company.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>12</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>5</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>6</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>7</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>7</Month><Day>9</Day><Hour>1</Hour><Minute>7</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>7</Month><Day>8</Day><Hour>18</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>8</Month><Day>3</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37421950</ArticleId><ArticleId IdType="mid">NIHMS1910415</ArticleId><ArticleId IdType="pmc">PMC10527432</ArticleId><ArticleId IdType="doi">10.1016/j.cell.2023.06.004</ArticleId><ArticleId IdType="pii">S0092-8674(23)00644-X</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Dev KK, Hofele K, Barbieri S, Buchman VL, and van der Putten H (2003). Part II: alpha-synuclein and its molecular pathophysiological role in neurodegenerative disease. Neuropharmacology 45, 14&#x2013;44.</Citation><ArticleIdList><ArticleId IdType="pubmed">12814657</ArticleId></ArticleIdList></Reference><Reference><Citation>Theillet FX, Binolfi A, Bekei B, Martorana A, Rose HM, Stuiver M, Verzini S, Lorenz D, van Rossum M, Goldfarb D, and Selenko P (2016). Structural disorder of monomeric alpha-synuclein persists in mammalian cells. Nature 530, 45&#x2013;50. 10.1038/nature16531.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature16531</ArticleId><ArticleId IdType="pubmed">26808899</ArticleId></ArticleIdList></Reference><Reference><Citation>Olanow CW, and Brundin P (2013). Parkinson&#x2019;s disease and alpha synuclein: is Parkinson&#x2019;s disease a prion-like disorder? Mov. Disord 28, 31&#x2013;40. 10.1002/mds.25373.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.25373</ArticleId><ArticleId IdType="pubmed">23390095</ArticleId></ArticleIdList></Reference><Reference><Citation>Jucker M, and Walker LC (2013). Self-propagation of pathogenic protein aggregates in neurodegenerative diseases. Nature 501, 45&#x2013;51. 10.1038/nature12481.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature12481</ArticleId><ArticleId IdType="pmc">PMC3963807</ArticleId><ArticleId IdType="pubmed">24005412</ArticleId></ArticleIdList></Reference><Reference><Citation>Shahnawaz M, Mukherjee A, Pritzkow S, Mendez N, Rabadia P, Liu X, Hu B, Schmeichel A, Singer W, Wu G, et al. (2020). Discriminating alpha-synuclein strains in Parkinson&#x2019;s disease and multiple system atrophy. Nature 578, 273&#x2013;277. 10.1038/s41586-020-1984-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-1984-7</ArticleId><ArticleId IdType="pmc">PMC7066875</ArticleId><ArticleId IdType="pubmed">32025029</ArticleId></ArticleIdList></Reference><Reference><Citation>Peelaerts W, Bousset L, Van der Perren A, Moskalyuk A, Pulizzi R, Giugliano M, Van den Haute C, Melki R, and Baekelandt V (2015). Alpha-synuclein strains cause distinct synucleinopathies after local and systemic administration. Nature 522, 340&#x2013;344. 10.1038/nature14547.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature14547</ArticleId><ArticleId IdType="pubmed">26061766</ArticleId></ArticleIdList></Reference><Reference><Citation>Volpicelli-Daley L, and Brundin P (2018). Prion-like propagation of pathology in Parkinson disease. Handb. Clin. Neurol 153, 321&#x2013;335. 10.1016/B978-0-444-63945-5.00017-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/B978-0-444-63945-5.00017-9</ArticleId><ArticleId IdType="pmc">PMC6625652</ArticleId><ArticleId IdType="pubmed">29887143</ArticleId></ArticleIdList></Reference><Reference><Citation>Galpern WR, and Lang AE (2006). Interface between tauopathies and synucleinopathies: a tale of two proteins. Ann. Neurol 59, 449&#x2013;458. 10.1002/ana.20819.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.20819</ArticleId><ArticleId IdType="pubmed">16489609</ArticleId></ArticleIdList></Reference><Reference><Citation>Gomperts SN, Locascio JJ, Makaretz SJ, Schultz A, Caso C, Vasdev N, Sperling R, Growdon JH, Dickerson BC, and Johnson K (2016). Tau positron emission tomographic imaging in the Lewy body diseases. JAMA Neurol. 73, 1334&#x2013;1341. 10.1001/jamaneurol.2016.3338.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2016.3338</ArticleId><ArticleId IdType="pmc">PMC5287290</ArticleId><ArticleId IdType="pubmed">27654968</ArticleId></ArticleIdList></Reference><Reference><Citation>Schumacher J, Gunter JL, Przybelski SA, Jones DT, Graff-Radford J, Savica R, Schwarz CG, Senjem ML, Jack CR, Lowe VJ, et al. (2021). Dementia with Lewy bodies: association of Alzheimer pathology with functional connectivity networks. Brain 144, 3212&#x2013;3225. 10.1093/brain/awab218.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awab218</ArticleId><ArticleId IdType="pmc">PMC8634124</ArticleId><ArticleId IdType="pubmed">34114602</ArticleId></ArticleIdList></Reference><Reference><Citation>U&#xe9;da K, Fukushima H, Masliah E, Xia Y, Iwai A, Yoshimoto M, Otero DA, Kondo J, Ihara Y, and Saitoh T (1993). Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease. Proc. Natl. Acad. Sci. USA 90, 11282&#x2013;11286.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC47966</ArticleId><ArticleId IdType="pubmed">8248242</ArticleId></ArticleIdList></Reference><Reference><Citation>Masliah E, Rockenstein E, Veinbergs I, Sagara Y, Mallory M, Hashimoto M, and Mucke L (2001). Beta-amyloid peptides enhance alpha-synuclein accumulation and neuronal deficits in a transgenic mouse model linking Alzheimer&#x2019;s disease and Parkinson&#x2019;s disease. Proc. Natl. Acad. Sci. USA 98, 12245&#x2013;12250. 10.1073/pnas.211412398.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.211412398</ArticleId><ArticleId IdType="pmc">PMC59799</ArticleId><ArticleId IdType="pubmed">11572944</ArticleId></ArticleIdList></Reference><Reference><Citation>Wakisaka Y, Furuta A, Tanizaki Y, Kiyohara Y, Iida M, and Iwaki T (2003). Age-associated prevalence and risk factors of Lewy body pathology in a general population: the Hisayama study. Acta Neuropathol. 106, 374&#x2013;382. 10.1007/s00401-003-0750-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-003-0750-x</ArticleId><ArticleId IdType="pubmed">12904992</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurata T, Kawarabayashi T, Murakami T, Miyazaki K, Morimoto N, Ohta Y, Takehisa Y, Nagai M, Ikeda M, Matsubara E, Westaway D, Hyslop PS, Harigaya Y, Kamiya T, Shoji M, and Abe K (2007). Enhanced accumulation of phosphorylated alpha-synuclein in double transgenic mice expressing mutant beta-amyloid precursor protein and presenilin-1 [J]. J Neurosci Res 85 (10), 2246&#x2013;2252.</Citation><ArticleIdList><ArticleId IdType="pubmed">17526016</ArticleId></ArticleIdList></Reference><Reference><Citation>Goedert M, Clavaguera F, and Tolnay M (2010). The propagation of prion-like protein inclusions in neurodegenerative diseases. Trends Neurosci. 33, 317&#x2013;325. 10.1016/j.tins.2010.04.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tins.2010.04.003</ArticleId><ArticleId IdType="pubmed">20493564</ArticleId></ArticleIdList></Reference><Reference><Citation>Harada R, Okamura N, Furumoto S, and Yanai K (2018). Imaging protein misfolding in the brain using beta-sheet ligands. Front. Neurosci 12, 585. 10.3389/fnins.2018.00585.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2018.00585</ArticleId><ArticleId IdType="pmc">PMC6110819</ArticleId><ArticleId IdType="pubmed">30186106</ArticleId></ArticleIdList></Reference><Reference><Citation>Jovalekic A, Koglin N, Mueller A, and Stephens AW (2017). New protein deposition tracers in the pipeline. EJNMMI Radiopharm. Chem 1, 11. 10.1186/s41181-016-0015-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s41181-016-0015-3</ArticleId><ArticleId IdType="pmc">PMC5843813</ArticleId><ArticleId IdType="pubmed">29564387</ArticleId></ArticleIdList></Reference><Reference><Citation>Raval NR, Madsen CA, Shalgunov V, Nasser A, Battisti UM, Beaman EE, Juhl M, J&#xf8;rgensen LM, Herth MM, Hansen HD, et al. (2022). Evaluation of the alpha-synuclein PET radiotracer (d(3))-[(11)C] MODAG-001 in pigs. Nucl. Med. Biol 114&#x2013;115, 42&#x2013;48. 10.1016/j.nucmedbio.2022.08.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nucmedbio.2022.08.001</ArticleId><ArticleId IdType="pubmed">36095921</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen MK, Kuwabara H, Zhou Y, Adams RJ, Brasi&#x107; JR, McGlothan JL, Verina T, Burton NC, Alexander M, Kumar A, et al. (2008). VMAT2 and dopamine neuron loss in a primate model of Parkinson&#x2019;s disease. J. Neurochem 105, 78&#x2013;90. 10.1111/j.1471-4159.2007.05108.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2007.05108.x</ArticleId><ArticleId IdType="pmc">PMC4137401</ArticleId><ArticleId IdType="pubmed">17988241</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishiwata K, Kimura Y, Oda K, Ishii K, Sakata M, Kawasaki K, Nariai T, Suzuki Y, Ishibashi K, Mishina M, et al. (2010). Development of PET radiopharmaceuticals and their clinical applications at the Positron Medical Center. Geriatr. Gerontol. Int 10, S180&#x2013;S196. 10.1111/j.1447-0594.2010.00594.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1447-0594.2010.00594.x</ArticleId><ArticleId IdType="pubmed">20590833</ArticleId></ArticleIdList></Reference><Reference><Citation>de la Fuente-Fern&#xe1;ndez R. (2012). Role of DaTSCAN and clinical diagnosis in Parkinson disease. Neurology 78, 696&#x2013;701. 10.1212/WNL.0b013e318248e520.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e318248e520</ArticleId><ArticleId IdType="pubmed">22323748</ArticleId></ArticleIdList></Reference><Reference><Citation>Perlmutter JS, and Eidelberg D (2012). To scan or not to scan: DaT is the question. Neurology 78, 688&#x2013;689. 10.1212/WNL.0b013e3182494c72.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e3182494c72</ArticleId><ArticleId IdType="pubmed">22323757</ArticleId></ArticleIdList></Reference><Reference><Citation>Winogrodzka A, Wagenaar RC, Booij J, and Wolters EC (2005). Rigidity and bradykinesia reduce interlimb coordination in Parkinsonian gait [J]. Arch Phys Med Rehabil 86, 183&#x2013;189.</Citation><ArticleIdList><ArticleId IdType="pubmed">15706541</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Z, Kang SS, Liu X, Ahn EH, Zhang Z, He L, Iuvone PM, Duong DM, Seyfried NT, Benskey MJ, et al. (2017). Asparagine endopeptidase cleaves alpha-synuclein and mediates pathologic activities in Parkinson&#x2019;s disease. Nat. Struct. Mol. Biol 24, 632&#x2013;642. 10.1038/nsmb.3433.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nsmb.3433</ArticleId><ArticleId IdType="pmc">PMC5871868</ArticleId><ArticleId IdType="pubmed">28671665</ArticleId></ArticleIdList></Reference><Reference><Citation>Conway KA, Rochet JC, Bieganski RM, and Lansbury PT Jr. (2001). Kinetic stabilization of the alpha-synuclein protofibril by a dopamine-alpha-synuclein adduct. Science 294, 1346&#x2013;1349. 10.1126/science.1063522.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1063522</ArticleId><ArticleId IdType="pubmed">11701929</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu Q, Uversky VN, Huang M, Kang H, Xu F, Liu X, Lian L, Liang Q, Jiang H, Liu A, et al. (2016). Baicalein inhibits alpha-synuclein oligomer formation and prevents progression of alpha-synuclein accumulation in a rotenone mouse model of Parkinson&#x2019;sdisease. Biochim. Biophys. Acta 1862, 1883&#x2013;1890. 10.1016/j.bbadis.2016.07.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2016.07.008</ArticleId><ArticleId IdType="pubmed">27425033</ArticleId></ArticleIdList></Reference><Reference><Citation>Hung KC, Huang HJ, Wang YT, and Lin AM (2016). Baicalein attenuates alpha-synuclein aggregation, inflammasome activation and autophagy in the MPP(+)-treated nigrostriatal dopaminergic system in vivo. J. Ethnopharmacol 194, 522&#x2013;529. 10.1016/j.jep.2016.10.040.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jep.2016.10.040</ArticleId><ArticleId IdType="pubmed">27742410</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X, Jin H, Padakanti PK, Li J, Yang H, Fan J, Mach RH, Kotzbauer P, and Tu Z (2014). Radiosynthesis and in vivo evaluation of two PET radioligands for imaging alpha-synuclein. Appl. Sci. (Basel) 4, 66&#x2013;78. 10.3390/app4010066.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/app4010066</ArticleId><ArticleId IdType="pmc">PMC4310556</ArticleId><ArticleId IdType="pubmed">25642331</ArticleId></ArticleIdList></Reference><Reference><Citation>Wagner J, Ryazanov S, Leonov A, Levin J, Shi S, Schmidt F, Prix C, Pan-Montojo F, Bertsch U, Mitteregger-Kretzschmar G, et al. (2013). Anle138b: a novel oligomer modulator for disease-modifying therapy of neurodegenerative diseases such as prion and Parkinson&#x2019;s disease. Acta Neuropathol. 125, 795&#x2013;813. 10.1007/s00401-013-1114-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-013-1114-9</ArticleId><ArticleId IdType="pmc">PMC3661926</ArticleId><ArticleId IdType="pubmed">23604588</ArticleId></ArticleIdList></Reference><Reference><Citation>Volpicelli-Daley LA, Gamble KL, Schultheiss CE, Riddle DM, West AB, and Lee VM (2014). Formation of alpha-synuclein Lewy neurite-like aggregates in axons impedes the transport of distinct endosomes. Mol. Biol. Cell 25, 4010&#x2013;4023. 10.1091/mbc.E14-02-0741.</Citation><ArticleIdList><ArticleId IdType="doi">10.1091/mbc.E14-02-0741</ArticleId><ArticleId IdType="pmc">PMC4263445</ArticleId><ArticleId IdType="pubmed">25298402</ArticleId></ArticleIdList></Reference><Reference><Citation>Fodero-Tavoletti MT, Mulligan RS, Okamura N, Furumoto S, Rowe CC, Kudo Y, Masters CL, Cappai R, Yanai K, and Villemagne VL (2009). In vitro characterisation of BF227 binding to alpha-synuclein/Lewy bodies. Eur. J. Pharmacol 617, 54&#x2013;58. 10.1016/j.ejphar.2009.06.042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejphar.2009.06.042</ArticleId><ArticleId IdType="pubmed">19576880</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheres SHW (2020). Amyloid structure determination in RELION-3.1. Acta Crystallogr. Sect.: Struct. Biol 76, 94&#x2013;101.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7008511</ArticleId><ArticleId IdType="pubmed">32038040</ArticleId></ArticleIdList></Reference><Reference><Citation>Guerrero-Ferreira R, Taylor NM, Arteni AA, Kumari P, Mona D, Ringler P, Britschgi M, Lauer ME, Makky A, Verasdonck J, et al. (2019). Two new polymorphic structures of human full-length alpha-synuclein fibrils solved by cryo-electron microscopy. eLife 8, e48907. 10.7554/eLife.48907.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.48907</ArticleId><ArticleId IdType="pmc">PMC6957273</ArticleId><ArticleId IdType="pubmed">31815671</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Zhao C, Luo F, Liu Z, Gui X, Luo Z, Zhang X, Li D, Liu C, and Li X (2018). Amyloid fibril structure of &#x3b1;-synuclein determined by cryo-electron microscopy. Cell Res. 28, 897&#x2013;903.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6123497</ArticleId><ArticleId IdType="pubmed">30065316</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Y, Li J, Gu H, Wei D, Xu Y-C, Fu W, and Yu Z (2015). Conformational preferences of &#x3c0;&#x2013;&#x3c0; stacking between ligand and protein, analysis derived from crystal structure data geometric preference of &#x3c0;&#x2013;&#x3c0; interaction. Interdiscip. Sci. Comp. Life Sci 7, 211&#x2013;220.</Citation><ArticleIdList><ArticleId IdType="pubmed">26370211</ArticleId></ArticleIdList></Reference><Reference><Citation>&#x160;ukalovi&#x107; V, Zlatovi&#x107; M, Rogli&#x107; G, Kosti&#x107; Raja&#x10d;i&#x107; S, and Andri&#x107; D (2009). Application of hybrid density functional theory in calculation of edge-to-face interactions of receptor-ligand system. Acta Chim. Slov 56, 270&#x2013;277.</Citation></Reference><Reference><Citation>Lucas X, Bauz&#xe1; A, Frontera A, and Qui&#xf1;onero D (2016). A thorough anion&#x2013;&#x3c0; interaction study in biomolecules: on the importance of cooperativity effects. Chem. Sci 7, 1038&#x2013;1050.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5967298</ArticleId><ArticleId IdType="pubmed">29899893</ArticleId></ArticleIdList></Reference><Reference><Citation>Auffinger P, Hays FA, Westhof E, and Ho PS (2004). Halogen bonds in biological molecules. Proc. Natl. Acad. Sci. USA 101, 16789&#x2013;16794.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC529416</ArticleId><ArticleId IdType="pubmed">15557000</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Y, Hou S, Zhao K, Long H, Liu Z, Gao J, Zhang Y, Su X-D, Li D, and Liu C (2020). Cryo-EM structure of full-length &#x3b1;-synuclein amyloid fibril with Parkinson&#x2019;s disease familial A53T mutation. Cell Res. 30, 360&#x2013;362.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7118165</ArticleId><ArticleId IdType="pubmed">32203130</ArticleId></ArticleIdList></Reference><Reference><Citation>Schweighauser M, Shi Y, Tarutani A, Kametani F, Murzin AG, Ghetti B, Matsubara T, Tomita T, Ando T, and Hasegawa K (2020). Structures of &#x3b1;-synuclein filaments from multiple system atrophy. Nature 585, 464&#x2013;469.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7116528</ArticleId><ArticleId IdType="pubmed">32461689</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimozawa A, Ono M, Takahara D, Tarutani A, Imura S, Masuda-Suzukake M, Higuchi M, Yanai K, Hisanaga SI, and Hasegawa M (2017). Propagation of pathological &#x3b1;-synuclein in marmoset brain. Acta Neuropathol. Commun 5, 12. 10.1186/s40478-017-0413-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-017-0413-0</ArticleId><ArticleId IdType="pmc">PMC5289012</ArticleId><ArticleId IdType="pubmed">28148299</ArticleId></ArticleIdList></Reference><Reference><Citation>Eslamboli A, Romero-Ramos M, Burger C, Bjorklund T, Muzyczka N, Mandel RJ, Baker H, Ridley RM, and Kirik D (2007). Long-term consequences of human alpha-synuclein overexpression in the primate ventral midbrain. Brain 130, 799&#x2013;815. 10.1093/brain/awl382.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awl382</ArticleId><ArticleId IdType="pubmed">17303591</ArticleId></ArticleIdList></Reference><Reference><Citation>Villemagne VL, Okamura N, Pejoska S, Drago J, Mulligan RS, Ch&#xe9;telat G, O&#x2019;Keefe G, Jones G, Kung HF, Pontecorvo M, et al. (2012). Differential diagnosis in Alzheimer&#x2019;s disease and dementia with Lewy bodies via VMAT2 and amyloid imaging. Neurodegener. Dis 10, 161&#x2013;165. 10.1159/000334535.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000334535</ArticleId><ArticleId IdType="pubmed">22261520</ArticleId></ArticleIdList></Reference><Reference><Citation>Okamura N, Furumoto S, Fodero-Tavoletti MT, Mulligan RS, Harada R, Yates P, Pejoska S, Kudo Y, Masters CL, Yanai K, et al. (2014). Non-invasive assessment of Alzheimer&#x2019;s disease neurofibrillary pathology using 18F-THK5105 PET. Brain 137, 1762&#x2013;1771. 10.1093/brain/awu064.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awu064</ArticleId><ArticleId IdType="pubmed">24681664</ArticleId></ArticleIdList></Reference><Reference><Citation>Kikuchi T, Okamura T, Zhang MR, Fukushi K, and Irie T (2010). In vivo evaluation of N-[18F]fluoroethylpiperidin-4ylmethyl acetate in rats compared with MP4A as a probe for measuring cerebral acetylcholinesterase activity. Synapse 64, 209&#x2013;215. 10.1002/syn.20720.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/syn.20720</ArticleId><ArticleId IdType="pubmed">19862687</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu L, Cui J, Padakanti PK, Engel L, Bagchi DP, Kotzbauer PT, and Tu Z (2012). Synthesis and in vitro evaluation of alpha-synuclein ligands. Bioorg. Med. Chem 20, 4625&#x2013;4634. 10.1016/j.bmc.2012.06.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bmc.2012.06.023</ArticleId><ArticleId IdType="pmc">PMC3401268</ArticleId><ArticleId IdType="pubmed">22789706</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu W, Zhou D, Gaba V, Liu J, Li S, Peng X, Xu J, Dhavale D, Bagchi DP, d&#x2019;Avignon A, et al. (2015). Design, synthesis, and characterization of 3-(benzylidene)indolin-2-one derivatives as ligands for alpha-synuclein fibrils. J. Med. Chem 58, 6002&#x2013;6017. 10.1021/acs.jmedchem.5b00571.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jmedchem.5b00571</ArticleId><ArticleId IdType="pmc">PMC4624220</ArticleId><ArticleId IdType="pubmed">26177091</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu M, Rajamani S, Kaylor J, Han S, Zhou F, and Fink AL (2004). The flavonoid baicalein inhibits fibrillation of alpha-synuclein and disaggregates existing fibrils. J. Biol. Chem 279, 26846&#x2013;26857. 10.1074/jbc.M403129200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M403129200</ArticleId><ArticleId IdType="pubmed">15096521</ArticleId></ArticleIdList></Reference><Reference><Citation>Meng X, Munishkina LA, Fink AL, and Uversky VN (2009). Molecular mechanisms underlying the flavonoid-induced inhibition of alpha-synuclein fibrillation. Biochemistry 48, 8206&#x2013;8224. 10.1021/bi900506b.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/bi900506b</ArticleId><ArticleId IdType="pubmed">19634918</ArticleId></ArticleIdList></Reference><Reference><Citation>Sch&#xfc;tz AK, Soragni A, Hornemann S, Aguzzi A, Ernst M, B&#xf6;ckmann A, and Meier BH (2011). The amyloid&#x2013;Congo red interface at atomic resolution. Angew. Chem. Int. Ed. Engl 50, 5956&#x2013;5960.</Citation><ArticleIdList><ArticleId IdType="pubmed">21591034</ArticleId></ArticleIdList></Reference><Reference><Citation>Landau M, Sawaya MR, Faull KF, Laganowsky A, Jiang L, Sievers SA, Liu J, Barrio JR, and Eisenberg D (2011). Towards a pharmacophore for amyloid. PLoS Biol. 9, e1001080.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3114762</ArticleId><ArticleId IdType="pubmed">21695112</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolfe LS, Calabrese MF, Nath A, Blaho DV, Miranker AD, and Xiong Y (2010). Protein-induced photophysical changes to the amyloid indicator dye Thioflavin T. Proc. Natl. Acad. Sci. USA 107, 16863&#x2013;16868.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2947910</ArticleId><ArticleId IdType="pubmed">20826442</ArticleId></ArticleIdList></Reference><Reference><Citation>Childers WS, Mehta AK, Lu K, and Lynn DG (2009). Templating molecular arrays in amyloid&#x2019;s cross-&#x3b2; grooves. J. Am. Chem. Soc 131, 10165&#x2013;10172.</Citation><ArticleIdList><ArticleId IdType="pubmed">19569651</ArticleId></ArticleIdList></Reference><Reference><Citation>Krebs MR, Bromley EH, and Donald AM (2005). The binding of thioflavin-T to amyloid fibrils: localisation and implications. J. Struct. Biol 149, 30&#x2013;37.</Citation><ArticleIdList><ArticleId IdType="pubmed">15629655</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi Y, Murzin AG, Falcon B, Epstein A, Machin J, Tempest P, Newell KL, Vidal R, Garringer HJ, and Sahara N (2021). Cryo-EM structures of tau filaments from Alzheimer&#x2019;s disease with PET ligand APN-1607. Acta Neuropathol. 141, 697&#x2013;708.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8043864</ArticleId><ArticleId IdType="pubmed">33723967</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrie JJ, Lengyel-Zhand Z, Janssen B, Lougee MG, Giannakoulias S, Hsieh C-J, Pagar VV, Weng C-C, Xu H, and Graham TJ (2020). Identification of a nanomolar affinity &#x3b1;-synuclein fibril imaging probe by ultra-high throughput in silico screening. Chem. Sci 11, 12746&#x2013;12754.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8047729</ArticleId><ArticleId IdType="pubmed">33889379</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang L, Liu C, Leibly D, Landau M, Zhao M, Hughes MP, and Eisenberg DS (2013). Structure-based discovery of fiber-binding compounds that reduce the cytotoxicity of amyloid beta. eLife 2, e00857.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3713518</ArticleId><ArticleId IdType="pubmed">23878726</ArticleId></ArticleIdList></Reference><Reference><Citation>Korat &#x160;, Bidesi NSR, Bonanno F, Di Nanni A, Ho&#xe0;ng ANN, Herfert K, Maurer A, Battisti UM, Bowden GD, and Thonon D (2021). Alpha-synuclein PET tracer development&#x2014;an overview about current efforts. Pharmaceuticals (Basel) 14, 847.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8466155</ArticleId><ArticleId IdType="pubmed">34577548</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y, Shi Y, Schweighauser M, Zhang X, Kotecha A, Murzin AG, Garringer HJ, Cullinane PW, Saito Y, Foroud T, et al. (2022). Structures of alpha-synuclein filaments from human brains with Lewy pathology [J]. Nature 610, 791&#x2013;795.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7613749</ArticleId><ArticleId IdType="pubmed">36108674</ArticleId></ArticleIdList></Reference><Reference><Citation>Schneider CA, Rasband WS, and Eliceiri KW (2012). NIH Image to ImageJ: 25 years of image analysis. Nat. Methods 9, 671&#x2013;675. 10.1038/nmeth.2089.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.2089</ArticleId><ArticleId IdType="pmc">PMC5554542</ArticleId><ArticleId IdType="pubmed">22930834</ArticleId></ArticleIdList></Reference><Reference><Citation>Emsley P, Lohkamp B, Scott WG, and Cowtan K (2010). Features and development of coot. Acta Crystallogr. D Biol. Crystallogr 66, 486&#x2013;501. 10.1107/S0907444910007493.</Citation><ArticleIdList><ArticleId IdType="doi">10.1107/S0907444910007493</ArticleId><ArticleId IdType="pmc">PMC2852313</ArticleId><ArticleId IdType="pubmed">20383002</ArticleId></ArticleIdList></Reference><Reference><Citation>Adams PD, Afonine PV, Bunk&#xf3;czi G, Chen VB, Davis IW, Echols N, Headd JJ, Hung LW, Kapral GJ, Grosse-Kunstleve RW, et al. (2010). Phenix: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr. D Biol. Crystallogr 66, 213&#x2013;221. 10.1107/S0907444909052925.</Citation><ArticleIdList><ArticleId IdType="doi">10.1107/S0907444909052925</ArticleId><ArticleId IdType="pmc">PMC2815670</ArticleId><ArticleId IdType="pubmed">20124702</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiu L, Jiang H, Yu Y, Gu J, Wang J, Zhao H, Huang T, Gropler RJ, Klein RS, Perlmutter JS, and Tu Z (2022). Radiosynthesis and evaluation of a fluorine-18 radiotracer [(18)F]FS1P1 for imaging sphingo-sine-1-phosphate receptor 1. Org. Biomol. Chem 20, 1041&#x2013;1052. 10.1039/d1ob02225c.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/d1ob02225c</ArticleId><ArticleId IdType="pmc">PMC8970350</ArticleId><ArticleId IdType="pubmed">35029272</ArticleId></ArticleIdList></Reference><Reference><Citation>Bindoli S, Galozzi P, Magnani F, Rubin L, Campi C, Doria A, Cecchin D, and Sfriso P (2020). F-Fluorodeoxyglucose positron emission tomography and computed tomography with magnetic resonance for diagnosing adult-onset Still&#x2019;s disease. Front. Med. (Lausanne) 18, 544412. 10.3389/fmed.2020.544412.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2020.544412</ArticleId><ArticleId IdType="pmc">PMC7649810</ArticleId><ArticleId IdType="pubmed">33195296</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang ZH, Liu P, Liu X, Yu SP, Wang JZ, and Ye K (2018). Delta-secretase (AEP) mediates tau-splicing imbalance and accelerates cognitive decline in tauopathies. J. Exp. Med 215, 3038&#x2013;3056. 10.1084/jem.20180539.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20180539</ArticleId><ArticleId IdType="pmc">PMC6279401</ArticleId><ArticleId IdType="pubmed">30373880</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahn EH, Kang SS, Liu X, Chen G, Zhang Z, Chandrasekharan B, Alam AM, Neish AS, Cao X, and Ye K (2020). Initiation of Parkinson&#x2019;s disease from gut to brain by delta-secretase. Cell Res. 30, 70&#x2013;87. 10.1038/s41422-019-0241-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41422-019-0241-9</ArticleId><ArticleId IdType="pmc">PMC6951265</ArticleId><ArticleId IdType="pubmed">31649329</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller DL, Papayannopoulos IA, Styles J, Bobin SA, Lin YY, Biemann K, and Iqbal K (1993). Peptide compositions of the cerebrovascular and senile plaque core amyloid deposits of Alzheimer&#x2019;s disease. Arch. Biochem. Biophys 301, 41&#x2013;52. 10.1006/abbi.1993.1112.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/abbi.1993.1112</ArticleId><ArticleId IdType="pubmed">8442665</ArticleId></ArticleIdList></Reference><Reference><Citation>Fitzpatrick AWP, Falcon B, He S, Murzin AG, Murshudov G, Garringer HJ, Crowther RA, Ghetti B, Goedert M, and Scheres SHW (2017). Cryo-EM structures oftau filaments from Alzheimer&#x2019;s disease. Nature 547, 185&#x2013;190. 10.1038/nature23002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature23002</ArticleId><ArticleId IdType="pmc">PMC5552202</ArticleId><ArticleId IdType="pubmed">28678775</ArticleId></ArticleIdList></Reference><Reference><Citation>Goedert M, Spillantini MG, Cairns NJ, and Crowther RA (1992). Tau proteins of Alzheimer paired helical filaments: abnormal phosphorylation of all six brain isoforms. Neuron 8, 159&#x2013;168. 10.1016/0896-6273(92)90117-v.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0896-6273(92)90117-v</ArticleId><ArticleId IdType="pubmed">1530909</ArticleId></ArticleIdList></Reference><Reference><Citation>Iqbal K, Zaidi T, Thompson CH, Merz PA, and Wisniewski HM (1984). Alzheimer paired helical filaments: bulk isolation, solubility, and protein composition. Acta Neuropathol. 62, 167&#x2013;177. 10.1007/BF00691849.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF00691849</ArticleId><ArticleId IdType="pubmed">6538056</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng C, Gathagan RJ, Covell DJ, Medellin C, Stieber A, Robinson JL, Zhang B, Pitkin RM, Olufemi MF, Luk KC, et al. (2018). Cellular milieu imparts distinct pathological alpha-synuclein strains in alpha-synucleinopathies. Nature 557, 558&#x2013;563. 10.1038/s41586-018-0104-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-018-0104-4</ArticleId><ArticleId IdType="pmc">PMC5970994</ArticleId><ArticleId IdType="pubmed">29743672</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheldrick GM (2015). Crystal structure refinement with SHELXL. Acta Crystallogr. C Struct. Chem 71, 3&#x2013;8. 10.1107/S2053229614024218.</Citation><ArticleIdList><ArticleId IdType="doi">10.1107/S2053229614024218</ArticleId><ArticleId IdType="pmc">PMC4294323</ArticleId><ArticleId IdType="pubmed">25567568</ArticleId></ArticleIdList></Reference><Reference><Citation>Dolomanov OV, Bourhis LJ, Gildea RJ, Howard JAK, and Puschmann H (2009). OLEX2: A complete structure solution, refinement and analysis program. J. Appl. Crystallogr 42, 339&#x2013;341. 10.1107/S0021889808042726.</Citation><ArticleIdList><ArticleId IdType="doi">10.1107/S0021889808042726</ArticleId></ArticleIdList></Reference><Reference><Citation>Klunk WE, Wang Y, Huang GF, Debnath ML, Holt DP, Shao L, Hamilton RL, Ikonomovic MD, DeKosky ST, and Mathis CA (2003). The binding of 2-(4&#x2032;-methylaminophenyl)benzothiazole to post-mortem brain homogenates is dominated by the amyloid component. J. Neurosci 23, 2086&#x2013;2092.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6741999</ArticleId><ArticleId IdType="pubmed">12657667</ArticleId></ArticleIdList></Reference><Reference><Citation>Hostetler ED, Walji AM, Zeng Z, Miller P, Bennacef I, Salinas C, Connolly B, Gantert L, Haley H, Holahan M, et al. (2016). Preclinical characterization of 18F-MK-6240, a promising PET tracer for in vivo quantification of human neurofibrillary tangles. J. Nucl. Med 57, 1599&#x2013;1606. 10.2967/jnumed.115.171678.</Citation><ArticleIdList><ArticleId IdType="doi">10.2967/jnumed.115.171678</ArticleId><ArticleId IdType="pubmed">27230925</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng SQ, Palovcak E, Armache J-P, Verba KA, Cheng Y, and Agard DA (2017). MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy. Nat. Methods 14, 331&#x2013;332.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5494038</ArticleId><ArticleId IdType="pubmed">28250466</ArticleId></ArticleIdList></Reference><Reference><Citation>Rohou A, and Grigorieff N (2015). CTFFIND4: fast and accurate defocus estimation from electron micrographs. J. Struct. Biol 192, 216&#x2013;221.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6760662</ArticleId><ArticleId IdType="pubmed">26278980</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37443334</PMID><DateCompleted><Year>2023</Year><Month>08</Month><Day>17</Day></DateCompleted><DateRevised><Year>2024</Year><Month>06</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1546-170X</ISSN><JournalIssue CitedMedium="Internet"><Volume>29</Volume><Issue>8</Issue><PubDate><Year>2023</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Nature medicine</Title><ISOAbbreviation>Nat Med</ISOAbbreviation></Journal><ArticleTitle>CSF MTBR-tau243 is a specific biomarker of tau tangle pathology in Alzheimer's disease.</ArticleTitle><Pagination><StartPage>1954</StartPage><EndPage>1963</EndPage><MedlinePgn>1954-1963</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41591-023-02443-z</ELocationID><Abstract><AbstractText>Aggregated insoluble tau is one of two defining features of Alzheimer's disease. Because clinical symptoms are strongly correlated with tau aggregates, drug development and clinical diagnosis need cost-effective and accessible specific fluid biomarkers of tau aggregates; however, recent studies suggest that the fluid biomarkers currently available cannot specifically track tau aggregates. We show that the microtubule-binding region (MTBR) of tau containing the residue 243 (MTBR-tau243) is a new cerebrospinal fluid (CSF) biomarker specific for insoluble tau aggregates and compared it to multiple other phosphorylated tau measures (p-tau181, p-tau205, p-tau217 and p-tau231) in two independent cohorts (BioFINDER-2, n&#x2009;=&#x2009;448; and Knight Alzheimer Disease Research Center, n&#x2009;=&#x2009;219). MTBR-tau243 was most strongly associated with tau-positron emission tomography (PET) and cognition, whereas showing the lowest association with amyloid-PET. In combination with p-tau205, MTBR-tau243 explained most of the total variance in tau-PET burden (0.58&#x2009;&#x2264;&#x2009;R<sup>2</sup>&#x2009;&#x2264;&#x2009;0.75) and the performance in predicting cognitive measures (0.34&#x2009;&#x2264;&#x2009;R<sup>2</sup>&#x2009;&#x2264;&#x2009;0.48) approached that of tau-PET (0.44&#x2009;&#x2264;&#x2009;R<sup>2</sup>&#x2009;&#x2264;&#x2009;0.52). MTBR-tau243 levels longitudinally increased with insoluble tau aggregates, unlike CSF p-tau species. CSF MTBR-tau243 is a specific biomarker of tau aggregate pathology, which may be utilized in interventional trials and in the diagnosis of patients. Based on these findings, we propose to revise the A/T/(N) criteria to include MTBR-tau243 as representing insoluble tau aggregates ('T').</AbstractText><CopyrightInformation>&#xa9; 2023. This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Horie</LastName><ForeName>Kanta</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0001-7736-2614</Identifier><AffiliationInfo><Affiliation>The Tracy Family SILQ Center, Washington University School of Medicine, St Louis, MO, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Washington University School of Medicine, St. Louis, MO, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Eisai Inc., Nutley, NJ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Salvad&#xf3;</LastName><ForeName>Gemma</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-5210-9230</Identifier><AffiliationInfo><Affiliation>Clinical Memory Research Unit, Department of Clinical Sciences Malm&#xf6;, Lund University, Lund, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barth&#xe9;lemy</LastName><ForeName>Nicolas R</ForeName><Initials>NR</Initials><AffiliationInfo><Affiliation>The Tracy Family SILQ Center, Washington University School of Medicine, St Louis, MO, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Washington University School of Medicine, St. Louis, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Janelidze</LastName><ForeName>Shorena</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-2869-8378</Identifier><AffiliationInfo><Affiliation>Clinical Memory Research Unit, Department of Clinical Sciences Malm&#xf6;, Lund University, Lund, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Yan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Neurology, Washington University School of Medicine, St. Louis, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>He</LastName><ForeName>Yingxin</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0003-2543-4553</Identifier><AffiliationInfo><Affiliation>The Tracy Family SILQ Center, Washington University School of Medicine, St Louis, MO, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Washington University School of Medicine, St. Louis, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saef</LastName><ForeName>Benjamin</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Neurology, Washington University School of Medicine, St. Louis, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Charles D</ForeName><Initials>CD</Initials><AffiliationInfo><Affiliation>Department of Radiology, Washington University School of Medicine, St. Louis, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Hong</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Neurology, Washington University School of Medicine, St. Louis, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Strandberg</LastName><ForeName>Olof</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Clinical Memory Research Unit, Department of Clinical Sciences Malm&#xf6;, Lund University, Lund, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pichet Binette</LastName><ForeName>Alexa</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-5218-3337</Identifier><AffiliationInfo><Affiliation>Clinical Memory Research Unit, Department of Clinical Sciences Malm&#xf6;, Lund University, Lund, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Palmqvist</LastName><ForeName>Sebastian</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-9267-1930</Identifier><AffiliationInfo><Affiliation>Clinical Memory Research Unit, Department of Clinical Sciences Malm&#xf6;, Lund University, Lund, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Memory Clinic, Sk&#xe5;ne University Hospital, Malm&#xf6;, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sato</LastName><ForeName>Chihiro</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-7639-8727</Identifier><AffiliationInfo><Affiliation>The Tracy Family SILQ Center, Washington University School of Medicine, St Louis, MO, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Washington University School of Medicine, St. Louis, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sachdev</LastName><ForeName>Pallavi</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Eisai Inc., Nutley, NJ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koyama</LastName><ForeName>Akihiko</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Eisai Inc., Nutley, NJ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gordon</LastName><ForeName>Brian A</ForeName><Initials>BA</Initials><Identifier Source="ORCID">0000-0003-2109-2955</Identifier><AffiliationInfo><Affiliation>Department of Radiology, Washington University School of Medicine, St. Louis, MO, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Knight Alzheimer Disease Research Center, Washington University School of Medicine, St. Louis, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Benzinger</LastName><ForeName>Tammie L S</ForeName><Initials>TLS</Initials><Identifier Source="ORCID">0000-0002-8114-0552</Identifier><AffiliationInfo><Affiliation>Department of Radiology, Washington University School of Medicine, St. Louis, MO, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Knight Alzheimer Disease Research Center, Washington University School of Medicine, St. Louis, MO, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hope Center for Neurological Disorders, Washington University School of Medicine, St. Louis, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Holtzman</LastName><ForeName>David M</ForeName><Initials>DM</Initials><Identifier Source="ORCID">0000-0002-3400-0856</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Washington University School of Medicine, St. Louis, MO, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Knight Alzheimer Disease Research Center, Washington University School of Medicine, St. Louis, MO, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hope Center for Neurological Disorders, Washington University School of Medicine, St. Louis, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morris</LastName><ForeName>John C</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Department of Neurology, Washington University School of Medicine, St. Louis, MO, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Knight Alzheimer Disease Research Center, Washington University School of Medicine, St. Louis, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mattsson-Carlgren</LastName><ForeName>Niklas</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Clinical Memory Research Unit, Department of Clinical Sciences Malm&#xf6;, Lund University, Lund, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Wallenberg Center for Molecular Medicine, Lund University, Lund, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Sk&#xe5;ne University Hospital, Lund, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stomrud</LastName><ForeName>Erik</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Clinical Memory Research Unit, Department of Clinical Sciences Malm&#xf6;, Lund University, Lund, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Memory Clinic, Sk&#xe5;ne University Hospital, Malm&#xf6;, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ossenkoppele</LastName><ForeName>Rik</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0003-1584-7477</Identifier><AffiliationInfo><Affiliation>Clinical Memory Research Unit, Department of Clinical Sciences Malm&#xf6;, Lund University, Lund, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Alzheimer Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC location VUmc, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Amsterdam Neuroscience, Neurodegeneration, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schindler</LastName><ForeName>Suzanne E</ForeName><Initials>SE</Initials><Identifier Source="ORCID">0000-0002-1680-1465</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Washington University School of Medicine, St. Louis, MO, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Knight Alzheimer Disease Research Center, Washington University School of Medicine, St. Louis, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Hansson</LastName><ForeName>Oskar</ForeName><Initials>O</Initials><Identifier Source="ORCID">0000-0001-8467-7286</Identifier><AffiliationInfo><Affiliation>Clinical Memory Research Unit, Department of Clinical Sciences Malm&#xf6;, Lund University, Lund, Sweden. oskar.hansson@med.lu.se.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Memory Clinic, Sk&#xe5;ne University Hospital, Malm&#xf6;, Sweden. oskar.hansson@med.lu.se.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Bateman</LastName><ForeName>Randall J</ForeName><Initials>RJ</Initials><Identifier Source="ORCID">0000-0002-7729-1702</Identifier><AffiliationInfo><Affiliation>The Tracy Family SILQ Center, Washington University School of Medicine, St Louis, MO, USA. batemanr@wustl.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Washington University School of Medicine, St. Louis, MO, USA. batemanr@wustl.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Knight Alzheimer Disease Research Center, Washington University School of Medicine, St. Louis, MO, USA. batemanr@wustl.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hope Center for Neurological Disorders, Washington University School of Medicine, St. Louis, MO, USA. batemanr@wustl.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P30 AG066444</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG070941</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P01 AG003991</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P01 AG026276</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 NS048056</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>S10 OD025214</GrantID><Acronym>OD</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>07</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Nat Med</MedlineTA><NlmUniqueID>9502015</NlmUniqueID><ISSNLinking>1078-8956</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016875">tau Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016229">Amyloid beta-Peptides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Nat Rev Drug Discov. 2023 Sep;22(9):697. doi: 10.1038/d41573-023-00126-5.</RefSource><PMID Version="1">37528207</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016875" MajorTopicYN="N">tau Proteins</DescriptorName><QualifierName UI="Q000134" MajorTopicYN="N">cerebrospinal fluid</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016229" MajorTopicYN="N">Amyloid beta-Peptides</DescriptorName><QualifierName UI="Q000134" MajorTopicYN="N">cerebrospinal fluid</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D049268" MajorTopicYN="N">Positron-Emission Tomography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000134" MajorTopicYN="N">cerebrospinal fluid</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D060825" MajorTopicYN="Y">Cognitive Dysfunction</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>K.H. is an Eisai-sponsored voluntary research associate professor at Washington University and has received salary from Eisai. Washington University. R.J.B. and D.M.H. have equity ownership interest in C2N Diagnostics. R.J.B. and D.M.H. receive income from C2N Diagnostics for serving on the scientific advisory board. K.H., N.R.B., C.S. and R.J.B. may receive income based on technology (Methods to Detect MTBR-tau Isoforms and use Thereof) (PCT/US2020/046224) licensed by Washington University to C2N Diagnostics. H.J. and D.M.H. may receive income based on technology (Anti-tau MTBR Antibodies and Methods to Detect Endogenously Cleaved Fragments of Tau and uses Thereof) (USSN 63/400,345) licensed by Washington University to C2N Diagnostics. R.J.B. is an unpaid scientific advisory board member of Roche and Biogen and receives research funding from Avid Radiopharmaceuticals, Janssen, Roche/Genentech, Eli Lilly, Eisai, Biogen, AbbVie, Bristol Myers Squibb and Novartis. O.H. has acquired research support (for the institution) from ADx, Avid Radiopharmaceuticals, Biogen, Eli Lilly, Eisai, Fujirebio, GE Healthcare, Pfizer and Roche. In the past 2 years, he has received consultancy/speaker fees from AC Immune, Amylyx, Alzpath, BioArctic, Biogen, Cerveau, Eisai, Fujirebio, Genentech, Novartis, Roche and Siemens. S.E.S. has analyzed data provided by C2N Diagnostics to Washington University, but she has not received any research funding or personal compensation from C2N Diagnostics. She has served on a scientific advisory board for Eisai. D.M.H. is on the scientific advisory board of Genentech, Denali and Cajal Neurosciences and consults for Alector. S.P. has served on scientific advisory boards and/or given lectures in symposia sponsored by BioArtic, Biogen, Cytox, Eli Lilly, Geras Solutions and Roche. The remaining authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>1</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>6</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>17</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>7</Month><Day>14</Day><Hour>13</Hour><Minute>7</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>7</Month><Day>13</Day><Hour>23</Hour><Minute>58</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>7</Month><Day>13</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37443334</ArticleId><ArticleId IdType="pmc">PMC10427417</ArticleId><ArticleId IdType="doi">10.1038/s41591-023-02443-z</ArticleId><ArticleId IdType="pii">10.1038/s41591-023-02443-z</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ossenkoppele R, van der Kant R, Hansson O. Tau biomarkers in Alzheimer&#x2019;s disease: towards implementation in clinical practice and trials. Lancet Neurol. 2022;21:726&#x2013;734.</Citation><ArticleIdList><ArticleId IdType="pubmed">35643092</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith R, Wibom M, Pawlik D, Englund E, Hansson O. Correlation of in vivo [18f]flortaucipir with postmortem Alzheimer disease tau pathology. JAMA Neurol. 2019;76:310&#x2013;317.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6439731</ArticleId><ArticleId IdType="pubmed">30508025</ArticleId></ArticleIdList></Reference><Reference><Citation>Fleisher AS, et al. Positron emission tomography imaging with [18f]flortaucipir and postmortem assessment of Alzheimer disease neuropathologic changes. JAMA Neurol. 2020;77:829&#x2013;839.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7186920</ArticleId><ArticleId IdType="pubmed">32338734</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith R, et al. 18F-AV-1451 tau PET imaging correlates strongly with tau neuropathology in MAPT mutation carriers. Brain. 2016;139:2372&#x2013;2379.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4995360</ArticleId><ArticleId IdType="pubmed">27357347</ArticleId></ArticleIdList></Reference><Reference><Citation>Soleimani-Meigooni DN, et al. 18F-flortaucipir PET to autopsy comparisons in Alzheimer&#x2019;s disease and other neurodegenerative diseases. Brain. 2020;143:3477&#x2013;3494.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7719031</ArticleId><ArticleId IdType="pubmed">33141172</ArticleId></ArticleIdList></Reference><Reference><Citation>Lowe VJ, et al. Tau-positron emission tomography correlates with neuropathology findings. Alzheimers Dement. 2020;16:561&#x2013;571.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7067654</ArticleId><ArticleId IdType="pubmed">31784374</ArticleId></ArticleIdList></Reference><Reference><Citation>Ossenkoppele R, et al. Amyloid and tau PET-positive cognitively unimpaired individuals are at high risk for future cognitive decline. Nat. Med. 2022;28:2381&#x2013;2387.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9671808</ArticleId><ArticleId IdType="pubmed">36357681</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith R, et al. Tau-PET is superior to phospho-tau when predicting cognitive decline in symptomatic AD patients. Alzheimers Dement. 2023;19:2497&#x2013;2507.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10264552</ArticleId><ArticleId IdType="pubmed">36516028</ArticleId></ArticleIdList></Reference><Reference><Citation>Sato C, et al. Tau kinetics in neurons and the human central nervous system. Neuron. 2018;97:1284&#x2013;1298.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6137722</ArticleId><ArticleId IdType="pubmed">29566794</ArticleId></ArticleIdList></Reference><Reference><Citation>Cicognola C, et al. Novel tau fragments in cerebrospinal fluid: relation to tangle pathology and cognitive decline in Alzheimer&#x2019;s disease. Acta Neuropathol. 2019;137:279&#x2013;296.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6514201</ArticleId><ArticleId IdType="pubmed">30547227</ArticleId></ArticleIdList></Reference><Reference><Citation>Barth&#xe9;lemy, N. R., Horie, K., Sato, C. &amp; Bateman, R. J. Blood plasma phosphorylated-tau isoforms track CNS change in Alzheimer&#x2019;s disease. J. Exp. Med. 10.1084/jem.20200861 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7596823</ArticleId><ArticleId IdType="pubmed">32725127</ArticleId></ArticleIdList></Reference><Reference><Citation>Janelidze S, et al. Plasma P-tau181 in Alzheimer&#x2019;s disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer&#x2019;s dementia. Nat. Med. 2020;26:379&#x2013;386.</Citation><ArticleIdList><ArticleId IdType="pubmed">32123385</ArticleId></ArticleIdList></Reference><Reference><Citation>Palmqvist S, et al. Discriminative accuracy of plasma phospho-tau217 for Alzheimer disease vs other neurodegenerative disorders. JAMA. 2020;324:772&#x2013;781.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7388060</ArticleId><ArticleId IdType="pubmed">32722745</ArticleId></ArticleIdList></Reference><Reference><Citation>Thijssen EH, et al. Diagnostic value of plasma phosphorylated tau181 in Alzheimer&#x2019;s disease and frontotemporal lobar degeneration. Nat. Med. 2020;26:387&#x2013;397.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7101073</ArticleId><ArticleId IdType="pubmed">32123386</ArticleId></ArticleIdList></Reference><Reference><Citation>Karikari TK, et al. Blood phosphorylated tau 181 as a biomarker for Alzheimer&#x2019;s disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts. Lancet Neurol. 2020;19:422&#x2013;433.</Citation><ArticleIdList><ArticleId IdType="pubmed">32333900</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Connor A, et al. Plasma phospho-tau181 in presymptomatic and symptomatic familial Alzheimer&#x2019;s disease: a longitudinal cohort study. Mol. Psychiatry. 2021;26:5967&#x2013;5976.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7612227</ArticleId><ArticleId IdType="pubmed">32665603</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashton NJ, et al. Plasma p-tau231: a new biomarker for incipient Alzheimer&#x2019;s disease pathology. Acta Neuropathol. 2021;141:709&#x2013;724.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8043944</ArticleId><ArticleId IdType="pubmed">33585983</ArticleId></ArticleIdList></Reference><Reference><Citation>Therriault, J. et al. Association of phosphorylated tau biomarkers with amyloid positron emission tomography vs tau positron emission tomography. JAMA Neurol.10.1001/jamaneurol.2022.4485 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9856704</ArticleId><ArticleId IdType="pubmed">36508198</ArticleId></ArticleIdList></Reference><Reference><Citation>Mattsson&#x2010;Carlgren N, et al. Soluble P&#x2010;tau217 reflects amyloid and tau pathology and mediates the association of amyloid with tau. EMBO Mol. Med. 2021;13:e14022.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8185545</ArticleId><ArticleId IdType="pubmed">33949133</ArticleId></ArticleIdList></Reference><Reference><Citation>Salvad&#xf3;, G. et al. Specific associations between plasma biomarkers and postmortem amyloid plaque and tau tangle loads. EMBO Mol. Med.10.15252/emmm.202217123 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10165361</ArticleId><ArticleId IdType="pubmed">36912178</ArticleId></ArticleIdList></Reference><Reference><Citation>Barth&#xe9;lemy NR, et al. A soluble phosphorylated tau signature links tau, amyloid and the evolution of stages of dominantly inherited Alzheimer&#x2019;s disease. Nat. Med. 2020;26:398&#x2013;407.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7309367</ArticleId><ArticleId IdType="pubmed">32161412</ArticleId></ArticleIdList></Reference><Reference><Citation>Mil&#xe0;-Alom&#xe0;, M. etal. Plasma p-tau231 and p-tau217 as state markers of amyloid-&#x3b2; pathology in preclinical Alzheimer&#x2019;s disease. Nat. Med. 10.1038/s41591-022-01925-w (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9499867</ArticleId><ArticleId IdType="pubmed">35953717</ArticleId></ArticleIdList></Reference><Reference><Citation>Mattsson-Carlgren N, et al. A&#x3b2; deposition is associated with increases in soluble and phosphorylated tau that precede a positive Tau PET in Alzheimer&#x2019;s disease. Sci. Adv. 2020;6:eaaz2387.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7159908</ArticleId><ArticleId IdType="pubmed">32426454</ArticleId></ArticleIdList></Reference><Reference><Citation>Janelidze S, et al. Associations of plasma phospho-tau217 levels with tau positron emission tomography in early Alzheimer disease. JAMA Neurol. 2021;78:149&#x2013;156.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7653537</ArticleId><ArticleId IdType="pubmed">33165506</ArticleId></ArticleIdList></Reference><Reference><Citation>Pontecorvo, M. J. et al. Association of donanemab treatment with exploratory plasma biomarkers in early symptomatic Alzheimer disease: a secondary analysis of the TRAILBLAZER-ALZ randomized clinical trial. JAMA Neurol.10.1001/jamaneurol.2022.3392 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9577883</ArticleId><ArticleId IdType="pubmed">36251300</ArticleId></ArticleIdList></Reference><Reference><Citation>Budd Haeberlein S, et al. Two randomized phase 3 studies of aducanumab in early Alzheimer&#x2019;s disease. J. Prev. Alzheimers Dis. 2022;9:197&#x2013;210.</Citation><ArticleIdList><ArticleId IdType="pubmed">35542991</ArticleId></ArticleIdList></Reference><Reference><Citation>Salloway S, et al. A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer&#x2019;s disease. Nat. Med. 2021;27:1187&#x2013;1196.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8988051</ArticleId><ArticleId IdType="pubmed">34155411</ArticleId></ArticleIdList></Reference><Reference><Citation>van Dyck, C. H. et al. Lecanemab in early Alzheimer&#x2019;s disease. N. Engl. J. Med. 10.1056/NEJMoa2212948 (2022).</Citation></Reference><Reference><Citation>Barth&#xe9;lemy NR, et al. CSF tau phosphorylation occupancies at T217 and T205 represent improved biomarkers of amyloid and tau pathology in Alzheimer&#x2019;s disease. Nat. Aging. 2023;3:391&#x2013;401.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10154225</ArticleId><ArticleId IdType="pubmed">37117788</ArticleId></ArticleIdList></Reference><Reference><Citation>Schelle J, et al. Prevention of tau increase in cerebrospinal fluid of APP transgenic mice suggests downstream effect of BACE1 inhibition. Alzheimer&#x2019;s Dement. 2017;13:701&#x2013;709.</Citation><ArticleIdList><ArticleId IdType="pubmed">27750032</ArticleId></ArticleIdList></Reference><Reference><Citation>Maia LF, et al. Changes in amyloid-&#x3b2; and tau in the cerebrospinal fluid of transgenic mice overexpressing amyloid precursor protein. Sci. Transl. Med. 2013;5:194re2.</Citation><ArticleIdList><ArticleId IdType="pubmed">23863834</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaeser SA, et al. CSF p-tau increase in response to A&#x3b2;-type and Danish-type cerebral amyloidosis and in the absence of neurofibrillary tangles. Acta Neuropathol. 2022;143:287&#x2013;290.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8742811</ArticleId><ArticleId IdType="pubmed">34961894</ArticleId></ArticleIdList></Reference><Reference><Citation>Horie K, Barth&#xe9;lemy NR, Sato C, Bateman RJ. CSF tau microtubule binding region identifies tau tangle and clinical stages of Alzheimer&#x2019;s disease. Brain. 2021;144:515&#x2013;527.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7940175</ArticleId><ArticleId IdType="pubmed">33283854</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts M, et al. Pre-clinical characterisation of E2814, a high-affinity antibody targeting the microtubule-binding repeat domain of tau for passive immunotherapy in Alzheimer&#x2019;s disease. Acta Neuropathol. Commun. 2020;8:13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7001291</ArticleId><ArticleId IdType="pubmed">32019610</ArticleId></ArticleIdList></Reference><Reference><Citation>Taniguchi-Watanabe S, et al. Biochemical classification of tauopathies by immunoblot, protein sequence and mass spectrometric analyses of sarkosyl-insoluble and trypsin-resistant tau. Acta Neuropathol. 2016;131:267&#x2013;280.</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi Y, et al. Structure-based classification of tauopathies. Nature. 2021;598:359&#x2013;363.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7611841</ArticleId><ArticleId IdType="pubmed">34588692</ArticleId></ArticleIdList></Reference><Reference><Citation>Fitzpatrick AWP, et al. Cryo-EM structures of tau filaments from Alzheimer&#x2019;s disease. Nature. 2017;547:185&#x2013;190.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5552202</ArticleId><ArticleId IdType="pubmed">28678775</ArticleId></ArticleIdList></Reference><Reference><Citation>Janelidze, S. et al. Head-to-head comparison of 10 plasma phospho-tau assays in prodromal Alzheimer&#x2019;s disease. Brain10.1093/brain/awac333 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10115176</ArticleId><ArticleId IdType="pubmed">36087307</ArticleId></ArticleIdList></Reference><Reference><Citation>Binette AP, et al. Amyloid-associated increases in soluble tau is a key driver in accumulation of tau aggregates and cognitive decline in early Alzheimer&#x2019;s disease. Nat Commun. 2022;13:6635.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9636262</ArticleId><ArticleId IdType="pubmed">36333294</ArticleId></ArticleIdList></Reference><Reference><Citation>Folstein MF, Folstein SE, McHugh PR. &#x201c;Mini-mental state&#x201d;: A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 1975;12:189&#x2013;198.</Citation><ArticleIdList><ArticleId IdType="pubmed">1202204</ArticleId></ArticleIdList></Reference><Reference><Citation>Janelidze, S. et al. Cerebrospinal fluid p-tau217 performs better than p-tau181 as a biomarker of Alzheimer&#x2019;s disease. Nat. Commun.10.1038/s41467-020-15436-0 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7125218</ArticleId><ArticleId IdType="pubmed">32246036</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashton, N. J. et al. Differential roles of A&#x3b2;42/40, p-tau231 and p-tau217 for Alzheimer&#x2019;s trial selection and disease monitoring. Nat. Med. 10.1038/s41591-022-02074-w (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9800279</ArticleId><ArticleId IdType="pubmed">36456833</ArticleId></ArticleIdList></Reference><Reference><Citation>Mielke MM, et al. Comparison of plasma phosphorylated tau species with amyloid and tau positron emission tomography, neurodegeneration, vascular pathology, and cognitive outcomes. JAMA Neurol. 2021;78:1108&#x2013;1117.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8314178</ArticleId><ArticleId IdType="pubmed">34309632</ArticleId></ArticleIdList></Reference><Reference><Citation>Moscoso A, et al. Time course of phosphorylated-tau181 in blood across the Alzheimer&#x2019;s disease spectrum. Brain. 2021;144:325&#x2013;339.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7880671</ArticleId><ArticleId IdType="pubmed">33257949</ArticleId></ArticleIdList></Reference><Reference><Citation>Murray ME, et al. Global neuropathologic severity of Alzheimer&#x2019;s disease and locus coeruleus vulnerability influences plasma phosphorylated tau levels. Mol. Neurodegener. 2022;17:85.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9795667</ArticleId><ArticleId IdType="pubmed">36575455</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindquist SG, et al. Alzheimer disease-like clinical phenotype in a family with FTDP-17 caused by a MAPT R406W mutation. Eur. J. Neurol. 2008;15:377&#x2013;385.</Citation><ArticleIdList><ArticleId IdType="pubmed">18284428</ArticleId></ArticleIdList></Reference><Reference><Citation>de Silva R, et al. An immunohistochemical study of cases of sporadic and inherited frontotemporal lobar degeneration using 3R- and 4R-specific tau monoclonal antibodies. Acta Neuropathol. 2006;111:329&#x2013;340.</Citation><ArticleIdList><ArticleId IdType="pubmed">16552612</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolters EE, et al. [18F]Flortaucipir PET across various MAPT mutations in presymptomatic and symptomatic carriers. Neurology. 2021;97:e1017&#x2013;e1030.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8448551</ArticleId><ArticleId IdType="pubmed">34210823</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai RM, et al. 18F-flortaucipir (AV-1451) tau PET in frontotemporal dementia syndromes. Alzheimers Res. Ther. 2019;11:13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6357510</ArticleId><ArticleId IdType="pubmed">30704514</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones DT, et al. In vivo 18F-AV-1451 tau PET signal in MAPT mutation carriers varies by expected tau isoforms. Neurology. 2018;90:e947&#x2013;e954.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5858948</ArticleId><ArticleId IdType="pubmed">29440563</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashton NJ, et al. Differential roles of A&#x3b2;42/40, p-tau231 and p-tau217 for Alzheimer&#x2019;s trial selection and disease monitoring. Nat. Med. 2022;28:2555&#x2013;2562.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9800279</ArticleId><ArticleId IdType="pubmed">36456833</ArticleId></ArticleIdList></Reference><Reference><Citation>Jack CR, et al. A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers. Neurology. 2016;87:539&#x2013;547.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4970664</ArticleId><ArticleId IdType="pubmed">27371494</ArticleId></ArticleIdList></Reference><Reference><Citation>Therriault J, et al. Association of phosphorylated tau biomarkers with amyloid positron emission tomography vs tau positron emission tomography. JAMA Neurol. 2023;80:188&#x2013;199.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9856704</ArticleId><ArticleId IdType="pubmed">36508198</ArticleId></ArticleIdList></Reference><Reference><Citation>Clark CM, et al. Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-&#x3b2; plaques: a prospective cohort study. Lancet Neurol. 2012;11:669&#x2013;678.</Citation><ArticleIdList><ArticleId IdType="pubmed">22749065</ArticleId></ArticleIdList></Reference><Reference><Citation>Sabri O, et al. Florbetaben PET imaging to detect amyloid beta plaques in Alzheimer&#x2019;s disease: phase 3 study. Alzheimers Dement. 2015;11:964&#x2013;974.</Citation><ArticleIdList><ArticleId IdType="pubmed">25824567</ArticleId></ArticleIdList></Reference><Reference><Citation>Ikonomovic MD, et al. Post-mortem histopathology underlying &#x3b2;-amyloid PET imaging following flutemetamol F 18 injection. Acta Neuropathol. Commun. 2016;4:130.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5154022</ArticleId><ArticleId IdType="pubmed">27955679</ArticleId></ArticleIdList></Reference><Reference><Citation>Marqui&#xe9; M, et al. Validating novel tau positron emission tomography tracer [F-18]-AV-1451 (T807) on postmortem brain tissue. Ann. Neurol. 2015;78:787&#x2013;800.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4900162</ArticleId><ArticleId IdType="pubmed">26344059</ArticleId></ArticleIdList></Reference><Reference><Citation>Dubois B, et al. Clinical diagnosis of Alzheimer&#x2019;s disease: recommendations of the International Working Group. Lancet Neurol. 2021;20:484&#x2013;496.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8339877</ArticleId><ArticleId IdType="pubmed">33933186</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris JC. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology. 1993;43:2412a.</Citation><ArticleIdList><ArticleId IdType="pubmed">8232972</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris JC, et al. The Uniform Data Set (UDS): clinical and cognitive variables and descriptive data from Alzheimer disease centers. Alzheimer Dis. Assoc. Disord. 2006;20:210&#x2013;216.</Citation><ArticleIdList><ArticleId IdType="pubmed">17132964</ArticleId></ArticleIdList></Reference><Reference><Citation>Volluz KE, et al. Correspondence of CSF biomarkers measured by Lumipulse assays with amyloid PET. Alzheimers Dement. 2021;17:e051085.</Citation></Reference><Reference><Citation>Bourgeat P, et al. Implementing the centiloid transformation for 11C-PiB and &#x3b2;-amyloid 18F-PET tracers using CapAIBL. NeuroImage. 2018;183:387&#x2013;393.</Citation><ArticleIdList><ArticleId IdType="pubmed">30130643</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho H, et al. In vivo cortical spreading pattern of tau and amyloid in the Alzheimer disease spectrum. Ann. Neurol. 2016;80:247&#x2013;258.</Citation><ArticleIdList><ArticleId IdType="pubmed">27323247</ArticleId></ArticleIdList></Reference><Reference><Citation>Leuzy A, et al. A multicenter comparison of [18F]flortaucipir, [18F]RO948, and [18F]MK6240 tau PET tracers to detect a common target ROI for differential diagnosis. Eur. J. Nucl. Med. Mol. Imaging. 2021;48:2295&#x2013;2305.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8175317</ArticleId><ArticleId IdType="pubmed">34041562</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen CD, et al. Comparing tau PET visual interpretation with tau PET quantification, cerebrospinal fluid biomarkers, and longitudinal clinical assessment. J. Alzheimers Dis. 2023;93:765&#x2013;777.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10200228</ArticleId><ArticleId IdType="pubmed">37092225</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37459141</PMID><DateCompleted><Year>2023</Year><Month>08</Month><Day>09</Day></DateCompleted><DateRevised><Year>2024</Year><Month>03</Month><Day>26</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1538-3598</ISSN><JournalIssue CitedMedium="Internet"><Volume>330</Volume><Issue>6</Issue><PubDate><Year>2023</Year><Month>Aug</Month><Day>08</Day></PubDate></JournalIssue><Title>JAMA</Title><ISOAbbreviation>JAMA</ISOAbbreviation></Journal><ArticleTitle>Donanemab in Early Symptomatic Alzheimer Disease: The TRAILBLAZER-ALZ 2 Randomized Clinical Trial.</ArticleTitle><Pagination><StartPage>512</StartPage><EndPage>527</EndPage><MedlinePgn>512-527</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1001/jama.2023.13239</ELocationID><Abstract><AbstractText Label="IMPORTANCE">There are limited efficacious treatments for Alzheimer disease.</AbstractText><AbstractText Label="OBJECTIVE">To assess efficacy and adverse events of donanemab, an antibody designed to clear brain amyloid plaque.</AbstractText><AbstractText Label="DESIGN, SETTING, AND PARTICIPANTS">Multicenter (277 medical research centers/hospitals in 8 countries), randomized, double-blind, placebo-controlled, 18-month phase 3 trial that enrolled 1736 participants with early symptomatic Alzheimer disease (mild cognitive impairment/mild dementia) with amyloid and low/medium or high tau pathology based on positron emission tomography imaging from June 2020 to November 2021 (last patient visit for primary outcome in April 2023).</AbstractText><AbstractText Label="INTERVENTIONS">Participants were randomized in a 1:1 ratio to receive donanemab (n&#x2009;=&#x2009;860) or placebo (n&#x2009;=&#x2009;876) intravenously every 4 weeks for 72 weeks. Participants in the donanemab group were switched to receive placebo in a blinded manner if dose completion criteria were met.</AbstractText><AbstractText Label="MAIN OUTCOMES AND MEASURES">The primary outcome was change in integrated Alzheimer Disease Rating Scale (iADRS) score from baseline to 76 weeks (range, 0-144; lower scores indicate greater impairment). There were 24 gated outcomes (primary, secondary, and exploratory), including the secondary outcome of change in the sum of boxes of the Clinical Dementia Rating Scale (CDR-SB) score (range, 0-18; higher scores indicate greater impairment). Statistical testing allocated &#x3b1; of .04 to testing low/medium tau population outcomes, with the remainder (.01) for combined population outcomes.</AbstractText><AbstractText Label="RESULTS">Among 1736 randomized participants (mean age, 73.0 years; 996 [57.4%] women; 1182 [68.1%] with low/medium tau pathology and 552 [31.8%] with high tau pathology), 1320 (76%) completed the trial. Of the 24 gated outcomes, 23 were statistically significant. The least-squares mean (LSM) change in iADRS score at 76 weeks was -6.02 (95% CI, -7.01 to -5.03) in the donanemab group and -9.27 (95% CI, -10.23 to -8.31) in the placebo group (difference, 3.25 [95% CI, 1.88-4.62]; P&#x2009;&lt;&#x2009;.001) in the low/medium tau population and -10.2 (95% CI, -11.22 to -9.16) with donanemab and -13.1 (95% CI, -14.10 to -12.13) with placebo (difference, 2.92 [95% CI, 1.51-4.33]; P&#x2009;&lt;&#x2009;.001) in the combined population. LSM change in CDR-SB score at 76 weeks was 1.20 (95% CI, 1.00-1.41) with donanemab and 1.88 (95% CI, 1.68-2.08) with placebo (difference, -0.67 [95% CI, -0.95 to -0.40]; P&#x2009;&lt;&#x2009;.001) in the low/medium tau population and 1.72 (95% CI, 1.53-1.91) with donanemab and 2.42 (95% CI, 2.24-2.60) with placebo (difference, -0.7 [95% CI, -0.95 to -0.45]; P&#x2009;&lt;&#x2009;.001) in the combined population. Amyloid-related imaging abnormalities of edema or effusion occurred in 205 participants (24.0%; 52 symptomatic) in the donanemab group and 18 (2.1%; 0 symptomatic during study) in the placebo group and infusion-related reactions occurred in 74 participants (8.7%) with donanemab and 4 (0.5%) with placebo. Three deaths in the donanemab group and 1 in the placebo group were considered treatment related.</AbstractText><AbstractText Label="CONCLUSIONS AND RELEVANCE">Among participants with early symptomatic Alzheimer disease and amyloid and tau pathology, donanemab significantly slowed clinical progression at 76 weeks in those with low/medium tau and in the combined low/medium and high tau pathology population.</AbstractText><AbstractText Label="TRIAL REGISTRATION">ClinicalTrials.gov Identifier: NCT04437511.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sims</LastName><ForeName>John R</ForeName><Initials>JR</Initials><AffiliationInfo><Affiliation>Eli Lilly and Company, Indianapolis, Indiana.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zimmer</LastName><ForeName>Jennifer A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Eli Lilly and Company, Indianapolis, Indiana.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Evans</LastName><ForeName>Cynthia D</ForeName><Initials>CD</Initials><AffiliationInfo><Affiliation>Eli Lilly and Company, Indianapolis, Indiana.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>Ming</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Eli Lilly and Company, Indianapolis, Indiana.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ardayfio</LastName><ForeName>Paul</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Eli Lilly and Company, Indianapolis, Indiana.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sparks</LastName><ForeName>JonDavid</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Eli Lilly and Company, Indianapolis, Indiana.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wessels</LastName><ForeName>Alette M</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Eli Lilly and Company, Indianapolis, Indiana.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shcherbinin</LastName><ForeName>Sergey</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Eli Lilly and Company, Indianapolis, Indiana.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Hong</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Eli Lilly and Company, Indianapolis, Indiana.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Monkul Nery</LastName><ForeName>Emel Serap</ForeName><Initials>ES</Initials><AffiliationInfo><Affiliation>Eli Lilly and Company, Indianapolis, Indiana.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Collins</LastName><ForeName>Emily C</ForeName><Initials>EC</Initials><AffiliationInfo><Affiliation>Eli Lilly and Company, Indianapolis, Indiana.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Solomon</LastName><ForeName>Paul</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Boston Center for Memory and Boston University Alzheimer's Disease Center, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Salloway</LastName><ForeName>Stephen</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurology and Department of Psychiatry, Alpert Medical School of Brown University, Providence, Rhode Island.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Butler Hospital, Providence, Rhode Island.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Apostolova</LastName><ForeName>Liana G</ForeName><Initials>LG</Initials><AffiliationInfo><Affiliation>Department of Neurology, Indiana University School of Medicine, Indianapolis.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hansson</LastName><ForeName>Oskar</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Clinical Memory Research Unit, Department of Clinical Sciences Malm&#xf6;, Lund University, Lund, Sweden; Memory Clinic, Sk&#xe5;ne University Hospital, Lund, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ritchie</LastName><ForeName>Craig</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Scottish Brain Sciences, Edinburgh, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brooks</LastName><ForeName>Dawn A</ForeName><Initials>DA</Initials><AffiliationInfo><Affiliation>Eli Lilly and Company, Indianapolis, Indiana.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mintun</LastName><ForeName>Mark</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Eli Lilly and Company, Indianapolis, Indiana.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Skovronsky</LastName><ForeName>Daniel M</ForeName><Initials>DM</Initials><AffiliationInfo><Affiliation>Eli Lilly and Company, Indianapolis, Indiana.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>TRAILBLAZER-ALZ 2 Investigators</CollectiveName></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT04437511</AccessionNumber></AccessionNumberList></DataBank></DataBankList><GrantList CompleteYN="Y"><Grant><GrantID>S10 OD025214</GrantID><Acronym>OD</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JAMA</MedlineTA><NlmUniqueID>7501160</NlmUniqueID><ISSNLinking>0098-7484</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000911">Antibodies, Monoclonal</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>JAMA. 2023 Aug 8;330(6):503-504. doi: 10.1001/jama.2023.11701.</RefSource><PMID Version="1">37459123</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>JAMA. 2023 Aug 8;330(6):507-509. doi: 10.1001/jama.2023.11703.</RefSource><PMID Version="1">37459124</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>JAMA. 2023 Aug 8;330(6):510-511. doi: 10.1001/jama.2023.11704.</RefSource><PMID Version="1">37459138</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Nat Rev Neurol. 2023 Oct;19(10):581-582. doi: 10.1038/s41582-023-00869-0.</RefSource><PMID Version="1">37658242</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>JAMA. 2023 Dec 19;330(23):2304-2305. doi: 10.1001/jama.2023.21109.</RefSource><PMID Version="1">38112817</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>JAMA. 2023 Dec 19;330(23):2304. doi: 10.1001/jama.2023.21106.</RefSource><PMID Version="1">38112820</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004311" MajorTopicYN="N">Double-Blind Method</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060825" MajorTopicYN="Y">Cognitive Dysfunction</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000911" MajorTopicYN="N">Antibodies, Monoclonal</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading></MeshHeadingList><CoiStatement><b>Conflict of Interest Disclosures:</b> Dr Sims reported being an employee of Eli Lilly and Company during the conduct of the study. Dr Zimmer reported receiving personal fees from and being a shareholder in Eli Lilly and Company during the conduct of the study. Dr Evans reported being an employee of and minority shareholder in Eli Lilly and Company during the conduct of the study. Dr Lu reported being an employee of and stockholder in Eli Lilly. Dr Ardayfio reported being an employee of and stockholder in Eli Lilly during the conduct of the study. Dr Wessels reported being a minor shareholder in Eli Lilly and Company outside the submitted work. Dr Shcherbinin reported being an employee of and stockholder in Eli Lilly and Company during the conduct of the study and Eli Lilly and Company having patents pending relevant to this research. Dr Nery reported being an employee of and shareholder in Eli Lilly and Company during the conduct of the study. Dr Collins reported being an employee of and stockholder in from Eli Lilly and Company during the conduct of the study. Dr Salloway reported receiving personal fees and grants from Biogen, Eli Lilly, Genentech, Avid, Roche, Eisai, Novartis, Acumen, NovoNordisk, and Prothena during the conduct of the study. Dr Apostolova reported receiving grants from NIA, Alzheimer Association, AVID Radiopharmaceuticals, Life Molecular Imaging, and Roche Diagnostics and personal fees from Eli Lilly, Biogen, Two Labs, IQVIA, Genentech, Siemens, Corium, GE Healthcare, Eisa, Roche Diagnostics, Alnylam, Alzheimer Association, and from the US Food And Drug Administration outside the submitted work. Dr Hansson reported personal fees from AC Immune, Amylyx, Alzpath, BioArtic, Biogen, Cerveau, Eisai, Eli Lilly, Fujirebio, Merk, Novartis, Novo Nordisk, Roche, Sanofi, and Siemens outside the submitted work. Dr Ritchie reported receiving personal fees from Actinogen, Biogen, Cogstate, Eisai, Eli Lilly, Janssen Cilag, Merck, Novo Nordisk, Roche Diagnostics, and Signant and being founder of and majority shareholder in Scottish Brain Sciences outside the submitted work. Dr Brooks reported being an employee of and shareholder in Eli Lilly and Company. Dr Mintun reported being an employee of and shareholder in Eli Lilly and Company and having a patent pending with Eli Lilly and Company. Dr Skovronsky reported being an employee of and shareholder in Eli Lilly and Company. No other disclosures were reported.</CoiStatement><InvestigatorList><Investigator ValidYN="Y"><LastName>Abreu</LastName><ForeName>Rafael</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Agarwal</LastName><ForeName>Pinky</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Aggarwal</LastName><ForeName>Puja</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Agronin</LastName><ForeName>Marc</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Allen</LastName><ForeName>Alison</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Altamirano</LastName><ForeName>Dario</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Alva</LastName><ForeName>Gustavo</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Andersen</LastName><ForeName>James</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Anderson</LastName><ForeName>Allan</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Anderson</LastName><ForeName>Donald</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Arnold</LastName><ForeName>Jennifer</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Asada</LastName><ForeName>Takashi</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Aso</LastName><ForeName>Yasuhiro</ForeName><Initials>Y</Initials></Investigator><Investigator ValidYN="Y"><LastName>Atit</LastName><ForeName>Vikram</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ayala</LastName><ForeName>Ricardo</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Badruddoja</LastName><ForeName>Michael</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Badzio-Jagiello</LastName><ForeName>Hanna</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bajacek</LastName><ForeName>Michal</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Barton</LastName><ForeName>David</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bear</LastName><ForeName>David</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Benjamin</LastName><ForeName>Sabrina</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bergeron</LastName><ForeName>Richard</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bhatia</LastName><ForeName>Perminder</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Black</LastName><ForeName>Sandra</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Block</LastName><ForeName>Allan</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bolouri</LastName><ForeName>Mohammad</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bond</LastName><ForeName>Wendy</ForeName><Initials>W</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bouthillier</LastName><ForeName>Jean</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Brangman</LastName><ForeName>Sharon</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Brew</LastName><ForeName>Bruce</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Brisbin</LastName><ForeName>Sarah</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Brisken</LastName><ForeName>Toby</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Brodtmann</LastName><ForeName>Amy</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Brody</LastName><ForeName>Mark</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Brosch</LastName><ForeName>Jared</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Brown</LastName><ForeName>Celia</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Brownstone</LastName><ForeName>Paul</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bukowczan</LastName><ForeName>Sylwia</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Burns</LastName><ForeName>Jeffrey</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cabrera</LastName><ForeName>Alicia</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Capote</LastName><ForeName>Horace</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Carrasco</LastName><ForeName>Angel</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cevallos Yepez</LastName><ForeName>Jose</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chavez</LastName><ForeName>Eric</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chertkow</LastName><ForeName>Howard</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chyrchel-Paszkiewicz</LastName><ForeName>Urszula</ForeName><Initials>U</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ciabarra</LastName><ForeName>Anthony</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Clemmons</LastName><ForeName>Edward</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cohen</LastName><ForeName>Daniel</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cohen</LastName><ForeName>Robert</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cohen</LastName><ForeName>Ian</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Concha</LastName><ForeName>Mauricio</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Costell</LastName><ForeName>Brian</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Crimmins</LastName><ForeName>Denis</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cruz-Pagan</LastName><ForeName>Yvette</ForeName><Initials>Y</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cueli</LastName><ForeName>Adolfo</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cupelo</LastName><ForeName>Robert</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Czarnecki</LastName><ForeName>Maciej</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Darby</LastName><ForeName>David</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dautzenberg</LastName><ForeName>P L J</ForeName><Initials>PLJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>De Deyn</LastName><ForeName>Peter</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>De La Gandara</LastName><ForeName>Jose</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Deck</LastName><ForeName>Kenneth</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dibenedetto</LastName><ForeName>David</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dibuono</LastName><ForeName>Mark</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dinnerstein</LastName><ForeName>Eric</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dirican</LastName><ForeName>Ahmet</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dixit</LastName><ForeName>Shanker</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dobryniewski</LastName><ForeName>Jacek</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Drake</LastName><ForeName>Ryan</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Drysdale</LastName><ForeName>Peter</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Duara</LastName><ForeName>Ranjan</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Duffy</LastName><ForeName>John</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ellenbogen</LastName><ForeName>Aaron</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Faradji</LastName><ForeName>Victor</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Feinberg</LastName><ForeName>Marc</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Feldman</LastName><ForeName>Robert</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fishman</LastName><ForeName>Simon</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Flitman</LastName><ForeName>Stephen</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Forchetti</LastName><ForeName>Concetta</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fraga</LastName><ForeName>Ivonne</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Frank</LastName><ForeName>Andrew</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Frishberg</LastName><ForeName>Benjamin</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fujigasaki</LastName><ForeName>Hiroto</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fukase</LastName><ForeName>Hiroyuki</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fumero</LastName><ForeName>Ileana</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Furihata</LastName><ForeName>Kenichi</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Galloway</LastName><ForeName>Christopher</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gandhi</LastName><ForeName>Rekha</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>George</LastName><ForeName>Kristi</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Germain</LastName><ForeName>Marcel</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gitelman</LastName><ForeName>Darren</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Goetsch</LastName><ForeName>Nicholas</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Goldfarb</LastName><ForeName>Danielle</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Goldstein</LastName><ForeName>Mark</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Goldstick</LastName><ForeName>Lawrence</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gonzalez Rojas</LastName><ForeName>Yaneicy</ForeName><Initials>Y</Initials></Investigator><Investigator ValidYN="Y"><LastName>Goodman</LastName><ForeName>Ira</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Greeley</LastName><ForeName>David</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Griffin</LastName><ForeName>Carl</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Grigsby</LastName><ForeName>Eric</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Grosz</LastName><ForeName>Daniel</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hafner</LastName><ForeName>Karl</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hart</LastName><ForeName>David</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Henein</LastName><ForeName>Sam</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Herskowitz</LastName><ForeName>Brad</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Higashi</LastName><ForeName>Shinji</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Higashi</LastName><ForeName>Yasuto</ForeName><Initials>Y</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ho</LastName><ForeName>Gilbert</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hodgson</LastName><ForeName>Jonathan</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hohenberg</LastName><ForeName>Mark</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hollenbeck</LastName><ForeName>Larry</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Holub</LastName><ForeName>Richard</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hori</LastName><ForeName>Tomokatsu</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hort</LastName><ForeName>Jakub</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ilkowski</LastName><ForeName>Jan</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ingram</LastName><ForeName>K Jennifer</ForeName><Initials>KJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Isaac</LastName><ForeName>Mitchell</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ishikawa</LastName><ForeName>Mitsunori</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Janu</LastName><ForeName>Lubos</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Johnston</LastName><ForeName>Mark</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Julio</LastName><ForeName>William</ForeName><Initials>W</Initials></Investigator><Investigator ValidYN="Y"><LastName>Justiz</LastName><ForeName>William</ForeName><Initials>W</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kaga</LastName><ForeName>Tomotsugu</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kakigi</LastName><ForeName>Tatsuya</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kalafer</LastName><ForeName>Marvin</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kamijo</LastName><ForeName>Mikiko</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kaplan</LastName><ForeName>Jeffrey</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Karathanos</LastName><ForeName>Michael</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Katayama</LastName><ForeName>Sadao</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kaul</LastName><ForeName>Siddharth</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Keegan</LastName><ForeName>Andrew</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kerwin</LastName><ForeName>Diana</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Khan</LastName><ForeName>Uzma</ForeName><Initials>U</Initials></Investigator><Investigator ValidYN="Y"><LastName>Khan</LastName><ForeName>Arifulla</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kimura</LastName><ForeName>Noriyuki</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kirk</LastName><ForeName>Gregory</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Klodowska</LastName><ForeName>Gabriela</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kowa</LastName><ForeName>Hisatomo</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kutz</LastName><ForeName>Christen</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kwentus</LastName><ForeName>Joseph</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lai</LastName><ForeName>Rosalyn</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lall</LastName><ForeName>Ayesha</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lawrence</LastName><ForeName>Mary</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lee</LastName><ForeName>Elly</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Leon</LastName><ForeName>Ramon</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Linker</LastName><ForeName>Gary</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lisewski</LastName><ForeName>Pawel</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Liss</LastName><ForeName>Jonathan</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Liu</LastName><ForeName>Collins</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Losk</LastName><ForeName>Scott</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lukaszyk</LastName><ForeName>Ewelina</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lynch</LastName><ForeName>Jennifer</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Macfarlane</LastName><ForeName>Stephen</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Macsweeney</LastName><ForeName>Josephine</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mannering</LastName><ForeName>Nicholas</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Markovic</LastName><ForeName>Oto</ForeName><Initials>O</Initials></Investigator><Investigator ValidYN="Y"><LastName>Marks</LastName><ForeName>Donald</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Masdeu</LastName><ForeName>Joseph</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Matsui</LastName><ForeName>Yutaka</ForeName><Initials>Y</Initials></Investigator><Investigator ValidYN="Y"><LastName>Matsuishi</LastName><ForeName>Kunitaka</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mcallister</LastName><ForeName>Peter</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mcconnehey</LastName><ForeName>Brock</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mcelveen</LastName><ForeName>Alvin</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mcgill</LastName><ForeName>Lora</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mecca</LastName><ForeName>Adam</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mega</LastName><ForeName>Michael</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mensah</LastName><ForeName>Jason</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mickielewicz</LastName><ForeName>Anatol</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Minaeian</LastName><ForeName>Artin</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mocherla</LastName><ForeName>Bharat</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Murphy</LastName><ForeName>Cynthia</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Murphy</LastName><ForeName>Paul</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nagashima</LastName><ForeName>Hirotaka</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nair</LastName><ForeName>Anil</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nair</LastName><ForeName>Malini</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nardandrea</LastName><ForeName>John</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nash</LastName><ForeName>Marshall</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nasreddine</LastName><ForeName>Ziad</ForeName><Initials>Z</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nishida</LastName><ForeName>Yoshihiko</ForeName><Initials>Y</Initials></Investigator><Investigator ValidYN="Y"><LastName>Norton</LastName><ForeName>Jeffrey</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nunez</LastName><ForeName>Lazaro</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ochiai</LastName><ForeName>Jun</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ohkubo</LastName><ForeName>Takuya</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Okamura</LastName><ForeName>Yasuyuki</ForeName><Initials>Y</Initials></Investigator><Investigator ValidYN="Y"><LastName>Okorie</LastName><ForeName>Eugene</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Olivera</LastName><ForeName>Esteban</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>O'mahony</LastName><ForeName>John</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Omidvar</LastName><ForeName>Omid</ForeName><Initials>O</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ortiz-Cruz</LastName><ForeName>Desiree</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Osowa</LastName><ForeName>Alexander</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Papka</LastName><ForeName>Michelle</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Parker</LastName><ForeName>Alicia</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Patel</LastName><ForeName>Paayal</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Patel</LastName><ForeName>Ashok</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Patel</LastName><ForeName>Meenakshi</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Patry</LastName><ForeName>Claude</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Peckham</LastName><ForeName>Elizabeth</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pfeffer</LastName><ForeName>Michael</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pietras</LastName><ForeName>Alison</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Plopper</LastName><ForeName>Michael</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Porsteinsson</LastName><ForeName>Anton</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Poulin Robitaille</LastName><ForeName>Raphael</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Prins</LastName><ForeName>Niels</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Puente</LastName><ForeName>Orlando</ForeName><Initials>O</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ratajczak</LastName><ForeName>Marcin</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rhee</LastName><ForeName>Margaret</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ritter</LastName><ForeName>Angela</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rodriguez</LastName><ForeName>Ramon</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rodriguez Ables</LastName><ForeName>Lilia</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rojas</LastName><ForeName>Julio</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ross</LastName><ForeName>Jeffrey</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Royer</LastName><ForeName>Paule</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rubin</LastName><ForeName>Jay</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Russell</LastName><ForeName>David</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rutgers</LastName><ForeName>Sterre Malou</ForeName><Initials>SM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rutrick</LastName><ForeName>Stephanie</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sadowski</LastName><ForeName>Martin</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Safirstein</LastName><ForeName>Beth</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sagisaka</LastName><ForeName>Takafumi</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Scharre</LastName><ForeName>Douglas</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Schneider</LastName><ForeName>Lon</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Schreiber</LastName><ForeName>Curtis</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Schrift</LastName><ForeName>Michael</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Schulz</LastName><ForeName>Paul</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Schwartz</LastName><ForeName>Harvey</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Schwartzbard</LastName><ForeName>Julie</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Scott</LastName><ForeName>John</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Selem</LastName><ForeName>Lissette</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sethi</LastName><ForeName>Pramod</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sha</LastName><ForeName>Sharon</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sharlin</LastName><ForeName>Kenneth</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sharma</LastName><ForeName>Sanjiv</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Shiovitz</LastName><ForeName>Thomas</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Shiwach</LastName><ForeName>Rajinder</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sladek</LastName><ForeName>Martin</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sloan</LastName><ForeName>Bart</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Smith</LastName><ForeName>Amanda</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Solomon</LastName><ForeName>Paul</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sorial</LastName><ForeName>Ehab</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sosa</LastName><ForeName>Evelio</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Stedman</LastName><ForeName>Mary</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Steen</LastName><ForeName>Susan</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Stein</LastName><ForeName>Lee</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Stolyar</LastName><ForeName>Arkadiy</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Stoukides</LastName><ForeName>John</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sudoh</LastName><ForeName>Shinji</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sutton</LastName><ForeName>James</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Syed</LastName><ForeName>Junaid</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Szigeti</LastName><ForeName>Kinga</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tachibana</LastName><ForeName>Hisatsugu</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Takahashi</LastName><ForeName>Yuichi</ForeName><Initials>Y</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tateno</LastName><ForeName>Amane</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Taylor</LastName><ForeName>James Dale</ForeName><Initials>JD</Initials></Investigator><Investigator ValidYN="Y"><LastName>Taylor</LastName><ForeName>Kelly</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tcheremissine</LastName><ForeName>Oleg</ForeName><Initials>O</Initials></Investigator><Investigator ValidYN="Y"><LastName>Thebaud</LastName><ForeName>Adly</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Thein</LastName><ForeName>Stephen</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Thurman</LastName><ForeName>Louise</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Toenjes</LastName><ForeName>Steven</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Toji</LastName><ForeName>Hiromasa</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Toma</LastName><ForeName>Misaki</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tran</LastName><ForeName>Duc</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Trueba</LastName><ForeName>Pilar</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tsujimoto</LastName><ForeName>Masashi</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Turner</LastName><ForeName>Raymond</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Uchiyama</LastName><ForeName>Akiyoshi</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ussorowska</LastName><ForeName>Dorota</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vaishnavi</LastName><ForeName>Sanjeev</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Valor</LastName><ForeName>Elena</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vandersluis</LastName><ForeName>Joel</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vasquez</LastName><ForeName>Alberto</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Velez</LastName><ForeName>Juan</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Verghese</LastName><ForeName>Cherian</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vodickova-Borzova</LastName><ForeName>Klaudia</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Watson</LastName><ForeName>David</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Weidman</LastName><ForeName>David</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Weisman</LastName><ForeName>David</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>White</LastName><ForeName>Alexander</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Willingham</LastName><ForeName>Katherine</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Winkel</LastName><ForeName>Izabela</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Winner</LastName><ForeName>Paul</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Winston</LastName><ForeName>Jaron</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wolff</LastName><ForeName>Adam</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Yagi</LastName><ForeName>Hideo</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Yamamoto</LastName><ForeName>Hideki</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Yathiraj</LastName><ForeName>Sanjay</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Yoshiyama</LastName><ForeName>Yasumasa</ForeName><Initials>Y</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zboch</LastName><ForeName>Marzena</ForeName><Initials>M</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>9</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>7</Month><Day>17</Day><Hour>15</Hour><Minute>9</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>7</Month><Day>17</Day><Hour>11</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>1</Month><Day>17</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37459141</ArticleId><ArticleId IdType="pmc">PMC10352931</ArticleId><ArticleId IdType="doi">10.1001/jama.2023.13239</ArticleId><ArticleId IdType="pii">2807533</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hansson O. Biomarkers for neurodegenerative diseases. Nat Med. 2021;27(6):954-963. doi:10.1038/s41591-021-01382-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01382-x</ArticleId><ArticleId IdType="pubmed">34083813</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardy JA, Higgins GA. Alzheimer&#x2019;s disease: the amyloid cascade hypothesis. Science. 1992;256(5054):184-185. doi:10.1126/science.1566067</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1566067</ArticleId><ArticleId IdType="pubmed">1566067</ArticleId></ArticleIdList></Reference><Reference><Citation>Jack CR Jr, Bennett DA, Blennow K, et al. ; Contributors . NIA-AA research framework: toward a biological definition of Alzheimer&#x2019;s disease. Alzheimers Dement. 2018;14(4):535-562. doi:10.1016/j.jalz.2018.02.018</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2018.02.018</ArticleId><ArticleId IdType="pmc">PMC5958625</ArticleId><ArticleId IdType="pubmed">29653606</ArticleId></ArticleIdList></Reference><Reference><Citation>Ostrowitzki S, Bittner T, Sink KM, et al. . Evaluating the safety and efficacy of crenezumab vs placebo in adults with early alzheimer disease: two phase 3 randomized placebo-controlled trials. JAMA Neurol. 2022;79(11):1113-1121. doi:10.1001/jamaneurol.2022.2909</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2022.2909</ArticleId><ArticleId IdType="pmc">PMC9486635</ArticleId><ArticleId IdType="pubmed">36121669</ArticleId></ArticleIdList></Reference><Reference><Citation>Doody RS, Thomas RG, Farlow M, et al. ; Alzheimer&#x2019;s Disease Cooperative Study Steering Committee; Solanezumab Study Group . Phase 3 trials of solanezumab for mild-to-moderate Alzheimer&#x2019;s disease. N Engl J Med. 2014;370(4):311-321. doi:10.1056/NEJMoa1312889</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1312889</ArticleId><ArticleId IdType="pubmed">24450890</ArticleId></ArticleIdList></Reference><Reference><Citation>Honig LS, Vellas B, Woodward M, et al. . Trial of solanezumab for mild dementia due to alzheimer&#x2019;s disease. N Engl J Med. 2018;378(4):321-330. doi:10.1056/NEJMoa1705971</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1705971</ArticleId><ArticleId IdType="pubmed">29365294</ArticleId></ArticleIdList></Reference><Reference><Citation>Salloway S, Farlow M, McDade E, et al. ; Dominantly Inherited Alzheimer Network&#x2013;Trials Unit . A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer&#x2019;s disease. Nat Med. 2021;27(7):1187-1196. doi:10.1038/s41591-021-01369-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01369-8</ArticleId><ArticleId IdType="pmc">PMC8988051</ArticleId><ArticleId IdType="pubmed">34155411</ArticleId></ArticleIdList></Reference><Reference><Citation>Budd Haeberlein S, Aisen PS, Barkhof F, et al. . Two randomized phase 3 studies of aducanumab in early Alzheimer&#x2019;s disease. J Prev Alzheimers Dis. 2022;9(2):197-210. doi:10.14283/jpad.2022.30</Citation><ArticleIdList><ArticleId IdType="doi">10.14283/jpad.2022.30</ArticleId><ArticleId IdType="pubmed">35542991</ArticleId></ArticleIdList></Reference><Reference><Citation>Mintun MA, Lo AC, Duggan Evans C, et al. . Donanemab in early Alzheimer&#x2019;s disease. N Engl J Med. 2021;384(18):1691-1704. doi:10.1056/NEJMoa2100708</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2100708</ArticleId><ArticleId IdType="pubmed">33720637</ArticleId></ArticleIdList></Reference><Reference><Citation>van Dyck CH, Swanson CJ, Aisen P, et al. . Lecanemab in early Alzheimer&#x2019;s disease. N Engl J Med. 2023;388(1):9-21. doi:10.1056/NEJMoa2212948</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2212948</ArticleId><ArticleId IdType="pubmed">36449413</ArticleId></ArticleIdList></Reference><Reference><Citation>Demattos RB, Lu J, Tang Y, et al. . A plaque-specific antibody clears existing &#x3b2;-amyloid plaques in Alzheimer&#x2019;s disease mice. Neuron. 2012;76(5):908-920. doi:10.1016/j.neuron.2012.10.029</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2012.10.029</ArticleId><ArticleId IdType="pubmed">23217740</ArticleId></ArticleIdList></Reference><Reference><Citation>Albert MS, DeKosky ST, Dickson D, et al. . The diagnosis of mild cognitive impairment due to Alzheimer&#x2019;s disease: recommendations from the National Institute on Aging-Alzheimer&#x2019;s Association workgroups on diagnostic guidelines for Alzheimer&#x2019;s disease. Alzheimers Dement. 2011;7(3):270-279. doi:10.1016/j.jalz.2011.03.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2011.03.008</ArticleId><ArticleId IdType="pmc">PMC3312027</ArticleId><ArticleId IdType="pubmed">21514249</ArticleId></ArticleIdList></Reference><Reference><Citation>AmyvidTM . (Florbetapir F 18 Injection). Avid Radiopharmaceuticals, a wholly-owned subsidiary of Eli Lilly and Co. Accessed March 4, 2022. https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/202008s000lbl.pdf</Citation></Reference><Reference><Citation>NEURACEQ . (florbetaben F 18 injection), for intravenous use. https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/204677s000lbl.pdf</Citation></Reference><Reference><Citation>TauvidTM (flortaucipir F 18 injection). Avid Radiopharmaceuticals, a wholly-owned subsidiary of Eli Lilly and Co. Accessed March 4, 2022. https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/212123s000lbl.pdf.</Citation></Reference><Reference><Citation>Devous MD Sr, Joshi AD, Navitsky M, et al. . Test-retest reproducibility for the tau PET imaging agent flortaucipir F 18. J Nucl Med. 2018;59(6):937-943. doi:10.2967/jnumed.117.200691</Citation><ArticleIdList><ArticleId IdType="doi">10.2967/jnumed.117.200691</ArticleId><ArticleId IdType="pubmed">29284675</ArticleId></ArticleIdList></Reference><Reference><Citation>Fleisher AS, Pontecorvo MJ, Devous MD Sr, et al. ; A16 Study Investigators . Positron emission tomography imaging with [18F]flortaucipir and postmortem assessment of alzheimer disease neuropathologic changes. JAMA Neurol. 2020;77(7):829-839. doi:10.1001/jamaneurol.2020.0528</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2020.0528</ArticleId><ArticleId IdType="pmc">PMC7186920</ArticleId><ArticleId IdType="pubmed">32338734</ArticleId></ArticleIdList></Reference><Reference><Citation>Irizarry MC, Fleisher AS, Hake AM, et al. . P4-388: TRAILBLAZER-ALZ (NCT03367403): a phase 2 disease-modification combination therapy trial targeting multiple mechanisms of action along the amyloid pathway. Alzheimers Dement. 2018;14(7S_Part_31):P1622-P1623. doi:10.1016/j.jalz.2018.07.212</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2018.07.212</ArticleId></ArticleIdList></Reference><Reference><Citation>Joshi AD, Pontecorvo MJ, Lu M, Skovronsky DM, Mintun MA, Devous MD Sr. A semiautomated method for quantification of F 18 Florbetapir PET images. J Nucl Med. 2015;56(11):1736-1741. doi:10.2967/jnumed.114.153494</Citation><ArticleIdList><ArticleId IdType="doi">10.2967/jnumed.114.153494</ArticleId><ArticleId IdType="pubmed">26338898</ArticleId></ArticleIdList></Reference><Reference><Citation>Pontecorvo MJ, Devous MD, Kennedy I, et al. . A multicentre longitudinal study of flortaucipir (18F) in normal ageing, mild cognitive impairment and Alzheimer&#x2019;s disease dementia. Brain. 2019;142(6):1723-1735. doi:10.1093/brain/awz090</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awz090</ArticleId><ArticleId IdType="pmc">PMC6536847</ArticleId><ArticleId IdType="pubmed">31009046</ArticleId></ArticleIdList></Reference><Reference><Citation>Gueorguieva I, Chua L, Willis BA, Sims JR, Wessels AM. Disease progression model using the integrated Alzheimer&#x2019;s Disease Rating Scale. Alzheimers Dement. Published online November 30, 2022. doi:10.1002/alz.12876</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alz.12876</ArticleId><ArticleId IdType="pubmed">36450003</ArticleId></ArticleIdList></Reference><Reference><Citation>Wessels AM, Andersen SW, Dowsett SA, Siemers ER. The Integrated Alzheimer&#x2019;s Disease Rating Scale (iADRS): findings from the EXPEDITION3 trial. J Prev Alzheimers Dis. 2018;5(2):134-136. doi:10.14283/jpad.2018.10</Citation><ArticleIdList><ArticleId IdType="doi">10.14283/jpad.2018.10</ArticleId><ArticleId IdType="pubmed">29616706</ArticleId></ArticleIdList></Reference><Reference><Citation>Wessels AM, Belger M, Johnston JA, et al. . Demonstration of clinical meaningfulness of the Integrated Alzheimer&#x2019;s Disease Rating Scale (iADRS): association Between Change in iADRS scores and patient and caregiver health outcomes. J Alzheimers Dis. 2022;88(2):577-588. doi:10.3233/JAD-220303</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-220303</ArticleId><ArticleId IdType="pmc">PMC9398086</ArticleId><ArticleId IdType="pubmed">35694928</ArticleId></ArticleIdList></Reference><Reference><Citation>Wessels AM, Dennehy EB, Dowsett SA, Dickson SP, Hendrix SB. Meaningful clinical changes in alzheimer disease measured with the iADRS and illustrated using the donanemab TRAILBLAZER-ALZ study findings. Neurol Clin Pract. 2023;13(2):e200127. doi:10.1212/CPJ.0000000000200127</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/CPJ.0000000000200127</ArticleId><ArticleId IdType="pmc">PMC9987204</ArticleId><ArticleId IdType="pubmed">36891463</ArticleId></ArticleIdList></Reference><Reference><Citation>Wessels AM, Rentz DM, Case M, Lauzon S, Sims JR. Integrated Alzheimer&#x2019;s Disease Rating Scale: clinically meaningful change estimates. Alzheimers Dement (N Y). 2022;8(1):e12312. doi:10.1002/trc2.12312</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/trc2.12312</ArticleId><ArticleId IdType="pmc">PMC9169866</ArticleId><ArticleId IdType="pubmed">35676941</ArticleId></ArticleIdList></Reference><Reference><Citation>Wessels AM, Siemers ER, Yu P, et al. . A combined measure of cognition and function for clinical trials: the Integrated Alzheimer&#x2019;s Disease Rating Scale (iADRS). J Prev Alzheimers Dis. 2015;2(4):227-241. doi:10.14283/jpad.2015.82</Citation><ArticleIdList><ArticleId IdType="doi">10.14283/jpad.2015.82</ArticleId><ArticleId IdType="pmc">PMC4806404</ArticleId><ArticleId IdType="pubmed">27019841</ArticleId></ArticleIdList></Reference><Reference><Citation>Wessels AM, Tariot PN, Zimmer JA, et al. . Efficacy and safety of lanabecestat for treatment of early and mild Alzheimer disease: the AMARANTH and DAYBREAK-ALZ randomized clinical trials. JAMA Neurol. 2020;77(2):199-209. doi:10.1001/jamaneurol.2019.3988</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2019.3988</ArticleId><ArticleId IdType="pmc">PMC6902191</ArticleId><ArticleId IdType="pubmed">31764959</ArticleId></ArticleIdList></Reference><Reference><Citation>US Food and Drug Administration . Patient-focused drug development public workshop: incorporating clinical outcome assessments into endpoints for regulatory decision-making. December 6, 2019. Accessed July 11, 2023. https://www.fda.gov/media/132505/download</Citation></Reference><Reference><Citation>Navitsky M, Joshi AD, Kennedy I, et al. . Standardization of amyloid quantitation with florbetapir standardized uptake value ratios to the Centiloid scale. Alzheimers Dement. 2018;14(12):1565-1571. doi:10.1016/j.jalz.2018.06.1353</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2018.06.1353</ArticleId><ArticleId IdType="pubmed">30006100</ArticleId></ArticleIdList></Reference><Reference><Citation>Barakos J, Purcell D, Suhy J, et al. . Detection and management of amyloid-related imaging abnormalities in patients with Alzheimer&#x2019;s disease treated with anti-amyloid beta therapy. J Prev Alzheimers Dis. 2022;9(2):211-220. doi:10.14283/jpad.2022.21</Citation><ArticleIdList><ArticleId IdType="doi">10.14283/jpad.2022.21</ArticleId><ArticleId IdType="pubmed">35542992</ArticleId></ArticleIdList></Reference><Reference><Citation>Barakos J, Sperling R, Salloway S, et al. . MR imaging features of amyloid-related imaging abnormalities. AJNR Am J Neuroradiol. 2013;34(10):1958-1965. doi:10.3174/ajnr.A3500</Citation><ArticleIdList><ArticleId IdType="doi">10.3174/ajnr.A3500</ArticleId><ArticleId IdType="pmc">PMC7965435</ArticleId><ArticleId IdType="pubmed">23578674</ArticleId></ArticleIdList></Reference><Reference><Citation>Doessegger L, Banholzer ML. Clinical development methodology for infusion-related reactions with monoclonal antibodies. Clin Transl Immunology. 2015;4(7):e39. doi:10.1038/cti.2015.14</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cti.2015.14</ArticleId><ArticleId IdType="pmc">PMC4524952</ArticleId><ArticleId IdType="pubmed">26246897</ArticleId></ArticleIdList></Reference><Reference><Citation>Bretz F, Maurer W, Brannath W, Posch M. A graphical approach to sequentially rejective multiple test procedures. Stat Med. 2009;28(4):586-604. doi:10.1002/sim.3495</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.3495</ArticleId><ArticleId IdType="pubmed">19051220</ArticleId></ArticleIdList></Reference><Reference><Citation>Bretz F, Posch M, Glimm E, Klinglmueller F, Maurer W, Rohmeyer K. Graphical approaches for multiple comparison procedures using weighted Bonferroni, Simes, or parametric tests. Biom J. 2011;53(6):894-913. doi:10.1002/bimj.201000239</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/bimj.201000239</ArticleId><ArticleId IdType="pmc">PMC3427907</ArticleId><ArticleId IdType="pubmed">21837623</ArticleId></ArticleIdList></Reference><Reference><Citation>Holdridge KC, Yaari R, Hoban DB, Andersen S, Sims JR. Targeting amyloid &#x3b2; in Alzheimer&#x2019;s disease: meta-analysis of low-dose solanezumab in Alzheimer&#x2019;s disease with mild dementia studies. Alzheimers Dement. Published March 22, 2023. doi:10.1002/alz.13031</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alz.13031</ArticleId><ArticleId IdType="pubmed">36946603</ArticleId></ArticleIdList></Reference><Reference><Citation>Southekal S, Devous MD Sr, Kennedy I, et al. . Flortaucipir F 18 quantitation using parametric estimation of reference signal intensity. J Nucl Med. 2018;59(6):944-951. doi:10.2967/jnumed.117.200006</Citation><ArticleIdList><ArticleId IdType="doi">10.2967/jnumed.117.200006</ArticleId><ArticleId IdType="pubmed">29191858</ArticleId></ArticleIdList></Reference><Reference><Citation>Salvad&#xf3; G, Ossenkoppele R, Ashton NJ, et al. . Specific associations between plasma biomarkers and postmortem amyloid plaque and tau tangle loads. EMBO Mol Med. 2023;15(5):e17123. doi:10.15252/emmm.202217123</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/emmm.202217123</ArticleId><ArticleId IdType="pmc">PMC10165361</ArticleId><ArticleId IdType="pubmed">36912178</ArticleId></ArticleIdList></Reference><Reference><Citation>Shcherbinin S, Evans CD, Lu M, et al. . Association of amyloid reduction after donanemab treatment with tau pathology and clinical outcomes: the TRAILBLAZER-ALZ randomized clinical trial. JAMA Neurol. 2022;79(10):1015-1024. doi:10.1001/jamaneurol.2022.2793</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2022.2793</ArticleId><ArticleId IdType="pmc">PMC9468959</ArticleId><ArticleId IdType="pubmed">36094645</ArticleId></ArticleIdList></Reference><Reference><Citation>Abushakra S, Porsteinsson A, Vellas B, et al. . Clinical benefits of tramiprosate in Alzheimer&#x2019;s disease are associated with higher number of APOE4 alleles: the &#x201c;APOE4 Gene-Dose Effect&#x201d;. J Prev Alzheimers Dis. 2016;3(4):219-228. doi:10.14283/jpad.2016.115</Citation><ArticleIdList><ArticleId IdType="doi">10.14283/jpad.2016.115</ArticleId><ArticleId IdType="pubmed">29199323</ArticleId></ArticleIdList></Reference><Reference><Citation>Vellas B, Andrieu S, Sampaio C, Wilcock G; European Task Force group . Disease-modifying trials in Alzheimer&#x2019;s disease: a European task force consensus. Lancet Neurol. 2007;6(1):56-62. doi:10.1016/S1474-4422(06)70677-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(06)70677-9</ArticleId><ArticleId IdType="pubmed">17166802</ArticleId></ArticleIdList></Reference><Reference><Citation>Insel PS, Weiner M, Mackin RS, et al. . Determining clinically meaningful decline in preclinical Alzheimer disease. Neurology. 2019;93(4):e322-e333. doi:10.1212/WNL.0000000000007831</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000007831</ArticleId><ArticleId IdType="pmc">PMC6669933</ArticleId><ArticleId IdType="pubmed">31289148</ArticleId></ArticleIdList></Reference><Reference><Citation>Alves F, Kalinowski P, Ayton S. Accelerated Brain volume loss caused by anti&#x2013;&#x3b2;-amyloid drugs. a systematic review and meta-analysis. Neurology. 2023;100(20):e2114-e2124. doi:10.1212/WNL.0000000000207156</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000207156</ArticleId><ArticleId IdType="pmc">PMC10186239</ArticleId><ArticleId IdType="pubmed">36973044</ArticleId></ArticleIdList></Reference><Reference><Citation>Aisen PS, Jimenez-Maggiora GA, Rafii MS, Walter S, Raman R. Early-stage Alzheimer disease: getting trial-ready. Nat Rev Neurol. 2022;18(7):389-399. doi:10.1038/s41582-022-00645-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-022-00645-6</ArticleId><ArticleId IdType="pmc">PMC8978175</ArticleId><ArticleId IdType="pubmed">35379951</ArticleId></ArticleIdList></Reference><Reference><Citation>Hampel H, Au R, Mattke S, et al. . Designing the next-generation clinical care pathway for Alzheimer&#x2019;s disease. Nat Aging. 2022;2(8):692-703. doi:10.1038/s43587-022-00269-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s43587-022-00269-x</ArticleId><ArticleId IdType="pmc">PMC10148953</ArticleId><ArticleId IdType="pubmed">37118137</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37464059</PMID><DateCompleted><Year>2023</Year><Month>08</Month><Day>17</Day></DateCompleted><DateRevised><Year>2023</Year><Month>09</Month><Day>14</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1546-170X</ISSN><JournalIssue CitedMedium="Internet"><Volume>29</Volume><Issue>8</Issue><PubDate><Year>2023</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Nature medicine</Title><ISOAbbreviation>Nat Med</ISOAbbreviation></Journal><ArticleTitle>Cognitive effects of Lewy body pathology in clinically unimpaired individuals.</ArticleTitle><Pagination><StartPage>1971</StartPage><EndPage>1978</EndPage><MedlinePgn>1971-1978</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41591-023-02450-0</ELocationID><Abstract><AbstractText>&#x3b1;-Synuclein aggregates constitute the pathology of Lewy body (LB) disease. Little is known about the effects of LB pathology in preclinical (presymptomatic) individuals, either as isolated pathology or coexisting with Alzheimer's disease (AD) pathology (&#x3b2;-amyloid (A&#x3b2;) and tau). We examined the effects of LB pathology using a cerebrospinal fluid &#x3b1;-synuclein-seed amplification assay in 1,182&#x2009;cognitively and neurologically unimpaired participants from the BioFINDER study: 8% were LB positive, 26% A&#x3b2; positive (13% of those were LB positive) and 16% tau positive. LB positivity occurred more often in the presence of A&#x3b2; positivity but not tau positivity. LB pathology had independently negative effects on cross-sectional and longitudinal global cognition and memory and on longitudinal attention/executive function. Tau had cognitive effects of a similar magnitude, but these were less pronounced for A&#x3b2;. Participants with both LB and AD (A&#x3b2; and tau) pathology exhibited faster cognitive decline than those with only LB or AD pathology. LB, but not AD, pathology was associated with reduced sense of smell. Only LB-positive participants progressed to clinical LB disease over 10&#x2009;years. These results are important for individualized prognosis, recruitment and choice of outcome measures in preclinical LB disease trials, but also for the design of early AD trials because &gt;10% of individuals with preclinical AD have coexisting LB pathology.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Palmqvist</LastName><ForeName>Sebastian</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-9267-1930</Identifier><AffiliationInfo><Affiliation>Clinical Memory Research Unit, Department of Clinical Sciences, Malm&#xf6;, Lund University, Lund, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Memory Clinic, Sk&#xe5;ne University Hospital, Malm&#xf6;, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Rossi</LastName><ForeName>Marcello</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hall</LastName><ForeName>Sara</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Clinical Memory Research Unit, Department of Clinical Sciences, Malm&#xf6;, Lund University, Lund, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Memory Clinic, Sk&#xe5;ne University Hospital, Malm&#xf6;, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Quadalti</LastName><ForeName>Corinne</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mattsson-Carlgren</LastName><ForeName>Niklas</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Clinical Memory Research Unit, Department of Clinical Sciences, Malm&#xf6;, Lund University, Lund, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Sk&#xe5;ne University Hospital, Lund University, Lund, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Wallenberg Center for Molecular Medicine, Lund University, Lund, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dellavalle</LastName><ForeName>Sofia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tideman</LastName><ForeName>Pontus</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Clinical Memory Research Unit, Department of Clinical Sciences, Malm&#xf6;, Lund University, Lund, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Memory Clinic, Sk&#xe5;ne University Hospital, Malm&#xf6;, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pereira</LastName><ForeName>Joana B</ForeName><Initials>JB</Initials><AffiliationInfo><Affiliation>Clinical Memory Research Unit, Department of Clinical Sciences, Malm&#xf6;, Lund University, Lund, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nilsson</LastName><ForeName>Maria H</ForeName><Initials>MH</Initials><Identifier Source="ORCID">0000-0002-6580-6721</Identifier><AffiliationInfo><Affiliation>Memory Clinic, Sk&#xe5;ne University Hospital, Malm&#xf6;, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Health Sciences, Lund University, Lund, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mammana</LastName><ForeName>Angela</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Janelidze</LastName><ForeName>Shorena</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-2869-8378</Identifier><AffiliationInfo><Affiliation>Clinical Memory Research Unit, Department of Clinical Sciences, Malm&#xf6;, Lund University, Lund, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Memory Clinic, Sk&#xe5;ne University Hospital, Malm&#xf6;, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baiardi</LastName><ForeName>Simone</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-7702-7856</Identifier><AffiliationInfo><Affiliation>IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stomrud</LastName><ForeName>Erik</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Clinical Memory Research Unit, Department of Clinical Sciences, Malm&#xf6;, Lund University, Lund, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Memory Clinic, Sk&#xe5;ne University Hospital, Malm&#xf6;, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Parchi</LastName><ForeName>Piero</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-9444-9524</Identifier><AffiliationInfo><Affiliation>IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy. piero.parchi@unibo.it.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy. piero.parchi@unibo.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Hansson</LastName><ForeName>Oskar</ForeName><Initials>O</Initials><Identifier Source="ORCID">0000-0001-8467-7286</Identifier><AffiliationInfo><Affiliation>Clinical Memory Research Unit, Department of Clinical Sciences, Malm&#xf6;, Lund University, Lund, Sweden. oskar.hansson@med.lu.se.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Memory Clinic, Sk&#xe5;ne University Hospital, Malm&#xf6;, Sweden. oskar.hansson@med.lu.se.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>07</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Nat Med</MedlineTA><NlmUniqueID>9502015</NlmUniqueID><ISSNLinking>1078-8956</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051844">alpha-Synuclein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016875">tau Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016229">Amyloid beta-Peptides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051844" MajorTopicYN="N">alpha-Synuclein</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016631" MajorTopicYN="N">Lewy Bodies</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016875" MajorTopicYN="N">tau Proteins</DescriptorName><QualifierName UI="Q000134" MajorTopicYN="N">cerebrospinal fluid</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020961" MajorTopicYN="Y">Lewy Body Disease</DescriptorName><QualifierName UI="Q000134" MajorTopicYN="N">cerebrospinal fluid</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016229" MajorTopicYN="N">Amyloid beta-Peptides</DescriptorName><QualifierName UI="Q000134" MajorTopicYN="N">cerebrospinal fluid</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003071" MajorTopicYN="N">Cognition</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060825" MajorTopicYN="Y">Cognitive Dysfunction</DescriptorName><QualifierName UI="Q000134" MajorTopicYN="N">cerebrospinal fluid</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000134" MajorTopicYN="N">cerebrospinal fluid</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D049268" MajorTopicYN="N">Positron-Emission Tomography</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>None of the authors have any financial interest in the &#x3b1;-syn SAA test. S.P. has acquired research support (for the institution) from ki elements/Alzheimer Drug Discoveries Foundation. In the past 2&#x2009;years he has received consultancy/speaker fees from Bioartic, Biogen, Eli Lilly and Roche. O.H. has acquired research support (for the institution) from ADx, AVID Radiopharmaceuticals, Biogen, Eli Lilly, Eisai, Fujirebio, GE Healthcare, Pfizer and Roche. In the past 2&#x2009;years he has received consultancy/speaker fees from AC Immune, Amylyx, Alzpath, BioArctic, Biogen, Cerveau, Eisai, Eli Lilly, Fujirebio, Genentech, Novartis, Novo Nordisk, Roche and Siemens. The remaining authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>1</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>6</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>17</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>7</Month><Day>19</Day><Hour>1</Hour><Minute>6</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>7</Month><Day>18</Day><Hour>23</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>7</Month><Day>18</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37464059</ArticleId><ArticleId IdType="pmc">PMC10427420</ArticleId><ArticleId IdType="doi">10.1038/s41591-023-02450-0</ArticleId><ArticleId IdType="pii">10.1038/s41591-023-02450-0</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Taylor JP, et al. New evidence on the management of Lewy body dementia. Lancet Neurol. 2020;19:157&#x2013;169.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7017451</ArticleId><ArticleId IdType="pubmed">31519472</ArticleId></ArticleIdList></Reference><Reference><Citation>Hansson O. Biomarkers for neurodegenerative diseases. Nat. Med. 2021;27:954&#x2013;963.</Citation><ArticleIdList><ArticleId IdType="pubmed">34083813</ArticleId></ArticleIdList></Reference><Reference><Citation>Horvath J, Herrmann FR, Burkhard PR, Bouras C, Kovari E. Neuropathology of dementia in a large cohort of patients with Parkinson&#x2019;s disease. Parkinsonism Relat. Disord. 2013;19:864&#x2013;868.</Citation><ArticleIdList><ArticleId IdType="pubmed">23746454</ArticleId></ArticleIdList></Reference><Reference><Citation>Gibb WR, Lees AJ. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson&#x2019;s disease. J. Neurol. Neurosurg. Psychiatry. 1988;51:745&#x2013;752.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1033142</ArticleId><ArticleId IdType="pubmed">2841426</ArticleId></ArticleIdList></Reference><Reference><Citation>Klos KJ, et al. Alpha-synuclein pathology in the spinal cords of neurologically asymptomatic aged individuals. Neurology. 2006;66:1100&#x2013;1102.</Citation><ArticleIdList><ArticleId IdType="pubmed">16606927</ArticleId></ArticleIdList></Reference><Reference><Citation>Parkkinen L, Soininen H, Laakso M, Alafuzoff I. Alpha-synuclein pathology is highly dependent on the case selection. Neuropathol. Appl. Neurobiol. 2001;27:314&#x2013;325.</Citation><ArticleIdList><ArticleId IdType="pubmed">11532162</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellomo G, et al. alpha-Synuclein seed amplification assays for diagnosing synucleinopathies: the way forward. Neurology. 2022;99:195&#x2013;205.</Citation><ArticleIdList><ArticleId IdType="pubmed">35914941</ArticleId></ArticleIdList></Reference><Reference><Citation>Hall S, et al. Performance of alphaSynuclein RT-QuIC in relation to neuropathological staging of Lewy body disease. Acta Neuropathol. Commun. 2022;10:90.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9219141</ArticleId><ArticleId IdType="pubmed">35733234</ArticleId></ArticleIdList></Reference><Reference><Citation>Groveman BR, et al. Rapid and ultra-sensitive quantitation of disease-associated alpha-synuclein seeds in brain and cerebrospinal fluid by alphaSyn RT-QuIC. Acta Neuropathol. Commun. 2018;6:7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5806364</ArticleId><ArticleId IdType="pubmed">29422107</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossi M, et al. Ultrasensitive RT-QuIC assay with high sensitivity and specificity for Lewy body-associated synucleinopathies. Acta Neuropathol. 2020;140:49&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7299922</ArticleId><ArticleId IdType="pubmed">32342188</ArticleId></ArticleIdList></Reference><Reference><Citation>Siderowf A, et al. Assessment of heterogeneity among participants in the Parkinson&#x2019;s Progression Markers Initiative cohort using alpha-synuclein seed amplification: a cross-sectional study. Lancet Neurol. 2023;22:407&#x2013;417.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10627170</ArticleId><ArticleId IdType="pubmed">37059509</ArticleId></ArticleIdList></Reference><Reference><Citation>Jack CR, Jr., et al. NIA-AA Research Framework: toward a biological definition of Alzheimer&#x2019;s disease. Alzheimers Dement. 2018;14:535&#x2013;562.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5958625</ArticleId><ArticleId IdType="pubmed">29653606</ArticleId></ArticleIdList></Reference><Reference><Citation>Ossenkoppele R, et al. Amyloid and tau PET-positive cognitively unimpaired individuals are at high risk for future cognitive decline. Nat. Med. 2022;28:2381&#x2013;2387.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9671808</ArticleId><ArticleId IdType="pubmed">36357681</ArticleId></ArticleIdList></Reference><Reference><Citation>Berron D, et al. Early stages of tau pathology and its associations with functional connectivity, atrophy and memory. Brain. 2021;144:2771&#x2013;2783.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8557349</ArticleId><ArticleId IdType="pubmed">33725124</ArticleId></ArticleIdList></Reference><Reference><Citation>Tideman P, et al. Association of beta-amyloid accumulation with executive function in adults with unimpaired cognition. Neurology. 2022;98:e1525&#x2013;e1533.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9012270</ArticleId><ArticleId IdType="pubmed">35022305</ArticleId></ArticleIdList></Reference><Reference><Citation>Vogel JW, et al. Four distinct trajectories of tau deposition identified in Alzheimer&#x2019;s disease. Nat. Med. 2021;27:871&#x2013;881.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8686688</ArticleId><ArticleId IdType="pubmed">33927414</ArticleId></ArticleIdList></Reference><Reference><Citation>Economou A, Routsis C, Papageorgiou SG. Episodic memory in Alzheimer disease, frontotemporal dementia, and dementia with Lewy bodies/Parkinson disease dementia: disentangling retrieval from consolidation. Alzheimer Dis. Assoc. Disord. 2016;30:47&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pubmed">25730300</ArticleId></ArticleIdList></Reference><Reference><Citation>Adler CH, et al. Unified staging system for Lewy body disorders: clinicopathologic correlations and comparison to Braak staging. J. Neuropathol. Exp. Neurol. 2019;78:891&#x2013;899.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6751070</ArticleId><ArticleId IdType="pubmed">31504679</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu J, et al. Dopamine-dependent neurotoxicity of alpha-synuclein: a mechanism for selective neurodegeneration in Parkinson disease. Nat. Med. 2002;8:600&#x2013;606.</Citation><ArticleIdList><ArticleId IdType="pubmed">12042811</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee JY, et al. Dopamine facilitates associative memory encoding in the entorhinal cortex. Nature. 2021;598:321&#x2013;326.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8744500</ArticleId><ArticleId IdType="pubmed">34552245</ArticleId></ArticleIdList></Reference><Reference><Citation>Palmqvist S, et al. Earliest accumulation of beta-amyloid occurs within the default-mode network and concurrently affects brain connectivity. Nat. Commun. 2017;8:1214.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5663717</ArticleId><ArticleId IdType="pubmed">29089479</ArticleId></ArticleIdList></Reference><Reference><Citation>Hung A, Schneider M, Lopez MH, McClellan M. Preclinical Alzheimer disease drug development: early considerations based on Phase 3 clinical trials. J. Manag. Care Spec. Pharm. 2020;26:888&#x2013;900.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10391091</ArticleId><ArticleId IdType="pubmed">32584672</ArticleId></ArticleIdList></Reference><Reference><Citation>Mintun MA, et al. Donanemab in early Alzheimer&#x2019;s disease. N. Engl. J. Med. 2021;384:1691&#x2013;1704.</Citation><ArticleIdList><ArticleId IdType="pubmed">33720637</ArticleId></ArticleIdList></Reference><Reference><Citation>Swanson CJ, et al. A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer&#x2019;s disease with lecanemab, an anti-Abeta protofibril antibody. Alzheimers Res. Ther. 2021;13:80.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8053280</ArticleId><ArticleId IdType="pubmed">33865446</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamilton RL. Lewy bodies in Alzheimer&#x2019;s disease: a neuropathological review of 145 cases using alpha-synuclein immunohistochemistry. Brain Pathol. 2000;10:378&#x2013;384.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8098522</ArticleId><ArticleId IdType="pubmed">10885656</ArticleId></ArticleIdList></Reference><Reference><Citation>Mikolaenko I, et al. Alpha-synuclein lesions in normal aging, Parkinson disease, and Alzheimer disease: evidence from the Baltimore Longitudinal Study of Aging (BLSA) J. Neuropathol. Exp. Neurol. 2005;64:156&#x2013;162.</Citation><ArticleIdList><ArticleId IdType="pubmed">15751230</ArticleId></ArticleIdList></Reference><Reference><Citation>Bassil F, et al. Amyloid-beta (Abeta) plaques promote seeding and spreading of alpha-synuclein and tau in a mouse model of Lewy body disorders with Abeta pathology. Neuron. 2020;105:260&#x2013;275.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6981053</ArticleId><ArticleId IdType="pubmed">31759806</ArticleId></ArticleIdList></Reference><Reference><Citation>Dickson DW, et al. APOE epsilon4 is associated with severity of Lewy body pathology independent of Alzheimer pathology. Neurology. 2018;91:e1182&#x2013;e1195.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6161556</ArticleId><ArticleId IdType="pubmed">30143564</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsuang DW, et al. Genetic association between the APOE*4 allele and Lewy bodies in Alzheimer disease. Neurology. 2005;64:509&#x2013;513.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1487185</ArticleId><ArticleId IdType="pubmed">15699383</ArticleId></ArticleIdList></Reference><Reference><Citation>Lippa CF, Schmidt ML, Lee VM, Trojanowski JQ. Antibodies to alpha-synuclein detect Lewy bodies in many Down&#x2019;s syndrome brains with Alzheimer&#x2019;s disease. Ann. Neurol. 1999;45:353&#x2013;357.</Citation><ArticleIdList><ArticleId IdType="pubmed">10072050</ArticleId></ArticleIdList></Reference><Reference><Citation>Lippa CF, et al. Lewy bodies contain altered alpha-synuclein in brains of many familial Alzheimer&#x2019;s disease patients with mutations in presenilin and amyloid precursor protein genes. Am. J. Pathol. 1998;153:1365&#x2013;1370.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1853391</ArticleId><ArticleId IdType="pubmed">9811326</ArticleId></ArticleIdList></Reference><Reference><Citation>Upcott M, Chaprov KD, Buchman VL. Toward a disease-modifying therapy of alpha-synucleinopathies: new molecules and new approaches came into the limelight. Molecules. 2021;26:7351.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8658846</ArticleId><ArticleId IdType="pubmed">34885933</ArticleId></ArticleIdList></Reference><Reference><Citation>Concha-Marambio L, et al. Accurate detection of alpha-synuclein seeds in cerebrospinal fluid from isolated rapid eye movement sleep behavior disorder and patients with Parkinson&#x2019;s disease in the DeNovo Parkinson (DeNoPa) cohort. Mov. Disord. 2023;38:567&#x2013;578.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10153075</ArticleId><ArticleId IdType="pubmed">36781413</ArticleId></ArticleIdList></Reference><Reference><Citation>Russo MJ, et al. High diagnostic performance of independent alpha-synuclein seed amplification assays for detection of early Parkinson&#x2019;s disease. Acta Neuropathol. Commun. 2021;9:179.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8572469</ArticleId><ArticleId IdType="pubmed">34742348</ArticleId></ArticleIdList></Reference><Reference><Citation>Kluge A, et al. Detection of neuron-derived pathological alpha-synuclein in blood. Brain. 2022;145:3058&#x2013;3071.</Citation><ArticleIdList><ArticleId IdType="pubmed">35722765</ArticleId></ArticleIdList></Reference><Reference><Citation>Mammana A, et al. RT-QuIC detection of pathological alpha-synuclein in skin punches of patients with Lewy body disease. Mov. Disord. 2021;36:2173&#x2013;2177.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8518528</ArticleId><ArticleId IdType="pubmed">34002890</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Z, et al. Skin alpha-synuclein aggregation seeding activity as a novel biomarker for Parkinson disease. JAMA Neurol. 2020;78:1&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7522783</ArticleId><ArticleId IdType="pubmed">32986090</ArticleId></ArticleIdList></Reference><Reference><Citation>Adler CH, et al. Incidental Lewy body disease: clinical comparison to a control cohort. Mov. Disord. 2010;25:642&#x2013;646.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2935627</ArticleId><ArticleId IdType="pubmed">20175211</ArticleId></ArticleIdList></Reference><Reference><Citation>Beach TG, et al. Severe hyposmia distinguishes neuropathologically confirmed dementia with Lewy bodies from Alzheimer&#x2019;s disease dementia. PLoS ONE. 2020;15:e0231720.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7176090</ArticleId><ArticleId IdType="pubmed">32320406</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva MME, Mercer PBS, Witt MCZ, Pessoa RR. Olfactory dysfunction in Alzheimer&#x2019;s disease Systematic review and meta-analysis. Dement. Neuropsychol. 2018;12:123&#x2013;132.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6022986</ArticleId><ArticleId IdType="pubmed">29988355</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong YC, Krainc D. Alpha-synuclein toxicity in neurodegeneration: mechanism and therapeutic strategies. Nat. Med. 2017;23:1&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8480197</ArticleId><ArticleId IdType="pubmed">28170377</ArticleId></ArticleIdList></Reference><Reference><Citation>McKeith IG, et al. Research criteria for the diagnosis of prodromal dementia with Lewy bodies. Neurology. 2020;94:743&#x2013;755.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7274845</ArticleId><ArticleId IdType="pubmed">32241955</ArticleId></ArticleIdList></Reference><Reference><Citation>Brenowitz WD, et al. Mixed neuropathologies and associations with domain-specific cognitive decline. Neurology. 2017;89:1773&#x2013;1781.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5664309</ArticleId><ArticleId IdType="pubmed">28939667</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryman SG, et al. Cognition at each stage of Lewy body disease with co-occurring Alzheimer&#x2019;s disease pathology. J. Alzheimers Dis. 2021;80:1243&#x2013;1256.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8150665</ArticleId><ArticleId IdType="pubmed">33646154</ArticleId></ArticleIdList></Reference><Reference><Citation>Dubois B, et al. Clinical diagnosis of Alzheimer&#x2019;s disease: recommendations of the International Working Group. Lancet Neurol. 2021;20:484&#x2013;496.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8339877</ArticleId><ArticleId IdType="pubmed">33933186</ArticleId></ArticleIdList></Reference><Reference><Citation>Palmqvist S, et al. Discriminative accuracy of plasma phospho-tau217 for Alzheimer disease vs other neurodegenerative disorders. JAMA. 2020;324:772&#x2013;781.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7388060</ArticleId><ArticleId IdType="pubmed">32722745</ArticleId></ArticleIdList></Reference><Reference><Citation>Janelidze S, et al. Cerebrospinal fluid p-tau217 performs better than p-tau181 as a biomarker of Alzheimer&#x2019;s disease. Nat. Commun. 2020;11:1683.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7125218</ArticleId><ArticleId IdType="pubmed">32246036</ArticleId></ArticleIdList></Reference><Reference><Citation>Postuma RB, et al. A single-question screen for rapid eye movement sleep behavior disorder: a multicenter validation study. Mov. Disord. 2012;27:913&#x2013;916.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4043389</ArticleId><ArticleId IdType="pubmed">22729987</ArticleId></ArticleIdList></Reference><Reference><Citation>Gelb DJ, Oliver E, Gilman S. Diagnostic criteria for Parkinson disease. Arch. Neurol. 1999;56:33&#x2013;39.</Citation><ArticleIdList><ArticleId IdType="pubmed">9923759</ArticleId></ArticleIdList></Reference><Reference><Citation>McKeith IG, et al. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology. 2005;65:1863&#x2013;1872.</Citation><ArticleIdList><ArticleId IdType="pubmed">16237129</ArticleId></ArticleIdList></Reference><Reference><Citation>Palmqvist S, et al. Performance of fully automated plasma assays as screening tests for Alzheimer disease-related beta-amyloid status. JAMA Neurol. 2019;76:1060&#x2013;1069.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6593637</ArticleId><ArticleId IdType="pubmed">31233127</ArticleId></ArticleIdList></Reference><Reference><Citation>Palmqvist S, et al. Prediction of future Alzheimer&#x2019;s disease dementia using plasma phospho-tau combined with other accessible measures. Nat. Med. 2021;27:1034&#x2013;1042.</Citation><ArticleIdList><ArticleId IdType="pubmed">34031605</ArticleId></ArticleIdList></Reference><Reference><Citation>Palmqvist S, et al. An accurate fully automated panel of plasma biomarkers for Alzheimer&#x2019;s disease. Alzheimers Dement. 2022;19:1204&#x2013;1215.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9918613</ArticleId><ArticleId IdType="pubmed">35950735</ArticleId></ArticleIdList></Reference><Reference><Citation>Postuma RB, et al. MDS clinical diagnostic criteria for Parkinson&#x2019;s disease. Mov. Disord. 2015;30:1591&#x2013;1601.</Citation><ArticleIdList><ArticleId IdType="pubmed">26474316</ArticleId></ArticleIdList></Reference><Reference><Citation>Petrazzuoli F, et al. Brief cognitive tests used in primary care cannot accurately differentiate mild cognitive impairment from subjective cognitive decline. J. Alzheimers Dis. 2020;75:1191&#x2013;1201.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7369041</ArticleId><ArticleId IdType="pubmed">32417771</ArticleId></ArticleIdList></Reference><Reference><Citation>Borland E, Stomrud E, van Westen D, Hansson O, Palmqvist S. The age-related effect on cognitive performance in cognitively healthy elderly is mainly caused by underlying AD pathology or cerebrovascular lesions: implications for cutoffs regarding cognitive impairment. Alzheimers Res. Ther. 2020;12:30.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7093968</ArticleId><ArticleId IdType="pubmed">32209137</ArticleId></ArticleIdList></Reference><Reference><Citation>Borland E, et al. The Montreal Cognitive Assessment: normative data from a large Swedish population-based cohort. J. Alzheimers Dis. 2017;59:893&#x2013;901.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5545909</ArticleId><ArticleId IdType="pubmed">28697562</ArticleId></ArticleIdList></Reference><Reference><Citation>Shirk SD, et al. A web-based normative calculator for the uniform data set (UDS) neuropsychological test battery. Alzheimers Res. Ther. 2011;3:32.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3308021</ArticleId><ArticleId IdType="pubmed">22078663</ArticleId></ArticleIdList></Reference><Reference><Citation>Papp KV, Rentz DM, Orlovsky I, Sperling RA, Mormino EC. Optimizing the preclinical Alzheimer&#x2019;s cognitive composite with semantic processing: the PACC5. Alzheimers Dement. (N.Y.) 2017;3:668&#x2013;677.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5726754</ArticleId><ArticleId IdType="pubmed">29264389</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen WG, Mohs RC, Davis KL. A new rating scale for Alzheimer&#x2019;s disease. Am. J. Psychiatry. 1984;141:1356&#x2013;1364.</Citation><ArticleIdList><ArticleId IdType="pubmed">6496779</ArticleId></ArticleIdList></Reference><Reference><Citation>Insel PS, et al. Determining clinically meaningful decline in preclinical Alzheimer disease. Neurology. 2019;93:e322&#x2013;e333.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6669933</ArticleId><ArticleId IdType="pubmed">31289148</ArticleId></ArticleIdList></Reference><Reference><Citation>Pichet Binette A, et al. Combining plasma phospho-tau and accessible measures to evaluate progression to Alzheimer&#x2019;s dementia in mild cognitive impairment patients. Alzheimers Res. Ther. 2022;14:46.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8966264</ArticleId><ArticleId IdType="pubmed">35351181</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith, A. Symbol Digit Modalities Test (Western Psychological Services, 1991).</Citation></Reference><Reference><Citation>Folstein MF, Folstein SE, McHugh PR. &#x2018;Mini-mental state&#x2019;. A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 1975;12:189&#x2013;198.</Citation><ArticleIdList><ArticleId IdType="pubmed">1202204</ArticleId></ArticleIdList></Reference><Reference><Citation>Doty RL, Marcus A, Lee WW. Development of the 12-item Cross-Cultural Smell Identification Test (CC-SIT) Laryngoscope. 1996;106:353&#x2013;356.</Citation><ArticleIdList><ArticleId IdType="pubmed">8614203</ArticleId></ArticleIdList></Reference><Reference><Citation>Cantone E, Maione N, Di Rubbo V, Esposito F, Iengo M. Olfactory performance after crenotherapy in chronic rhinosinusitis in the elderly. Laryngoscope. 2015;125:1529&#x2013;1534.</Citation><ArticleIdList><ArticleId IdType="pubmed">25639589</ArticleId></ArticleIdList></Reference><Reference><Citation>&#xc5;strand, R., Rolstad, S. &amp; Wallin, A. Cognitive Impairment Questionnaire (CIMP-QUEST): reported topographic symptoms in MCI and dementia. Acta Neurol. Scand.121, 384&#x2013;391 (2010).</Citation><ArticleIdList><ArticleId IdType="pubmed">20055769</ArticleId></ArticleIdList></Reference><Reference><Citation>Fahn S. in Recent Developments in Parkinson&#x2019;s Disease (eds Marsden, C. D. et al.) 153&#x2013;163 (Macmillan Healthcare Information, 1987).</Citation></Reference><Reference><Citation>Benaglia T, Chauveau D, Hunter DR, Young D. S. mixtools: an R Package for analyzing finite mixture models. J. Stat. Softw. 2009;32:1&#x2013;29.</Citation></Reference><Reference><Citation>Janelidze S, et al. Concordance between different amyloid immunoassays and visual amyloid positron emission tomographic assessment. JAMA Neurol. 2017;74:1492&#x2013;1501.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5822196</ArticleId><ArticleId IdType="pubmed">29114726</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossi M, et al. Diagnostic value of the CSF alpha-synuclein real-time quaking-induced conversion assay at the prodromal MCI stage of dementia with Lewy bodies. Neurology. 2021;97:e930&#x2013;e940.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8408510</ArticleId><ArticleId IdType="pubmed">34210822</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37464058</PMID><DateCompleted><Year>2023</Year><Month>08</Month><Day>17</Day></DateCompleted><DateRevised><Year>2023</Year><Month>09</Month><Day>14</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1546-170X</ISSN><JournalIssue CitedMedium="Internet"><Volume>29</Volume><Issue>8</Issue><PubDate><Year>2023</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Nature medicine</Title><ISOAbbreviation>Nat Med</ISOAbbreviation></Journal><ArticleTitle>Clinical effects of Lewy body pathology in cognitively impaired individuals.</ArticleTitle><Pagination><StartPage>1964</StartPage><EndPage>1970</EndPage><MedlinePgn>1964-1970</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41591-023-02449-7</ELocationID><Abstract><AbstractText>There is poor knowledge about the clinical effects of Lewy body (LB) pathology in patients with cognitive impairment, especially when coexisting with Alzheimer's disease (AD) pathology (amyloid-&#x3b2; and tau). Using a seed amplification assay, we analyzed cerebrospinal fluid for misfolded LB-associated &#x3b1;-synuclein in 883 memory clinic patients with mild cognitive impairment or dementia from the BioFINDER study. Twenty-three percent had LB pathology, of which only 21% fulfilled clinical criteria of Parkinson's disease or dementia with Lewy bodies at baseline. Among these LB-positive patients, 48% had AD pathology. Fifty-four percent had AD pathology in the whole sample (17% of mild cognitive impairment and 24% of patients with dementia were also LB-positive). When examining independent cross-sectional effects, LB pathology but not amyloid-&#x3b2; or tau, was associated with hallucinations and worse attention/executive, visuospatial and motor function. LB pathology was also associated with faster longitudinal decline in all examined cognitive functions, independent of amyloid-&#x3b2;, tau, cognitive stage and a baseline diagnosis of dementia with Lewy bodies/Parkinson's disease. LB status provides a better precision-medicine approach to predict clinical trajectories independent of AD biomarkers and a clinical diagnosis, which could have implications for the clinical management of cognitive impairment and the design of AD and LB drug trials.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Quadalti</LastName><ForeName>Corinne</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>IRCCS, Istituto delle Scienze Neurologiche di Bologna (ISNB), Bologna, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Palmqvist</LastName><ForeName>Sebastian</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-9267-1930</Identifier><AffiliationInfo><Affiliation>Clinical Memory Research Unit, Department of Clinical Sciences, Malm&#xf6;, Lund University, Lund, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Memory Clinic, Sk&#xe5;ne University Hospital, Malm&#xf6;, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hall</LastName><ForeName>Sara</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Clinical Memory Research Unit, Department of Clinical Sciences, Malm&#xf6;, Lund University, Lund, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Memory Clinic, Sk&#xe5;ne University Hospital, Malm&#xf6;, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rossi</LastName><ForeName>Marcello</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>IRCCS, Istituto delle Scienze Neurologiche di Bologna (ISNB), Bologna, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mammana</LastName><ForeName>Angela</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>IRCCS, Istituto delle Scienze Neurologiche di Bologna (ISNB), Bologna, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Janelidze</LastName><ForeName>Shorena</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-2869-8378</Identifier><AffiliationInfo><Affiliation>Clinical Memory Research Unit, Department of Clinical Sciences, Malm&#xf6;, Lund University, Lund, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dellavalle</LastName><ForeName>Sofia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>IRCCS, Istituto delle Scienze Neurologiche di Bologna (ISNB), Bologna, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mattsson-Carlgren</LastName><ForeName>Niklas</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Clinical Memory Research Unit, Department of Clinical Sciences, Malm&#xf6;, Lund University, Lund, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neurology Clinic, Sk&#xe5;ne University Hospital, Lund, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Wallenberg Center for Molecular Medicine, Lund University, Lund, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baiardi</LastName><ForeName>Simone</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-7702-7856</Identifier><AffiliationInfo><Affiliation>IRCCS, Istituto delle Scienze Neurologiche di Bologna (ISNB), Bologna, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stomrud</LastName><ForeName>Erik</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Clinical Memory Research Unit, Department of Clinical Sciences, Malm&#xf6;, Lund University, Lund, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Memory Clinic, Sk&#xe5;ne University Hospital, Malm&#xf6;, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Hansson</LastName><ForeName>Oskar</ForeName><Initials>O</Initials><Identifier Source="ORCID">0000-0001-8467-7286</Identifier><AffiliationInfo><Affiliation>Clinical Memory Research Unit, Department of Clinical Sciences, Malm&#xf6;, Lund University, Lund, Sweden. oskar.hansson@med.lu.se.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Memory Clinic, Sk&#xe5;ne University Hospital, Malm&#xf6;, Sweden. oskar.hansson@med.lu.se.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Parchi</LastName><ForeName>Piero</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-9444-9524</Identifier><AffiliationInfo><Affiliation>IRCCS, Istituto delle Scienze Neurologiche di Bologna (ISNB), Bologna, Italy. piero.parchi@unibo.it.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy. piero.parchi@unibo.it.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>07</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Nat Med</MedlineTA><NlmUniqueID>9502015</NlmUniqueID><ISSNLinking>1078-8956</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016229">Amyloid beta-Peptides</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016631" MajorTopicYN="N">Lewy Bodies</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020961" MajorTopicYN="Y">Lewy Body Disease</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010300" MajorTopicYN="Y">Parkinson Disease</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D060825" MajorTopicYN="Y">Cognitive Dysfunction</DescriptorName><QualifierName UI="Q000134" MajorTopicYN="N">cerebrospinal fluid</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016229" MajorTopicYN="N">Amyloid beta-Peptides</DescriptorName><QualifierName UI="Q000134" MajorTopicYN="N">cerebrospinal fluid</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>None of the authors has any financial interest in the &#x3b1;-syn SAA test. S.P. has acquired research support (for the institution) from ki elements/Alzheimer Drug Discoveries Foundation. In the past 2 years, he has received consultancy/speaker fees from Bioartic, Biogen, Lilly and Roche. O.H. has acquired research support (for the institution) from ADx, AVID Radiopharmaceuticals, Biogen, Eli Lilly, Eisai, Fujirebio, GE Healthcare, Pfizer and Roche. In the past 2 years, he has received consultancy/speaker fees from AC Immune, Amylyx, Alzpath, BioArctic, Biogen, Cerveau, Eisai, Eli Lilly, Fujirebio, Genentech, Merck, Novartis, Novo Nordisk, Roche, Sanofi and Siemens. M.R., S.H., C.Q., N.M.C., S.D., A.M., S.J., S.B., E.S. and P.P. declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>1</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>6</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>17</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>7</Month><Day>19</Day><Hour>1</Hour><Minute>6</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>7</Month><Day>18</Day><Hour>23</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>7</Month><Day>18</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37464058</ArticleId><ArticleId IdType="pmc">PMC10427416</ArticleId><ArticleId IdType="doi">10.1038/s41591-023-02449-7</ArticleId><ArticleId IdType="pii">10.1038/s41591-023-02449-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hansson O. Biomarkers for neurodegenerative diseases. Nat. Med. 2021;27:954&#x2013;963.</Citation><ArticleIdList><ArticleId IdType="pubmed">34083813</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor JP, et al. New evidence on the management of Lewy body dementia. Lancet Neurol. 2020;19:157&#x2013;169.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7017451</ArticleId><ArticleId IdType="pubmed">31519472</ArticleId></ArticleIdList></Reference><Reference><Citation>DeTure MA, Dickson DW. The neuropathological diagnosis of Alzheimer&#x2019;s disease. Mol. Neurodegener. 2019;14:32.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6679484</ArticleId><ArticleId IdType="pubmed">31375134</ArticleId></ArticleIdList></Reference><Reference><Citation>Dubois B, et al. Clinical diagnosis of Alzheimer&#x2019;s disease: recommendations of the International Working Group. Lancet Neurol. 2021;20:484&#x2013;496.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8339877</ArticleId><ArticleId IdType="pubmed">33933186</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellomo G, et al. &#x3b1;-Synuclein seed amplification assays for diagnosing synucleinopathies: the way forward. Neurology. 2022;99:195&#x2013;205.</Citation><ArticleIdList><ArticleId IdType="pubmed">35914941</ArticleId></ArticleIdList></Reference><Reference><Citation>Bargar C, et al. Streamlined &#x3b1;-synuclein RT-QuIC assay for various biospecimens in Parkinson&#x2019;s disease and dementia with Lewy bodies. Acta Neuropathol. Commun. 2021;9:62.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8028088</ArticleId><ArticleId IdType="pubmed">33827706</ArticleId></ArticleIdList></Reference><Reference><Citation>Hall S, et al. Performance of &#x3b1;-Synuclein RT-QuIC in relation to neuropathological staging of Lewy body disease. Acta Neuropathol. Commun. 2022;10:90.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9219141</ArticleId><ArticleId IdType="pubmed">35733234</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossi M, et al. Ultrasensitive RT-QuIC assay with high sensitivity and specificity for Lewy body-associated synucleinopathies. Acta Neuropathol. 2020;140:49&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7299922</ArticleId><ArticleId IdType="pubmed">32342188</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold MR, et al. &#x3b1;-Synuclein seed amplification in CSF and brain from patients with different brain distributions of pathological &#x3b1;-synuclein in the context of co-pathology and non-LBD diagnoses. Ann. Neurol. 2022;92:650&#x2013;662.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9489647</ArticleId><ArticleId IdType="pubmed">35808984</ArticleId></ArticleIdList></Reference><Reference><Citation>Siderowf A, et al. Assessment of heterogeneity among participants in the Parkinson&#x2019;s Progression Markers Initiative cohort using &#x3b1;-synuclein seed amplification: a cross-sectional study. Lancet Neurol. 2023;22:407&#x2013;417.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10627170</ArticleId><ArticleId IdType="pubmed">37059509</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang UJ, et al. Comparative study of cerebrospinal fluid &#x3b1;-synuclein seeding aggregation assays for diagnosis of Parkinson&#x2019;s disease. Mov. Disord. 2019;34:536&#x2013;544.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6519150</ArticleId><ArticleId IdType="pubmed">30840785</ArticleId></ArticleIdList></Reference><Reference><Citation>Poggiolini, I. et al. RT-QuIC using C-terminally truncated &#x3b1;-synuclein forms detects differences in seeding propensity of different brain regions from synucleinopathies. Biomolecules10.3390/biom11060820 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8226794</ArticleId><ArticleId IdType="pubmed">34072869</ArticleId></ArticleIdList></Reference><Reference><Citation>Jack CR, Jr., et al. NIA-AA research framework: toward a biological definition of Alzheimer&#x2019;s disease. Alzheimers Dement. 2018;14:535&#x2013;562.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5958625</ArticleId><ArticleId IdType="pubmed">29653606</ArticleId></ArticleIdList></Reference><Reference><Citation>Attems J, et al. Neuropathological consensus criteria for the evaluation of Lewy pathology in post-mortem brains: a multi-centre study. Acta Neuropathol. 2021;141:159&#x2013;172.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7847437</ArticleId><ArticleId IdType="pubmed">33399945</ArticleId></ArticleIdList></Reference><Reference><Citation>Postuma RB, et al. MDS clinical diagnostic criteria for Parkinson&#x2019;s disease. Mov. Disord. 2015;30:1591&#x2013;1601.</Citation><ArticleIdList><ArticleId IdType="pubmed">26474316</ArticleId></ArticleIdList></Reference><Reference><Citation>McKeith IG, et al. Research criteria for the diagnosis of prodromal dementia with Lewy bodies. Neurology. 2020;94:743&#x2013;755.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7274845</ArticleId><ArticleId IdType="pubmed">32241955</ArticleId></ArticleIdList></Reference><Reference><Citation>McKeith IG, et al. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology. 2005;65:1863&#x2013;1872.</Citation><ArticleIdList><ArticleId IdType="pubmed">16237129</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferman TJ, et al. The limbic and neocortical contribution of &#x3b1;-synuclein, tau, and amyloid &#x3b2; to disease duration in dementia with Lewy bodies. Alzheimers Dement. 2018;14:330&#x2013;339.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5899889</ArticleId><ArticleId IdType="pubmed">29100980</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas AJ, et al. Improving the identification of dementia with Lewy bodies in the context of an Alzheimer&#x2019;s-type dementia. Alzheimers Res Ther. 2018;10:27.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5831205</ArticleId><ArticleId IdType="pubmed">29490691</ArticleId></ArticleIdList></Reference><Reference><Citation>Coughlin D, et al. Cognitive and pathological influences of tau pathology in Lewy body disorders. Ann. Neurol. 2019;85:259&#x2013;271.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6375484</ArticleId><ArticleId IdType="pubmed">30549331</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryman SG, et al. Cognition at each stage of Lewy body disease with co-occurring Alzheimer&#x2019;s disease pathology. J. Alzheimers Dis. 2021;80:1243&#x2013;1256.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8150665</ArticleId><ArticleId IdType="pubmed">33646154</ArticleId></ArticleIdList></Reference><Reference><Citation>Brenowitz WD, et al. Mixed neuropathologies and associations with domain-specific cognitive decline. Neurology. 2017;89:1773&#x2013;1781.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5664309</ArticleId><ArticleId IdType="pubmed">28939667</ArticleId></ArticleIdList></Reference><Reference><Citation>Malek-Ahmadi M, et al. Faster cognitive decline in dementia due to Alzheimer disease with clinically undiagnosed Lewy body disease. PLoS ONE. 2019;14:e0217566.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6592515</ArticleId><ArticleId IdType="pubmed">31237877</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu Y, et al. Clinical trajectories at the end of life in autopsy-confirmed dementia patients with Alzheimer disease and Lewy bodies pathologies. Neurology. 2022;98:e2140&#x2013;e2149.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9169937</ArticleId><ArticleId IdType="pubmed">35379761</ArticleId></ArticleIdList></Reference><Reference><Citation>Mammana A, et al. RT-QuIC detection of pathological &#x3b1;-synuclein in skin punches of patients with Lewy body disease. Mov. Disord. 2021;36:2173&#x2013;2177.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8518528</ArticleId><ArticleId IdType="pubmed">34002890</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Z, et al. Skin &#x3b1;-synuclein aggregation seeding activity as a novel biomarker for Parkinson disease. JAMA Neurol. 2020;78:1&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7522783</ArticleId><ArticleId IdType="pubmed">32986090</ArticleId></ArticleIdList></Reference><Reference><Citation>Iranzo, A. et al. Misfolded &#x3b1;-synuclein assessment in skin and CSF by RT-QuIC in isolated REM sleep behavior disorder. Neurology10.1212/WNL.0000000000207147 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10159765</ArticleId><ArticleId IdType="pubmed">36931726</ArticleId></ArticleIdList></Reference><Reference><Citation>Kluge A, et al. Detection of neuron-derived pathological &#x3b1;-synuclein in blood. Brain. 2022;145:3058&#x2013;3071.</Citation><ArticleIdList><ArticleId IdType="pubmed">35722765</ArticleId></ArticleIdList></Reference><Reference><Citation>Spina S, et al. Comorbid neuropathological diagnoses in early versus late-onset Alzheimer&#x2019;s disease. Brain. 2021;144:2186&#x2013;2198.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8502474</ArticleId><ArticleId IdType="pubmed">33693619</ArticleId></ArticleIdList></Reference><Reference><Citation>Twohig D, Nielsen H. &#x3b1;-Synuclein in the pathophysiology of Alzheimer&#x2019;s disease. Mol. Neurodegener. 2019;14:23.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6558879</ArticleId><ArticleId IdType="pubmed">31186026</ArticleId></ArticleIdList></Reference><Reference><Citation>Toledo JB, et al. Dementia with Lewy bodies: impact of co-pathologies and implications for clinical trial design. Alzheimers Dement. 2023;19:318&#x2013;332.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9881193</ArticleId><ArticleId IdType="pubmed">36239924</ArticleId></ArticleIdList></Reference><Reference><Citation>Parkkinen L, Soininen H, Laakso M, Alafuzoff I. &#x3b1;-Synuclein pathology is highly dependent on the case selection. Neuropathol. Appl. Neurobiol. 2001;27:314&#x2013;325.</Citation><ArticleIdList><ArticleId IdType="pubmed">11532162</ArticleId></ArticleIdList></Reference><Reference><Citation>Jellinger KA, Attems J. Prevalence and pathology of dementia with Lewy bodies in the oldest old: a comparison with other dementing disorders. Dement Geriatr. Cogn. Disord. 2011;31:309&#x2013;316.</Citation><ArticleIdList><ArticleId IdType="pubmed">21502762</ArticleId></ArticleIdList></Reference><Reference><Citation>Palmqvist S, et al. Discriminative accuracy of plasma phospho-tau217 for Alzheimer disease vs other neurodegenerative disorders. JAMA. 2020;324:772&#x2013;781.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7388060</ArticleId><ArticleId IdType="pubmed">32722745</ArticleId></ArticleIdList></Reference><Reference><Citation>Nelson PT, et al. Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report. Brain. 2019;142:1503&#x2013;1527.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6536849</ArticleId><ArticleId IdType="pubmed">31039256</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosler TW, et al. Four-repeat tauopathies. Prog. Neurobiol. 2019;180:101644.</Citation><ArticleIdList><ArticleId IdType="pubmed">31238088</ArticleId></ArticleIdList></Reference><Reference><Citation>Kapasi A, et al. Limbic-predominant age-related TDP-43 encephalopathy, ADNC pathology, and cognitive decline in aging. Neurology. 2020;95:e1951&#x2013;e1962.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7682843</ArticleId><ArticleId IdType="pubmed">32753441</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker, J. M. et al. Cognitive and neuropsychological profiles in Alzheimer&#x2019;s disease and primary age-related tauopathy and the influence of comorbid neuropathologies. J. Alzheimers Dis.10.3233/JAD-230022 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11138480</ArticleId><ArticleId IdType="pubmed">36847012</ArticleId></ArticleIdList></Reference><Reference><Citation>Postuma RB, et al. A single-question screen for rapid eye movement sleep behavior disorder: a multicenter validation study. Mov. Disord. 2012;27:913&#x2013;916.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4043389</ArticleId><ArticleId IdType="pubmed">22729987</ArticleId></ArticleIdList></Reference><Reference><Citation>Palmqvist S, et al. Performance of fully automated plasma assays as screening tests for Alzheimer disease-related &#x3b2;-amyloid status. JAMA Neurol. 2019;76:1060&#x2013;1069.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6593637</ArticleId><ArticleId IdType="pubmed">31233127</ArticleId></ArticleIdList></Reference><Reference><Citation>Palmqvist S, et al. Prediction of future Alzheimer&#x2019;s disease dementia using plasma phospho-tau combined with other accessible measures. Nat. Med. 2021;27:1034&#x2013;1042.</Citation><ArticleIdList><ArticleId IdType="pubmed">34031605</ArticleId></ArticleIdList></Reference><Reference><Citation>American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition(DSM-5) 607&#x2013;608 (American Psychiatric Publishing, 2013).</Citation></Reference><Reference><Citation>Petrazzuoli F, et al. Brief cognitive tests used in primary care cannot accurately differentiate mild cognitive impairment from subjective cognitive decline. J. Alzheimers Dis. 2020;75:1191&#x2013;1201.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7369041</ArticleId><ArticleId IdType="pubmed">32417771</ArticleId></ArticleIdList></Reference><Reference><Citation>Borland E, Stomrud E, van Westen D, Hansson O, Palmqvist S. The age-related effect on cognitive performance in cognitively healthy elderly is mainly caused by underlying AD pathology or cerebrovascular lesions: implications for cutoffs regarding cognitive impairment. Alzheimers Res. Ther. 2020;12:30.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7093968</ArticleId><ArticleId IdType="pubmed">32209137</ArticleId></ArticleIdList></Reference><Reference><Citation>Borland E, et al. The Montreal cognitive assessment: normative data from a large Swedish population-based cohort. J. Alzheimers Dis. 2017;59:893&#x2013;901.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5545909</ArticleId><ArticleId IdType="pubmed">28697562</ArticleId></ArticleIdList></Reference><Reference><Citation>Shirk SD, et al. A web-based normative calculator for the uniform data set (UDS) neuropsychological test battery. Alzheimers Res. Ther. 2011;3:32.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3308021</ArticleId><ArticleId IdType="pubmed">22078663</ArticleId></ArticleIdList></Reference><Reference><Citation>Gelb DJ, Oliver E, Gilman S. Diagnostic criteria for Parkinson disease. Arch. Neurol. 1999;56:33&#x2013;39.</Citation><ArticleIdList><ArticleId IdType="pubmed">9923759</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoglinger GU, et al. Clinical diagnosis of progressive supranuclear palsy: The Movement Disorder Society criteria. Mov. Disord. 2017;32:853&#x2013;864.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5516529</ArticleId><ArticleId IdType="pubmed">28467028</ArticleId></ArticleIdList></Reference><Reference><Citation>Gilman S, et al. Second consensus statement on the diagnosis of multiple system atrophy. Neurology. 2008;71:670&#x2013;676.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2676993</ArticleId><ArticleId IdType="pubmed">18725592</ArticleId></ArticleIdList></Reference><Reference><Citation>Armstrong MJ, et al. Criteria for the diagnosis of corticobasal degeneration. Neurology. 2013;80:496&#x2013;503.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3590050</ArticleId><ArticleId IdType="pubmed">23359374</ArticleId></ArticleIdList></Reference><Reference><Citation>Gorno-Tempini ML, et al. Classification of primary progressive aphasia and its variants. Neurology. 2011;76:1006&#x2013;1014.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3059138</ArticleId><ArticleId IdType="pubmed">21325651</ArticleId></ArticleIdList></Reference><Reference><Citation>Papp KV, Rentz DM, Orlovsky I, Sperling RA, Mormino EC. Optimizing the preclinical Alzheimer&#x2019;s cognitive composite with semantic processing: the PACC5. Alzheimers Dement. 2017;3:668&#x2013;677.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5726754</ArticleId><ArticleId IdType="pubmed">29264389</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen WG, Mohs RC, Davis KL. A new rating scale for Alzheimer&#x2019;s disease. Am. J. Psychiatry. 1984;141:1356&#x2013;1364.</Citation><ArticleIdList><ArticleId IdType="pubmed">6496779</ArticleId></ArticleIdList></Reference><Reference><Citation>Insel PS, et al. Determining clinically meaningful decline in preclinical Alzheimer disease. Neurology. 2019;93:e322&#x2013;e333.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6669933</ArticleId><ArticleId IdType="pubmed">31289148</ArticleId></ArticleIdList></Reference><Reference><Citation>Pichet Binette A, et al. Combining plasma phospho-tau and accessible measures to evaluate progression to Alzheimer&#x2019;s dementia in mild cognitive impairment patients. Alzheimers Res. Ther. 2022;14:46.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8966264</ArticleId><ArticleId IdType="pubmed">35351181</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith, A. Symbol Digit Modalities Test (Western Psychological Services, 1991).</Citation></Reference><Reference><Citation>Folstein MF, Folstein SE, McHugh PR. &#x2018;Mini-mental state&#x2019;. A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 1975;12:189&#x2013;198.</Citation><ArticleIdList><ArticleId IdType="pubmed">1202204</ArticleId></ArticleIdList></Reference><Reference><Citation>Astrand R, Rolstad S, Wallin A. Cognitive Impairment Questionnaire (CIMP-QUEST): reported topographic symptoms in MCI and dementia. Acta Neurol. Scand. 2010;121:384&#x2013;391.</Citation><ArticleIdList><ArticleId IdType="pubmed">20055769</ArticleId></ArticleIdList></Reference><Reference><Citation>Benaglia T, Chauveau D, Hunter DR, Young D. S. mixtools: an R package for analyzing finite mixture models. J. Stat. Softw. 2009;32:1&#x2013;29.</Citation></Reference><Reference><Citation>Palmqvist, S. et al. An accurate fully automated panel of plasma biomarkers for Alzheimer&#x2019;s disease. Alzheimers Dement. 10.1002/alz.12751 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9918613</ArticleId><ArticleId IdType="pubmed">35950735</ArticleId></ArticleIdList></Reference><Reference><Citation>Blennow K, et al. Second-generation Elecsys cerebrospinal fluid immunoassays aid diagnosis of early Alzheimer&#x2019;s disease. Clin. Chem. Lab. Med. 2023;61:234&#x2013;244.</Citation><ArticleIdList><ArticleId IdType="pubmed">36282960</ArticleId></ArticleIdList></Reference><Reference><Citation>Palmqvist S, et al. Accuracy of brain amyloid detection in clinical practice using cerebrospinal fluid &#x3b2;-amyloid 42: a cross-validation study against amyloid positron emission tomography. JAMA Neurol. 2014;71:1282&#x2013;1289.</Citation><ArticleIdList><ArticleId IdType="pubmed">25155658</ArticleId></ArticleIdList></Reference><Reference><Citation>Groveman BR, et al. Rapid and ultra-sensitive quantitation of disease-associated &#x3b1;-synuclein seeds in brain and cerebrospinal fluid by &#x3b1;Syn RT-QuIC. Acta Neuropathol. Commun. 2018;6:7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5806364</ArticleId><ArticleId IdType="pubmed">29422107</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossi M, et al. Diagnostic value of the CSF &#x3b1;-synuclein real-time quaking-induced conversion assay at the prodromal MCI stage of dementia with Lewy bodies. Neurology. 2021;97:e930&#x2013;e940.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8408510</ArticleId><ArticleId IdType="pubmed">34210822</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37467317</PMID><DateCompleted><Year>2023</Year><Month>07</Month><Day>21</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>30</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1946-6242</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><Issue>705</Issue><PubDate><Year>2023</Year><Month>Jul</Month><Day>19</Day></PubDate></JournalIssue><Title>Science translational medicine</Title><ISOAbbreviation>Sci Transl Med</ISOAbbreviation></Journal><ArticleTitle>Proteomics analysis of plasma from middle-aged adults identifies protein markers of dementia risk in later life.</ArticleTitle><Pagination><StartPage>eadf5681</StartPage><MedlinePgn>eadf5681</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1126/scitranslmed.adf5681</ELocationID><Abstract><AbstractText>A diverse set of biological processes have been implicated in the pathophysiology of Alzheimer's disease (AD) and related dementias. However, there is limited understanding of the peripheral biological mechanisms relevant in the earliest phases of the disease. Here, we used a large-scale proteomics platform to examine the association of 4877 plasma proteins with 25-year dementia risk in 10,981 middle-aged adults. We found 32 dementia-associated plasma proteins that were involved in proteostasis, immunity, synaptic function, and extracellular matrix organization. We then replicated the association between 15 of these proteins and clinically relevant neurocognitive outcomes in two independent cohorts. We demonstrated that 12 of these 32 dementia-associated proteins were associated with cerebrospinal fluid (CSF) biomarkers of AD, neurodegeneration, or neuroinflammation. We found that eight of these candidate protein markers were abnormally expressed in human postmortem brain tissue from patients with AD, although some of the proteins that were most strongly associated with dementia risk, such as GDF15, were not detected in these brain tissue samples. Using network analyses, we found a protein signature for dementia risk that was characterized by dysregulation of specific immune and proteostasis/autophagy pathways in adults in midlife ~20 years before dementia onset, as well as abnormal coagulation and complement signaling ~10 years before dementia onset. Bidirectional two-sample Mendelian randomization genetically validated nine of our candidate proteins as markers of AD in midlife and inferred causality of SERPINA3 in AD pathogenesis. Last, we prioritized a set of candidate markers for AD and dementia risk prediction in midlife.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Walker</LastName><ForeName>Keenan A</ForeName><Initials>KA</Initials><Identifier Source="ORCID">0000-0002-5989-9853</Identifier><AffiliationInfo><Affiliation>Laboratory of Behavioral Neuroscience, National Institute on Aging, Intramural Research Program, Baltimore, MD 21224, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Jingsha</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21210, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shi</LastName><ForeName>Liu</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Novo Nordisk Research Centre Oxford (NNRCO), Oxford OX3 7FZ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Yunju</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0002-9747-8363</Identifier><AffiliationInfo><Affiliation>Brown Foundation Institute of Molecular Medicine, McGovern Medical School and Human Genetics Center, School of Public Health, University of Texas Health Science Center at Houston, Houston, TX 77030, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fornage</LastName><ForeName>Myriam</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-0677-8158</Identifier><AffiliationInfo><Affiliation>Brown Foundation Institute of Molecular Medicine, McGovern Medical School and Human Genetics Center, School of Public Health, University of Texas Health Science Center at Houston, Houston, TX 77030, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Linda</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21210, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schlosser</LastName><ForeName>Pascal</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-8460-0462</Identifier><AffiliationInfo><Affiliation>Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21210, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Surapaneni</LastName><ForeName>Aditya</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-4978-5980</Identifier><AffiliationInfo><Affiliation>Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21210, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grams</LastName><ForeName>Morgan E</ForeName><Initials>ME</Initials><Identifier Source="ORCID">0000-0002-4430-6023</Identifier><AffiliationInfo><Affiliation>Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21210, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Nephrology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21210, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Duggan</LastName><ForeName>Michael R</ForeName><Initials>MR</Initials><Identifier Source="ORCID">0000-0002-1029-4423</Identifier><AffiliationInfo><Affiliation>Laboratory of Behavioral Neuroscience, National Institute on Aging, Intramural Research Program, Baltimore, MD 21224, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peng</LastName><ForeName>Zhongsheng</ForeName><Initials>Z</Initials><Identifier Source="ORCID">0000-0001-7000-8647</Identifier><AffiliationInfo><Affiliation>Laboratory of Behavioral Neuroscience, National Institute on Aging, Intramural Research Program, Baltimore, MD 21224, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gomez</LastName><ForeName>Gabriela T</ForeName><Initials>GT</Initials><Identifier Source="ORCID">0000-0002-1761-0070</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD 21210, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tin</LastName><ForeName>Adrienne</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-4207-5866</Identifier><AffiliationInfo><Affiliation>MIND Center and Division of Nephrology, University of Mississippi Medical Center, Jackson, MS 39216, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hoogeveen</LastName><ForeName>Ron C</ForeName><Initials>RC</Initials><Identifier Source="ORCID">0000-0003-2399-4653</Identifier><AffiliationInfo><Affiliation>Section of Cardiovascular Research, Department of Medicine, Baylor College of Medicine, Houston, TX 77030, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sullivan</LastName><ForeName>Kevin J</ForeName><Initials>KJ</Initials><Identifier Source="ORCID">0000-0001-9147-0988</Identifier><AffiliationInfo><Affiliation>Department of Medicine, Division of Geriatrics, University of Mississippi Medical Center, Jackson, MS 39216, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ganz</LastName><ForeName>Peter</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-0437-8882</Identifier><AffiliationInfo><Affiliation>Department of Medicine, University of California-San&#xa0;Francisco, San&#xa0;Francisco, CA 94115, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lindbohm</LastName><ForeName>Joni V</ForeName><Initials>JV</Initials><AffiliationInfo><Affiliation>Broad Institute of the Massachusetts Institute of Technology and Harvard University, Cambridge, MA 02142, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kivimaki</LastName><ForeName>Mika</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-4699-5627</Identifier><AffiliationInfo><Affiliation>Department of Mental Health of Older People, Faculty of Brain Sciences, University College London, London WC1E 6BT, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinicum, Faculty of Medicine, University of Helsinki, Helsinki 00100, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nevado-Holgado</LastName><ForeName>Alejo J</ForeName><Initials>AJ</Initials><Identifier Source="ORCID">0000-0001-9276-2720</Identifier><AffiliationInfo><Affiliation>Department of Psychiatry, University of Oxford, Oxford OX1 2JD, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Buckley</LastName><ForeName>Noel</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, University of Oxford, Oxford OX1 2JD, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gottesman</LastName><ForeName>Rebecca F</ForeName><Initials>RF</Initials><Identifier Source="ORCID">0000-0002-9504-1256</Identifier><AffiliationInfo><Affiliation>National Institute of Neurological Disorders and Stroke, Intramural Research Program, Bethesda, MD 20892, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mosley</LastName><ForeName>Thomas H</ForeName><Initials>TH</Initials><Identifier Source="ORCID">0000-0003-3343-1352</Identifier><AffiliationInfo><Affiliation>Department of Medicine, Division of Geriatrics, University of Mississippi Medical Center, Jackson, MS 39216, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boerwinkle</LastName><ForeName>Eric</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, Human Genetics and Environmental Sciences, School of Public Health, University of Texas Health Science Center at Houston; Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX 77030, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ballantyne</LastName><ForeName>Christie M</ForeName><Initials>CM</Initials><Identifier Source="ORCID">0000-0002-6432-1730</Identifier><AffiliationInfo><Affiliation>Section of Cardiovascular Research, Department of Medicine, Baylor College of Medicine, Houston, TX 77030, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Coresh</LastName><ForeName>Josef</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-4598-0669</Identifier><AffiliationInfo><Affiliation>Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21210, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 DK115534</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>RF1 AG059421</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 HL096917</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HL059367</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HL086694</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AR073178</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K24 HL155861</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>HHSN268201700001I</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 HL096814</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>ZIA AG000348</GrantID><Acronym>ImNIH</Acronym><Agency>Intramural NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HL070825</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HL134320</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>HHSN268201700003I</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG056477</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>ZIA AG000349</GrantID><Acronym>ImNIH</Acronym><Agency>Intramural NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 HL096812</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>MR/R024227/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>UL1 RR025005</GrantID><Acronym>RR</Acronym><Agency>NCRR NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>Z99 AG999999</GrantID><Acronym>ImNIH</Acronym><Agency>Intramural NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R024227/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>221854/Z/20/Z</GrantID><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MRC S011676</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MRC R024227/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>U01 HL096902</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>HHSN268201700002C</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>RF1 AG062553</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 AG058589</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>HHSN268201700004I</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AG066546</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 DK108803</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 AG052409</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 DK124399</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>HHSN268201700005C</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>HHSN268201700001C</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>MR/S011676/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>HHSN268201700003C</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 HL096899</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>HHSN268201700004C</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>HHSN268201700002I</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>HHSN268201700005I</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 DK100446</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HL087641</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D052060">Research Support, N.I.H., Intramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>07</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Sci Transl Med</MedlineTA><NlmUniqueID>101505086</NlmUniqueID><ISSNLinking>1946-6234</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016229">Amyloid beta-Peptides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016875">tau Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D040901" MajorTopicYN="Y">Proteomics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016229" MajorTopicYN="N">Amyloid beta-Peptides</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016875" MajorTopicYN="N">tau Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><CoiStatement><b>Competing interests:</b> R.C.H. has received research grants (to his institution) from Denka Seiken and is a consultant for Denka Seiken. PG serves on the medical advisory board of SomaLogic for which he accepts no financial remuneration. A.J.N.-H. receives research funding from Janssen Pharmaceuticals, Ono Pharma, and GlaxoSmithKline. J. Coresh is a scientific advisor receiving fees from SomaLogic and Healthy.io. The other authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>7</Month><Day>21</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>7</Month><Day>19</Day><Hour>19</Hour><Minute>8</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>7</Month><Day>19</Day><Hour>14</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>7</Month><Day>19</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37467317</ArticleId><ArticleId IdType="mid">NIHMS1938899</ArticleId><ArticleId IdType="pmc">PMC10665113</ArticleId><ArticleId IdType="doi">10.1126/scitranslmed.adf5681</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Karch CM, Goate AM, Alzheimer&#x2019;s disease risk genes and mechanisms of disease pathogenesis. Biol. Psychiatry 77, 43&#x2013;51 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4234692</ArticleId><ArticleId IdType="pubmed">24951455</ArticleId></ArticleIdList></Reference><Reference><Citation>Yousef H, Czupalla CJ, Lee D, Chen MB, Burke AN, Zera KA, Zandstra J, Berber E, Lehallier B, Mathur V, Nair RV, Bonanno LN, Yang AC, Peterson T, Hadeiba H, Merkel T, K&#xf6;rbelin J, Schwaninger M, Buckwalter MS, Quake SR, Butcher EC, Wyss-Coray T, Aged blood impairs hippocampal neural precursor activity and activates microglia via brain endothelial cell VCAM1. Nat. Med 25, 988&#x2013;1000 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6642642</ArticleId><ArticleId IdType="pubmed">31086348</ArticleId></ArticleIdList></Reference><Reference><Citation>Sipil&#xe4; PN, Lindbohm JV, Singh-Manoux A, Shipley MJ, Kiiskinen T, Havulinna AS, Vahtera J, Nyberg ST, Pentti J, Kivim&#xe4;ki M, Long-term risk of dementia following hospitalization due to physical diseases: A multicohort study. Alzheimers Dement 16, 1686&#x2013;1695 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7754402</ArticleId><ArticleId IdType="pubmed">32886434</ArticleId></ArticleIdList></Reference><Reference><Citation>Gottesman RF, Schneider ALC, Zhou Y, Coresh J, Green E, Gupta N, Knopman DS, Mintz A, Rahmim A, Sharrett AR, Wagenknecht LE, Wong DF, Mosley TH, Association between midlife vascular risk factors and estimated brain amyloid deposition. JAMA 317, 1443&#x2013;1450 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5921896</ArticleId><ArticleId IdType="pubmed">28399252</ArticleId></ArticleIdList></Reference><Reference><Citation>Villeda SA, Plambeck KE, Middeldorp J, Castellano JM, Mosher KI, Luo J, Smith LK, Bieri G, Lin K, Berdnik D, Wabl R, Udeochu J, Wheatley EG, Zou B, Simmons DA, Xie XS, Longo FM, Wyss-Coray T, Young blood reverses age-related impairments in cognitive function and synaptic plasticity in mice. Nat. Med 20, 659&#x2013;663 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4224436</ArticleId><ArticleId IdType="pubmed">24793238</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang C, Farias FHG, Ibanez L, Suhy A, Sadler B, Fernandez MV, Wang F, Bradley JL, Eiffert B, Bahena JA, Budde JP, Li Z, Dube U, Sung YJ, Mihindukulasuriya KA, Morris JC, Fagan AM, Perrin RJ, Benitez BA, Rhinn H, Harari O, Cruchaga C, Genomic atlas of the proteome from brain, CSF and plasma prioritizes proteins implicated in neurological disorders. Nat. Neurosci 24, 1302&#x2013;1312 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8521603</ArticleId><ArticleId IdType="pubmed">34239129</ArticleId></ArticleIdList></Reference><Reference><Citation>Pietzner M, Wheeler E, Carrasco-Zanini J, Cortes A, Koprulu M, W&#xf6;rheide MA, Oerton E, Cook J, Stewart ID, Kerrison ND, Luan J, Raffler J, Arnold M, Arlt W, O&#x2019;Rahilly S, Kastenm&#xfc;ller G, Gamazon ER, Hingorani AD, Scott RA, Wareham NJ, Langenberg C, Mapping the proteo-genomic convergence of human diseases. Science 374, eabj1541 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9904207</ArticleId><ArticleId IdType="pubmed">34648354</ArticleId></ArticleIdList></Reference><Reference><Citation>Higginbotham L, Ping L, Dammer EB, Duong DM, Zhou M, Gearing M, Hurst C, Glass JD, Factor SA, Johnson ECB, Hajjar I, Lah JJ, Levey AI, Seyfried NT, Integrated proteomics reveals brain-based cerebrospinal fluid biomarkers in asymptomatic and symptomatic Alzheimer&#x2019;s disease. Sci. Adv 6, eaaz9360 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7577712</ArticleId><ArticleId IdType="pubmed">33087358</ArticleId></ArticleIdList></Reference><Reference><Citation>Schneider JA, Arvanitakis Z, Bang W, Bennett DA, Mixed brain pathologies account for most dementia cases in community-dwelling older persons. Neurology 69, 2197&#x2013;2204 (2007).</Citation><ArticleIdList><ArticleId IdType="pubmed">17568013</ArticleId></ArticleIdList></Reference><Reference><Citation>van Dyck CH, Swanson CJ, Aisen P, Bateman RJ, Chen CB, Gee M, Kanekiyo M, Li D, Reyderman L, Cohen S, Froelich L, Katayama S, Sabbagh M, Vellas B, Watson D, Dhadda S, Irizarry M, Kramer LD, Iwatsubo T, Lecanemab in early Alzheimer&#x2019;s disease. N. Engl. J. Med 388, 9&#x2013;21 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">36449413</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker KA, Chen J, Wu A, Tin A, Mosley TH, Fornage M, Ballantyne CM, Boerwinkle E, Sullivan KJ, Zeger SL, Ganz P, Gottesman RF, Coresh J, Large-scale plasma proteomic analysis identifies proteins and pathways associated with dementia risk. Nat. Aging 1, 473&#x2013;489 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10154040</ArticleId><ArticleId IdType="pubmed">37118015</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindbohm JV, Mars N, Walker KA, Singh-Manoux A, Livingston G, Brunner EJ, Sipil&#xe4; PN, Saksela K, Ferrie JE, Lovering RC, Williams SA, Hingorani AD, Gottesman RF, Zetterberg H, Kivim&#xe4;ki M, Plasma proteins, cognitive decline, and 20-year risk of dementia in the Whitehall II and Atherosclerosis Risk in Communities studies. Alzheimers Dement 18, 612&#x2013;624 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9292245</ArticleId><ArticleId IdType="pubmed">34338426</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamboh MI, Minster RL, Kenney M, Ozturk A, Desai PP, Kammerer CM, DeKosky ST, Alpha-1-antichymotrypsin (ACT or SERPINA3) polymorphism may affect age-at-onset and disease duration of Alzheimer&#x2019;s disease. Neurobiol. Aging 27, 1435&#x2013;1439 (2006).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1609963</ArticleId><ArticleId IdType="pubmed">16137793</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellenguez C, K&#xfc;&#xe7;&#xfc;kali F, Jansen I, Andrade V, Moreno-Grau S, Amin N, Naj AC, Grenier-Boley B, Campos-Martin R, Holmans PA, Boland A, Kleineidam L, Damotte V, van der Lee SJ, Kuulasmaa T, Yang Q, de Rojas I, Bis JC, Yaqub A, Prokic I, Costa MR, Chapuis J, Ahmad S, Giedraitis V, Boada M, Aarsland D, Garc&#xed;a-Gonz&#xe1;lez P, Abdelnour C, Alarc&#xf3;n-Mart&#xed;n E, Alegret M, Alvarez I, &#xc1;lvarez V, Armstrong NJ, Tsolaki A, Ant&#xfa;nez C, Appollonio I, Arcaro M, Archetti S, Pastor AA, Arosio B, Athanasiu L, Bailly H, Banaj N, Baquero M, Pastor AB, Benussi L, Berr C, Besse C, Bessi V, Binetti G, Bizzarro A, Alcolea D, Blesa R, Borroni B, Boschi S, Boss&#xf9; P, Br&#xe5;then G, Bresner C, Brookes KJ, Brusco LI, B&#xfb;rger K, Bullido MJ, Burholt V, Bush WS, Calero M, Dufouil C, Carracedo &#xc1;, Cecchetti R, Cervera-Carles L, Charbonnier C, Chillotti C, Brodaty H, Ciccone S, Claassen JAHR, Clark C, Conti E, Corma-G&#xf3;mez A, Costantini E, Custodero C, Daian D, Dalmasso MC, Daniele A, Dardiotis E, Dartigues J-F, de Deyn PP, de Paiva Lopes K, de Witte LD, Debette S, Deckert J, del Ser T, Denning N, De Stefano A, Dichgans M, Diehl-Schmid J, Diez-Fairen M, Rossi PD, Djurovic S, Duron E, D&#xfc;zel E, Engelborghs S, Escott-Price V, Espinosa A, Buiza-Rueda D, Ewers M, Tagliavini F, Nielsen SF, Farotti L, Fenoglio C, Fern&#xe1;ndez-Fuertes M, Hardy J, Ferrari R, Ferreira CB, Ferri E, Fin B, Fischer P, Fladby T, Flie&#xdf;bach K, Fortea J, Fostinelli S, Fox NC, Franco-Mac&#xed;as E, Frank-Garc&#xed;a A, Froelich L, Galimberti D, Garc&#xed;a-Alberca JM, Garcia-Madrona S, Garc&#xed;a-Ribas G, Chene G, Ghidoni R, Giegling I, Giaccone G, Goldhardt O, Gonz&#xe1;lez-P&#xe9;rez A, Graff C, Grande G, Green E, Grimmer T, Gr&#xfc;nblatt E, Guetta-Baranes T, Haapasalo A, Hadjigeorgiou G, Haines JL, Hamilton-Nelson KL; EADB; Gra@ce; ADGC; Charge; DemGen; FinnGen; EADI; GERAD, Hampel H, Hanon O, Hartmann AM, Hausner L, Harwood J, Heilmann-Heimbach S, Helisalmi S, Heneka MT, Hern&#xe1;ndez I, Herrmann MJ, Hoffmann P, Holmes C, Holstege H, Vilas RH, Hulsman M, Humphrey J, Biessels GJ, Johansson C, Kehoe PG, Kilander L, St&#xe5;hlbom AK, Kivipelto M, Koivisto A, Kornhuber J, Kosmidis MH, Kuksa PP, Kunkle BW, Lage C, Laukka EJ, Lauria A, Lee C-Y, Lehtisalo J, Satizabal CL, Lerch O, Lle&#xf3; A, Lopez R, Lopez O, Lopez de Munain A, Love S, L&#xf6;wemark M, Luckcuck L, Mac&#xed;as J, MacLeod CA, Maier W, Mangialasche F, Spallazzi M, Marqui&#xe9; M, Marshall R, Martin ER, Montes AM, Rodr&#xed;guez CM, Masullo C, Mayeux R, Mead S, Mecocci P, Medina M, Meggy A, Mendoza S, Men&#xe9;ndez-Gonz&#xe1;lez M, Mir P, Peri&#xf1;&#xe1;n MT, Mol M, Molina-Porcel L, Montrreal L, Morelli L, Moreno F, Morgan K, N&#xf6;then MM, Muchnik C, Nacmias B, Ngandu T, Nicolas G, Nordestgaard BG, Olaso R, Orellana A, Orsini M, Ortega G, Padovani A, Caffarra P, Papenberg G, Parnetti L, Pasquier F, Pastor P, P&#xe9;rez-Cord&#xf3;n A, P&#xe9;rez-Tur J, Pericard P, Peters O, Pijnenburg YAL, Pineda JA, Pi&#xf1;ol-Ripoll G, Pisanu C, Polak T, Popp J, Posthuma D, Priller J, Puerta R, Quenez O, Quintela I, Thomassen JQ, R&#xe1;bano A, Rainero I, Ramakers I, Real LM, Reinders MJT, Riedel-Heller S, Riederer P, Rodriguez-Rodriguez E, Rongve A, Allende IR, Rosende-Roca M, Royo JL, Rubino E, Rujescu D, S&#xe1;ez ME, Sakka P, Saltvedt I, Sanabria &#xc1;, S&#xe1;nchez-Arjona MB, Sanchez-Garcia F, Mehrabian S, S&#xe1;nchez-Juan P, S&#xe1;nchez-Valle R, Sando SB, Scamosci M, Scarmeas N, Scarpini E, Scheltens P, Scherbaum N, Scherer M, Schmid M, Schneider A, Schott JM, Selb&#xe6;k G, Sha J, Shadrin AA, Skrobot O, Snijders GJL, Soininen H, Solfrizzi V, Solomon A, Sorbi S, Sotolongo-Grau O, Spalletta G, Spottke A, Squassina A, Tartari JP, T&#xe1;rraga L, Tes&#xed; N, Thalamuthu A, Tegos T, Traykov L, Tremolizzo L, Tybj&#xe6;rg-Hansen A, Uitterlinden A, Ullgren A, Ulstein I, Valero S, Van Broeckhoven C, van der Lugt A, Van Dongen J, van Rooij J, van Swieten J, Vandenberghe R, Verhey F, Vidal J-S, Vogelgsang J, Vyhnalek M, Wagner M, Wallon D, Wang L-S, Wang R, Weinhold L, Wiltfang J, Windle G, Woods B, Yannakoulia M, Zhao Y, Zulaica M, Serrano-Rios M, Seripa D, Stordal E, Farrer LA, Psaty BM, Ghanbari M, Raj T, Sachdev P, Mather K, Jessen F, Arfan Ikram M, de Mendon&#xe7;a A, Hort J, Tsolaki M, Pericak-Vance MA, Amouyel P, Williams J, Frikke-Schmidt R, Clarimon J, Deleuze J-F, Rossi G, Seshadri S, Andreassen OA, Ingelsson M, Hiltunen M, Sleegers K, Schellenberg GD, van Duijn CM, Sims R, van der Flier WM, Ruiz A, Ramirez A, Lambert J-C, New insights on the genetic etiology of Alzheimer&#x2019;s and related dementia. medRxiv, 2020.10.01.20200659 (2020).</Citation></Reference><Reference><Citation>Kamboh MI, Demirci FY, Wang X, Minster RL, Carrasquillo MM, Pankratz VS, Younkin SG, Saykin AJ, Jun G, Baldwin C, Logue MW, Buros J, Farrer L, Pericak-Vance MA, Haines JL, Sweet RA, Ganguli M, Feingold E, Dekosky ST, Lopez OL, Barmada MM, Genome-wide association study of Alzheimer&#x2019;s disease. Transl. Psychiatry 2, e117 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3365264</ArticleId><ArticleId IdType="pubmed">22832961</ArticleId></ArticleIdList></Reference><Reference><Citation>Agora Nominated Target List; https://agora.adknowledgeportal.org/genes/(genes-router:genes-list).</Citation></Reference><Reference><Citation>Younes L, Albert M, Moghekar A, Soldan A, Pettigrew C, Miller MI, Identifying changepoints in biomarkers during the preclinical phase of Alzheimer&#x2019;s disease. Front. Aging Neurosci 11, 74 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6454004</ArticleId><ArticleId IdType="pubmed">31001108</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson ECB, Dammer EB, Duong DM, Ping L, Zhou M, Yin L, Higginbotham LA, Guajardo A, White B, Troncoso JC, Thambisetty M, Montine TJ, Lee EB, Trojanowski JQ, Beach TG, Reiman EM, Haroutunian V, Wang M, Schadt E, Zhang B, Dickson DW, Ertekin-Taner N, Golde TE, Petyuk VA, De Jager PL, Bennett DA, Wingo TS, Rangaraju S, Hajjar I, Shulman JM, Lah JJ, Levey AI, Seyfried NT, Large-scale proteomic analysis of Alzheimer&#x2019;s disease brain and cerebrospinal fluid reveals early changes in energy metabolism associated with microglia and astrocyte activation. Nat. Med 26, 769&#x2013;780 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7405761</ArticleId><ArticleId IdType="pubmed">32284590</ArticleId></ArticleIdList></Reference><Reference><Citation>Wingo AP, Fan W, Duong DM, Gerasimov ES, Dammer EB, Liu Y, Harerimana NV, White B, Thambisetty M, Troncoso JC, Kim N, Schneider JA, Hajjar IM, Lah JJ, Bennett DA, Seyfried NT, Levey AI, Wingo TS, Shared proteomic effects of cerebral atherosclerosis and Alzheimer&#x2019;s disease on the human brain. Nat. Neurosci 23, 696&#x2013;700 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7269838</ArticleId><ArticleId IdType="pubmed">32424284</ArticleId></ArticleIdList></Reference><Reference><Citation>De Jager PL, Ma Y, McCabe C, Xu J, Vardarajan BN, Felsky D, Klein HU, White CC, Peters MA, Lodgson B, Nejad P, Tang A, Mangravite LM, Yu L, Gaiteri C, Mostafavi S, Schneider JA, Bennett DA, A multi-omic atlas of the human frontal cortex for aging and Alzheimer&#x2019;s disease research. Sci. Data 5, 180142 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6080491</ArticleId><ArticleId IdType="pubmed">30084846</ArticleId></ArticleIdList></Reference><Reference><Citation>Konishi Y, Yang LB, He P, Lindholm K, Lu B, Li R, Shen Y, Deficiency of GDNF receptor GFR&#x3b1;1 in Alzheimer&#x2019;s neurons results in neuronal death. J. Neurosci 34, 13127&#x2013;13138 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4172805</ArticleId><ArticleId IdType="pubmed">25253858</ArticleId></ArticleIdList></Reference><Reference><Citation>Honkala AT, Tailor D, Malhotra SV, Guanylate-binding protein 1: An emerging target in inflammation and cancer. Front. Immunol 0, 3139 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7025589</ArticleId><ArticleId IdType="pubmed">32117203</ArticleId></ArticleIdList></Reference><Reference><Citation>Veroni C, Serafini B, Rosicarelli B, Fagnani C, Aloisi F, Agresti C, Connecting immune cell infiltration to the multitasking microglia response and TNF receptor 2 induction in the multiple sclerosis brain. Front. Cell. Neurosci 14, 190 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7359043</ArticleId><ArticleId IdType="pubmed">32733206</ArticleId></ArticleIdList></Reference><Reference><Citation>Fissolo N, Matute-Blanch C, Osman M, Costa C, Pinteac R, Mir&#xf3; B, Sanchez A, Brito V, Dujmovic I, Voortman M, Khalil M, Borr&#xe0;s E, Sabid&#xf3; E, Issazadeh-Navikas S, Montalban X, Comabella Lopez M, CSF SERPINA3 levels are elevated in patients with progressive MS. Neurol. Neuroimmunol. Neuroinflamm 8, e941 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8105904</ArticleId><ArticleId IdType="pubmed">33436375</ArticleId></ArticleIdList></Reference><Reference><Citation>Takamiya A, Takeda M, Yoshida A, Kiyama H, Inflammation induces serine protease inhibitor 3 expression in the rat pineal gland. Neuroscience 113, 387&#x2013;394 (2002).</Citation><ArticleIdList><ArticleId IdType="pubmed">12127095</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma J, Yee A, Brewer HB, Das S, Potter H, Amyloid-associated proteins &#x3b1;1-antichymotrypsin and apolipoprotein e promote assembly of Alzheimer &#x3b2;-protein into filaments. Nature 372, 92&#x2013;94 (1994).</Citation><ArticleIdList><ArticleId IdType="pubmed">7969426</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng J, Haberland V, Baird D, Walker V, Haycock PC, Hurle MR, Gutteridge A, Erola P, Liu Y, Luo S, Robinson J, Richardson TG, Staley JR, Elsworth B, Burgess S, Sun BB, Danesh J, Runz H, Maranville JC, Martin HM, Yarmolinsky J, Laurin C, Holmes MV, Liu JZ, Estrada K, Santos R, McCarthy L, Waterworth D, Nelson MR, Davey Smith G, Butterworth AS, Hemani G, Scott RA, Gaunt TR, Phenome-wide Mendelian randomization mapping the influence of the plasma proteome on complex diseases. Nat. Genet 52, 1122&#x2013;1131 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7610464</ArticleId><ArticleId IdType="pubmed">32895551</ArticleId></ArticleIdList></Reference><Reference><Citation>Pluvinage JV, Wyss-Coray T, Systemic factors as mediators of brain homeostasis, ageing and neurodegeneration. Nat. Rev. Neurosci 21, 93&#x2013;102 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">31913356</ArticleId></ArticleIdList></Reference><Reference><Citation>Agora; https://agora.ampadportal.org/genes.</Citation></Reference><Reference><Citation>Lezak M, Malec J, Manual for the Mayo-Portland Adaptability Inventory (MPAI-4) for adults, children and adolescents (2008).</Citation></Reference><Reference><Citation>Freund A, Orjalo AV, Desprez PY, Campisi J, Inflammatory networks during cellular senescence: Causes and consequences. Trends Mol. Med 16, 238&#x2013;246 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2879478</ArticleId><ArticleId IdType="pubmed">20444648</ArticleId></ArticleIdList></Reference><Reference><Citation>Fuchs T, Trollor JN, Crawford J, Brown DA, Baune BT, Samaras K, Campbell L, Breit SN, Brodaty H, Sachdev P, Smith E, Macrophage inhibitory cytokine-1 is associated with cognitive impairment and predicts cognitive decline - the Sydney Memory and Aging Study. Aging Cell 12, 882&#x2013;889 (2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">23758647</ArticleId></ArticleIdList></Reference><Reference><Citation>Deming Y, Filipello F, Cignarella F, Cantoni C, Hsu S, Mikesell R, Li Z, Del-Aguila JL, Dube U, Farias FG, Bradley J, Budde J, Ibanez L, Fernandez MV, Blennow K, Zetterberg H, Heslegrave A, Johansson PM, Svensson J, Nellg&#xe5;rd B, Lleo A, Alcolea D, Clarimon J, Rami L, Molinuevo JL, Su&#xe1;rez-Calvet M, Morenas-Rodr&#xed;guez E, Kleinberger G, Ewers M, Harari O, Haass C, Brett TJ, Benitez BA, Karch CM, Piccio L, Cruchaga C, The MS4A gene cluster is a key modulator of soluble TREM2 and Alzheimer&#x2019;s disease risk. Sci. Transl. Med 11, eaau8891 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6697053</ArticleId><ArticleId IdType="pubmed">31413141</ArticleId></ArticleIdList></Reference><Reference><Citation>Mansour HM, Fawzy HM, El-Khatib AS, Khattab MM, Potential repositioning of anticancer EGFR inhibitors in Alzheimer&#x2019;s disease: Current perspectives and challenging prospects. Neuroscience 469, 191&#x2013;196 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34139302</ArticleId></ArticleIdList></Reference><Reference><Citation>UKBiobank PheWeb (2018); http://nealelab.is/uk-biobank/.</Citation></Reference><Reference><Citation>Sniekers S, Stringer S, Watanabe K, Jansen PR, Coleman JRI, Krapohl E, Taskesen E, Hammerschlag AR, Okbay A, Zabaneh D, Amin N, Breen G, Cesarini D, Chabris CF, Iacono WG, Ikram MA, Johannesson M, Koellinger P, Lee JJ, Magnusson PKE, McGue M, Miller MB, Ollier WER, Payton A, Pendleton N, Plomin R, Rietveld CA, Tiemeier H, Van Duijn CM, Posthuma D, Genome-wide association meta-analysis of 78,308 individuals identifies new loci and genes influencing human intelligence. Nat. Genet 49, 1107&#x2013;1112 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5665562</ArticleId><ArticleId IdType="pubmed">28530673</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohammadnejad A, Nygaard M, Li S, Zhang D, Xu C, Li W, Lund J, Christiansen L, Baumbach J, Christensen K, Hjelmborg JVB, Tan Q, Generalized correlation coefficient for genome-wide association analysis of cognitive ability in twins. Aging 12, 22457&#x2013;22494 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7746382</ArticleId><ArticleId IdType="pubmed">33232274</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee JJ, Wedow R, Okbay A, Kong E, Maghzian O, Zacher M, Nguyen-Viet TA, Bowers P, Sidorenko J, Linn&#xe9;r RK, Fontana MA, Kundu T, Lee C, Li H, Li R, Royer R, Timshel PN, Walters RK, Willoughby EA, Yengo L; 23andMe Research Team; COGENT (Cognitive Genomics Consortium); Social Science Genetic Association Consortium, Alver M, Bao Y, Clark DW, Day FR, Furlotte NA, Joshi PK, Kemper KE, Kleinman A, Langenberg C, M&#xe4;gi R, Trampush JW, Verma SS, Wu Y, Lam M, Zhao JH, Zheng Z, Boardman JD, Campbell H, Freese J, Harris KM, Hayward C, Herd P, Kumari M, Lencz T, Luan J, Malhotra AK, Metspalu A, Milani L, Ong KK, Perry JRB, Porteous DJ, Ritchie MD, Smart MC, Smith BH, Tung JY, Wareham NJ, Wilson JF, Beauchamp JP, Conley DC, Esko T, Lehrer SF, Magnusson PKE, Oskarsson S, Pers TH, Robinson MR, Thom K, Watson C, Chabris CF, Meyer MN, Laibson DI, Yang J, Johannesson M, Koellinger PD, Turley P, Visscher PM, Benjamin DJ, Cesarini D, Gene discovery and polygenic prediction from a genome-wide association study of educational attainment in 1.1 million individuals. Nat. Genet 50, 1112&#x2013;1121 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6393768</ArticleId><ArticleId IdType="pubmed">30038396</ArticleId></ArticleIdList></Reference><Reference><Citation>Uchida Y, Nakano SI, Gomi F, Takahashi H, Up-regulation of calsyntenin-3 by &#x3b2;-amyloid increases vulnerability of cortical neurons. FEBS Lett 585, 651&#x2013;656 (2011).</Citation><ArticleIdList><ArticleId IdType="pubmed">21256848</ArticleId></ArticleIdList></Reference><Reference><Citation>Behl T, Kaur G, Sehgal A, Bhardwaj S, Singh S, Buhas C, Judea-Pusta C, Uivarosan D, Munteanu MA, Bungau S, Multifaceted role of matrix metalloproteinases in neurodegenerative diseases: Pathophysiological and therapeutic perspectives. Int. J. Mol. Sci 22, 1413 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7866808</ArticleId><ArticleId IdType="pubmed">33573368</ArticleId></ArticleIdList></Reference><Reference><Citation>Knopman DS, Griswold ME, Lirette ST, Gottesman RF, Kantarci K, Sharrett AR, Jack CR, Graff-Radford J, Schneider ALC, Windham BG, Coker LH, Albert MS, Mosley TH, Coresh J, Roche KB, Selnes OA, McKhann G, Alonso A, Folsom AR, Eckfeldt J, Wagenknecht LE, Heiss G, Couper D, Wruck L, Vascular Imaging abnormalities and cognition: Mediation by cortical volume in nondemented individuals: Atherosclerosis risk in communities-neurocognitive study. Stroke 46, 433&#x2013;440 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4308430</ArticleId><ArticleId IdType="pubmed">25563642</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith LK, He Y, Park JS, Bieri G, Snethlage CE, Lin K, Gontier G, Wabl R, Plambeck KE, Udeochu J, Wheatley EG, Bouchard J, Eggel A, Narasimha R, Grant JL, Luo J, Wyss-Coray T, Villeda SA, &#x3b2;2-microglobulin is a systemic pro-aging factor that impairs cognitive function and neurogenesis. Nat. Med 21, 932&#x2013;937 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4529371</ArticleId><ArticleId IdType="pubmed">26147761</ArticleId></ArticleIdList></Reference><Reference><Citation>Wright JD, Folsom AR, Coresh J, Sharrett AR, Couper D, Wagenknecht LE, Mosley TH Jr., Ballantyne CM, Boerwinkle EA, Rosamond WD, Heiss G, The ARIC (Atherosclerosis Risk In Communities): JACC Focus Seminar 3/8. J. Am. Coll. Cardiol 77, 2939&#x2013;2959 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8667593</ArticleId><ArticleId IdType="pubmed">34112321</ArticleId></ArticleIdList></Reference><Reference><Citation>Tin A, Yu B, Ma J, Masushita K, Daya N, Hoogeveen RC, Ballantyne CM, Couper D, Rebholz CM, Grams ME, Alonso A, Mosley T, Heiss G, Ganz P, Selvin E, Boerwinkle E, Coresh J, Reproducibility and variability of protein analytes measured using a multiplexed modified aptamer assay. J. Appl. Lab. Med 4, 30&#x2013;39 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6814271</ArticleId><ArticleId IdType="pubmed">31639705</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun BB, Maranville JC, Peters JE, Stacey D, Staley JR, Blackshaw J, Burgess S, Jiang T, Paige E, Surendran P, Oliver-Williams C, Kamat MA, Prins BP, Wilcox SK, Zimmerman ES, Chi A, Bansal N, Spain SL, Wood AM, Morrell NW, Bradley JR, Janjic N, Roberts DJ, Ouwehand WH, Todd JA, Soranzo N, Suhre K, Paul DS, Fox CS, Plenge RM, Danesh J, Runz H, Butterworth AS, Genomic atlas of the human plasma proteome. Nature 558, 73&#x2013;79 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6697541</ArticleId><ArticleId IdType="pubmed">29875488</ArticleId></ArticleIdList></Reference><Reference><Citation>Gottesman RF, Albert MS, Alonso A, Coker LH, Coresh J, Davis SM, Deal JA, McKhann GM, Mosley TH, Sharrett AR, Schneider ALC, Windham BG, Wruck LM, Knopman DS, Associations between midlife vascular risk factors and 25-year incident dementia in the Atherosclerosis Risk in Communities (ARIC) cohort. JAMA Neurol 388, 797&#x2013;805 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5710244</ArticleId><ArticleId IdType="pubmed">28783817</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker KA, Sharrett AR, Wu A, Schneider ALC, Albert M, Lutsey PL, Bandeen-Roche K, Coresh J, Gross AL, Windham BG, Knopman DS, Power MC, Rawlings AM, Mosley TH, Gottesman RF, Association of midlife to late-life blood pressure patterns with incident dementia. JAMA 322, 535&#x2013;545 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6692677</ArticleId><ArticleId IdType="pubmed">31408138</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J, Code. Midlife proteome-wide analysis identifies plasma biomarkers for 25-year dementia risk linked to diverse pathophysiology | ZenodoZenobo (2023); https://zenodo.org/record/7992838.</Citation></Reference><Reference><Citation>Yang AC, Kern F, Losada PM, Agam MR, Maat CA, Schmartz GP, Fehlmann T, Stein JA, Schaum N, Lee DP, Calcuttawala K, Vest RT, Berdnik D, Lu N, Hahn O, Gate D, McNerney MW, Channappa D, Cobos I, Ludwig N, Schulz-Schaeffer WJ, Keller A, Wyss-Coray T, Dysregulation of brain and choroid plexus cell types in severe COVID-19. Nature 595, 565&#x2013;571 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8400927</ArticleId><ArticleId IdType="pubmed">34153974</ArticleId></ArticleIdList></Reference><Reference><Citation>Muntner P, He J, Astor BC, Folsom AR, Coresh J, Traditional and nontraditional risk factors predict coronary heart disease in chronic kidney disease: Results from the atherosclerosis risk in communities study. J. Am. Soc. Nephrol 16, 529&#x2013;538 (2005).</Citation><ArticleIdList><ArticleId IdType="pubmed">15625072</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayden KM, Reed BR, Manly JJ, Tommet D, Pietrzak RH, Chelune GJ, Yang FM, Revell AJ, Bennett DA, Jones RN, Cognitive decline in the elderly: An analysis of population heterogeneity. Age Ageing 40, 684&#x2013;689 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3199215</ArticleId><ArticleId IdType="pubmed">21890481</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilson RS, Li Y, Bienias L, Bennett DA, Cognitive decline in old age: Separating retest effects from the effects of growing older. Psychol. Aging 21, 774&#x2013;789 (2006).</Citation><ArticleIdList><ArticleId IdType="pubmed">17201497</ArticleId></ArticleIdList></Reference><Reference><Citation>Knopman DS, Gottesman RF, Sharrett AR, Wruck LM, Windham BG, Coker L, Schneider ALC, Hengrui S, Alonso A, Coresh J, Albert MS, Mosley TH Jr., Mild cognitive impairment and dementia prevalence: The Atherosclerosis Risk in Communities Neurocognitive Study. Alzheimer&#x2019;s Dement 2, 1&#x2013;11 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4772876</ArticleId><ArticleId IdType="pubmed">26949733</ArticleId></ArticleIdList></Reference><Reference><Citation>American Psychiatric Association, DSM-5: Diagnostic and Statistical Manual of Mental Disorders (American Psychiatric Association, Washington, DC, ed. 5, 2013).</Citation></Reference><Reference><Citation>Bos I, Vos S, Vandenberghe R, Scheltens P, Engelborghs S, Frisoni G, Molinuevo JL, Wallin A, Lle&#xf3; A, Popp J, Martinez-Lage P, Baird A, Dobson R, Legido-Quigley C, Sleegers K, Van Broeckhoven C, Bertram L, Ten Kate M, Barkhof F, Zetterberg H, Lovestone S, Streffer J, Visser PJ, The EMIF-AD Multimodal Biomarker Discovery study: Design, methods and cohort characteristics. Alzheimers Res. Ther 10, 64 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6035398</ArticleId><ArticleId IdType="pubmed">29980228</ArticleId></ArticleIdList></Reference><Reference><Citation>Jack CR, Bennett DA, Blennow K, Carrillo MC, Dunn B, Haeberlein SB, Holtzman DM, Jagust W, Jessen F, Karlawish J, Liu E, Molinuevo JL, Montine T, Phelps C, Rankin KP, Rowe CC, Scheltens P, Siemers E, Snyder HM, Sperling R, Elliott C, Masliah E, Ryan L, Silverberg N, NIA-AA Research Framework: Toward a biological definition of Alzheimer&#x2019;s disease. Alzheimers Dement 14, 535&#x2013;562 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5958625</ArticleId><ArticleId IdType="pubmed">29653606</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris JC, The Clinical Dementia Rating (CDR): Current version and scoring rules. Neurology 43, 2412&#x2013;2414 (1993).</Citation><ArticleIdList><ArticleId IdType="pubmed">8232972</ArticleId></ArticleIdList></Reference><Reference><Citation>Reisberg B, Ferris SH, De Leon MJ, Crook T, The Global Deterioration Scale for assessment of primary degenerative dementia. Am. J. Psychiatry 139, 1136&#x2013;1139 (1982).</Citation><ArticleIdList><ArticleId IdType="pubmed">7114305</ArticleId></ArticleIdList></Reference><Reference><Citation>Petersen RC, Mild cognitive impairment as a diagnostic entity. J. Intern. Med 256, 183&#x2013;194 (2004).</Citation><ArticleIdList><ArticleId IdType="pubmed">15324362</ArticleId></ArticleIdList></Reference><Reference><Citation>Winblad B, Palmer K, Kivipelto M, Jelic V, Fratiglioni L, Wahlund LO, Nordberg A, B&#xe4;ckman L, Albert M, Almkvist O, Arai H, Basun H, Blennow K, De Leon M, Decarli C, Erkinjuntti T, Giacobini E, Graff C, Hardy J, Jack C, Jorm A, Ritchie K, Van Duijn C, Visser P, Petersen RC, Mild cognitive impairment - beyond controversies, towards a consensus: Report of the International Working Group on Mild Cognitive Impairment. J. Intern. Med 256, 240&#x2013;246 (2004).</Citation><ArticleIdList><ArticleId IdType="pubmed">15324367</ArticleId></ArticleIdList></Reference><Reference><Citation>Inker LA, Schmid CH, Tighiouart H, Eckfeldt JH, Feldman HI, Greene T, Kusek JW, Manzi J, Van Lente F, Zhang YL, Coresh J, Levey AS, Estimating glomerular filtration rate from serum creatinine and cystatin C. N. Engl. J. Med 367, 20&#x2013;29 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4398023</ArticleId><ArticleId IdType="pubmed">22762315</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller SA, Dykes DD, Polesky HF, A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16, 1215 (1988).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC334765</ArticleId><ArticleId IdType="pubmed">3344216</ArticleId></ArticleIdList></Reference><Reference><Citation>Heim A, AH 4 Group Test of General Intelligence (NFER-Nelson Publishing Company, 1970).</Citation></Reference><Reference><Citation>Lonsdale J, Thomas J, Salvatore M, Phillips R, Lo E, Shad S, Hasz R, Walters G, Garcia F, Young N, Foster B, Moser M, Karasik E, Gillard B, Ramsey K, Sullivan S, Bridge J, Magazine H, Syron J, Fleming J, Siminoff L, Traino H, Mosavel M, Barker L, Jewell S, Rohrer D, Maxim D, Filkins D, Harbach P, Cortadillo E, Berghuis B, Turner L, Hudson E, Feenstra K, Sobin L, Robb J, Branton P, Korzeniewski G, Shive C, Tabor D, Qi L, Groch K, Nampally S, Buia S, Zimmerman A, Smith A, Burges R, Robinson K, Valentino K, Bradbury D, Cosentino M, Diaz-Mayoral N, Kennedy M, Engel T, Williams P, Erickson K, Ardlie K, Winckler W, Getz G, DeLuca D, MacArthur D, Kellis M, Thomson A, Young T, Gelfand E, Donovan M, Meng Y, Grant G, Mash D, Marcus Y, Basile M, Liu J, Zhu J, Tu Z, Cox NJ, Nicolae DL, Gamazon ER, Im HK, Konkashbaev A, Pritchard J, Stevens M, Flutre T, Wen X, Dermitzakis ET, Lappalainen T, Guigo R, Monlong J, Sammeth M, Koller D, Battle A, Mostafavi S, McCarthy M, Rivas M, Maller J, Rusyn I, Nobel A, Wright F, Shabalin A, Feolo M, Sharopova N, Sturcke A, Paschal J, Anderson JM, Wilder EL, Derr LK, Green ED, Struewing JP, Temple G, Volpi S, Boyer JT, Thomson EJ, Guyer MS, Ng C, Abdallah A, Colantuoni D, Insel TR, Koester SE, Little AR, Bender PK, Lehner T, Yao Y, Compton CC, Vaught JB, Sawyer S, Lockhart NC, Demchok J, Moore HF, The Genotype-Tissue Expression (GTEx) project. Nat. Genet 45, 580&#x2013;585 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4010069</ArticleId><ArticleId IdType="pubmed">23715323</ArticleId></ArticleIdList></Reference><Reference><Citation>Uhl&#xe9;n M, Fagerberg L, Hallstr&#xf6;m BM, Lindskog C, Oksvold P, Mardinoglu A, Sivertsson &#xc5;, Kampf C, Sj&#xf6;stedt E, Asplund A, Olsson IM, Edlund K, Lundberg E, Navani S, Szigyarto CAK, Odeberg J, Djureinovic D, Takanen JO, Hober S, Alm T, Edqvist PH, Berling H, Tegel H, Mulder J, Rockberg J, Nilsson P, Schwenk JM, Hamsten M, Von Feilitzen K, Forsberg M, Persson L, Johansson F, Zwahlen M, Von Heijne G, Nielsen J, Pont&#xe9;n F, Tissue-based map of the human proteome. Science 347, 1260419 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">25613900</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Sloan SA, Clarke LE, Caneda C, Plaza CA, Blumenthal PD, Vogel H, Steinberg GK, Edwards MSB, Li G, Duncan JA, Cheshier SH, Shuer LM, Chang EF, Grant GA, Gephart MGH, Barres BA, Purification and characterization of progenitor and mature human astrocytes reveals transcriptional and functional differences with mouse. Neuron 89, 37&#x2013;53 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4707064</ArticleId><ArticleId IdType="pubmed">26687838</ArticleId></ArticleIdList></Reference><Reference><Citation>Hage C, Micha&#xeb;lsson E, Linde C, Donal E, Daubert JC, Gan L-M, Lund LH, Inflammatory biomarkers predict heart failure severity and prognosis in patients with heart failure with preserved ejection fraction: A holistic proteomic approach. Circ. Cardiovasc. Genet 10, e001633 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28100627</ArticleId></ArticleIdList></Reference><Reference><Citation>Helleman J, Smid M, Jansen MPHM, van der Burg MEL, Berns EMJJ, Pathway analysis of gene lists associated with platinum-based chemotherapy resistance in ovarian cancer: The big picture. Gynecol. Oncol 117, 170&#x2013;176 (2010).</Citation><ArticleIdList><ArticleId IdType="pubmed">20132968</ArticleId></ArticleIdList></Reference><Reference><Citation>Kr&#xe4;mer A, Green J, Pollard J, Tugendreich S, Causal analysis approaches in ingenuity pathway analysis. Bioinformatics 30, 523&#x2013;530 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3928520</ArticleId><ArticleId IdType="pubmed">24336805</ArticleId></ArticleIdList></Reference><Reference><Citation>Schlosser P, Li Y, Sekula P, Raffler J, Grundner-Culemann F, Pietzner M, Cheng Y, Wuttke M, Steinbrenner I, Schultheiss UT, Kotsis F, Kacprowski T, Forer L, Hausknecht B, Ekici AB, Nauck M, V&#xf6;lker U, Walz G, Oefner PJ, Kronenberg F, Mohney RP, K&#xf6;ttgen M, Suhre K, Eckardt KU, Kastenm&#xfc;ller G, K&#xf6;ttgen A, Genetic studies of urinary metabolites illuminate mechanisms of detoxification and excretion in humans. Nat. Genet 52, 167&#x2013;176 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7484970</ArticleId><ArticleId IdType="pubmed">31959995</ArticleId></ArticleIdList></Reference><Reference><Citation>Schlosser P, Knaus J, Schmutz M, Dohner K, Plass C, Bullinger L, Claus R, Binder H, Lubbert M, Schumacher M, Netboost: Boosting-supported network analysis improves high-dimensional omics prediction in acute myeloid leukemia and Huntington&#x2019;s disease. IEEE/ACM Trans. Comput. Biol. Bioinform 18, 2635&#x2013;2648 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">32365034</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT, Harris MA, Hill DP, Issel-Tarver L, Kasarskis A, Lewis S, Matese JC, Richardson JE, Ringwald M, Rubin GM, Sherlock G, Gene ontology: Tool for the unification of biology. The Gene Ontology Consortium. Nat. Genet 25, 25 (2000).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3037419</ArticleId><ArticleId IdType="pubmed">10802651</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanehisa M, Sato Y, Kawashima M, Furumichi M, Tanabe M, KEGG as a reference resource for gene and protein annotation. Nucleic Acids Res 44, D457&#x2013;D462 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4702792</ArticleId><ArticleId IdType="pubmed">26476454</ArticleId></ArticleIdList></Reference><Reference><Citation>Griss J, Viteri G, Sidiropoulos K, Nguyen V, Fabregat A, Hermjakob H, ReactomeGSA-efficient multi-omics comparative pathway analysis. Mol. Cell. Proteomics 19, 2115&#x2013;2125 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7710148</ArticleId><ArticleId IdType="pubmed">32907876</ArticleId></ArticleIdList></Reference><Reference><Citation>Bohler A, Wu G, Kutmon M, Pradhana LA, Coort SL, Hanspers K, Haw R, Pico AR, Evelo CT, Reactome from a WikiPathways perspective. PLOS Comput. Biol 12, e1004941 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4874630</ArticleId><ArticleId IdType="pubmed">27203685</ArticleId></ArticleIdList></Reference><Reference><Citation>Matys V, Fricke E, Geffers R, G&#xf6;&#xdf;ling E, Haubrock M, Hehl R, Hornischer K, Karas D, Kel AE, Kel-Margoulis OV, Kloos DU, Land S, Lewicki-Potapov B, Michael H, M&#xfc;nch R, Reuter I, Rotert S, Saxel H, Scheer M, Thiele S, Wingender E, TRANSFAC&#xae;: Transcriptional regulation, from patterns to profiles. Nucleic Acids Res 31, 374&#x2013;378 (2003).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC165555</ArticleId><ArticleId IdType="pubmed">12520026</ArticleId></ArticleIdList></Reference><Reference><Citation>Langfelder P, Horvath S, WGCNA: An R package for weighted correlation network analysis. BMC Bioinformatics 9, 559 (2008).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2631488</ArticleId><ArticleId IdType="pubmed">19114008</ArticleId></ArticleIdList></Reference><Reference><Citation>Loewenstein Y, Portugaly E, Fromer M, Linial M, Efficient algorithms for accurate hierarchical clustering of huge datasets: Tackling the entire protein space. Bioinformatics 24, i41&#x2013;i49 (2008).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2718652</ArticleId><ArticleId IdType="pubmed">18586742</ArticleId></ArticleIdList></Reference><Reference><Citation>Langfelder P, Zhang B, Horvath S, Defining clusters from a hierarchical cluster tree: The Dynamic Tree Cut package for R. Bioinformatics 24, 719&#x2013;720 (2008).</Citation><ArticleIdList><ArticleId IdType="pubmed">18024473</ArticleId></ArticleIdList></Reference><Reference><Citation>Emilsson V, Ilkov M, Lamb JR, Finkel N, Gudmundsson EF, Pitts R, Hoover H, Gudmundsdottir V, Horman SR, Aspelund T, Shu L, Trifonov V, Sigurdsson S, Manolescu A, Zhu J, Olafsson &#xd6;, Jakobsdottir J, Lesley SA, To J, Zhang J, Harris TB, Launer LJ, Zhang B, Eiriksdottir G, Yang X, Orth AP, Jennings LL, Gudnason V, Coregulatory networks of human serum proteins link genetics to disease. Science 361, 769&#x2013;773 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6190714</ArticleId><ArticleId IdType="pubmed">30072576</ArticleId></ArticleIdList></Reference><Reference><Citation>Burgess S, Butterworth A, Thompson SG, Mendelian randomization analysis with multiple genetic variants using summarized data. Genet. Epidemiol 37, 658&#x2013;665 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4377079</ArticleId><ArticleId IdType="pubmed">24114802</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowden J, Davey Smith G, Burgess S, Mendelian randomization with invalid instruments: Effect estimation and bias detection through Egger regression. Int. J. Epidemiol 44, 512&#x2013;525 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4469799</ArticleId><ArticleId IdType="pubmed">26050253</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowden J, Davey Smith G, Haycock PC, Burgess S, Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator. Genet. Epidemiol 40, 304&#x2013;314 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4849733</ArticleId><ArticleId IdType="pubmed">27061298</ArticleId></ArticleIdList></Reference><Reference><Citation>Burgess S, Foley CN, Allara E, Staley JR, Howson JMM, A robust and efficient method for Mendelian randomization with hundreds of genetic variants. Nat. Commun 11, 376 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6969055</ArticleId><ArticleId IdType="pubmed">31953392</ArticleId></ArticleIdList></Reference><Reference><Citation>Staiger D, Stock JH, Instrumental Variables Regression with Weak Instruments (National Bureau of Economic Research Inc., 1994).</Citation></Reference><Reference><Citation>Bowden J, Fabiola Del Greco M, Minelli C, Davey Smith G, Sheehan NA, Thompson JR, Assessing the suitability of summary data for two-sample mendelian randomization analyses using MR-Egger regression: The role of the I2 statistic. Int. J. Epidemiol 45, 1961&#x2013;1974 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5446088</ArticleId><ArticleId IdType="pubmed">27616674</ArticleId></ArticleIdList></Reference><Reference><Citation>Burgess S, Thompson SG, Interpreting findings from Mendelian randomization using the MR-Egger method. Eur. J. Epidemiol 32, 377&#x2013;389 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5506233</ArticleId><ArticleId IdType="pubmed">28527048</ArticleId></ArticleIdList></Reference><Reference><Citation>Verbanck M, Chen CY, Neale B, Do R, Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nat. Genet 50, 693&#x2013;698 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6083837</ArticleId><ArticleId IdType="pubmed">29686387</ArticleId></ArticleIdList></Reference><Reference><Citation>Cochran W, The combination of estimates from different experiments. Biometrics 10, 101&#x2013;129 (1954).</Citation></Reference><Reference><Citation>Bowden J, Spiller W, Del Greco F, Sheehan MN, Thompson J, Minelli C, Davey Smith G, Improving the visualization, interpretation and analysis of two-sample summary data Mendelian randomization via the Radial plot and Radial regression. Int. J. Epidemiol 47, 1264&#x2013;1278 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6124632</ArticleId><ArticleId IdType="pubmed">29961852</ArticleId></ArticleIdList></Reference><Reference><Citation>Hemani G, Zheng J, Elsworth B, Wade KH, Haberland V, Baird D, Laurin C, Burgess S, Bowden J, Langdon R, Tan VY, Yarmolinsky J, Shihab HA, Timpson NJ, Evans DM, Relton C, Martin RM, Davey Smith G, Gaunt TR, Haycock PC, The MR-base platform supports systematic causal inference across the human phenome. eLife 7, e34408 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5976434</ArticleId><ArticleId IdType="pubmed">29846171</ArticleId></ArticleIdList></Reference><Reference><Citation>Burgess S, Scott RA, Timpson NJ, Davey Smith G, Thompson SG, Using published data in Mendelian randomization: A blueprint for efficient identification of causal risk factors. Eur. J. Epidemiol 30, 543&#x2013;552 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4516908</ArticleId><ArticleId IdType="pubmed">25773750</ArticleId></ArticleIdList></Reference><Reference><Citation>Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MAR, Bender D, Maller J, Sklar P, De Bakker PIW, Daly MJ, Sham PC, PLINK: A tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet 81, 559&#x2013;575 (2007).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1950838</ArticleId><ArticleId IdType="pubmed">17701901</ArticleId></ArticleIdList></Reference><Reference><Citation>Machiela MJ, Chanock SJ, LDlink: A web-based application for exploring population-specific haplotype structure and linking correlated alleles of possible functional variants. Bioinformatics 31, 3555&#x2013;3557 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4626747</ArticleId><ArticleId IdType="pubmed">26139635</ArticleId></ArticleIdList></Reference><Reference><Citation>Kunkle BW, Grenier-Boley B, Sims R, Bis JC, Damotte V, Naj AC, Boland A, Vronskaya M, van der Lee SJ, Amlie-Wolf A, Bellenguez C, Frizatti A, Chouraki V, Martin ER, Sleegers K, Badarinarayan N, Jakobsdottir J, Hamilton-Nelson KL, Moreno-Grau S, Olaso R, Raybould R, Chen Y, Kuzma AB, Hiltunen M, Morgan T, Ahmad S, Vardarajan BN, Epelbaum J, Hoffmann P, Boada M, Beecham GW, Garnier JG, Harold D, Fitzpatrick AL, Valladares O, Moutet ML, Gerrish A, Smith AV, Qu L, Bacq D, Denning N, Jian X, Zhao Y, Del Zompo M, Fox NC, Choi SH, Mateo I, Hughes JT, Adams HH, Malamon J, Sanchez-Garcia F, Patel Y, Brody JA, Dombroski BA, Naranjo MCD, Daniilidou M, Eiriksdottir G, Mukherjee S, Wallon D, Uphill J, Aspelund T, Cantwell LB, Garzia F, Galimberti D, Hofer E, Butkiewicz M, Fin B, Scarpini E, Sarnowski C, Bush WS, Meslage S, Kornhuber J, White CC, Song Y, Barber RC, Engelborghs S, Sordon S, Voijnovic D, Adams PM, Vandenberghe R, Mayhaus M, Cupples LA, Albert MS, De Deyn PP, Gu W, Himali JJ, Beekly D, Squassina A, Hartmann AM, Orellana A, Blacker D, Rodriguez-Rodriguez E, Lovestone S, Garcia ME, Doody RS, Munoz-Fernadez C, Sussams R, Lin H, Fairchild TJ, Benito YA, Holmes C, Karamuji&#x107;-&#x10c;omi&#x107; H, Frosch MP, Thonberg H, Maier W, Roschupkin G, Ghetti B, Giedraitis V, Kawalia A, Li S, Huebinger RM, Kilander L, Moebus S, Hern&#xe1;ndez I, Kamboh MI, Brundin RM, Turton J, Yang Q, Katz MJ, Concari L, Lord J, Beiser AS, Keene CD, Helisalmi S, Kloszewska I, Kukull WA, Koivisto AM, Lynch A, Tarraga L, Larson EB, Haapasalo A, Lawlor B, Mosley TH, Lipton RB, Solfrizzi V, Gill M, Longstreth WT, Montine TJ, Frisardi V, Diez-Fairen M, Rivadeneira F, Petersen RC, Deramecourt V, Alvarez I, Salani F, Ciaramella A, Boerwinkle E, Reiman EM, Fievet N, Rotter JI, Reisch JS, Hanon O, Cupidi C, Andre Uitterlinden AG, Royall DR, Dufouil C, Maletta RG, de Rojas I, Sano M, Brice A, Cecchetti R, George-Hyslop PS, Ritchie K, Tsolaki M, Tsuang DW, Dubois B, Craig D, Wu CK, Soininen H, Avramidou D, Albin RL, Fratiglioni L, Germanou A, Apostolova LG, Keller L, Koutroumani M, Arnold SE, Panza F, Gkatzima O, Asthana S, Hannequin D, Whitehead P, Atwood CS, Caffarra P, Hampel H, Quintela I, Carracedo &#xc1;, Lannfelt L, Rubinsztein DC, Barnes LL, Pasquier F, Fr&#xf6;lich L, Barral S, McGuinness B, Beach TG, Johnston JA, Becker JT, Passmore P, Bigio EH, Schott JM, Bird TD, Warren JD, Boeve BF, Lupton MK, Bowen JD, Proitsi P, Boxer A, Powell JF, Burke JR, Kauwe JSK, Burns JM, Mancuso M, Buxbaum JD, Bonuccelli U, Cairns NJ, McQuillin A, Cao C, Livingston G, Carlson CS, Bass NJ, Carlsson CM, Hardy J, Carney RM, Bras J, Carrasquillo MM, Guerreiro R, Allen M, Chui HC, Fisher E, Masullo C, Crocco EA, DeCarli C, Bisceglio G, Dick M, Ma L, Duara R, Graff-Radford NR, Evans DA, Hodges A, Faber KM, Scherer M, Fallon KB, Riemenschneider M, Fardo DW, Heun R, Farlow MR, K&#xf6;lsch H, Ferris S, Leber M, Foroud TM, Heuser I, Galasko DR, Giegling I, Gearing M, H&#xfc;ll M, Geschwind DH, Gilbert JR, Morris J, Green RC, Mayo K, Growdon JH, Feulner T, Hamilton RL, Harrell LE, Drichel D, Honig LS, Cushion TD, Huentelman MJ, Hollingworth P, Hulette CM, Hyman BT, Marshall R, Jarvik GP, Meggy A, Abner E, Menzies GE, Jin LW, Leonenko G, Real LM, Jun GR, Baldwin CT, Grozeva D, Karydas A, Russo G, Kaye JA, Kim R, Jessen F, Kowall NW, Vellas B, Kramer JH, Vardy E, LaFerla FM, J&#xf6;ckel KH, Lah JJ, Dichgans M, Leverenz JB, Mann D, Levey AI, Pickering-Brown S, Lieberman AP, Klopp N, Lunetta KL, Wichmann HE, Lyketsos CG, Morgan K, Marson DC, Brown K, Martiniuk F, Medway C, Mash DC, N&#xf6;then MM, Masliah E, Hooper NM, McCormick WC, Daniele A, McCurry SM, Bayer A, McDavid AN, Gallacher J, McKee AC, van den Bussche H, Mesulam M, Brayne C, Miller BL, Riedel-Heller S, Miller CA, Miller JW, Al-Chalabi A, Morris JC, Shaw CE, Myers AJ, Wiltfang J, O&#x2019;Bryant S, Olichney JM, Alvarez V, Parisi JE, Singleton AB, Paulson HL, Collinge J, Perry WR, Mead S, Peskind E, Cribbs DH, Rossor M, Pierce A, Ryan NS, Poon WW, Nacmias B, Potter H, Sorbi S, Quinn JF, Sacchinelli E, Raj A, Spalletta G, Raskind M, Caltagirone C, Boss&#xf9; P, Orfei MD, Reisberg B, Clarke R, Reitz C, Smith AD, Ringman JM, Warden D, Roberson ED, Wilcock G, Rogaeva E, Bruni AC, Rosen HJ, Gallo M, Rosenberg RN, Ben-Shlomo Y, Sager MA, Mecocci P, Saykin AJ, Pastor P, Cuccaro ML, Vance JM, Schneider JA, Schneider LS, Slifer S, Seeley WW, Smith AG, Sonnen JA, Spina S, Stern RA, Swerdlow RH, Tang M, Tanzi RE, Trojanowski JQ, Troncoso JC, Van Deerlin VM, Van Eldik LJ, Vinters HV, Vonsattel JP, Weintraub S, Welsh-Bohmer KA, Wilhelmsen KC, Williamson J, Wingo TS, Woltjer RL, Wright CB, Yu CE, Yu L, Saba Y, Pilotto A, Bullido MJ, Peters O, Crane PK, Bennett D, Bosco P, Coto E, Boccardi V, De Jager PL, Lleo A, Warner N, Lopez OL, Ingelsson M, Deloukas P, Cruchaga C, Graff C, Gwilliam R, Fornage M, Goate AM, Sanchez-Juan P, Kehoe PG, Amin N, Ertekin-Taner N, Berr C, Debette S, Love S, Launer LJ, Younkin SG, Dartigues JF, Corcoran C, Ikram MA, Dickson DW, Nicolas G, Campion D, Tschanz JA, Schmidt H, Hakonarson H, Clarimon J, Munger R, Schmidt R, Farrer LA, Van Broeckhoven C, O&#x2019;Donovan MC, DeStefano AL, Jones L, Haines JL, Deleuze JF, Owen MJ, Gudnason V, Mayeux R, Escott-Price V, Psaty BM, Ramirez A, Wang LS, Ruiz A, van Duijn CM, Holmans PA, Seshadri S, Williams J, Amouyel P, Schellenberg GD, Lambert JC, Pericak-Vance MA; Alzheimer Disease Genetics Consortium (ADGC); European Alzheimer&#x2019;s Disease Initiative (EADI); Cohorts for Heart and Aging Research in Genomic Epidemiology Consortium (CHARGE); Genetic and Environmental Risk in AD/Defining Genetic, Polygenic and Environmental Risk for Alzheimer&#x2019;s Disease Consortium (GERAD/PERADES), Genetic meta-analysis of diagnosed Alzheimer&#x2019;s disease identifies new risk loci and implicates A&#x3b2;, tau, immunity and lipid processing. Nat. Genet 51, 414&#x2013;430 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6463297</ArticleId><ArticleId IdType="pubmed">30820047</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe K, Taskesen E, Van Bochoven A, Posthuma D, Functional mapping and annotation of genetic associations with FUMA. Nat. Commun 8, 1826 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5705698</ArticleId><ArticleId IdType="pubmed">29184056</ArticleId></ArticleIdList></Reference><Reference><Citation>Kircher M, Witten DM, Jain P, O&#x2019;Roak BJ, Cooper GM, Shendure J, A general framework for estimating the relative pathogenicity of human genetic variants. Nat. Genet 46, 310&#x2013;315 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3992975</ArticleId><ArticleId IdType="pubmed">24487276</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramasamy A, Trabzuni D, Guelfi S, Varghese V, Smith C, Walker R, De T, Coin L, De Silva R, Cookson MR, Singleton AB, Hardy J, Ryten M, Weale ME, Genetic variability in the regulation of gene expression in ten regions of the human brain. Nat. Neurosci 17, 1418&#x2013;1428 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4208299</ArticleId><ArticleId IdType="pubmed">25174004</ArticleId></ArticleIdList></Reference><Reference><Citation>Aguet F, Barbeira AN, Bonazzola R, Brown A, Castel SE, Jo B, Kasela S, Kim-Hellmuth S, Liang Y, Oliva M, Parsana PE, Flynn E, Fresard L, Gaamzon ER, Hamel AR, He Y, Hormozdiari F, Mohammadi P, Mu&#xf1;oz-Aguirre M, Park Y, Saha A, Segr&#x107; AV, Strober BJ, Wen X, Wucher V, Das S, Garrido-Mart&#xed;n D, Gay NR, Handsaker RE, Hoffman PJ, Kashin S, Kwong A, Li X, MacArthur D, Rouhana JM, Stephens M, Todres E, Vi&#xf1;uela A, Wang G, Zou Y; GTEx Consortium, Brown CD, Cox N, Dermitzakis E, Engelhardt BE, Getz G, Guigo R, Montgomery SB, Stranger BE, Im HK, Battle A, Ardlie KG, Lappalainen T, The GTEx Consortium atlas of genetic regulatory effects across human tissues. bioRxiv, 787903 (2019).</Citation></Reference><Reference><Citation>Fromer M, Roussos P, Sieberts SK, Johnson JS, Kavanagh DH, Perumal TM, Ruderfer DM, Oh EC, Topol A, Shah HR, Klei LL, Kramer R, Pinto D, G&#xfc;m&#xfc;&#x15f; ZH, Cicek AE, Dang KK, Browne A, Lu C, Xie L, Readhead B, Stahl EA, Xiao J, Parvizi M, Hamamsy T, Fullard JF, Wang YC, Mahajan MC, Derry JMJ, Dudley JT, Hemby SE, Logsdon BA, Talbot K, Raj T, Bennett DA, De Jager PL, Zhu J, Zhang B, Sullivan PF, Chess A, Purcell SM, Shinobu LA, Mangravite LM, Toyoshiba H, Gur RE, Hahn CG, Lewis DA, Haroutunian V, Peters MA, Lipska BK, Buxbaum JD, Schadt EE, Hirai K, Roeder K, Brennand KJ, Katsanis N, Domenici E, Devlin B, Sklar P, Gene expression elucidates functional impact of polygenic risk for schizophrenia. Nat. Neurosci 19, 1442&#x2013;1453 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5083142</ArticleId><ArticleId IdType="pubmed">27668389</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaffe AE, Straub RE, Shin JH, Tao R, Gao Y, Collado-Torres L, Kam-Thong T, Xi HS, Quan J, Chen Q, Colantuoni C, Ulrich WS, Maher BJ, Deep-Soboslay A, Cross AJ, Brandon NJ, Leek JT, Hyde TM, Kleinman JE, Weinberger DR, Developmental and genetic regulation of the human cortex transcriptome illuminate schizophrenia pathogenesis. Nat. Neurosci 21, 1117&#x2013;1125 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6438700</ArticleId><ArticleId IdType="pubmed">30050107</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang D, Liu S, Warrell J, Won H, Shi X, Navarro FCP, Clarke D, Gu M, Emani P, Yang YT, Min X, Gandal MJ, Lou S, Zhang J, Park JJ, Yan C, KyongRhie S, Manakongtreecheep K, Zhou H, Aparna Natha A, Peters M, Mattei E, Fitzgerald D, Brunetti T, Moore J, Jiang Y, Girdhar K, Hoffman GE, Kalayci S, G&#xfc;m&#xfc;&#x15f; ZH, Crawford GE, Roussos P, Akbarian S, Jaffe AE, White KP, Weng Z, Sestan N, Geschwind DH, Knowles JA, Gerstein MB, Comprehensive functional genomic resource and integrative model for the human brain. Science 362, eaat8464 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6413328</ArticleId><ArticleId IdType="pubmed">30545857</ArticleId></ArticleIdList></Reference><Reference><Citation>Giambartolomei C, Vukcevic D, Schadt EE, Franke L, Hingorani AD, Wallace C, Plagnol V, Bayesian test for colocalisation between pairs of genetic association studies using summary statistics. PLOS Genet 10, e1004383 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4022491</ArticleId><ArticleId IdType="pubmed">24830394</ArticleId></ArticleIdList></Reference><Reference><Citation>Sieberts SK, Perumal TM, Carrasquillo MM, Allen M, Reddy JS, Hoffman GE, Dang KK, Calley J, Ebert PJ, Eddy J, Wang X, Greenwood AK, Mostafavi S, Akbarian S, Bendl J, Breen MS, Brennand K, Brown L, Browne A, Buxbaum JD, Charney A, Chess A, Couto L, Crawford G, Devillers O, Devlin B, Dobbyn A, Domenici E, Filosi M, Flatow E, Francoeur N, Fullard J, Gil SE, Girdhar K, Guly&#xe1;s-Kov&#xe1;cs A, Gur R, Hahn CG, Haroutunian V, Hauberg ME, Huckins L, Jacobov R, Jiang Y, Johnson JS, Kassim B, Kim Y, Klei L, Kramer R, Lauria M, Lehner T, Lewis DA, Lipska BK, Montgomery K, Park R, Rosenbluh C, Roussos P, Ruderfer DM, Senthil G, Shah HR, Sloofman L, Song L, Stahl E, Sullivan P, Visintainer R, Wang J, Wang YC, Wiseman J, Xia E, Zhang W, Zharovsky E, Addis L, Addo SN, Airey DC, Arnold M, Bennett DA, Bi Y, Biber K, Blach C, Bradhsaw E, Brennan P, Canet-Aviles R, Cao S, Cavalla A, Chae Y, Chen WW, Cheng J, Collier DA, Dage JL, Dammer EB, Davis JW, Davis J, Drake D, Duong D, Eastwood BJ, Ehrlich M, Ellingson B, Engelmann BW, Esmaeelinieh S, Felsky D, Funk C, Gaiteri C, Gandy S, Gao F, Gileadi O, Golde T, Grosskurth SE, Gupta RR, Gutteridge AX, Haroutunian V, Hooli B, Humphryes-Kirilov N, Iijima K, James C, Jung PM, Kaddurah-Daouk R, Kastenmuller G, Klein HU, Kummer M, Lacor PN, Lah J, Laing E, Levey A, Li Y, Lipsky S, Liu Y, Liu J, Liu Z, Louie G, Lu T, Ma Y, Matsuoka YY, Menon V, Miller B, Misko TP, Mollon JE, Montgomery K, Mukherjee S, Noggle S, Pao PC, Pearce TY, Pearson N, Penny M, Petyuk VA, Price N, Quarless DX, Ravikumar B, Ried JS, Ruble CLA, Runz H, Saykin AJ, Schadt E, Scherschel JE, Seyfried N, Shulman JM, Snyder P, Soares H, Srivastava GP, Stockmann H, Taga M, Tasaki S, Tenenbaum J, Tsai LH, Vasanthakumar A, Wachter A, Wang Y, Wang H, Wang M, Whelan CD, White C, Woo KH, Wren P, Wu JW, Xi HS, Yankner BA, Younkin SG, Yu L, Zavodszky M, Zhang W, Zhang G, Zhang B, Zhu J, Omberg L, Peters MA, Logsdon BA, De Jager PL, Ertekin-Taner N, Mangravite LM, Large eQTL meta-analysis reveals differing patterns between cerebral cortical and cerebellar brain regions. Sci. Data 7, 340 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7550587</ArticleId><ArticleId IdType="pubmed">33046718</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams SA, Kivimaki M, Langenberg C, Hingorani AD, Casas JP, Bouchard C, Jonasson C, Sarzynski MA, Shipley MJ, Alexander L, Ash J, Bauer T, Chadwick J, Datta G, DeLisle RK, Hagar Y, Hinterberg M, Ostroff R, Weiss S, Ganz P, Wareham NJ, Plasma protein patterns as comprehensive indicators of health. Nat. Med 25, 1851&#x2013;1857 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6922049</ArticleId><ArticleId IdType="pubmed">31792462</ArticleId></ArticleIdList></Reference><Reference><Citation>Yanai I, Benjamin H, Shmoish M, Chalifa-Caspi V, Shklar M, Ophir R, Bar-Even A, Horn-Saban S, Safran M, Domany E, Lancet D, Shmueli O, Genome-wide midrange transcription profiles reveal expression level relationships in human tissue specification. Bioinformatics 21, 650&#x2013;659 (2005).</Citation><ArticleIdList><ArticleId IdType="pubmed">15388519</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37494443</PMID><DateCompleted><Year>2023</Year><Month>07</Month><Day>28</Day></DateCompleted><DateRevised><Year>2023</Year><Month>09</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2375-2548</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><Issue>30</Issue><PubDate><Year>2023</Year><Month>Jul</Month><Day>28</Day></PubDate></JournalIssue><Title>Science advances</Title><ISOAbbreviation>Sci Adv</ISOAbbreviation></Journal><ArticleTitle>Lysosomal dysfunction in Down syndrome and Alzheimer mouse models is caused by v-ATPase inhibition by Tyr<sup>682</sup>-phosphorylated APP &#x3b2;CTF.</ArticleTitle><Pagination><StartPage>eadg1925</StartPage><MedlinePgn>eadg1925</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">eadg1925</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1126/sciadv.adg1925</ELocationID><Abstract><AbstractText>Lysosome dysfunction arises early and propels Alzheimer's disease (AD). Herein, we show that amyloid precursor protein (APP), linked to early-onset AD in Down syndrome (DS), acts directly via its &#x3b2;-C-terminal fragment (&#x3b2;CTF) to disrupt lysosomal vacuolar (H<sup>+</sup>)-adenosine triphosphatase (v-ATPase) and acidification. In human DS fibroblasts, the phosphorylated <sup>682</sup>YENPTY internalization motif of APP-&#x3b2;CTF binds selectively within a pocket of the v-ATPase V0a1 subunit cytoplasmic domain and competitively inhibits association of the V1 subcomplex of v-ATPase, thereby reducing its activity. Lowering APP-&#x3b2;CTF Tyr<sup>682</sup> phosphorylation restores v-ATPase and lysosome function in DS fibroblasts and in vivo in brains of DS model mice. Notably, lowering APP-&#x3b2;CTF Tyr<sup>682</sup> phosphorylation below normal constitutive levels boosts v-ATPase assembly and activity, suggesting that v-ATPase may also be modulated tonically by phospho-APP-&#x3b2;CTF. Elevated APP-&#x3b2;CTF Tyr<sup>682</sup> phosphorylation in two mouse AD models similarly disrupts v-ATPase function. These findings offer previously unknown insight into the pathogenic mechanism underlying faulty lysosomes in all forms of AD.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Im</LastName><ForeName>Eunju</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-7839-8878</Identifier><AffiliationInfo><Affiliation>Center for Dementia Research, Nathan S.&#xa0;Kline Institute, Orangeburg, NY 10962, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychiatry, New&#xa0;York University Grossman School of Medicine, New&#xa0;York, NY 10016, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Ying</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0003-0219-7807</Identifier><AffiliationInfo><Affiliation>Center for Dementia Research, Nathan S.&#xa0;Kline Institute, Orangeburg, NY 10962, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychiatry, New&#xa0;York University Grossman School of Medicine, New&#xa0;York, NY 10016, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stavrides</LastName><ForeName>Philip H</ForeName><Initials>PH</Initials><AffiliationInfo><Affiliation>Center for Dementia Research, Nathan S.&#xa0;Kline Institute, Orangeburg, NY 10962, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Darji</LastName><ForeName>Sandipkumar</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-4197-4971</Identifier><AffiliationInfo><Affiliation>Center for Dementia Research, Nathan S.&#xa0;Kline Institute, Orangeburg, NY 10962, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Erdjument-Bromage</LastName><ForeName>Hediye</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0003-0224-3594</Identifier><AffiliationInfo><Affiliation>Department of Cell Biology, New&#xa0;York University Grossman School of Medicine, New&#xa0;York, NY 10016, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Kimmel Center for Biology and Medicine at the Skirball Institute, New&#xa0;York University Grossman School of Medicine, New&#xa0;York, NY, 10016, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Neubert</LastName><ForeName>Thomas A</ForeName><Initials>TA</Initials><Identifier Source="ORCID">0000-0001-7049-2088</Identifier><AffiliationInfo><Affiliation>Department of Cell Biology, New&#xa0;York University Grossman School of Medicine, New&#xa0;York, NY 10016, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Kimmel Center for Biology and Medicine at the Skirball Institute, New&#xa0;York University Grossman School of Medicine, New&#xa0;York, NY, 10016, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Choi</LastName><ForeName>Jun Yong</ForeName><Initials>JY</Initials><Identifier Source="ORCID">0000-0001-8218-6440</Identifier><AffiliationInfo><Affiliation>Department of Chemistry and Biochemistry, Queens College, Queens, NY 11367, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Ph.D. Programs in Chemistry and Biochemistry, The Graduate Center of the City University of New&#xa0;York, New&#xa0;York, NY 10016, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wegiel</LastName><ForeName>Jerzy</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-3685-0694</Identifier><AffiliationInfo><Affiliation>Department of Developmental Neurobiology, New&#xa0;York State Institute for Basic Research in Developmental Disabilities, Staten Island, NY 10314, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Ju-Hyun</ForeName><Initials>JH</Initials><Identifier Source="ORCID">0000-0002-0280-8375</Identifier><AffiliationInfo><Affiliation>Center for Dementia Research, Nathan S.&#xa0;Kline Institute, Orangeburg, NY 10962, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychiatry, New&#xa0;York University Grossman School of Medicine, New&#xa0;York, NY 10016, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nixon</LastName><ForeName>Ralph A</ForeName><Initials>RA</Initials><Identifier Source="ORCID">0000-0003-2352-4715</Identifier><AffiliationInfo><Affiliation>Center for Dementia Research, Nathan S.&#xa0;Kline Institute, Orangeburg, NY 10962, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychiatry, New&#xa0;York University Grossman School of Medicine, New&#xa0;York, NY 10016, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cell Biology, New&#xa0;York University Grossman School of Medicine, New&#xa0;York, NY 10016, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NYU Neuroscience Institute, New&#xa0;York University Grossman School of Medicine, New&#xa0;York, NY 10016, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P01 AG017617</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG062376</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>S10 RR027990</GrantID><Acronym>RR</Acronym><Agency>NCRR NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>07</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Sci Adv</MedlineTA><NlmUniqueID>101653440</NlmUniqueID><ISSNLinking>2375-2548</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016564">Amyloid beta-Protein Precursor</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.1.-</RegistryNumber><NameOfSubstance UI="D000251">Adenosine Triphosphatases</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016229">Amyloid beta-Peptides</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016564" MajorTopicYN="N">Amyloid beta-Protein Precursor</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004314" MajorTopicYN="Y">Down Syndrome</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000251" MajorTopicYN="N">Adenosine Triphosphatases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008247" MajorTopicYN="N">Lysosomes</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016229" MajorTopicYN="N">Amyloid beta-Peptides</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>7</Month><Day>28</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>7</Month><Day>26</Day><Hour>19</Hour><Minute>11</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>7</Month><Day>26</Day><Hour>14</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>7</Month><Day>26</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37494443</ArticleId><ArticleId IdType="pmc">PMC10371027</ArticleId><ArticleId IdType="doi">10.1126/sciadv.adg1925</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>D. S.&#xa0;Knopman, H.&#xa0;Amieva, R. C.&#xa0;Petersen, G.&#xa0;Ch&#xe9;telat, D. M.&#xa0;Holtzman, B. T.&#xa0;Hyman, R. A.&#xa0;Nixon, D. T.&#xa0;Jones, Alzheimer disease. Nat. Rev. Dis. Primers 7, 33 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8574196</ArticleId><ArticleId IdType="pubmed">33986301</ArticleId></ArticleIdList></Reference><Reference><Citation>R. A.&#xa0;Nixon, The role of autophagy in neurodegenerative disease. Nat. Med. 19, 983&#x2013;997 (2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">23921753</ArticleId></ArticleIdList></Reference><Reference><Citation>I.&#xa0;Lauritzen, R.&#xa0;Pardossi-Piquard, A.&#xa0;Bourgeois, S.&#xa0;Pagnotta, M. G.&#xa0;Biferi, M.&#xa0;Barkats, P.&#xa0;Lacor, W.&#xa0;Klein, C.&#xa0;Bauer, F.&#xa0;Checler, Intraneuronal aggregation of the &#x3b2;-CTF fragment of APP (C99) induces A&#x3b2;-independent lysosomal-autophagic pathology. Acta Neuropathol. 132, 257&#x2013;276 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4947121</ArticleId><ArticleId IdType="pubmed">27138984</ArticleId></ArticleIdList></Reference><Reference><Citation>R.&#xa0;Tamayev, S.&#xa0;Matsuda, O.&#xa0;Arancio, L.&#xa0;D'Adamio, &#x3b2;- but not &#x3b3;-secretase proteolysis of APP causes synaptic and memory deficits in a mouse model of dementia. EMBO Mol. Med. 4, 171&#x2013;179 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3376850</ArticleId><ArticleId IdType="pubmed">22170863</ArticleId></ArticleIdList></Reference><Reference><Citation>Y.&#xa0;Jiang, Y.&#xa0;Sato, E.&#xa0;Im, M.&#xa0;Berg, M.&#xa0;Bordi, S.&#xa0;Darji, A.&#xa0;Kumar, P. S.&#xa0;Mohan, U.&#xa0;Bandyopadhyay, A.&#xa0;Diaz, A. M.&#xa0;Cuervo, R. A.&#xa0;Nixon, Lysosomal Dysfunction in Down Syndrome Is APP-Dependent and Mediated by APP-&#x3b2;CTF (C99). J. Neurosci. 39, 5255&#x2013;5268 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6607756</ArticleId><ArticleId IdType="pubmed">31043483</ArticleId></ArticleIdList></Reference><Reference><Citation>R. A.&#xa0;Nixon, D. S.&#xa0;Yang, J. H.&#xa0;Lee, Neurodegenerative lysosomal disorders: A continuum from development to late age. Autophagy 4, 590&#x2013;599 (2008).</Citation><ArticleIdList><ArticleId IdType="pubmed">18497567</ArticleId></ArticleIdList></Reference><Reference><Citation>A. M.&#xa0;Cataldo, C. M.&#xa0;Peterhoff, S. D.&#xa0;Schmidt, N. B.&#xa0;Terio, K.&#xa0;Duff, M.&#xa0;Beard, P. M.&#xa0;Mathews, R. A.&#xa0;Nixon, Presenilin mutations in familial Alzheimer disease and transgenic mouse models accelerate neuronal lysosomal pathology. J. Neuropathol. Exp. Neurol. 63, 821&#x2013;830 (2004).</Citation><ArticleIdList><ArticleId IdType="pubmed">15330337</ArticleId></ArticleIdList></Reference><Reference><Citation>F.&#xa0;Checler, E.&#xa0;Afram, R.&#xa0;Pardossi-Piquard, I.&#xa0;Lauritzen, Is &#x3b3;-secretase a beneficial inactivating enzyme of the toxic APP C-terminal fragment C99? J. Biol. Chem. 296, 100489 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8027268</ArticleId><ArticleId IdType="pubmed">33662398</ArticleId></ArticleIdList></Reference><Reference><Citation>R. A.&#xa0;Nixon, Autophagy, amyloidogenesis and Alzheimer disease. J. Cell Sci. 120, 4081&#x2013;4091 (2007).</Citation><ArticleIdList><ArticleId IdType="pubmed">18032783</ArticleId></ArticleIdList></Reference><Reference><Citation>Y.&#xa0;Wang, M.&#xa0;Martinez-Vicente, U.&#xa0;Kr&#xfc;ger, S.&#xa0;Kaushik, E.&#xa0;Wong, E. M.&#xa0;Mandelkow, A. M.&#xa0;Cuervo, E.&#xa0;Mandelkow, Tau fragmentation, aggregation and clearance: the dual role of lysosomal processing. Hum. Mol. Genet. 18, 4153&#x2013;4170 (2009).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2758146</ArticleId><ArticleId IdType="pubmed">19654187</ArticleId></ArticleIdList></Reference><Reference><Citation>B.&#xa0;Boland, W. H.&#xa0;Yu, O.&#xa0;Corti, B.&#xa0;Mollereau, A.&#xa0;Henriques, E.&#xa0;Bezard, G. M.&#xa0;Pastores, D. C.&#xa0;Rubinsztein, R. A.&#xa0;Nixon, M. R.&#xa0;Duchen, G. R.&#xa0;Mallucci, G.&#xa0;Kroemer, B.&#xa0;Levine, E. L.&#xa0;Eskelinen, F.&#xa0;Mochel, M.&#xa0;Spedding, C.&#xa0;Louis, O. R.&#xa0;Martin, M. J.&#xa0;Millan, Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing. Nat. Rev. Drug Discov. 17, 660&#x2013;688 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6456907</ArticleId><ArticleId IdType="pubmed">30116051</ArticleId></ArticleIdList></Reference><Reference><Citation>J.&#xa0;Hwang, C. M.&#xa0;Estick, U. S.&#xa0;Ikonne, D.&#xa0;Butler, M. C.&#xa0;Pait, L. H.&#xa0;Elliott, S.&#xa0;Ruiz, K.&#xa0;Smith, K. M.&#xa0;Rentschler, C.&#xa0;Mundell, M. F.&#xa0;Almeida, N. S.&#xa0;Bear, J. P.&#xa0;Locklear, Y.&#xa0;Abumohsen, C. M.&#xa0;Ivey, K.&#xa0;L.&#xa0;G.&#xa0;Farizatto, B. A.&#xa0;Bahr, The Role of Lysosomes in a Broad Disease-Modifying Approach Evaluated across Transgenic Mouse Models of Alzheimer's Disease and Parkinson's Disease and Models of Mild Cognitive Impairment. Int. J.&#xa0;Mol. Sci. 20, 4432 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6770842</ArticleId><ArticleId IdType="pubmed">31505809</ArticleId></ArticleIdList></Reference><Reference><Citation>J. H.&#xa0;Lee, M. V.&#xa0;Rao, D. S.&#xa0;Yang, P.&#xa0;Stavrides, E.&#xa0;Im, A.&#xa0;Pensalfini, C.&#xa0;Huo, P.&#xa0;Sarkar, T.&#xa0;Yoshimori, R. A.&#xa0;Nixon, Transgenic expression of a ratiometric autophagy probe specifically in neurons enables the interrogation of brain autophagy in vivo. Autophagy 15, 543&#x2013;557 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6351128</ArticleId><ArticleId IdType="pubmed">30269645</ArticleId></ArticleIdList></Reference><Reference><Citation>J. A.&#xa0;Mindell, Lysosomal acidification mechanisms. Annu. Rev. Physiol. 74, 69&#x2013;86 (2012).</Citation><ArticleIdList><ArticleId IdType="pubmed">22335796</ArticleId></ArticleIdList></Reference><Reference><Citation>A.&#xa0;Ballabio, J. S.&#xa0;Bonifacino, Lysosomes as dynamic regulators of cell and organismal homeostasis. Nat. Rev. Mol. Cell Biol. 21, 101&#x2013;118 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">31768005</ArticleId></ArticleIdList></Reference><Reference><Citation>P.&#xa0;P.&#xa0;Y.&#xa0;Lie, L.&#xa0;Yoo, C. N.&#xa0;Goulbourne, M. J.&#xa0;Berg, P.&#xa0;Stavrides, C.&#xa0;Huo, J.-H.&#xa0;Lee, R. A.&#xa0;Nixon, Axonal transport of late endosomes and amphisomes is selectively modulated by local Ca2+ efflux and disrupted by PSEN1 loss of function. Sci. Adv. 8, eabj5716 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9054012</ArticleId><ArticleId IdType="pubmed">35486730</ArticleId></ArticleIdList></Reference><Reference><Citation>M.&#xa0;Forgac, Vacuolar ATPases: Rotary proton pumps in physiology and pathophysiology. Nat. Rev. Mol. Cell Biol. 8, 917&#x2013;929 (2007).</Citation><ArticleIdList><ArticleId IdType="pubmed">17912264</ArticleId></ArticleIdList></Reference><Reference><Citation>K.&#xa0;Cotter, L.&#xa0;Stransky, C.&#xa0;McGuire, M.&#xa0;Forgac, Recent insights into the structure, regulation, and function of the V-ATPases. Trends Biochem. Sci. 40, 611&#x2013;622 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4589219</ArticleId><ArticleId IdType="pubmed">26410601</ArticleId></ArticleIdList></Reference><Reference><Citation>R.&#xa0;Liberman, S.&#xa0;Bond, M. G.&#xa0;Shainheit, M. J.&#xa0;Stadecker, M.&#xa0;Forgac, Regulated assembly of vacuolar ATPase is increased during cluster disruption-induced maturation of dendritic cells through a phosphatidylinositol 3-kinase/mTOR-dependent pathway. J. Biol. Chem. 289, 1355&#x2013;1363 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3894320</ArticleId><ArticleId IdType="pubmed">24273170</ArticleId></ArticleIdList></Reference><Reference><Citation>L. A.&#xa0;Stransky, M.&#xa0;Forgac, Amino Acid Availability Modulates Vacuolar H+-ATPase Assembly. J. Biol. Chem. 290, 27360&#x2013;27369 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4646367</ArticleId><ArticleId IdType="pubmed">26378229</ArticleId></ArticleIdList></Reference><Reference><Citation>J.&#xa0;Zhao, S.&#xa0;Benlekbir, J. L.&#xa0;Rubinstein, Electron cryomicroscopy observation of rotational states in a eukaryotic V-ATPase. Nature 521, 241&#x2013;245 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">25971514</ArticleId></ArticleIdList></Reference><Reference><Citation>R.&#xa0;Zoncu, L.&#xa0;Bar-Peled, A.&#xa0;Efeyan, S.&#xa0;Wang, Y.&#xa0;Sancak, D. M.&#xa0;Sabatini, mTORC1 senses lysosomal amino acids through an inside-out mechanism that requires the vacuolar H(+)-ATPase. Science 334, 678&#x2013;683 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3211112</ArticleId><ArticleId IdType="pubmed">22053050</ArticleId></ArticleIdList></Reference><Reference><Citation>G. E.&#xa0;Mortimore, C. M.&#xa0;Schworer, Induction of autophagy by amino-acid deprivation in perfused rat liver. Nature 270, 174&#x2013;176 (1977).</Citation><ArticleIdList><ArticleId IdType="pubmed">927529</ArticleId></ArticleIdList></Reference><Reference><Citation>D. J.&#xa0;Colacurcio, R. A.&#xa0;Nixon, Disorders of lysosomal acidification-The emerging role of v-ATPase in aging and neurodegenerative disease. Ageing Res. Rev. 32, 75&#x2013;88 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5112157</ArticleId><ArticleId IdType="pubmed">27197071</ArticleId></ArticleIdList></Reference><Reference><Citation>J. H.&#xa0;Lee, W. H.&#xa0;Yu, A.&#xa0;Kumar, S.&#xa0;Lee, P. S.&#xa0;Mohan, C. M.&#xa0;Peterhoff, D. M.&#xa0;Wolfe, M.&#xa0;Martinez-Vicente, A. C.&#xa0;Massey, G.&#xa0;Sovak, Y.&#xa0;Uchiyama, D.&#xa0;Westaway, A. M.&#xa0;Cuervo, R. A.&#xa0;Nixon, Lysosomal proteolysis and autophagy require presenilin 1 and are disrupted by Alzheimer-related PS1 mutations. Cell 141, 1146&#x2013;1158 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3647462</ArticleId><ArticleId IdType="pubmed">20541250</ArticleId></ArticleIdList></Reference><Reference><Citation>J.-H.&#xa0;Lee, D.-S.&#xa0;Yang, C. N.&#xa0;Goulbourne, E.&#xa0;Im, P.&#xa0;Stavrides, A.&#xa0;Pensalfini, H.&#xa0;Chan, C.&#xa0;Bouchet-Marquis, C.&#xa0;Bleiwas, M. J.&#xa0;Berg, C.&#xa0;Huo, J.&#xa0;Peddy, M.&#xa0;Pawlik, E.&#xa0;Levy, M.&#xa0;Rao, M.&#xa0;Staufenbiel, R. A.&#xa0;Nixon, Faulty autolysosome acidification in Alzheimer's disease mouse models induces autophagic build-up of A&#x3b2; in neurons, yielding senile plaques. Nat. Neurosci. 25, 688&#x2013;701 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9174056</ArticleId><ArticleId IdType="pubmed">35654956</ArticleId></ArticleIdList></Reference><Reference><Citation>Z.&#xa0;Diwu, C. S.&#xa0;Chen, C.&#xa0;Zhang, D. H.&#xa0;Klaubert, R. P.&#xa0;Haugland, A novel acidotropic pH indicator and its potential application in labeling acidic organelles of live cells. Chem. Biol. 6, 411&#x2013;418 (1999).</Citation><ArticleIdList><ArticleId IdType="pubmed">10381401</ArticleId></ArticleIdList></Reference><Reference><Citation>M. W.&#xa0;Walker, E.&#xa0;Lloyd-Evans, A rapid method for the preparation of ultrapure, functional lysosomes using functionalized superparamagnetic iron oxide nanoparticles. Methods Cell Biol. 126, 21&#x2013;43 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">25665439</ArticleId></ArticleIdList></Reference><Reference><Citation>S.&#xa0;Kim, Y.&#xa0;Sato, P. S.&#xa0;Mohan, C.&#xa0;Peterhoff, A.&#xa0;Pensalfini, A.&#xa0;Rigoglioso, Y.&#xa0;Jiang, R. A.&#xa0;Nixon, Evidence that the rab5 effector APPL1 mediates APP-&#x3b2;CTF-induced dysfunction of endosomes in Down syndrome and Alzheimer's disease. Mol. Psychiatry 21, 707&#x2013;716 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4721948</ArticleId><ArticleId IdType="pubmed">26194181</ArticleId></ArticleIdList></Reference><Reference><Citation>M.&#xa0;Pera, D.&#xa0;Alcolea, R.&#xa0;S&#xe1;nchez-Valle, C.&#xa0;Guardia-Laguarta, M.&#xa0;Colom-Cadena, N.&#xa0;Badiola, M.&#xa0;Su&#xe1;rez-Calvet, A.&#xa0;Llad&#xf3;, A. A.&#xa0;Barrera-Ocampo, D.&#xa0;Sepulveda-Falla, R.&#xa0;Blesa, J. L.&#xa0;Molinuevo, J.&#xa0;Clarim&#xf3;n, I.&#xa0;Ferrer, E.&#xa0;Gelpi, A.&#xa0;Lle&#xf3;, Distinct patterns of APP processing in the CNS in autosomal-dominant and sporadic Alzheimer disease. Acta Neuropathol. 125, 201&#x2013;213 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3623032</ArticleId><ArticleId IdType="pubmed">23224319</ArticleId></ArticleIdList></Reference><Reference><Citation>Y.&#xa0;Jiang, K. A.&#xa0;Mullaney, C. M.&#xa0;Peterhoff, S.&#xa0;Che, S. D.&#xa0;Schmidt, A.&#xa0;Boyer-Boiteau, S. D.&#xa0;Ginsberg, A. M.&#xa0;Cataldo, P. M.&#xa0;Mathews, R. A.&#xa0;Nixon, Alzheimer's-related endosome dysfunction in Down syndrome is Abeta-independent but requires APP and is reversed by BACE-1 inhibition. Proc. Natl. Acad. Sci. U.S.A. 107, 1630&#x2013;1635 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2824382</ArticleId><ArticleId IdType="pubmed">20080541</ArticleId></ArticleIdList></Reference><Reference><Citation>S. E.&#xa0;Hoey, R. J.&#xa0;Williams, M. S.&#xa0;Perkinton, Synaptic NMDA receptor activation stimulates alpha-secretase amyloid precursor protein processing and inhibits amyloid-beta production. J. Neurosci. 29, 4442&#x2013;4460 (2009).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6665739</ArticleId><ArticleId IdType="pubmed">19357271</ArticleId></ArticleIdList></Reference><Reference><Citation>D.&#xa0;Del Prete, F.&#xa0;Lombino, X.&#xa0;Liu, L.&#xa0;D'Adamio, APP is cleaved by Bace1 in pre-synaptic vesicles and establishes a pre-synaptic interactome, via its intracellular domain, with molecular complexes that regulate pre-synaptic vesicles functions. PLOS ONE 9, e108576 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4172690</ArticleId><ArticleId IdType="pubmed">25247712</ArticleId></ArticleIdList></Reference><Reference><Citation>O.&#xa0;S&#xf6;derberg, M.&#xa0;Gullberg, M.&#xa0;Jarvius, K.&#xa0;Ridderstr&#xe5;le, K.-J.&#xa0;Leuchowius, J.&#xa0;Jarvius, K.&#xa0;Wester, P.&#xa0;Hydbring, F.&#xa0;Bahram, L.-G.&#xa0;Larsson, U.&#xa0;Landegren, Direct observation of individual endogenous protein complexes in situ by proximity ligation. Nat. Methods 3, 995&#x2013;1000 (2006).</Citation><ArticleIdList><ArticleId IdType="pubmed">17072308</ArticleId></ArticleIdList></Reference><Reference><Citation>K.&#xa0;Ando, K. I.&#xa0;Iijima, J. I.&#xa0;Elliott, Y.&#xa0;Kirino, T.&#xa0;Suzuki, Phosphorylation-dependent regulation of the interaction of amyloid precursor protein with Fe65 affects the production of beta-amyloid. J. Biol. Chem. 276, 40353&#x2013;40361 (2001).</Citation><ArticleIdList><ArticleId IdType="pubmed">11517218</ArticleId></ArticleIdList></Reference><Reference><Citation>S.&#xa0;Das, M.&#xa0;Raychaudhuri, U.&#xa0;Sen, D.&#xa0;Mukhopadhyay, Functional implications of the conformational switch in AICD peptide upon binding to Grb2-SH2 domain. J. Mol. Biol. 414, 217&#x2013;230 (2011).</Citation><ArticleIdList><ArticleId IdType="pubmed">22001015</ArticleId></ArticleIdList></Reference><Reference><Citation>J.&#xa0;Radzimanowski, B.&#xa0;Simon, M.&#xa0;Sattler, K.&#xa0;Beyreuther, I.&#xa0;Sinning, K.&#xa0;Wild, Structure of the intracellular domain of the amyloid precursor protein in complex with Fe65-PTB2. EMBO Rep. 9, 1134&#x2013;1140 (2008).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2581855</ArticleId><ArticleId IdType="pubmed">18833287</ArticleId></ArticleIdList></Reference><Reference><Citation>C.&#xa0;Russo, S.&#xa0;Salis, V.&#xa0;Dolcini, V.&#xa0;Venezia, X.&#xa0;Song, J. K.&#xa0;Teller, G.&#xa0;Schettini, Amino-terminal modification and tyrosine phosphorylation of [corrected] carboxy-terminal fragments of the amyloid precursor protein in Alzheimer's disease and Down's syndrome brain. Neurobiol. Dis. 8, 173&#x2013;180 (2001).</Citation><ArticleIdList><ArticleId IdType="pubmed">11162251</ArticleId></ArticleIdList></Reference><Reference><Citation>F.&#xa0;Iannuzzi, R.&#xa0;Sirabella, N.&#xa0;Canu, T. J.&#xa0;Maier, L.&#xa0;Annunziato, C.&#xa0;Matrone, Fyn Tyrosine Kinase Elicits Amyloid Precursor Protein Tyr682 Phosphorylation in Neurons from Alzheimer's Disease Patients. Cell 9, 1807 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7463977</ArticleId><ArticleId IdType="pubmed">32751526</ArticleId></ArticleIdList></Reference><Reference><Citation>Y. M.&#xa0;Abbas, D.&#xa0;Wu, S. A.&#xa0;Bueler, C. V.&#xa0;Robinson, J. L.&#xa0;Rubinstein, Structure of V-ATPase from the mammalian brain. Science 367, 1240&#x2013;1246 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7324285</ArticleId><ArticleId IdType="pubmed">32165585</ArticleId></ArticleIdList></Reference><Reference><Citation>D. A.&#xa0;Case, T. E.&#xa0;Cheatham 3rd, T.&#xa0;Darden, H.&#xa0;Gohlke, R.&#xa0;Luo, K. M.&#xa0;Merz Jr., A.&#xa0;Onufriev, C.&#xa0;Simmerling, B.&#xa0;Wang, R. J.&#xa0;Woods, The Amber biomolecular simulation programs. J. Comput. Chem. 26, 1668&#x2013;1688 (2005).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1989667</ArticleId><ArticleId IdType="pubmed">16200636</ArticleId></ArticleIdList></Reference><Reference><Citation>T. A.&#xa0;Halgren, R. B.&#xa0;Murphy, R. A.&#xa0;Friesner, H. S.&#xa0;Beard, L. L.&#xa0;Frye, W. T.&#xa0;Pollard, J. L.&#xa0;Banks, Glide: A new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening. J. Med. Chem. 47, 1750&#x2013;1759 (2004).</Citation><ArticleIdList><ArticleId IdType="pubmed">15027866</ArticleId></ArticleIdList></Reference><Reference><Citation>V.&#xa0;Tsui, D. A.&#xa0;Case, Theory and applications of the generalized Born solvation model in macromolecular simulations. Biopolymers 56, 275&#x2013;291 (2000).</Citation><ArticleIdList><ArticleId IdType="pubmed">11754341</ArticleId></ArticleIdList></Reference><Reference><Citation>E. T.&#xa0;Poulsen, F.&#xa0;Iannuzzi, H. F.&#xa0;Rasmussen, T. J.&#xa0;Maier, J. J.&#xa0;Enghild, A. L.&#xa0;J&#xf8;rgensen, C.&#xa0;Matrone, RETRACTED An Aberrant Phosphorylation of Amyloid Precursor Protein Tyrosine Regulates Its Trafficking and the Binding to the Clathrin Endocytic Complex in Neural Stem Cells of Alzheimer's Disease Patients. Front. Mol. Neurosci. 10, 59 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5350151</ArticleId><ArticleId IdType="pubmed">28360834</ArticleId></ArticleIdList></Reference><Reference><Citation>A. J.&#xa0;Villar, P. V.&#xa0;Belichenko, A. M.&#xa0;Gillespie, H. M.&#xa0;Kozy, W. C.&#xa0;Mobley, C. J.&#xa0;Epstein, Identification and characterization of a new Down syndrome model, Ts[Rb(12.1716)]2Cje, resulting from a spontaneous Robertsonian fusion between T(171)65Dn and mouse chromosome 12. Mamm. Genome 16, 79&#x2013;90 (2005).</Citation><ArticleIdList><ArticleId IdType="pubmed">15859352</ArticleId></ArticleIdList></Reference><Reference><Citation>A. M.&#xa0;Cataldo, S.&#xa0;Petanceska, C. M.&#xa0;Peterhoff, N. B.&#xa0;Terio, C. J.&#xa0;Epstein, A.&#xa0;Villar, E. J.&#xa0;Carlson, M.&#xa0;Staufenbiel, R. A.&#xa0;Nixon, App gene dosage modulates endosomal abnormalities of Alzheimer's disease in a segmental trisomy 16 mouse model of down syndrome. J. Neurosci. 23, 6788&#x2013;6792 (2003).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6740714</ArticleId><ArticleId IdType="pubmed">12890772</ArticleId></ArticleIdList></Reference><Reference><Citation>A. M.&#xa0;Cataldo, J. L.&#xa0;Barnett, C.&#xa0;Pieroni, R. A.&#xa0;Nixon, Increased neuronal endocytosis and protease delivery to early endosomes in sporadic Alzheimer's disease: Neuropathologic evidence for a mechanism of increased beta-amyloidogenesis. J. Neurosci. 17, 6142&#x2013;6151 (1997).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6568334</ArticleId><ArticleId IdType="pubmed">9236226</ArticleId></ArticleIdList></Reference><Reference><Citation>Y.&#xa0;Jiang, A.&#xa0;Rigoglioso, C. M.&#xa0;Peterhoff, M.&#xa0;Pawlik, Y.&#xa0;Sato, C.&#xa0;Bleiwas, P.&#xa0;Stavrides, J. F.&#xa0;Smiley, S. D.&#xa0;Ginsberg, P. M.&#xa0;Mathews, E.&#xa0;Levy, R. A.&#xa0;Nixon, Partial BACE1 reduction in a Down syndrome mouse model blocks Alzheimer-related endosomal anomalies and cholinergic neurodegeneration: Role of APP-CTF. Neurobiol. Aging 39, 90&#x2013;98 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4773919</ArticleId><ArticleId IdType="pubmed">26923405</ArticleId></ArticleIdList></Reference><Reference><Citation>A. C.&#xa0;Kaufman, S. V.&#xa0;Salazar, L. T.&#xa0;Haas, J.&#xa0;Yang, M. A.&#xa0;Kostylev, A. T.&#xa0;Jeng, S. A.&#xa0;Robinson, E. C.&#xa0;Gunther, C. H.&#xa0;van Dyck, H. B.&#xa0;Nygaard, S. M.&#xa0;Strittmatter, Fyn inhibition rescues established memory and synapse loss in Alzheimer mice. Ann. Neurol. 77, 953&#x2013;971 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4447598</ArticleId><ArticleId IdType="pubmed">25707991</ArticleId></ArticleIdList></Reference><Reference><Citation>C.&#xa0;Hirata-Fukae, H.-F.&#xa0;Li, H.-S.&#xa0;Hoe, A. J.&#xa0;Gray, S. S.&#xa0;Minami, K.&#xa0;Hamada, T.&#xa0;Niikura, F.&#xa0;Hua, H.&#xa0;Tsukagoshi-Nagai, Y.&#xa0;Horikoshi-Sakuraba, M.&#xa0;Mughal, G. W.&#xa0;Rebeck, F. M.&#xa0;LaFerla, M. P.&#xa0;Mattson, N.&#xa0;Iwata, T. C.&#xa0;Saido, W. L.&#xa0;Klein, K. E.&#xa0;Duff, P. S.&#xa0;Aisen, Y.&#xa0;Matsuoka, Females exhibit more extensive amyloid, but not tau, pathology in an Alzheimer transgenic model. Brain Res. 1216, 92&#x2013;103 (2008).</Citation><ArticleIdList><ArticleId IdType="pubmed">18486110</ArticleId></ArticleIdList></Reference><Reference><Citation>L. M.&#xa0;Tai, J.&#xa0;Maldonado Weng, M. J.&#xa0;LaDu, S. T.&#xa0;Brady, Relevance of transgenic mouse models for Alzheimer's disease. Prog. Mol. Biol. Transl. Sci. 177, 1&#x2013;48 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8163103</ArticleId><ArticleId IdType="pubmed">33453936</ArticleId></ArticleIdList></Reference><Reference><Citation>M. H.&#xa0;&#x10c;esen, K.&#xa0;Pegan, A.&#xa0;Spes, B.&#xa0;Turk, Lysosomal pathways to cell death and their therapeutic applications. Exp. Cell Res. 318, 1245&#x2013;1251 (2012).</Citation><ArticleIdList><ArticleId IdType="pubmed">22465226</ArticleId></ArticleIdList></Reference><Reference><Citation>M. F.&#xa0;Almeida, B. A.&#xa0;Bahr, S. T.&#xa0;Kinsey, Endosomal-lysosomal dysfunction in metabolic diseases and Alzheimer's disease. Int. Rev. Neurobiol. 154, 303&#x2013;324 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8428780</ArticleId><ArticleId IdType="pubmed">32739009</ArticleId></ArticleIdList></Reference><Reference><Citation>R. A.&#xa0;Nixon, D. S.&#xa0;Yang, Autophagy and neuronal cell death in neurological disorders. Cold Spring Harb. Perspect. Biol. 4, a008839 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3475163</ArticleId><ArticleId IdType="pubmed">22983160</ArticleId></ArticleIdList></Reference><Reference><Citation>E.&#xa0;Doran, D.&#xa0;Keator, E.&#xa0;Head, M. J.&#xa0;Phelan, R.&#xa0;Kim, M.&#xa0;Totoiu, J. R.&#xa0;Barrio, G. W.&#xa0;Small, S. G.&#xa0;Potkin, I. T.&#xa0;Lott, Down Syndrome, Partial Trisomy 21, and Absence of Alzheimer's Disease: The Role of APP. J. Alzheimers Dis. 56, 459&#x2013;470 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5662115</ArticleId><ArticleId IdType="pubmed">27983553</ArticleId></ArticleIdList></Reference><Reference><Citation>D. J.&#xa0;Colacurcio, A.&#xa0;Pensalfini, Y.&#xa0;Jiang, R. A.&#xa0;Nixon, Dysfunction of autophagy and endosomal-lysosomal pathways: Roles in pathogenesis of Down syndrome and Alzheimer's Disease. Free Radic. Biol. Med. 114, 40&#x2013;51 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5748263</ArticleId><ArticleId IdType="pubmed">28988799</ArticleId></ArticleIdList></Reference><Reference><Citation>I. T.&#xa0;Lott, E.&#xa0;Head, Dementia in Down syndrome: Unique insights for Alzheimer disease research. Nat. Rev. Neurol. 15, 135&#x2013;147 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8061428</ArticleId><ArticleId IdType="pubmed">30733618</ArticleId></ArticleIdList></Reference><Reference><Citation>B.&#xa0;De Strooper, Loss-of-function presenilin mutations in Alzheimer disease. Talking Point on the role of presenilin mutations in Alzheimer disease. EMBO Rep. 8, 141&#x2013;146 (2007).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1796779</ArticleId><ArticleId IdType="pubmed">17268505</ArticleId></ArticleIdList></Reference><Reference><Citation>J.-H.&#xa0;Lee, M. K.&#xa0;McBrayer, D. M.&#xa0;Wolfe, L. J.&#xa0;Haslett, A.&#xa0;Kumar, Y.&#xa0;Sato, P.&#xa0;P.&#xa0;Y.&#xa0;Lie, P.&#xa0;Mohan, E. E.&#xa0;Coffey, U.&#xa0;Kompella, C. H.&#xa0;Mitchell, E.&#xa0;Lloyd-Evans, R. A.&#xa0;Nixon, Presenilin 1 maintains lysosomal Ca(2+) homeostasis via TRPML1 by regulating vATPase-mediated lysosome acidification. Cell Rep. 12, 1430&#x2013;1444 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4558203</ArticleId><ArticleId IdType="pubmed">26299959</ArticleId></ArticleIdList></Reference><Reference><Citation>R.&#xa0;Wallings, N.&#xa0;Connor-Robson, R.&#xa0;Wade-Martins, LRRK2 interacts with the vacuolar-type H+-ATPase pump a1 subunit to regulate lysosomal function. Hum. Mol. Genet. 28, 2696&#x2013;2710 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6687951</ArticleId><ArticleId IdType="pubmed">31039583</ArticleId></ArticleIdList></Reference><Reference><Citation>M. B.&#xa0;Bagh, S.&#xa0;Peng, G.&#xa0;Chandra, Z.&#xa0;Zhang, S. P.&#xa0;Singh, N.&#xa0;Pattabiraman, A.&#xa0;Liu, A. B.&#xa0;Mukherjee, Misrouting of v-ATPase subunit V0a1 dysregulates lysosomal acidification in a neurodegenerative lysosomal storage disease model. Nat. Commun. 8, 14612 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5344305</ArticleId><ArticleId IdType="pubmed">28266544</ArticleId></ArticleIdList></Reference><Reference><Citation>A. M.&#xa0;Cataldo, P. M.&#xa0;Mathews, A. B.&#xa0;Boiteau, L. C.&#xa0;Hassinger, C. M.&#xa0;Peterhoff, Y.&#xa0;Jiang, K.&#xa0;Mullaney, R. L.&#xa0;Neve, J.&#xa0;Gruenberg, R. A.&#xa0;Nixon, Down syndrome fibroblast model of Alzheimer-related endosome pathology: Accelerated endocytosis promotes late endocytic defects. Am. J.&#xa0;Pathol. 173, 370&#x2013;384 (2008).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2475775</ArticleId><ArticleId IdType="pubmed">18535180</ArticleId></ArticleIdList></Reference><Reference><Citation>N.&#xa0;Zambrano, P.&#xa0;Bruni, G.&#xa0;Minopoli, R.&#xa0;Mosca, D.&#xa0;Molino, C.&#xa0;Russo, G.&#xa0;Schettini, M.&#xa0;Sudol, T.&#xa0;Russo, The beta-amyloid precursor protein APP is tyrosine-phosphorylated in cells expressing a constitutively active form of the Abl protoncogene. J. Biol. Chem. 276, 19787&#x2013;19792 (2001).</Citation><ArticleIdList><ArticleId IdType="pubmed">11279131</ArticleId></ArticleIdList></Reference><Reference><Citation>P. E.&#xa0;Tarr, C.&#xa0;Contursi, R.&#xa0;Roncarati, C.&#xa0;Noviello, E.&#xa0;Ghersi, M. H.&#xa0;Scheinfeld, N.&#xa0;Zambrano, T.&#xa0;Russo, L.&#xa0;D'Adamio, Evidence for a role of the nerve growth factor receptor TrkA in tyrosine phosphorylation and processing of beta-APP. Biochem. Biophys. Res. Commun. 295, 324&#x2013;329 (2002).</Citation><ArticleIdList><ArticleId IdType="pubmed">12150951</ArticleId></ArticleIdList></Reference><Reference><Citation>H.-S.&#xa0;Hoe, S. S.&#xa0;Minami, A.&#xa0;Makarova, J.&#xa0;Lee, B. T.&#xa0;Hyman, Y.&#xa0;Matsuoka, G. W.&#xa0;Rebeck, Fyn modulation of Dab1 effects on amyloid precursor protein and ApoE receptor 2 processing. J. Biol. Chem. 283, 6288&#x2013;6299 (2008).</Citation><ArticleIdList><ArticleId IdType="pubmed">18089558</ArticleId></ArticleIdList></Reference><Reference><Citation>G. J.&#xa0;Ho, M.&#xa0;Hashimoto, A.&#xa0;Adame, M.&#xa0;Izu, M. F.&#xa0;Alford, L. J.&#xa0;Thal, L. A.&#xa0;Hansen, E.&#xa0;Masliah, Altered p59Fyn kinase expression accompanies disease progression in Alzheimer's disease: Implications for its functional role. Neurobiol. Aging 26, 625&#x2013;635 (2005).</Citation><ArticleIdList><ArticleId IdType="pubmed">15708437</ArticleId></ArticleIdList></Reference><Reference><Citation>C.&#xa0;De Jonghe, C.&#xa0;Esselens, S.&#xa0;Kumar-Singh, K.&#xa0;Craessaerts, S.&#xa0;Serneels, F.&#xa0;Checler, W.&#xa0;Annaert, C.&#xa0;Van Broeckhoven, B.&#xa0;De Strooper, Pathogenic APP mutations near the gamma-secretase cleavage site differentially affect Abeta secretion and APP C-terminal fragment stability. Hum. Mol. Genet. 10, 1665&#x2013;1671 (2001).</Citation><ArticleIdList><ArticleId IdType="pubmed">11487570</ArticleId></ArticleIdList></Reference><Reference><Citation>A.&#xa0;Salehi, J. D.&#xa0;Delcroix, P. V.&#xa0;Belichenko, K.&#xa0;Zhan, C.&#xa0;Wu, J. S.&#xa0;Valletta, R.&#xa0;Takimoto-Kimura, A. M.&#xa0;Kleschevnikov, K.&#xa0;Sambamurti, P. P.&#xa0;Chung, W.&#xa0;Xia, A.&#xa0;Villar, W. A.&#xa0;Campbell, L. S.&#xa0;Kulnane, R. A.&#xa0;Nixon, B. T.&#xa0;Lamb, C. J.&#xa0;Epstein, G. B.&#xa0;Stokin, L.&#xa0;S.&#xa0;B.&#xa0;Goldstein, W. C.&#xa0;Mobley, Increased App expression in a mouse model of Down's syndrome disrupts NGF transport and causes cholinergic neuron degeneration. Neuron 51, 29&#x2013;42 (2006).</Citation><ArticleIdList><ArticleId IdType="pubmed">16815330</ArticleId></ArticleIdList></Reference><Reference><Citation>G.&#xa0;Woodruff, S. M.&#xa0;Reyna, M.&#xa0;Dunlap, R.&#xa0;van der Kant, J. A.&#xa0;Callender, J. E.&#xa0;Young, E. A.&#xa0;Roberts, L.&#xa0;S.&#xa0;B.&#xa0;Goldstein, Defective Transcytosis of APP and Lipoproteins in Human iPSC-Derived Neurons with Familial Alzheimer's Disease Mutations. Cell Rep. 17, 759&#x2013;773 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5796664</ArticleId><ArticleId IdType="pubmed">27732852</ArticleId></ArticleIdList></Reference><Reference><Citation>L.-B.&#xa0;Yang, K.&#xa0;Lindholm, R.&#xa0;Yan, M.&#xa0;Citron, W.&#xa0;Xia, X.-L.&#xa0;Yang, T.&#xa0;Beach, L.&#xa0;Sue, P.&#xa0;Wong, D.&#xa0;Price, R.&#xa0;Li, Y.&#xa0;Shen, Elevated beta-secretase expression and enzymatic activity detected in sporadic Alzheimer disease. Nat. Med. 9, 3&#x2013;4 (2003).</Citation><ArticleIdList><ArticleId IdType="pubmed">12514700</ArticleId></ArticleIdList></Reference><Reference><Citation>G.&#xa0;Zuliani, A.&#xa0;Trentini, V.&#xa0;Rosta, R.&#xa0;Guerrini, S.&#xa0;Pacifico, S.&#xa0;Bonazzi, A.&#xa0;Guiotto, A.&#xa0;Passaro, D.&#xa0;Seripa, G.&#xa0;Valacchi, C.&#xa0;Cervellati, Increased blood BACE1 activity as a potential common pathogenic factor of vascular dementia and late onset Alzheimer's disease. Sci. Rep. 10, 14980 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7486910</ArticleId><ArticleId IdType="pubmed">32917964</ArticleId></ArticleIdList></Reference><Reference><Citation>M. J.&#xa0;Y&#xe1;&#xf1;ez, O.&#xa0;Belbin, L. D.&#xa0;Estrada, N.&#xa0;Leal, P. S.&#xa0;Contreras, A.&#xa0;Lle&#xf3;, P. V.&#xa0;Burgos, S.&#xa0;Zanlungo, A. R.&#xa0;Alvarez, c-Abl links APP-BACE1 interaction promoting APP amyloidogenic processing in Niemann-Pick type C disease. Biochim. Biophys. Acta 1862, 2158&#x2013;2167 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">27565738</ArticleId></ArticleIdList></Reference><Reference><Citation>R.&#xa0;Shen, X.&#xa0;Zhao, L.&#xa0;He, Y.&#xa0;Ding, W.&#xa0;Xu, S.&#xa0;Lin, S.&#xa0;Fang, W.&#xa0;Yang, K.&#xa0;Sung, B.&#xa0;Spencer, R. A.&#xa0;Rissman, M.&#xa0;Lei, J.&#xa0;Ding, C.&#xa0;Wu, Upregulation of RIN3 induces endosomal dysfunction in Alzheimer's disease. Transl. Neurodegener. 9, 26 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7301499</ArticleId><ArticleId IdType="pubmed">32552912</ArticleId></ArticleIdList></Reference><Reference><Citation>Z.&#xa0;Wang, Q.&#xa0;Zhang, J.-R.&#xa0;Lin, M. R.&#xa0;Jabalameli, J.&#xa0;Mitra, N.&#xa0;Nguyen, Z. D.&#xa0;Zhang, Deep post-GWAS analysis identifies potential risk genes and risk variants for Alzheimer's disease, providing new insights into its disease mechanisms. Sci. Rep. 11, 20511 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8519945</ArticleId><ArticleId IdType="pubmed">34654853</ArticleId></ArticleIdList></Reference><Reference><Citation>D. A.&#xa0;Butterfield, F.&#xa0;Di Domenico, A. M.&#xa0;Swomley, E.&#xa0;Head, M.&#xa0;Perluigi, Redox proteomics analysis to decipher the neurobiology of Alzheimer-like neurodegeneration: Overlaps in Down's syndrome and Alzheimer's disease brain. Biochem. J. 463, 177&#x2013;189 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4686233</ArticleId><ArticleId IdType="pubmed">25242166</ArticleId></ArticleIdList></Reference><Reference><Citation>M.&#xa0;Perluigi, D. A.&#xa0;Butterfield, Oxidative Stress and Down Syndrome: A Route toward Alzheimer-Like Dementia. Curr. Gerontol. Geriatr. Res. 2012, 724904 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3235450</ArticleId><ArticleId IdType="pubmed">22203843</ArticleId></ArticleIdList></Reference><Reference><Citation>R. A.&#xa0;Nixon, The aging lysosome: An essential catalyst for late-onset neurodegenerative diseases. Biochim. Biophys. Acta Proteins Proteom. 1868, 140443 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7388076</ArticleId><ArticleId IdType="pubmed">32416272</ArticleId></ArticleIdList></Reference><Reference><Citation>J.&#xa0;H.&#xa0;K.&#xa0;Tam, M. R.&#xa0;Cobb, C.&#xa0;Seah, S. H.&#xa0;Pasternak, Tyrosine binding protein sites regulate the intracellular trafficking and processing of amyloid precursor protein through a novel lysosome-directed pathway. PLOS ONE 11, e0161445 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5077117</ArticleId><ArticleId IdType="pubmed">27776132</ArticleId></ArticleIdList></Reference><Reference><Citation>Y.&#xa0;Tian, J. C.&#xa0;Chang, P.&#xa0;Greengard, M.&#xa0;Flajolet, The convergence of endosomal and autophagosomal pathways: Implications for APP-CTF degradation. Autophagy 10, 694&#x2013;696 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4091156</ArticleId><ArticleId IdType="pubmed">24447917</ArticleId></ArticleIdList></Reference><Reference><Citation>G. R.&#xa0;Richo, G. E.&#xa0;Conner, Structural requirements of procathepsin D activation and maturation. J. Biol. Chem. 269, 14806&#x2013;14812 (1994).</Citation><ArticleIdList><ArticleId IdType="pubmed">8182087</ArticleId></ArticleIdList></Reference><Reference><Citation>R.&#xa0;Singh, S.&#xa0;Kaushik, Y.&#xa0;Wang, Y.&#xa0;Xiang, I.&#xa0;Novak, M.&#xa0;Komatsu, K.&#xa0;Tanaka, A. M.&#xa0;Cuervo, M. J.&#xa0;Czaja, Autophagy regulates lipid metabolism. Nature 458, 1131&#x2013;1135 (2009).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2676208</ArticleId><ArticleId IdType="pubmed">19339967</ArticleId></ArticleIdList></Reference><Reference><Citation>T.&#xa0;Asano, M.&#xa0;Komatsu, Y.&#xa0;Yamaguchi-Iwai, F.&#xa0;Ishikawa, N.&#xa0;Mizushima, K.&#xa0;Iwai, Distinct mechanisms of ferritin delivery to lysosomes in iron-depleted and iron-replete cells. Mol. Cell. Biol. 31, 2040&#x2013;2052 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3133360</ArticleId><ArticleId IdType="pubmed">21444722</ArticleId></ArticleIdList></Reference><Reference><Citation>N.&#xa0;Nakamura, A.&#xa0;Matsuura, Y.&#xa0;Wada, Y.&#xa0;Ohsumi, Acidification of vacuoles is required for autophagic degradation in the yeast, Saccharomyces cerevisiae. J. Biochem. 121, 338&#x2013;344 (1997).</Citation><ArticleIdList><ArticleId IdType="pubmed">9089409</ArticleId></ArticleIdList></Reference><Reference><Citation>I.&#xa0;Kukic, S. L.&#xa0;Kelleher, K.&#xa0;Kiselyov, Zn2+ efflux through lysosomal exocytosis prevents Zn2+&#x2212;induced toxicity. J. Cell Sci. 127, 3094&#x2013;3103 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4095854</ArticleId><ArticleId IdType="pubmed">24829149</ArticleId></ArticleIdList></Reference><Reference><Citation>P.&#xa0;P.&#xa0;Y.&#xa0;Lie, D.-S.&#xa0;Yang, P.&#xa0;Stavrides, C. N.&#xa0;Goulbourne, P.&#xa0;Zheng, P. S.&#xa0;Mohan, A. M.&#xa0;Cataldo, R. A.&#xa0;Nixon, Post-Golgi carriers, not lysosomes, confer lysosomal properties to pre-degradative organelles in normal and dystrophic axons. Cell Rep. 35, 109034 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8135226</ArticleId><ArticleId IdType="pubmed">33910020</ArticleId></ArticleIdList></Reference><Reference><Citation>C.&#xa0;McGuire, L.&#xa0;Stransky, K.&#xa0;Cotter, M.&#xa0;Forgac, Regulation of V-ATPase activity. Front. Biosci. (Landmark Ed.) 22, 609&#x2013;622 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">27814636</ArticleId></ArticleIdList></Reference><Reference><Citation>L.&#xa0;Wang, D.&#xa0;Wu, C. V.&#xa0;Robinson, H.&#xa0;Wu, T. M.&#xa0;Fu, Structures of a Complete Human V-ATPase Reveal Mechanisms of Its Assembly. Mol. Cell 80, 501&#x2013;511.e3 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7655608</ArticleId><ArticleId IdType="pubmed">33065002</ArticleId></ArticleIdList></Reference><Reference><Citation>Y.-S.&#xa0;Jung, S.&#xa0;Jun, M. J.&#xa0;Kim, S. H.&#xa0;Lee, H. N.&#xa0;Suh, E. M.&#xa0;Lien, H.-Y.&#xa0;Jung, S.&#xa0;Lee, J.&#xa0;Zhang, J.-I.&#xa0;Yang, H.&#xa0;Ji, J. Y.&#xa0;Wu, W.&#xa0;Wang, R. K.&#xa0;Miller, J.&#xa0;Chen, P. D.&#xa0;McCrea, S.&#xa0;Kopetz, J.-I.&#xa0;Park, TMEM9 promotes intestinal tumorigenesis through vacuolar-ATPase-activated Wnt/&#x3b2;-catenin signalling. Nat. Cell Biol. 20, 1421&#x2013;1433 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6261670</ArticleId><ArticleId IdType="pubmed">30374053</ArticleId></ArticleIdList></Reference><Reference><Citation>B.&#xa0;Zhong, M.&#xa0;Liu, C.&#xa0;Bai, Y.&#xa0;Ruan, Y.&#xa0;Wang, L.&#xa0;Qiu, Y.&#xa0;Hong, X.&#xa0;Wang, L.&#xa0;Li, B.&#xa0;Li, Caspase-8 Induces Lysosome-Associated Cell Death in Cancer Cells. Mol. Ther. 28, 1078&#x2013;1091 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7132614</ArticleId><ArticleId IdType="pubmed">32053770</ArticleId></ArticleIdList></Reference><Reference><Citation>Z. A.&#xa0;Klein, H.&#xa0;Takahashi, M.&#xa0;Ma, M.&#xa0;Stagi, M.&#xa0;Zhou, T.&#xa0;K.&#xa0;T.&#xa0;Lam, S. M.&#xa0;Strittmatter, Loss of TMEM106B Ameliorates Lysosomal and Frontotemporal Dementia-Related Phenotypes in Progranulin-Deficient Mice. Neuron 95, 281&#x2013;296.e6 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5558861</ArticleId><ArticleId IdType="pubmed">28728022</ArticleId></ArticleIdList></Reference><Reference><Citation>R. A.&#xa0;Nixon, D.-S.&#xa0;Yang, Autophagy failure in Alzheimer's disease--locating the primary defect. Neurobiol. Dis. 43, 38&#x2013;45 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3096679</ArticleId><ArticleId IdType="pubmed">21296668</ArticleId></ArticleIdList></Reference><Reference><Citation>A. M.&#xa0;Cataldo, D. J.&#xa0;Hamilton, J. L.&#xa0;Barnett, P. A.&#xa0;Paskevich, R. A.&#xa0;Nixon, Properties of the endosomal-lysosomal system in the human central nervous system: Disturbances mark most neurons in populations at risk to degenerate in Alzheimer's disease. J. Neurosci. 16, 186&#x2013;199 (1996).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6578706</ArticleId><ArticleId IdType="pubmed">8613784</ArticleId></ArticleIdList></Reference><Reference><Citation>R. A.&#xa0;Nixon, Amyloid precursor protein and endosomal-lysosomal dysfunction in Alzheimer's disease: Inseparable partners in a multifactorial disease. FASEB J. 31, 2729&#x2013;2743 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6137496</ArticleId><ArticleId IdType="pubmed">28663518</ArticleId></ArticleIdList></Reference><Reference><Citation>M.&#xa0;Brouillard, P.&#xa0;Barth&#xe9;l&#xe9;my, B.&#xa0;Dehay, S.&#xa0;Crauste-Manciet, V.&#xa0;Desvergnes, Nucleolipid Acid-Based Nanocarriers Restore Neuronal Lysosomal Acidification Defects. Front. Chem. 9, 736554 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8417785</ArticleId><ArticleId IdType="pubmed">34490217</ArticleId></ArticleIdList></Reference><Reference><Citation>J. H.&#xa0;Lee, D. M.&#xa0;Wolfe, S.&#xa0;Darji, M. K.&#xa0;McBrayer, D. J.&#xa0;Colacurcio, A.&#xa0;Kumar, P.&#xa0;Stavrides, P. S.&#xa0;Mohan, R. A.&#xa0;Nixon, &#x3b2;2-adrenergic agonists rescue lysosome acidification and function in PSEN1 deficiency by reversing defective ER-to-lysosome delivery of ClC-7. J. Mol. Biol. 432, 2633&#x2013;2650 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7211125</ArticleId><ArticleId IdType="pubmed">32105735</ArticleId></ArticleIdList></Reference><Reference><Citation>P.&#xa0;P.&#xa0;Y.&#xa0;Lie, R. A.&#xa0;Nixon, Lysosome trafficking and signaling in health and neurodegenerative diseases. Neurobiol. Dis. 122, 94&#x2013;105 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6381838</ArticleId><ArticleId IdType="pubmed">29859318</ArticleId></ArticleIdList></Reference><Reference><Citation>J.&#xa0;Rappsilber, M.&#xa0;Mann, Y.&#xa0;Ishihama, Protocol for micro-purification, enrichment, pre-fractionation and storage of peptides for proteomics using StageTips. Nat. Protoc. 2, 1896&#x2013;1906 (2007).</Citation><ArticleIdList><ArticleId IdType="pubmed">17703201</ArticleId></ArticleIdList></Reference><Reference><Citation>P. M.&#xa0;Mathews, Y.&#xa0;Jiang, S. D.&#xa0;Schmidt, O. M.&#xa0;Grbovic, M.&#xa0;Mercken, R. A.&#xa0;Nixon, Calpain activity regulates the cell surface distribution of amyloid precursor protein. inhibition of calpains enhances endosomal generation of beta-cleaved C-terminal APP fragments. J. Biol. Chem. 277, 36415&#x2013;36424 (2002).</Citation><ArticleIdList><ArticleId IdType="pubmed">12087104</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37532932</PMID><DateCompleted><Year>2023</Year><Month>08</Month><Day>14</Day></DateCompleted><DateRevised><Year>2023</Year><Month>08</Month><Day>14</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1476-4687</ISSN><JournalIssue CitedMedium="Internet"><Volume>620</Volume><Issue>7973</Issue><PubDate><Year>2023</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Nature</Title><ISOAbbreviation>Nature</ISOAbbreviation></Journal><ArticleTitle>cGAS-STING drives ageing-related inflammation and neurodegeneration.</ArticleTitle><Pagination><StartPage>374</StartPage><EndPage>380</EndPage><MedlinePgn>374-380</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41586-023-06373-1</ELocationID><Abstract><AbstractText>Low-grade inflammation is a hallmark of old age and a central driver of ageing-associated impairment and disease<sup>1</sup>. Multiple factors can contribute to ageing-associated inflammation<sup>2</sup>; however, the molecular pathways that transduce aberrant inflammatory signalling and their impact in natural ageing remain unclear. Here we show that the cGAS-STING signalling pathway, which mediates immune sensing of DNA<sup>3</sup>, is a critical driver of chronic inflammation and functional decline during ageing. Blockade of STING suppresses the inflammatory phenotypes of senescent human cells and tissues, attenuates ageing-related inflammation in multiple peripheral organs and the brain in mice, and leads to an improvement in tissue function. Focusing on the ageing brain, we reveal that activation of STING triggers reactive microglial transcriptional states, neurodegeneration and cognitive decline. Cytosolic DNA released from perturbed mitochondria elicits cGAS activity in old microglia, defining a mechanism by which cGAS-STING signalling is engaged in the ageing brain. Single-nucleus RNA-sequencing analysis of microglia and hippocampi of a cGAS gain-of-function mouse model demonstrates that engagement of cGAS in microglia is sufficient to direct ageing-associated transcriptional microglial states leading to bystander cell inflammation, neurotoxicity and impaired memory capacity. Our findings establish the cGAS-STING pathway as a driver of ageing-related inflammation in peripheral organs and the brain, and reveal blockade of cGAS-STING signalling as a potential strategy to halt neurodegenerative processes during old age.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Gulen</LastName><ForeName>Muhammet F</ForeName><Initials>MF</Initials><Identifier Source="ORCID">0000-0002-7139-6781</Identifier><AffiliationInfo><Affiliation>Global Health Institute, Swiss Federal Institute of Technology Lausanne (EPFL), Lausanne, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Samson</LastName><ForeName>Natasha</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Global Health Institute, Swiss Federal Institute of Technology Lausanne (EPFL), Lausanne, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Keller</LastName><ForeName>Alexander</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Global Health Institute, Swiss Federal Institute of Technology Lausanne (EPFL), Lausanne, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schwabenland</LastName><ForeName>Marius</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-2205-5427</Identifier><AffiliationInfo><Affiliation>Institute of Neuropathology, Faculty of Medicine, University of Freiburg, Freiburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Chong</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0001-6853-9625</Identifier><AffiliationInfo><Affiliation>Global Health Institute, Swiss Federal Institute of Technology Lausanne (EPFL), Lausanne, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gl&#xfc;ck</LastName><ForeName>Selene</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Global Health Institute, Swiss Federal Institute of Technology Lausanne (EPFL), Lausanne, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thacker</LastName><ForeName>Vivek V</ForeName><Initials>VV</Initials><Identifier Source="ORCID">0000-0002-1681-627X</Identifier><AffiliationInfo><Affiliation>Global Health Institute, Swiss Federal Institute of Technology Lausanne (EPFL), Lausanne, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Favre</LastName><ForeName>Lucie</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0003-0337-3219</Identifier><AffiliationInfo><Affiliation>Division of Endocrinology, Diabetology and Metabolism, Lausanne University Hospital, Lausanne, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mangeat</LastName><ForeName>Bastien</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0003-2592-0236</Identifier><AffiliationInfo><Affiliation>Gene Expression Core Facility, Swiss Federal Institute of Technology Lausanne (EPFL), Lausanne, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kroese</LastName><ForeName>Lona J</ForeName><Initials>LJ</Initials><AffiliationInfo><Affiliation>Animal Modeling Facility, The Netherlands Cancer Institute, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Krimpenfort</LastName><ForeName>Paul</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Animal Modeling Facility, The Netherlands Cancer Institute, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prinz</LastName><ForeName>Marco</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-0349-1955</Identifier><AffiliationInfo><Affiliation>Institute of Neuropathology, Faculty of Medicine, University of Freiburg, Freiburg, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Basics in NeuroModulation (NeuroModulBasics), Faculty of Medicine, University of Freiburg, Freiburg, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Signalling Research Centres BIOSS and CIBSS, University of Freiburg, Freiburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ablasser</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-8475-8999</Identifier><AffiliationInfo><Affiliation>Global Health Institute, Swiss Federal Institute of Technology Lausanne (EPFL), Lausanne, Switzerland. andrea.ablasser@epfl.ch.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Cancer Research (ISREC), Swiss Federal Institute of Technology Lausanne (EPFL), Lausanne, Switzerland. andrea.ablasser@epfl.ch.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>08</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nature</MedlineTA><NlmUniqueID>0410462</NlmUniqueID><ISSNLinking>0028-0836</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 2.7.7.-</RegistryNumber><NameOfSubstance UI="C578390">cGAS protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.7.-</RegistryNumber><NameOfSubstance UI="C578391">cGAS protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>9007-49-2</RegistryNumber><NameOfSubstance UI="D004247">DNA</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008565">Membrane Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.7.-</RegistryNumber><NameOfSubstance UI="D009713">Nucleotidyltransferases</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C532857">STING1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C530855">Sting1 protein, mouse</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000375" MajorTopicYN="Y">Aging</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="Y">Brain</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D024201" MajorTopicYN="N">Bystander Effect</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060825" MajorTopicYN="Y">Cognitive Dysfunction</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004247" MajorTopicYN="N">DNA</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007249" MajorTopicYN="Y">Inflammation</DescriptorName><QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008565" MajorTopicYN="Y">Membrane Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008569" MajorTopicYN="N">Memory Disorders</DescriptorName><QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017628" MajorTopicYN="N">Microglia</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008928" MajorTopicYN="N">Mitochondria</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="Y">Neurodegenerative Diseases</DescriptorName><QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009713" MajorTopicYN="Y">Nucleotidyltransferases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009928" MajorTopicYN="N">Organ Specificity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006624" MajorTopicYN="N">Hippocampus</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>A.A. is a scientific co-founder of IFM Due. The other authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>9</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>6</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>11</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>8</Month><Day>3</Day><Hour>1</Hour><Minute>6</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>8</Month><Day>2</Day><Hour>23</Hour><Minute>30</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>8</Month><Day>2</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37532932</ArticleId><ArticleId IdType="pmc">PMC10412454</ArticleId><ArticleId IdType="doi">10.1038/s41586-023-06373-1</ArticleId><ArticleId IdType="pii">10.1038/s41586-023-06373-1</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Franceschi C, Garagnani P, Parini P, Giuliani C, Santoro A. Inflammaging: a new immune&#x2013;metabolic viewpoint for age-related diseases. Nat. Rev. Endocrinol. 2018;14:576&#x2013;590. doi: 10.1038/s41574-018-0059-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41574-018-0059-4</ArticleId><ArticleId IdType="pubmed">30046148</ArticleId></ArticleIdList></Reference><Reference><Citation>Frasca D, Blomberg BB. Inflammaging decreases adaptive and innate immune responses in mice and humans. Biogerontology. 2016;17:7&#x2013;19. doi: 10.1007/s10522-015-9578-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10522-015-9578-8</ArticleId><ArticleId IdType="pmc">PMC4626429</ArticleId><ArticleId IdType="pubmed">25921609</ArticleId></ArticleIdList></Reference><Reference><Citation>Ablasser, A. &amp; Chen, Z. J. cGAS in action: expanding roles in immunity and inflammation. Science363, eaat8657 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">30846571</ArticleId></ArticleIdList></Reference><Reference><Citation>Partridge L, Fuentealba M, Kennedy BK. The quest to slow ageing through drug discovery. Nat. Rev. Drug Discov. 2020;19:513&#x2013;532. doi: 10.1038/s41573-020-0067-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41573-020-0067-7</ArticleId><ArticleId IdType="pubmed">32467649</ArticleId></ArticleIdList></Reference><Reference><Citation>Gluck S, et al. Innate immune sensing of cytosolic chromatin fragments through cGAS promotes senescence. Nat. Cell Biol. 2017;19:1061&#x2013;1070. doi: 10.1038/ncb3586.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncb3586</ArticleId><ArticleId IdType="pmc">PMC5826565</ArticleId><ArticleId IdType="pubmed">28759028</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang H, Wang H, Ren J, Chen Q, Chen ZJ. cGAS is essential for cellular senescence. Proc. Natl Acad. Sci. USA. 2017;114:E4612&#x2013;E4620. doi: 10.1073/pnas.1705499114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1705499114</ArticleId><ArticleId IdType="pmc">PMC5468617</ArticleId><ArticleId IdType="pubmed">28533362</ArticleId></ArticleIdList></Reference><Reference><Citation>Dou Z, et al. Cytoplasmic chromatin triggers inflammation in senescence and cancer. Nature. 2017;550:402&#x2013;406. doi: 10.1038/nature24050.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature24050</ArticleId><ArticleId IdType="pmc">PMC5850938</ArticleId><ArticleId IdType="pubmed">28976970</ArticleId></ArticleIdList></Reference><Reference><Citation>van Deursen JM. The role of senescent cells in ageing. Nature. 2014;509:439&#x2013;446. doi: 10.1038/nature13193.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature13193</ArticleId><ArticleId IdType="pmc">PMC4214092</ArticleId><ArticleId IdType="pubmed">24848057</ArticleId></ArticleIdList></Reference><Reference><Citation>Haag SM, et al. Targeting STING with covalent small-molecule inhibitors. Nature. 2018;559:269&#x2013;273. doi: 10.1038/s41586-018-0287-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-018-0287-8</ArticleId><ArticleId IdType="pubmed">29973723</ArticleId></ArticleIdList></Reference><Reference><Citation>Campisi J. Aging, cellular senescence, and cancer. Annu. Rev. Physiol. 2013;75:685&#x2013;705. doi: 10.1146/annurev-physiol-030212-183653.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-physiol-030212-183653</ArticleId><ArticleId IdType="pmc">PMC4166529</ArticleId><ArticleId IdType="pubmed">23140366</ArticleId></ArticleIdList></Reference><Reference><Citation>Dimri GP, et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc. Natl Acad. Sci. USA. 1995;92:9363&#x2013;9367. doi: 10.1073/pnas.92.20.9363.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.92.20.9363</ArticleId><ArticleId IdType="pmc">PMC40985</ArticleId><ArticleId IdType="pubmed">7568133</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu M, et al. Senolytics improve physical function and increase lifespan in old age. Nat. Med. 2018;24:1246&#x2013;1256. doi: 10.1038/s41591-018-0092-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-018-0092-9</ArticleId><ArticleId IdType="pmc">PMC6082705</ArticleId><ArticleId IdType="pubmed">29988130</ArticleId></ArticleIdList></Reference><Reference><Citation>Almanzar N, et al. A single-cell transcriptomic atlas characterizes ageing tissues in the mouse. Nature. 2020;583:590&#x2013;595. doi: 10.1038/s41586-020-2496-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2496-1</ArticleId><ArticleId IdType="pmc">PMC8240505</ArticleId><ArticleId IdType="pubmed">32669714</ArticleId></ArticleIdList></Reference><Reference><Citation>Richardson A, et al. Measures of healthspan as indices of aging in mice&#x2014;a recommendation. J. Gerontol. A. 2015;71:427&#x2013;430. doi: 10.1093/gerona/glv080.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/gerona/glv080</ArticleId><ArticleId IdType="pmc">PMC4834833</ArticleId><ArticleId IdType="pubmed">26297941</ArticleId></ArticleIdList></Reference><Reference><Citation>Baruch K, et al. Aging-induced type I interferon response at the choroid plexus negatively affects brain function. Science. 2014;346:89&#x2013;93. doi: 10.1126/science.1252945.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1252945</ArticleId><ArticleId IdType="pmc">PMC4869326</ArticleId><ArticleId IdType="pubmed">25147279</ArticleId></ArticleIdList></Reference><Reference><Citation>Wyss-Coray T. Ageing, neurodegeneration and brain rejuvenation. Nature. 2016;539:180&#x2013;186. doi: 10.1038/nature20411.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature20411</ArticleId><ArticleId IdType="pmc">PMC5172605</ArticleId><ArticleId IdType="pubmed">27830812</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwabenland M, et al. Analyzing microglial phenotypes across neuropathologies: a practical guide. Acta Neuropathol. 2021;142:923&#x2013;936. doi: 10.1007/s00401-021-02370-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-021-02370-8</ArticleId><ArticleId IdType="pmc">PMC8498770</ArticleId><ArticleId IdType="pubmed">34623511</ArticleId></ArticleIdList></Reference><Reference><Citation>Villeda SA, et al. The ageing systemic milieu negatively regulates neurogenesis and cognitive function. Nature. 2011;477:90&#x2013;94. doi: 10.1038/nature10357.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature10357</ArticleId><ArticleId IdType="pmc">PMC3170097</ArticleId><ArticleId IdType="pubmed">21886162</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang C, et al. Structural basis of STING binding with and phosphorylation by TBK1. Nature. 2019;567:394&#x2013;398. doi: 10.1038/s41586-019-1000-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-019-1000-2</ArticleId><ArticleId IdType="pmc">PMC6862768</ArticleId><ArticleId IdType="pubmed">30842653</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao B, et al. A conserved PLPLRT/SD motif of STING mediates the recruitment and activation of TBK1. Nature. 2019;569:718&#x2013;722. doi: 10.1038/s41586-019-1228-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-019-1228-x</ArticleId><ArticleId IdType="pmc">PMC6596994</ArticleId><ArticleId IdType="pubmed">31118511</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun L, Wu J, Du F, Chen X, Chen ZJ. Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway. Science. 2013;339:786&#x2013;791. doi: 10.1126/science.1232458.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1232458</ArticleId><ArticleId IdType="pmc">PMC3863629</ArticleId><ArticleId IdType="pubmed">23258413</ArticleId></ArticleIdList></Reference><Reference><Citation>Ablasser A, et al. cGAS produces a 2&#x2032;-5&#x2032;-linked cyclic dinucleotide second messenger that activates STING. Nature. 2013;498:380&#x2013;384. doi: 10.1038/nature12306.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature12306</ArticleId><ArticleId IdType="pmc">PMC4143541</ArticleId><ArticleId IdType="pubmed">23722158</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao P, et al. Cyclic [G(2&#x2032;,5&#x2032;)pA(3&#x2032;,5&#x2032;)p] is the metazoan second messenger produced by DNA-activated cyclic GMP-AMP synthase. Cell. 2013;153:1094&#x2013;1107. doi: 10.1016/j.cell.2013.04.046.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2013.04.046</ArticleId><ArticleId IdType="pmc">PMC4382009</ArticleId><ArticleId IdType="pubmed">23647843</ArticleId></ArticleIdList></Reference><Reference><Citation>Diner EJ, et al. The innate immune DNA sensor cGAS produces a noncanonical cyclic dinucleotide that activates human STING. Cell Rep. 2013;3:1355&#x2013;1361. doi: 10.1016/j.celrep.2013.05.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2013.05.009</ArticleId><ArticleId IdType="pmc">PMC3706192</ArticleId><ArticleId IdType="pubmed">23707065</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X, et al. Cyclic GMP-AMP containing mixed phosphodiester linkages is an endogenous high-affinity ligand for STING. Mol. Cell. 2013;51:226&#x2013;235. doi: 10.1016/j.molcel.2013.05.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2013.05.022</ArticleId><ArticleId IdType="pmc">PMC3808999</ArticleId><ArticleId IdType="pubmed">23747010</ArticleId></ArticleIdList></Reference><Reference><Citation>Prinz M, Masuda T, Wheeler MA, Quintana FJ. Microglia and central nervous system-associated macrophages-from origin to disease modulation. Annu. Rev. Immunol. 2021;39:251&#x2013;277. doi: 10.1146/annurev-immunol-093019-110159.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-immunol-093019-110159</ArticleId><ArticleId IdType="pmc">PMC8085109</ArticleId><ArticleId IdType="pubmed">33556248</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu S, et al. Phosphorylation of innate immune adaptor proteins MAVS, STING, and TRIF induces IRF3 activation. Science. 2015;347:aaa2630. doi: 10.1126/science.aaa2630.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaa2630</ArticleId><ArticleId IdType="pubmed">25636800</ArticleId></ArticleIdList></Reference><Reference><Citation>West AP, et al. Mitochondrial DNA stress primes the antiviral innate immune response. Nature. 2015;520:553&#x2013;557. doi: 10.1038/nature14156.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature14156</ArticleId><ArticleId IdType="pmc">PMC4409480</ArticleId><ArticleId IdType="pubmed">25642965</ArticleId></ArticleIdList></Reference><Reference><Citation>Lima T, Li TY, Mottis A, Auwerx J. Pleiotropic effects of mitochondria in aging. Nat. Aging. 2022;2:199&#x2013;213. doi: 10.1038/s43587-022-00191-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s43587-022-00191-2</ArticleId><ArticleId IdType="pubmed">37118378</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J, et al. VDAC oligomers form mitochondrial pores to release mtDNA fragments and promote lupus-like disease. Science. 2019;366:1531&#x2013;1536. doi: 10.1126/science.aav4011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aav4011</ArticleId><ArticleId IdType="pmc">PMC8325171</ArticleId><ArticleId IdType="pubmed">31857488</ArticleId></ArticleIdList></Reference><Reference><Citation>Labzin LI, Heneka MT, Latz E. Innate immunity and neurodegeneration. Annu. Rev. Med. 2018;69:437&#x2013;449. doi: 10.1146/annurev-med-050715-104343.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-med-050715-104343</ArticleId><ArticleId IdType="pubmed">29106805</ArticleId></ArticleIdList></Reference><Reference><Citation>Pathare, G. R. et al. Structural mechanism of cGAS inhibition by the nucleosome. Nature587, 668&#x2013;672 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32911482</ArticleId></ArticleIdList></Reference><Reference><Citation>Michalski, S. et al. Structural basis for sequestration and autoinhibition of cGAS by chromatin. Nature587, 678&#x2013;682 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32911480</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao, B. et al. The molecular basis of tight nuclear tethering and inactivation of cGAS. Nature587, 673&#x2013;677 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7704945</ArticleId><ArticleId IdType="pubmed">32911481</ArticleId></ArticleIdList></Reference><Reference><Citation>Kujirai, T. et al. Structural basis for the inhibition of cGAS by nucleosomes. Science370, 455&#x2013;458 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7584773</ArticleId><ArticleId IdType="pubmed">32912999</ArticleId></ArticleIdList></Reference><Reference><Citation>Boyer, J. A. et al. Structural basis of nucleosome-dependent cGAS inhibition. Science370, 450&#x2013;454 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8189757</ArticleId><ArticleId IdType="pubmed">32913000</ArticleId></ArticleIdList></Reference><Reference><Citation>Volkman, H. E., Cambier, S., Gray, E. E. &amp; Stetson, D. B. Tight nuclear tethering of cGAS is essential for preventing autoreactivity. eLife8, e47491 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6927687</ArticleId><ArticleId IdType="pubmed">31808743</ArticleId></ArticleIdList></Reference><Reference><Citation>Keren-Shaul H, et al. A unique microglia type associated with restricting development of Alzheimer&#x2019;s disease. Cell. 2017;169:1276&#x2013;1290. doi: 10.1016/j.cell.2017.05.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2017.05.018</ArticleId><ArticleId IdType="pubmed">28602351</ArticleId></ArticleIdList></Reference><Reference><Citation>Friedman BA, et al. Diverse brain myeloid expression profiles reveal distinct microglial activation states and aspects of Alzheimer&#x2019;s disease not evident in mouse models. Cell Rep. 2018;22:832&#x2013;847. doi: 10.1016/j.celrep.2017.12.066.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2017.12.066</ArticleId><ArticleId IdType="pubmed">29346778</ArticleId></ArticleIdList></Reference><Reference><Citation>Sala Frigerio C, et al. The major risk factors for Alzheimer&#x2019;s disease: age, sex, and genes modulate the microglia response to A&#x3b2; plaques. Cell Rep. 2019;27:1293&#x2013;1306. doi: 10.1016/j.celrep.2019.03.099.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2019.03.099</ArticleId><ArticleId IdType="pmc">PMC7340153</ArticleId><ArticleId IdType="pubmed">31018141</ArticleId></ArticleIdList></Reference><Reference><Citation>Masuda T, Sankowski R, Staszewski O, Prinz M. Microglia heterogeneity in the single-cell era. Cell Rep. 2020;30:1271&#x2013;1281. doi: 10.1016/j.celrep.2020.01.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2020.01.010</ArticleId><ArticleId IdType="pubmed">32023447</ArticleId></ArticleIdList></Reference><Reference><Citation>Dulken BW, et al. Single-cell analysis reveals T cell infiltration in old neurogenic niches. Nature. 2019;571:205&#x2013;210. doi: 10.1038/s41586-019-1362-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-019-1362-5</ArticleId><ArticleId IdType="pmc">PMC7111535</ArticleId><ArticleId IdType="pubmed">31270459</ArticleId></ArticleIdList></Reference><Reference><Citation>Ximerakis M, et al. Single-cell transcriptomic profiling of the aging mouse brain. Nat. Neurosci. 2019;22:1696&#x2013;1708. doi: 10.1038/s41593-019-0491-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-019-0491-3</ArticleId><ArticleId IdType="pubmed">31551601</ArticleId></ArticleIdList></Reference><Reference><Citation>Benayoun BA, et al. Remodeling of epigenome and transcriptome landscapes with aging in mice reveals widespread induction of inflammatory responses. Genome Res. 2019;29:697&#x2013;709. doi: 10.1101/gr.240093.118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gr.240093.118</ArticleId><ArticleId IdType="pmc">PMC6442391</ArticleId><ArticleId IdType="pubmed">30858345</ArticleId></ArticleIdList></Reference><Reference><Citation>Shavlakadze T, et al. Age-related gene expression signature in rats demonstrate early, late, and linear transcriptional changes from multiple tissues. Cell Rep. 2019;28:3263&#x2013;3273. doi: 10.1016/j.celrep.2019.08.043.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2019.08.043</ArticleId><ArticleId IdType="pubmed">31533046</ArticleId></ArticleIdList></Reference><Reference><Citation>Hammond TR, et al. Single-cell RNA sequencing of microglia throughout the mouse lifespan and in the injured brain reveals complex cell-state changes. Immunity. 2019;50:253&#x2013;271. doi: 10.1016/j.immuni.2018.11.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2018.11.004</ArticleId><ArticleId IdType="pmc">PMC6655561</ArticleId><ArticleId IdType="pubmed">30471926</ArticleId></ArticleIdList></Reference><Reference><Citation>Olah M, et al. A transcriptomic atlas of aged human microglia. Nat. Commun. 2018;9:539. doi: 10.1038/s41467-018-02926-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-018-02926-5</ArticleId><ArticleId IdType="pmc">PMC5803269</ArticleId><ArticleId IdType="pubmed">29416036</ArticleId></ArticleIdList></Reference><Reference><Citation>Grabert K, et al. Microglial brain region-dependent diversity and selective regional sensitivities to aging. Nat. Neurosci. 2016;19:504&#x2013;516. doi: 10.1038/nn.4222.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.4222</ArticleId><ArticleId IdType="pmc">PMC4768346</ArticleId><ArticleId IdType="pubmed">26780511</ArticleId></ArticleIdList></Reference><Reference><Citation>Deczkowska A, et al. Mef2C restrains microglial inflammatory response and is lost in brain ageing in an IFN-I-dependent manner. Nat. Commun. 2017;8:717. doi: 10.1038/s41467-017-00769-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-017-00769-0</ArticleId><ArticleId IdType="pmc">PMC5620041</ArticleId><ArticleId IdType="pubmed">28959042</ArticleId></ArticleIdList></Reference><Reference><Citation>Holtman IR, et al. Induction of a common microglia gene expression signature by aging and neurodegenerative conditions: a co-expression meta-analysis. Acta Neuropathol. Commun. 2015;3:31. doi: 10.1186/s40478-015-0203-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-015-0203-5</ArticleId><ArticleId IdType="pmc">PMC4489356</ArticleId><ArticleId IdType="pubmed">26001565</ArticleId></ArticleIdList></Reference><Reference><Citation>Krasemann S, et al. The TREM2-APOE pathway drives the transcriptional phenotype of dysfunctional microglia in neurodegenerative diseases. Immunity. 2017;47:566&#x2013;581. doi: 10.1016/j.immuni.2017.08.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2017.08.008</ArticleId><ArticleId IdType="pmc">PMC5719893</ArticleId><ArticleId IdType="pubmed">28930663</ArticleId></ArticleIdList></Reference><Reference><Citation>De Cecco M, et al. L1 drives IFN in senescent cells and promotes age-associated inflammation. Nature. 2019;566:73&#x2013;78. doi: 10.1038/s41586-018-0784-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-018-0784-9</ArticleId><ArticleId IdType="pmc">PMC6519963</ArticleId><ArticleId IdType="pubmed">30728521</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie, X. et al. Activation of innate immune cGAS-STING pathway contributes to Alzheimer&#x2019;s pathogenesis in 5&#xd7;FAD mice. Nat. Aging3, 202&#x2013;212 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">37118112</ArticleId></ArticleIdList></Reference><Reference><Citation>Sliter, D. A. et al. Parkin and PINK1 mitigate STING-induced inflammation. Nature561, 258&#x2013;262 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7362342</ArticleId><ArticleId IdType="pubmed">30135585</ArticleId></ArticleIdList></Reference><Reference><Citation>Hinkle JT, et al. STING mediates neurodegeneration and neuroinflammation in nigrostriatal &#x3b1;-synucleinopathy. Proc. Natl Acad. Sci. USA. 2022;119:e2118819119. doi: 10.1073/pnas.2118819119.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2118819119</ArticleId><ArticleId IdType="pmc">PMC9169780</ArticleId><ArticleId IdType="pubmed">35394877</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu, C. H. et al. TDP-43 triggers mitochondrial DNA release via mPTP to activate cGAS/STING in ALS. Cell183, 636&#x2013;649.e18 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7599077</ArticleId><ArticleId IdType="pubmed">33031745</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu, T.-T. et al. Tonic prime-boost of STING signalling mediates Niemann&#x2013;Pick disease type C. Nature596, 570&#x2013;575 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8859990</ArticleId><ArticleId IdType="pubmed">34290407</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwabenland M, et al. Deep spatial profiling of human COVID-19 brains reveals neuroinflammation with distinct microanatomical microglia-T-cell interactions. Immunity. 2021;54:1594&#x2013;1610. doi: 10.1016/j.immuni.2021.06.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2021.06.002</ArticleId><ArticleId IdType="pmc">PMC8188302</ArticleId><ArticleId IdType="pubmed">34174183</ArticleId></ArticleIdList></Reference><Reference><Citation>Hao Y, et al. Integrated analysis of multimodal single-cell data. Cell. 2021;184:3573&#x2013;3587. doi: 10.1016/j.cell.2021.04.048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2021.04.048</ArticleId><ArticleId IdType="pmc">PMC8238499</ArticleId><ArticleId IdType="pubmed">34062119</ArticleId></ArticleIdList></Reference><Reference><Citation>Stuart T, et al. Comprehensive integration of single-cell data. Cell. 2019;177:1888&#x2013;1902. doi: 10.1016/j.cell.2019.05.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2019.05.031</ArticleId><ArticleId IdType="pmc">PMC6687398</ArticleId><ArticleId IdType="pubmed">31178118</ArticleId></ArticleIdList></Reference><Reference><Citation>Choudhary S, Satija R. Comparison and evaluation of statistical error models for scRNA-seq. Genome Biol. 2022;23:27. doi: 10.1186/s13059-021-02584-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13059-021-02584-9</ArticleId><ArticleId IdType="pmc">PMC8764781</ArticleId><ArticleId IdType="pubmed">35042561</ArticleId></ArticleIdList></Reference><Reference><Citation>Tirosh I, et al. Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq. Science. 2016;352:189&#x2013;196. doi: 10.1126/science.aad0501.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aad0501</ArticleId><ArticleId IdType="pmc">PMC4944528</ArticleId><ArticleId IdType="pubmed">27124452</ArticleId></ArticleIdList></Reference><Reference><Citation>Finak G, et al. MAST: a flexible statistical framework for assessing transcriptional changes and characterizing heterogeneity in single-cell RNA sequencing data. Genome Biol. 2015;16:278. doi: 10.1186/s13059-015-0844-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13059-015-0844-5</ArticleId><ArticleId IdType="pmc">PMC4676162</ArticleId><ArticleId IdType="pubmed">26653891</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37532939</PMID><DateCompleted><Year>2023</Year><Month>08</Month><Day>26</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>30</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1476-4687</ISSN><JournalIssue CitedMedium="Internet"><Volume>620</Volume><Issue>7975</Issue><PubDate><Year>2023</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Nature</Title><ISOAbbreviation>Nature</ISOAbbreviation></Journal><ArticleTitle>TDP-43 forms amyloid filaments with a distinct fold in type A FTLD-TDP.</ArticleTitle><Pagination><StartPage>898</StartPage><EndPage>903</EndPage><MedlinePgn>898-903</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41586-023-06405-w</ELocationID><Abstract><AbstractText>The abnormal assembly of TAR DNA-binding protein 43 (TDP-43) in neuronal and glial cells characterizes nearly all cases of amyotrophic lateral sclerosis (ALS) and around half of cases of frontotemporal lobar degeneration (FTLD)<sup>1,2</sup>. A causal role for TDP-43 assembly in neurodegeneration is evidenced by dominantly inherited missense mutations in TARDBP, the gene encoding TDP-43, that promote assembly and give rise to ALS and FTLD<sup>3-7</sup>. At least four types (A-D) of FTLD with TDP-43 pathology (FTLD-TDP) are defined by distinct brain distributions of assembled TDP-43 and are associated with different clinical presentations of frontotemporal dementia<sup>8</sup>. We previously showed, using cryo-electron&#xa0;microscopy, that TDP-43 assembles into amyloid filaments in ALS and type B FTLD-TDP<sup>9</sup>. However, the structures of assembled TDP-43 in FTLD without ALS remained unknown. Here we report the cryo-electron microscopy structures of assembled TDP-43 from the brains of three individuals with the most common type of FTLD-TDP, type A. TDP-43 formed amyloid filaments with a new fold that was the same across individuals, indicating that this fold may characterize type A FTLD-TDP. The fold resembles a chevron badge and is unlike the double-spiral-shaped fold of ALS and type B FTLD-TDP, establishing that distinct filament folds of TDP-43 characterize different neurodegenerative conditions. The structures, in combination with mass spectrometry, led to the identification of two new post-translational modifications of assembled TDP-43, citrullination and monomethylation of R293, and indicate that they may facilitate filament formation and observed structural variation in individual filaments. The structures of TDP-43 filaments from type A FTLD-TDP will guide mechanistic studies of TDP-43 assembly, as well as the development of diagnostic and therapeutic compounds for TDP-43 proteinopathies.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Arseni</LastName><ForeName>Diana</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0001-7585-288X</Identifier><AffiliationInfo><Affiliation>MRC Laboratory of Molecular Biology, Cambridge, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Renren</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>MRC Laboratory of Molecular Biology, Cambridge, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Murzin</LastName><ForeName>Alexey G</ForeName><Initials>AG</Initials><AffiliationInfo><Affiliation>MRC Laboratory of Molecular Biology, Cambridge, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peak-Chew</LastName><ForeName>Sew Y</ForeName><Initials>SY</Initials><Identifier Source="ORCID">0000-0002-7602-6384</Identifier><AffiliationInfo><Affiliation>MRC Laboratory of Molecular Biology, Cambridge, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garringer</LastName><ForeName>Holly J</ForeName><Initials>HJ</Initials><Identifier Source="ORCID">0000-0002-1899-7676</Identifier><AffiliationInfo><Affiliation>Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Newell</LastName><ForeName>Kathy L</ForeName><Initials>KL</Initials><AffiliationInfo><Affiliation>Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kametani</LastName><ForeName>Fuyuki</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0001-9125-7001</Identifier><AffiliationInfo><Affiliation>Department of Brain and Neurosciences, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Robinson</LastName><ForeName>Andrew C</ForeName><Initials>AC</Initials><Identifier Source="ORCID">0000-0003-2208-7728</Identifier><AffiliationInfo><Affiliation>Division of Neuroscience, Faculty of Biology, Medicine and Health, School of Biological Sciences, University of Manchester, Salford Royal Hospital, Salford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vidal</LastName><ForeName>Ruben</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ghetti</LastName><ForeName>Bernardino</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0002-1842-8019</Identifier><AffiliationInfo><Affiliation>Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hasegawa</LastName><ForeName>Masato</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-7415-8159</Identifier><AffiliationInfo><Affiliation>Department of Brain and Neurosciences, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ryskeldi-Falcon</LastName><ForeName>Benjamin</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0002-8176-2618</Identifier><AffiliationInfo><Affiliation>MRC Laboratory of Molecular Biology, Cambridge, UK. bfalcon@mrc-lmb.cam.ac.uk.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>MC_UP_1201/25</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>P30 AG010133</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>RF1 AG071177</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AG072976</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 NS110437</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG071177</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>08</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nature</MedlineTA><NlmUniqueID>0410462</NlmUniqueID><ISSNLinking>0028-0836</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000598624">TARDBP protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Nat Rev Neurol. 2023 Oct;19(10):574. doi: 10.1038/s41582-023-00870-7.</RefSource><PMID Version="1">37608120</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000076302" MajorTopicYN="N">Citrullination</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020285" MajorTopicYN="N">Cryoelectron Microscopy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004268" MajorTopicYN="Y">DNA-Binding Proteins</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000648" MajorTopicYN="N">ultrastructure</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057180" MajorTopicYN="Y">Frontotemporal Dementia</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057174" MajorTopicYN="Y">Frontotemporal Lobar Degeneration</DescriptorName><QualifierName UI="Q000145" MajorTopicYN="N">classification</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008745" MajorTopicYN="N">Methylation</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>2</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>7</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>25</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>8</Month><Day>3</Day><Hour>1</Hour><Minute>6</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>8</Month><Day>2</Day><Hour>23</Hour><Minute>30</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>8</Month><Day>2</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37532939</ArticleId><ArticleId IdType="pmc">PMC10447236</ArticleId><ArticleId IdType="doi">10.1038/s41586-023-06405-w</ArticleId><ArticleId IdType="pii">10.1038/s41586-023-06405-w</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Neumann M, et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006;314:130&#x2013;133. doi: 10.1126/science.1134108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1134108</ArticleId><ArticleId IdType="pubmed">17023659</ArticleId></ArticleIdList></Reference><Reference><Citation>Arai T, et al. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem. Biophys. Res. Commun. 2006;351:602&#x2013;611. doi: 10.1016/j.bbrc.2006.10.093.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2006.10.093</ArticleId><ArticleId IdType="pubmed">17084815</ArticleId></ArticleIdList></Reference><Reference><Citation>Sreedharan J, et al. TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science. 2008;319:1668&#x2013;1672. doi: 10.1126/science.1154584.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1154584</ArticleId><ArticleId IdType="pmc">PMC7116650</ArticleId><ArticleId IdType="pubmed">18309045</ArticleId></ArticleIdList></Reference><Reference><Citation>Kabashi E, et al. TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis. Nat. Genet. 2008;40:572&#x2013;574. doi: 10.1038/ng.132.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.132</ArticleId><ArticleId IdType="pubmed">18372902</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Deerlin VM, et al. TARDBP mutations in amyotrophic lateral sclerosis with TDP-43 neuropathology: a genetic and histopathological analysis. Lancet Neurol. 2008;7:409&#x2013;416. doi: 10.1016/S1474-4422(08)70071-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(08)70071-1</ArticleId><ArticleId IdType="pmc">PMC3546119</ArticleId><ArticleId IdType="pubmed">18396105</ArticleId></ArticleIdList></Reference><Reference><Citation>Borroni B, et al. Mutation within TARDBP leads to frontotemporal dementia without motor neuron disease. Hum. Mutat. 2009;30:E974&#x2013;E983. doi: 10.1002/humu.21100.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/humu.21100</ArticleId><ArticleId IdType="pubmed">19655382</ArticleId></ArticleIdList></Reference><Reference><Citation>Kovacs GG, et al. TARDBP variation associated with frontotemporal dementia, supranuclear gaze palsy, and chorea. Mov. Disord. 2009;24:1842&#x2013;1847. doi: 10.1002/mds.22697.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.22697</ArticleId><ArticleId IdType="pubmed">19609911</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie IRA, et al. A harmonized classification system for FTLD-TDP pathology. Acta Neuropathol. 2011;122:111&#x2013;113. doi: 10.1007/s00401-011-0845-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-011-0845-8</ArticleId><ArticleId IdType="pmc">PMC3285143</ArticleId><ArticleId IdType="pubmed">21644037</ArticleId></ArticleIdList></Reference><Reference><Citation>Arseni D, et al. Structure of pathological TDP-43 filaments from ALS with FTLD. Nature. 2022;601:139&#x2013;143. doi: 10.1038/s41586-021-04199-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-04199-3</ArticleId><ArticleId IdType="pmc">PMC7612255</ArticleId><ArticleId IdType="pubmed">34880495</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayala YM, et al. Structural determinants of the cellular localization and shuttling of TDP-43. J. Cell Sci. 2008;121:3778&#x2013;3785. doi: 10.1242/jcs.038950.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.038950</ArticleId><ArticleId IdType="pubmed">18957508</ArticleId></ArticleIdList></Reference><Reference><Citation>Afroz T, et al. Functional and dynamic polymerization of the ALS-linked protein TDP-43 antagonizes its pathologic aggregation. Nat. Commun. 2017;8:45. doi: 10.1038/s41467-017-00062-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-017-00062-0</ArticleId><ArticleId IdType="pmc">PMC5491494</ArticleId><ArticleId IdType="pubmed">28663553</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasegawa M, et al. Phosphorylated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Ann. Neurol. 2008;64:60&#x2013;70. doi: 10.1002/ana.21425.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.21425</ArticleId><ArticleId IdType="pmc">PMC2674108</ArticleId><ArticleId IdType="pubmed">18546284</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin W-L, Dickson DW. Ultrastructural localization of TDP-43 in filamentous neuronal inclusions in various neurodegenerative diseases. Acta Neuropathol. 2008;116:205&#x2013;213. doi: 10.1007/s00401-008-0408-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-008-0408-9</ArticleId><ArticleId IdType="pmc">PMC2706695</ArticleId><ArticleId IdType="pubmed">18607609</ArticleId></ArticleIdList></Reference><Reference><Citation>Mori F, et al. Maturation process of TDP-43-positive neuronal cytoplasmic inclusions in amyotrophic lateral sclerosis with and without dementia. Acta Neuropathol. 2008;116:193&#x2013;203. doi: 10.1007/s00401-008-0396-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-008-0396-9</ArticleId><ArticleId IdType="pubmed">18560845</ArticleId></ArticleIdList></Reference><Reference><Citation>Thorpe JR, Tang H, Atherton J, Cairns NJ. Fine structural analysis of the neuronal inclusions of frontotemporal lobar degeneration with TDP-43 proteinopathy. J. Neural Transm. 2008;115:1661&#x2013;1671. doi: 10.1007/s00702-008-0137-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00702-008-0137-1</ArticleId><ArticleId IdType="pmc">PMC2789307</ArticleId><ArticleId IdType="pubmed">18974920</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishihira Y, et al. Sporadic amyotrophic lateral sclerosis: two pathological patterns shown by analysis of distribution of TDP-43-immunoreactive neuronal and glial cytoplasmic inclusions. Acta Neuropathol. 2008;116:169&#x2013;182. doi: 10.1007/s00401-008-0385-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-008-0385-z</ArticleId><ArticleId IdType="pubmed">18481073</ArticleId></ArticleIdList></Reference><Reference><Citation>Nonaka T, et al. Prion-like properties of pathological TDP-43 aggregates from diseased brains. Cell Rep. 2013;4:124&#x2013;134. doi: 10.1016/j.celrep.2013.06.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2013.06.007</ArticleId><ArticleId IdType="pubmed">23831027</ArticleId></ArticleIdList></Reference><Reference><Citation>Cracco L, et al. Distinguishing post-translational modifications in dominantly inherited frontotemporal dementias: FTLD-TDP type A (GRN) vs type B (C9orf72) Neuropathol. Appl. Neurobiol. 2022;48:e12836. doi: 10.1111/nan.12836.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nan.12836</ArticleId><ArticleId IdType="pmc">PMC9452479</ArticleId><ArticleId IdType="pubmed">35836354</ArticleId></ArticleIdList></Reference><Reference><Citation>Tarutani A, et al. Ultrastructural and biochemical classification of pathogenic tau, &#x3b1;-synuclein and TDP-43. Acta Neuropathol. 2022;143:613&#x2013;640. doi: 10.1007/s00401-022-02426-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-022-02426-3</ArticleId><ArticleId IdType="pmc">PMC9107452</ArticleId><ArticleId IdType="pubmed">35513543</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson JL, et al. TDP-43 skeins show properties of amyloid in a subset of ALS cases. Acta Neuropathol. 2013;125:121&#x2013;131. doi: 10.1007/s00401-012-1055-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-012-1055-8</ArticleId><ArticleId IdType="pmc">PMC3536927</ArticleId><ArticleId IdType="pubmed">23124365</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang YX, et al. Amyloid fibrils in FTLD-TDP are composed of TMEM106B and not TDP-43. Nature. 2022;605:304&#x2013;309. doi: 10.1038/s41586-022-04670-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04670-9</ArticleId><ArticleId IdType="pmc">PMC9844993</ArticleId><ArticleId IdType="pubmed">35344984</ArticleId></ArticleIdList></Reference><Reference><Citation>Schweighauser M, et al. Age-dependent formation of TMEM106B amyloid filaments in human brains. Nature. 2022;605:310&#x2013;314. doi: 10.1038/s41586-022-04650-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04650-z</ArticleId><ArticleId IdType="pmc">PMC9095482</ArticleId><ArticleId IdType="pubmed">35344985</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang A, et al. Homotypic fibrillization of TMEM106B across diverse neurodegenerative diseases. Cell. 2022;185:1346&#x2013;1355.e15. doi: 10.1016/j.cell.2022.02.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.02.026</ArticleId><ArticleId IdType="pmc">PMC9018563</ArticleId><ArticleId IdType="pubmed">35247328</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan Y, et al. Generic amyloid fibrillation of TMEM106B in patient with Parkinson&#x2019;s disease dementia and normal elders. Cell Res. 2022;32:585&#x2013;588. doi: 10.1038/s41422-022-00665-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41422-022-00665-3</ArticleId><ArticleId IdType="pmc">PMC9160068</ArticleId><ArticleId IdType="pubmed">35477998</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoq MdR, et al. Cross-&#x3b2; helical filaments of tau and TMEM106B in gray and white matter of multiple system tauopathy with presenile dementia. Acta Neuropathol. 2023;145:707&#x2013;710. doi: 10.1007/s00401-023-02563-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-023-02563-3</ArticleId><ArticleId IdType="pmc">PMC10119215</ArticleId><ArticleId IdType="pubmed">36952000</ArticleId></ArticleIdList></Reference><Reference><Citation>Baker M, et al. Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. Nature. 2006;442:916&#x2013;919. doi: 10.1038/nature05016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature05016</ArticleId><ArticleId IdType="pubmed">16862116</ArticleId></ArticleIdList></Reference><Reference><Citation>Cruts M, et al. Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21. Nature. 2006;442:920&#x2013;924. doi: 10.1038/nature05017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature05017</ArticleId><ArticleId IdType="pubmed">16862115</ArticleId></ArticleIdList></Reference><Reference><Citation>Perneel J, et al. Accumulation of TMEM106B C-terminal fragments in neurodegenerative disease and aging. Acta Neuropathol. 2022;145:285&#x2013;302. doi: 10.1007/s00401-022-02531-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-022-02531-3</ArticleId><ArticleId IdType="pubmed">36527486</ArticleId></ArticleIdList></Reference><Reference><Citation>Vicente,&#xa0; C. T. et al. C-terminal TMEM106B fragments in human brain correlate with disease-associated TMEM106B haplotypes. Brain&#xa0;10.1093/brain/awad133 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10545506</ArticleId><ArticleId IdType="pubmed">37100087</ArticleId></ArticleIdList></Reference><Reference><Citation>Kametani F, et al. Mass spectrometric analysis of accumulated TDP-43 in amyotrophic lateral sclerosis brains. Sci. Rep. 2016;6:23281. doi: 10.1038/srep23281.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep23281</ArticleId><ArticleId IdType="pmc">PMC4793195</ArticleId><ArticleId IdType="pubmed">26980269</ArticleId></ArticleIdList></Reference><Reference><Citation>Ulamec SM, Brockwell DJ, Radford SE. Looking beyond the core: the role of flanking regions in the aggregation of amyloidogenic peptides and proteins. Front. Neurosci. 2020;14:611285. doi: 10.3389/fnins.2020.611285.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2020.611285</ArticleId><ArticleId IdType="pmc">PMC7736610</ArticleId><ArticleId IdType="pubmed">33335475</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y, et al. Structures of &#x3b1;-synuclein filaments from human brains with Lewy pathology. Nature. 2022;610:791&#x2013;795. doi: 10.1038/s41586-022-05319-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-05319-3</ArticleId><ArticleId IdType="pmc">PMC7613749</ArticleId><ArticleId IdType="pubmed">36108674</ArticleId></ArticleIdList></Reference><Reference><Citation>Falcon B, et al. Novel tau filament fold in chronic traumatic encephalopathy encloses hydrophobic molecules. Nature. 2019;568:420&#x2013;423. doi: 10.1038/s41586-019-1026-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-019-1026-5</ArticleId><ArticleId IdType="pmc">PMC6472968</ArticleId><ArticleId IdType="pubmed">30894745</ArticleId></ArticleIdList></Reference><Reference><Citation>Schweighauser M, et al. Structures of &#x3b1;-synuclein filaments from multiple system atrophy. Nature. 2020;585:464&#x2013;469. doi: 10.1038/s41586-020-2317-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2317-6</ArticleId><ArticleId IdType="pmc">PMC7116528</ArticleId><ArticleId IdType="pubmed">32461689</ArticleId></ArticleIdList></Reference><Reference><Citation>Radamaker L, et al. Cryo-EM reveals structural breaks in a patient-derived amyloid fibril from systemic AL amyloidosis. Nat. Commun. 2021;12:875. doi: 10.1038/s41467-021-21126-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-21126-2</ArticleId><ArticleId IdType="pmc">PMC7870857</ArticleId><ArticleId IdType="pubmed">33558536</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo A, et al. Immunoaffinity enrichment and mass spectrometry analysis of protein methylation. Mol. Cell. Proteomics. 2014;13:372&#x2013;387. doi: 10.1074/mcp.O113.027870.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/mcp.O113.027870</ArticleId><ArticleId IdType="pmc">PMC3879628</ArticleId><ArticleId IdType="pubmed">24129315</ArticleId></ArticleIdList></Reference><Reference><Citation>Aikio, M. et al. Opposing roles of p38&#x3b1;-mediated phosphorylation and arginine methylation in driving TDP-43 proteinopathy. Preprint at bioRxiv10.1101/2021.08.04.455154 (2021).</Citation></Reference><Reference><Citation>Blanc RS, Richard S. Arginine methylation: the coming of age. Mol. Cell. 2017;65:8&#x2013;24. doi: 10.1016/j.molcel.2016.11.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2016.11.003</ArticleId><ArticleId IdType="pubmed">28061334</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanikawa C, et al. Citrullination of RGG motifs in FET proteins by PAD4 regulates protein aggregation and ALS susceptibility. Cell Rep. 2018;22:1473&#x2013;1483. doi: 10.1016/j.celrep.2018.01.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2018.01.031</ArticleId><ArticleId IdType="pubmed">29425503</ArticleId></ArticleIdList></Reference><Reference><Citation>Mondal S, Thompson PR. Chemical biology of protein citrullination by the protein A arginine deiminases. Curr. Opin. Chem. Biol. 2021;63:19&#x2013;27. doi: 10.1016/j.cbpa.2021.01.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cbpa.2021.01.010</ArticleId><ArticleId IdType="pmc">PMC8384633</ArticleId><ArticleId IdType="pubmed">33676233</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi Y, et al. Structure-based classification of tauopathies. Nature. 2021;598:359&#x2013;363. doi: 10.1038/s41586-021-03911-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03911-7</ArticleId><ArticleId IdType="pmc">PMC7611841</ArticleId><ArticleId IdType="pubmed">34588692</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsuji H, et al. Molecular analysis and biochemical classification of TDP-43 proteinopathy. Brain. 2012;135:3380&#x2013;3391. doi: 10.1093/brain/aws230.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/aws230</ArticleId><ArticleId IdType="pubmed">23035040</ArticleId></ArticleIdList></Reference><Reference><Citation>Kato M, et al. Cell-free formation of RNA granules: low complexity sequence domains form dynamic fibers within hydrogels. Cell. 2012;149:753&#x2013;767. doi: 10.1016/j.cell.2012.04.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2012.04.017</ArticleId><ArticleId IdType="pmc">PMC6347373</ArticleId><ArticleId IdType="pubmed">22579281</ArticleId></ArticleIdList></Reference><Reference><Citation>Conicella AE, Zerze GH, Mittal J, Fawzi NL. ALS mutations disrupt phase separation mediated by &#x3b1;-helical structure in the TDP-43 low-complexity C-terminal domain. Structure. 2016;24:1537&#x2013;1549. doi: 10.1016/j.str.2016.07.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.str.2016.07.007</ArticleId><ArticleId IdType="pmc">PMC5014597</ArticleId><ArticleId IdType="pubmed">27545621</ArticleId></ArticleIdList></Reference><Reference><Citation>Knight AC, et al. Head-to-head comparison of Tau-PET radioligands for imaging TDP-43 in post-mortem ALS brain. Mol. Imaging Biol. 2023;25:513&#x2013;527. doi: 10.1007/s11307-022-01779-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11307-022-01779-1</ArticleId><ArticleId IdType="pubmed">36258099</ArticleId></ArticleIdList></Reference><Reference><Citation>Laferri&#xe8;re F, et al. TDP-43 extracted from frontotemporal lobar degeneration subject brains displays distinct aggregate assemblies and neurotoxic effects reflecting disease progression rates. Nat. Neurosci. 2019;22:65. doi: 10.1038/s41593-018-0294-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-018-0294-y</ArticleId><ArticleId IdType="pubmed">30559480</ArticleId></ArticleIdList></Reference><Reference><Citation>De Rossi P, et al. FTLD-TDP assemblies seed neoaggregates with subtype-specific features via a prion-like cascade. EMBO Rep. 2021;22:e53877. doi: 10.15252/embr.202153877.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embr.202153877</ArticleId><ArticleId IdType="pmc">PMC8647015</ArticleId><ArticleId IdType="pubmed">34806807</ArticleId></ArticleIdList></Reference><Reference><Citation>Porta S, et al. Patient-derived frontotemporal lobar degeneration brain extracts induce formation and spreading of TDP-43 pathology in vivo. Nat. Commun. 2018;9:4220. doi: 10.1038/s41467-018-06548-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-018-06548-9</ArticleId><ArticleId IdType="pmc">PMC6181940</ArticleId><ArticleId IdType="pubmed">30310141</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao Q, Boyer DR, Sawaya MR, Ge P, Eisenberg DS. Cryo-EM structures of four polymorphic TDP-43 amyloid cores. Nat. Struct. Mol. Biol. 2019;26:619&#x2013;627. doi: 10.1038/s41594-019-0248-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41594-019-0248-4</ArticleId><ArticleId IdType="pmc">PMC7047951</ArticleId><ArticleId IdType="pubmed">31235914</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Q, Babinchak WM, Surewicz WK. Cryo-EM structure of amyloid fibrils formed by the entire low complexity domain of TDP-43. Nat. Commun. 2021;12:1620. doi: 10.1038/s41467-021-21912-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-21912-y</ArticleId><ArticleId IdType="pmc">PMC7955110</ArticleId><ArticleId IdType="pubmed">33712624</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar ST, et al. Seeding the aggregation of TDP-43 requires post-fibrillization proteolytic cleavage. Nat. Neurosci. 2023;26:983&#x2013;996. doi: 10.1038/s41593-023-01341-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-023-01341-4</ArticleId><ArticleId IdType="pmc">PMC10244175</ArticleId><ArticleId IdType="pubmed">37248338</ArticleId></ArticleIdList></Reference><Reference><Citation>Huey ED, et al. Characteristics of frontotemporal dementia patients with a Progranulin mutation. Ann. Neurol. 2006;60:374&#x2013;380. doi: 10.1002/ana.20969.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.20969</ArticleId><ArticleId IdType="pmc">PMC2987739</ArticleId><ArticleId IdType="pubmed">16983677</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton AE, et al. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron. 2011;72:257&#x2013;268. doi: 10.1016/j.neuron.2011.09.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.09.010</ArticleId><ArticleId IdType="pmc">PMC3200438</ArticleId><ArticleId IdType="pubmed">21944779</ArticleId></ArticleIdList></Reference><Reference><Citation>Spina S, et al. Clinicopathologic features of frontotemporal dementia with Progranulin sequence variation. Neurology. 2007;68:820&#x2013;827. doi: 10.1212/01.wnl.0000254460.31273.2d.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000254460.31273.2d</ArticleId><ArticleId IdType="pubmed">17202431</ArticleId></ArticleIdList></Reference><Reference><Citation>Zivanov J, Nakane T, Scheres SHW. A Bayesian approach to beam-induced motion correction in cryo-EM single-particle analysis. IUCrJ. 2019;6:5&#x2013;17. doi: 10.1107/S205225251801463X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1107/S205225251801463X</ArticleId><ArticleId IdType="pmc">PMC6327179</ArticleId><ArticleId IdType="pubmed">30713699</ArticleId></ArticleIdList></Reference><Reference><Citation>Rohou A, Grigorieff N. CTFFIND4: fast and accurate defocus estimation from electron micrographs. J. Struct. Biol. 2015;192:216&#x2013;221. doi: 10.1016/j.jsb.2015.08.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jsb.2015.08.008</ArticleId><ArticleId IdType="pmc">PMC6760662</ArticleId><ArticleId IdType="pubmed">26278980</ArticleId></ArticleIdList></Reference><Reference><Citation>He S, Scheres SHW. Helical reconstruction in RELION. J. Struct. Biol. 2017;198:163&#x2013;176. doi: 10.1016/j.jsb.2017.02.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jsb.2017.02.003</ArticleId><ArticleId IdType="pmc">PMC5479445</ArticleId><ArticleId IdType="pubmed">28193500</ArticleId></ArticleIdList></Reference><Reference><Citation>Kimanius D, Dong L, Sharov G, Nakane T, Scheres SHW. New tools for automated cryo-EM single-particle analysis in RELION-4.0. Biochem. J. 2021;478:4169&#x2013;4185. doi: 10.1042/BCJ20210708.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BCJ20210708</ArticleId><ArticleId IdType="pmc">PMC8786306</ArticleId><ArticleId IdType="pubmed">34783343</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheres SHW. Amyloid structure determination in RELION -3.1. Acta Crystallogr. D Struct. Biol. 2020;76:94&#x2013;101. doi: 10.1107/S2059798319016577.</Citation><ArticleIdList><ArticleId IdType="doi">10.1107/S2059798319016577</ArticleId><ArticleId IdType="pmc">PMC7008511</ArticleId><ArticleId IdType="pubmed">32038040</ArticleId></ArticleIdList></Reference><Reference><Citation>Zivanov J, Nakane T, Scheres SHW. Estimation of high-order aberrations and anisotropic magnification from cryo-EM data sets in RELION-3.1. IUCrJ. 2020;7:253&#x2013;267. doi: 10.1107/S2052252520000081.</Citation><ArticleIdList><ArticleId IdType="doi">10.1107/S2052252520000081</ArticleId><ArticleId IdType="pmc">PMC7055373</ArticleId><ArticleId IdType="pubmed">32148853</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen S, et al. High-resolution noise substitution to measure overfitting and validate resolution in 3D structure determination by single particle electron cryomicroscopy. Ultramicroscopy. 2013;135:24&#x2013;35. doi: 10.1016/j.ultramic.2013.06.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ultramic.2013.06.004</ArticleId><ArticleId IdType="pmc">PMC3834153</ArticleId><ArticleId IdType="pubmed">23872039</ArticleId></ArticleIdList></Reference><Reference><Citation>Casa&#xf1;al A, Lohkamp B, Emsley P. Current developments in Coot for macromolecular model building of electron cryo-microscopy and crystallographic data. Protein Sci. 2020;29:1055&#x2013;1064. doi: 10.1002/pro.3791.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pro.3791</ArticleId><ArticleId IdType="pmc">PMC7096722</ArticleId><ArticleId IdType="pubmed">31730249</ArticleId></ArticleIdList></Reference><Reference><Citation>Croll TI. ISOLDE: a physically realistic environment for model building into low-resolution electron-density maps. Acta Crystallogr. D Struct. Biol. 2018;74:519&#x2013;530. doi: 10.1107/S2059798318002425.</Citation><ArticleIdList><ArticleId IdType="doi">10.1107/S2059798318002425</ArticleId><ArticleId IdType="pmc">PMC6096486</ArticleId><ArticleId IdType="pubmed">29872003</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown A, et al. Tools for macromolecular model building and refinement into electron cryo-microscopy reconstructions. Acta Crystallogr. D Struct. Biol. 2015;71:136&#x2013;153. doi: 10.1107/S1399004714021683.</Citation><ArticleIdList><ArticleId IdType="doi">10.1107/S1399004714021683</ArticleId><ArticleId IdType="pmc">PMC4304694</ArticleId><ArticleId IdType="pubmed">25615868</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamashita K, Palmer CM, Burnley T, Murshudov GN. Cryo-EM single-particle structure refinement and map calculation using Servalcat. Acta Crystallogr. D Struct. Biol. 2021;77:1282&#x2013;1291. doi: 10.1107/S2059798321009475.</Citation><ArticleIdList><ArticleId IdType="doi">10.1107/S2059798321009475</ArticleId><ArticleId IdType="pmc">PMC8489229</ArticleId><ArticleId IdType="pubmed">34605431</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams CJ, et al. MolProbity: more and better reference data for improved all-atom structure validation. Protein Sci. 2018;27:293&#x2013;315. doi: 10.1002/pro.3330.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pro.3330</ArticleId><ArticleId IdType="pmc">PMC5734394</ArticleId><ArticleId IdType="pubmed">29067766</ArticleId></ArticleIdList></Reference><Reference><Citation>Pettersen EF, et al. UCSF ChimeraX: structure visualization for researchers, educators, and developers. Protein Sci. 2021;30:70&#x2013;82. doi: 10.1002/pro.3943.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pro.3943</ArticleId><ArticleId IdType="pmc">PMC7737788</ArticleId><ArticleId IdType="pubmed">32881101</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37550416</PMID><DateCompleted><Year>2023</Year><Month>10</Month><Day>25</Day></DateCompleted><DateRevised><Year>2024</Year><Month>02</Month><Day>14</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1546-170X</ISSN><JournalIssue CitedMedium="Internet"><Volume>29</Volume><Issue>8</Issue><PubDate><Year>2023</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Nature medicine</Title><ISOAbbreviation>Nat Med</ISOAbbreviation></Journal><ArticleTitle>Cerebrospinal fluid proteomics define the natural history of autosomal dominant Alzheimer's disease.</ArticleTitle><Pagination><StartPage>1979</StartPage><EndPage>1988</EndPage><MedlinePgn>1979-1988</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41591-023-02476-4</ELocationID><Abstract><AbstractText>Alzheimer's disease (AD) pathology develops many years before the onset of cognitive symptoms. Two pathological processes-aggregation of the amyloid-&#x3b2; (A&#x3b2;) peptide into plaques and the microtubule protein tau into neurofibrillary tangles (NFTs)-are hallmarks of the disease. However, other pathological brain processes are thought to be key disease mediators of A&#x3b2; plaque and NFT pathology. How these additional pathologies evolve over the course of the disease is currently unknown. Here we show that proteomic measurements in autosomal dominant AD cerebrospinal fluid (CSF) linked to brain protein coexpression can be used to characterize the evolution of AD pathology over a timescale spanning six decades. SMOC1 and SPON1 proteins associated with A&#x3b2; plaques were elevated in AD CSF nearly 30 years before the onset of symptoms, followed by changes in synaptic proteins, metabolic proteins, axonal proteins, inflammatory proteins and finally decreases in neurosecretory proteins. The proteome discriminated mutation carriers from noncarriers before symptom onset as well or better than A&#x3b2; and tau measures. Our results highlight the multifaceted landscape of AD pathophysiology and its temporal evolution. Such knowledge will be critical for developing precision therapeutic interventions and biomarkers for AD beyond those associated with A&#x3b2; and tau.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Johnson</LastName><ForeName>Erik C B</ForeName><Initials>ECB</Initials><Identifier Source="ORCID">0000-0002-0604-2944</Identifier><AffiliationInfo><Affiliation>Goizueta Alzheimer's Disease Research Center, Emory University School of Medicine, Atlanta, GA, USA. erik.johnson@emory.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Emory University School of Medicine, Atlanta, GA, USA. erik.johnson@emory.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Bian</LastName><ForeName>Shijia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Biostatistics and Bioinformatics, Rollins School of Public Health, Emory University, Atlanta, GA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Haque</LastName><ForeName>Rafi U</ForeName><Initials>RU</Initials><AffiliationInfo><Affiliation>Goizueta Alzheimer's Disease Research Center, Emory University School of Medicine, Atlanta, GA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carter</LastName><ForeName>E Kathleen</ForeName><Initials>EK</Initials><Identifier Source="ORCID">0000-0002-5083-0614</Identifier><AffiliationInfo><Affiliation>Goizueta Alzheimer's Disease Research Center, Emory University School of Medicine, Atlanta, GA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biochemistry, Emory University School of Medicine, Atlanta, GA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Watson</LastName><ForeName>Caroline M</ForeName><Initials>CM</Initials><Identifier Source="ORCID">0000-0001-6574-0833</Identifier><AffiliationInfo><Affiliation>Goizueta Alzheimer's Disease Research Center, Emory University School of Medicine, Atlanta, GA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Emory University School of Medicine, Atlanta, GA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gordon</LastName><ForeName>Brian A</ForeName><Initials>BA</Initials><Identifier Source="ORCID">0000-0003-2109-2955</Identifier><AffiliationInfo><Affiliation>Mallinckrodt Institute of Radiology, Washington University in St Louis, St Louis, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ping</LastName><ForeName>Lingyan</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Goizueta Alzheimer's Disease Research Center, Emory University School of Medicine, Atlanta, GA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Emory University School of Medicine, Atlanta, GA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biochemistry, Emory University School of Medicine, Atlanta, GA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Duong</LastName><ForeName>Duc M</ForeName><Initials>DM</Initials><AffiliationInfo><Affiliation>Goizueta Alzheimer's Disease Research Center, Emory University School of Medicine, Atlanta, GA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biochemistry, Emory University School of Medicine, Atlanta, GA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Epstein</LastName><ForeName>Michael P</ForeName><Initials>MP</Initials><Identifier Source="ORCID">0000-0001-9647-9738</Identifier><AffiliationInfo><Affiliation>Department of Human Genetics, Emory University School of Medicine, Atlanta, GA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McDade</LastName><ForeName>Eric</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-6764-3866</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Washington University in St Louis, St Louis, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barth&#xe9;lemy</LastName><ForeName>Nicolas R</ForeName><Initials>NR</Initials><AffiliationInfo><Affiliation>Department of Neurology, Washington University in St Louis, St Louis, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Karch</LastName><ForeName>Celeste M</ForeName><Initials>CM</Initials><Identifier Source="ORCID">0000-0002-6854-5547</Identifier><AffiliationInfo><Affiliation>Department of Psychiatry, Washington University in St Louis, St Louis, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xiong</LastName><ForeName>Chengjie</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Neurology, Washington University in St Louis, St Louis, MO, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Biostatistics, Washington University in St Louis, St Louis, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cruchaga</LastName><ForeName>Carlos</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-0276-2899</Identifier><AffiliationInfo><Affiliation>Department of Psychiatry, Washington University in St Louis, St Louis, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perrin</LastName><ForeName>Richard J</ForeName><Initials>RJ</Initials><Identifier Source="ORCID">0000-0002-3443-7716</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Washington University in St Louis, St Louis, MO, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathology and Immunology, Washington University in St Louis, St Louis, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wingo</LastName><ForeName>Aliza P</ForeName><Initials>AP</Initials><Identifier Source="ORCID">0000-0002-6360-6726</Identifier><AffiliationInfo><Affiliation>Goizueta Alzheimer's Disease Research Center, Emory University School of Medicine, Atlanta, GA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychiatry, Emory University School of Medicine, Atlanta, GA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Mental Health, Atlanta VA Medical Center, Atlanta, GA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wingo</LastName><ForeName>Thomas S</ForeName><Initials>TS</Initials><Identifier Source="ORCID">0000-0002-7679-6282</Identifier><AffiliationInfo><Affiliation>Goizueta Alzheimer's Disease Research Center, Emory University School of Medicine, Atlanta, GA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Emory University School of Medicine, Atlanta, GA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Human Genetics, Emory University School of Medicine, Atlanta, GA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chhatwal</LastName><ForeName>Jasmeer P</ForeName><Initials>JP</Initials><Identifier Source="ORCID">0000-0002-7792-1698</Identifier><AffiliationInfo><Affiliation>Massachusetts General and Brigham &amp; Women's Hospitals, Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Day</LastName><ForeName>Gregory S</ForeName><Initials>GS</Initials><Identifier Source="ORCID">0000-0001-5133-5538</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Mayo Clinic, Jacksonville, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Noble</LastName><ForeName>James M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Department of Neurology, Taub Institute for Research on Alzheimer's Disease and the Aging Brain, and GH Sergievsky Center, Columbia University Irving Medical Center, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Berman</LastName><ForeName>Sarah B</ForeName><Initials>SB</Initials><AffiliationInfo><Affiliation>Departments of Neurology and Clinical and Translational Science, Pittsburgh Institute for Neurodegenerative Diseases, University of Pittsburgh, Pittsburgh, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martins</LastName><ForeName>Ralph</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Edith Cowan University, Perth, Western Australia, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Graff-Radford</LastName><ForeName>Neill R</ForeName><Initials>NR</Initials><AffiliationInfo><Affiliation>Department of Neurology, Mayo Clinic, Jacksonville, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schofield</LastName><ForeName>Peter R</ForeName><Initials>PR</Initials><Identifier Source="ORCID">0000-0003-2967-9662</Identifier><AffiliationInfo><Affiliation>Neuroscience Research Australia, Sydney, New South Wales, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Biomedical Sciences, University of New South Wales, Sydney, New South Wales, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ikeuchi</LastName><ForeName>Takeshi</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0001-8828-8085</Identifier><AffiliationInfo><Affiliation>Department of Molecular Genetics, Brain Research Institute, Niigata University, Niigata, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mori</LastName><ForeName>Hiroshi</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Osaka Metropolitan University Medical School, Nagaoka Sutoku University, Nagaoka, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Levin</LastName><ForeName>Johannes</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurology, Ludwig-Maximilians-Universit&#xe4;t M&#xfc;nchen, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Farlow</LastName><ForeName>Martin</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-7897-5471</Identifier><AffiliationInfo><Affiliation>Indiana University, Bloomington, IN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lah</LastName><ForeName>James J</ForeName><Initials>JJ</Initials><Identifier Source="ORCID">0000-0002-8810-620X</Identifier><AffiliationInfo><Affiliation>Goizueta Alzheimer's Disease Research Center, Emory University School of Medicine, Atlanta, GA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Emory University School of Medicine, Atlanta, GA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Haass</LastName><ForeName>Christian</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-4869-1627</Identifier><AffiliationInfo><Affiliation>German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Metabolic Biochemistry, Biomedical Center (BMC), Ludwig-Maximilians University, Munich, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jucker</LastName><ForeName>Mathias</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-9045-1072</Identifier><AffiliationInfo><Affiliation>Department of Cellular Neurology, Hertie Institute for Clinical Brain Research, University of T&#xfc;bingen, T&#xfc;bingen, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>German Center for Neurodegenerative Diseases (DZNE), T&#xfc;bingen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morris</LastName><ForeName>John C</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Department of Neurology, Washington University in St Louis, St Louis, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Benzinger</LastName><ForeName>Tammie L S</ForeName><Initials>TLS</Initials><Identifier Source="ORCID">0000-0002-8114-0552</Identifier><AffiliationInfo><Affiliation>Mallinckrodt Institute of Radiology, Washington University in St Louis, St Louis, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roberts</LastName><ForeName>Blaine R</ForeName><Initials>BR</Initials><Identifier Source="ORCID">0000-0001-5466-0053</Identifier><AffiliationInfo><Affiliation>Goizueta Alzheimer's Disease Research Center, Emory University School of Medicine, Atlanta, GA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biochemistry, Emory University School of Medicine, Atlanta, GA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bateman</LastName><ForeName>Randall J</ForeName><Initials>RJ</Initials><Identifier Source="ORCID">0000-0002-7729-1702</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Washington University in St Louis, St Louis, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fagan</LastName><ForeName>Anne M</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Department of Neurology, Washington University in St Louis, St Louis, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seyfried</LastName><ForeName>Nicholas T</ForeName><Initials>NT</Initials><Identifier Source="ORCID">0000-0002-4507-624X</Identifier><AffiliationInfo><Affiliation>Goizueta Alzheimer's Disease Research Center, Emory University School of Medicine, Atlanta, GA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Emory University School of Medicine, Atlanta, GA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biochemistry, Emory University School of Medicine, Atlanta, GA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Levey</LastName><ForeName>Allan I</ForeName><Initials>AI</Initials><Identifier Source="ORCID">0000-0002-3153-502X</Identifier><AffiliationInfo><Affiliation>Goizueta Alzheimer's Disease Research Center, Emory University School of Medicine, Atlanta, GA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Emory University School of Medicine, Atlanta, GA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>Dominantly Inherited Alzheimer Network</CollectiveName></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P30 AG066444</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AG066511</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG072120</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG056533</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P01 AG003991</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P01 AG026276</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U19 AG024904</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 AG061357</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UF1 AG032438</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>S10 OD025214</GrantID><Acronym>OD</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG075827</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U19 AG032438</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS092865</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>RF1 AG071170</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K08 AG068604</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>08</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Nat Med</MedlineTA><NlmUniqueID>9502015</NlmUniqueID><ISSNLinking>1078-8956</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C468135">SMOC1 protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName><QualifierName UI="Q000134" MajorTopicYN="N">cerebrospinal fluid</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D040901" MajorTopicYN="Y">Proteomics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017668" MajorTopicYN="N">Age of Onset</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>D.M.D., N.T.S. and A.I.L. are founders of EmTheraPro. T.S.W. is a co-founder of revXon. The other authors declare no competing interests.</CoiStatement><InvestigatorList><Investigator ValidYN="Y"><LastName>V&#xf6;glein</LastName><ForeName>Jonathan</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Allegri</LastName><ForeName>Ricardo</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mendez</LastName><ForeName>Patricio Chrem</ForeName><Initials>PC</Initials></Investigator><Investigator ValidYN="Y"><LastName>Surace</LastName><ForeName>Ezequiel</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Berman</LastName><ForeName>Sarah B</ForeName><Initials>SB</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ikonomovic</LastName><ForeName>Snezana</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nadkarni</LastName><ForeName>Neelesh</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lopera</LastName><ForeName>Francisco</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ramirez</LastName><ForeName>Laura</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Aguillon</LastName><ForeName>David</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Leon</LastName><ForeName>Yudy</ForeName><Initials>Y</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ramos</LastName><ForeName>Claudia</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Alzate</LastName><ForeName>Diana</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Baena</LastName><ForeName>Ana</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Londono</LastName><ForeName>Natalia</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Moreno</LastName><ForeName>Sonia</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Laske</LastName><ForeName>Christoph</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kuder-Buletta</LastName><ForeName>Elke</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Graber-Sultan</LastName><ForeName>Susanne</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Preische</LastName><ForeName>Oliver</ForeName><Initials>O</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hofmann</LastName><ForeName>Anna</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kasuga</LastName><ForeName>Kensaku</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Niimi</LastName><ForeName>Yoshiki</ForeName><Initials>Y</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ishii</LastName><ForeName>Kenji</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Senda</LastName><ForeName>Michio</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sanchez-Valle</LastName><ForeName>Raquel</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rosa-Neto</LastName><ForeName>Pedro</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fox</LastName><ForeName>Nick</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cash</LastName><ForeName>Dave</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lee</LastName><ForeName>Jae-Hong</ForeName><Initials>JH</Initials></Investigator><Investigator ValidYN="Y"><LastName>Roh</LastName><ForeName>Jee Hoon</ForeName><Initials>JH</Initials></Investigator><Investigator ValidYN="Y"><LastName>Riddle</LastName><ForeName>Meghan</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Menard</LastName><ForeName>William</ForeName><Initials>W</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bodge</LastName><ForeName>Courtney</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Surti</LastName><ForeName>Mustafa</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Takada</LastName><ForeName>Leonel Tadao</ForeName><Initials>LT</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sanchez-Gonzalez</LastName><ForeName>V J</ForeName><Initials>VJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Orozco-Barajas</LastName><ForeName>Maribel</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Goate</LastName><ForeName>Alison</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Renton</LastName><ForeName>Alan</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Esposito</LastName><ForeName>Bianca</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Marsh</LastName><ForeName>Jacob</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cruchaga</LastName><ForeName>Carlos</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fernandez</LastName><ForeName>Victoria</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jerome</LastName><ForeName>Gina</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Herries</LastName><ForeName>Elizabeth</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Llibre-Guerra</LastName><ForeName>Jorge</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Brooks</LastName><ForeName>William</ForeName><Initials>W</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bechara</LastName><ForeName>Jacob</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hassenstab</LastName><ForeName>Jason</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Franklin</LastName><ForeName>Erin</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chen</LastName><ForeName>Allison</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chen</LastName><ForeName>Charles</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Flores</LastName><ForeName>Shaney</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Friedrichsen</LastName><ForeName>Nelly</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hantler</LastName><ForeName>Nancy</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hornbeck</LastName><ForeName>Russ</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jarman</LastName><ForeName>Steve</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Keefe</LastName><ForeName>Sarah</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Koudelis</LastName><ForeName>Deborah</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Massoumzadeh</LastName><ForeName>Parinaz</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>McCullough</LastName><ForeName>Austin</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>McKay</LastName><ForeName>Nicole</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nicklaus</LastName><ForeName>Joyce</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pulizos</LastName><ForeName>Christine</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wang</LastName><ForeName>Qing</ForeName><Initials>Q</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mishall</LastName><ForeName>Sheetal</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sabaredzovic</LastName><ForeName>Edita</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Deng</LastName><ForeName>Emily</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Candela</LastName><ForeName>Madison</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Smith</LastName><ForeName>Hunter</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hobbs</LastName><ForeName>Diana</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Scott</LastName><ForeName>Jalen</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wang</LastName><ForeName>Peter</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Xu</LastName><ForeName>Xiong</ForeName><Initials>X</Initials></Investigator><Investigator ValidYN="Y"><LastName>Li</LastName><ForeName>Yan</ForeName><Initials>Y</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gremminger</LastName><ForeName>Emily</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ma</LastName><ForeName>Yinjiao</ForeName><Initials>Y</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bui</LastName><ForeName>Ryan</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lu</LastName><ForeName>Ruijin</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ortiz</LastName><ForeName>Ana Luisa Sosa</ForeName><Initials>ALS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Daniels</LastName><ForeName>Alisha</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Courtney</LastName><ForeName>Laura</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Supnet-Bell</LastName><ForeName>Charlene</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Xu</LastName><ForeName>Jinbin</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ringman</LastName><ForeName>John</ForeName><Initials>J</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>2</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>6</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>17</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>8</Month><Day>8</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>8</Month><Day>7</Day><Hour>23</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>8</Month><Day>7</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37550416</ArticleId><ArticleId IdType="pmc">PMC10427428</ArticleId><ArticleId IdType="doi">10.1038/s41591-023-02476-4</ArticleId><ArticleId IdType="pii">10.1038/s41591-023-02476-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>GBD 2019 Dementia Forecasting Collaborators. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019. Lancet Public Health. 2022;7:e105&#x2013;e125. doi: 10.1016/S2468-2667(21)00249-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2468-2667(21)00249-8</ArticleId><ArticleId IdType="pmc">PMC8810394</ArticleId><ArticleId IdType="pubmed">34998485</ArticleId></ArticleIdList></Reference><Reference><Citation>Jack CR, Jr, et al. NIA-AA research framework: toward a biological definition of Alzheimer&#x2019;s disease. Alzheimers Dement. 2018;14:535&#x2013;562. doi: 10.1016/j.jalz.2018.02.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2018.02.018</ArticleId><ArticleId IdType="pmc">PMC5958625</ArticleId><ArticleId IdType="pubmed">29653606</ArticleId></ArticleIdList></Reference><Reference><Citation>Boerwinkle AH, et al. Temporal correlation of CSF and neuroimaging in the amyloid-tau-neurodegeneration model of Alzheimer disease. Neurology. 2021;97:e76&#x2013;e87. doi: 10.1212/WNL.0000000000012123.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000012123</ArticleId><ArticleId IdType="pmc">PMC8312859</ArticleId><ArticleId IdType="pubmed">33931538</ArticleId></ArticleIdList></Reference><Reference><Citation>Karikari TK, et al. Diagnostic performance and prediction of clinical progression of plasma phospho-tau181 in the Alzheimer&#x2019;s Disease Neuroimaging Initiative. Mol. Psychiatry. 2021;26:429&#x2013;442. doi: 10.1038/s41380-020-00923-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41380-020-00923-z</ArticleId><ArticleId IdType="pubmed">33106600</ArticleId></ArticleIdList></Reference><Reference><Citation>Leuzy A, et al. Blood-based biomarkers for Alzheimer&#x2019;s disease. EMBO Mol. Med. 2022;14:e14408. doi: 10.15252/emmm.202114408.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/emmm.202114408</ArticleId><ArticleId IdType="pmc">PMC8749476</ArticleId><ArticleId IdType="pubmed">34859598</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, et al. Validation of plasma amyloid-beta 42/40 for detecting Alzheimer disease amyloid plaques. Neurology. 2022;98:e688&#x2013;e699. doi: 10.1212/WNL.0000000000013211.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000013211</ArticleId><ArticleId IdType="pmc">PMC8865895</ArticleId><ArticleId IdType="pubmed">34906975</ArticleId></ArticleIdList></Reference><Reference><Citation>Neff RA, et al. Molecular subtyping of Alzheimer&#x2019;s disease using RNA sequencing data reveals novel mechanisms and targets. Sci. Adv. 2021;7:eabb5398. doi: 10.1126/sciadv.abb5398.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.abb5398</ArticleId><ArticleId IdType="pmc">PMC7787497</ArticleId><ArticleId IdType="pubmed">33523961</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson ECB, et al. Large-scale deep multi-layer analysis of Alzheimer&#x2019;s disease brain reveals strong proteomic disease-related changes not observed at the RNA level. Nat. Neurosci. 2022;25:213&#x2013;225. doi: 10.1038/s41593-021-00999-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-021-00999-y</ArticleId><ArticleId IdType="pmc">PMC8825285</ArticleId><ArticleId IdType="pubmed">35115731</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson ECB, et al. Large-scale proteomic analysis of Alzheimer&#x2019;s disease brain and cerebrospinal fluid reveals early changes in energy metabolism associated with microglia and astrocyte activation. Nat. Med. 2020;26:769&#x2013;780. doi: 10.1038/s41591-020-0815-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-0815-6</ArticleId><ArticleId IdType="pmc">PMC7405761</ArticleId><ArticleId IdType="pubmed">32284590</ArticleId></ArticleIdList></Reference><Reference><Citation>Wan YW, et al. Meta-analysis of the Alzheimer&#x2019;s disease human brain transcriptome and functional dissection in mouse models. Cell Rep. 2020;32:107908. doi: 10.1016/j.celrep.2020.107908.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2020.107908</ArticleId><ArticleId IdType="pmc">PMC7428328</ArticleId><ArticleId IdType="pubmed">32668255</ArticleId></ArticleIdList></Reference><Reference><Citation>Bateman RJ, et al. Autosomal-dominant Alzheimer&#x2019;s disease: a review and proposal for the prevention of Alzheimer&#x2019;s disease. Alzheimers Res. Ther. 2011;3:1. doi: 10.1186/alzrt59.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/alzrt59</ArticleId><ArticleId IdType="pmc">PMC3109410</ArticleId><ArticleId IdType="pubmed">21211070</ArticleId></ArticleIdList></Reference><Reference><Citation>Potter R, et al. Increased in vivo amyloid-beta42 production, exchange, and loss in presenilin mutation carriers. Sci. Transl. Med. 2013;5:189ra177. doi: 10.1126/scitranslmed.3005615.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.3005615</ArticleId><ArticleId IdType="pmc">PMC3838868</ArticleId><ArticleId IdType="pubmed">23761040</ArticleId></ArticleIdList></Reference><Reference><Citation>Bateman RJ, et al. Clinical and biomarker changes in dominantly inherited Alzheimer&#x2019;s disease. N. Engl. J. Med. 2012;367:795&#x2013;804. doi: 10.1056/NEJMoa1202753.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1202753</ArticleId><ArticleId IdType="pmc">PMC3474597</ArticleId><ArticleId IdType="pubmed">22784036</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris JC, et al. Autosomal dominant and sporadic late onset Alzheimer disease share a common in vivo pathophysiology. Brain. 2022;145:3594&#x2013;3607. doi: 10.1093/brain/awac181.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awac181</ArticleId><ArticleId IdType="pmc">PMC9989348</ArticleId><ArticleId IdType="pubmed">35580594</ArticleId></ArticleIdList></Reference><Reference><Citation>Dayon L, et al. Alzheimer disease pathology and the cerebrospinal fluid proteome. Alzheimers Res. Ther. 2018;10:66. doi: 10.1186/s13195-018-0397-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13195-018-0397-4</ArticleId><ArticleId IdType="pmc">PMC6052524</ArticleId><ArticleId IdType="pubmed">30021611</ArticleId></ArticleIdList></Reference><Reference><Citation>Higginbotham L, et al. Integrated proteomics reveals brain-based cerebrospinal fluid biomarkers in asymptomatic and symptomatic Alzheimer&#x2019;s disease. Sci. Adv. 2020;6:eaaz9360. doi: 10.1126/sciadv.aaz9360.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.aaz9360</ArticleId><ArticleId IdType="pmc">PMC7577712</ArticleId><ArticleId IdType="pubmed">33087358</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou M, et al. Targeted mass spectrometry to quantify brain-derived cerebrospinal fluid biomarkers in Alzheimer&#x2019;s disease. Clin. Proteomics. 2020;17:19. doi: 10.1186/s12014-020-09285-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12014-020-09285-8</ArticleId><ArticleId IdType="pmc">PMC7257173</ArticleId><ArticleId IdType="pubmed">32514259</ArticleId></ArticleIdList></Reference><Reference><Citation>Spellman DS, et al. Development and evaluation of a multiplexed mass spectrometry based assay for measuring candidate peptide biomarkers in Alzheimer&#x2019;s Disease Neuroimaging Initiative (ADNI) CSF. Proteomics Clin. Appl. 2015;9:715&#x2013;731. doi: 10.1002/prca.201400178.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/prca.201400178</ArticleId><ArticleId IdType="pmc">PMC4739636</ArticleId><ArticleId IdType="pubmed">25676562</ArticleId></ArticleIdList></Reference><Reference><Citation>Gillette MA, Carr SA. Quantitative analysis of peptides and proteins in biomedicine by targeted mass spectrometry. Nat. Methods. 2013;10:28&#x2013;34. doi: 10.1038/nmeth.2309.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.2309</ArticleId><ArticleId IdType="pmc">PMC3943160</ArticleId><ArticleId IdType="pubmed">23269374</ArticleId></ArticleIdList></Reference><Reference><Citation>Preische O, et al. Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer&#x2019;s disease. Nat. Med. 2019;25:277&#x2013;283. doi: 10.1038/s41591-018-0304-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-018-0304-3</ArticleId><ArticleId IdType="pmc">PMC6367005</ArticleId><ArticleId IdType="pubmed">30664784</ArticleId></ArticleIdList></Reference><Reference><Citation>Janelidze S, et al. CSF Abeta42/Abeta40 and Abeta42/Abeta38 ratios: better diagnostic markers of Alzheimer disease. Ann. Clin. Transl. Neurol. 2016;3:154&#x2013;165. doi: 10.1002/acn3.274.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.274</ArticleId><ArticleId IdType="pmc">PMC4774260</ArticleId><ArticleId IdType="pubmed">27042676</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai B, et al. Deep multilayer brain proteomics identifies molecular networks in Alzheimer&#x2019;s disease progression. Neuron. 2020;105:975&#x2013;991 e977. doi: 10.1016/j.neuron.2019.12.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2019.12.015</ArticleId><ArticleId IdType="pmc">PMC7318843</ArticleId><ArticleId IdType="pubmed">31926610</ArticleId></ArticleIdList></Reference><Reference><Citation>Hynes RO, Naba A. Overview of the matrisome&#x2014;an inventory of extracellular matrix constituents and functions. Cold Spring Harb. Perspect. Biol. 2012;4:a004903. doi: 10.1101/cshperspect.a004903.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a004903</ArticleId><ArticleId IdType="pmc">PMC3249625</ArticleId><ArticleId IdType="pubmed">21937732</ArticleId></ArticleIdList></Reference><Reference><Citation>Esteve P, et al. Elevated levels of Secreted-Frizzled-Related-Protein 1 contribute to Alzheimer&#x2019;s disease pathogenesis. Nat. Neurosci. 2019;22:1258&#x2013;1268. doi: 10.1038/s41593-019-0432-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-019-0432-1</ArticleId><ArticleId IdType="pubmed">31308530</ArticleId></ArticleIdList></Reference><Reference><Citation>Hondius DC, et al. Proteomics analysis identifies new markers associated with capillary cerebral amyloid angiopathy in Alzheimer&#x2019;s disease. Acta Neuropathol. Commun. 2018;6:46. doi: 10.1186/s40478-018-0540-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-018-0540-2</ArticleId><ArticleId IdType="pmc">PMC5985582</ArticleId><ArticleId IdType="pubmed">29860944</ArticleId></ArticleIdList></Reference><Reference><Citation>Wisniewski T, et al. HB-GAM is a cytokine present in Alzheimer&#x2019;s and Down&#x2019;s syndrome lesions. Neuroreport. 1996;7:667&#x2013;671. doi: 10.1097/00001756-199601310-00068.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00001756-199601310-00068</ArticleId><ArticleId IdType="pubmed">8730853</ArticleId></ArticleIdList></Reference><Reference><Citation>Campbell MR, et al. P-tau/A&#x3b2;42 and A&#x3b2;42/40 ratios in CSF are equally predictive of amyloid PET status. Alzheimers Dement. 2021;13:e12190.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8129859</ArticleId><ArticleId IdType="pubmed">34027020</ArticleId></ArticleIdList></Reference><Reference><Citation>Suarez-Calvet M, et al. Novel tau biomarkers phosphorylated at T181, T217 or T231 rise in the initial stages of the preclinical Alzheimer&#x2019;s continuum when only subtle changes in A&#x3b2; pathology are detected. EMBO Mol. Med. 2020;12:e12921. doi: 10.15252/emmm.202012921.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/emmm.202012921</ArticleId><ArticleId IdType="pmc">PMC7721364</ArticleId><ArticleId IdType="pubmed">33169916</ArticleId></ArticleIdList></Reference><Reference><Citation>Fagan AM, et al. Cerebrospinal fluid tau and ptau(181) increase with cortical amyloid deposition in cognitively normal individuals: implications for future clinical trials of Alzheimer&#x2019;s disease. EMBO Mol. Med. 2009;1:371&#x2013;380. doi: 10.1002/emmm.200900048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/emmm.200900048</ArticleId><ArticleId IdType="pmc">PMC2806678</ArticleId><ArticleId IdType="pubmed">20049742</ArticleId></ArticleIdList></Reference><Reference><Citation>Ossenkoppele R, van der Kant R, Hansson O. Tau biomarkers in Alzheimer&#x2019;s disease: towards implementation in clinical practice and trials. Lancet Neurol. 2022;21:726&#x2013;734. doi: 10.1016/S1474-4422(22)00168-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(22)00168-5</ArticleId><ArticleId IdType="pubmed">35643092</ArticleId></ArticleIdList></Reference><Reference><Citation>Bridel C, et al. Diagnostic value of cerebrospinal fluid neurofilament light protein in neurology: a systematic review and meta-analysis. JAMA Neurol. 2019;76:1035&#x2013;1048. doi: 10.1001/jamaneurol.2019.1534.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2019.1534</ArticleId><ArticleId IdType="pmc">PMC6580449</ArticleId><ArticleId IdType="pubmed">31206160</ArticleId></ArticleIdList></Reference><Reference><Citation>Townley RA, Boeve BF, Benarroch EE. Progranulin: functions and neurologic correlations. Neurology. 2018;90:118&#x2013;125. doi: 10.1212/WNL.0000000000004840.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000004840</ArticleId><ArticleId IdType="pmc">PMC5772162</ArticleId><ArticleId IdType="pubmed">29263224</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen WL, et al. Neuroprotective effects of hydrogen sulfide and the underlying signaling pathways. Rev. Neurosci. 2015;26:129&#x2013;142. doi: 10.1515/revneuro-2014-0051.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/revneuro-2014-0051</ArticleId><ArticleId IdType="pubmed">25528761</ArticleId></ArticleIdList></Reference><Reference><Citation>Dopico-Lopez A, et al. Inhibition of endogenous blood glutamate oxaloacetate transaminase enhances the ischemic damage. Transl. Res. 2021;230:68&#x2013;81. doi: 10.1016/j.trsl.2020.10.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.trsl.2020.10.004</ArticleId><ArticleId IdType="pubmed">33132087</ArticleId></ArticleIdList></Reference><Reference><Citation>Kremer DM, et al. GOT1 inhibition promotes pancreatic cancer cell death by ferroptosis. Nat. Commun. 2021;12:4860. doi: 10.1038/s41467-021-24859-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-24859-2</ArticleId><ArticleId IdType="pmc">PMC8357841</ArticleId><ArticleId IdType="pubmed">34381026</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan J, et al. Glia maturation factor-beta: a potential therapeutic target in neurodegeneration and neuroinflammation. Neuropsychiatr. Dis. Treat. 2018;14:495&#x2013;504. doi: 10.2147/NDT.S157099.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/NDT.S157099</ArticleId><ArticleId IdType="pmc">PMC5810533</ArticleId><ArticleId IdType="pubmed">29445286</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajkumar K, et al. Understanding perspectives of signalling mechanisms regulating PEBP1 function. Cell Biochem. Funct. 2016;34:394&#x2013;403. doi: 10.1002/cbf.3198.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cbf.3198</ArticleId><ArticleId IdType="pubmed">27385268</ArticleId></ArticleIdList></Reference><Reference><Citation>Morenas-Rodriguez E, et al. Soluble TREM2 in CSF and its association with other biomarkers and cognition in autosomal-dominant Alzheimer&#x2019;s disease: a longitudinal observational study. Lancet Neurol. 2022;21:329&#x2013;341. doi: 10.1016/S1474-4422(22)00027-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(22)00027-8</ArticleId><ArticleId IdType="pmc">PMC8926925</ArticleId><ArticleId IdType="pubmed">35305339</ArticleId></ArticleIdList></Reference><Reference><Citation>Ulland TK, et al. TREM2 maintains microglial metabolic fitness in Alzheimer&#x2019;s disease. Cell. 2017;170:649&#x2013;663 e613. doi: 10.1016/j.cell.2017.07.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2017.07.023</ArticleId><ArticleId IdType="pmc">PMC5573224</ArticleId><ArticleId IdType="pubmed">28802038</ArticleId></ArticleIdList></Reference><Reference><Citation>Schultz SA, et al. Serum neurofilament light chain levels are associated with white matter integrity in autosomal dominant Alzheimer&#x2019;s disease. Neurobiol. Dis. 2020;142:104960. doi: 10.1016/j.nbd.2020.104960.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2020.104960</ArticleId><ArticleId IdType="pmc">PMC7363568</ArticleId><ArticleId IdType="pubmed">32522711</ArticleId></ArticleIdList></Reference><Reference><Citation>Strain JF, et al. CSF Tau phosphorylation at Thr205 is associated with loss of white matter integrity in autosomal dominant Alzheimer disease. Neurobiol. Dis. 2022;168:105714. doi: 10.1016/j.nbd.2022.105714.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2022.105714</ArticleId><ArticleId IdType="pmc">PMC9701560</ArticleId><ArticleId IdType="pubmed">35358703</ArticleId></ArticleIdList></Reference><Reference><Citation>Cantor H, Shinohara ML. Regulation of T-helper-cell lineage development by osteopontin: the inside story. Nat. Rev. Immunol. 2009;9:137&#x2013;141. doi: 10.1038/nri2460.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri2460</ArticleId><ArticleId IdType="pmc">PMC2696694</ArticleId><ArticleId IdType="pubmed">19096390</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosmus DD, Lange C, Ludwig F, Ajami B, Wieghofer P. The role of osteopontin in microglia biology: current concepts and future perspectives. Biomedicines. 2022;10:840. doi: 10.3390/biomedicines10040840.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines10040840</ArticleId><ArticleId IdType="pmc">PMC9027630</ArticleId><ArticleId IdType="pubmed">35453590</ArticleId></ArticleIdList></Reference><Reference><Citation>Connolly K, et al. Potential role of chitinase-3-like protein 1 (CHI3L1/YKL-40) in neurodegeneration and Alzheimer&#x2019;s disease. Alzheimers Dement. 2022;19:9&#x2013;24. doi: 10.1002/alz.12612.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alz.12612</ArticleId><ArticleId IdType="pmc">PMC9437141</ArticleId><ArticleId IdType="pubmed">35234337</ArticleId></ArticleIdList></Reference><Reference><Citation>Craig-Schapiro R, et al. YKL-40: a novel prognostic fluid biomarker for preclinical Alzheimer&#x2019;s disease. Biol. Psychiatry. 2010;68:903&#x2013;912. doi: 10.1016/j.biopsych.2010.08.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopsych.2010.08.025</ArticleId><ArticleId IdType="pmc">PMC3011944</ArticleId><ArticleId IdType="pubmed">21035623</ArticleId></ArticleIdList></Reference><Reference><Citation>Dammer EB, et al. Multi-platform proteomic analysis of Alzheimer&#x2019;s disease cerebrospinal fluid and plasma reveals network biomarkers associated with proteostasis and the matrisome. Alzheimers Res. Ther. 2022;14:174. doi: 10.1186/s13195-022-01113-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13195-022-01113-5</ArticleId><ArticleId IdType="pmc">PMC9670630</ArticleId><ArticleId IdType="pubmed">36384809</ArticleId></ArticleIdList></Reference><Reference><Citation>Watson CM, et al. Quantitative mass spectrometry analysis of cerebrospinal fluid biomarker proteins reveals stage-specific changes in Alzheimer&#x2019;s disease. Sci. Data. 2023;10:261. doi: 10.1038/s41597-023-02158-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41597-023-02158-3</ArticleId><ArticleId IdType="pmc">PMC10170100</ArticleId><ArticleId IdType="pubmed">37160957</ArticleId></ArticleIdList></Reference><Reference><Citation>Karch CM, Goate AM. Alzheimer&#x2019;s disease risk genes and mechanisms of disease pathogenesis. Biol. Psychiatry. 2015;77:43&#x2013;51. doi: 10.1016/j.biopsych.2014.05.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopsych.2014.05.006</ArticleId><ArticleId IdType="pmc">PMC4234692</ArticleId><ArticleId IdType="pubmed">24951455</ArticleId></ArticleIdList></Reference><Reference><Citation>Arboleda-Velasquez JF, et al. Resistance to autosomal dominant Alzheimer&#x2019;s disease in an APOE3 Christchurch homozygote: a case report. Nat. Med. 2019;25:1680&#x2013;1683. doi: 10.1038/s41591-019-0611-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-019-0611-3</ArticleId><ArticleId IdType="pmc">PMC6898984</ArticleId><ArticleId IdType="pubmed">31686034</ArticleId></ArticleIdList></Reference><Reference><Citation>Reiman EM, et al. Exceptionally low likelihood of Alzheimer&#x2019;s dementia in APOE2 homozygotes from a 5,000-person neuropathological study. Nat. Commun. 2020;11:667. doi: 10.1038/s41467-019-14279-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-14279-8</ArticleId><ArticleId IdType="pmc">PMC6997393</ArticleId><ArticleId IdType="pubmed">32015339</ArticleId></ArticleIdList></Reference><Reference><Citation>Tchaikovski V, Fellbrich G, Waltenberger J. The molecular basis of VEGFR-1 signal transduction pathways in primary human monocytes. Arterioscler. Thromb. Vasc. Biol. 2008;28:322&#x2013;328. doi: 10.1161/ATVBAHA.107.158022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/ATVBAHA.107.158022</ArticleId><ArticleId IdType="pubmed">18079407</ArticleId></ArticleIdList></Reference><Reference><Citation>Klar A, Baldassare M, Jessell TM. F-spondin: a gene expressed at high levels in the floor plate encodes a secreted protein that promotes neural cell adhesion and neurite extension. Cell. 1992;69:95&#x2013;110. doi: 10.1016/0092-8674(92)90121-R.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0092-8674(92)90121-R</ArticleId><ArticleId IdType="pubmed">1555244</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez S, et al. SPON1 is associated with amyloid-beta and APOE epsilon4-related cognitive decline in cognitively normal adults. J. Alzheimers Dis. Rep. 2021;5:111&#x2013;120. doi: 10.3233/ADR-200246.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/ADR-200246</ArticleId><ArticleId IdType="pmc">PMC7990462</ArticleId><ArticleId IdType="pubmed">33782664</ArticleId></ArticleIdList></Reference><Reference><Citation>Sherva R, et al. Genome-wide association study of the rate of cognitive decline in Alzheimer&#x2019;s disease. Alzheimers Dement. 2014;10:45&#x2013;52. doi: 10.1016/j.jalz.2013.01.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2013.01.008</ArticleId><ArticleId IdType="pmc">PMC3760995</ArticleId><ArticleId IdType="pubmed">23535033</ArticleId></ArticleIdList></Reference><Reference><Citation>Newington JT, et al. Amyloid beta resistance in nerve cell lines is mediated by the Warburg effect. PLoS ONE. 2011;6:e19191. doi: 10.1371/journal.pone.0019191.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0019191</ArticleId><ArticleId IdType="pmc">PMC3082554</ArticleId><ArticleId IdType="pubmed">21541279</ArticleId></ArticleIdList></Reference><Reference><Citation>Shippy DC, Ulland TK. Microglial immunometabolism in Alzheimer&#x2019;s disease. Front. Cell Neurosci. 2020;14:563446. doi: 10.3389/fncel.2020.563446.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2020.563446</ArticleId><ArticleId IdType="pmc">PMC7531234</ArticleId><ArticleId IdType="pubmed">33192310</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiang X, et al. Microglial activation states drive glucose uptake and FDG-PET alterations in neurodegenerative diseases. Sci. Transl. Med. 2021;13:eabe5640. doi: 10.1126/scitranslmed.abe5640.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.abe5640</ArticleId><ArticleId IdType="pubmed">34644146</ArticleId></ArticleIdList></Reference><Reference><Citation>Salvad&#xf3; G, et al. Reactive astrogliosis is associated with higher cerebral glucose consumption in the early Alzheimer&#x2019;s continuum. Eur. J. Nucl. Med. Mol. Imaging. 2022;49:4567&#x2013;4579. doi: 10.1007/s00259-022-05897-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00259-022-05897-4</ArticleId><ArticleId IdType="pmc">PMC9606048</ArticleId><ArticleId IdType="pubmed">35849149</ArticleId></ArticleIdList></Reference><Reference><Citation>Magistretti PJ, Allaman I. A cellular perspective on brain energy metabolism and functional imaging. Neuron. 2015;86:883&#x2013;901. doi: 10.1016/j.neuron.2015.03.035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2015.03.035</ArticleId><ArticleId IdType="pubmed">25996133</ArticleId></ArticleIdList></Reference><Reference><Citation>Barthelemy NR, et al. A soluble phosphorylated tau signature links tau, amyloid and the evolution of stages of dominantly inherited Alzheimer&#x2019;s disease. Nat. Med. 2020;26:398&#x2013;407. doi: 10.1038/s41591-020-0781-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-0781-z</ArticleId><ArticleId IdType="pmc">PMC7309367</ArticleId><ArticleId IdType="pubmed">32161412</ArticleId></ArticleIdList></Reference><Reference><Citation>Ringman JM, et al. Neuropathology of autosomal dominant Alzheimer disease in the National Alzheimer Coordinating Center database. J. Neuropathol. Exp. Neurol. 2016;75:284&#x2013;290. doi: 10.1093/jnen/nlv028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jnen/nlv028</ArticleId><ArticleId IdType="pmc">PMC4934612</ArticleId><ArticleId IdType="pubmed">26888304</ArticleId></ArticleIdList></Reference><Reference><Citation>Nelson PT, et al. Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report. Brain. 2019;142:1503&#x2013;1527. doi: 10.1093/brain/awz099.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awz099</ArticleId><ArticleId IdType="pmc">PMC6536849</ArticleId><ArticleId IdType="pubmed">31039256</ArticleId></ArticleIdList></Reference><Reference><Citation>Mawuenyega KG, et al. Decreased clearance of CNS beta-amyloid in Alzheimer&#x2019;s disease. Science. 2010;330:1774. doi: 10.1126/science.1197623.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1197623</ArticleId><ArticleId IdType="pmc">PMC3073454</ArticleId><ArticleId IdType="pubmed">21148344</ArticleId></ArticleIdList></Reference><Reference><Citation>Buchhave P, et al. Cerebrospinal fluid levels of beta-amyloid 1-42, but not of tau, are fully changed already 5 to 10 years before the onset of Alzheimer dementia. Arch. Gen. Psychiatry. 2012;69:98&#x2013;106. doi: 10.1001/archgenpsychiatry.2011.155.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archgenpsychiatry.2011.155</ArticleId><ArticleId IdType="pubmed">22213792</ArticleId></ArticleIdList></Reference><Reference><Citation>Rother C, et al. Experimental evidence for temporal uncoupling of brain Abeta deposition and neurodegenerative sequelae. Nat. Commun. 2022;13:7333. doi: 10.1038/s41467-022-34538-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-34538-5</ArticleId><ArticleId IdType="pmc">PMC9705543</ArticleId><ArticleId IdType="pubmed">36443293</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryman DC, et al. Symptom onset in autosomal dominant Alzheimer disease: a systematic review and meta-analysis. Neurology. 2014;83:253&#x2013;260. doi: 10.1212/WNL.0000000000000596.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000000596</ArticleId><ArticleId IdType="pmc">PMC4117367</ArticleId><ArticleId IdType="pubmed">24928124</ArticleId></ArticleIdList></Reference><Reference><Citation>Raulin AC, et al. ApoE in Alzheimer&#x2019;s disease: pathophysiology and therapeutic strategies. Mol. Neurodegener. 2022;17:72. doi: 10.1186/s13024-022-00574-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-022-00574-4</ArticleId><ArticleId IdType="pmc">PMC9644639</ArticleId><ArticleId IdType="pubmed">36348357</ArticleId></ArticleIdList></Reference><Reference><Citation>Suarez-Calvet M, et al. CSF progranulin increases in the course of Alzheimer&#x2019;s disease and is associated with sTREM2, neurodegeneration and cognitive decline. EMBO Mol. Med. 2018;10:e9712. doi: 10.15252/emmm.201809712.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/emmm.201809712</ArticleId><ArticleId IdType="pmc">PMC6284390</ArticleId><ArticleId IdType="pubmed">30482868</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon BA, et al. Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer&#x2019;s disease: a longitudinal study. Lancet Neurol. 2018;17:241&#x2013;250. doi: 10.1016/S1474-4422(18)30028-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(18)30028-0</ArticleId><ArticleId IdType="pmc">PMC5816717</ArticleId><ArticleId IdType="pubmed">29397305</ArticleId></ArticleIdList></Reference><Reference><Citation>McKay, N. S. et al. Positron emission tomography and magnetic resonance imaging methods and datasets within the Dominantly Inherited Alzheimer Network (DIAN). Nat. Neurosci.10.1038/s41593-023-01359-8 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10400428</ArticleId><ArticleId IdType="pubmed">37429916</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris JC. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology. 1993;43:2412&#x2013;2414. doi: 10.1212/WNL.43.11.2412-a.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.43.11.2412-a</ArticleId><ArticleId IdType="pubmed">8232972</ArticleId></ArticleIdList></Reference><Reference><Citation>Folstein MF, Folstein SE, McHugh PR. &#x2018;Mini-mental state&#x2019;. A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 1975;12:189&#x2013;198. doi: 10.1016/0022-3956(75)90026-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0022-3956(75)90026-6</ArticleId><ArticleId IdType="pubmed">1202204</ArticleId></ArticleIdList></Reference><Reference><Citation>Carr SA, et al. Targeted peptide measurements in biology and medicine: best practices for mass spectrometry-based assay development using a fit-for-purpose approach. Mol. Cell Proteomics. 2014;13:907&#x2013;917. doi: 10.1074/mcp.M113.036095.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/mcp.M113.036095</ArticleId><ArticleId IdType="pmc">PMC3945918</ArticleId><ArticleId IdType="pubmed">24443746</ArticleId></ArticleIdList></Reference><Reference><Citation>B&#xfc;rkner P-C. brms: An R Package for Bayesian multilevel models using stan. J. Stat. Softw. 2017;80:1&#x2013;28. doi: 10.18637/jss.v080.i01.</Citation><ArticleIdList><ArticleId IdType="doi">10.18637/jss.v080.i01</ArticleId></ArticleIdList></Reference><Reference><Citation>B&#xfc;rkner P-C. Advanced bayesian multilevel modeling with the R package brms. R J. 2018;10:395&#x2013;411. doi: 10.32614/RJ-2018-017.</Citation><ArticleIdList><ArticleId IdType="doi">10.32614/RJ-2018-017</ArticleId></ArticleIdList></Reference><Reference><Citation>Bandos AI, Rockette HE, Gur D. A permutation test sensitive to differences in areas for comparing ROC curves from a paired design. Stat. Med. 2005;24:2873&#x2013;2893. doi: 10.1002/sim.2149.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.2149</ArticleId><ArticleId IdType="pubmed">16134144</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">37577527</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>23</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2692-8205</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2024</Year><Month>Apr</Month><Day>23</Day></PubDate></JournalIssue><Title>bioRxiv : the preprint server for biology</Title><ISOAbbreviation>bioRxiv</ISOAbbreviation></Journal><ArticleTitle>Alzheimer's disease linked A&#x3b2;42 exerts product feedback inhibition on &#x3b3;-secretase impairing downstream cell signaling.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2023.08.02.551596</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1101/2023.08.02.551596</ELocationID><Abstract><AbstractText>Amyloid &#x3b2; (A&#x3b2;) peptides accumulating in the brain are proposed to trigger Alzheimer's disease (AD). However, molecular cascades underlying their toxicity are poorly defined. Here, we explored a novel hypothesis for A&#x3b2;42 toxicity that arises from its proven affinity for &#x3b3;-secretases. We hypothesized that the reported increases in A&#x3b2;42, particularly in the endolysosomal compartment, promote the establishment of a product feedback inhibitory mechanism on &#x3b3;-secretases, and thereby impair downstream signaling events. We show that human A&#x3b2;42 peptides, but neither murine A&#x3b2;42 nor human A&#x3b2;17-42 (p3), inhibit &#x3b3;-secretases and trigger accumulation of unprocessed substrates in neurons, including C-terminal fragments (CTFs) of APP, p75 and pan-cadherin. Moreover, A&#x3b2;42 treatment dysregulated cellular -homeostasis, as shown by the induction of p75-dependent neuronal death in two distinct cellular systems. Our findings raise the possibility that pathological elevations in A&#x3b2;42 contribute to cellular toxicity via the &#x3b3;-secretase inhibition, and provide a novel conceptual framework to address A&#x3b2; toxicity in the context of &#x3b3;-secretase-dependent homeostatic signaling.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zoltowska</LastName><ForeName>Katarzyna Marta</ForeName><Initials>KM</Initials><Identifier Source="ORCID">0000-0001-5853-3465</Identifier><AffiliationInfo><Affiliation>VIB-KU Leuven Center for Brain &amp; Disease Research, VIB, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Das</LastName><ForeName>Utpal</ForeName><Initials>U</Initials><Identifier Source="ORCID">0000-0002-1635-9849</Identifier><AffiliationInfo><Affiliation>Department of Neurosciences, University of California San Diego, La Jolla, CA, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lismont</LastName><ForeName>Sam</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-5825-9590</Identifier><AffiliationInfo><Affiliation>VIB-KU Leuven Center for Brain &amp; Disease Research, VIB, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Enzlein</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0003-1789-4090</Identifier><AffiliationInfo><Affiliation>VIB-KU Leuven Center for Brain &amp; Disease Research, VIB, Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Mass Spectrometry and Optical Spectroscopy (CeMOS), Mannheim University of Applied Sciences, Mannheim, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maesako</LastName><ForeName>Masato</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-1970-2462</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Massachusetts General Hospital/Harvard Medical School, Charlestown, MA, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Houser</LastName><ForeName>Mei Cq</ForeName><Initials>MC</Initials><AffiliationInfo><Affiliation>Department of Neurology, Massachusetts General Hospital/Harvard Medical School, Charlestown, MA, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Franco</LastName><ForeName>Mar&#xed;a Luisa</ForeName><Initials>ML</Initials><AffiliationInfo><Affiliation>Molecular Basis of Neurodegeneration Unit, Institute of Biomedicine of Val&#xe8;ncia (IBV-CSIC), Val&#xe8;ncia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>&#xd6;zcan</LastName><ForeName>Burcu</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>VIB-KU Leuven Center for Brain &amp; Disease Research, VIB, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moreira</LastName><ForeName>Diana Gomes</ForeName><Initials>DG</Initials><Identifier Source="ORCID">0000-0003-2937-1772</Identifier><AffiliationInfo><Affiliation>VIB-KU Leuven Center for Brain &amp; Disease Research, VIB, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Karachentsev</LastName><ForeName>Dmitry</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Neurosciences, University of California San Diego, La Jolla, CA, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Becker</LastName><ForeName>Ann</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neurosciences, University of California San Diego, La Jolla, CA, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hopf</LastName><ForeName>Carsten</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0003-0802-6451</Identifier><AffiliationInfo><Affiliation>Center for Mass Spectrometry and Optical Spectroscopy (CeMOS), Mannheim University of Applied Sciences, Mannheim, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical Faculty, Heidelberg University, Heidelberg, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Mannheim Center for Translational Neuroscience (MCTN), Medical Faculty Mannheim, Heidelberg University, Heidelberg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vilar</LastName><ForeName>Mar&#xe7;al</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-9376-6544</Identifier><AffiliationInfo><Affiliation>Molecular Basis of Neurodegeneration Unit, Institute of Biomedicine of Val&#xe8;ncia (IBV-CSIC), Val&#xe8;ncia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Berezovska</LastName><ForeName>Oksana</ForeName><Initials>O</Initials><Identifier Source="ORCID">0000-0003-4898-5788</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Massachusetts General Hospital/Harvard Medical School, Charlestown, MA, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mobley</LastName><ForeName>William</ForeName><Initials>W</Initials><Identifier Source="ORCID">0000-0002-6408-9548</Identifier><AffiliationInfo><Affiliation>Department of Neurosciences, University of California San Diego, La Jolla, CA, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ch&#xe1;vez-Guti&#xe9;rrez</LastName><ForeName>Luc&#xed;a</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-8239-559X</Identifier><AffiliationInfo><Affiliation>VIB-KU Leuven Center for Brain &amp; Disease Research, VIB, Leuven, Belgium.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 AG055523</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P01 AG015379</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>RF1 AG044486</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG044486</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG070154</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D000076942">Preprint</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>04</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>bioRxiv</MedlineTA><NlmUniqueID>101680187</NlmUniqueID><ISSNLinking>2692-8205</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="UpdateIn"><RefSource>Elife. 2024 Jul 19;12:RP90690. doi: 10.7554/eLife.90690.</RefSource><PMID Version="1">39027984</PMID></CommentsCorrections></CommentsCorrectionsList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Alzheimer&#x2019;s disease</Keyword><Keyword MajorTopicYN="N">amyloid beta</Keyword><Keyword MajorTopicYN="N">amyloid toxicity</Keyword><Keyword MajorTopicYN="N">gamma-secretase</Keyword><Keyword MajorTopicYN="N">presenilin</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>8</Month><Day>14</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>14</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>8</Month><Day>14</Day><Hour>5</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>4</Month><Day>24</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37577527</ArticleId><ArticleId IdType="pmc">PMC10418207</ArticleId><ArticleId IdType="doi">10.1101/2023.08.02.551596</ArticleId><ArticleId IdType="pii">2023.08.02.551596</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ch&#xe1;vez-Guti&#xe9;rrez L., Szaruga M., Mechanisms of neurodegeneration - Insights from familial Alzheimer&#x2019;s disease. Semin Cell Dev Biol 105, 75&#x2013;85 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32418657</ArticleId></ArticleIdList></Reference><Reference><Citation>Selkoe D. J., Hardy J., The amyloid hypothesis of Alzheimer&#x2019;s disease at 25 years. EMBO Mol Med 8, 595&#x2013;608 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4888851</ArticleId><ArticleId IdType="pubmed">27025652</ArticleId></ArticleIdList></Reference><Reference><Citation>Haapasalo A., Kovacs D. M., The many substrates of presenilin/&#x3b3;-secretase. J Alzheimers Dis 25, 3&#x2013;28 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3281584</ArticleId><ArticleId IdType="pubmed">21335653</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xfc;ner G., Lichtenthaler S. F., The substrate repertoire of &#x3b3;-secretase/presenilin. Semin Cell Dev Biol 105, 27&#x2013;42 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32616437</ArticleId></ArticleIdList></Reference><Reference><Citation>Jurisch-Yaksi N., Sannerud R., Annaert W., A fast growing spectrum of biological functions of &#x3b3;-secretase in development and disease. Biochim Biophys Acta 1828, 2815&#x2013;2827 (2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">24099003</ArticleId></ArticleIdList></Reference><Reference><Citation>Carroll C. M., Li Y.-M., Physiological and pathological roles of the &#x3b3;-secretase complex. Brain Research Bulletin 126, 199&#x2013;206 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5436903</ArticleId><ArticleId IdType="pubmed">27133790</ArticleId></ArticleIdList></Reference><Reference><Citation>Doody R. S. et al., A phase 3 trial of semagacestat for treatment of Alzheimer&#x2019;s disease. N Engl J Med 369, 341&#x2013;350 (2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">23883379</ArticleId></ArticleIdList></Reference><Reference><Citation>Acx H. et al., Inactivation of &#x3b3;-secretases leads to accumulation of substrates and non-Alzheimer neurodegeneration. EMBO Mol Med 9, 1088&#x2013;1099 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5538297</ArticleId><ArticleId IdType="pubmed">28588032</ArticleId></ArticleIdList></Reference><Reference><Citation>Wines-Samuelson M. et al., Characterization of age-dependent and progressive cortical neuronal degeneration in presenilin conditional mutant mice. PLoS One 5, e10195 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2855368</ArticleId><ArticleId IdType="pubmed">20419112</ArticleId></ArticleIdList></Reference><Reference><Citation>Tabuchi K., Chen G., S&#xfc;dhof T. C., Shen J., Conditional forebrain inactivation of nicastrin causes progressive memory impairment and age-related neurodegeneration. J Neurosci 29, 7290&#x2013;7301 (2009).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2719251</ArticleId><ArticleId IdType="pubmed">19494151</ArticleId></ArticleIdList></Reference><Reference><Citation>C. A. Saura et al., Loss of presenilin function causes impairments of memory and synaptic plasticity followed by age-dependent neurodegeneration. Neuron 42, 23&#x2013;36 (2004).</Citation><ArticleIdList><ArticleId IdType="pubmed">15066262</ArticleId></ArticleIdList></Reference><Reference><Citation>Bi H. R. et al., Neuron-specific deletion of presenilin enhancer2 causes progressive astrogliosis and age-related neurodegeneration in the cortex independent of the Notch signaling. CNS Neurosci Ther 27, 174&#x2013;185 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7816208</ArticleId><ArticleId IdType="pubmed">32961023</ArticleId></ArticleIdList></Reference><Reference><Citation>Maesako M., Houser M. C. Q., Turchyna Y., Wolfe M. S., Berezovska O., Presenilin/&#x3b3;-Secretase Activity Is Located in Acidic Compartments of Live Neurons. J Neurosci 42, 145&#x2013;154 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8741161</ArticleId><ArticleId IdType="pubmed">34810230</ArticleId></ArticleIdList></Reference><Reference><Citation>Vassar R. et al., Beta-secretase cleavage of Alzheimer&#x2019;s amyloid precursor protein by the transmembrane aspartic protease BACE. Science 286, 735&#x2013;741 (1999).</Citation><ArticleIdList><ArticleId IdType="pubmed">10531052</ArticleId></ArticleIdList></Reference><Reference><Citation>Takami M. et al., gamma-Secretase: successive tripeptide and tetrapeptide release from the transmembrane domain of beta-carboxyl terminal fragment. J Neurosci 29, 13042&#x2013;13052 (2009).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6665297</ArticleId><ArticleId IdType="pubmed">19828817</ArticleId></ArticleIdList></Reference><Reference><Citation>Bolduc D. M., Montagna D. R., Seghers M. C., Wolfe M. S., Selkoe D. J., The amyloid-beta forming tripeptide cleavage mechanism of &#x3b3;-secretase. Elife 5, (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5134833</ArticleId><ArticleId IdType="pubmed">27580372</ArticleId></ArticleIdList></Reference><Reference><Citation>Ch&#xe1;vez-Guti&#xe9;rrez L. et al., The mechanism of &#x3b3;-Secretase dysfunction in familial Alzheimer disease. Embo j 31, 2261&#x2013;2274 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3364747</ArticleId><ArticleId IdType="pubmed">22505025</ArticleId></ArticleIdList></Reference><Reference><Citation>Qi-Takahara Y. et al., Longer forms of amyloid beta protein: implications for the mechanism of intramembrane cleavage by gamma-secretase. J Neurosci 25, 436&#x2013;445 (2005).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6725472</ArticleId><ArticleId IdType="pubmed">15647487</ArticleId></ArticleIdList></Reference><Reference><Citation>Funamoto S. et al., Truncated carboxyl-terminal fragments of beta-amyloid precursor protein are processed to amyloid beta-proteins 40 and 42. Biochemistry 43, 13532&#x2013;13540 (2004).</Citation><ArticleIdList><ArticleId IdType="pubmed">15491160</ArticleId></ArticleIdList></Reference><Reference><Citation>Kakuda N. et al., Distinct deposition of amyloid-&#x3b2; species in brains with Alzheimer&#x2019;s disease pathology visualized with MALDI imaging mass spectrometry. Acta Neuropathol Commun 5, 73 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5641992</ArticleId><ArticleId IdType="pubmed">29037261</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu L. et al., Comparison of neurotoxicity of different aggregated forms of A&#x3b2;40, A&#x3b2;42 and A&#x3b2;43 in cell cultures. J Pept Sci 23, 245&#x2013;251 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28211253</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuhn A. J., Raskatov J., Is the p3 Peptide (A&#x3b2;17&#x2013;40, A&#x3b2;17&#x2013;42) Relevant to the Pathology of Alzheimer&#x2019;s Disease?1. J Alzheimers Dis 74, 43&#x2013;53 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7443050</ArticleId><ArticleId IdType="pubmed">32176648</ArticleId></ArticleIdList></Reference><Reference><Citation>Lichtenthaler S. F., &#x3b1;-secretase in Alzheimer&#x2019;s disease: molecular identity, regulation and therapeutic potential. J Neurochem 116, 10&#x2013;21 (2011).</Citation><ArticleIdList><ArticleId IdType="pubmed">21044078</ArticleId></ArticleIdList></Reference><Reference><Citation>Tambini M. D., Norris K. A., D&#x2019;Adamio L., Opposite changes in APP processing and human A&#x3b2; levels in rats carrying either a protective or a pathogenic APP mutation. Elife 9, (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7018507</ArticleId><ArticleId IdType="pubmed">32022689</ArticleId></ArticleIdList></Reference><Reference><Citation>Mullan M. et al., A pathogenic mutation for probable Alzheimer&#x2019;s disease in the APP gene at the N-terminus of beta-amyloid. Nature genetics 1, 345&#x2013;347 (1992).</Citation><ArticleIdList><ArticleId IdType="pubmed">1302033</ArticleId></ArticleIdList></Reference><Reference><Citation>Pagnon de la Vega M. et al., The Uppsala APP deletion causes early onset autosomal dominant Alzheimer&#x2019;s disease by altering APP processing and increasing amyloid &#x3b2; fibril formation. Science translational medicine 13, (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34380771</ArticleId></ArticleIdList></Reference><Reference><Citation>Jansen I. E. et al., Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer&#x2019;s disease risk. Nat Genet 51, 404&#x2013;413 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6836675</ArticleId><ArticleId IdType="pubmed">30617256</ArticleId></ArticleIdList></Reference><Reference><Citation>Veugelen S., Saito T., Saido T. C., Ch&#xe1;vez-Guti&#xe9;rrez L., De Strooper B., Familial Alzheimer&#x2019;s Disease Mutations in Presenilin Generate Amyloidogenic A&#x3b2; Peptide Seeds. Neuron 90, 410&#x2013;416 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">27100199</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez M. A., Klutkowski J. A., Freret T., Wolfe M. S., Alzheimer presenilin-1 mutations dramatically reduce trimming of long amyloid &#x3b2;-peptides (A&#x3b2;) by &#x3b3;-secretase to increase 42-to-40-residue A&#x3b2;. J Biol Chem 289, 31043&#x2013;31052 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4223309</ArticleId><ArticleId IdType="pubmed">25239621</ArticleId></ArticleIdList></Reference><Reference><Citation>Szaruga M. et al., Alzheimer&#x2019;s-Causing Mutations Shift A&#x3b2; Length by Destabilizing &#x3b3;-Secretase-A&#x3b2;n Interactions. Cell 170, 443&#x2013;456.e414 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28753424</ArticleId></ArticleIdList></Reference><Reference><Citation>Devkota S., Williams T. D., Wolfe M. S., Familial Alzheimer&#x2019;s disease mutations in amyloid protein precursor alter proteolysis by &#x3b3;-secretase to increase amyloid &#x3b2;-peptides of &gt;45 residues. J Biol Chem, 100281 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7948801</ArticleId><ArticleId IdType="pubmed">33450230</ArticleId></ArticleIdList></Reference><Reference><Citation>Kretner B. et al., Generation and deposition of A&#x3b2;43 by the virtually inactive presenilin-1 L435F mutant contradicts the presenilin loss-of-function hypothesis of Alzheimer&#x2019;s disease. 8, 458&#x2013;465 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5119496</ArticleId><ArticleId IdType="pubmed">26988102</ArticleId></ArticleIdList></Reference><Reference><Citation>Petit D. et al., A&#x3b2; profiles generated by Alzheimer&#x2019;s disease causing PSEN1 variants determine the pathogenicity of the mutation and predict age at disease onset. Molecular Psychiatry, (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9156411</ArticleId><ArticleId IdType="pubmed">35365805</ArticleId></ArticleIdList></Reference><Reference><Citation>Mawuenyega K. G. et al., Decreased clearance of CNS beta-amyloid in Alzheimer&#x2019;s disease. Science (New York, N.Y.) 330, 1774 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3073454</ArticleId><ArticleId IdType="pubmed">21148344</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu L. et al., Identification of the A&#x3b2;37/42 peptide ratio in CSF as an improved A&#x3b2; biomarker for Alzheimer&#x2019;s disease. Alzheimers Dement, (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9464800</ArticleId><ArticleId IdType="pubmed">35278341</ArticleId></ArticleIdList></Reference><Reference><Citation>Brinkmalm G. et al., Identification of neurotoxic cross-linked amyloid-&#x3b2; dimers in the Alzheimer&#x2019;s brain. Brain 142, 1441&#x2013;1457 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6487330</ArticleId><ArticleId IdType="pubmed">31032851</ArticleId></ArticleIdList></Reference><Reference><Citation>Walsh D. M. et al., Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416, 535&#x2013;539 (2002).</Citation><ArticleIdList><ArticleId IdType="pubmed">11932745</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong W. et al., Diffusible, highly bioactive oligomers represent a critical minority of soluble A&#x3b2; in Alzheimer&#x2019;s disease brain. Acta Neuropathol 136, 19&#x2013;40 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6647843</ArticleId><ArticleId IdType="pubmed">29687257</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Z. et al., Human Brain-Derived A&#x3b2; Oligomers Bind to Synapses and Disrupt Synaptic Activity in a Manner That Requires APP. J Neurosci 37, 11947&#x2013;11966 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5719975</ArticleId><ArticleId IdType="pubmed">29101243</ArticleId></ArticleIdList></Reference><Reference><Citation>Lauritzen I., Pardossi-Piquard R., Bourgeois A., B&#xe9;cot A., Checler F., Does Intraneuronal Accumulation of Carboxyl-terminal Fragments of the Amyloid Precursor Protein Trigger Early Neurotoxicity in Alzheimer&#x2019;s Disease? Curr Alzheimer Res 16, 453&#x2013;457 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">30907322</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu W. et al., Amyloid precursor protein-mediated endocytic pathway disruption induces axonal dysfunction and neurodegeneration. J Clin Invest 126, 1815&#x2013;1833 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4855914</ArticleId><ArticleId IdType="pubmed">27064279</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwart D. et al., A Large Panel of Isogenic APP and PSEN1 Mutant Human iPSC Neurons Reveals Shared Endosomal Abnormalities Mediated by APP &#x3b2;-CTFs, Not A&#x3b2;. Neuron 104, 1022 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">31805257</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim S. et al., Evidence that the rab5 effector APPL1 mediates APP-&#x3b2;CTF-induced dysfunction of endosomes in Down syndrome and Alzheimer&#x2019;s disease. Mol Psychiatry 21, 707&#x2013;716 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4721948</ArticleId><ArticleId IdType="pubmed">26194181</ArticleId></ArticleIdList></Reference><Reference><Citation>Franco M. L. et al., TrkA-mediated endocytosis of p75-CTF prevents cholinergic neuron death upon &#x3b3;-secretase inhibition. Life Sci Alliance 4, (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7898468</ArticleId><ArticleId IdType="pubmed">33536237</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsumura N. et al., gamma-Secretase associated with lipid rafts: multiple interactive pathways in the stepwise processing of beta-carboxyl-terminal fragment. J Biol Chem 289, 5109&#x2013;5121 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3931069</ArticleId><ArticleId IdType="pubmed">24375443</ArticleId></ArticleIdList></Reference><Reference><Citation>Shelton C. C. et al., A miniaturized 1536-well format gamma-secretase assay. Assay Drug Dev Technol 7, 461&#x2013;470 (2009).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3096545</ArticleId><ArticleId IdType="pubmed">19715456</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu X. et al., Amyloid seeds formed by cellular uptake, concentration, and aggregation of the amyloid-beta peptide. Proc Natl Acad Sci U S A 106, 20324&#x2013;20329 (2009).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2787156</ArticleId><ArticleId IdType="pubmed">19910533</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Y., Chang P. T., Acidic pH promotes the formation of toxic fibrils from beta-amyloid peptide. Brain Res 893, 287&#x2013;291 (2001).</Citation><ArticleIdList><ArticleId IdType="pubmed">11223020</ArticleId></ArticleIdList></Reference><Reference><Citation>Sch&#xfc;tzmann M. P. et al., Endo-lysosomal A&#x3b2; concentration and pH trigger formation of A&#x3b2; oligomers that potently induce Tau missorting. Nat Commun 12, 4634 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8324842</ArticleId><ArticleId IdType="pubmed">34330900</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu R. Q. et al., Membrane localization of beta-amyloid 1&#x2013;42 in lysosomes: a possible mechanism for lysosome labilization. J Biol Chem 285, 19986&#x2013;19996 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2888410</ArticleId><ArticleId IdType="pubmed">20430896</ArticleId></ArticleIdList></Reference><Reference><Citation>Esbj&#xf6;rner E. K. et al., Direct observations of amyloid &#x3b2; self-assembly in live cells provide insights into differences in the kinetics of A&#x3b2;(1&#x2013;40) and A&#x3b2;(1&#x2013;42) aggregation. Chem Biol 21, 732&#x2013;742 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4067742</ArticleId><ArticleId IdType="pubmed">24856820</ArticleId></ArticleIdList></Reference><Reference><Citation>Friedrich R. P. et al., Mechanism of amyloid plaque formation suggests an intracellular basis of Abeta pathogenicity. Proc Natl Acad Sci U S A 107, 1942&#x2013;1947 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2836607</ArticleId><ArticleId IdType="pubmed">20133839</ArticleId></ArticleIdList></Reference><Reference><Citation>Maesako M. et al., Visualization of PS/&#x3b3;-Secretase Activity in Living Cells. iScience 23, 101139 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7235286</ArticleId><ArticleId IdType="pubmed">32438286</ArticleId></ArticleIdList></Reference><Reference><Citation>Houser M. C. et al., A Novel NIR-FRET Biosensor for Reporting PS/&#x3b3;-Secretase Activity in Live Cells. Sensors (Basel) 20, (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7660074</ArticleId><ArticleId IdType="pubmed">33105735</ArticleId></ArticleIdList></Reference><Reference><Citation>Schneider-Poetsch T. et al., Inhibition of eukaryotic translation elongation by cycloheximide and lactimidomycin. Nat Chem Biol 6, 209&#x2013;217 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2831214</ArticleId><ArticleId IdType="pubmed">20118940</ArticleId></ArticleIdList></Reference><Reference><Citation>Uemura K. et al., Characterization of sequential N-cadherin cleavage by ADAM10 and PS1. Neurosci Lett 402, 278&#x2013;283 (2006).</Citation><ArticleIdList><ArticleId IdType="pubmed">16687212</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong L. W., Wang Z., Ang S. R. X., Sajikumar S., Fading memories in aging and neurodegeneration: Is p75 neurotrophin receptor a culprit? Ageing Res Rev 75, 101567 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35051645</ArticleId></ArticleIdList></Reference><Reference><Citation>Conroy J. N., Coulson E. J., High-affinity TrkA and p75 neurotrophin receptor complexes: a twisted affair. J Biol Chem, 101568 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8889134</ArticleId><ArticleId IdType="pubmed">35051416</ArticleId></ArticleIdList></Reference><Reference><Citation>Loeb D. M. et al., The trk proto-oncogene rescues NGF responsiveness in mutant NGF-nonresponsive PC12 cell lines. Cell 66, 961&#x2013;966 (1991).</Citation><ArticleIdList><ArticleId IdType="pubmed">1653650</ArticleId></ArticleIdList></Reference><Reference><Citation>Pickett E. K. et al., Non-Fibrillar Oligomeric Amyloid-&#x3b2; within Synapses. J Alzheimers Dis 53, 787&#x2013;800 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">27258414</ArticleId></ArticleIdList></Reference><Reference><Citation>Schedin-Weiss S., Caesar I., Winblad B., Blom H., Tjernberg L. O., Super-resolution microscopy reveals &#x3b3;-secretase at both sides of the neuronal synapse. Acta Neuropathol Commun 4, 29 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4818506</ArticleId><ArticleId IdType="pubmed">27036709</ArticleId></ArticleIdList></Reference><Reference><Citation>Dunkley P. R., Jarvie P. E., Robinson P. J., A rapid Percoll gradient procedure for preparation of synaptosomes. Nat Protoc 3, 1718&#x2013;1728 (2008).</Citation><ArticleIdList><ArticleId IdType="pubmed">18927557</ArticleId></ArticleIdList></Reference><Reference><Citation>Fonseca-Ornelas L. et al., Altered conformation of &#x3b1;-synuclein drives dysfunction of synaptic vesicles in a synaptosomal model of Parkinson&#x2019;s disease. Cell Rep 36, 109333 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8552450</ArticleId><ArticleId IdType="pubmed">34233191</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheltens P. et al., Alzheimer&#x2019;s disease. Lancet 397, 1577&#x2013;1590 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8354300</ArticleId><ArticleId IdType="pubmed">33667416</ArticleId></ArticleIdList></Reference><Reference><Citation>Knopman D. S. et al., Alzheimer disease. Nat Rev Dis Primers 7, 33 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8574196</ArticleId><ArticleId IdType="pubmed">33986301</ArticleId></ArticleIdList></Reference><Reference><Citation>Festa G. et al., Aggregation States of A. Int J Mol Sci 20, (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6747079</ArticleId><ArticleId IdType="pubmed">31450543</ArticleId></ArticleIdList></Reference><Reference><Citation>Dulin F. et al., P3 peptide, a truncated form of A beta devoid of synaptotoxic effect, does not assemble into soluble oligomers. FEBS Lett 582, 1865&#x2013;1870 (2008).</Citation><ArticleIdList><ArticleId IdType="pubmed">18474239</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins L. S., Murphy G. M., Forno L. S., Catalano R., Cordell B., P3 beta-amyloid peptide has a unique and potentially pathogenic immunohistochemical profile in Alzheimer&#x2019;s disease brain. Am J Pathol 149, 585&#x2013;596 (1996).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1865300</ArticleId><ArticleId IdType="pubmed">8701997</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf3;pez M. de la Paz, L. Serrano, Sequence determinants of amyloid fibril formation. Proc Natl Acad Sci U S A 101, 87&#x2013;92 (2004).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC314143</ArticleId><ArticleId IdType="pubmed">14691246</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuhn A. J., Abrams B. S., Knowlton S., Raskatov J. A., Alzheimer&#x2019;s Disease &#x201c;Non-amyloidogenic&#x201d; p3 Peptide Revisited: A Case for Amyloid-&#x3b1;. ACS Chem Neurosci 11, 1539&#x2013;1544 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7443049</ArticleId><ArticleId IdType="pubmed">32412731</ArticleId></ArticleIdList></Reference><Reference><Citation>Saido T. C., Yamao-Harigaya W., Iwatsubo T., Kawashima S., Amino- and carboxyl-terminal heterogeneity of beta-amyloid peptides deposited in human brain. Neurosci Lett 215, 173&#x2013;176 (1996).</Citation><ArticleIdList><ArticleId IdType="pubmed">8899741</ArticleId></ArticleIdList></Reference><Reference><Citation>Lalowski M. et al., The &#x201c;nonamyloidogenic&#x201d; p3 fragment (amyloid beta17&#x2013;42) is a major constituent of Down&#x2019;s syndrome cerebellar preamyloid. J Biol Chem 271, 33623&#x2013;33631 (1996).</Citation><ArticleIdList><ArticleId IdType="pubmed">8969231</ArticleId></ArticleIdList></Reference><Reference><Citation>Gowing E. et al., Chemical characterization of A beta 17&#x2013;42 peptide, a component of diffuse amyloid deposits of Alzheimer disease. J Biol Chem 269, 10987&#x2013;10990 (1994).</Citation><ArticleIdList><ArticleId IdType="pubmed">8157623</ArticleId></ArticleIdList></Reference><Reference><Citation>Vadukul D. M. et al., Internalisation and toxicity of amyloid-&#x3b2; 1&#x2013;42 are influenced by its conformation and assembly state rather than size. FEBS Lett 594, 3490&#x2013;3503 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32871611</ArticleId></ArticleIdList></Reference><Reference><Citation>Wes&#xe9;n E., Jeffries G. D. M., Matson Dzebo M., Esbj&#xf6;rner E. K., Endocytic uptake of monomeric amyloid-&#x3b2; peptides is clathrin- and dynamin-independent and results in selective accumulation of A&#x3b2;(1&#x2013;42) compared to A&#x3b2;(1&#x2013;40). Sci Rep 7, 2021 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5435687</ArticleId><ArticleId IdType="pubmed">28515429</ArticleId></ArticleIdList></Reference><Reference><Citation>Ling D., Magallanes M., Salvaterra P. M., Accumulation of amyloid-like A&#x3b2;1&#x2013;42 in AEL (autophagy-endosomal-lysosomal) vesicles: potential implications for plaque biogenesis. ASN Neuro 6, (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4379859</ArticleId><ArticleId IdType="pubmed">24521233</ArticleId></ArticleIdList></Reference><Reference><Citation>Bahr B. A. et al., Amyloid beta protein is internalized selectively by hippocampal field CA1 and causes neurons to accumulate amyloidogenic carboxyterminal fragments of the amyloid precursor protein. J Comp Neurol 397, 139&#x2013;147 (1998).</Citation><ArticleIdList><ArticleId IdType="pubmed">9671284</ArticleId></ArticleIdList></Reference><Reference><Citation>Sotthibundhu A. et al., Beta-amyloid(1&#x2013;42) induces neuronal death through the p75 neurotrophin receptor. J Neurosci 28, 3941&#x2013;3946 (2008).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6670462</ArticleId><ArticleId IdType="pubmed">18400893</ArticleId></ArticleIdList></Reference><Reference><Citation>Coulson E. J. et al., p75 neurotrophin receptor mediates neuronal cell death by activating GIRK channels through phosphatidylinositol 4,5-bisphosphate. J Neurosci 28, 315&#x2013;324 (2008).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6671158</ArticleId><ArticleId IdType="pubmed">18171948</ArticleId></ArticleIdList></Reference><Reference><Citation>Weissmiller A. M. et al., A &#x3b3;-secretase inhibitor, but not a &#x3b3;-secretase modulator, induced defects in BDNF axonal trafficking and signaling: evidence for a role for APP. PLoS One 10, e0118379 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4339551</ArticleId><ArticleId IdType="pubmed">25710492</ArticleId></ArticleIdList></Reference><Reference><Citation>Sawa M. et al., Impact of increased APP gene dose in Down syndrome and the Dp16 mouse model. Alzheimers Dement 18, 1203&#x2013;1234 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9085977</ArticleId><ArticleId IdType="pubmed">34757693</ArticleId></ArticleIdList></Reference><Reference><Citation>Salehi A. et al., Increased App expression in a mouse model of Down&#x2019;s syndrome disrupts NGF transport and causes cholinergic neuron degeneration. Neuron 51, 29&#x2013;42 (2006).</Citation><ArticleIdList><ArticleId IdType="pubmed">16815330</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang Y. et al., Lysosomal Dysfunction in Down Syndrome Is APP-Dependent and Mediated by APP-&#x3b2;CTF (C99). J Neurosci 39, 5255&#x2013;5268 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6607756</ArticleId><ArticleId IdType="pubmed">31043483</ArticleId></ArticleIdList></Reference><Reference><Citation>Hou P. et al., The &#x3b3;-secretase substrate proteome and its role in cell signaling regulation. Mol Cell 83, 4106&#x2013;4122.e4110 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">37977120</ArticleId></ArticleIdList></Reference><Reference><Citation>Koch M. et al., APP substrate ectodomain defines amyloid-&#x3b2; peptide length by restraining &#x3b3;-secretase processivity and facilitating product release. EMBO J 42, e114372 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10690472</ArticleId><ArticleId IdType="pubmed">37853914</ArticleId></ArticleIdList></Reference><Reference><Citation>McInnes J. et al., Synaptogyrin-3 Mediates Presynaptic Dysfunction Induced by Tau. Neuron 97, 823&#x2013;835.e828 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">29398363</ArticleId></ArticleIdList></Reference><Reference><Citation>Ittner L. M. et al., Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer&#x2019;s disease mouse models. Cell 142, 387&#x2013;397 (2010).</Citation><ArticleIdList><ArticleId IdType="pubmed">20655099</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberson E. D. et al., Reducing endogenous tau ameliorates amyloid beta-induced deficits in an Alzheimer&#x2019;s disease mouse model. Science 316, 750&#x2013;754 (2007).</Citation><ArticleIdList><ArticleId IdType="pubmed">17478722</ArticleId></ArticleIdList></Reference><Reference><Citation>Spires-Jones T. L., Hyman B. T., The intersection of amyloid beta and tau at synapses in Alzheimer&#x2019;s disease. Neuron 82, 756&#x2013;771 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4135182</ArticleId><ArticleId IdType="pubmed">24853936</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrer-Ravent&#xf3;s P. et al., Amyloid precursor protein. Neuropathol Appl Neurobiol 49, e12879 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">36702749</ArticleId></ArticleIdList></Reference><Reference><Citation>Pera M. et al., Distinct patterns of APP processing in the CNS in autosomal-dominant and sporadic Alzheimer disease. Acta Neuropathol 125, 201&#x2013;213 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3623032</ArticleId><ArticleId IdType="pubmed">23224319</ArticleId></ArticleIdList></Reference><Reference><Citation>Szaruga M. et al., Qualitative changes in human &#x3b3;-secretase underlie familial Alzheimer&#x2019;s disease. J Exp Med 212, 2003&#x2013;2013 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4647268</ArticleId><ArticleId IdType="pubmed">26481686</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen J., Kelleher R. J., The presenilin hypothesis of Alzheimer&#x2019;s disease: evidence for a loss-of-function pathogenic mechanism. Proc Natl Acad Sci U S A 104, 403&#x2013;409 (2007).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1766397</ArticleId><ArticleId IdType="pubmed">17197420</ArticleId></ArticleIdList></Reference><Reference><Citation>Maesako M. et al., Pathogenic PS1 phosphorylation at Ser367. Elife 6, (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5279945</ArticleId><ArticleId IdType="pubmed">28132667</ArticleId></ArticleIdList></Reference><Reference><Citation>Chavez-Gutierrez L. et al., The mechanism of gamma-Secretase dysfunction in familial Alzheimer disease. EMBO J 31, 2261&#x2013;2274 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3364747</ArticleId><ArticleId IdType="pubmed">22505025</ArticleId></ArticleIdList></Reference><Reference><Citation>Gore A. et al., Somatic coding mutations in human induced pluripotent stem cells. Nature 471, 63&#x2013;67 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3074107</ArticleId><ArticleId IdType="pubmed">21368825</ArticleId></ArticleIdList></Reference><Reference><Citation>Young J. E. et al., Elucidating molecular phenotypes caused by the SORL1 Alzheimer&#x2019;s disease genetic risk factor using human induced pluripotent stem cells. Cell Stem Cell 16, 373&#x2013;385 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4388804</ArticleId><ArticleId IdType="pubmed">25772071</ArticleId></ArticleIdList></Reference><Reference><Citation>Fong L. K. et al., Full-length amyloid precursor protein regulates lipoprotein metabolism and amyloid-&#x3b2; clearance in human astrocytes. J Biol Chem 293, 11341&#x2013;11357 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6065173</ArticleId><ArticleId IdType="pubmed">29858247</ArticleId></ArticleIdList></Reference><Reference><Citation>Das U. et al., Activity-induced convergence of APP and BACE-1 in acidic microdomains via an endocytosis-dependent pathway. Neuron 79, 447&#x2013;460 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3741682</ArticleId><ArticleId IdType="pubmed">23931995</ArticleId></ArticleIdList></Reference><Reference><Citation>Shankar G. M., Welzel A. T., McDonald J. M., Selkoe D. J., Walsh D. M., Isolation of low-n amyloid &#x3b2;-protein oligomers from cultured cells, CSF, and brain. Methods Mol Biol 670, 33&#x2013;44 (2011).</Citation><ArticleIdList><ArticleId IdType="pubmed">20967581</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson-Wood K. et al., Amyloid precursor protein processing and A beta42 deposition in a transgenic mouse model of Alzheimer disease. Proc Natl Acad Sci U S A 94, 1550&#x2013;1555 (1997).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC19829</ArticleId><ArticleId IdType="pubmed">9037091</ArticleId></ArticleIdList></Reference><Reference><Citation>Wickham H., in Use R!,. (Springer International Publishing : Imprint: Springer,, Cham, 2016), pp. 1 online resource (XVI, 260 pages 232 illustrations, 140 illustrations in color.</Citation></Reference><Reference><Citation>Wickham H.. (Journal of Statistical Software, 2007), vol. 21, pp. 1&#x2013;20.</Citation></Reference><Reference><Citation>Wickham H.. (Journal of Statistical Software, 2011), vol. 40, pp. 1&#x2013;29.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37578787</PMID><DateCompleted><Year>2023</Year><Month>10</Month><Day>10</Day></DateCompleted><DateRevised><Year>2024</Year><Month>05</Month><Day>01</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2168-6157</ISSN><JournalIssue CitedMedium="Internet"><Volume>80</Volume><Issue>10</Issue><PubDate><Year>2023</Year><Month>Oct</Month><Day>01</Day></PubDate></JournalIssue><Title>JAMA neurology</Title><ISOAbbreviation>JAMA Neurol</ISOAbbreviation></Journal><ArticleTitle>Increased Medial Temporal Tau Positron Emission Tomography Uptake in the Absence of Amyloid-&#x3b2; Positivity.</ArticleTitle><Pagination><StartPage>1051</StartPage><EndPage>1061</EndPage><MedlinePgn>1051-1061</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1001/jamaneurol.2023.2560</ELocationID><Abstract><AbstractText Label="IMPORTANCE">An increased tau positron emission tomography (PET) signal in the medial temporal lobe (MTL) has been observed in older individuals in the absence of amyloid-&#x3b2; (A&#x3b2;) pathology. Little is known about the longitudinal course of this condition, and its association with Alzheimer disease (AD) remains unclear.</AbstractText><AbstractText Label="OBJECTIVE">To study the pathologic and clinical course of older individuals with PET-evidenced MTL tau deposition (TMTL+) in the absence of A&#x3b2; pathology (A-), and the association of this condition with the AD continuum.</AbstractText><AbstractText Label="DESIGN, SETTING, AND PARTICIPANTS">A multicentric, observational, longitudinal cohort study was conducted using pooled data from the Alzheimer's Disease Neuroimaging Initiative (ADNI), Harvard Aging Brain Study (HABS), and the AVID-A05 study, collected between July 2, 2015, and August 23, 2021. Participants in the ADNI, HABS, and AVID-A05 studies (N&#x2009;=&#x2009;1093) with varying degrees of cognitive performance were deemed eligible if they had available tau PET, A&#x3b2; PET, and magnetic resonance imaging scans at baseline. Of these, 128 participants did not meet inclusion criteria based on A&#x3b2; PET and tau PET biomarker profiles (A+ TMTL-).</AbstractText><AbstractText Label="EXPOSURES">Tau and A&#x3b2; PET, magnetic resonance imaging, cerebrospinal fluid biomarkers, and cognitive assessments.</AbstractText><AbstractText Label="MAIN OUTCOMES AND MEASURES">Cross-sectional and longitudinal measures for tau and A&#x3b2; PET, cortical atrophy, cognitive scores, and core AD cerebrospinal fluid biomarkers (A&#x3b2;42/40 and tau phosphorylated at threonine 181 p-tau181 available in a subset).</AbstractText><AbstractText Label="RESULTS">Among the 965 individuals included in the study, 503 were women (52.1%) and the mean (SD) age was 73.9 (8.1) years. A total of 51% of A- individuals and 78% of A+ participants had increased tau PET signal in the entorhinal cortex (TMTL+) compared with healthy younger (aged &lt;39 years) controls. Compared with A- TMTL-, A- TMTL+ participants showed statistically significant, albeit moderate, longitudinal (mean [SD], 1.83 [0.84] years) tau PET increases that were largely limited to the temporal lobe, whereas those with A+ TMTL+ showed faster and more cortically widespread tau PET increases. In contrast to participants with A+ TMTL+, those with A- TMTL+ did not show any noticeable A&#x3b2; accumulation over follow-up (mean [SD], 2.36 [0.76] years). Complementary cerebrospinal fluid analysis confirmed longitudinal p-tau181 increases in A- TMTL+ in the absence of increased A&#x3b2; accumulation. Participants with A- TMTL+ had accelerated MTL atrophy, whereas those with A+ TMTL+ showed accelerated atrophy in widespread temporoparietal brain regions. Increased MTL tau PET uptake in A- individuals was associated with cognitive decline, but at a significantly slower rate compared with A+ TMTL+.</AbstractText><AbstractText Label="CONCLUSIONS AND RELEVANCE">In this study, individuals with A- TMTL+ exhibited progressive tau accumulation and neurodegeneration, but these processes were comparably slow, remained largely restricted to the MTL, were associated with only subtle changes in global cognitive performance, and were not accompanied by detectable accumulation of A&#x3b2; biomarkers. These data suggest that individuals with A- TMTL+ are not on a pathologic trajectory toward AD.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Costoya-S&#xe1;nchez</LastName><ForeName>Alejandro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Universidade de Santiago de Compostela, Santiago de Compostela, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Nuclear Medicine Department and Molecular Imaging Group, Instituto de Investigaci&#xf3;n Sanitaria de Santiago de Compostel, Traves&#xed;a da Choupana s/n, Santiago de Compostela, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red sobre Enfermedades Neurodegenerativas, Instituto de Salud Carlos III, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moscoso</LastName><ForeName>Alexis</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Wallenberg Centre for Molecular and Translational Medicine, University of Gothenburg, Gothenburg, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychiatry and Neurochemistry, Institute of Physiology and Neuroscience, University of Gothenburg, Gothenburg, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Silva-Rodr&#xed;guez</LastName><ForeName>Jes&#xfa;s</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red sobre Enfermedades Neurodegenerativas, Instituto de Salud Carlos III, Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Unidad de Trastornos del Movimiento, Servicio de Neurolog&#xed;a y Neurofisiolog&#xed;a Cl&#xed;nica, Instituto de Biomedicina de Sevilla, Hospital Universitario Virgen del Roc&#xed;o/CSIC/Universidad de Sevilla, Seville, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pontecorvo</LastName><ForeName>Michael J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Avid Radiopharmaceuticals, Philadelphia, Pennsylvania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Eli Lilly and Company, Indianapolis, Indiana.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Devous</LastName><ForeName>Michael D</ForeName><Initials>MD</Initials><Suffix>Sr</Suffix><AffiliationInfo><Affiliation>Avid Radiopharmaceuticals, Philadelphia, Pennsylvania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Eli Lilly and Company, Indianapolis, Indiana.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aguiar</LastName><ForeName>Pablo</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Universidade de Santiago de Compostela, Santiago de Compostela, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Nuclear Medicine Department and Molecular Imaging Group, Instituto de Investigaci&#xf3;n Sanitaria de Santiago de Compostel, Traves&#xed;a da Choupana s/n, Santiago de Compostela, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red sobre Enfermedades Neurodegenerativas, Instituto de Salud Carlos III, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sch&#xf6;ll</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Wallenberg Centre for Molecular and Translational Medicine, University of Gothenburg, Gothenburg, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychiatry and Neurochemistry, Institute of Physiology and Neuroscience, University of Gothenburg, Gothenburg, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Dementia Research Centre, Institute of Neurology, University College London, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grothe</LastName><ForeName>Michel J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red sobre Enfermedades Neurodegenerativas, Instituto de Salud Carlos III, Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Wallenberg Centre for Molecular and Translational Medicine, University of Gothenburg, Gothenburg, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Unidad de Trastornos del Movimiento, Servicio de Neurolog&#xed;a y Neurofisiolog&#xed;a Cl&#xed;nica, Instituto de Biomedicina de Sevilla, Hospital Universitario Virgen del Roc&#xed;o/CSIC/Universidad de Sevilla, Seville, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>Alzheimer&#x2019;s Disease Neuroimaging Initiative and the Harvard Aging Brain Study</CollectiveName></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P01 AG036694</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AG072972</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016420">Comment</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JAMA Neurol</MedlineTA><NlmUniqueID>101589536</NlmUniqueID><ISSNLinking>2168-6149</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016875">tau Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016229">Amyloid beta-Peptides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentOn"><RefSource>JAMA Neurol. 2023 Oct 1;80(10):1025-1027. doi: 10.1001/jamaneurol.2023.1081.</RefSource><PMID Version="1">37578768</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000134" MajorTopicYN="N">cerebrospinal fluid</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008137" MajorTopicYN="N">Longitudinal Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016875" MajorTopicYN="N">tau Proteins</DescriptorName><QualifierName UI="Q000134" MajorTopicYN="N">cerebrospinal fluid</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016229" MajorTopicYN="N">Amyloid beta-Peptides</DescriptorName><QualifierName UI="Q000134" MajorTopicYN="N">cerebrospinal fluid</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D049268" MajorTopicYN="N">Positron-Emission Tomography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000134" MajorTopicYN="N">cerebrospinal fluid</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001284" MajorTopicYN="N">Atrophy</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement><b>Conflict of Interest Disclosures:</b> Dr Silva-Rodr&#xed;guez reported that he is a founder and advisor for Qubiotech Health Intelligence SL, a company commercializing neuroimaging quantification software. Dr Pontecorvo reported being an Eli Lilly and Company employee and minor stockholder outside the submitted work. Dr Devous reported being an Eli Lilly and Company employee and minor stockholder outside the submitted work. Dr Aguiar reported being a cofounder of Qubiotech Health Intelligence SL. Dr Sch&#xf6;ll has served on advisory boards for Roche and Novo Nordisk (outside scope of submitted work). No other disclosures were reported.</CoiStatement><InvestigatorList><Investigator ValidYN="Y"><LastName>Weiner</LastName><ForeName>Michael W</ForeName><Initials>MW</Initials></Investigator><Investigator ValidYN="Y"><LastName>Aisen</LastName><ForeName>Paul</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Petersen</LastName><ForeName>Ronald</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jack</LastName><ForeName>Clifford R</ForeName><Initials>CR</Initials><Suffix>Jr</Suffix></Investigator><Investigator ValidYN="Y"><LastName>Jagust</LastName><ForeName>William</ForeName><Initials>W</Initials></Investigator><Investigator ValidYN="Y"><LastName>Trojanowki</LastName><ForeName>John Q</ForeName><Initials>JQ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Toga</LastName><ForeName>Arthur W</ForeName><Initials>AW</Initials></Investigator><Investigator ValidYN="Y"><LastName>Beckett</LastName><ForeName>Laurel</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Green</LastName><ForeName>Robert C</ForeName><Initials>RC</Initials></Investigator><Investigator ValidYN="Y"><LastName>Saykin</LastName><ForeName>Andrew J</ForeName><Initials>AJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Morris</LastName><ForeName>John C</ForeName><Initials>JC</Initials></Investigator><Investigator ValidYN="Y"><LastName>Perrin</LastName><ForeName>Richard J</ForeName><Initials>RJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Shaw</LastName><ForeName>Leslie M</ForeName><Initials>LM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Khachaturian</LastName><ForeName>Zaven</ForeName><Initials>Z</Initials></Investigator><Investigator ValidYN="Y"><LastName>Carrillo</LastName><ForeName>Maria</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Potter</LastName><ForeName>William</ForeName><Initials>W</Initials></Investigator><Investigator ValidYN="Y"><LastName>Barnes</LastName><ForeName>Lisa</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bernard</LastName><ForeName>Marie</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gonzalez</LastName><ForeName>Hector</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ho</LastName><ForeName>Carole</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hsiao</LastName><ForeName>John K</ForeName><Initials>JK</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jackson</LastName><ForeName>Jonathan</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Masliah</LastName><ForeName>Eliezer</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Masterman</LastName><ForeName>Donna</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Okonkwo</LastName><ForeName>Ozioma</ForeName><Initials>O</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ryan</LastName><ForeName>Laurie</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Silverberg</LastName><ForeName>Nina</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fleisher</LastName><ForeName>Adam</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sacrey</LastName><ForeName>Diana T</ForeName><Initials>DT</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fockler</LastName><ForeName>Juliet</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Conti</LastName><ForeName>Cat</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Veitch</LastName><ForeName>Dallas</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Neuhaus</LastName><ForeName>John</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jin</LastName><ForeName>Chengshi</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nosheny</LastName><ForeName>Rachel</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ashford</LastName><ForeName>Mariam</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Flenniken</LastName><ForeName>Derek</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kormos</LastName><ForeName>Adrienne</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Montine</LastName><ForeName>Tom</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rafii</LastName><ForeName>Michael</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Raman</LastName><ForeName>Rema</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jimenez</LastName><ForeName>Gustavo</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Donohue</LastName><ForeName>Michael</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gessert</LastName><ForeName>Devon</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Salazar</LastName><ForeName>Jennifer</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zimmerman</LastName><ForeName>Caileigh</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cabrera</LastName><ForeName>Yuliana</ForeName><Initials>Y</Initials></Investigator><Investigator ValidYN="Y"><LastName>Walter</LastName><ForeName>Sarah</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Miller</LastName><ForeName>Garrett</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Coker</LastName><ForeName>Godfrey</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Clanton</LastName><ForeName>Taylor</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hergesheimer</LastName><ForeName>Lindsey</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Smith</LastName><ForeName>Stephanie</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Adegoke</LastName><ForeName>Olusegun</ForeName><Initials>O</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mahboubi</LastName><ForeName>Payam</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Moore</LastName><ForeName>Shelley</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pizzola</LastName><ForeName>Jeremy</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Shaffer</LastName><ForeName>Elizabeth</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Harvey</LastName><ForeName>Danielle</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Forghanian-Arani</LastName><ForeName>Arvin</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Borowski</LastName><ForeName>Bret</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ward</LastName><ForeName>Chad</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Schwarz</LastName><ForeName>Christopher</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jones</LastName><ForeName>David</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gunter</LastName><ForeName>Jeff</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kantarci</LastName><ForeName>Kejal</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Senjem</LastName><ForeName>Matthew</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vemuri</LastName><ForeName>Prashanthi</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Reid</LastName><ForeName>Robert</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fox</LastName><ForeName>Nick C</ForeName><Initials>NC</Initials></Investigator><Investigator ValidYN="Y"><LastName>Malone</LastName><ForeName>Ian</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Thompson</LastName><ForeName>Paul</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Thomopoulos</LastName><ForeName>Sophia I</ForeName><Initials>SI</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nir</LastName><ForeName>Talia M</ForeName><Initials>TM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jahanshad</LastName><ForeName>Neda</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>DeCarli</LastName><ForeName>Charles</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Knaack</LastName><ForeName>Alexander</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fletcher</LastName><ForeName>Evan</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tosun-Turgut</LastName><ForeName>Duygu</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chen</LastName><ForeName>Stephanie R</ForeName><Initials>SR</Initials></Investigator><Investigator ValidYN="Y"><LastName>Choe</LastName><ForeName>Mark</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Crawford</LastName><ForeName>Karen</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Yuschkevich</LastName><ForeName>Paul A</ForeName><Initials>PA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Das</LastName><ForeName>Sandhitsu</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Koeppe</LastName><ForeName>Robert A</ForeName><Initials>RA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Reiman</LastName><ForeName>Eric M</ForeName><Initials>EM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chen</LastName><ForeName>Kewei</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mathis</LastName><ForeName>Chet</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Landau</LastName><ForeName>Susan</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cairns</LastName><ForeName>Nigel J</ForeName><Initials>NJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Householder</LastName><ForeName>Erin</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Franklin</LastName><ForeName>Erin</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bernhardt</LastName><ForeName>Haley</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Taylor-Reinwald</LastName><ForeName>Lisa</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Korecka</LastName><ForeName>Magdalena</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Figurski</LastName><ForeName>Michal</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Neu</LastName><ForeName>Scott</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nho</LastName><ForeName>Kwangsik</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Risacher</LastName><ForeName>Shannon L</ForeName><Initials>SL</Initials></Investigator><Investigator ValidYN="Y"><LastName>Apostolova</LastName><ForeName>Liana G</ForeName><Initials>LG</Initials></Investigator><Investigator ValidYN="Y"><LastName>Shen</LastName><ForeName>Li</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Foroud</LastName><ForeName>Tatiana M</ForeName><Initials>TM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nudelman</LastName><ForeName>Kelly</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Faber</LastName><ForeName>Kelley</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wilmes</LastName><ForeName>Kristi</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Thal</LastName><ForeName>Leon</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Johnson</LastName><ForeName>Keith A</ForeName><Initials>KA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sperling</LastName><ForeName>Reisa A</ForeName><Initials>RA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rentz</LastName><ForeName>Dorene</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>E Amariglio</LastName><ForeName>Rebecca</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Blacker</LastName><ForeName>Deborah</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Buckley</LastName><ForeName>Rachel</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chhatwal</LastName><ForeName>Jasmeer P</ForeName><Initials>JP</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dickerson</LastName><ForeName>Brad</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Donovan</LastName><ForeName>Nancy</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Farrell</LastName><ForeName>Michelle</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gagliardi</LastName><ForeName>Geoffroy</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gatchel</LastName><ForeName>Jennifer</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Guzman-Velez</LastName><ForeName>Edmarie</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jacobs</LastName><ForeName>Heidi</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jutten</LastName><ForeName>Roos</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lois Gomez</LastName><ForeName>Cristina</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Marshall</LastName><ForeName>Gad</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Oaoo</LastName><ForeName>Kate</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pardilla-Delgado</LastName><ForeName>Enmanuelle</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Price</LastName><ForeName>Juliet</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Prokopiou</LastName><ForeName>Prokopis</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Quiroz</LastName><ForeName>Yakeel</ForeName><Initials>Y</Initials></Investigator><Investigator ValidYN="Y"><LastName>Reynolds</LastName><ForeName>Gretchen</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Schultz</LastName><ForeName>Aaron</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Schultz</LastName><ForeName>Stephanie</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sepulcre</LastName><ForeName>Jorge</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Skylar-Scott</LastName><ForeName>Irina</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vannini</LastName><ForeName>Patrizia</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vila-Castelar</LastName><ForeName>Clara</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Yang</LastName><ForeName>Hyun-Sik</ForeName><Initials>HS</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>10</Month><Day>10</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>8</Month><Day>14</Day><Hour>12</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>8</Month><Day>14</Day><Hour>11</Hour><Minute>35</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>8</Month><Day>14</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37578787</ArticleId><ArticleId IdType="pmc">PMC10425864</ArticleId><ArticleId IdType="doi">10.1001/jamaneurol.2023.2560</ArticleId><ArticleId IdType="pii">2808497</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Duyckaerts C, Delatour B, Potier M-C. Classification and basic pathology of Alzheimer disease. Acta Neuropathol. 2009;118(1):5-36. doi:10.1007/s00401-009-0532-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-009-0532-1</ArticleId><ArticleId IdType="pubmed">19381658</ArticleId></ArticleIdList></Reference><Reference><Citation>Serrano-Pozo A, Frosch MP, Masliah E, Hyman BT. Neuropathological alterations in Alzheimer disease. Cold Spring Harb Perspect Med. 2011;1(1):a006189-a006189. doi:10.1101/cshperspect.a006189</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a006189</ArticleId><ArticleId IdType="pmc">PMC3234452</ArticleId><ArticleId IdType="pubmed">22229116</ArticleId></ArticleIdList></Reference><Reference><Citation>Bennett DA, Schneider JA, Wilson RS, Bienias JL, Arnold SE. Neurofibrillary tangles mediate the association of amyloid load with clinical Alzheimer disease and level of cognitive function. Arch Neurol. 2004;61(3):378-384. doi:10.1001/archneur.61.3.378</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneur.61.3.378</ArticleId><ArticleId IdType="pubmed">15023815</ArticleId></ArticleIdList></Reference><Reference><Citation>Braak H, Thal DR, Ghebremedhin E, Del Tredici K. Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years. J Neuropathol Exp Neurol. 2011;70(11):960-969. doi:10.1097/NEN.0b013e318232a379</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/NEN.0b013e318232a379</ArticleId><ArticleId IdType="pubmed">22002422</ArticleId></ArticleIdList></Reference><Reference><Citation>Crary JF, Trojanowski JQ, Schneider JA, et al. . Primary age-related tauopathy (PART): a common pathology associated with human aging. Acta Neuropathol. 2014;128(6):755-766. doi:10.1007/s00401-014-1349-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-014-1349-0</ArticleId><ArticleId IdType="pmc">PMC4257842</ArticleId><ArticleId IdType="pubmed">25348064</ArticleId></ArticleIdList></Reference><Reference><Citation>Josephs KA, Murray ME, Tosakulwong N, et al. . Tau aggregation influences cognition and hippocampal atrophy in the absence of beta-amyloid: a clinico-imaging-pathological study of primary age-related tauopathy (PART). Acta Neuropathol. 2017;133(5):705-715. doi:10.1007/s00401-017-1681-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-017-1681-2</ArticleId><ArticleId IdType="pmc">PMC6091858</ArticleId><ArticleId IdType="pubmed">28160067</ArticleId></ArticleIdList></Reference><Reference><Citation>Besser LM, Crary JF, Mock C, Kukull WA. Comparison of symptomatic and asymptomatic persons with primary age-related tauopathy. Neurology. 2017;89(16):1707-1715. doi:10.1212/WNL.0000000000004521</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000004521</ArticleId><ArticleId IdType="pmc">PMC5644462</ArticleId><ArticleId IdType="pubmed">28916532</ArticleId></ArticleIdList></Reference><Reference><Citation>Jefferson-George KS, Wolk DA, Lee EB, McMillan CT. Cognitive decline associated with pathological burden in primary age-related tauopathy. Alzheimers Dement. 2017;13(9):1048-1053. doi:10.1016/j.jalz.2017.01.028</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2017.01.028</ArticleId><ArticleId IdType="pmc">PMC5585025</ArticleId><ArticleId IdType="pubmed">28322204</ArticleId></ArticleIdList></Reference><Reference><Citation>Bell WR, An Y, Kageyama Y, et al. . Neuropathologic, genetic, and longitudinal cognitive profiles in primary age-related tauopathy (PART) and Alzheimer&#x2019;s disease. Alzheimers Dement. 2019;15(1):8-16. doi:10.1016/j.jalz.2018.07.215</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2018.07.215</ArticleId><ArticleId IdType="pmc">PMC6542566</ArticleId><ArticleId IdType="pubmed">30465754</ArticleId></ArticleIdList></Reference><Reference><Citation>Besser LM, Mock C, Teylan MA, Hassenstab J, Kukull WA, Crary JF. Differences in cognitive impairment in primary age-related tauopathy versus Alzheimer disease. J Neuropathol Exp Neurol. 2019;78(3):219-228. doi:10.1093/jnen/nly132</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jnen/nly132</ArticleId><ArticleId IdType="pmc">PMC6380319</ArticleId><ArticleId IdType="pubmed">30715383</ArticleId></ArticleIdList></Reference><Reference><Citation>Jack CR Jr, Bennett DA, Blennow K, et al. ; Contributors . NIA-AA Research Framework: toward a biological definition of Alzheimer&#x2019;s disease. Alzheimers Dement. 2018;14(4):535-562. doi:10.1016/j.jalz.2018.02.018</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2018.02.018</ArticleId><ArticleId IdType="pmc">PMC5958625</ArticleId><ArticleId IdType="pubmed">29653606</ArticleId></ArticleIdList></Reference><Reference><Citation>Duyckaerts C, Braak H, Brion JP, et al. . PART is part of Alzheimer disease. Acta Neuropathol. 2015;129(5):749-756. doi:10.1007/s00401-015-1390-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-015-1390-7</ArticleId><ArticleId IdType="pmc">PMC4405349</ArticleId><ArticleId IdType="pubmed">25628035</ArticleId></ArticleIdList></Reference><Reference><Citation>Jellinger KA, Alafuzoff I, Attems J, et al. . PART, a distinct tauopathy, different from classical sporadic Alzheimer disease. Acta Neuropathol. 2015;129(5):757-762. doi:10.1007/s00401-015-1407-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-015-1407-2</ArticleId><ArticleId IdType="pmc">PMC4534004</ArticleId><ArticleId IdType="pubmed">25778618</ArticleId></ArticleIdList></Reference><Reference><Citation>Jack CR Jr. PART and SNAP. Acta Neuropathol. 2014;128(6):773-776. doi:10.1007/s00401-014-1362-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-014-1362-3</ArticleId><ArticleId IdType="pmc">PMC4231211</ArticleId><ArticleId IdType="pubmed">25380757</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoon B, Guo T, Provost K, et al. ; Alzheimer&#x2019;s Disease Neuroimaging Initiative . Abnormal tau in amyloid PET negative individuals. Neurobiol Aging. 2022;109:125-134. doi:10.1016/j.neurobiolaging.2021.09.019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2021.09.019</ArticleId><ArticleId IdType="pmc">PMC9695003</ArticleId><ArticleId IdType="pubmed">34715443</ArticleId></ArticleIdList></Reference><Reference><Citation>Altomare D, Caprioglio C, Assal F, et al. . Diagnostic value of amyloid-PET and tau-PET: a head-to-head comparison. Eur J Nucl Med Mol Imaging. 2021;48(7):2200-2211. doi:10.1007/s00259-021-05246-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00259-021-05246-x</ArticleId><ArticleId IdType="pmc">PMC8175315</ArticleId><ArticleId IdType="pubmed">33638661</ArticleId></ArticleIdList></Reference><Reference><Citation>Weigand AJ, Bangen KJ, Thomas KR, et al. ; Alzheimer&#x2019;s Disease Neuroimaging Initiative . Is tau in the absence of amyloid on the Alzheimer&#x2019;s continuum? a study of discordant PET positivity. Brain Commun. 2020;2(1):fcz046. doi:10.1093/braincomms/fcz046</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/braincomms/fcz046</ArticleId><ArticleId IdType="pmc">PMC7001143</ArticleId><ArticleId IdType="pubmed">32051933</ArticleId></ArticleIdList></Reference><Reference><Citation>Jagust WJ, Landau SM, Shaw LM, et al. ; Alzheimer&#x2019;s Disease Neuroimaging Initiative . Relationships between biomarkers in aging and dementia. Neurology. 2009;73(15):1193-1199. doi:10.1212/WNL.0b013e3181bc010c</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e3181bc010c</ArticleId><ArticleId IdType="pmc">PMC2764726</ArticleId><ArticleId IdType="pubmed">19822868</ArticleId></ArticleIdList></Reference><Reference><Citation>Dagley A, LaPoint M, Huijbers W, et al. . Harvard Aging Brain Study: dataset and accessibility. Neuroimage. 2017;144(pt B):255-258. doi:10.1016/j.neuroimage.2015.03.069</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroimage.2015.03.069</ArticleId><ArticleId IdType="pmc">PMC4592689</ArticleId><ArticleId IdType="pubmed">25843019</ArticleId></ArticleIdList></Reference><Reference><Citation>Braak H, Alafuzoff I, Arzberger T, Kretzschmar H, Del Tredici K. Staging of Alzheimer disease&#x2013;associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol. 2006;112(4):389-404. doi:10.1007/s00401-006-0127-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-006-0127-z</ArticleId><ArticleId IdType="pmc">PMC3906709</ArticleId><ArticleId IdType="pubmed">16906426</ArticleId></ArticleIdList></Reference><Reference><Citation>Biel D, Brendel M, Rubinski A, et al. ; Alzheimer&#x2019;s Disease Neuroimaging Initiative (ADNI) . Tau-PET and in vivo Braak-staging as prognostic markers of future cognitive decline in cognitively normal to demented individuals. Alzheimers Res Ther. 2021;13(1):137. doi:10.1186/s13195-021-00880-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13195-021-00880-x</ArticleId><ArticleId IdType="pmc">PMC8361801</ArticleId><ArticleId IdType="pubmed">34384484</ArticleId></ArticleIdList></Reference><Reference><Citation>Jagust WJ, Bandy D, Chen K, et al. ; Alzheimer&#x2019;s Disease Neuroimaging Initiative . The Alzheimer&#x2019;s Disease Neuroimaging Initiative positron emission tomography core. Alzheimers Dement. 2010;6(3):221-229. doi:10.1016/j.jalz.2010.03.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2010.03.003</ArticleId><ArticleId IdType="pmc">PMC2920531</ArticleId><ArticleId IdType="pubmed">20451870</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf3;pez-Gonz&#xe1;lez FJ, Costoya-S&#xe1;nchez A, Paredes-Pacheco J, Moscoso A, Silva-Rodr&#xed;guez J, Aguiar P; Alzheimer&#x2019;s Disease Neuroimaging Initiative . Impact of spill-in counts from off-target regions on [18F]flortaucipir PET quantification. Neuroimage. 2022;259:119396. doi:10.1016/j.neuroimage.2022.119396</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroimage.2022.119396</ArticleId><ArticleId IdType="pubmed">35753593</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas BA, Erlandsson K, Modat M, et al. . The importance of appropriate partial volume correction for PET quantification in Alzheimer&#x2019;s disease. Eur J Nucl Med Mol Imaging. 2011;38(6):1104-1119. doi:10.1007/s00259-011-1745-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00259-011-1745-9</ArticleId><ArticleId IdType="pubmed">21336694</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas BA, Cuplov V, Bousse A, et al. . PETPVC: a toolbox for performing partial volume correction techniques in positron emission tomography. Phys Med Biol. 2016;61(22):7975-7993. doi:10.1088/0031-9155/61/22/7975</Citation><ArticleIdList><ArticleId IdType="doi">10.1088/0031-9155/61/22/7975</ArticleId><ArticleId IdType="pubmed">27779136</ArticleId></ArticleIdList></Reference><Reference><Citation>Baker SL, Maass A, Jagust WJ. Considerations and code for partial volume correcting [18F]-AV-1451 tau PET data. Data Brief. 2017;15:648-657. doi:10.1016/j.dib.2017.10.024</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dib.2017.10.024</ArticleId><ArticleId IdType="pmc">PMC5671473</ArticleId><ArticleId IdType="pubmed">29124088</ArticleId></ArticleIdList></Reference><Reference><Citation>Klunk WE, Koeppe RA, Price JC, et al. . The Centiloid Project: standardizing quantitative amyloid plaque estimation by PET. Alzheimers Dement. 2015;11(1):1-15.e1, 4. doi:10.1016/j.jalz.2014.07.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2014.07.003</ArticleId><ArticleId IdType="pmc">PMC4300247</ArticleId><ArticleId IdType="pubmed">25443857</ArticleId></ArticleIdList></Reference><Reference><Citation>Dale AM, Fischl B, Sereno MI. Cortical surface-based analysis, I: segmentation and surface reconstruction. Neuroimage. 1999;9(2):179-194. doi:10.1006/nimg.1998.0395</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/nimg.1998.0395</ArticleId><ArticleId IdType="pubmed">9931268</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischl B, Sereno MI, Dale AM. Cortical surface-based analysis, II: inflation, flattening, and a surface-based coordinate system. Neuroimage. 1999;9(2):195-207. doi:10.1006/nimg.1998.0396</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/nimg.1998.0396</ArticleId><ArticleId IdType="pubmed">9931269</ArticleId></ArticleIdList></Reference><Reference><Citation>Diedrichsen J. A spatially unbiased atlas template of the human cerebellum. Neuroimage. 2006;33(1):127-138. doi:10.1016/j.neuroimage.2006.05.056</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroimage.2006.05.056</ArticleId><ArticleId IdType="pubmed">16904911</ArticleId></ArticleIdList></Reference><Reference><Citation>Mormino EC, Insel PS. Uncertainties in the PET defined A-/TNeocortical+ subtype. Alzheimers Dement (Amst). 2022;14(1):e12348.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9413468</ArticleId><ArticleId IdType="pubmed">36051175</ArticleId></ArticleIdList></Reference><Reference><Citation>Krishnadas N, Dor&#xe9; V, Laws SM, et al. . Exploring discordant low amyloid beta and high neocortical tau positron emission tomography cases. Alzheimers Dement (Amst). 2022;14(1):e12326. doi:10.1002/dad2.12326</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/dad2.12326</ArticleId><ArticleId IdType="pmc">PMC9413469</ArticleId><ArticleId IdType="pubmed">36051174</ArticleId></ArticleIdList></Reference><Reference><Citation>La Joie R, Ayakta N, Seeley WW, et al. . Multisite study of the relationships between antemortem [11C]PIB-PET centiloid values and postmortem measures of Alzheimer&#x2019;s disease neuropathology. Alzheimers Dement. 2019;15(2):205-216. doi:10.1016/j.jalz.2018.09.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2018.09.001</ArticleId><ArticleId IdType="pmc">PMC6368897</ArticleId><ArticleId IdType="pubmed">30347188</ArticleId></ArticleIdList></Reference><Reference><Citation>Jack CR Jr, Wiste HJ, Weigand SD, et al. . Defining imaging biomarker cut points for brain aging and Alzheimer&#x2019;s disease. Alzheimers Dement. 2017;13(3):205-216. doi:10.1016/j.jalz.2016.08.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2016.08.005</ArticleId><ArticleId IdType="pmc">PMC5344738</ArticleId><ArticleId IdType="pubmed">27697430</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang JH, Korecka M, Figurski MJ, et al. ; Alzheimer&#x2019;s Disease Neuroimaging Initiative . The Alzheimer&#x2019;s Disease Neuroimaging Initiative 2 Biomarker Core: a review of progress and plans. Alzheimers Dement. 2015;11(7):772-791. doi:10.1016/j.jalz.2015.05.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2015.05.003</ArticleId><ArticleId IdType="pmc">PMC5127404</ArticleId><ArticleId IdType="pubmed">26194312</ArticleId></ArticleIdList></Reference><Reference><Citation>Donohue MC, Sperling RA, Salmon DP, et al. ; Australian Imaging, Biomarkers, and Lifestyle Flagship Study of Ageing; Alzheimer&#x2019;s Disease Neuroimaging Initiative; Alzheimer&#x2019;s Disease Cooperative Study . The preclinical Alzheimer cognitive composite: measuring amyloid-related decline. JAMA Neurol. 2014;71(8):961-970. doi:10.1001/jamaneurol.2014.803</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2014.803</ArticleId><ArticleId IdType="pmc">PMC4439182</ArticleId><ArticleId IdType="pubmed">24886908</ArticleId></ArticleIdList></Reference><Reference><Citation>Jack CR Jr, Wiste HJ, Weigand SD, et al. . Age-specific and sex-specific prevalence of cerebral &#x3b2;-amyloidosis, tauopathy, and neurodegeneration in cognitively unimpaired individuals aged 50-95 years: a cross-sectional study. Lancet Neurol. 2017;16(6):435-444. doi:10.1016/S1474-4422(17)30077-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(17)30077-7</ArticleId><ArticleId IdType="pmc">PMC5516534</ArticleId><ArticleId IdType="pubmed">28456479</ArticleId></ArticleIdList></Reference><Reference><Citation>Lowe VJ, Lundt ES, Albertson SM, et al. . Tau-positron emission tomography correlates with neuropathology findings. Alzheimers Dement. 2020;16(3):561-571. doi:10.1016/j.jalz.2019.09.079</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2019.09.079</ArticleId><ArticleId IdType="pmc">PMC7067654</ArticleId><ArticleId IdType="pubmed">31784374</ArticleId></ArticleIdList></Reference><Reference><Citation>Fleisher AS, Pontecorvo MJ, Devous MD Sr, et al. ; A16 Study Investigators . Positron emission tomography imaging with [18F]flortaucipir and postmortem assessment of Alzheimer disease neuropathologic changes. JAMA Neurol. 2020;77(7):829-839. doi:10.1001/jamaneurol.2020.0528</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2020.0528</ArticleId><ArticleId IdType="pmc">PMC7186920</ArticleId><ArticleId IdType="pubmed">32338734</ArticleId></ArticleIdList></Reference><Reference><Citation>Moscoso A, Wren MC, Lashley T, et al. . Imaging tau pathology in Alzheimer&#x2019;s disease with positron emission tomography: lessons learned from imaging-neuropathology validation studies. Mol Neurodegener. 2022;17(1):39. doi:10.1186/s13024-022-00543-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-022-00543-x</ArticleId><ArticleId IdType="pmc">PMC9166480</ArticleId><ArticleId IdType="pubmed">35659709</ArticleId></ArticleIdList></Reference><Reference><Citation>Soleimani-Meigooni DN, Iaccarino L, La Joie R, et al. . 18F-flortaucipir PET to autopsy comparisons in Alzheimer&#x2019;s disease and other neurodegenerative diseases. Brain. 2020;143(11):3477-3494. doi:10.1093/brain/awaa276</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awaa276</ArticleId><ArticleId IdType="pmc">PMC7719031</ArticleId><ArticleId IdType="pubmed">33141172</ArticleId></ArticleIdList></Reference><Reference><Citation>Lowe VJ, Curran G, Fang P, et al. . An autoradiographic evaluation of AV-1451 Tau PET in dementia. Acta Neuropathol Commun. 2016;4(1):58. doi:10.1186/s40478-016-0315-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-016-0315-6</ArticleId><ArticleId IdType="pmc">PMC4906968</ArticleId><ArticleId IdType="pubmed">27296779</ArticleId></ArticleIdList></Reference><Reference><Citation>Marqui&#xe9; M, Siao Tick Chong M, Ant&#xf3;n-Fern&#xe1;ndez A, et al. . [F-18]-AV-1451 binding correlates with postmortem neurofibrillary tangle Braak staging. Acta Neuropathol. 2017;134(4):619-628. doi:10.1007/s00401-017-1740-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-017-1740-8</ArticleId><ArticleId IdType="pmc">PMC5772971</ArticleId><ArticleId IdType="pubmed">28612291</ArticleId></ArticleIdList></Reference><Reference><Citation>Groot C, Dor&#xe9; V, Robertson J, et al. . Mesial temporal tau is related to worse cognitive performance and greater neocortical tau load in amyloid-&#x3b2;&#x2013;negative cognitively normal individuals. Neurobiol Aging. 2021;97:41-48. doi:10.1016/j.neurobiolaging.2020.09.017</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2020.09.017</ArticleId><ArticleId IdType="pubmed">33130455</ArticleId></ArticleIdList></Reference><Reference><Citation>Krishnadas N, Dor&#xe9; V, Groot C, et al. ; AIBL research group . Mesial temporal tau in amyloid-&#x3b2;&#x2013;negative cognitively normal older persons. Alzheimers Res Ther. 2022;14(1):51. doi:10.1186/s13195-022-00993-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13195-022-00993-x</ArticleId><ArticleId IdType="pmc">PMC8991917</ArticleId><ArticleId IdType="pubmed">35395950</ArticleId></ArticleIdList></Reference><Reference><Citation>Marqui&#xe9; M, Normandin MD, Vanderburg CR, et al. . Validating novel tau positron emission tomography tracer [F-18]-AV-1451 (T807) on postmortem brain tissue. Ann Neurol. 2015;78(5):787-800. doi:10.1002/ana.24517</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.24517</ArticleId><ArticleId IdType="pmc">PMC4900162</ArticleId><ArticleId IdType="pubmed">26344059</ArticleId></ArticleIdList></Reference><Reference><Citation>Marqui&#xe9; M, Normandin MD, Meltzer AC, et al. . Pathological correlations of [F-18]-AV-1451 imaging in non-Alzheimer tauopathies. Ann Neurol. 2017;81(1):117-128. doi:10.1002/ana.24844</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.24844</ArticleId><ArticleId IdType="pmc">PMC5319193</ArticleId><ArticleId IdType="pubmed">27997036</ArticleId></ArticleIdList></Reference><Reference><Citation>Serrano-Pozo A, Qian J, Monsell SE, et al. . Mild to moderate Alzheimer dementia with insufficient neuropathological changes. Ann Neurol. 2014;75(4):597-601. doi:10.1002/ana.24125</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.24125</ArticleId><ArticleId IdType="pmc">PMC4016558</ArticleId><ArticleId IdType="pubmed">24585367</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai RM, Bejanin A, Lesman-Segev O, et al. . 18F-flortaucipir (AV-1451) tau PET in frontotemporal dementia syndromes. Alzheimers Res Ther. 2019;11(1):13. doi:10.1186/s13195-019-0470-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13195-019-0470-7</ArticleId><ArticleId IdType="pmc">PMC6357510</ArticleId><ArticleId IdType="pubmed">30704514</ArticleId></ArticleIdList></Reference><Reference><Citation>Makaretz SJ, Quimby M, Collins J, et al. . Flortaucipir tau PET imaging in semantic variant primary progressive aphasia. J Neurol Neurosurg Psychiatry. 2018;89(10):1024-1031. doi:10.1136/jnnp-2017-316409</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2017-316409</ArticleId><ArticleId IdType="pmc">PMC5964045</ArticleId><ArticleId IdType="pubmed">28986472</ArticleId></ArticleIdList></Reference><Reference><Citation>Josephs KA, Martin PR, Botha H, et al. . [18 F]AV-1451 tau-PET and primary progressive aphasia. Ann Neurol. 2018;83(3):599-611. doi:10.1002/ana.25183</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.25183</ArticleId><ArticleId IdType="pmc">PMC5896771</ArticleId><ArticleId IdType="pubmed">29451323</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolters EE, Papma JM, Verfaillie SCJ, et al. . [18F]flortaucipir PET across various MAPT mutations in presymptomatic and symptomatic carriers. Neurology. 2021;97(10):e1017-e1030. doi:10.1212/WNL.0000000000012448</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000012448</ArticleId><ArticleId IdType="pmc">PMC8448551</ArticleId><ArticleId IdType="pubmed">34210823</ArticleId></ArticleIdList></Reference><Reference><Citation>Schaeverbeke J, Celen S, Cornelis J, et al. . Binding of [18F]AV1451 in post mortem brain slices of semantic variant primary progressive aphasia patients. Eur J Nucl Med Mol Imaging. 2020;47(8):1949-1960. doi:10.1007/s00259-019-04631-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00259-019-04631-x</ArticleId><ArticleId IdType="pmc">PMC7300115</ArticleId><ArticleId IdType="pubmed">31848674</ArticleId></ArticleIdList></Reference><Reference><Citation>Carlos AF, Tosakulwong N, Weigand SD, et al. . TDP-43 pathology effect on volume and flortaucipir uptake in Alzheimer&#x2019;s disease. Alzheimers Dement. 2023;19(6):2343-2354. doi:10.1002/alz.12878</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alz.12878</ArticleId><ArticleId IdType="pmc">PMC10239529</ArticleId><ArticleId IdType="pubmed">36463537</ArticleId></ArticleIdList></Reference><Reference><Citation>Aksman LM, Oxtoby NP, Scelsi MA, et al. . Tau-first subtype of Alzheimer&#x2019;s disease consistently identified across in vivo and post mortem studies. bioRxiv. Preprint posted online December 19, 2020. doi:10.1101/2020.12.18.418004</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.12.18.418004</ArticleId></ArticleIdList></Reference><Reference><Citation>Das SR, Xie L, Wisse LEM, et al. ; Alzheimer&#x2019;s Disease Neuroimaging Initiative . In vivo measures of tau burden are associated with atrophy in early Braak stage medial temporal lobe regions in amyloid-negative individuals. Alzheimers Dement. 2019;15(10):1286-1295. doi:10.1016/j.jalz.2019.05.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2019.05.009</ArticleId><ArticleId IdType="pmc">PMC6941656</ArticleId><ArticleId IdType="pubmed">31495603</ArticleId></ArticleIdList></Reference><Reference><Citation>Weigand AJ, Maass A, Eglit GL, Bondi MW. What&#x2019;s the cut-point? a systematic investigation of tau PET thresholding methods. Alzheimers Res Ther. 2022;14(1):49. doi:10.1186/s13195-022-00986-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13195-022-00986-w</ArticleId><ArticleId IdType="pmc">PMC8985353</ArticleId><ArticleId IdType="pubmed">35382866</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37575021</PMID><DateCompleted><Year>2024</Year><Month>01</Month><Day>29</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>15</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1460-2075</ISSN><JournalIssue CitedMedium="Internet"><Volume>42</Volume><Issue>19</Issue><PubDate><Year>2023</Year><Month>Oct</Month><Day>04</Day></PubDate></JournalIssue><Title>The EMBO journal</Title><ISOAbbreviation>EMBO J</ISOAbbreviation></Journal><ArticleTitle>Microglia-synapse engulfment via PtdSer-TREM2 ameliorates neuronal hyperactivity in Alzheimer's disease models.</ArticleTitle><Pagination><StartPage>e113246</StartPage><MedlinePgn>e113246</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e113246</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.15252/embj.2022113246</ELocationID><Abstract><AbstractText>Neuronal hyperactivity is a key feature of early stages of Alzheimer's disease (AD). Genetic studies in AD support that microglia act as potential cellular drivers of disease risk, but the molecular determinants of microglia-synapse engulfment associated with neuronal hyperactivity in AD are unclear. Here, using super-resolution microscopy, 3D-live imaging of co-cultures, and in vivo imaging of lipids in genetic models, we found that spines become hyperactive upon A&#x3b2; oligomer stimulation and externalize phosphatidylserine (ePtdSer), a canonical "eat-me" signal. These apoptotic-like spines are targeted by microglia for engulfment via TREM2 leading to amelioration of A&#x3b2; oligomer-induced synaptic hyperactivity. We also show the in vivo relevance of ePtdSer-TREM2 signaling in microglia-synapse engulfment in the hAPP NL-F knock-in mouse model of AD. Higher levels of apoptotic-like synapses in mice as well as humans that carry TREM2 loss-of-function variants were also observed. Our work supports that microglia remove hyperactive ePtdSer<sup>+</sup> synapses in A&#x3b2;-relevant context and suggest a potential beneficial role for microglia in the earliest stages of AD.</AbstractText><CopyrightInformation>&#xa9; 2023 The Authors. Published under the terms of the CC BY 4.0 license.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Rueda-Carrasco</LastName><ForeName>Javier</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-9280-6612</Identifier><AffiliationInfo><Affiliation>UK Dementia Research Institute, Institute of Neurology, University College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Sokolova</LastName><ForeName>Dimitra</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>UK Dementia Research Institute, Institute of Neurology, University College London, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neuroscience BioPharmaceuticals R&amp;D, AstraZeneca, Cambridge, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Lee</LastName><ForeName>Sang-Eun</ForeName><Initials>SE</Initials><AffiliationInfo><Affiliation>UK Dementia Research Institute, Institute of Neurology, University College London, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Physiology and Biomedical Sciences, Seoul National University College of Medicine, Seoul, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Childs</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0003-1048-8495</Identifier><AffiliationInfo><Affiliation>UK Dementia Research Institute, Institute of Neurology, University College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jur&#x10d;&#xe1;kov&#xe1;</LastName><ForeName>Nat&#xe1;lia</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>UK Dementia Research Institute, Institute of Neurology, University College London, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neuroscience, Physiology and Pharmacology, University College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Crowley</LastName><ForeName>Gerard</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>UK Dementia Research Institute, Institute of Neurology, University College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Schepper</LastName><ForeName>Sebastiaan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>UK Dementia Research Institute, Institute of Neurology, University College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ge</LastName><ForeName>Judy Z</ForeName><Initials>JZ</Initials><AffiliationInfo><Affiliation>UK Dementia Research Institute, Institute of Neurology, University College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lachica</LastName><ForeName>Joanne I</ForeName><Initials>JI</Initials><AffiliationInfo><Affiliation>The Queen Square Brain Bank for Neurological Disorders, UCL Queen Square Institute of Neurology, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Toomey</LastName><ForeName>Christina E</ForeName><Initials>CE</Initials><Identifier Source="ORCID">0000-0002-5146-3326</Identifier><AffiliationInfo><Affiliation>The Queen Square Brain Bank for Neurological Disorders, UCL Queen Square Institute of Neurology, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Freeman</LastName><ForeName>Oliver J</ForeName><Initials>OJ</Initials><Identifier Source="ORCID">0000-0003-4009-282X</Identifier><AffiliationInfo><Affiliation>Neuroscience BioPharmaceuticals R&amp;D, AstraZeneca, Cambridge, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hardy</LastName><ForeName>John</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-3122-0423</Identifier><AffiliationInfo><Affiliation>UK Dementia Research Institute, Institute of Neurology, University College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barnes</LastName><ForeName>Samuel J</ForeName><Initials>SJ</Initials><AffiliationInfo><Affiliation>UK Dementia Research Institute, Department of Brain Sciences, Imperial College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lashley</LastName><ForeName>Tammaryn</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0001-7389-0348</Identifier><AffiliationInfo><Affiliation>The Queen Square Brain Bank for Neurological Disorders, UCL Queen Square Institute of Neurology, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurodegenerative Diseases, UCL Queen Square Institute of Neurology, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stevens</LastName><ForeName>Beth</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>F.M. Kirby Neurobiology Center, Boston Children's Hospital, Boston, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Howard Hughes Medical Institute, Boston Children's Hospital, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>Sunghoe</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Physiology and Biomedical Sciences, Seoul National University College of Medicine, Seoul, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hong</LastName><ForeName>Soyon</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-5744-4871</Identifier><AffiliationInfo><Affiliation>UK Dementia Research Institute, Institute of Neurology, University College London, London, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>P50 HD105351</GrantID><Acronym>HD</Acronym><Agency>NICHD NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>08</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>EMBO J</MedlineTA><NlmUniqueID>8208664</NlmUniqueID><ISSNLinking>0261-4189</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016229">Amyloid beta-Peptides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C498715">TREM2 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008562">Membrane Glycoproteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011971">Receptors, Immunologic</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="ErratumIn"><RefSource>EMBO J. 2024 Sep;43(17):3807-3811. doi: 10.1038/s44318-024-00159-5.</RefSource><PMID Version="1">39085649</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017628" MajorTopicYN="N">Microglia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013569" MajorTopicYN="N">Synapses</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016229" MajorTopicYN="N">Amyloid beta-Peptides</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008562" MajorTopicYN="N">Membrane Glycoproteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011971" MajorTopicYN="N">Receptors, Immunologic</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Abeta oligomers</Keyword><Keyword MajorTopicYN="N">Alzheimer's disease</Keyword><Keyword MajorTopicYN="N">microglia</Keyword><Keyword MajorTopicYN="N">pruning</Keyword><Keyword MajorTopicYN="N">synapses</Keyword></KeywordList><CoiStatement>OJF is employed by AstraZeneca. The following patents have been granted or applied for PCT/2015/010288, US14/988387, and EP14822330 (SH). All the other authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>7</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>12</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>7</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>1</Month><Day>29</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>8</Month><Day>14</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>8</Month><Day>14</Day><Hour>3</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>8</Month><Day>14</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37575021</ArticleId><ArticleId IdType="pmc">PMC10548173</ArticleId><ArticleId IdType="doi">10.15252/embj.2022113246</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Altrock WD, Tom Dieck S, Sokolov M, Meyer AC, Sigler A, Brakebusch C, F&#xe4;ssler R, Richter K, Boeckers TM, Potschka H et&#xa0;al (2003) Functional inactivation of a fraction of excitatory synapses in mice deficient for the active zone protein bassoon. Neuron 37: 787&#x2013;800</Citation><ArticleIdList><ArticleId IdType="pubmed">12628169</ArticleId></ArticleIdList></Reference><Reference><Citation>Arbel&#x2010;Ornath M, Hudry E, Boivin JR, Hashimoto T, Takeda S, Kuchibhotla KV, Hou S, Lattarulo CR, Belcher AM, Shakerdge N et&#xa0;al (2017) Soluble oligomeric amyloid&#x2010;&#x3b2; induces calcium dyshomeostasis that precedes synapse loss in the living mouse brain. Mol Neurodegener 12: 27</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5361864</ArticleId><ArticleId IdType="pubmed">28327181</ArticleId></ArticleIdList></Reference><Reference><Citation>Bader Lange ML, Cenini G, Piroddi M, Mohmmad Abdul H, Sultana R, Galli F, Memo M, Butterfield DA (2008) Loss of phospholipid asymmetry and elevated brain apoptotic protein levels in subjects with amnestic mild cognitive impairment and Alzheimer disease. Neurobiol Dis 29: 456&#x2013;464</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2292396</ArticleId><ArticleId IdType="pubmed">18077176</ArticleId></ArticleIdList></Reference><Reference><Citation>Badimon A, Strasburger HJ, Ayata P, Chen X, Nair A, Ikegami A, Hwang P, Chan AT, Graves SM, Uweru JO et&#xa0;al (2020) Negative feedback control of neuronal activity by microglia. Nature 586: 417&#x2013;423</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7577179</ArticleId><ArticleId IdType="pubmed">32999463</ArticleId></ArticleIdList></Reference><Reference><Citation>Bartels T, De Schepper S, Hong S (2020) Microglia modulate neurodegeneration in Alzheimer's and Parkinson's diseases. Science 370: 66&#x2013;69</Citation><ArticleIdList><ArticleId IdType="pubmed">33004513</ArticleId></ArticleIdList></Reference><Reference><Citation>Brelstaff J, Tolkovsky AM, Ghetti B, Goedert M, Spillantini MG (2018) Living neurons with tau filaments aberrantly expose phosphatidylserine and are phagocytosed by microglia. Cell Rep 24: 1939&#x2013;1948</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6161320</ArticleId><ArticleId IdType="pubmed">30134156</ArticleId></ArticleIdList></Reference><Reference><Citation>Butovsky O, Jedrychowski MP, Moore CS, Cialic R, Lanser AJ, Gabriely G, Koeglsperger T, Dake B, Wu PM, Doykan CE et&#xa0;al (2014) Identification of a unique TGF&#x2010;&#x3b2;&#x2010;dependent molecular and functional signature in microglia. Nat Neurosci 17: 131&#x2013;143</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4066672</ArticleId><ArticleId IdType="pubmed">24316888</ArticleId></ArticleIdList></Reference><Reference><Citation>Cirrito JR, Kang JE, Lee J, Stewart FR, Verges DK, Silverio LM, Bu G, Mennerick S, Holtzman DM (2008) Endocytosis is required for synaptic activity&#x2010;dependent release of amyloid&#x2010;&#x3b2; in vivo. Neuron 58: 42&#x2013;51</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2390913</ArticleId><ArticleId IdType="pubmed">18400162</ArticleId></ArticleIdList></Reference><Reference><Citation>Colom&#x2010;Cadena M, Spires&#x2010;Jones T, Zetterberg H, Blennow K, Caggiano A, Dekosky ST, Fillit H, Harrison JE, Schneider LS, Scheltens P et&#xa0;al (2020) The clinical promise of biomarkers of synapse damage or loss in Alzheimer's disease. Alzheimers Res Ther 12: 21</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7053087</ArticleId><ArticleId IdType="pubmed">32122400</ArticleId></ArticleIdList></Reference><Reference><Citation>Cser&#xe9;p C, P&#xf3;sfai B, L&#xe9;n&#xe1;rt N, Fekete R, L&#xe1;szl&#xf3; ZI, Lele Z, Orsolits B, Moln&#xe1;r G, Heindl S, Schwarcz AD et&#xa0;al (2020) Microglia monitor and protect neuronal function through specialized somatic purinergic junctions. Science 367: 528&#x2013;537</Citation><ArticleIdList><ArticleId IdType="pubmed">31831638</ArticleId></ArticleIdList></Reference><Reference><Citation>D'Amelio M, Cavallucci V, Middei S, Marchetti C, Pacioni S, Ferri A, Diamantini A, De Zio D, Carrara P, Battistini L et&#xa0;al (2011) Caspase&#x2010;3 triggers early synaptic dysfunction in a mouse model of Alzheimer's disease. Nat Neurosci 14: 69&#x2013;79</Citation><ArticleIdList><ArticleId IdType="pubmed">21151119</ArticleId></ArticleIdList></Reference><Reference><Citation>Damisah EC, Hill RA, Rai A, Chen F, Rothlin CV, Ghosh S, Grutzendler J (2020) Astrocytes and microglia play orchestrated roles and respect phagocytic territories during neuronal corpse removal in vivo . Sci Adv 6: eaba3239</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7319765</ArticleId><ArticleId IdType="pubmed">32637606</ArticleId></ArticleIdList></Reference><Reference><Citation>De Schepper S, Crowley G, Hong S (2021) Understanding microglial diversity and implications for neuronal function in health and disease. Dev Neurobiol 81: 507&#x2013;523</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8438703</ArticleId><ArticleId IdType="pubmed">32757416</ArticleId></ArticleIdList></Reference><Reference><Citation>De Schepper S, Ge JZ, Crowley G, Ferreira LSS, Garceau D, Toomey CE, Sokolova D, Rueda&#x2010;Carrasco J, Shin SH, Kim JS et&#xa0;al (2023) Perivascular cells induce microglial phagocytic states and synaptic engulfment via SPP1 in mouse models of Alzheimer's disease. Nat Neurosci 26: 406&#x2013;415</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9991912</ArticleId><ArticleId IdType="pubmed">36747024</ArticleId></ArticleIdList></Reference><Reference><Citation>Deczkowska A, Weiner A, Amit I (2020) The physiology, pathology, and potential therapeutic applications of the TREM2 signaling pathway. Cell 181: 1207&#x2013;1217</Citation><ArticleIdList><ArticleId IdType="pubmed">32531244</ArticleId></ArticleIdList></Reference><Reference><Citation>Dejanovic B, Huntley MA, De Mazi&#xe8;re A, Meilandt WJ, Wu T, Srinivasan K, Jiang Z, Gandham V, Friedman BA, Ngu H et&#xa0;al (2018) Changes in the synaptic proteome in tauopathy and rescue of tau&#x2010;induced synapse loss by C1q antibodies. Neuron 100: 1322&#x2013;1336</Citation><ArticleIdList><ArticleId IdType="pubmed">30392797</ArticleId></ArticleIdList></Reference><Reference><Citation>Doran AC, Yurdagul A, Tabas I (2020) Efferocytosis in health and disease. Nat Rev Immunol 20: 254&#x2013;267</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7667664</ArticleId><ArticleId IdType="pubmed">31822793</ArticleId></ArticleIdList></Reference><Reference><Citation>Ebihara T, Kawabata I, Usui S, Sobue K, Okabe S (2003) Synchronized formation and remodeling of postsynaptic densities: long&#x2010;term visualization of hippocampal neurons expressing postsynaptic density proteins tagged with green fluorescent protein. J Neurosci 23: 2170&#x2013;2181</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6742042</ArticleId><ArticleId IdType="pubmed">12657676</ArticleId></ArticleIdList></Reference><Reference><Citation>Ert&#xfc;rk A, Wang Y, Sheng M (2014) Local pruning of dendrites and spines by caspase&#x2010;3&#x2010;dependent and proteasome&#x2010;limited mechanisms. J Neurosci 34: 1672&#x2013;1688</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6827581</ArticleId><ArticleId IdType="pubmed">24478350</ArticleId></ArticleIdList></Reference><Reference><Citation>Filipello F, Morini R, Corradini I, Zerbi V, Canzi A, Michalski B, Erreni M, Markicevic M, Starvaggi&#x2010;Cucuzza C, Otero K et&#xa0;al (2018) The microglial innate immune receptor TREM2 is required for synapse elimination and normal brain connectivity. Immunity 48: 979&#x2013;991</Citation><ArticleIdList><ArticleId IdType="pubmed">29752066</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia&#x2010;Reitboeck P, Phillips A, Piers TM, Villegas&#x2010;Llerena C, Butler M, Mallach A, Rodrigues C, Arber CE, Heslegrave A, Zetterberg H et&#xa0;al (2018) Human induced pluripotent stem cell&#x2010;derived microglia&#x2010;like cells harboring TREM2 missense mutations show specific deficits in phagocytosis. Cell Rep 24: 2300&#x2013;2311</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6130048</ArticleId><ArticleId IdType="pubmed">30157425</ArticleId></ArticleIdList></Reference><Reference><Citation>Gosselin D, Skola D, Coufal NG, Holtman IR, Schlachetzki JCM, Sajti E, Jaeger BN, O'Connor C, Fitzpatrick C, Pasillas MP et&#xa0;al (2017) An environment&#x2010;dependent transcriptional network specifies human microglia identity. Science 356: 1248&#x2013;1259</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5858585</ArticleId><ArticleId IdType="pubmed">28546318</ArticleId></ArticleIdList></Reference><Reference><Citation>Gratuze M, Leyns CEG, Sauerbeck AD, St&#x2010;Pierre M&#x2010;K, Xiong M, Kim N, Remolina Serrano J, Tremblay M&#x2010;&#xc8;, Kummer TT, Colonna M et&#xa0;al (2020) Impact of TREM2R47H variant on tau pathology&#x2010;induced gliosis and neurodegeneration. J Clin Invest 130: 4954&#x2013;4968</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7456230</ArticleId><ArticleId IdType="pubmed">32544086</ArticleId></ArticleIdList></Reference><Reference><Citation>Guerreiro R, Wojtas A, Bras J, Carrasquillo M, Rogaeva E, Majounie E, Cruchaga C, Sassi C, Kauwe JSK, Younkin S et&#xa0;al (2013) TREM2 variants in Alzheimer's disease. N Engl J Med 368: 117&#x2013;127</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3631573</ArticleId><ArticleId IdType="pubmed">23150934</ArticleId></ArticleIdList></Reference><Reference><Citation>Gy&#xf6;rffy BA, Kun J, T&#xf6;r&#xf6;k G, Buly&#xe1;ki &#xc9;, Borhegyi Z, Guly&#xe1;ssy P, Kis V, Szocsics P, Micsonai A, Matk&#xf3; J et&#xa0;al (2018) Local apoptotic&#x2010;like mechanisms underlie complementmediated synaptic pruning. Proc Natl Acad Sci U S A 115: 6303&#x2013;6308</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6004452</ArticleId><ArticleId IdType="pubmed">29844190</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanshaw RG, Lakshmi C, Lambert TN, Johnson JR, Smith BD (2005) Fluorescent detection of apoptotic cells by using zinc coordination complexes with a selective affinity for membrane surfaces enriched with phosphatidylserine. Chembiochem 6: 2214&#x2013;2220</Citation><ArticleIdList><ArticleId IdType="pubmed">16276499</ArticleId></ArticleIdList></Reference><Reference><Citation>Hesse R, Hurtado ML, Jackson RJ, Eaton SL, Herrmann AG, Colom&#x2010;Cadena M, King D, Rose J, Tulloch J, McKenzie CA et&#xa0;al (2019) Comparative profiling of the synaptic proteome from Alzheimer's disease patients with focus on the APOE genotype. Acta Neuropathol Commun 7: 1&#x2013;18</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6925519</ArticleId><ArticleId IdType="pubmed">31862015</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong S, Beja&#x2010;Glasser VF, Nfonoyim BM, Frouin A, Li S, Ramakrishnan S, Merry KM, Shi Q, Rosenthal A, Barres BA et&#xa0;al (2016) Complement and microglia mediate early synapse loss in Alzheimer mouse models. Science 352: 712&#x2013;716</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5094372</ArticleId><ArticleId IdType="pubmed">27033548</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong S, Wilton DK, Stevens B, Richardson DS (2017) Structured illumination microscopy for the investigation of synaptic structure and function BT &#x2013; synapse development: methods and protocols. Methods Mol Biol 1538: 155&#x2013;167</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5479421</ArticleId><ArticleId IdType="pubmed">27943190</ArticleId></ArticleIdList></Reference><Reference><Citation>Jonsson T, Stefansson H, Steinberg S, Jonsdottir I, Jonsson PV, Snaedal J, Bjornsson S, Huttenlocher J, Levey AI, Lah JJ et&#xa0;al (2013) Variant of TREM2 associated with the risk of Alzheimer's disease. N Engl J Med 368: 107&#x2013;116</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3677583</ArticleId><ArticleId IdType="pubmed">23150908</ArticleId></ArticleIdList></Reference><Reference><Citation>Keren&#x2010;Shaul H, Spinrad A, Weiner A, Matcovitch&#x2010;Natan O, Dvir&#x2010;Szternfeld R, Ulland TK, David E, Baruch K, Lara&#x2010;Astaiso D, Toth B et&#xa0;al (2017) A unique microglia type associated with restricting development of Alzheimer's disease. Cell 169: 1276&#x2013;1290</Citation><ArticleIdList><ArticleId IdType="pubmed">28602351</ArticleId></ArticleIdList></Reference><Reference><Citation>Kleinberger G, Yamanishi Y, Su&#xe1;rez&#x2010;Calvet M, Czirr E, Lohmann E, Cuyvers E, Struyfs H, Pettkus N, Wenninger&#x2010;Weinzierl A, Mazaheri F et&#xa0;al (2014) TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis. Sci Transl Med 6: 243ra86</Citation><ArticleIdList><ArticleId IdType="pubmed">24990881</ArticleId></ArticleIdList></Reference><Reference><Citation>Krahling S, Callahan MK, Williamson P, Schlegel RA (1999) Exposure of phosphatidylserine is a general feature in the phagocytosis of apoptotic lymphocytes by macrophages. Cell Death Differ 6: 183&#x2013;189</Citation><ArticleIdList><ArticleId IdType="pubmed">10200565</ArticleId></ArticleIdList></Reference><Reference><Citation>Lazarevic V, Sch&#xf6;ne C, Heine M, Gundelfinger ED, Fejtova A (2011) Extensive remodeling of the presynaptic cytomatrix upon homeostatic adaptation to network activity silencing. J Neurosci 31: 10189&#x2013;10200</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6623065</ArticleId><ArticleId IdType="pubmed">21752995</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee SE, Kim Y, Han JK, Park H, Lee U, Na M, Jeong S, Chung C, Cestra G, Chang S (2016) NArgBP2 regulates excitatory synapse formation by controlling dendritic spine morphology. Proc Natl Acad Sci U S A 113: 6749&#x2013;6754</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4914163</ArticleId><ArticleId IdType="pubmed">27226294</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee SH, Meilandt WJ, Xie L, Gandham VD, Ngu H, Barck KH, Rezzonico MG, Imperio J, Lalehzadeh G, Huntley MA et&#xa0;al (2021) Trem2 restrains the enhancement of tau accumulation and neurodegeneration by &#x3b2;&#x2010;amyloid pathology. Neuron 109: 1283&#x2013;1301</Citation><ArticleIdList><ArticleId IdType="pubmed">33675684</ArticleId></ArticleIdList></Reference><Reference><Citation>Lehrman EK, Wilton DK, Litvina EY, Welsh CA, Chang ST, Frouin A, Walker AJ, Heller MD, Umemori H, Chen C et&#xa0;al (2018) CD47 protects synapses from excess microglia&#x2010;mediated pruning during development. Neuron 100: 120&#x2013;134</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6314207</ArticleId><ArticleId IdType="pubmed">30308165</ArticleId></ArticleIdList></Reference><Reference><Citation>Lemke G (2019) How macrophages deal with death. Nat Rev Immunol 19: 539&#x2013;549</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6733267</ArticleId><ArticleId IdType="pubmed">31019284</ArticleId></ArticleIdList></Reference><Reference><Citation>Li S, Hong S, Shepardson NE, Walsh DM, Shankar GM, Selkoe D (2009) Soluble oligomers of amyloid &#x3b2; protein facilitate hippocampal long&#x2010;term depression by disrupting neuronal glutamate uptake. Neuron 62: 788&#x2013;801</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2702854</ArticleId><ArticleId IdType="pubmed">19555648</ArticleId></ArticleIdList></Reference><Reference><Citation>Li T, Chiou B, Gilman CK, Luo R, Koshi T, Yu D, Oak HC, Giera S, Johnson&#x2010;Venkatesh E, Muthukumar AK et&#xa0;al (2020) A splicing isoform of GPR56 mediates microglial synaptic refinement via phosphatidylserine binding. EMBO J 39: e104136</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7429740</ArticleId><ArticleId IdType="pubmed">32452062</ArticleId></ArticleIdList></Reference><Reference><Citation>Lui H, Zhang J, Makinson SR, Cahill MK, Kelley KW, Huang HY, Shang Y, Oldham MC, Martens LH, Gao F et&#xa0;al (2016) Progranulin deficiency promotes circuit&#x2010;specific synaptic pruning by microglia via complement activation. Cell 165: 921&#x2013;935</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4860138</ArticleId><ArticleId IdType="pubmed">27114033</ArticleId></ArticleIdList></Reference><Reference><Citation>Mattson MP, Keller JN, Begley JG (1998) Evidence for synaptic apoptosis. Exp Neurol 153: 35&#x2013;48</Citation><ArticleIdList><ArticleId IdType="pubmed">9743565</ArticleId></ArticleIdList></Reference><Reference><Citation>Neniskyte U, Neher JJ, Brown GC (2011) Neuronal death induced by nanomolar amyloid &#x3b2; is mediated by primary phagocytosis of neurons by microglia. J Biol Chem 286: 39904&#x2013;39913</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3220594</ArticleId><ArticleId IdType="pubmed">21903584</ArticleId></ArticleIdList></Reference><Reference><Citation>Pa&#xef;dassi H, Tacnet&#x2010;delorme P, Garlatti V, Darnault C, Ghebrehiwet B, Arlaud GJ, Frachet P, Tacnet&#x2010;delorme P, Garlatti V, Darnault C et&#xa0;al (2008) C1q binds phosphatidylserine and likely acts as a multiligand&#x2010;bridging molecule in apoptotic cell recognition. J Immunol 180: 2329&#x2013;2338</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2632962</ArticleId><ArticleId IdType="pubmed">18250442</ArticleId></ArticleIdList></Reference><Reference><Citation>Park G, Nhan HS, Tyan SH, Kawakatsu Y, Zhang C, Navarro M, Koo EH (2020) Caspase activation and caspase&#x2010;mediated cleavage of APP is associated with amyloid &#x3b2;&#x2010;protein&#x2010;induced synapse loss in Alzheimer's disease. Cell Rep 31: 107839</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7375398</ArticleId><ArticleId IdType="pubmed">32610140</ArticleId></ArticleIdList></Reference><Reference><Citation>Phongpreecha T, Gajera CR, Liu CC, Vijayaragavan K, Chang AL, Becker M, Fallahzadeh R, Fernandez R, Postupna N, Sherfield E et&#xa0;al (2021) Single&#x2010;synapse analyses of Alzheimer's disease implicate pathologic tau, DJ1, CD47, and ApoE. Sci Adv 7: 1&#x2013;15</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8673771</ArticleId><ArticleId IdType="pubmed">34910503</ArticleId></ArticleIdList></Reference><Reference><Citation>Podle&#x15b;ny&#x2010;Drabiniok A, Marcora E, Goate AM (2020) Microglial phagocytosis: a disease&#x2010;associated process emerging from Alzheimer's disease genetics. Trends Neurosci 43: 965&#x2013;979</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9080913</ArticleId><ArticleId IdType="pubmed">33127097</ArticleId></ArticleIdList></Reference><Reference><Citation>Renner M, Lacor PN, Velasco PT, Xu J, Contractor A, Klein WL, Triller A (2010) Deleterious effects of amyloid &#x3b2; oligomers acting as an extracellular scaffold for mGluR5. Neuron 66: 739&#x2013;754</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3111138</ArticleId><ArticleId IdType="pubmed">20547131</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruggiero L, Connor MP, Chen J, Langen R, Finnemann SC (2012) Diurnal, localized exposure of phosphatidylserine by rod outer segment tips in wild&#x2010;type but not Itgb5&#x2212;/&#x2212; or Mfge8&#x2212;/&#x2212; mouse retina. Proc Natl Acad Sci U S A 109: 8145&#x2013;8148</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3361434</ArticleId><ArticleId IdType="pubmed">22566632</ArticleId></ArticleIdList></Reference><Reference><Citation>Saito T, Matsuba Y, Mihira N, Takano J, Nilsson P, Itohara S, Iwata N, Saido TC (2014) Single App knock&#x2010;in mouse models of Alzheimer's disease. Nat Neurosci 17: 661&#x2013;663</Citation><ArticleIdList><ArticleId IdType="pubmed">24728269</ArticleId></ArticleIdList></Reference><Reference><Citation>Schafer DP, Lehrman EK, Kautzman AG, Koyama R, Mardinly AR, Yamasaki R, Ransohoff RM, Greenberg ME, Barres BA, Stevens B (2012) Microglia sculpt postnatal neural circuits in an activity and complement&#x2010;dependent manner. Neuron 74: 691&#x2013;705</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3528177</ArticleId><ArticleId IdType="pubmed">22632727</ArticleId></ArticleIdList></Reference><Reference><Citation>Scott&#x2010;Hewitt N, Perrucci F, Morini R, Erreni M, Mahoney M, Witkowska A, Carey A, Faggiani E, Schuetz LT, Mason S et&#xa0;al (2020) Local externalization of phosphatidylserine mediates developmental synaptic pruning by microglia. EMBO J 39: e105380</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7429741</ArticleId><ArticleId IdType="pubmed">32657463</ArticleId></ArticleIdList></Reference><Reference><Citation>Segawa K, Kurata S, Yanagihashi Y, Brummelkamp TR, Matsuda F, Nagata S (2014) Caspase&#x2010;mediated cleavage of phospholipid flippase for apoptotic phosphatidylserine exposure. Science 344: 1164&#x2013;1168</Citation><ArticleIdList><ArticleId IdType="pubmed">24904167</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi Q, Chowdhury S, Ma R, Le KX, Hong S, Caldarone BJ, Stevens B, Lemere CA (2017) Complement C3 deficiency protects against neurodegeneration in aged plaque&#x2010;rich APP/PS1 mice. Sci Transl Med 9: eaaf6295</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6936623</ArticleId><ArticleId IdType="pubmed">28566429</ArticleId></ArticleIdList></Reference><Reference><Citation>Sodero AO, Weissmann C, Ledesma MD, Dotti CG (2011) Cellular stress from excitatory neurotransmission contributes to cholesterol loss in hippocampal neurons aging in vitro. Neurobiol Aging 32: 1043&#x2013;1053</Citation><ArticleIdList><ArticleId IdType="pubmed">20663588</ArticleId></ArticleIdList></Reference><Reference><Citation>Sokolova D, Childs T, Hong S (2021) Insight into the role of phosphatidylserine in complement&#x2010;mediated synapse loss in Alzheimer's disease. Fac Rev 10: 19</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7946395</ArticleId><ArticleId IdType="pubmed">33718936</ArticleId></ArticleIdList></Reference><Reference><Citation>Stevens B, Allen NJ, Vazquez LE, Howell GR, Christopherson KS, Nouri N, Micheva KD, Mehalow AK, Huberman AD, Stafford B et&#xa0;al (2007) The classical complement cascade mediates CNS synapse elimination. Cell 131: 1164&#x2013;1178</Citation><ArticleIdList><ArticleId IdType="pubmed">18083105</ArticleId></ArticleIdList></Reference><Reference><Citation>Tufail Y, Cook D, Fourgeaud L, Powers CJ, Merten K, Clark CL, Hoffman E, Ngo A, Sekiguchi KJ, O'Shea CC et&#xa0;al (2017) Phosphatidylserine exposure controls viral innate immune responses by microglia. Neuron 93: 574&#x2013;586</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5600182</ArticleId><ArticleId IdType="pubmed">28111081</ArticleId></ArticleIdList></Reference><Reference><Citation>Vukojicic A, Delestr&#xe9;e N, Fletcher EV, Pagiazitis JG, Sankaranarayanan S, Yednock TA, Barres BA, Mentis GZ (2019) The classical complement pathway mediates microglia&#x2010;dependent remodeling of spinal motor circuits during development and in SMA. Cell Rep 29: 3087&#x2013;3100</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6937140</ArticleId><ArticleId IdType="pubmed">31801075</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Sudhakar S, Colonna M, Robinette ML, Cirrito JR, Krishnan GM, Zinselmeyer BH, Mallinson K, Young KL, Cella M et&#xa0;al (2015) TREM2 lipid sensing sustains the microglial response in an Alzheimer's disease model. Cell 160: 1061&#x2013;1071</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4477963</ArticleId><ArticleId IdType="pubmed">25728668</ArticleId></ArticleIdList></Reference><Reference><Citation>Weinhard L, Di Bartolomei G, Bolasco G, Machado P, Schieber NL, Neniskyte U, Exiga M, Vadisiute A, Raggioli A, Schertel A et&#xa0;al (2018) Microglia remodel synapses by presynaptic trogocytosis and spine head filopodia induction. Nat Commun 9: 1228</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5964317</ArticleId><ArticleId IdType="pubmed">29581545</ArticleId></ArticleIdList></Reference><Reference><Citation>Werneburg S, Jung J, Kunjamma RB, Ha SK, Luciano NJ, Willis CM, Gao G, Biscola NP, Havton LA, Crocker SJ et&#xa0;al (2020) Targeted complement inhibition at synapses prevents microglial synaptic engulfment and synapse loss in demyelinating disease. Immunity 52: 167&#x2013;182</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6996144</ArticleId><ArticleId IdType="pubmed">31883839</ArticleId></ArticleIdList></Reference><Reference><Citation>Wood JI, Wong E, Joghee R, Cummings DM, Hardy J, Edwards FA, Wood JI, Wong E, Joghee R, Balbaa A et&#xa0;al (2022) Plaque contact and unimpaired Trem2 is required for the microglial response to amyloid pathology. Cell Rep 41: 111686</Citation><ArticleIdList><ArticleId IdType="pubmed">36417868</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu T, Dejanovic B, Gandham VD, Gogineni A, Edmonds R, Schauer S, Srinivasan K, Huntley MA, Wang Y, Wang TM et&#xa0;al (2019) Complement C3 is activated in human AD brain and is required for neurodegeneration in mouse models of amyloidosis and tauopathy. Cell Rep 28: 2111&#x2013;2123</Citation><ArticleIdList><ArticleId IdType="pubmed">31433986</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiang X, Piers TM, Wefers B, Zhu K, Mallach A, Brunner B, Kleinberger G, Song W, Colonna M, Herms J et&#xa0;al (2018) The Trem2 R47H Alzheimer's risk variant impairs splicing and reduces Trem2 mRNA and protein in mice but not in humans. Mol Neurodegener 13: 1&#x2013;14</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6126019</ArticleId><ArticleId IdType="pubmed">30185230</ArticleId></ArticleIdList></Reference><Reference><Citation>Zott B, Simon MM, Hong W, Unger F, Chen&#x2010;Engerer HJ, Frosch MP, Sakmann B, Walsh DM, Konnerth A (2019) A vicious cycle of &#x3b2; amyloid&#x2212;dependent neuronal hyperactivation. Science 365: 559&#x2013;565</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6690382</ArticleId><ArticleId IdType="pubmed">31395777</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">37578768</PMID><DateRevised><Year>2023</Year><Month>10</Month><Day>09</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2168-6157</ISSN><JournalIssue CitedMedium="Internet"><Volume>80</Volume><Issue>10</Issue><PubDate><Year>2023</Year><Month>Oct</Month><Day>01</Day></PubDate></JournalIssue><Title>JAMA neurology</Title><ISOAbbreviation>JAMA Neurol</ISOAbbreviation></Journal><ArticleTitle>Tau Pathology Without A&#x3b2;-A Limited PART of Clinical Progression.</ArticleTitle><Pagination><StartPage>1025</StartPage><EndPage>1027</EndPage><MedlinePgn>1025-1027</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1001/jamaneurol.2023.1081</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Landau</LastName><ForeName>Susan M</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Helen Wills Neuroscience Institute, University of California, Berkeley.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mormino</LastName><ForeName>Elizabeth C</ForeName><Initials>EC</Initials><AffiliationInfo><Affiliation>Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, California.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Wu Tsai Neuroscience Institute, Stanford, California.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JAMA Neurol</MedlineTA><NlmUniqueID>101589536</NlmUniqueID><ISSNLinking>2168-6149</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>JAMA Neurol. 2023 Oct 1;80(10):1051-1061. doi: 10.1001/jamaneurol.2023.2560.</RefSource><PMID Version="1">37578787</PMID></CommentsCorrections></CommentsCorrectionsList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>8</Month><Day>14</Day><Hour>12</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>14</Day><Hour>12</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>8</Month><Day>14</Day><Hour>11</Hour><Minute>35</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37578768</ArticleId><ArticleId IdType="doi">10.1001/jamaneurol.2023.1081</ArticleId><ArticleId IdType="pii">2808499</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37591465</PMID><DateCompleted><Year>2023</Year><Month>09</Month><Day>22</Day></DateCompleted><DateRevised><Year>2023</Year><Month>12</Month><Day>05</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1095-953X</ISSN><JournalIssue CitedMedium="Internet"><Volume>186</Volume><PubDate><Year>2023</Year><Month>Oct</Month><Day>01</Day></PubDate></JournalIssue><Title>Neurobiology of disease</Title><ISOAbbreviation>Neurobiol Dis</ISOAbbreviation></Journal><ArticleTitle>Alzheimer risk-increasing TREM2 variant causes aberrant cortical synapse density and promotes network hyperexcitability in mouse models.</ArticleTitle><Pagination><StartPage>106263</StartPage><MedlinePgn>106263</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.nbd.2023.106263</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0969-9961(23)00278-4</ELocationID><Abstract><AbstractText>The R47H variant of triggering receptor expressed on myeloid cells 2 (TREM2) increases the risk of Alzheimer's disease (AD). To investigate potential mechanisms, we analyzed knockin mice expressing human TREM2-R47H from one mutant mouse Trem2 allele. TREM2-R47H mice showed increased seizure activity in response to an acute excitotoxin challenge, compared to wildtype controls or knockin mice expressing the common variant of human TREM2. TREM2-R47H also increased spontaneous thalamocortical epileptiform activity in App knockin mice expressing amyloid precursor proteins bearing autosomal dominant AD mutations and a humanized amyloid-&#x3b2; sequence. In mice with or without such App modifications, TREM2-R47H increased the density of putative synapses in cortical regions without amyloid plaques. TREM2-R47H did not affect synaptic density in hippocampal regions with or without plaques. We conclude that TREM2-R47H increases AD-related network hyperexcitability and that it may do so, at least in part, by causing an imbalance in synaptic densities across brain regions.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 The Authors. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Das</LastName><ForeName>Melanie</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Gladstone Institute of Neurological Disease, Gladstone Institutes, San Francisco, CA 94158, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mao</LastName><ForeName>Wenjie</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Gladstone Institute of Neurological Disease, Gladstone Institutes, San Francisco, CA 94158, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Voskobiynyk</LastName><ForeName>Yuliya</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Gladstone Institute of Neurological Disease, Gladstone Institutes, San Francisco, CA 94158, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Necula</LastName><ForeName>Deanna</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Gladstone Institute of Neurological Disease, Gladstone Institutes, San Francisco, CA 94158, USA; Neuroscience Graduate Program, University of California, San Francisco, CA 94158, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lew</LastName><ForeName>Irene</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Gladstone Institute of Neurological Disease, Gladstone Institutes, San Francisco, CA 94158, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Petersen</LastName><ForeName>Cathrine</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Gladstone Institute of Neurological Disease, Gladstone Institutes, San Francisco, CA 94158, USA; Neuroscience Graduate Program, University of California, San Francisco, CA 94158, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zahn</LastName><ForeName>Allie</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Gladstone Institute of Neurological Disease, Gladstone Institutes, San Francisco, CA 94158, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Gui-Qiu</ForeName><Initials>GQ</Initials><AffiliationInfo><Affiliation>Gladstone Institute of Neurological Disease, Gladstone Institutes, San Francisco, CA 94158, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Xinxing</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Gladstone Institute of Neurological Disease, Gladstone Institutes, San Francisco, CA 94158, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smith</LastName><ForeName>Nicholas</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Gladstone Institute of Neurological Disease, Gladstone Institutes, San Francisco, CA 94158, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sayed</LastName><ForeName>Faten A</ForeName><Initials>FA</Initials><AffiliationInfo><Affiliation>Gladstone Institute of Neurological Disease, Gladstone Institutes, San Francisco, CA 94158, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gan</LastName><ForeName>Li</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Helen and Robert Appel Alzheimer's Disease Research Institute, Weill Cornell Medicine, New York City, NY 10065, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Paz</LastName><ForeName>Jeanne T</ForeName><Initials>JT</Initials><AffiliationInfo><Affiliation>Gladstone Institute of Neurological Disease, Gladstone Institutes, San Francisco, CA 94158, USA; Neuroscience Graduate Program, University of California, San Francisco, CA 94158, USA; Department of Neurology and Weill Institute for Neurosciences, University of California, San Francisco, CA 94158, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mucke</LastName><ForeName>Lennart</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Gladstone Institute of Neurological Disease, Gladstone Institutes, San Francisco, CA 94158, USA; Neuroscience Graduate Program, University of California, San Francisco, CA 94158, USA; Department of Neurology and Weill Institute for Neurosciences, University of California, San Francisco, CA 94158, USA. Electronic address: lennart.mucke@gladstone.ucsf.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>F32 NS127998</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>RF1 AG063519</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>08</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Neurobiol Dis</MedlineTA><NlmUniqueID>9500169</NlmUniqueID><ISSNLinking>0969-9961</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016229">Amyloid beta-Peptides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C498715">TREM2 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008562">Membrane Glycoproteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011971">Receptors, Immunologic</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C498716">Trem2 protein, mouse</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000483" MajorTopicYN="N">Alleles</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012640" MajorTopicYN="N">Seizures</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016229" MajorTopicYN="N">Amyloid beta-Peptides</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058225" MajorTopicYN="N">Plaque, Amyloid</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013569" MajorTopicYN="N">Synapses</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008562" MajorTopicYN="N">Membrane Glycoproteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011971" MajorTopicYN="N">Receptors, Immunologic</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Alzheimer's disease</Keyword><Keyword MajorTopicYN="N">Amyloid precursor protein</Keyword><Keyword MajorTopicYN="N">EEG</Keyword><Keyword MajorTopicYN="N">Epilepsy</Keyword><Keyword MajorTopicYN="N">Glia</Keyword><Keyword MajorTopicYN="N">Hyperexcitability</Keyword><Keyword MajorTopicYN="N">Microglia</Keyword><Keyword MajorTopicYN="N">Network dysfunction</Keyword><Keyword MajorTopicYN="N">Synapses</Keyword><Keyword MajorTopicYN="N">TREM2</Keyword></KeywordList><CoiStatement>Declaration of Interests. None.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>5</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>7</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>8</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>22</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>8</Month><Day>18</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>8</Month><Day>17</Day><Hour>19</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>11</Month><Day>27</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37591465</ArticleId><ArticleId IdType="mid">NIHMS1941825</ArticleId><ArticleId IdType="pmc">PMC10681293</ArticleId><ArticleId IdType="doi">10.1016/j.nbd.2023.106263</ArticleId><ArticleId IdType="pii">S0969-9961(23)00278-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Akaike H (1974). A new look at the statistical model identification. IEEE Trans. Autom. Control, 19, 716&#x2013;723. doi:10.1109/TAC.1974.1100705.</Citation><ArticleIdList><ArticleId IdType="doi">10.1109/TAC.1974.1100705</ArticleId></ArticleIdList></Reference><Reference><Citation>Atagi Y, Liu CC, Painter MM, Chen XF, Verbeeck C, Zheng H, Li X, Rademakers R, Kang SS, Xu H, et al. (2015). Apolipoprotein E Is a ligand for triggering receptor expressed on myeloid cells 2 (TREM2). J. Biol. Chem, 290, 26043&#x2013;26050. doi:10.1074/jbc.M115.679043.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M115.679043</ArticleId><ArticleId IdType="pmc">PMC4646257</ArticleId><ArticleId IdType="pubmed">26374899</ArticleId></ArticleIdList></Reference><Reference><Citation>Baddeley A, Rubak E &amp; Turner R 2015. Spatial point patterns: methodology and applications with R, New York, CRC press.</Citation></Reference><Reference><Citation>Badimon A, Strasburger HJ, Ayata P, Chen X, Nair A, Ikegami A, Hwang P, Chan AT, Graves SM, Uweru JO, et al. (2020). Negative feedback control of neuronal activity by microglia. Nature, 586, 417&#x2013;423. doi:10.1038/s41586-020-2777-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2777-8</ArticleId><ArticleId IdType="pmc">PMC7577179</ArticleId><ArticleId IdType="pubmed">32999463</ArticleId></ArticleIdList></Reference><Reference><Citation>Bates D, M&#xe4;chler M, Bolker B &amp; Walker S (2015). Fitting linear mixed-effects models using lme4. J. Stat. Softw, 67, 1&#x2013;48. doi:10.18637/jss.v067.i01.</Citation><ArticleIdList><ArticleId IdType="doi">10.18637/jss.v067.i01</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellenguez C, Kucukali F, Jansen IE, Kleineidam L, Moreno-Grau S, Amin N, Naj AC, Campos-Martin R, Grenier-Boley B, Andrade V, et al. (2022). New insights into the genetic etiology of Alzheimer&#x2019;s disease and related dementias. Nat. Genet, 54, 412&#x2013;436. doi:10.1038/s41588-022-01024-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-022-01024-z</ArticleId><ArticleId IdType="pmc">PMC9005347</ArticleId><ArticleId IdType="pubmed">35379992</ArticleId></ArticleIdList></Reference><Reference><Citation>Bianchin MM, Capella HM, Chaves DL, Steindel M, Grisard EC, Ganev GG, Da Silva Junior JP, Neto Evaldo S, Poffo MA, Walz R, et al. (2004). Nasu-Hakola disease (polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy--PLOSL): a dementia associated with bone cystic lesions. From clinical to genetic and molecular aspects. Cell. Mol. Neurobiol, 24, 1&#x2013;24. doi:10.1023/b:cemn.0000012721.08168.ee.</Citation><ArticleIdList><ArticleId IdType="doi">10.1023/b:cemn.0000012721.08168.ee</ArticleId><ArticleId IdType="pmc">PMC11529946</ArticleId><ArticleId IdType="pubmed">15049507</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng-Hathaway PJ, Reed-Geaghan EG, Jay TR, Casali BT, Bemiller SM, Puntambekar SS, Von Saucken VE, Williams RY, Karlo JC, Moutinho M, et al. (2018). The Trem2 R47H variant confers loss-of-function-like phenotypes in Alzheimer&#x2019;s disease. Mol. Neurodegener, 13, 1&#x2013;12. doi:10.1186/s13024-018-0262-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-018-0262-8</ArticleId><ArticleId IdType="pmc">PMC5984804</ArticleId><ArticleId IdType="pubmed">29859094</ArticleId></ArticleIdList></Reference><Reference><Citation>Chin J, Palop JJ, Yu G-Q, Kojima N, Masliah E &amp; Mucke L (2004). Fyn kinase modulates synaptotoxicity, but not aberrant sprouting, in human amyloid precursor protein transgenic mice. J. Neurosci, 24, 4692&#x2013;4697.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6729387</ArticleId><ArticleId IdType="pubmed">15140940</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu Y, Jin X, Parada I, Pesic A, Stevens B, Barres B &amp; Prince DA (2010). Enhanced synaptic connectivity and epilepsy in C1q knockout mice. Proc. Natl. Acad. Sci. U. S. A, 107, 7975&#x2013;7980. doi:10.1073/pnas.0913449107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0913449107</ArticleId><ArticleId IdType="pmc">PMC2867906</ArticleId><ArticleId IdType="pubmed">20375278</ArticleId></ArticleIdList></Reference><Reference><Citation>Das M, Mao W, Shao E, Tamhankar S, Yu GQ, Yu X, Ho K, Wang X, Wang J &amp; Mucke L (2021). Interdependence of neural network dysfunction and microglial alterations in Alzheimer&#x2019;s disease-related models. iScience, 24, 1. doi:10.1016/j.isci.2021.103245.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2021.103245</ArticleId><ArticleId IdType="pmc">PMC8561005</ArticleId><ArticleId IdType="pubmed">34755090</ArticleId></ArticleIdList></Reference><Reference><Citation>Deczkowska A, Weiner A &amp; Amit I (2020). The physiology, pathology, and potential therapeutic applications of the TREM2 signaling pathway. Cell, 181, 1207&#x2013;1217. doi:10.1016/j.cell.2020.05.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.05.003</ArticleId><ArticleId IdType="pubmed">32531244</ArticleId></ArticleIdList></Reference><Reference><Citation>deIpolyi AR, Rankin KP, Mucke L, Miller BL &amp; Gorno-Tempini ML (2007). Spatial cognition and the human navigation network in AD and MCI. Neurology, 69, 986&#x2013;997.</Citation><ArticleIdList><ArticleId IdType="pubmed">17785667</ArticleId></ArticleIdList></Reference><Reference><Citation>Del-Aguila JL, Fernandez MV, Schindler S, Ibanez L, Deming Y, Ma S, Saef B, Black K, Budde J, Norton J, et al. (2018). Assessment of the genetic architecture of Alzheimer&#x2019;s disease risk in rate of memory decline. J. Alzheimers Dis, 62, 745&#x2013;756. doi:10.3233/JAD-170834.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-170834</ArticleId><ArticleId IdType="pmc">PMC5989565</ArticleId><ArticleId IdType="pubmed">29480181</ArticleId></ArticleIdList></Reference><Reference><Citation>Essex AL, Huot JR, Deosthale P, Wagner A, Figueras J, Davis A, Damrath J, Pin F, Wallace J, Bonetto A, et al. (2022). Triggering receptor expressed on myeloid cells 2 (TREM2) R47H variant causes distinct age- and sex-dependent musculoskeletal alterations in mice. J. Bone Miner. Res, 37, 1366&#x2013;1381. doi:10.1002/jbmr.4572.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jbmr.4572</ArticleId><ArticleId IdType="pmc">PMC9307075</ArticleId><ArticleId IdType="pubmed">35575023</ArticleId></ArticleIdList></Reference><Reference><Citation>Eyo UB, Peng J, Swiatkowski P, Mukherjee A, Bispo A &amp; Wu LJ (2014). Neuronal hyperactivity recruits microglial processes via neuronal NMDA receptors and microglial P2Y12 receptors after status epilepticus. J. Neurosci, 34, 10528&#x2013;10540. doi:10.1523/JNEUROSCI.0416-14.2014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.0416-14.2014</ArticleId><ArticleId IdType="pmc">PMC4200107</ArticleId><ArticleId IdType="pubmed">25100587</ArticleId></ArticleIdList></Reference><Reference><Citation>Faria LC, Gu F, Parada I, Barres B, Luo ZD &amp; Prince DA (2017). Epileptiform activity and behavioral arrests in mice overexpressing the calcium channel subunit alpha2delta-1. Neurobiol. Dis, 102, 70&#x2013;80. doi:10.1016/j.nbd.2017.01.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2017.01.009</ArticleId><ArticleId IdType="pubmed">28193459</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrara SJ, Chaudhary P, Debell MJ, Marracci G, Miller H, Calkins E, Pocius E, Napier BA, Emery B, Bourdette D, et al. (2022). TREM2 is thyroid hormone regulated making the TREM2 pathway druggable with ligands for thyroid hormone receptor. Cell Chem. Biol, 29, 239&#x2013;248 e4. doi:10.1016/j.chembiol.2021.07.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chembiol.2021.07.014</ArticleId><ArticleId IdType="pmc">PMC8818810</ArticleId><ArticleId IdType="pubmed">34375614</ArticleId></ArticleIdList></Reference><Reference><Citation>Filipello F, Morini R, Corradini I, Zerbi V, Canzi A, Michalski B, Erreni M, Markicevic M, Starvaggi-Cucuzza C, Otero K, et al. (2018). The microglial innate immune receptor TREM2 is required for synapse elimination and normal brain connectivity. Immunity, 48, 979&#x2013;991 e8. doi:10.1016/j.immuni.2018.04.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2018.04.016</ArticleId><ArticleId IdType="pubmed">29752066</ArticleId></ArticleIdList></Reference><Reference><Citation>Frere S &amp; Slutsky I (2018). Alzheimer&#x2019;s disease: From firing instability to homeostasis network collapse. Neuron, 97, 32&#x2013;58. doi:10.1016/j.neuron.2017.11.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2017.11.028</ArticleId><ArticleId IdType="pubmed">29301104</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghatak S, Talantova M, Mckercher SR &amp; Lipton SA (2021). Novel therapeutic approach for excitatory/inhibitory imbalance in neurodevelopmental and neurodegenerative diseases. Annu. Rev. Pharmacol. Toxicol, 61, 701&#x2013;721. doi:10.1146/annurev-pharmtox-032320-015420.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-pharmtox-032320-015420</ArticleId><ArticleId IdType="pubmed">32997602</ArticleId></ArticleIdList></Reference><Reference><Citation>Gratuze M, Leyns CE, Sauerbeck AD, St-Pierre MK, Xiong M, Kim N, Serrano JR, Tremblay ME, Kummer TT, Colonna M, et al. (2020). Impact of TREM2R47H variant on tau pathology-induced gliosis and neurodegeneration. J. Clin. Invest, 130, 4954&#x2013;4968. doi:10.1172/JCI138179.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI138179</ArticleId><ArticleId IdType="pmc">PMC7456230</ArticleId><ArticleId IdType="pubmed">32544086</ArticleId></ArticleIdList></Reference><Reference><Citation>Guerreiro R, Wojtas A, Bras J, Carrasquillo M, Rogaeva E, Majounie E, Cruchaga C, Sassi C, Kauwe JS, Younkin S, et al. (2013). TREM2 variants in Alzheimer&#x2019;s disease. N. Engl. J. Med, 368, 117&#x2013;127. doi:10.1056/NEJMoa1211851.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1211851</ArticleId><ArticleId IdType="pmc">PMC3631573</ArticleId><ArticleId IdType="pubmed">23150934</ArticleId></ArticleIdList></Reference><Reference><Citation>Guerreiro RJ, Baquero M, Blesa R, Boada M, Bras JM, Bullido MJ, Calado A, Crook R, Ferreira C, Frank A, et al. (2010). Genetic screening of Alzheimer&#x2019;s disease genes in Iberian and African samples yields novel mutations in presenilins and APP. Neurobiol. Aging, 31, 725&#x2013;731. doi:10.1016/j.neurobiolaging.2008.06.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2008.06.012</ArticleId><ArticleId IdType="pmc">PMC2850052</ArticleId><ArticleId IdType="pubmed">18667258</ArticleId></ArticleIdList></Reference><Reference><Citation>Haass C &amp; Selkoe D (2022). If amyloid drives Alzheimer disease, why have anti-amyloid therapies not yet slowed cognitive decline? PLoS Biol, 20, e3001694. doi:10.1371/journal.pbio.3001694.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pbio.3001694</ArticleId><ArticleId IdType="pmc">PMC9302755</ArticleId><ArticleId IdType="pubmed">35862308</ArticleId></ArticleIdList></Reference><Reference><Citation>Han RT, Vainchtein ID, Schlachetzki JCM, Cho FS, Dorman LC, Ahn E, Kim DK, Barron JJ, Nakao-Inoue H, Molofsky AB, et al. (2023). Microglial pattern recognition via IL-33 promotes synaptic refinement in developing corticothalamic circuits in mice. J. Exp. Med, 220, 1&#x2013;19. doi:10.1084/jem.20220605.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20220605</ArticleId><ArticleId IdType="pmc">PMC9757845</ArticleId><ArticleId IdType="pubmed">36520518</ArticleId></ArticleIdList></Reference><Reference><Citation>Hellier JL &amp; Dudek FE (2005). Chemoconvulsant model of chronic spontaneous seizures. Curr. Protoc. Neurosci, Chapter 9, 9.19.1&#x2013;9.19.12. doi:10.1002/0471142301.ns0919s31.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/0471142301.ns0919s31</ArticleId><ArticleId IdType="pubmed">18428628</ArticleId></ArticleIdList></Reference><Reference><Citation>Horv&#xe1;th A, Szucs A, Barcs G &amp; Kamondi A (2017). Sleep EEG detects epileptiform activity in Alzheimer&#x2019;s disease with high sensitivity. J. Alzheimers Dis, 56, 1175&#x2013;1183. doi:10.3233/JAD-160994.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-160994</ArticleId><ArticleId IdType="pubmed">28128769</ArticleId></ArticleIdList></Reference><Reference><Citation>Horv&#xe1;th AA, Papp A, Zsuffa J, Szucs A, Luckl J, Radai F, Nagy F, Hidasi Z, Csukly G, Barcs G, et al. (2021). Subclinical epileptiform activity accelerates the progression of Alzheimer&#x2019;s disease: A long-term EEG study. Clin. Neurophysiol, 132, 1982&#x2013;1989. doi:10.1016/j.clinph.2021.03.050.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinph.2021.03.050</ArticleId><ArticleId IdType="pubmed">34034963</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobs HI, Van Boxtel MP, Jolles J, Verhey FR &amp; Uylings HB (2012). Parietal cortex matters in Alzheimer&#x2019;s disease: an overview of structural, functional and metabolic findings. Neurosci. Biobehav. Rev, 36, 297&#x2013;309. doi:10.1016/j.neubiorev.2011.06.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neubiorev.2011.06.009</ArticleId><ArticleId IdType="pubmed">21741401</ArticleId></ArticleIdList></Reference><Reference><Citation>Jay TR, Von Saucken VE &amp; Landreth GE (2017). TREM2 in neurodegenerative diseases. Mol. Neurodegener, 12, 1&#x2013;33. doi:10.1186/s13024-017-0197-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-017-0197-5</ArticleId><ArticleId IdType="pmc">PMC5541421</ArticleId><ArticleId IdType="pubmed">28768545</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson ECB, Ho K, Yu GQ, Das M, Sanchez PE, Biljana D, Lopez I, Yu X, Gill M, Zhang W, et al. (2020). Behavioral and neural network abnormalities in human APP transgenic mice resemble those of App knock-in mice and are modulated by familial Alzheimer&#x2019;s disease mutations but not by inhibition of BACE1. Mol. Neurodegener, 15, 1&#x2013;26. doi:10.1186/s13024-020-00393-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-020-00393-5</ArticleId><ArticleId IdType="pmc">PMC7489007</ArticleId><ArticleId IdType="pubmed">32921309</ArticleId></ArticleIdList></Reference><Reference><Citation>Jonsson T, Stefansson H, Steinberg S, Jonsdottir I, Jonsson PV, Snaedal J, Bjornsson S, Huttenlocher J, Levey AI, Lah JJ, et al. (2013). Variant of TREM2 associated with the risk of Alzheimer&#x2019;s disease. N. Engl. J. Med, 368, 107&#x2013;116. doi:10.1056/NEJMoa1211103.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1211103</ArticleId><ArticleId IdType="pmc">PMC3677583</ArticleId><ArticleId IdType="pubmed">23150908</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalaria RN &amp; Sepulveda-Falla D (2021). Cerebral small vessel disease in sporadic and familial Alzheimer disease. Am. J. Pathol, 191, 1888&#x2013;1905. doi:10.1016/j.ajpath.2021.07.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajpath.2021.07.004</ArticleId><ArticleId IdType="pmc">PMC8573679</ArticleId><ArticleId IdType="pubmed">34331941</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaneko M, Sano K, Nakayama J &amp; Amano N (2010). Nasu-Hakola disease: The first case reported by Nasu and review: The 50th Anniversary of Japanese Society of Neuropathology. Neuropathology, 30, 463&#x2013;470. doi:10.1111/j.1440-1789.2010.01127.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1440-1789.2010.01127.x</ArticleId><ArticleId IdType="pubmed">20500450</ArticleId></ArticleIdList></Reference><Reference><Citation>Karch CM &amp; Goate AM (2015). Alzheimer&#x2019;s disease risk genes and mechanisms of disease pathogenesis. Biol. Psychiatry, 77, 43&#x2013;51. doi:10.1016/j.biopsych.2014.05.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopsych.2014.05.006</ArticleId><ArticleId IdType="pmc">PMC4234692</ArticleId><ArticleId IdType="pubmed">24951455</ArticleId></ArticleIdList></Reference><Reference><Citation>Laird NM &amp; Ware JH (1982). Random-effects models for longitudinal data. Biometrics, 38, 963&#x2013;974.</Citation><ArticleIdList><ArticleId IdType="pubmed">7168798</ArticleId></ArticleIdList></Reference><Reference><Citation>Lam AD, Deck G, Goldman A, Eskandar EN, Noebels J &amp; Cole AJ (2017). Silent hippocampal seizures and spikes identified by foramen ovale electrodes in Alzheimer&#x2019;s disease. Nat. Med, 23, 678&#x2013;680. doi:10.1038/nm.4330.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.4330</ArticleId><ArticleId IdType="pmc">PMC5461182</ArticleId><ArticleId IdType="pubmed">28459436</ArticleId></ArticleIdList></Reference><Reference><Citation>Lam AD &amp; Noebels J (2020). Night watch on the Titanic: detecting early signs of epileptogenesis in Alzheimer disease. Epilepsy Curr, 20, 369&#x2013;374. doi:10.1177/1535759720964775.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1535759720964775</ArticleId><ArticleId IdType="pmc">PMC7818196</ArticleId><ArticleId IdType="pubmed">33081517</ArticleId></ArticleIdList></Reference><Reference><Citation>Lam AD, Sarkis RA, Pellerin KR, Jing J, Dworetzky BA, Hoch DB, Jacobs CS, Lee JW, Weisholtz DS, Zepeda R, et al. (2020). Association of epileptiform abnormalities and seizures in Alzheimer disease. Neurology, 95, e2259&#x2013;e2270. doi:10.1212/WNL.0000000000010612.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000010612</ArticleId><ArticleId IdType="pmc">PMC7713786</ArticleId><ArticleId IdType="pubmed">32764101</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee CYD, Daggett A, Gu X, Jiang LL, Langfelder P, Li X, Wang N, Zhao Y, Park CS, Cooper Y, et al. (2018). Elevated TREM2 gene dosage reprograms microglia responsivity and ameliorates pathological phenotypes in Alzheimer&#x2019;s disease models. Neuron, 97, 1032&#x2013;1048.e5. doi:10.1016/j.neuron.2018.02.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2018.02.002</ArticleId><ArticleId IdType="pmc">PMC5927822</ArticleId><ArticleId IdType="pubmed">29518357</ArticleId></ArticleIdList></Reference><Reference><Citation>Lenth RV, Bolker B, Buerkner P, Gine-Vazquez I, Herve M, Jung M, Love J, Miguez F, Riebl H &amp; Singmann H 2022. emmeans: Estimated Marginal Means, aka Least-Squares Means. 1.8.7 ed.</Citation></Reference><Reference><Citation>Lewcock JW, Schlepckow K, Di Paolo G, Tahirovic S, Monroe KM &amp; Haass C (2020). Emerging microglia biology defines novel therapeutic approaches for Alzheimer&#x2019;s disease. Neuron, 108, 801&#x2013;821. doi:10.1016/j.neuron.2020.09.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2020.09.029</ArticleId><ArticleId IdType="pubmed">33096024</ArticleId></ArticleIdList></Reference><Reference><Citation>Matarin M, Salih DA, Yasvoina M, Cummings DM, Guelfi S, Liu W, Nahaboo Solim MA, Moens TG, Paublete RM, Ali SS, et al. (2015). A genome&#x2013;wide gene-expression analysis and database in transgenic mice during development of amyloid or tau pathology. Cell Rep., 10, 633&#x2013;644. doi:10.1016/j.celrep.2014.12.041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2014.12.041</ArticleId><ArticleId IdType="pubmed">25620700</ArticleId></ArticleIdList></Reference><Reference><Citation>Melchior B, Garcia AE, Hsiung BK, Lo KM, Doose JM, Thrash JC, Stalder AK, Staufenbiel M, Neumann H &amp; Carson MJ (2010). Dual induction of TREM2 and tolerance-related transcript, Tmem176b, in amyloid transgenic mice: implications for vaccine-based therapies for Alzheimer&#x2019;s disease. ASN Neuro., 2, 157&#x2013;170. doi:10.1042/AN20100010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/AN20100010</ArticleId><ArticleId IdType="pmc">PMC2905103</ArticleId><ArticleId IdType="pubmed">20640189</ArticleId></ArticleIdList></Reference><Reference><Citation>Merlini M, Rafalski VA, Ma K, Kim KY, Bushong EA, Rios Coronado PE, Yan Z, Mendiola AS, Sozmen EG, Ryu JK, et al. (2021). Microglial Gi-dependent dynamics regulate brain network hyperexcitability. Nat. Neurosci, 24, 19&#x2013;23. doi:10.1038/s41593-020-00756-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-020-00756-7</ArticleId><ArticleId IdType="pmc">PMC8118167</ArticleId><ArticleId IdType="pubmed">33318667</ArticleId></ArticleIdList></Reference><Reference><Citation>Morrison JH &amp; Baxter MG (2012). The ageing cortical synapse: Hallmarks and implications for cognitive decline. Nat. Rev. Neurosci, 13, 240&#x2013;250. doi:10.1038/nrn3200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn3200</ArticleId><ArticleId IdType="pmc">PMC3592200</ArticleId><ArticleId IdType="pubmed">22395804</ArticleId></ArticleIdList></Reference><Reference><Citation>Mucke L, Masliah E, Yu G-Q, Mallory M, Rockenstein E, Tatsuno G, Hu K, Kholodenko D, Johnson-Wood K &amp; Mcconlogue L (2000). High-level neuronal expression of A&#x3b2;1-42 in wild-type human amyloid protein precursor transgenic mice: Synaptotoxicity without plaque formation. J. Neurosci, 20, 4050&#x2013;4058. doi:10.1523/JNEUROSCI.20-11-04050.2000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.20-11-04050.2000</ArticleId><ArticleId IdType="pmc">PMC6772621</ArticleId><ArticleId IdType="pubmed">10818140</ArticleId></ArticleIdList></Reference><Reference><Citation>Mullan M, Crawford F, Axelman K, Houlden H, Lilius L, Winblad B &amp; Lannfelt L (1992). A pathogenic mutation for probable Alzheimer&#x2019;s disease in the APP gene at the N-terminus of &#x3b2;-amyloid. Nat. Genet, 1, 345&#x2013;347. doi:10.1038/ng0892-345.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng0892-345</ArticleId><ArticleId IdType="pubmed">1302033</ArticleId></ArticleIdList></Reference><Reference><Citation>Multhaup G, Huber O, Buee L &amp; Galas MC (2015). Amyloid Precursor Protein (APP) metabolites APP Intracellular Fragment (AICD), Abeta42, and Tau in nuclear roles. J. Biol. Chem, 290, 23515&#x2013;23522. doi:10.1074/jbc.R115.677211.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.R115.677211</ArticleId><ArticleId IdType="pmc">PMC4583011</ArticleId><ArticleId IdType="pubmed">26296890</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakamagoe K, Shioya A, Yamaguchi T, Takahashi H, Koide R, Monzen T, Satoh J &amp; Tamaoka A (2011). A Japanese case with Nasu-Hakola disease of DAP12 gene mutation exhibiting precuneus hypoperfusion. Intern. Med, 50, 2839&#x2013;2844. doi:10.2169/internalmedicine.50.5891.</Citation><ArticleIdList><ArticleId IdType="doi">10.2169/internalmedicine.50.5891</ArticleId><ArticleId IdType="pubmed">22082900</ArticleId></ArticleIdList></Reference><Reference><Citation>Nilsberth C, Westlind-Danielsson A, Eckman CB, Condron MM, Axelman K, Forsell C, Stenh C, Luthman J, Teplow DB, Younkin SG, et al. (2001). The &#x2018;Arctic&#x2019; APP mutation (E693G) causes Alzheimer&#x2019;s disease by enhanced A&#x3b2; protofibril formation. Nat. Neurosci, 4, 887&#x2013;893.</Citation><ArticleIdList><ArticleId IdType="pubmed">11528419</ArticleId></ArticleIdList></Reference><Reference><Citation>Nygaard HB, Kaufman AC, Sekine-Konno T, Huh LL, Going H, Feldman SJ, Kostylev MA &amp; Strittmatter SM (2015). Brivaracetam, but not ethosuximide, reverses memory impairments in an Alzheimer&#x2019;s disease mouse model. Alzheimer Res. Ther, 7, 1&#x2013;12. doi:10.1186/s13195-015-0110-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13195-015-0110-9</ArticleId><ArticleId IdType="pmc">PMC4419386</ArticleId><ArticleId IdType="pubmed">25945128</ArticleId></ArticleIdList></Reference><Reference><Citation>Onos KD, Quinney SK, Jones DR, Masters AR, Pandey R, Keezer KJ, Biesdorf C, Metzger IF, Meyers JA, Peters J, et al. (2022). Pharmacokinetic, pharmacodynamic, and transcriptomic analysis of chronic levetiracetam treatment in 5XFAD mice: A MODEL-AD preclinical testing core study. Alzheimers Dement. (N. Y.), 8, 1&#x2013;14. doi:10.1002/trc2.12329.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/trc2.12329</ArticleId><ArticleId IdType="pmc">PMC9398229</ArticleId><ArticleId IdType="pubmed">36016830</ArticleId></ArticleIdList></Reference><Reference><Citation>Paloneva J, Manninen T, Christman G, Hovanes K, Mandelin J, Adolfsson R, Bianchin M, Bird T, Miranda R, Salmaggi A, et al. (2002). Mutations in two genes encoding different subunits of a receptor signaling complex result in an identical disease phenotype. Am. J. Hum. Genet, 71, 656&#x2013;662. doi:10.1086/342259.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/342259</ArticleId><ArticleId IdType="pmc">PMC379202</ArticleId><ArticleId IdType="pubmed">12080485</ArticleId></ArticleIdList></Reference><Reference><Citation>Palop JJ &amp; Mucke L (2016). Network abnormalities and interneuron dysfunction in Alzheimer disease. Nat. Rev. Neurosci, 17, 777&#x2013;792. doi:10.1038/nrn.2016.141.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn.2016.141</ArticleId><ArticleId IdType="pmc">PMC8162106</ArticleId><ArticleId IdType="pubmed">27829687</ArticleId></ArticleIdList></Reference><Reference><Citation>Paz JT, Chavez M, Saillet S, Deniau JM &amp; Charpier S (2007). Activity of ventral medial thalamic neurons during absence seizures and modulation of cortical paroxysms by the nigrothalamic pathway. J. Neurosci, 27, 929&#x2013;941. doi:10.1523/JNEUROSCI.4677-06.2007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.4677-06.2007</ArticleId><ArticleId IdType="pmc">PMC6672924</ArticleId><ArticleId IdType="pubmed">17251435</ArticleId></ArticleIdList></Reference><Reference><Citation>Paz JT, Davidson TJ, Frechette ES, Delord B, Parada I, Peng K, Deisseroth K &amp; Huguenard JR (2013). Closed-loop optogenetic control of thalamus as a tool for interrupting seizures after cortical injury. Nat. Neurosci, 16, 64&#x2013;70. doi:10.1038/nn.3269.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3269</ArticleId><ArticleId IdType="pmc">PMC3700812</ArticleId><ArticleId IdType="pubmed">23143518</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren S, Yao W, Tambini MD, Yin T, Norris KA &amp; D&#x2019;adamio L (2020). Microglia TREM2(R47H) Alzheimer-linked variant enhances excitatory transmission and reduces LTP via increased TNF-alpha levels. Elife, 9, 1&#x2013;18. doi:10.7554/eLife.57513.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.57513</ArticleId><ArticleId IdType="pmc">PMC7338048</ArticleId><ArticleId IdType="pubmed">32579116</ArticleId></ArticleIdList></Reference><Reference><Citation>Saito T, Matsuba Y, Mihira N, Takano J, Nilsson P, Itohara S, Iwata N &amp; Saido TC (2014). Single App knock-in mouse models of Alzheimer&#x2019;s disease. Nat. Neurosci, 17, 661&#x2013;663. doi:10.1038/nn.3697.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3697</ArticleId><ArticleId IdType="pubmed">24728269</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanchez PE, Zhu L, Verret L, Vossel KA, Orr AG, Cirrito JR, Devidze N, Ho K, Yu G-Q, Palop JJ, et al. (2012). Levetiracetam suppresses neuronal network dysfunction and reverses synaptic and cognitive deficits in an Alzheimer&#x2019;s disease model. Proc. Natl. Acad. Sci. USA, 109, E2895&#x2013;E2903. doi:10.1073/pnas.1121081109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1121081109</ArticleId><ArticleId IdType="pmc">PMC3479491</ArticleId><ArticleId IdType="pubmed">22869752</ArticleId></ArticleIdList></Reference><Reference><Citation>Sato SM &amp; Woolley CS (2016). Acute inhibition of neurosteroid estrogen synthesis suppresses status epilepticus in an animal model. Elife, 5, 1&#x2013;25. doi:10.7554/eLife.12917.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.12917</ArticleId><ArticleId IdType="pmc">PMC4862752</ArticleId><ArticleId IdType="pubmed">27083045</ArticleId></ArticleIdList></Reference><Reference><Citation>Sauerbeck AD, Gangolli M, Reitz SJ, Salyards MH, Kim SH, Hemingway C, Gratuze M, Makkapati T, Kerschensteiner M, Holtzman DM, et al. (2020). SEQUIN multiscale imaging of mammalian central synapses reveals loss of synaptic connectivity resulting from diffuse traumatic brain injury. Neuron, 107, 257&#x2013;273 e5. doi:10.1016/j.neuron.2020.04.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2020.04.012</ArticleId><ArticleId IdType="pmc">PMC7381374</ArticleId><ArticleId IdType="pubmed">32392471</ArticleId></ArticleIdList></Reference><Reference><Citation>Sayed FA, Kodama L, Fan L, Carling GK, Udeochu JC, Le D, Li Q, Zhou L, Wong MY, Horowitz R, et al. (2021). AD-linked R47H-TREM2 mutation induces disease-enhancing microglial states via AKT hyperactivation. Sci. Transl. Med, 13, eabe3947. doi:10.1126/scitranslmed.abe3947.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.abe3947</ArticleId><ArticleId IdType="pmc">PMC9345574</ArticleId><ArticleId IdType="pubmed">34851693</ArticleId></ArticleIdList></Reference><Reference><Citation>Scarmeas N, Honig LS, Choi H, Cantero J, Brandt J, Blacker D, Albert M, Amatniek JC, Marder K, Bell K, et al. (2009). Seizures in Alzheimer disease: Who, when, and how common? Arch. Neurol, 66, 992&#x2013;997. doi:10.1001/archneurol.2009.130.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneurol.2009.130</ArticleId><ArticleId IdType="pmc">PMC2768279</ArticleId><ArticleId IdType="pubmed">19667221</ArticleId></ArticleIdList></Reference><Reference><Citation>Schafer DP, Lehrman EK, Kautzman AG, Koyama R, Mardinly AR, Yamasaki R, Ransohoff RM, Greenberg ME, Barres BA &amp; Stevens B (2012). Microglia sculpt postnatal neural circuits in an activity and complement-dependent manner. Neuron, 74, 691&#x2013;705. doi:10.1016/j.neuron.2012.03.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2012.03.026</ArticleId><ArticleId IdType="pmc">PMC3528177</ArticleId><ArticleId IdType="pubmed">22632727</ArticleId></ArticleIdList></Reference><Reference><Citation>Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, Preibisch S, Rueden C, Saalfeld S, Schmid B, et al. (2012). Fiji: an open-source platform for biological-image analysis. Nat. Methods, 9, 676&#x2013;682. doi:10.1038/nmeth.2019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.2019</ArticleId><ArticleId IdType="pmc">PMC3855844</ArticleId><ArticleId IdType="pubmed">22743772</ArticleId></ArticleIdList></Reference><Reference><Citation>Schlepckow K, Monroe KM, Kleinberger G, Cantuti-Castelvetri L, Parhizkar S, Xia D, Willem M, Werner G, Pettkus N, Brunner B, et al. (2020). Enhancing protective microglial activities with a dual function TREM2 antibody to the stalk region. EMBO Mol. Med, 12, e11227. doi:10.15252/emmm.201911227.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/emmm.201911227</ArticleId><ArticleId IdType="pmc">PMC7136959</ArticleId><ArticleId IdType="pubmed">32154671</ArticleId></ArticleIdList></Reference><Reference><Citation>Schoch KM, Ezerskiy LA, Morhaus MM, Bannon RN, Sauerbeck AD, Shabsovich M, Jafar-Nejad P, Rigo F &amp; Miller TM (2021). Acute Trem2 reduction triggers increased microglial phagocytosis, slowing amyloid deposition in mice. Proc. Natl. Acad. Sci. U S A, 118, 1&#x2013;10. doi:10.1073/pnas.2100356118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2100356118</ArticleId><ArticleId IdType="pmc">PMC8271763</ArticleId><ArticleId IdType="pubmed">34187891</ArticleId></ArticleIdList></Reference><Reference><Citation>Scott-Hewitt N, Perrucci F, Morini R, Erreni M, Mahoney M, Witkowska A, Carey A, Faggiani E, Schuetz LT, Mason S, et al. (2020). Local externalization of phosphatidylserine mediates developmental synaptic pruning by microglia. EMBO J, 39, 1&#x2013;20. doi:10.15252/embj.2020105380.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.2020105380</ArticleId><ArticleId IdType="pmc">PMC7429741</ArticleId><ArticleId IdType="pubmed">32657463</ArticleId></ArticleIdList></Reference><Reference><Citation>Shanbhag NM, Evans MD, Mao W, Nana AL, Seeley WW, Adame A, Rissman RA, Masliah E &amp; Mucke L (2019). Early neuronal accumulation of DNA double strand breaks in Alzheimer&#x2019;s disease. Acta Neuropathol. Commun, 7, 1&#x2013;18. doi:10.1186/s40478-019-0723-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-019-0723-5</ArticleId><ArticleId IdType="pmc">PMC6524256</ArticleId><ArticleId IdType="pubmed">31101070</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi Y &amp; Holtzman DM (2018). Interplay between innate immunity and Alzheimer disease: APOE and TREM2 in the spotlight. Nat. Rev. Immunol, 18, 759&#x2013;772. doi:10.1038/s41577-018-0051-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-018-0051-1</ArticleId><ArticleId IdType="pmc">PMC6425488</ArticleId><ArticleId IdType="pubmed">30140051</ArticleId></ArticleIdList></Reference><Reference><Citation>Shih AY, Blinder P, Tsai PS, Friedman B, Stanley G, Lyden PD &amp; Kleinfeld D (2013). The smallest stroke: occlusion of one penetrating vessel leads to infarction and a cognitive deficit. Nat. Neurosci, 16, 55&#x2013;63. doi:10.1038/nn.3278.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3278</ArticleId><ArticleId IdType="pmc">PMC3952571</ArticleId><ArticleId IdType="pubmed">23242312</ArticleId></ArticleIdList></Reference><Reference><Citation>Song W, Hooli B, Mullin K, Jin SC, Cella M, Ulland TK, Wang Y, Tanzi RE &amp; Colonna M (2017). Alzheimer&#x2019;s disease-associated TREM2 variants exhibit either decreased or increased ligand-dependent activation. Alzheimers Dement, 13, 381&#x2013;387. doi:10.1016/j.jalz.2016.07.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2016.07.004</ArticleId><ArticleId IdType="pmc">PMC5299056</ArticleId><ArticleId IdType="pubmed">27520774</ArticleId></ArticleIdList></Reference><Reference><Citation>Stevens B, Allen NJ, Vazquez LE, Howell GR, Christopherson KS, Nouri N, Micheva KD, Mehalow AK, Huberman AD, Stafford B, et al. (2007). The classical complement cascade mediates CNS synapse elimination. Cell, 131, 1164&#x2013;1178. doi:10.1016/j.cell.2007.10.036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2007.10.036</ArticleId><ArticleId IdType="pubmed">18083105</ArticleId></ArticleIdList></Reference><Reference><Citation>Stoiljkovic M, Gutierrez KO, Kelley C, Horvath TL &amp; Hajos M (2022). TREM2 deficiency disrupts network oscillations leading to epileptic activity and aggravates Amyloid-beta-Related hippocampal pathophysiology in mice. J. Alzheimers Dis, 88, 837&#x2013;847. doi:10.3233/JAD-210041.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-210041</ArticleId><ArticleId IdType="pmc">PMC8898080</ArticleId><ArticleId IdType="pubmed">34120899</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudom A, Talreja S, Danao J, Bragg E, Kegel R, Min X, Richardson J, Zhang Z, Sharkov N, Marcora E, et al. (2018). Molecular basis for the loss-of-function effects of the Alzheimer&#x2019;s disease-associated R47H variant of the immune receptor TREM2. J. Biol. Chem, 293, 12634&#x2013;12646. doi:10.1074/jbc.RA118.002352.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.RA118.002352</ArticleId><ArticleId IdType="pmc">PMC6093241</ArticleId><ArticleId IdType="pubmed">29794134</ArticleId></ArticleIdList></Reference><Reference><Citation>Terry RD, Masliah E, Salmon DP, Butters N, Deteresa R, Hill R, Hansen LA &amp; Katzman R (1991). Physical basis of cognitive alterations in Alzheimer&#x2019;s disease: synapse loss is the major correlate of cognitive impairment. Ann. Neurol, 30, 572&#x2013;580. doi:10.1002/ana.410300410.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.410300410</ArticleId><ArticleId IdType="pubmed">1789684</ArticleId></ArticleIdList></Reference><Reference><Citation>Terzic B, Cui Y, Edmondson AC, Tang S, Sarmiento N, Zaitseva D, Marsh ED, Coulter DA &amp; Zhou Z (2021). X-linked cellular mosaicism underlies age-dependent occurrence of seizure-like events in mouse models of CDKL5 deficiency disorder. Neurobiol. Dis, 148, 105176. doi:10.1016/j.nbd.2020.105176.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2020.105176</ArticleId><ArticleId IdType="pmc">PMC7856307</ArticleId><ArticleId IdType="pubmed">33197557</ArticleId></ArticleIdList></Reference><Reference><Citation>Tse K, Puttachary S, Beamer E, Sills GJ &amp; Thippeswamy T (2014). Advantages of repeated low dose against single high dose of kainate in C57BL/6J mouse model of status epilepticus: behavioral and electroencephalographic studies. PLoS One, 9, 1&#x2013;12. doi:10.1371/journal.pone.0096622.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0096622</ArticleId><ArticleId IdType="pmc">PMC4011859</ArticleId><ArticleId IdType="pubmed">24802808</ArticleId></ArticleIdList></Reference><Reference><Citation>Ulland TK &amp; Colonna M (2018). TREM2 - a key player in microglial biology and Alzheimer disease. Nat. Rev. Neurol, 14, 667&#x2013;675. doi:10.1038/s41582-018-0072-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-018-0072-1</ArticleId><ArticleId IdType="pubmed">30266932</ArticleId></ArticleIdList></Reference><Reference><Citation>Ulrich JD, Finn MB, Wang Y, Shen A, Mahan TE, Jiang H, Stewart FR, Piccio L, Colonna M &amp; Holtzman DM (2014). Altered microglial response to Abeta plaques in APPPS1-21 mice heterozygous for TREM2. Mol. Neurodegener, 9, 1&#x2013;9. doi:10.1186/1750-1326-9-20.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1750-1326-9-20</ArticleId><ArticleId IdType="pmc">PMC4049806</ArticleId><ArticleId IdType="pubmed">24893973</ArticleId></ArticleIdList></Reference><Reference><Citation>Ulrich JD, Ulland TK, Colonna M &amp; Holtzman DM (2017). Elucidating the role of TREM2 in Alzheimer&#x2019;s disease. Neuron, 94, 237&#x2013;248. doi:10.1016/j.neuron.2017.02.042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2017.02.042</ArticleId><ArticleId IdType="pubmed">28426958</ArticleId></ArticleIdList></Reference><Reference><Citation>Umpierre AD, Bennett IV, Nebeker LD, Newell TG, Tian BB, Thomson KE, White HS, White JA &amp; Wilcox KS (2016). Repeated low-dose kainate administration in C57BL/6J mice produces temporal lobe epilepsy pathology but infrequent spontaneous seizures. Exp. Neurol, 279, 116&#x2013;126. doi:10.1016/j.expneurol.2016.02.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2016.02.014</ArticleId><ArticleId IdType="pmc">PMC5382800</ArticleId><ArticleId IdType="pubmed">26896834</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Erum J, Van Dam D &amp; De Deyn PP (2019). PTZ-induced seizures in mice require a revised Racine scale. Epilepsy Behav, 95, 51&#x2013;55. doi:10.1016/j.yebeh.2019.02.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yebeh.2019.02.029</ArticleId><ArticleId IdType="pubmed">31026782</ArticleId></ArticleIdList></Reference><Reference><Citation>Verstraelen P, Garcia-Diaz Barriga G, Verschuuren M, Asselbergh B, Nuydens R, Larsen PH, Timmermans JP &amp; De Vos WH (2020). Systematic quantification of synapses in primary neuronal culture. iScience, 23, 1&#x2013;14. doi:10.1016/j.isci.2020.101542.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2020.101542</ArticleId><ArticleId IdType="pmc">PMC7516133</ArticleId><ArticleId IdType="pubmed">33083769</ArticleId></ArticleIdList></Reference><Reference><Citation>Voglein J, Noachtar S, Mcdade E, Quaid KA, Salloway S, Ghetti B, Noble J, Berman S, Chhatwal J, Mori H, et al. (2019). Seizures as an early symptom of autosomal dominant Alzheimer&#x2019;s disease. Neurobiol. Aging, 76, 18&#x2013;23. doi:10.1016/j.neurobiolaging.2018.11.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2018.11.022</ArticleId><ArticleId IdType="pmc">PMC6572755</ArticleId><ArticleId IdType="pubmed">30616208</ArticleId></ArticleIdList></Reference><Reference><Citation>Vossel KA, Ranasinghe KG, Beagle AJ, Mizuiri D, Honma SM, Dowling AF, Darwish SM, Van Berlo V, Barnes DE, Mantle M, et al. (2016). Incidence and impact of subclinical epileptiform activity in Alzheimer&#x2019;s disease. Ann. Neurol, 80, 858&#x2013;870. doi:10.1002/ana.24794.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.24794</ArticleId><ArticleId IdType="pmc">PMC5177487</ArticleId><ArticleId IdType="pubmed">27696483</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C, Yue H, Hu Z, Shen Y, Ma J, Li J, Wang XD, Wang L, Sun B, Shi P, et al. (2020). Microglia mediate forgetting via complement-dependent synaptic elimination. Science, 367, 688&#x2013;694. doi:10.1126/science.aaz2288.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaz2288</ArticleId><ArticleId IdType="pubmed">32029629</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Ulland TK, Ulrich JD, Song W, Tzaferis JA, Hole JT, Yuan P, Mahan TE, Shi Y, Gilfillan S, et al. (2016). TREM2-mediated early microglial response limits diffusion and toxicity of amyloid plaques. J. Exp. Med, 213, 667&#x2013;675. doi:10.1084/jem.20151948.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20151948</ArticleId><ArticleId IdType="pmc">PMC4854736</ArticleId><ArticleId IdType="pubmed">27091843</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitesell JD, Buckley AR, Knox JE, Kuan L, Graddis N, Pelos A, Mukora A, Wakeman W, Bohn P, Ho A, et al. (2019). Whole brain imaging reveals distinct spatial patterns of amyloid beta deposition in three mouse models of Alzheimer&#x2019;s disease. J. Comp. Neurol, 527, 2122&#x2013;2145. doi:10.1002/cne.24555.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cne.24555</ArticleId><ArticleId IdType="pmc">PMC8026112</ArticleId><ArticleId IdType="pubmed">30311654</ArticleId></ArticleIdList></Reference><Reference><Citation>Wood JI, Wong E, Joghee R, Balbaa A, Vitanova KS, Stringer KM, Vanshoiack A, Phelan SJ, Launchbury F, Desai S, et al. (2022). Plaque contact and unimpaired Trem2 is required for the microglial response to amyloid pathology. Cell Rep, 41, 1&#x2013;13. doi:10.1016/j.celrep.2022.111686.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2022.111686</ArticleId><ArticleId IdType="pubmed">36417868</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia D, Lianoglou S, Sandmann T, Calvert M, Suh JH, Thomsen E, Dugas J, Pizzo ME, Devos SL, Earr TK, et al. (2022). Novel App knock-in mouse model shows key features of amyloid pathology and reveals profound metabolic dysregulation of microglia. Mol. Neurodegener, 17, 1&#x2013;29. doi:10.1186/s13024-022-00547-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-022-00547-7</ArticleId><ArticleId IdType="pmc">PMC9188195</ArticleId><ArticleId IdType="pubmed">35690868</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeh FL, Wang Y, Tom I, Gonzalez LC &amp; Sheng M (2016). TREM2 binds to apolipoproteins, including APOE and CLU/APOJ, and thereby facilitates uptake of Amyloid-Beta by microglia. Neuron, 91, 328&#x2013;340. doi:10.1016/j.neuron.2016.06.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2016.06.015</ArticleId><ArticleId IdType="pubmed">27477018</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan P, Condello C, Keene CD, Wang Y, Bird TD, Paul SM, Luo W, Colonna M, Baddeley D &amp; Grutzendler J (2016). TREM2 haplodeficiency in mice and humans impairs the microglia barrier function leading to decreased amyloid compaction and severe axonal dystrophy. Neuron, 90, 724&#x2013;739. doi:10.1016/j.neuron.2016.05.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2016.05.003</ArticleId><ArticleId IdType="pmc">PMC4898967</ArticleId><ArticleId IdType="pubmed">27196974</ArticleId></ArticleIdList></Reference><Reference><Citation>Zarea A, Charbonnier C, Rovelet-Lecrux A, Nicolas G, Rousseau S, Borden A, Pariente J, Le Ber I, Pasquier F, Formaglio M, et al. (2016). Seizures in dominantly inherited Alzheimer disease. Neurology, 87, 912&#x2013;919. doi:10.1212/WNL.0000000000003048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000003048</ArticleId><ArticleId IdType="pubmed">27466472</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng H, Jia L, Liu CC, Rong Z, Zhong L, Yang L, Chen XF, Fryer JD, Wang X, Zhang YW, et al. (2017). TREM2 promotes microglial survival by activating Wnt/beta-Catenin pathway. J. Neurosci, 37, 1772&#x2013;1784. doi:10.1523/JNEUROSCI.2459-16.2017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.2459-16.2017</ArticleId><ArticleId IdType="pmc">PMC5320608</ArticleId><ArticleId IdType="pubmed">28077724</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y, Song WM, Andhey PS, Swain A, Levy T, Miller KR, Poliani PL, Cominelli M, Grover S, Gilfillan S, et al. (2020). Human and mouse single-nucleus transcriptomics reveal TREM2-dependent and TREM2-independent cellular responses in Alzheimer&#x2019;s disease. Nat. Med, 26, 131&#x2013;142. doi:10.1038/s41591-019-0695-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-019-0695-9</ArticleId><ArticleId IdType="pmc">PMC6980793</ArticleId><ArticleId IdType="pubmed">31932797</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37620442</PMID><DateCompleted><Year>2023</Year><Month>09</Month><Day>04</Day></DateCompleted><DateRevised><Year>2024</Year><Month>08</Month><Day>09</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1546-1726</ISSN><JournalIssue CitedMedium="Internet"><Volume>26</Volume><Issue>9</Issue><PubDate><Year>2023</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Nature neuroscience</Title><ISOAbbreviation>Nat Neurosci</ISOAbbreviation></Journal><ArticleTitle>Infiltrating CD8<sup>+</sup> T cells exacerbate Alzheimer's disease pathology in a 3D human neuroimmune axis model.</ArticleTitle><Pagination><StartPage>1489</StartPage><EndPage>1504</EndPage><MedlinePgn>1489-1504</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41593-023-01415-3</ELocationID><Abstract><AbstractText>Brain infiltration of peripheral immune cells and their interactions with brain-resident cells may contribute to Alzheimer's disease (AD) pathology. To examine these interactions, in the present study we developed a three-dimensional human neuroimmune axis model comprising stem cell-derived neurons, astrocytes and microglia, together with peripheral immune cells. We observed an increase in the number of T cells (but not B cells) and monocytes selectively infiltrating into AD relative to control cultures. Infiltration of CD8<sup>+</sup> T cells into AD cultures led to increased microglial activation, neuroinflammation and neurodegeneration. Using single-cell RNA-sequencing, we identified that infiltration of T cells into AD cultures led to induction of interferon-&#x3b3; and neuroinflammatory pathways in glial cells. We found key roles for the C-X-C motif chemokine ligand 10 (CXCL10) and its receptor, CXCR3, in regulating T cell infiltration and neuronal damage in AD cultures. This human neuroimmune axis model is a useful tool to study the effects of peripheral immune cells in brain disease.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s), under exclusive licence to Springer Nature America, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Jorfi</LastName><ForeName>Mehdi</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-4724-6190</Identifier><AffiliationInfo><Affiliation>Genetics and Aging Research Unit, McCance Center for Brain Health, Mass General Institute for Neurodegenerative Disease, Department of Neurology, Massachusetts General Hospital, Charlestown, MA, USA. mjorfi@mgh.harvard.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Harvard Medical School, Boston, MA, USA. mjorfi@mgh.harvard.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Engineering in Medicine and Surgery, Massachusetts General Hospital, Charlestown, MA, USA. mjorfi@mgh.harvard.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Park</LastName><ForeName>Joseph</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Genetics and Aging Research Unit, McCance Center for Brain Health, Mass General Institute for Neurodegenerative Disease, Department of Neurology, Massachusetts General Hospital, Charlestown, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hall</LastName><ForeName>Clare K</ForeName><Initials>CK</Initials><AffiliationInfo><Affiliation>Genetics and Aging Research Unit, McCance Center for Brain Health, Mass General Institute for Neurodegenerative Disease, Department of Neurology, Massachusetts General Hospital, Charlestown, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Chih-Chung Jerry</ForeName><Initials>CJ</Initials><AffiliationInfo><Affiliation>Genetics and Aging Research Unit, McCance Center for Brain Health, Mass General Institute for Neurodegenerative Disease, Department of Neurology, Massachusetts General Hospital, Charlestown, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Meng</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Genetics and Aging Research Unit, McCance Center for Brain Health, Mass General Institute for Neurodegenerative Disease, Department of Neurology, Massachusetts General Hospital, Charlestown, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>von Maydell</LastName><ForeName>Djuna</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Genetics and Aging Research Unit, McCance Center for Brain Health, Mass General Institute for Neurodegenerative Disease, Department of Neurology, Massachusetts General Hospital, Charlestown, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kruskop</LastName><ForeName>Jane M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Genetics and Aging Research Unit, McCance Center for Brain Health, Mass General Institute for Neurodegenerative Disease, Department of Neurology, Massachusetts General Hospital, Charlestown, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kang</LastName><ForeName>Byunghoon</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Genetics and Aging Research Unit, McCance Center for Brain Health, Mass General Institute for Neurodegenerative Disease, Department of Neurology, Massachusetts General Hospital, Charlestown, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Choi</LastName><ForeName>Younjung</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Genetics and Aging Research Unit, McCance Center for Brain Health, Mass General Institute for Neurodegenerative Disease, Department of Neurology, Massachusetts General Hospital, Charlestown, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prokopenko</LastName><ForeName>Dmitry</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Genetics and Aging Research Unit, McCance Center for Brain Health, Mass General Institute for Neurodegenerative Disease, Department of Neurology, Massachusetts General Hospital, Charlestown, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Irimia</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0001-7347-2082</Identifier><AffiliationInfo><Affiliation>Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Engineering in Medicine and Surgery, Massachusetts General Hospital, Charlestown, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Shriners Burns Hospital, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Doo Yeon</ForeName><Initials>DY</Initials><Identifier Source="ORCID">0000-0002-6969-0340</Identifier><AffiliationInfo><Affiliation>Genetics and Aging Research Unit, McCance Center for Brain Health, Mass General Institute for Neurodegenerative Disease, Department of Neurology, Massachusetts General Hospital, Charlestown, MA, USA. dkim@helix.mgh.harvard.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Harvard Medical School, Boston, MA, USA. dkim@helix.mgh.harvard.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tanzi</LastName><ForeName>Rudolph E</ForeName><Initials>RE</Initials><Identifier Source="ORCID">0000-0002-7032-1454</Identifier><AffiliationInfo><Affiliation>Genetics and Aging Research Unit, McCance Center for Brain Health, Mass General Institute for Neurodegenerative Disease, Department of Neurology, Massachusetts General Hospital, Charlestown, MA, USA. tanzi@helix.mgh.harvard.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Harvard Medical School, Boston, MA, USA. tanzi@helix.mgh.harvard.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>T32 AG000222</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>08</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Nat Neurosci</MedlineTA><NlmUniqueID>9809671</NlmUniqueID><ISSNLinking>1097-6256</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018414" MajorTopicYN="Y">CD8-Positive T-Lymphocytes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015213" MajorTopicYN="N">Neuroimmunomodulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009457" MajorTopicYN="N">Neuroglia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009474" MajorTopicYN="N">Neurons</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>Competing interests. The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>8</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>7</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>4</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>8</Month><Day>25</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>8</Month><Day>24</Day><Hour>23</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>6</Month><Day>18</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37620442</ArticleId><ArticleId IdType="mid">NIHMS1991963</ArticleId><ArticleId IdType="pmc">PMC11184920</ArticleId><ArticleId IdType="doi">10.1038/s41593-023-01415-3</ArticleId><ArticleId IdType="pii">10.1038/s41593-023-01415-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Jorfi M, Maaser-Hecker A &amp; Tanzi RE The neuroimmune axis of Alzheimer&#x2019;s disease. Genome Med. 15, 6 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9878767</ArticleId><ArticleId IdType="pubmed">36703235</ArticleId></ArticleIdList></Reference><Reference><Citation>Bettcher BM, Tansey MG, Doroth&#xe9;e G &amp; Heneka MT Peripheral and central immune system crosstalk in Alzheimer disease&#x2014;a research prospectus. Nat. Rev. Neurol. 17, 689&#x2013;701 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8439173</ArticleId><ArticleId IdType="pubmed">34522039</ArticleId></ArticleIdList></Reference><Reference><Citation>Arlehamn CSL, Garretti F, Sulzer D &amp; Sette A Roles for the adaptive immune system in Parkinson&#x2019;s and Alzheimer&#x2019;s diseases. Curr. Opin. Immunol. 59, 115&#x2013;120 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6774843</ArticleId><ArticleId IdType="pubmed">31430650</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu K-M et al. The role of the immune system in Alzheimer&#x2019;s disease. Ageing Res. Rev. 70, 101409 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34273589</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao W &amp; Zheng H Peripheral immune system in aging and Alzheimer&#x2019;s disease. Mol. Neurodegen. 13, 51 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6169078</ArticleId><ArticleId IdType="pubmed">30285785</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogers J, Luber-Narod J, Styren SD &amp; Civin WH Expression of immune system-associated antigens by cells of the human central nervous system: relationship to the pathology of Alzheimer&#x2019;s disease. Neurobiol. Aging 9, 339&#x2013;349 (1988).</Citation><ArticleIdList><ArticleId IdType="pubmed">3263583</ArticleId></ArticleIdList></Reference><Reference><Citation>Itagaki S, McGeer PL &amp; Akiyama H Presence of T-cytotoxic suppressor and leucocyte common antigen positive cells in Alzheimer&#x2019;s disease brain tissue. Neurosci. Lett. 91, 259&#x2013;264 (1988).</Citation><ArticleIdList><ArticleId IdType="pubmed">2972943</ArticleId></ArticleIdList></Reference><Reference><Citation>Togo T et al. Occurrence of T cells in the brain of Alzheimer&#x2019;s disease and other neurological diseases. J. Neuroimmunol. 124, 83&#x2013;92 (2002).</Citation><ArticleIdList><ArticleId IdType="pubmed">11958825</ArticleId></ArticleIdList></Reference><Reference><Citation>Merlini M, Kirabali T, Kulic L, Nitsch RM &amp; Ferretti MT Extravascular CD3+ T cells in brains of Alzheimer disease patients correlate with tau but not with amyloid pathology: an immunohistochemical study. Neurodegener. Dis. 18, 49&#x2013;56 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">29402847</ArticleId></ArticleIdList></Reference><Reference><Citation>Unger MS et al. CD8+ T-cells infiltrate Alzheimer&#x2019;s disease brains and regulate neuronal- and synapse-related gene expression in APP-PS1 transgenic mice. Brain Behav. Immun. 89, 67&#x2013;86 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32479993</ArticleId></ArticleIdList></Reference><Reference><Citation>Gate D et al. Clonally expanded CD8 T cells patrol the cerebrospinal fluid in Alzheimer&#x2019;s disease. Nature 577, 399&#x2013;404 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7445078</ArticleId><ArticleId IdType="pubmed">31915375</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferretti MT et al. T-cell brain infiltration and immature antigen-presenting cells in transgenic models of Alzheimer&#x2019;s disease-like cerebral amyloidosis. Brain Behav. Immun. 54, 211&#x2013;225 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">26872418</ArticleId></ArticleIdList></Reference><Reference><Citation>Browne TC et al. IFN-&#x3b3; production by amyloid &#x3b2;-specific Th1 cells promotes microglial activation and increases plaque burden in a mouse model of Alzheimer&#x2019;s disease. J. Immunol. 190, 2241&#x2013;2251 (2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">23365075</ArticleId></ArticleIdList></Reference><Reference><Citation>MacPherson KP et al. Peripheral administration of the soluble TNF inhibitor XPro1595 modifies brain immune cell profiles, decreases beta-amyloid plaque load, and rescues impaired long-term potentiation in 5xFAD mice. Neurobiol. Dis. 102, 81&#x2013;95 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5464789</ArticleId><ArticleId IdType="pubmed">28237313</ArticleId></ArticleIdList></Reference><Reference><Citation>Shukla AK et al. CD11a expression distinguishes infiltrating myeloid cells from plaque&#x2010;associated microglia in Alzheimer&#x2019;s disease. Glia 67, 844&#x2013;856 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7375697</ArticleId><ArticleId IdType="pubmed">30588668</ArticleId></ArticleIdList></Reference><Reference><Citation>Monsonego A et al. A&#x3b2;-induced meningoencephalitis is IFN-&#x3b3;-dependent and is associated with T cell-dependent clearance of A&#x3b2; in a mouse model of Alzheimer&#x2019;s disease. Proc. Natl Acad. Sci. USA 103, 5048&#x2013;5053 (2006).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1458792</ArticleId><ArticleId IdType="pubmed">16549802</ArticleId></ArticleIdList></Reference><Reference><Citation>Machhi J et al. CD4+ effector T cells accelerate Alzheimer&#x2019;s disease in mice. J. Neuroinflamm. 18, 272 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8603581</ArticleId><ArticleId IdType="pubmed">34798897</ArticleId></ArticleIdList></Reference><Reference><Citation>Pietronigro E et al. Blockade of &#x3b1;4 integrins reduces leukocyte&#x2013;endothelial interactions in cerebral vessels and improves memory in a mouse model of Alzheimer&#x2019;s disease. Sci. Rep. 9, 12055 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6700124</ArticleId><ArticleId IdType="pubmed">31427644</ArticleId></ArticleIdList></Reference><Reference><Citation>Gate D et al. CD4+ T cells contribute to neurodegeneration in Lewy body dementia. Science 374, 868&#x2013;874 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9122025</ArticleId><ArticleId IdType="pubmed">34648304</ArticleId></ArticleIdList></Reference><Reference><Citation>Wareham LK et al. Solving neurodegeneration: common mechanisms and strategies for new treatments. Mol. Neurodegen. 17, 23 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8935795</ArticleId><ArticleId IdType="pubmed">35313950</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xf6;tz J, Bodea L-G &amp; Goedert M Rodent models for Alzheimer disease. Nat. Rev. Neurosci. 19, 583&#x2013;598 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">30194347</ArticleId></ArticleIdList></Reference><Reference><Citation>Scearce-Levie K, Sanchez PE &amp; Lewcock JW Leveraging preclinical models for the development of Alzheimer disease therapeutics. Nat. Rev. Drug Discov. 19, 1&#x2013;16 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32612262</ArticleId></ArticleIdList></Reference><Reference><Citation>Blanchard JW, Victor MB &amp; Tsai L-H Dissecting the complexities of Alzheimer disease with in vitro models of the human brain. Nat. Rev. Neurol. 18, 25&#x2013;39 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34750588</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi SH, Kim YH, Quinti L, Tanzi RE &amp; Kim DY 3D culture models of Alzheimer&#x2019;s disease: a road map to a &#x2018;cure-in-a-dish&#x2019;. Mol. Neurodegen. 11, 75 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5148918</ArticleId><ArticleId IdType="pubmed">27938410</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi SH et al. A three-dimensional human neural cell culture model of Alzheimer&#x2019;s disease. Nature 515, 274&#x2013;278 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4366007</ArticleId><ArticleId IdType="pubmed">25307057</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim YH et al. A 3D human neural cell culture system for modeling Alzheimer&#x2019;s disease. Nat. Protoc. 10, 985&#x2013;1006 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4499058</ArticleId><ArticleId IdType="pubmed">26068894</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwak SS et al. Amyloid-&#x3b2;42/40 ratio drives tau pathology in 3D human neural cell culture models of Alzheimer&#x2019;s disease. Nat. Commun. 11, 1377 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7070004</ArticleId><ArticleId IdType="pubmed">32170138</ArticleId></ArticleIdList></Reference><Reference><Citation>Park J et al. A 3D human triculture system modeling neurodegeneration and neuroinflammation in Alzheimer&#x2019;s disease. Nat. Neurosci. 21, 941&#x2013;951 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6800152</ArticleId><ArticleId IdType="pubmed">29950669</ArticleId></ArticleIdList></Reference><Reference><Citation>Abud EM et al. iPSC-derived human microglia-like cells to study neurological diseases. Neuron 94, 278&#x2013;293.e9 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5482419</ArticleId><ArticleId IdType="pubmed">28426964</ArticleId></ArticleIdList></Reference><Reference><Citation>McQuade A et al. Development and validation of a simplified method to generate human microglia from pluripotent stem cells. Mol. Neurodegen. 13, 67 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6303871</ArticleId><ArticleId IdType="pubmed">30577865</ArticleId></ArticleIdList></Reference><Reference><Citation>Doorn KJ et al. Microglia in olfactory bulb of AD and PD patients. Brain Pathol. 24, 152&#x2013;165 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8029318</ArticleId><ArticleId IdType="pubmed">24033473</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson KG et al. Intravascular staining for discrimination of vascular and tissue leukocytes. Nat. Protoc. 9, 209&#x2013;222 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4428344</ArticleId><ArticleId IdType="pubmed">24385150</ArticleId></ArticleIdList></Reference><Reference><Citation>Browaeys R, Saelens W &amp; Saeys Y NicheNet: modeling intercellular communication by linking ligands to target genes. Nat. Methods 17, 159&#x2013;162 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">31819264</ArticleId></ArticleIdList></Reference><Reference><Citation>Takata K et al. Role of high mobility group protein-1 (HMG1) in amyloid-&#x3b2; homeostasis. Biochem Biophys. Res. Commun. 301, 699&#x2013;703 (2003).</Citation><ArticleIdList><ArticleId IdType="pubmed">12565837</ArticleId></ArticleIdList></Reference><Reference><Citation>Smit MJ et al. CXCR3-mediated chemotaxis of human T cells is regulated by a Gi- and phospholipase C-dependent pathway and not via activation of MEK/p44/p42 MAPK nor Akt/PI-3 kinase. Blood 102, 1959&#x2013;1965 (2003).</Citation><ArticleIdList><ArticleId IdType="pubmed">12750173</ArticleId></ArticleIdList></Reference><Reference><Citation>Lund H et al. Competitive repopulation of an empty microglial niche yields functionally distinct subsets of microglia-like cells. Nat. Commun. 9, 4845 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6242869</ArticleId><ArticleId IdType="pubmed">30451869</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee SM, Hudobenko J, McCullough LD &amp; Chauhan A Microglia depletion increase brain injury after acute ischemic stroke in aged mice. Exp. Neurol. 336, 113530 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7856174</ArticleId><ArticleId IdType="pubmed">33221396</ArticleId></ArticleIdList></Reference><Reference><Citation>Laurent C et al. Hippocampal T cell infiltration promotes neuroinflammation and cognitive decline in a mouse model of tauopathy. Brain 140, 184&#x2013;200 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5382942</ArticleId><ArticleId IdType="pubmed">27818384</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu L et al. T&#x2010;cell infiltration, contribution and regulation in the central nervous system post&#x2010;traumatic injury. Cell Prolifer. 54, e13092 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8349661</ArticleId><ArticleId IdType="pubmed">34189783</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaya T et al. CD8+ T cells induce interferon-responsive oligodendrocytes and microglia in white matter aging. Nat. Neurosci. 25, 1446&#x2013;1457 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9630119</ArticleId><ArticleId IdType="pubmed">36280798</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulz O, Hammerschmidt SI, Moschovakis GL &amp; F&#xf6;rster R Chemokines and chemokine receptors in lymphoid tissue dynamics. Annu. Rev. Immunol. 34, 1&#x2013;40 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">26907216</ArticleId></ArticleIdList></Reference><Reference><Citation>Sokol CL &amp; Luster AD The chemokine system in innate immunity. Cold Spring Harb. Perspect. Biol. 7, a016303 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4448619</ArticleId><ArticleId IdType="pubmed">25635046</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuena AR, Casolini P, Lattanzi R &amp; Maftei D Chemokines in Alzheimer&#x2019;s disease: new insights Into prokineticins, chemokine-like proteins. Front. Pharm. 10, 622 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6568308</ArticleId><ArticleId IdType="pubmed">31231219</ArticleId></ArticleIdList></Reference><Reference><Citation>Galimberti D et al. Intrathecal chemokine synthesis in mild cognitive impairment and Alzheimer disease. Arch. Neurol. 63, 538&#x2013;543 (2006).</Citation><ArticleIdList><ArticleId IdType="pubmed">16606766</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia MQ, Bacskai BJ, Knowles RB, Qin SX &amp; Hyman BT Expression of the chemokine receptor CXCR3 on neurons and the elevated expression of its ligand IP-10 in reactive astrocytes: in vitro ERK1/2 activation and role in Alzheimer&#x2019;s disease. J. Neuroimmunol. 108, 227&#x2013;235 (2000).</Citation><ArticleIdList><ArticleId IdType="pubmed">10900358</ArticleId></ArticleIdList></Reference><Reference><Citation>Wojcieszak J, Kuczy&#x144;ska K &amp; Zawilska JB Role of chemokines in the development and progression of Alzheimer&#x2019;s disease. J. Mol. Neurosci. 72, 1929&#x2013;1951 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9392685</ArticleId><ArticleId IdType="pubmed">35821178</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaheer S et al. Enhanced expression of glia maturation factor correlates with glial activation in the brain of triple transgenic Alzheimer&#x2019;s disease mice. Neurochem. Res. 38, 218&#x2013;225 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3527678</ArticleId><ArticleId IdType="pubmed">23086473</ArticleId></ArticleIdList></Reference><Reference><Citation>Duan R-S et al. Decreased fractalkine and increased IP-10 expression in aged brain of APPswe transgenic mice. Neurochem. Res. 33, 1085&#x2013;1089 (2008).</Citation><ArticleIdList><ArticleId IdType="pubmed">18095157</ArticleId></ArticleIdList></Reference><Reference><Citation>Groom JR &amp; Luster AD CXCR3 in T cell function. Exp. Cell Res. 317, 620&#x2013;631 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3065205</ArticleId><ArticleId IdType="pubmed">21376175</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurachi M et al. Chemokine receptor CXCR3 facilitates CD8+ T cell differentiation into short-lived effector cells leading to memory degeneration. J. Exp. Med. 208, 1605&#x2013;1620 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3149224</ArticleId><ArticleId IdType="pubmed">21788406</ArticleId></ArticleIdList></Reference><Reference><Citation>Krummel MF, Bartumeus F &amp; G&#xe9;rard A T cell migration, search strategies and mechanisms. Nat. Rev. Immunol. 16, 193&#x2013;201 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4869523</ArticleId><ArticleId IdType="pubmed">26852928</ArticleId></ArticleIdList></Reference><Reference><Citation>Maurice NJ, McElrath MJ, Andersen-Nissen E, Frahm N &amp; Prlic M CXCR3 enables recruitment and site-specific bystander activation of memory CD8+ T cells. Nat. Commun. 10, 4987 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6825240</ArticleId><ArticleId IdType="pubmed">31676770</ArticleId></ArticleIdList></Reference><Reference><Citation>Krauthausen M et al. CXCR3 promotes plaque formation and behavioral deficits in an Alzheimer&#x2019;s disease model. J. Clin. Invest. 125, 365&#x2013;378 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4382235</ArticleId><ArticleId IdType="pubmed">25500888</ArticleId></ArticleIdList></Reference><Reference><Citation>Ozga AJ et al. CXCL10 chemokine regulates heterogeneity of the CD8+ T cell response and viral set point during chronic infection. Immunity 55, 82&#x2013;97.e8 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8755631</ArticleId><ArticleId IdType="pubmed">34847356</ArticleId></ArticleIdList></Reference><Reference><Citation>Gericke C et al. Early &#x3b2;&#x2010;amyloid accumulation in the brain is associated with peripheral T cell alterations. Alzheimer&#x2019;s Dement. 10.1002/alz.13136 (2023).</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alz.13136</ArticleId><ArticleId IdType="pubmed">37314431</ArticleId></ArticleIdList></Reference><Reference><Citation>Piehl N et al. Cerebrospinal fluid immune dysregulation during healthy brain aging and cognitive impairment. Cell 185, 5028&#x2013;5039 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9815831</ArticleId><ArticleId IdType="pubmed">36516855</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X et al. Microglia-mediated T cell infiltration drives neurodegeneration in tauopathy. Nature 615, 668&#x2013;677 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10258627</ArticleId><ArticleId IdType="pubmed">36890231</ArticleId></ArticleIdList></Reference><Reference><Citation>Korsunsky I et al. Fast, sensitive and accurate integration of single-cell data with Harmony. Nat. Methods 16, 1289&#x2013;1296 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6884693</ArticleId><ArticleId IdType="pubmed">31740819</ArticleId></ArticleIdList></Reference><Reference><Citation>Hao Y et al. Integrated analysis of multimodal single-cell data. Cell 184, 3573&#x2013;3587.e29 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8238499</ArticleId><ArticleId IdType="pubmed">34062119</ArticleId></ArticleIdList></Reference><Reference><Citation>Hao Y et al. Dictionary learning for integrative, multimodal, and scalable single-cell analysis. Preprint at Nat. Biotech. 10.1038/s41587-023-01767-y (2023).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41587-023-01767-y</ArticleId><ArticleId IdType="pmc">PMC10928517</ArticleId><ArticleId IdType="pubmed">37231261</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37647388</PMID><DateCompleted><Year>2023</Year><Month>09</Month><Day>01</Day></DateCompleted><DateRevised><Year>2024</Year><Month>05</Month><Day>30</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1946-6242</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><Issue>711</Issue><PubDate><Year>2023</Year><Month>Aug</Month><Day>30</Day></PubDate></JournalIssue><Title>Science translational medicine</Title><ISOAbbreviation>Sci Transl Med</ISOAbbreviation></Journal><ArticleTitle>A blood-based marker of mitochondrial DNA damage in Parkinson's disease.</ArticleTitle><Pagination><StartPage>eabo1557</StartPage><MedlinePgn>eabo1557</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1126/scitranslmed.abo1557</ELocationID><Abstract><AbstractText>Parkinson's disease (PD) is the most common neurodegenerative movement disorder, and neuroprotective or disease-modifying interventions remain elusive. High-throughput markers aimed at stratifying patients on the basis of shared etiology are required to ensure the success of disease-modifying therapies in clinical trials. Mitochondrial dysfunction plays a prominent role in the pathogenesis of PD. Previously, we found brain region-specific accumulation of mitochondrial DNA (mtDNA) damage in PD neuronal culture and animal models, as well as in human PD postmortem brain tissue. To investigate mtDNA damage as a potential blood-based marker for PD, we describe herein a PCR-based assay (Mito DNA<sub>DX</sub>) that allows for the accurate real-time quantification of mtDNA damage in a scalable platform. We found that mtDNA damage was increased in peripheral blood mononuclear cells derived from patients with idiopathic PD and those harboring the PD-associated leucine-rich repeat kinase 2 (<i>LRRK2</i>) G2019S mutation in comparison with age-matched controls. In addition, mtDNA damage was elevated in non-disease-manifesting <i>LRRK2</i> mutation carriers, demonstrating that mtDNA damage can occur irrespective of a PD diagnosis. We further established that <i>Lrrk2</i> G2019S knock-in mice displayed increased mtDNA damage, whereas <i>Lrrk2</i> knockout mice showed fewer mtDNA lesions in the ventral midbrain, compared with wild-type control mice. Furthermore, a small-molecule kinase inhibitor of LRRK2 mitigated mtDNA damage in a rotenone PD rat midbrain neuron model and in idiopathic PD patient-derived lymphoblastoid cell lines. Quantifying mtDNA damage using the Mito DNA<sub>DX</sub> assay may have utility as a candidate marker of PD and for measuring the pharmacodynamic response to LRRK2 kinase inhibitors.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Qi</LastName><ForeName>Rui</ForeName><Initials>R</Initials><Identifier Source="ORCID">0009-0004-4852-373X</Identifier><AffiliationInfo><Affiliation>Departments of Neurology and Pathology, Duke University School of Medicine, Durham, NC 27710, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Duke Center for Neurodegeneration and Neurotherapeutics, Duke University, Durham, NC 27710, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sammler</LastName><ForeName>Esther</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0003-3218-7116</Identifier><AffiliationInfo><Affiliation>Molecular and Clinical Medicine, Ninewells Hospital and Medical School, University of Dundee, Dundee DD1 9SY, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical Research Council Protein Phosphorylation and Ubiquitylation Unit, University of Dundee, Dundee, DD1 5EH UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gonzalez-Hunt</LastName><ForeName>Claudia P</ForeName><Initials>CP</Initials><Identifier Source="ORCID">0000-0002-2736-0001</Identifier><AffiliationInfo><Affiliation>Departments of Neurology and Pathology, Duke University School of Medicine, Durham, NC 27710, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Duke Center for Neurodegeneration and Neurotherapeutics, Duke University, Durham, NC 27710, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barraza</LastName><ForeName>Ivana</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Departments of Neurology and Pathology, Duke University School of Medicine, Durham, NC 27710, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Duke Center for Neurodegeneration and Neurotherapeutics, Duke University, Durham, NC 27710, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pena</LastName><ForeName>Nicholas</ForeName><Initials>N</Initials><Identifier Source="ORCID">0009-0008-1724-5641</Identifier><AffiliationInfo><Affiliation>Departments of Neurology and Pathology, Duke University School of Medicine, Durham, NC 27710, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Duke Center for Neurodegeneration and Neurotherapeutics, Duke University, Durham, NC 27710, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rouanet</LastName><ForeName>Jeremy P</ForeName><Initials>JP</Initials><Identifier Source="ORCID">0000-0002-1800-9690</Identifier><AffiliationInfo><Affiliation>Departments of Neurology and Pathology, Duke University School of Medicine, Durham, NC 27710, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Naaldijk</LastName><ForeName>Yahaira</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0003-2701-3963</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology and Department of Physiology, Pharmacology and Neuroscience, Rutgers New Jersey Medical School, Newark, NJ 07103, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goodson</LastName><ForeName>Steven</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-2428-8371</Identifier><AffiliationInfo><Affiliation>Departments of Neurology and Pathology, Duke University School of Medicine, Durham, NC 27710, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Duke Center for Neurodegeneration and Neurotherapeutics, Duke University, Durham, NC 27710, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fuzzati</LastName><ForeName>Marie</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-6386-2885</Identifier><AffiliationInfo><Affiliation>IRCCS Mondino Foundation, National Institute of Neurology, Pavia 27100, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blandini</LastName><ForeName>Fabio</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0002-0178-1289</Identifier><AffiliationInfo><Affiliation>Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan 20122, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Brain and Behavioral Sciences, University of Pavia, 27100 Pavia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Erickson</LastName><ForeName>Kirk I</ForeName><Initials>KI</Initials><Identifier Source="ORCID">0000-0001-8736-981X</Identifier><AffiliationInfo><Affiliation>Department of Psychology, University of Pittsburgh, Pittsburgh, PA 15213, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>AdventHealth Research Institute, Neuroscience, Orlando, FL 32804, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weinstein</LastName><ForeName>Andrea M</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, School of Medicine, University of Pittsburgh, PA 15213, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lutz</LastName><ForeName>Michael W</ForeName><Initials>MW</Initials><Identifier Source="ORCID">0000-0001-8809-5574</Identifier><AffiliationInfo><Affiliation>Departments of Neurology and Pathology, Duke University School of Medicine, Durham, NC 27710, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kwok</LastName><ForeName>John B</ForeName><Initials>JB</Initials><Identifier Source="ORCID">0000-0001-9574-6195</Identifier><AffiliationInfo><Affiliation>School of Medical Sciences, Faculty of Medicine and Health and the Brain and Mind Centre, University of Sydney, Camperdown, New South Wales 2050, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Halliday</LastName><ForeName>Glenda M</ForeName><Initials>GM</Initials><Identifier Source="ORCID">0000-0003-0422-8398</Identifier><AffiliationInfo><Affiliation>School of Medical Sciences, Faculty of Medicine and Health and the Brain and Mind Centre, University of Sydney, Camperdown, New South Wales 2050, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dzamko</LastName><ForeName>Nicolas</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>School of Medical Sciences, Faculty of Medicine and Health and the Brain and Mind Centre, University of Sydney, Camperdown, New South Wales 2050, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Padmanabhan</LastName><ForeName>Shalini</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-6933-416X</Identifier><AffiliationInfo><Affiliation>Michael J. Fox Foundation for Parkinson's Research, Grand Central Station, P.O. Box 4777, New York, NY 10120, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alcalay</LastName><ForeName>Roy N</ForeName><Initials>RN</Initials><Identifier Source="ORCID">0000-0002-5717-4875</Identifier><AffiliationInfo><Affiliation>Columbia University Irving Medical Center, New York, NY 10032, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Movement Disorders Unit, Neurological Institute, Tel Aviv Sourasky Medical Centre, Sackler School of Medicine, Sagol School of Neurosciences, Tel Aviv University, Tel Aviv, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Waters</LastName><ForeName>Cheryl</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Columbia University Irving Medical Center, New York, NY 10032, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hogarth</LastName><ForeName>Penelope</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0003-1328-6311</Identifier><AffiliationInfo><Affiliation>Departments of Molecular and Medical Genetics and Neurology, Oregon Health and Science University, Portland, OR 97239, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Simuni</LastName><ForeName>Tanya</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-2347-1644</Identifier><AffiliationInfo><Affiliation>Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smith</LastName><ForeName>Danielle</ForeName><Initials>D</Initials><Identifier Source="ORCID">0009-0005-7310-4999</Identifier><AffiliationInfo><Affiliation>Indiana University School of Medicine, Indianapolis, IN 46202, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marras</LastName><ForeName>Connie</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Edmond J. Safra Program in Parkinson's Disease, Toronto Western Hospital, University Health Network, University of Toronto, Toronto, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tonelli</LastName><ForeName>Francesca</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0002-4600-6630</Identifier><AffiliationInfo><Affiliation>Medical Research Council Protein Phosphorylation and Ubiquitylation Unit, University of Dundee, Dundee, DD1 5EH UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alessi</LastName><ForeName>Dario R</ForeName><Initials>DR</Initials><Identifier Source="ORCID">0000-0002-2140-9185</Identifier><AffiliationInfo><Affiliation>Medical Research Council Protein Phosphorylation and Ubiquitylation Unit, University of Dundee, Dundee, DD1 5EH UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>West</LastName><ForeName>Andrew B</ForeName><Initials>AB</Initials><Identifier Source="ORCID">0000-0002-3034-4061</Identifier><AffiliationInfo><Affiliation>Duke Center for Neurodegeneration and Neurotherapeutics, Duke University, Durham, NC 27710, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pharmacology and Cancer Biology, Duke University School of Medicine, Durham, NC 27710, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shiva</LastName><ForeName>Sruti</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-3535-2113</Identifier><AffiliationInfo><Affiliation>Department of Pharmacology and Chemical Biology and Medicine, Vascular Medicine Institute, University of Pittsburgh, Pittsburgh, PA 15260, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hilfiker</LastName><ForeName>Sabine</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-5167-7682</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology and Department of Physiology, Pharmacology and Neuroscience, Rutgers New Jersey Medical School, Newark, NJ 07103, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sanders</LastName><ForeName>Laurie H</ForeName><Initials>LH</Initials><Identifier Source="ORCID">0000-0003-1617-9562</Identifier><AffiliationInfo><Affiliation>Departments of Neurology and Pathology, Duke University School of Medicine, Durham, NC 27710, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Duke Center for Neurodegeneration and Neurotherapeutics, Duke University, Durham, NC 27710, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P30 AG024827</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS064934</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P50 AG005133</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K23 AG076663</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>SCAF/18/01</GrantID><Acronym>CSO_</Acronym><Agency>Chief Scientist Office</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MCUU12016/2</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>F31 NS089111</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS119528</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>08</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Sci Transl Med</MedlineTA><NlmUniqueID>101505086</NlmUniqueID><ISSNLinking>1946-6234</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004272">DNA, Mitochondrial</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004272" MajorTopicYN="Y">DNA, Mitochondrial</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010300" MajorTopicYN="Y">Parkinson Disease</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007963" MajorTopicYN="N">Leukocytes, Mononuclear</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008928" MajorTopicYN="N">Mitochondria</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004249" MajorTopicYN="N">DNA Damage</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement><b>Competing interests:</b> L.H.S. and S.S. are coinventors on US patent application number 17/227,186 entitled &#x201c;Mitochondrial health parameters as clinical predictors of Parkinson&#x2019;s disease.&#x201d; L.H.S. is on the scientific advisory board of Lucy Therapeutics. R.N.A. received consultation fees from Avrobio, Biohaven, Capsida, Caraway, Gain Therapeutics, Genzyme/Sanofi, and Takeda. C.M. acted as advisor to the MJFF for the creation and management of FBN. C.M. received funding from the MJFF as the principal investigator of FBN. T.S. has served as a consultant for AcureX, Adamas, AskBio, Amneal, Blue Rock Therapeutics, Critical Path for Parkinson&#x2019;s Consortium (CPP), Denali, MJFF, Neuroderm, Sanofi, Sinopia, Roche, Takeda, and Vanqua Bio. T.S. served on the ad board for AcureX, Adamas, AskBio, Denali, and Roche. T.S. has served as a member of the scientific advisory board of Neuroderm, Sanofi, and UCB. T.S. has received research funding from Amneal, Biogen, Neuroderm, Prevail, Roche, and UCB and is an investigator for National Institute of Neurological Disorders and Stroke (NINDS), MJFF, and the Parkinson&#x2019;s Foundation. The other authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>1</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>8</Month><Day>30</Day><Hour>18</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>8</Month><Day>30</Day><Hour>14</Hour><Minute>5</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>5</Month><Day>29</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37647388</ArticleId><ArticleId IdType="mid">NIHMS1991164</ArticleId><ArticleId IdType="pmc">PMC11135133</ArticleId><ArticleId IdType="doi">10.1126/scitranslmed.abo1557</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Fearnley JM, Lees AJ, Ageing and Parkinson&#x2019;s disease: Substantia nigra regional selectivity. Brain 114 (Pt 5), 2283&#x2013;2301 (1991).</Citation><ArticleIdList><ArticleId IdType="pubmed">1933245</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng HC, Ulane CM, Burke RE, Clinical progression in Parkinson disease and the neurobiology of axons. Ann. Neurol. 67, 715&#x2013;725 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2918373</ArticleId><ArticleId IdType="pubmed">20517933</ArticleId></ArticleIdList></Reference><Reference><Citation>Marras C, Lang A, Parkinson&#x2019;s disease subtypes: Lost in translation? J. Neurol. Neurosurg. Psychiatry 84, 409&#x2013;415 (2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">22952329</ArticleId></ArticleIdList></Reference><Reference><Citation>Mestre TA, Fereshtehnejad SM, Berg D, Bohnen NI, Dujardin K, Erro R, Espay AJ, Halliday G, van Hilten JJ, Hu MT, Jeon B, Klein C, Leentjens AFG, Marinus J, Mollenhauer B, Postuma R, Rajalingam R, Rodriguez-Violante M, Simuni T, Surmeier DJ, Weintraub D, McDermott MP, Lawton M, Marras C, Parkinson&#x2019;s disease subtypes: Critical appraisal and recommendations. J. Parkinsons Dis. 11, 395&#x2013;404 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8150501</ArticleId><ArticleId IdType="pubmed">33682731</ArticleId></ArticleIdList></Reference><Reference><Citation>Espay AJ, Schwarzschild MA, Tanner CM, Fernandez HH, Simon DK, Leverenz JB, Merola A, Chen-Plotkin A, Brundin P, Kauffman MA, Erro R, Kieburtz K, Woo D, Macklin EA, Standaert DG, Lang AE, Biomarker-driven phenotyping in Parkinson&#x2019;s disease: A translational missing link in disease-modifying clinical trials. Mov. Disord. 32, 319&#x2013;324 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5359057</ArticleId><ArticleId IdType="pubmed">28233927</ArticleId></ArticleIdList></Reference><Reference><Citation>Malpartida AB, Williamson M, Narendra DP, Wade-Martins R, Ryan BJ, Mitochondrial dysfunction and mitophagy in Parkinson&#x2019;s disease: From mechanism to therapy. Trends Biochem. Sci. 46, 329&#x2013;343 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33323315</ArticleId></ArticleIdList></Reference><Reference><Citation>De Miranda BR, Van Houten B, Sanders LH, Mitochondrial Mechanisms of Degeneration and Repair in Parkinson&#x2019;s Disease (Springer, 2016).</Citation></Reference><Reference><Citation>Sanders LH, Paul KC, Howlett EH, Lawal H, Boppana S, Bronstein JM, Ritz B, Greenamyre JT, Editor&#x2019;s highlight: Base excision repair variants and pesticide exposure increase Parkinson&#x2019;s disease risk. Toxicol. Sci. 158, 188&#x2013;198 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6075191</ArticleId><ArticleId IdType="pubmed">28460087</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanders LH, Timothy Greenamyre J, Oxidative damage to macromolecules in human Parkinson disease and the rotenone model. Free Radic. Biol. Med. 62, 111&#x2013;120 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3677955</ArticleId><ArticleId IdType="pubmed">23328732</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalez-Hunt CP, Sanders LH, DNA damage and repair in Parkinson&#x2019;s disease: Recent advances and new opportunities. J. Neurosci. Res. 99, 180&#x2013;189 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">32048327</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanders LH, McCoy J, Hu X, Mastroberardino PG, Dickinson BC, Chang CJ, Chu CT, Van Houten B, Greenamyre JT, Mitochondrial DNA damage: Molecular marker of vulnerable nigral neurons in Parkinson&#x2019;s disease. Neurobiol. Dis. 70, 214&#x2013;223 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4144978</ArticleId><ArticleId IdType="pubmed">24981012</ArticleId></ArticleIdList></Reference><Reference><Citation>Arduino DM, Esteves AR, Swerdlow RH, Cardoso SM, A cybrid cell model for the assessment of the link between mitochondrial deficits and sporadic Parkinson&#x2019;s disease. Methods Mol. Biol. 1265, 415&#x2013;424 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4612525</ArticleId><ArticleId IdType="pubmed">25634293</ArticleId></ArticleIdList></Reference><Reference><Citation>Dulovic-Mahlow M, Konig IR, Trinh J, Diaw SH, Urban PP, Knappe E, Kuhnke N, Ingwersen LC, Hinrichs F, Weber J, Kupnicka P, Balck A, Delcambre S, Vollbrandt T, Grunewald A, Klein C, Seibler P, Lohmann K, Discordant monozygotic Parkinson disease twins: Role of mitochondrial integrity. Ann. Neurol. 89, 158&#x2013;164 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33094862</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaare JJ, Nido GS, Sztromwasser P, Knappskog PM, Dahl O, Lund-Johansen M, Maple-Grodem J, Alves G, Tysnes OB, Johansson S, Haugarvoll K, Tzoulis C, Rare genetic variation in mitochondrial pathways influences the risk for Parkinson&#x2019;s disease. Mov. Disord. 33, 1591&#x2013;1600 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6282592</ArticleId><ArticleId IdType="pubmed">30256453</ArticleId></ArticleIdList></Reference><Reference><Citation>Howlett EH, Jensen N, Belmonte F, Zafar F, Hu X, Kluss J, Schule B, Kaufman BA, Greenamyre JT, Sanders LH, LRRK2 G2019S-induced mitochondrial DNA damage is LRRK2 kinase dependent and inhibition restores mtDNA integrity in Parkinson&#x2019;s disease. Hum. Mol. Genet. 26, 4340&#x2013;4351 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5886254</ArticleId><ArticleId IdType="pubmed">28973664</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanders LH, Laganiere J, Cooper O, Mak SK, Vu BJ, Huang YA, Paschon DE, Vangipuram M, Sundararajan R, Urnov FD, Langston JW, Gregory PD, Zhang HS, Greenamyre JT, Isacson O, Schule B, LRRK2 mutations cause mitochondrial DNA damage in iPSC-derived neural cells from Parkinson&#x2019;s disease patients: Reversal by gene correction. Neurobiol. Dis. 62, 381&#x2013;386 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3877733</ArticleId><ArticleId IdType="pubmed">24148854</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanders LH, Howlett EH, McCoy J, Greenamyre JT, Mitochondrial DNA damage as a peripheral biomarker for mitochondrial toxin exposure in rats. Toxicol. Sci. 142, 395&#x2013;402 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4250844</ArticleId><ArticleId IdType="pubmed">25237061</ArticleId></ArticleIdList></Reference><Reference><Citation>Paris I, Munoz P, Huenchuguala S, Couve E, Sanders LH, Greenamyre JT, Caviedes P, Segura-Aguilar J, Autophagy protects against aminochrome-induced cell death in substantia nigra-derived cell line. Toxicol. Sci. 121, 376&#x2013;388 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3145404</ArticleId><ArticleId IdType="pubmed">21427056</ArticleId></ArticleIdList></Reference><Reference><Citation>Munoz P, Paris I, Sanders LH, Greenamyre JT, Segura-Aguilar J, Overexpression of VMAT-2 and DT-diaphorase protects substantia nigra-derived cells against aminochrome neurotoxicity. Biochim. Biophys. Acta 1822, 1125&#x2013;1136 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3874718</ArticleId><ArticleId IdType="pubmed">22483869</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalez-Hunt CP, Thacker EA, Toste CM, Boularand S, Deprets S, Dubois L, Sanders LH, Mitochondrial DNA damage as a potential biomarker of LRRK2 kinase activity in LRRK2 Parkinson&#x2019;s disease. Sci. Rep. 10, 17293 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7557909</ArticleId><ArticleId IdType="pubmed">33057100</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandavilli BS, Ali SF, Van Houten B, DNA damage in brain mitochondria caused by aging and MPTP treatment. Brain Res. 885, 45&#x2013;52 (2000).</Citation><ArticleIdList><ArticleId IdType="pubmed">11121528</ArticleId></ArticleIdList></Reference><Reference><Citation>Berwick DC, Heaton GR, Azeggagh S, Harvey K, LRRK2 biology from structure to dysfunction: Research progresses, but the themes remain the same. Mol. Neurodegener 14, 49 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6925518</ArticleId><ArticleId IdType="pubmed">31864390</ArticleId></ArticleIdList></Reference><Reference><Citation>Alessi DR, Sammler E, LRRK2 kinase in Parkinson&#x2019;s disease. Science 360, 36&#x2013;37 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">29622645</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor M, Alessi DR, Advances in elucidating the function of leucine-rich repeat protein kinase-2 in normal cells and Parkinson&#x2019;s disease. Curr. Opin. Cell Biol. 63, 102&#x2013;113 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7262585</ArticleId><ArticleId IdType="pubmed">32036294</ArticleId></ArticleIdList></Reference><Reference><Citation>Paisan-Ruiz C, Jain S, Evans EW, Gilks WP, Simon J, van der Brug M, Lopez de Munain A, Aparicio S, Gil AM, Khan N, Johnson J, Martinez JR, Nicholl D, Marti Carrera I, Pena AS, de Silva R, Lees A, Marti-Masso JF, Perez-Tur J, Wood NW, Singleton AB, Cloning of the gene containing mutations that cause PARK8-linked Parkinson&#x2019;s disease. Neuron 44, 595&#x2013;600 (2004).</Citation><ArticleIdList><ArticleId IdType="pubmed">15541308</ArticleId></ArticleIdList></Reference><Reference><Citation>Zimprich A, Biskup S, Leitner P, Lichtner P, Farrer M, Lincoln S, Kachergus J, Hulihan M, Uitti RJ, Calne DB, Stoessl AJ, Pfeiffer RF, Patenge N, Carbajal IC, Vieregge P, Asmus F, Muller-Myhsok B, Dickson DW, Meitinger T, Strom TM, Wszolek ZK, Gasser T, Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron 44, 601&#x2013;607 (2004).</Citation><ArticleIdList><ArticleId IdType="pubmed">15541309</ArticleId></ArticleIdList></Reference><Reference><Citation>Steger M, Tonelli F, Ito G, Davies P, Trost M, Vetter M, Wachter S, Lorentzen E, Duddy G, Wilson S, Baptista MA, Fiske BK, Fell MJ, Morrow JA, Reith AD, Alessi DR, Mann M, Phosphoproteomics reveals that Parkinson&#x2019;s disease kinase LRRK2 regulates a subset of Rab GTPases. eLife 5, (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4769169</ArticleId><ArticleId IdType="pubmed">26824392</ArticleId></ArticleIdList></Reference><Reference><Citation>Tolosa E, Vila M, Klein C, Rascol O, LRRK2 in Parkinson disease: Challenges of clinical trials. Nat. Rev. Neurol 16, 97&#x2013;107 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">31980808</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalls MA, Blauwendraat C, Vallerga CL, Heilbron K, Bandres-Ciga S, Chang D, Tan M, Kia DA, Noyce AJ, Xue A, Bras J, Young E, von Coelln R, Simon-Sanchez J, Schulte C, Sharma M, Krohn L, Pihlstrom L, Siitonen A, Iwaki H, Leonard H, Faghri F, Gibbs JR, Hernandez DG, Scholz SW, Botia JA, Martinez M, Corvol JC, Lesage S, Jankovic J, Shulman LM, Sutherland M, Tienari P, Majamaa K, Toft M, Andreassen OA, Bangale T, Brice A, Yang J, Gan-Or Z, Gasser T, Heutink P, Shulman JM, Wood NW, Hinds DA, Hardy JA, Morris HR, Gratten J, Visscher PM, Graham RR, Singleton AB; 23andMe Research Team; System Genomics of Parkinson&#x2019;s Disease Consortium; International Parkinson&#x2019;s Disease Genomics Consortium, Identification of novel risk loci, causal insights, and heritable risk for Parkinson&#x2019;s disease: A meta-analysis of genome-wide association studies. Lancet Neurol. 18, 1091&#x2013;1102 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8422160</ArticleId><ArticleId IdType="pubmed">31701892</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Maio R, Hoffman EK, Rocha EM, Keeney MT, Sanders LH, De Miranda BR, Zharikov A, Van Laar A, Stepan AF, Lanz TA, Kofler JK, Burton EA, Alessi DR, Hastings TG, Greenamyre JT, LRRK2 activation in idiopathic Parkinson&#x2019;s disease. Sci. Transl. Med. 10, (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6344941</ArticleId><ArticleId IdType="pubmed">30045977</ArticleId></ArticleIdList></Reference><Reference><Citation>Padmanabhan S, Fiske BK, Baptista MAS, The Michael J Fox Foundation&#x2019;s strategies for accelerating translation of LRRK2 into therapies for Parkinson disease. Cell 9, 1878 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7466022</ArticleId><ArticleId IdType="pubmed">32796584</ArticleId></ArticleIdList></Reference><Reference><Citation>Healy DG, Falchi M, O&#x2019;Sullivan SS, Bonifati V, Durr A, Bressman S, Brice A, Aasly J, Zabetian CP, Goldwurm S, Ferreira JJ, Tolosa E, Kay DM, Klein C, Williams DR, Marras C, Lang AE, Wszolek ZK, Berciano J, Schapira AH, Lynch T, Bhatia KP, Gasser T, Lees AJ, Wood NW; International LRRK2 Consortium, Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson&#x2019;s disease: A case-control study. Lancet Neurol. 7, 583&#x2013;590 (2008).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2832754</ArticleId><ArticleId IdType="pubmed">18539534</ArticleId></ArticleIdList></Reference><Reference><Citation>Delcambre S, Ghelfi J, Ouzren N, Grandmougin L, Delbrouck C, Seibler P, Wasner K, Aasly JO, Klein C, Trinh J, Pereira SL, Grunewald A, Mitochondrial mechanisms of LRRK2 G2019S penetrance. Front. Neurol. 11, 881 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7477385</ArticleId><ArticleId IdType="pubmed">32982917</ArticleId></ArticleIdList></Reference><Reference><Citation>Podlesniy P, Puigros M, Serra N, Fernandez-Santiago R, Ezquerra M, Tolosa E, Trullas R, Accumulation of mitochondrial 7S DNA in idiopathic and LRRK2 associated Parkinson&#x2019;s disease. EBioMedicine 48, 554&#x2013;567 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6838390</ArticleId><ArticleId IdType="pubmed">31631040</ArticleId></ArticleIdList></Reference><Reference><Citation>Ouzren N, Delcambre S, Ghelfi J, Seibler P, Farrer MJ, Konig IR, Aasly JO, Trinh J, Klein C, Grunewald A, Mitochondrial DNA deletions discriminate affected from unaffected LRRK2 mutation carriers. Ann. Neurol. 86, 324&#x2013;326 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6900150</ArticleId><ArticleId IdType="pubmed">31148195</ArticleId></ArticleIdList></Reference><Reference><Citation>Weindel CG, Bell SL, Vail KJ, West KO, Patrick KL, Watson RO, LRRK2 maintains mitochondrial homeostasis and regulates innate immune responses to Mycobacterium tuberculosis. eLife 9, (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7159881</ArticleId><ArticleId IdType="pubmed">32057291</ArticleId></ArticleIdList></Reference><Reference><Citation>Pena N, Gonzalez-Hunt CP, Qi R, Barlow C, Shanks NF, Carlisle HJ, Sanders LH, G2019S selective LRRK2 kinase inhibitor abrogates mitochondrial DNA damage. bioRxiv 517979 [Preprint]. 1 December 2022. 10.1101/2022.11.30.517979.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.11.30.517979</ArticleId><ArticleId IdType="pmc">PMC10907374</ArticleId><ArticleId IdType="pubmed">38429321</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalia LV, Lang AE, Hazrati LN, Fujioka S, Wszolek ZK, Dickson DW, Ross OA, Van Deerlin VM, Trojanowski JQ, Hurtig HI, Alcalay RN, Marder KS, Clark LN, Gaig C, Tolosa E, Ruiz-Martinez J, Marti-Masso JF, Ferrer I, Lopez de Munain A, Goldman SM, Schule B, Langston JW, Aasly JO, Giordana MT, Bonifati V, Puschmann A, Canesi M, Pezzoli G, Maues De Paula A, Hasegawa K, Duyckaerts C, Brice A, Stoessl AJ, Marras C, Clinical correlations with Lewy body pathology in LRRK2-related Parkinson disease. JAMA Neurol. 72, 100&#x2013;105 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4399368</ArticleId><ArticleId IdType="pubmed">25401511</ArticleId></ArticleIdList></Reference><Reference><Citation>Agin-Liebes J, Cortes E, Vonsattel JP, Marder K, Alcalay RN, Movement disorders rounds: A case of missing pathology in a patient with LRRK2 Parkinson&#x2019;s disease. Parkinsonism Relat. Disord. 74, 76&#x2013;77 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7374981</ArticleId><ArticleId IdType="pubmed">31734038</ArticleId></ArticleIdList></Reference><Reference><Citation>von Linstow CU, Gan-Or Z, Brundin P, Precision medicine in Parkinson&#x2019;s disease patients with LRRK2 and GBA risk variants&#x2014;Let&#x2019;s get even more personal. Transl. Neurodegener. 9, 39 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7565766</ArticleId><ArticleId IdType="pubmed">33066808</ArticleId></ArticleIdList></Reference><Reference><Citation>Furda AM, Marrangoni AM, Lokshin A, Van Houten B, Oxidants and not alkylating agents induce rapid mtDNA loss and mitochondrial dysfunction. DNA Repair 11, 684&#x2013;692 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3878289</ArticleId><ArticleId IdType="pubmed">22766155</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanders LH, Rouanet JP, Howlett EH, Leuthner TC, Rooney JP, Greenamyre JT, Meyer JN, Newly revised quantitative PCR-based assay for mitochondrial and nuclear DNA damage. Curr. Protoc. Toxicol. 76, e50 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6060631</ArticleId><ArticleId IdType="pubmed">30040241</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashour ME, Byrum AK, Meroni A, Xia J, Singh S, Galletto R, Rosenberg SM, Vindigni A, Mosammaparast N, Rapid profiling of DNA replication dynamics using mass spectrometry-based analysis of nascent DNA. J. Cell Biol. 222, (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9960042</ArticleId><ArticleId IdType="pubmed">36795402</ArticleId></ArticleIdList></Reference><Reference><Citation>Yue M, Hinkle KM, Davies P, Trushina E, Fiesel FC, Christenson TA, Schroeder AS, Zhang L, Bowles E, Behrouz B, Lincoln SJ, Beevers JE, Milnerwood AJ, Kurti A, McLean PJ, Fryer JD, Springer W, Dickson DW, Farrer MJ, Melrose HL, Progressive dopaminergic alterations and mitochondrial abnormalities in LRRK2 G2019S knock-in mice. Neurobiol. Dis. 78, 172&#x2013;195 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4526103</ArticleId><ArticleId IdType="pubmed">25836420</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh F, Prescott AR, Rosewell P, Ball G, Reith AD, Ganley IG, Pharmacological rescue of impaired mitophagy in Parkinson&#x2019;s disease-related LRRK2 G2019S knock-in mice. eLife 10, (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8331189</ArticleId><ArticleId IdType="pubmed">34340748</ArticleId></ArticleIdList></Reference><Reference><Citation>Kustrimovic N, Rasini E, Legnaro M, Bombelli R, Aleksic I, Blandini F, Comi C, Mauri M, Minafra B, Riboldazzi G, Sanchez-Guajardo V, Marino F, Cosentino M, Dopaminergic receptors on CD4+ T naive and memory lymphocytes correlate with motor impairment in patients with Parkinson&#x2019;s disease. Sci. Rep. 6, 33738 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5031979</ArticleId><ArticleId IdType="pubmed">27652978</ArticleId></ArticleIdList></Reference><Reference><Citation>Kustrimovic N, Comi C, Magistrelli L, Rasini E, Legnaro M, Bombelli R, Aleksic I, Blandini F, Minafra B, Riboldazzi G, Sturchio A, Mauri M, Bono G, Marino F, Cosentino M, Parkinson&#x2019;s disease patients have a complex phenotypic and functional Th1 bias: Cross-sectional studies of CD4+ TH1/TH2/T17 and Treg in drug-na&#xef;ve and drug-treated patients. J. Neuroinflammation 15, 205 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6044047</ArticleId><ArticleId IdType="pubmed">30001736</ArticleId></ArticleIdList></Reference><Reference><Citation>Marino M, Gigliotti L, Moller P, Riso P, Porrini M, Del Bo C, Impact of 12-month cryopreservation on endogenous DNA damage in whole blood and isolated mononuclear cells evaluated by the comet assay. Sci. Rep. 11, 363 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7801598</ArticleId><ArticleId IdType="pubmed">33432000</ArticleId></ArticleIdList></Reference><Reference><Citation>Adler CH, Beach TG, Hentz JG, Shill HA, Caviness JN, Driver-Dunckley E, Sabbagh MN, Sue LI, Jacobson SA, Belden CM, Dugger BN, Low clinical diagnostic accuracy of early vs advanced Parkinson disease: Clinicopathologic study. Neurology 83, 406&#x2013;412 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4132570</ArticleId><ArticleId IdType="pubmed">24975862</ArticleId></ArticleIdList></Reference><Reference><Citation>Zweig MH, Campbell G, Receiver-operating characteristic (ROC) plots: A fundamental evaluation tool in clinical medicine. Clin. Chem. 39, 561&#x2013;577 (1993).</Citation><ArticleIdList><ArticleId IdType="pubmed">8472349</ArticleId></ArticleIdList></Reference><Reference><Citation>Tasegian A, Singh F, Ganley IG, Reith AD, Alessi DR, Impact of Type II LRRK2 inhibitors on signaling and mitophagy. Biochem. J. 478, 3555&#x2013;3573 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8589421</ArticleId><ArticleId IdType="pubmed">34515301</ArticleId></ArticleIdList></Reference><Reference><Citation>Macchi B, Di Paola R, Marino-Merlo F, Felice MR, Cuzzocrea S, Mastino A, Inflammatory and cell death pathways in brain and peripheral blood in Parkinson&#x2019;s disease. CNS Neurol. Disord. Drug Targets 14, 313&#x2013;324 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">25714978</ArticleId></ArticleIdList></Reference><Reference><Citation>Blake CI, Spitz E, Leehey M, Hoffer BJ, Boyson SJ, Platelet mitochondrial respiratory chain function in Parkinson&#x2019;s disease. Mov. Disord. 12, 3&#x2013;8 (1997).</Citation><ArticleIdList><ArticleId IdType="pubmed">8990047</ArticleId></ArticleIdList></Reference><Reference><Citation>Haas RH, Nasirian F, Nakano K, Ward D, Pay M, Hill R, Shults CW, Low platelet mitochondrial complex I and complex II/III activity in early untreated Parkinson&#x2019;s disease. Ann. Neurol. 37, 714&#x2013;722 (1995).</Citation><ArticleIdList><ArticleId IdType="pubmed">7778844</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalez-Hunt CP, Wadhwa M, Sanders LH, DNA damage by oxidative stress: Measurement strategies for two genomes. Curr. Opin. Toxicol. 7, 87&#x2013;94 (2018).</Citation></Reference><Reference><Citation>Ayala-Torres S, Chen Y, Svoboda T, Rosenblatt J, Van Houten B, Analysis of gene-specific DNA damage and repair using quantitative polymerase chain reaction. Methods 22, 135&#x2013;147 (2000).</Citation><ArticleIdList><ArticleId IdType="pubmed">11020328</ArticleId></ArticleIdList></Reference><Reference><Citation>Borsche M, Pereira SL, Klein C, Grunewald A, Mitochondria and Parkinson&#x2019;s disease: Clinical, molecular, and translational aspects. J. Parkinsons Dis 11, 45&#x2013;60 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7990451</ArticleId><ArticleId IdType="pubmed">33074190</ArticleId></ArticleIdList></Reference><Reference><Citation>Horsager J, Andersen KB, Knudsen K, Skjaerbaek C, Fedorova TD, Okkels N, Schaeffer E, Bonkat SK, Geday J, Otto M, Sommerauer M, Danielsen EH, Bech E, Kraft J, Munk OL, Hansen SD, Pavese N, Goder R, Brooks DJ, Berg D, Borghammer P, Brain-first versus body-first Parkinson&#x2019;s disease: A multimodal imaging case-control study. Brain 143, 3077&#x2013;3088 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32830221</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Z, Cao Z, Zhang W, Gu M, Zhou ZD, Li B, Li J, Tan EK, Zeng L, LRRK2 interacts with ATM and regulates Mdm2-p53 cell proliferation axis in response to genotoxic stress. Hum. Mol. Genet. 26, 4494&#x2013;4505 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28973420</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh F, Ganley IG, Parkinson&#x2019;s disease and mitophagy: An emerging role for LRRK2. Biochem. Soc. Trans. 49, 551&#x2013;562 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8106497</ArticleId><ArticleId IdType="pubmed">33769432</ArticleId></ArticleIdList></Reference><Reference><Citation>Horowitz MP, Milanese C, Di Maio R, Hu X, Montero LM, Sanders LH, Tapias V, Sepe S, van Cappellen WA, Burton EA, Greenamyre JT, Mastroberardino PG, Single-cell redox imaging demonstrates a distinctive response of dopaminergic neurons to oxidative insults. Antioxid. Redox Signal. 15, 855&#x2013;871 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3135271</ArticleId><ArticleId IdType="pubmed">21395478</ArticleId></ArticleIdList></Reference><Reference><Citation>Sepe S, Milanese C, Gabriels S, Derks KW, Payan-Gomez C, van IJcken WF, Rijksen YM, Nigg AL, Moreno S, Cerri S, Blandini F, Hoeijmakers JH, Mastroberardino PG, Inefficient DNA repair is an aging-related modifier of Parkinson&#x2019;s disease. Cell Rep. 15, 1866&#x2013;1875 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4893155</ArticleId><ArticleId IdType="pubmed">27210754</ArticleId></ArticleIdList></Reference><Reference><Citation>Atashrazm F, Hammond D, Perera G, Bolliger MF, Matar E, Halliday GM, Schule B, Lewis SJG, Nichols RJ, Dzamko N, LRRK2-mediated Rab10 phosphorylation in immune cells from Parkinson&#x2019;s disease patients. Mov. Disord. 34, 406&#x2013;415 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">30597610</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez B, Lara Ordonez AJ, Fdez E, Mutez E, Comptdaer T, Leghay C, Kreisler A, Simonin C, Vandewynckel L, Defebvre L, Destee A, Bleuse S, Taymans JM, Chartier-Harlin MC, Hilfiker S, Centrosomal cohesion deficits as cellular biomarker in lymphoblastoid cell lines from LRRK2 Parkinson&#x2019;s disease patients. Biochem. J. 476, 2797&#x2013;2813 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6792036</ArticleId><ArticleId IdType="pubmed">31527116</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S, Unnithan S, Bryant N, Chang A, Rosenthal LS, Pantelyat A, Dawson TM, Al-Khalidi HR, West AB, Elevated urinary Rab10 phosphorylation in idiopathic Parkinson disease. Mov. Disord. 37, 1454&#x2013;1464 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9308673</ArticleId><ArticleId IdType="pubmed">35521944</ArticleId></ArticleIdList></Reference><Reference><Citation>Prasuhn J, Davis RL, Kumar KR, Targeting mitochondrial impairment in Parkinson&#x2019;s disease: Challenges and opportunities. Front Cell Dev. Biol. 8, 615461 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7813753</ArticleId><ArticleId IdType="pubmed">33469539</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai R, Zhang Y, Simmering JE, Schultz JL, Li Y, Fernandez-Carasa I, Consiglio A, Raya A, Polgreen PM, Narayanan NS, Yuan Y, Chen Z, Su W, Han Y, Zhao C, Gao L, Ji X, Welsh MJ, Liu L, Enhancing glycolysis attenuates Parkinson&#x2019;s disease progression in models and clinical databases. J. Clin. Invest. 129, 4539&#x2013;4549 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6763248</ArticleId><ArticleId IdType="pubmed">31524631</ArticleId></ArticleIdList></Reference><Reference><Citation>Sastre D, Zafar F, Torres CAM, Piper D, Kirik D, Sanders LH, Qi S, Sch&#xfc;le B, Nuclease-dead S aureus Cas9 downregulates &#x3b1;-synuclein and reduces mtDNA damage and oxidative stress levels in patient-derived stem cell model of Parkinson&#x2019;s disease. bioRxiv 525105 [Preprint]. 24 January 2023. 10.1101/2023.01.24.525105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2023.01.24.525105</ArticleId><ArticleId IdType="pmc">PMC10584834</ArticleId><ArticleId IdType="pubmed">37853101</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng S, Chen Y, Monforte JA, Higuchi R, Van Houten B, Template integrity is essential for PCR amplification of 20- to 30-kb sequences from genomic DNA. PCR Methods Appl. 4, 294&#x2013;298 (1995).</Citation><ArticleIdList><ArticleId IdType="pubmed">7580917</ArticleId></ArticleIdList></Reference><Reference><Citation>Troutman SBW, Erickson KI, Grove G, Weinstein AM, Sedentary time is associated with worse attention in Parkinson&#x2019;s disease: A pilot study. J. Mov. Disord. 13, 146&#x2013;149 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7280940</ArticleId><ArticleId IdType="pubmed">32498498</ArticleId></ArticleIdList></Reference><Reference><Citation>Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W, Obeso J, Marek K, Litvan I, Lang AE, Halliday G, Goetz CG, Gasser T, Dubois B, Chan P, Bloem BR, Adler CH, Deuschl G, MDS clinical diagnostic criteria for Parkinson&#x2019;s disease. Mov. Disord. 30, 1591&#x2013;1601 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">26474316</ArticleId></ArticleIdList></Reference><Reference><Citation>Goetz CG, Tilley BC, Shaftman SR, Stebbins GT, Fahn S, Martinez-Martin P, Poewe W, Sampaio C, Stern MB, Dodel R, Dubois B, Holloway R, Jankovic J, Kulisevsky J, Lang AE, Lees A, Leurgans S, LeWitt PA, Nyenhuis D, Olanow CW, Rascol O, Schrag A, Teresi JA, van Hilten JJ, LaPelle N; Movement Disorder Society UPDRS Revision Task Force, Movement Disorder Society-sponsored revision of the Unified Parkinson&#x2019;s Disease Rating Scale (MDS-UPDRS): Scale presentation and clinimetric testing results. Mov. Disord. 23, 2129&#x2013;2170 (2008).</Citation><ArticleIdList><ArticleId IdType="pubmed">19025984</ArticleId></ArticleIdList></Reference><Reference><Citation>Fell MJ, Mirescu C, Basu K, Cheewatrakoolpong B, DeMong DE, Ellis JM, Hyde LA, Lin Y, Markgraf CG, Mei H, Miller M, Poulet FM, Scott JD, Smith MD, Yin Z, Zhou X, Parker EM, Kennedy ME, Morrow JA, MLi-2, a potent, selective, and centrally active compound for exploring the therapeutic potential and safety of LRRK2 kinase inhibition. J. Pharmacol. Exp. Ther. 355, 397&#x2013;409 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">26407721</ArticleId></ArticleIdList></Reference><Reference><Citation>Louie LG, King MC, A novel approach to establishing permanent lymphoblastoid cell lines: Epstein-Barr virus transformation of cryopreserved lymphocytes. Am. J. Hum. Genet. 48, 637&#x2013;638 (1991).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1682991</ArticleId><ArticleId IdType="pubmed">1847792</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan Y, Howden AJM, Sarhan AR, Lis P, Ito G, Martinez TN, Brockmann K, Gasser T, Alessi DR, Sammler EM, Interrogating Parkinson&#x2019;s disease LRRK2 kinase pathway activity by assessing Rab10 phosphorylation in human neutrophils. Biochem. J. 475, 23&#x2013;44 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5748842</ArticleId><ArticleId IdType="pubmed">29127255</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37647397</PMID><DateCompleted><Year>2023</Year><Month>09</Month><Day>01</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2375-2548</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><Issue>35</Issue><PubDate><Year>2023</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Science advances</Title><ISOAbbreviation>Sci Adv</ISOAbbreviation></Journal><ArticleTitle>Human cerebrospinal fluid contains diverse lipoprotein subspecies enriched in proteins implicated in central nervous system health.</ArticleTitle><Pagination><StartPage>eadi5571</StartPage><MedlinePgn>eadi5571</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">eadi5571</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1126/sciadv.adi5571</ELocationID><Abstract><AbstractText>Lipoproteins in cerebrospinal fluid (CSF) of the central nervous system (CNS) resemble plasma high-density lipoproteins (HDLs), which are a compositionally and structurally diverse spectrum of nanoparticles with pleiotropic functionality. Whether CSF lipoproteins (CSF-Lps) exhibit similar heterogeneity is poorly understood because they are present at 100-fold lower concentrations than plasma HDL. To investigate the diversity of CSF-Lps, we developed a sensitive fluorescent technology to characterize lipoprotein subspecies in small volumes of human CSF. We identified 10 distinctly sized populations of CSF-Lps, most of which were larger than plasma HDL. Mass spectrometric analysis identified 303 proteins across the populations, over half of which have not been reported in plasma HDL. Computational analysis revealed that CSF-Lps are enriched in proteins important for wound healing, inflammation, immune response, and both neuron generation and development. Network analysis indicated that different subpopulations of CSF-Lps contain unique combinations of these proteins. Our study demonstrates that CSF-Lp subspecies likely exist that contain compositional signatures related to CNS health.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Merrill</LastName><ForeName>Nathaniel J</ForeName><Initials>NJ</Initials><Identifier Source="ORCID">0000-0002-1998-0980</Identifier><AffiliationInfo><Affiliation>Biological Sciences Division, Pacific Northwest National Laboratory, Richland, WA 99354, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Davidson</LastName><ForeName>W Sean</ForeName><Initials>WS</Initials><Identifier Source="ORCID">0000-0003-2756-2989</Identifier><AffiliationInfo><Affiliation>Center for Lipid and Arteriosclerosis Science, Department of Pathology and Laboratory Medicine, University of Cincinnati, Cincinnati, OH 45237, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>He</LastName><ForeName>Yi</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0002-5565-5579</Identifier><AffiliationInfo><Affiliation>Department of Medicine, University of Washington School of Medicine, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>D&#xed;az Ludovico</LastName><ForeName>Ivo</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0002-3475-5191</Identifier><AffiliationInfo><Affiliation>Biological Sciences Division, Pacific Northwest National Laboratory, Richland, WA 99354, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sarkar</LastName><ForeName>Snigdha</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-4551-0314</Identifier><AffiliationInfo><Affiliation>Biological Sciences Division, Pacific Northwest National Laboratory, Richland, WA 99354, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Berger</LastName><ForeName>Madelyn R</ForeName><Initials>MR</Initials><Identifier Source="ORCID">0000-0003-3789-2500</Identifier><AffiliationInfo><Affiliation>Biological Sciences Division, Pacific Northwest National Laboratory, Richland, WA 99354, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McDermott</LastName><ForeName>Jason E</ForeName><Initials>JE</Initials><Identifier Source="ORCID">0000-0003-2961-2572</Identifier><AffiliationInfo><Affiliation>Biological Sciences Division, Pacific Northwest National Laboratory, Richland, WA 99354, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Molecular Microbiology and Immunology, Oregon Health and Science University, Portland, OR 97239, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van Eldik</LastName><ForeName>Linda J</ForeName><Initials>LJ</Initials><Identifier Source="ORCID">0000-0002-8139-6400</Identifier><AffiliationInfo><Affiliation>Sanders-Brown Center on Aging, University of Kentucky, Lexington, KY 40504, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wilcock</LastName><ForeName>Donna M</ForeName><Initials>DM</Initials><Identifier Source="ORCID">0000-0003-3388-1564</Identifier><AffiliationInfo><Affiliation>Sanders-Brown Center on Aging, University of Kentucky, Lexington, KY 40504, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Monroe</LastName><ForeName>Matthew E</ForeName><Initials>ME</Initials><Identifier Source="ORCID">0000-0002-1210-7169</Identifier><AffiliationInfo><Affiliation>Biological Sciences Division, Pacific Northwest National Laboratory, Richland, WA 99354, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kyle</LastName><ForeName>Jennifer E</ForeName><Initials>JE</Initials><AffiliationInfo><Affiliation>Biological Sciences Division, Pacific Northwest National Laboratory, Richland, WA 99354, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bruce</LastName><ForeName>Kimberley D</ForeName><Initials>KD</Initials><AffiliationInfo><Affiliation>Division of Endocrinology, Metabolism and Diabetes, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Heinecke</LastName><ForeName>Jay W</ForeName><Initials>JW</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of Washington School of Medicine, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vaisar</LastName><ForeName>Tomas</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-7406-6606</Identifier><AffiliationInfo><Affiliation>Department of Medicine, University of Washington School of Medicine, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Raber</LastName><ForeName>Jacob</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurology, Oregon Health and Science University, Portland, OR 97239, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Neuroscience, Department of Behavioral Neuroscience and Radiation Medicine, ONPRC, Oregon Health and Science University, Portland, OR 97239, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Quinn</LastName><ForeName>Joseph F</ForeName><Initials>JF</Initials><Identifier Source="ORCID">0000-0001-7305-2256</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Oregon Health and Science University, Portland, OR 97239, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology and Parkinson's Disease Research Education and Clinical Care Center (PADRECC), VA Portland Healthcare System, Portland OR 97239, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Melchior</LastName><ForeName>John T</ForeName><Initials>JT</Initials><Identifier Source="ORCID">0000-0003-3781-2566</Identifier><AffiliationInfo><Affiliation>Biological Sciences Division, Pacific Northwest National Laboratory, Richland, WA 99354, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Lipid and Arteriosclerosis Science, Department of Pathology and Laboratory Medicine, University of Cincinnati, Cincinnati, OH 45237, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Oregon Health and Science University, Portland, OR 97239, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P30 DK048520</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P01 HL128203</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG079217</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R03 AG070480</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AG072946</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AG066518</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>08</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Sci Adv</MedlineTA><NlmUniqueID>101653440</NlmUniqueID><ISSNLinking>2375-2548</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008070">Lipopolysaccharides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008074">Lipoproteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008075">Lipoproteins, HDL</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004396">Coloring Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008070" MajorTopicYN="Y">Lipopolysaccharides</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002490" MajorTopicYN="Y">Central Nervous System</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008074" MajorTopicYN="N">Lipoproteins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008075" MajorTopicYN="N">Lipoproteins, HDL</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004396" MajorTopicYN="N">Coloring Agents</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>1</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>8</Month><Day>30</Day><Hour>18</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>8</Month><Day>30</Day><Hour>14</Hour><Minute>5</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>8</Month><Day>30</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37647397</ArticleId><ArticleId IdType="pmc">PMC10468133</ArticleId><ArticleId IdType="doi">10.1126/sciadv.adi5571</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>C. A.&#xa0;Lutomski, S. M.&#xa0;Gordon, A. T.&#xa0;Remaley, M. F.&#xa0;Jarrold, Resolution of lipoprotein subclasses by charge detection mass spectrometry. Anal. Chem. 90, 6353&#x2013;6356 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">29756771</ArticleId></ArticleIdList></Reference><Reference><Citation>S. M.&#xa0;Gordon, J.&#xa0;Deng, L. J.&#xa0;Lu, W. S.&#xa0;Davidson, Proteomic characterization of human plasma high density lipoprotein fractionated by gel filtration chromatography. J. Proteome Res. 9, 5239&#x2013;5249 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3100175</ArticleId><ArticleId IdType="pubmed">20718489</ArticleId></ArticleIdList></Reference><Reference><Citation>W. S.&#xa0;Davidson, A. S.&#xa0;Shah, H.&#xa0;Sexmith, S. M.&#xa0;Gordon, The HDL proteome watch: Compilation of studies leads to new insights on HDL function. Biochim. Biophys. Acta. Mol. Cell. Biol. Lipids 1867, 159072 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8715479</ArticleId><ArticleId IdType="pubmed">34800735</ArticleId></ArticleIdList></Reference><Reference><Citation>T.&#xa0;Vaisar, S.&#xa0;Pennathur, P. S.&#xa0;Green, S. A.&#xa0;Gharib, A. N.&#xa0;Hoofnagle, M. C.&#xa0;Cheung, J.&#xa0;Byun, S.&#xa0;Vuletic, S.&#xa0;Kassim, P.&#xa0;Singh, H.&#xa0;Chea, R. H.&#xa0;Knopp, J.&#xa0;Brunzell, R.&#xa0;Geary, A.&#xa0;Chait, X. Q.&#xa0;Zhao, K.&#xa0;Elkon, S.&#xa0;Marcovina, P.&#xa0;Ridker, J. F.&#xa0;Oram, J. W.&#xa0;Heinecke, Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL. J. Clin. Invest. 117, 746&#x2013;756 (2007).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1804352</ArticleId><ArticleId IdType="pubmed">17332893</ArticleId></ArticleIdList></Reference><Reference><Citation>M. P.&#xa0;Molina-Portela, M.&#xa0;Samanovic, J.&#xa0;Raper, Distinct roles of apolipoprotein components within the trypanosome lytic factor complex revealed in a novel transgenic mouse model. J. Exp. Med. 205, 1721&#x2013;1728 (2008).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2525602</ArticleId><ArticleId IdType="pubmed">18606856</ArticleId></ArticleIdList></Reference><Reference><Citation>W. S.&#xa0;Davidson, A. L.&#xa0;Cooke, D. K.&#xa0;Swertfeger, A. S.&#xa0;Shah, The difference between high density lipoprotein subfractions and subspecies: An evolving model in cardiovascular disease and diabetes. Curr. Atheroscler. Rep. 23, 23 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8258923</ArticleId><ArticleId IdType="pubmed">33772657</ArticleId></ArticleIdList></Reference><Reference><Citation>C. M.&#xa0;Rueda, A. L.&#xa0;Rodriguez-Perea, M.&#xa0;Moreno-Fernandez, C. M.&#xa0;Jackson, J. T.&#xa0;Melchior, W. S.&#xa0;Davidson, C. A.&#xa0;Chougnet, High density lipoproteins selectively promote the survival of human regulatory T cells. J. Lipid Res. 58, 1514&#x2013;1523 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5538275</ArticleId><ArticleId IdType="pubmed">28377425</ArticleId></ArticleIdList></Reference><Reference><Citation>P. J.&#xa0;Barter, K. A.&#xa0;Rye, High density lipoproteins and coronary heart disease. Atherosclerosis 121, 1&#x2013;12 (1996).</Citation><ArticleIdList><ArticleId IdType="pubmed">8678914</ArticleId></ArticleIdList></Reference><Reference><Citation>M. A.&#xa0;Fryirs, P. J.&#xa0;Barter, M.&#xa0;Appavoo, B. E.&#xa0;Tuch, F.&#xa0;Tabet, A. K.&#xa0;Heather, K. A.&#xa0;Rye, Effects of high-density lipoproteins on pancreatic &#x3b2;-cell insulin secretion. Arterioscler. Thromb. Vasc. Biol. 30, 1642&#x2013;1648 (2010).</Citation><ArticleIdList><ArticleId IdType="pubmed">20466975</ArticleId></ArticleIdList></Reference><Reference><Citation>M.&#xa0;Navab, S. Y.&#xa0;Hama, C. J.&#xa0;Cooke, G. M.&#xa0;Anantharamaiah, M.&#xa0;Chaddha, L.&#xa0;Jin, G.&#xa0;Subbanagounder, K. F.&#xa0;Faull, S. T.&#xa0;Reddy, N. E.&#xa0;Miller, A. M.&#xa0;Fogelman, Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: Step 1. J. Lipid Res. 41, 1481&#x2013;1494 (2000).</Citation><ArticleIdList><ArticleId IdType="pubmed">10974056</ArticleId></ArticleIdList></Reference><Reference><Citation>F. M.&#xa0;Sacks, L.&#xa0;Liang, J. D.&#xa0;Furtado, T.&#xa0;Cai, W. S.&#xa0;Davidson, Z.&#xa0;He, R. L.&#xa0;McClelland, E. B.&#xa0;Rimm, M. K.&#xa0;Jensen, Protein-defined subspecies of HDLs (High-Density Lipoproteins) and differential risk of coronary heart disease in 4 prospective studies. Arterioscler. Thromb. Vasc. Biol. 40, 2714&#x2013;2727 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7577984</ArticleId><ArticleId IdType="pubmed">32907368</ArticleId></ArticleIdList></Reference><Reference><Citation>C. M.&#xa0;Gibson, S.&#xa0;H.&#xa0;A.&#xa0;Kazmi, S.&#xa0;Korjian, G.&#xa0;Chi, A. T.&#xa0;Phillips, S. M.&#xa0;Montazerin, D.&#xa0;Duffy, B.&#xa0;Zheng, M.&#xa0;Heise, C.&#xa0;Liss, L. I.&#xa0;Deckelbaum, S. D.&#xa0;Wright, A.&#xa0;Gille, CSL112 (Apolipoprotein A-I [Human]) strongly enhances plasma apoa-I and cholesterol efflux capacity in post-acute myocardial infarction patients: A PK/PD substudy of the AEGIS-I trial. J. Cardiovasc. Pharmacol. Ther. 27, 107424842211215 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">36282079</ArticleId></ArticleIdList></Reference><Reference><Citation>S.&#xa0;Didichenko, A.&#xa0;Navdaev, M.&#xa0;Saxenhofer, S.&#xa0;Graeter, A.&#xa0;Schaub, A.&#xa0;Rovo, G. J.&#xa0;Kato, B.&#xa0;Kingwell, CSL112 increases plasma cholesterol efflux capacity and reduces erythrocyte membrane cholesterol content in blood samples from patients with sickle cell disease. Blood 140, 2528&#x2013;2529 (2022).</Citation></Reference><Reference><Citation>D. A.&#xa0;Hottman, D.&#xa0;Chernick, S.&#xa0;Cheng, Z.&#xa0;Wang, L.&#xa0;Li, HDL and cognition in neurodegenerative disorders. Neurobiol. Dis. 72, 22&#x2013;36 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4252583</ArticleId><ArticleId IdType="pubmed">25131449</ArticleId></ArticleIdList></Reference><Reference><Citation>S.&#xa0;Koch, N.&#xa0;Donarski, K.&#xa0;Goetze, M.&#xa0;Kreckel, H. J.&#xa0;Stuerenburg, C.&#xa0;Buhmann, U.&#xa0;Beisiegel, Characterization of four lipoprotein classes in human cerebrospinal fluid. J. Lipid Res. 42, 1143&#x2013;1151 (2001).</Citation><ArticleIdList><ArticleId IdType="pubmed">11441143</ArticleId></ArticleIdList></Reference><Reference><Citation>M. J.&#xa0;LaDu, S. M.&#xa0;Gilligan, J. R.&#xa0;Lukens, V. G.&#xa0;Cabana, C. A.&#xa0;Reardon, L. J.&#xa0;Van Eldik, D. M.&#xa0;Holtzman, Nascent astrocyte particles differ from lipoproteins in CSF. J. Neurochem. 70, 2070&#x2013;2081 (1998).</Citation><ArticleIdList><ArticleId IdType="pubmed">9572293</ArticleId></ArticleIdList></Reference><Reference><Citation>P. S.&#xa0;Roheim, M.&#xa0;Carey, T.&#xa0;Forte, G. L.&#xa0;Vega, Apolipoproteins in human cerebrospinal fluid. Proc. Natl. Acad. Sci. U.S.A. 76, 4646&#x2013;4649 (1979).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC411636</ArticleId><ArticleId IdType="pubmed">291993</ArticleId></ArticleIdList></Reference><Reference><Citation>N.&#xa0;Demeester, G.&#xa0;Castro, C.&#xa0;Desrumaux, C.&#xa0;De Geitere, J. C.&#xa0;Fruchart, P.&#xa0;Santens, E.&#xa0;Mulleners, S.&#xa0;Engelborghs, P. P.&#xa0;De Deyn, J.&#xa0;Vandekerckhove, M.&#xa0;Rosseneu, C.&#xa0;Labeur, Characterization and functional studies of lipoproteins, lipid transfer proteins, and lecithin: Cholesterol acyltransferase in CSF of normal individuals and patients with Alzheimer's disease. J. Lipid Res. 41, 963&#x2013;974 (2000).</Citation><ArticleIdList><ArticleId IdType="pubmed">10828089</ArticleId></ArticleIdList></Reference><Reference><Citation>T.&#xa0;Langmann, J.&#xa0;Klucken, M.&#xa0;Reil, G.&#xa0;Liebisch, M. F.&#xa0;Luciani, G.&#xa0;Chimini, W. E.&#xa0;Kaminski, G.&#xa0;Schmitz, Molecular cloning of the human ATP-binding cassette transporter 1 (hABC1): Evidence for sterol-dependent regulation in macrophages. Biochem. Biophys. Res. Commun. 257, 29&#x2013;33 (1999).</Citation><ArticleIdList><ArticleId IdType="pubmed">10092505</ArticleId></ArticleIdList></Reference><Reference><Citation>S. M.&#xa0;Gordon, W. S.&#xa0;Davidson, E. M.&#xa0;Urbina, L. M.&#xa0;Dolan, A.&#xa0;Heink, H.&#xa0;Zang, L. J.&#xa0;Lu, A. S.&#xa0;Shah, The effects of type 2 diabetes on lipoprotein composition and arterial stiffness in male youth. Diabetes 62, 2958&#x2013;2967 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3717874</ArticleId><ArticleId IdType="pubmed">23835332</ArticleId></ArticleIdList></Reference><Reference><Citation>W. S.&#xa0;Davidson, A.&#xa0;Heink, H.&#xa0;Sexmith, L. M.&#xa0;Dolan, S. M.&#xa0;Gordon, J. D.&#xa0;Otvos, J. T.&#xa0;Melchior, D. A.&#xa0;Elder, J.&#xa0;Khoury, E.&#xa0;Geh, A. S.&#xa0;Shah, Obesity is associated with an altered HDL subspecies profile among adolescents with metabolic disease. J. Lipid Res. 58, 1916&#x2013;1923 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5580903</ArticleId><ArticleId IdType="pubmed">28743729</ArticleId></ArticleIdList></Reference><Reference><Citation>J. T.&#xa0;Melchior, D. K.&#xa0;Swertfeger, J.&#xa0;Morris, S. E.&#xa0;Street, C. R.&#xa0;Warshak, J. A.&#xa0;Welge, A. T.&#xa0;Remaley, J. M.&#xa0;Catov, W. S.&#xa0;Davidson, L. A.&#xa0;Woollett, Pregnancy is accompanied by larger high density lipoprotein particles and compositionally distinct subspecies. J. Lipid Res. 62, 100107 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8441201</ArticleId><ArticleId IdType="pubmed">34416270</ArticleId></ArticleIdList></Reference><Reference><Citation>J. T.&#xa0;Melchior, S. E.&#xa0;Street, A. B.&#xa0;Andraski, J. D.&#xa0;Furtado, F. M.&#xa0;Sacks, R. L.&#xa0;Shute, E. I.&#xa0;Greve, D. K.&#xa0;Swertfeger, H.&#xa0;Li, A. S.&#xa0;Shah, L. J.&#xa0;Lu, W. S.&#xa0;Davidson, Apolipoprotein A-II alters the proteome of human lipoproteins and enhances cholesterol efflux from ABCA1. J. Lipid Res. 58, 1374&#x2013;1385 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5496035</ArticleId><ArticleId IdType="pubmed">28476857</ArticleId></ArticleIdList></Reference><Reference><Citation>J. T.&#xa0;Melchior, S. E.&#xa0;Street, T.&#xa0;Vaisar, R.&#xa0;Hart, J.&#xa0;Jerome, Z.&#xa0;Kuklenyik, N.&#xa0;Clouet-Foraison, C.&#xa0;Thornock, S.&#xa0;Bedi, A. S.&#xa0;Shah, J. P.&#xa0;Segrest, J. W.&#xa0;Heinecke, W. S.&#xa0;Davidson, Apolipoprotein A-I modulates HDL particle size in the absence of apolipoprotein A-II. J. Lipid Res. 62, 100099 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8385444</ArticleId><ArticleId IdType="pubmed">34324889</ArticleId></ArticleIdList></Reference><Reference><Citation>H.&#xa0;Li, S. M.&#xa0;Gordon, X.&#xa0;Zhu, J.&#xa0;Deng, D. K.&#xa0;Swertfeger, W. S.&#xa0;Davidson, L. J.&#xa0;Lu, Network-based analysis on orthogonal separation of human plasma uncovers distinct high density lipoprotein complexes. J. Proteome Res. 14, 3082&#x2013;3094 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6524531</ArticleId><ArticleId IdType="pubmed">26057100</ArticleId></ArticleIdList></Reference><Reference><Citation>C. Y.&#xa0;Lee, W.&#xa0;Tse, J. D.&#xa0;Smith, G. E.&#xa0;Landreth, Apolipoprotein E promotes &#x3b2;-Amyloid trafficking and degradation by modulating microglial cholesterol levels. J. Biol. Chem. 287, 2032&#x2013;2044 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3265883</ArticleId><ArticleId IdType="pubmed">22130662</ArticleId></ArticleIdList></Reference><Reference><Citation>R. E.&#xa0;Pitas, J. K.&#xa0;Boyles, S. H.&#xa0;Lee, D.&#xa0;Hui, K. H.&#xa0;Weisgraber, Lipoproteins and their receptors in the central nervous system. characterization of the lipoproteins in cerebrospinal fluid and identification of apolipoprotein B,E(LDL) receptors in the brain. J. Biol. Chem. 262, 14352&#x2013;14360 (1987).</Citation><ArticleIdList><ArticleId IdType="pubmed">3115992</ArticleId></ArticleIdList></Reference><Reference><Citation>J. R.&#xa0;Guyton, S. E.&#xa0;Miller, M. E.&#xa0;Martin, W. A.&#xa0;Khan, A. D.&#xa0;Roses, W. J.&#xa0;Strittmatter, Novel large apolipoprotein E-containing lipoproteins of density 1.006-1.060 g/ml in human cerebrospinal fluid. J. Neurochem. 70, 1235&#x2013;1240 (1998).</Citation><ArticleIdList><ArticleId IdType="pubmed">9489746</ArticleId></ArticleIdList></Reference><Reference><Citation>A. R.&#xa0;Koudinov, N. V.&#xa0;Koudinova, A.&#xa0;Kumar, R. C.&#xa0;Beavis, J.&#xa0;Ghiso, Biochemical characterization of alzheimer's soluble amyloid beta protein in human cerebrospinal fluid: Association with high density lipoproteins. Biochem. Biophys. Res. Commun. 223, 592&#x2013;597 (1996).</Citation><ArticleIdList><ArticleId IdType="pubmed">8687441</ArticleId></ArticleIdList></Reference><Reference><Citation>P. J.&#xa0;Blanche, E. L.&#xa0;Gong, T. M.&#xa0;Forte, A. V.&#xa0;Nichols, Characterization of human high-density lipoproteins by gradient gel electrophoresis. Biochim. Biophys. Acta 665, 408&#x2013;419 (1981).</Citation><ArticleIdList><ArticleId IdType="pubmed">7295744</ArticleId></ArticleIdList></Reference><Reference><Citation>R. A.&#xa0;Silva, R.&#xa0;Huang, J.&#xa0;Morris, J.&#xa0;Fang, E. O.&#xa0;Gracheva, G.&#xa0;Ren, A.&#xa0;Kontush, W. G.&#xa0;Jerome, K. A.&#xa0;Rye, W. S.&#xa0;Davidson, Structure of apolipoprotein A-I in spherical high density lipoproteins of different sizes. Proc. Natl. Acad. Sci. U.S.A. 105, 12176&#x2013;12181 (2008).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2527885</ArticleId><ArticleId IdType="pubmed">18719128</ArticleId></ArticleIdList></Reference><Reference><Citation>R.&#xa0;Huang, R. A.&#xa0;Silva, W. G.&#xa0;Jerome, A.&#xa0;Kontush, M. J.&#xa0;Chapman, L. K.&#xa0;Curtiss, T. J.&#xa0;Hodges, W. S.&#xa0;Davidson, Apolipoprotein A-I structural organization in high-density lipoproteins isolated from human plasma. Nat. Struct. Mol. Biol. 18, 416&#x2013;422 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3079355</ArticleId><ArticleId IdType="pubmed">21399642</ArticleId></ArticleIdList></Reference><Reference><Citation>N. A.&#xa0;Elshourbagy, W. S.&#xa0;Liao, R. W.&#xa0;Mahley, J. M.&#xa0;Taylor, Apolipoprotein E mRNA is abundant in the brain and adrenals, as well as in the liver, and is present in other peripheral tissues of rats and marmosets. Proc. Natl. Acad. Sci. U.S.A. 82, 203&#x2013;207 (1985).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC397000</ArticleId><ArticleId IdType="pubmed">3918303</ArticleId></ArticleIdList></Reference><Reference><Citation>M. F.&#xa0;Linton, R.&#xa0;Gish, S. T.&#xa0;Hubl, E.&#xa0;Butler, C.&#xa0;Esquivel, W. I.&#xa0;Bry, J. K.&#xa0;Boyles, M. R.&#xa0;Wardell, S. G.&#xa0;Young, Phenotypes of apolipoprotein B and apolipoprotein E after liver transplantation. J. Clin. Invest. 88, 270&#x2013;281 (1991).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC296029</ArticleId><ArticleId IdType="pubmed">2056122</ArticleId></ArticleIdList></Reference><Reference><Citation>D. A.&#xa0;Elliott, C. S.&#xa0;Weickert, B.&#xa0;Garner, Apolipoproteins in the brain: Implications for neurological and psychiatric disorders. Clin. Lipidol. 51, 555&#x2013;573 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3058497</ArticleId><ArticleId IdType="pubmed">21423873</ArticleId></ArticleIdList></Reference><Reference><Citation>A. L.&#xa0;Cooke, J.&#xa0;Morris, J. T.&#xa0;Melchior, S. E.&#xa0;Street, W. G.&#xa0;Jerome, R.&#xa0;Huang, A. B.&#xa0;Herr, L. E.&#xa0;Smith, J. P.&#xa0;Segrest, A. T.&#xa0;Remaley, A. S.&#xa0;Shah, T. B.&#xa0;Thompson, W. S.&#xa0;Davidson, A thumbwheel mechanism for APOA1 activation of LCAT activity in HDL. J. Lipid Res. 59, 1244&#x2013;1255 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6027914</ArticleId><ArticleId IdType="pubmed">29773713</ArticleId></ArticleIdList></Reference><Reference><Citation>L.&#xa0;Zhang, F.&#xa0;Yan, S.&#xa0;Zhang, D.&#xa0;Lei, M. A.&#xa0;Charles, G.&#xa0;Cavigiolio, M.&#xa0;Oda, R. M.&#xa0;Krauss, K. H.&#xa0;Weisgraber, K. A.&#xa0;Rye, H. J.&#xa0;Pownall, X.&#xa0;Qiu, G.&#xa0;Ren, Structural basis of transfer between lipoproteins by cholesteryl ester transfer protein. Nat. Chem. Biol. 8, 342&#x2013;349 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3792710</ArticleId><ArticleId IdType="pubmed">22344176</ArticleId></ArticleIdList></Reference><Reference><Citation>N.&#xa0;Laurens, P.&#xa0;Koolwijk, M. P.&#xa0;de Maat, Fibrin structure and wound healing. J. Thromb. Haemost. 4, 932&#x2013;939 (2006).</Citation><ArticleIdList><ArticleId IdType="pubmed">16689737</ArticleId></ArticleIdList></Reference><Reference><Citation>J. R.&#xa0;Dunkelberger, W. C.&#xa0;Song, Complement and its role in innate and adaptive immune responses. Cell Res. 20, 34&#x2013;50 (2010).</Citation><ArticleIdList><ArticleId IdType="pubmed">20010915</ArticleId></ArticleIdList></Reference><Reference><Citation>S. M.&#xa0;Gordon, J.&#xa0;Deng, A. B.&#xa0;Tomann, A. S.&#xa0;Shah, L. J.&#xa0;Lu, W. S.&#xa0;Davidson, Multi-dimensional co-separation analysis reveals protein:protein interactions defining plasma lipoprotein subspecies. Mol. Cell. Proteomics 12, 3123&#x2013;3134 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3820928</ArticleId><ArticleId IdType="pubmed">23882025</ArticleId></ArticleIdList></Reference><Reference><Citation>G.&#xa0;Boyce, E.&#xa0;Button, S.&#xa0;Soo, C.&#xa0;Wellington, The pleiotropic vasoprotective functions of high density lipoproteins (HDL). J. Biomed. Res. 32, 164&#x2013;182 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6265396</ArticleId><ArticleId IdType="pubmed">28550271</ArticleId></ArticleIdList></Reference><Reference><Citation>G. P.&#xa0;Demyanenko, V.&#xa0;Mohan, X.&#xa0;Zhang, L. H.&#xa0;Brennaman, K. E.&#xa0;Dharbal, T. S.&#xa0;Tran, P. B.&#xa0;Manis, P. F.&#xa0;Maness, Neural cell adhesion molecule NrCAM regulates Semaphorin 3F-induced dendritic spine remodeling. J. Neurosci. 34, 11274&#x2013;11287 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4138338</ArticleId><ArticleId IdType="pubmed">25143608</ArticleId></ArticleIdList></Reference><Reference><Citation>A.&#xa0;Zuko, A.&#xa0;Oguro-Ando, R.&#xa0;van Dijk, S.&#xa0;Gregorio-Jordan, B.&#xa0;van der Zwaag, J. P.&#xa0;Burbach, Developmental role of the cell adhesion molecule Contactin-6 in the cerebral cortex and hippocampus. Cell Adh. Migr. 10, 378&#x2013;392 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4986711</ArticleId><ArticleId IdType="pubmed">26939565</ArticleId></ArticleIdList></Reference><Reference><Citation>J. A.&#xa0;Osterhout, B. K.&#xa0;Stafford, P. L.&#xa0;Nguyen, Y.&#xa0;Yoshihara, A. D.&#xa0;Huberman, Contactin-4 mediates axon-target specificity and functional development of the accessory optic system. Neuron 86, 985&#x2013;999 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4706364</ArticleId><ArticleId IdType="pubmed">25959733</ArticleId></ArticleIdList></Reference><Reference><Citation>E. I.&#xa0;de Chaves, A. E.&#xa0;Rusinol, D. E.&#xa0;Vance, R. B.&#xa0;Campenot, J. E.&#xa0;Vance, Role of lipoproteins in the delivery of lipids to axons during axonal regeneration. J. Biol. Chem. 272, 30766&#x2013;30773 (1997).</Citation><ArticleIdList><ArticleId IdType="pubmed">9388216</ArticleId></ArticleIdList></Reference><Reference><Citation>H. A.&#xa0;Taylor, K. J.&#xa0;Simmons, E. M.&#xa0;Clavane, C. J.&#xa0;Trevelyan, J. M.&#xa0;Brown, L.&#xa0;Przemylska, N. T.&#xa0;Watt, L. C.&#xa0;Matthews, P. J.&#xa0;Meakin, PTPRD and DCC are novel BACE1 substrates differentially expressed in alzheimer's disease: A data mining and bioinformatics study. Int. J.&#xa0;Mol. Sci. 23, 4568 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9103286</ArticleId><ArticleId IdType="pubmed">35562959</ArticleId></ArticleIdList></Reference><Reference><Citation>B.&#xa0;Dislich, F.&#xa0;Wohlrab, T.&#xa0;Bachhuber, S. A.&#xa0;Muller, P. H.&#xa0;Kuhn, S.&#xa0;Hogl, M.&#xa0;Meyer-Luehmann, S. F.&#xa0;Lichtenthaler, Label-free quantitative proteomics of mouse cerebrospinal fluid detects &#x3b2;-Site APP cleaving enzyme (BACE1) protease substrates In vivo. Mol. Cell. Proteomics 14, 2550&#x2013;2563 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>S. A.&#xa0;Muller, S. D.&#xa0;Scilabra, S. F.&#xa0;Lichtenthaler, Proteomic substrate identification for membrane proteases in the brain. Front. Mol. Neurosci. 9, 96 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>J.&#xa0;Aoto, C.&#xa0;Foldy, S. M.&#xa0;Ilcus, K.&#xa0;Tabuchi, T. C.&#xa0;Sudhof, Distinct circuit-dependent functions of presynaptic neurexin-3 at GABAergic and glutamatergic synapses. Nat. Neurosci. 18, 997&#x2013;1007 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4482778</ArticleId><ArticleId IdType="pubmed">26030848</ArticleId></ArticleIdList></Reference><Reference><Citation>S.&#xa0;Schilling, A.&#xa0;Mehr, S.&#xa0;Ludewig, J.&#xa0;Stephan, M.&#xa0;Zimmermann, A.&#xa0;August, P.&#xa0;Strecker, M.&#xa0;Korte, E. H.&#xa0;Koo, U. C.&#xa0;Muller, S.&#xa0;Kins, S.&#xa0;Eggert, APLP1 is a synaptic cell adhesion molecule, supporting maintenance of dendritic spines and basal synaptic transmission. J. Neurosci. 37, 5345&#x2013;5365 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6596463</ArticleId><ArticleId IdType="pubmed">28450540</ArticleId></ArticleIdList></Reference><Reference><Citation>O.&#xa0;Levi, A. L.&#xa0;Jongen-Relo, J.&#xa0;Feldon, A. D.&#xa0;Roses, D. M.&#xa0;Michaelson, ApoE4 impairs hippocampal plasticity isoform-specifically and blocks the environmental stimulation of synaptogenesis and memory. Neurobiol. Dis. 13, 273&#x2013;282 (2003).</Citation><ArticleIdList><ArticleId IdType="pubmed">12901842</ArticleId></ArticleIdList></Reference><Reference><Citation>S. F.&#xa0;Miller-Delaney, I.&#xa0;Lieberam, P.&#xa0;Murphy, K. J.&#xa0;Mitchell, Plxdc2 is a mitogen for neural progenitors. PLOS ONE 6, e14565 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3024984</ArticleId><ArticleId IdType="pubmed">21283688</ArticleId></ArticleIdList></Reference><Reference><Citation>K. A.&#xa0;Bruggink, H. B.&#xa0;Kuiperij, J.&#xa0;Gloerich, I.&#xa0;Otte-Holler, A. J.&#xa0;Rozemuller, J. A.&#xa0;Claassen, B.&#xa0;Kusters, M. M.&#xa0;Verbeek, Dickkopf-related protein 3 is a potential A&#x3b2;-associated protein in Alzheimer's disease. J. Neurochem. 134, 1152&#x2013;1162 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">26119087</ArticleId></ArticleIdList></Reference><Reference><Citation>A.&#xa0;Ashraf, N. J.&#xa0;Ashton, P.&#xa0;Chatterjee, K.&#xa0;Goozee, K.&#xa0;Shen, J.&#xa0;Fripp, D.&#xa0;Ames, C.&#xa0;Rowe, C. L.&#xa0;Masters, V.&#xa0;Villemagne, A.&#xa0;Hye, R. N.&#xa0;Martins, P. W.&#xa0;So, Plasma transferrin and hemopexin are associated with altered A&#x3b2; uptake and cognitive decline in Alzheimer's disease pathology. Alzheimers Res. Ther. 12, 72 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7285604</ArticleId><ArticleId IdType="pubmed">32517787</ArticleId></ArticleIdList></Reference><Reference><Citation>H.&#xa0;Wang, R. H.&#xa0;Eckel, What are lipoproteins doing in the brain? Trends Endocrinol. Metab. 25, 8&#x2013;14 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4062975</ArticleId><ArticleId IdType="pubmed">24189266</ArticleId></ArticleIdList></Reference><Reference><Citation>R. W.&#xa0;Mahley, Central nervous system lipoproteins: ApoE and regulation of cholesterol metabolism. Arterioscler. Thromb. Vasc. Biol. 36, 1305&#x2013;1315 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4942259</ArticleId><ArticleId IdType="pubmed">27174096</ArticleId></ArticleIdList></Reference><Reference><Citation>D. A.&#xa0;Jaitin, L.&#xa0;Adlung, C. A.&#xa0;Thaiss, A.&#xa0;Weiner, B.&#xa0;Li, H.&#xa0;Descamps, P.&#xa0;Lundgren, C.&#xa0;Bleriot, Z.&#xa0;Liu, A.&#xa0;Deczkowska, H.&#xa0;Keren-Shaul, E.&#xa0;David, N.&#xa0;Zmora, S. M.&#xa0;Eldar, N.&#xa0;Lubezky, O.&#xa0;Shibolet, D. A.&#xa0;Hill, M. A.&#xa0;Lazar, M.&#xa0;Colonna, F.&#xa0;Ginhoux, H.&#xa0;Shapiro, E.&#xa0;Elinav, I.&#xa0;Amit, Lipid-associated macrophages control metabolic homeostasis in a Trem2-dependent manner. Cell 178, 686&#x2013;698 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7068689</ArticleId><ArticleId IdType="pubmed">31257031</ArticleId></ArticleIdList></Reference><Reference><Citation>S. S.&#xa0;Kang, M.&#xa0;T.&#xa0;W.&#xa0;Ebbert, K. E.&#xa0;Baker, C.&#xa0;Cook, X.&#xa0;Wang, J. P.&#xa0;Sens, J. P.&#xa0;Kocher, L.&#xa0;Petrucelli, J. D.&#xa0;Fryer, Microglial translational profiling reveals a convergent APOE pathway from aging, amyloid, and tau. J. Exp. Med. 215, 2235&#x2013;2245 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6122978</ArticleId><ArticleId IdType="pubmed">30082275</ArticleId></ArticleIdList></Reference><Reference><Citation>S.&#xa0;De Schepper, J. Z.&#xa0;Ge, G.&#xa0;Crowley, L.&#xa0;S.&#xa0;S.&#xa0;Ferreira, D.&#xa0;Garceau, C. E.&#xa0;Toomey, D.&#xa0;Sokolova, J.&#xa0;Rueda-Carrasco, S. H.&#xa0;Shin, J. S.&#xa0;Kim, T.&#xa0;Childs, T.&#xa0;Lashley, J. J.&#xa0;Burden, M.&#xa0;Sasner, C.&#xa0;Sala Frigerio, S.&#xa0;Jung, S.&#xa0;Hong, Perivascular cells induce microglial phagocytic states and synaptic engulfment via SPP1 in mouse models of Alzheimer's disease. Nat. Neurosci. 26, 406&#x2013;415 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9991912</ArticleId><ArticleId IdType="pubmed">36747024</ArticleId></ArticleIdList></Reference><Reference><Citation>C.&#xa0;Yin, S.&#xa0;Ackermann, Z.&#xa0;Ma, S. K.&#xa0;Mohanta, C.&#xa0;Zhang, Y.&#xa0;Li, S.&#xa0;Nietzsche, M.&#xa0;Westermann, L.&#xa0;Peng, D.&#xa0;Hu, S. V.&#xa0;Bontha, P.&#xa0;Srikakulapu, M.&#xa0;Beer, R.&#xa0;T.&#xa0;A.&#xa0;Megens, S.&#xa0;Steffens, M.&#xa0;Hildner, L. D.&#xa0;Halder, H. H.&#xa0;Eckstein, J.&#xa0;Pelisek, J.&#xa0;Herms, S.&#xa0;Roeber, T.&#xa0;Arzberger, A.&#xa0;Borodovsky, L.&#xa0;Habenicht, C. J.&#xa0;Binder, C.&#xa0;Weber, P. F.&#xa0;Zipfel, C.&#xa0;Skerka, A.&#xa0;J.&#xa0;R.&#xa0;Habenicht, ApoE attenuates unresolvable inflammation by complex formation with activated C1q. Nat. Med. 25, 496&#x2013;506 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6420126</ArticleId><ArticleId IdType="pubmed">30692699</ArticleId></ArticleIdList></Reference><Reference><Citation>N.&#xa0;R.&#xa0;W.&#xa0;Cleland, K. D.&#xa0;Bruce, Fatty acid sensing in the brain: The role of glial-neuronal metabolic crosstalk and horizontal lipid flux. Biochimie 20, S0300-9084(22)00216-4 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35998849</ArticleId></ArticleIdList></Reference><Reference><Citation>C.&#xa0;Vitali, C. L.&#xa0;Wellington, L.&#xa0;Calabresi, HDL and cholesterol handling in the brain. Cardiovasc. Res. 103, 405&#x2013;413 (2014).</Citation><ArticleIdList><ArticleId IdType="pubmed">24907980</ArticleId></ArticleIdList></Reference><Reference><Citation>C.&#xa0;Picard, N.&#xa0;Nilsson, A.&#xa0;Labonte, D.&#xa0;Auld, P.&#xa0;Rosa-Neto; Alzheimer's Disease Neuroimaging Initiative, N. J.&#xa0;Ashton, H.&#xa0;Zetterberg, K.&#xa0;Blennow, J.&#xa0;C.&#xa0;B.&#xa0;Breitner, S.&#xa0;Villeneuve, J.&#xa0;Poirier; PREVENT-AD research group , Apolipoprotein B is a novel marker for early tau pathology in Alzheimer's disease. Alzheimers Dement. 18, 875&#x2013;887 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9293308</ArticleId><ArticleId IdType="pubmed">34590423</ArticleId></ArticleIdList></Reference><Reference><Citation>J. K.&#xa0;Wong, A. K.&#xa0;Roselle, T. M.&#xa0;Shue, S.&#xa0;J.&#xa0;E.&#xa0;Shimshak, J. M.&#xa0;Beaty, N. M.&#xa0;Celestin, I.&#xa0;Gao, R. P.&#xa0;Griffin, M. E.&#xa0;Cudkowicz, S. A.&#xa0;Sadiq, Apolipoprotein B-100-mediated motor neuron degeneration in sporadic amyotrophic lateral sclerosis. Brain Commun. 4, fcac207 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9416068</ArticleId><ArticleId IdType="pubmed">36043141</ArticleId></ArticleIdList></Reference><Reference><Citation>K.&#xa0;Barkovits, N.&#xa0;Kruse, A.&#xa0;Linden, L.&#xa0;Tonges, K.&#xa0;Pfeiffer, B.&#xa0;Mollenhauer, K.&#xa0;Marcus, Blood contamination in CSF and its impact on quantitative analysis of alpha-synuclein. Cell 9, 370 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7072133</ArticleId><ArticleId IdType="pubmed">32033488</ArticleId></ArticleIdList></Reference><Reference><Citation>D.&#xa0;Faizullin, Y.&#xa0;Valiullina, V.&#xa0;Salnikov, Y.&#xa0;Zuev, Direct interaction of fibrinogen with lipid microparticles modulates clotting kinetics and clot structure. Nanomedicine 23, 102098 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">31655206</ArticleId></ArticleIdList></Reference><Reference><Citation>G. J.&#xa0;van der Vusse, Albumin as fatty acid transporter. Drug Metab. Pharmacokinet. 24, 300&#x2013;307 (2009).</Citation><ArticleIdList><ArticleId IdType="pubmed">19745557</ArticleId></ArticleIdList></Reference><Reference><Citation>W. S.&#xa0;Davidson, T. H.&#xa0;Inge, H.&#xa0;Sexmith, A.&#xa0;Heink, D.&#xa0;Elder, D. Y.&#xa0;Hui, J. T.&#xa0;Melchior, T.&#xa0;Kelesidis, A. S.&#xa0;Shah, Weight loss surgery in adolescents corrects high-density lipoprotein subspecies and their function. Int. J.&#xa0;Obes. (Lond) 41, 83&#x2013;89 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5209276</ArticleId><ArticleId IdType="pubmed">27780977</ArticleId></ArticleIdList></Reference><Reference><Citation>S.&#xa0;Tyanova, T.&#xa0;Temu, J.&#xa0;Cox, The MaxQuant computational platform for mass spectrometry-based shotgun proteomics. Nat. Protoc. 11, 2301&#x2013;2319 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">27809316</ArticleId></ArticleIdList></Reference><Reference><Citation>B. T.&#xa0;Sherman, M.&#xa0;Hao, J.&#xa0;Qiu, X.&#xa0;Jiao, M. W.&#xa0;Baseler, H. C.&#xa0;Lane, T.&#xa0;Imamichi, W.&#xa0;Chang, DAVID: A web server for functional enrichment analysis and functional annotation of gene lists (2021 update). Nucleic Acids Res. 50, W216&#x2013;W221 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9252805</ArticleId><ArticleId IdType="pubmed">35325185</ArticleId></ArticleIdList></Reference><Reference><Citation>D.&#xa0;Szklarczyk, A. L.&#xa0;Gable, K. C.&#xa0;Nastou, D.&#xa0;Lyon, R.&#xa0;Kirsch, S.&#xa0;Pyysalo, N. T.&#xa0;Doncheva, M.&#xa0;Legeay, T.&#xa0;Fang, P.&#xa0;Bork, L. J.&#xa0;Jensen, C.&#xa0;von Mering, The STRING database in 2021: Customizable protein-protein networks, and functional characterization of user-uploaded gene/measurement sets. Nucleic Acids Res. 49, D605&#x2013;D612 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7779004</ArticleId><ArticleId IdType="pubmed">33237311</ArticleId></ArticleIdList></Reference><Reference><Citation>R. G.&#xa0;Stacey, M. A.&#xa0;Skinnider, N. E.&#xa0;Scott, L. J.&#xa0;Foster, A rapid and accurate approach for prediction of interactomes from co-elution data (PrInCE). BMC Bioinformatics 18, 457 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5654062</ArticleId><ArticleId IdType="pubmed">29061110</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37652017</PMID><DateCompleted><Year>2023</Year><Month>09</Month><Day>25</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>30</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2666-3791</ISSN><JournalIssue CitedMedium="Internet"><Volume>4</Volume><Issue>9</Issue><PubDate><Year>2023</Year><Month>Sep</Month><Day>19</Day></PubDate></JournalIssue><Title>Cell reports. Medicine</Title><ISOAbbreviation>Cell Rep Med</ISOAbbreviation></Journal><ArticleTitle>Human astrocytes and microglia show augmented ingestion of synapses in Alzheimer's disease via MFG-E8.</ArticleTitle><Pagination><StartPage>101175</StartPage><MedlinePgn>101175</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">101175</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.xcrm.2023.101175</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2666-3791(23)00328-2</ELocationID><Abstract><AbstractText>Synapse loss correlates with cognitive decline in Alzheimer's disease (AD). Data from mouse models suggests microglia are important for synapse degeneration, but direct human evidence for any glial involvement in synapse removal in human AD remains to be established. Here we observe astrocytes and microglia from human brains contain greater amounts of synaptic protein in AD compared with non-disease controls, and that proximity to amyloid-&#x3b2; plaques and the APOE4 risk gene exacerbate this effect. In culture, mouse and human astrocytes and primary mouse and human microglia phagocytose AD patient-derived synapses more than synapses from controls. Inhibiting interactions of MFG-E8 rescues the elevated engulfment of AD synapses by astrocytes and microglia without affecting control synapse uptake. Thus, AD promotes increased synapse ingestion by human glial cells at least in part via an MFG-E8 opsonophagocytic mechanism with potential for targeted therapeutic manipulation.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 The Author(s). Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tzioras</LastName><ForeName>Makis</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>UK Dementia Research Institute, the University of Edinburgh, Edinburgh EH8 9JZ, UK; Centre for Discovery Brain Sciences, the University of Edinburgh, Edinburgh EH8 9JZ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Daniels</LastName><ForeName>Michael J D</ForeName><Initials>MJD</Initials><AffiliationInfo><Affiliation>UK Dementia Research Institute, the University of Edinburgh, Edinburgh EH8 9JZ, UK; Centre for Discovery Brain Sciences, the University of Edinburgh, Edinburgh EH8 9JZ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Davies</LastName><ForeName>Caitlin</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>UK Dementia Research Institute, the University of Edinburgh, Edinburgh EH8 9JZ, UK; Centre for Discovery Brain Sciences, the University of Edinburgh, Edinburgh EH8 9JZ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baxter</LastName><ForeName>Paul</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>UK Dementia Research Institute, the University of Edinburgh, Edinburgh EH8 9JZ, UK; Centre for Discovery Brain Sciences, the University of Edinburgh, Edinburgh EH8 9JZ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>King</LastName><ForeName>Declan</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>UK Dementia Research Institute, the University of Edinburgh, Edinburgh EH8 9JZ, UK; Centre for Discovery Brain Sciences, the University of Edinburgh, Edinburgh EH8 9JZ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McKay</LastName><ForeName>Sean</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>UK Dementia Research Institute, the University of Edinburgh, Edinburgh EH8 9JZ, UK; Centre for Discovery Brain Sciences, the University of Edinburgh, Edinburgh EH8 9JZ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Varga</LastName><ForeName>Balazs</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Wellcome - MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge CB2 0AW, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Popovic</LastName><ForeName>Karla</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>UK Dementia Research Institute, the University of Edinburgh, Edinburgh EH8 9JZ, UK; Centre for Discovery Brain Sciences, the University of Edinburgh, Edinburgh EH8 9JZ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hernandez</LastName><ForeName>Madison</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>UK Dementia Research Institute, the University of Edinburgh, Edinburgh EH8 9JZ, UK; Centre for Discovery Brain Sciences, the University of Edinburgh, Edinburgh EH8 9JZ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stevenson</LastName><ForeName>Anna J</ForeName><Initials>AJ</Initials><AffiliationInfo><Affiliation>UK Dementia Research Institute, the University of Edinburgh, Edinburgh EH8 9JZ, UK; Centre for Discovery Brain Sciences, the University of Edinburgh, Edinburgh EH8 9JZ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barrington</LastName><ForeName>Jack</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>UK Dementia Research Institute, the University of Edinburgh, Edinburgh EH8 9JZ, UK; Centre for Discovery Brain Sciences, the University of Edinburgh, Edinburgh EH8 9JZ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Drinkwater</LastName><ForeName>Elizabeth</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>UK Dementia Research Institute, the University of Edinburgh, Edinburgh EH8 9JZ, UK; Centre for Discovery Brain Sciences, the University of Edinburgh, Edinburgh EH8 9JZ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Borella</LastName><ForeName>Julia</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>UK Dementia Research Institute, the University of Edinburgh, Edinburgh EH8 9JZ, UK; Centre for Discovery Brain Sciences, the University of Edinburgh, Edinburgh EH8 9JZ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Holloway</LastName><ForeName>Rebecca K</ForeName><Initials>RK</Initials><AffiliationInfo><Affiliation>MRC Centre for Reproductive Health, the University of Edinburgh, Edinburgh EH16 4TJ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tulloch</LastName><ForeName>Jane</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>UK Dementia Research Institute, the University of Edinburgh, Edinburgh EH8 9JZ, UK; Centre for Discovery Brain Sciences, the University of Edinburgh, Edinburgh EH8 9JZ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moss</LastName><ForeName>Jonathan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>MRC Centre for Reproductive Health, the University of Edinburgh, Edinburgh EH16 4TJ, UK; The Roslin Institute, the Royal (Dick) School of Veterinary Studies, the University of Edinburgh, Edinburgh EH25 9RG, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Latta</LastName><ForeName>Clare</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>UK Dementia Research Institute, the University of Edinburgh, Edinburgh EH8 9JZ, UK; Centre for Discovery Brain Sciences, the University of Edinburgh, Edinburgh EH8 9JZ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kandasamy</LastName><ForeName>Jothy</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Clinical Neurosciences, Royal Infirmary of Edinburgh, Edinburgh EH16 4SA, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sokol</LastName><ForeName>Drahoslav</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Clinical Neurosciences, Royal Infirmary of Edinburgh, Edinburgh EH16 4SA, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smith</LastName><ForeName>Colin</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Centre for Clinical Brain Sciences, the University of Edinburgh, Edinburgh EH16 4SB, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miron</LastName><ForeName>Veronique E</ForeName><Initials>VE</Initials><AffiliationInfo><Affiliation>UK Dementia Research Institute, the University of Edinburgh, Edinburgh EH8 9JZ, UK; MRC Centre for Reproductive Health, the University of Edinburgh, Edinburgh EH16 4TJ, UK; Barlo Multiple Sclerosis Centre at St. Michael's Hospital, Keenan Research Centre for Biomedical Science, Toronto, ON M5B 1T8, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>K&#xe1;rad&#xf3;ttir</LastName><ForeName>Ragnhildur Th&#xf3;ra</ForeName><Initials>RT</Initials><AffiliationInfo><Affiliation>Wellcome - MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge CB2 0AW, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hardingham</LastName><ForeName>Giles E</ForeName><Initials>GE</Initials><AffiliationInfo><Affiliation>UK Dementia Research Institute, the University of Edinburgh, Edinburgh EH8 9JZ, UK; Centre for Discovery Brain Sciences, the University of Edinburgh, Edinburgh EH8 9JZ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Henstridge</LastName><ForeName>Christopher M</ForeName><Initials>CM</Initials><AffiliationInfo><Affiliation>Division of Systems Medicine, School of Medicine, University of Dundee, Dundee DD1 9SY, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brennan</LastName><ForeName>Paul M</ForeName><Initials>PM</Initials><AffiliationInfo><Affiliation>Department of Clinical Neurosciences, Royal Infirmary of Edinburgh, Edinburgh EH16 4SA, UK; Centre for Clinical Brain Sciences, the University of Edinburgh, Edinburgh EH16 4SB, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McColl</LastName><ForeName>Barry W</ForeName><Initials>BW</Initials><AffiliationInfo><Affiliation>UK Dementia Research Institute, the University of Edinburgh, Edinburgh EH8 9JZ, UK; Centre for Discovery Brain Sciences, the University of Edinburgh, Edinburgh EH8 9JZ, UK. Electronic address: barry.mccoll@ed.ac.uk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spires-Jones</LastName><ForeName>Tara L</ForeName><Initials>TL</Initials><AffiliationInfo><Affiliation>UK Dementia Research Institute, the University of Edinburgh, Edinburgh EH8 9JZ, UK; Centre for Discovery Brain Sciences, the University of Edinburgh, Edinburgh EH8 9JZ, UK. Electronic address: tara.spires-jones@ed.ac.uk.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>MC_PC_17230</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><Acronym>BB_</Acronym><Agency>Biotechnology and Biological Sciences Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MR/L003384/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MR/V031260/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>08</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cell Rep Med</MedlineTA><NlmUniqueID>101766894</NlmUniqueID><ISSNLinking>2666-3791</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C098942">MFGE8 protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001253" MajorTopicYN="N">Astrocytes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004435" MajorTopicYN="N">Eating</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017628" MajorTopicYN="Y">Microglia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013569" MajorTopicYN="N">Synapses</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Alzheimer&#x2019;s disease</Keyword><Keyword MajorTopicYN="N">MFGE8</Keyword><Keyword MajorTopicYN="N">astrocytes</Keyword><Keyword MajorTopicYN="N">microglia</Keyword><Keyword MajorTopicYN="N">synapse loss</Keyword><Keyword MajorTopicYN="N">synapses</Keyword></KeywordList><CoiStatement>Declaration of interests T.L.S.-J. is on the Scientific Advisory Board of Cognition Therapeutics and Scottish Brain Sciences and receives collaborative grant funding from two industry partners. None of these had any influence over the current paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>8</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>1</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>8</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>22</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>9</Month><Day>1</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>8</Month><Day>31</Day><Hour>18</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>8</Month><Day>30</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37652017</ArticleId><ArticleId IdType="pmc">PMC10518633</ArticleId><ArticleId IdType="doi">10.1016/j.xcrm.2023.101175</ArticleId><ArticleId IdType="pii">S2666-3791(23)00328-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Braak H., Braak E. Staging of Alzheimer&#x2019;s disease-related neurofibrillary changes. Neurobiol. Aging. 1995;16:271&#x2013;278. doi: 10.1016/0197-4580(95)00021-6. discussion 278-284.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0197-4580(95)00021-6</ArticleId><ArticleId IdType="pubmed">7566337</ArticleId></ArticleIdList></Reference><Reference><Citation>Thal D.R., R&#xfc;b U., Orantes M., Braak H. Phases of A beta-deposition in the human brain and its relevance for the development of AD. Neurology. 2002;58:1791&#x2013;1800. doi: 10.1212/wnl.58.12.1791.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/wnl.58.12.1791</ArticleId><ArticleId IdType="pubmed">12084879</ArticleId></ArticleIdList></Reference><Reference><Citation>Pickett E.K., Herrmann A.G., McQueen J., Abt K., Dando O., Tulloch J., Jain P., Dunnett S., Sohrabi S., Fjeldstad M.P., et al. Amyloid beta and tau cooperate to cause reversible behavioral and transcriptional deficits in a model of Alzheimer&#x2019;s disease. Cell Rep. 2019;29:3592&#x2013;3604.e5. doi: 10.1016/j.celrep.2019.11.044.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2019.11.044</ArticleId><ArticleId IdType="pmc">PMC6915767</ArticleId><ArticleId IdType="pubmed">31825838</ArticleId></ArticleIdList></Reference><Reference><Citation>King D., Holt K., Toombs J., He X., Dando O., Okely J.A., Rose J., Gunn C., Correia A., Montero C., et al. Synaptic resilience is associated with maintained cognition during ageing. Alzheimers Dement. 2022;19:2560&#x2013;2574. doi: 10.1101/2022.05.04.22274679.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.05.04.22274679</ArticleId><ArticleId IdType="pmc">PMC11497288</ArticleId><ArticleId IdType="pubmed">36547260</ArticleId></ArticleIdList></Reference><Reference><Citation>Colom-Cadena M., Davies C., Sirisi S., Lee J.-E., Simzer E.M., Tzioras M., Querol-Vilaseca M., S&#xe1;nchez-Aced &#xc9;., Chang Y.Y., Holt K., et al. Synaptic oligomeric tau in Alzheimer&#x2019;s disease &#x2014; A potential culprit in the spread of tau pathology through the brain. Neuron. 2023;111:2170&#x2013;2183.e6. doi: 10.1016/j.neuron.2023.04.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2023.04.020</ArticleId><ArticleId IdType="pubmed">37192625</ArticleId></ArticleIdList></Reference><Reference><Citation>Koffie R.M., Hashimoto T., Tai H.-C., Kay K.R., Serrano-Pozo A., Joyner D., Hou S., Kopeikina K.J., Frosch M.P., Lee V.M., et al. Apolipoprotein E4 effects in Alzheimer&#x2019;s disease are mediated by synaptotoxic oligomeric amyloid-&#x3b2;. Brain. 2012;135:2155&#x2013;2168. doi: 10.1093/brain/aws127.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/aws127</ArticleId><ArticleId IdType="pmc">PMC3381721</ArticleId><ArticleId IdType="pubmed">22637583</ArticleId></ArticleIdList></Reference><Reference><Citation>DeKosky S.T., Scheff S.W. Synapse loss in frontal cortex biopsies in Alzheimer&#x2019;s disease: correlation with cognitive severity. Ann. Neurol. 1990;27:457&#x2013;464. doi: 10.1002/ana.410270502.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.410270502</ArticleId><ArticleId IdType="pubmed">2360787</ArticleId></ArticleIdList></Reference><Reference><Citation>Terry R.D., Masliah E., Salmon D.P., Butters N., DeTeresa R., Hill R., Hansen L.A., Katzman R. Physical basis of cognitive alterations in Alzheimer&#x2019;s disease: synapse loss is the major correlate of cognitive impairment. Ann. Neurol. 1991;30:572&#x2013;580. doi: 10.1002/ana.410300410.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.410300410</ArticleId><ArticleId IdType="pubmed">1789684</ArticleId></ArticleIdList></Reference><Reference><Citation>Paolicelli R.C., Bolasco G., Pagani F., Maggi L., Scianni M., Panzanelli P., Giustetto M., Ferreira T.A., Guiducci E., Dumas L., et al. Synaptic pruning by microglia is necessary for normal brain development. Science. 2011;333:1456&#x2013;1458. doi: 10.1126/science.1202529.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1202529</ArticleId><ArticleId IdType="pubmed">21778362</ArticleId></ArticleIdList></Reference><Reference><Citation>Schafer D.P., Lehrman E.K., Kautzman A.G., Koyama R., Mardinly A.R., Yamasaki R., Ransohoff R.M., Greenberg M.E., Barres B.A., Stevens B. Microglia sculpt postnatal neural circuits in an activity and complement-dependent manner. Neuron. 2012;74:691&#x2013;705. doi: 10.1016/j.neuron.2012.03.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2012.03.026</ArticleId><ArticleId IdType="pmc">PMC3528177</ArticleId><ArticleId IdType="pubmed">22632727</ArticleId></ArticleIdList></Reference><Reference><Citation>Cser&#xe9;p C., P&#xf3;sfai B., L&#xe9;n&#xe1;rt N., Fekete R., L&#xe1;szl&#xf3; Z.I., Lele Z., Orsolits B., Moln&#xe1;r G., Heindl S., Schwarcz A.D., et al. Microglia monitor and protect neuronal function through specialized somatic purinergic junctions. Science. 2020;367:528&#x2013;537. doi: 10.1126/science.aax6752.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aax6752</ArticleId><ArticleId IdType="pubmed">31831638</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J.-H., Kim J.-Y., Noh S., Lee H., Lee S.Y., Mun J.Y., Park H., Chung W.-S. Astrocytes phagocytose adult hippocampal synapses for circuit homeostasis. Nature. 2021;590:612&#x2013;617. doi: 10.1038/s41586-020-03060-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-03060-3</ArticleId><ArticleId IdType="pubmed">33361813</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung W.-S., Clarke L.E., Wang G.X., Stafford B.K., Sher A., Chakraborty C., Joung J., Foo L.C., Thompson A., Chen C., et al. Astrocytes mediate synapse elimination through MEGF10 and MERTK pathways. Nature. 2013;504:394&#x2013;400. doi: 10.1038/nature12776.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature12776</ArticleId><ArticleId IdType="pmc">PMC3969024</ArticleId><ArticleId IdType="pubmed">24270812</ArticleId></ArticleIdList></Reference><Reference><Citation>Vainchtein I.D., Chin G., Cho F.S., Kelley K.W., Miller J.G., Chien E.C., Liddelow S.A., Nguyen P.T., Nakao-Inoue H., Dorman L.C., et al. Astrocyte-derived interleukin-33 promotes microglial synapse engulfment and neural circuit development. Science. 2018;359:1269&#x2013;1273. doi: 10.1126/science.aal3589.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aal3589</ArticleId><ArticleId IdType="pmc">PMC6070131</ArticleId><ArticleId IdType="pubmed">29420261</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayata P., Badimon A., Strasburger H.J., Duff M.K., Montgomery S.E., Loh Y.-H.E., Ebert A., Pimenova A.A., Ramirez B.R., Chan A.T., et al. Epigenetic regulation of brain region-specific microglia clearance activity. Nat. Neurosci. 2018;21:1049&#x2013;1060. doi: 10.1038/s41593-018-0192-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-018-0192-3</ArticleId><ArticleId IdType="pmc">PMC6090564</ArticleId><ArticleId IdType="pubmed">30038282</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong S., Beja-Glasser V.F., Nfonoyim B.M., Frouin A., Li S., Ramakrishnan S., Merry K.M., Shi Q., Rosenthal A., Barres B.A., et al. Complement and microglia mediate early synapse loss in Alzheimer mouse models. Science. 2016;352:712&#x2013;716. doi: 10.1126/science.aad8373.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aad8373</ArticleId><ArticleId IdType="pmc">PMC5094372</ArticleId><ArticleId IdType="pubmed">27033548</ArticleId></ArticleIdList></Reference><Reference><Citation>Bie B., Wu J., Foss J.F., Naguib M. Activation of mGluR1 mediates C1q-dependent microglial phagocytosis of glutamatergic synapses in Alzheimer&#x2019;s rodent models. Mol. Neurobiol. 2019;56:5568&#x2013;5585. doi: 10.1007/s12035-019-1467-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-019-1467-8</ArticleId><ArticleId IdType="pmc">PMC6615956</ArticleId><ArticleId IdType="pubmed">30652266</ArticleId></ArticleIdList></Reference><Reference><Citation>Beckman D., Ott S., Donis-Cox K., Janssen W.G., Bliss-Moreau E., Rudebeck P.H., Baxter M.G., Morrison J.H. Oligomeric A&#x3b2; in the monkey brain impacts synaptic integrity and induces accelerated cortical aging. Proc. Natl. Acad. Sci. USA. 2019;116:26239&#x2013;26246. doi: 10.1073/pnas.1902301116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1902301116</ArticleId><ArticleId IdType="pmc">PMC6936351</ArticleId><ArticleId IdType="pubmed">31871145</ArticleId></ArticleIdList></Reference><Reference><Citation>Spurrier J., Nicholson L., Fang X.T., Stoner A.J., Toyonaga T., Holden D., Siegert T.R., Laird W., Allnutt M.A., Chiasseu M., et al. Reversal of synapse loss in Alzheimer mouse models by targeting mGluR5 to prevent synaptic tagging by C1Q. Sci. Transl. Med. 2022;14:eabi8593. doi: 10.1126/scitranslmed.abi8593.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.abi8593</ArticleId><ArticleId IdType="pmc">PMC9554345</ArticleId><ArticleId IdType="pubmed">35648810</ArticleId></ArticleIdList></Reference><Reference><Citation>Dejanovic B., Huntley M.A., De Mazi&#xe8;re A., Meilandt W.J., Wu T., Srinivasan K., Jiang Z., Gandham V., Friedman B.A., Ngu H., et al. Changes in the synaptic proteome in tauopathy and rescue of tau-induced synapse loss by C1q antibodies. Neuron. 2018;100:1322&#x2013;1336.e7. doi: 10.1016/j.neuron.2018.10.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2018.10.014</ArticleId><ArticleId IdType="pubmed">30392797</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu T., Dejanovic B., Gandham V.D., Gogineni A., Edmonds R., Schauer S., Srinivasan K., Huntley M.A., Wang Y., Wang T.-M., et al. Complement C3 is activated in human AD brain and is required for neurodegeneration in mouse models of amyloidosis and tauopathy. Cell Rep. 2019;28:2111&#x2013;2123.e6. doi: 10.1016/j.celrep.2019.07.060.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2019.07.060</ArticleId><ArticleId IdType="pubmed">31433986</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi Q., Chowdhury S., Ma R., Le K.X., Hong S., Caldarone B.J., Stevens B., Lemere C.A. Complement C3 deficiency protects against neurodegeneration in aged plaque-rich APP/PS1 mice. Sci. Transl. Med. 2017;9:eaaf6295. doi: 10.1126/scitranslmed.aaf6295.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.aaf6295</ArticleId><ArticleId IdType="pmc">PMC6936623</ArticleId><ArticleId IdType="pubmed">28566429</ArticleId></ArticleIdList></Reference><Reference><Citation>Tzioras M., McGeachan R.I., Durrant C.S., Spires-Jones T.L. Synaptic degeneration in Alzheimer disease. Nat. Rev. Neurol. 2023;19:19&#x2013;38. doi: 10.1038/s41582-022-00749-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-022-00749-z</ArticleId><ArticleId IdType="pubmed">36513730</ArticleId></ArticleIdList></Reference><Reference><Citation>Saunders T.S., Pozzolo F.E., Heslegrave A., King D., McGeachan R.I., Spires-Jones M.P., Harris S.E., Ritchie C., Muniz-Terrera G., Deary I.J., et al. Predictive blood biomarkers and brain changes associated with age-related cognitive decline. Brain Commun. 2023;5:fcad113. doi: 10.1093/braincomms/fcad113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/braincomms/fcad113</ArticleId><ArticleId IdType="pmc">PMC10167767</ArticleId><ArticleId IdType="pubmed">37180996</ArticleId></ArticleIdList></Reference><Reference><Citation>Bennett M.L., Bennett F.C., Liddelow S.A., Ajami B., Zamanian J.L., Fernhoff N.B., Mulinyawe S.B., Bohlen C.J., Adil A., Tucker A., et al. New tools for studying microglia in the mouse and human CNS. Proc. Natl. Acad. Sci. USA. 2016;113:E1738&#x2013;E1746. doi: 10.1073/pnas.1525528113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1525528113</ArticleId><ArticleId IdType="pmc">PMC4812770</ArticleId><ArticleId IdType="pubmed">26884166</ArticleId></ArticleIdList></Reference><Reference><Citation>Tai H.-C., Serrano-Pozo A., Hashimoto T., Frosch M.P., Spires-Jones T.L., Hyman B.T. The synaptic accumulation of hyperphosphorylated tau oligomers in Alzheimer disease is associated with dysfunction of the ubiquitin-proteasome system. Am. J. Pathol. 2012;181:1426&#x2013;1435. doi: 10.1016/j.ajpath.2012.06.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajpath.2012.06.033</ArticleId><ArticleId IdType="pmc">PMC3463637</ArticleId><ArticleId IdType="pubmed">22867711</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham L.C., Naldrett M.J., Kohama S.G., Smith C., Lamont D.J., McColl B.W., Gillingwater T.H., Skehel P., Urbanski H.F., Wishart T.M. Regional molecular mapping of primate synapses during normal healthy aging. Cell Rep. 2019;27:1018&#x2013;1026.e4. doi: 10.1016/j.celrep.2019.03.096.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2019.03.096</ArticleId><ArticleId IdType="pmc">PMC6486486</ArticleId><ArticleId IdType="pubmed">31018120</ArticleId></ArticleIdList></Reference><Reference><Citation>Byun Y.G., Chung W.-S. A novel in&#xa0;vitro live-imaging assay of astrocyte-mediated phagocytosis using pH indicator-conjugated synaptosomes. J.&#xa0;Vis. Exp. 2018:e56647. doi: 10.3791/56647.</Citation><ArticleIdList><ArticleId IdType="doi">10.3791/56647</ArticleId><ArticleId IdType="pmc">PMC5912350</ArticleId><ArticleId IdType="pubmed">29443098</ArticleId></ArticleIdList></Reference><Reference><Citation>Lehrman E.K., Wilton D.K., Litvina E.Y., Welsh C.A., Chang S.T., Frouin A., Walker A.J., Heller M.D., Umemori H., Chen C., et al. CD47 protects synapses from excess microglia-mediated pruning during development. Neuron. 2018;100:120&#x2013;134.e6. doi: 10.1016/j.neuron.2018.09.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2018.09.017</ArticleId><ArticleId IdType="pmc">PMC6314207</ArticleId><ArticleId IdType="pubmed">30308165</ArticleId></ArticleIdList></Reference><Reference><Citation>Grabert K., Michoel T., Karavolos M.H., Clohisey S., Baillie J.K., Stevens M.P., Freeman T.C., Summers K.M., McColl B.W. Microglial brain region-dependent diversity and selective regional sensitivities to aging. Nat. Neurosci. 2016;19:504&#x2013;516. doi: 10.1038/nn.4222.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.4222</ArticleId><ArticleId IdType="pmc">PMC4768346</ArticleId><ArticleId IdType="pubmed">26780511</ArticleId></ArticleIdList></Reference><Reference><Citation>Brelstaff J., Tolkovsky A.M., Ghetti B., Goedert M., Spillantini M.G. Living neurons with tau filaments aberrantly expose phosphatidylserine and are phagocytosed by microglia. Cell Rep. 2018;24:1939&#x2013;1948.e4. doi: 10.1016/j.celrep.2018.07.072.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2018.07.072</ArticleId><ArticleId IdType="pmc">PMC6161320</ArticleId><ArticleId IdType="pubmed">30134156</ArticleId></ArticleIdList></Reference><Reference><Citation>Neniskyte U., Brown G.C. Lactadherin/MFG-E8 is essential for microglia-mediated neuronal loss and phagoptosis induced by amyloid &#x3b2;. J.&#xa0;Neurochem. 2013;126:312&#x2013;317. doi: 10.1111/jnc.12288.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.12288</ArticleId><ArticleId IdType="pubmed">23647050</ArticleId></ArticleIdList></Reference><Reference><Citation>Fricker M., Oliva-Mart&#xed;n M.J., Brown G.C. Primary phagocytosis of viable neurons by microglia activated with LPS or A&#x3b2; is dependent on calreticulin/LRP phagocytic signalling. J.&#xa0;Neuroinflammation. 2012;9:196. doi: 10.1186/1742-2094-9-196.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1742-2094-9-196</ArticleId><ArticleId IdType="pmc">PMC3481398</ArticleId><ArticleId IdType="pubmed">22889139</ArticleId></ArticleIdList></Reference><Reference><Citation>Tibaldi L., Leyman S., Nicolas A., Notebaert S., Dewulf M., Ngo T.H., Zuany-Amorim C., Amzallag N., Bernard-Pierrot I., Sastre-Garau X., et al. New blocking antibodies impede adhesion, migration and survival of ovarian cancer cells, highlighting MFGE8 as a potential therapeutic target of human ovarian carcinoma. PLoS One. 2013;8:e72708. doi: 10.1371/journal.pone.0072708.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0072708</ArticleId><ArticleId IdType="pmc">PMC3745384</ArticleId><ArticleId IdType="pubmed">23977342</ArticleId></ArticleIdList></Reference><Reference><Citation>Fracassi A., Marcatti M., Tumurbaatar B., Woltjer R., Moreno S., Taglialatela G. TREM2-induced activation of microglia contributes to synaptic integrity in cognitively intact aged individuals with Alzheimer&#x2019;s neuropathology. Brain Pathol. 2023;33:e13108. doi: 10.1111/bpa.13108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bpa.13108</ArticleId><ArticleId IdType="pmc">PMC9836373</ArticleId><ArticleId IdType="pubmed">35816404</ArticleId></ArticleIdList></Reference><Reference><Citation>Hesse R., Hurtado M.L., Jackson R.J., Eaton S.L., Herrmann A.G., Colom-Cadena M., Tzioras M., King D., Rose J., Tulloch J., et al. Comparative profiling of the synaptic proteome from Alzheimer&#x2019;s disease patients with focus on the APOE genotype. Acta Neuropathol. Commun. 2019;7:214. doi: 10.1186/s40478-019-0847-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-019-0847-7</ArticleId><ArticleId IdType="pmc">PMC6925519</ArticleId><ArticleId IdType="pubmed">31862015</ArticleId></ArticleIdList></Reference><Reference><Citation>J&#xe4;kel S., Agirre E., Mendanha Falc&#xe3;o A., van Bruggen D., Lee K.W., Knuesel I., Malhotra D., Ffrench-Constant C., Williams A., Castelo-Branco G. Altered human oligodendrocyte heterogeneity in multiple sclerosis. Nature. 2019;566:543&#x2013;547. doi: 10.1038/s41586-019-0903-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-019-0903-2</ArticleId><ArticleId IdType="pmc">PMC6544546</ArticleId><ArticleId IdType="pubmed">30747918</ArticleId></ArticleIdList></Reference><Reference><Citation>El Hajj H., Savage J.C., Bisht K., Parent M., Valli&#xe8;res L., Rivest S., Tremblay M.&#xc8;. Ultrastructural evidence of microglial heterogeneity in Alzheimer&#x2019;s disease amyloid pathology. J.&#xa0;Neuroinflammation. 2019;16:87. doi: 10.1186/s12974-019-1473-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-019-1473-9</ArticleId><ArticleId IdType="pmc">PMC6469225</ArticleId><ArticleId IdType="pubmed">30992040</ArticleId></ArticleIdList></Reference><Reference><Citation>Gomez-Arboledas A., Davila J.C., Sanchez-Mejias E., Navarro V., Nu&#xf1;ez-Diaz C., Sanchez-Varo R., Sanchez-Mico M.V., Trujillo-Estrada L., Fernandez-Valenzuela J.J., Vizuete M., et al. Phagocytic clearance of presynaptic dystrophies by reactive astrocytes in Alzheimer&#x2019;s disease. Glia. 2018;66:637&#x2013;653. doi: 10.1002/glia.23270.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.23270</ArticleId><ArticleId IdType="pmc">PMC5814816</ArticleId><ArticleId IdType="pubmed">29178139</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanchez-Mico M.V., Jimenez S., Gomez-Arboledas A., Mu&#xf1;oz-Castro C., Romero-Molina C., Navarro V., Sanchez-Mejias E., Nu&#xf1;ez-Diaz C., Sanchez-Varo R., Galea E., et al. Amyloid-&#x3b2; impairs the phagocytosis of dystrophic synapses by astrocytes in Alzheimer&#x2019;s disease. Glia. 2021;69:997&#x2013;1011. doi: 10.1002/glia.23943.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.23943</ArticleId><ArticleId IdType="pubmed">33283891</ArticleId></ArticleIdList></Reference><Reference><Citation>Sellgren C.M., Gracias J., Watmuff B., Biag J.D., Thanos J.M., Whittredge P.B., Fu T., Worringer K., Brown H.E., Wang J., et al. Increased synapse elimination by microglia in schizophrenia patient-derived models of synaptic pruning. Nat. Neurosci. 2019;22:374&#x2013;385. doi: 10.1038/s41593-018-0334-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-018-0334-7</ArticleId><ArticleId IdType="pmc">PMC6410571</ArticleId><ArticleId IdType="pubmed">30718903</ArticleId></ArticleIdList></Reference><Reference><Citation>Tzioras M., Stevenson A.J., Boche D., Spires-Jones T.L. Microglial contribution to synaptic uptake in the prefrontal cortex in schizophrenia. Neuropathol. Appl. Neurobiol. 2021;47:346&#x2013;351. doi: 10.1111/nan.12660.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nan.12660</ArticleId><ArticleId IdType="pubmed">32892388</ArticleId></ArticleIdList></Reference><Reference><Citation>Paolicelli R.C., Jawaid A., Henstridge C.M., Valeri A., Merlini M., Robinson J.L., Lee E.B., Rose J., Appel S., Lee V.M.-Y., et al. TDP-43 depletion in microglia promotes amyloid clearance but also induces synapse loss. Neuron. 2017;95:297&#x2013;308.e6. doi: 10.1016/j.neuron.2017.05.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2017.05.037</ArticleId><ArticleId IdType="pmc">PMC5519492</ArticleId><ArticleId IdType="pubmed">28669544</ArticleId></ArticleIdList></Reference><Reference><Citation>Del-Aguila J.L., Li Z., Dube U., Mihindukulasuriya K.A., Budde J.P., Fernandez M.V., Ibanez L., Bradley J., Wang F., Bergmann K., et al. A single-nuclei RNA sequencing study of Mendelian and sporadic AD in the human brain. Alzheimer's Res. Ther. 2019;11:71. doi: 10.1186/s13195-019-0524-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13195-019-0524-x</ArticleId><ArticleId IdType="pmc">PMC6689177</ArticleId><ArticleId IdType="pubmed">31399126</ArticleId></ArticleIdList></Reference><Reference><Citation>Lau S.-F., Cao H., Fu A.K.Y., Ip N.Y. Single-nucleus transcriptome analysis reveals dysregulation of angiogenic endothelial cells and neuroprotective glia in Alzheimer&#x2019;s disease. Proc. Natl. Acad. Sci. USA. 2020;117:25800&#x2013;25809. doi: 10.1073/pnas.2008762117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2008762117</ArticleId><ArticleId IdType="pmc">PMC7568283</ArticleId><ArticleId IdType="pubmed">32989152</ArticleId></ArticleIdList></Reference><Reference><Citation>Sokolova D., Childs T., Hong S. Insight into the role of phosphatidylserine in complement-mediated synapse loss in Alzheimer&#x2019;s disease. Fac. Rev. 2021;10:19.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7946395</ArticleId><ArticleId IdType="pubmed">33718936</ArticleId></ArticleIdList></Reference><Reference><Citation>Thrupp N., Sala Frigerio C., Wolfs L., Skene N.G., Fattorelli N., Poovathingal S., Fourne Y., Matthews P.M., Theys T., Mancuso R., et al. Single-nucleus RNA-seq is not suitable for detection of microglial activation genes in humans. Cell Rep. 2020;32:108189. doi: 10.1016/j.celrep.2020.108189.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2020.108189</ArticleId><ArticleId IdType="pmc">PMC7527779</ArticleId><ArticleId IdType="pubmed">32997994</ArticleId></ArticleIdList></Reference><Reference><Citation>Olmos-Alonso A., Schetters S.T.T., Sri S., Askew K., Mancuso R., Vargas-Caballero M., Holscher C., Perry V.H., Gomez-Nicola D. Pharmacological targeting of CSF1R inhibits microglial proliferation and prevents the progression of Alzheimer&#x2019;s-like pathology. Brain. 2016;139:891&#x2013;907. doi: 10.1093/brain/awv379.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awv379</ArticleId><ArticleId IdType="pmc">PMC4766375</ArticleId><ArticleId IdType="pubmed">26747862</ArticleId></ArticleIdList></Reference><Reference><Citation>Grabert K., McColl B.W. Isolation and phenotyping of adult mouse microglial cells. Methods Mol. Biol. 2018;1784:77&#x2013;86. doi: 10.1007/978-1-4939-7837-3_7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-4939-7837-3_7</ArticleId><ArticleId IdType="pubmed">29761389</ArticleId></ArticleIdList></Reference><Reference><Citation>Blain M., Miron V., Lambert C., Darlington P.J., Cui Q.-L., Saikali P., Wee Yong V., Ante J.P. Protocols for Neural Cell Culture. 2010. Isolation and culture of primary human CNS neural cells.</Citation></Reference><Reference><Citation>Hasel P., Dando O., Jiwaji Z., Baxter P., Todd A.C., Heron S., M&#xe1;rkus N.M., McQueen J., Hampton D.W., Torvell M., et al. Neurons and neuronal activity control gene expression in astrocytes to regulate their development and metabolism. Nat. Commun. 2017;8:15132. doi: 10.1038/ncomms15132.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms15132</ArticleId><ArticleId IdType="pmc">PMC5418577</ArticleId><ArticleId IdType="pubmed">28462931</ArticleId></ArticleIdList></Reference><Reference><Citation>Baxter P.S., Dando O., Emelianova K., He X., McKay S., Hardingham G.E., Qiu J. Microglial identity and inflammatory responses are controlled by the combined effects of neurons and astrocytes. Cell Rep. 2021;34:108882. doi: 10.1016/j.celrep.2021.108882.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2021.108882</ArticleId><ArticleId IdType="pmc">PMC7994374</ArticleId><ArticleId IdType="pubmed">33761343</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y., Sloan S.A., Clarke L.E., Caneda C., Plaza C.A., Blumenthal P.D., Vogel H., Steinberg G.K., Edwards M.S.B., Li G., et al. Purification and characterization of progenitor and mature human astrocytes reveals transcriptional and functional differences with mouse. Neuron. 2016;89:37&#x2013;53. doi: 10.1016/j.neuron.2015.11.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2015.11.013</ArticleId><ArticleId IdType="pmc">PMC4707064</ArticleId><ArticleId IdType="pubmed">26687838</ArticleId></ArticleIdList></Reference><Reference><Citation>Team, Rs . 2022. RStudio: Integrated Development Environment for R.</Citation></Reference><Reference><Citation>Spires-Jones T.L. Using R to improve rigour and transparency in translational neuroscience&#x2014;or is it just a rabbit hole? Brain Commun. 2022;4:fcab290. doi: 10.1093/braincomms/fcab290.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/braincomms/fcab290</ArticleId><ArticleId IdType="pmc">PMC8833583</ArticleId><ArticleId IdType="pubmed">35169697</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37659412</PMID><DateCompleted><Year>2023</Year><Month>09</Month><Day>18</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1097-4180</ISSN><JournalIssue CitedMedium="Internet"><Volume>56</Volume><Issue>9</Issue><PubDate><Year>2023</Year><Month>Sep</Month><Day>12</Day></PubDate></JournalIssue><Title>Immunity</Title><ISOAbbreviation>Immunity</ISOAbbreviation></Journal><ArticleTitle>Genetic variants of phospholipase C-&#x3b3;2 alter the phenotype and function of microglia and confer differential risk for Alzheimer's disease.</ArticleTitle><Pagination><StartPage>2121</StartPage><EndPage>2136.e6</EndPage><MedlinePgn>2121-2136.e6</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.immuni.2023.08.008</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1074-7613(23)00364-3</ELocationID><Abstract><AbstractText>Genetic association studies have demonstrated the critical involvement of the microglial immune response in Alzheimer's disease (AD) pathogenesis. Phospholipase C-gamma-2 (PLCG2) is selectively expressed by microglia and functions in many immune receptor signaling pathways. In AD, PLCG2 is induced uniquely in plaque-associated microglia. A genetic variant of PLCG2, PLCG2<sup>P522R</sup>, is a mild hypermorph that attenuates AD risk. Here, we identified a loss-of-function PLCG2 variant, PLCG2<sup>M28L</sup>, that confers an increased AD risk. PLCG2<sup>P522R</sup> attenuated disease in an amyloidogenic murine AD model, whereas PLCG2<sup>M28L</sup> exacerbated the plaque burden associated with altered phagocytosis and A&#x3b2; clearance. The variants bidirectionally modulated disease pathology by inducing distinct transcriptional programs that identified microglial subpopulations associated with protective or detrimental phenotypes. These findings identify PLCG2<sup>M28L</sup> as a potential AD risk variant and demonstrate that PLCG2 variants can differentially orchestrate microglial responses in AD pathogenesis that can be therapeutically targeted.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 The Author(s). Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tsai</LastName><ForeName>Andy P</ForeName><Initials>AP</Initials><AffiliationInfo><Affiliation>Stark Neurosciences Research Institute, Indiana University School of Medicine, Indianapolis, IN, USA; Wu Tsai Neurosciences Institute, Stanford University School of Medicine, Stanford, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dong</LastName><ForeName>Chuanpeng</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Medical and Molecular Genetics, Center for Computational Biology and Bioinformatics, Indiana University School of Medicine, Indianapolis, IN, USA; Department of Genetics, Yale University School of Medicine, New Haven, CT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Peter Bor-Chian</ForeName><Initials>PB</Initials><AffiliationInfo><Affiliation>Stark Neurosciences Research Institute, Indiana University School of Medicine, Indianapolis, IN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oblak</LastName><ForeName>Adrian L</ForeName><Initials>AL</Initials><AffiliationInfo><Affiliation>Stark Neurosciences Research Institute, Indiana University School of Medicine, Indianapolis, IN, USA; Department of Radiology &amp; Imaging Sciences, Indiana University School of Medicine, Indianapolis, IN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Viana Di Prisco</LastName><ForeName>Gonzalo</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Stark Neurosciences Research Institute, Indiana University School of Medicine, Indianapolis, IN, USA; Department of Pharmacology and Toxicology, Indiana University School of Medicine, Indianapolis, IN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Nian</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Stark Neurosciences Research Institute, Indiana University School of Medicine, Indianapolis, IN, USA; Department of Radiology &amp; Imaging Sciences, Indiana University School of Medicine, Indianapolis, IN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hajicek</LastName><ForeName>Nicole</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Pharmacology, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carr</LastName><ForeName>Adam J</ForeName><Initials>AJ</Initials><AffiliationInfo><Affiliation>Division of Chemical Biology and Medicinal Chemistry, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lendy</LastName><ForeName>Emma K</ForeName><Initials>EK</Initials><AffiliationInfo><Affiliation>Department of Biochemistry, Purdue University, West Lafayette, IN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hahn</LastName><ForeName>Oliver</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Wu Tsai Neurosciences Institute, Stanford University School of Medicine, Stanford, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Atkins</LastName><ForeName>Micaiah</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Wu Tsai Neurosciences Institute, Stanford University School of Medicine, Stanford, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Foltz</LastName><ForeName>Aulden G</ForeName><Initials>AG</Initials><AffiliationInfo><Affiliation>Wu Tsai Neurosciences Institute, Stanford University School of Medicine, Stanford, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Patel</LastName><ForeName>Jheel</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Stark Neurosciences Research Institute, Indiana University School of Medicine, Indianapolis, IN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Guixiang</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Stark Neurosciences Research Institute, Indiana University School of Medicine, Indianapolis, IN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moutinho</LastName><ForeName>Miguel</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Stark Neurosciences Research Institute, Indiana University School of Medicine, Indianapolis, IN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sondek</LastName><ForeName>John</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Pharmacology, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Qisheng</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Pharmacology, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA; Division of Chemical Biology and Medicinal Chemistry, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mesecar</LastName><ForeName>Andrew D</ForeName><Initials>AD</Initials><AffiliationInfo><Affiliation>Department of Biochemistry, Purdue University, West Lafayette, IN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Yunlong</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Medical and Molecular Genetics, Center for Computational Biology and Bioinformatics, Indiana University School of Medicine, Indianapolis, IN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Atwood</LastName><ForeName>Brady K</ForeName><Initials>BK</Initials><AffiliationInfo><Affiliation>Stark Neurosciences Research Institute, Indiana University School of Medicine, Indianapolis, IN, USA; Department of Pharmacology and Toxicology, Indiana University School of Medicine, Indianapolis, IN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wyss-Coray</LastName><ForeName>Tony</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Wu Tsai Neurosciences Institute, Stanford University School of Medicine, Stanford, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nho</LastName><ForeName>Kwangsik</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Radiology &amp; Imaging Sciences, Indiana University School of Medicine, Indianapolis, IN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bissel</LastName><ForeName>Stephanie J</ForeName><Initials>SJ</Initials><AffiliationInfo><Affiliation>Stark Neurosciences Research Institute, Indiana University School of Medicine, Indianapolis, IN, USA; Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lamb</LastName><ForeName>Bruce T</ForeName><Initials>BT</Initials><AffiliationInfo><Affiliation>Stark Neurosciences Research Institute, Indiana University School of Medicine, Indianapolis, IN, USA; Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Landreth</LastName><ForeName>Gary E</ForeName><Initials>GE</Initials><AffiliationInfo><Affiliation>Stark Neurosciences Research Institute, Indiana University School of Medicine, Indianapolis, IN, USA; Department of Anatomy, Cell Biology and Physiology, Indiana University School of Medicine, Indianapolis, IN, USA. Electronic address: glandret@iu.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>U54 AG054345</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K01 AG054753</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R35 GM149299</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>RF1 AG074566</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 LM012535</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS125020</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R03 AG063250</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>09</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Immunity</MedlineTA><NlmUniqueID>9432918</NlmUniqueID><ISSNLinking>1074-7613</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 3.1.4.3</RegistryNumber><NameOfSubstance UI="D051966">Phospholipase C gamma</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.1.4.11</RegistryNumber><NameOfSubstance UI="C000730156">Plcg2 protein, mouse</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Immunity. 2023 Sep 12;56(9):1985-1987. doi: 10.1016/j.immuni.2023.08.012.</RefSource><PMID Version="1">37703828</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D056726" MajorTopicYN="N">Genetic Association Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017628" MajorTopicYN="N">Microglia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010587" MajorTopicYN="N">Phagocytosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051966" MajorTopicYN="Y">Phospholipase C gamma</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058225" MajorTopicYN="N">Plaque, Amyloid</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Alzheimer&#x2019;s disease</Keyword><Keyword MajorTopicYN="N">P522R and M28L variant</Keyword><Keyword MajorTopicYN="N">amyloid pathology</Keyword><Keyword MajorTopicYN="N">microglia</Keyword><Keyword MajorTopicYN="N">microglia-plaque interactions</Keyword><Keyword MajorTopicYN="N">microglial uptake capacity</Keyword><Keyword MajorTopicYN="N">neuroinflammation</Keyword><Keyword MajorTopicYN="N">phospholipase C-gamma-2</Keyword><Keyword MajorTopicYN="N">synaptic function</Keyword><Keyword MajorTopicYN="N">transcriptional programs</Keyword></KeywordList><CoiStatement>Declaration of interests The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>12</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>6</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>8</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>15</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>9</Month><Day>3</Day><Hour>0</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>9</Month><Day>2</Day><Hour>18</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>12</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37659412</ArticleId><ArticleId IdType="mid">NIHMS1927965</ArticleId><ArticleId IdType="pmc">PMC10564391</ArticleId><ArticleId IdType="doi">10.1016/j.immuni.2023.08.008</ArticleId><ArticleId IdType="pii">S1074-7613(23)00364-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Olah M, Menon V, Habib N, Taga MF, Ma Y, Yung CJ, Cimpean M, Khairallah A, Coronas-Samano G, Sankowski R, et al. (2020). Single cell RNA sequencing of human microglia uncovers a subset associated with Alzheimer&#x2019;s disease. Nat Commun 11, 6129. 10.1038/s41467-020-19737-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-19737-2</ArticleId><ArticleId IdType="pmc">PMC7704703</ArticleId><ArticleId IdType="pubmed">33257666</ArticleId></ArticleIdList></Reference><Reference><Citation>Masuda T, Sankowski R, Staszewski O, B&#xf6;ttcher C, Amann L, Sagar, Scheiwe C, Nessler S, Kunz P, van Loo G, et al. (2019). Spatial and temporal heterogeneity of mouse and human microglia at single-cell resolution. Nature 566, 388&#x2013;392. 10.1038/s41586-019-0924-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-019-0924-x</ArticleId><ArticleId IdType="pubmed">30760929</ArticleId></ArticleIdList></Reference><Reference><Citation>Keren-Shaul H, Spinrad A, Weiner A, Matcovitch-Natan O, Dvir-Szternfeld R, Ulland TK, David E, Baruch K, Lara-Astaiso D, Toth B, et al. (2017). A Unique Microglia Type Associated with Restricting Development of Alzheimer&#x2019;s Disease. Cell 169, 1276&#x2013;1290.e1217. 10.1016/j.cell.2017.05.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2017.05.018</ArticleId><ArticleId IdType="pubmed">28602351</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewcock JW, Schlepckow K, Di Paolo G, Tahirovic S, Monroe KM, and Haass C (2020). Emerging Microglia Biology Defines Novel Therapeutic Approaches for Alzheimer&#x2019;s Disease. Neuron 108, 801&#x2013;821. 10.1016/j.neuron.2020.09.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2020.09.029</ArticleId><ArticleId IdType="pubmed">33096024</ArticleId></ArticleIdList></Reference><Reference><Citation>Andreone BJ, Przybyla L, Llapashtica C, Rana A, Davis SS, van Lengerich B, Lin K, Shi J, Mei Y, Astarita G, et al. (2020). Alzheimer&#x2019;s-associated PLC&#x3b3;2 is a signaling node required for both TREM2 function and the inflammatory response in human microglia. Nature Neuroscience 23, 927&#x2013;938. 10.1038/s41593-020-0650-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-020-0650-6</ArticleId><ArticleId IdType="pubmed">32514138</ArticleId></ArticleIdList></Reference><Reference><Citation>Sims R, van der Lee SJ, Naj AC, Bellenguez C, Badarinarayan N, Jakobsdottir J, Kunkle BW, Boland A, Raybould R, Bis JC, et al. (2017). Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer&#x2019;s disease. Nat Genet 49, 1373&#x2013;1384. 10.1038/ng.3916.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.3916</ArticleId><ArticleId IdType="pmc">PMC5669039</ArticleId><ArticleId IdType="pubmed">28714976</ArticleId></ArticleIdList></Reference><Reference><Citation>Bunney TD, Opaleye O, Roe SM, Vatter P, Baxendale RW, Walliser C, Everett KL, Josephs MB, Christow C, Rodrigues-Lima F, et al. (2009). Structural insights into formation of an active signaling complex between Rac and phospholipase C gamma 2. Mol Cell 34, 223&#x2013;233. 10.1016/j.molcel.2009.02.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2009.02.023</ArticleId><ArticleId IdType="pubmed">19394299</ArticleId></ArticleIdList></Reference><Reference><Citation>Walliser C, Tron K, Clauss K, Gutman O, Kobitski AY, Retlich M, Schade A, R&#xf6;cker C, Henis YI, Nienhaus GU, and Gierschik P (2015). Rac-mediated Stimulation of Phospholipase C&#x3b3;2 Amplifies B Cell Receptor-induced Calcium Signaling. J Biol Chem 290, 17056&#x2013;17072. 10.1074/jbc.M115.645739.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M115.645739</ArticleId><ArticleId IdType="pmc">PMC4498044</ArticleId><ArticleId IdType="pubmed">25903139</ArticleId></ArticleIdList></Reference><Reference><Citation>Falasca M, Logan SK, Lehto VP, Baccante G, Lemmon MA, and Schlessinger J (1998). Activation of phospholipase C gamma by PI 3-kinase-induced PH domain-mediated membrane targeting. EMBO J 17, 414&#x2013;422. 10.1093/emboj/17.2.414.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/emboj/17.2.414</ArticleId><ArticleId IdType="pmc">PMC1170392</ArticleId><ArticleId IdType="pubmed">9430633</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulze-Luehrmann J, and Ghosh S (2006). Antigen-receptor signaling to nuclear factor kappa B. Immunity 25, 701&#x2013;715. 10.1016/j.immuni.2006.10.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2006.10.010</ArticleId><ArticleId IdType="pubmed">17098202</ArticleId></ArticleIdList></Reference><Reference><Citation>Jing H, Reed A, Ulanovskaya OA, Grigoleit JS, Herbst DM, Henry CL, Li H, Barbas S, Germain J, Masuda K, and Cravatt BF (2021). Phospholipase C&#x3b3;2 regulates endocannabinoid and eicosanoid networks in innate immune cells. Proc Natl Acad Sci U S A 118. 10.1073/pnas.2112971118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2112971118</ArticleId><ArticleId IdType="pmc">PMC8522274</ArticleId><ArticleId IdType="pubmed">34607960</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai AP, Dong C, Lin PB, Messenger EJ, Casali BT, Moutinho M, Liu Y, Oblak AL, Lamb BT, Landreth GE, et al. (2022). PLCG2 is associated with the inflammatory response and is induced by amyloid plaques in Alzheimer&#x2019;s disease. Genome Med 14, 17. 10.1186/s13073-022-01022-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13073-022-01022-0</ArticleId><ArticleId IdType="pmc">PMC8857783</ArticleId><ArticleId IdType="pubmed">35180881</ArticleId></ArticleIdList></Reference><Reference><Citation>Romero-Molina C, Garretti F, Andrews SJ, Marcora E, and Goate AM (2022). Microglial efferocytosis: Diving into the Alzheimer&#x2019;s disease gene pool. Neuron 110, 3513&#x2013;3533. 10.1016/j.neuron.2022.10.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2022.10.015</ArticleId><ArticleId IdType="pubmed">36327897</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Lee SJ, Conway OJ, Jansen I, Carrasquillo MM, Kleineidam L, van den Akker E, Hern&#xe1;ndez I, van Eijk KR, Stringa N, Chen JA, et al. (2019). A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer&#x2019;s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity. Acta Neuropathol 138, 237&#x2013;250. 10.1007/s00401-019-02026-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-019-02026-8</ArticleId><ArticleId IdType="pmc">PMC6660501</ArticleId><ArticleId IdType="pubmed">31131421</ArticleId></ArticleIdList></Reference><Reference><Citation>Kleineidam L, Chouraki V, Pr&#xf3;chnicki T, van der Lee SJ, Madrid-M&#xe1;rquez L, Wagner-Thelen H, Karaca I, Weinhold L, Wolfsgruber S, Boland A, et al. (2020). PLCG2 protective variant p.P522R modulates tau pathology and disease progression in patients with mild cognitive impairment. Acta Neuropathol 139, 1025&#x2013;1044. 10.1007/s00401-020-02138-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-020-02138-6</ArticleId><ArticleId IdType="pmc">PMC7244617</ArticleId><ArticleId IdType="pubmed">32166339</ArticleId></ArticleIdList></Reference><Reference><Citation>Takalo M, Wittrahm R, Wefers B, Parhizkar S, Jokivarsi K, Kuulasmaa T, Makinen P, Martiskainen H, Wurst W, Xiang X, et al. (2020). The Alzheimer&#x2019;s disease-associated protective Plcgamma2-P522R variant promotes immune functions. Mol Neurodegener 15, 52. 10.1186/s13024-020-00402-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-020-00402-7</ArticleId><ArticleId IdType="pmc">PMC7488484</ArticleId><ArticleId IdType="pubmed">32917267</ArticleId></ArticleIdList></Reference><Reference><Citation>Maguire E, Menzies GE, Phillips T, Sasner M, Williams HM, Czubala MA, Evans N, Cope EL, Sims R, Howell GR, et al. (2021). PIP2 depletion and altered endocytosis caused by expression of Alzheimer&#x2019;s disease-protective variant PLCgamma2 R522. EMBO J 40, e105603. 10.15252/embj.2020105603.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.2020105603</ArticleId><ArticleId IdType="pmc">PMC8408593</ArticleId><ArticleId IdType="pubmed">34254352</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu S, Huo J, Lee KG, Kurosaki T, and Lam KP (2009). Phospholipase Cgamma2 is critical for Dectin-1-mediated Ca2+ flux and cytokine production in dendritic cells. J Biol Chem 284, 7038&#x2013;7046. 10.1074/jbc.M806650200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M806650200</ArticleId><ArticleId IdType="pmc">PMC2652331</ArticleId><ArticleId IdType="pubmed">19136564</ArticleId></ArticleIdList></Reference><Reference><Citation>Obba S, Hizir Z, Boyer L, Selimoglu-Buet D, Pfeifer A, Michel G, Hamouda MA, Gon&#xe7;alv&#xe8;s D, Cerezo M, Marchetti S, et al. (2015). The PRKAA1/AMPK&#x3b1;1 pathway triggers autophagy during CSF1-induced human monocyte differentiation and is a potential target in CMML. Autophagy 11, 1114&#x2013;1129. 10.1080/15548627.2015.1034406.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2015.1034406</ArticleId><ArticleId IdType="pmc">PMC4590592</ArticleId><ArticleId IdType="pubmed">26029847</ArticleId></ArticleIdList></Reference><Reference><Citation>Ombrello MJ, Remmers EF, Sun G, Freeman AF, Datta S, Torabi-Parizi P, Subramanian N, Bunney TD, Baxendale RW, Martins MS, et al. (2012). Cold urticaria, immunodeficiency, and autoimmunity related to PLCG2 deletions. N Engl J Med 366, 330&#x2013;338. 10.1056/NEJMoa1102140.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1102140</ArticleId><ArticleId IdType="pmc">PMC3298368</ArticleId><ArticleId IdType="pubmed">22236196</ArticleId></ArticleIdList></Reference><Reference><Citation>Woyach JA, Furman RR, Liu TM, Ozer HG, Zapatka M, Ruppert AS, Xue L, Li DH, Steggerda SM, Versele M, et al. (2014). Resistance mechanisms for the Bruton&#x2019;s tyrosine kinase inhibitor ibrutinib. N Engl J Med 370, 2286&#x2013;2294. 10.1056/NEJMoa1400029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1400029</ArticleId><ArticleId IdType="pmc">PMC4144824</ArticleId><ArticleId IdType="pubmed">24869598</ArticleId></ArticleIdList></Reference><Reference><Citation>Kunkle BW, Grenier-Boley B, Sims R, Bis JC, Damotte V, Naj AC, Boland A, Vronskaya M, van der Lee SJ, Amlie-Wolf A, et al. (2019). Genetic meta-analysis of diagnosed Alzheimer&#x2019;s disease identifies new risk loci and implicates A&#x3b2;, tau, immunity and lipid processing. Nature Genetics 51, 414&#x2013;430. 10.1038/s41588-019-0358-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-019-0358-2</ArticleId><ArticleId IdType="pmc">PMC6463297</ArticleId><ArticleId IdType="pubmed">30820047</ArticleId></ArticleIdList></Reference><Reference><Citation>Walliser C, Hermkes E, Schade A, Wiese S, Deinzer J, Zapatka M, Desire L, Mertens D, Stilgenbauer S, and Gierschik P (2016). The Phospholipase Cgamma2 Mutants R665W and L845F Identified in Ibrutinib-resistant Chronic Lymphocytic Leukemia Patients Are Hypersensitive to the Rho GTPase Rac2 Protein. J Biol Chem 291, 22136&#x2013;22148. 10.1074/jbc.M116.746842.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M116.746842</ArticleId><ArticleId IdType="pmc">PMC5063995</ArticleId><ArticleId IdType="pubmed">27542411</ArticleId></ArticleIdList></Reference><Reference><Citation>Keaney J, Gasser J, Gillet G, Scholz D, and Kadiu I (2019). Inhibition of Bruton&#x2019;s Tyrosine Kinase Modulates Microglial Phagocytosis: Therapeutic Implications for Alzheimer&#x2019;s Disease. J Neuroimmune Pharmacol 14, 448&#x2013;461. 10.1007/s11481-019-09839-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11481-019-09839-0</ArticleId><ArticleId IdType="pmc">PMC6707957</ArticleId><ArticleId IdType="pubmed">30758770</ArticleId></ArticleIdList></Reference><Reference><Citation>Olive C, Ibanez L, Farias FHG, Wang F, Budde JP, Norton JB, Gentsch J, Morris JC, Li Z, Dube U, et al. (2020). Examination of the Effect of Rare Variants in TREM2, ABI3, and PLCG2 in LOAD Through Multiple Phenotypes. J Alzheimers Dis 77, 1469&#x2013;1482. 10.3233/jad-200019.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/jad-200019</ArticleId><ArticleId IdType="pmc">PMC7927150</ArticleId><ArticleId IdType="pubmed">32894242</ArticleId></ArticleIdList></Reference><Reference><Citation>Magno L, Bunney TD, Mead E, Svensson F, and Bictash MN (2021). TREM2/PLC&#x3b3;2 signalling in immune cells: function, structural insight, and potential therapeutic modulation. Mol Neurodegener 16, 22. 10.1186/s13024-021-00436-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-021-00436-5</ArticleId><ArticleId IdType="pmc">PMC8022522</ArticleId><ArticleId IdType="pubmed">33823896</ArticleId></ArticleIdList></Reference><Reference><Citation>Oakley H, Cole SL, Logan S, Maus E, Shao P, Craft J, Guillozet-Bongaarts A, Ohno M, Disterhoft J, Van Eldik L, et al. (2006). Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer&#x2019;s disease mutations: potential factors in amyloid plaque formation. J Neurosci 26, 10129&#x2013;10140. 10.1523/jneurosci.1202-06.2006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/jneurosci.1202-06.2006</ArticleId><ArticleId IdType="pmc">PMC6674618</ArticleId><ArticleId IdType="pubmed">17021169</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan P, Condello C, Keene CD, Wang Y, Bird TD, Paul SM, Luo W, Colonna M, Baddeley D, and Grutzendler J (2016). TREM2 Haplodeficiency in Mice and Humans Impairs the Microglia Barrier Function Leading to Decreased Amyloid Compaction and Severe Axonal Dystrophy. Neuron 90, 724&#x2013;739. 10.1016/j.neuron.2016.05.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2016.05.003</ArticleId><ArticleId IdType="pmc">PMC4898967</ArticleId><ArticleId IdType="pubmed">27196974</ArticleId></ArticleIdList></Reference><Reference><Citation>Masuda T, Sankowski R, Staszewski O, and Prinz M (2020). Microglia Heterogeneity in the Single-Cell Era. Cell Rep 30, 1271&#x2013;1281. 10.1016/j.celrep.2020.01.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2020.01.010</ArticleId><ArticleId IdType="pubmed">32023447</ArticleId></ArticleIdList></Reference><Reference><Citation>Kinney JW, Bemiller SM, Murtishaw AS, Leisgang AM, Salazar AM, and Lamb BT (2018). Inflammation as a central mechanism in Alzheimer&#x2019;s disease. Alzheimers Dement (N Y) 4, 575&#x2013;590. 10.1016/j.trci.2018.06.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.trci.2018.06.014</ArticleId><ArticleId IdType="pmc">PMC6214864</ArticleId><ArticleId IdType="pubmed">30406177</ArticleId></ArticleIdList></Reference><Reference><Citation>Klyubin I, Walsh DM, Lemere CA, Cullen WK, Shankar GM, Betts V, Spooner ET, Jiang L, Anwyl R, Selkoe DJ, and Rowan MJ (2005). Amyloid beta protein immunotherapy neutralizes Abeta oligomers that disrupt synaptic plasticity in vivo. Nat Med 11, 556&#x2013;561. 10.1038/nm1234.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm1234</ArticleId><ArticleId IdType="pubmed">15834427</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson JT, Mulazzani E, Nutt SL, and Masters SL (2021). The role of PLC&#x3b3;2 in immunological disorders, cancer, and neurodegeneration. J Biol Chem 297, 100905. 10.1016/j.jbc.2021.100905.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbc.2021.100905</ArticleId><ArticleId IdType="pmc">PMC8318911</ArticleId><ArticleId IdType="pubmed">34157287</ArticleId></ArticleIdList></Reference><Reference><Citation>Krasemann S, Madore C, Cialic R, Baufeld C, Calcagno N, El Fatimy R, Beckers L, O&#x2019;Loughlin E, Xu Y, Fanek Z, et al. (2017). The TREM2-APOE Pathway Drives the Transcriptional Phenotype of Dysfunctional Microglia in Neurodegenerative Diseases. Immunity 47, 566&#x2013;581.e569. 10.1016/j.immuni.2017.08.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2017.08.008</ArticleId><ArticleId IdType="pmc">PMC5719893</ArticleId><ArticleId IdType="pubmed">28930663</ArticleId></ArticleIdList></Reference><Reference><Citation>Magno L, Lessard CB, Martins M, Lang V, Cruz P, Asi Y, Katan M, Bilsland J, Lashley T, Chakrabarty P, et al. (2019). Alzheimer&#x2019;s disease phospholipase C-gamma-2 (PLCG2) protective variant is a functional hypermorph. Alzheimers Res Ther 11, 16. 10.1186/s13195-019-0469-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13195-019-0469-0</ArticleId><ArticleId IdType="pmc">PMC6359863</ArticleId><ArticleId IdType="pubmed">30711010</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai AP, Dong C, Lin PB-C, Messenger EJ, Casali BT, Moutinho M, Liu Y, Oblak AL, Lamb BT, Landreth GE, et al. (2022). PLCG2 is associated with the inflammatory response and is induced by amyloid plaques in Alzheimer&#x2019;s disease. Genome Medicine 14, 17. 10.1186/s13073-022-01022-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13073-022-01022-0</ArticleId><ArticleId IdType="pmc">PMC8857783</ArticleId><ArticleId IdType="pubmed">35180881</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng-Hathaway PJ, Reed-Geaghan EG, Jay TR, Casali BT, Bemiller SM, Puntambekar SS, von Saucken VE, Williams RY, Karlo JC, Moutinho M, et al. (2018). The Trem2 R47H variant confers loss-of-function-like phenotypes in Alzheimer&#x2019;s disease. Molecular Neurodegeneration 13, 29. 10.1186/s13024-018-0262-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-018-0262-8</ArticleId><ArticleId IdType="pmc">PMC5984804</ArticleId><ArticleId IdType="pubmed">29859094</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang EH, Savage MJ, Flood DG, Thomas JM, Levy RB, Mahadomrongkul V, Shirao T, Aoki C, and Huerta PT (2006). AMPA receptor downscaling at the onset of Alzheimer&#x2019;s disease pathology in double knockin mice. Proc Natl Acad Sci U S A 103, 3410&#x2013;3415. 10.1073/pnas.0507313103.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0507313103</ArticleId><ArticleId IdType="pmc">PMC1413872</ArticleId><ArticleId IdType="pubmed">16492745</ArticleId></ArticleIdList></Reference><Reference><Citation>Danysz W, and Parsons CG (2012). Alzheimer&#x2019;s disease, &#x3b2;-amyloid, glutamate, NMDA receptors and memantine--searching for the connections. Br J Pharmacol 167, 324&#x2013;352. 10.1111/j.1476-5381.2012.02057.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1476-5381.2012.02057.x</ArticleId><ArticleId IdType="pmc">PMC3481041</ArticleId><ArticleId IdType="pubmed">22646481</ArticleId></ArticleIdList></Reference><Reference><Citation>Claes C, England WE, Danhash EP, Kiani Shabestari S, Jairaman A, Chadarevian JP, Hasselmann J, Tsai AP, Coburn MA, Sanchez J, et al. (2022). The P522R protective variant of PLCG2 promotes the expression of antigen presentation genes by human microglia in an Alzheimer&#x2019;s disease mouse model. Alzheimers Dement. 10.1002/alz.12577.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alz.12577</ArticleId><ArticleId IdType="pmc">PMC9360195</ArticleId><ArticleId IdType="pubmed">35142046</ArticleId></ArticleIdList></Reference><Reference><Citation>Moutinho M, Puntambekar SS, Tsai AP, Coronel I, Lin PB, Casali BT, Martinez P, Oblak AL, Lasagna-Reeves CA, Lamb BT, and Landreth GE (2022). The niacin receptor HCAR2 modulates microglial response and limits disease progression in a mouse model of Alzheimer&#x2019;s disease. Sci Transl Med 14, eabl7634. 10.1126/scitranslmed.abl7634.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.abl7634</ArticleId><ArticleId IdType="pmc">PMC10161396</ArticleId><ArticleId IdType="pubmed">35320002</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H, and Durbin R (2010). Fast and accurate long-read alignment with Burrows-Wheeler transform. Bioinformatics 26, 589&#x2013;595. 10.1093/bioinformatics/btp698.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btp698</ArticleId><ArticleId IdType="pmc">PMC2828108</ArticleId><ArticleId IdType="pubmed">20080505</ArticleId></ArticleIdList></Reference><Reference><Citation>DePristo MA, Banks E, Poplin R, Garimella KV, Maguire JR, Hartl C, Philippakis AA, del Angel G, Rivas MA, Hanna M, et al. (2011). A framework for variation discovery and genotyping using next-generation DNA sequencing data. Nat Genet 43, 491&#x2013;498. 10.1038/ng.806.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.806</ArticleId><ArticleId IdType="pmc">PMC3083463</ArticleId><ArticleId IdType="pubmed">21478889</ArticleId></ArticleIdList></Reference><Reference><Citation>Nho K, West JD, Li H, Henschel R, Bharthur A, Tavares MC, and Saykin AJ (2014). Comparison of Multi-Sample Variant Calling Methods for Whole Genome Sequencing. IEEE Int Conf Systems Biol 2014, 59&#x2013;62. 10.1109/ISB.2014.6990432.</Citation><ArticleIdList><ArticleId IdType="doi">10.1109/ISB.2014.6990432</ArticleId><ArticleId IdType="pmc">PMC4496949</ArticleId><ArticleId IdType="pubmed">26167514</ArticleId></ArticleIdList></Reference><Reference><Citation>Oblak AL, Kotredes KP, Pandey RS, Reagan AM, Ingraham C, Perkins B, Lloyd C, Baker D, Lin PB, Soni DM, et al. (2022). Plcg2(M28L) Interacts With High Fat/High Sugar Diet to Accelerate Alzheimer&#x2019;s Disease-Relevant Phenotypes in Mice. Front Aging Neurosci 14, 886575. 10.3389/fnagi.2022.886575.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2022.886575</ArticleId><ArticleId IdType="pmc">PMC9263289</ArticleId><ArticleId IdType="pubmed">35813947</ArticleId></ArticleIdList></Reference><Reference><Citation>Hajicek N, Keith NC, Siraliev-Perez E, Temple BR, Huang W, Zhang Q, Harden TK, and Sondek J (2019). Structural basis for the activation of PLC-gamma isozymes by phosphorylation and cancer-associated mutations. Elife 8. 10.7554/eLife.51700.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.51700</ArticleId><ArticleId IdType="pmc">PMC7004563</ArticleId><ArticleId IdType="pubmed">31889510</ArticleId></ArticleIdList></Reference><Reference><Citation>Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, and Smyth GK (2015). limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res 43, e47. 10.1093/nar/gkv007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkv007</ArticleId><ArticleId IdType="pmc">PMC4402510</ArticleId><ArticleId IdType="pubmed">25605792</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu G, Wang LG, Han Y, and He QY (2012). clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS 16, 284&#x2013;287. 10.1089/omi.2011.0118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/omi.2011.0118</ArticleId><ArticleId IdType="pmc">PMC3339379</ArticleId><ArticleId IdType="pubmed">22455463</ArticleId></ArticleIdList></Reference><Reference><Citation>Styren SD, Hamilton RL, Styren GC, and Klunk WE (2000). X-34, a fluorescent derivative of Congo red: a novel histochemical stain for Alzheimer&#x2019;s disease pathology. J Histochem Cytochem 48, 1223&#x2013;1232. 10.1177/002215540004800906.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/002215540004800906</ArticleId><ArticleId IdType="pubmed">10950879</ArticleId></ArticleIdList></Reference><Reference><Citation>Schneider CA, Rasband WS, and Eliceiri KW (2012). NIH Image to ImageJ: 25 years of image analysis. Nat Methods 9, 671&#x2013;675. 10.1038/nmeth.2089.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.2089</ArticleId><ArticleId IdType="pmc">PMC5554542</ArticleId><ArticleId IdType="pubmed">22930834</ArticleId></ArticleIdList></Reference><Reference><Citation>Maharjan S, Tsai AP, Lin PB, Ingraham C, Jewett MR, Landreth GE, Oblak AL, and Wang N (2022). Age-dependent microstructure alterations in 5xFAD mice by high-resolution diffusion tensor imaging. Front Neurosci 16, 964654. 10.3389/fnins.2022.964654.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2022.964654</ArticleId><ArticleId IdType="pmc">PMC9428354</ArticleId><ArticleId IdType="pubmed">36061588</ArticleId></ArticleIdList></Reference><Reference><Citation>Yushkevich PA, Piven J, Hazlett HC, Smith RG, Ho S, Gee JC, and Gerig G (2006). User-guided 3D active contour segmentation of anatomical structures: significantly improved efficiency and reliability. Neuroimage 31, 1116&#x2013;1128. 10.1016/j.neuroimage.2006.01.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroimage.2006.01.015</ArticleId><ArticleId IdType="pubmed">16545965</ArticleId></ArticleIdList></Reference><Reference><Citation>Saura J, Tusell JM, and Serratosa J (2003). High-yield isolation of murine microglia by mild trypsinization. Glia 44, 183&#x2013;189. 10.1002/glia.10274.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.10274</ArticleId><ArticleId IdType="pubmed">14603460</ArticleId></ArticleIdList></Reference><Reference><Citation>Reilly AM, Tsai AP, Lin PB, Ericsson AC, Oblak AL, and Ren H (2020). Metabolic Defects Caused by High-Fat Diet Modify Disease Risk through Inflammatory and Amyloidogenic Pathways in a Mouse Model of Alzheimer&#x2019;s Disease. Nutrients 12. 10.3390/nu12102977.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu12102977</ArticleId><ArticleId IdType="pmc">PMC7600118</ArticleId><ArticleId IdType="pubmed">33003412</ArticleId></ArticleIdList></Reference><Reference><Citation>Preuss C, Pandey R, Piazza E, Fine A, Uyar A, Perumal T, Garceau D, Kotredes KP, Williams H, Mangravite LM, et al. (2020). A novel systems biology approach to evaluate mouse models of late-onset Alzheimer&#x2019;s disease. Mol Neurodegener 15, 67. 10.1186/s13024-020-00412-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-020-00412-5</ArticleId><ArticleId IdType="pmc">PMC7656729</ArticleId><ArticleId IdType="pubmed">33172468</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, Batut P, Chaisson M, and Gingeras TR (2013). STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15&#x2013;21. 10.1093/bioinformatics/bts635.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/bts635</ArticleId><ArticleId IdType="pmc">PMC3530905</ArticleId><ArticleId IdType="pubmed">23104886</ArticleId></ArticleIdList></Reference><Reference><Citation>Oblak AL, Lin PB, Kotredes KP, Pandey RS, Garceau D, Williams HM, Uyar A, O&#x2019;Rourke R, O&#x2019;Rourke S, Ingraham C, et al. (2021). Comprehensive Evaluation of the 5XFAD Mouse Model for Preclinical Testing Applications: A MODEL-AD Study. Front Aging Neurosci 13, 713726. 10.3389/fnagi.2021.713726.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2021.713726</ArticleId><ArticleId IdType="pmc">PMC8346252</ArticleId><ArticleId IdType="pubmed">34366832</ArticleId></ArticleIdList></Reference><Reference><Citation>Hahn O, Fehlmann T, Zhang H, Munson CN, Vest RT, Borcherding A, Liu S, Villarosa C, Drmanac S, Drmanac R, et al. (2021). CoolMPS for robust sequencing of single-nuclear RNAs captured by droplet-based method. Nucleic Acids Res 49, e11. 10.1093/nar/gkaa1127.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkaa1127</ArticleId><ArticleId IdType="pmc">PMC7826285</ArticleId><ArticleId IdType="pubmed">33264392</ArticleId></ArticleIdList></Reference><Reference><Citation>Habib N, Avraham-Davidi I, Basu A, Burks T, Shekhar K, Hofree M, Choudhury SR, Aguet F, Gelfand E, Ardlie K, et al. (2017). Massively parallel single-nucleus RNA-seq with DroNc-seq. Nature Methods 14, 955&#x2013;958. 10.1038/nmeth.4407.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.4407</ArticleId><ArticleId IdType="pmc">PMC5623139</ArticleId><ArticleId IdType="pubmed">28846088</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37667404</PMID><DateCompleted><Year>2023</Year><Month>09</Month><Day>27</Day></DateCompleted><DateRevised><Year>2025</Year><Month>02</Month><Day>27</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2047-9158</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Sep</Month><Day>04</Day></PubDate></JournalIssue><Title>Translational neurodegeneration</Title><ISOAbbreviation>Transl Neurodegener</ISOAbbreviation></Journal><ArticleTitle>Large-scale proximity extension assay reveals CSF midkine and DOPA decarboxylase as supportive diagnostic biomarkers for Parkinson's disease.</ArticleTitle><Pagination><StartPage>42</StartPage><MedlinePgn>42</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">42</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s40035-023-00374-w</ELocationID><Abstract><AbstractText Label="BACKGROUND">There is a need for biomarkers to support an accurate diagnosis of Parkinson's disease (PD). Cerebrospinal fluid (CSF) has been a successful biofluid for finding neurodegenerative biomarkers, and modern highly sensitive multiplexing methods offer the possibility to perform discovery studies. Using a large-scale multiplex proximity extension assay (PEA) approach, we aimed to discover novel diagnostic protein biomarkers allowing accurate discrimination of PD from both controls and atypical Parkinsonian disorders (APD).</AbstractText><AbstractText Label="METHODS">CSF from patients with PD, corticobasal syndrome (CBS), progressive supranuclear palsy (PSP), multiple system atrophy and controls, were analysed with Olink PEA panels. Three cohorts were used in this study, comprising 192, 88 and 36 cases, respectively. All samples were run on the Cardiovascular II, Oncology II and Metabolism PEA panels.</AbstractText><AbstractText Label="RESULTS">Our analysis revealed that 26 and 39 proteins were differentially expressed in the CSF of test and validation PD cohorts, respectively, compared to controls. Among them, 6 proteins were changed in both cohorts. Midkine (MK) was increased in PD with the strongest effect size and results were validated with ELISA. Another most increased protein in PD, DOPA decarboxylase (DDC), which catalyses the decarboxylation of DOPA (L-3,4-dihydroxyphenylalanine) to dopamine, was strongly correlated with dopaminergic treatment. Moreover, Kallikrein 10 was specifically changed in APD compared with both PD and controls, but unchanged between PD and controls. Wnt inhibitory factor 1 was consistently downregulated in CBS and PSP patients in two independent cohorts.</AbstractText><AbstractText Label="CONCLUSIONS">Using the large-scale PEA approach, we have identified potential novel PD diagnostic biomarkers, most notably MK and DDC, in the CSF of PD patients.</AbstractText><CopyrightInformation>&#xa9; 2023. Ruijin Hospital, Shanghai Jiao Tong University.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Paslawski</LastName><ForeName>Wojciech</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Laboratory of Translational Neuropharmacology, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Khosousi</LastName><ForeName>Shervin</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Laboratory of Translational Neuropharmacology, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Old Age Psychiatry, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hertz</LastName><ForeName>Ellen</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Laboratory of Translational Neuropharmacology, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Markaki</LastName><ForeName>Ioanna</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Laboratory of Translational Neuropharmacology, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boxer</LastName><ForeName>Adam</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Memory and Aging Center, University of California, San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Svenningsson</LastName><ForeName>Per</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0001-6727-3802</Identifier><AffiliationInfo><Affiliation>Laboratory of Translational Neuropharmacology, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden. per.svenningsson@ki.se.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Basic and Clinical Neuroscience, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK. per.svenningsson@ki.se.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P01 AG019724</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG038791</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U19 AG063911</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U54 NS092089</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>09</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Transl Neurodegener</MedlineTA><NlmUniqueID>101591861</NlmUniqueID><ISSNLinking>2047-9158</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 4.1.1.-</RegistryNumber><NameOfSubstance UI="D004296">Dopa Decarboxylase</NameOfSubstance></Chemical><Chemical><RegistryNumber>VTD58H1Z2X</RegistryNumber><NameOfSubstance UI="D004298">Dopamine</NameOfSubstance></Chemical><Chemical><RegistryNumber>137497-38-2</RegistryNumber><NameOfSubstance UI="D000078792">Midkine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Cell Chem Biol. 2023 Nov 16;30(11):1340-1342. doi: 10.1016/j.chembiol.2023.10.018.</RefSource><PMID Version="1">37977130</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004296" MajorTopicYN="Y">Dopa Decarboxylase</DescriptorName><QualifierName UI="Q000134" MajorTopicYN="N">cerebrospinal fluid</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004298" MajorTopicYN="N">Dopamine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000078792" MajorTopicYN="Y">Midkine</DescriptorName><QualifierName UI="Q000134" MajorTopicYN="N">cerebrospinal fluid</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010300" MajorTopicYN="Y">Parkinson Disease</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Atypical Parkinsonian disorders</Keyword><Keyword MajorTopicYN="N">Biomarker</Keyword><Keyword MajorTopicYN="N">Cerebrospinal fluid</Keyword><Keyword MajorTopicYN="N">Corticobasal syndrome</Keyword><Keyword MajorTopicYN="N">DOPA decarboxylase</Keyword><Keyword MajorTopicYN="N">Midkine</Keyword><Keyword MajorTopicYN="N">Multiple system atrophy</Keyword><Keyword MajorTopicYN="N">Parkinson&#x2019;s disease</Keyword><Keyword MajorTopicYN="N">Progressive supranuclear palsy</Keyword><Keyword MajorTopicYN="N">Proximity extension assay</Keyword></KeywordList><CoiStatement>Authors declare no competing interests. WP reports grants unrelated to this work from &#xc5;ke Wibergs Stiftelse and The Michael J. Fox Foundation for Parkinson&#x2019;s Research. AB reports consultancy unrelated to this work for AGTC, Alector (stock/options), Arkuda (options), Arvinas (options), Asceneuron, AZTherapies (options), Bioage, GSK, Humana, Lundbeck, Ono, Roche, Samumed, Sangamo, Stealth Therapeutics, Third Rock, Transposon, UCB and Wave, and received research support from the Association for Frontotemporal Degeneration, Biogen, Bluefield Project to Cure Frontotemporal Dementia, Eli Lilly, Eisai, National Institutes of Health (U19AG063911, U54NS092089, R01AG031278), and the Rainwater Charitable Foundation. PS reports grants from Karin and Sten M&#xf6;rtstedt CBD Solutions AB, the Swedish Parkinson fund, the ALF program of the Stockholm Stockholm City, Knut and Alice Wallenberg Foundation, The Michael J. Fox Foundation for Parkinson&#x2019;s Research, the Swedish Parkinson foundation, Lexa/Nordstjernan, ASAP, and Van Geest Foundation.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>4</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>8</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>6</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>9</Month><Day>5</Day><Hour>0</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>9</Month><Day>4</Day><Hour>23</Hour><Minute>54</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>9</Month><Day>4</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37667404</ArticleId><ArticleId IdType="pmc">PMC10476347</ArticleId><ArticleId IdType="doi">10.1186/s40035-023-00374-w</ArticleId><ArticleId IdType="pii">10.1186/s40035-023-00374-w</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Rotunno MS, Lane M, Zhang W, Wolf P, Oliva P, Viel C, et al. Cerebrospinal fluid proteomics implicates the granin family in Parkinson&#x2019;s disease. Sci Rep. 2020;10(1):2479. doi: 10.1038/s41598-020-59414-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-59414-4</ArticleId><ArticleId IdType="pmc">PMC7015906</ArticleId><ArticleId IdType="pubmed">32051502</ArticleId></ArticleIdList></Reference><Reference><Citation>Halbgebauer S, Ockl P, Wirth K, Steinacker P, Otto M. Protein biomarkers in Parkinson&#x2019;s disease: focus on cerebrospinal fluid markers and synaptic proteins. Mov Disord. 2016;31(6):848&#x2013;860. doi: 10.1002/mds.26635.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.26635</ArticleId><ArticleId IdType="pubmed">27134134</ArticleId></ArticleIdList></Reference><Reference><Citation>Fairfoul G, McGuire LI, Pal S, Ironside JW, Neumann J, Christie S, et al. Alpha-synuclein RT-QuIC in the CSF of patients with alpha-synucleinopathies. Ann Clin Transl Neurol. 2016;3(10):812&#x2013;818. doi: 10.1002/acn3.338.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.338</ArticleId><ArticleId IdType="pmc">PMC5048391</ArticleId><ArticleId IdType="pubmed">27752516</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossi M, Candelise N, Baiardi S, Capellari S, Giannini G, Orru CD, et al. Ultrasensitive RT-QuIC assay with high sensitivity and specificity for Lewy body-associated synucleinopathies. Acta Neuropathol. 2020;140(1):49&#x2013;62. doi: 10.1007/s00401-020-02160-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-020-02160-8</ArticleId><ArticleId IdType="pmc">PMC7299922</ArticleId><ArticleId IdType="pubmed">32342188</ArticleId></ArticleIdList></Reference><Reference><Citation>Siderowf A, Concha-Marambio L, Lafontant D-E, Farris CM, Ma Y, Urenia PA, et al. Assessment of heterogeneity among participants in the Parkinson&#x2019;s Progression Markers Initiative cohort using &#x3b1;-synuclein seed amplification: a cross-sectional study. Lancet Neurol. 2023;22(5):407&#x2013;417. doi: 10.1016/S1474-4422(23)00109-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(23)00109-6</ArticleId><ArticleId IdType="pmc">PMC10627170</ArticleId><ArticleId IdType="pubmed">37059509</ArticleId></ArticleIdList></Reference><Reference><Citation>Tolosa E, Garrido A, Scholz SW, Poewe W. Challenges in the diagnosis of Parkinson&#x2019;s disease. Lancet Neurol. 2021;20(5):385&#x2013;397. doi: 10.1016/S1474-4422(21)00030-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(21)00030-2</ArticleId><ArticleId IdType="pmc">PMC8185633</ArticleId><ArticleId IdType="pubmed">33894193</ArticleId></ArticleIdList></Reference><Reference><Citation>Magdalinou N, Lees AJ, Zetterberg H. Cerebrospinal fluid biomarkers in parkinsonian conditions: an update and future directions. J Neurol Neurosurg Psychiatry. 2014;85(10):1065&#x2013;1075. doi: 10.1136/jnnp-2013-307539.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2013-307539</ArticleId><ArticleId IdType="pmc">PMC4173749</ArticleId><ArticleId IdType="pubmed">24691581</ArticleId></ArticleIdList></Reference><Reference><Citation>Magdalinou NK, Paterson RW, Schott JM, Fox NC, Mummery C, Blennow K, et al. A panel of nine cerebrospinal fluid biomarkers may identify patients with atypical parkinsonian syndromes. J Neurol Neurosurg Psychiatry. 2015;86(11):1240&#x2013;1247. doi: 10.1136/jnnp-2014-309562.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2014-309562</ArticleId><ArticleId IdType="pmc">PMC4564944</ArticleId><ArticleId IdType="pubmed">25589779</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashton NJ, Janelidze S, Al Khleifat A, Leuzy A, van der Ende EL, Karikari TK, et al. A multicentre validation study of the diagnostic value of plasma neurofilament light. Nat Commun. 2021;12(1):3400. doi: 10.1038/s41467-021-23620-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-23620-z</ArticleId><ArticleId IdType="pmc">PMC8185001</ArticleId><ArticleId IdType="pubmed">34099648</ArticleId></ArticleIdList></Reference><Reference><Citation>Meeter LH, Dopper EG, Jiskoot LC, Sanchez-Valle R, Graff C, Benussi L, et al. Neurofilament light chain: a biomarker for genetic frontotemporal dementia. Ann Clin Transl Neurol. 2016;3(8):623&#x2013;636. doi: 10.1002/acn3.325.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.325</ArticleId><ArticleId IdType="pmc">PMC4999594</ArticleId><ArticleId IdType="pubmed">27606344</ArticleId></ArticleIdList></Reference><Reference><Citation>Assarsson E, Lundberg M, Holmquist G, Bjorkesten J, Thorsen SB, Ekman D, et al. Homogenous 96-plex PEA immunoassay exhibiting high sensitivity, specificity, and excellent scalability. PLoS ONE. 2014;9(4):e95192. doi: 10.1371/journal.pone.0095192.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0095192</ArticleId><ArticleId IdType="pmc">PMC3995906</ArticleId><ArticleId IdType="pubmed">24755770</ArticleId></ArticleIdList></Reference><Reference><Citation>Whelan CD, Mattsson N, Nagle MW, Vijayaraghavan S, Hyde C, Janelidze S, et al. Multiplex proteomics identifies novel CSF and plasma biomarkers of early Alzheimer&#x2019;s disease. Acta Neuropathol Commun. 2019;7(1):169. doi: 10.1186/s40478-019-0795-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-019-0795-2</ArticleId><ArticleId IdType="pmc">PMC6836495</ArticleId><ArticleId IdType="pubmed">31694701</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang J, Khademi M, Fugger L, Lindhe O, Novakova L, Axelsson M, et al. Inflammation-related plasma and CSF biomarkers for multiple sclerosis. Proc Natl Acad Sci U S A. 2020;117(23):12952&#x2013;12960. doi: 10.1073/pnas.1912839117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1912839117</ArticleId><ArticleId IdType="pmc">PMC7293699</ArticleId><ArticleId IdType="pubmed">32457139</ArticleId></ArticleIdList></Reference><Reference><Citation>Carlyle BC, Trombetta BA, Arnold SE. Proteomic approaches for the discovery of biofluid biomarkers of neurodegenerative dementias. Proteomes. 2018;6(3):32. doi: 10.3390/proteomes6030032.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/proteomes6030032</ArticleId><ArticleId IdType="pmc">PMC6161166</ArticleId><ArticleId IdType="pubmed">30200280</ArticleId></ArticleIdList></Reference><Reference><Citation>Jabbari E, Woodside J, Guo T, Magdalinou NK, Chelban V, Athauda D, et al. Proximity extension assay testing reveals novel diagnostic biomarkers of atypical parkinsonian syndromes. J Neurol Neurosurg Psychiatry. 2019;90(7):768&#x2013;773. doi: 10.1136/jnnp-2018-320151.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2018-320151</ArticleId><ArticleId IdType="pmc">PMC6585258</ArticleId><ArticleId IdType="pubmed">30867224</ArticleId></ArticleIdList></Reference><Reference><Citation>Santaella A, Kuiperij HB, van Rumund A, Esselink RAJ, van Gool AJ, Bloem BR, et al. Inflammation biomarker discovery in Parkinson&#x2019;s disease and atypical parkinsonisms. BMC Neurol. 2020;20(1):26. doi: 10.1186/s12883-020-1608-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12883-020-1608-8</ArticleId><ArticleId IdType="pmc">PMC6967088</ArticleId><ArticleId IdType="pubmed">31952511</ArticleId></ArticleIdList></Reference><Reference><Citation>Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W, et al. MDS clinical diagnostic criteria for Parkinson&#x2019;s disease. Mov Disord. 2015;30(12):1591&#x2013;1601. doi: 10.1002/mds.26424.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.26424</ArticleId><ArticleId IdType="pubmed">26474316</ArticleId></ArticleIdList></Reference><Reference><Citation>Gilman S, Low PA, Quinn N, Albanese A, Ben-Shlomo Y, Fowler CJ, et al. Consensus statement on the diagnosis of multiple system atrophy. J Neurol Sci. 1999;163(1):94&#x2013;98. doi: 10.1016/S0022-510X(98)00304-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-510X(98)00304-9</ArticleId><ArticleId IdType="pubmed">10223419</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoglinger GU, Respondek G, Stamelou M, Kurz C, Josephs KA, Lang AE, et al. Clinical diagnosis of progressive supranuclear palsy: the movement disorder society criteria. Mov Disord. 2017;32(6):853&#x2013;864. doi: 10.1002/mds.26987.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.26987</ArticleId><ArticleId IdType="pmc">PMC5516529</ArticleId><ArticleId IdType="pubmed">28467028</ArticleId></ArticleIdList></Reference><Reference><Citation>Armstrong MJ, Litvan I, Lang AE, Bak TH, Bhatia KP, Borroni B, et al. Criteria for the diagnosis of corticobasal degeneration. Neurology. 2013;80(5):496&#x2013;503. doi: 10.1212/WNL.0b013e31827f0fd1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e31827f0fd1</ArticleId><ArticleId IdType="pmc">PMC3590050</ArticleId><ArticleId IdType="pubmed">23359374</ArticleId></ArticleIdList></Reference><Reference><Citation>Markaki I, Ntetsika T, Sorjonen K, Svenningsson P, BioPark Study Group Euglycemia indicates favorable motor outcome in Parkinson&#x2019;s disease. Mov Disord. 2021;36(6):1430&#x2013;1434. doi: 10.1002/mds.28545.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.28545</ArticleId><ArticleId IdType="pubmed">33634916</ArticleId></ArticleIdList></Reference><Reference><Citation>Goetz CG, Tilley BC, Shaftman SR, Stebbins GT, Fahn S, Martinez-Martin P, et al. Movement Disorder Society-sponsored revision of the Unified Parkinson&#x2019;s Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord. 2008;23(15):2129&#x2013;2170. doi: 10.1002/mds.22340.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.22340</ArticleId><ArticleId IdType="pubmed">19025984</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasreddine ZS, Phillips NA, Bedirian V, Charbonneau S, Whitehead V, Collin I, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53(4):695&#x2013;699. doi: 10.1111/j.1532-5415.2005.53221.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1532-5415.2005.53221.x</ArticleId><ArticleId IdType="pubmed">15817019</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomlinson CL, Stowe R, Patel S, Rick C, Gray R, Clarke CE. Systematic review of levodopa dose equivalency reporting in Parkinson&#x2019;s disease. Mov Disord. 2010;25(15):2649&#x2013;2653. doi: 10.1002/mds.23429.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.23429</ArticleId><ArticleId IdType="pubmed">21069833</ArticleId></ArticleIdList></Reference><Reference><Citation>Jenkinson C, Fitzpatrick R, Peto V, Greenhall R, Hyman N. The Parkinson&#x2019;s Disease Questionnaire (PDQ-39): development and validation of a Parkinson&#x2019;s disease summary index score. Age Ageing. 1997;26(5):353&#x2013;357. doi: 10.1093/ageing/26.5.353.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ageing/26.5.353</ArticleId><ArticleId IdType="pubmed">9351479</ArticleId></ArticleIdList></Reference><Reference><Citation>Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361&#x2013;370. doi: 10.1111/j.1600-0447.1983.tb09716.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-0447.1983.tb09716.x</ArticleId><ArticleId IdType="pubmed">6880820</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaudhuri KR, Martinez-Martin P, Schapira AH, Stocchi F, Sethi K, Odin P, et al. International multicenter pilot study of the first comprehensive self-completed nonmotor symptoms questionnaire for Parkinson's disease: the NMSQuest study. Mov Disord. 2006;21(7):916&#x2013;923. doi: 10.1002/mds.20844.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.20844</ArticleId><ArticleId IdType="pubmed">16547944</ArticleId></ArticleIdList></Reference><Reference><Citation>Buysse DJ, Reynolds CF, 3rd, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989;28(2):193&#x2013;213. doi: 10.1016/0165-1781(89)90047-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0165-1781(89)90047-4</ArticleId><ArticleId IdType="pubmed">2748771</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang UJ, Goldman JG, Alcalay RN, Xie T, Tuite P, Henchcliffe C, et al. The BioFIND study: characteristics of a clinically typical Parkinson's disease biomarker cohort. Mov Disord. 2016;31(6):924&#x2013;932. doi: 10.1002/mds.26613.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.26613</ArticleId><ArticleId IdType="pmc">PMC5021110</ArticleId><ArticleId IdType="pubmed">27113479</ArticleId></ArticleIdList></Reference><Reference><Citation>Paslawski W, Zareba-Paslawska J, Zhang X, Holzl K, Wadensten H, Shariatgorji M, et al. alpha-synuclein-lipoprotein interactions and elevated ApoE level in cerebrospinal fluid from Parkinson&#x2019;s disease patients. Proc Natl Acad Sci U S A. 2019;116(30):15226&#x2013;15235. doi: 10.1073/pnas.1821409116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1821409116</ArticleId><ArticleId IdType="pmc">PMC6660770</ArticleId><ArticleId IdType="pubmed">31270237</ArticleId></ArticleIdList></Reference><Reference><Citation>Paslawski W, Bergstr&#xf6;m S, Zhang X, Remnest&#xe5;l J, He Y, Boxer A, et al. Cerebrospinal fluid proteins altered in corticobasal degeneration. Mov Disord. 2021;36(5):1278&#x2013;1280. doi: 10.1002/mds.28543.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.28543</ArticleId><ArticleId IdType="pubmed">33660876</ArticleId></ArticleIdList></Reference><Reference><Citation>Geut H, Hepp DH, Foncke E, Berendse HW, Rozemuller JM, Huitinga I, et al. Neuropathological correlates of parkinsonian disorders in a large Dutch autopsy series. Acta Neuropathol Commun. 2020;8(1):39. doi: 10.1186/s40478-020-00914-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-020-00914-9</ArticleId><ArticleId IdType="pmc">PMC7098103</ArticleId><ArticleId IdType="pubmed">32216828</ArticleId></ArticleIdList></Reference><Reference><Citation>Suwijn SR, van Boheemen CJ, de Haan RJ, Tissingh G, Booij J, de Bie RM. The diagnostic accuracy of dopamine transporter SPECT imaging to detect nigrostriatal cell loss in patients with Parkinson&#x2019;s disease or clinically uncertain parkinsonism: a systematic review. EJNMMI Res. 2015;5:12. doi: 10.1186/s13550-015-0087-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13550-015-0087-1</ArticleId><ArticleId IdType="pmc">PMC4385258</ArticleId><ArticleId IdType="pubmed">25853018</ArticleId></ArticleIdList></Reference><Reference><Citation>Ito M, Oshima Y, Yajima S, Suzuki T, Nanami T, Shiratori F, et al. Diagnostic impact of high serum midkine level in patients with gastric cancer. Ann Gastroenterol Surg. 2019;3(2):195&#x2013;201. doi: 10.1002/ags3.12226.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ags3.12226</ArticleId><ArticleId IdType="pmc">PMC6422803</ArticleId><ArticleId IdType="pubmed">30923789</ArticleId></ArticleIdList></Reference><Reference><Citation>Jing X, Cui X, Liang H, Hao C, Han C. Diagnostic accuracy of ELISA for detecting serum midkine in cancer patients. PLoS ONE. 2017;12(7):e0180511. doi: 10.1371/journal.pone.0180511.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0180511</ArticleId><ArticleId IdType="pmc">PMC5501560</ArticleId><ArticleId IdType="pubmed">28686647</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones DR. Measuring midkine: the utility of midkine as a biomarker in cancer and other diseases. Br J Pharmacol. 2014;171(12):2925&#x2013;2939. doi: 10.1111/bph.12601.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bph.12601</ArticleId><ArticleId IdType="pmc">PMC4055197</ArticleId><ArticleId IdType="pubmed">24460734</ArticleId></ArticleIdList></Reference><Reference><Citation>Ikematsu S, Yano A, Aridome K, Kikuchi M, Kumai H, Nagano H, et al. Serum midkine levels are increased in patients with various types of carcinomas. Br J Cancer. 2000;83(6):701&#x2013;706. doi: 10.1054/bjoc.2000.1339.</Citation><ArticleIdList><ArticleId IdType="doi">10.1054/bjoc.2000.1339</ArticleId><ArticleId IdType="pmc">PMC2363529</ArticleId><ArticleId IdType="pubmed">10952771</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimizu E, Matsuzawa D. Midkine in psychiatric and neurodegenerative diseases. In: Erg&#xfc;ven M, Muramatsu T, Bilir A, editors. Midkine: from embryogenesis to pathogenesis and therapy. Dordrecht: Springer Netherlands; 2012. pp. 165&#x2013;170.</Citation></Reference><Reference><Citation>Ohgake S, Shimizu E, Hashimoto K, Okamura N, Koike K, Koizumi H, et al. Dopaminergic hypofunctions and prepulse inhibition deficits in mice lacking midkine. Prog Neuropsychopharmacol Biol Psychiatry. 2009;33(3):541&#x2013;546. doi: 10.1016/j.pnpbp.2009.02.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pnpbp.2009.02.005</ArticleId><ArticleId IdType="pubmed">19217924</ArticleId></ArticleIdList></Reference><Reference><Citation>Prediger RD, Rojas-Mayorquin AE, Aguiar AS, Jr, Chevarin C, Mongeau R, Hamon M, et al. Mice with genetic deletion of the heparin-binding growth factor midkine exhibit early preclinical features of Parkinson's disease. J Neural Transm (Vienna) 2011;118(8):1215&#x2013;1225. doi: 10.1007/s00702-010-0568-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00702-010-0568-3</ArticleId><ArticleId IdType="pubmed">21301897</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu X, Sun S, Liu D. IL-17D: a less studied cytokine of IL-17 family. Int Arch Allergy Immunol. 2020;181(8):618&#x2013;623. doi: 10.1159/000508255.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000508255</ArticleId><ArticleId IdType="pubmed">32516792</ArticleId></ArticleIdList></Reference><Reference><Citation>Casella G, Finardi A, Descamps H, Colombo F, Maiorino C, Ruffini F, et al. IL-27, but not IL-35, inhibits neuroinflammation through modulating GM-CSF expression. Sci Rep. 2017;7(1):16547. doi: 10.1038/s41598-017-16702-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-16702-w</ArticleId><ArticleId IdType="pmc">PMC5707351</ArticleId><ArticleId IdType="pubmed">29185463</ArticleId></ArticleIdList></Reference><Reference><Citation>Poewe W, Antonini A, Zijlmans JC, Burkhard PR, Vingerhoets F. Levodopa in the treatment of Parkinson&#x2019;s disease: an old drug still going strong. Clin Interv Aging. 2010;5:229&#x2013;238.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2938030</ArticleId><ArticleId IdType="pubmed">20852670</ArticleId></ArticleIdList></Reference><Reference><Citation>Hauser RA. Levodopa: past, present, and future. Eur Neurol. 2009;62(1):1&#x2013;8. doi: 10.1159/000215875.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000215875</ArticleId><ArticleId IdType="pubmed">19407449</ArticleId></ArticleIdList></Reference><Reference><Citation>Rutledge J, Lehallier B, Zarifkar P, Losada PM, Ryman S, Yutsis M, et al. Aromatic L-Amino Acid Decarboxylase is a novel fluid biomarker of Parkinson&#x2019;s disease. Preprint at https://www.medrxiv.org/content/10.1101/2022.11.09.22282149v1</Citation></Reference><Reference><Citation>Bertoldi M. Mammalian Dopa decarboxylase: structure, catalytic activity and inhibition. Arch Biochem Biophys. 2014;546:1&#x2013;7. doi: 10.1016/j.abb.2013.12.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.abb.2013.12.020</ArticleId><ArticleId IdType="pubmed">24407024</ArticleId></ArticleIdList></Reference><Reference><Citation>Eisenberg DP, Kohn PD, Hegarty CE, Ianni AM, Kolachana B, Gregory MD, et al. Common variation in the DOPA decarboxylase (DDC) gene and human striatal DDC activity in vivo. Neuropsychopharmacology. 2016;41(9):2303&#x2013;2308. doi: 10.1038/npp.2016.31.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/npp.2016.31</ArticleId><ArticleId IdType="pmc">PMC4946061</ArticleId><ArticleId IdType="pubmed">26924680</ArticleId></ArticleIdList></Reference><Reference><Citation>Li L, Lin H, Hua P, Yan L, Dong H, Li T, et al. Polymorphism of the Dopa-decarboxylase gene modifies the motor response to levodopa in Chinese patients with Parkinson&#x2019;s disease. Front Neurol. 2020;11:520934. doi: 10.3389/fneur.2020.520934.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2020.520934</ArticleId><ArticleId IdType="pmc">PMC7673431</ArticleId><ArticleId IdType="pubmed">33250838</ArticleId></ArticleIdList></Reference><Reference><Citation>Devos D, Lejeune S, Cormier-Dequaire F, Tahiri K, Charbonnier-Beaupel F, Rouaix N, et al. Dopa-decarboxylase gene polymorphisms affect the motor response to l-dopa in Parkinson&#x2019;s disease. Parkinsonism Relat Disord. 2014;20(2):170&#x2013;175. doi: 10.1016/j.parkreldis.2013.10.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.parkreldis.2013.10.017</ArticleId><ArticleId IdType="pubmed">24216088</ArticleId></ArticleIdList></Reference><Reference><Citation>Mochizuki H, Choong CJ, Baba K. Parkinson&#x2019;s disease and iron. J Neural Transm (Vienna) 2020;127(2):181&#x2013;187. doi: 10.1007/s00702-020-02149-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00702-020-02149-3</ArticleId><ArticleId IdType="pubmed">32025811</ArticleId></ArticleIdList></Reference><Reference><Citation>Ueberham U, Arendt T. The role of Smad proteins for development, differentiation and dedifferentiation of neurons. In: Wislet-Gendebien S, editor. Trends in Cell Signaling Pathways in Neuronal Fate Decision. UK: IntechOpen; 2013.</Citation></Reference><Reference><Citation>Guo X, Wang XF. Signaling cross-talk between TGF-beta/BMP and other pathways. Cell Res. 2009;19(1):71&#x2013;88. doi: 10.1038/cr.2008.302.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cr.2008.302</ArticleId><ArticleId IdType="pmc">PMC3606489</ArticleId><ArticleId IdType="pubmed">19002158</ArticleId></ArticleIdList></Reference><Reference><Citation>Babitt JL, Huang FW, Xia Y, Sidis Y, Andrews NC, Lin HY. Modulation of bone morphogenetic protein signaling in vivo regulates systemic iron balance. J Clin Invest. 2007;117(7):1933&#x2013;1939. doi: 10.1172/JCI31342.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI31342</ArticleId><ArticleId IdType="pmc">PMC1904317</ArticleId><ArticleId IdType="pubmed">17607365</ArticleId></ArticleIdList></Reference><Reference><Citation>Crews L, Adame A, Patrick C, Delaney A, Pham E, Rockenstein E, et al. Increased BMP6 levels in the brains of Alzheimer&#x2019;s disease patients and APP transgenic mice are accompanied by impaired neurogenesis. J Neurosci. 2010;30(37):12252&#x2013;12262. doi: 10.1523/JNEUROSCI.1305-10.2010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1305-10.2010</ArticleId><ArticleId IdType="pmc">PMC2978735</ArticleId><ArticleId IdType="pubmed">20844121</ArticleId></ArticleIdList></Reference><Reference><Citation>Jordan J, Bottner M, Schluesener HJ, Unsicker K, Krieglstein K. Bone morphogenetic proteins: neurotrophic roles for midbrain dopaminergic neurons and implications of astroglial cells. Eur J Neurosci. 1997;9(8):1699&#x2013;1709. doi: 10.1111/j.1460-9568.1997.tb01527.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1460-9568.1997.tb01527.x</ArticleId><ArticleId IdType="pubmed">9283824</ArticleId></ArticleIdList></Reference><Reference><Citation>Herman MP, Sukhova GK, Kisiel W, Foster D, Kehry MR, Libby P, et al. Tissue factor pathway inhibitor-2 is a novel inhibitor of matrix metalloproteinases with implications for atherosclerosis. J Clin Invest. 2001;107(9):1117&#x2013;1126. doi: 10.1172/JCI10403.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI10403</ArticleId><ArticleId IdType="pmc">PMC209273</ArticleId><ArticleId IdType="pubmed">11342575</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackman N, Taubman M. Tissue factor: past, present, and future. Arterioscler Thromb Vasc Biol. 2009;29(12):1986&#x2013;1988. doi: 10.1161/ATVBAHA.109.198929.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/ATVBAHA.109.198929</ArticleId><ArticleId IdType="pmc">PMC2848486</ArticleId><ArticleId IdType="pubmed">19923557</ArticleId></ArticleIdList></Reference><Reference><Citation>Wood JP, Ellery PE, Maroney SA, Mast AE. Biology of tissue factor pathway inhibitor. Blood. 2014;123(19):2934&#x2013;2943. doi: 10.1182/blood-2013-11-512764.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2013-11-512764</ArticleId><ArticleId IdType="pmc">PMC4014837</ArticleId><ArticleId IdType="pubmed">24620349</ArticleId></ArticleIdList></Reference><Reference><Citation>Fisher MJ. Brain regulation of thrombosis and hemostasis: from theory to practice. Stroke. 2013;44(11):3275&#x2013;3285. doi: 10.1161/STROKEAHA.113.000736.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.113.000736</ArticleId><ArticleId IdType="pmc">PMC3954774</ArticleId><ArticleId IdType="pubmed">24085025</ArticleId></ArticleIdList></Reference><Reference><Citation>Kryza T, Silva ML, Loessner D, Heuze-Vourc'h N, Clements JA. The kallikrein-related peptidase family: dysregulation and functions during cancer progression. Biochimie. 2016;122:283&#x2013;299. doi: 10.1016/j.biochi.2015.09.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biochi.2015.09.002</ArticleId><ArticleId IdType="pubmed">26343558</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalinska M, Meyer-Hoffert U, Kantyka T, Potempa J. Kallikreins&#x2014;the melting pot of activity and function. Biochimie. 2016;122:270&#x2013;282. doi: 10.1016/j.biochi.2015.09.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biochi.2015.09.023</ArticleId><ArticleId IdType="pmc">PMC4747678</ArticleId><ArticleId IdType="pubmed">26408415</ArticleId></ArticleIdList></Reference><Reference><Citation>Mella C, Figueroa CD, Otth C, Ehrenfeld P. Involvement of kallikrein-related peptidases in nervous system disorders. Front Cell Neurosci. 2020;14(166):166. doi: 10.3389/fncel.2020.00166.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2020.00166</ArticleId><ArticleId IdType="pmc">PMC7324807</ArticleId><ArticleId IdType="pubmed">32655372</ArticleId></ArticleIdList></Reference><Reference><Citation>Diamandis EP, Scorilas A, Kishi T, Blennow K, Luo LY, Soosaipillai A, et al. Altered kallikrein 7 and 10 concentrations in cerebrospinal fluid of patients with Alzheimer&#x2019;s disease and frontotemporal dementia. Clin Biochem. 2004;37(3):230&#x2013;237. doi: 10.1016/j.clinbiochem.2003.11.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinbiochem.2003.11.012</ArticleId><ArticleId IdType="pubmed">14972646</ArticleId></ArticleIdList></Reference><Reference><Citation>Anastas JN, Moon RT. WNT signalling pathways as therapeutic targets in cancer. Nat Rev Cancer. 2013;13(1):11&#x2013;26. doi: 10.1038/nrc3419.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrc3419</ArticleId><ArticleId IdType="pubmed">23258168</ArticleId></ArticleIdList></Reference><Reference><Citation>Poggi L, Casarosa S, Carl M. An eye on the Wnt inhibitory factor Wif1. Front Cell Dev Biol. 2018;6:167. doi: 10.3389/fcell.2018.00167.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcell.2018.00167</ArticleId><ArticleId IdType="pmc">PMC6292148</ArticleId><ArticleId IdType="pubmed">30574494</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37672565</PMID><DateCompleted><Year>2023</Year><Month>09</Month><Day>28</Day></DateCompleted><DateRevised><Year>2024</Year><Month>03</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1946-6242</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><Issue>712</Issue><PubDate><Year>2023</Year><Month>Sep</Month><Day>06</Day></PubDate></JournalIssue><Title>Science translational medicine</Title><ISOAbbreviation>Sci Transl Med</ISOAbbreviation></Journal><ArticleTitle>A protein panel in cerebrospinal fluid for diagnostic and predictive assessment of Alzheimer's disease.</ArticleTitle><Pagination><StartPage>eadg4122</StartPage><MedlinePgn>eadg4122</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1126/scitranslmed.adg4122</ELocationID><Abstract><AbstractText>Alzheimer's disease (AD) is a neurodegenerative disease with heterogenous pathophysiological changes that develop years before the onset of clinical symptoms. These preclinical changes have generated considerable interest in identifying markers for the pathophysiological mechanisms linked to AD and AD-related disorders (ADRD). On the basis of our prior work integrating cerebrospinal fluid (CSF) and brain proteome networks, we developed a reliable and high-throughput mass spectrometry-selected reaction monitoring assay that targets 48 key proteins altered in CSF. To test the diagnostic utility of these proteins and compare them with existing AD biomarkers, CSF collected at baseline visits was assayed from 706 participants recruited from the Alzheimer's Disease Neuroimaging Initiative. We found that the targeted CSF panel of 48 proteins (CSF 48 panel) performed at least as well as existing AD CSF biomarkers (A&#x3b2;<sub>42</sub>, tTau, and pTau<sub>181</sub>) for predicting clinical diagnosis, FDG PET, hippocampal volume, and measures of cognitive and dementia severity. In addition, for each of those outcomes, the CSF 48 panel plus the existing AD CSF biomarkers significantly improved diagnostic performance. Furthermore, the CSF 48 panel plus existing AD CSF biomarkers significantly improved predictions for changes in FDG PET, hippocampal volume, and measures of cognitive decline and dementia severity compared with either measure alone. A potential reason for these improvements is that the CSF 48 panel reflects a range of altered biology observed in AD/ADRD. In conclusion, we show that the CSF 48 panel complements existing AD CSF biomarkers to improve diagnosis and predict future cognitive decline and dementia severity.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Haque</LastName><ForeName>Rafi</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0003-0489-9167</Identifier><AffiliationInfo><Affiliation>Goizueta Alzheimer's Disease Research Center, Emory University School of Medicine, Atlanta, GA 30329, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Emory University School of Medicine, Atlanta, GA 30329, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Watson</LastName><ForeName>Caroline M</ForeName><Initials>CM</Initials><Identifier Source="ORCID">0000-0001-6574-0833</Identifier><AffiliationInfo><Affiliation>Goizueta Alzheimer's Disease Research Center, Emory University School of Medicine, Atlanta, GA 30329, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Emory University School of Medicine, Atlanta, GA 30329, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Jiaqi</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-3480-3234</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Emory University School of Medicine, Atlanta, GA 30329, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carter</LastName><ForeName>E Kathleen</ForeName><Initials>EK</Initials><Identifier Source="ORCID">0000-0002-5083-0614</Identifier><AffiliationInfo><Affiliation>Goizueta Alzheimer's Disease Research Center, Emory University School of Medicine, Atlanta, GA 30329, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biochemistry, Emory University School of Medicine, Atlanta, GA 30322, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Duong</LastName><ForeName>Duc M</ForeName><Initials>DM</Initials><Identifier Source="ORCID">0000-0001-5880-1888</Identifier><AffiliationInfo><Affiliation>Goizueta Alzheimer's Disease Research Center, Emory University School of Medicine, Atlanta, GA 30329, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biochemistry, Emory University School of Medicine, Atlanta, GA 30322, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lah</LastName><ForeName>James J</ForeName><Initials>JJ</Initials><Identifier Source="ORCID">0000-0002-8810-620X</Identifier><AffiliationInfo><Affiliation>Goizueta Alzheimer's Disease Research Center, Emory University School of Medicine, Atlanta, GA 30329, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Emory University School of Medicine, Atlanta, GA 30329, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wingo</LastName><ForeName>Aliza P</ForeName><Initials>AP</Initials><Identifier Source="ORCID">0000-0002-6360-6726</Identifier><AffiliationInfo><Affiliation>Division of Mental Health Atlanta VA Medical Center, Decatur, GA 30033, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychiatry, Emory University School of Medicine, Atlanta, GA 30329, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roberts</LastName><ForeName>Blaine R</ForeName><Initials>BR</Initials><Identifier Source="ORCID">0000-0001-5466-0053</Identifier><AffiliationInfo><Affiliation>Goizueta Alzheimer's Disease Research Center, Emory University School of Medicine, Atlanta, GA 30329, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Emory University School of Medicine, Atlanta, GA 30329, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biochemistry, Emory University School of Medicine, Atlanta, GA 30322, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Johnson</LastName><ForeName>Erik C B</ForeName><Initials>ECB</Initials><Identifier Source="ORCID">0000-0002-0604-2944</Identifier><AffiliationInfo><Affiliation>Goizueta Alzheimer's Disease Research Center, Emory University School of Medicine, Atlanta, GA 30329, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Emory University School of Medicine, Atlanta, GA 30329, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saykin</LastName><ForeName>Andrew J</ForeName><Initials>AJ</Initials><Identifier Source="ORCID">0000-0002-1376-8532</Identifier><AffiliationInfo><Affiliation>Department of Radiology and Imaging Sciences, Indiana University School of Medicine, Indianapolis, IN 46204, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shaw</LastName><ForeName>Leslie M</ForeName><Initials>LM</Initials><Identifier Source="ORCID">0000-0002-7650-1210</Identifier><AffiliationInfo><Affiliation>Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Neurodegenerative Disease Research, University of Pennsylvania, Philadelphia, PA 19104, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seyfried</LastName><ForeName>Nicholas T</ForeName><Initials>NT</Initials><Identifier Source="ORCID">0000-0002-8694-9211</Identifier><AffiliationInfo><Affiliation>Goizueta Alzheimer's Disease Research Center, Emory University School of Medicine, Atlanta, GA 30329, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Emory University School of Medicine, Atlanta, GA 30329, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biochemistry, Emory University School of Medicine, Atlanta, GA 30322, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wingo</LastName><ForeName>Thomas S</ForeName><Initials>TS</Initials><Identifier Source="ORCID">0000-0002-7679-6282</Identifier><AffiliationInfo><Affiliation>Goizueta Alzheimer's Disease Research Center, Emory University School of Medicine, Atlanta, GA 30329, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Emory University School of Medicine, Atlanta, GA 30329, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Human Genetics, Emory University School of Medicine, Atlanta, GA 30322, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Levey</LastName><ForeName>Allan I</ForeName><Initials>AI</Initials><Identifier Source="ORCID">0000-0002-3153-502X</Identifier><AffiliationInfo><Affiliation>Goizueta Alzheimer's Disease Research Center, Emory University School of Medicine, Atlanta, GA 30329, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Emory University School of Medicine, Atlanta, GA 30329, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>U24 AG021886</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AG066511</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG072120</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U19 AG024904</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG075827</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG079170</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>RF1 AG057471</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG061800</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>RF1 AG062181</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG056533</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 AG024904</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 AG061357</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG070937</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>09</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Sci Transl Med</MedlineTA><NlmUniqueID>101505086</NlmUniqueID><ISSNLinking>1946-6234</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D002556">Cerebrospinal Fluid Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName><QualifierName UI="Q000134" MajorTopicYN="N">cerebrospinal fluid</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000134" MajorTopicYN="N">cerebrospinal fluid</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D023381" MajorTopicYN="N">Endpoint Determination</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057166" MajorTopicYN="N">High-Throughput Screening Assays</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002556" MajorTopicYN="Y">Cerebrospinal Fluid Proteins</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D049268" MajorTopicYN="N">Positron-Emission Tomography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006624" MajorTopicYN="N">Hippocampus</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009929" MajorTopicYN="N">Organ Size</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement><b>Competing interests:</b> DND, NTS, and AIL are founders of EmTheraPro. RH is a consultant for EmTheraPro. TSW is a co-founder of revXon. JJL is a consultant for Roche Diagnostics. A.J.S. is on the Scientific Advisory Board for Bayer Oncology, Eisai; on the Dementia Advisory Board for Siemens Medical Solutions USA, Inc.; on the MESA Observational Study Monitoring Board for NIH NHLBI; on Multiple ADRC and consortium External Advisory Board and the Editorial Office Support as Editor-in-Chief, Brain Imaging and Behavior for Springer-Nature Publishing. All other authors declare no competing financial interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>8</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>9</Month><Day>6</Day><Hour>18</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>9</Month><Day>6</Day><Hour>14</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>2</Month><Day>21</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37672565</ArticleId><ArticleId IdType="mid">NIHMS1945153</ArticleId><ArticleId IdType="pmc">PMC10880442</ArticleId><ArticleId IdType="doi">10.1126/scitranslmed.adg4122</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Jack CR Jr., Bennett DA, Blennow K, Carrillo MC, Dunn B, Haeberlein SB, Holtzman DM, Jagust W, Jessen F, Karlawish J, Liu E, Molinuevo JL, Montine T, Phelps C, Rankin KP, Rowe CC, Scheltens P, Siemers E, Snyder HM, Sperling R, Contributors, NIA-AA Research Framework: Toward a biological definition of Alzheimer&#x2019;s disease. Alzheimers Dement 14, 535&#x2013;562 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5958625</ArticleId><ArticleId IdType="pubmed">29653606</ArticleId></ArticleIdList></Reference><Reference><Citation>Serrano-Pozo A, Frosch MP, Masliah E, Hyman BT, Neuropathological alterations in Alzheimer disease. Cold Spring Harb Perspect Med 1, a006189 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3234452</ArticleId><ArticleId IdType="pubmed">22229116</ArticleId></ArticleIdList></Reference><Reference><Citation>Braak H, Alafuzoff I, Arzberger T, Kretzschmar H, Del Tredici K, Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol 112, 389&#x2013;404 (2006).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3906709</ArticleId><ArticleId IdType="pubmed">16906426</ArticleId></ArticleIdList></Reference><Reference><Citation>Braak H, Thal DR, Ghebremedhin E, Del Tredici K, Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years. J Neuropathol Exp Neurol 70, 960&#x2013;969 (2011).</Citation><ArticleIdList><ArticleId IdType="pubmed">22002422</ArticleId></ArticleIdList></Reference><Reference><Citation>Hampel H, Cummings J, Blennow K, Gao P, Jack CR Jr., Vergallo A, Developing the ATX(N) classification for use across the Alzheimer disease continuum. Nat Rev Neurol 17, 580&#x2013;589 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34239130</ArticleId></ArticleIdList></Reference><Reference><Citation>Bennett DA, Schneider JA, Arvanitakis Z, Kelly JF, Aggarwal NT, Shah RC, Wilson RS, Neuropathology of older persons without cognitive impairment from two community-based studies. Neurology 66, 1837&#x2013;1844 (2006).</Citation><ArticleIdList><ArticleId IdType="pubmed">16801647</ArticleId></ArticleIdList></Reference><Reference><Citation>Knopman DS, Parisi JE, Salviati A, Floriach-Robert M, Boeve BF, Ivnik RJ, Smith GE, Dickson DW, Johnson KA, Petersen LE, McDonald WC, Braak H, Petersen RC, Neuropathology of cognitively normal elderly. J Neuropathol Exp Neurol 62, 1087&#x2013;1095 (2003).</Citation><ArticleIdList><ArticleId IdType="pubmed">14656067</ArticleId></ArticleIdList></Reference><Reference><Citation>Price JL, McKeel DW Jr., Buckles VD, Roe CM, Xiong C, Grundman M, Hansen LA, Petersen RC, Parisi JE, Dickson DW, Smith CD, Davis DG, Schmitt FA, Markesbery WR, Kaye J, Kurlan R, Hulette C, Kurland BF, Higdon R, Kukull W, Morris JC, Neuropathology of nondemented aging: presumptive evidence for preclinical Alzheimer disease. Neurobiol Aging 30, 1026&#x2013;1036 (2009).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2737680</ArticleId><ArticleId IdType="pubmed">19376612</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson ECB, Carter EK, Dammer EB, Duong DM, Gerasimov ES, Liu Y, Liu J, Betarbet R, Ping L, Yin L, Serrano GE, Beach TG, Peng J, De Jager PL, Haroutunian V, Zhang B, Gaiteri C, Bennett DA, Gearing M, Wingo TS, Wingo AP, Lah JJ, Levey AI, Seyfried NT, Large-scale deep multi-layer analysis of Alzheimer&#x2019;s disease brain reveals strong proteomic disease-related changes not observed at the RNA level. Nat Neurosci 25, 213&#x2013;225 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8825285</ArticleId><ArticleId IdType="pubmed">35115731</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson ECB, Dammer EB, Duong DM, Ping L, Zhou M, Yin L, Higginbotham LA, Guajardo A, White B, Troncoso JC, Thambisetty M, Montine TJ, Lee EB, Trojanowski JQ, Beach TG, Reiman EM, Haroutunian V, Wang M, Schadt E, Zhang B, Dickson DW, Ertekin-Taner N, Golde TE, Petyuk VA, De Jager PL, Bennett DA, Wingo TS, Rangaraju S, Hajjar I, Shulman JM, Lah JJ, Levey AI, Seyfried NT, Large-scale proteomic analysis of Alzheimer&#x2019;s disease brain and cerebrospinal fluid reveals early changes in energy metabolism associated with microglia and astrocyte activation. Nat Med 26, 769&#x2013;780 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7405761</ArticleId><ArticleId IdType="pubmed">32284590</ArticleId></ArticleIdList></Reference><Reference><Citation>Mostafavi S, Gaiteri C, Sullivan SE, White CC, Tasaki S, Xu J, Taga M, Klein HU, Patrick E, Komashko V, McCabe C, Smith R, Bradshaw EM, Root DE, Regev A, Yu L, Chibnik LB, Schneider JA, Young-Pearse TL, Bennett DA, De Jager PL, A molecular network of the aging human brain provides insights into the pathology and cognitive decline of Alzheimer&#x2019;s disease. Nat Neurosci 21, 811&#x2013;819 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6599633</ArticleId><ArticleId IdType="pubmed">29802388</ArticleId></ArticleIdList></Reference><Reference><Citation>Neff RA, Wang M, Vatansever S, Guo L, Ming C, Wang Q, Wang E, Horgusluoglu-Moloch E, Song WM, Li A, Castranio EL, Tcw J, Ho L, Goate A, Fossati V, Noggle S, Gandy S, Ehrlich ME, Katsel P, Schadt E, Cai D, Brennand KJ, Haroutunian V, Zhang B, Molecular subtyping of Alzheimer&#x2019;s disease using RNA sequencing data reveals novel mechanisms and targets. Sci Adv 7, (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7787497</ArticleId><ArticleId IdType="pubmed">33523961</ArticleId></ArticleIdList></Reference><Reference><Citation>Seyfried NT, Dammer EB, Swarup V, Nandakumar D, Duong DM, Yin L, Deng Q, Nguyen T, Hales CM, Wingo T, Glass J, Gearing M, Thambisetty M, Troncoso JC, Geschwind DH, Lah JJ, Levey AI, A Multi-network Approach Identifies Protein-Specific Co-expression in Asymptomatic and Symptomatic Alzheimer&#x2019;s Disease. Cell Syst 4, 60&#x2013;72 e64 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5269514</ArticleId><ArticleId IdType="pubmed">27989508</ArticleId></ArticleIdList></Reference><Reference><Citation>Wingo AP, Dammer EB, Breen MS, Logsdon BA, Duong DM, Troncosco JC, Thambisetty M, Beach TG, Serrano GE, Reiman EM, Caselli RJ, Lah JJ, Seyfried NT, Levey AI, Wingo TS, Large-scale proteomic analysis of human brain identifies proteins associated with cognitive trajectory in advanced age. Nat Commun 10, 1619 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6453881</ArticleId><ArticleId IdType="pubmed">30962425</ArticleId></ArticleIdList></Reference><Reference><Citation>Wingo AP, Fan W, Duong DM, Gerasimov ES, Dammer EB, Liu Y, Harerimana NV, White B, Thambisetty M, Troncoso JC, Kim N, Schneider JA, Hajjar IM, Lah JJ, Bennett DA, Seyfried NT, Levey AI, Wingo TS, Shared proteomic effects of cerebral atherosclerosis and Alzheimer&#x2019;s disease on the human brain. Nat Neurosci 23, 696&#x2013;700 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7269838</ArticleId><ArticleId IdType="pubmed">32424284</ArticleId></ArticleIdList></Reference><Reference><Citation>Higginbotham L, Ping L, Dammer EB, Duong DM, Zhou M, Gearing M, Hurst C, Glass JD, Factor SA, Johnson ECB, Hajjar I, Lah JJ, Levey AI, Seyfried NT, Integrated proteomics reveals brain-based cerebrospinal fluid biomarkers in asymptomatic and symptomatic Alzheimer&#x2019;s disease. Sci Adv 6, eaaz9360 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7577712</ArticleId><ArticleId IdType="pubmed">33087358</ArticleId></ArticleIdList></Reference><Reference><Citation>Watson CM, Dammer EB, Ping L, Duong DM, Modeste E, Carter EK, Johnson ECB, Levey AI, Lah JJ, Roberts BR, Seyfried NT, Quantitative Mass Spectrometry Analysis of Cerebrospinal Fluid Biomarker Proteins Reveals Stage-Specific Changes in Alzheimer&#x2019;s Disease. medRxiv, 2022.2008.2030.22279370 (2022).</Citation></Reference><Reference><Citation>Foote M, Zhou Y, 14-3-3 proteins in neurological disorders. Int J Biochem Mol Biol 3, 152&#x2013;164 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3388734</ArticleId><ArticleId IdType="pubmed">22773956</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou M, Haque RU, Dammer EB, Duong DM, Ping L, Johnson ECB, Lah JJ, Levey AI, Seyfried NT, Targeted mass spectrometry to quantify brain-derived cerebrospinal fluid biomarkers in Alzheimer&#x2019;s disease. Clin Proteomics 17, 19 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7257173</ArticleId><ArticleId IdType="pubmed">32514259</ArticleId></ArticleIdList></Reference><Reference><Citation>Cornell B, Toyo-Oka K, 14-3-3 Proteins in Brain Development: Neurogenesis, Neuronal Migration and Neuromorphogenesis. Front Mol Neurosci 10, 318 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5643407</ArticleId><ArticleId IdType="pubmed">29075177</ArticleId></ArticleIdList></Reference><Reference><Citation>Villemagne VL, Dore V, Burnham SC, Masters CL, Rowe CC, Imaging tau and amyloid-beta proteinopathies in Alzheimer disease and other conditions. Nat Rev Neurol 14, 225&#x2013;236 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">29449700</ArticleId></ArticleIdList></Reference><Reference><Citation>Blennow K, Mattsson N, Scholl M, Hansson O, Zetterberg H, Amyloid biomarkers in Alzheimer&#x2019;s disease. Trends Pharmacol Sci 36, 297&#x2013;309 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">25840462</ArticleId></ArticleIdList></Reference><Reference><Citation>Zetterberg H, Bendlin BB, Biomarkers for Alzheimer&#x2019;s disease-preparing for a new era of disease-modifying therapies. Mol Psychiatry 26, 296&#x2013;308 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8172244</ArticleId><ArticleId IdType="pubmed">32251378</ArticleId></ArticleIdList></Reference><Reference><Citation>Olsson B, Lautner R, Andreasson U, Ohrfelt A, Portelius E, Bjerke M, Holtta M, Rosen C, Olsson C, Strobel G, Wu E, Dakin K, Petzold M, Blennow K, Zetterberg H, CSF and blood biomarkers for the diagnosis of Alzheimer&#x2019;s disease: a systematic review and meta-analysis. Lancet Neurol 15, 673&#x2013;684 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">27068280</ArticleId></ArticleIdList></Reference><Reference><Citation>Jack CR Jr., Wiste HJ, Therneau TM, Weigand SD, Knopman DS, Mielke MM, Lowe VJ, Vemuri P, Machulda MM, Schwarz CG, Gunter JL, Senjem ML, Graff-Radford J, Jones DT, Roberts RO, Rocca WA, Petersen RC, Associations of Amyloid, Tau, and Neurodegeneration Biomarker Profiles With Rates of Memory Decline Among Individuals Without Dementia. JAMA 321, 2316&#x2013;2325 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6582267</ArticleId><ArticleId IdType="pubmed">31211344</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou M, Haque RU, Dammer EB, Duong DM, Ping L, Johnson ECB, Lah JJ, Levey AI, Seyfried NT, Targeted mass spectrometry to quantify brain-derived cerebrospinal fluid biomarkers in Alzheimer&#x2019;s disease. Clin Proteomics 17, 19 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7257173</ArticleId><ArticleId IdType="pubmed">32514259</ArticleId></ArticleIdList></Reference><Reference><Citation>Bader JM, Geyer PE, Muller JB, Strauss MT, Koch M, Leypoldt F, Koertvelyessy P, Bittner D, Schipke CG, Incesoy EI, Peters O, Deigendesch N, Simons M, Jensen MK, Zetterberg H, Mann M, Proteome profiling in cerebrospinal fluid reveals novel biomarkers of Alzheimer&#x2019;s disease. Mol Syst Biol 16, e9356 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7266499</ArticleId><ArticleId IdType="pubmed">32485097</ArticleId></ArticleIdList></Reference><Reference><Citation>Visser PJ, Reus LM, Gobom J, Jansen I, Dicks E, van der Lee SJ, Tsolaki M, Verhey FRJ, Popp J, Martinez-Lage P, Vandenberghe R, Lleo A, Molinuevo JL, Engelborghs S, Freund-Levi Y, Froelich L, Sleegers K, Dobricic V, Lovestone S, Streffer J, Vos SJB, Bos I, Adni A. B. Smit, Blennow K, Scheltens P, Teunissen CE, Bertram L, Zetterberg H, Tijms BM, Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer&#x2019;s disease. Mol Neurodegener 17, 27 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8962234</ArticleId><ArticleId IdType="pubmed">35346299</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai B, Wang X, Li Y, Chen PC, Yu K, Dey KK, Yarbro JM, Han X, Lutz BM, Rao S, Jiao Y, Sifford JM, Han J, Wang M, Tan H, Shaw TI, Cho JH, Zhou S, Wang H, Niu M, Mancieri A, Messler KA, Sun X, Wu Z, Pagala V, High AA, Bi W, Zhang H, Chi H, Haroutunian V, Zhang B, Beach TG, Yu G, Peng J, Deep Multilayer Brain Proteomics Identifies Molecular Networks in Alzheimer&#x2019;s Disease Progression. Neuron 106, 700 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7322979</ArticleId><ArticleId IdType="pubmed">32437656</ArticleId></ArticleIdList></Reference><Reference><Citation>ADNI Procedures Manual(Accessed: URL: https://adni.loni.usc.edu/wp-content/uploads/2008/07/adni2-procedures-manual.pdf</Citation></Reference><Reference><Citation>Shaw LM, Trojanowski JQ, for the Alzheimer&#x2019;s Disease Neuroimaging Initiative, Methods Report, ADNI3: Batch analyses of Ab42, t-tau, and p-tau181 in ADNI1, GO, 2 CSF samples using the fully automated Roche Elecsys and cobas e immunoassay analyzer system&#x201d;(Accessed: 12/13/2022) URL: https://adni.loni.usc.edu/wp-content/uploads/2018/04/PPT-set-102-PPSB-FTF-Boston-10-31-2017.pptx</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37679556</PMID><DateCompleted><Year>2024</Year><Month>01</Month><Day>10</Day></DateCompleted><DateRevised><Year>2025</Year><Month>01</Month><Day>15</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2522-5812</ISSN><JournalIssue CitedMedium="Internet"><Volume>5</Volume><Issue>10</Issue><PubDate><Year>2023</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Nature metabolism</Title><ISOAbbreviation>Nat Metab</ISOAbbreviation></Journal><ArticleTitle>Alleviating symptoms of neurodegenerative disorders by astrocyte-specific overexpression of TMEM164 in mice.</ArticleTitle><Pagination><StartPage>1787</StartPage><EndPage>1802</EndPage><MedlinePgn>1787-1802</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s42255-023-00887-8</ELocationID><Abstract><AbstractText>Neuroinflammatory microglia secrete cytokines to induce neurotoxic reactive astrocytes, which are one of the major causes of neuronal death. However, the intrinsic key regulators underlying neurotoxic reactive astrocytes induction are unknown. Here we show that the transmembrane protein 164 (TMEM164) is an early-response intrinsic factor that regulates neurotoxic astrocyte reactivity. TMEM164 overexpression inhibits the induction of neurotoxic reactive astrocytes, maintains normal astrocytic functions and suppresses neurotoxic reactive astrocyte-mediated neuronal death by decreasing the secretion of neurotoxic saturated lipids. Adeno-associated virus-mediated, astrocyte-specific TMEM164 overexpression in male and female mice prevents the induction of neurotoxic reactive astrocytes, dopaminergic neuronal loss and motor deficits in a Parkinson's disease model. Notably, brain-wide astrocyte-specific TMEM164 overexpression prevents the induction of neurotoxic reactive astrocytes, amyloid &#x3b2; deposition, neurodegeneration and memory decline in the 5XFAD Alzheimer's disease mouse model, suggesting that TMEM164 could serve as a potential therapeutic target for neurodegenerative disorders.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s), under exclusive licence to Springer Nature Limited.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Zhang</LastName><ForeName>Liansheng</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0001-6444-6421</Identifier><AffiliationInfo><Affiliation>Institute of Neuroscience, State Key Laboratory of Neuroscience, Key Laboratory of Primate Neurobiology, Center for Excellence in Brain Science and Intelligence Technology, Chinese Academy of Sciences, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Jia</LastName><ForeName>Zhiheng</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Institute of Neuroscience, State Key Laboratory of Neuroscience, Key Laboratory of Primate Neurobiology, Center for Excellence in Brain Science and Intelligence Technology, Chinese Academy of Sciences, Shanghai, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of the Chinese Academy of Sciences, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Wu</LastName><ForeName>Qiang</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Institute of Neuroscience, State Key Laboratory of Neuroscience, Key Laboratory of Primate Neurobiology, Center for Excellence in Brain Science and Intelligence Technology, Chinese Academy of Sciences, Shanghai, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of the Chinese Academy of Sciences, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bai</LastName><ForeName>Tao</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Institute of Neuroscience, State Key Laboratory of Neuroscience, Key Laboratory of Primate Neurobiology, Center for Excellence in Brain Science and Intelligence Technology, Chinese Academy of Sciences, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Bo</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0003-2894-5252</Identifier><AffiliationInfo><Affiliation>Institute of Neuroscience, State Key Laboratory of Neuroscience, Key Laboratory of Primate Neurobiology, Center for Excellence in Brain Science and Intelligence Technology, Chinese Academy of Sciences, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Xinde</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Genemagic Biosciences, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Tianwen</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Fudan University Huashan Hospital, Department of Neurosurgery, National Center for Neurological Disorders, National Key Laboratory for Medical Neurobiology, Shanghai Key Library of Brain Function and Regeneration, Institutes of Brain Science, MOE Frontiers Center for Brain Science, Shanghai Medical College-Fudan University, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Xingyu</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Institute of Neuroscience, State Key Laboratory of Neuroscience, Key Laboratory of Primate Neurobiology, Center for Excellence in Brain Science and Intelligence Technology, Chinese Academy of Sciences, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fu</LastName><ForeName>Jiqiang</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Institute of Neuroscience, State Key Laboratory of Neuroscience, Key Laboratory of Primate Neurobiology, Center for Excellence in Brain Science and Intelligence Technology, Chinese Academy of Sciences, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Yuelei</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Stem Cell Bank/Stem Cell Core Facility, Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ding</LastName><ForeName>Xiaoyan</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Stem Cell Bank/Stem Cell Core Facility, Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Zhen</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Institute of Neuroscience, State Key Laboratory of Neuroscience, Key Laboratory of Primate Neurobiology, Center for Excellence in Brain Science and Intelligence Technology, Chinese Academy of Sciences, Shanghai, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Shanghai Center for Brain Science and Brain-Inspired Intelligence Technology, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Zhengzheng</ForeName><Initials>Z</Initials><Identifier Source="ORCID">0000-0003-3901-8147</Identifier><AffiliationInfo><Affiliation>Institute of Neuroscience, State Key Laboratory of Neuroscience, Key Laboratory of Primate Neurobiology, Center for Excellence in Brain Science and Intelligence Technology, Chinese Academy of Sciences, Shanghai, China. zzxu@ion.ac.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Haibo</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0002-9686-5329</Identifier><AffiliationInfo><Affiliation>Institute of Neuroscience, State Key Laboratory of Neuroscience, Key Laboratory of Primate Neurobiology, Center for Excellence in Brain Science and Intelligence Technology, Chinese Academy of Sciences, Shanghai, China. hbzhou@ion.ac.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Shanghai Center for Brain Science and Brain-Inspired Intelligence Technology, Shanghai, China. hbzhou@ion.ac.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>09</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Nat Metab</MedlineTA><NlmUniqueID>101736592</NlmUniqueID><ISSNLinking>2522-5812</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016229">Amyloid beta-Peptides</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001253" MajorTopicYN="Y">Astrocytes</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016229" MajorTopicYN="N">Amyloid beta-Peptides</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017628" MajorTopicYN="N">Microglia</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009474" MajorTopicYN="N">Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>1</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>8</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>1</Month><Day>10</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>9</Month><Day>8</Day><Hour>0</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>9</Month><Day>7</Day><Hour>23</Hour><Minute>36</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37679556</ArticleId><ArticleId IdType="doi">10.1038/s42255-023-00887-8</ArticleId><ArticleId IdType="pii">10.1038/s42255-023-00887-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Liddelow, S. A. &amp; Barres, B. A. Reactive astrocytes: production, function, and therapeutic potential. Immunity 46, 957&#x2013;967 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28636962</ArticleId><ArticleId IdType="doi">10.1016/j.immuni.2017.06.006</ArticleId></ArticleIdList></Reference><Reference><Citation>Clarke, L. E. &amp; Barres, B. A. Emerging roles of astrocytes in neural circuit development. Nat. Rev. Neurosci. 14, 311&#x2013;321 (2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">23595014</ArticleId><ArticleId IdType="pmc">4431630</ArticleId><ArticleId IdType="doi">10.1038/nrn3484</ArticleId></ArticleIdList></Reference><Reference><Citation>Sofroniew, M. V. Molecular dissection of reactive astrogliosis and glial scar formation. Trends Neurosci. 32, 638&#x2013;647 (2009).</Citation><ArticleIdList><ArticleId IdType="pubmed">19782411</ArticleId><ArticleId IdType="pmc">2787735</ArticleId><ArticleId IdType="doi">10.1016/j.tins.2009.08.002</ArticleId></ArticleIdList></Reference><Reference><Citation>Liddelow, S. A. et al. Neurotoxic reactive astrocytes are induced by activated microglia. Nature 541, 481&#x2013;487 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28099414</ArticleId><ArticleId IdType="pmc">5404890</ArticleId><ArticleId IdType="doi">10.1038/nature21029</ArticleId></ArticleIdList></Reference><Reference><Citation>Zamanian, J. L. et al. Genomic analysis of reactive astrogliosis. J. Neurosci. 32, 6391&#x2013;6410 (2012).</Citation><ArticleIdList><ArticleId IdType="pubmed">22553043</ArticleId><ArticleId IdType="pmc">3480225</ArticleId><ArticleId IdType="doi">10.1523/JNEUROSCI.6221-11.2012</ArticleId></ArticleIdList></Reference><Reference><Citation>Guttenplan, K. A. et al. Neurotoxic reactive astrocytes induce cell death via saturated lipids. Nature 599, 102&#x2013;107 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34616039</ArticleId><ArticleId IdType="doi">10.1038/s41586-021-03960-y</ArticleId></ArticleIdList></Reference><Reference><Citation>Yun, S. P. et al. Block of A1 astrocyte conversion by microglia is neuroprotective in models of Parkinson&#x2019;s disease. Nat. Med. 24, 931&#x2013;938 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">29892066</ArticleId><ArticleId IdType="pmc">6039259</ArticleId><ArticleId IdType="doi">10.1038/s41591-018-0051-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Guttenplan, K. A. et al. Knockout of reactive astrocyte activating factors slows disease progression in an ALS mouse model. Nat. Commun. 11, 3753 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32719333</ArticleId><ArticleId IdType="pmc">7385161</ArticleId><ArticleId IdType="doi">10.1038/s41467-020-17514-9</ArticleId></ArticleIdList></Reference><Reference><Citation>Guttenplan, K. A. et al. Neurotoxic reactive astrocytes drive neuronal death after retinal Injury. Cell Rep. 31, 107776 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32579912</ArticleId><ArticleId IdType="pmc">8091906</ArticleId><ArticleId IdType="doi">10.1016/j.celrep.2020.107776</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou, Y. et al. Molecular landscapes of human hippocampal immature neurons across lifespan. Nature 607, 527&#x2013;533 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35794479</ArticleId><ArticleId IdType="pmc">9316413</ArticleId><ArticleId IdType="doi">10.1038/s41586-022-04912-w</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang, A. C. et al. A human brain vascular atlas reveals diverse mediators of Alzheimer&#x2019;s risk. Nature 603, 885&#x2013;892 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35165441</ArticleId><ArticleId IdType="pmc">9635042</ArticleId><ArticleId IdType="doi">10.1038/s41586-021-04369-3</ArticleId></ArticleIdList></Reference><Reference><Citation>Otero-Garcia, M. et al. Molecular signatures underlying neurofibrillary tangle susceptibility in Alzheimer&#x2019;s disease. Neuron 110, 2929&#x2013;2948 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35882228</ArticleId><ArticleId IdType="pmc">9509477</ArticleId><ArticleId IdType="doi">10.1016/j.neuron.2022.06.021</ArticleId></ArticleIdList></Reference><Reference><Citation>Morabito, S. et al. Single-nucleus chromatin accessibility and transcriptomic characterization of Alzheimer&#x2019;s disease. Nat. Genet. 53, 1143&#x2013;1155 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34239132</ArticleId><ArticleId IdType="pmc">8766217</ArticleId><ArticleId IdType="doi">10.1038/s41588-021-00894-z</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou, Y. et al. Human and mouse single-nucleus transcriptomics reveal TREM2-dependent and TREM2-independent cellular responses in Alzheimer&#x2019;s disease. Nat. Med. 26, 131&#x2013;142 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">31932797</ArticleId><ArticleId IdType="pmc">6980793</ArticleId><ArticleId IdType="doi">10.1038/s41591-019-0695-9</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathys, H. et al. Single-cell transcriptomic analysis of Alzheimer&#x2019;s disease. Nature 570, 332&#x2013;337 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">31042697</ArticleId><ArticleId IdType="pmc">6865822</ArticleId><ArticleId IdType="doi">10.1038/s41586-019-1195-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Grubman, A. et al. A single-cell atlas of entorhinal cortex from individuals with Alzheimer&#x2019;s disease reveals cell-type-specific gene expression regulation. Nat. Neurosci. 22, 2087&#x2013;2097 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">31768052</ArticleId><ArticleId IdType="doi">10.1038/s41593-019-0539-4</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang, Q. et al. Single-cell transcriptomic atlas of the human substantia nigra in Parkinson&#x2019;s disease. Preprint at bioRxiv https://doi.org/10.1101/2022.03.25.485846 (2022).</Citation></Reference><Reference><Citation>Garcia, F. J. et al. Single-cell dissection of the human brain vasculature. Nature 603, 893&#x2013;899 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35158371</ArticleId><ArticleId IdType="pmc">9680899</ArticleId><ArticleId IdType="doi">10.1038/s41586-022-04521-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee, H. et al. Cell type-specific transcriptomics reveals that mutant huntingtin leads to mitochondrial RNA release and neuronal innate immune activation. Neuron 107, 891&#x2013;908 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32681824</ArticleId><ArticleId IdType="pmc">7486278</ArticleId><ArticleId IdType="doi">10.1016/j.neuron.2020.06.021</ArticleId></ArticleIdList></Reference><Reference><Citation>J&#xe4;kel, S. et al. Altered human oligodendrocyte heterogeneity in multiple sclerosis. Nature 566, 543&#x2013;547 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">30747918</ArticleId><ArticleId IdType="pmc">6544546</ArticleId><ArticleId IdType="doi">10.1038/s41586-019-0903-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Pineda, S. S. et al. Single-cell profiling of the human primary motor cortex in ALS and FTLD. Preprint at bioRxiv https://doi.org/10.1101/2021.07.07.451374 (2021).</Citation></Reference><Reference><Citation>Barbar, L. et al. CD49f is a novel marker of functional and reactive human iPSC-derived astrocytes. Neuron 107, 436&#x2013;453 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32485136</ArticleId><ArticleId IdType="pmc">8274549</ArticleId><ArticleId IdType="doi">10.1016/j.neuron.2020.05.014</ArticleId></ArticleIdList></Reference><Reference><Citation>Varadi, M. et al. AlphaFold Protein Structure Database: massively expanding the structural coverage of protein-sequence space with high-accuracy models. Nucleic Acids Res. 50, D439&#x2013;D444 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">34791371</ArticleId><ArticleId IdType="doi">10.1093/nar/gkab1061</ArticleId></ArticleIdList></Reference><Reference><Citation>Jumper, J. et al. Highly accurate protein structure prediction with AlphaFold. Nature 596, 583&#x2013;589 (2021).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03819-2</ArticleId><ArticleId IdType="pubmed">34265844</ArticleId><ArticleId IdType="pmc">8371605</ArticleId></ArticleIdList></Reference><Reference><Citation>He, D. et al. Activation of HCA2 regulates microglial responses to alleviate neurodegeneration in LPS-induced in vivo and in vitro models. J. Neuroinflammation 20, 86 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">36991440</ArticleId><ArticleId IdType="pmc">10053461</ArticleId><ArticleId IdType="doi">10.1186/s12974-023-02762-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Han, X. et al. Small molecule-driven NLRP3 inflammation inhibition via interplay between ubiquitination and autophagy: implications for Parkinson disease. Autophagy 15, 1860&#x2013;1881 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">30966861</ArticleId><ArticleId IdType="pmc">6844502</ArticleId><ArticleId IdType="doi">10.1080/15548627.2019.1596481</ArticleId></ArticleIdList></Reference><Reference><Citation>Mendes-Oliveira, J., Lopes Campos, F., Videira, R. A. &amp; Baltazar, G. GPER activation is effective in protecting against inflammation-induced nigral dopaminergic loss and motor function impairment. Brain Behav. Immun. 64, 296&#x2013;307 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28450223</ArticleId><ArticleId IdType="doi">10.1016/j.bbi.2017.04.016</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoban, D. B. et al. Further characterisation of the LPS model of Parkinson&#x2019;s disease: a comparison of intra-nigral and intra-striatal lipopolysaccharide administration on motor function, microgliosis and nigrostriatal neurodegeneration in the rat. Brain Behav. Immun. 27, 91&#x2013;100 (2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">23044176</ArticleId><ArticleId IdType="doi">10.1016/j.bbi.2012.10.001</ArticleId></ArticleIdList></Reference><Reference><Citation>Herrera, A. J., Casta&#xf1;o, A., Venero, J. L., Cano, J. &amp; Machado, A. The single intranigral injection of LPS as a new model for studying the selective effects of inflammatory reactions on dopaminergic system. Neurobiol. Dis. 7, 429&#x2013;447 (2000).</Citation><ArticleIdList><ArticleId IdType="pubmed">10964613</ArticleId><ArticleId IdType="doi">10.1006/nbdi.2000.0289</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee, Y., Messing, A., Su, M. &amp; Brenner, M. GFAP promoter elements required for region-specific and astrocyte-specific expression. Glia 56, 481&#x2013;493 (2008).</Citation><ArticleIdList><ArticleId IdType="pubmed">18240313</ArticleId><ArticleId IdType="doi">10.1002/glia.20622</ArticleId></ArticleIdList></Reference><Reference><Citation>Escartin, C. et al. Reactive astrocyte nomenclature, definitions, and future directions. Nat. Neurosci. 24, 312&#x2013;325 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33589835</ArticleId><ArticleId IdType="pmc">8007081</ArticleId><ArticleId IdType="doi">10.1038/s41593-020-00783-4</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasel, P., Aisenberg, W. H., Bennett, F. C. &amp; Liddelow, S. A. Molecular and metabolic heterogeneity of astrocytes and microglia. Cell Metab. 35, 555&#x2013;570 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">36958329</ArticleId><ArticleId IdType="doi">10.1016/j.cmet.2023.03.006</ArticleId></ArticleIdList></Reference><Reference><Citation>Sadick, J. S. et al. Astrocytes and oligodendrocytes undergo subtype-specific transcriptional changes in Alzheimer&#x2019;s disease. Neuron 110, 1788&#x2013;1805 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35381189</ArticleId><ArticleId IdType="pmc">9167747</ArticleId><ArticleId IdType="doi">10.1016/j.neuron.2022.03.008</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasel, P., Rose, I. V. L., Sadick, J. S., Kim, R. D. &amp; Liddelow, S. A. Neuroinflammatory astrocyte subtypes in the mouse brain. Nat. Neurosci. 24, 1475&#x2013;1487 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34413515</ArticleId><ArticleId IdType="doi">10.1038/s41593-021-00905-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Oakley, H. et al. Intraneuronal &#x3b2;-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer&#x2019;s disease mutations: potential factors in amyloid plaque formation. J. Neurosci. 26, 10129&#x2013;10140 (2006).</Citation><ArticleIdList><ArticleId IdType="pubmed">17021169</ArticleId><ArticleId IdType="pmc">6674618</ArticleId><ArticleId IdType="doi">10.1523/JNEUROSCI.1202-06.2006</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan, K. Y. et al. Engineered AAVs for efficient noninvasive gene delivery to the central and peripheral nervous systems. Nat. Neurosci. 20, 1172&#x2013;1179 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28671695</ArticleId><ArticleId IdType="pmc">5529245</ArticleId><ArticleId IdType="doi">10.1038/nn.4593</ArticleId></ArticleIdList></Reference><Reference><Citation>Caccamo, A. et al. Necroptosis activation in Alzheimer&#x2019;s disease. Nat. Neurosci. 20, 1236&#x2013;1246 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28758999</ArticleId><ArticleId IdType="doi">10.1038/nn.4608</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen, R. et al. Monoacylglycerol lipase is a therapeutic target for Alzheimer&#x2019;s disease. Cell Rep. 2, 1329&#x2013;1339 (2012).</Citation><ArticleIdList><ArticleId IdType="pubmed">23122958</ArticleId><ArticleId IdType="pmc">3513645</ArticleId><ArticleId IdType="doi">10.1016/j.celrep.2012.09.030</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, L. et al. BAD-mediated neuronal apoptosis and neuroinflammation contribute to Alzheimer&#x2019;s disease pathology. iScience 24, 102942 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34430820</ArticleId><ArticleId IdType="pmc">8369003</ArticleId><ArticleId IdType="doi">10.1016/j.isci.2021.102942</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu, J. et al. TMEM164 is a new determinant of autophagy-dependent ferroptosis. Autophagy 19, 945&#x2013;956 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">35947500</ArticleId><ArticleId IdType="doi">10.1080/15548627.2022.2111635</ArticleId></ArticleIdList></Reference><Reference><Citation>Reed, A., Ware, T., Li, H., Fernando Bazan, J. &amp; Cravatt, B. F. TMEM164 is an acyltransferase that forms ferroptotic C20:4 ether phospholipids. Nat. Chem. Biol. 19, 378&#x2013;388 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">36782012</ArticleId><ArticleId IdType="pmc">10362496</ArticleId><ArticleId IdType="doi">10.1038/s41589-022-01253-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Dunkley, P. R., Jarvie, P. E. &amp; Robinson, P. J. A rapid Percoll gradient procedure for preparation of synaptosomes. Nat. Protoc. 3, 1718&#x2013;1728 (2008).</Citation><ArticleIdList><ArticleId IdType="pubmed">18927557</ArticleId><ArticleId IdType="doi">10.1038/nprot.2008.171</ArticleId></ArticleIdList></Reference><Reference><Citation>Beaudoin, G. M. J. 3rd et al. Culturing pyramidal neurons from the early postnatal mouse hippocampus and cortex. Nat. Protoc. 7, 1741&#x2013;1754 (2012).</Citation><ArticleIdList><ArticleId IdType="pubmed">22936216</ArticleId><ArticleId IdType="doi">10.1038/nprot.2012.099</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, Y. et al. Rapid single-step induction of functional neurons from human pluripotent stem cells. Neuron 78, 785&#x2013;798 (2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">23764284</ArticleId><ArticleId IdType="pmc">3751803</ArticleId><ArticleId IdType="doi">10.1016/j.neuron.2013.05.029</ArticleId></ArticleIdList></Reference><Reference><Citation>Leger, M. et al. Object recognition test in mice. Nat. Protoc. 8, 2531&#x2013;2537 (2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">24263092</ArticleId><ArticleId IdType="doi">10.1038/nprot.2013.155</ArticleId></ArticleIdList></Reference><Reference><Citation>Martorell, A. J. et al. Multi-sensory gamma stimulation ameliorates Alzheimer&#x2019;s-associated pathology and improves cognition. Cell 177, 256&#x2013;271 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">30879788</ArticleId><ArticleId IdType="pmc">6774262</ArticleId><ArticleId IdType="doi">10.1016/j.cell.2019.02.014</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou, H. et al. Glia-to-neuron conversion by CRISPR-CasRx alleviates symptoms of neurological disease in mice. Cell 181, 590&#x2013;603 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32272060</ArticleId><ArticleId IdType="doi">10.1016/j.cell.2020.03.024</ArticleId></ArticleIdList></Reference><Reference><Citation>Poewe, W. et al. Parkinson disease. Nat. Rev. Dis. Primers 3, 17013 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28332488</ArticleId><ArticleId IdType="doi">10.1038/nrdp.2017.13</ArticleId></ArticleIdList></Reference><Reference><Citation>Compston, A. &amp; Coles, A. Multiple sclerosis. Lancet 359, 1221&#x2013;1231 (2002).</Citation><ArticleIdList><ArticleId IdType="pubmed">11955556</ArticleId><ArticleId IdType="doi">10.1016/S0140-6736(02)08220-X</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37689059</PMID><DateCompleted><Year>2023</Year><Month>11</Month><Day>20</Day></DateCompleted><DateRevised><Year>2025</Year><Month>01</Month><Day>04</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1097-4199</ISSN><JournalIssue CitedMedium="Internet"><Volume>111</Volume><Issue>22</Issue><PubDate><Year>2023</Year><Month>Nov</Month><Day>15</Day></PubDate></JournalIssue><Title>Neuron</Title><ISOAbbreviation>Neuron</ISOAbbreviation></Journal><ArticleTitle>Irisin reduces amyloid-&#x3b2; by inducing the release of neprilysin from astrocytes following downregulation of ERK-STAT3 signaling.</ArticleTitle><Pagination><StartPage>3619</StartPage><EndPage>3633.e8</EndPage><MedlinePgn>3619-3633.e8</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.neuron.2023.08.012</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0896-6273(23)00623-2</ELocationID><Abstract><AbstractText>A pathological hallmark of Alzheimer's disease (AD) is the deposition of amyloid-&#x3b2; (A&#x3b2;) protein in the brain. Physical exercise has been shown to reduce A&#x3b2; burden in various AD mouse models, but the underlying mechanisms have not been elucidated. Irisin, an exercise-induced hormone, is the secreted form of fibronectin type-III-domain-containing 5 (FNDC5). Here, using a three-dimensional (3D) cell culture model of AD, we show that irisin significantly reduces A&#x3b2; pathology by increasing astrocytic release of the A&#x3b2;-degrading enzyme neprilysin (NEP). This is mediated by downregulation of ERK-STAT3 signaling. Finally, we show that integrin &#x3b1;V/&#x3b2;5 acts as the irisin receptor on astrocytes required for irisin-induced release of astrocytic NEP, leading to clearance of A&#x3b2;. Our findings reveal for the first time a cellular and molecular mechanism by which exercise-induced irisin attenuates A&#x3b2; pathology, suggesting a new target pathway for therapies aimed at the prevention and treatment of AD.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 The Author(s). Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Eunhee</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Genetics and Aging Research Unit, MassGeneral Institute for Neurodegenerative Disease, Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA 02129, USA; McCance Center for Brain Health, Massachusetts General Hospital, Boston, MA 02114, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Hyeonwoo</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02115, USA; Department of Cell Biology, Harvard University Medical School, Boston, MA 02115, USA; Department of Biological Sciences, Korea Advanced Institute of Science &amp; Technology (KAIST), Daejeon 34141, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jedrychowski</LastName><ForeName>Mark P</ForeName><Initials>MP</Initials><AffiliationInfo><Affiliation>Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02115, USA; Department of Cell Biology, Harvard University Medical School, Boston, MA 02115, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bakiasi</LastName><ForeName>Grisilda</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Genetics and Aging Research Unit, MassGeneral Institute for Neurodegenerative Disease, Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA 02129, USA; McCance Center for Brain Health, Massachusetts General Hospital, Boston, MA 02114, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Joseph</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Genetics and Aging Research Unit, MassGeneral Institute for Neurodegenerative Disease, Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA 02129, USA; McCance Center for Brain Health, Massachusetts General Hospital, Boston, MA 02114, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kruskop</LastName><ForeName>Jane</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Genetics and Aging Research Unit, MassGeneral Institute for Neurodegenerative Disease, Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA 02129, USA; McCance Center for Brain Health, Massachusetts General Hospital, Boston, MA 02114, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Choi</LastName><ForeName>Younjung</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Genetics and Aging Research Unit, MassGeneral Institute for Neurodegenerative Disease, Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA 02129, USA; McCance Center for Brain Health, Massachusetts General Hospital, Boston, MA 02114, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kwak</LastName><ForeName>Sang Su</ForeName><Initials>SS</Initials><AffiliationInfo><Affiliation>Genetics and Aging Research Unit, MassGeneral Institute for Neurodegenerative Disease, Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA 02129, USA; McCance Center for Brain Health, Massachusetts General Hospital, Boston, MA 02114, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Quinti</LastName><ForeName>Luisa</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Genetics and Aging Research Unit, MassGeneral Institute for Neurodegenerative Disease, Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA 02129, USA; McCance Center for Brain Health, Massachusetts General Hospital, Boston, MA 02114, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Doo Yeon</ForeName><Initials>DY</Initials><AffiliationInfo><Affiliation>Genetics and Aging Research Unit, MassGeneral Institute for Neurodegenerative Disease, Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA 02129, USA; McCance Center for Brain Health, Massachusetts General Hospital, Boston, MA 02114, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wrann</LastName><ForeName>Christiane D</ForeName><Initials>CD</Initials><AffiliationInfo><Affiliation>McCance Center for Brain Health, Massachusetts General Hospital, Boston, MA 02114, USA; Cardiovascular Research Center, Massachusetts General Hospital and Harvard Medical School, Charlestown, MA 02129, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spiegelman</LastName><ForeName>Bruce M</ForeName><Initials>BM</Initials><AffiliationInfo><Affiliation>Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02115, USA; Department of Cell Biology, Harvard University Medical School, Boston, MA 02115, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tanzi</LastName><ForeName>Rudolph E</ForeName><Initials>RE</Initials><AffiliationInfo><Affiliation>Genetics and Aging Research Unit, MassGeneral Institute for Neurodegenerative Disease, Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA 02129, USA; McCance Center for Brain Health, Massachusetts General Hospital, Boston, MA 02114, USA. Electronic address: tanzi@helix.mgh.harvard.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Choi</LastName><ForeName>Se Hoon</ForeName><Initials>SH</Initials><AffiliationInfo><Affiliation>Genetics and Aging Research Unit, MassGeneral Institute for Neurodegenerative Disease, Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA 02129, USA; McCance Center for Brain Health, Massachusetts General Hospital, Boston, MA 02114, USA. Electronic address: choi.sehoon@mgh.harvard.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 NS117694</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R21 AG062904</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R56 AG072054</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>RF1 AG048080</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>09</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Neuron</MedlineTA><NlmUniqueID>8809320</NlmUniqueID><ISSNLinking>0896-6273</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 3.4.24.11</RegistryNumber><NameOfSubstance UI="D015260">Neprilysin</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005353">Fibronectins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016229">Amyloid beta-Peptides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C571428">FNDC5 protein, mouse</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015260" MajorTopicYN="Y">Neprilysin</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005353" MajorTopicYN="N">Fibronectins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015536" MajorTopicYN="N">Down-Regulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001253" MajorTopicYN="N">Astrocytes</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016229" MajorTopicYN="N">Amyloid beta-Peptides</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Alzheimer's disease</Keyword><Keyword MajorTopicYN="N">A&#x3b2;</Keyword><Keyword MajorTopicYN="N">ERK</Keyword><Keyword MajorTopicYN="N">STAT3</Keyword><Keyword MajorTopicYN="N">amyloid-&#x3b2;</Keyword><Keyword MajorTopicYN="N">astrocytes</Keyword><Keyword MajorTopicYN="N">integrin &#x3b1;V/&#x3b2;5</Keyword><Keyword MajorTopicYN="N">irisin</Keyword><Keyword MajorTopicYN="N">neprilysin</Keyword></KeywordList><CoiStatement>Declaration of interests The authors declare the following competing interests: B.M.S. and C.D.W. hold a patent related to irisin (WO2015051007A1). B.M.S. and C.D.W. are academic co-founders and consultants for Aevum Therapeutics. C.D.W. has a financial interest in Aevum Therapeutics, a company developing drugs that harness the protective molecular mechanisms of exercise to treat neurodegenerative and neuromuscular disorders. C.D.W.&#x2019;s interests were reviewed and are managed by MGH and Mass General Brigham in accordance with their conflict-of-interest policies.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>2</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>3</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>8</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>11</Month><Day>20</Day><Hour>6</Hour><Minute>55</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>9</Month><Day>10</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>9</Month><Day>9</Day><Hour>18</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>11</Month><Day>15</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37689059</ArticleId><ArticleId IdType="mid">NIHMS1926742</ArticleId><ArticleId IdType="pmc">PMC10840702</ArticleId><ArticleId IdType="doi">10.1016/j.neuron.2023.08.012</ArticleId><ArticleId IdType="pii">S0896-6273(23)00623-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Tanzi RE, and Bertram L. (2005). Twenty years of the Alzheimer&#x2019;s disease amyloid hypothesis: a genetic perspective. Cell 120, 545&#x2013;555. 10.1016/j.cell.2005.02.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2005.02.008</ArticleId><ArticleId IdType="pubmed">15734686</ArticleId></ArticleIdList></Reference><Reference><Citation>Lazarov O, Robinson J, Tang YP, Hairston IS, Korade-Mirnics Z, Lee VM, Hersh LB, Sapolsky RM, Mirnics K, and Sisodia SS (2005). Environmental enrichment reduces Abeta levels and amyloid deposition in transgenic mice. Cell 120, 701&#x2013;713. 10.1016/j.cell.2005.01.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2005.01.015</ArticleId><ArticleId IdType="pubmed">15766532</ArticleId></ArticleIdList></Reference><Reference><Citation>Adlard PA, Perreau VM, Pop V, and Cotman CW (2005). Voluntary exercise decreases amyloid load in a transgenic model of Alzheimer&#x2019;s disease. J Neurosci 25, 4217&#x2013;4221. 10.1523/JNEUROSCI.0496-05.2005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.0496-05.2005</ArticleId><ArticleId IdType="pmc">PMC6725122</ArticleId><ArticleId IdType="pubmed">15858047</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Z, Chen Q, Liu J, and Du Y. (2020). Physical Exercise Ameliorates the Cognitive Function and Attenuates the Neuroinflammation of Alzheimer&#x2019;s Disease via miR-129&#x2013;5p. Dement Geriatr Cogn Disord, 1&#x2013;7. 10.1159/000507285.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000507285</ArticleId><ArticleId IdType="pubmed">32434194</ArticleId></ArticleIdList></Reference><Reference><Citation>Nichol KE, Poon WW, Parachikova AI, Cribbs DH, Glabe CG, and Cotman CW (2008). Exercise alters the immune profile in Tg2576 Alzheimer mice toward a response coincident with improved cognitive performance and decreased amyloid. J Neuroinflammation 5, 13. 10.1186/1742-2094-5-13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1742-2094-5-13</ArticleId><ArticleId IdType="pmc">PMC2329612</ArticleId><ArticleId IdType="pubmed">18400101</ArticleId></ArticleIdList></Reference><Reference><Citation>Belarbi K, Burnouf S, Fernandez-Gomez FJ, Laurent C, Lestavel S, Figeac M, Sultan A, Troquier L, Leboucher A, Caillierez R, et al. (2011). Beneficial effects of exercise in a transgenic mouse model of Alzheimer&#x2019;s disease-like Tau pathology. Neurobiol Dis 43, 486&#x2013;494. 10.1016/j.nbd.2011.04.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2011.04.022</ArticleId><ArticleId IdType="pubmed">21569847</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi SH, Bylykbashi E, Chatila ZK, Lee SW, Pulli B, Clemenson GD, Kim E, Rompala A, Oram MK, Asselin C, et al. (2018). Combined adult neurogenesis and BDNF mimic exercise effects on cognition in an Alzheimer&#x2019;s mouse model. Science 361. 10.1126/science.aan8821.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aan8821</ArticleId><ArticleId IdType="pmc">PMC6149542</ArticleId><ArticleId IdType="pubmed">30190379</ArticleId></ArticleIdList></Reference><Reference><Citation>Maliszewska-Cyna E, Xhima K, and Aubert I. (2016). A Comparative Study Evaluating the Impact of Physical Exercise on Disease Progression in a Mouse Model of Alzheimer&#x2019;s Disease. J Alzheimers Dis 53, 243&#x2013;257. 10.3233/JAD-150660.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-150660</ArticleId><ArticleId IdType="pubmed">27163797</ArticleId></ArticleIdList></Reference><Reference><Citation>Maesako M, Uemura K, Kubota M, Kuzuya A, Sasaki K, Hayashida N, AsadaUtsugi M, Watanabe K, Uemura M, Kihara T, et al. (2012). Exercise is more effective than diet control in preventing high fat diet-induced beta-amyloid deposition and memory deficit in amyloid precursor protein transgenic mice. J Biol Chem 287, 23024-23033. 10.1074/jbc.M112.367011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M112.367011</ArticleId><ArticleId IdType="pmc">PMC3391129</ArticleId><ArticleId IdType="pubmed">22563077</ArticleId></ArticleIdList></Reference><Reference><Citation>Moore KM, Girens RE, Larson SK, Jones MR, Restivo JL, Holtzman DM, Cirrito JR, Yuede CM, Zimmerman SD, and Timson BF (2016). A spectrum of exercise training reduces soluble Abeta in a dose-dependent manner in a mouse model of Alzheimer&#x2019;s disease. Neurobiol Dis 85, 218&#x2013;224. 10.1016/j.nbd.2015.11.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2015.11.004</ArticleId><ArticleId IdType="pubmed">26563933</ArticleId></ArticleIdList></Reference><Reference><Citation>Bostrom P, Wu J, Jedrychowski MP, Korde A, Ye L, Lo JC, Rasbach KA, Bostrom EA, Choi JH, Long JZ, et al. (2012). A PGC1-alpha-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature 481, 463&#x2013;468. 10.1038/nature10777.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature10777</ArticleId><ArticleId IdType="pmc">PMC3522098</ArticleId><ArticleId IdType="pubmed">22237023</ArticleId></ArticleIdList></Reference><Reference><Citation>Erickson HP (2013). Irisin and FNDC5 in retrospect: An exercise hormone or a transmembrane receptor? Adipocyte 2, 289&#x2013;293. 10.4161/adip.26082.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/adip.26082</ArticleId><ArticleId IdType="pmc">PMC3774709</ArticleId><ArticleId IdType="pubmed">24052909</ArticleId></ArticleIdList></Reference><Reference><Citation>Shan T, Liang X, Bi P, and Kuang S. (2013). Myostatin knockout drives browning of white adipose tissue through activating the AMPK-PGC1alpha-Fndc5 pathway in muscle. FASEB J 27, 1981&#x2013;1989. 10.1096/fj.12-225755.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.12-225755</ArticleId><ArticleId IdType="pmc">PMC3633817</ArticleId><ArticleId IdType="pubmed">23362117</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu J, Bostrom P, Sparks LM, Ye L, Choi JH, Giang AH, Khandekar M, Virtanen KA, Nuutila P, Schaart G, et al. (2012). Beige adipocytes are a distinct type of thermogenic fat cell in mouse and human. Cell 150, 366&#x2013;376. 10.1016/j.cell.2012.05.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2012.05.016</ArticleId><ArticleId IdType="pmc">PMC3402601</ArticleId><ArticleId IdType="pubmed">22796012</ArticleId></ArticleIdList></Reference><Reference><Citation>Lourenco MV, Frozza RL, de Freitas GB, Zhang H, Kincheski GC, Ribeiro FC, Goncalves RA, Clarke JR, Beckman D, Staniszewski A, et al. (2019). Exercise-linked FNDC5/irisin rescues synaptic plasticity and memory defects in Alzheimer&#x2019;s models. Nat Med 25, 165&#x2013;175. 10.1038/s41591-018-0275-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-018-0275-4</ArticleId><ArticleId IdType="pmc">PMC6327967</ArticleId><ArticleId IdType="pubmed">30617325</ArticleId></ArticleIdList></Reference><Reference><Citation>Wrann CD, White JP, Salogiannnis J, Laznik-Bogoslavski D, Wu J, Ma D, Lin JD, Greenberg ME, and Spiegelman BM (2013). Exercise induces hippocampal BDNF through a PGC-1alpha/FNDC5 pathway. Cell Metab 18, 649&#x2013;659. 10.1016/j.cmet.2013.09.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2013.09.008</ArticleId><ArticleId IdType="pmc">PMC3980968</ArticleId><ArticleId IdType="pubmed">24120943</ArticleId></ArticleIdList></Reference><Reference><Citation>Islam MR, Valaris S, Young MF, Haley EB, Luo R, Bond SF, Mazuera S, Kitchen RR, Caldarone BJ, Bettio LEB, et al. (2021). Exercise hormone irisin is a critical regulator of cognitive function. Nat Metab 3, 1058&#x2013;1070. 10.1038/s42255-021-00438-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42255-021-00438-z</ArticleId><ArticleId IdType="pmc">PMC10317538</ArticleId><ArticleId IdType="pubmed">34417591</ArticleId></ArticleIdList></Reference><Reference><Citation>Lourenco MV, Ribeiro FC, Sudo FK, Drummond C, Assuncao N, Vanderborght B, Tovar-Moll F, Mattos P, De Felice FG, and Ferreira ST (2020). Cerebrospinal fluid irisin correlates with amyloid-beta, BDNF, and cognition in Alzheimer&#x2019;s disease. Alzheimers Dement (Amst) 12, e12034. 10.1002/dad2.12034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/dad2.12034</ArticleId><ArticleId IdType="pmc">PMC7306518</ArticleId><ArticleId IdType="pubmed">32582833</ArticleId></ArticleIdList></Reference><Reference><Citation>Jedrychowski MP, Wrann CD, Paulo JA, Gerber KK, Szpyt J, Robinson MM, Nair KS, Gygi SP, and Spiegelman BM (2015). Detection and Quantitation of Circulating Human Irisin by Tandem Mass Spectrometry. Cell Metab 22, 734&#x2013;740. 10.1016/j.cmet.2015.08.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2015.08.001</ArticleId><ArticleId IdType="pmc">PMC4802359</ArticleId><ArticleId IdType="pubmed">26278051</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi SH, Kim YH, Hebisch M, Sliwinski C, Lee S, D&#x2019;Avanzo C, Chen H, Hooli B, Asselin C, Muffat J, et al. (2014). A three-dimensional human neural cell culture model of Alzheimer&#x2019;s disease. Nature 515, 274&#x2013;278. 10.1038/nature13800.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature13800</ArticleId><ArticleId IdType="pmc">PMC4366007</ArticleId><ArticleId IdType="pubmed">25307057</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim YH, Choi SH, D&#x2019;Avanzo C, Hebisch M, Sliwinski C, Bylykbashi E, Washicosky KJ, Klee JB, Brustle O, Tanzi RE, and Kim DY (2015). A 3D human neural cell culture system for modeling Alzheimer&#x2019;s disease. Nat Protoc 10, 985&#x2013;1006. 10.1038/nprot.2015.065.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nprot.2015.065</ArticleId><ArticleId IdType="pmc">PMC4499058</ArticleId><ArticleId IdType="pubmed">26068894</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwak SS, Washicosky KJ, Brand E, von Maydell D, Aronson J, Kim S, Capen DE, Cetinbas M, Sadreyev R, Ning S, et al. (2020). Amyloid-beta42/40 ratio drives tau pathology in 3D human neural cell culture models of Alzheimer&#x2019;s disease. Nat Commun 11, 1377. 10.1038/s41467-020-15120-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-15120-3</ArticleId><ArticleId IdType="pmc">PMC7070004</ArticleId><ArticleId IdType="pubmed">32170138</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim H, Wrann CD, Jedrychowski M, Vidoni S, Kitase Y, Nagano K, Zhou C, Chou J, Parkman VA, Novick SJ, et al. (2018). Irisin Mediates Effects on Bone and Fat via alphaV Integrin Receptors. Cell 175, 1756&#x2013;1768 e1717. 10.1016/j.cell.2018.10.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2018.10.025</ArticleId><ArticleId IdType="pmc">PMC6298040</ArticleId><ArticleId IdType="pubmed">30550785</ArticleId></ArticleIdList></Reference><Reference><Citation>Nigam SM, Xu S, Kritikou JS, Marosi K, Brodin L, and Mattson MP (2017). Exercise and BDNF reduce Abeta production by enhancing alpha-secretase processing of APP. J Neurochem 142, 286&#x2013;296. 10.1111/jnc.14034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.14034</ArticleId><ArticleId IdType="pmc">PMC5498234</ArticleId><ArticleId IdType="pubmed">28382744</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamaguchi H, Nakazato Y, Kawarabayashi T, Ishiguro K, Ihara Y, Morimatsu M, and Hirai S. (1991). Extracellular neurofibrillary tangles associated with degenerating neurites and neuropil threads in Alzheimer-type dementia. Acta Neuropathol 81, 603&#x2013;609. 10.1007/BF00296369.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF00296369</ArticleId><ArticleId IdType="pubmed">1882636</ArticleId></ArticleIdList></Reference><Reference><Citation>Barcikowska M, Wisniewski HM, Bancher C, and Grundke-Iqbal I. (1989). About the presence of paired helical filaments in dystrophic neurites participating in the plaque formation. Acta Neuropathol 78, 225&#x2013;231. 10.1007/BF00687751.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF00687751</ArticleId><ArticleId IdType="pubmed">2669434</ArticleId></ArticleIdList></Reference><Reference><Citation>Duyckaerts C, Panchal M, Delatour B, and Potier MC (2009). [Morphologic and molecular neuropathology of Alzheimer&#x2019;s disease]. Ann Pharm Fr 67, 127&#x2013;135. 10.1016/j.pharma.2009.01.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pharma.2009.01.001</ArticleId><ArticleId IdType="pubmed">19298896</ArticleId></ArticleIdList></Reference><Reference><Citation>Abramov E, Dolev I, Fogel H, Ciccotosto GD, Ruff E, and Slutsky I. (2009). Amyloid-beta as a positive endogenous regulator of release probability at hippocampal synapses. Nat Neurosci 12, 1567&#x2013;1576. 10.1038/nn.2433.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.2433</ArticleId><ArticleId IdType="pubmed">19935655</ArticleId></ArticleIdList></Reference><Reference><Citation>Busche MA, Eichhoff G, Adelsberger H, Abramowski D, Wiederhold KH, Haass C, Staufenbiel M, Konnerth A, and Garaschuk O. (2008). Clusters of hyperactive neurons near amyloid plaques in a mouse model of Alzheimer&#x2019;s disease. Science 321, 1686&#x2013;1689. 10.1126/science.1162844.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1162844</ArticleId><ArticleId IdType="pubmed">18802001</ArticleId></ArticleIdList></Reference><Reference><Citation>Hector A, and Brouillette J. (2020). Hyperactivity Induced by Soluble Amyloid-beta Oligomers in the Early Stages of Alzheimer&#x2019;s Disease. Front Mol Neurosci 13, 600084. 10.3389/fnmol.2020.600084.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2020.600084</ArticleId><ArticleId IdType="pmc">PMC7817907</ArticleId><ArticleId IdType="pubmed">33488358</ArticleId></ArticleIdList></Reference><Reference><Citation>Quiroz YT, Budson AE, Celone K, Ruiz A, Newmark R, Castrillon G, Lopera F, and Stern CE (2010). Hippocampal hyperactivation in presymptomatic familial Alzheimer&#x2019;s disease. Ann Neurol 68, 865&#x2013;875. 10.1002/ana.22105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.22105</ArticleId><ArticleId IdType="pmc">PMC3175143</ArticleId><ArticleId IdType="pubmed">21194156</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuchibhotla KV, Lattarulo CR, Hyman BT, and Bacskai BJ (2009). Synchronous hyperactivity and intercellular calcium waves in astrocytes in Alzheimer mice. Science 323, 1211&#x2013;1215. 10.1126/science.1169096.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1169096</ArticleId><ArticleId IdType="pmc">PMC2884172</ArticleId><ArticleId IdType="pubmed">19251629</ArticleId></ArticleIdList></Reference><Reference><Citation>Park J, Wetzel I, Marriott I, Dreau D, D&#x2019;Avanzo C, Kim DY, Tanzi RE, and Cho H. (2018). A 3D human triculture system modeling neurodegeneration and neuroinflammation in Alzheimer&#x2019;s disease. Nat Neurosci 21, 941&#x2013;951. 10.1038/s41593-018-0175-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-018-0175-4</ArticleId><ArticleId IdType="pmc">PMC6800152</ArticleId><ArticleId IdType="pubmed">29950669</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, Studzinski C, Beckett T, Murphy MP, Klein RL, and Hersh LB (2010). Circulating neprilysin clears brain amyloid. Mol Cell Neurosci 45, 101&#x2013;107. 10.1016/j.mcn.2010.05.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mcn.2010.05.014</ArticleId><ArticleId IdType="pmc">PMC2923273</ArticleId><ArticleId IdType="pubmed">20558294</ArticleId></ArticleIdList></Reference><Reference><Citation>Park MH, Lee JK, Choi S, Ahn J, Jin HK, Park JS, and Bae JS (2013). Recombinant soluble neprilysin reduces amyloid-beta accumulation and improves memory impairment in Alzheimer&#x2019;s disease mice. Brain Res 1529, 113&#x2013;124. 10.1016/j.brainres.2013.05.045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2013.05.045</ArticleId><ArticleId IdType="pubmed">23831521</ArticleId></ArticleIdList></Reference><Reference><Citation>Son SM, Cha MY, Choi H, Kang S, Choi H, Lee MS, Park SA, and Mook-Jung I. (2016). Insulin-degrading enzyme secretion from astrocytes is mediated by an autophagy-based unconventional secretory pathway in Alzheimer disease. Autophagy 12, 784&#x2013;800. 10.1080/15548627.2016.1159375.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2016.1159375</ArticleId><ArticleId IdType="pmc">PMC4854558</ArticleId><ArticleId IdType="pubmed">26963025</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamamoto N, Fujii Y, Kasahara R, Tanida M, Ohora K, Ono Y, Suzuki K, and Sobue K. (2016). Simvastatin and atorvastatin facilitates amyloid beta-protein degradation in extracellular spaces by increasing neprilysin secretion from astrocytes through activation of MAPK/Erk1/2 pathways. Glia 64, 952&#x2013;962. 10.1002/glia.22974.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.22974</ArticleId><ArticleId IdType="pubmed">26875818</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamamoto N, Shibata M, Ishikuro R, Tanida M, Taniguchi Y, Ikeda-Matsuo Y, and Sobue K. (2017). Epigallocatechin gallate induces extracellular degradation of amyloid beta-protein by increasing neprilysin secretion from astrocytes through activation of ERK and PI3K pathways. Neuroscience 362, 70&#x2013;78. 10.1016/j.neuroscience.2017.08.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2017.08.030</ArticleId><ArticleId IdType="pubmed">28844000</ArticleId></ArticleIdList></Reference><Reference><Citation>Grimm MO, Mett J, Stahlmann CP, Haupenthal VJ, Zimmer VC, and Hartmann T. (2013). Neprilysin and Abeta Clearance: Impact of the APP Intracellular Domain in NEP Regulation and Implications in Alzheimer&#x2019;s Disease. Front Aging Neurosci 5, 98. 10.3389/fnagi.2013.00098.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2013.00098</ArticleId><ArticleId IdType="pmc">PMC3870290</ArticleId><ArticleId IdType="pubmed">24391587</ArticleId></ArticleIdList></Reference><Reference><Citation>Lafrance MH, Vezina C, Wang Q, Boileau G, Crine P, and Lemay G. (1994). Role of glycosylation in transport and enzymic activity of neutral endopeptidase-24.11. Biochem J 302 (Pt 2), 451&#x2013;454. 10.1042/bj3020451.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/bj3020451</ArticleId><ArticleId IdType="pmc">PMC1137249</ArticleId><ArticleId IdType="pubmed">8092997</ArticleId></ArticleIdList></Reference><Reference><Citation>Malfroy B, Kuang WJ, Seeburg PH, Mason AJ, and Schofield PR (1988). Molecular cloning and amino acid sequence of human enkephalinase (neutral endopeptidase). FEBS Lett 229, 206&#x2013;210. 10.1016/0014-5793(88)80828-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0014-5793(88)80828-7</ArticleId><ArticleId IdType="pubmed">3162217</ArticleId></ArticleIdList></Reference><Reference><Citation>Oefner C, D&#x2019;Arcy A, Hennig M, Winkler FK, and Dale GE (2000). Structure of human neutral endopeptidase (Neprilysin) complexed with phosphoramidon. J Mol Biol 296, 341&#x2013;349. 10.1006/jmbi.1999.3492.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/jmbi.1999.3492</ArticleId><ArticleId IdType="pubmed">10669592</ArticleId></ArticleIdList></Reference><Reference><Citation>Relton JM, Gee NS, Matsas R, Turner AJ, and Kenny AJ (1983). Purification of endopeptidase-24.11 (&#x2018;enkephalinase&#x2019;) from pig brain by immunoadsorbent chromatography. Biochem J 215, 519&#x2013;523. 10.1042/bj2150519.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/bj2150519</ArticleId><ArticleId IdType="pmc">PMC1152431</ArticleId><ArticleId IdType="pubmed">6419725</ArticleId></ArticleIdList></Reference><Reference><Citation>Oguri Y, Shinoda K, Kim H, Alba DL, Bolus WR, Wang Q, Brown Z, Pradhan RN, Tajima K, Yoneshiro T, et al. (2020). CD81 Controls Beige Fat Progenitor Cell Growth and Energy Balance via FAK Signaling. Cell 182, 563&#x2013;577 e520. 10.1016/j.cell.2020.06.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.06.021</ArticleId><ArticleId IdType="pmc">PMC7415677</ArticleId><ArticleId IdType="pubmed">32615086</ArticleId></ArticleIdList></Reference><Reference><Citation>Foo LC, Allen NJ, Bushong EA, Ventura PB, Chung WS, Zhou L, Cahoy JD, Daneman R, Zong H, Ellisman MH, and Barres BA (2011). Development of a method for the purification and culture of rodent astrocytes. Neuron 71, 799&#x2013;811. 10.1016/j.neuron.2011.07.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.07.022</ArticleId><ArticleId IdType="pmc">PMC3172573</ArticleId><ArticleId IdType="pubmed">21903074</ArticleId></ArticleIdList></Reference><Reference><Citation>Milner R. (2009). Microglial expression of alphavbeta3 and alphavbeta5 integrins is regulated by cytokines and the extracellular matrix: beta5 integrin null microglia show no defects in adhesion or MMP-9 expression on vitronectin. Glia 57, 714&#x2013;723. 10.1002/glia.20799.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.20799</ArticleId><ArticleId IdType="pubmed">18985734</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith JW, Vestal DJ, Irwin SV, Burke TA, and Cheresh DA (1990). Purification and functional characterization of integrin alpha v beta 5. An adhesion receptor for vitronectin. J Biol Chem 265, 11008&#x2013;11013.</Citation><ArticleIdList><ArticleId IdType="pubmed">1694173</ArticleId></ArticleIdList></Reference><Reference><Citation>Khurgel M, Koo AC, and Ivy GO (1996). Selective ablation of astrocytes by intracerebral injections of alpha-aminoadipate. Glia 16, 351&#x2013;358. 10.1002/(SICI)1098-1136(199604)16:4&lt;351::AID-GLIA7&gt;3.0.CO;2-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/(SICI)1098-1136(199604)16:4&lt;351::AID-GLIA7&gt;3.0.CO;2-2</ArticleId><ArticleId IdType="pubmed">8721675</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Amico M, Hulit J, Amanatullah DF, Zafonte BT, Albanese C, Bouzahzah B, Fu M, Augenlicht LH, Donehower LA, Takemaru K, et al. (2000). The integrin-linked kinase regulates the cyclin D1 gene through glycogen synthase kinase 3beta and cAMP-responsive element-binding protein-dependent pathways. J Biol Chem 275, 32649&#x2013;32657. 10.1074/jbc.M000643200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M000643200</ArticleId><ArticleId IdType="pubmed">10915780</ArticleId></ArticleIdList></Reference><Reference><Citation>Giancotti FG, and Ruoslahti E. (1999). Integrin signaling. Science 285, 1028&#x2013;1032. 10.1126/science.285.5430.1028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.285.5430.1028</ArticleId><ArticleId IdType="pubmed">10446041</ArticleId></ArticleIdList></Reference><Reference><Citation>Reichenbach N, Delekate A, Plescher M, Schmitt F, Krauss S, Blank N, Halle A, and Petzold GC (2019). Inhibition of Stat3-mediated astrogliosis ameliorates pathology in an Alzheimer&#x2019;s disease model. EMBO Mol Med 11. 10.15252/emmm.201809665.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/emmm.201809665</ArticleId><ArticleId IdType="pmc">PMC6365929</ArticleId><ArticleId IdType="pubmed">30617153</ArticleId></ArticleIdList></Reference><Reference><Citation>Clarke LE, Liddelow SA, Chakraborty C, Munch AE, Heiman M, and Barres BA (2018). Normal aging induces A1-like astrocyte reactivity. Proc Natl Acad Sci U S A 115, E1896&#x2013;E1905. 10.1073/pnas.1800165115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1800165115</ArticleId><ArticleId IdType="pmc">PMC5828643</ArticleId><ArticleId IdType="pubmed">29437957</ArticleId></ArticleIdList></Reference><Reference><Citation>Lian H, Litvinchuk A, Chiang AC, Aithmitti N, Jankowsky JL, and Zheng H. (2016). Astrocyte-Microglia Cross Talk through Complement Activation Modulates Amyloid Pathology in Mouse Models of Alzheimer&#x2019;s Disease. J Neurosci 36, 577&#x2013;589. 10.1523/JNEUROSCI.2117-15.2016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.2117-15.2016</ArticleId><ArticleId IdType="pmc">PMC4710776</ArticleId><ArticleId IdType="pubmed">26758846</ArticleId></ArticleIdList></Reference><Reference><Citation>Lian H, Yang L, Cole A, Sun L, Chiang AC, Fowler SW, Shim DJ, Rodriguez-Rivera J, Taglialatela G, Jankowsky JL, et al. (2015). NFkappaB-activated astroglial release of complement C3 compromises neuronal morphology and function associated with Alzheimer&#x2019;s disease. Neuron 85, 101&#x2013;115. 10.1016/j.neuron.2014.11.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2014.11.018</ArticleId><ArticleId IdType="pmc">PMC4289109</ArticleId><ArticleId IdType="pubmed">25533482</ArticleId></ArticleIdList></Reference><Reference><Citation>Litvinchuk A, Wan YW, Swartzlander DB, Chen F, Cole A, Propson NE, Wang Q, Zhang B, Liu Z, and Zheng H. (2018). Complement C3aR Inactivation Attenuates Tau Pathology and Reverses an Immune Network Deregulated in Tauopathy Models and Alzheimer&#x2019;s Disease. Neuron 100, 1337&#x2013;1353 e1335. 10.1016/j.neuron.2018.10.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2018.10.031</ArticleId><ArticleId IdType="pmc">PMC6309202</ArticleId><ArticleId IdType="pubmed">30415998</ArticleId></ArticleIdList></Reference><Reference><Citation>Lahiri DK (2004). Apolipoprotein E as a target for developing new therapeutics for Alzheimer&#x2019;s disease based on studies from protein, RNA, and regulatory region of the gene. J Mol Neurosci 23, 225&#x2013;233. 10.1385/JMN:23:3:225.</Citation><ArticleIdList><ArticleId IdType="doi">10.1385/JMN:23:3:225</ArticleId><ArticleId IdType="pubmed">15181251</ArticleId></ArticleIdList></Reference><Reference><Citation>Ben Haim L, Carrillo-de Sauvage MA, Ceyzeriat K, and Escartin C. (2015). Elusive roles for reactive astrocytes in neurodegenerative diseases. Front Cell Neurosci 9, 278. 10.3389/fncel.2015.00278.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2015.00278</ArticleId><ArticleId IdType="pmc">PMC4522610</ArticleId><ArticleId IdType="pubmed">26283915</ArticleId></ArticleIdList></Reference><Reference><Citation>Ben Haim L, Ceyzeriat K, Carrillo-de Sauvage MA, Aubry F, Auregan G, Guillermier M, Ruiz M, Petit F, Houitte D, Faivre E, et al. (2015). The JAK/STAT3 pathway is a common inducer of astrocyte reactivity in Alzheimer&#x2019;s and Huntington&#x2019;s diseases. J Neurosci 35, 2817&#x2013;2829. 10.1523/JNEUROSCI.3516-14.2015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.3516-14.2015</ArticleId><ArticleId IdType="pmc">PMC6605603</ArticleId><ArticleId IdType="pubmed">25673868</ArticleId></ArticleIdList></Reference><Reference><Citation>Griswold AJ, Celis K, Bussies PL, Rajabli F, Whitehead PL, Hamilton-Nelson KL, Beecham GW, Dykxhoorn DM, Nuytemans K, Wang L, et al. (2021). Increased APOE epsilon4 expression is associated with the difference in Alzheimer&#x2019;s disease risk from diverse ancestral backgrounds. Alzheimers Dement 17, 1179&#x2013;1188. 10.1002/alz.12287.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alz.12287</ArticleId><ArticleId IdType="pmc">PMC8843031</ArticleId><ArticleId IdType="pubmed">33522086</ArticleId></ArticleIdList></Reference><Reference><Citation>Li ZW, Li JJ, Wang L, Zhang JP, Wu JJ, Mao XQ, Shi GF, Wang Q, Wang F, and Zou J. (2014). Epidermal growth factor receptor inhibitor ameliorates excessive astrogliosis and improves the regeneration microenvironment and functional recovery in adult rats following spinal cord injury. J Neuroinflammation 11, 71. 10.1186/1742-2094-11-71.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1742-2094-11-71</ArticleId><ArticleId IdType="pmc">PMC4030311</ArticleId><ArticleId IdType="pubmed">24708754</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu B, Chen H, Johns TG, and Neufeld AH (2006). Epidermal growth factor receptor activation: an upstream signal for transition of quiescent astrocytes into reactive astrocytes after neural injury. J Neurosci 26, 7532&#x2013;7540. 10.1523/JNEUROSCI.1004-06.2006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1004-06.2006</ArticleId><ArticleId IdType="pmc">PMC6674203</ArticleId><ArticleId IdType="pubmed">16837601</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu B, and Neufeld AH (2007). Activation of epidermal growth factor receptors in astrocytes: from development to neural injury. J Neurosci Res 85, 3523&#x2013;3529. 10.1002/jnr.21364.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jnr.21364</ArticleId><ArticleId IdType="pubmed">17526018</ArticleId></ArticleIdList></Reference><Reference><Citation>Zamanian JL, Xu L, Foo LC, Nouri N, Zhou L, Giffard RG, and Barres BA (2012). Genomic analysis of reactive astrogliosis. J Neurosci 32, 6391&#x2013;6410. 10.1523/JNEUROSCI.6221-11.2012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.6221-11.2012</ArticleId><ArticleId IdType="pmc">PMC3480225</ArticleId><ArticleId IdType="pubmed">22553043</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandell JW, and VandenBerg SR (1999). ERK/MAP kinase is chronically activated in human reactive astrocytes. Neuroreport 10, 3567&#x2013;3572. 10.1097/00001756-199911260-00019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00001756-199911260-00019</ArticleId><ArticleId IdType="pubmed">10619645</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun A, Liu M, Nguyen XV, and Bing G. (2003). P38 MAP kinase is activated at early stages in Alzheimer&#x2019;s disease brain. Exp Neurol 183, 394&#x2013;405. 10.1016/s0014-4886(03)00180-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0014-4886(03)00180-8</ArticleId><ArticleId IdType="pubmed">14552880</ArticleId></ArticleIdList></Reference><Reference><Citation>Heinrich PC, Behrmann I, Haan S, Hermanns HM, Muller-Newen G, and Schaper F. (2003). Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochem J 374, 1&#x2013;20. 10.1042/BJ20030407.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BJ20030407</ArticleId><ArticleId IdType="pmc">PMC1223585</ArticleId><ArticleId IdType="pubmed">12773095</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H, Zhao YT, Zhang S, Dubielecka PM, Du J, Yano N, Chin YE, Zhuang S, Qin G, and Zhao TC (2017). Irisin plays a pivotal role to protect the heart against ischemia and reperfusion injury. J Cell Physiol 232, 3775&#x2013;3785. 10.1002/jcp.25857.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcp.25857</ArticleId><ArticleId IdType="pmc">PMC5550372</ArticleId><ArticleId IdType="pubmed">28181692</ArticleId></ArticleIdList></Reference><Reference><Citation>Brasier AR (2010). The nuclear factor-kappaB-interleukin-6 signalling pathway mediating vascular inflammation. Cardiovasc Res 86, 211&#x2013;218. 10.1093/cvr/cvq076.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cvr/cvq076</ArticleId><ArticleId IdType="pmc">PMC2912657</ArticleId><ArticleId IdType="pubmed">20202975</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu RX, Huang C, Bennett DA, Li H, and Wang R. (2016). The characteristics of astrocyte on Abeta clearance altered in Alzheimer&#x2019;s disease were reversed by anti-inflammatory agent (+)-2-(1-hydroxyl-4-oxocyclohexyl) ethyl caffeate. Am J Transl Res 8, 4082&#x2013;4094.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5095303</ArticleId><ArticleId IdType="pubmed">27829994</ArticleId></ArticleIdList></Reference><Reference><Citation>Dorfman VB, Pasquini L, Riudavets M, Lopez-Costa JJ, Villegas A, Troncoso JC, Lopera F, Castano EM, and Morelli L. (2010). Differential cerebral deposition of IDE and NEP in sporadic and familial Alzheimer&#x2019;s disease. Neurobiol Aging 31, 1743&#x2013;1757. 10.1016/j.neurobiolaging.2008.09.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2008.09.016</ArticleId><ArticleId IdType="pmc">PMC3266723</ArticleId><ArticleId IdType="pubmed">19019493</ArticleId></ArticleIdList></Reference><Reference><Citation>Apelt J, Ach K, and Schliebs R. (2003). Aging-related down-regulation of neprilysin, a putative beta-amyloid-degrading enzyme, in transgenic Tg2576 Alzheimer-like mouse brain is accompanied by an astroglial upregulation in the vicinity of beta-amyloid plaques. Neurosci Lett 339, 183&#x2013;186. 10.1016/s0304-3940(03)00030-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0304-3940(03)00030-2</ArticleId><ArticleId IdType="pubmed">12633883</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J, Guo Y, Wang Y, Song L, Zhang R, and Du Y. (2018). Long-term treadmill exercise attenuates Abeta burdens and astrocyte activation in APP/PS1 mouse model of Alzheimer&#x2019;s disease. Neurosci Lett 666, 70&#x2013;77. 10.1016/j.neulet.2017.12.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2017.12.025</ArticleId><ArticleId IdType="pubmed">29246793</ArticleId></ArticleIdList></Reference><Reference><Citation>Leem YH, Lee YI, Son HJ, and Lee SH (2011). Chronic exercise ameliorates the neuroinflammation in mice carrying NSE/htau23. Biochem Biophys Res Commun 406, 359&#x2013;365. 10.1016/j.bbrc.2011.02.046.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2011.02.046</ArticleId><ArticleId IdType="pubmed">21329662</ArticleId></ArticleIdList></Reference><Reference><Citation>Khodadadi D, Gharakhanlou R, Naghdi N, Salimi M, Azimi M, Shahed A, and Heysieattalab S. (2018). Treadmill Exercise Ameliorates Spatial Learning and Memory Deficits Through Improving the Clearance of Peripheral and Central Amyloid-Beta Levels. Neurochem Res 43, 1561&#x2013;1574. 10.1007/s11064-018-2571-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11064-018-2571-2</ArticleId><ArticleId IdType="pubmed">29948724</ArticleId></ArticleIdList></Reference><Reference><Citation>He XF, Liu DX, Zhang Q, Liang FY, Dai GY, Zeng JS, Pei Z, Xu GQ, and Lan Y. (2017). Voluntary Exercise Promotes Glymphatic Clearance of Amyloid Beta and Reduces the Activation of Astrocytes and Microglia in Aged Mice. Front Mol Neurosci 10, 144. 10.3389/fnmol.2017.00144.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2017.00144</ArticleId><ArticleId IdType="pmc">PMC5437122</ArticleId><ArticleId IdType="pubmed">28579942</ArticleId></ArticleIdList></Reference><Reference><Citation>Liddelow SA, Guttenplan KA, Clarke LE, Bennett FC, Bohlen CJ, Schirmer L, Bennett ML, Munch AE, Chung WS, Peterson TC, et al. (2017). Neurotoxic reactive astrocytes are induced by activated microglia. Nature 541, 481&#x2013;487. 10.1038/nature21029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature21029</ArticleId><ArticleId IdType="pmc">PMC5404890</ArticleId><ArticleId IdType="pubmed">28099414</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamamoto N, Tanida M, Ono Y, Kasahara R, Fujii Y, Ohora K, Suzuki K, and Sobue K. (2014). Leptin inhibits amyloid beta-protein degradation through decrease of neprilysin expression in primary cultured astrocytes. Biochem Biophys Res Commun 445, 214&#x2013;217. 10.1016/j.bbrc.2014.01.168.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2014.01.168</ArticleId><ArticleId IdType="pubmed">24508800</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamamoto N, Ishikuro R, Tanida M, Suzuki K, Ikeda-Matsuo Y, and Sobue K. (2018). Insulin-signaling Pathway Regulates the Degradation of Amyloid beta-protein via Astrocytes. Neuroscience 385, 227&#x2013;236. 10.1016/j.neuroscience.2018.06.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2018.06.018</ArticleId><ArticleId IdType="pubmed">29932983</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamamoto N, Arima H, Naruse K, Kasahara R, Taniura H, Hirate H, Sugiura T, Suzuki K, and Sobue K. (2013). Ketamine reduces amyloid beta-protein degradation by suppressing neprilysin expression in primary cultured astrocytes. Neurosci Lett 545, 54&#x2013;58. 10.1016/j.neulet.2013.04.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2013.04.016</ArticleId><ArticleId IdType="pubmed">23624023</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazurov D, Barbashova L, and Filatov A. (2013). Tetraspanin protein CD9 interacts with metalloprotease CD10 and enhances its release via exosomes. FEBS J 280, 1200&#x2013;1213. 10.1111/febs.12110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/febs.12110</ArticleId><ArticleId IdType="pubmed">23289620</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuruppu S, Rajapakse NW, Minond D, and Smith AI (2014). Production of soluble Neprilysin by endothelial cells. Biochem Biophys Res Commun 446, 423&#x2013;427. 10.1016/j.bbrc.2014.01.158.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2014.01.158</ArticleId><ArticleId IdType="pubmed">24495806</ArticleId></ArticleIdList></Reference><Reference><Citation>Katsuda T, Tsuchiya R, Kosaka N, Yoshioka Y, Takagaki K, Oki K, Takeshita F, Sakai Y, Kuroda M, and Ochiya T. (2013). Human adipose tissue-derived mesenchymal stem cells secrete functional neprilysin-bound exosomes. Sci Rep 3, 1197. 10.1038/srep01197.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep01197</ArticleId><ArticleId IdType="pmc">PMC3561625</ArticleId><ArticleId IdType="pubmed">23378928</ArticleId></ArticleIdList></Reference><Reference><Citation>Webster B, Hansen L, Adame A, Crews L, Torrance M, Thal L, and Masliah E. (2006). Astroglial activation of extracellular-regulated kinase in early stages of Alzheimer disease. J Neuropathol Exp Neurol 65, 142&#x2013;151. 10.1097/01.jnen.0000199599.63204.6f.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.jnen.0000199599.63204.6f</ArticleId><ArticleId IdType="pubmed">16462205</ArticleId></ArticleIdList></Reference><Reference><Citation>Huell M, Strauss S, Volk B, Berger M, and Bauer J. (1995). Interleukin-6 is present in early stages of plaque formation and is restricted to the brains of Alzheimer&#x2019;s disease patients. Acta Neuropathol 89, 544&#x2013;551. 10.1007/BF00571510.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF00571510</ArticleId><ArticleId IdType="pubmed">7676810</ArticleId></ArticleIdList></Reference><Reference><Citation>Heyser CJ, Masliah E, Samimi A, Campbell IL, and Gold LH (1997). Progressive decline in avoidance learning paralleled by inflammatory neurodegeneration in transgenic mice expressing interleukin 6 in the brain. Proc Natl Acad Sci U S A 94, 1500&#x2013;1505. 10.1073/pnas.94.4.1500.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.94.4.1500</ArticleId><ArticleId IdType="pmc">PMC19820</ArticleId><ArticleId IdType="pubmed">9037082</ArticleId></ArticleIdList></Reference><Reference><Citation>Campbell IL, Abraham CR, Masliah E, Kemper P, Inglis JD, Oldstone MB, and Mucke L. (1993). Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6. Proc Natl Acad Sci U S A 90, 10061&#x2013;10065. 10.1073/pnas.90.21.10061.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.90.21.10061</ArticleId><ArticleId IdType="pmc">PMC47713</ArticleId><ArticleId IdType="pubmed">7694279</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong J, Dong Y, Dong Y, Chen F, Mitch WE, and Zhang L. (2016). Inhibition of myostatin in mice improves insulin sensitivity via irisin-mediated cross talk between muscle and adipose tissues. Int J Obes (Lond) 40, 434&#x2013;442. 10.1038/ijo.2015.200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ijo.2015.200</ArticleId><ArticleId IdType="pmc">PMC4783239</ArticleId><ArticleId IdType="pubmed">26435323</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang K, Li H, Wang H, Wang JH, Song F, and Sun Y. (2018). Irisin Exerts Neuroprotective Effects on Cultured Neurons by Regulating Astrocytes. Mediators Inflamm 2018, 9070341. 10.1155/2018/9070341.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2018/9070341</ArticleId><ArticleId IdType="pmc">PMC6178172</ArticleId><ArticleId IdType="pubmed">30356412</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang K, Song F, Xu K, Liu Z, Han S, Li F, and Sun Y. (2019). Irisin Attenuates Neuroinflammation and Prevents the Memory and Cognitive Deterioration in Streptozotocin-Induced Diabetic Mice. Mediators Inflamm 2019, 1567179. 10.1155/2019/1567179.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2019/1567179</ArticleId><ArticleId IdType="pmc">PMC6590589</ArticleId><ArticleId IdType="pubmed">31281225</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong XQ, Geng Z, Zhou B, Zhang F, Han Y, Zhou YB, Wang JJ, Gao XY, Chen Q, Li YH, et al. (2018). FNDC5 attenuates adipose tissue inflammation and insulin resistance via AMPK-mediated macrophage polarization in obesity. Metabolism 83, 31&#x2013;41. 10.1016/j.metabol.2018.01.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.metabol.2018.01.013</ArticleId><ArticleId IdType="pubmed">29374559</ArticleId></ArticleIdList></Reference><Reference><Citation>Mrak RE, Sheng JG, and Griffin WS (1996). Correlation of astrocytic S100 beta expression with dystrophic neurites in amyloid plaques of Alzheimer&#x2019;s disease. J Neuropathol Exp Neurol 55, 273&#x2013;279. 10.1097/00005072-199603000-00002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00005072-199603000-00002</ArticleId><ArticleId IdType="pmc">PMC3833601</ArticleId><ArticleId IdType="pubmed">8786385</ArticleId></ArticleIdList></Reference><Reference><Citation>Ortinski PI, Dong J, Mungenast A, Yue C, Takano H, Watson DJ, Haydon PG, and Coulter DA (2010). Selective induction of astrocytic gliosis generates deficits in neuronal inhibition. Nat Neurosci 13, 584&#x2013;591. 10.1038/nn.2535.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.2535</ArticleId><ArticleId IdType="pmc">PMC3225960</ArticleId><ArticleId IdType="pubmed">20418874</ArticleId></ArticleIdList></Reference><Reference><Citation>Li L, Welser JV, Dore-Duffy P, del Zoppo GJ, Lamanna JC, and Milner R. (2010). In the hypoxic central nervous system, endothelial cell proliferation is followed by astrocyte activation, proliferation, and increased expression of the alpha 6 beta 4 integrin and dystroglycan. Glia 58, 1157&#x2013;1167. 10.1002/glia.20995.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.20995</ArticleId><ArticleId IdType="pmc">PMC2914614</ArticleId><ArticleId IdType="pubmed">20544851</ArticleId></ArticleIdList></Reference><Reference><Citation>Sofroniew MV (2009). Molecular dissection of reactive astrogliosis and glial scar formation. Trends Neurosci 32, 638&#x2013;647. 10.1016/j.tins.2009.08.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tins.2009.08.002</ArticleId><ArticleId IdType="pmc">PMC2787735</ArticleId><ArticleId IdType="pubmed">19782411</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanigami H, Okamoto T, Yasue Y, and Shimaoka M. (2012). Astroglial integrins in the development and regulation of neurovascular units. Pain Res Treat 2012, 964652. 10.1155/2012/964652.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2012/964652</ArticleId><ArticleId IdType="pmc">PMC3529429</ArticleId><ArticleId IdType="pubmed">23304493</ArticleId></ArticleIdList></Reference><Reference><Citation>A M, Wales TE, Zhou H, Draga-Coleta SV, Gorgulla C, Blackmore KA, Mittenbuhler MJ, Kim CR, Bogoslavski, Zhang, et al. (2023). Irisin acts through its integrin receptor in a two-step process involving extracellular Hsp90alpha. Mol Cell 83, 1903&#x2013;1920 e1912. 10.1016/j.molcel.2023.05.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2023.05.008</ArticleId><ArticleId IdType="pmc">PMC10984146</ArticleId><ArticleId IdType="pubmed">37267907</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen WT, Lu A, Craessaerts K, Pavie B, Sala Frigerio C, Corthout N, Qian X, Lalakova J, Kuhnemund M, Voytyuk I, et al. (2020). Spatial Transcriptomics and In Situ Sequencing to Study Alzheimer&#x2019;s Disease. Cell 182, 976&#x2013;991 e919. 10.1016/j.cell.2020.06.038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.06.038</ArticleId><ArticleId IdType="pubmed">32702314</ArticleId></ArticleIdList></Reference><Reference><Citation>Grammas P, Samany PG, and Thirumangalakudi L. (2006). Thrombin and inflammatory proteins are elevated in Alzheimer&#x2019;s disease microvessels: implications for disease pathogenesis. J Alzheimers Dis 9, 51&#x2013;58.</Citation><ArticleIdList><ArticleId IdType="pubmed">16627934</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanaka T, Lavery R, Varma V, Fantoni G, Colpo M, Thambisetty M, Candia J, Resnick SM, Bennett DA, Biancotto A, et al. (2020). Plasma proteomic signatures predict dementia and cognitive impairment. Alzheimers Dement (N Y) 6, e12018. 10.1002/trc2.12018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/trc2.12018</ArticleId><ArticleId IdType="pmc">PMC7210784</ArticleId><ArticleId IdType="pubmed">32607407</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang LY, Guo Q, Guan GF, Cheng W, Cheng P, and Wu AH (2019). Integrin Beta 5 Is a Prognostic Biomarker and Potential Therapeutic Target in Glioblastoma. Front Oncol 9, 904. 10.3389/fonc.2019.00904.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fonc.2019.00904</ArticleId><ArticleId IdType="pmc">PMC6764112</ArticleId><ArticleId IdType="pubmed">31616629</ArticleId></ArticleIdList></Reference><Reference><Citation>Hill MA, and Gammie SC (2022). Alzheimer&#x2019;s disease large-scale gene expression portrait identifies exercise as the top theoretical treatment. Sci Rep 12, 17189. 10.1038/s41598-022-22179-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-22179-z</ArticleId><ArticleId IdType="pmc">PMC9561721</ArticleId><ArticleId IdType="pubmed">36229643</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson KL, and Ferreira A. (2004). alpha1 Integrin activation: a link between beta-amyloid deposition and neuronal death in aging hippocampal neurons. J Neurosci Res 75, 688&#x2013;697. 10.1002/jnr.20018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jnr.20018</ArticleId><ArticleId IdType="pubmed">14991844</ArticleId></ArticleIdList></Reference><Reference><Citation>Czirr E, Castello NA, Mosher KI, Castellano JM, Hinkson IV, Lucin KM, Baeza-Raja B, Ryu JK, Li L, Farina SN, et al. (2017). Microglial complement receptor 3 regulates brain Abeta levels through secreted proteolytic activity. J Exp Med 214, 1081&#x2013;1092. 10.1084/jem.20162011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20162011</ArticleId><ArticleId IdType="pmc">PMC5379986</ArticleId><ArticleId IdType="pubmed">28298456</ArticleId></ArticleIdList></Reference><Reference><Citation>Tzioras M, Davies C, Newman A, Jackson R, and Spires-Jones T. (2019). Invited Review: APOE at the interface of inflammation, neurodegeneration and pathological protein spread in Alzheimer&#x2019;s disease. Neuropathol Appl Neurobiol 45, 327&#x2013;346. 10.1111/nan.12529.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nan.12529</ArticleId><ArticleId IdType="pmc">PMC6563457</ArticleId><ArticleId IdType="pubmed">30394574</ArticleId></ArticleIdList></Reference><Reference><Citation>Huynh TV, Liao F, Francis CM, Robinson GO, Serrano JR, Jiang H, Roh J, Finn MB, Sullivan PM, Esparza TJ, et al. (2017). Age-Dependent Effects of apoE Reduction Using Antisense Oligonucleotides in a Model of beta-amyloidosis. Neuron 96, 1013&#x2013;1023 e1014. 10.1016/j.neuron.2017.11.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2017.11.014</ArticleId><ArticleId IdType="pmc">PMC5728673</ArticleId><ArticleId IdType="pubmed">29216448</ArticleId></ArticleIdList></Reference><Reference><Citation>Alves S, Churlaud G, Audrain M, Michaelsen-Preusse K, Fol R, Souchet B, Braudeau J, Korte M, Klatzmann D, and Cartier N. (2017). Interleukin-2 improves amyloid pathology, synaptic failure and memory in Alzheimer&#x2019;s disease mice. Brain 140, 826&#x2013;842. 10.1093/brain/aww330.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/aww330</ArticleId><ArticleId IdType="pubmed">28003243</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu W, Ocak U, Gao L, Tu S, Lenahan CJ, Zhang J, and Shao A. (2021). Selective autophagy as a therapeutic target for neurological diseases. Cell Mol Life Sci 78, 1369&#x2013;1392. 10.1007/s00018-020-03667-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-020-03667-9</ArticleId><ArticleId IdType="pmc">PMC7904548</ArticleId><ArticleId IdType="pubmed">33067655</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu CC, Hu J, Zhao N, Wang J, Wang N, Cirrito JR, Kanekiyo T, Holtzman DM, and Bu G. (2017). Astrocytic LRP1 Mediates Brain Abeta Clearance and Impacts Amyloid Deposition. J Neurosci 37, 4023&#x2013;4031. 10.1523/JNEUROSCI.3442-16.2017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.3442-16.2017</ArticleId><ArticleId IdType="pmc">PMC5391682</ArticleId><ArticleId IdType="pubmed">28275161</ArticleId></ArticleIdList></Reference><Reference><Citation>Griciuc A, Serrano-Pozo A, Parrado AR, Lesinski AN, Asselin CN, Mullin K, Hooli B, Choi SH, Hyman BT, and Tanzi RE (2013). Alzheimer&#x2019;s disease risk gene CD33 inhibits microglial uptake of amyloid beta. Neuron 78, 631&#x2013;643. 10.1016/j.neuron.2013.04.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2013.04.014</ArticleId><ArticleId IdType="pmc">PMC3706457</ArticleId><ArticleId IdType="pubmed">23623698</ArticleId></ArticleIdList></Reference><Reference><Citation>Benzing WC, Mufson EJ, and Armstrong DM (1993). Alzheimer&#x2019;s disease-like dystrophic neurites characteristically associated with senile plaques are not found within other neurodegenerative diseases unless amyloid beta-protein deposition is present. Brain Res 606, 10&#x2013;18. 10.1016/0006-8993(93)91563-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0006-8993(93)91563-8</ArticleId><ArticleId IdType="pubmed">8096426</ArticleId></ArticleIdList></Reference><Reference><Citation>McAlister GC, Nusinow DP, Jedrychowski MP, Wuhr M, Huttlin EL, Erickson BK, Rad R, Haas W, and Gygi SP (2014). MultiNotch MS3 enables accurate, sensitive, and multiplexed detection of differential expression across cancer cell line proteomes. Anal Chem 86, 7150&#x2013;7158. 10.1021/ac502040v.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/ac502040v</ArticleId><ArticleId IdType="pmc">PMC4215866</ArticleId><ArticleId IdType="pubmed">24927332</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein AM, Mazutis L, Akartuna I, Tallapragada N, Veres A, Li V, Peshkin L, Weitz DA, and Kirschner MW (2015). Droplet barcoding for single-cell transcriptomics applied to embryonic stem cells. Cell 161, 1187&#x2013;1201. 10.1016/j.cell.2015.04.044.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2015.04.044</ArticleId><ArticleId IdType="pmc">PMC4441768</ArticleId><ArticleId IdType="pubmed">26000487</ArticleId></ArticleIdList></Reference><Reference><Citation>Zilionis R, Nainys J, Veres A, Savova V, Zemmour D, Klein AM, and Mazutis L. (2017). Single-cell barcoding and sequencing using droplet microfluidics. Nat Protoc 12, 44&#x2013;73. 10.1038/nprot.2016.154.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nprot.2016.154</ArticleId><ArticleId IdType="pubmed">27929523</ArticleId></ArticleIdList></Reference><Reference><Citation>Tirosh I, Izar B, Prakadan SM, Wadsworth MH 2nd, Treacy D, Trombetta JJ, Rotem A, Rodman C, Lian C, Murphy G, et al. (2016). Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq. Science 352, 189&#x2013;196. 10.1126/science.aad0501.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aad0501</ArticleId><ArticleId IdType="pmc">PMC4944528</ArticleId><ArticleId IdType="pubmed">27124452</ArticleId></ArticleIdList></Reference><Reference><Citation>Finak G, McDavid A, Yajima M, Deng J, Gersuk V, Shalek AK, Slichter CK, Miller HW, McElrath MJ, Prlic M, et al. (2015). MAST: a flexible statistical framework for assessing transcriptional changes and characterizing heterogeneity in single-cell RNA sequencing data. Genome Biol 16, 278. 10.1186/s13059-015-0844-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13059-015-0844-5</ArticleId><ArticleId IdType="pmc">PMC4676162</ArticleId><ArticleId IdType="pubmed">26653891</ArticleId></ArticleIdList></Reference><Reference><Citation>Korsunsky I, Millard N, Fan J, Slowikowski K, Zhang F, Wei K, Baglaenko Y, Brenner M, Loh PR, and Raychaudhuri S. (2019). Fast, sensitive and accurate integration of single-cell data with Harmony. Nat Methods 16, 1289&#x2013;1296. 10.1038/s41592-019-0619-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41592-019-0619-0</ArticleId><ArticleId IdType="pmc">PMC6884693</ArticleId><ArticleId IdType="pubmed">31740819</ArticleId></ArticleIdList></Reference><Reference><Citation>Butler A, Hoffman P, Smibert P, Papalexi E, and Satija R. (2018). Integrating single-cell transcriptomic data across different conditions, technologies, and species. Nat Biotechnol 36, 411&#x2013;420. 10.1038/nbt.4096.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt.4096</ArticleId><ArticleId IdType="pmc">PMC6700744</ArticleId><ArticleId IdType="pubmed">29608179</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenberg SG, and Davies P. (1990). A preparation of Alzheimer paired helical filaments that displays distinct tau proteins by polyacrylamide gel electrophoresis. Proc Natl Acad Sci U S A 87, 5827&#x2013;5831. 10.1073/pnas.87.15.5827.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.87.15.5827</ArticleId><ArticleId IdType="pmc">PMC54421</ArticleId><ArticleId IdType="pubmed">2116006</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37698562</PMID><DateCompleted><Year>2023</Year><Month>09</Month><Day>13</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>30</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1538-3598</ISSN><JournalIssue CitedMedium="Internet"><Volume>330</Volume><Issue>10</Issue><PubDate><Year>2023</Year><Month>Sep</Month><Day>12</Day></PubDate></JournalIssue><Title>JAMA</Title><ISOAbbreviation>JAMA</ISOAbbreviation></Journal><ArticleTitle>Intracerebral Hemorrhage Among Blood Donors and Their Transfusion Recipients.</ArticleTitle><Pagination><StartPage>941</StartPage><EndPage>950</EndPage><MedlinePgn>941-950</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1001/jama.2023.14445</ELocationID><Abstract><AbstractText Label="IMPORTANCE">Recent reports have suggested that cerebral amyloid angiopathy, a common cause of multiple spontaneous intracerebral hemorrhages (ICHs), may be transmissible through parenteral injection of contaminated cadaveric pituitary hormone in humans.</AbstractText><AbstractText Label="OBJECTIVE">To determine whether spontaneous ICH in blood donors after blood donation is associated with development of spontaneous ICH in transfusion recipients.</AbstractText><AbstractText Label="DESIGN, SETTING, AND PARTICIPANTS">Exploratory retrospective cohort study using nationwide blood bank and health register data from Sweden (main cohort) and Denmark (validation cohort) and including all 1&#x202f;089&#x202f;370 patients aged 5 to 80 years recorded to have received a red blood cell transfusion from January 1, 1970 (Sweden), or January 1, 1980 (Denmark), until December 31, 2017.</AbstractText><AbstractText Label="EXPOSURES">Receipt of red blood cell transfusions from blood donors who subsequently developed (1) a single spontaneous ICH, (2) multiple spontaneous ICHs, or (3) no spontaneous ICH.</AbstractText><AbstractText Label="MAIN OUTCOMES AND MEASURES">Spontaneous ICH in transfusion recipients; ischemic stroke was a negative control outcome.</AbstractText><AbstractText Label="RESULTS">A total of 759&#x202f;858 patients from Sweden (median age, 65 [IQR, 48-73] years; 59% female) and 329&#x202f;512 from Denmark (median age, 64 [IQR, 50-73] years; 58% female) were included, with a median follow-up of 5.8 (IQR, 1.4-12.5) years and 6.1 (IQR, 1.5-11.6) years, respectively. Patients who underwent transfusion with red blood cell units from donors who developed multiple spontaneous ICHs had a significantly higher risk of a single spontaneous ICH themselves, compared with patients receiving transfusions from donors who did not develop spontaneous ICH, in both the Swedish cohort (unadjusted incidence rate [IR], 3.16 vs 1.12 per 1000 person-years; adjusted hazard ratio [HR], 2.73; 95% CI, 1.72-4.35; P&#x2009;&lt;&#x2009;.001) and the Danish cohort (unadjusted IR, 2.82 vs 1.09 per 1000 person-years; adjusted HR, 2.32; 95% CI, 1.04-5.19; P&#x2009;=&#x2009;.04). No significant difference was found for patients receiving transfusions from donors who developed a single spontaneous ICH in the Swedish cohort (unadjusted IR, 1.35 vs 1.12 per 1000 person-years; adjusted HR, 1.06; 95% CI, 0.84-1.36; P&#x2009;=&#x2009;.62) nor the Danish cohort (unadjusted IR, 1.36 vs 1.09 per 1000 person-years; adjusted HR, 1.06; 95% CI, 0.70-1.60; P&#x2009;=&#x2009;.73), nor for ischemic stroke as a negative control outcome.</AbstractText><AbstractText Label="CONCLUSIONS AND RELEVANCE">In an exploratory analysis of patients who received red blood cell transfusions, patients who underwent transfusion with red blood cells from donors who later developed multiple spontaneous ICHs were at significantly increased risk of spontaneous ICH themselves. This may suggest a transfusion-transmissible agent associated with some types of spontaneous ICH, although the findings may be susceptible to selection bias and residual confounding, and further research is needed to investigate if transfusion transmission of cerebral amyloid angiopathy might explain this association.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Jingcheng</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Medicine, Solna, Clinical Epidemiology Division, Karolinska Institutet, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rostgaard</LastName><ForeName>Klaus</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Danish Cancer Society Research Center, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lauwers</LastName><ForeName>Elsa</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>VIB Center for Brain and Disease Research, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dahl&#xe9;n</LastName><ForeName>Torsten</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Medicine, Solna, Clinical Epidemiology Division, Karolinska Institutet, Stockholm, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hematology Department, Karolinska University Hospital, Stockholdm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ostrowski</LastName><ForeName>Sisse Rye</ForeName><Initials>SR</Initials><AffiliationInfo><Affiliation>Department of Clinical Immunology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Erikstrup</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Clinical Immunology, Aarhus University Hospital, Aarhus, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pedersen</LastName><ForeName>Ole Birger</ForeName><Initials>OB</Initials><AffiliationInfo><Affiliation>Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Immunology, Zealand University Hospital, K&#xf8;ge, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Strooper</LastName><ForeName>Bart</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>VIB Center for Brain and Disease Research, Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory for the Research of Neurodegenerative Diseases, Department of Neurosciences, Leuven Brain Institute, KU Leuven (University of Leuven), Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Dementia Research Institute, University College London, London, England.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lemmens</LastName><ForeName>Robin</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>VIB Center for Brain and Disease Research, Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory for the Research of Neurodegenerative Diseases, Department of Neurosciences, Leuven Brain Institute, KU Leuven (University of Leuven), Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, University Hospitals Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hjalgrim</LastName><ForeName>Henrik</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Danish Cancer Society Research Center, Copenhagen, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Hematology, Rigshospitalet, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Edgren</LastName><ForeName>Gustaf</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Medicine, Solna, Clinical Epidemiology Division, Karolinska Institutet, Stockholm, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cardiology, S&#xf6;dersjukhuset, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>430</GrantID><Acronym>ALZS_</Acronym><Agency>Alzheimer's Society</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>834682</GrantID><Acronym>ERC_</Acronym><Agency>European Research Council</Agency><Country>International</Country></Grant><Grant><GrantID>MR/Y014847/1</GrantID><Acronym>ERC_</Acronym><Agency>European Research Council</Agency><Country>International</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JAMA</MedlineTA><NlmUniqueID>7501160</NlmUniqueID><ISSNLinking>0098-7484</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>JAMA. 2023 Sep 12;330(10):921-922. doi: 10.1001/jama.2023.14522.</RefSource><PMID Version="1">37698576</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001782" MajorTopicYN="N">Blood Donors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016657" MajorTopicYN="Y">Cerebral Amyloid Angiopathy</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002543" MajorTopicYN="Y">Cerebral Hemorrhage</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000083242" MajorTopicYN="N">Ischemic Stroke</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017707" MajorTopicYN="Y">Erythrocyte Transfusion</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012042" MajorTopicYN="N">Registries</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013548" MajorTopicYN="N" Type="Geographic">Sweden</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003718" MajorTopicYN="N" Type="Geographic">Denmark</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D066027" MajorTopicYN="N">Transplant Recipients</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003141" MajorTopicYN="Y">Communicable Diseases</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000635" MajorTopicYN="N">transmission</QualifierName></MeshHeading></MeshHeadingList><CoiStatement><b>Conflict of Interest Disclosures:</b> Outside of the submitted work, Dr Pedersen reported grants from Danish Regions, the Danish Independent Research Council Research in IBD, and Zealand Region Denmark Research. Dr de Strooper reported consulting for and holding shares in Muna as founding director, being founding director of Agustine, and consulting for Eisai and AbbVie. Dr Hjalgrim reported grants from Helsefonden (21-B-0432) during the conduct of this study. No other disclosures were reported.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>13</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>9</Month><Day>12</Day><Hour>12</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>9</Month><Day>12</Day><Hour>11</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>3</Month><Day>12</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37698562</ArticleId><ArticleId IdType="pmc">PMC10498336</ArticleId><ArticleId IdType="doi">10.1001/jama.2023.14445</ArticleId><ArticleId IdType="pii">2809417</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Biffi A, Greenberg SM. Cerebral amyloid angiopathy: a systematic review. J Clin Neurol. 2011;7(1):1-9. doi:10.3988/jcn.2011.7.1.1</Citation><ArticleIdList><ArticleId IdType="doi">10.3988/jcn.2011.7.1.1</ArticleId><ArticleId IdType="pmc">PMC3079153</ArticleId><ArticleId IdType="pubmed">21519520</ArticleId></ArticleIdList></Reference><Reference><Citation>Charidimou A, Imaizumi T, Moulin S, et al. . Brain hemorrhage recurrence, small vessel disease type, and cerebral microbleeds: a meta-analysis. Neurology. 2017;89(8):820-829. doi:10.1212/WNL.0000000000004259</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000004259</ArticleId><ArticleId IdType="pmc">PMC5580863</ArticleId><ArticleId IdType="pubmed">28747441</ArticleId></ArticleIdList></Reference><Reference><Citation>Meretoja A, Strbian D, Putaala J, et al. . SMASH-U: a proposal for etiologic classification of intracerebral hemorrhage. Stroke. 2012;43(10):2592-2597. doi:10.1161/STROKEAHA.112.661603</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.112.661603</ArticleId><ArticleId IdType="pubmed">22858729</ArticleId></ArticleIdList></Reference><Reference><Citation>Jia Y, Li G, Song G, et al. . SMASH-U aetiological classification: a predictor of long-term functional outcome after intracerebral haemorrhage. Eur J Neurol. 2022;29(1):178-187. doi:10.1111/ene.15111</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.15111</ArticleId><ArticleId IdType="pubmed">34534389</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeh SJ, Tang SC, Tsai LK, Jeng JS. Pathogenetical subtypes of recurrent intracerebral hemorrhage: designations by SMASH-U classification system. Stroke. 2014;45(9):2636-2642. doi:10.1161/STROKEAHA.114.005598</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.114.005598</ArticleId><ArticleId IdType="pubmed">25052320</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaunmuktane Z, Mead S, Ellis M, et al. . Evidence for human transmission of amyloid-&#x3b2; pathology and cerebral amyloid angiopathy. Nature. 2015;525(7568):247-250. doi:10.1038/nature15369</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature15369</ArticleId><ArticleId IdType="pubmed">26354483</ArticleId></ArticleIdList></Reference><Reference><Citation>Purro SA, Farrow MA, Linehan J, et al. . Transmission of amyloid-&#x3b2; protein pathology from cadaveric pituitary growth hormone. Nature. 2018;564(7736):415-419. doi:10.1038/s41586-018-0790-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-018-0790-y</ArticleId><ArticleId IdType="pmc">PMC6708408</ArticleId><ArticleId IdType="pubmed">30546139</ArticleId></ArticleIdList></Reference><Reference><Citation>Ritchie DL, Adlard P, Peden AH, et al. . Amyloid-&#x3b2; accumulation in the CNS in human growth hormone recipients in the UK. Acta Neuropathol. 2017;134(2):221-240. doi:10.1007/s00401-017-1703-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-017-1703-0</ArticleId><ArticleId IdType="pmc">PMC5508038</ArticleId><ArticleId IdType="pubmed">28349199</ArticleId></ArticleIdList></Reference><Reference><Citation>Cali I, Cohen ML, Haik S, et al. . Iatrogenic Creutzfeldt-Jakob disease with amyloid-&#x3b2; pathology: an international study. Acta Neuropathol Commun. 2018;6(1):5. doi:10.1186/s40478-017-0503-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-017-0503-z</ArticleId><ArticleId IdType="pmc">PMC5759292</ArticleId><ArticleId IdType="pubmed">29310723</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaunmuktane Z, Quaegebeur A, Taipa R, et al. . Evidence of amyloid-&#x3b2; cerebral amyloid angiopathy transmission through neurosurgery. Acta Neuropathol. 2018;135(5):671-679. doi:10.1007/s00401-018-1822-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-018-1822-2</ArticleId><ArticleId IdType="pmc">PMC5904220</ArticleId><ArticleId IdType="pubmed">29450646</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyer-Luehmann M, Coomaraswamy J, Bolmont T, et al. . Exogenous induction of cerebral beta-amyloidogenesis is governed by agent and host. Science. 2006;313(5794):1781-1784. doi:10.1126/science.1131864</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1131864</ArticleId><ArticleId IdType="pubmed">16990547</ArticleId></ArticleIdList></Reference><Reference><Citation>Eisele YS, Oberm&#xfc;ller U, Heilbronner G, et al. . Peripherally applied A&#x3b2;-containing inoculates induce cerebral &#x3b2;-amyloidosis. Science. 2010;330(6006):980-982. doi:10.1126/science.1194516</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1194516</ArticleId><ArticleId IdType="pmc">PMC3233904</ArticleId><ArticleId IdType="pubmed">20966215</ArticleId></ArticleIdList></Reference><Reference><Citation>Morales R, Duran-Aniotz C, Bravo-Alegria J, et al. . Infusion of blood from mice displaying cerebral amyloidosis accelerates amyloid pathology in animal models of Alzheimer&#x2019;s disease. Acta Neuropathol Commun. 2020;8(1):213. doi:10.1186/s40478-020-01087-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-020-01087-1</ArticleId><ArticleId IdType="pmc">PMC7720397</ArticleId><ArticleId IdType="pubmed">33287898</ArticleId></ArticleIdList></Reference><Reference><Citation>Burwinkel M, Lutzenberger M, Heppner FL, Schulz-Schaeffer W, Baier M. Intravenous injection of beta-amyloid seeds promotes cerebral amyloid angiopathy (CAA). Acta Neuropathol Commun. 2018;6(1):23. doi:10.1186/s40478-018-0511-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-018-0511-7</ArticleId><ArticleId IdType="pmc">PMC5836327</ArticleId><ArticleId IdType="pubmed">29506560</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown P, Brandel JP, Sato T, et al. . Iatrogenic Creutzfeldt-Jakob disease, final assessment. Emerg Infect Dis. 2012;18(6):901-907. doi:10.3201/eid1806.120116</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid1806.120116</ArticleId><ArticleId IdType="pmc">PMC3358170</ArticleId><ArticleId IdType="pubmed">22607808</ArticleId></ArticleIdList></Reference><Reference><Citation>Lauwers E, Lalli G, Brandner S, et al. . Potential human transmission of amyloid &#x3b2; pathology: surveillance and risks. Lancet Neurol. 2020;19(10):872-878. doi:10.1016/S1474-4422(20)30238-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(20)30238-6</ArticleId><ArticleId IdType="pubmed">32949547</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao J, Rostgaard K, Hjalgrim H, Edgren G. The Swedish Scandinavian Donations and Transfusions Database (SCANDAT3-S)&#x2014;50&#x2009;years of donor and recipient follow-up. Transfusion. 2020;60(12):3019-3027. doi:10.1111/trf.16027</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/trf.16027</ArticleId><ArticleId IdType="pmc">PMC7754339</ArticleId><ArticleId IdType="pubmed">32827155</ArticleId></ArticleIdList></Reference><Reference><Citation>Edgren G, Rostgaard K, Vasan SK, et al. . The new Scandinavian Donations and Transfusions Database (SCANDAT2): a blood safety resource with added versatility. Transfusion. 2015;55(7):1600-1606. doi:10.1111/trf.12986</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/trf.12986</ArticleId><ArticleId IdType="pubmed">25573303</ArticleId></ArticleIdList></Reference><Reference><Citation>Edgren G, Hjalgrim H, Rostgaard K, et al. . Transmission of neurodegenerative disorders through blood transfusion: a cohort study. Ann Intern Med. 2016;165(5):316-324. doi:10.7326/M15-2421</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M15-2421</ArticleId><ArticleId IdType="pubmed">27368068</ArticleId></ArticleIdList></Reference><Reference><Citation>Edgren G, Hjalgrim H, Rostgaard K, et al. ; NHLBI Recipient Epidemiology and Donor Evaluation Study III (REDS-III) . Searching for unknown transfusion-transmitted hepatitis viruses: a binational cohort study of 1.5 million transfused patients. J Intern Med. 2018;284(1):92-103. doi:10.1111/joim.12762</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.12762</ArticleId><ArticleId IdType="pmc">PMC6013371</ArticleId><ArticleId IdType="pubmed">29624755</ArticleId></ArticleIdList></Reference><Reference><Citation>Dahl V, Majeed A, Wikman A, Norda R, Edgren G. Transmission of viral hepatitis through blood transfusion in Sweden, 1968 to 2012. Euro Surveill. 2020;25(29):25. doi:10.2807/1560-7917.ES.2020.25.29.1900537</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.ES.2020.25.29.1900537</ArticleId><ArticleId IdType="pmc">PMC7384284</ArticleId><ArticleId IdType="pubmed">32720634</ArticleId></ArticleIdList></Reference><Reference><Citation>Reijmer YD, van Veluw SJ, Greenberg SM. Ischemic brain injury in cerebral amyloid angiopathy. J Cereb Blood Flow Metab. 2016;36(1):40-54. doi:10.1038/jcbfm.2015.88</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/jcbfm.2015.88</ArticleId><ArticleId IdType="pmc">PMC4758563</ArticleId><ArticleId IdType="pubmed">25944592</ArticleId></ArticleIdList></Reference><Reference><Citation>Shanwell A, Andersson TM, Rostgaard K, et al. . Post-transfusion mortality among recipients of ABO-compatible but non-identical plasma. Vox Sang. 2009;96(4):316-323. doi:10.1111/j.1423-0410.2009.01167.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1423-0410.2009.01167.x</ArticleId><ArticleId IdType="pubmed">19254234</ArticleId></ArticleIdList></Reference><Reference><Citation>Auvinen MK, Zhao J, Lass&#xe9;n E, et al. . Patterns of blood use in Sweden from 2008 to 2017: a nationwide cohort study. Transfusion. 2020;60(11):2529-2536. doi:10.1111/trf.16092</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/trf.16092</ArticleId><ArticleId IdType="pubmed">32964488</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathur MB, Ding P, Riddell CA, VanderWeele TJ. Web site and R package for computing E-values. Epidemiology. 2018;29(5):e45-e47. doi:10.1097/EDE.0000000000000864</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/EDE.0000000000000864</ArticleId><ArticleId IdType="pmc">PMC6066405</ArticleId><ArticleId IdType="pubmed">29912013</ArticleId></ArticleIdList></Reference><Reference><Citation>VanderWeele TJ, Ding P. Sensitivity analysis in observational research: introducing the E-value. Ann Intern Med. 2017;167(4):268-274. doi:10.7326/M16-2607</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M16-2607</ArticleId><ArticleId IdType="pubmed">28693043</ArticleId></ArticleIdList></Reference><Reference><Citation>Hern&#xe1;n MA. The hazards of hazard ratios. Epidemiology. 2010;21(1):13-15. doi:10.1097/EDE.0b013e3181c1ea43</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/EDE.0b013e3181c1ea43</ArticleId><ArticleId IdType="pmc">PMC3653612</ArticleId><ArticleId IdType="pubmed">20010207</ArticleId></ArticleIdList></Reference><Reference><Citation>Rostgaard K. Methods for stratification of person-time and events&#x2014;a prerequisite for Poisson regression and SIR estimation. Epidemiol Perspect Innov. 2008;5:7. doi:10.1186/1742-5573-5-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1742-5573-5-7</ArticleId><ArticleId IdType="pmc">PMC2615420</ArticleId><ArticleId IdType="pubmed">19014582</ArticleId></ArticleIdList></Reference><Reference><Citation>Lambert P. STPM2: Stata Module To Estimate Flexible Parametric Survival Models. Boston College Dept of Economics; 2010.</Citation></Reference><Reference><Citation>Lambert PC. Marginal Estimates Through Regression Standardization in Competing Risks and Relative Survival Models. Stata Users Group; 2020.</Citation></Reference><Reference><Citation>Greenberg SM, Bacskai BJ, Hernandez-Guillamon M, Pruzin J, Sperling R, van Veluw SJ. Cerebral amyloid angiopathy and Alzheimer disease&#x2014;one peptide, two pathways. Nat Rev Neurol. 2020;16(1):30-42. doi:10.1038/s41582-019-0281-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-019-0281-2</ArticleId><ArticleId IdType="pmc">PMC7268202</ArticleId><ArticleId IdType="pubmed">31827267</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaunmuktane Z, Brandner S. The role of prion-like mechanisms in neurodegenerative diseases. Neuropathol Appl Neurobiol. 2020;46(6):522-545. doi:10.1111/nan.12592</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nan.12592</ArticleId><ArticleId IdType="pmc">PMC7687189</ArticleId><ArticleId IdType="pubmed">31868945</ArticleId></ArticleIdList></Reference><Reference><Citation>Banerjee G, Samra K, Adams ME, et al. . Iatrogenic cerebral amyloid angiopathy: an emerging clinical phenomenon. J Neurol Neurosurg Psychiatry. 2022;93:693-700.</Citation><ArticleIdList><ArticleId IdType="pubmed">35577510</ArticleId></ArticleIdList></Reference><Reference><Citation>Friesen M, Meyer-Luehmann M. A&#x3b2; seeding as a tool to study cerebral amyloidosis and associated pathology. Front Mol Neurosci. 2019;12:233. doi:10.3389/fnmol.2019.00233</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2019.00233</ArticleId><ArticleId IdType="pmc">PMC6783493</ArticleId><ArticleId IdType="pubmed">31632238</ArticleId></ArticleIdList></Reference><Reference><Citation>J&#xe4;kel L, De Kort AM, Klijn CJM, Schreuder F, Verbeek MM. Prevalence of cerebral amyloid angiopathy: a systematic review and meta-analysis. Alzheimers Dement. 2022;18(1):10-28. doi:10.1002/alz.12366</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alz.12366</ArticleId><ArticleId IdType="pmc">PMC9290643</ArticleId><ArticleId IdType="pubmed">34057813</ArticleId></ArticleIdList></Reference><Reference><Citation>J&#xe4;kel L, Kuiperij HB, Gerding LP, et al. . Disturbed balance in the expression of MMP9 and TIMP3 in cerebral amyloid angiopathy-related intracerebral haemorrhage. Acta Neuropathol Commun. 2020;8(1):99. doi:10.1186/s40478-020-00972-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-020-00972-z</ArticleId><ArticleId IdType="pmc">PMC7336459</ArticleId><ArticleId IdType="pubmed">32631441</ArticleId></ArticleIdList></Reference><Reference><Citation>McCarron MO, Nicoll JA, Ironside JW, Love S, Alberts MJ, Bone I. Cerebral amyloid angiopathy-related hemorrhage: interaction of APOE &#x3b5;2 with putative clinical risk factors. Stroke. 1999;30(8):1643-1646. doi:10.1161/01.STR.30.8.1643</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.STR.30.8.1643</ArticleId><ArticleId IdType="pubmed">10436115</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37698563</PMID><DateCompleted><Year>2023</Year><Month>09</Month><Day>13</Day></DateCompleted><DateRevised><Year>2024</Year><Month>04</Month><Day>27</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1538-3598</ISSN><JournalIssue CitedMedium="Internet"><Volume>330</Volume><Issue>10</Issue><PubDate><Year>2023</Year><Month>Sep</Month><Day>12</Day></PubDate></JournalIssue><Title>JAMA</Title><ISOAbbreviation>JAMA</ISOAbbreviation></Journal><ArticleTitle>Sedentary Behavior and Incident Dementia Among Older Adults.</ArticleTitle><Pagination><StartPage>934</StartPage><EndPage>940</EndPage><MedlinePgn>934-940</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1001/jama.2023.15231</ELocationID><Abstract><AbstractText Label="IMPORTANCE">Sedentary behavior is associated with cardiometabolic disease and mortality, but its association with dementia is unclear.</AbstractText><AbstractText Label="OBJECTIVE">To investigate whether accelerometer-assessed sedentary behavior is associated with incident dementia.</AbstractText><AbstractText Label="DESIGN, SETTING, AND PARTICIPANTS">A retrospective study of prospectively collected data from the UK Biobank including 49&#x202f;841 adults aged 60 years or older without a diagnosis of dementia at the time of wearing the wrist accelerometer and living in England, Scotland, or Wales. Follow-up began at the time of wearing the accelerometer (February 2013 to December 2015) and continued until September 2021 in England, July 2021 in Scotland, and February 2018 in Wales.</AbstractText><AbstractText Label="EXPOSURES">Mean daily sedentary behavior time (included in the primary analysis) and mean daily sedentary bout length, maximum daily sedentary bout length, and mean number of daily sedentary bouts (included in the secondary analyses) were derived from a machine learning-based analysis of 1 week of wrist-worn accelerometer data.</AbstractText><AbstractText Label="MAIN OUTCOME AND MEASURES">Incident all-cause dementia diagnosis from inpatient hospital records and death registry data. Cox proportional hazard models with linear and cubic spline terms were used to assess associations.</AbstractText><AbstractText Label="RESULTS">A total of 49&#x202f;841 older adults (mean age, 67.19 [SD, 4.29] years; 54.7% were female) were followed up for a mean of 6.72 years (SD, 0.95 years). During this time, 414 individuals were diagnosed with incident all-cause dementia. In the fully adjusted models, there was a significant nonlinear association between time spent in sedentary behavior and incident dementia. Relative to a median of 9.27 hours/d for sedentary behavior, the hazard ratios (HRs) for dementia were 1.08 (95% CI, 1.04-1.12, P&#x2009;&lt;&#x2009;.001) for 10 hours/d, 1.63 (95% CI, 1.35-1.97, P&#x2009;&lt;&#x2009;.001) for 12 hours/d, and 3.21 (95% CI, 2.05-5.04, P&#x2009;&lt;&#x2009;.001) for 15 hours/d. The adjusted incidence rate of dementia per 1000 person-years was 7.49 (95% CI, 7.48-7.49) for 9.27 hours/d of sedentary behavior, 8.06 (95% CI, 7.76-8.36) for 10 hours/d, 12.00 (95% CI, 10.00-14.36) for 12 hours/d, and 22.74 (95% CI, 14.92-34.11) for 15 hours/d. Mean daily sedentary bout length (HR, 1.53 [95% CI, 1.03-2.27], P&#x2009;=&#x2009;.04 and 0.65 [95% CI, 0.04-1.57] more dementia cases per 1000 person-years for a 1-hour increase from the mean of 0.48 hours) and maximum daily sedentary bout length (HR, 1.15 [95% CI, 1.02-1.31], P&#x2009;=&#x2009;.02 and 0.19 [95% CI, 0.02-0.38] more dementia cases per 1000 person-years for a 1-hour increase from the mean of 1.95 hours) were significantly associated with higher risk of incident dementia. The number of sedentary bouts per day was not associated with higher risk of incident dementia (HR, 1.00 [95% CI, 0.99-1.01], P&#x2009;=&#x2009;.89). In the sensitivity analyses, after adjustment for time spent in sedentary behavior, the mean daily sedentary bout length and the maximum daily sedentary bout length were no longer significantly associated with incident dementia.</AbstractText><AbstractText Label="CONCLUSIONS AND RELEVANCE">Among older adults, more time spent in sedentary behaviors was significantly associated with higher incidence of all-cause dementia. Future research is needed to determine whether the association between sedentary behavior and risk of dementia is causal.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Raichlen</LastName><ForeName>David A</ForeName><Initials>DA</Initials><AffiliationInfo><Affiliation>Human and Evolutionary Biology Section, Department of Biological Sciences, University of Southern California, Los Angeles.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anthropology, University of Southern California, Los Angeles.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aslan</LastName><ForeName>Daniel H</ForeName><Initials>DH</Initials><AffiliationInfo><Affiliation>Human and Evolutionary Biology Section, Department of Biological Sciences, University of Southern California, Los Angeles.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sayre</LastName><ForeName>M Katherine</ForeName><Initials>MK</Initials><AffiliationInfo><Affiliation>Human and Evolutionary Biology Section, Department of Biological Sciences, University of Southern California, Los Angeles.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bharadwaj</LastName><ForeName>Pradyumna K</ForeName><Initials>PK</Initials><AffiliationInfo><Affiliation>Department of Psychology, University of Arizona, Tucson.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ally</LastName><ForeName>Madeline</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Psychology, University of Arizona, Tucson.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maltagliati</LastName><ForeName>Silvio</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Universite of Grenoble Alpes, SENS, Grenoble, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lai</LastName><ForeName>Mark H C</ForeName><Initials>MHC</Initials><AffiliationInfo><Affiliation>Department of Psychology, University of Southern California, Los Angeles.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wilcox</LastName><ForeName>Rand R</ForeName><Initials>RR</Initials><AffiliationInfo><Affiliation>Department of Psychology, University of Southern California, Los Angeles.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Klimentidis</LastName><ForeName>Yann C</ForeName><Initials>YC</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Biostatistics, Mel and Enid Zuckerman College of Public Health, University of Arizona, Tucson.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>BIO5 Institute, University of Arizona, Tucson.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alexander</LastName><ForeName>Gene E</ForeName><Initials>GE</Initials><AffiliationInfo><Affiliation>Department of Psychology, University of Arizona, Tucson.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>BIO5 Institute, University of Arizona, Tucson.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Evelyn F. McKnight Brain Institute, University of Arizona, Tucson.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychiatry, University of Arizona, Tucson.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neuroscience Graduate Interdisciplinary Program, University of Arizona, Tucson.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Physiological Sciences Graduate Interdisciplinary Program, University of Arizona, Tucson.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Arizona Alzheimer's Consortium, Phoenix.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P30 AG072980</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AG019610</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG072445</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R56 AG067200</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG064587</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JAMA</MedlineTA><NlmUniqueID>7501160</NlmUniqueID><ISSNLinking>0098-7484</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>JAMA. 2024 Feb 6;331(5):442-443. doi: 10.1001/jama.2023.25172.</RefSource><PMID Version="1">38319336</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003704" MajorTopicYN="Y">Dementia</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004739" MajorTopicYN="N" Type="Geographic">England</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057185" MajorTopicYN="Y">Sedentary Behavior</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D061725" MajorTopicYN="N">Accelerometry</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006113" MajorTopicYN="N" Type="Geographic">United Kingdom</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012042" MajorTopicYN="N">Registries</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading></MeshHeadingList><CoiStatement><b>Conflict of Interest Disclosures:</b> None reported.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>13</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>9</Month><Day>12</Day><Hour>12</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>9</Month><Day>12</Day><Hour>11</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>3</Month><Day>12</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37698563</ArticleId><ArticleId IdType="pmc">PMC10498332</ArticleId><ArticleId IdType="doi">10.1001/jama.2023.15231</ArticleId><ArticleId IdType="pii">2809418</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Matthews CE, Carlson SA, Saint-Maurice PF, et al. . Sedentary behavior in US adults: fall 2019. Med Sci Sports Exerc. 2021;53(12):2512-2519. doi:10.1249/MSS.0000000000002751</Citation><ArticleIdList><ArticleId IdType="doi">10.1249/MSS.0000000000002751</ArticleId><ArticleId IdType="pmc">PMC8595506</ArticleId><ArticleId IdType="pubmed">34310489</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellettiere J, LaMonte MJ, Evenson KR, et al. . Sedentary behavior and cardiovascular disease in older women: the Objective Physical Activity and Cardiovascular Health (OPACH) study. Circulation. 2019;139(8):1036-1046. doi:10.1161/CIRCULATIONAHA.118.035312</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.118.035312</ArticleId><ArticleId IdType="pmc">PMC6481298</ArticleId><ArticleId IdType="pubmed">31031411</ArticleId></ArticleIdList></Reference><Reference><Citation>Ekelund U, Tarp J, Steene-Johannessen J, et al. . Dose-response associations between accelerometry measured physical activity and sedentary time and all cause mortality: systematic review and harmonised meta-analysis. BMJ. 2019;366:l4570. doi:10.1136/bmj.l4570</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.l4570</ArticleId><ArticleId IdType="pmc">PMC6699591</ArticleId><ArticleId IdType="pubmed">31434697</ArticleId></ArticleIdList></Reference><Reference><Citation>Bakrania K, Edwardson CL, Khunti K, Bandelow S, Davies MJ, Yates T. Associations between sedentary behaviors and cognitive function: cross-sectional and prospective findings from the UK Biobank. Am J Epidemiol. 2018;187(3):441-454. doi:10.1093/aje/kwx273</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/aje/kwx273</ArticleId><ArticleId IdType="pubmed">28992036</ArticleId></ArticleIdList></Reference><Reference><Citation>Siddarth P, Burggren AC, Eyre HA, Small GW, Merrill DA. Sedentary behavior associated with reduced medial temporal lobe thickness in middle-aged and older adults. PLoS One. 2018;13(4):e0195549. doi:10.1371/journal.pone.0195549</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0195549</ArticleId><ArticleId IdType="pmc">PMC5896959</ArticleId><ArticleId IdType="pubmed">29649304</ArticleId></ArticleIdList></Reference><Reference><Citation>Tremblay MS, Aubert S, Barnes JD, et al. ; SBRN Terminology Consensus Project Participants . Sedentary Behavior Research Network (SBRN)&#x2013;terminology consensus project process and outcome. Int J Behav Nutr Phys Act. 2017;14(1):75. doi:10.1186/s12966-017-0525-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12966-017-0525-8</ArticleId><ArticleId IdType="pmc">PMC5466781</ArticleId><ArticleId IdType="pubmed">28599680</ArticleId></ArticleIdList></Reference><Reference><Citation>Raichlen DA, Klimentidis YC, Sayre MK, et al. . Leisure-time sedentary behaviors are differentially associated with all-cause dementia regardless of engagement in physical activity. Proc Natl Acad Sci U S A. 2022;119(35):e2206931119. doi:10.1073/pnas.2206931119</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2206931119</ArticleId><ArticleId IdType="pmc">PMC9436362</ArticleId><ArticleId IdType="pubmed">35994664</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen S, LaCroix AZ, Hayden KM, et al. . Accelerometer-measured physical activity and sitting with incident mild cognitive impairment or probable dementia among older women. Alzheimers Dement. 2023;19(7):3041-3054. doi:10.1002/alz.12908</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alz.12908</ArticleId><ArticleId IdType="pmc">PMC10366337</ArticleId><ArticleId IdType="pubmed">36695426</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudlow C, Gallacher J, Allen N, et al. . UK Biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med. 2015;12(3):e1001779. doi:10.1371/journal.pmed.1001779</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1001779</ArticleId><ArticleId IdType="pmc">PMC4380465</ArticleId><ArticleId IdType="pubmed">25826379</ArticleId></ArticleIdList></Reference><Reference><Citation>Doherty A, Jackson D, Hammerla N, et al. . Large scale population assessment of physical activity using wrist worn accelerometers: the UK Biobank study. PLoS One. 2017;12(2):e0169649. doi:10.1371/journal.pone.0169649</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0169649</ArticleId><ArticleId IdType="pmc">PMC5287488</ArticleId><ArticleId IdType="pubmed">28146576</ArticleId></ArticleIdList></Reference><Reference><Citation>Walmsley R, Chan S, Smith-Byrne K, et al. . Reallocation of time between device-measured movement behaviours and risk of incident cardiovascular disease. Br J Sports Med. 2021;56(18):1008-1017. doi:10.1136/bjsports-2021-104050</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bjsports-2021-104050</ArticleId><ArticleId IdType="pmc">PMC9484395</ArticleId><ArticleId IdType="pubmed">34489241</ArticleId></ArticleIdList></Reference><Reference><Citation>Ainsworth BE, Haskell WL, Herrmann SD, et al. . 2011 Compendium of Physical Activities: a second update of codes and MET values. Med Sci Sports Exerc. 2011;43(8):1575-1581. doi:10.1249/MSS.0b013e31821ece12</Citation><ArticleIdList><ArticleId IdType="doi">10.1249/MSS.0b013e31821ece12</ArticleId><ArticleId IdType="pubmed">21681120</ArticleId></ArticleIdList></Reference><Reference><Citation>Lourida I, Hannon E, Littlejohns TJ, et al. . Association of lifestyle and genetic risk with incidence of dementia. JAMA. 2019;322(5):430-437. doi:10.1001/jama.2019.9879</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2019.9879</ArticleId><ArticleId IdType="pmc">PMC6628594</ArticleId><ArticleId IdType="pubmed">31302669</ArticleId></ArticleIdList></Reference><Reference><Citation>Schoenfeld D. Partial residuals for the proportional hazards regression model. Biometrika. 1982;69(1):239-241. doi:10.1093/biomet/69.1.239</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/biomet/69.1.239</ArticleId></ArticleIdList></Reference><Reference><Citation>Yerramalla MS, van Hees VT, Chen M, Fayosse A, Chastin SF, Sabia S. Objectively measured total sedentary time and pattern of sedentary accumulation in older adults: associations with incident cardiovascular disease and all-cause mortality. J Gerontol A Biol Sci Med Sci. 2022;77(4):842-850.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8974336</ArticleId><ArticleId IdType="pubmed">35094083</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilcox RR. Introduction to Robust Estimation and Hypothesis Testing. 5th ed. Academic Press; 2022.</Citation></Reference><Reference><Citation>Van Buuren S, Groothuis-Oudshoorn K. MICE: multivariate imputation by chained equations in R. J Stat Softw. 2011;45:1-67. doi:10.18637/jss.v045.i03</Citation><ArticleIdList><ArticleId IdType="doi">10.18637/jss.v045.i03</ArticleId></ArticleIdList></Reference><Reference><Citation>Del Pozo Cruz B, Ahmadi M, Naismith SL, Stamatakis E. Association of daily step count and intensity with incident dementia in 78 430 adults living in the UK. JAMA Neurol. 2022;79(10):1059-1063. doi:10.1001/jamaneurol.2022.2672</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2022.2672</ArticleId><ArticleId IdType="pmc">PMC9449869</ArticleId><ArticleId IdType="pubmed">36066874</ArticleId></ArticleIdList></Reference><Reference><Citation>Rabin JS, Klein H, Kirn DR, et al. . Associations of physical activity and &#x3b2;-amyloid with longitudinal cognition and neurodegeneration in clinically normal older adults. JAMA Neurol. 2019;76(10):1203-1210. doi:10.1001/jamaneurol.2019.1879</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2019.1879</ArticleId><ArticleId IdType="pmc">PMC6635892</ArticleId><ArticleId IdType="pubmed">31312836</ArticleId></ArticleIdList></Reference><Reference><Citation>Falck RS, Davis JC, Liu-Ambrose T. What is the association between sedentary behaviour and cognitive function? a systematic review. Br J Sports Med. 2017;51(10):800-811. doi:10.1136/bjsports-2015-095551</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bjsports-2015-095551</ArticleId><ArticleId IdType="pubmed">27153869</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37698576</PMID><DateCompleted><Year>2023</Year><Month>09</Month><Day>13</Day></DateCompleted><DateRevised><Year>2023</Year><Month>09</Month><Day>14</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1538-3598</ISSN><JournalIssue CitedMedium="Internet"><Volume>330</Volume><Issue>10</Issue><PubDate><Year>2023</Year><Month>Sep</Month><Day>12</Day></PubDate></JournalIssue><Title>JAMA</Title><ISOAbbreviation>JAMA</ISOAbbreviation></Journal><ArticleTitle>Blood Transfusion and Brain Amyloidosis: Should We Be Worried?</ArticleTitle><Pagination><StartPage>921</StartPage><EndPage>922</EndPage><MedlinePgn>921-922</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1001/jama.2023.14522</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Greenberg</LastName><ForeName>Steven M</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Hemorrhagic Stroke Research Program, Massachusetts General Hospital, Department of Neurology, Harvard Medical School, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016421">Editorial</PublicationType><PublicationType UI="D016420">Comment</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JAMA</MedlineTA><NlmUniqueID>7501160</NlmUniqueID><ISSNLinking>0098-7484</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentOn"><RefSource>JAMA. 2023 Sep 12;330(10):941-950. doi: 10.1001/jama.2023.14445.</RefSource><PMID Version="1">37698562</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D001803" MajorTopicYN="Y">Blood Transfusion</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000686" MajorTopicYN="Y">Amyloidosis</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001927" MajorTopicYN="Y">Brain Diseases</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>13</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>9</Month><Day>12</Day><Hour>12</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>9</Month><Day>12</Day><Hour>11</Hour><Minute>4</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37698576</ArticleId><ArticleId IdType="doi">10.1001/jama.2023.14522</ArticleId><ArticleId IdType="pii">2809443</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37704597</PMID><DateCompleted><Year>2023</Year><Month>09</Month><Day>15</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>23</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2041-1723</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Sep</Month><Day>13</Day></PubDate></JournalIssue><Title>Nature communications</Title><ISOAbbreviation>Nat Commun</ISOAbbreviation></Journal><ArticleTitle>CSF proteome profiling reveals biomarkers to discriminate dementia with Lewy bodies from Alzheimer&#xb4;s disease.</ArticleTitle><Pagination><StartPage>5635</StartPage><MedlinePgn>5635</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">5635</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41467-023-41122-y</ELocationID><Abstract><AbstractText>Diagnosis of dementia with Lewy bodies (DLB) is challenging and specific biofluid biomarkers are highly needed. We employed proximity extension-based assays to measure 665 proteins in the cerebrospinal fluid (CSF) from patients with DLB (n&#x2009;=&#x2009;109), Alzheimer&#xb4;s disease (AD, n&#x2009;=&#x2009;235) and cognitively unimpaired controls (n&#x2009;=&#x2009;190). We identified over 50 CSF proteins dysregulated in DLB, enriched in myelination processes among others. The dopamine biosynthesis enzyme DDC was the strongest dysregulated protein, and could efficiently discriminate DLB from controls and AD (AUC:0.91 and 0.81 respectively). Classification modeling unveiled a 7-CSF biomarker panel that better discriminate DLB from AD (AUC:0.93). A custom multiplex panel for six of these markers (DDC, CRH, MMP-3, ABL1, MMP-10, THOP1) was developed and validated in independent cohorts, including an AD and DLB autopsy cohort. This DLB CSF proteome study identifies DLB-specific protein changes and translates these findings to a practicable biomarker panel that accurately identifies DLB patients, providing promising diagnostic and clinical trial testing opportunities.</AbstractText><CopyrightInformation>&#xa9; 2023. Springer Nature Limited.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Del Campo</LastName><ForeName>Marta</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-2808-3699</Identifier><AffiliationInfo><Affiliation>Neurochemistry Laboratory and Biobank, Department of Clinical Chemistry, Amsterdam Neuroscience, Amsterdam University Medical Centers, Location VUmc, Amsterdam, The Netherlands. mcampo@barcelonabeta.org.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Barcelona&#xdf;eta Brain Research Center, Pasqual Maragall Foundation, Barcelona, Spain. mcampo@barcelonabeta.org.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Departamento de Ciencias Farmac&#xe9;uticas y de la Salud, Facultad de Farmacia, Universidad San Pablo-CEU, CEU Universities, Madrid, Spain. mcampo@barcelonabeta.org.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vermunt</LastName><ForeName>Lisa</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Neurochemistry Laboratory and Biobank, Department of Clinical Chemistry, Amsterdam Neuroscience, Amsterdam University Medical Centers, Location VUmc, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Amsterdam University Medical Centers, Location VUmc, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peeters</LastName><ForeName>Carel F W</ForeName><Initials>CFW</Initials><AffiliationInfo><Affiliation>Mathematical &amp; Statistical Methods group (Biometris), Wageningen University &amp; Research, Wageningen, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sieben</LastName><ForeName>Anne</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Lab of neuropathology, Neurobiobank, Institute Born-Bunge, Antwerp University, Edegem, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hok-A-Hin</LastName><ForeName>Yanaika S</ForeName><Initials>YS</Initials><Identifier Source="ORCID">0000-0001-9713-116X</Identifier><AffiliationInfo><Affiliation>Neurochemistry Laboratory and Biobank, Department of Clinical Chemistry, Amsterdam Neuroscience, Amsterdam University Medical Centers, Location VUmc, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lle&#xf3;</LastName><ForeName>Alberto</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neurology, Institut d'Investigacions Biom&#xe8;diques Sant Pau (IIB SANT PAU) - Hospital de Sant Pau, Universitat Aut&#xf2;noma de Barcelona, Hospital de la Santa Creu i Sant Pau, Barcelona, Catalunya, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center of Biomedical Investigation Network for Neurodegenerative Diseases (CIBERNED), Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alcolea</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-3819-3245</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Institut d'Investigacions Biom&#xe8;diques Sant Pau (IIB SANT PAU) - Hospital de Sant Pau, Universitat Aut&#xf2;noma de Barcelona, Hospital de la Santa Creu i Sant Pau, Barcelona, Catalunya, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center of Biomedical Investigation Network for Neurodegenerative Diseases (CIBERNED), Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Nee</LastName><ForeName>Mirrelijn</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Epidemiology &amp; Data Science, Amsterdam Public Health research institute, Amsterdam University Medical Centers, Location VUmc, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Engelborghs</LastName><ForeName>Sebastiaan</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-0304-9785</Identifier><AffiliationInfo><Affiliation>Reference Center for Biological Markers of Dementia (BIODEM), Laboratory of Neurochemistry and Behavior, Institute Born-Bunge, University of Antwerp, Antwerp, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Vrije Universiteit Brussel, Center for Neurosciences (C4N), Neuroprotection and Neuromodulation Research Group (NEUR), Brussels, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Universitair Ziekenhuis Brussel, Department of Neurology, Brussels, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Alphen</LastName><ForeName>Juliette L</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Amsterdam University Medical Centers, Location VUmc, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arezoumandan</LastName><ForeName>Sanaz</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen-Plotkin</LastName><ForeName>Alice</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Irwin</LastName><ForeName>David J</ForeName><Initials>DJ</Initials><AffiliationInfo><Affiliation>Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van der Flier</LastName><ForeName>Wiesje M</ForeName><Initials>WM</Initials><Identifier Source="ORCID">0000-0001-8766-6224</Identifier><AffiliationInfo><Affiliation>Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Amsterdam University Medical Centers, Location VUmc, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Epidemiology &amp; Data Science, Amsterdam Public Health research institute, Amsterdam University Medical Centers, Location VUmc, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lemstra</LastName><ForeName>Afina W</ForeName><Initials>AW</Initials><AffiliationInfo><Affiliation>Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Amsterdam University Medical Centers, Location VUmc, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Teunissen</LastName><ForeName>Charlotte E</ForeName><Initials>CE</Initials><Identifier Source="ORCID">0000-0002-4061-0837</Identifier><AffiliationInfo><Affiliation>Neurochemistry Laboratory and Biobank, Department of Clinical Chemistry, Amsterdam Neuroscience, Amsterdam University Medical Centers, Location VUmc, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P30 AG010124</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P50 NS053488</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 ES013508</GrantID><Acronym>ES</Acronym><Agency>NIEHS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P01 AG066597</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U19 AG062418</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AG072979</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>09</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nat Commun</MedlineTA><NlmUniqueID>101528555</NlmUniqueID><ISSNLinking>2041-1723</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D020543">Proteome</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Cell Chem Biol. 2023 Nov 16;30(11):1340-1342. doi: 10.1016/j.chembiol.2023.10.018.</RefSource><PMID Version="1">37977130</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020961" MajorTopicYN="Y">Lewy Body Disease</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020543" MajorTopicYN="N">Proteome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001344" MajorTopicYN="N">Autopsy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>M.C. has been an invited speaker at Eisai, is an associate editor at Alzheimer&#xb4;s Research &amp; Therapy and has been an invited writer for Springer Healthcare. L.V. received a grant for CORAL consortium by Olink. D.I. is a Scientific Advisory Board Member for Denali Therapeutics. D.A. participated in advisory boards from Fujirebio-Europe and Roche Diagnostics and received speaker honoraria from Fujirebio-Europe, Roche Diagnostics, Nutricia, Krka Farmac&#xe9;utica S.L., Zambon S.A.U. and Esteve Pharmaceuticals S.A. D.A., and A.L. declare a filed patent application (Title: Markers of synaptopathy in neurodegenerative disease; Applicant: Fundaci&#xf3; Institut de Recerca de l&#x2019;Hospital de la Santa Creu i Sant Pau, Inventors: Olivia BELBIN; Alberto LLE&#xd3;; Alejandro BAY&#xc9;S; Juan FORTEA; Daniel ALCOLEA; Application number: PCT/EP2019/056535; International Publication Number: WO 2019/175379 A1; Current status: Active. Licensed to ADx Neurociences NV (Ghent, Belgium); This patent is not related to any specific aspect of the current manuscript). W.F. has performed contract research for Biogen MA Inc, and Boehringer Ingelheim. W.F. has been an invited speaker at Boehringer Ingelheim, Biogen MA Inc, Danone, Eisai, WebMD Neurology (Medscape), Springer Healthcare. W.F. is consultant to Oxford Health Policy Forum CIC, Roche, and Biogen MA Inc. WF participated in advisory boards of Biogen MA Inc and Roche. All funding is paid to her institution. W.F. is a member of the steering committee of PAVE, and Think Brain Health. WF was associate editor of Alzheimer, Research &amp; Therapy in 2020/2021. W.F. is an associate editor at Brain. C.E.T. has a collaboration contract with ADx Neurosciences, Quanterix and Eli Lilly, performed contract research or received grants from AC-Immune, Axon Neurosciences, Bioconnect, Bioorchestra, Brainstorm Therapeutics, Celgene, EIP Pharma, Eisai, Grifols, Novo Nordisk, PeopleBio, Roche, Toyama, Vivoryon. She serves on editorial boards of Medidact Neurologie/Springer, Alzheimer Research and Therapy, Neurology: Neuroimmunology &amp; Neuroinflammation, and is editor of a Neuromethods book Springer. She had speaker contracts for Roche, Grifols, Novo Nordisk. The rest of the authors declare no competing interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>12</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>8</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>15</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>9</Month><Day>14</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>9</Month><Day>13</Day><Hour>23</Hour><Minute>15</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>9</Month><Day>13</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37704597</ArticleId><ArticleId IdType="pmc">PMC10499811</ArticleId><ArticleId IdType="doi">10.1038/s41467-023-41122-y</ArticleId><ArticleId IdType="pii">10.1038/s41467-023-41122-y</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>McKeith I, et al. Dementia with Lewy bodies. Lancet Neurol. 2004;3:19&#x2013;28.</Citation><ArticleIdList><ArticleId IdType="pubmed">14693108</ArticleId></ArticleIdList></Reference><Reference><Citation>Spillantini MG, et al. &#x3b1;-Synuclein in Lewy bodies. Nature. 1997;388:839&#x2013;840.</Citation><ArticleIdList><ArticleId IdType="pubmed">9278044</ArticleId></ArticleIdList></Reference><Reference><Citation>Nelson PT, et al. Low sensitivity in clinical diagnoses of dementia with Lewy bodies. J. Neurol. 2010;257:359&#x2013;366.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2839040</ArticleId><ArticleId IdType="pubmed">19795154</ArticleId></ArticleIdList></Reference><Reference><Citation>McKeith IG, et al. Diagnosis and management of dementia with Lewy bodies Fourth consensus report of the DLB Consortium. Neurology. 2017;89:1&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5496518</ArticleId><ArticleId IdType="pubmed">28592453</ArticleId></ArticleIdList></Reference><Reference><Citation>Donadio V, et al. A new potential biomarker for dementia with Lewy bodies. Neurology. 2017;89:318&#x2013;326.</Citation><ArticleIdList><ArticleId IdType="pubmed">28667178</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Z-Y, et al. Use of CSF &#x3b1;-synuclein in the differential diagnosis between Alzheimer&#x2019;s disease and other neurodegenerative disorders. Int Psychogeriatr. 2015;27:1429&#x2013;1438.</Citation><ArticleIdList><ArticleId IdType="pubmed">25851548</ArticleId></ArticleIdList></Reference><Reference><Citation>Slaets, S. et al. Increased CSF a-synuclein levels in Alzheimer&#x2019;s disease: Correlation with tau levels. Alzheimer&#x2019;s Dement.10, S290&#x2013;S298 (2014).</Citation><ArticleIdList><ArticleId IdType="pubmed">24439167</ArticleId></ArticleIdList></Reference><Reference><Citation>Kasuga K, Nishizawa M, Ikeuchi T. &#x3b1;-synuclein as CSF and blood biomarker of dementia with Lewy bodies. Int. J. Alzheimer&#x2019;s Dis. 2012;2012:437025.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3463927</ArticleId><ArticleId IdType="pubmed">23056991</ArticleId></ArticleIdList></Reference><Reference><Citation>Groveman BR, et al. Rapid and ultra-sensitive quantitation of disease-associated &#x3b1;-synuclein seeds in brain and cerebrospinal fluid by &#x3b1;Syn RT-QuIC. Acta Neuropathol. Commun. 2018;6:7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5806364</ArticleId><ArticleId IdType="pubmed">29422107</ArticleId></ArticleIdList></Reference><Reference><Citation>Fairfoul G, et al. Alpha-synuclein RT-QuIC in the CSF of patients with alpha-synucleinopathies. Ann. Clin. Transl. Neurol. 2016;3:812&#x2013;818.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5048391</ArticleId><ArticleId IdType="pubmed">27752516</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossi M, et al. Ultrasensitive RT-QuIC assay with high sensitivity and specificity for Lewy body-associated synucleinopathies. Acta Neuropathol. 2020;140:49&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7299922</ArticleId><ArticleId IdType="pubmed">32342188</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Z, et al. Skin &#x3b1;-synuclein aggregation seeding activity as a novel biomarker for parkinson disease. JAMA Neurol. 2021;78:30&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7522783</ArticleId><ArticleId IdType="pubmed">32986090</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson JL, et al. Neurodegenerative disease concomitant proteinopathies are prevalent, age-related and APOE4-associated. Brain. 2018;141:2181&#x2013;2193.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6022546</ArticleId><ArticleId IdType="pubmed">29878075</ArticleId></ArticleIdList></Reference><Reference><Citation>McKhann GM, et al. The diagnosis of dementia due to Alzheimer&#x2019;s disease: recommendations from the National Institute on Aging-Alzheimer&#x2019;s Association workgroups on diagnostic guidelines for Alzheimer&#x2019;s disease. Alzheimers Dement. 2011;7:263&#x2013;269.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3312024</ArticleId><ArticleId IdType="pubmed">21514250</ArticleId></ArticleIdList></Reference><Reference><Citation>van Harten AC, et al. Tau and p-tau as CSF biomarkers in dementia: a meta-analysis. Clin. Chem. Lab Med. 2011;49:353&#x2013;366.</Citation><ArticleIdList><ArticleId IdType="pubmed">21342021</ArticleId></ArticleIdList></Reference><Reference><Citation>Parnetti L, et al. CSF phosphorylated tau is a possible marker for discriminating Alzheimer&#x2019;s disease from dementia with Lewy bodies E. Vanmechelen 2 @BULLET F. Hulstaert 2 for the Phospho-Tau International Study Group*. Neurol. Sci. 2001;22:77&#x2013;78.</Citation><ArticleIdList><ArticleId IdType="pubmed">11487210</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersson M, Zetterberg H, Minthon L, Blennow K, Londos E. The cognitive profile and CSF biomarkers in dementia with Lewy bodies and Parkinson&#x2019;s disease dementia. Int J. Geriatr. Psychiatry. 2011;26:100&#x2013;105.</Citation><ArticleIdList><ArticleId IdType="pubmed">21157855</ArticleId></ArticleIdList></Reference><Reference><Citation>van Steenoven I, et al. Cerebrospinal fluid Alzheimer&#x2019;s disease biomarkers across the spectrum of Lewy body diseases: results from a large multicenter cohort. J. Alzheimers Dis. 2016;54:287&#x2013;295.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5535729</ArticleId><ArticleId IdType="pubmed">27567832</ArticleId></ArticleIdList></Reference><Reference><Citation>Bader, J. M. et al. Proteome profiling in cerebrospinal fluid reveals novel biomarkers of Alzheimer&#x2019; s disease. Mol. Syst. Biol.16, e9356 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7266499</ArticleId><ArticleId IdType="pubmed">32485097</ArticleId></ArticleIdList></Reference><Reference><Citation>Higginbotham L, et al. Integrated proteomics reveals brain-based cerebrospinal fluid biomarkers in asymptomatic and symptomatic Alzheimer&#x2019;s disease. Sci. Adv. 2020;6:eaaz9360.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7577712</ArticleId><ArticleId IdType="pubmed">33087358</ArticleId></ArticleIdList></Reference><Reference><Citation>del Campo M, et al. CSF proteome profiling across the Alzheimer&#x2019;s disease spectrum reflects the multifactorial nature of the disease and identifies specific biomarker panels. Nat. Aging. 2022;2:1040&#x2013;1053.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10292920</ArticleId><ArticleId IdType="pubmed">37118088</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Steenoven I, et al. Identification of novel cerebrospinal fluid biomarker candidates for dementia with Lewy bodies: a proteomic approach. Mol. Neurodegener. 2020;15:36.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7301448</ArticleId><ArticleId IdType="pubmed">32552841</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdi F, et al. Detection of biomarkers with a multiplex quantitative proteomic platform in cerebrospinal fluid of patients with neurodegenerative disorders. J. Alzheimers Dis. 2006;9:293&#x2013;348.</Citation><ArticleIdList><ArticleId IdType="pubmed">16914840</ArticleId></ArticleIdList></Reference><Reference><Citation>Dieks JK, et al. Low-abundant cerebrospinal fluid proteome alterations in dementia with Lewy bodies. J. Alzheimers Dis. 2013;34:387&#x2013;397.</Citation><ArticleIdList><ArticleId IdType="pubmed">23254635</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Bryant SE, et al. A proteomic signature for dementia with Lewy bodies. Alzheimer&#x2019;s Dement.: Diagnosis, Assess. Dis. Monit. 2019;11:270&#x2013;276.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6424013</ArticleId><ArticleId IdType="pubmed">30923734</ArticleId></ArticleIdList></Reference><Reference><Citation>Enroth S, et al. High throughput proteomics identifies a high-accuracy 11 plasma protein biomarker signature for ovarian cancer. Commun. Biol. 2019;2:221.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6586828</ArticleId><ArticleId IdType="pubmed">31240259</ArticleId></ArticleIdList></Reference><Reference><Citation>Eikelboom WS, et al. Neuropsychiatric and cognitive symptoms across the alzheimer disease clinical spectrum: cross-sectional and longitudinal associations. Neurology. 2021;97:e1276.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8480405</ArticleId><ArticleId IdType="pubmed">34413181</ArticleId></ArticleIdList></Reference><Reference><Citation>Cummings JL. The Neuropsychiatric Inventory. Neurology. 1997;48:10S&#x2013;16S.</Citation><ArticleIdList><ArticleId IdType="pubmed">9153155</ArticleId></ArticleIdList></Reference><Reference><Citation>Goetz CG, et al. Movement Disorder Society-sponsored revision of the Unified Parkinson&#x2019;s Disease Rating Scale (MDS-UPDRS): Scale presentation and clinimetric testing results. Mov. Disord. 2008;23:2129&#x2013;2170.</Citation><ArticleIdList><ArticleId IdType="pubmed">19025984</ArticleId></ArticleIdList></Reference><Reference><Citation>Braak H, et al. Staging of brain pathology related to sporadic Parkinson&#x2019;s disease. Neurobiol. Aging. 2003;24:197&#x2013;211.</Citation><ArticleIdList><ArticleId IdType="pubmed">12498954</ArticleId></ArticleIdList></Reference><Reference><Citation>McKeith IG, et al. Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium. Neurology. 2017;89:88&#x2013;100.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5496518</ArticleId><ArticleId IdType="pubmed">28592453</ArticleId></ArticleIdList></Reference><Reference><Citation>Marek K, et al. The Parkinson&#x2019;s progression markers initiative (PPMI)&#x2014;establishing a PD biomarker cohort. Ann. Clin. Transl. Neurol. 2018;5:1460&#x2013;1477.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6292383</ArticleId><ArticleId IdType="pubmed">30564614</ArticleId></ArticleIdList></Reference><Reference><Citation>Scott GD, et al. Fluid and tissue biomarkers of Lewy body dementia: report of an LBDA Symposium. Front. Neurol. 2022;12:2624.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8841880</ArticleId><ArticleId IdType="pubmed">35173668</ArticleId></ArticleIdList></Reference><Reference><Citation>Rabinovici GD, et al. Multiple comorbid neuropathologies in the setting of Alzheimer&#x2019;s disease neuropathology and implications for drug development. Alzheimer&#x2019;s Dement. Transl. Res. Clin. Interventions. 2017;3:83&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5651346</ArticleId><ArticleId IdType="pubmed">29067320</ArticleId></ArticleIdList></Reference><Reference><Citation>van Steenoven I, et al. Identification of novel cerebrospinal fluid biomarker candidates for dementia with Lewy bodies: a proteomic approach. Mol. Neurodegener. 2020;15:1&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7301448</ArticleId><ArticleId IdType="pubmed">32552841</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajkumar AP, et al. Next-generation RNA-sequencing of serum small extracellular vesicles discovers potential diagnostic biomarkers for dementia with Lewy bodies. Am. J. Geriatr. Psychiatry. 2021;29:573&#x2013;584.</Citation><ArticleIdList><ArticleId IdType="pubmed">33160816</ArticleId></ArticleIdList></Reference><Reference><Citation>Feleke R, et al. Cross-platform transcriptional profiling identifies common and distinct molecular pathologies in Lewy body diseases. Acta Neuropathol. 2021;142:449&#x2013;474.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8357687</ArticleId><ArticleId IdType="pubmed">34309761</ArticleId></ArticleIdList></Reference><Reference><Citation>Pietrzak M, et al. Gene expression profiling of brain samples from patients with Lewy body dementia. Biochem. Biophys. Res. Commun. 2016;479:875.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5079284</ArticleId><ArticleId IdType="pubmed">27666482</ArticleId></ArticleIdList></Reference><Reference><Citation>Erskine D, et al. Molecular changes in the absence of severe pathology in the pulvinar in dementia with Lewy bodies. Mov. Disord. 2018;33:982&#x2013;991.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6172958</ArticleId><ArticleId IdType="pubmed">29570843</ArticleId></ArticleIdList></Reference><Reference><Citation>Grigoletto J, et al. Higher levels of myelin phospholipids in brains of neuronal &#x3b1;-Synuclein transgenic mice precede myelin loss. Acta Neuropathol. Commun. 2017;5:37.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5421332</ArticleId><ArticleId IdType="pubmed">28482862</ArticleId></ArticleIdList></Reference><Reference><Citation>Ettle B, et al. &#x3b1;-Synuclein-induced myelination deficit defines a novel interventional target for multiple system atrophy. Acta Neuropathol. 2016;132:59.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4912450</ArticleId><ArticleId IdType="pubmed">27059609</ArticleId></ArticleIdList></Reference><Reference><Citation>Belda X, Armario A. Dopamine D1 and D2 dopamine receptors regulate immobilization stress-induced activation of the hypothalamus-pituitary-adrenal axis. Psychopharmacology (Berl.) 2009;206:355&#x2013;365.</Citation><ArticleIdList><ArticleId IdType="pubmed">19621214</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsigos C, Chrousos GP. Hypothalamic&#x2013;pituitary&#x2013;adrenal axis, neuroendocrine factors and stress. J. Psychosom. Res. 2002;53:865&#x2013;871.</Citation><ArticleIdList><ArticleId IdType="pubmed">12377295</ArticleId></ArticleIdList></Reference><Reference><Citation>Schultz K, et al. Reduced CSF CART in dementia with Lewy bodies. Neurosci. Lett. 2009;453:104&#x2013;106.</Citation><ArticleIdList><ArticleId IdType="pubmed">19356602</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitwell JL, et al. Focal atrophy in Dementia with Lewy bodies on MRI: a distinct pattern from Alzheimer&#x2019;s disease NIH Public Access. Brain. 2007;130:708&#x2013;719.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2730778</ArticleId><ArticleId IdType="pubmed">17267521</ArticleId></ArticleIdList></Reference><Reference><Citation>Hadjiconstantinou M, Neff NH. Enhancing aromatic L&#x2010;amino acid decarboxylase activity: implications for L&#x2010;DOPA treatment in Parkinson&#x2019;s disease. CNS Neurosci. Ther. 2008;14:340.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6494005</ArticleId><ArticleId IdType="pubmed">19040557</ArticleId></ArticleIdList></Reference><Reference><Citation>Sj&#xf6;stedt E, et al. An atlas of the protein-coding genes in the human, pig, and mouse brain. Science. 2020;367:eaay5947.</Citation><ArticleIdList><ArticleId IdType="pubmed">32139519</ArticleId></ArticleIdList></Reference><Reference><Citation>Vogel C, Marcotte EM. Insights into the regulation of protein abundance from proteomic and transcriptomic analyses. Nat. Rev. Genet. 2012;13:227&#x2013;232.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3654667</ArticleId><ArticleId IdType="pubmed">22411467</ArticleId></ArticleIdList></Reference><Reference><Citation>van Rumund A, et al. Peripheral decarboxylase inhibitors paradoxically induce aromatic L-amino acid decarboxylase. NPJ Parkinsons Dis. 2021;7:29.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7979935</ArticleId><ArticleId IdType="pubmed">33741988</ArticleId></ArticleIdList></Reference><Reference><Citation>Piggott MA, et al. Striatal dopaminergic markers in dementia with Lewy bodies, Alzheimer&#x2019;s and Parkinson&#x2019;s diseases: rostrocaudal distribution. Brain. 1999;122:1449&#x2013;1468.</Citation><ArticleIdList><ArticleId IdType="pubmed">10430831</ArticleId></ArticleIdList></Reference><Reference><Citation>Whelan CD, et al. Multiplex proteomics identifies novel CSF and plasma biomarkers of early Alzheimer&#x2019;s disease. Acta Neuropathol. Commun. 2019;7:169.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6836495</ArticleId><ArticleId IdType="pubmed">31694701</ArticleId></ArticleIdList></Reference><Reference><Citation>Duits FH, et al. Matrix metalloproteinases in Alzheimer&#x2019;s disease and concurrent cerebral microbleeds. J. Alzheimer&#x2019;s Dis. 2015;48:711&#x2013;720.</Citation><ArticleIdList><ArticleId IdType="pubmed">26402072</ArticleId></ArticleIdList></Reference><Reference><Citation>Philibert KD, Marr RA, Norstrom EM, Glucksman MJ. Identification and characterization of A&#x3b2; peptide interactors in Alzheimer&#x2019;s disease by structural approaches. Front. Aging Neurosci. 2014;6:1&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4191344</ArticleId><ArticleId IdType="pubmed">25346686</ArticleId></ArticleIdList></Reference><Reference><Citation>Pollio, G. et al. Increased expression of the oligopeptidase THOP1 is a neuroprotective response to A&#x3b2; toxicity. Neurobiol. Dis.10.1016/j.nbd.2008.04.004 (2008).</Citation><ArticleIdList><ArticleId IdType="pubmed">18571100</ArticleId></ArticleIdList></Reference><Reference><Citation>Derkinderen P, et al. Tyrosine 394 is phosphorylated in Alzheimer&#x2019;s paired helical filament tau and in fetal tau with c-Abl as the candidate tyrosine kinase. J. Neurosci. 2005;25:6584&#x2013;6593.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6725430</ArticleId><ArticleId IdType="pubmed">16014719</ArticleId></ArticleIdList></Reference><Reference><Citation>Lonskaya I, Hebron ML, Desforges NM, Franjie A, Moussa CE. &#x2010;H. Tyrosine kinase inhibition increases functional parkin&#x2010; eclin&#x2010;1 interaction and enhances amyloid clearance and cognitive performance. EMBO Mol. Med. 2013;5:1247&#x2013;1262.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3944464</ArticleId><ArticleId IdType="pubmed">23737459</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker L, Stefanis L, Attems J. Clinical and neuropathological differences between Parkinson&#x2019;s disease, Parkinson&#x2019;s disease dementia and dementia with Lewy bodies&#x2014;current issues and future directions. J. Neurochemistry. 2019;150:467&#x2013;474.</Citation><ArticleIdList><ArticleId IdType="pubmed">30892688</ArticleId></ArticleIdList></Reference><Reference><Citation>Teunissen, C. E. et al. Blood-based biomarkers for Alzheimer&#x2019;s disease: towards clinical implementation. Lancet Neurol.21, 66&#x2013;77 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34838239</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossi M, et al. Diagnostic value of the CSF &#x3b1;-synuclein real-time quaking-induced conversion assay at the prodromal MCI stage of dementia with Lewy bodies. Neurology. 2021;97:e930&#x2013;e940.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8408510</ArticleId><ArticleId IdType="pubmed">34210822</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldman JG, et al. Challenges and opportunities for improving the landscape for Lewy body dementia clinical trials. Alzheimers Res Ther. 2020;12:1&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7597002</ArticleId><ArticleId IdType="pubmed">33121510</ArticleId></ArticleIdList></Reference><Reference><Citation>Armstrong MJ. Advances in dementia with Lewy bodies. Ther. Adv. Neurol. Disord. 2021;14:17562864211057666.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8613883</ArticleId><ArticleId IdType="pubmed">34840608</ArticleId></ArticleIdList></Reference><Reference><Citation>Teunissen CE, Otto M, Engelborghs S, Herukka S-K, Lehmann S. White paper by the Society for CSF analysis and clinical neurochemistry: overcoming barriers in biomarker development and clinical translation. Alzheimer&#x2019;s Res. Ther. 2018;12:23.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5855933</ArticleId><ArticleId IdType="pubmed">29544527</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Flier WM, Scheltens P. Amsterdam dementia cohort: performing research to optimize care. J. Alzheimer&#x2019;s Dis. 2018;62:1091&#x2013;1111.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5870023</ArticleId><ArticleId IdType="pubmed">29562540</ArticleId></ArticleIdList></Reference><Reference><Citation>van de Beek M, et al. Characterization of symptoms and determinants of disease burden in dementia with Lewy bodies: DEvELOP design and baseline results. Alzheimers Res. Ther. 2021;13:53.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7908769</ArticleId><ArticleId IdType="pubmed">33637117</ArticleId></ArticleIdList></Reference><Reference><Citation>Lle&#xf3; A, et al. A 2-step cerebrospinal algorithm for the selection of frontotemporal lobar degeneration subtypes. JAMA Neurol. 2018;75:738&#x2013;745.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5885205</ArticleId><ArticleId IdType="pubmed">29554190</ArticleId></ArticleIdList></Reference><Reference><Citation>Alcolea D, et al. The Sant Pau Initiative on Neurodegeneration (SPIN) cohort: A data set for biomarker discovery and validation in neurodegenerative disorders. Alzheimer&#x2019;s Dement. Transl. Res. Clin. Interventions. 2019;5:597&#x2013;609.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6804606</ArticleId><ArticleId IdType="pubmed">31650016</ArticleId></ArticleIdList></Reference><Reference><Citation>Bridel, C. Associating Alzheimer&#x2019;s disease pathology with its cerebrospinal fluid biomarkers. Brain145, 4056&#x2013;4064 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35026840</ArticleId></ArticleIdList></Reference><Reference><Citation>Willemse EAJ, et al. Neurogranin as biomarker in CSF is non-specific to Alzheimer&#x2019;s disease dementia. Neurobiol. Aging. 2021;108:99&#x2013;109.</Citation><ArticleIdList><ArticleId IdType="pubmed">34551375</ArticleId></ArticleIdList></Reference><Reference><Citation>del Campo M, et al. Recommendations to standardize preanalytical confounding factors in Alzheimer&#x2019;s and Parkinson&#x2019;s disease cerebrospinal fluid biomarkers: an update. Biomark. Med. 2012;6:419&#x2013;430.</Citation><ArticleIdList><ArticleId IdType="pubmed">22917144</ArticleId></ArticleIdList></Reference><Reference><Citation>McKeith IG, et al. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology. 2005;65:1863&#x2013;1872.</Citation><ArticleIdList><ArticleId IdType="pubmed">16237129</ArticleId></ArticleIdList></Reference><Reference><Citation>Dubois B, et al. Research criteria for the diagnosis of Alzheimer&#x2019;s disease: revising the NINCDS-ADRDA criteria. Lancet Neurol. 2007;6:734&#x2013;746.</Citation><ArticleIdList><ArticleId IdType="pubmed">17616482</ArticleId></ArticleIdList></Reference><Reference><Citation>Montine TJ, et al. National Institute on Aging-Alzheimer&#x2019;s Association guidelines for the neuropathologic assessment of Alzheimer&#x2019;s disease: a practical approach NIH Public Access. Acta Neuropathol. 2012;123:1&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3268003</ArticleId><ArticleId IdType="pubmed">22101365</ArticleId></ArticleIdList></Reference><Reference><Citation>Albert MS, et al. The diagnosis of mild cognitive impairment due to Alzheimer&#x2019;s disease: recommendations from the National Institute on Aging-Alzheimer&#x2019;s Association workgroups on diagnostic guidelines for Alzheimer&#x2019;s disease. Alzheimers Dement. 2011;7:270&#x2013;279.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3312027</ArticleId><ArticleId IdType="pubmed">21514249</ArticleId></ArticleIdList></Reference><Reference><Citation>Jessen F, et al. A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer&#x2019;s disease. Alzheimers Dement. 2014;10:844&#x2013;852.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4317324</ArticleId><ArticleId IdType="pubmed">24798886</ArticleId></ArticleIdList></Reference><Reference><Citation>Petersen RC. Mild cognitive impairment as a diagnostic entity. J. Intern. Med. 2004;256:183&#x2013;194.</Citation><ArticleIdList><ArticleId IdType="pubmed">15324362</ArticleId></ArticleIdList></Reference><Reference><Citation>van de Beek M, et al. Association of the ATN research framework with clinical profile, ccognitive decline, and mortality in patients with dementia with Lewy bodies. Neurology. 2022;98:e1262&#x2013;e1272.</Citation><ArticleIdList><ArticleId IdType="pubmed">35074893</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaw LM, et al. Cerebrospinal fluid biomarker signature in Alzheimer&#x2019;s disease neuroimaging initiative subjects. Ann. Neurol. 2009;65:403&#x2013;413.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2696350</ArticleId><ArticleId IdType="pubmed">19296504</ArticleId></ArticleIdList></Reference><Reference><Citation>Duits FH, et al. The cerebrospinal fluid &#x2018;alzheimer profile&#x2019;: Easily said, but what does it mean? Alzheimer&#x2019;s Dement. 2014;10:713&#x2013;723.e2.</Citation><ArticleIdList><ArticleId IdType="pubmed">24721526</ArticleId></ArticleIdList></Reference><Reference><Citation>Duits FH, et al. The cerebrospinal fluid "Alzheimer profile": easily said, but what does it mean? Alzheimers Dement. 2014;10:713&#x2013;723.e2.</Citation><ArticleIdList><ArticleId IdType="pubmed">24721526</ArticleId></ArticleIdList></Reference><Reference><Citation>Irwin DJ, et al. Comparison of cerebrospinal fluid levels of tau and A&#x3b2; 1-42 in Alzheimer disease and frontotemporal degeneration using 2 analytical platforms. Arch. Neurol. 2012;69:1018&#x2013;1025.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3528180</ArticleId><ArticleId IdType="pubmed">22490326</ArticleId></ArticleIdList></Reference><Reference><Citation>Ottoy J, et al. Association of short-term cognitive decline and MCI-to-AD dementia conversion with CSF, MRI, amyloid- and 18 F-FDG-PET imaging. Neuroimage Clin. 2019;22:101771.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6444289</ArticleId><ArticleId IdType="pubmed">30927601</ArticleId></ArticleIdList></Reference><Reference><Citation>Leeuw FA, et al. Blood&#x2010;based metabolic signatures in Alzheimer&#x2019;s disease. Alzheimer&#x2019;s Dement. Diagnosis, Assess. Dis. Monit. 2017;8:196&#x2013;207.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5607205</ArticleId><ArticleId IdType="pubmed">28951883</ArticleId></ArticleIdList></Reference><Reference><Citation>Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. B. 1995;57:289&#x2013;300.</Citation></Reference><Reference><Citation>Friedman J, Hastie T, Tibshirani R. Regularization paths for generalized linear models via coordinate descent. J. Stat. Softw. 2010;33:1&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2929880</ArticleId><ArticleId IdType="pubmed">20808728</ArticleId></ArticleIdList></Reference><Reference><Citation>Tijms BM, et al. Unbiased approach to counteract upward drift in cerebrospinal fluid amyloid-&#x3b2; 1&#x2013;42 analysis results. Clin. Chem. 2018;64:576&#x2013;585.</Citation><ArticleIdList><ArticleId IdType="pubmed">29208658</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou, Y. et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat Commun.10, 1523 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6447622</ArticleId><ArticleId IdType="pubmed">30944313</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37723208</PMID><DateCompleted><Year>2023</Year><Month>10</Month><Day>23</Day></DateCompleted><DateRevised><Year>2024</Year><Month>01</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2662-8465</ISSN><JournalIssue CitedMedium="Internet"><Volume>3</Volume><Issue>10</Issue><PubDate><Year>2023</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Nature aging</Title><ISOAbbreviation>Nat Aging</ISOAbbreviation></Journal><ArticleTitle>DOPA decarboxylase is an emerging biomarker for Parkinsonian disorders including preclinical Lewy body disease.</ArticleTitle><Pagination><StartPage>1201</StartPage><EndPage>1209</EndPage><MedlinePgn>1201-1209</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s43587-023-00478-y</ELocationID><Abstract><AbstractText>The diagnosis of Parkinsonian disorders is currently based on clinical criteria, which have limited sensitivity until most dopaminergic neurons are lost. Here we show that cerebrospinal fluid levels of DOPA decarboxylase (DDC) (also known as aromatic L-amino acid decarboxylase) can accurately identify patients with Lewy body disease (LBD) (area under the curve (AUC)&#x2009;=&#x2009;0.89; P<sub>FDR</sub>&#x2009;=&#x2009;2.6&#x2009;&#xd7;&#x2009;10<sup>-13</sup>) and are associated with worse cognitive performance (P&#x2009;&lt;&#x2009;0.05). We also found that DDC can detect preclinical LBD stages in clinically unimpaired individuals with a positive seed amplification &#x3b1;-synuclein assay (AUC&#x2009;=&#x2009;0.81, P&#x2009;=&#x2009;1.0&#x2009;&#xd7;&#x2009;10<sup>-5</sup>) and that this biomarker could predict progression to clinical LBD over a 3-year period in preclinical cases (hazard ratio&#x2009;=&#x2009;3.7 per s.d. change, confidence interval&#x2009;=&#x2009;1.1-12.7). Moreover, DDC levels were also increased in atypical Parkinsonian disorders but not in non-Parkinsonian neurodegenerative disorders. These cerebrospinal fluid results were replicated in an independent cohort, where we also found that DDC levels in plasma could identify both LBD and atypical Parkinsonian disorders (AUC&#x2009;=&#x2009;0.92, P&#x2009;=&#x2009;1.3&#x2009;&#xd7;&#x2009;10<sup>-14</sup>). Our results show that DDC might have a future role in clinical practice as a biomarker of dopaminergic dysfunction to detect Parkinsonian disorders even during the preclinical disease stages and predict their progression to clinical LBD.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Pereira</LastName><ForeName>Joana B</ForeName><Initials>JB</Initials><AffiliationInfo><Affiliation>Division of Neuro, Department of Clinical Neutaroscience, Karolinska Institutet, Solna, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical Memory Research Unit, Department of Clinical Sciences, Lund University, Malm&#xf6;, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Kumar</LastName><ForeName>Atul</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-2166-4805</Identifier><AffiliationInfo><Affiliation>Clinical Memory Research Unit, Department of Clinical Sciences, Lund University, Malm&#xf6;, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hall</LastName><ForeName>Sara</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-6585-9105</Identifier><AffiliationInfo><Affiliation>Clinical Memory Research Unit, Department of Clinical Sciences, Lund University, Malm&#xf6;, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Memory Clinic, Sk&#xe5;ne University Hospital, Malm&#xf6;, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Palmqvist</LastName><ForeName>Sebastian</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-9267-1930</Identifier><AffiliationInfo><Affiliation>Clinical Memory Research Unit, Department of Clinical Sciences, Lund University, Malm&#xf6;, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Memory Clinic, Sk&#xe5;ne University Hospital, Malm&#xf6;, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stomrud</LastName><ForeName>Erik</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Clinical Memory Research Unit, Department of Clinical Sciences, Lund University, Malm&#xf6;, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Memory Clinic, Sk&#xe5;ne University Hospital, Malm&#xf6;, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bali</LastName><ForeName>Divya</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Clinical Memory Research Unit, Department of Clinical Sciences, Lund University, Malm&#xf6;, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Parchi</LastName><ForeName>Piero</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-9444-9524</Identifier><AffiliationInfo><Affiliation>Istituto di Ricovero e Cura a Carattere Scientifico, Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mattsson-Carlgren</LastName><ForeName>Niklas</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Clinical Memory Research Unit, Department of Clinical Sciences, Lund University, Malm&#xf6;, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Sk&#xe5;ne University Hospital, Lund University, Lund, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Wallenberg Center for Molecular Medicine, Lund University, Lund, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Janelidze</LastName><ForeName>Shorena</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Clinical Memory Research Unit, Department of Clinical Sciences, Lund University, Malm&#xf6;, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hansson</LastName><ForeName>Oskar</ForeName><Initials>O</Initials><Identifier Source="ORCID">0000-0001-8467-7286</Identifier><AffiliationInfo><Affiliation>Clinical Memory Research Unit, Department of Clinical Sciences, Lund University, Malm&#xf6;, Sweden. Oskar.Hansson@med.lu.se.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Memory Clinic, Sk&#xe5;ne University Hospital, Malm&#xf6;, Sweden. Oskar.Hansson@med.lu.se.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>09</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Nat Aging</MedlineTA><NlmUniqueID>101773306</NlmUniqueID><ISSNLinking>2662-8465</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 4.1.1.-</RegistryNumber><NameOfSubstance UI="D004296">Dopa Decarboxylase</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Nat Aging. 2023 Oct;3(10):1180-1182. doi: 10.1038/s43587-023-00501-2.</RefSource><PMID Version="1">37735241</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Cell Chem Biol. 2023 Nov 16;30(11):1340-1342. doi: 10.1016/j.chembiol.2023.10.018.</RefSource><PMID Version="1">37977130</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020961" MajorTopicYN="Y">Lewy Body Disease</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004296" MajorTopicYN="N">Dopa Decarboxylase</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020734" MajorTopicYN="Y">Parkinsonian Disorders</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="Y">Neurodegenerative Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000134" MajorTopicYN="N">cerebrospinal fluid</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>O.H. has acquired research support (for the institution) from ADx, AVID Radiopharmaceuticals, Biogen, Eli Lilly, Eisai, Fujirebio, GE Healthcare, Pfizer and Roche. In the past 2 years, he has received consultancy and speaker fees from AC Immune, Amylyx, Alzpath, BioArctic, Biogen, Cerveau, Eisai, Eli Lilly, Fujirebio, Genentech, Merck, Novartis, Novo Nordisk, Roche, Sanofi and Siemens. S.P. has acquired research support (for the institution) from ki elements/ADDF. In the past 2 years, he has received consultancy and speaker fees from Bioartic, Biogen, Cytox, Eli Lilly, Geras Solutions and Roche. The other authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>2</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>8</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>10</Month><Day>23</Day><Hour>1</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>9</Month><Day>19</Day><Hour>0</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>9</Month><Day>18</Day><Hour>23</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>9</Month><Day>18</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37723208</ArticleId><ArticleId IdType="pmc">PMC10570139</ArticleId><ArticleId IdType="doi">10.1038/s43587-023-00478-y</ArticleId><ArticleId IdType="pii">10.1038/s43587-023-00478-y</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Dorsey ER, George BP, Leff B, Willis AW. The coming crisis: obtaining care for the growing burden of neurodegenerative conditions. Neurology. 2013;80:1989&#x2013;1996. doi: 10.1212/WNL.0b013e318293e2ce.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e318293e2ce</ArticleId><ArticleId IdType="pmc">PMC3716348</ArticleId><ArticleId IdType="pubmed">23616157</ArticleId></ArticleIdList></Reference><Reference><Citation>Poewe W, et al. Parkinson disease. Nat. Rev. Dis. Primers. 2017;3:17013. doi: 10.1038/nrdp.2017.13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrdp.2017.13</ArticleId><ArticleId IdType="pubmed">28332488</ArticleId></ArticleIdList></Reference><Reference><Citation>Amaoutoglou NA, O&#x2019;Brien JT, Underwood BR. Dementia with Lewy bodies&#x2014;from scientific knowledge to clinical insights. Nat. Rev. Neurol. 2019;15:103&#x2013;112. doi: 10.1038/s41582-018-0107-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-018-0107-7</ArticleId><ArticleId IdType="pubmed">30559465</ArticleId></ArticleIdList></Reference><Reference><Citation>Parnetti L, et al. CSF and blood biomarkers for Parkinson&#x2019;s disease. Lancet Neurol. 2019;18:573&#x2013;586. doi: 10.1016/S1474-4422(19)30024-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(19)30024-9</ArticleId><ArticleId IdType="pubmed">30981640</ArticleId></ArticleIdList></Reference><Reference><Citation>van Dijk KD, et al. Diagnostic cerebrospinal fluid biomarkers for Parkinson&#x2019;s disease: a pathogenetically based approach. Neurobiol. Dis. 2010;39:229&#x2013;241. doi: 10.1016/j.nbd.2010.04.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2010.04.020</ArticleId><ArticleId IdType="pmc">PMC7126274</ArticleId><ArticleId IdType="pubmed">20451609</ArticleId></ArticleIdList></Reference><Reference><Citation>Lle&#xf3; A, et al. Cerebrospinal fluid biomarkers in trials for Alzheimer and Parkinson diseases. Nat. Rev. Neurol. 2015;11:41&#x2013;55. doi: 10.1038/nrneurol.2014.232.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2014.232</ArticleId><ArticleId IdType="pubmed">25511894</ArticleId></ArticleIdList></Reference><Reference><Citation>Eusebi P, et al. Diagnostic utility of cerebrospinal fluid &#x3b1;-synuclein in Parkinson&#x2019;s disease: a systematic review and meta-analysis. Mov. Disord. 2017;32:1389&#x2013;1400. doi: 10.1002/mds.27110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.27110</ArticleId><ArticleId IdType="pubmed">28880418</ArticleId></ArticleIdList></Reference><Reference><Citation>Barbour R, et al. Red blood cells are the major source of alpha-synuclein in blood. Neurodegener. Dis. 2008;5:55&#x2013;59. doi: 10.1159/000112832.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000112832</ArticleId><ArticleId IdType="pubmed">18182779</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossi M, et al. Ultrasensitive RT-QuIC assay with high sensitivity and specificity for Lewy body-associated synucleinopathies. Acta Neuropathol. 2020;140:49&#x2013;62. doi: 10.1007/s00401-020-02160-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-020-02160-8</ArticleId><ArticleId IdType="pmc">PMC7299922</ArticleId><ArticleId IdType="pubmed">32342188</ArticleId></ArticleIdList></Reference><Reference><Citation>Bargar C, et al. Streamlined alpha-synuclein RT-QuIC assay for various biospecimens in Parkinson&#x2019;s disease and dementia with Lewy bodies. Acta Neuropathol. Comm. 2021;9:62. doi: 10.1186/s40478-021-01175-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-021-01175-w</ArticleId><ArticleId IdType="pmc">PMC8028088</ArticleId><ArticleId IdType="pubmed">33827706</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossi M, et al. Diagnostic value of the CSF &#x3b1;-synuclein real-time quaking-induced conversion assay at the prodromal MCI stage of dementia with Lewy bodies. Neurology. 2021;97:e930&#x2013;e940. doi: 10.1212/WNL.0000000000012438.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000012438</ArticleId><ArticleId IdType="pmc">PMC8408510</ArticleId><ArticleId IdType="pubmed">34210822</ArticleId></ArticleIdList></Reference><Reference><Citation>Assarsson E, et al. Homogenous 96-plex PEA immunoassay exhibiting high sensitivity, specificity, and excellent scalability. PLoS ONE. 2014;9:e95192. doi: 10.1371/journal.pone.0095192.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0095192</ArticleId><ArticleId IdType="pmc">PMC3995906</ArticleId><ArticleId IdType="pubmed">24755770</ArticleId></ArticleIdList></Reference><Reference><Citation>Benjamini Y, Hochberg YJ. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Statist. Soc. B. 1995;57:289&#x2013;300.</Citation></Reference><Reference><Citation>van Rumund A, et al. Peripheral decarboxylase inhibitors paradoxically induce aromatic l-amino acid decarboxylase. NPJ Parkinsons Dis. 2021;7:29. doi: 10.1038/s41531-021-00172-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41531-021-00172-z</ArticleId><ArticleId IdType="pmc">PMC7979935</ArticleId><ArticleId IdType="pubmed">33741988</ArticleId></ArticleIdList></Reference><Reference><Citation>Wassenberg T, et al. Consensus guideline for the diagnosis and treatment of aromatic l-amino acid decarboxylase (AADC) deficiency. Orphanet J. Rare Dis. 2017;12:1&#x2013;2. doi: 10.1186/s13023-016-0522-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13023-016-0522-z</ArticleId><ArticleId IdType="pmc">PMC5241937</ArticleId><ArticleId IdType="pubmed">28100251</ArticleId></ArticleIdList></Reference><Reference><Citation>Hadjiconstantinou M, Neff NH. Enhancing aromatic l-amino acid decarboxylase activity: implications for l-DOPA treatment in Parkinson&#x2019;s disease. CNS Neurosci. Ther. 2008;14:340&#x2013;351. doi: 10.1111/j.1755-5949.2008.00058.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1755-5949.2008.00058.x</ArticleId><ArticleId IdType="pmc">PMC6494005</ArticleId><ArticleId IdType="pubmed">19040557</ArticleId></ArticleIdList></Reference><Reference><Citation>Quadalti C, et al. Neurofilament light chain and &#x3b1;-synuclein RT-QuIC as differential diagnostic biomarkers in parkinsonisms and related syndromes. NPJ Parkinsons Dis. 2021;7:93. doi: 10.1038/s41531-021-00232-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41531-021-00232-4</ArticleId><ArticleId IdType="pmc">PMC8505434</ArticleId><ArticleId IdType="pubmed">34635674</ArticleId></ArticleIdList></Reference><Reference><Citation>Singer W, et al. Alpha-synuclein oligomers and neurofilament light chain in spinal fluid differentiate multiple system atrophy from Lewy body synucleinopathies. Ann. Neurol. 2020;88:503&#x2013;512. doi: 10.1002/ana.25824.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.25824</ArticleId><ArticleId IdType="pmc">PMC7719613</ArticleId><ArticleId IdType="pubmed">32557811</ArticleId></ArticleIdList></Reference><Reference><Citation>Compta Y, et al. Combined CSF &#x3b1;-SYN RT-QuIC, CSF NFL and midbrain-pons planimetry in degenerative parkinsonisms: from bedside to bench, and back again. Parkinsonism Relat. Disord. 2022;99:33&#x2013;41. doi: 10.1016/j.parkreldis.2022.05.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.parkreldis.2022.05.006</ArticleId><ArticleId IdType="pubmed">35594661</ArticleId></ArticleIdList></Reference><Reference><Citation>Singer W, et al. Alpha-synuclein oligomers and neurofilament light chain predict phenoconversion of pure autonomic failure. Ann. Neurol. 2021;89:1212&#x2013;1220. doi: 10.1002/ana.26089.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.26089</ArticleId><ArticleId IdType="pmc">PMC8168720</ArticleId><ArticleId IdType="pubmed">33881777</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Rumund A, et al. &#x3b1;&#x2010;Synuclein real&#x2010;time quaking&#x2010;induced conversion in the cerebrospinal fluid of uncertain cases of parkinsonism. Ann. Neurol. 2019;85:777&#x2013;781. doi: 10.1002/ana.25447.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.25447</ArticleId><ArticleId IdType="pmc">PMC6593725</ArticleId><ArticleId IdType="pubmed">30801759</ArticleId></ArticleIdList></Reference><Reference><Citation>Chouliaras L, et al. Differential levels of plasma biomarkers of neurodegeneration in Lewy body dementia, Alzheimer&#x2019;s disease, frontotemporal dementia and progressive supranuclear palsy. J. Neurol. Neurosurg. Psychiatry. 2022;93:651&#x2013;658. doi: 10.1136/jnnp-2021-327788.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2021-327788</ArticleId><ArticleId IdType="pmc">PMC9148982</ArticleId><ArticleId IdType="pubmed">35078917</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossi M, et al. Differential levels of plasma biomarkers of neurodegeneration in Lewy body dementia, Alzheimer&#x2019;s disease, frontotemporal dementia and progressive supranuclear palsy. Acta Neuropathol. 2020;140:49&#x2013;62. doi: 10.1007/s00401-020-02160-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-020-02160-8</ArticleId><ArticleId IdType="pmc">PMC9148982</ArticleId><ArticleId IdType="pubmed">35078917</ArticleId></ArticleIdList></Reference><Reference><Citation>Shahnawaz M, et al. Discriminating &#x3b1;-synuclein strains in Parkinson&#x2019;s disease and multiple system atrophy. Nature. 2020;578:273&#x2013;277. doi: 10.1038/s41586-020-1984-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-1984-7</ArticleId><ArticleId IdType="pmc">PMC7066875</ArticleId><ArticleId IdType="pubmed">32025029</ArticleId></ArticleIdList></Reference><Reference><Citation>Schweighauser M, et al. Discriminating &#x3b1;-synuclein strains in Parkinson&#x2019;s disease and multiple system atrophy. Nature. 2020;585:464&#x2013;469. doi: 10.1038/s41586-020-2317-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2317-6</ArticleId><ArticleId IdType="pmc">PMC7116528</ArticleId><ArticleId IdType="pubmed">32461689</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamasaki TR, et al. Parkinson&#x2019;s disease and multiple system atrophy have distinct &#x3b1;-synuclein seed characteristics. J. Biol. Chem. 2019;294:1045&#x2013;1058. doi: 10.1074/jbc.RA118.004471.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.RA118.004471</ArticleId><ArticleId IdType="pmc">PMC6341389</ArticleId><ArticleId IdType="pubmed">30478174</ArticleId></ArticleIdList></Reference><Reference><Citation>Palmqvist S, et al. Discriminative accuracy of plasma phospho-tau217 for Alzheimer disease vs other neurodegenerative disorders. JAMA. 2020;324:772&#x2013;781. doi: 10.1001/jama.2020.12134.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12134</ArticleId><ArticleId IdType="pmc">PMC7388060</ArticleId><ArticleId IdType="pubmed">32722745</ArticleId></ArticleIdList></Reference><Reference><Citation>Fahn, S. &amp; Elton, R. L. in Recent Developments in Parkinsons Disease, Vol. 2 (eds Marsden C. D. et al.) 153&#x2013;163 (Macmillan Healthcare Information, 1987).</Citation></Reference><Reference><Citation>Tomlinson CL, et al. Systematic review of levodopa dose equivalency reporting in Parkinson&#x2019;s disease. Mov. Disord. 2010;25:2649&#x2013;2653. doi: 10.1002/mds.23429.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.23429</ArticleId><ArticleId IdType="pubmed">21069833</ArticleId></ArticleIdList></Reference><Reference><Citation>Papp KV, Rentz DM, Orlovsky I, Sperling RA, Mormino EC. Optimizing the preclinical Alzheimer&#x2019;s cognitive composite with semantic processing: the PACC5. Alzheimers Dement. 2017;3:668&#x2013;677. doi: 10.1016/j.trci.2017.10.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.trci.2017.10.004</ArticleId><ArticleId IdType="pmc">PMC5726754</ArticleId><ArticleId IdType="pubmed">29264389</ArticleId></ArticleIdList></Reference><Reference><Citation>Jalakas M, et al. A quick test of cognitive speed can predict development of dementia in Parkinson&#x2019;s disease. Sci. Rep. 2019;9:15417. doi: 10.1038/s41598-019-51505-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-51505-1</ArticleId><ArticleId IdType="pmc">PMC6817840</ArticleId><ArticleId IdType="pubmed">31659172</ArticleId></ArticleIdList></Reference><Reference><Citation>Abwender DA, Swan JG, Bowerman JT, Connolly SW. Qualitative analysis of verbal fluency output: review and comparison of several scoring methods. Assessment. 2001;8:323&#x2013;338. doi: 10.1177/107319110100800308.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/107319110100800308</ArticleId><ArticleId IdType="pubmed">11575625</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohs RC. The Alzheimer&#x2019;s disease assessment scale. Int. Psychogeriatr. 1996;8:195&#x2013;203. doi: 10.1017/S1041610296002578.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S1041610296002578</ArticleId><ArticleId IdType="pubmed">8994890</ArticleId></ArticleIdList></Reference><Reference><Citation>Rapport LJ, Millis SR, Bonello PJ. Validation of the Warrington theory of visual processing and the visual object and space perception battery. J. Clin. Exp. Neuropsychol. 1998;20:211&#x2013;220. doi: 10.1076/jcen.20.2.211.1169.</Citation><ArticleIdList><ArticleId IdType="doi">10.1076/jcen.20.2.211.1169</ArticleId><ArticleId IdType="pubmed">9777475</ArticleId></ArticleIdList></Reference><Reference><Citation>Palmqvist S, et al. Prediction of future Alzheimer&#x2019;s disease dementia using plasma phospho-tau combined with other accessible measures. Nat. Med. 2021;27:1034&#x2013;1042. doi: 10.1038/s41591-021-01348-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01348-z</ArticleId><ArticleId IdType="pubmed">34031605</ArticleId></ArticleIdList></Reference><Reference><Citation>Gelb DJ, Oliver E, Gilman S. Diagnostic criteria for Parkinson disease. Arch. Neurol. 1999;56:33&#x2013;39. doi: 10.1001/archneur.56.1.33.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneur.56.1.33</ArticleId><ArticleId IdType="pubmed">9923759</ArticleId></ArticleIdList></Reference><Reference><Citation>McKeith IG, et al. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology. 2005;65:1863&#x2013;1872. doi: 10.1212/01.wnl.0000187889.17253.b1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000187889.17253.b1</ArticleId><ArticleId IdType="pubmed">16237129</ArticleId></ArticleIdList></Reference><Reference><Citation>Emre M, et al. Clinical diagnostic criteria for dementia associated with Parkinson&#x2019;s disease. Mov. Disord. 2007;22:1689&#x2013;1707. doi: 10.1002/mds.21507.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.21507</ArticleId><ArticleId IdType="pubmed">17542011</ArticleId></ArticleIdList></Reference><Reference><Citation>Gilman S, et al. Second consensus statement on the diagnosis of multiple system atrophy. Neurology. 2008;71:670&#x2013;676. doi: 10.1212/01.wnl.0000324625.00404.15.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000324625.00404.15</ArticleId><ArticleId IdType="pmc">PMC2676993</ArticleId><ArticleId IdType="pubmed">18725592</ArticleId></ArticleIdList></Reference><Reference><Citation>H&#xf6;glinger GU, et al. Clinical diagnosis of progressive supranuclear palsy: the movement disorder society criteria. Mov. Disord. 2017;32:853&#x2013;864. doi: 10.1002/mds.26987.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.26987</ArticleId><ArticleId IdType="pmc">PMC5516529</ArticleId><ArticleId IdType="pubmed">28467028</ArticleId></ArticleIdList></Reference><Reference><Citation>Armstrong MJ, et al. Criteria for the diagnosis of corticobasal degeneration. Neurology. 2013;80:496&#x2013;503. doi: 10.1212/WNL.0b013e31827f0fd1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e31827f0fd1</ArticleId><ArticleId IdType="pmc">PMC3590050</ArticleId><ArticleId IdType="pubmed">23359374</ArticleId></ArticleIdList></Reference><Reference><Citation>Jack CR, Jr, et al. NIA-AA Research Framework: toward a biological definition of Alzheimer&#x2019;s disease. Alzheimers Dement. 2018;14:535&#x2013;562. doi: 10.1016/j.jalz.2018.02.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2018.02.018</ArticleId><ArticleId IdType="pmc">PMC5958625</ArticleId><ArticleId IdType="pubmed">29653606</ArticleId></ArticleIdList></Reference><Reference><Citation>American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 5th edn (APA, 2013).</Citation></Reference><Reference><Citation>Hall S, et al. Cerebrospinal fluid concentrations of inflammatory markers in Parkinson&#x2019;s disease and atypical parkinsonian disorders. Sci. Rep. 2018;8:13276. doi: 10.1038/s41598-018-31517-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-31517-z</ArticleId><ArticleId IdType="pmc">PMC6125576</ArticleId><ArticleId IdType="pubmed">30185816</ArticleId></ArticleIdList></Reference><Reference><Citation>Palmqvist S, et al. Cognitive effects of Lewy body pathology in clinically unimpaired individuals. Nat. Med. 2023 doi: 10.1038/s41591-023-02450-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-023-02450-0</ArticleId><ArticleId IdType="pmc">PMC10427420</ArticleId><ArticleId IdType="pubmed">37464059</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37735240</PMID><DateCompleted><Year>2023</Year><Month>10</Month><Day>23</Day></DateCompleted><DateRevised><Year>2024</Year><Month>01</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2662-8465</ISSN><JournalIssue CitedMedium="Internet"><Volume>3</Volume><Issue>10</Issue><PubDate><Year>2023</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Nature aging</Title><ISOAbbreviation>Nat Aging</ISOAbbreviation></Journal><ArticleTitle>The VCAM1-ApoE pathway directs microglial chemotaxis and alleviates Alzheimer's disease pathology.</ArticleTitle><Pagination><StartPage>1219</StartPage><EndPage>1236</EndPage><MedlinePgn>1219-1236</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s43587-023-00491-1</ELocationID><Abstract><AbstractText>In Alzheimer's disease (AD), sensome receptor dysfunction impairs microglial danger-associated molecular pattern (DAMP) clearance and exacerbates disease pathology. Although extrinsic signals, including interleukin-33 (IL-33), can restore microglial DAMP clearance, it remains largely unclear how the sensome receptor is regulated and interacts with DAMP during phagocytic clearance. Here, we show that IL-33 induces VCAM1 in microglia, which promotes microglial chemotaxis toward amyloid-beta (A&#x3b2;) plaque-associated ApoE, and leads to A&#x3b2; clearance. We show that IL-33 stimulates a chemotactic state in microglia, characterized by A&#x3b2;-directed migration. Functional screening identified that VCAM1 directs microglial A&#x3b2; chemotaxis by sensing A&#x3b2; plaque-associated ApoE. Moreover, we found that disrupting VCAM1-ApoE interaction abolishes microglial A&#x3b2; chemotaxis, resulting in decreased microglial clearance of A&#x3b2;. In patients with AD, higher cerebrospinal fluid levels of soluble VCAM1 were correlated with impaired microglial A&#x3b2; chemotaxis. Together, our findings demonstrate that promoting VCAM1-ApoE-dependent microglial functions ameliorates AD pathology.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Lau</LastName><ForeName>Shun-Fat</ForeName><Initials>SF</Initials><Identifier Source="ORCID">0000-0002-8527-3205</Identifier><AffiliationInfo><Affiliation>Division of Life Science, State Key Laboratory of Molecular Neuroscience, Molecular Neuroscience Center, The Hong Kong University of Science and Technology, Clear Water Bay, Hong Kong, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hong Kong Center for Neurodegenerative Diseases, Hong Kong Science Park, Hong Kong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Wu</LastName><ForeName>Wei</ForeName><Initials>W</Initials><Identifier Source="ORCID">0000-0003-4228-2416</Identifier><AffiliationInfo><Affiliation>Division of Life Science, State Key Laboratory of Molecular Neuroscience, Molecular Neuroscience Center, The Hong Kong University of Science and Technology, Clear Water Bay, Hong Kong, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hong Kong Center for Neurodegenerative Diseases, Hong Kong Science Park, Hong Kong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wong</LastName><ForeName>Hiu Yi</ForeName><Initials>HY</Initials><AffiliationInfo><Affiliation>Division of Life Science, State Key Laboratory of Molecular Neuroscience, Molecular Neuroscience Center, The Hong Kong University of Science and Technology, Clear Water Bay, Hong Kong, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hong Kong Center for Neurodegenerative Diseases, Hong Kong Science Park, Hong Kong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ouyang</LastName><ForeName>Li</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Division of Life Science, State Key Laboratory of Molecular Neuroscience, Molecular Neuroscience Center, The Hong Kong University of Science and Technology, Clear Water Bay, Hong Kong, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hong Kong Center for Neurodegenerative Diseases, Hong Kong Science Park, Hong Kong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qiao</LastName><ForeName>Yi</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Division of Life Science, State Key Laboratory of Molecular Neuroscience, Molecular Neuroscience Center, The Hong Kong University of Science and Technology, Clear Water Bay, Hong Kong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Jiahui</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Division of Life Science, State Key Laboratory of Molecular Neuroscience, Molecular Neuroscience Center, The Hong Kong University of Science and Technology, Clear Water Bay, Hong Kong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lau</LastName><ForeName>Jessica Hiu-Yan</ForeName><Initials>JH</Initials><Identifier Source="ORCID">0009-0004-0081-3578</Identifier><AffiliationInfo><Affiliation>Division of Life Science, State Key Laboratory of Molecular Neuroscience, Molecular Neuroscience Center, The Hong Kong University of Science and Technology, Clear Water Bay, Hong Kong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wong</LastName><ForeName>Carlton</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Division of Life Science, State Key Laboratory of Molecular Neuroscience, Molecular Neuroscience Center, The Hong Kong University of Science and Technology, Clear Water Bay, Hong Kong, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hong Kong Center for Neurodegenerative Diseases, Hong Kong Science Park, Hong Kong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Yuanbing</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0001-8585-0714</Identifier><AffiliationInfo><Affiliation>Division of Life Science, State Key Laboratory of Molecular Neuroscience, Molecular Neuroscience Center, The Hong Kong University of Science and Technology, Clear Water Bay, Hong Kong, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hong Kong Center for Neurodegenerative Diseases, Hong Kong Science Park, Hong Kong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Holtzman</LastName><ForeName>David M</ForeName><Initials>DM</Initials><AffiliationInfo><Affiliation>Department of Neurology, Hope Center for Neurological Disorders, Charles F. and Joanne Knight Alzheimer's Disease Research Center, Washington University School of Medicine, St. Louis, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fu</LastName><ForeName>Amy K Y</ForeName><Initials>AKY</Initials><AffiliationInfo><Affiliation>Division of Life Science, State Key Laboratory of Molecular Neuroscience, Molecular Neuroscience Center, The Hong Kong University of Science and Technology, Clear Water Bay, Hong Kong, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hong Kong Center for Neurodegenerative Diseases, Hong Kong Science Park, Hong Kong, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Guangdong Provincial Key Laboratory of Brain Science, Disease and Drug Development, HKUST Shenzhen Research Institute, Shenzhen-Hong Kong Institute of Brain Science, Shenzhen, Guangdong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ip</LastName><ForeName>Nancy Y</ForeName><Initials>NY</Initials><Identifier Source="ORCID">0000-0002-2763-8907</Identifier><AffiliationInfo><Affiliation>Division of Life Science, State Key Laboratory of Molecular Neuroscience, Molecular Neuroscience Center, The Hong Kong University of Science and Technology, Clear Water Bay, Hong Kong, China. boip@ust.hk.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hong Kong Center for Neurodegenerative Diseases, Hong Kong Science Park, Hong Kong, China. boip@ust.hk.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Guangdong Provincial Key Laboratory of Brain Science, Disease and Drug Development, HKUST Shenzhen Research Institute, Shenzhen-Hong Kong Institute of Brain Science, Shenzhen, Guangdong, China. boip@ust.hk.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>09</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Nat Aging</MedlineTA><NlmUniqueID>101773306</NlmUniqueID><ISSNLinking>2662-8465</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000067596">Interleukin-33</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016229">Amyloid beta-Peptides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001057">Apolipoproteins E</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Nat Rev Neurol. 2023 Nov;19(11):639. doi: 10.1038/s41582-023-00885-0.</RefSource><PMID Version="1">37813951</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017628" MajorTopicYN="N">Microglia</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000067596" MajorTopicYN="N">Interleukin-33</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002633" MajorTopicYN="N">Chemotaxis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016229" MajorTopicYN="N">Amyloid beta-Peptides</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001057" MajorTopicYN="N">Apolipoproteins E</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>Y.J., A.K.F. and N.Y.I. are inventors on a patent licensed by The Hong Kong University of Science and Technology to Cognitact, and Y.J. co-founded Cognitact. D.M.H. is an inventor on a patent licensed by Washington University to C2N Diagnostics on the therapeutic use of anti-tau antibodies and on a patent licensed to NextCure on the therapeutic use of anti-ApoE antibodies. D.M.H. co-founded and is on the scientific advisory board of C2N Diagnostics. D.M.H. is also on the scientific advisory boards of Denali, Genentech and Cajal Neuroscience and consults for Alector. The remaining authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>12</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>8</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>10</Month><Day>23</Day><Hour>1</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>9</Month><Day>22</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>9</Month><Day>21</Day><Hour>23</Hour><Minute>48</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>9</Month><Day>21</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37735240</ArticleId><ArticleId IdType="pmc">PMC10570140</ArticleId><ArticleId IdType="doi">10.1038/s43587-023-00491-1</ArticleId><ArticleId IdType="pii">10.1038/s43587-023-00491-1</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Heneka MT, et al. Neuroinflammation in Alzheimer&#x2019;s disease. Lancet Neurol. 2015;14:388&#x2013;405. doi: 10.1016/S1474-4422(15)70016-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(15)70016-5</ArticleId><ArticleId IdType="pmc">PMC5909703</ArticleId><ArticleId IdType="pubmed">25792098</ArticleId></ArticleIdList></Reference><Reference><Citation>Ransohoff RM, Perry VH. Microglial physiology: Unique stimuli, specialized responses. Annu. Rev. Immunol. 2009;27:119&#x2013;145. doi: 10.1146/annurev.immunol.021908.132528.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.immunol.021908.132528</ArticleId><ArticleId IdType="pubmed">19302036</ArticleId></ArticleIdList></Reference><Reference><Citation>Perry VH, Holmes C. Microglial priming in neurodegenerative disease. Nat. Rev. Neurol. 2014;10:217&#x2013;224. doi: 10.1038/nrneurol.2014.38.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2014.38</ArticleId><ArticleId IdType="pubmed">24638131</ArticleId></ArticleIdList></Reference><Reference><Citation>Glass CK, Natoli G. Molecular control of activation and priming in macrophages. Nat. Immunol. 2016;17:26&#x2013;33. doi: 10.1038/ni.3306.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.3306</ArticleId><ArticleId IdType="pmc">PMC4795476</ArticleId><ArticleId IdType="pubmed">26681459</ArticleId></ArticleIdList></Reference><Reference><Citation>De Strooper B, Karran E. The cellular phase of Alzheimer&#x2019;s disease. Cell. 2016;164:603&#x2013;615. doi: 10.1016/j.cell.2015.12.056.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2015.12.056</ArticleId><ArticleId IdType="pubmed">26871627</ArticleId></ArticleIdList></Reference><Reference><Citation>Lau SF, Fu AKY, Ip NY. Cytokine signaling convergence regulates the microglial state transition in Alzheimer&#x2019;s disease. Cell. Mol. Life Sci. 2021;78:4703&#x2013;4712. doi: 10.1007/s00018-021-03810-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-021-03810-0</ArticleId><ArticleId IdType="pmc">PMC8195901</ArticleId><ArticleId IdType="pubmed">33847763</ArticleId></ArticleIdList></Reference><Reference><Citation>Gomez-Nicola D, Perry VH. Microglial dynamics and role in the healthy and diseased brain: A paradigm of functional plasticity. Neuroscientist. 2015;21:169&#x2013;184. doi: 10.1177/1073858414530512.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1073858414530512</ArticleId><ArticleId IdType="pmc">PMC4412879</ArticleId><ArticleId IdType="pubmed">24722525</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen GF, et al. Amyloid beta: Structure, biology and structure-based therapeutic development. Acta Pharmacol. Sin. 2017;38:1205&#x2013;1235. doi: 10.1038/aps.2017.28.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/aps.2017.28</ArticleId><ArticleId IdType="pmc">PMC5589967</ArticleId><ArticleId IdType="pubmed">28713158</ArticleId></ArticleIdList></Reference><Reference><Citation>Hickman SE, et al. The microglial sensome revealed by direct RNA sequencing. Nat. Neurosci. 2013;16:1896&#x2013;1905. doi: 10.1038/nn.3554.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3554</ArticleId><ArticleId IdType="pmc">PMC3840123</ArticleId><ArticleId IdType="pubmed">24162652</ArticleId></ArticleIdList></Reference><Reference><Citation>Podle&#x15b;ny-Drabiniok A, Marcora E, Goate AM. Microglial phagocytosis: A disease-associated process emerging from Alzheimer&#x2019;s disease genetics. Trends Neurosci. 2020;43:965&#x2013;979. doi: 10.1016/j.tins.2020.10.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tins.2020.10.002</ArticleId><ArticleId IdType="pmc">PMC9080913</ArticleId><ArticleId IdType="pubmed">33127097</ArticleId></ArticleIdList></Reference><Reference><Citation>Deane R, et al. A multimodal RAGE-specific inhibitor reduces amyloid &#x3b2;-mediated brain disorder in a mouse model of Alzheimer disease. J. Clin. Invest. 2012;122:1377&#x2013;1392. doi: 10.1172/JCI58642.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI58642</ArticleId><ArticleId IdType="pmc">PMC3314449</ArticleId><ArticleId IdType="pubmed">22406537</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu S, et al. TLR2 is a primary receptor for Alzheimer&#x2019;s amyloid &#x3b2; peptide to trigger neuroinflammatory activation. J. Immunol. 2012;188:1098&#x2013;1107. doi: 10.4049/jimmunol.1101121.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1101121</ArticleId><ArticleId IdType="pubmed">22198949</ArticleId></ArticleIdList></Reference><Reference><Citation>Keren-Shaul H, et al. A unique microglia type associated with restricting development of Alzheimer&#x2019;s disease. Cell. 2017;169:1276&#x2013;1290. doi: 10.1016/j.cell.2017.05.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2017.05.018</ArticleId><ArticleId IdType="pubmed">28602351</ArticleId></ArticleIdList></Reference><Reference><Citation>Sala Frigerio C, et al. The major risk factors for Alzheimer&#x2019;s disease: Age, sex, and genes modulate the microglia response to A&#x3b2; plaques. Cell Rep. 2019;27:1293&#x2013;1306. doi: 10.1016/j.celrep.2019.03.099.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2019.03.099</ArticleId><ArticleId IdType="pmc">PMC7340153</ArticleId><ArticleId IdType="pubmed">31018141</ArticleId></ArticleIdList></Reference><Reference><Citation>Krasemann S, et al. The TREM2-APOE pathway drives the transcriptional phenotype of dysfunctional microglia in neurodegenerative diseases. Immunity. 2017;47:566&#x2013;581. doi: 10.1016/j.immuni.2017.08.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2017.08.008</ArticleId><ArticleId IdType="pmc">PMC5719893</ArticleId><ArticleId IdType="pubmed">28930663</ArticleId></ArticleIdList></Reference><Reference><Citation>Naj AC, et al. Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer&#x2019;s disease. Nat. Genet. 2011;43:436&#x2013;443. doi: 10.1038/ng.801.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.801</ArticleId><ArticleId IdType="pmc">PMC3090745</ArticleId><ArticleId IdType="pubmed">21460841</ArticleId></ArticleIdList></Reference><Reference><Citation>Hollingworth P, et al. Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer&#x2019;s disease. Nat. Genet. 2011;43:429&#x2013;436. doi: 10.1038/ng.803.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.803</ArticleId><ArticleId IdType="pmc">PMC3084173</ArticleId><ArticleId IdType="pubmed">21460840</ArticleId></ArticleIdList></Reference><Reference><Citation>Lambert JC, et al. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer&#x2019;s disease. Nat. Genet. 2013;45:1452&#x2013;1458. doi: 10.1038/ng.2802.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.2802</ArticleId><ArticleId IdType="pmc">PMC3896259</ArticleId><ArticleId IdType="pubmed">24162737</ArticleId></ArticleIdList></Reference><Reference><Citation>Thornton P, et al. TREM 2 shedding by cleavage at the H157&#x2010;S158 bond is accelerated for the Alzheimer&#x2019;s disease&#x2010;associated H157Y variant. EMBO Mol. Med. 2017;9:1366&#x2013;1378. doi: 10.15252/emmm.201707673.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/emmm.201707673</ArticleId><ArticleId IdType="pmc">PMC5623839</ArticleId><ArticleId IdType="pubmed">28855301</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan P, et al. TREM2 haplodeficiency in mice and humans impairs the microglia barrier function leading to decreased amyloid compaction and severe axonal dystrophy. Neuron. 2016;90:724&#x2013;739. doi: 10.1016/j.neuron.2016.05.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2016.05.003</ArticleId><ArticleId IdType="pmc">PMC4898967</ArticleId><ArticleId IdType="pubmed">27196974</ArticleId></ArticleIdList></Reference><Reference><Citation>Griciuc A, et al. Alzheimer&#x2019;s disease risk gene cd33 inhibits microglial uptake of amyloid beta. Neuron. 2013;78:631&#x2013;643. doi: 10.1016/j.neuron.2013.04.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2013.04.014</ArticleId><ArticleId IdType="pmc">PMC3706457</ArticleId><ArticleId IdType="pubmed">23623698</ArticleId></ArticleIdList></Reference><Reference><Citation>Jay TR, et al. Disease progression-dependent effects of TREM2 deficiency in a mouse model of Alzheimer&#x2019;s disease. J. Neurosci. 2017;37:637&#x2013;647. doi: 10.1523/JNEUROSCI.2110-16.2016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.2110-16.2016</ArticleId><ArticleId IdType="pmc">PMC5242410</ArticleId><ArticleId IdType="pubmed">28100745</ArticleId></ArticleIdList></Reference><Reference><Citation>Lau SF, et al. IL-33-PU.1 transcriptome reprogramming drives functional state transition andclearance activity of microglia in Alzheimer&#x2019;s disease. Cell Rep. 2020;31:107530. doi: 10.1016/j.celrep.2020.107530.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2020.107530</ArticleId><ArticleId IdType="pubmed">32320664</ArticleId></ArticleIdList></Reference><Reference><Citation>Shellard A, Mayor R. All roads lead to directional cell migration. Trends Cell Biol. 2020;30:852&#x2013;868. doi: 10.1016/j.tcb.2020.08.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tcb.2020.08.002</ArticleId><ArticleId IdType="pubmed">32873438</ArticleId></ArticleIdList></Reference><Reference><Citation>SenGupta S, Parent CA, Bear JE. The principles of directed cell migration. Nat. Rev. Mol. Cell Biol. 2021;22:529&#x2013;547. doi: 10.1038/s41580-021-00366-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41580-021-00366-6</ArticleId><ArticleId IdType="pmc">PMC8663916</ArticleId><ArticleId IdType="pubmed">33990789</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong F, Ge W, Ma C. Quantitative proteomics reveals distinct composition of amyloid plaques in Alzheimer&#x2019;s disease. Alzheimer&#x2019;s Dement. 2019;15:429&#x2013;440. doi: 10.1016/j.jalz.2018.10.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2018.10.006</ArticleId><ArticleId IdType="pubmed">30502339</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao N, Liu CC, Qiao W, Bu G. Apolipoprotein E, receptors, and modulation of Alzheimer&#x2019;s disease. Biol. Psychiatry. 2018;83:347&#x2013;357. doi: 10.1016/j.biopsych.2017.03.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopsych.2017.03.003</ArticleId><ArticleId IdType="pmc">PMC5599322</ArticleId><ArticleId IdType="pubmed">28434655</ArticleId></ArticleIdList></Reference><Reference><Citation>Bu G. Apolipoprotein e and its receptors in Alzheimer&#x2019;s disease: Pathways, pathogenesis and therapy. Nat. Rev. Neurosci. 2009;10:333&#x2013;344. doi: 10.1038/nrn2620.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn2620</ArticleId><ArticleId IdType="pmc">PMC2908393</ArticleId><ArticleId IdType="pubmed">19339974</ArticleId></ArticleIdList></Reference><Reference><Citation>Holtzman DM, Herz J, Bu G. Apolipoprotein E and apolipoprotein E receptors: Normal biology and roles in Alzheimer disease. Cold Spring Harb. Perspect. Med. 2012;2:a006312. doi: 10.1101/cshperspect.a006312.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a006312</ArticleId><ArticleId IdType="pmc">PMC3282491</ArticleId><ArticleId IdType="pubmed">22393530</ArticleId></ArticleIdList></Reference><Reference><Citation>Martens YA, et al. ApoE cascade hypothesis in the pathogenesis of Alzheimer&#x2019;s disease and related dementias. Neuron. 2022;110:1304&#x2013;1317. doi: 10.1016/j.neuron.2022.03.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2022.03.004</ArticleId><ArticleId IdType="pmc">PMC9035117</ArticleId><ArticleId IdType="pubmed">35298921</ArticleId></ArticleIdList></Reference><Reference><Citation>Zalocusky KA, et al. Neuronal ApoE upregulates MHC-I expression to drive selective neurodegeneration in Alzheimer&#x2019;s disease. Nat. Neurosci. 2021;24:786&#x2013;798. doi: 10.1038/s41593-021-00851-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-021-00851-3</ArticleId><ArticleId IdType="pmc">PMC9145692</ArticleId><ArticleId IdType="pubmed">33958804</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu CC, et al. ApoE4 accelerates early seeding of amyloid pathology. Neuron. 2017;96:1024&#x2013;1032. doi: 10.1016/j.neuron.2017.11.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2017.11.013</ArticleId><ArticleId IdType="pmc">PMC5948105</ArticleId><ArticleId IdType="pubmed">29216449</ArticleId></ArticleIdList></Reference><Reference><Citation>Huynh TPV, et al. Age-dependent effects of apoE reduction using antisense oligonucleotides in a model of &#x3b2;-amyloidosis. Neuron. 2017;96:1013&#x2013;1023. doi: 10.1016/j.neuron.2017.11.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2017.11.014</ArticleId><ArticleId IdType="pmc">PMC5728673</ArticleId><ArticleId IdType="pubmed">29216448</ArticleId></ArticleIdList></Reference><Reference><Citation>Ulrich JD, et al. ApoE facilitates the microglial response to amyloid plaque pathology. J. Exp. Med. 2018;215:1047&#x2013;1058. doi: 10.1084/jem.20171265.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20171265</ArticleId><ArticleId IdType="pmc">PMC5881464</ArticleId><ArticleId IdType="pubmed">29483128</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao F, et al. Targeting of nonlipidated, aggregated apoE with antibodies inhibits amyloid accumulation. J. Clin. Invest. 2018;128:2144&#x2013;2155. doi: 10.1172/JCI96429.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI96429</ArticleId><ArticleId IdType="pmc">PMC5919821</ArticleId><ArticleId IdType="pubmed">29600961</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J, et al. Anti-apoE immunotherapy inhibits amyloid accumulation in a transgenic mouse model of A&#x3b2; amyloidosis. J. Exp. Med. 2012;209:2149&#x2013;2156. doi: 10.1084/jem.20121274.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20121274</ArticleId><ArticleId IdType="pmc">PMC3501350</ArticleId><ArticleId IdType="pubmed">23129750</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang Y, et al. Large-scale plasma proteomic profiling identifies a high-performance biomarker panel for Alzheimer&#x2019;s disease screening and staging. Alzheimer&#x2019;s Dement. 2022;18:88&#x2013;102. doi: 10.1002/alz.12369.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alz.12369</ArticleId><ArticleId IdType="pmc">PMC9292367</ArticleId><ArticleId IdType="pubmed">34032364</ArticleId></ArticleIdList></Reference><Reference><Citation>Osborn L, et al. Direct expression cloning of vascular cell adhesion molecule 1, a cytokine-induced endothelial protein that binds to lymphocytes. Cell. 1989;59:1203&#x2013;1211. doi: 10.1016/0092-8674(89)90775-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0092-8674(89)90775-7</ArticleId><ArticleId IdType="pubmed">2688898</ArticleId></ArticleIdList></Reference><Reference><Citation>Rice GE, Bevilacqua MP. An inducible endothelial cell surface glycoprotein mediates melanoma adhesion. Science (80-.). 1989;246:1303&#x2013;1306. doi: 10.1126/science.2588007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.2588007</ArticleId><ArticleId IdType="pubmed">2588007</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Wetering S, et al. VCAM-1-mediated Rac signaling controls endothelial cell-cell contacts and leukocyte transmigration. Am. J. Physiol. - Cell Physiol. 2003;285:C343&#x2013;C352. doi: 10.1152/ajpcell.00048.2003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpcell.00048.2003</ArticleId><ArticleId IdType="pubmed">12700137</ArticleId></ArticleIdList></Reference><Reference><Citation>Osborn L. Leukocyte adhesion to endothelium in inflammation. Cell. 1990;62:3&#x2013;6. doi: 10.1016/0092-8674(90)90230-C.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0092-8674(90)90230-C</ArticleId><ArticleId IdType="pubmed">2194672</ArticleId></ArticleIdList></Reference><Reference><Citation>Koni PA, et al. Conditional vascular cell adhesion molecule 1 deletion in mice: Impaired lymphocyte migration to bone marrow. J. Exp. Med. 2001;193:741&#x2013;753. doi: 10.1084/jem.193.6.741.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.193.6.741</ArticleId><ArticleId IdType="pmc">PMC2193418</ArticleId><ArticleId IdType="pubmed">11257140</ArticleId></ArticleIdList></Reference><Reference><Citation>Peterson JW, et al. VCAM-1-positive microglia target oligodendrocytes at the border of multiple sclerosis lesions. J. Neuropathol. Exp. Neurol. 2002;61:539&#x2013;546. doi: 10.1093/jnen/61.6.539.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jnen/61.6.539</ArticleId><ArticleId IdType="pubmed">12071637</ArticleId></ArticleIdList></Reference><Reference><Citation>Makinde HM, et al. A novel microglia-specific transcriptional signature correlates with behavioral deficits in neuropsychiatric lupus. Front. Immunol. 2020;11:230. doi: 10.3389/fimmu.2020.00230.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.00230</ArticleId><ArticleId IdType="pmc">PMC7055359</ArticleId><ArticleId IdType="pubmed">32174913</ArticleId></ArticleIdList></Reference><Reference><Citation>Li D, et al. VCAM-1+ macrophages guide the homing of HSPCs to a vascular niche. Nature. 2018;564:119&#x2013;124. doi: 10.1038/s41586-018-0709-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-018-0709-7</ArticleId><ArticleId IdType="pmc">PMC6492262</ArticleId><ArticleId IdType="pubmed">30455424</ArticleId></ArticleIdList></Reference><Reference><Citation>Guedes JR, Lao T, Cardoso AL, El Khoury J. Roles of microglial and monocyte chemokines and their receptors in regulating Alzheimer&#x2019;s disease-associated amyloid-&#x3b2; and tau pathologies. Front. Neurol. 2018;9:549. doi: 10.3389/fneur.2018.00549.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2018.00549</ArticleId><ArticleId IdType="pmc">PMC6104478</ArticleId><ArticleId IdType="pubmed">30158892</ArticleId></ArticleIdList></Reference><Reference><Citation>El Khoury J, et al. Ccr2 deficiency impairs microglial accumulation and accelerates progression of Alzheimer-like disease. Nat. Med. 2007;13:432&#x2013;438. doi: 10.1038/nm1555.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm1555</ArticleId><ArticleId IdType="pubmed">17351623</ArticleId></ArticleIdList></Reference><Reference><Citation>McAlpine CS, et al. Astrocytic interleukin-3 programs microglia and limits Alzheimer&#x2019;s disease. Nature. 2021;595:701&#x2013;706. doi: 10.1038/s41586-021-03734-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03734-6</ArticleId><ArticleId IdType="pmc">PMC8934148</ArticleId><ArticleId IdType="pubmed">34262178</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu AKY, et al. IL-33 ameliorates Alzheimer&#x2019;s disease-like pathology and cognitive decline. Proc. Natl. Acad. Sci. USA. 2016;113:E2705&#x2013;E2713. doi: 10.1073/pnas.1604032113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1604032113</ArticleId><ArticleId IdType="pmc">PMC4868478</ArticleId><ArticleId IdType="pubmed">27091974</ArticleId></ArticleIdList></Reference><Reference><Citation>Parhizkar S, et al. Loss of TREM2 function increases amyloid seeding but reduces plaque-associated ApoE. Nat. Neurosci. 2019;22:191&#x2013;204. doi: 10.1038/s41593-018-0296-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-018-0296-9</ArticleId><ArticleId IdType="pmc">PMC6417433</ArticleId><ArticleId IdType="pubmed">30617257</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang Q, et al. ApoE promotes the proteolytic degradation of A&#x3b2;. Neuron. 2008;58:681&#x2013;693. doi: 10.1016/j.neuron.2008.04.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2008.04.010</ArticleId><ArticleId IdType="pmc">PMC2493297</ArticleId><ArticleId IdType="pubmed">18549781</ArticleId></ArticleIdList></Reference><Reference><Citation>Terwel D, et al. Critical role of astroglial apolipoprotein E and liver X receptor-&#x3b1; expression for microglial A&#x3b2; phagocytosis. J. Neurosci. 2011;31:7049&#x2013;7059. doi: 10.1523/JNEUROSCI.6546-10.2011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.6546-10.2011</ArticleId><ArticleId IdType="pmc">PMC6703224</ArticleId><ArticleId IdType="pubmed">21562267</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeh FL, Hansen DV, Sheng M. TREM2, microglia, and neurodegenerative diseases. Trends Mol. Med. 2017;23:512&#x2013;533. doi: 10.1016/j.molmed.2017.03.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molmed.2017.03.008</ArticleId><ArticleId IdType="pubmed">28442216</ArticleId></ArticleIdList></Reference><Reference><Citation>Hansen DV, Hanson JE, Sheng M. Microglia in Alzheimer&#x2019;s disease. J. Cell Biol. 2018;217:459&#x2013;472. doi: 10.1083/jcb.201709069.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.201709069</ArticleId><ArticleId IdType="pmc">PMC5800817</ArticleId><ArticleId IdType="pubmed">29196460</ArticleId></ArticleIdList></Reference><Reference><Citation>Kong DH, Kim YK, Kim MR, Jang JH, Lee S. Emerging roles of vascular cell adhesion molecule-1 (VCAM-1) in immunological disorders and cancer. Int. J. Mol. Sci. 2018;19:1057. doi: 10.3390/ijms19041057.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms19041057</ArticleId><ArticleId IdType="pmc">PMC5979609</ArticleId><ArticleId IdType="pubmed">29614819</ArticleId></ArticleIdList></Reference><Reference><Citation>Cook-Mills JM, Marchese ME, Abdala-Valencia H. Vascular cell adhesion molecule-1 expression and signaling during disease: Regulation by reactive oxygen species and antioxidants. Antioxidants Redox Signal. 2011;15:1607&#x2013;1638. doi: 10.1089/ars.2010.3522.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ars.2010.3522</ArticleId><ArticleId IdType="pmc">PMC3151426</ArticleId><ArticleId IdType="pubmed">21050132</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeh FL, Wang Y, Tom I, Gonzalez LC, Sheng M. TREM2 binds to apolipoproteins, Including APOE and CLU/APOJ, and thereby facilitates uptake of amyloid-beta by microglia. Neuron. 2016;91:328&#x2013;340. doi: 10.1016/j.neuron.2016.06.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2016.06.015</ArticleId><ArticleId IdType="pubmed">27477018</ArticleId></ArticleIdList></Reference><Reference><Citation>Gratuze M, Leyns CEG, Holtzman DM. New insights into the role of TREM2 in Alzheimer&#x2019;s disease. Mol. Neurodegener. 2018;13:1&#x2013;16. doi: 10.1186/s13024-018-0298-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-018-0298-9</ArticleId><ArticleId IdType="pmc">PMC6302500</ArticleId><ArticleId IdType="pubmed">30572908</ArticleId></ArticleIdList></Reference><Reference><Citation>Konishi H, Kiyama H. Microglial TREM2/DAP12 signaling: A double-edged sword in neural diseases. Front. Cell. Neurosci. 2018;12:206. doi: 10.3389/fncel.2018.00206.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2018.00206</ArticleId><ArticleId IdType="pmc">PMC6087757</ArticleId><ArticleId IdType="pubmed">30127720</ArticleId></ArticleIdList></Reference><Reference><Citation>Verghese PB, et al. ApoE influences amyloid-&#x3b2; (A&#x3b2;) clearance despite minimal apoE/A&#x3b2; association in physiological conditions. Proc. Natl. Acad. Sci. USA. 2013;110:E1807&#x2013;E1816. doi: 10.1073/pnas.1220484110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1220484110</ArticleId><ArticleId IdType="pmc">PMC3651443</ArticleId><ArticleId IdType="pubmed">23620513</ArticleId></ArticleIdList></Reference><Reference><Citation>Cook-Mills JM, et al. Calcium mobilization and Rac1 activation are required for VCAM-1 (vascular cell adhesion molecule-1) stimulation of NADPH oxidase activity. Biochem. J. 2004;378:539&#x2013;547. doi: 10.1042/bj20030794.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/bj20030794</ArticleId><ArticleId IdType="pmc">PMC1223954</ArticleId><ArticleId IdType="pubmed">14594451</ArticleId></ArticleIdList></Reference><Reference><Citation>Ries M, Sastre M. Mechanisms of A&#x3b2; clearance and degradation by glial cells. Front. Aging Neurosci. 2016;8:160. doi: 10.3389/fnagi.2016.00160.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2016.00160</ArticleId><ArticleId IdType="pmc">PMC4932097</ArticleId><ArticleId IdType="pubmed">27458370</ArticleId></ArticleIdList></Reference><Reference><Citation>Hopperton KE, Mohammad D, Tr&#xe9;panier MO, Giuliano V, Bazinet RP. Markers of microglia in post-mortem brain samples from patients with Alzheimer&#x2019;s disease: A systematic review. Mol. Psychiatry. 2018;23:177&#x2013;198. doi: 10.1038/mp.2017.246.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/mp.2017.246</ArticleId><ArticleId IdType="pmc">PMC5794890</ArticleId><ArticleId IdType="pubmed">29230021</ArticleId></ArticleIdList></Reference><Reference><Citation>Perlmutter LS, Scott SA, Barr&#xf3;n E, Chui HC. MHC class II&#x2010;positive microglia in human brain: Association with Alzheimer lesions. J. Neurosci. Res. 1992;33:549&#x2013;558. doi: 10.1002/jnr.490330407.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jnr.490330407</ArticleId><ArticleId IdType="pubmed">1484388</ArticleId></ArticleIdList></Reference><Reference><Citation>Grubman A, et al. A single-cell atlas of entorhinal cortex from individuals with Alzheimer&#x2019;s disease reveals cell-type-specific gene expression regulation. Nat. Neurosci. 2019;22:2087&#x2013;2097. doi: 10.1038/s41593-019-0539-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-019-0539-4</ArticleId><ArticleId IdType="pubmed">31768052</ArticleId></ArticleIdList></Reference><Reference><Citation>Lau SF, Cao H, Fu AKY, Ip NY. Single-nucleus transcriptome analysis reveals dysregulation of angiogenic endothelial cells and neuroprotective glia in Alzheimer&#x2019;s disease. Proc. Natl. Acad. Sci. U.S.A. 2020;117:25800&#x2013;25809. doi: 10.1073/pnas.2008762117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2008762117</ArticleId><ArticleId IdType="pmc">PMC7568283</ArticleId><ArticleId IdType="pubmed">32989152</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathys H, et al. Single-cell transcriptomic analysis of Alzheimer&#x2019;s disease. Nature. 2019;570:332&#x2013;337. doi: 10.1038/s41586-019-1195-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-019-1195-2</ArticleId><ArticleId IdType="pmc">PMC6865822</ArticleId><ArticleId IdType="pubmed">31042697</ArticleId></ArticleIdList></Reference><Reference><Citation>Chapuis J, et al. Transcriptomic and genetic studies identify IL-33 as a candidate gene for Alzheimer&#x2019;s disease. Mol. Psychiatry. 2009;14:1004&#x2013;1016. doi: 10.1038/mp.2009.10.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/mp.2009.10</ArticleId><ArticleId IdType="pmc">PMC2860783</ArticleId><ArticleId IdType="pubmed">19204726</ArticleId></ArticleIdList></Reference><Reference><Citation>Yousef H, et al. Aged blood impairs hippocampal neural precursor activity and activates microglia via brain endothelial cell VCAM1. Nat. Med. 2019;25:988&#x2013;1000. doi: 10.1038/s41591-019-0440-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-019-0440-4</ArticleId><ArticleId IdType="pmc">PMC6642642</ArticleId><ArticleId IdType="pubmed">31086348</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, et al. Astrocyte-secreted IL-33 mediates homeostatic synaptic plasticity in the adult hippocampus. Proc. Natl. Acad. Sci. U.S.A. 2021;118:e2020810118. doi: 10.1073/pnas.2020810118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2020810118</ArticleId><ArticleId IdType="pmc">PMC7817131</ArticleId><ArticleId IdType="pubmed">33443211</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen PT, et al. Microglial remodeling of the extracellular matrix promotes synapse plasticity. Cell. 2020;182:388&#x2013;403.e15. doi: 10.1016/j.cell.2020.05.050.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.05.050</ArticleId><ArticleId IdType="pmc">PMC7497728</ArticleId><ArticleId IdType="pubmed">32615087</ArticleId></ArticleIdList></Reference><Reference><Citation>Vainchtein ID, et al. Astrocyte-derived interleukin-33 promotes microglial synapse engulfment and neural circuit development. Science. 2018;359:1269&#x2013;1273. doi: 10.1126/science.aal3589.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aal3589</ArticleId><ArticleId IdType="pmc">PMC6070131</ArticleId><ArticleId IdType="pubmed">29420261</ArticleId></ArticleIdList></Reference><Reference><Citation>Townsend MJ, Fallon PG, Matthews DJ, Jolin HE, McKenzie ANJ. T1/ST2-deficient mice demonstrate the importance of T1/ST2 in developing primary T helper cell type 2 responses. J. Exp. Med. 2000;191:1069&#x2013;1075. doi: 10.1084/jem.191.6.1069.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.191.6.1069</ArticleId><ArticleId IdType="pmc">PMC2193113</ArticleId><ArticleId IdType="pubmed">10727469</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang Y, et al. An IL1RL1 genetic variant lowers soluble ST2 levels and the risk effects of APOE-&#x3b5;4 in female patients with Alzheimer&#x2019;s disease. Nat. Aging. 2022;2:616&#x2013;634. doi: 10.1038/s43587-022-00241-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s43587-022-00241-9</ArticleId><ArticleId IdType="pmc">PMC10154240</ArticleId><ArticleId IdType="pubmed">37117777</ArticleId></ArticleIdList></Reference><Reference><Citation>Kish DD, Volokh N, Baldwin WM, Fairchild RL. Hapten application to the skin induces an inflammatory program directing hapten-primed effector CD8 T cell interaction with hapten-presenting endothelial cells. J. Immunol. 2011;186:2117&#x2013;2126. doi: 10.4049/jimmunol.1002337.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1002337</ArticleId><ArticleId IdType="pmc">PMC4388432</ArticleId><ArticleId IdType="pubmed">21239709</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas SY, et al. PLZF induces an intravascular surveillance program mediated by long-lived LFA-1-ICAM-1 interactions. J. Exp. Med. 2011;208:1179&#x2013;1188. doi: 10.1084/jem.20102630.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20102630</ArticleId><ArticleId IdType="pmc">PMC3173247</ArticleId><ArticleId IdType="pubmed">21624939</ArticleId></ArticleIdList></Reference><Reference><Citation>De Juan A, et al. Artery-associated sympathetic innervation drives rhythmic vascular inflammation of arteries and veins. Circulation. 2019;140:1100&#x2013;1114. doi: 10.1161/CIRCULATIONAHA.119.040232.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.119.040232</ArticleId><ArticleId IdType="pmc">PMC6756975</ArticleId><ArticleId IdType="pubmed">31401849</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao FY, et al. Helicobacter pylori&#x2013;induced Rev-erb&#x3b1; fosters gastric bacteria colonization by impairing host innate and adaptive defense. Cmgh. 2021;12:395&#x2013;425.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8255816</ArticleId><ArticleId IdType="pubmed">33676046</ArticleId></ArticleIdList></Reference><Reference><Citation>Lau SF, Wu W, Seo H, Fu AKY, Ip NY. Quantitative in vivo assessment of amyloid-beta phagocytic capacity in an Alzheimer&#x2019;s disease mouse model. STAR Protoc. 2021;2:100265. doi: 10.1016/j.xpro.2020.100265.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xpro.2020.100265</ArticleId><ArticleId IdType="pmc">PMC7811161</ArticleId><ArticleId IdType="pubmed">33490981</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobin A, et al. STAR: Ultrafast universal RNA-seq aligner. Bioinformatics. 2013;29:15&#x2013;21. doi: 10.1093/bioinformatics/bts635.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/bts635</ArticleId><ArticleId IdType="pmc">PMC3530905</ArticleId><ArticleId IdType="pubmed">23104886</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao Y, Smyth GK, Shi W. The R package Rsubread is easier, faster, cheaper and better for alignment and quantification of RNA sequencing reads. Nucleic Acids Res. 2019;47:e47. doi: 10.1093/nar/gkz114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkz114</ArticleId><ArticleId IdType="pmc">PMC6486549</ArticleId><ArticleId IdType="pubmed">30783653</ArticleId></ArticleIdList></Reference><Reference><Citation>Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:550. doi: 10.1186/s13059-014-0550-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13059-014-0550-8</ArticleId><ArticleId IdType="pmc">PMC4302049</ArticleId><ArticleId IdType="pubmed">25516281</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng GXY, et al. Massively parallel digital transcriptional profiling of single cells. Nat. Commun. 2017;8:14049. doi: 10.1038/ncomms14049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms14049</ArticleId><ArticleId IdType="pmc">PMC5241818</ArticleId><ArticleId IdType="pubmed">28091601</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiu X, et al. Reversed graph embedding resolves complex single-cell trajectories. Nat. Methods. 2017;14:979&#x2013;982. doi: 10.1038/nmeth.4402.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.4402</ArticleId><ArticleId IdType="pmc">PMC5764547</ArticleId><ArticleId IdType="pubmed">28825705</ArticleId></ArticleIdList></Reference><Reference><Citation>Halle A, et al. The NALP3 inflammasome is involved in the innate immune response to amyloid-&#x3b2;. Nat. Immunol. 2008;9:857&#x2013;865. doi: 10.1038/ni.1636.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.1636</ArticleId><ArticleId IdType="pmc">PMC3101478</ArticleId><ArticleId IdType="pubmed">18604209</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun A, Nguyen XV, Bing G. Comparative analysis of an improved thioflavin-S stain, Gallyas silver stain, and immunohistochemistry for neurofibrillary tangle demonstration on the same sections. J. Histochem. Cytochem. 2002;50:463&#x2013;472. doi: 10.1177/002215540205000403.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/002215540205000403</ArticleId><ArticleId IdType="pubmed">11897799</ArticleId></ArticleIdList></Reference><Reference><Citation>Hrvatin S, et al. Single-cell analysis of experience-dependent transcriptomic states in the mouse visual cortex. Nat. Neurosci. 2018;21:120&#x2013;129. doi: 10.1038/s41593-017-0029-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-017-0029-5</ArticleId><ArticleId IdType="pmc">PMC5742025</ArticleId><ArticleId IdType="pubmed">29230054</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J, et al. Overexpression of low-density lipoprotein receptor in the brain markedly inhibits amyloid deposition and increases extracellular A&#x3b2; clearance. Neuron. 2009;64:632&#x2013;644. doi: 10.1016/j.neuron.2009.11.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2009.11.013</ArticleId><ArticleId IdType="pmc">PMC2787195</ArticleId><ArticleId IdType="pubmed">20005821</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37730840</PMID><DateCompleted><Year>2024</Year><Month>03</Month><Day>07</Day></DateCompleted><DateRevised><Year>2024</Year><Month>06</Month><Day>18</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1476-5578</ISSN><JournalIssue CitedMedium="Internet"><Volume>28</Volume><Issue>11</Issue><PubDate><Year>2023</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Molecular psychiatry</Title><ISOAbbreviation>Mol Psychiatry</ISOAbbreviation></Journal><ArticleTitle>Long non-coding RNA SNHG8 drives stress granule formation in tauopathies.</ArticleTitle><Pagination><StartPage>4889</StartPage><EndPage>4901</EndPage><MedlinePgn>4889-4901</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41380-023-02237-2</ELocationID><Abstract><AbstractText>Tauopathies are a heterogenous group of neurodegenerative disorders characterized by tau aggregation in the brain. In a subset of tauopathies, rare mutations in the MAPT gene, which encodes the tau protein, are sufficient to cause disease; however, the events downstream of MAPT mutations are poorly understood. Here, we investigate the role of long non-coding RNAs (lncRNAs), transcripts &gt;200 nucleotides with low/no coding potential that regulate transcription and translation, and their role in tauopathy. Using stem cell derived neurons from patients carrying a MAPT p.P301L, IVS10 + 16, or p.R406W mutation and CRISPR-corrected isogenic controls, we identified transcriptomic changes that occur as a function of the MAPT mutant allele. We identified 15 lncRNAs that were commonly differentially expressed across the three MAPT mutations. The commonly differentially expressed lncRNAs interact with RNA-binding proteins that regulate stress granule formation. Among these lncRNAs, SNHG8 was significantly reduced in a mouse model of tauopathy and in FTLD-tau, progressive supranuclear palsy, and Alzheimer's disease brains. We show that SNHG8 interacts with tau and stress granule-associated RNA-binding protein TIA1. Overexpression of mutant tau in vitro is sufficient to reduce SNHG8 expression and induce stress granule formation. Rescuing SNHG8 expression leads to reduced stress granule formation and reduced TIA1 levels in immortalized cells and in MAPT mutant neurons, suggesting that dysregulation of this non-coding RNA is a causal factor driving stress granule formation via TIA1 in tauopathies.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bhagat</LastName><ForeName>Reshma</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0001-7135-1930</Identifier><AffiliationInfo><Affiliation>Department of Psychiatry, Washington University in St Louis, St Louis, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Minaya</LastName><ForeName>Miguel A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, Washington University in St Louis, St Louis, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Renganathan</LastName><ForeName>Arun</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-6722-8136</Identifier><AffiliationInfo><Affiliation>Department of Psychiatry, Washington University in St Louis, St Louis, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mehra</LastName><ForeName>Muneshwar</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neuroscience, Washington University in St Louis, St Louis, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marsh</LastName><ForeName>Jacob</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, Washington University in St Louis, St Louis, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martinez</LastName><ForeName>Rita</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, Washington University in St Louis, St Louis, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eteleeb</LastName><ForeName>Abdallah M</ForeName><Initials>AM</Initials><Identifier Source="ORCID">0000-0001-9045-250X</Identifier><AffiliationInfo><Affiliation>Department of Psychiatry, Washington University in St Louis, St Louis, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nana</LastName><ForeName>Alissa L</ForeName><Initials>AL</Initials><AffiliationInfo><Affiliation>Department of Neurology, UCSF Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spina</LastName><ForeName>Salvatore</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-3570-9143</Identifier><AffiliationInfo><Affiliation>Department of Neurology, UCSF Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seeley</LastName><ForeName>William W</ForeName><Initials>WW</Initials><AffiliationInfo><Affiliation>Department of Neurology, UCSF Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathology, University of California, San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grinberg</LastName><ForeName>Lea T</ForeName><Initials>LT</Initials><Identifier Source="ORCID">0000-0002-6809-0618</Identifier><AffiliationInfo><Affiliation>Department of Neurology, UCSF Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathology, University of California, San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathology, University of Sao Paulo, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Karch</LastName><ForeName>Celeste M</ForeName><Initials>CM</Initials><Identifier Source="ORCID">0000-0002-6854-5547</Identifier><AffiliationInfo><Affiliation>Department of Psychiatry, Washington University in St Louis, St Louis, MO, USA. karchc@wustl.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Knight Alzheimer Disease Research Center, Washington University in St Louis, St Louis, MO, USA. karchc@wustl.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P30 AG066444</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 AG057195</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K24 AG053435</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG038791</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P01 AG026276</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U54 NS123985</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AG062422</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K24 DC015544</GrantID><Acronym>DC</Acronym><Agency>NIDCD NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U19 AG063911</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P01 AG003991</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P01 AG019724</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>RF1 NS110890</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>S10 OD021629</GrantID><Acronym>OD</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002345</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>09</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Mol Psychiatry</MedlineTA><NlmUniqueID>9607835</NlmUniqueID><ISSNLinking>1359-4184</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D062085">RNA, Long Noncoding</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016875">tau Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000626297">long noncoding RNA SNHG8, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C054369">MAPT protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="UpdateOf"><RefSource>medRxiv. 2023 Mar 01:2023.02.27.23286548. doi: 10.1101/2023.02.27.23286548.</RefSource><PMID Version="1">36909621</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009474" MajorTopicYN="N">Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D062085" MajorTopicYN="Y">RNA, Long Noncoding</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000088162" MajorTopicYN="N">Stress Granules</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016875" MajorTopicYN="N">tau Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D024801" MajorTopicYN="Y">Tauopathies</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>2</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>8</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>8</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>3</Month><Day>7</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>9</Month><Day>21</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>9</Month><Day>21</Day><Hour>0</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>9</Month><Day>21</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37730840</ArticleId><ArticleId IdType="mid">NIHMS1964753</ArticleId><ArticleId IdType="pmc">PMC10914599</ArticleId><ArticleId IdType="doi">10.1038/s41380-023-02237-2</ArticleId><ArticleId IdType="pii">10.1038/s41380-023-02237-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bodea LG, Eckert A, Ittner LM, Piguet O, G&#xf6;tz J. Tau physiology and pathomechanisms in frontotemporal lobar degeneration. J Neurochem. 2016;138:71&#x2013;94. doi: 10.1111/jnc.13600.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.13600</ArticleId><ArticleId IdType="pmc">PMC5094566</ArticleId><ArticleId IdType="pubmed">27306859</ArticleId></ArticleIdList></Reference><Reference><Citation>Pottier C, Ravenscroft TA, Sanchez-Contreras M, Rademakers R. Genetics of FTLD: overview and what else we can expect from genetic studies. J Neurochem. 2016;138:32&#x2013;53. doi: 10.1111/jnc.13622.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.13622</ArticleId><ArticleId IdType="pubmed">27009575</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Swieten J, Spillantini MG. Hereditary frontotemporal dementia caused by Tau gene mutations. Brain Pathol. 2007;17:63&#x2013;73. doi: 10.1111/j.1750-3639.2007.00052.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1750-3639.2007.00052.x</ArticleId><ArticleId IdType="pmc">PMC8095608</ArticleId><ArticleId IdType="pubmed">17493040</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu M, Zhang S, Tian X, Wu C. Mask mitigates MAPT- and FUS-induced degeneration by enhancing autophagy through lysosomal acidification. Autophagy. 2017;13:1924&#x2013;38. 10.1080/15548627.2017.1362524.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5788473</ArticleId><ArticleId IdType="pubmed">28806139</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahali S, Martinez R, King M, Verbeck A, Harari O, Benitez BA, et al. Defective proteostasis in induced pluripotent stem cell models of frontotemporal lobar degeneration. Transl Psychiatry. 2022;12:508. doi: 10.1038/s41398-022-02274-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41398-022-02274-5</ArticleId><ArticleId IdType="pmc">PMC9734180</ArticleId><ArticleId IdType="pubmed">36494352</ArticleId></ArticleIdList></Reference><Reference><Citation>Caballero B, Wang Y, Diaz A, Tasset I, Juste YR, Stiller B, et al. Interplay of pathogenic forms of human tau with different autophagic pathways. Aging Cell. 2018;17:e12692. doi: 10.1111/acel.12692.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/acel.12692</ArticleId><ArticleId IdType="pmc">PMC5770880</ArticleId><ArticleId IdType="pubmed">29024336</ArticleId></ArticleIdList></Reference><Reference><Citation>Frost B, Bardai FH, Feany MB. Lamin dysfunction mediates neurodegeneration in tauopathies. Curr Biol. 2016;26:129&#x2013;36. doi: 10.1016/j.cub.2015.11.039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cub.2015.11.039</ArticleId><ArticleId IdType="pmc">PMC4713335</ArticleId><ArticleId IdType="pubmed">26725200</ArticleId></ArticleIdList></Reference><Reference><Citation>Tracy TE, Madero-P&#xe9;rez J, Swaney DL, Chang TS, Moritz M, Konrad C, et al. Tau interactome maps synaptic and mitochondrial processes associated with neurodegeneration. Cell. 2022;185:712&#x2013;28.e14. doi: 10.1016/j.cell.2021.12.041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2021.12.041</ArticleId><ArticleId IdType="pmc">PMC8857049</ArticleId><ArticleId IdType="pubmed">35063084</ArticleId></ArticleIdList></Reference><Reference><Citation>Pradeepkiran JA, Hemachandra Reddy P. Defective mitophagy in Alzheimer&#x2019;s disease. Ageing Res Rev. 2020;64:101191. doi: 10.1016/j.arr.2020.101191.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arr.2020.101191</ArticleId><ArticleId IdType="pmc">PMC7710581</ArticleId><ArticleId IdType="pubmed">33022416</ArticleId></ArticleIdList></Reference><Reference><Citation>Simone R, Javad F, Emmett W, Wilkins OG, Almeida FL, Barahona-Torres N, et al. MIR-NATs repress MAPT translation and aid proteostasis in neurodegeneration. Nature. 2021;594:117&#x2013;23. doi: 10.1038/s41586-021-03556-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03556-6</ArticleId><ArticleId IdType="pmc">PMC7610982</ArticleId><ArticleId IdType="pubmed">34012113</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan Y, Yan H, Teng Y, Wang Q, Yang P, Zhang L, et al. Long non-coding RNA 00507/miRNA-181c-5p/TTBK1/MAPT axis regulates tau hyperphosphorylation in Alzheimer&#x2019;s disease. J Gene Med. 2020;22:3268. doi: 10.1002/jgm.3268.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jgm.3268</ArticleId><ArticleId IdType="pubmed">32891070</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang S, Wen N, Li Z, Dube U, Del Aguila J, Budde J, et al. Integrative system biology analyses of CRISPR-edited iPSC-derived neurons and human brains reveal deficiencies of presynaptic signaling in FTLD and PSP. Transl Psychiatry. 2018;8:265. doi: 10.1038/s41398-018-0319-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41398-018-0319-z</ArticleId><ArticleId IdType="pmc">PMC6293323</ArticleId><ArticleId IdType="pubmed">30546007</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowles KR, Silva MC, Whitney K, Bertucci T, Berlind JE, Lai JD, et al. ELAVL4, splicing, and glutamatergic dysfunction precede neuron loss in MAPT mutation cerebral organoids. Cell. 2021;184:4547&#x2013;63.e17. 10.1016/j.cell.2021.07.003.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8635409</ArticleId><ArticleId IdType="pubmed">34314701</ArticleId></ArticleIdList></Reference><Reference><Citation>Hernandez I, Luna G, Rauch JN, Reis SA, Giroux M, Karch CM, et al. A farnesyltransferase inhibitor activates lysosomes and reduces tau pathology in mice with tauopathy. Sci Transl Med. 2019;11. 10.1126/scitranslmed.aat3005.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7961212</ArticleId><ArticleId IdType="pubmed">30918111</ArticleId></ArticleIdList></Reference><Reference><Citation>Minaya MA, Mahali S, Iyer AK, Eteleeb AM, Martinez R, Huang G, et al. Conserved gene signatures shared among MAPT mutations reveal defects in calcium signaling. Front Mol Biosci. 2023;10:1051494. doi: 10.3389/fmolb.2023.1051494.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmolb.2023.1051494</ArticleId><ArticleId IdType="pmc">PMC9948093</ArticleId><ArticleId IdType="pubmed">36845551</ArticleId></ArticleIdList></Reference><Reference><Citation>Oo JA, Brandes RP, Leisegang MS. Long non-coding RNAs: novel regulators of cellular physiology and function. Pflug Arch Eur J Physiol. 2022;474:191&#x2013;204. doi: 10.1007/s00424-021-02641-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00424-021-02641-z</ArticleId><ArticleId IdType="pmc">PMC8766390</ArticleId><ArticleId IdType="pubmed">34791525</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X, Wang W, Zhu W, Dong J, Cheng Y, Yin Z, et al. Mechanisms and functions of long non-coding RNAs at multiple regulatory levels. Int J Mol Sci. 2019;20:5573. doi: 10.3390/ijms20225573.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20225573</ArticleId><ArticleId IdType="pmc">PMC6888083</ArticleId><ArticleId IdType="pubmed">31717266</ArticleId></ArticleIdList></Reference><Reference><Citation>Khong A, Matheny T, Jain S, Mitchell SF, Wheeler JR, Parker R. The stress granule transcriptome reveals principles of mRNA accumulation in stress granules. Mol Cell. 2017;68:808&#x2013;20.e5. 10.1016/j.molcel.2017.10.015.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5728175</ArticleId><ArticleId IdType="pubmed">29129640</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Treeck B, Protter DSW, Matheny T, Khong A, Link CD, Parker R. RNA self-assembly contributes to stress granule formation and defining the stress granule transcriptome. Proc Natl Acad Sci USA. 2018;115:2734&#x2013;9. doi: 10.1073/pnas.1800038115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1800038115</ArticleId><ArticleId IdType="pmc">PMC5856561</ArticleId><ArticleId IdType="pubmed">29483269</ArticleId></ArticleIdList></Reference><Reference><Citation>Karch CM, Kao AW, Karydas A, Onanuga K, Martinez R, Argouarch A, et al. A comprehensive resource for induced pluripotent stem cells from patients with primary tauopathies. Stem Cell Rep. 2019;13:939&#x2013;55. 10.1016/j.stemcr.2019.09.006.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6895712</ArticleId><ArticleId IdType="pubmed">31631020</ArticleId></ArticleIdList></Reference><Reference><Citation>Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126:663&#x2013;76. 10.1016/j.cell.2006.07.024.</Citation><ArticleIdList><ArticleId IdType="pubmed">16904174</ArticleId></ArticleIdList></Reference><Reference><Citation>Ban H, Nishishita N, Fusaki N, Tabata T, Saeki K, Shikamura M, et al. Efficient generation of transgene-free human induced pluripotent stem cells (iPSCs) by temperature-sensitive Sendai virus vectors. Proc Natl Acad Sci USA. 2011;108:14234&#x2013;9. doi: 10.1073/pnas.1103509108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1103509108</ArticleId><ArticleId IdType="pmc">PMC3161531</ArticleId><ArticleId IdType="pubmed">21821793</ArticleId></ArticleIdList></Reference><Reference><Citation>Sato C, Barth&#xe9;lemy NR, Mawuenyega KG, Patterson BW, Gordon BA, Jockel-Balsarotti J, et al. Tau kinetics in neurons and the human central nervous system. Neuron. 2018;97:1284&#x2013;98.e7. 10.1016/j.neuron.2018.02.015.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6137722</ArticleId><ArticleId IdType="pubmed">29566794</ArticleId></ArticleIdList></Reference><Reference><Citation>Patro R, Duggal G, Love MI, Irizarry RA, Kingsford C. Salmon provides fast and bias-aware quantification of transcript expression. Nat Methods. 2017;14:417&#x2013;9. doi: 10.1038/nmeth.4197.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.4197</ArticleId><ArticleId IdType="pmc">PMC5600148</ArticleId><ArticleId IdType="pubmed">28263959</ArticleId></ArticleIdList></Reference><Reference><Citation>Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:550. doi: 10.1186/s13059-014-0550-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13059-014-0550-8</ArticleId><ArticleId IdType="pmc">PMC4302049</ArticleId><ArticleId IdType="pubmed">25516281</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilkinson L. ggplot2: elegant graphics for data analysis by WICKHAM, H. Biometrics. 2011;67:678&#x2013;9. 10.1111/j.1541-0420.2011.01616.x.</Citation></Reference><Reference><Citation>Chen J, Zhang J, Gao Y, Li Y, Feng C, Song C, et al. LncSEA: a platform for long non-coding RNA related sets and enrichment analysis. Nucleic Acids Res. 2021;49:D969&#x2013;80. doi: 10.1093/nar/gkaa806.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkaa806</ArticleId><ArticleId IdType="pmc">PMC7778898</ArticleId><ArticleId IdType="pubmed">33045741</ArticleId></ArticleIdList></Reference><Reference><Citation>Montojo J, Zuberi K, Rodriguez H, Kazi F, Wright G, Donaldson SL, et al. GeneMANIA cytoscape plugin: fast gene function predictions on the desktop. Bioinformatics. 2010;26:2927&#x2013;8. doi: 10.1093/bioinformatics/btq562.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btq562</ArticleId><ArticleId IdType="pmc">PMC2971582</ArticleId><ArticleId IdType="pubmed">20926419</ArticleId></ArticleIdList></Reference><Reference><Citation>Armaos A, Colantoni A, Proietti G, Rupert J, Tartaglia GG. CatRAPID omics v2.0: Going deeper and wider in the prediction of protein-RNA interactions. Nucleic Acids Res. 2021;49:W72&#x2013;9. doi: 10.1093/nar/gkab393.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkab393</ArticleId><ArticleId IdType="pmc">PMC8262727</ArticleId><ArticleId IdType="pubmed">34086933</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellucci M, Agostini F, Masin M, Tartaglia GG. Predicting protein associations with long noncoding RNAs. Nat Methods. 2011;8:444&#x2013;5. doi: 10.1038/nmeth.1611.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.1611</ArticleId><ArticleId IdType="pubmed">21623348</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoover BR, Reed MN, Su J, Penrod RD, Kotilinek LA, Grant MK, et al. Tau mislocalization to dendritic spines mediates synaptic dysfunction independently of neurodegeneration. Neuron. 2010;68:1067&#x2013;81. 10.1016/j.neuron.2010.11.030.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3026458</ArticleId><ArticleId IdType="pubmed">21172610</ArticleId></ArticleIdList></Reference><Reference><Citation>Karch CM, Jeng AT, Goate AM. Extracellular tau levels are influenced by variability in tau that is associated with tauopathies. J Biol Chem. 2012;287:42751&#x2013;62. doi: 10.1074/jbc.M112.380642.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M112.380642</ArticleId><ArticleId IdType="pmc">PMC3522274</ArticleId><ArticleId IdType="pubmed">23105105</ArticleId></ArticleIdList></Reference><Reference><Citation>Bierhoff H. Analysis of lncRNA-protein interactions by RNA-protein pull-down assays and RNA immunoprecipitation (RIP) Methods Mol Biol. 2018;1686:241&#x2013;50. doi: 10.1007/978-1-4939-7371-2_17.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-4939-7371-2_17</ArticleId><ArticleId IdType="pubmed">29030825</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramsden M, Kotilinek L, Forster C, Paulson J, McGowan E, SantaCruz K, et al. Age-dependent neurofibrillary tangle formation, neuron loss, and memory impairment in a mouse model of human tauopathy (P301L). J Neurosci. 2005;25:10637&#x2013;47. 10.1523/JNEUROSCI.3279-05.2005.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6725849</ArticleId><ArticleId IdType="pubmed">16291936</ArticleId></ArticleIdList></Reference><Reference><Citation>Matarin M, Salih DA, Yasvoina M, Cummings DM, Guelfi S, Liu W, et al. A Genome-wide gene-expression analysis and database in transgenic mice during development of amyloid or tau pathology. Cell Rep. 2015;10:633&#x2013;44. doi: 10.1016/j.celrep.2014.12.041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2014.12.041</ArticleId><ArticleId IdType="pubmed">25620700</ArticleId></ArticleIdList></Reference><Reference><Citation>Allen M, Carrasquillo MM, Funk C, Heavner BD, Zou F, Younkin CS, et al. Human whole genome genotype and transcriptome data for Alzheimer&#x2019;s and other neurodegenerative diseases. Sci Data. 2016;3:160089. 10.1038/sdata.2016.89.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5058336</ArticleId><ArticleId IdType="pubmed">27727239</ArticleId></ArticleIdList></Reference><Reference><Citation>Gilks N, Kedersha N, Ayodele M, Shen L, Stoecklin G, Dember LM, et al. Stress granule assembly is mediated by prion-like aggregation of TIA-1. Mol Biol Cell. 2004;15:5383&#x2013;98. doi: 10.1091/mbc.E04-08-0715.</Citation><ArticleIdList><ArticleId IdType="doi">10.1091/mbc.E04-08-0715</ArticleId><ArticleId IdType="pmc">PMC532018</ArticleId><ArticleId IdType="pubmed">15371533</ArticleId></ArticleIdList></Reference><Reference><Citation>Kedersha N, Anderson P. Mammalian stress granules and processing bodies. Methods Enzymol. 2007;431:61&#x2013;81. doi: 10.1016/S0076-6879(07)31005-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0076-6879(07)31005-7</ArticleId><ArticleId IdType="pubmed">17923231</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanson KK, Mair GR. Stress granules and plasmodium liver stage infection. Biol Open. 2014;3:103&#x2013;7. doi: 10.1242/bio.20136833.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/bio.20136833</ArticleId><ArticleId IdType="pmc">PMC3892165</ArticleId><ArticleId IdType="pubmed">24357231</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang K, Daigle JG, Cunningham KM, Coyne AN, Ruan K, Grima JC, et al. Stress granule assembly disrupts nucleocytoplasmic transport. Cell. 2018;173:958&#x2013;971.e17. 10.1016/j.cell.2018.03.025.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6083872</ArticleId><ArticleId IdType="pubmed">29628143</ArticleId></ArticleIdList></Reference><Reference><Citation>Brunello CA, Yan X, Huttunen HJ. Internalized Tau sensitizes cells to stress by promoting formation and stability of stress granules. Sci Rep. 2016;6:30498. doi: 10.1038/srep30498.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep30498</ArticleId><ArticleId IdType="pmc">PMC4962319</ArticleId><ArticleId IdType="pubmed">27460788</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakamura M, Shiozawa S, Tsuboi D, Amano M, Watanabe H, Maeda S, et al. Pathological progression induced by the frontotemporal dementia-associated R406W tau mutation in patient-derived iPSCs. Stem Cell Rep. 2019;13:684&#x2013;99. 10.1016/j.stemcr.2019.08.011.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6829766</ArticleId><ArticleId IdType="pubmed">31543469</ArticleId></ArticleIdList></Reference><Reference><Citation>Capano LS, Sato C, Ficulle E, Yu A, Horie K, Barthelemy NR, et al. Recapitulation of endogenous 4R tau expression and formation of insoluble tau in directly reprogrammed human neurons. SSRN Electron J. 2021. 10.2139/ssrn.3899434.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9176216</ArticleId><ArticleId IdType="pubmed">35659876</ArticleId></ArticleIdList></Reference><Reference><Citation>Statello L, Guo CJ, Chen LL, Huarte M. Gene regulation by long non-coding RNAs and its biological functions. Nat Rev Mol Cell Biol. 2021;22:96&#x2013;118. doi: 10.1038/s41580-020-00315-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41580-020-00315-9</ArticleId><ArticleId IdType="pmc">PMC7754182</ArticleId><ArticleId IdType="pubmed">33353982</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang KC, Chang HY. Molecular mechanisms of long noncoding RNAs. Mol Cell. 2011;43:904&#x2013;14. doi: 10.1016/j.molcel.2011.08.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2011.08.018</ArticleId><ArticleId IdType="pmc">PMC3199020</ArticleId><ArticleId IdType="pubmed">21925379</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y, Wen L, Zhu H. Unveiling the hidden function of long non-coding RNA by identifying its major partner-protein. Cell Biosci. 2015;5:59. doi: 10.1186/s13578-015-0050-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13578-015-0050-x</ArticleId><ArticleId IdType="pmc">PMC4618879</ArticleId><ArticleId IdType="pubmed">26500759</ArticleId></ArticleIdList></Reference><Reference><Citation>Ash PEA, Lei S, Shattuck J, Boudeau S, Carlomagno Y, Medalla M, et al. TIA1 potentiates tau phase separation and promotes generation of toxic oligomeric tau. Proc Natl Acad Sci USA. 2021;118. 10.1073/pnas.2014188118.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7936275</ArticleId><ArticleId IdType="pubmed">33619090</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerstberger S, Hafner M, Ascano M, Tuschl T. Evolutionary conservation and expression of human RNA-Binding proteins and their role in human genetic disease. Adv Exp Med Biol. 2014;825:1&#x2013;55. doi: 10.1007/978-1-4939-1221-6_1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-4939-1221-6_1</ArticleId><ArticleId IdType="pmc">PMC4180674</ArticleId><ArticleId IdType="pubmed">25201102</ArticleId></ArticleIdList></Reference><Reference><Citation>Latimer CS, Keene CD, Kraemer BC, Liachko NF. TDP-43 promotes pathological tau phosphorylation and selective neurotoxicity in C. elegans. Alzheimers Dement. 2021;17. 10.1002/alz.058137.</Citation></Reference><Reference><Citation>Montalbano M, McAllen S, Cascio FL, Sengupta U, Garcia S, Bhatt N, et al. TDP-43 and tau oligomers in Alzheimer&#x2019;s disease, amyotrophic lateral sclerosis, and frontotemporal dementia. Neurobiol Dis. 2020;146:105130. 10.1016/j.nbd.2020.105130.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7703712</ArticleId><ArticleId IdType="pubmed">33065281</ArticleId></ArticleIdList></Reference><Reference><Citation>Urwin H, Josephs KA, Rohrer JD, MacKenzie IR, Neumann M, Authier A, et al. FUS pathology defines the majority of tau-and TDP-43-negative frontotemporal lobar degeneration. Acta Neuropathol. 2010;120:33&#x2013;41. doi: 10.1007/s00401-010-0698-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-010-0698-6</ArticleId><ArticleId IdType="pmc">PMC2887939</ArticleId><ArticleId IdType="pubmed">20490813</ArticleId></ArticleIdList></Reference><Reference><Citation>Lester E, Ooi FK, Bakkar N, Ayers J, Woerman AL, Wheeler J, et al. Tau aggregates are RNA-protein assemblies that mislocalize multiple nuclear speckle components. Neuron. 2021;109:1675&#x2013;91.e9. 10.1016/j.neuron.2021.03.026.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8141031</ArticleId><ArticleId IdType="pubmed">33848474</ArticleId></ArticleIdList></Reference><Reference><Citation>Lennox AL, Hoye ML, Jiang R, Johnson-Kerner BL, Suit LA, Venkataramanan S, et al. Pathogenic DDX3X mutations impair RNA metabolism and neurogenesis during fetal cortical development. Neuron. 2020;106:404&#x2013;20.e8. 10.1016/j.neuron.2020.01.042.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7331285</ArticleId><ArticleId IdType="pubmed">32135084</ArticleId></ArticleIdList></Reference><Reference><Citation>Vanderweyde T, Apicco DJ, Youmans-Kidder K, Ash PEA, Cook C, Lummertz da Rocha E, et al.Interaction of tau with the RNA-binding protein TIA1 regulates tau pathophysiology and toxicity. Cell Rep. 2016;15:1455&#x2013;66. 10.1016/j.celrep.2016.04.045.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5325702</ArticleId><ArticleId IdType="pubmed">27160897</ArticleId></ArticleIdList></Reference><Reference><Citation>Maziuk BF, Apicco DJ, Cruz AL, Jiang L, Ash PEA, da Rocha EL, et al. RNA binding proteins co-localize with small tau inclusions in tauopathy. Acta Neuropathol Commun. 2018;6:71. doi: 10.1186/s40478-018-0574-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-018-0574-5</ArticleId><ArticleId IdType="pmc">PMC6069705</ArticleId><ArticleId IdType="pubmed">30068389</ArticleId></ArticleIdList></Reference><Reference><Citation>Patani R, Lewis PA, Trabzuni D, Puddifoot CA, Wyllie DJA, Walker R, et al. Investigating the utility of human embryonic stem cell-derived neurons to model ageing and neurodegenerative disease using whole-genome gene expression and splicing analysis. J Neurochem. 2012;122:738&#x2013;51. 10.1111/j.1471-4159.2012.07825.x.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3504076</ArticleId><ArticleId IdType="pubmed">22681703</ArticleId></ArticleIdList></Reference><Reference><Citation>Sposito T, Preza E, Mahoney CJ, Set&#xf3;-Salvia N, Ryan NS, Morris HR, et al. Developmental regulation of tau splicing is disrupted in stem cell-derived neurons from frontotemporal dementia patients with the 10 + 16 splice-site mutation in MAPT. Hum Mol Genet. 2015;24:5260&#x2013;9. doi: 10.1093/hmg/ddv246.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddv246</ArticleId><ArticleId IdType="pmc">PMC4550814</ArticleId><ArticleId IdType="pubmed">26136155</ArticleId></ArticleIdList></Reference><Reference><Citation>Hefti MM, Farrell K, Kim SH, Bowles KR, Fowkes ME, Raj T, et al. High-resolution temporal and regional mapping of MAPT expression and splicing in human brain development. PLoS One. 2018;13:e0195771. doi: 10.1371/journal.pone.0195771.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0195771</ArticleId><ArticleId IdType="pmc">PMC5892924</ArticleId><ArticleId IdType="pubmed">29634760</ArticleId></ArticleIdList></Reference><Reference><Citation>Piatnitskaia S, Takahashi M, Kitaura H, Katsuragi Y, Kakihana T, Zhang L, et al. USP10 is a critical factor for Tau-positive stress granule formation in neuronal cells. Sci Rep. 2019;9:10591. doi: 10.1038/s41598-019-47033-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-47033-7</ArticleId><ArticleId IdType="pmc">PMC6646309</ArticleId><ArticleId IdType="pubmed">31332267</ArticleId></ArticleIdList></Reference><Reference><Citation>Marcelo A, Koppenol R, de Almeida LP, Matos CA, N&#xf3;brega C. Stress granules, RNA-binding proteins and polyglutamine diseases: too much aggregation? Cell Death Dis. 2021;12:592. doi: 10.1038/s41419-021-03873-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-021-03873-8</ArticleId><ArticleId IdType="pmc">PMC8187637</ArticleId><ArticleId IdType="pubmed">34103467</ArticleId></ArticleIdList></Reference><Reference><Citation>Glasauer SMK, Goderie SK, Rauch JN, Guzman E, Audouard M, Bertucci T, et al. Human tau mutations in cerebral organoids induce a progressive dyshomeostasis of cholesterol. Stem Cell Rep. 2022;17:2127&#x2013;40. doi: 10.1016/j.stemcr.2022.07.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2022.07.011</ArticleId><ArticleId IdType="pmc">PMC9481908</ArticleId><ArticleId IdType="pubmed">35985329</ArticleId></ArticleIdList></Reference><Reference><Citation>Gunawardana CG, Mehrabian M, Wang X, Mueller I, Lubambo IB, Jonkman JEN, et al. The human tau interactome: binding to the ribonucleoproteome, and impaired binding of the proline-to-leucine mutant at position 301 (P301L) to chaperones and the proteasome. Mol Cell Proteom. 2015;14:3000&#x2013;14. doi: 10.1074/mcp.M115.050724.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/mcp.M115.050724</ArticleId><ArticleId IdType="pmc">PMC4638042</ArticleId><ArticleId IdType="pubmed">26269332</ArticleId></ArticleIdList></Reference><Reference><Citation>Maziuk B, Ballance HI, Wolozin B. Dysregulation of RNA binding protein aggregation in neurodegenerative disorders. Front Mol Neurosci. 2017;10:89. doi: 10.3389/fnmol.2017.00089.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2017.00089</ArticleId><ArticleId IdType="pmc">PMC5378767</ArticleId><ArticleId IdType="pubmed">28420962</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006;314:130&#x2013;3. doi: 10.1126/science.1134108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1134108</ArticleId><ArticleId IdType="pubmed">17023659</ArticleId></ArticleIdList></Reference><Reference><Citation>Meier S, Bell M, Lyons DN, Rodriguez-Rivera J, Ingram A, Fontaine SN, et al. Pathological tau promotes neuronal damage by impairing ribosomal function and decreasing protein synthesis. J Neurosci. 2016;36:1001&#x2013;7. 10.1523/JNEUROSCI.3029-15.2016.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4719006</ArticleId><ArticleId IdType="pubmed">26791227</ArticleId></ArticleIdList></Reference><Reference><Citation>McMillan PJ, Benbow SJ, Uhrich R, Saxton A, Baum M, Strovas T, et al. Tau-RNA complexes inhibit microtubule polymerization and drive disease-relevant conformation change. Brain. 2023;146:3206&#x2013;20. doi: 10.1093/brain/awad032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awad032</ArticleId><ArticleId IdType="pmc">PMC10393409</ArticleId><ArticleId IdType="pubmed">36732296</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahboubi H, Stochaj U. Cytoplasmic stress granules: dynamic modulators of cell signaling and disease. Biochim. Biophys. Acta Mol Basis Dis. 2017;1863:884&#x2013;95. doi: 10.1016/j.bbadis.2016.12.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2016.12.022</ArticleId><ArticleId IdType="pubmed">28095315</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolozin B, Ivanov P. Stress granules and neurodegeneration. Nat Rev Neurosci. 2019;20:649&#x2013;66. doi: 10.1038/s41583-019-0222-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41583-019-0222-5</ArticleId><ArticleId IdType="pmc">PMC6986315</ArticleId><ArticleId IdType="pubmed">31582840</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan X, Yan Y, Xue M. Small nucleolar RNA host gene 8: a rising star in the targets for cancer therapy. Biomed Pharmacother. 2021;139:111622. doi: 10.1016/j.biopha.2021.111622.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2021.111622</ArticleId><ArticleId IdType="pubmed">33894626</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams GT, Farzaneh F. Are snoRNAs and snoRNA host genes new players in cancer. Nat Rev Cancer. 2012;12:84&#x2013;88. doi: 10.1038/nrc3195.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrc3195</ArticleId><ArticleId IdType="pubmed">22257949</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Chen K, Sloan SA, Bennett ML, Scholze AR, O&#x2019;Keeffe S, et al. An RNA-sequencing transcriptome and splicing database of glia, neurons, and vascular cells of the cerebral cortex. J Neurosci. 2014;34:11929&#x2013;47. 10.1523/JNEUROSCI.1860-14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4152602</ArticleId><ArticleId IdType="pubmed">25186741</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou C, Liao J, Hu D, Su Y, Lin H, Lin K, et al. SNHG8 promotes the progression of Epstein&#x2013;Barr virus-associated gastric cancer via sponging miR-512-5p and targeting TRIM28. Front Oncol. 2021;11:734694. 10.3389/fonc.2021.734694.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8554152</ArticleId><ArticleId IdType="pubmed">34722282</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu B, Wang B, Wu Z, Wu C, Ling J, Gao X, et al. LncRNA SNHG8 promotes proliferation and inhibits apoptosis of diffuse large B-cell lymphoma via sponging miR-335-5p. Front Oncol. 2021;11:650287. 10.3389/fonc.2021.650287.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8017314</ArticleId><ArticleId IdType="pubmed">33816305</ArticleId></ArticleIdList></Reference><Reference><Citation>Miao W, Lu T, Liu X, Yin W, Zhang H. LncRNA SNHG8 induces ovarian carcinoma cells cellular process and stemness through Wnt/&#x3b2;-catenin pathway. Cancer Biomark. 2020;28:459&#x2013;71. doi: 10.3233/CBM-190640.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/CBM-190640</ArticleId><ArticleId IdType="pubmed">32538821</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian J, Liu Y, Wang Z, Zhang S, Yang Y, Zhu Y, et al. LncRNA Snhg8 attenuates microglial inflammation response and blood&#x2013;brain barrier damage in ischemic stroke through regulating miR-425-5p mediated SIRT1/NF-&#x3ba;B signaling. J Biochem Mol Toxicol. 2021;35:22724. doi: 10.1002/jbt.22724.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jbt.22724</ArticleId><ArticleId IdType="pubmed">33491845</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C, Yang Q, Han Y, Liu H, Wang Y, Huang Y, et al. A reduced level of the long non-coding RNA SNHG8 activates the NF-kappaB pathway by releasing functional HIF-1alpha in a hypoxic inflammatory microenvironment. Stem Cell Res Ther. 2022;13:229. doi: 10.1186/s13287-022-02897-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13287-022-02897-x</ArticleId><ArticleId IdType="pmc">PMC9166574</ArticleId><ArticleId IdType="pubmed">35659362</ArticleId></ArticleIdList></Reference><Reference><Citation>Protter DSW, Parker R. Principles and properties of stress granules. Trends Cell Biol. 2016;26:668&#x2013;79. doi: 10.1016/j.tcb.2016.05.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tcb.2016.05.004</ArticleId><ArticleId IdType="pmc">PMC4993645</ArticleId><ArticleId IdType="pubmed">27289443</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37739953</PMID><DateCompleted><Year>2023</Year><Month>09</Month><Day>28</Day></DateCompleted><DateRevised><Year>2023</Year><Month>11</Month><Day>17</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2041-1723</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Sep</Month><Day>22</Day></PubDate></JournalIssue><Title>Nature communications</Title><ISOAbbreviation>Nat Commun</ISOAbbreviation></Journal><ArticleTitle>Acetylation discriminates disease-specific tau deposition.</ArticleTitle><Pagination><StartPage>5919</StartPage><MedlinePgn>5919</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">5919</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41467-023-41672-1</ELocationID><Abstract><AbstractText>Pathogenic aggregation of the protein tau is a hallmark of Alzheimer's disease and several other tauopathies. Tauopathies are characterized by the deposition of specific tau isoforms as disease-related tau filament structures. The molecular processes that determine isoform-specific deposition of tau are however enigmatic. Here we show that acetylation of tau discriminates its isoform-specific aggregation. We reveal that acetylation strongly attenuates aggregation of four-repeat tau protein, but promotes amyloid formation of three-repeat tau. We further identify acetylation of lysine 298 as a hot spot for isoform-specific tau aggregation. Solid-state NMR spectroscopy demonstrates that amyloid fibrils formed by unmodified and acetylated three-repeat tau differ in structure indicating that site-specific acetylation modulates tau structure. The results implicate acetylation as a critical regulator that guides the selective aggregation of three-repeat tau and the development of tau isoform-specific neurodegenerative diseases.</AbstractText><CopyrightInformation>&#xa9; 2023. Springer Nature Limited.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chakraborty</LastName><ForeName>Pijush</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0003-1749-5225</Identifier><AffiliationInfo><Affiliation>German Center for Neurodegenerative Diseases (DZNE), Von-Siebold-Str. 3a, 37075, G&#xf6;ttingen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rivi&#xe8;re</LastName><ForeName>Gwladys</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>German Center for Neurodegenerative Diseases (DZNE), Von-Siebold-Str. 3a, 37075, G&#xf6;ttingen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hebestreit</LastName><ForeName>Alina</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-4147-7919</Identifier><AffiliationInfo><Affiliation>German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Opakua</LastName><ForeName>Alain Ib&#xe1;&#xf1;ez</ForeName><Initials>AI</Initials><Identifier Source="ORCID">0000-0003-1700-9354</Identifier><AffiliationInfo><Affiliation>German Center for Neurodegenerative Diseases (DZNE), Von-Siebold-Str. 3a, 37075, G&#xf6;ttingen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vorberg</LastName><ForeName>Ina M</ForeName><Initials>IM</Initials><Identifier Source="ORCID">0000-0003-0583-4015</Identifier><AffiliationInfo><Affiliation>German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Rheinische Friedrich-Wilhelms-Universit&#xe4;t, Bonn, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Andreas</LastName><ForeName>Loren B</ForeName><Initials>LB</Initials><AffiliationInfo><Affiliation>Department for NMR-based Structural Biology, Max Planck Institute for Multidisciplinary Sciences, Am Fa&#xdf;berg 11, 37077, G&#xf6;ttingen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zweckstetter</LastName><ForeName>Markus</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-2536-6581</Identifier><AffiliationInfo><Affiliation>German Center for Neurodegenerative Diseases (DZNE), Von-Siebold-Str. 3a, 37075, G&#xf6;ttingen, Germany. markus.zweckstetter@dzne.de.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department for NMR-based Structural Biology, Max Planck Institute for Multidisciplinary Sciences, Am Fa&#xdf;berg 11, 37077, G&#xf6;ttingen, Germany. markus.zweckstetter@dzne.de.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>09</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nat Commun</MedlineTA><NlmUniqueID>101528555</NlmUniqueID><ISSNLinking>2041-1723</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D048948">14-3-3 Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016875">tau Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C054369">MAPT protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D048948" MajorTopicYN="N">14-3-3 Proteins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000107" MajorTopicYN="N">Acetylation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016875" MajorTopicYN="N">tau Proteins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D024801" MajorTopicYN="Y">Tauopathies</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>1</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>9</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>25</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>9</Month><Day>23</Day><Hour>11</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>9</Month><Day>22</Day><Hour>23</Hour><Minute>16</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>9</Month><Day>22</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37739953</ArticleId><ArticleId IdType="pmc">PMC10517010</ArticleId><ArticleId IdType="doi">10.1038/s41467-023-41672-1</ArticleId><ArticleId IdType="pii">10.1038/s41467-023-41672-1</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Dugger, B. N. &amp; Dickson, D. W. Pathology of neurodegenerative diseases. Cold Spring Harb. Perspect. Biol.9, 10.1101/cshperspect.a028035 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5495060</ArticleId><ArticleId IdType="pubmed">28062563</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Mandelkow E. Tau in physiology and pathology. Nat. Rev. Neurosci. 2016;17:5&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pubmed">26631930</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi Y, et al. Structure-based classification of tauopathies. Nature. 2021;598:359&#x2013;363.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7611841</ArticleId><ArticleId IdType="pubmed">34588692</ArticleId></ArticleIdList></Reference><Reference><Citation>Li D, Liu C. Hierarchical chemical determination of amyloid polymorphs in neurodegenerative disease. Nat. Chem. Biol. 2021;17:237&#x2013;245.</Citation><ArticleIdList><ArticleId IdType="pubmed">33432239</ArticleId></ArticleIdList></Reference><Reference><Citation>Andreadis A. Misregulation of tau alternative splicing in neurodegeneration and dementia. Prog. Mol. Subcell. Biol. 2006;44:89&#x2013;107.</Citation><ArticleIdList><ArticleId IdType="pubmed">17076266</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghetti B, et al. Invited review: Frontotemporal dementia caused by microtubule-associated protein tau gene (MAPT) mutations: a chameleon for neuropathology and neuroimaging. Neuropathol. Appl. Neurobiol. 2015;41:24&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4329416</ArticleId><ArticleId IdType="pubmed">25556536</ArticleId></ArticleIdList></Reference><Reference><Citation>Goedert M, Jakes R. Expression of separate isoforms of human tau protein: correlation with the tau pattern in brain and effects on tubulin polymerization. EMBO J. 1990;9:4225&#x2013;4230.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC552204</ArticleId><ArticleId IdType="pubmed">2124967</ArticleId></ArticleIdList></Reference><Reference><Citation>Falcon B, et al. Structures of filaments from Pick&#x2019;s disease reveal a novel tau protein fold. Nature. 2018;561:137&#x2013;140.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6204212</ArticleId><ArticleId IdType="pubmed">30158706</ArticleId></ArticleIdList></Reference><Reference><Citation>Alquezar C, Arya S, Kao AW. Tau post-translational modifications: dynamic transformers of tau function, degradation, and aggregation. Front. Neurol. 2020;11:595532.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7817643</ArticleId><ArticleId IdType="pubmed">33488497</ArticleId></ArticleIdList></Reference><Reference><Citation>Min SW, et al. Critical role of acetylation in tau-mediated neurodegeneration and cognitive deficits. Nat. Med. 2015;21:1154&#x2013;1162.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4598295</ArticleId><ArticleId IdType="pubmed">26390242</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X, et al. Promoting tau secretion and propagation by hyperactive p300/CBP via autophagy-lysosomal pathway in tauopathy. Mol. Neurodegener. 2020;15:2.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6945522</ArticleId><ArticleId IdType="pubmed">31906970</ArticleId></ArticleIdList></Reference><Reference><Citation>Schueller E, et al. Dysregulation of histone acetylation pathways in hippocampus and frontal cortex of Alzheimer&#x2019;s disease patients. Eur. Neuropsychopharmacol. 2020;33:101&#x2013;116.</Citation><ArticleIdList><ArticleId IdType="pubmed">32057591</ArticleId></ArticleIdList></Reference><Reference><Citation>Arakhamia T, et al. Posttranslational modifications mediate the structural diversity of tauopathy strains. Cell. 2020;180:633&#x2013;644 e612.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7491959</ArticleId><ArticleId IdType="pubmed">32032505</ArticleId></ArticleIdList></Reference><Reference><Citation>Kametani F, et al. Comparison of common and disease-specific post-translational modifications of pathological Tau associated with a wide range of tauopathies. Front. Neurosci. 2020;14:581936.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7672045</ArticleId><ArticleId IdType="pubmed">33250706</ArticleId></ArticleIdList></Reference><Reference><Citation>Caballero B, et al. Acetylated tau inhibits chaperone-mediated autophagy and promotes tau pathology propagation in mice. Nat. Commun. 2021;12:2238.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8047017</ArticleId><ArticleId IdType="pubmed">33854069</ArticleId></ArticleIdList></Reference><Reference><Citation>Alquezar C, et al. TSC1 loss increases risk for tauopathy by inducing tau acetylation and preventing tau clearance via chaperone-mediated autophagy. Sci. Adv. 2021;7:eabg3897.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8570595</ArticleId><ArticleId IdType="pubmed">34739309</ArticleId></ArticleIdList></Reference><Reference><Citation>Shin MK, et al. Reducing acetylated tau is neuroprotective in brain injury. Cell. 2021;184:2715&#x2013;2732 e2723.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8491234</ArticleId><ArticleId IdType="pubmed">33852912</ArticleId></ArticleIdList></Reference><Reference><Citation>Constantinidis J, Richard J, Tissot R. Pick&#x2019;s disease. Histological and clinical correlations. Eur. Neurol. 1974;11:208&#x2013;217.</Citation><ArticleIdList><ArticleId IdType="pubmed">4137107</ArticleId></ArticleIdList></Reference><Reference><Citation>Chakraborty P, et al. Co-factor-free aggregation of tau into seeding-competent RNA-sequestering amyloid fibrils. Nat. Commun. 2021;12:4231.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8270918</ArticleId><ArticleId IdType="pubmed">34244499</ArticleId></ArticleIdList></Reference><Reference><Citation>Jicha GA, Bowser R, Kazam IG, Davies P. Alz-50 and MC-1, a new monoclonal antibody raised to paired helical filaments, recognize conformational epitopes on recombinant tau. J. Neurosci. Res. 1997;48:128&#x2013;132.</Citation><ArticleIdList><ArticleId IdType="pubmed">9130141</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen TJ, Friedmann D, Hwang AW, Marmorstein R, Lee VM. The microtubule-associated tau protein has intrinsic acetyltransferase activity. Nat. Struct. Mol. Biol. 2013;20:756&#x2013;762.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3827724</ArticleId><ArticleId IdType="pubmed">23624859</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen TJ, Constance BH, Hwang AW, James M, Yuan CX. Intrinsic Tau acetylation is coupled to auto-proteolytic Tau fragmentation. PLoS ONE. 2016;11:e0158470.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4934699</ArticleId><ArticleId IdType="pubmed">27383765</ArticleId></ArticleIdList></Reference><Reference><Citation>Weingarten MD, Lockwood AH, Hwo SY, Kirschner MW. A protein factor essential for microtubule assembly. Proc. Natl Acad. Sci. USA. 1975;72:1858&#x2013;1862.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC432646</ArticleId><ArticleId IdType="pubmed">1057175</ArticleId></ArticleIdList></Reference><Reference><Citation>Gustke N, Trinczek B, Biernat J, Mandelkow EM, Mandelkow E. Domains of tau protein and interactions with microtubules. Biochemistry. 1994;33:9511&#x2013;9522.</Citation><ArticleIdList><ArticleId IdType="pubmed">8068626</ArticleId></ArticleIdList></Reference><Reference><Citation>Kellogg EH, et al. Near-atomic model of microtubule-tau interactions. Science. 2018;360:1242&#x2013;1246.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6225777</ArticleId><ArticleId IdType="pubmed">29748322</ArticleId></ArticleIdList></Reference><Reference><Citation>Irwin DJ, et al. Acetylated tau, a novel pathological signature in Alzheimer&#x2019;s disease and other tauopathies. Brain. 2012;135:807&#x2013;818.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3286338</ArticleId><ArticleId IdType="pubmed">22366796</ArticleId></ArticleIdList></Reference><Reference><Citation>Irwin DJ, et al. Acetylated tau neuropathology in sporadic and hereditary tauopathies. Am. J. Pathol. 2013;183:344&#x2013;351.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3730769</ArticleId><ArticleId IdType="pubmed">23885714</ArticleId></ArticleIdList></Reference><Reference><Citation>Trzeciakiewicz H, et al. An HDAC6-dependent surveillance mechanism suppresses tau-mediated neurodegeneration and cognitive decline. Nat. Commun. 2020;11:5522.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7606452</ArticleId><ArticleId IdType="pubmed">33139698</ArticleId></ArticleIdList></Reference><Reference><Citation>Gorsky MK, Burnouf S, Dols J, Mandelkow E, Partridge L. Acetylation mimic of lysine 280 exacerbates human Tau neurotoxicity in vivo. Sci. Rep. 2016;6:22685.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4778021</ArticleId><ArticleId IdType="pubmed">26940749</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujimoto H, et al. A possible overestimation of the effect of acetylation on lysine residues in KQ mutant analysis. J. Comput. Chem. 2012;33:239&#x2013;246.</Citation><ArticleIdList><ArticleId IdType="pubmed">22072565</ArticleId></ArticleIdList></Reference><Reference><Citation>Chalker JM, Lercher L, Rose NR, Schofield CJ, Davis BG. Conversion of cysteine into dehydroalanine enables access to synthetic histones bearing diverse post-translational modifications. Angew. Chem. Int. Ed. Engl. 2012;51:1835&#x2013;1839.</Citation><ArticleIdList><ArticleId IdType="pubmed">22247073</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhattacharya K, Rank KB, Evans DB, Sharma SK. Role of cysteine-291 and cysteine-322 in the polymerization of human tau into Alzheimer-like filaments. Biochem. Biophys. Res. Commun. 2001;285:20&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pubmed">11437366</ArticleId></ArticleIdList></Reference><Reference><Citation>Spillantini MG, Goedert M. Tau pathology and neurodegeneration. Lancet Neurol. 2013;12:609&#x2013;622.</Citation><ArticleIdList><ArticleId IdType="pubmed">23684085</ArticleId></ArticleIdList></Reference><Reference><Citation>Min SW, et al. Acetylation of tau inhibits its degradation and contributes to tauopathy. Neuron. 2010;67:953&#x2013;966.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3035103</ArticleId><ArticleId IdType="pubmed">20869593</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen TJ, et al. The acetylation of tau inhibits its function and promotes pathological tau aggregation. Nat. Commun. 2011;2:252.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3120096</ArticleId><ArticleId IdType="pubmed">21427723</ArticleId></ArticleIdList></Reference><Reference><Citation>Tracy TE, et al. Acetylated Tau obstructs KIBRA-mediated signaling in synaptic plasticity and promotes tauopathy-related memory loss. Neuron. 2016;90:245&#x2013;260.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4859346</ArticleId><ArticleId IdType="pubmed">27041503</ArticleId></ArticleIdList></Reference><Reference><Citation>Sohn PD, et al. Acetylated tau destabilizes the cytoskeleton in the axon initial segment and is mislocalized to the somatodendritic compartment. Mol. Neurodegener. 2016;11:47.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4928318</ArticleId><ArticleId IdType="pubmed">27356871</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang W, et al. Novel tau filament fold in corticobasal degeneration. Nature. 2020;580:283&#x2013;287.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7148158</ArticleId><ArticleId IdType="pubmed">32050258</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiang, X. et al. Role of molecular polymorphism in defining tau filament structures in neurodegenerative diseases. Preprint at bioRxiv10.1101/2021.05.24.445353 (2021).</Citation></Reference><Reference><Citation>Mukrasch MD, et al. Sites of tau important for aggregation populate beta-structure and bind to microtubules and polyanions. J. Biol. Chem. 2005;280:24978&#x2013;24986.</Citation><ArticleIdList><ArticleId IdType="pubmed">15855160</ArticleId></ArticleIdList></Reference><Reference><Citation>Mukrasch MD, et al. Structural polymorphism of 441-residue tau at single residue resolution. PLoS Biol. 2009;7:e34.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2642882</ArticleId><ArticleId IdType="pubmed">19226187</ArticleId></ArticleIdList></Reference><Reference><Citation>Narayanan RL, et al. Automatic assignment of the intrinsically disordered protein Tau with 441-residues. J. Am. Chem. Soc. 2010;132:11906&#x2013;11907.</Citation><ArticleIdList><ArticleId IdType="pubmed">20687558</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamah A, et al. Nuclear magnetic resonance analysis of the acetylation pattern of the neuronal Tau protein. Biochemistry. 2014;53:3020&#x2013;3032.</Citation><ArticleIdList><ArticleId IdType="pubmed">24708343</ArticleId></ArticleIdList></Reference><Reference><Citation>Barbet-Massin E, et al. Rapid proton-detected NMR assignment for proteins with fast magic angle spinning. J. Am. Chem. Soc. 2014;136:12489&#x2013;12497.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4156866</ArticleId><ArticleId IdType="pubmed">25102442</ArticleId></ArticleIdList></Reference><Reference><Citation>Vranken WF, et al. The CCPN data model for NMR spectroscopy: development of a software pipeline. Proteins. 2005;59:687&#x2013;696.</Citation><ArticleIdList><ArticleId IdType="pubmed">15815974</ArticleId></ArticleIdList></Reference><Reference><Citation>Fitzpatrick AWP, et al. Cryo-EM structures of tau filaments from Alzheimer&#x2019;s disease. Nature. 2017;547:185&#x2013;190.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5552202</ArticleId><ArticleId IdType="pubmed">28678775</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37739965</PMID><DateCompleted><Year>2023</Year><Month>09</Month><Day>25</Day></DateCompleted><DateRevised><Year>2023</Year><Month>11</Month><Day>19</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2041-1723</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Sep</Month><Day>22</Day></PubDate></JournalIssue><Title>Nature communications</Title><ISOAbbreviation>Nat Commun</ISOAbbreviation></Journal><ArticleTitle>Altered ubiquitin signaling induces Alzheimer's disease-like hallmarks in a three-dimensional human neural cell culture model.</ArticleTitle><Pagination><StartPage>5922</StartPage><MedlinePgn>5922</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">5922</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41467-023-41545-7</ELocationID><Abstract><AbstractText>Alzheimer's disease (AD) is characterized by toxic protein accumulation in the brain. Ubiquitination is essential for protein clearance in cells, making altered ubiquitin signaling crucial in AD development. A defective variant, ubiquitin B&#x2009;+&#x2009;1 (UBB<sup>+1</sup>), created by a non-hereditary RNA frameshift mutation, is found in all AD patient brains post-mortem. We now detect UBB<sup>+1</sup> in human brains during early AD stages. Our study employs a 3D neural culture platform derived from human neural progenitors, demonstrating that UBB<sup>+1</sup> alone induces extracellular amyloid-&#x3b2; (A&#x3b2;) deposits and insoluble hyperphosphorylated tau aggregates. UBB<sup>+1</sup> competes with ubiquitin for binding to the deubiquitinating enzyme UCHL1, leading to elevated levels of amyloid precursor protein (APP), secreted A&#x3b2; peptides, and A&#x3b2; build-up. Crucially, silencing UBB<sup>+1</sup> expression impedes the emergence of AD hallmarks in this model system. Our findings highlight the significance of ubiquitin signalling as a variable contributing to AD pathology and present a nonclinical platform for testing potential therapeutics.</AbstractText><CopyrightInformation>&#xa9; 2023. Springer Nature Limited.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Maniv</LastName><ForeName>Inbal</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Biology, Technion Israel Institute of Technology, Haifa, 3200003, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Sarji</LastName><ForeName>Mahasen</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Biology, Technion Israel Institute of Technology, Haifa, 3200003, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Bdarneh</LastName><ForeName>Anwar</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Biology, Technion Israel Institute of Technology, Haifa, 3200003, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Feldman</LastName><ForeName>Alona</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Biology, Technion Israel Institute of Technology, Haifa, 3200003, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ankawa</LastName><ForeName>Roi</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Biology, Technion Israel Institute of Technology, Haifa, 3200003, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koren</LastName><ForeName>Elle</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Biology, Technion Israel Institute of Technology, Haifa, 3200003, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Magid-Gold</LastName><ForeName>Inbar</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Biology, Technion Israel Institute of Technology, Haifa, 3200003, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reis</LastName><ForeName>Noa</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Biology, Technion Israel Institute of Technology, Haifa, 3200003, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Soteriou</LastName><ForeName>Despina</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Biology, Technion Israel Institute of Technology, Haifa, 3200003, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Salomon-Zimri</LastName><ForeName>Shiran</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurobiology, The George S. Wise Faculty of Life Sciences, The Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, 69978, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lavy</LastName><ForeName>Tali</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Biology, Technion Israel Institute of Technology, Haifa, 3200003, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kesselman</LastName><ForeName>Ellina</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>The Wolfson Department of Chemical Engineering, The Technion Center for Electron Microscopy of Soft Matter, Technion Israel Institute of Technology, Haifa, 3200003, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koifman</LastName><ForeName>Naama</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>The Wolfson Department of Chemical Engineering, The Technion Center for Electron Microscopy of Soft Matter, Technion Israel Institute of Technology, Haifa, 3200003, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kurz</LastName><ForeName>Thimo</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0003-0700-6993</Identifier><AffiliationInfo><Affiliation>School of Molecular Biosciences, University of Glasgow, Glasgow, G12 8QQ, Scotland, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kleifeld</LastName><ForeName>Oded</ForeName><Initials>O</Initials><Identifier Source="ORCID">0000-0003-3091-7154</Identifier><AffiliationInfo><Affiliation>Department of Biology, Technion Israel Institute of Technology, Haifa, 3200003, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Michaelson</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Neurobiology, The George S. Wise Faculty of Life Sciences, The Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, 69978, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Leeuwen</LastName><ForeName>Fred W</ForeName><Initials>FW</Initials><AffiliationInfo><Affiliation>Department of Neuroscience, Maastricht University, 6229 ER, Maastricht, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Verheijen</LastName><ForeName>Bert M</ForeName><Initials>BM</Initials><AffiliationInfo><Affiliation>Department of Biology, Technion Israel Institute of Technology, Haifa, 3200003, Israel.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neuroscience, Maastricht University, 6229 ER, Maastricht, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fuchs</LastName><ForeName>Yaron</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0003-4391-9386</Identifier><AffiliationInfo><Affiliation>Department of Biology, Technion Israel Institute of Technology, Haifa, 3200003, Israel. yaronfox@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Augmanity, Rehovot, 7670308, Israel. yaronfox@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Glickman</LastName><ForeName>Michael H</ForeName><Initials>MH</Initials><Identifier Source="ORCID">0000-0002-1222-8104</Identifier><AffiliationInfo><Affiliation>Department of Biology, Technion Israel Institute of Technology, Haifa, 3200003, Israel. glickman@technion.ac.il.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>09</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nat Commun</MedlineTA><NlmUniqueID>101528555</NlmUniqueID><ISSNLinking>2041-1723</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016229">Amyloid beta-Peptides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016564">Amyloid beta-Protein Precursor</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016229" MajorTopicYN="N">Amyloid beta-Peptides</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016564" MajorTopicYN="N">Amyloid beta-Protein Precursor</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000087603" MajorTopicYN="N">Cell Culture Techniques, Three Dimensional</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>4</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>9</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>25</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>9</Month><Day>23</Day><Hour>11</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>9</Month><Day>22</Day><Hour>23</Hour><Minute>17</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>9</Month><Day>22</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37739965</ArticleId><ArticleId IdType="pmc">PMC10516951</ArticleId><ArticleId IdType="doi">10.1038/s41467-023-41545-7</ArticleId><ArticleId IdType="pii">10.1038/s41467-023-41545-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Perneczky R, et al. Anti-amyloid antibody therapies in Alzheimer&#x2019;s disease. Brain: J. Neurol. 2023;146:842&#x2013;849.</Citation><ArticleIdList><ArticleId IdType="pubmed">36655336</ArticleId></ArticleIdList></Reference><Reference><Citation>De Strooper B, Karran E. The cellular phase of Alzheimer&#x2019;s disease. Cell. 2016;164:603&#x2013;615.</Citation><ArticleIdList><ArticleId IdType="pubmed">26871627</ArticleId></ArticleIdList></Reference><Reference><Citation>Knopman DS, et al. Alzheimer disease. Nat. Rev. Dis. Prim. 2021;7:33.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8574196</ArticleId><ArticleId IdType="pubmed">33986301</ArticleId></ArticleIdList></Reference><Reference><Citation>Yarns BC, Holiday KA, Carlson DM, Cosgrove CK, Melrose RJ. Pathophysiology of Alzheimer&#x2019;s disease. Psychiatr. Clin. North Am. 2022;45:663&#x2013;676.</Citation><ArticleIdList><ArticleId IdType="pubmed">36396271</ArticleId></ArticleIdList></Reference><Reference><Citation>Tramutola A, Di Domenico F, Barone E, Perluigi M, Butterfield DA. It is all about (U)biquitin: role of altered ubiquitin-proteasome system and UCHL1 in Alzheimer disease. Oxid. Med. Cell Longev. 2016;2016:2756068.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4736377</ArticleId><ArticleId IdType="pubmed">26881020</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Chen X, Zhao Y, Ponnusamy M, Liu Y. The role of ubiquitin proteasomal system and autophagy-lysosome pathway in Alzheimer&#x2019;s disease. Rev. Neurosci. 2017;28:861&#x2013;868.</Citation><ArticleIdList><ArticleId IdType="pubmed">28704199</ArticleId></ArticleIdList></Reference><Reference><Citation>McKinnon C, Tabrizi SJ. The ubiquitin-proteasome system in neurodegeneration. Antioxid. Redox Signal. 2014;21:2302&#x2013;2321.</Citation><ArticleIdList><ArticleId IdType="pubmed">24437518</ArticleId></ArticleIdList></Reference><Reference><Citation>Glickman MH, Ciechanover A. The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. Physiol. Rev. 2002;82:373&#x2013;428.</Citation><ArticleIdList><ArticleId IdType="pubmed">11917093</ArticleId></ArticleIdList></Reference><Reference><Citation>Chocron ES, et al. Genetic and pharmacologic proteasome augmentation ameliorates Alzheimer&#x2019;s-like pathology in mouse and fly APP overexpression models. Sci. Adv. 2022;8:eabk2252.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9177073</ArticleId><ArticleId IdType="pubmed">35675410</ArticleId></ArticleIdList></Reference><Reference><Citation>van Leeuwen FW, et al. Frameshift mutants of beta-amyloid precursor protein and ubiquitin-B in Alzheimer&#x2019;s and down patients. Science. 1998;279:242&#x2013;247.</Citation><ArticleIdList><ArticleId IdType="pubmed">9422699</ArticleId></ArticleIdList></Reference><Reference><Citation>Krutauz D, et al. Extended ubiquitin species are protein-based DUB inhibitors. Nat. Chem. Biol. 2014;10:664&#x2013;670.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4466224</ArticleId><ArticleId IdType="pubmed">24997605</ArticleId></ArticleIdList></Reference><Reference><Citation>Gentier RJ, van Leeuwen FW. Misframed ubiquitin and impaired protein quality control: an early event in Alzheimer&#x2019;s disease. Front Mol. Neurosci. 2015;8:47.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4557111</ArticleId><ArticleId IdType="pubmed">26388726</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X, Petranovic D. Role of frameshift ubiquitin B protein in Alzheimer&#x2019;s disease. Wiley Interdiscip. Rev. Syst. Biol. Med. 2016;8:300&#x2013;313.</Citation><ArticleIdList><ArticleId IdType="pubmed">27240056</ArticleId></ArticleIdList></Reference><Reference><Citation>Watamura N, Sato K, Saido TC. Mouse models of Alzheimer&#x2019;s disease for preclinical research. Neurochem. Int. 2022;158:105361.</Citation><ArticleIdList><ArticleId IdType="pubmed">35618239</ArticleId></ArticleIdList></Reference><Reference><Citation>Aerts L, et al. Do we still need animals? Surveying the role of animal-free models in Alzheimer&#x2019;s and Parkinson&#x2019;s disease research. EMBO J. 2022;41:e110002.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8922267</ArticleId><ArticleId IdType="pubmed">35199384</ArticleId></ArticleIdList></Reference><Reference><Citation>Finch CE, Austad SN. Commentary: is Alzheimer&#x2019;s disease uniquely human? Neurobiol. aging. 2015;36:553&#x2013;555.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4394838</ArticleId><ArticleId IdType="pubmed">25533426</ArticleId></ArticleIdList></Reference><Reference><Citation>Cenini G, et al. Dissecting Alzheimer&#x2019;s disease pathogenesis in human 2D and 3D models. Mol. Cell Neurosci. 2021;110:103568.</Citation><ArticleIdList><ArticleId IdType="pubmed">33068718</ArticleId></ArticleIdList></Reference><Reference><Citation>Arber C, Lovejoy C, Wray S. Stem cell models of Alzheimer&#x2019;s disease: progress and challenges. Alzheimer&#x2019;s Res. Ther. 2017;9:42.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5470327</ArticleId><ArticleId IdType="pubmed">28610595</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi SH, Kim YH, Quinti L, Tanzi RE, Kim DY. 3D culture models of Alzheimer&#x2019;s disease: a road map to a &#x201c;cure-in-a-dish&#x201d;. Mol. Neurodegener. 2016;11:75.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5148918</ArticleId><ArticleId IdType="pubmed">27938410</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi SH, et al. A three-dimensional human neural cell culture model of Alzheimer&#x2019;s disease. Nature. 2014;515:274&#x2013;278.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4366007</ArticleId><ArticleId IdType="pubmed">25307057</ArticleId></ArticleIdList></Reference><Reference><Citation>Olajide OJ, Suvanto ME, Chapman CA. Molecular mechanisms of neurodegeneration in the entorhinal cortex that underlie its selective vulnerability during the pathogenesis of Alzheimer&#x2019;s disease. Biol. open. 2021;10:bio056796.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7860115</ArticleId><ArticleId IdType="pubmed">33495355</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y, Strickland MR, Soranno A, Holtzman DM. Apolipoprotein E: structural Insights and Links to Alzheimer disease pathogenesis. Neuron. 2021;109:205&#x2013;221.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7931158</ArticleId><ArticleId IdType="pubmed">33176118</ArticleId></ArticleIdList></Reference><Reference><Citation>Martens YA, et al. ApoE cascade hypothesis in the pathogenesis of Alzheimer&#x2019;s disease and related dementias. Neuron. 2022;110:1304&#x2013;1317.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9035117</ArticleId><ArticleId IdType="pubmed">35298921</ArticleId></ArticleIdList></Reference><Reference><Citation>Raulin AC, et al. ApoE in Alzheimer&#x2019;s disease: pathophysiology and therapeutic strategies. Mol. Neurodegener. 2022;17:72.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9644639</ArticleId><ArticleId IdType="pubmed">36348357</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C, et al. Gain of toxic apolipoprotein E4 effects in human iPSC-derived neurons is ameliorated by a small-molecule structure corrector. Nat. Med. 2018;24:647&#x2013;657.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5948154</ArticleId><ArticleId IdType="pubmed">29632371</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi Y, et al. ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy. Nature. 2017;549:523&#x2013;527.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5641217</ArticleId><ArticleId IdType="pubmed">28959956</ArticleId></ArticleIdList></Reference><Reference><Citation>Liraz O, Boehm-Cagan A, Michaelson DM. ApoE4 induces Abeta42, tau, and neuronal pathology in the hippocampus of young targeted replacement apoE4 mice. Mol. Neurodegeneration. 2013;8:16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3659080</ArticleId><ArticleId IdType="pubmed">23684315</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodriguez GA, Burns MP, Weeber EJ, Rebeck GW. Young APOE4 targeted replacement mice exhibit poor spatial learning and memory, with reduced dendritic spine density in the medial entorhinal cortex. Learn. Mem. 2013;20:256&#x2013;266.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3630489</ArticleId><ArticleId IdType="pubmed">23592036</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim YH, et al. A 3D human neural cell culture system for modeling Alzheimer&#x2019;s disease. Nat. Protoc. 2015;10:985&#x2013;1006.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4499058</ArticleId><ArticleId IdType="pubmed">26068894</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindsten K, et al. Mutant ubiquitin found in neurodegenerative disorders is a ubiquitin fusion degradation substrate that blocks proteasomal degradation. J. Cell Biol. 2002;157:417&#x2013;427.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2173284</ArticleId><ArticleId IdType="pubmed">11980917</ArticleId></ArticleIdList></Reference><Reference><Citation>Arber C, et al. Familial Alzheimer&#x2019;s disease patient-derived neurons reveal distinct mutation-specific effects on amyloid beta. Mol. psychiatry. 2020;25:2919&#x2013;2931.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7577860</ArticleId><ArticleId IdType="pubmed">30980041</ArticleId></ArticleIdList></Reference><Reference><Citation>Hansson O. Biomarkers for neurodegenerative diseases. Nat. Med. 2021;27:954&#x2013;963.</Citation><ArticleIdList><ArticleId IdType="pubmed">34083813</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwak SS, et al. Amyloid-beta42/40 ratio drives tau pathology in 3D human neural cell culture models of Alzheimer&#x2019;s disease. Nat. Commun. 2020;11:1377.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7070004</ArticleId><ArticleId IdType="pubmed">32170138</ArticleId></ArticleIdList></Reference><Reference><Citation>Reilly P, et al. Novel human neuronal tau model exhibiting neurofibrillary tangles and transcellular propagation. Neurobiol. Dis. 2017;106:222&#x2013;234.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5593133</ArticleId><ArticleId IdType="pubmed">28610892</ArticleId></ArticleIdList></Reference><Reference><Citation>Fitzpatrick AWP, et al. Cryo-EM structures of tau filaments from Alzheimer&#x2019;s disease. Nature. 2017;547:185&#x2013;190.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5552202</ArticleId><ArticleId IdType="pubmed">28678775</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi Y, et al. Structure-based classification of tauopathies. Nature. 2021;598:359&#x2013;363.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7611841</ArticleId><ArticleId IdType="pubmed">34588692</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang M, et al. Increase in tau pathology in P290S mapt knock-in mice crossed with app (NL-G-F) mice. eNeuro. 2022;9:.0247&#x2013;22.2022.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9770019</ArticleId><ArticleId IdType="pubmed">36635241</ArticleId></ArticleIdList></Reference><Reference><Citation>Falcon B, et al. Structures of filaments from Pick&#x2019;s disease reveal a novel tau protein fold. Nature. 2018;561:137&#x2013;140.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6204212</ArticleId><ArticleId IdType="pubmed">30158706</ArticleId></ArticleIdList></Reference><Reference><Citation>He Z, et al. Amyloid-beta plaques enhance Alzheimer&#x2019;s brain tau-seeded pathologies by facilitating neuritic plaque tau aggregation. Nat. Med. 2018;24:29&#x2013;38.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5760353</ArticleId><ArticleId IdType="pubmed">29200205</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen GF, et al. Amyloid beta: structure, biology and structure-based therapeutic development. Acta Pharm. Sin. 2017;38:1205&#x2013;1235.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5589967</ArticleId><ArticleId IdType="pubmed">28713158</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong CO. Endosomal-lysosomal processing of neurodegeneration-associated proteins in astrocytes. Int J. Mol. Sci. 2020;21:5149.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7404029</ArticleId><ArticleId IdType="pubmed">32708198</ArticleId></ArticleIdList></Reference><Reference><Citation>Lorenzen A, et al. Rapid and direct transport of cell surface app to the lysosome defines a novel selective pathway. Mol. Brain. 2010;3:11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2868040</ArticleId><ArticleId IdType="pubmed">20409323</ArticleId></ArticleIdList></Reference><Reference><Citation>Irmler M, et al. Long-term proteasomal inhibition in transgenic mice by UBB(+1) expression results in dysfunction of central respiration control reminiscent of brainstem neuropathology in Alzheimer patients. Acta Neuropathol. 2012;124:187&#x2013;197.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3400757</ArticleId><ArticleId IdType="pubmed">22730000</ArticleId></ArticleIdList></Reference><Reference><Citation>Osaka H, et al. Ubiquitin carboxy-terminal hydrolase L1 binds to and stabilizes monoubiquitin in neuron. Hum. Mol. Genet. 2003;12:1945&#x2013;1958.</Citation><ArticleIdList><ArticleId IdType="pubmed">12913066</ArticleId></ArticleIdList></Reference><Reference><Citation>Bishop P, Rubin P, Thomson AR, Rocca D, Henley JM. The ubiquitin C-terminal hydrolase L1 (UCH-L1) C terminus plays a key role in protein stability, but its farnesylation is not required for membrane association in primary neurons. J. Biol. Chem. 2014;289:36140&#x2013;36149.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4276877</ArticleId><ArticleId IdType="pubmed">25326379</ArticleId></ArticleIdList></Reference><Reference><Citation>Das C, et al. Structural basis for conformational plasticity of the Parkinson&#x2019;s disease-associated ubiquitin hydrolase UCH-L1. Proc. Natl Acad. Sci. USA. 2006;103:4675&#x2013;4680.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1450230</ArticleId><ArticleId IdType="pubmed">16537382</ArticleId></ArticleIdList></Reference><Reference><Citation>Bett JS, et al. Ubiquitin C-terminal hydrolases cleave isopeptide- and peptide-linked ubiquitin from structured proteins but do not edit ubiquitin homopolymers. Biochem. J. 2015;466:489&#x2013;498.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4353193</ArticleId><ArticleId IdType="pubmed">25489924</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, Fallon L, Lashuel HA, Liu Z, Lansbury PT., Jr. The UCH-L1 gene encodes two opposing enzymatic activities that affect alpha-synuclein degradation and Parkinson&#x2019;s disease susceptibility. Cell. 2002;111:209&#x2013;218.</Citation><ArticleIdList><ArticleId IdType="pubmed">12408865</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang M, Cai F, Zhang S, Zhang S, Song W. Overexpression of ubiquitin carboxyl-terminal hydrolase L1 (UCHL1) delays Alzheimer&#x2019;s progression in vivo. Sci. Rep. 2014;4:7298.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4252905</ArticleId><ArticleId IdType="pubmed">25466238</ArticleId></ArticleIdList></Reference><Reference><Citation>Gong B, et al. Ubiquitin hydrolase Uch-L1 rescues beta-amyloid-induced decreases in synaptic function and contextual memory. Cell. 2006;126:775&#x2013;788.</Citation><ArticleIdList><ArticleId IdType="pubmed">16923396</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan Y, et al. X-linked ubiquitin-specific peptidase 11 increases tauopathy vulnerability in women. Cell. 2022;185:3913&#x2013;3930 e3919.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9588697</ArticleId><ArticleId IdType="pubmed">36198316</ArticleId></ArticleIdList></Reference><Reference><Citation>Ihara Y, Morishima-Kawashima M, Nixon R. The ubiquitin-proteasome system and the autophagic-lysosomal system in Alzheimer disease. Cold Spring Harb. Perspect. Med. 2012;2:a006361.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3405832</ArticleId><ArticleId IdType="pubmed">22908190</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee JH, et al. Faulty autolysosome acidification in Alzheimer&#x2019;s disease mouse models induces autophagic build-up of Abeta in neurons, yielding senile plaques. Nat. Neurosci. 2022;25:688&#x2013;701.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9174056</ArticleId><ArticleId IdType="pubmed">35654956</ArticleId></ArticleIdList></Reference><Reference><Citation>Pohl C, Dikic I. Cellular quality control by the ubiquitin-proteasome system and autophagy. Science. 2019;366:818&#x2013;822.</Citation><ArticleIdList><ArticleId IdType="pubmed">31727826</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang YW, Thompson R, Zhang H, Xu H. APP processing in Alzheimer&#x2019;s disease. Mol. Brain. 2011;4:3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3022812</ArticleId><ArticleId IdType="pubmed">21214928</ArticleId></ArticleIdList></Reference><Reference><Citation>Jorda-Siquier T, et al. APP accumulates with presynaptic proteins around amyloid plaques: A role for presynaptic mechanisms in Alzheimer&#x2019;s disease? Alzheimer&#x2019;s Dement.: J. Alzheimer&#x2019;s Assoc. 2022;18:2099&#x2013;2116.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9786597</ArticleId><ArticleId IdType="pubmed">35076178</ArticleId></ArticleIdList></Reference><Reference><Citation>Han JJ. FDA modernization Act 2.0 allows for alternatives to animal testing. Artif. Organs. 2023;47:449&#x2013;450.</Citation><ArticleIdList><ArticleId IdType="pubmed">36762462</ArticleId></ArticleIdList></Reference><Reference><Citation>Park J, et al. A 3D human triculture system modeling neurodegeneration and neuroinflammation in Alzheimer&#x2019;s disease. Nat. Neurosci. 2018;21:941&#x2013;951.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6800152</ArticleId><ArticleId IdType="pubmed">29950669</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischer DF, et al. Disease-specific accumulation of mutant ubiquitin as a marker for proteasomal dysfunction in the brain. FASEB J. 2003;17:2014&#x2013;2024.</Citation><ArticleIdList><ArticleId IdType="pubmed">14597671</ArticleId></ArticleIdList></Reference><Reference><Citation>Bussiere T, et al. Morphological characterization of Thioflavin-S-positive amyloid plaques in transgenic Alzheimer mice and effect of passive Abeta immunotherapy on their clearance. Am. J. Pathol. 2004;165:987&#x2013;995.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1618604</ArticleId><ArticleId IdType="pubmed">15331422</ArticleId></ArticleIdList></Reference><Reference><Citation>Case A, Stein RL. Mechanistic studies of ubiquitin C-terminal hydrolase L1. Biochemistry. 2006;45:2443&#x2013;2452.</Citation><ArticleIdList><ArticleId IdType="pubmed">16475834</ArticleId></ArticleIdList></Reference><Reference><Citation>Schagger H. Tricine-SDS-PAGE. Nat. Protoc. 2006;1:16&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pubmed">17406207</ArticleId></ArticleIdList></Reference><Reference><Citation>Youmans KL, et al. Amyloid-beta42 alters apolipoprotein E solubility in brains of mice with five familial AD mutations. J. Neurosci. Methods. 2011;196:51&#x2013;59.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3049315</ArticleId><ArticleId IdType="pubmed">21219931</ArticleId></ArticleIdList></Reference><Reference><Citation>Wagh AR, Sulakshane P, Glickman MH. Alzheimer&#x2019;s disease-associated mutant ubiquitin (UBB(+1)) is secreted through an autophagosome-like vesicle-mediated unconventional pathway. Biochim. Biophys. Acta Gene Regul. Mech. 2023;1866:194936.</Citation><ArticleIdList><ArticleId IdType="pubmed">37075976</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37749326</PMID><DateCompleted><Year>2023</Year><Month>10</Month><Day>30</Day></DateCompleted><DateRevised><Year>2024</Year><Month>11</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1529-2916</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>11</Issue><PubDate><Year>2023</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Nature immunology</Title><ISOAbbreviation>Nat Immunol</ISOAbbreviation></Journal><ArticleTitle>APOE4 impairs the microglial response in Alzheimer's disease by inducing TGF&#x3b2;-mediated checkpoints.</ArticleTitle><Pagination><StartPage>1839</StartPage><EndPage>1853</EndPage><MedlinePgn>1839-1853</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41590-023-01627-6</ELocationID><Abstract><AbstractText>The APOE4 allele is the strongest genetic risk factor for late-onset Alzheimer's disease (AD). The contribution of microglial APOE4 to AD pathogenesis is unknown, although APOE has the most enriched gene expression in neurodegenerative microglia (MGnD). Here, we show in mice and humans a negative role of microglial APOE4 in the induction of the MGnD response to neurodegeneration. Deletion of microglial APOE4 restores the MGnD phenotype associated with neuroprotection in P301S tau transgenic mice and decreases pathology in APP/PS1 mice. MGnD-astrocyte cross-talk associated with &#x3b2;-amyloid (A&#x3b2;) plaque encapsulation and clearance are mediated via LGALS3 signaling following microglial APOE4 deletion. In the brains of AD donors carrying the APOE4 allele, we found a sex-dependent reciprocal induction of AD risk factors associated with suppression of MGnD genes in females, including LGALS3, compared to individuals homozygous for the APOE3 allele. Mechanistically, APOE4-mediated induction of ITGB8-transforming growth factor-&#x3b2; (TGF&#x3b2;) signaling impairs the MGnD response via upregulation of microglial homeostatic checkpoints, including Inpp5d, in mice. Deletion of Inpp5d in microglia restores MGnD-astrocyte cross-talk and facilitates plaque clearance in APP/PS1 mice. We identify the microglial APOE4-ITGB8-TGF&#x3b2; pathway as a negative regulator of microglial response to AD pathology, and restoring the MGnD phenotype via blocking ITGB8-TGF&#x3b2; signaling provides a promising therapeutic intervention for AD.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s), under exclusive licence to Springer Nature America, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Yin</LastName><ForeName>Zhuoran</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Ophthalmology, Massachusetts Eye and Ear, Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Rosenzweig</LastName><ForeName>Neta</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kleemann</LastName><ForeName>Kilian L</ForeName><Initials>KL</Initials><AffiliationInfo><Affiliation>Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Computing, University of Portsmouth, Portsmouth, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Xiaoming</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brand&#xe3;o</LastName><ForeName>Wesley</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Margeta</LastName><ForeName>Milica A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Ophthalmology, Massachusetts Eye and Ear, Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schroeder</LastName><ForeName>Caitlin</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sivanathan</LastName><ForeName>Kisha N</ForeName><Initials>KN</Initials><AffiliationInfo><Affiliation>Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Evergrande Center for Immunologic Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Silveira</LastName><ForeName>Sebastian</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gauthier</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mallah</LastName><ForeName>Dania</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pitts</LastName><ForeName>Kristen M</ForeName><Initials>KM</Initials><Identifier Source="ORCID">0000-0001-7049-0883</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Ophthalmology, Massachusetts Eye and Ear, Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Durao</LastName><ForeName>Ana</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Herron</LastName><ForeName>Shawn</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shorey</LastName><ForeName>Hannah</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cheng</LastName><ForeName>Yiran</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barry</LastName><ForeName>Jen-Li</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Krishnan</LastName><ForeName>Rajesh K</ForeName><Initials>RK</Initials><AffiliationInfo><Affiliation>Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Evergrande Center for Immunologic Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wakelin</LastName><ForeName>Sam</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rhee</LastName><ForeName>Jared</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yung</LastName><ForeName>Anthony</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-1338-9401</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aronchik</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Chao</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Neurology, Hope Center for Neurological Disorders, Knight Alzheimer Disease Research Center, Washington University School of Medicine, St. Louis, MO, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Brain Science and Disease, Chongqing Medical University, Chongqing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jain</LastName><ForeName>Nimansha</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Neurology, Hope Center for Neurological Disorders, Knight Alzheimer Disease Research Center, Washington University School of Medicine, St. Louis, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bao</LastName><ForeName>Xin</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Neurology, Hope Center for Neurological Disorders, Knight Alzheimer Disease Research Center, Washington University School of Medicine, St. Louis, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gerrits</LastName><ForeName>Emma</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences of Cells &amp; Systems, Section Molecular Neurobiology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brouwer</LastName><ForeName>Nieske</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences of Cells &amp; Systems, Section Molecular Neurobiology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Deik</LastName><ForeName>Amy</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-9687-0953</Identifier><AffiliationInfo><Affiliation>Broad Institute of MIT and Harvard, Cambridge, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tenen</LastName><ForeName>Daniel G</ForeName><Initials>DG</Initials><Identifier Source="ORCID">0000-0002-6423-3888</Identifier><AffiliationInfo><Affiliation>Harvard Stem Cell Institute, Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Cancer Science Institute, National University of Singapore, Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ikezu</LastName><ForeName>Tsuneya</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-3979-8596</Identifier><AffiliationInfo><Affiliation>Department of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neuroscience, Mayo Clinic Florida, Jacksonville, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Santander</LastName><ForeName>Nicolas G</ForeName><Initials>NG</Initials><Identifier Source="ORCID">0000-0001-8919-833X</Identifier><AffiliationInfo><Affiliation>Department of Pediatrics, University of California, San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Instituto de Ciencias de la Salud, Universidad de O&#xb4;Higgins, Rancagua, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McKinsey</LastName><ForeName>Gabriel L</ForeName><Initials>GL</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, University of California, San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baufeld</LastName><ForeName>Caroline</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sheppard</LastName><ForeName>Dean</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-6277-2036</Identifier><AffiliationInfo><Affiliation>Department of Medicine, Cardiovascular Research Center, University of California, San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Krasemann</LastName><ForeName>Susanne</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-8795-818X</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Neuropathology, University Medical Center Hamburg-Eppendorf UKE, Hamburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nowarski</LastName><ForeName>Roni</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Evergrande Center for Immunologic Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eggen</LastName><ForeName>Bart J L</ForeName><Initials>BJL</Initials><Identifier Source="ORCID">0000-0001-8941-0353</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Sciences of Cells &amp; Systems, Section Molecular Neurobiology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Clish</LastName><ForeName>Clary</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0001-8259-9245</Identifier><AffiliationInfo><Affiliation>Broad Institute of MIT and Harvard, Cambridge, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tanzi</LastName><ForeName>Rudolph E</ForeName><Initials>RE</Initials><Identifier Source="ORCID">0000-0002-7032-1454</Identifier><AffiliationInfo><Affiliation>Genetics and Aging Research Unit, Massachusetts General Hospital, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Madore</LastName><ForeName>Charlotte</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratoire NutriNeuro, UMR1286, INRAE, Bordeaux INP, University of Bordeaux, Bordeaux, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arnold</LastName><ForeName>Thomas D</ForeName><Initials>TD</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, University of California, San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Holtzman</LastName><ForeName>David M</ForeName><Initials>DM</Initials><AffiliationInfo><Affiliation>Department of Neurology, Hope Center for Neurological Disorders, Knight Alzheimer Disease Research Center, Washington University School of Medicine, St. Louis, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Butovsky</LastName><ForeName>Oleg</ForeName><Initials>O</Initials><Identifier Source="ORCID">0000-0003-0186-8867</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. obutovsky@bwh.harvard.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Evergrande Center for Immunologic Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. obutovsky@bwh.harvard.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 GM132668</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 DK040561</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>RF1 NS090934</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R21 NS101673</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG075509</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K12 EY016335</GrantID><Acronym>EY</Acronym><Agency>NEI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 EY027921</GrantID><Acronym>EY</Acronym><Agency>NEI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG054672</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K08 EY030160</GrantID><Acronym>EY</Acronym><Agency>NEI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>AARF-21-846786</GrantID><Acronym>ALZ</Acronym><Agency>Alzheimer's Association</Agency><Country>United States</Country></Grant><Grant><GrantID>R21 NS104609</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG051812</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS088137</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R21 AG076982</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG080992</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>09</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Nat Immunol</MedlineTA><NlmUniqueID>100941354</NlmUniqueID><ISSNLinking>1529-2908</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D053327">Apolipoprotein E4</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D037502">Galectin 3</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016229">Amyloid beta-Peptides</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053327" MajorTopicYN="N">Apolipoprotein E4</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017628" MajorTopicYN="N">Microglia</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D037502" MajorTopicYN="N">Galectin 3</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016229" MajorTopicYN="N">Amyloid beta-Peptides</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement><b>Competing Interests:</b> O.B., Z.Y. and N.R. are inventors of a
patent licensed by Brigham and Women&#x2019;s Hospital for use of LGALS3 for
treatment of neurodegenerative diseases. O.B., Z.Y., N.R., X.Z., T.D.A. and D.S.
are inventors for a patent licensed by Brigham and Women&#x2019;s Hospital and
University of California, San Francisco, for use of an ITGB8 blocker for
treatment of neurodegenerative diseases. O.B. has a collaboration with GSK and
Regulus Therapeutics, receives research funding from Sanofi and GSK and receives
honoraria for lectures and consultancy from UCB, Camp4, Ono Pharma USA and
General Biophysics. D.M.H. is an inventor on a patent licensed by Washington
University to C2N Diagnostics on the therapeutic use of antibodies to tau and on
a patent licensed to NextCure on antibodies to APOE. D.M.H. cofounded and is on
the scientific advisory board of C2N Diagnostics. D.M.H. is on the scientific
advisory board of Denali, Genentech and Cajal Neuroscience and consults for
Alector. All other authors have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>11</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>8</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>10</Month><Day>30</Day><Hour>6</Hour><Minute>47</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>9</Month><Day>26</Day><Hour>0</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>9</Month><Day>25</Day><Hour>23</Hour><Minute>32</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>11</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37749326</ArticleId><ArticleId IdType="mid">NIHMS1956310</ArticleId><ArticleId IdType="pmc">PMC10863749</ArticleId><ArticleId IdType="doi">10.1038/s41590-023-01627-6</ArticleId><ArticleId IdType="pii">10.1038/s41590-023-01627-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Jansen IE et al. Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer&#x2019;s disease risk. Nat Genet 51, 404&#x2013;413 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6836675</ArticleId><ArticleId IdType="pubmed">30617256</ArticleId></ArticleIdList></Reference><Reference><Citation>Wightman DP et al. A genome-wide association study with 1,126,563 individuals identifies new risk loci for Alzheimer&#x2019;s disease. Nat Genet 53, 1276&#x2013;1282 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10243600</ArticleId><ArticleId IdType="pubmed">34493870</ArticleId></ArticleIdList></Reference><Reference><Citation>Nott A et al. Brain cell type-specific enhancer-promoter interactome maps and disease-risk association. Science 366, 1134&#x2013;1139 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7028213</ArticleId><ArticleId IdType="pubmed">31727856</ArticleId></ArticleIdList></Reference><Reference><Citation>Krasemann S et al. The TREM2-APOE Pathway Drives the Transcriptional Phenotype of Dysfunctional Microglia in Neurodegenerative Diseases. Immunity 47, 566&#x2013;581 e569 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5719893</ArticleId><ArticleId IdType="pubmed">28930663</ArticleId></ArticleIdList></Reference><Reference><Citation>Keren-Shaul H et al. A Unique Microglia Type Associated with Restricting Development of Alzheimer&#x2019;s Disease. Cell 169, 1276&#x2013;1290 e1217 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28602351</ArticleId></ArticleIdList></Reference><Reference><Citation>Farrer LA et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA 278, 1349&#x2013;1356 (1997).</Citation><ArticleIdList><ArticleId IdType="pubmed">9343467</ArticleId></ArticleIdList></Reference><Reference><Citation>Corder EH et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer&#x2019;s disease in late onset families. Science 261, 921&#x2013;923 (1993).</Citation><ArticleIdList><ArticleId IdType="pubmed">8346443</ArticleId></ArticleIdList></Reference><Reference><Citation>Strittmatter WJ et al. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci U S A 90, 1977&#x2013;1981 (1993).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC46003</ArticleId><ArticleId IdType="pubmed">8446617</ArticleId></ArticleIdList></Reference><Reference><Citation>Raber J et al. Isoform-specific effects of human apolipoprotein E on brain function revealed in ApoE knockout mice: increased susceptibility of females. Proc Natl Acad Sci U S A 95, 10914&#x2013;10919 (1998).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC27995</ArticleId><ArticleId IdType="pubmed">9724804</ArticleId></ArticleIdList></Reference><Reference><Citation>Youmans KL et al. APOE4-specific changes in Abeta accumulation in a new transgenic mouse model of Alzheimer disease. J Biol Chem 287, 41774&#x2013;41786 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3516726</ArticleId><ArticleId IdType="pubmed">23060451</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu DS et al. APOE4 enhances age-dependent decline in cognitive function by down-regulating an NMDA receptor pathway in EFAD-Tg mice. Mol Neurodegener 10, 7 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4391134</ArticleId><ArticleId IdType="pubmed">25871877</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C et al. Selective removal of astrocytic APOE4 strongly protects against tau-mediated neurodegeneration and decreases synaptic phagocytosis by microglia. Neuron 109, 1657&#x2013;1674 e1657 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8141024</ArticleId><ArticleId IdType="pubmed">33831349</ArticleId></ArticleIdList></Reference><Reference><Citation>Butovsky O et al. Identification of a unique TGF-beta-dependent molecular and functional signature in microglia. Nat Neurosci 17, 131&#x2013;143 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4066672</ArticleId><ArticleId IdType="pubmed">24316888</ArticleId></ArticleIdList></Reference><Reference><Citation>Margeta MA et al. Apolipoprotein E4 impairs the response of neurodegenerative retinal microglia and prevents neuronal loss in glaucoma. Immunity (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9488669</ArticleId><ArticleId IdType="pubmed">35977543</ArticleId></ArticleIdList></Reference><Reference><Citation>Parkhurst CN et al. Microglia promote learning-dependent synapse formation through brain-derived neurotrophic factor. Cell 155, 1596&#x2013;1609 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4033691</ArticleId><ArticleId IdType="pubmed">24360280</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldmann T et al. Origin, fate and dynamics of macrophages at central nervous system interfaces. Nat Immunol 17, 797&#x2013;805 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4968048</ArticleId><ArticleId IdType="pubmed">27135602</ArticleId></ArticleIdList></Reference><Reference><Citation>Cugurra A et al. Skull and vertebral bone marrow are myeloid cell reservoirs for the meninges and CNS parenchyma. Science 373 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8863069</ArticleId><ArticleId IdType="pubmed">34083447</ArticleId></ArticleIdList></Reference><Reference><Citation>Gosselin D et al. Environment drives selection and function of enhancers controlling tissue-specific macrophage identities. Cell 159, 1327&#x2013;1340 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4364385</ArticleId><ArticleId IdType="pubmed">25480297</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang KL et al. A common haplotype lowers PU.1 expression in myeloid cells and delays onset of Alzheimer&#x2019;s disease. Nat Neurosci 20, 1052&#x2013;1061 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5759334</ArticleId><ArticleId IdType="pubmed">28628103</ArticleId></ArticleIdList></Reference><Reference><Citation>Serrano-Pozo A, Frosch MP, Masliah E &amp; Hyman BT Neuropathological alterations in Alzheimer disease. Cold Spring Harb Perspect Med 1, a006189 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3234452</ArticleId><ArticleId IdType="pubmed">22229116</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi Y et al. ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy. Nature 549, 523&#x2013;527 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5641217</ArticleId><ArticleId IdType="pubmed">28959956</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshiyama Y et al. Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model. Neuron 53, 337&#x2013;351 (2007).</Citation><ArticleIdList><ArticleId IdType="pubmed">17270732</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenzweig N et al. PD-1/PD-L1 checkpoint blockade harnesses monocyte-derived macrophages to combat cognitive impairment in a tauopathy mouse model. Nat Commun 10, 465 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6349941</ArticleId><ArticleId IdType="pubmed">30692527</ArticleId></ArticleIdList></Reference><Reference><Citation>Radde R et al. Abeta42-driven cerebral amyloidosis in transgenic mice reveals early and robust pathology. EMBO Rep 7, 940&#x2013;946 (2006).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1559665</ArticleId><ArticleId IdType="pubmed">16906128</ArticleId></ArticleIdList></Reference><Reference><Citation>Bennett FC et al. A Combination of Ontogeny and CNS Environment Establishes Microglial Identity. Neuron 98, 1170&#x2013;1183 e1178 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6023731</ArticleId><ArticleId IdType="pubmed">29861285</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Hove H et al. A single-cell atlas of mouse brain macrophages reveals unique transcriptional identities shaped by ontogeny and tissue environment. Nat Neurosci 22, 1021&#x2013;1035 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">31061494</ArticleId></ArticleIdList></Reference><Reference><Citation>Mrdjen D et al. High-Dimensional Single-Cell Mapping of Central Nervous System Immune Cells Reveals Distinct Myeloid Subsets in Health, Aging, and Disease. Immunity 48, 380&#x2013;395 e386 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">29426702</ArticleId></ArticleIdList></Reference><Reference><Citation>Jordao MJC et al. Single-cell profiling identifies myeloid cell subsets with distinct fates during neuroinflammation. Science 363 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">30679343</ArticleId></ArticleIdList></Reference><Reference><Citation>Habib N et al. Disease-associated astrocytes in Alzheimer&#x2019;s disease and aging. Nat Neurosci 23, 701&#x2013;706 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9262034</ArticleId><ArticleId IdType="pubmed">32341542</ArticleId></ArticleIdList></Reference><Reference><Citation>Munger JS &amp; Sheppard D Cross talk among TGF-beta signaling pathways, integrins, and the extracellular matrix. Cold Spring Harb Perspect Biol 3, a005017 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3220354</ArticleId><ArticleId IdType="pubmed">21900405</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold TD et al. Impaired alphaVbeta8 and TGFbeta signaling lead to microglial dysmaturation and neuromotor dysfunction. J Exp Med 216, 900&#x2013;915 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6446869</ArticleId><ArticleId IdType="pubmed">30846482</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolf Y, Anderson AC &amp; Kuchroo VK TIM3 comes of age as an inhibitory receptor. Nat Rev Immunol 20, 173&#x2013;185 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7327798</ArticleId><ArticleId IdType="pubmed">31676858</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakao A et al. TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4. EMBO J 16, 5353&#x2013;5362 (1997).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1170167</ArticleId><ArticleId IdType="pubmed">9311995</ArticleId></ArticleIdList></Reference><Reference><Citation>Olah M et al. Single cell RNA sequencing of human microglia uncovers a subset associated with Alzheimer&#x2019;s disease. Nat Commun 11, 6129 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7704703</ArticleId><ArticleId IdType="pubmed">33257666</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y et al. Human and mouse single-nucleus transcriptomics reveal TREM2-dependent and TREM2-independent cellular responses in Alzheimer&#x2019;s disease. Nat Med 26, 131&#x2013;142 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6980793</ArticleId><ArticleId IdType="pubmed">31932797</ArticleId></ArticleIdList></Reference><Reference><Citation>Travis MA et al. Loss of integrin alpha(v)beta8 on dendritic cells causes autoimmunity and colitis in mice. Nature 449, 361&#x2013;365 (2007).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2670239</ArticleId><ArticleId IdType="pubmed">17694047</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakawesi J et al. alphavbeta8 integrin-expression by BATF3-dependent dendritic cells facilitates early IgA responses to Rotavirus. Mucosal Immunol 14, 53&#x2013;67 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">32161355</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y et al. An RNA-sequencing transcriptome and splicing database of glia, neurons, and vascular cells of the cerebral cortex. J Neurosci 34, 11929&#x2013;11947 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4152602</ArticleId><ArticleId IdType="pubmed">25186741</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Z et al. Fate Mapping via Ms4a3-Expression History Traces Monocyte-Derived Cells. Cell 178, 1509&#x2013;1525 e1519 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">31491389</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong K et al. Mice deficient in NRROS show abnormal microglial development and neurological disorders. Nat Immunol 18, 633&#x2013;641 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28459434</ArticleId></ArticleIdList></Reference><Reference><Citation>Samuels JD et al. The Alzheimer&#x2019;s disease risk factor INPP5D restricts neuroprotective microglial responses in amyloid beta-mediated pathology. Alzheimers Dement (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10576836</ArticleId><ArticleId IdType="pubmed">37061460</ArticleId></ArticleIdList></Reference><Reference><Citation>Iguchi A et al. INPP5D modulates TREM2 loss-of-function phenotypes in a beta-amyloidosis mouse model. iScience 26, 106375 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10074152</ArticleId><ArticleId IdType="pubmed">37035000</ArticleId></ArticleIdList></Reference><Reference><Citation>Dodagatta-Marri E et al. Integrin alphavbeta8 on T cells suppresses anti-tumor immunity in multiple models and is a promising target for tumor immunotherapy. Cell Rep 36, 109309 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8321414</ArticleId><ArticleId IdType="pubmed">34233193</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahan TE et al. Selective reduction of astrocyte apoE3 and apoE4 strongly reduces Abeta accumulation and plaque-related pathology in a mouse model of amyloidosis. Mol Neurodegener 17, 13 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8811969</ArticleId><ArticleId IdType="pubmed">35109920</ArticleId></ArticleIdList></Reference><Reference><Citation>Rohn TT &amp; Moore ZD Nuclear Localization of Apolipoprotein E4: A New Trick for an Old Protein. Int J Neurol Neurother 4 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5734658</ArticleId><ArticleId IdType="pubmed">29264400</ArticleId></ArticleIdList></Reference><Reference><Citation>Theendakara V et al. Direct Transcriptional Effects of Apolipoprotein E. J Neurosci 36, 685&#x2013;700 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4719010</ArticleId><ArticleId IdType="pubmed">26791201</ArticleId></ArticleIdList></Reference><Reference><Citation>Hollingworth P et al. Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer&#x2019;s disease. Nat Genet 43, 429&#x2013;435 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3084173</ArticleId><ArticleId IdType="pubmed">21460840</ArticleId></ArticleIdList></Reference><Reference><Citation>Pimenova AA et al. Alzheimer&#x2019;s-associated PU.1 expression levels regulate microglial inflammatory response. Neurobiol Dis 148, 105217 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7808757</ArticleId><ArticleId IdType="pubmed">33301878</ArticleId></ArticleIdList></Reference><Reference><Citation>Gosselin D et al. An environment-dependent transcriptional network specifies human microglia identity. Science 356 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5858585</ArticleId><ArticleId IdType="pubmed">28546318</ArticleId></ArticleIdList></Reference><Reference><Citation>Liddelow SA et al. Neurotoxic reactive astrocytes are induced by activated microglia. Nature 541, 481&#x2013;487 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5404890</ArticleId><ArticleId IdType="pubmed">28099414</ArticleId></ArticleIdList></Reference><Reference><Citation>Katsouri L et al. Ablation of reactive astrocytes exacerbates disease pathology in a model of Alzheimer&#x2019;s disease. Glia 68, 1017&#x2013;1030 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7383629</ArticleId><ArticleId IdType="pubmed">31799735</ArticleId></ArticleIdList></Reference><Reference><Citation>Boza-Serrano A et al. Galectin-3, a novel endogenous TREM2 ligand, detrimentally regulates inflammatory response in Alzheimer&#x2019;s disease. Acta Neuropathol 138, 251&#x2013;273 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6660511</ArticleId><ArticleId IdType="pubmed">31006066</ArticleId></ArticleIdList></Reference><Reference><Citation>Tao CC et al. Galectin-3 promotes Abeta oligomerization and Abeta toxicity in a mouse model of Alzheimer&#x2019;s disease. Cell Death Differ 27, 192&#x2013;209 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7206130</ArticleId><ArticleId IdType="pubmed">31127200</ArticleId></ArticleIdList></Reference><Reference><Citation>Mabuchi F et al. The apolipoprotein E gene polymorphism is associated with open angle glaucoma in the Japanese population. Mol Vis 11, 609&#x2013;612 (2005).</Citation><ArticleIdList><ArticleId IdType="pubmed">16110302</ArticleId></ArticleIdList></Reference><Reference><Citation>Lam CY et al. Association of apolipoprotein E polymorphisms with normal tension glaucoma in a Chinese population. J Glaucoma 15, 218&#x2013;222 (2006).</Citation><ArticleIdList><ArticleId IdType="pubmed">16778644</ArticleId></ArticleIdList></Reference><Reference><Citation>Margeta MA et al. Association of APOE With Primary Open-Angle Glaucoma Suggests a Protective Effect for APOE epsilon4. Invest Ophthalmol Vis Sci 61, 3 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7425753</ArticleId><ArticleId IdType="pubmed">32614373</ArticleId></ArticleIdList></Reference><Reference><Citation>Tesseur I et al. Deficiency in neuronal TGF-beta signaling promotes neurodegeneration and Alzheimer&#x2019;s pathology. J Clin Invest 116, 3060&#x2013;3069 (2006).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1626127</ArticleId><ArticleId IdType="pubmed">17080199</ArticleId></ArticleIdList></Reference><Reference><Citation>Wyss-Coray T et al. Amyloidogenic role of cytokine TGF-beta1 in transgenic mice and in Alzheimer&#x2019;s disease. Nature 389, 603&#x2013;606 (1997).</Citation><ArticleIdList><ArticleId IdType="pubmed">9335500</ArticleId></ArticleIdList></Reference><Reference><Citation>Kandasamy M et al. TGF-beta Signaling: A Therapeutic Target to Reinstate Regenerative Plasticity in Vascular Dementia? Aging Dis 11, 828&#x2013;850 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7390515</ArticleId><ArticleId IdType="pubmed">32765949</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin Z et al. Identification of a protective microglial state mediated by miR-155 and interferon-gamma signaling in a mouse model of Alzheimer&#x2019;s disease. Nat Neurosci 26, 1196&#x2013;1207 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10619638</ArticleId><ArticleId IdType="pubmed">37291336</ArticleId></ArticleIdList></Reference><Reference><Citation>Lund H et al. Fatal demyelinating disease is induced by monocyte-derived macrophages in the absence of TGF-&#x3b2; signaling. Nat Immunol 19, 1&#x2013;7 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7309278</ArticleId><ArticleId IdType="pubmed">29662171</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaiser T &amp; Feng G Tmem119-EGFP and Tmem119-CreERT2 Transgenic Mice for Labeling and Manipulating Microglia. eNeuro 6 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6712208</ArticleId><ArticleId IdType="pubmed">31371457</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang JW et al. Influence of SHIP on the NK repertoire and allogeneic bone marrow transplantation. Science 295, 2094&#x2013;2097 (2002).</Citation><ArticleIdList><ArticleId IdType="pubmed">11896280</ArticleId></ArticleIdList></Reference><Reference><Citation>Ju W et al. Deletion of Smad2 in mouse liver reveals novel functions in hepatocyte growth and differentiation. Mol Cell Biol 26, 654&#x2013;667 (2006).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1346892</ArticleId><ArticleId IdType="pubmed">16382155</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Q et al. Redundant roles of SMAD2 and SMAD3 in ovarian granulosa cells in vivo. Mol Cell Biol 28, 7001&#x2013;7011 (2008).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2593383</ArticleId><ArticleId IdType="pubmed">18809571</ArticleId></ArticleIdList></Reference><Reference><Citation>Huynh TV et al. Lack of hepatic apoE does not influence early Abeta deposition: observations from a new APOE knock-in model. Mol Neurodegener 14, 37 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6796484</ArticleId><ArticleId IdType="pubmed">31623648</ArticleId></ArticleIdList></Reference><Reference><Citation>Sullivan PM et al. Targeted replacement of the mouse apolipoprotein E gene with the common human APOE3 allele enhances diet-induced hypercholesterolemia and atherosclerosis. J Biol Chem 272, 17972&#x2013;17980 (1997).</Citation><ArticleIdList><ArticleId IdType="pubmed">9218423</ArticleId></ArticleIdList></Reference><Reference><Citation>Knouff C et al. Apo E structure determines VLDL clearance and atherosclerosis risk in mice. J Clin Invest 103, 1579&#x2013;1586 (1999).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC408371</ArticleId><ArticleId IdType="pubmed">10359567</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwasaki H et al. Distinctive and indispensable roles of PU.1 in maintenance of hematopoietic stem cells and their differentiation. Blood 106, 1590&#x2013;1600 (2005).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1895212</ArticleId><ArticleId IdType="pubmed">15914556</ArticleId></ArticleIdList></Reference><Reference><Citation>Proctor JM, Zang K, Wang D, Wang R &amp; Reichardt LF Vascular development of the brain requires beta8 integrin expression in the neuroepithelium. J Neurosci 25, 9940&#x2013;9948 (2005).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2849654</ArticleId><ArticleId IdType="pubmed">16251442</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao XF et al. Targeting Microglia Using Cx3cr1-Cre Lines: Revisiting the Specificity. eNeuro 6 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6620394</ArticleId><ArticleId IdType="pubmed">31201215</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanmarco LM et al. Gut-licensed IFNgamma(+) NK cells drive LAMP1(+)TRAIL(+) anti-inflammatory astrocytes. Nature 590, 473&#x2013;479 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8039910</ArticleId><ArticleId IdType="pubmed">33408417</ArticleId></ArticleIdList></Reference><Reference><Citation>Hao Y et al. Integrated analysis of multimodal single-cell data. Cell 184, 3573&#x2013;3587 e3529 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8238499</ArticleId><ArticleId IdType="pubmed">34062119</ArticleId></ArticleIdList></Reference><Reference><Citation>Ianevski A, Giri AK &amp; Aittokallio T Fully-automated and ultra-fast cell-type identification using specific marker combinations from single-cell transcriptomic data. Nat Commun 13, 1246 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8913782</ArticleId><ArticleId IdType="pubmed">35273156</ArticleId></ArticleIdList></Reference><Reference><Citation>Picelli S et al. Smart-seq2 for sensitive full-length transcriptome profiling in single cells. Nat Methods 10, 1096&#x2013;1098 (2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">24056875</ArticleId></ArticleIdList></Reference><Reference><Citation>Love MI, Huber W &amp; Anders S Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol 15, 550 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4302049</ArticleId><ArticleId IdType="pubmed">25516281</ArticleId></ArticleIdList></Reference><Reference><Citation>Mootha VK et al. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 34, 267&#x2013;273 (2003).</Citation><ArticleIdList><ArticleId IdType="pubmed">12808457</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanian A et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 102, 15545&#x2013;15550 (2005).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1239896</ArticleId><ArticleId IdType="pubmed">16199517</ArticleId></ArticleIdList></Reference><Reference><Citation>Browaeys R, Saelens W &amp; Saeys Y NicheNet: modeling intercellular communication by linking ligands to target genes. Nat Methods 17, 159&#x2013;162 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">31819264</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu Z, Gu L, Eils R, Schlesner M &amp; Brors B circlize Implements and enhances circular visualization in R. Bioinformatics 30, 2811&#x2013;2812 (2014).</Citation><ArticleIdList><ArticleId IdType="pubmed">24930139</ArticleId></ArticleIdList></Reference><Reference><Citation>Langmead B &amp; Salzberg SL Fast gapped-read alignment with Bowtie 2. Nat Methods 9, 357&#x2013;359 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3322381</ArticleId><ArticleId IdType="pubmed">22388286</ArticleId></ArticleIdList></Reference><Reference><Citation>Tarasov A, Vilella AJ, Cuppen E, Nijman IJ &amp; Prins P Sambamba: fast processing of NGS alignment formats. Bioinformatics 31, 2032&#x2013;2034 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4765878</ArticleId><ArticleId IdType="pubmed">25697820</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H et al. The Sequence Alignment/Map format and SAMtools. Bioinformatics 25, 2078&#x2013;2079 (2009).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2723002</ArticleId><ArticleId IdType="pubmed">19505943</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramirez F, Dundar F, Diehl S, Gruning BA &amp; Manke T deepTools: a flexible platform for exploring deep-sequencing data. Nucleic Acids Res 42, W187&#x2013;191 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4086134</ArticleId><ArticleId IdType="pubmed">24799436</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y et al. Model-based analysis of ChIP-Seq (MACS). Genome Biol 9, R137 (2008).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2592715</ArticleId><ArticleId IdType="pubmed">18798982</ArticleId></ArticleIdList></Reference><Reference><Citation>Bero AW et al. Bidirectional relationship between functional connectivity and amyloid-beta deposition in mouse brain. J Neurosci 32, 4334&#x2013;4340 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3326343</ArticleId><ArticleId IdType="pubmed">22457485</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37730744</PMID><DateCompleted><Year>2023</Year><Month>09</Month><Day>22</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>23</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2041-1723</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Sep</Month><Day>20</Day></PubDate></JournalIssue><Title>Nature communications</Title><ISOAbbreviation>Nat Commun</ISOAbbreviation></Journal><ArticleTitle>VE-cadherin in arachnoid and pia mater cells serves as a suitable landmark for in vivo imaging of CNS immune surveillance and inflammation.</ArticleTitle><Pagination><StartPage>5837</StartPage><MedlinePgn>5837</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">5837</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41467-023-41580-4</ELocationID><Abstract><AbstractText>Meninges cover the surface of the brain and spinal cord and contribute to protection and immune surveillance of the central nervous system (CNS). How the meningeal layers establish CNS compartments with different accessibility to immune cells and immune mediators is, however, not well understood. Here, using 2-photon imaging in female transgenic reporter mice, we describe VE-cadherin at intercellular junctions of arachnoid and pia mater cells that form the leptomeninges and border the subarachnoid space (SAS) filled with cerebrospinal fluid (CSF). VE-cadherin expression also marked a layer of Prox1<sup>+</sup> cells located within the arachnoid beneath and separate from E-cadherin<sup>+</sup> arachnoid barrier cells. In vivo imaging of the spinal cord and brain in female VE-cadherin-GFP reporter mice allowed for direct observation of accessibility of CSF derived tracers and T cells into the SAS bordered by the arachnoid and pia mater during health and neuroinflammation, and detection of volume changes of the SAS during CNS pathology. Together, the findings identified VE-cadherin as an informative landmark for in vivo imaging of the leptomeninges that can be used to visualize the borders of the SAS and thus potential barrier properties of the leptomeninges in controlling access of immune mediators and immune cells into the CNS during health and neuroinflammation.</AbstractText><CopyrightInformation>&#xa9; 2023. Springer Nature Limited.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Mapunda</LastName><ForeName>Josephine A</ForeName><Initials>JA</Initials><Identifier Source="ORCID">0000-0002-5810-5636</Identifier><AffiliationInfo><Affiliation>Theodor Kocher Institute, University of Bern, Bern, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Pareja</LastName><ForeName>Javier</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-7563-1443</Identifier><AffiliationInfo><Affiliation>Theodor Kocher Institute, University of Bern, Bern, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vladymyrov</LastName><ForeName>Mykhailo</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-5720-9740</Identifier><AffiliationInfo><Affiliation>Theodor Kocher Institute, University of Bern, Bern, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bouillet</LastName><ForeName>Elisa</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-5405-6128</Identifier><AffiliationInfo><Affiliation>Theodor Kocher Institute, University of Bern, Bern, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>H&#xe9;lie</LastName><ForeName>Pauline</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-5747-4894</Identifier><AffiliationInfo><Affiliation>Theodor Kocher Institute, University of Bern, Bern, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pleska&#x10d;</LastName><ForeName>Petr</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Theodor Kocher Institute, University of Bern, Bern, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barcos</LastName><ForeName>Sara</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Theodor Kocher Institute, University of Bern, Bern, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Andrae</LastName><ForeName>Johanna</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-0700-4381</Identifier><AffiliationInfo><Affiliation>Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vestweber</LastName><ForeName>Dietmar</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-3517-732X</Identifier><AffiliationInfo><Affiliation>Max-Planck- Institute for Molecular Biomedicine, M&#xfc;nster, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McDonald</LastName><ForeName>Donald M</ForeName><Initials>DM</Initials><Identifier Source="ORCID">0000-0002-6985-9564</Identifier><AffiliationInfo><Affiliation>Cardiovascular Research Institute, UCSF Helen Diller Family Comprehensive Cancer Center, and Department of Anatomy, University of California San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Betsholtz</LastName><ForeName>Christer</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine-Huddinge, Karolinska Institute, Campus Flemingsberg, Huddinge, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Deutsch</LastName><ForeName>Urban</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>Theodor Kocher Institute, University of Bern, Bern, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Proulx</LastName><ForeName>Steven T</ForeName><Initials>ST</Initials><AffiliationInfo><Affiliation>Theodor Kocher Institute, University of Bern, Bern, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Engelhardt</LastName><ForeName>Britta</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0003-3059-9846</Identifier><AffiliationInfo><Affiliation>Theodor Kocher Institute, University of Bern, Bern, Switzerland. britta.engelhardt@unibe.ch.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 HL059157</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HL127402</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HL143896</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>09</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nat Commun</MedlineTA><NlmUniqueID>101528555</NlmUniqueID><ISSNLinking>2041-1723</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C094954">cadherin 5</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015820">Cadherins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010841" MajorTopicYN="Y">Pia Mater</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000090862" MajorTopicYN="Y">Neuroinflammatory Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002490" MajorTopicYN="N">Central Nervous System</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001099" MajorTopicYN="N">Arachnoid</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015820" MajorTopicYN="N">Cadherins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>10</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>9</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>22</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>9</Month><Day>21</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>9</Month><Day>20</Day><Hour>23</Hour><Minute>54</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>9</Month><Day>20</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37730744</ArticleId><ArticleId IdType="pmc">PMC10511632</ArticleId><ArticleId IdType="doi">10.1038/s41467-023-41580-4</ArticleId><ArticleId IdType="pii">10.1038/s41467-023-41580-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Decimo I, Fumagalli G, Berton V, Krampera M, Bifari F. Meninges: from protective membrane to stem cell niche. Am. J. Stem Cells. 2012;1:92&#x2013;105.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3636743</ArticleId><ArticleId IdType="pubmed">23671802</ArticleId></ArticleIdList></Reference><Reference><Citation>Haines, D. E. &amp; Mihailoff., G. A. Fundamental neuroscience for basic and clinical application. In:Science Direct; Elsevier Publishing Company: Amsterdam, The Netherlands, 107&#x2013;121 (2018).</Citation></Reference><Reference><Citation>Balin BJ, Broadwell RD, Salcman M, el-Kalliny M. Avenues for entry of peripherally administered protein to the central nervous system in mouse, rat, and squirrel monkey. J. Comp. Neurol. 1986;251:260&#x2013;280.</Citation><ArticleIdList><ArticleId IdType="pubmed">3782501</ArticleId></ArticleIdList></Reference><Reference><Citation>Aspelund A, et al. A dural lymphatic vascular system that drains brain interstitial fluid and macromolecules. J. Exp. Med. 2015;212:991&#x2013;999.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4493418</ArticleId><ArticleId IdType="pubmed">26077718</ArticleId></ArticleIdList></Reference><Reference><Citation>Louveau A, et al. Structural and functional features of central nervous system lymphatic vessels. Nature. 2015;523:337&#x2013;341.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4506234</ArticleId><ArticleId IdType="pubmed">26030524</ArticleId></ArticleIdList></Reference><Reference><Citation>Da Mesquita S, Fu Z, Kipnis J. The meningeal lymphatic system: a new player in neurophysiology. Neuron. 2018;100:375&#x2013;388.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6268162</ArticleId><ArticleId IdType="pubmed">30359603</ArticleId></ArticleIdList></Reference><Reference><Citation>Nabeshima, S., Reese, T. S., Landis, D. M. D. &amp; Brightman, M. W. Junctions in the meninges and marginal glia. J. Comp. Neurol.164, 127&#x2013;169 (1975).</Citation><ArticleIdList><ArticleId IdType="pubmed">810497</ArticleId></ArticleIdList></Reference><Reference><Citation>Haines DE. On the question of a subdural space. Anat. Rec. 1991;230:3&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pubmed">2064027</ArticleId></ArticleIdList></Reference><Reference><Citation>Andres, K. H. [On the fine structure of the arachnoidea and dura mater of mammals]. Z. Zellforsch. Mikrosk. Anat.79, 272&#x2013;295 (1967).</Citation><ArticleIdList><ArticleId IdType="pubmed">4877297</ArticleId></ArticleIdList></Reference><Reference><Citation>Del Gaudio, F. et al. Distinct fibroblast subtypes populate specific brain barriers. Neuron Sneak Peek (2023). https://ssrn.com/abstract=4240422.</Citation></Reference><Reference><Citation>Krisch B, Leonhardt H, Oksche A. The meningeal compartments of the median eminence and the cortex. A comparative analysis in the rat. Cell Tissue Res. 1983;228:597&#x2013;640.</Citation><ArticleIdList><ArticleId IdType="pubmed">6831534</ArticleId></ArticleIdList></Reference><Reference><Citation>Alcolado R, Weller RO, Parrish EP, Garrod D. The cranial arachnoid and pia mater in man: anatomical and ultrastructural observations. Neuropathol. Appl. Neurobiol. 1988;14:1&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="pubmed">3374751</ArticleId></ArticleIdList></Reference><Reference><Citation>Yasuda K, et al. Drug transporters on arachnoid barrier cells contribute to the blood-cerebrospinal fluid barrier. Drug Metab. Dispos. 2013;41:923&#x2013;931.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3608452</ArticleId><ArticleId IdType="pubmed">23298861</ArticleId></ArticleIdList></Reference><Reference><Citation>Brochner CB, Holst CB, Mollgard K. Outer brain barriers in rat and human development. Front. Neurosci. 2015;9:75.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4360706</ArticleId><ArticleId IdType="pubmed">25852456</ArticleId></ArticleIdList></Reference><Reference><Citation>Derk J, et al. Formation and function of the meningeal arachnoid barrier around the developing mouse brain. Dev. Cell. 2023;58:635&#x2013;644 e634.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10231667</ArticleId><ArticleId IdType="pubmed">36996816</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Z, Tachikawa M, Uchida Y, Terasaki T. Drug clearance from cerebrospinal fluid mediated by organic anion transporters 1 (Slc22a6) and 3 (Slc22a8) at arachnoid membrane of rats. Mol. Pharm. 2018;15:911&#x2013;922.</Citation><ArticleIdList><ArticleId IdType="pubmed">29436232</ArticleId></ArticleIdList></Reference><Reference><Citation>Uchida Y, et al. A human blood-arachnoid barrier atlas of transporters, receptors, enzymes, and tight junction and marker proteins: comparison with dog and pig in absolute abundance. J. Neurochem. 2022;161:187&#x2013;208.</Citation><ArticleIdList><ArticleId IdType="pubmed">35226354</ArticleId></ArticleIdList></Reference><Reference><Citation>Saboori P, Sadegh A. Histology and morphology of the brain subarachnoid trabeculae. Anat. Res Int. 2015;2015:279814&#x2013;279814.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4458278</ArticleId><ArticleId IdType="pubmed">26090230</ArticleId></ArticleIdList></Reference><Reference><Citation>Hutchings M, Weller RO. Anatomical relationships of the pia mater to cerebral blood vessels in man. J. Neurosurg. 1986;65:316&#x2013;325.</Citation><ArticleIdList><ArticleId IdType="pubmed">3734882</ArticleId></ArticleIdList></Reference><Reference><Citation>Brightman MW, Reese TS. Junctions between intimately apposed cell membranes in the vertebrate brain. J. Cell Biol. 1969;40:648&#x2013;677.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2107650</ArticleId><ArticleId IdType="pubmed">5765759</ArticleId></ArticleIdList></Reference><Reference><Citation>Rennels ML, Gregory TF, Blaumanis OR, Fujimoto K, Grady PA. Evidence for a &#x2018;paravascular&#x2019; fluid circulation in the mammalian central nervous system, provided by the rapid distribution of tracer protein throughout the brain from the subarachnoid space. Brain Res. 1985;326:47&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pubmed">3971148</ArticleId></ArticleIdList></Reference><Reference><Citation>Weller RO. Microscopic morphology and histology of the human meninges. Morphologie. 2005;89:22&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pubmed">15943078</ArticleId></ArticleIdList></Reference><Reference><Citation>Engelhardt B, Vajkoczy P, Weller RO. The movers and shapers in immune privilege of the CNS. Nat. Immunol. 2017;18:123&#x2013;131.</Citation><ArticleIdList><ArticleId IdType="pubmed">28092374</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar NN, et al. Delivery of immunoglobulin G antibodies to the rat nervous system following intranasal administration: Distribution, dose-response, and mechanisms of delivery. J. Control Release. 2018;286:467&#x2013;484.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7234798</ArticleId><ArticleId IdType="pubmed">30081144</ArticleId></ArticleIdList></Reference><Reference><Citation>Agrawal S, et al. Dystroglycan is selectively cleaved at the parenchymal basement membrane at sites of leukocyte extravasation in experimental autoimmune encephalomyelitis. J. Exp. Med. 2006;203:1007&#x2013;1019.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2118280</ArticleId><ArticleId IdType="pubmed">16585265</ArticleId></ArticleIdList></Reference><Reference><Citation>Song J, et al. Focal MMP-2 and MMP-9 activity at the blood-brain barrier promotes chemokine-induced leukocyte migration. Cell Rep. 2015;10:1040&#x2013;1054.</Citation><ArticleIdList><ArticleId IdType="pubmed">25704809</ArticleId></ArticleIdList></Reference><Reference><Citation>Cugurra, A. et al. Skull and vertebral bone marrow are myeloid cell reservoirs for the meninges and CNS parenchyma. Science373, eabf7844 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8863069</ArticleId><ArticleId IdType="pubmed">34083447</ArticleId></ArticleIdList></Reference><Reference><Citation>Schafflick D, et al. Single-cell profiling of CNS border compartment leukocytes reveals that B cells and their progenitors reside in non-diseased meninges. Nat. Neurosci. 2021;24:1225&#x2013;1234.</Citation><ArticleIdList><ArticleId IdType="pubmed">34253922</ArticleId></ArticleIdList></Reference><Reference><Citation>Brioschi, S. et al. Heterogeneity of meningeal B cells reveals a lymphopoietic niche at the CNS borders. Science373, eabf9277 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8448524</ArticleId><ArticleId IdType="pubmed">34083450</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma T, Wang F, Xu S, Huang JH. Meningeal immunity: Structure, function and a potential therapeutic target of neurodegenerative diseases. Brain Behav. Immun. 2021;93:264&#x2013;276.</Citation><ArticleIdList><ArticleId IdType="pubmed">33548498</ArticleId></ArticleIdList></Reference><Reference><Citation>Kierdorf K, Masuda T, Jord&#xe3;o MJC, Prinz M. Macrophages at CNS interfaces: ontogeny and function in health and disease. Nat. Rev. Neurosci. 2019;20:547&#x2013;562.</Citation><ArticleIdList><ArticleId IdType="pubmed">31358892</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldmann T, et al. Origin, fate and dynamics of macrophages at central nervous system interfaces. Nat. Immunol. 2016;17:797&#x2013;805.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4968048</ArticleId><ArticleId IdType="pubmed">27135602</ArticleId></ArticleIdList></Reference><Reference><Citation>Mrdjen D, et al. High-dimensional single-cell mapping of central nervous system immune cells reveals distinct myeloid subsets in health, aging, and disease. Immunity. 2018;48:380&#x2013;395.e386.</Citation><ArticleIdList><ArticleId IdType="pubmed">29426702</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Hove H, et al. A single-cell atlas of mouse brain macrophages reveals unique transcriptional identities shaped by ontogeny and tissue environment. Nat. Neurosci. 2019;22:1021&#x2013;1035.</Citation><ArticleIdList><ArticleId IdType="pubmed">31061494</ArticleId></ArticleIdList></Reference><Reference><Citation>Louveau A, et al. CNS lymphatic drainage and neuroinflammation are regulated by meningeal lymphatic vasculature. Nat. Neurosci. 2018;21:1380&#x2013;1391.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6214619</ArticleId><ArticleId IdType="pubmed">30224810</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazzitelli JA, et al. Cerebrospinal fluid regulates skull bone marrow niches via direct access through dural channels. Nat. Neurosci. 2022;25:555&#x2013;560.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9081158</ArticleId><ArticleId IdType="pubmed">35301477</ArticleId></ArticleIdList></Reference><Reference><Citation>Castro Dias M, Mapunda JA, Vladymyrov M, Engelhardt B. Structure and junctional complexes of endothelial, epithelial and glial brain barriers. Int J. Mol. Sci. 2019;20:5372.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6862204</ArticleId><ArticleId IdType="pubmed">31671721</ArticleId></ArticleIdList></Reference><Reference><Citation>Haghayegh Jahromi N, et al. A novel cervical spinal cord window preparation allows for two-photon imaging of T-cell interactions with the cervical spinal cord microvasculature during experimental autoimmune encephalomyelitis. Front. Immunol. 2017;8:406&#x2013;406.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5387098</ArticleId><ArticleId IdType="pubmed">28443093</ArticleId></ArticleIdList></Reference><Reference><Citation>Duong CN, Vestweber D. Mechanisms ensuring endothelial junction integrity beyond VE-cadherin. Front. Physiol. 2020;11:519.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7326147</ArticleId><ArticleId IdType="pubmed">32670077</ArticleId></ArticleIdList></Reference><Reference><Citation>Winderlich M, et al. VE-PTP controls blood vessel development by balancing Tie-2 activity. J. Cell Biol. 2009;185:657&#x2013;671.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2711575</ArticleId><ArticleId IdType="pubmed">19451274</ArticleId></ArticleIdList></Reference><Reference><Citation>Vladymyrov, M., Haghayegh Jahromi, N., Kaba, E., Engelhardt, B. &amp; Ariga, A. VivoFollow 2: distortion-free multiphoton intravital imaging. 7, 222 (2020).</Citation></Reference><Reference><Citation>Etchevers HC, Couly G, Vincent C, Le Douarin NM. Anterior cephalic neural crest is required for forebrain viability. Development. 1999;126:3533&#x2013;3543.</Citation><ArticleIdList><ArticleId IdType="pubmed">10409500</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Rahilly R, M&#xfc;ller F. The meninges in human development. J. Neuropathol. Exp. Neurol. 1986;45:588&#x2013;608.</Citation><ArticleIdList><ArticleId IdType="pubmed">3746345</ArticleId></ArticleIdList></Reference><Reference><Citation>McLone DG, Bondareff W. Developmental morphology of the subarachnoid space and contiguous structures in the mouse. Am. J. Anat. 1975;142:273&#x2013;293.</Citation><ArticleIdList><ArticleId IdType="pubmed">1119412</ArticleId></ArticleIdList></Reference><Reference><Citation>Oda Y, Nakanishi I. Ultrastructure of the mouse leptomeninx. J. Comp. Neurol. 1984;225:448&#x2013;457.</Citation><ArticleIdList><ArticleId IdType="pubmed">6202729</ArticleId></ArticleIdList></Reference><Reference><Citation>Uhl C, et al. EphB4 mediates resistance to antiangiogenic therapy in experimental glioma. Angiogenesis. 2018;21:873&#x2013;881.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6208883</ArticleId><ArticleId IdType="pubmed">29987450</ArticleId></ArticleIdList></Reference><Reference><Citation>Dejana, E. &amp; Vestweber, D. In: Progress in molecular biology and translational science, 116 (ed. F. van Roy) 119&#x2013;144 (Academic Press, 2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">23481193</ArticleId></ArticleIdList></Reference><Reference><Citation>Privratsky JR, Newman PJ. PECAM-1: regulator of endothelial junctional integrity. Cell Tissue Res. 2014;355:607&#x2013;619.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3975704</ArticleId><ArticleId IdType="pubmed">24435645</ArticleId></ArticleIdList></Reference><Reference><Citation>Burrell BE, et al. Lymph node stromal fiber ER-TR7 modulates CD4+ T cell lymph node trafficking and transplant tolerance. Transplantation. 2015;99:1119&#x2013;1125.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4452399</ArticleId><ArticleId IdType="pubmed">25769074</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumamoto Y, Denda-Nagai K, Aida S, Higashi N, Irimura T. MGL2 dermal dendritic cells are sufficient to initiate contact hypersensitivity in vivo. PloS One. 2009;4:e5619.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2680031</ArticleId><ArticleId IdType="pubmed">19440334</ArticleId></ArticleIdList></Reference><Reference><Citation>Cupovic J, et al. Central nervous system stromal cells control local CD8(+) T cell responses during virus-induced neuroinflammation. Immunity. 2016;44:622&#x2013;633.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7111064</ArticleId><ArticleId IdType="pubmed">26921107</ArticleId></ArticleIdList></Reference><Reference><Citation>Buhusi M, et al. ALCAM regulates mediolateral retinotopic mapping in the superior colliculus. J. Neurosci. 2009;29:15630.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6666192</ArticleId><ArticleId IdType="pubmed">20016077</ArticleId></ArticleIdList></Reference><Reference><Citation>Hannocks MJ, et al. Molecular characterization of perivascular drainage pathways in the murine brain. J. Cereb. Blood Flow. Metab. 2018;38:669&#x2013;686.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5888861</ArticleId><ArticleId IdType="pubmed">29283289</ArticleId></ArticleIdList></Reference><Reference><Citation>Holman DW, Grzybowski DM, Mehta BC, Katz SE, Lubow M. Characterization of cytoskeletal and junctional proteins expressed by cells cultured from human arachnoid granulation tissue. Cerebrospinal Fluid Res. 2005;2:9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1285366</ArticleId><ArticleId IdType="pubmed">16223448</ArticleId></ArticleIdList></Reference><Reference><Citation>Morita K, Sasaki H, Fujimoto K, Furuse M, Tsukita S. Claudin-11/OSP-based tight junctions of myelin sheaths in brain and Sertoli cells in testis. J. Cell Biol. 1999;145:579&#x2013;588.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2185072</ArticleId><ArticleId IdType="pubmed">10225958</ArticleId></ArticleIdList></Reference><Reference><Citation>Gow A, et al. CNS myelin and sertoli cell tight junction strands are absent in Osp/claudin-11 null mice. Cell. 1999;99:649&#x2013;659.</Citation><ArticleIdList><ArticleId IdType="pubmed">10612400</ArticleId></ArticleIdList></Reference><Reference><Citation>Farquhar MG, Palade GE. Junctional complexes in various epithelia. J. Cell Biol. 1963;17:375&#x2013;412.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2106201</ArticleId><ArticleId IdType="pubmed">13944428</ArticleId></ArticleIdList></Reference><Reference><Citation>Friend DS, Gilula NB. Variations in tight and gap junctions in mammalian tissues. J. Cell Biol. 1972;53:758&#x2013;776.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2108762</ArticleId><ArticleId IdType="pubmed">4337577</ArticleId></ArticleIdList></Reference><Reference><Citation>Mollgard K, et al. A mesothelium divides the subarachnoid space into functional compartments. Science. 2023;379:84&#x2013;88.</Citation><ArticleIdList><ArticleId IdType="pubmed">36603070</ArticleId></ArticleIdList></Reference><Reference><Citation>Kato K, et al. Prox1 inhibits proliferation and is required for differentiation of the oligodendrocyte cell lineage in the mouse. PloS One. 2015;10:e0145334.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4692484</ArticleId><ArticleId IdType="pubmed">26709696</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaltezioti V, et al. Prox1 regulates Olig2 expression to modulate binary fate decisions in spinal cord neurons. J. Neurosci. 2014;34:15816&#x2013;15831.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6608434</ArticleId><ArticleId IdType="pubmed">25411508</ArticleId></ArticleIdList></Reference><Reference><Citation>Proulx, S. T. &amp; Engelhardt, B. Central nervous system zoning: how brain barriers establish subdivisions for CNS immune privilege and immune surveillance. J. Int. Med.292, 47&#x2013;67 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9314672</ArticleId><ArticleId IdType="pubmed">35184353</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma Q, Ineichen BV, Detmar M, Proulx ST. Outflow of cerebrospinal fluid is predominantly through lymphatic vessels and is reduced in aged mice. Nat. Commun. 2017;8:1434.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5681558</ArticleId><ArticleId IdType="pubmed">29127332</ArticleId></ArticleIdList></Reference><Reference><Citation>Krishnamoorthy G, Wekerle H. EAE: an immunologist&#x2019;s magic eye. Eur. J. Immunol. 2009;39:2031&#x2013;2035.</Citation><ArticleIdList><ArticleId IdType="pubmed">19672898</ArticleId></ArticleIdList></Reference><Reference><Citation>Owens T, Bechmann I, Engelhardt B. Perivascular spaces and the two steps to neuroinflammation. J. Neuropathol. Exp. Neurol. 2008;67:1113&#x2013;1121.</Citation><ArticleIdList><ArticleId IdType="pubmed">19018243</ArticleId></ArticleIdList></Reference><Reference><Citation>Engelhardt B, et al. Vascular, glial, and lymphatic immune gateways of the central nervous system. Acta Neuropathol. 2016;132:317&#x2013;338.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4992028</ArticleId><ArticleId IdType="pubmed">27522506</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao Y, et al. Induction of experimental autoimmune encephalomyelitis in transgenic mice expressing ovalbumin in oligodendrocytes. Eur. J. Immunol. 2006;36:207&#x2013;215.</Citation><ArticleIdList><ArticleId IdType="pubmed">16342234</ArticleId></ArticleIdList></Reference><Reference><Citation>Page N, et al. Expression of the DNA-binding factor TOX promotes the encephalitogenic potential of microbe-induced autoreactive CD8(+) T cells. Immunity. 2019;50:763.</Citation><ArticleIdList><ArticleId IdType="pubmed">30893589</ArticleId></ArticleIdList></Reference><Reference><Citation>Aydin S, et al. Antigen recognition detains CD8(+) T cells at the blood-brain barrier and contributes to its breakdown. Nat. Commun. 2023;14:3106.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10229608</ArticleId><ArticleId IdType="pubmed">37253744</ArticleId></ArticleIdList></Reference><Reference><Citation>Mapunda JA, Tibar H, Regragui W, Engelhardt B. How does the immune system enter the brain? Front. Immunol. 2022;13:805657.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8902072</ArticleId><ArticleId IdType="pubmed">35273596</ArticleId></ArticleIdList></Reference><Reference><Citation>Iliff JJ, et al. A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid &#x3b2;. Sci. Transl. Med. 2012;4:147ra111.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3551275</ArticleId><ArticleId IdType="pubmed">22896675</ArticleId></ArticleIdList></Reference><Reference><Citation>Rustenhoven J, et al. Functional characterization of the dural sinuses as a neuroimmune interface. Cell. 2021;184:1000&#x2013;1016.e1027.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8487654</ArticleId><ArticleId IdType="pubmed">33508229</ArticleId></ArticleIdList></Reference><Reference><Citation>Vestweber D. VE-cadherin: the major endothelial adhesion molecule controlling cellular junctions and blood vessel formation. Arterioscler. Thromb. Vasc. Biol. 2008;28:223&#x2013;232.</Citation><ArticleIdList><ArticleId IdType="pubmed">18162609</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamada S, Pokutta S, Drees F, Weis WI, Nelson WJ. Deconstructing the cadherin-catenin-actin complex. Cell. 2005;123:889&#x2013;901.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3368712</ArticleId><ArticleId IdType="pubmed">16325582</ArticleId></ArticleIdList></Reference><Reference><Citation>Dorrier, C. E., Jones, H. E., Pintari&#x107;, L., Siegenthaler, J. A. &amp; Daneman, R. Emerging roles for CNS fibroblasts in health, injury and disease. Nat. Rev. Neurosci.23, 23&#x2013;34 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8527980</ArticleId><ArticleId IdType="pubmed">34671105</ArticleId></ArticleIdList></Reference><Reference><Citation>He L, et al. Single-cell RNA sequencing of mouse brain and lung vascular and vessel-associated cell types. Sci. Data. 2018;5:180160.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6103262</ArticleId><ArticleId IdType="pubmed">30129931</ArticleId></ArticleIdList></Reference><Reference><Citation>Key, A. &amp; Retzius, G. Studien in der Anatomie des Nervensystems und des Bindegewebes. (Samson &amp; Wallin, 1875).</Citation></Reference><Reference><Citation>Shanthaveerappa TR, Bourne GH. The perineural epithelium: nature and significance. Nature. 1963;199:577&#x2013;579.</Citation><ArticleIdList><ArticleId IdType="pubmed">14072008</ArticleId></ArticleIdList></Reference><Reference><Citation>Uchida Y, et al. Involvement of claudin-11 in disruption of blood-brain, -spinal cord, and -arachnoid barriers in multiple sclerosis. Mol. Neurobiol. 2019;56:2039&#x2013;2056.</Citation><ArticleIdList><ArticleId IdType="pubmed">29984400</ArticleId></ArticleIdList></Reference><Reference><Citation>Weller RO, Sharp MM, Christodoulides M, Carare RO, M&#xf8;llg&#xe5;rd K. The meninges as barriers and facilitators for the movement of fluid, cells and pathogens related to the rodent and human CNS. Acta Neuropathol. 2018;135:363&#x2013;385.</Citation><ArticleIdList><ArticleId IdType="pubmed">29368214</ArticleId></ArticleIdList></Reference><Reference><Citation>DeSisto J, et al. Single-cell transcriptomic analyses of the developing meninges reveal meningeal fibroblast diversity and function. Dev. Cell. 2020;54:43&#x2013;59.e44.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7769050</ArticleId><ArticleId IdType="pubmed">32634398</ArticleId></ArticleIdList></Reference><Reference><Citation>Hughes CE, Nibbs RJB. A guide to chemokines and their receptors. FEBS J. 2018;285:2944&#x2013;2971.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6120486</ArticleId><ArticleId IdType="pubmed">29637711</ArticleId></ArticleIdList></Reference><Reference><Citation>Clements CS, et al. The crystal structure of myelin oligodendrocyte glycoprotein, a key autoantigen in multiple sclerosis. Proc. Natl. Acad. Sci. USA. 2003;100:11059&#x2013;11064.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC196926</ArticleId><ArticleId IdType="pubmed">12960396</ArticleId></ArticleIdList></Reference><Reference><Citation>Schl&#xe4;ger C, et al. Effector T-cell trafficking between the leptomeninges and the cerebrospinal fluid. Nature. 2016;530:349&#x2013;353.</Citation><ArticleIdList><ArticleId IdType="pubmed">26863192</ArticleId></ArticleIdList></Reference><Reference><Citation>Marchetti L, Engelhardt B. Immune cell trafficking across the blood-brain barrier in the absence and presence of neuroinflammation. Vasc. Biol. 2020;2:H1&#x2013;H18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7439848</ArticleId><ArticleId IdType="pubmed">32923970</ArticleId></ArticleIdList></Reference><Reference><Citation>Schachenmayr W, Friede RL. The origin of subdural neomembranes. I. Fine structure of the dura-arachnoid interface in man. Am. J. Pathol. 1978;92:53&#x2013;68.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2018597</ArticleId><ArticleId IdType="pubmed">686148</ArticleId></ArticleIdList></Reference><Reference><Citation>Dillon SR, Jameson SC, Fink PJ. V beta 5+ T cell receptors skew toward OVA+H-2Kb recognition. J. Immunol. 1994;152:1790&#x2013;1801.</Citation><ArticleIdList><ArticleId IdType="pubmed">8120388</ArticleId></ArticleIdList></Reference><Reference><Citation>Gong S, et al. A gene expression atlas of the central nervous system based on bacterial artificial chromosomes. Nature. 2003;425:917&#x2013;925.</Citation><ArticleIdList><ArticleId IdType="pubmed">14586460</ArticleId></ArticleIdList></Reference><Reference><Citation>Engelhardt B, et al. P-selectin glycoprotein ligand 1 is not required for the development of experimental autoimmune encephalomyelitis in SJL and C57BL/6 mice. J. Immunol. 2005;175:1267&#x2013;1275.</Citation><ArticleIdList><ArticleId IdType="pubmed">16002731</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#xf6;ring A, Wild M, Vestweber D, Deutsch U, Engelhardt B. E- and P-selectin are not required for the development of experimental autoimmune encephalomyelitis in C57BL/6 and SJL mice. J. Immunol. 2007;179:8470&#x2013;8479.</Citation><ArticleIdList><ArticleId IdType="pubmed">18056394</ArticleId></ArticleIdList></Reference><Reference><Citation>Tietz SM, et al. Refined clinical scoring in comparative EAE studies does not enhance the chance to observe statistically significant differences. Eur. J. Immunol. 2016;46:2481&#x2013;2483.</Citation><ArticleIdList><ArticleId IdType="pubmed">27469626</ArticleId></ArticleIdList></Reference><Reference><Citation>Coisne, C., Lyck, R. &amp; Engelhardt, B. Live cell imaging techniques to study T cell trafficking across the blood-brain barrier in vitro and in vivo. Fluids Barriers CNS10, 7 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3560242</ArticleId><ArticleId IdType="pubmed">23336847</ArticleId></ArticleIdList></Reference><Reference><Citation>Au - Xavier, A. L. R. et al. Cannula implantation into the cisterna magna of rodents. JoVE, e57378 (2018). 10.3791/57378.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6101354</ArticleId><ArticleId IdType="pubmed">29889209</ArticleId></ArticleIdList></Reference><Reference><Citation>Isshiki M, Okabe S. Evaluation of cranial window types for in vivo two-photon imaging of brain microstructures. Microscopy. 2014;63:53&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pubmed">24212360</ArticleId></ArticleIdList></Reference><Reference><Citation>Cramer SW, et al. Through the looking glass: a review of cranial window technology for optical access to the brain. J. Neurosci. Methods. 2021;354:109100.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8100903</ArticleId><ArticleId IdType="pubmed">33600850</ArticleId></ArticleIdList></Reference><Reference><Citation>Foltz RM, et al. A pial window model for the intracranial study of human glioma microvascular function. Neurosurgery. 1995;36:976&#x2013;985.</Citation><ArticleIdList><ArticleId IdType="pubmed">7791991</ArticleId></ArticleIdList></Reference><Reference><Citation>Christie RH, et al. Growth arrest of individual senile plaques in a model of Alzheimer&#x2019;s disease observed by in vivo multiphoton microscopy. J. Neurosci. 2001;21:858&#x2013;864.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6762315</ArticleId><ArticleId IdType="pubmed">11157072</ArticleId></ArticleIdList></Reference><Reference><Citation>Park K, You J, Du C, Pan Y. Cranial window implantation on mouse cortex to study microvascular change induced by cocaine. Quant. Imaging Med Surg. 2015;5:97&#x2013;107.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4312290</ArticleId><ArticleId IdType="pubmed">25694959</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37774677</PMID><DateCompleted><Year>2023</Year><Month>10</Month><Day>02</Day></DateCompleted><DateRevised><Year>2024</Year><Month>12</Month><Day>16</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1097-4172</ISSN><JournalIssue CitedMedium="Internet"><Volume>186</Volume><Issue>20</Issue><PubDate><Year>2023</Year><Month>Sep</Month><Day>28</Day></PubDate></JournalIssue><Title>Cell</Title><ISOAbbreviation>Cell</ISOAbbreviation></Journal><ArticleTitle>Single-cell atlas reveals correlates of high cognitive function, dementia, and resilience to Alzheimer's disease pathology.</ArticleTitle><Pagination><StartPage>4365</StartPage><EndPage>4385.e27</EndPage><MedlinePgn>4365-4385.e27</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.cell.2023.08.039</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0092-8674(23)00973-X</ELocationID><Abstract><AbstractText>Alzheimer's disease (AD) is the most common cause of dementia worldwide, but the molecular and cellular mechanisms underlying cognitive impairment remain poorly understood. To address this, we generated a single-cell transcriptomic atlas of the aged human prefrontal cortex covering 2.3 million cells from postmortem human brain samples of 427 individuals with varying degrees of AD pathology and cognitive impairment. Our analyses identified AD-pathology-associated alterations shared between excitatory neuron subtypes, revealed a coordinated increase of the cohesin complex and DNA damage response factors in excitatory neurons and in oligodendrocytes, and uncovered genes and pathways associated with high cognitive function, dementia, and resilience to AD pathology. Furthermore, we identified selectively vulnerable somatostatin inhibitory neuron subtypes depleted in AD, discovered two distinct groups of inhibitory neurons that were more abundant in individuals with preserved high cognitive function late in life, and uncovered a link between inhibitory neurons and resilience to AD pathology.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 The Authors. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mathys</LastName><ForeName>Hansruedi</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Picower Institute for Learning and Memory, MIT, Cambridge, MA 02139, USA; Department of Brain and Cognitive Sciences, MIT, Cambridge, MA 02139, USA; University of Pittsburgh Brain Institute and Department of Neurobiology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA. Electronic address: mathysh@pitt.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peng</LastName><ForeName>Zhuyu</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Picower Institute for Learning and Memory, MIT, Cambridge, MA 02139, USA; Department of Brain and Cognitive Sciences, MIT, Cambridge, MA 02139, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boix</LastName><ForeName>Carles A</ForeName><Initials>CA</Initials><AffiliationInfo><Affiliation>Computer Science and Artificial Intelligence Laboratory, MIT, Cambridge, MA 02139, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Victor</LastName><ForeName>Matheus B</ForeName><Initials>MB</Initials><AffiliationInfo><Affiliation>Picower Institute for Learning and Memory, MIT, Cambridge, MA 02139, USA; Department of Brain and Cognitive Sciences, MIT, Cambridge, MA 02139, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leary</LastName><ForeName>Noelle</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Picower Institute for Learning and Memory, MIT, Cambridge, MA 02139, USA; Department of Brain and Cognitive Sciences, MIT, Cambridge, MA 02139, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Babu</LastName><ForeName>Sudhagar</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>University of Pittsburgh Brain Institute and Department of Neurobiology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abdelhady</LastName><ForeName>Ghada</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>University of Pittsburgh Brain Institute and Department of Neurobiology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Xueqiao</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Picower Institute for Learning and Memory, MIT, Cambridge, MA 02139, USA; Department of Brain and Cognitive Sciences, MIT, Cambridge, MA 02139, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ng</LastName><ForeName>Ayesha P</ForeName><Initials>AP</Initials><AffiliationInfo><Affiliation>Picower Institute for Learning and Memory, MIT, Cambridge, MA 02139, USA; Department of Brain and Cognitive Sciences, MIT, Cambridge, MA 02139, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ghafari</LastName><ForeName>Kimia</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>University of Pittsburgh Brain Institute and Department of Neurobiology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kunisky</LastName><ForeName>Alexander K</ForeName><Initials>AK</Initials><AffiliationInfo><Affiliation>University of Pittsburgh Brain Institute and Department of Neurobiology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mantero</LastName><ForeName>Julio</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Computer Science and Artificial Intelligence Laboratory, MIT, Cambridge, MA 02139, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Galani</LastName><ForeName>Kyriaki</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Computer Science and Artificial Intelligence Laboratory, MIT, Cambridge, MA 02139, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lohia</LastName><ForeName>Vanshika N</ForeName><Initials>VN</Initials><AffiliationInfo><Affiliation>University of Pittsburgh Brain Institute and Department of Neurobiology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fortier</LastName><ForeName>Gabrielle E</ForeName><Initials>GE</Initials><AffiliationInfo><Affiliation>University of Pittsburgh Brain Institute and Department of Neurobiology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lotfi</LastName><ForeName>Yasmine</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>University of Pittsburgh Brain Institute and Department of Neurobiology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ivey</LastName><ForeName>Jason</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>University of Pittsburgh Brain Institute and Department of Neurobiology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brown</LastName><ForeName>Hannah P</ForeName><Initials>HP</Initials><AffiliationInfo><Affiliation>University of Pittsburgh Brain Institute and Department of Neurobiology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Patel</LastName><ForeName>Pratham R</ForeName><Initials>PR</Initials><AffiliationInfo><Affiliation>University of Pittsburgh Brain Institute and Department of Neurobiology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chakraborty</LastName><ForeName>Nehal</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>University of Pittsburgh Brain Institute and Department of Neurobiology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beaudway</LastName><ForeName>Jacob I</ForeName><Initials>JI</Initials><AffiliationInfo><Affiliation>University of Pittsburgh Brain Institute and Department of Neurobiology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Imhoff</LastName><ForeName>Elizabeth J</ForeName><Initials>EJ</Initials><AffiliationInfo><Affiliation>University of Pittsburgh Brain Institute and Department of Neurobiology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Keeler</LastName><ForeName>Cameron F</ForeName><Initials>CF</Initials><AffiliationInfo><Affiliation>University of Pittsburgh Brain Institute and Department of Neurobiology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McChesney</LastName><ForeName>Maren M</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>University of Pittsburgh Brain Institute and Department of Neurobiology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Patel</LastName><ForeName>Haishal H</ForeName><Initials>HH</Initials><AffiliationInfo><Affiliation>University of Pittsburgh Brain Institute and Department of Neurobiology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Patel</LastName><ForeName>Sahil P</ForeName><Initials>SP</Initials><AffiliationInfo><Affiliation>University of Pittsburgh Brain Institute and Department of Neurobiology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thai</LastName><ForeName>Megan T</ForeName><Initials>MT</Initials><AffiliationInfo><Affiliation>University of Pittsburgh Brain Institute and Department of Neurobiology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bennett</LastName><ForeName>David A</ForeName><Initials>DA</Initials><AffiliationInfo><Affiliation>Rush Alzheimer's Disease Center, Chicago, IL 60612, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kellis</LastName><ForeName>Manolis</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Computer Science and Artificial Intelligence Laboratory, MIT, Cambridge, MA 02139, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA. Electronic address: manoli@mit.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsai</LastName><ForeName>Li-Huei</ForeName><Initials>LH</Initials><AffiliationInfo><Affiliation>Picower Institute for Learning and Memory, MIT, Cambridge, MA 02139, USA; Department of Brain and Cognitive Sciences, MIT, Cambridge, MA 02139, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA. Electronic address: lhtsai@mit.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Acronym>HHMI</Acronym><Agency>Howard Hughes Medical Institute</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG074003</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>RF1 AG062377</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 GM087237</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AG010161</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG081017</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>RF1 AG054321</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 NS110453</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG062335</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG067151</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 MH119509</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG015819</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AG072975</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 AG077227</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 DA053631</GrantID><Acronym>DA</Acronym><Agency>NIDA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>RF1 AG054012</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 AG046152</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG058002</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HG008155</GrantID><Acronym>HG</Acronym><Agency>NHGRI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 NS007433</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 AG061356</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UG3 NS115064</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG017917</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UH3 NS115064</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS127187</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>RF1 NS129032</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cell</MedlineTA><NlmUniqueID>0413066</NlmUniqueID><ISSNLinking>0092-8674</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Cell. 2023 Sep 28;186(20):4257-4259. doi: 10.1016/j.cell.2023.09.001.</RefSource><PMID Version="1">37774675</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="Y">Brain</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003071" MajorTopicYN="N">Cognition</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060825" MajorTopicYN="N">Cognitive Dysfunction</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009474" MajorTopicYN="N">Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Alzheimer's disease</Keyword><Keyword MajorTopicYN="N">DNA damage response</Keyword><Keyword MajorTopicYN="N">cognitive impairment</Keyword><Keyword MajorTopicYN="N">cognitive resilience</Keyword><Keyword MajorTopicYN="N">cohesin complex</Keyword><Keyword MajorTopicYN="N">inhibitory neurons</Keyword><Keyword MajorTopicYN="N">neurodegeneration</Keyword><Keyword MajorTopicYN="N">single-cell transcriptomic atlas</Keyword></KeywordList><CoiStatement>Declaration of interests L.-H.T. is a member of the Scientific Advisory Boards of Cognito Therapeutics, 4M Therapeutics, Cell Signaling Technology, and Souvien Therapeutics, which have no association to the work described in this manuscript.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>9</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>5</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>8</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>10</Month><Day>2</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>9</Month><Day>30</Day><Hour>9</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>9</Month><Day>29</Day><Hour>18</Hour><Minute>16</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>28</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37774677</ArticleId><ArticleId IdType="mid">NIHMS1933514</ArticleId><ArticleId IdType="pmc">PMC10601493</ArticleId><ArticleId IdType="doi">10.1016/j.cell.2023.08.039</ArticleId><ArticleId IdType="pii">S0092-8674(23)00973-X</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Wilson RS, Segawa E, Boyle PA, Anagnos SE, Hizel LP, and Bennett DA (2012). The Natural History of Cognitive Decline in Alzheimer&#x2019;s Disease. Psychol. Aging 27, 1008. 10.1037/A0029857.</Citation><ArticleIdList><ArticleId IdType="doi">10.1037/A0029857</ArticleId><ArticleId IdType="pmc">PMC3534850</ArticleId><ArticleId IdType="pubmed">22946521</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson ECB, Dammer EB, Duong DM, Ping L, Zhou M, Yin L, Higginbotham LA, Guajardo A, White B, Troncoso JC, et al. (2020). Large-scale proteomic analysis of Alzheimer&#x2019;s disease brain and cerebrospinal fluid reveals early changes in energy metabolism associated with microglia and astrocyte activation. Nat. Med 2020 265 26, 769&#x2013;780. 10.1038/S41591-020-0815-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/S41591-020-0815-6</ArticleId><ArticleId IdType="pmc">PMC7405761</ArticleId><ArticleId IdType="pubmed">32284590</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheltens P, Blennow K, Breteler MMB, De Strooper B, Frisoni GB, Salloway S, and Van Der Flier WM (2016). Alzheimer&#x2019;s disease, www.thelancet.com.
10.1016/S0140-6736(15)01124-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(15)01124-1</ArticleId><ArticleId IdType="pubmed">26921134</ArticleId></ArticleIdList></Reference><Reference><Citation>Masters CL, Bateman R, Blennow K, Rowe CC, Sperling RA, and Cummings JL (2015). Alzheimer&#x2019;s disease. Nat. Publ. Gr 10.1038/nrdp.2015.56.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrdp.2015.56</ArticleId><ArticleId IdType="pubmed">27188934</ArticleId></ArticleIdList></Reference><Reference><Citation>Serrano-Pozo A, Frosch MP, Masliah E, and Hyman BT (2011). Neuropathological alterations in Alzheimer disease. Cold Spring Harb. Perspect. Med 1, a006189. 10.1101/cshperspect.a006189.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a006189</ArticleId><ArticleId IdType="pmc">PMC3234452</ArticleId><ArticleId IdType="pubmed">22229116</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardy J, and Selkoe DJ (2002). The amyloid hypothesis of Alzheimer&#x2019;s disease: progress and problems on the road to therapeutics. Science 297, 353&#x2013;356. 10.1126/SCIENCE.1072994.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/SCIENCE.1072994</ArticleId><ArticleId IdType="pubmed">12130773</ArticleId></ArticleIdList></Reference><Reference><Citation>Braak H, and Braak E (1991). Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 82, 239&#x2013;259. 10.1007/BF00308809.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF00308809</ArticleId><ArticleId IdType="pubmed">1759558</ArticleId></ArticleIdList></Reference><Reference><Citation>Beach TG, Walker R, and McGeer EG (1989). Patterns of gliosis in Alzheimer&#x2019;s disease and aging cerebrum. Glia 2, 420&#x2013;436. 10.1002/GLIA.440020605.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/GLIA.440020605</ArticleId><ArticleId IdType="pubmed">2531723</ArticleId></ArticleIdList></Reference><Reference><Citation>Heneka MT, Carson MJ, Khoury J. El, Landreth GE, Brosseron F, Feinstein DL, Jacobs AH, Wyss-Coray T, Vitorica J, Ransohoff RM, et al. (2015). Neuroinflammation in Alzheimer&#x2019;s disease. Lancet Neurol. 14, 388&#x2013;405. 10.1016/S1474-4422(15)70016-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(15)70016-5</ArticleId><ArticleId IdType="pmc">PMC5909703</ArticleId><ArticleId IdType="pubmed">25792098</ArticleId></ArticleIdList></Reference><Reference><Citation>Wyss-Coray T. (2016). Ageing, neurodegeneration and brain rejuvenation. Nat. 2016 5397628 539, 180&#x2013;186. 10.1038/nature20411.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature20411</ArticleId><ArticleId IdType="pmc">PMC5172605</ArticleId><ArticleId IdType="pubmed">27830812</ArticleId></ArticleIdList></Reference><Reference><Citation>Almanzar N, Antony J, Baghel AS, Bakerman I, Bansal I, Barres BA, Beachy PA, Berdnik D, Bilen B, Brownfield D, et al. (2020). A single-cell transcriptomic atlas characterizes ageing tissues in the mouse. Nat. 2020 5837817 583, 590&#x2013;595. 10.1038/s41586-020-2496-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2496-1</ArticleId><ArticleId IdType="pmc">PMC8240505</ArticleId><ArticleId IdType="pubmed">32669714</ArticleId></ArticleIdList></Reference><Reference><Citation>Delorey TM, Ziegler CGK, Heimberg G, Normand R, Yang Y, Segerstolpe &#xc5;, Abbondanza D, Fleming SJ, Subramanian A, Montoro DT, et al. (2021). COVID-19 tissue atlases reveal SARS-CoV-2 pathology and cellular targets. Nat. 2021 5957865 595, 107&#x2013;113. 10.1038/S41586-021-03570-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/S41586-021-03570-8</ArticleId><ArticleId IdType="pmc">PMC8919505</ArticleId><ArticleId IdType="pubmed">33915569</ArticleId></ArticleIdList></Reference><Reference><Citation>Grubman A, Chew G, Ouyang JF, Sun G, Choo XY, McLean C, Simmons RK, Buckberry S, Vargas-Landin DB, Poppe D, et al. (2019). A single-cell atlas of entorhinal cortex from individuals with Alzheimer&#x2019;s disease reveals cell-type-specific gene expression regulation. Nat. Neurosci 2019 2212 22, 2087&#x2013;2097. 10.1038/s41593-019-0539-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-019-0539-4</ArticleId><ArticleId IdType="pubmed">31768052</ArticleId></ArticleIdList></Reference><Reference><Citation>Leng K, Li E, Eser R, Piergies A, Sit R, Tan M, Neff N, Li SH, Rodriguez RD, Suemoto CK, et al. (2021). Molecular characterization of selectively vulnerable neurons in Alzheimer&#x2019;s disease. Nat. Neurosci 2021 242 24, 276&#x2013;287. 10.1038/s41593-020-00764-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-020-00764-7</ArticleId><ArticleId IdType="pmc">PMC7854528</ArticleId><ArticleId IdType="pubmed">33432193</ArticleId></ArticleIdList></Reference><Reference><Citation>Morabito S, Miyoshi E, Michael N, Shahin S, Martini AC, Head E, Silva J, Leavy K, Perez-Rosendahl M, and Swarup V (2021). Single-nucleus chromatin accessibility and transcriptomic characterization of Alzheimer&#x2019;s disease. Nat. Genet 2021 538 53, 1143&#x2013;1155. 10.1038/S41588-021-00894-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/S41588-021-00894-z</ArticleId><ArticleId IdType="pmc">PMC8766217</ArticleId><ArticleId IdType="pubmed">34239132</ArticleId></ArticleIdList></Reference><Reference><Citation>Sadick JS, O&#x2019;Dea MR, Hasel P, Dykstra T, Faustin A, and Liddelow SA (2022). Astrocytes and oligodendrocytes undergo subtype-specific transcriptional changes in Alzheimer&#x2019;s disease. Neuron 110, 1788&#x2013;1805.e10. 10.1016/J.NEURON.2022.03.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.NEURON.2022.03.008</ArticleId><ArticleId IdType="pmc">PMC9167747</ArticleId><ArticleId IdType="pubmed">35381189</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y, Song WM, Andhey PS, Swain A, Levy T, Miller KR, Poliani PL, Cominelli M, Grover S, Gilfillan S, et al. (2020). Human and mouse single-nucleus transcriptomics reveal TREM2-dependent and TREM2-independent cellular responses in Alzheimer&#x2019;s disease. Nat. Med 26, 131&#x2013;142. 10.1038/S41591-019-0695-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/S41591-019-0695-9</ArticleId><ArticleId IdType="pmc">PMC6980793</ArticleId><ArticleId IdType="pubmed">31932797</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuner SM, Telpoukhovskaia M, Menon V, O&#x2019;Connell KMS, Hohman TJ, and Kaczorowski CC (2022). Translational approaches to understanding resilience to Alzheimer&#x2019;s disease. Trends Neurosci. 45, 369&#x2013;383. 10.1016/J.TINS.2022.02.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.TINS.2022.02.005</ArticleId><ArticleId IdType="pmc">PMC9035083</ArticleId><ArticleId IdType="pubmed">35307206</ArticleId></ArticleIdList></Reference><Reference><Citation>Wagner M, Wilson RS, Leurgans SE, Boyle PA, Bennett DA, Grodstein F, and Capuano AW (2022). Quantifying longitudinal cognitive resilience to Alzheimer&#x2019;s disease and other neuropathologies. Alzheimer&#x2019;s Dement. 10.1002/alz.12576.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alz.12576</ArticleId><ArticleId IdType="pmc">PMC10119432</ArticleId><ArticleId IdType="pubmed">35102704</ArticleId></ArticleIdList></Reference><Reference><Citation>Bennett DA, Buchman AS, Boyle PA, Barnes LL, Wilson RS, and Schneider JA (2018). Religious Orders Study and Rush Memory and Aging Project. J. Alzheimers. Dis 64, S161. 10.3233/JAD-179939.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-179939</ArticleId><ArticleId IdType="pmc">PMC6380522</ArticleId><ArticleId IdType="pubmed">29865057</ArticleId></ArticleIdList></Reference><Reference><Citation>Hodge RD, Bakken TE, Miller JA, Smith KA, Barkan ER, Graybuck LT, Close JL, Long B, Johansen N, Penn O, et al. (2019). Conserved cell types with divergent features in human versus mouse cortex. Nature 573, 61&#x2013;68. 10.1038/S41586-019-1506-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/S41586-019-1506-7</ArticleId><ArticleId IdType="pmc">PMC6919571</ArticleId><ArticleId IdType="pubmed">31435019</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun N, Victor MB, Park Y, Xiong X, Scannail AN, Leary N, Prosper S, Viswanathan S, Luna X, Boix CA, et al. Human Microglial State Dynamics in Alzheimer&#x2019;s Disease Progression.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10644954</ArticleId><ArticleId IdType="pubmed">37774678</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathys H, Davila-Velderrain J, Peng Z, Gao F, Mohammadi S, Young JZ, Menon M, He L, Abdurrob F, Jiang X, et al. (2019). Single-cell transcriptomic analysis of Alzheimer&#x2019;s disease. Nat. 2019 5707761 570, 332&#x2013;337. 10.1038/s41586-019-1195-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-019-1195-2</ArticleId><ArticleId IdType="pmc">PMC6865822</ArticleId><ArticleId IdType="pubmed">31042697</ArticleId></ArticleIdList></Reference><Reference><Citation>Lau SF, Cao H, Fu AKY, and Ip NY (2020). Single-nucleus transcriptome analysis reveals dysregulation of angiogenic endothelial cells and neuroprotective glia in Alzheimer&#x2019;s disease. Proc. Natl. Acad. Sci. U. S. A 117, 25800&#x2013;25809. 10.1073/PNAS.2008762117/-/DCSUPPLEMENTAL.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/PNAS.2008762117/-/DCSUPPLEMENTAL</ArticleId><ArticleId IdType="pmc">PMC7568283</ArticleId><ArticleId IdType="pubmed">32989152</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Y, Zhou Y, Bennett ML, Li S, Carceles-Cordon M, Lu L, Huh S, Jimenez-Cyrus D, Kennedy BC, Kessler SK, et al. (2022). A single-cell transcriptome atlas of glial diversity in the human hippocampus across the postnatal lifespan. Cell Stem Cell 29, 1594&#x2013;1610.e8. 10.1016/j.stem.2022.09.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stem.2022.09.010</ArticleId><ArticleId IdType="pmc">PMC9844262</ArticleId><ArticleId IdType="pubmed">36332572</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang S, Corbett SE, Koga Y, Wang Z, Johnson WE, Yajima M, and Campbell JD (2020). Decontamination of ambient RNA in single-cell RNA-seq with DecontX. Genome Biol. 21, 1&#x2013;15. 10.1186/S13059-020-1950-6/FIGURES/6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/S13059-020-1950-6/FIGURES/6</ArticleId><ArticleId IdType="pmc">PMC7059395</ArticleId><ArticleId IdType="pubmed">32138770</ArticleId></ArticleIdList></Reference><Reference><Citation>Green GS, Fujita M, Yang H-S, Taga M, McCabe C, Cain A, White CC, Schmidtner AK, Zeng L, Wang Y, et al. (2023). Cellular dynamics across aged human brains uncover a multicellular cascade leading to Alzheimer&#x2019;s disease. bioRxiv, 2023.03.07.531493. 10.1101/2023.03.07.531493.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2023.03.07.531493</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujita M, Gao Z, Zeng L, McCabe C, White CC, Ng B, Green GS, Rozenblatt-Rosen O, Phillips D, Amir-Zilberstein L, et al. (2022). Cell-subtype specific effects of genetic variation in the aging and Alzheimer cortex. bioRxiv, 2022.11.07.515446. 10.1101/2022.11.07.515446.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.11.07.515446</ArticleId><ArticleId IdType="pubmed">38514782</ArticleId></ArticleIdList></Reference><Reference><Citation>Gabitto MI, Travaglini KJ, Rachleff VM, Kaplan ES, Long B, Ariza J, Ding Y, Mahoney JT, Dee N, Goldy J, et al. (2023). Integrated multimodal cell atlas of Alzheimer&#x2019;s disease. bioRxiv, 2023.05.08.539485. 10.1101/2023.05.08.539485.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2023.05.08.539485</ArticleId></ArticleIdList></Reference><Reference><Citation>Koopmans F, van Nierop P, Andres-Alonso M, Byrnes A, Cijsouw T, Coba MP, Cornelisse LN, Farrell RJ, Goldschmidt HL, Howrigan DP, et al. (2019). SynGO: An Evidence-Based, Expert-Curated Knowledge Base for the Synapse. Neuron 103, 217&#x2013;234.e4. 10.1016/J.NEURON.2019.05.002/ATTACHMENT/80038C21-9CDC-40DD-AEB4-3DAC61339481/MMC8.XLSX.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.NEURON.2019.05.002/ATTACHMENT/80038C21-9CDC-40DD-AEB4-3DAC61339481/MMC8.XLSX</ArticleId><ArticleId IdType="pmc">PMC6764089</ArticleId><ArticleId IdType="pubmed">31171447</ArticleId></ArticleIdList></Reference><Reference><Citation>Otero-Garcia M, Xue Y-Q, Shakouri T, Deng Y, Morabito S, Allison T, Lowry WE, Kawaguchi R, Swarup V, and Cobos I (2020). Single-soma transcriptomics of tangle-bearing neurons in Alzheimer&#x2019;s disease reveals the signatures of tau-associated synaptic dysfunction. bioRxiv, 2020.05.11.088591. 10.1101/2020.05.11.088591.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.05.11.088591</ArticleId></ArticleIdList></Reference><Reference><Citation>Pfanner N, van der Laan M, Amati P, Capaldi RA, Caudy AA, Chacinska A, Darshi M, Deckers M, Hoppins S, Icho T, et al. (2014). Uniform nomenclature for the mitochondrial contact site and cristae organizing system. J. Cell Biol 204, 1083&#x2013;1086. 10.1083/JCB.201401006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/JCB.201401006</ArticleId><ArticleId IdType="pmc">PMC3971754</ArticleId><ArticleId IdType="pubmed">24687277</ArticleId></ArticleIdList></Reference><Reference><Citation>Giurgiu M, Reinhard J, Brauner B, Dunger-Kaltenbach I, Fobo G, Frishman G, Montrone C, and Ruepp A (2019). CORUM: The comprehensive resource of mammalian protein complexes - 2019. Nucleic Acids Res. 10.1093/nar/gky973.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gky973</ArticleId><ArticleId IdType="pmc">PMC6323970</ArticleId><ArticleId IdType="pubmed">30357367</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim H, Dejsuphong D, Adelmant G, Ceccaldi R, Yang K, Marto JA, and D&#x2019;Andrea AD (2014). A Transcriptional Repressor ZBTB1 Promotes Chromatin Remodeling and Translesion DNA Synthesis. Mol. Cell 54, 107. 10.1016/J.MOLCEL.2014.02.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.MOLCEL.2014.02.017</ArticleId><ArticleId IdType="pmc">PMC3989074</ArticleId><ArticleId IdType="pubmed">24657165</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobbin MM, Madabhushi R, Pan L, Chen Y, Kim D, Gao J, Ahanonu B, Pao P-C, Qiu Y, Zhao Y, et al. (2013). SIRT1 collaborates with ATM and HDAC1 to maintain genomic stability in neurons. Nat. Neurosci 16, 1008&#x2013;1015. 10.1038/nn.3460.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3460</ArticleId><ArticleId IdType="pmc">PMC4758134</ArticleId><ArticleId IdType="pubmed">23852118</ArticleId></ArticleIdList></Reference><Reference><Citation>Oberdoerffer P, Michan S, McVay M, Mostoslavsky R, Vann J, Park SK, Hartlerode A, Stegmuller J, Hafner A, Loerch P, et al. (2008). SIRT1 Redistribution on Chromatin Promotes Genomic Stability but Alters Gene Expression during Aging. Cell 135, 907&#x2013;918. 10.1016/J.CELL.2008.10.025/ATTACHMENT/6E5B2D1C-D04E-4449-9E3A-E3DA8A658F42/MMC1.PDF.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.CELL.2008.10.025/ATTACHMENT/6E5B2D1C-D04E-4449-9E3A-E3DA8A658F42/MMC1.PDF</ArticleId><ArticleId IdType="pmc">PMC2853975</ArticleId><ArticleId IdType="pubmed">19041753</ArticleId></ArticleIdList></Reference><Reference><Citation>Farnung L, Vos SM, Wigge C, and Cramer P (2017). Nucleosome-Chd1 structure and implications for chromatin remodelling. Nature 550, 539&#x2013;542. 10.1038/NATURE24046.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/NATURE24046</ArticleId><ArticleId IdType="pmc">PMC5697743</ArticleId><ArticleId IdType="pubmed">29019976</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou J, Li J, Serafim RB, Ketchum S, Ferreira CG, Liu JC, Coe KA, Price BD, and Yusufzai T (2018). Human CHD1 is required for early DNA-damage signaling and is uniquely regulated by its N terminus. Nucleic Acids Res. 46, 3891. 10.1093/NAR/GKY128.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/NAR/GKY128</ArticleId><ArticleId IdType="pmc">PMC5934646</ArticleId><ArticleId IdType="pubmed">29529298</ArticleId></ArticleIdList></Reference><Reference><Citation>Bulut-Karslioglu A, Jin H, Kim YK, Cho B, Guzman-Ayala M, Williamson AJK, Hejna M, St&#xf6;tzel M, Whetton AD, Song JS, et al. (2021). Chd1 protects genome integrity at promoters to sustain hypertranscription in embryonic stem cells. Nat. Commun 2021 121 12, 1&#x2013;11. 10.1038/S41467-021-25088-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/S41467-021-25088-3</ArticleId><ArticleId IdType="pmc">PMC8357957</ArticleId><ArticleId IdType="pubmed">34381042</ArticleId></ArticleIdList></Reference><Reference><Citation>Kari V, Mansour WY, Raul SK, Baumgart SJ, Mund A, Grade M, Sirma H, Simon R, Will H, Dobbelstein M, et al. (2016). Loss of CHD1 causes DNA repair defects and enhances prostate cancer therapeutic responsiveness. EMBO Rep. 17, 1609&#x2013;1623. 10.15252/EMBR.201642352.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/EMBR.201642352</ArticleId><ArticleId IdType="pmc">PMC5090703</ArticleId><ArticleId IdType="pubmed">27596623</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiu LY, Gong F, and Miller KM (2017). Bromodomain proteins: repairing DNA damage within chromatin. Philos. Trans. R. Soc. B Biol. Sci 372. 10.1098/RSTB.2016.0286.</Citation><ArticleIdList><ArticleId IdType="doi">10.1098/RSTB.2016.0286</ArticleId><ArticleId IdType="pmc">PMC5577464</ArticleId><ArticleId IdType="pubmed">28847823</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu XS, Chandramouly G, Rass E, Guan Y, Wang G, Hobbs RM, Rajendran A, Xie A, Shah JV, Davis AJ, et al. (2015). LRF maintains genome integrity by regulating the non-homologous end joining pathway of DNA repair. Nat. Commun 2015 61 6, 1&#x2013;10. 10.1038/ncomms9325.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms9325</ArticleId><ArticleId IdType="pmc">PMC4633636</ArticleId><ArticleId IdType="pubmed">26446488</ArticleId></ArticleIdList></Reference><Reference><Citation>Bot C, Pfeiffer A, Giordano F, Manjeera DE, Dantuma NP, and Str&#xf6;m L (2017). Independent mechanisms recruit the cohesin loader protein NIPBL to sites of DNA damage. J. Cell Sci 130, 1134. 10.1242/JCS.197236.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/JCS.197236</ArticleId><ArticleId IdType="pmc">PMC5358341</ArticleId><ArticleId IdType="pubmed">28167679</ArticleId></ArticleIdList></Reference><Reference><Citation>Parsons JL, Dianova II, Khoronenkova SV, Edelmann MJ, Kessler BM, and Dianov GL (2011). USP47 is a deubiquitylating enzyme that regulates base excision repair by controlling steady-state levels of DNA polymerase &#x3b2;. Mol. Cell 41, 609&#x2013;615. 10.1016/J.MOLCEL.2011.02.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.MOLCEL.2011.02.016</ArticleId><ArticleId IdType="pubmed">21362556</ArticleId></ArticleIdList></Reference><Reference><Citation>Oppikofer M, Sagolla M, Haley B, Zhang HM, Kummerfeld SK, Sudhamsu J, Flynn EM, Bai T, Zhang J, Ciferri C, et al. (2017). Non-canonical reader modules of BAZ1A promote recovery from DNA damage. Nat. Commun 2017 81 8, 1&#x2013;15. 10.1038/s41467-017-00866-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-017-00866-0</ArticleId><ArticleId IdType="pmc">PMC5636791</ArticleId><ArticleId IdType="pubmed">29021563</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh R, Kalra RS, Hasan K, Kaul Z, Cheung CT, Huschtscha L, Reddel RR, Kaul SC, and Wadhwa R (2014). Molecular characterization of collaborator of ARF (CARF) as a DNA damage response and cell cycle checkpoint regulatory protein. Exp. Cell Res 322, 324&#x2013;334. 10.1016/J.YEXCR.2014.01.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.YEXCR.2014.01.022</ArticleId><ArticleId IdType="pubmed">24485912</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang X, Ma Y, Li Y, Dong Y, Yu LL, Wang H, Guo L, Wu C, Yu X, and Liu X (2020). Molecular basis for the MacroD1-mediated hydrolysis of ADP-ribosylation. DNA Repair (Amst). 94, 102899. 10.1016/J.DNAREP.2020.102899.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.DNAREP.2020.102899</ArticleId><ArticleId IdType="pmc">PMC7313891</ArticleId><ArticleId IdType="pubmed">32683309</ArticleId></ArticleIdList></Reference><Reference><Citation>Dileep V, Boix CA, Mathys H, Marco A, Welch GM, Meharena HS, Loon A, Jeloka R, Peng Z, Bennett DA, et al. Neuronal DNA double-strand breaks lead to chromosomal structural variations and 3D genome disruption in neurodegeneration.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10697236</ArticleId><ArticleId IdType="pubmed">37774679</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong X, James BT, Boix CA, Park Y, Galani K, Victor MB, Sun N, Hou L, Dileep V, Ho L-L, et al. Epigenomic dissection of Alzheimer&#x2019;s disease pinpoints causal variants and reveals epigenome erosion.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10782612</ArticleId><ArticleId IdType="pubmed">37774680</ArticleId></ArticleIdList></Reference><Reference><Citation>Arenaza-Urquijo EM, and Vemuri P (2018). Resistance vs resilience to Alzheimer disease: Clarifying terminology for preclinical studies. Neurology.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5894932</ArticleId><ArticleId IdType="pubmed">29592885</ArticleId></ArticleIdList></Reference><Reference><Citation>Stern Y, Arenaza-Urquijo EM, Bartr&#xe9;s-Faz D, Belleville S, Cantilon M, Chetelat G, Ewers M, Franzmeier N, Kempermann G, Kremen WS, et al. (2020). Whitepaper: Defining and investigating cognitive reserve, brain reserve, and brain maintenance. Alzheimer&#x2019;s Dement. 10.1016/j.jalz.2018.07.219.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2018.07.219</ArticleId><ArticleId IdType="pmc">PMC6417987</ArticleId><ArticleId IdType="pubmed">30222945</ArticleId></ArticleIdList></Reference><Reference><Citation>Barker SJ, Raju RM, Milman NEP, Wang J, Davila-Velderrain J, Gunter-Rahman F, Parro CC, Bozzelli PL, Abdurrob F, Abdelaal K, et al. (2021). MEF2 is a key regulator of cognitive potential and confers resilience to neurodegeneration. Sci. Transl. Med 13. 10.1126/SCITRANSLMED.ABD7695/SUPPL_FILE/SCITRANSLMED.ABD7695_DATA_FILE_S1.ZIP.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/SCITRANSLMED.ABD7695/SUPPL_FILE/SCITRANSLMED.ABD7695_DATA_FILE_S1.ZIP</ArticleId><ArticleId IdType="pmc">PMC9258338</ArticleId><ArticleId IdType="pubmed">34731014</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashleigh T, Swerdlow RH, and Beal MF (2022). The role of mitochondrial dysfunction in Alzheimer&#x2019;s disease pathogenesis. Alzheimer&#x2019;s Dement. 10.1002/ALZ.12683.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ALZ.12683</ArticleId><ArticleId IdType="pubmed">35522844</ArticleId></ArticleIdList></Reference><Reference><Citation>Welch G, Boix C, Schmauch E, Davila-Velderrain J, Victor MB, Dileep V, Bozzelli L, Su Q, Cheng J, Lee A, et al. (2021). Neurons burdened by DNA double strand breaks incite microglia activation through antiviral-like signaling in neurodegeneration. bioRxiv, 2021.12.23.474002. 10.1101/2021.12.23.474002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.12.23.474002</ArticleId><ArticleId IdType="pmc">PMC9519048</ArticleId><ArticleId IdType="pubmed">36170369</ArticleId></ArticleIdList></Reference><Reference><Citation>Chow HM, and Herrup K (2015). Genomic integrity and the ageing brain. Nat. Rev. Neurosci 2015 1611 16, 672&#x2013;684. 10.1038/nrn4020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn4020</ArticleId><ArticleId IdType="pubmed">26462757</ArticleId></ArticleIdList></Reference><Reference><Citation>Welch G, and Tsai L-H (2022). Mechanisms of DNA damage-mediated neurotoxicity in neurodegenerative disease. EMBO Rep. 23, e54217. 10.15252/EMBR.202154217.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/EMBR.202154217</ArticleId><ArticleId IdType="pmc">PMC9171412</ArticleId><ArticleId IdType="pubmed">35499251</ArticleId></ArticleIdList></Reference><Reference><Citation>Gelot C, Guirouilh-Barbat J, Le Guen T, Dardillac E, Chailleux C, Canitrot Y, and Lopez BS (2016). The Cohesin Complex Prevents the End Joining of Distant DNA Double-Strand Ends. Mol. Cell 61, 15&#x2013;26. 10.1016/J.MOLCEL.2015.11.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.MOLCEL.2015.11.002</ArticleId><ArticleId IdType="pubmed">26687679</ArticleId></ArticleIdList></Reference><Reference><Citation>Alder J, Thakker-Varia S, Bangasser DA, Kuroiwa M, Plummer MR, Shors TJ, and Black IB (2003). Brain-Derived Neurotrophic Factor-Induced Gene Expression Reveals Novel Actions of VGF in Hippocampal Synaptic Plasticity. J. Neurosci 23, 10800&#x2013;10808. 10.1523/JNEUROSCI.23-34-10800.2003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.23-34-10800.2003</ArticleId><ArticleId IdType="pmc">PMC3374594</ArticleId><ArticleId IdType="pubmed">14645472</ArticleId></ArticleIdList></Reference><Reference><Citation>Beckmann ND, Lin WJ, Wang M, Cohain AT, Charney AW, Wang P, Ma W, Wang YC, Jiang C, Audrain M, et al. (2020). Multiscale causal networks identify VGF as a key regulator of Alzheimer&#x2019;s disease. Nat. Commun 11. 10.1038/S41467-020-17405-Z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/S41467-020-17405-Z</ArticleId><ArticleId IdType="pmc">PMC7414858</ArticleId><ArticleId IdType="pubmed">32770063</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao MF, Xu D, Craig MT, Pelkey KA, Chien CC, Shi Y, Zhang J, Resnick S, Pletnikova O, Salmon D, et al. (2017). NPTX2 and cognitive dysfunction in Alzheimer&#x2019;s Disease. Elife 6, 1&#x2013;27. 10.7554/ELIFE.23798.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/ELIFE.23798</ArticleId><ArticleId IdType="pmc">PMC5404919</ArticleId><ArticleId IdType="pubmed">28440221</ArticleId></ArticleIdList></Reference><Reference><Citation>Cain A, Taga M, McCabe C, Green G, Hekselman I, White CC, Lee DI, Gaur P, Rozenblatt-Rosen O, Zhang F, et al. (2022). Multi-cellular communities are perturbed in the aging human brain and Alzheimer&#x2019;s disease. bioRxiv, 2020.12.22.424084. 10.1101/2020.12.22.424084.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.12.22.424084</ArticleId><ArticleId IdType="pmc">PMC10789499</ArticleId><ArticleId IdType="pubmed">37336975</ArticleId></ArticleIdList></Reference><Reference><Citation>Consens ME, Chen Y, Menon V, Wang Y, Schneider JA, De Jager PL, Bennett DA, Tripathy SJ, and Felsky D (2022). Bulk and Single-Nucleus Transcriptomics Highlight Intra-Telencephalic and Somatostatin Neurons in Alzheimer&#x2019;s Disease. Front. Mol. Neurosci 15. 10.3389/FNMOL.2022.903175.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/FNMOL.2022.903175</ArticleId><ArticleId IdType="pmc">PMC9231610</ArticleId><ArticleId IdType="pubmed">35754708</ArticleId></ArticleIdList></Reference><Reference><Citation>Davies P, Katzman R, and Terry RD (1980). Reduced somatostatin-like immunoreactivity in cerebral cortex from cases of Alzheimer disease and Alzheimer senile dementa. Nature 288, 279&#x2013;280. 10.1038/288279A0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/288279A0</ArticleId><ArticleId IdType="pubmed">6107862</ArticleId></ArticleIdList></Reference><Reference><Citation>Loomba S, Straehle J, Gangadharan V, Heike N, Khalifa A, Motta A, Ju N, Sievers M, Gempt J, Meyer HS, et al. (2022). Connectomic comparison of mouse and human cortex. Science (80-. ). 10.1126/SCIENCE.ABO0924.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/SCIENCE.ABO0924</ArticleId><ArticleId IdType="pubmed">35737810</ArticleId></ArticleIdList></Reference><Reference><Citation>Krienen FM, Goldman M, Zhang Q, C. H. del Rosario R, Florio M, Machold R, Saunders A, Levandowski K, Zaniewski H, Schuman B, et al. (2020). Innovations present in the primate interneuron repertoire. Nature 586, 262&#x2013;269. 10.1038/S41586-020-2781-Z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/S41586-020-2781-Z</ArticleId><ArticleId IdType="pmc">PMC7957574</ArticleId><ArticleId IdType="pubmed">32999462</ArticleId></ArticleIdList></Reference><Reference><Citation>Bakken TE, Jorstad NL, Hu Q, Lake BB, Tian W, Kalmbach BE, Crow M, Hodge RD, Krienen FM, Sorensen SA, et al. (2021). Comparative cellular analysis of motor cortex in human, marmoset and mouse. Nat. 2021 5987879 598, 111&#x2013;119. 10.1038/s41586-021-03465-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03465-8</ArticleId><ArticleId IdType="pmc">PMC8494640</ArticleId><ArticleId IdType="pubmed">34616062</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng Y, Bi M, Delerue F, Forrest SL, Chan G, Van Der Hoven J, Van Hummel A, Feiten AF, Lee S, Martinez-Valbuena Ivan, &#xb7;, et al. (2022). Loss of LAMP5 interneurons drives neuronal network dysfunction in Alzheimer&#x2019;s disease. Acta Neuropathol. 2022 1, 1&#x2013;14. 10.1007/S00401-022-02457-W.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/S00401-022-02457-W</ArticleId><ArticleId IdType="pmc">PMC9467963</ArticleId><ArticleId IdType="pubmed">35780436</ArticleId></ArticleIdList></Reference><Reference><Citation>Sohal VS, Zhang F, Yizhar O, and Deisseroth K (2009). Parvalbumin neurons and gamma rhythms enhance cortical circuit performance. Nat. 2009 4597247 459, 698&#x2013;702. 10.1038/nature07991.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature07991</ArticleId><ArticleId IdType="pmc">PMC3969859</ArticleId><ArticleId IdType="pubmed">19396159</ArticleId></ArticleIdList></Reference><Reference><Citation>Cardin JA, Carl&#xe9;n M, Meletis K, Knoblich U, Zhang F, Deisseroth K, Tsai LH, and Moore CI (2009). Driving fast-spiking cells induces gamma rhythm and controls sensory responses. Nature 459, 663. 10.1038/NATURE08002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/NATURE08002</ArticleId><ArticleId IdType="pmc">PMC3655711</ArticleId><ArticleId IdType="pubmed">19396156</ArticleId></ArticleIdList></Reference><Reference><Citation>DA B, AS B, PA B, LL B, RS W, and JA S (2018). Religious Orders Study and Rush Memory and Aging Project. J. Alzheimers. Dis 64, S161&#x2013;S189. 10.3233/JAD-179939.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-179939</ArticleId><ArticleId IdType="pmc">PMC6380522</ArticleId><ArticleId IdType="pubmed">29865057</ArticleId></ArticleIdList></Reference><Reference><Citation>DA B, RS W, JA S, DA E, LA B, NT A, LL B, JH F, and J B (2002). Natural history of mild cognitive impairment in older persons. Neurology 59, 198&#x2013;205. 10.1212/WNL.59.2.198.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.59.2.198</ArticleId><ArticleId IdType="pubmed">12136057</ArticleId></ArticleIdList></Reference><Reference><Citation>DA B, JA S, RS W, JL B, and SE A (2004). Neurofibrillary tangles mediate the association of amyloid load with clinical Alzheimer disease and level of cognitive function. Arch. Neurol 61, 378&#x2013;384. 10.1001/ARCHNEUR.61.3.378.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/ARCHNEUR.61.3.378</ArticleId><ArticleId IdType="pubmed">15023815</ArticleId></ArticleIdList></Reference><Reference><Citation>Bennett DA, Schneider JA, Tang Y, Arnold SE, and Wilson RS (2006). The effect of social networks on the relation between Alzheimer&#x2019;s disease pathology and level of cognitive function in old people: a longitudinal cohort study. Lancet. Neurol 5, 406&#x2013;412. 10.1016/S1474-4422(06)70417-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(06)70417-3</ArticleId><ArticleId IdType="pubmed">16632311</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilson RS, Boyle PA, Yu L, Barnes LL, Sytsma J, Buchman AS, Bennett DA, and Schneider JA (2015). Temporal course and pathologic basis of unawareness of memory loss in dementia. Neurology 85, 984. 10.1212/WNL.0000000000001935.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000001935</ArticleId><ArticleId IdType="pmc">PMC4567465</ArticleId><ArticleId IdType="pubmed">26311746</ArticleId></ArticleIdList></Reference><Reference><Citation>Boyle PA, Wang T, Yu L, Wilson RS, Dawe R, Arfanakis K, Schneider JA, Beck T, Rajan KB, Evans D, et al. (2021). The &#x201c;cognitive clock&#x201d;: A novel indicator of brain health. Alzheimers. Dement 17, 1923&#x2013;1937. 10.1002/ALZ.12351.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ALZ.12351</ArticleId><ArticleId IdType="pmc">PMC9014826</ArticleId><ArticleId IdType="pubmed">34060702</ArticleId></ArticleIdList></Reference><Reference><Citation>Buchman AS, Yu L, Klein H-U, Zammit AR, Oveisgharan S, Grodstein F, Tasaki S, Levey AI, Seyfried NT, and Bennett DA (2022). Proteome-wide discovery of cortical proteins that may provide motor resilience to offset the negative effects of pathologies in older adults. J. Gerontol. A. Biol. Sci. Med. Sci 10.1093/GERONA/GLAC105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/GERONA/GLAC105</ArticleId><ArticleId IdType="pmc">PMC9977240</ArticleId><ArticleId IdType="pubmed">35512265</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai Y, Wang J, Song R, Wang Z, Qi X, Buchman AS, Bennett DA, and Xu W (2022). Influence of cardiovascular risk burden on pulmonary function trajectory: role of physical and social activities. Aging (Albany. NY). 14, 6081&#x2013;6093. 10.18632/AGING.204201.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/AGING.204201</ArticleId><ArticleId IdType="pmc">PMC9417241</ArticleId><ArticleId IdType="pubmed">35929840</ArticleId></ArticleIdList></Reference><Reference><Citation>Grodstein F, Wang T, Leurgans SE, Wilson RS, and Bennett DA (2022). Modifiable psychosocial risk factors and delayed onset of dementia in older populations: analysis of two prospective US cohorts. BMJ Open 12. 10.1136/BMJOPEN-2021-059317.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/BMJOPEN-2021-059317</ArticleId><ArticleId IdType="pmc">PMC8981290</ArticleId><ArticleId IdType="pubmed">35379643</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilson RS, Wang T, Yu L, Grodstein F, Bennett DA, and Boyle PA (2021). Cognitive Activity and Onset Age of Incident Alzheimer Disease Dementia. Neurology 97, e922&#x2013;e929. 10.1212/WNL.0000000000012388.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000012388</ArticleId><ArticleId IdType="pmc">PMC8408511</ArticleId><ArticleId IdType="pubmed">34261788</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilson RS, Segawa E, Hizel LP, Boyle PA, and Bennett DA (2012). Terminal dedifferentiation of cognitive abilities. Neurology 78, 1116&#x2013;1122. 10.1212/WNL.0B013E31824F7FF2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0B013E31824F7FF2</ArticleId><ArticleId IdType="pmc">PMC3320052</ArticleId><ArticleId IdType="pubmed">22491858</ArticleId></ArticleIdList></Reference><Reference><Citation>Arvanitakis Z, Schneider JA, Wilson RS, Li Y, Arnold SE, Wang Z, and Bennett DA (2006). Diabetes is related to cerebral infarction but not to AD pathology in older persons. Neurology 67, 1960&#x2013;1965. 10.1212/01.WNL.0000247053.45483.4E.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.WNL.0000247053.45483.4E</ArticleId><ArticleId IdType="pubmed">17159101</ArticleId></ArticleIdList></Reference><Reference><Citation>Boyle PA, Wang T, Yu L, Wilson RS, Dawe R, Arfanakis K, Schneider JA, and Bennett DA (2021). To what degree is late life cognitive decline driven by age-related neuropathologies? Brain 144, 2166&#x2013;2175. 10.1093/BRAIN/AWAB092.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/BRAIN/AWAB092</ArticleId><ArticleId IdType="pmc">PMC8370442</ArticleId><ArticleId IdType="pubmed">33742668</ArticleId></ArticleIdList></Reference><Reference><Citation>Boyle PA, Yu L, Leurgans SE, Wilson RS, Brookmeyer R, Schneider JA, and Bennett DA (2019). Attributable risk of Alzheimer&#x2019;s dementia attributed to age-related neuropathologies. Ann. Neurol 85, 114&#x2013;124. 10.1002/ANA.25380.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ANA.25380</ArticleId><ArticleId IdType="pmc">PMC10128614</ArticleId><ArticleId IdType="pubmed">30421454</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng GXY, Terry JM, Belgrader P, Ryvkin P, Bent ZW, Wilson R, Ziraldo SB, Wheeler TD, McDermott GP, Zhu J, et al. (2017). Massively parallel digital transcriptional profiling of single cells. Nat. Commun 2017 81 8, 1&#x2013;12. 10.1038/ncomms14049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms14049</ArticleId><ArticleId IdType="pmc">PMC5241818</ArticleId><ArticleId IdType="pubmed">28091601</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolf FA, Angerer P, and Theis FJ (2018). SCANPY: Large-scale single-cell gene expression data analysis. Genome Biol. 19, 1&#x2013;5. 10.1186/S13059-017-1382-0/FIGURES/1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/S13059-017-1382-0/FIGURES/1</ArticleId><ArticleId IdType="pmc">PMC5802054</ArticleId><ArticleId IdType="pubmed">29409532</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolock SL, Lopez R, and Klein AM (2019). Scrublet: Computational Identification of Cell Doublets in Single-Cell Transcriptomic Data. Cell Syst. 8, 281&#x2013;291.e9. 10.1016/J.CELS.2018.11.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.CELS.2018.11.005</ArticleId><ArticleId IdType="pmc">PMC6625319</ArticleId><ArticleId IdType="pubmed">30954476</ArticleId></ArticleIdList></Reference><Reference><Citation>Hafemeister C, and Satija R (2019). Normalization and variance stabilization of single-cell RNA-seq data using regularized negative binomial regression. Genome Biol. 2019 201 20, 1&#x2013;15. 10.1186/S13059-019-1874-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/S13059-019-1874-1</ArticleId><ArticleId IdType="pmc">PMC6927181</ArticleId><ArticleId IdType="pubmed">31870423</ArticleId></ArticleIdList></Reference><Reference><Citation>Stuart T, Butler A, Hoffman P, Hafemeister C, Papalexi E, Mauck WM, Hao Y, Stoeckius M, Smibert P, and Satija R (2019). Comprehensive Integration of Single-Cell Data. Cell 177, 1888&#x2013;1902.e21. 10.1016/J.CELL.2019.05.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.CELL.2019.05.031</ArticleId><ArticleId IdType="pmc">PMC6687398</ArticleId><ArticleId IdType="pubmed">31178118</ArticleId></ArticleIdList></Reference><Reference><Citation>Lake BB, Chen S, Sos BC, Fan J, Kaeser GE, Yung YC, Duong TE, Gao D, Chun J, Kharchenko PV, et al. (2017). Integrative single-cell analysis of transcriptional and epigenetic states in the human adult brain. Nat. Biotechnol 36, 70&#x2013;80. 10.1038/nbt.4038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt.4038</ArticleId><ArticleId IdType="pmc">PMC5951394</ArticleId><ArticleId IdType="pubmed">29227469</ArticleId></ArticleIdList></Reference><Reference><Citation>Kierdorf K, Masuda T, Jord&#xe3;o MJC, and Prinz M (2019). Macrophages at CNS interfaces: ontogeny and function in health and disease. Nat. Rev. Neurosci 20, 547&#x2013;562. 10.1038/s41583-019-0201-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41583-019-0201-x</ArticleId><ArticleId IdType="pubmed">31358892</ArticleId></ArticleIdList></Reference><Reference><Citation>Habib N, Avraham-Davidi I, Basu A, Burks T, Shekhar K, Hofree M, Choudhury SR, Aguet F, Gelfand E, Ardlie K, et al. (2017). Massively parallel single-nucleus RNA-seq with DroNc-seq. Nat. Methods 14, 955&#x2013;958. 10.1038/nmeth.4407.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.4407</ArticleId><ArticleId IdType="pmc">PMC5623139</ArticleId><ArticleId IdType="pubmed">28846088</ArticleId></ArticleIdList></Reference><Reference><Citation>M V, L H, MA M, J A, K A, F DG, K N, T L, B L, L G, et al. (2018). A molecular atlas of cell types and zonation in the brain vasculature. Nature 554, 475&#x2013;480. 10.1038/NATURE25739.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/NATURE25739</ArticleId><ArticleId IdType="pubmed">29443965</ArticleId></ArticleIdList></Reference><Reference><Citation>Velmeshev D, Schirmer L, Jung D, Haeussler M, Perez Y, Mayer S, Bhaduri A, Goyal N, Rowitch DH, and Kriegstein AR (2019). Single-cell genomics identifies cell type&#x2013;specific molecular changes in autism. Science (80-. ). 364, 685&#x2013;689. 10.1126/SCIENCE.AAV8130.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/SCIENCE.AAV8130</ArticleId><ArticleId IdType="pmc">PMC7678724</ArticleId><ArticleId IdType="pubmed">31097668</ArticleId></ArticleIdList></Reference><Reference><Citation>Crowell HL, Soneson C, Germain PL, Calini D, Collin L, Raposo C, Malhotra D, and Robinson MD (2020). muscat detects subpopulation-specific state transitions from multi-sample multi-condition single-cell transcriptomics data. Nat. Commun 2020 111 11, 1&#x2013;12. 10.1038/S41467-020-19894-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/S41467-020-19894-4</ArticleId><ArticleId IdType="pmc">PMC7705760</ArticleId><ArticleId IdType="pubmed">33257685</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson MD, McCarthy DJ, and Smyth GK (2010). edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26, 139&#x2013;140. 10.1093/BIOINFORMATICS/BTP616.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/BIOINFORMATICS/BTP616</ArticleId><ArticleId IdType="pmc">PMC2796818</ArticleId><ArticleId IdType="pubmed">19910308</ArticleId></ArticleIdList></Reference><Reference><Citation>Risso D, Ngai J, Speed TP, and Dudoit S (2014). Normalization of RNA-seq data using factor analysis of control genes or samples. Nat. Biotechnol 2014 329 32, 896&#x2013;902. 10.1038/nbt.2931.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt.2931</ArticleId><ArticleId IdType="pmc">PMC4404308</ArticleId><ArticleId IdType="pubmed">25150836</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao S, Li CI, Guo Y, Sheng Q, and Shyr Y (2018). RnaSeqSampleSize: Real data based sample size estimation for RNA sequencing. BMC Bioinformatics 19, 1&#x2013;8. 10.1186/S12859-018-2191-5/FIGURES/5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/S12859-018-2191-5/FIGURES/5</ArticleId><ArticleId IdType="pmc">PMC5975570</ArticleId><ArticleId IdType="pubmed">29843589</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffman GE, Lee D, Bendl J, Fnu P, Hong A, Casey C, Alvia M, Shao Z, Argyriou S, Therrien K, et al. (2023). Efficient differential expression analysis of large-scale single cell transcriptomics data using dreamlet. bioRxiv, 2023.03.17.533005. 10.1101/2023.03.17.533005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2023.03.17.533005</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen L. (2023). GeneOverlap: Test and visualize gene overlaps.</Citation></Reference><Reference><Citation>Zhou Y, Zhou B, Pache L, Chang M, Khodabakhshi AH, Tanaseichuk O, Benner C, and Chanda SK (2019). Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat. Commun 10.1038/S41467-019-09234-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/S41467-019-09234-6</ArticleId><ArticleId IdType="pmc">PMC6447622</ArticleId><ArticleId IdType="pubmed">30944313</ArticleId></ArticleIdList></Reference><Reference><Citation>Kohonen T. (1990). The Self-Organizing Map. Proc. IEEE 78, 1464&#x2013;1480. 10.1109/5.58325.</Citation><ArticleIdList><ArticleId IdType="doi">10.1109/5.58325</ArticleId></ArticleIdList></Reference><Reference><Citation>Wehrens R, and Buydens LMC (2007). Self- and Super-organizing Maps in R: The kohonen Package. J. Stat. Softw 21, 1&#x2013;19. 10.18637/JSS.V021.I05.</Citation><ArticleIdList><ArticleId IdType="doi">10.18637/JSS.V021.I05</ArticleId></ArticleIdList></Reference><Reference><Citation>Hao Y, Hao S, Andersen-Nissen E, Mauck WM, Zheng S, Butler A, Lee MJ, Wilk AJ, Darby C, Zager M, et al. (2021). Integrated analysis of multimodal single-cell data. Cell. 10.1016/j.cell.2021.04.048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2021.04.048</ArticleId><ArticleId IdType="pmc">PMC8238499</ArticleId><ArticleId IdType="pubmed">34062119</ArticleId></ArticleIdList></Reference><Reference><Citation>Stuart T, Butler A, Hoffman P, Hafemeister C, Papalexi E, Mauck WM, Hao Y, Stoeckius M, Smibert P, and Satija R (2019). Comprehensive Integration of Single-Cell Data. Cell 177, 1888&#x2013;1902.e21. 10.1016/J.CELL.2019.05.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.CELL.2019.05.031</ArticleId><ArticleId IdType="pmc">PMC6687398</ArticleId><ArticleId IdType="pubmed">31178118</ArticleId></ArticleIdList></Reference><Reference><Citation>Butler A, Hoffman P, Smibert P, Papalexi E, and Satija R (2018). Integrating single-cell transcriptomic data across different conditions, technologies, and species. Nat. Biotechnol 10.1038/nbt.4096.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt.4096</ArticleId><ArticleId IdType="pmc">PMC6700744</ArticleId><ArticleId IdType="pubmed">29608179</ArticleId></ArticleIdList></Reference><Reference><Citation>Satija R, Farrell JA, Gennert D, Schier AF, and Regev A (2015). Spatial reconstruction of single-cell gene expression data. Nat. Biotechnol 33, 495&#x2013;502. 10.1038/nbt.3192.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt.3192</ArticleId><ArticleId IdType="pmc">PMC4430369</ArticleId><ArticleId IdType="pubmed">25867923</ArticleId></ArticleIdList></Reference><Reference><Citation>Dewey Michael (2022). metap: meta-analysis of significance values. R package version 1.8.</Citation></Reference><Reference><Citation>Liu Y, and Xie J (2020). Cauchy combination test: a powerful test with analytic p-value calculation under arbitrary dependency structures. J. Am. Stat. Assoc 115, 393. 10.1080/01621459.2018.1554485.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/01621459.2018.1554485</ArticleId><ArticleId IdType="pmc">PMC7531765</ArticleId><ArticleId IdType="pubmed">33012899</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X, Li Z, Zhou H, Gaynor SM, Liu Y, Chen H, Sun R, Dey R, Arnett DK, Aslibekyan S, et al. (2020). Dynamic incorporation of multiple in silico functional annotations empowers rare variant association analysis of large whole genome sequencing studies at scale. Nat. Genet 52, 969. 10.1038/S41588-020-0676-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/S41588-020-0676-4</ArticleId><ArticleId IdType="pmc">PMC7483769</ArticleId><ArticleId IdType="pubmed">32839606</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Z, Li X, Zhou H, Gaynor SM, Selvaraj MS, Arapoglou T, Quick C, Liu Y, Chen H, Sun R, et al. (2022). A framework for detecting noncoding rare variant associations of large-scale whole-genome sequencing studies. Nat. Methods 19, 1599. 10.1038/S41592-022-01640-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/S41592-022-01640-X</ArticleId><ArticleId IdType="pmc">PMC10008172</ArticleId><ArticleId IdType="pubmed">36303018</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu Z, Eils R, and Schlesner M (2016). Complex heatmaps reveal patterns and correlations in multidimensional genomic data. Bioinformatics. 10.1093/bioinformatics/btw313.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btw313</ArticleId><ArticleId IdType="pubmed">27207943</ArticleId></ArticleIdList></Reference><Reference><Citation>Love MI, Huber W, and Anders S (2014). Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 10.1186/s13059-014-0550-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13059-014-0550-8</ArticleId><ArticleId IdType="pmc">PMC4302049</ArticleId><ArticleId IdType="pubmed">25516281</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y, Lun ATL, and Smyth GK (2016). From reads to genes to pathways: Differential expression analysis of RNA-Seq experiments using Rsubread and the edgeR quasi-likelihood pipeline. F1000Research. 10.12688/F1000RESEARCH.8987.2.</Citation><ArticleIdList><ArticleId IdType="doi">10.12688/F1000RESEARCH.8987.2</ArticleId><ArticleId IdType="pmc">PMC4934518</ArticleId><ArticleId IdType="pubmed">27508061</ArticleId></ArticleIdList></Reference><Reference><Citation>McCarthy DJ, Chen Y, and Smyth GK (2012). Differential expression analysis of multifactor RNA-Seq experiments with respect to biological variation. Nucleic Acids Res. 10.1093/nar/gks042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gks042</ArticleId><ArticleId IdType="pmc">PMC3378882</ArticleId><ArticleId IdType="pubmed">22287627</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson MD, McCarthy DJ, and Smyth GK (2009). edgeR: A Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 10.1093/bioinformatics/btp616.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btp616</ArticleId><ArticleId IdType="pmc">PMC2796818</ArticleId><ArticleId IdType="pubmed">19910308</ArticleId></ArticleIdList></Reference><Reference><Citation>Crowell HL, Soneson C, Germain PL, Calini D, Collin L, Raposo C, Malhotra D, and Robinson MD (2020). muscat detects subpopulation-specific state transitions from multi-sample multi-condition single-cell transcriptomics data. Nat. Commun 10.1038/s41467-020-19894-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-19894-4</ArticleId><ArticleId IdType="pmc">PMC7705760</ArticleId><ArticleId IdType="pubmed">33257685</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujita M, Gao Z, Zeng L, McCabe C, White CC, Ng B, Green GS, Rozenblatt-Rosen O, Phillips D, Amir-Zilberstein L, et al. (2022). Cell-subtype specific effects of genetic variation in the aging and Alzheimer cortex. bioRxiv, 2022.11.07.515446. 10.1101/2022.11.07.515446.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.11.07.515446</ArticleId><ArticleId IdType="pubmed">38514782</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37774678</PMID><DateCompleted><Year>2023</Year><Month>10</Month><Day>24</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>12</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1097-4172</ISSN><JournalIssue CitedMedium="Internet"><Volume>186</Volume><Issue>20</Issue><PubDate><Year>2023</Year><Month>Sep</Month><Day>28</Day></PubDate></JournalIssue><Title>Cell</Title><ISOAbbreviation>Cell</ISOAbbreviation></Journal><ArticleTitle>Human microglial state dynamics in Alzheimer's disease progression.</ArticleTitle><Pagination><StartPage>4386</StartPage><EndPage>4403.e29</EndPage><MedlinePgn>4386-4403.e29</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.cell.2023.08.037</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0092-8674(23)00971-6</ELocationID><Abstract><AbstractText>Altered microglial states affect neuroinflammation, neurodegeneration, and disease but remain poorly understood. Here, we report 194,000 single-nucleus microglial transcriptomes and epigenomes across 443 human subjects and diverse Alzheimer's disease (AD) pathological phenotypes. We annotate 12 microglial transcriptional states, including AD-dysregulated homeostatic, inflammatory, and lipid-processing states. We identify 1,542 AD-differentially-expressed genes, including both microglia-state-specific and disease-stage-specific alterations. By integrating epigenomic, transcriptomic, and motif information, we infer upstream regulators of microglial cell states, gene-regulatory networks, enhancer-gene links, and transcription-factor-driven microglial state transitions. We demonstrate that ectopic expression of our predicted homeostatic-state activators induces homeostatic features in human iPSC-derived microglia-like cells, while inhibiting activators of inflammation can block inflammatory progression. Lastly, we pinpoint the expression of AD-risk genes in microglial states and differential expression of AD-risk genes and their regulators during AD progression. Overall, we provide insights underlying microglial states, including state-specific and AD-stage-specific microglial alterations at unprecedented resolution.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 The Authors. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Na</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>MIT Computer Science and Artificial Intelligence Laboratory, Cambridge, MA, USA; Broad Institute of MIT and Harvard, Cambridge, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Victor</LastName><ForeName>Matheus B</ForeName><Initials>MB</Initials><AffiliationInfo><Affiliation>Picower Institute for Learning and Memory, Massachusetts Institute of Technology, Cambridge, MA, USA; Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Yongjin P</ForeName><Initials>YP</Initials><AffiliationInfo><Affiliation>MIT Computer Science and Artificial Intelligence Laboratory, Cambridge, MA, USA; Broad Institute of MIT and Harvard, Cambridge, MA, USA; Department of Pathology and Laboratory Medicine, Department of Statistics, University of British Columbia, Vancouver, BC, Canada; Department of Molecular Oncology, BC Cancer, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xiong</LastName><ForeName>Xushen</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>MIT Computer Science and Artificial Intelligence Laboratory, Cambridge, MA, USA; Broad Institute of MIT and Harvard, Cambridge, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scannail</LastName><ForeName>Aine Ni</ForeName><Initials>AN</Initials><AffiliationInfo><Affiliation>Picower Institute for Learning and Memory, Massachusetts Institute of Technology, Cambridge, MA, USA; Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leary</LastName><ForeName>Noelle</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Picower Institute for Learning and Memory, Massachusetts Institute of Technology, Cambridge, MA, USA; Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prosper</LastName><ForeName>Shaniah</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Picower Institute for Learning and Memory, Massachusetts Institute of Technology, Cambridge, MA, USA; Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Viswanathan</LastName><ForeName>Soujanya</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Picower Institute for Learning and Memory, Massachusetts Institute of Technology, Cambridge, MA, USA; Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luna</LastName><ForeName>Xochitl</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Picower Institute for Learning and Memory, Massachusetts Institute of Technology, Cambridge, MA, USA; Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boix</LastName><ForeName>Carles A</ForeName><Initials>CA</Initials><AffiliationInfo><Affiliation>MIT Computer Science and Artificial Intelligence Laboratory, Cambridge, MA, USA; Broad Institute of MIT and Harvard, Cambridge, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>James</LastName><ForeName>Benjamin T</ForeName><Initials>BT</Initials><AffiliationInfo><Affiliation>MIT Computer Science and Artificial Intelligence Laboratory, Cambridge, MA, USA; Broad Institute of MIT and Harvard, Cambridge, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tanigawa</LastName><ForeName>Yosuke</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>MIT Computer Science and Artificial Intelligence Laboratory, Cambridge, MA, USA; Broad Institute of MIT and Harvard, Cambridge, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Galani</LastName><ForeName>Kyriaki</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>MIT Computer Science and Artificial Intelligence Laboratory, Cambridge, MA, USA; Broad Institute of MIT and Harvard, Cambridge, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mathys</LastName><ForeName>Hansruedi</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Picower Institute for Learning and Memory, Massachusetts Institute of Technology, Cambridge, MA, USA; Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge, MA, USA; Department of Neurobiology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Xueqiao</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Picower Institute for Learning and Memory, Massachusetts Institute of Technology, Cambridge, MA, USA; Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ng</LastName><ForeName>Ayesha P</ForeName><Initials>AP</Initials><AffiliationInfo><Affiliation>Picower Institute for Learning and Memory, Massachusetts Institute of Technology, Cambridge, MA, USA; Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bennett</LastName><ForeName>David A</ForeName><Initials>DA</Initials><AffiliationInfo><Affiliation>Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, IL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsai</LastName><ForeName>Li-Huei</ForeName><Initials>LH</Initials><AffiliationInfo><Affiliation>Broad Institute of MIT and Harvard, Cambridge, MA, USA; Picower Institute for Learning and Memory, Massachusetts Institute of Technology, Cambridge, MA, USA; Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge, MA, USA. Electronic address: lhtsai@mit.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kellis</LastName><ForeName>Manolis</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>MIT Computer Science and Artificial Intelligence Laboratory, Cambridge, MA, USA; Broad Institute of MIT and Harvard, Cambridge, MA, USA. Electronic address: manoli@mit.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Acronym>HHMI</Acronym><Agency>Howard Hughes Medical Institute</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG074003</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>RF1 AG062377</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AG010161</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>RF1 AG057473</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>RF1 AG054321</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG062335</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 MH119509</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG015819</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AG072975</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 AG077227</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 DA053631</GrantID><Acronym>DA</Acronym><Agency>NIDA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>RF1 AG054012</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 AG046152</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG058002</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HG008155</GrantID><Acronym>HG</Acronym><Agency>NHGRI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 AG061356</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UG3 NS115064</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG017917</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UH3 NS115064</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS127187</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>RF1 NS129032</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 NS110453</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R56 AG067151</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG067151</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 MH109978</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cell</MedlineTA><NlmUniqueID>0413066</NlmUniqueID><ISSNLinking>0092-8674</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014157">Transcription Factors</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Cell. 2023 Sep 28;186(20):4257-4259. doi: 10.1016/j.cell.2023.09.001.</RefSource><PMID Version="1">37774675</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005786" MajorTopicYN="N">Gene Expression Regulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017628" MajorTopicYN="Y">Microglia</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014157" MajorTopicYN="N">Transcription Factors</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D059467" MajorTopicYN="N">Transcriptome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000081122" MajorTopicYN="N">Epigenome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Alzheimer's</Keyword><Keyword MajorTopicYN="N">cell states</Keyword><Keyword MajorTopicYN="N">disease-stage response</Keyword><Keyword MajorTopicYN="N">iPSCs</Keyword><Keyword MajorTopicYN="N">inflammation</Keyword><Keyword MajorTopicYN="N">microglia</Keyword><Keyword MajorTopicYN="N">single-cell</Keyword><Keyword MajorTopicYN="N">transcription factors</Keyword></KeywordList><CoiStatement>Declaration of interests L.-H.T. is a member of the Scientific Advisory Board of Cognito Therapeutics, 4M Therapeutics, Cell Signaling Technology, and Souvien Therapeutics, which has no association to this study.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>9</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>3</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>8</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>10</Month><Day>23</Day><Hour>1</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>9</Month><Day>30</Day><Hour>9</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>9</Month><Day>29</Day><Hour>18</Hour><Minute>16</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>28</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37774678</ArticleId><ArticleId IdType="mid">NIHMS1933479</ArticleId><ArticleId IdType="pmc">PMC10644954</ArticleId><ArticleId IdType="doi">10.1016/j.cell.2023.08.037</ArticleId><ArticleId IdType="pii">S0092-8674(23)00971-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Butovsky O, and Weiner HL (2018). Microglial signatures and their role in health and disease. Nat. Rev. Neurosci. 19, 622&#x2013;635.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7255106</ArticleId><ArticleId IdType="pubmed">30206328</ArticleId></ArticleIdList></Reference><Reference><Citation>Ellwanger DC, Wang S, Brioschi S, Shao Z, Green L, Case R, Yoo D, Weishuhn D, Rathanaswami P, Bradley J, et al. (2021). Prior activation state shapes the microglia response to antihuman TREM2 in a mouse model of Alzheimer&#x2019;s disease. Proc. Natl. Acad. Sci. U. S. A. 118. 10.1073/pnas.2017742118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2017742118</ArticleId><ArticleId IdType="pmc">PMC7826333</ArticleId><ArticleId IdType="pubmed">33446504</ArticleId></ArticleIdList></Reference><Reference><Citation>Friedman BA, Srinivasan K, Ayalon G, Meilandt WJ, Lin H, Huntley MA, Cao Y, Lee S-H, Haddick PCG, Ngu H, et al. (2018). Diverse Brain Myeloid Expression Profiles Reveal Distinct Microglial Activation States and Aspects of Alzheimer&#x2019;s Disease Not Evident in Mouse Models. Cell Rep. 22, 832&#x2013;847.</Citation><ArticleIdList><ArticleId IdType="pubmed">29346778</ArticleId></ArticleIdList></Reference><Reference><Citation>Hammond TR., Dufort C., Dissing-Olesen L., Giera S., Young A., Wysoker A., Walker AJ., Gergits F., Segel M., Nemesh J., et al.. (2019). Single-Cell RNA Sequencing of Microglia throughout the Mouse Lifespan and in the Injured Brain Reveals Complex Cell-State Changes. Immunity 50, 253&#x2013;271.e6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6655561</ArticleId><ArticleId IdType="pubmed">30471926</ArticleId></ArticleIdList></Reference><Reference><Citation>Keren-Shaul H, Spinrad A, Weiner A, Matcovitch-Natan O, Dvir-Szternfeld R, Ulland TK, David E, Baruch K, Lara-Astaiso D, Toth B, et al. (2017). A Unique Microglia Type Associated with Restricting Development of Alzheimer&#x2019;s Disease. Cell 169, 1276&#x2013;1290.e17.</Citation><ArticleIdList><ArticleId IdType="pubmed">28602351</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathys H, Adaikkan C, Gao F, Young JZ, Manet E, Hemberg M, De Jager PL, Ransohoff RM, Regev A, and Tsai L-H (2017). Temporal Tracking of Microglia Activation in Neurodegeneration at Single-Cell Resolution. Cell Rep. 21, 366&#x2013;380.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5642107</ArticleId><ArticleId IdType="pubmed">29020624</ArticleId></ArticleIdList></Reference><Reference><Citation>Sala Frigerio C, Wolfs L, Fattorelli N, Thrupp N, Voytyuk I, Schmidt I, Mancuso R, Chen W-T, Woodbury ME, Srivastava G, et al. (2019). The Major Risk Factors for Alzheimer&#x2019;s Disease: Age, Sex, and Genes Modulate the Microglia Response to A&#x3b2; Plaques. Cell Rep. 27, 1293&#x2013;1306.e6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7340153</ArticleId><ArticleId IdType="pubmed">31018141</ArticleId></ArticleIdList></Reference><Reference><Citation>Srinivasan K, Friedman BA, Etxeberria A, Huntley MA, van der Brug MP, Foreman O, Paw JS, Modrusan Z, Beach TG, Serrano GE, et al. (2020). Alzheimer&#x2019;s Patient Microglia Exhibit Enhanced Aging and Unique Transcriptional Activation. Cell Rep. 31, 107843.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7422733</ArticleId><ArticleId IdType="pubmed">32610143</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerrits E, Brouwer N, Kooistra SM, Woodbury ME, Vermeiren Y, Lambourne M, Mulder J, Kummer M, M&#xf6;ller T, Biber K, et al. (2021). Distinct amyloid-&#x3b2; and tau-associated microglia profiles in Alzheimer&#x2019;s disease. Acta Neuropathol. 141, 681&#x2013;696.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8043951</ArticleId><ArticleId IdType="pubmed">33609158</ArticleId></ArticleIdList></Reference><Reference><Citation>Grubman A, Choo XY, Chew G, Ouyang JF, Sun G, Croft NP, Rossello FJ, Simmons R, Buckberry S, Landin DV, et al. (2021). Transcriptional signature in microglia associated with A&#x3b2; plaque phagocytosis. Nat. Commun. 12, 3015.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8140091</ArticleId><ArticleId IdType="pubmed">34021136</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathys H, Davila-Velderrain J, Peng Z, Gao F, Mohammadi S, Young JZ, Menon M, He L, Abdurrob F, Jiang X, et al. (2019). Single-cell transcriptomic analysis of Alzheimer&#x2019;s disease. Nature 570, 332&#x2013;337.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6865822</ArticleId><ArticleId IdType="pubmed">31042697</ArticleId></ArticleIdList></Reference><Reference><Citation>Olah M, Menon V, Habib N, Taga MF, Ma Y, Yung CJ, Cimpean M, Khairallah A, Coronas-Samano G, Sankowski R, et al. (2020). Single cell RNA sequencing of human microglia uncovers a subset associated with Alzheimer&#x2019;s disease. Nat. Commun. 11, 6129.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7704703</ArticleId><ArticleId IdType="pubmed">33257666</ArticleId></ArticleIdList></Reference><Reference><Citation>Sankowski R, B&#xf6;ttcher C, Masuda T, Geirsdottir L, Sagar, Sindram E, Seredenina T, Muhs A, Scheiwe C, Shah MJ, et al. (2019). Mapping microglia states in the human brain through the integration of high-dimensional techniques. Nat. Neurosci. 22, 2098&#x2013;2110.</Citation><ArticleIdList><ArticleId IdType="pubmed">31740814</ArticleId></ArticleIdList></Reference><Reference><Citation>Bennett DA, Buchman AS, Boyle PA, Barnes LL, Wilson RS, and Schneider JA (2018). Religious Orders Study and Rush Memory and Aging Project. J. Alzheimers. Dis. 64, S161&#x2013;S189.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6380522</ArticleId><ArticleId IdType="pubmed">29865057</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia FJ, Sun N, Lee H, Godlewski B, Mathys H, Galani K, Zhou B, Jiang X, Ng AP, Mantero J, et al. (2022). Single-cell dissection of the human brain vasculature. Nature 603, 893&#x2013;899.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9680899</ArticleId><ArticleId IdType="pubmed">35158371</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun N, Akay LA, Murdock MH, Park Y, Galiana-Melendez F, Bubnys A, Galani K, Mathys H, Jiang X, Ng AP, et al. (2023). Single-nucleus multiregion transcriptomic analysis of brain vasculature in Alzheimer&#x2019;s disease. Nat. Neurosci. 26, 970&#x2013;982.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10464935</ArticleId><ArticleId IdType="pubmed">37264161</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu H, Leak RK, and Hu X (2016). Neurotransmitter receptors on microglia. Stroke Vasc Neurol 1, 52&#x2013;58.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5435193</ArticleId><ArticleId IdType="pubmed">28959464</ArticleId></ArticleIdList></Reference><Reference><Citation>Krasemann S, Madore C, Cialic R, Baufeld C, Calcagno N, El Fatimy R, Beckers L, O&#x2019;Loughlin E, Xu Y, Fanek Z, et al. (2017). The TREM2-APOE Pathway Drives the Transcriptional Phenotype of Dysfunctional Microglia in Neurodegenerative Diseases. Immunity 47, 566&#x2013;581.e9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5719893</ArticleId><ArticleId IdType="pubmed">28930663</ArticleId></ArticleIdList></Reference><Reference><Citation>McQuade A., Coburn M., Tu CH., Hasselmann J., Davtyan H., and Blurton-Jones M. (2018). Development and validation of a simplified method to generate human microglia from pluripotent stem cells. Mol. Neurodegener. 13, 67.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6303871</ArticleId><ArticleId IdType="pubmed">30577865</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang KX, and Denhardt DT (2008). Osteopontin: role in immune regulation and stress responses. Cytokine Growth Factor Rev. 19, 333&#x2013;345.</Citation><ArticleIdList><ArticleId IdType="pubmed">18952487</ArticleId></ArticleIdList></Reference><Reference><Citation>da Fonseca ACC, Matias D, Garcia C, Amaral R, Geraldo LH, Freitas C, and Lima FRS (2014). The impact of microglial activation on blood-brain barrier in brain diseases. Front. Cell. Neurosci. 8, 362.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4217497</ArticleId><ArticleId IdType="pubmed">25404894</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen EY, Tan CM, Kou Y, Duan Q, Wang Z, Meirelles GV, Clark NR, and Ma&#x2019;ayan A (2013). Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool. BMC Bioinformatics 14, 128.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3637064</ArticleId><ArticleId IdType="pubmed">23586463</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith AM, Gibbons HM, Oldfield RL, Bergin PM, Mee EW, Faull RLM, and Dragunow M (2013). The transcription factor PU.1 is critical for viability and function of human brain microglia. Glia 61, 929&#x2013;942.</Citation><ArticleIdList><ArticleId IdType="pubmed">23483680</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim S, Yu N-K, and Kaang B-K (2015). CTCF as a multifunctional protein in genome regulation and gene expression. Exp. Mol. Med. 47, e166.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4491725</ArticleId><ArticleId IdType="pubmed">26045254</ArticleId></ArticleIdList></Reference><Reference><Citation>Helin K, Wu CL, Fattaey AR, Lees JA, Dynlacht BD, Ngwu C, and Harlow E (1993). Heterodimerization of the transcription factors E2F-1 and DP-1 leads to cooperative trans-activation. Genes Dev. 7, 1850&#x2013;1861.</Citation><ArticleIdList><ArticleId IdType="pubmed">8405995</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen H-W, King K, Tu J, Sanchez M, Luster AD, and Shresta S (2013). The roles of IRF-3 and IRF-7 in innate antiviral immunity against dengue virus. J. Immunol. 191, 4194&#x2013;4201.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3795795</ArticleId><ArticleId IdType="pubmed">24043884</ArticleId></ArticleIdList></Reference><Reference><Citation>Shang YC, Chong ZZ, Hou J, and Maiese K (2009). The forkhead transcription factor FOXO3a controls microglial inflammatory activation and eventual apoptotic injury through caspase 3. Curr. Neurovasc. Res. 6, 20&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2668140</ArticleId><ArticleId IdType="pubmed">19355923</ArticleId></ArticleIdList></Reference><Reference><Citation>March-Diaz R, Lara-Ure&#xf1;a N, Romero-Molina C, Heras-Garvin A, Ortega-de San Luis C, Alvarez-Vergara MI, Sanchez-Garcia MA, Sanchez-Mejias E, Davila JC, Rosales-Nieves AE, et al. (2021). Hypoxia compromises the mitochondrial metabolism of Alzheimer&#x2019;s disease microglia via HIF1. Nature Aging 1, 385&#x2013;399.</Citation><ArticleIdList><ArticleId IdType="pubmed">37117599</ArticleId></ArticleIdList></Reference><Reference><Citation>Lum JJ, Bui T, Gruber M, Gordan JD, DeBerardinis RJ, Covello KL, Simon MC, and Thompson CB (2007). The transcription factor HIF-1alpha plays a critical role in the growth factor-dependent regulation of both aerobic and anaerobic glycolysis. Genes Dev. 21, 1037&#x2013;1049.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1855230</ArticleId><ArticleId IdType="pubmed">17437992</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H-S, Zhou Y-N, Li L, Li S-F, Long D, Chen X-L, Zhang J-B, Feng L, and Li Y-P (2019). HIF-1&#x3b1; protects against oxidative stress by directly targeting mitochondria. Redox Biol 25, 101109.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6859547</ArticleId><ArticleId IdType="pubmed">30686776</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia-Alonso L, Holland CH, Ibrahim MM, Turei D, and Saez-Rodriguez J (2019). Benchmark and integration of resources for the estimation of human transcription factor activities. Genome Res. 29, 1363&#x2013;1375.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6673718</ArticleId><ArticleId IdType="pubmed">31340985</ArticleId></ArticleIdList></Reference><Reference><Citation>Timmerman R, Burm SM, and Bajramovic JJ (2018). An Overview of Methods to Study Microglia. Front. Cell. Neurosci. 12, 242.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6087748</ArticleId><ArticleId IdType="pubmed">30127723</ArticleId></ArticleIdList></Reference><Reference><Citation>Victor MB, Leary N, Luna X, Meharena HS, Scannail AN, Bozzelli PL, Samaan G, Murdock MH, von Maydell D, Effenberger AH, et al. (2022). Lipid accumulation induced by APOE4 impairs microglial surveillance of neuronal-network activity. Cell Stem Cell 29, 1197&#x2013;1212.e8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9623845</ArticleId><ArticleId IdType="pubmed">35931030</ArticleId></ArticleIdList></Reference><Reference><Citation>Colombo G., Cubero RJA., Kanari L., Venturino A., Schulz R., Scolamiero M., Agerberg J., Mathys H., Tsai L-H., Chach&#xf3;lski W., et al.. (2022). A tool for mapping microglial morphology, morphOMICs, reveals brain-region and sex-dependent phenotypes. Nat. Neurosci. 25, 1379&#x2013;1393.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9534764</ArticleId><ArticleId IdType="pubmed">36180790</ArticleId></ArticleIdList></Reference><Reference><Citation>Butovsky O, Jedrychowski MP, Moore CS, Cialic R, Lanser AJ, Gabriely G, Koeglsperger T, Dake B, Wu PM, Doykan CE, et al. (2014). Identification of a unique TGF-&#x3b2;-dependent molecular and functional signature in microglia. Nat. Neurosci. 17, 131&#x2013;143.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4066672</ArticleId><ArticleId IdType="pubmed">24316888</ArticleId></ArticleIdList></Reference><Reference><Citation>Finak G, McDavid A, Yajima M, Deng J, Gersuk V, Shalek AK, Slichter CK, Miller HW, McElrath MJ, Prlic M, et al. (2015). MAST: a flexible statistical framework for assessing transcriptional changes and characterizing heterogeneity in single-cell RNA sequencing data. Genome Biol. 16, 278.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4676162</ArticleId><ArticleId IdType="pubmed">26653891</ArticleId></ArticleIdList></Reference><Reference><Citation>Zimmerman KD, Espeland MA, and Langefeld CD (2021). A practical solution to pseudoreplication bias in single-cell studies. Nat. Commun. 12, 738.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7854630</ArticleId><ArticleId IdType="pubmed">33531494</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson MD, McCarthy DJ, and Smyth GK (2010). edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26, 139&#x2013;140.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2796818</ArticleId><ArticleId IdType="pubmed">19910308</ArticleId></ArticleIdList></Reference><Reference><Citation>Ji Y, Wang X, Kalicki C, Menta BW, Baumgardner M, Koppel SJ, Weidling IW, Perez-Ortiz J, Wilkins HM, and Swerdlow RH (2019). Effects of Microglial Cytokines on Alzheimer&#x2019;s Disease-Related Phenomena. J. Alzheimers. Dis. 67, 1021&#x2013;1034.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6568259</ArticleId><ArticleId IdType="pubmed">30714956</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W-Y, Tan M-S, Yu J-T, and Tan L (2015). Role of pro-inflammatory cytokines released from microglia in Alzheimer&#x2019;s disease. Ann Transl Med 3, 136.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4486922</ArticleId><ArticleId IdType="pubmed">26207229</ArticleId></ArticleIdList></Reference><Reference><Citation>Mockenhaupt K, Gonsiewski A, and Kordula T (2021). RelB and Neuroinflammation. Cells 10. 10.3390/cells10071609.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10071609</ArticleId><ArticleId IdType="pmc">PMC8307460</ArticleId><ArticleId IdType="pubmed">34198987</ArticleId></ArticleIdList></Reference><Reference><Citation>Jansen IE, Savage JE, Watanabe K, Bryois J, Williams DM, Steinberg S, Sealock J, Karlsson IK, H&#xe4;gg S, Athanasiu L, et al. (2019). Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer&#x2019;s disease risk. Nat. Genet. 51, 404&#x2013;413.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6836675</ArticleId><ArticleId IdType="pubmed">30617256</ArticleId></ArticleIdList></Reference><Reference><Citation>Kunkle BW, Grenier-Boley B, Sims R, Bis JC, Damotte V, Naj AC, Boland A, Vronskaya M, van der Lee SJ, Amlie-Wolf A, et al. (2019). Genetic meta-analysis of diagnosed Alzheimer&#x2019;s disease identifies new risk loci and implicates A&#x3b2;, tau, immunity and lipid processing. Nat. Genet. 51, 414&#x2013;430.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6463297</ArticleId><ArticleId IdType="pubmed">30820047</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang S, Gim J, Lee J, Gunasekaran TI, Choi KY, Lee JJ, Seo EH, Ko P-W, Chung JY, Choi S-M, et al. (2021). Potential Novel Genes for Late-Onset Alzheimer&#x2019;s Disease in East-Asian Descent Identified by APOE-Stratified Genome-Wide Association Study. J. Alzheimers. Dis. 82, 1451&#x2013;1460.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8461686</ArticleId><ArticleId IdType="pubmed">34151794</ArticleId></ArticleIdList></Reference><Reference><Citation>Skene NG, Bryois J, Bakken TE, Breen G, Crowley JJ, Gaspar HA, Giusti-Rodriguez P, Hodge RD, Miller JA, Mu&#xf1;oz-Manchado AB, et al. (2018). Genetic identification of brain cell types underlying schizophrenia. Nat. Genet. 50, 825&#x2013;833.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6477180</ArticleId><ArticleId IdType="pubmed">29785013</ArticleId></ArticleIdList></Reference><Reference><Citation>Buniello A., MacArthur JAL., Cerezo M., Harris LW., Hayhurst J., Malangone C., McMahon A., Morales J., Mountjoy E., Sollis E., et al.. (2019). The NHGRI-EBI GWAS Catalog of published genome-wide association studies, targeted arrays and summary statistics 2019. Nucleic Acids Res. 47, D1005&#x2013;D1012.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6323933</ArticleId><ArticleId IdType="pubmed">30445434</ArticleId></ArticleIdList></Reference><Reference><Citation>Nugent AA, Lin K, van Lengerich B, Lianoglou S, Przybyla L, Davis SS, Llapashtica C, Wang J, Kim DJ, Xia D, et al. (2020). TREM2 Regulates Microglial Cholesterol Metabolism upon Chronic Phagocytic Challenge. Neuron 105, 837&#x2013;854.e9.</Citation><ArticleIdList><ArticleId IdType="pubmed">31902528</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudwarts A, Ramesha S, Gao T, Ponnusamy M, Wang S, Hansen M, Kozlova A, Bitarafan S, Kumar P, Beaulieu-Abdelahad D, et al. (2022). BIN1 is a key regulator of proinflammatory and neurodegeneration-related activation in microglia. Mol. Neurodegener. 17, 33.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9077874</ArticleId><ArticleId IdType="pubmed">35526014</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang M-G, Sun L, Han J, Zheng C, Liang H, Zhu J, and Jin T (2019). Biological characteristics of transcription factor RelB in different immune cell types: implications for the treatment of multiple sclerosis. Mol. Brain 12, 115.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6935142</ArticleId><ArticleId IdType="pubmed">31881915</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernier L-P, York EM, and MacVicar BA (2020). Immunometabolism in the Brain: How Metabolism Shapes Microglial Function. Trends Neurosci. 43, 854&#x2013;869.</Citation><ArticleIdList><ArticleId IdType="pubmed">32958333</ArticleId></ArticleIdList></Reference><Reference><Citation>Bennett DA, Wilson RS, Schneider JA, Evans DA, Beckett LA, Aggarwal NT, Barnes LL, Fox JH, and Bach J (2002). Natural history of mild cognitive impairment in older persons. Neurology 59, 198&#x2013;205.</Citation><ArticleIdList><ArticleId IdType="pubmed">12136057</ArticleId></ArticleIdList></Reference><Reference><Citation>Bennett DA, Wilson RS, Schneider JA, Evans DA, Aggarwal NT, Arnold SE, Cochran EJ, Berry-Kravis E, and Bienias JL (2003). Apolipoprotein E epsilon4 allele, AD pathology, and the clinical expression of Alzheimer&#x2019;s disease. Neurology 60, 246&#x2013;252.</Citation><ArticleIdList><ArticleId IdType="pubmed">12552039</ArticleId></ArticleIdList></Reference><Reference><Citation>Bennett DA, Schneider JA, Arvanitakis Z, Kelly JF, Aggarwal NT, Shah RC, and Wilson RS (2006). Neuropathology of older persons without cognitive impairment from two community-based studies. Neurology 66, 1837&#x2013;1844.</Citation><ArticleIdList><ArticleId IdType="pubmed">16801647</ArticleId></ArticleIdList></Reference><Reference><Citation>Bennett DA, Schneider JA, Wilson RS, Bienias JL, and Arnold SE (2004). Neurofibrillary tangles mediate the association of amyloid load with clinical Alzheimer disease and level of cognitive function. Arch. Neurol. 61, 378&#x2013;384.</Citation><ArticleIdList><ArticleId IdType="pubmed">15023815</ArticleId></ArticleIdList></Reference><Reference><Citation>Bennett DA, Schneider JA, Aggarwal NT, Arvanitakis Z, Shah RC, Kelly JF, Fox JH, Cochran EJ, Arends D, Treinkman AD, et al. (2006). Decision rules guiding the clinical diagnosis of Alzheimer&#x2019;s disease in two community-based cohort studies compared to standard practice in a clinic-based cohort study. Neuroepidemiology 27, 169&#x2013;176.</Citation><ArticleIdList><ArticleId IdType="pubmed">17035694</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng GXY, Terry JM, Belgrader P, Ryvkin P, Bent ZW, Wilson R, Ziraldo SB, Wheeler TD, McDermott GP, Zhu J, et al. (2017). Massively parallel digital transcriptional profiling of single cells. Nat. Commun. 8, 14049.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5241818</ArticleId><ArticleId IdType="pubmed">28091601</ArticleId></ArticleIdList></Reference><Reference><Citation>Hao Y, Hao S, Andersen-Nissen E, Mauck WM 3rd, Zheng S, Butler A, Lee MJ, Wilk AJ, Darby C, Zager M, et al. (2021). Integrated analysis of multimodal single-cell data. Cell 184, 3573&#x2013;3587.e29.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8238499</ArticleId><ArticleId IdType="pubmed">34062119</ArticleId></ArticleIdList></Reference><Reference><Citation>Korsunsky I., Millard N., Fan J., Slowikowski K., Zhang F., Wei K., Baglaenko Y., Brenner M., Loh P-R., and Raychaudhuri S. (2019). Fast, sensitive and accurate integration of single-cell data with Harmony. Nat. Methods 16, 1289&#x2013;1296.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6884693</ArticleId><ArticleId IdType="pubmed">31740819</ArticleId></ArticleIdList></Reference><Reference><Citation>McGinnis CS, Murrow LM, and Gartner ZJ (2019). DoubletFinder: Doublet Detection in Single-Cell RNA Sequencing Data Using Artificial Nearest Neighbors. Cell Syst 8, 329&#x2013;337.e4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6853612</ArticleId><ArticleId IdType="pubmed">30954475</ArticleId></ArticleIdList></Reference><Reference><Citation>Satpathy AT, Granja JM, Yost KE, Qi Y, Meschi F, McDermott GP, Olsen BN, Mumbach MR, Pierce SE, Corces MR, et al. (2019). Massively parallel single-cell chromatin landscapes of human immune cell development and intratumoral T cell exhaustion. Nat. Biotechnol. 37, 925&#x2013;936.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7299161</ArticleId><ArticleId IdType="pubmed">31375813</ArticleId></ArticleIdList></Reference><Reference><Citation>Granja JM, Corces MR, Pierce SE, Bagdatli ST, Choudhry H, Chang HY, and Greenleaf WJ (2021). ArchR is a scalable software package for integrative single-cell chromatin accessibility analysis. Nat. Genet. 53, 403&#x2013;411.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8012210</ArticleId><ArticleId IdType="pubmed">33633365</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X, Lan Y, Xu J, Quan F, Zhao E, Deng C, Luo T, Xu L, Liao G, Yan M, et al. (2019). CellMarker: a manually curated resource of cell markers in human and mouse. Nucleic Acids Res. 47, D721&#x2013;D728.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6323899</ArticleId><ArticleId IdType="pubmed">30289549</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang D, Liu S, Warrell J, Won H, Shi X, Navarro FCP, Clarke D, Gu M, Emani P, Yang YT, et al. (2018). Comprehensive functional genomic resource and integrative model for the human brain. Science 362. 10.1126/science.aat8464.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aat8464</ArticleId><ArticleId IdType="pmc">PMC6413328</ArticleId><ArticleId IdType="pubmed">30545857</ArticleId></ArticleIdList></Reference><Reference><Citation>Phipson B, Sim CB, Porrello ER, Hewitt AW, Powell J, and Oshlack A (2022). propeller: testing for differences in cell type proportions in single cell data. Bioinformatics 38, 4720&#x2013;4726.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9563678</ArticleId><ArticleId IdType="pubmed">36005887</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Liu T, Meyer CA, Eeckhoute J, Johnson DS, Bernstein BE, Nusbaum C, Myers RM, Brown M, Li W, et al. (2008). Model-based analysis of ChIP-Seq (MACS). Genome Biol. 9, R137.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2592715</ArticleId><ArticleId IdType="pubmed">18798982</ArticleId></ArticleIdList></Reference><Reference><Citation>McLean CY, Bristor D, Hiller M, Clarke SL, Schaar BT, Lowe CB, Wenger AM, and Bejerano G (2010). GREAT improves functional interpretation of cis-regulatory regions. Nat. Biotechnol. 28, 495&#x2013;501.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4840234</ArticleId><ArticleId IdType="pubmed">20436461</ArticleId></ArticleIdList></Reference><Reference><Citation>Heinz S, Benner C, Spann N, Bertolino E, Lin YC, Laslo P, Cheng JX, Murre C, Singh H, and Glass CK (2010). Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol. Cell 38, 576&#x2013;589.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2898526</ArticleId><ArticleId IdType="pubmed">20513432</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Z, Bailey A, Kuleshov MV, Clarke DJB, Evangelista JE, Jenkins SL, Lachmann A, Wojciechowicz ML, Kropiwnicki E, Jagodnik KM, et al. (2021). Gene Set Knowledge Discovery with Enrichr. Curr Protoc 1, e90.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8152575</ArticleId><ArticleId IdType="pubmed">33780170</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuleshov MV, Jones MR, Rouillard AD, Fernandez NF, Duan Q, Wang Z, Koplev S, Jenkins SL, Jagodnik KM, Lachmann A, et al. (2016). Enrichr: a comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Res. 44, W90&#x2013;W97.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4987924</ArticleId><ArticleId IdType="pubmed">27141961</ArticleId></ArticleIdList></Reference><Reference><Citation>Victor MB, Richner M, Hermanstyne TO, Ransdell JL, Sobieski C, Deng P-Y, Klyachko VA, Nerbonne JM, and Yoo AS (2014). Generation of human striatal neurons by microRNA-dependent direct conversion of fibroblasts. Neuron 84, 311&#x2013;323.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4223654</ArticleId><ArticleId IdType="pubmed">25374357</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Michael Cherry J, Davis AP, Dolinski K, Dwight SS, Eppig JT, et al. (2000). Gene Ontology: tool for the unification of biology. Nat. Genet. 25, 25&#x2013;29.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3037419</ArticleId><ArticleId IdType="pubmed">10802651</ArticleId></ArticleIdList></Reference><Reference><Citation>The Gene Ontology Consortium (2019). The Gene Ontology Resource: 20 years and still GOing strong. Nucleic Acids Res. 47, D330&#x2013;D338.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6323945</ArticleId><ArticleId IdType="pubmed">30395331</ArticleId></ArticleIdList></Reference><Reference><Citation>Finucane HK, Bulik-Sullivan B, Gusev A, Trynka G, Reshef Y, Loh P-R, Anttila V, Xu H, Zang C, Farh K, et al. (2015). Partitioning heritability by functional annotation using genome-wide association summary statistics. Nat. Genet. 47, 1228&#x2013;1235.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4626285</ArticleId><ArticleId IdType="pubmed">26414678</ArticleId></ArticleIdList></Reference><Reference><Citation>Bentham J., Morris DL., Graham DSC., Pinder CL., Tombleson P., Behrens TW., Mart&#xed;n J., Fairfax BP., Knight JC., Chen L., et al.. (2015). Genetic association analyses implicate aberrant regulation of innate and adaptive immunity genes in the pathogenesis of systemic lupus erythematosus. Nat. Genet. 47, 1457&#x2013;1464.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4668589</ArticleId><ArticleId IdType="pubmed">26502338</ArticleId></ArticleIdList></Reference><Reference><Citation>Jostins L, Ripke S, Weersma RK, Duerr RH, McGovern DP, Hui KY, Lee JC, Schumm LP, Sharma Y, Anderson CA, et al. (2012). Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 491, 119&#x2013;124.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3491803</ArticleId><ArticleId IdType="pubmed">23128233</ArticleId></ArticleIdList></Reference><Reference><Citation>Speliotes EK, Willer CJ, Berndt SI, Monda KL, Thorleifsson G, Jackson AU, Lango Allen H, Lindgren CM, Luan J &#x2018;an, M&#xe4;gi R., et al. (2010). Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat. Genet. 42, 937&#x2013;948.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3014648</ArticleId><ArticleId IdType="pubmed">20935630</ArticleId></ArticleIdList></Reference><Reference><Citation>Teslovich TM, Musunuru K, Smith AV, Edmondson AC, Stylianou IM, Koseki M, Pirruccello JP, Ripatti S, Chasman DI, Willer CJ, et al. (2010). Biological, clinical and population relevance of 95 loci for blood lipids. Nature 466, 707&#x2013;713.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3039276</ArticleId><ArticleId IdType="pubmed">20686565</ArticleId></ArticleIdList></Reference><Reference><Citation>Okada Y, Wu D, Trynka G, Raj T, Terao C, Ikari K, Kochi Y, Ohmura K, Suzuki A, Yoshida S, et al. (2014). Genetics of rheumatoid arthritis contributes to biology and drug discovery. Nature 506, 376&#x2013;381.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3944098</ArticleId><ArticleId IdType="pubmed">24390342</ArticleId></ArticleIdList></Reference><Reference><Citation>Okbay A, Baselmans BML, De Neve J-E, Turley P, Nivard MG, Fontana MA, Meddens SFW, Linn&#xe9;r RK, Rietveld CA, Derringer J, et al. (2016). Genetic variants associated with subjective well-being, depressive symptoms, and neuroticism identified through genome-wide analyses. Nat. Genet. 48, 624&#x2013;633.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4884152</ArticleId><ArticleId IdType="pubmed">27089181</ArticleId></ArticleIdList></Reference><Reference><Citation>Thorgeirsson TE, Gudbjartsson DF, Surakka I, Vink JM, Amin N, Geller F, Sulem P, Rafnar T, Esko T, Walter S, et al. (2010). Sequence variants at CHRNB3-CHRNA6 and CYP2A6 affect smoking behavior. Nat. Genet. 42, 448&#x2013;453.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3080600</ArticleId><ArticleId IdType="pubmed">20418888</ArticleId></ArticleIdList></Reference><Reference><Citation>Schizophrenia Working Group of the Psychiatric Genomics Consortium (2014). Biological insights from 108 schizophrenia-associated genetic loci. Nature 511, 421&#x2013;427.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4112379</ArticleId><ArticleId IdType="pubmed">25056061</ArticleId></ArticleIdList></Reference><Reference><Citation>International Multiple Sclerosis Genetics Consortium, Wellcome Trust Case Control Consortium 2, Sawcer S, Hellenthal G, Pirinen M, Spencer CCA, Patsopoulos NA, Moutsianas L, Dilthey A, Su Z, et al. (2011). Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature 476, 214&#x2013;219.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3182531</ArticleId><ArticleId IdType="pubmed">21833088</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris AP., Voight BF., Teslovich TM., Ferreira T., Segr&#xe8; AV., Steinthorsdottir V., Strawbridge RJ., Khan H., Grallert H., Mahajan A., et al.. (2012). Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nat. Genet. 44, 981&#x2013;990.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3442244</ArticleId><ArticleId IdType="pubmed">22885922</ArticleId></ArticleIdList></Reference><Reference><Citation>Park YP, and Kellis M (2021). CoCoA-diff: counterfactual inference for single-cell gene expression analysis. Genome Biol. 22, 228.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8369635</ArticleId><ArticleId IdType="pubmed">34404460</ArticleId></ArticleIdList></Reference><Reference><Citation>Barber RF, and Cand&#xe8;s EJ (2015). Controlling the false discovery rate via knockoffs. aos 43, 2055&#x2013;2085.</Citation></Reference><Reference><Citation>Wang Y, and Blei DM (2019). The Blessings of Multiple Causes. J. Am. Stat. Assoc. 114, 1574&#x2013;1596.</Citation></Reference><Reference><Citation>Zhu Z, Fan Y, Kong Y, Lv J, and Sun F (2021). DeepLINK: Deep learning inference using knockoffs with applications to genomics. Proc. Natl. Acad. Sci. U. S. A. 118. 10.1073/pnas.2104683118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2104683118</ArticleId><ArticleId IdType="pmc">PMC8433583</ArticleId><ArticleId IdType="pubmed">34480002</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang T, Li Y, and Motsinger-Reif AA (2021). Knockoff boosted tree for model-free variable selection. Bioinformatics 37, 976&#x2013;983.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8128453</ArticleId><ArticleId IdType="pubmed">32966559</ArticleId></ArticleIdList></Reference><Reference><Citation>Candes E, Fan Y, Janson L, and Lv J (2018). Panning for gold:&#x2019;model-X&#x2019;knockoffs for high dimensional controlled variable selection. Journal of the Royal.</Citation></Reference><Reference><Citation>Gusev A, Ko A, Shi H, Bhatia G, Chung W, Penninx BWJH, Jansen R, de Geus EJC, Boomsma DI, Wright FA, et al. (2016). Integrative approaches for large-scale transcriptome-wide association studies. Nat. Genet. 48, 245&#x2013;252.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4767558</ArticleId><ArticleId IdType="pubmed">26854917</ArticleId></ArticleIdList></Reference><Reference><Citation>Gamazon ER, Wheeler HE, Shah KP, Mozaffari SV, Aquino-Michaels K, Carroll RJ, Eyler AE, Denny JC, GTEx Consortium, Nicolae DL, et al. (2015). A gene-based association method for mapping traits using reference transcriptome data. Nat. Genet. 47, 1091&#x2013;1098.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4552594</ArticleId><ArticleId IdType="pubmed">26258848</ArticleId></ArticleIdList></Reference><Reference><Citation>Berisa T, and Pickrell JK (2016). Approximately independent linkage disequilibrium blocks in human populations. Bioinformatics 32, 283&#x2013;285.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4731402</ArticleId><ArticleId IdType="pubmed">26395773</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang G, Sarkar A, Carbonetto P, and Stephens M (2020). A simple new approach to variable selection in regression, with application to genetic fine-mapping. bioRxiv, 501114. 10.1101/501114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/501114</ArticleId><ArticleId IdType="pmc">PMC10201948</ArticleId><ArticleId IdType="pubmed">37220626</ArticleId></ArticleIdList></Reference><Reference><Citation>Park Y, Sarkar AK, He L, Davila-Velderrain J, De Jager PL, and Kellis M (2017). A Bayesian approach to mediation analysis predicts 206 causal target genes in Alzheimer&#x2019;s disease. bioRxiv, 219428. 10.1101/219428.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/219428</ArticleId></ArticleIdList></Reference><Reference><Citation>Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Amin N, Schwikowski B, and Ideker T (2003). Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 13, 2498&#x2013;2504.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC403769</ArticleId><ArticleId IdType="pubmed">14597658</ArticleId></ArticleIdList></Reference><Reference><Citation>Horlbeck MA, Gilbert LA, Villalta JE, Adamson B, Pak RA, Chen Y, Fields AP, Park CY, Corn JE, Kampmann M, et al. (2016). Compact and highly active next-generation libraries for CRISPR-mediated gene repression and activation. Elife 5. 10.7554/eLife.19760.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.19760</ArticleId><ArticleId IdType="pmc">PMC5094855</ArticleId><ArticleId IdType="pubmed">27661255</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu Z, Eils R, and Schlesner M (2016). Complex heatmaps reveal patterns and correlations in multidimensional genomic data. Bioinformatics 32, 2847&#x2013;2849.</Citation><ArticleIdList><ArticleId IdType="pubmed">27207943</ArticleId></ArticleIdList></Reference><Reference><Citation>G Z. (2022). Complex heatmap visualization. Imeta 1. 10.1002/imt2.43.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/imt2.43</ArticleId><ArticleId IdType="pmc">PMC10989952</ArticleId><ArticleId IdType="pubmed">38868715</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37774679</PMID><DateCompleted><Year>2023</Year><Month>10</Month><Day>24</Day></DateCompleted><DateRevised><Year>2023</Year><Month>12</Month><Day>07</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1097-4172</ISSN><JournalIssue CitedMedium="Internet"><Volume>186</Volume><Issue>20</Issue><PubDate><Year>2023</Year><Month>Sep</Month><Day>28</Day></PubDate></JournalIssue><Title>Cell</Title><ISOAbbreviation>Cell</ISOAbbreviation></Journal><ArticleTitle>Neuronal DNA double-strand breaks lead to genome structural variations and 3D genome disruption in neurodegeneration.</ArticleTitle><Pagination><StartPage>4404</StartPage><EndPage>4421.e20</EndPage><MedlinePgn>4404-4421.e20</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.cell.2023.08.038</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0092-8674(23)00972-8</ELocationID><Abstract><AbstractText>Persistent DNA double-strand breaks (DSBs) in neurons are an early pathological hallmark of neurodegenerative diseases including Alzheimer's disease (AD), with the potential to disrupt genome integrity. We used single-nucleus RNA-seq in human postmortem prefrontal cortex samples and found that excitatory neurons in AD were enriched for somatic mosaic gene fusions. Gene fusions were particularly enriched in excitatory neurons with DNA damage repair and senescence gene signatures. In addition, somatic genome structural variations and gene fusions were enriched in neurons burdened with DSBs in the CK-p25 mouse model of neurodegeneration. Neurons enriched for DSBs also had elevated levels of cohesin along with progressive multiscale disruption of the 3D genome organization aligned with transcriptional changes in synaptic, neuronal development, and histone genes. Overall, this study demonstrates the disruption of genome stability and the 3D genome organization by DSBs in neurons as pathological steps in the progression of neurodegenerative diseases.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 The Authors. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Dileep</LastName><ForeName>Vishnu</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Picower Institute for Learning and Memory, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge, MA 02139, USA. Electronic address: vdileep@mit.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boix</LastName><ForeName>Carles A</ForeName><Initials>CA</Initials><AffiliationInfo><Affiliation>Computer Science and Artificial Intelligence Laboratory, Massachusetts Institute of Technology, Cambridge, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mathys</LastName><ForeName>Hansruedi</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Picower Institute for Learning and Memory, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marco</LastName><ForeName>Asaf</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Picower Institute for Learning and Memory, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Welch</LastName><ForeName>Gwyneth M</ForeName><Initials>GM</Initials><AffiliationInfo><Affiliation>Picower Institute for Learning and Memory, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meharena</LastName><ForeName>Hiruy S</ForeName><Initials>HS</Initials><AffiliationInfo><Affiliation>Picower Institute for Learning and Memory, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Loon</LastName><ForeName>Anjanet</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Picower Institute for Learning and Memory, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jeloka</LastName><ForeName>Ritika</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Picower Institute for Learning and Memory, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peng</LastName><ForeName>Zhuyu</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Picower Institute for Learning and Memory, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bennett</LastName><ForeName>David A</ForeName><Initials>DA</Initials><AffiliationInfo><Affiliation>Rush Alzheimer's Disease Center, Chicago, IL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kellis</LastName><ForeName>Manolis</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Computer Science and Artificial Intelligence Laboratory, Massachusetts Institute of Technology, Cambridge, MA, USA. Electronic address: manoli@mit.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsai</LastName><ForeName>Li-Huei</ForeName><Initials>LH</Initials><AffiliationInfo><Affiliation>Picower Institute for Learning and Memory, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA. Electronic address: lhtsai@mit.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P30 AG072975</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG058002</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS051874</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 AG061356</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG017917</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 GM087237</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 NS110453</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R37 NS051874</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>RF1 AG054012</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 AG046152</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AG010161</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS102730</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K99 AG073466</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG015819</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cell</MedlineTA><NlmUniqueID>0413066</NlmUniqueID><ISSNLinking>0092-8674</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>9007-49-2</RegistryNumber><NameOfSubstance UI="D004247">DNA</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Cell. 2023 Sep 28;186(20):4257-4259. doi: 10.1016/j.cell.2023.09.001.</RefSource><PMID Version="1">37774675</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="N">Alzheimer Disease</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004247" MajorTopicYN="N">DNA</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053903" MajorTopicYN="Y">DNA Breaks, Double-Stranded</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004260" MajorTopicYN="N">DNA Repair</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="Y">Neurodegenerative Diseases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009474" MajorTopicYN="N">Neurons</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D059010" MajorTopicYN="N">Single-Cell Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017423" MajorTopicYN="N">Sequence Analysis, RNA</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D042822" MajorTopicYN="N">Genomic Instability</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">3D genome organization</Keyword><Keyword MajorTopicYN="N">Alzheimer&#x2019;s disease</Keyword><Keyword MajorTopicYN="N">DNA double-strand breaks</Keyword><Keyword MajorTopicYN="N">epigenome</Keyword><Keyword MajorTopicYN="N">genome rearrangements</Keyword><Keyword MajorTopicYN="N">genomic mosaicism</Keyword><Keyword MajorTopicYN="N">neurodegeneration</Keyword><Keyword MajorTopicYN="N">senescence</Keyword><Keyword MajorTopicYN="N">structural variations</Keyword><Keyword MajorTopicYN="N">transcriptome</Keyword></KeywordList><CoiStatement>Declaration of interests L.-H.T. is a member of the Scientific Advisory Board of Cognito Therapeutics, 4M Therapeutics, Cell Signaling Technology, and Souvien Therapeutics, which has no association to the work described in this manuscript.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>9</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>4</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>8</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>10</Month><Day>23</Day><Hour>1</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>9</Month><Day>30</Day><Hour>9</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>9</Month><Day>29</Day><Hour>18</Hour><Minute>16</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>12</Month><Day>5</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37774679</ArticleId><ArticleId IdType="mid">NIHMS1939522</ArticleId><ArticleId IdType="pmc">PMC10697236</ArticleId><ArticleId IdType="doi">10.1016/j.cell.2023.08.038</ArticleId><ArticleId IdType="pii">S0092-8674(23)00972-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lu T, Pan Y, Kao SY, Li C, Kohane I, Chan J, and Yankner BA (2004). Gene regulation and DNA damage in the ageing human brain. Nature 429, 883&#x2013;891. 10.1038/nature02661.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature02661</ArticleId><ArticleId IdType="pubmed">15190254</ArticleId></ArticleIdList></Reference><Reference><Citation>Madabhushi R, Pan L, and Tsai LH (2014). DNA damage and its links to neurodegeneration. Neuron 83, 266&#x2013;282. 10.1016/j.neuron.2014.06.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2014.06.034</ArticleId><ArticleId IdType="pmc">PMC5564444</ArticleId><ArticleId IdType="pubmed">25033177</ArticleId></ArticleIdList></Reference><Reference><Citation>Provasek VE, Mitra J, Malojirao VH, and Hegde ML (2022). DNA Double-Strand Breaks as Pathogenic Lesions in Neurological Disorders. Int. J. Mol. Sci. 23. 10.3390/ijms23094653.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23094653</ArticleId><ArticleId IdType="pmc">PMC9099445</ArticleId><ArticleId IdType="pubmed">35563044</ArticleId></ArticleIdList></Reference><Reference><Citation>Adamec E, Vonsattel JP, and Nixon RA (1999). DNA strand breaks in Alzheimer&#x2019;s disease. Brain Res. 849, 67&#x2013;77. 10.1016/S0006-8993(99)02004-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0006-8993(99)02004-1</ArticleId><ArticleId IdType="pubmed">10592288</ArticleId></ArticleIdList></Reference><Reference><Citation>Thadathil N, Delotterie DF, Xiao J, Hori R, McDonald MP, and Khan MM (2020). DNA Double-Strand Break Accumulation in Alzheimer&#x2019;s Disease: Evidence from Experimental Models and Postmortem Human Brains. Mol. Neurobiol, 1&#x2013;14. 10.1007/s12035-020-02109-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-020-02109-8</ArticleId><ArticleId IdType="pubmed">32895786</ArticleId></ArticleIdList></Reference><Reference><Citation>Shanbhag NM, Evans MD, Mao W, Nana AL, Seeley WW, Adame A, Rissman RA, Masliah E, and Mucke L (2019). Early neuronal accumulation of DNA double strand breaks in Alzheimer&#x2019;s disease. Acta Neuropathol. Commun. 7, 1&#x2013;18. 10.1186/s40478-019-0723-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-019-0723-5</ArticleId><ArticleId IdType="pmc">PMC6524256</ArticleId><ArticleId IdType="pubmed">31101070</ArticleId></ArticleIdList></Reference><Reference><Citation>Tse KH, Cheng A, Ma F, and Herrup K (2018). DNA damage-associated oligodendrocyte degeneration precedes amyloid pathology and contributes to Alzheimer&#x2019;s disease and dementia. Alzheimer&#x2019;s Dement. 14. 10.1016/j.jalz.2017.11.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2017.11.010</ArticleId><ArticleId IdType="pmc">PMC5938117</ArticleId><ArticleId IdType="pubmed">29328926</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu W, Hill SE, Nathan WJ, Paiano J, Callen E, Wang D, Shinoda K, van Wietmarschen N, Col&#xf3;n-Mercado JM, Zong D, et al. (2021). Neuronal enhancers are hotspots for DNA single-strand break repair. Nature 593, 440&#x2013;444. 10.1038/s41586-021-03468-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03468-5</ArticleId><ArticleId IdType="pmc">PMC9827709</ArticleId><ArticleId IdType="pubmed">33767446</ArticleId></ArticleIdList></Reference><Reference><Citation>Madabhushi R, Gao F, Pfenning AR, Pan L, Yamakawa S, Seo J, Rueda R, Phan TX, Yamakawa H, Pao P-C, et al. (2015). Activity-Induced DNA Breaks Govern the Expression of Neuronal Early-Response Genes. Cell 161, 1592&#x2013;1605. 10.1016/j.cell.2015.05.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2015.05.032</ArticleId><ArticleId IdType="pmc">PMC4886855</ArticleId><ArticleId IdType="pubmed">26052046</ArticleId></ArticleIdList></Reference><Reference><Citation>Reid DA, Reed PJ, Schlachetzki JCMM, Nitulescu II, Chou G, Tsui EC, Jones JR, Chandran S, Lu AT, McClain CA, et al. (2021). Incorporation of a nucleoside analog maps genome repair sites in postmitotic human neurons. Science (80-. ). 372, 91&#x2013;94. 10.1126/science.abb9032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abb9032</ArticleId><ArticleId IdType="pmc">PMC9179101</ArticleId><ArticleId IdType="pubmed">33795458</ArticleId></ArticleIdList></Reference><Reference><Citation>Suberbielle E, Sanchez PE, Kravitz AV, Wang X, Ho K, Eilertson K, Devidze N, Kreitzer AC, and Mucke L (2013). Physiologic brain activity causes DNA double-strand breaks in neurons, with exacerbation by amyloid-&#x3b2;. Nat. Neurosci. 16, 613&#x2013;621. 10.1038/nn.3356.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3356</ArticleId><ArticleId IdType="pmc">PMC3637871</ArticleId><ArticleId IdType="pubmed">23525040</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo JU, Ma DK, Mo H, Ball MP, Jang MH, Bonaguidi MA, Balazer JA, Eaves HL, Xie B, Ford E, et al. (2011). Neuronal activity modifies the DNA methylation landscape in the adult brain. Nat. Neurosci. 14, 1345&#x2013;1351. 10.1038/NN.2900.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/NN.2900</ArticleId><ArticleId IdType="pmc">PMC3183401</ArticleId><ArticleId IdType="pubmed">21874013</ArticleId></ArticleIdList></Reference><Reference><Citation>DeNizio JE, Dow BJ, Serrano JC, Ghanty U, Drohat AC, and Kohli RM (2021). TET-TDG active DNA demethylation at CpG and non-CpG sites. J. Mol. Biol. 433, 166877. 10.1016/J.JMB.2021.166877.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.JMB.2021.166877</ArticleId><ArticleId IdType="pmc">PMC8005466</ArticleId><ArticleId IdType="pubmed">33561435</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu H, Harrison FE, and Xia F (2018). Altered DNA repair; An early pathogenic pathway in Alzheimer&#x2019;s disease and obesity. Sci. Rep. 8, 5600. 10.1038/s41598-018-23644-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-23644-4</ArticleId><ArticleId IdType="pmc">PMC5884847</ArticleId><ArticleId IdType="pubmed">29618789</ArticleId></ArticleIdList></Reference><Reference><Citation>Suberbielle E, Djukic B, Evans M, Kim DH, Taneja P, Wang X, Finucane M, Knox J, Ho K, Devidze N, et al. (2015). DNA repair factor BRCA1 depletion occurs in Alzheimer brains and impairs cognitive function in mice. Nat. Commun. 6, 1&#x2013;14. 10.1038/ncomms9897.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms9897</ArticleId><ArticleId IdType="pmc">PMC4674776</ArticleId><ArticleId IdType="pubmed">26615780</ArticleId></ArticleIdList></Reference><Reference><Citation>Aguilera A, and Garc&#xed;a-Muse T (2013). Causes of genome instability. Annu. Rev. Genet. 10.1146/annurev-genet-111212-133232.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-genet-111212-133232</ArticleId><ArticleId IdType="pubmed">23909437</ArticleId></ArticleIdList></Reference><Reference><Citation>Iyama T, and Wilson DM (2013). DNA repair mechanisms in dividing and non-dividing cells. DNA Repair (Amst). 12, 620. 10.1016/J.DNAREP.2013.04.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.DNAREP.2013.04.015</ArticleId><ArticleId IdType="pmc">PMC3720834</ArticleId><ArticleId IdType="pubmed">23684800</ArticleId></ArticleIdList></Reference><Reference><Citation>Richardson C, and Jasin M (2000). Frequent chromosomal translocations induced by DNA double-strand breaks. Nature 405, 697&#x2013;700. 10.1038/35015097.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/35015097</ArticleId><ArticleId IdType="pubmed">10864328</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferguson DO, and Alt FW (2001). DNA double strand break repair and chromosomal translocation: Lessons from animal models. Oncogene 20, 5572&#x2013;5579. 10.1038/sj.onc.1204767.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.onc.1204767</ArticleId><ArticleId IdType="pubmed">11607810</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin C, Yang L, Tanasa B, Hutt K, Ju B. gun, Ohgi K, Zhang J, Rose DW, Fu XD, Glass CK, et al. (2009). Nuclear Receptor-Induced Chromosomal Proximity and DNA Breaks Underlie Specific Translocations in Cancer. Cell 139, 1069&#x2013;1083. 10.1016/j.cell.2009.11.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2009.11.030</ArticleId><ArticleId IdType="pmc">PMC2812435</ArticleId><ArticleId IdType="pubmed">19962179</ArticleId></ArticleIdList></Reference><Reference><Citation>Rabbitts TH (1994). Chromosomal translocations in human cancer. Nat. 1994 3726502 372, 143&#x2013;149. 10.1038/372143a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/372143a0</ArticleId><ArticleId IdType="pubmed">7969446</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Roberts ND, Wala JA, Shapira O, Schumacher SE, Kumar K, Khurana E, Waszak S, Korbel JO, Haber JE, et al. (2020). Patterns of somatic structural variation in human cancer genomes. Nature 578. 10.1038/s41586-019-1913-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-019-1913-9</ArticleId><ArticleId IdType="pmc">PMC7025897</ArticleId><ArticleId IdType="pubmed">32025012</ArticleId></ArticleIdList></Reference><Reference><Citation>Dixon JR, Xu J, Dileep V, Zhan Y, Song F, Le VT, Yard&#x131;mc&#x131; GG, Chakraborty A, Bann DV, Wang Y, et al. (2018). Integrative detection and analysis of structural variation in cancer genomes. Nat. Genet. 10.1038/s41588-018-0195-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-018-0195-8</ArticleId><ArticleId IdType="pmc">PMC6301019</ArticleId><ArticleId IdType="pubmed">30202056</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu J, Song F, Lyu H, Kobayashi M, Zhang B, Zhao Z, Hou Y, Wang X, Luan Y, Jia B, et al. (2022). Subtype-specific 3D genome alteration in acute myeloid leukaemia. Nature 611. 10.1038/s41586-022-05365-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-05365-x</ArticleId><ArticleId IdType="pmc">PMC10060167</ArticleId><ArticleId IdType="pubmed">36289338</ArticleId></ArticleIdList></Reference><Reference><Citation>Botten GA, Zhang Y, Dudnyk K, Kim YJ, Liu X, Sanders JT, Imanci A, Droin N, Cao H, Kaphle P, et al. (2023). Structural variation cooperates with permissive chromatin to control enhancer hijacking&#x2013;mediated oncogenic transcription. Blood. 10.1182/blood.2022017555.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.2022017555</ArticleId><ArticleId IdType="pmc">PMC10447518</ArticleId><ArticleId IdType="pubmed">36947815</ArticleId></ArticleIdList></Reference><Reference><Citation>Caldecott KW, Ward ME, and Nussenzweig A (2022). The threat of programmed DNA damage to neuronal genome integrity and plasticity. Nat. Genet. 2022 542 54, 115&#x2013;120. 10.1038/s41588-021-01001-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-021-01001-y</ArticleId><ArticleId IdType="pubmed">35145299</ArticleId></ArticleIdList></Reference><Reference><Citation>Schoenfelder S, and Fraser P (2019). Long-range enhancer&#x2013;promoter contacts in gene expression control. Nat. Rev. Genet. 10.1038/s41576-019-0128-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41576-019-0128-0</ArticleId><ArticleId IdType="pubmed">31086298</ArticleId></ArticleIdList></Reference><Reference><Citation>Canela A, Maman Y, Jung S, Wong N, Callen E, Day A, Kieffer-Kwon K-R, Pekowska A, Zhang H, Rao SSP, et al. (2017). Genome Organization Drives Chromosome Fragility. Cell 170, 507&#x2013;521.e18. 10.1016/j.cell.2017.06.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2017.06.034</ArticleId><ArticleId IdType="pmc">PMC6133249</ArticleId><ArticleId IdType="pubmed">28735753</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H, Emerson DJ, Gilgenast TG, Titus KR, Lan Y, Huang P, Zhang D, Wang H, Keller CA, Giardine B, et al. (2019). Chromatin structure dynamics during the mitosis-to-G1 phase transition. Nature. 10.1038/s41586-019-1778-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-019-1778-y</ArticleId><ArticleId IdType="pmc">PMC6895436</ArticleId><ArticleId IdType="pubmed">31776509</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, McCord RP, Ho YJ, Lajoie BR, Hildebrand DG, Simon AC, Becker MS, Alt FW, and Dekker J (2012). Spatial organization of the mouse genome and its role in recurrent chromosomal translocations. Cell 148, 908&#x2013;921. 10.1016/j.cell.2012.02.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2012.02.002</ArticleId><ArticleId IdType="pmc">PMC3320767</ArticleId><ArticleId IdType="pubmed">22341456</ArticleId></ArticleIdList></Reference><Reference><Citation>Ba Z, Lou J, Ye AY, Dai HQ, Dring EW, Lin SG, Jain S, Kyritsis N, Kieffer-Kwon KR, Casellas R, et al. (2020). CTCF orchestrates long-range cohesin-driven V(D)J recombinational scanning. Nature. 10.1038/s41586-020-2578-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2578-0</ArticleId><ArticleId IdType="pmc">PMC7554077</ArticleId><ArticleId IdType="pubmed">32717742</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnould C, Rocher V, Finoux AL, Clouaire T, Li K, Zhou F, Caron P, Mangeot PE, Ricci EP, Mourad R, et al. (2021). Loop extrusion as a mechanism for formation of DNA damage repair foci. Nature 590, 660&#x2013;665.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7116834</ArticleId><ArticleId IdType="pubmed">33597753</ArticleId></ArticleIdList></Reference><Reference><Citation>Gibcus JH, Samejima K, Goloborodko A, Samejima I, Naumova N, Nuebler J, Kanemaki MT, Xie L, Paulson JR, Earnshaw WC, et al. (2018). A pathway for mitotic chromosome formation. Science (80-. ). 359. 10.1126/science.aao6135.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aao6135</ArticleId><ArticleId IdType="pmc">PMC5924687</ArticleId><ArticleId IdType="pubmed">29348367</ArticleId></ArticleIdList></Reference><Reference><Citation>Dileep V, Ay F, Sima J, Vera DL, Noble WS, and Gilbert DM (2015). Topologically associating domains and their long-range contacts are established during early G1 coincident with the establishment of the replication-timing program. Genome Res. 10.1101/gr.183699.114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gr.183699.114</ArticleId><ArticleId IdType="pmc">PMC4509995</ArticleId><ArticleId IdType="pubmed">25995270</ArticleId></ArticleIdList></Reference><Reference><Citation>Sima J, Chakraborty A, Dileep V, Michalski M, Klein KN, Holcomb NP, Turner JL, Paulsen MT, Rivera-Mulia JC, Trevilla-Garcia C, et al. (2019). Identifying cis Elements for Spatiotemporal Control of Mammalian DNA Replication. Cell 176. 10.1016/j.cell.2018.11.036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2018.11.036</ArticleId><ArticleId IdType="pmc">PMC6546437</ArticleId><ArticleId IdType="pubmed">30595451</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamada T, Yang Y, Valnegri P, Juric I, Abnousi A, Markwalter KH, Guthrie AN, Godec A, Oldenborg A, Hu M, et al. (2019). Sensory experience remodels genome architecture in neural circuit to drive motor learning. Nature. 10.1038/s41586-019-1190-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-019-1190-7</ArticleId><ArticleId IdType="pmc">PMC6542709</ArticleId><ArticleId IdType="pubmed">31068695</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez-Albert J, Lipinski M, Lopez-Cascales MT, Rowley MJ, Martin-Gonzalez AM, del Blanco B, Corces VG, and Barco A (2019). Immediate and deferred epigenomic signatures of in vivo neuronal activation in mouse hippocampus. Nat. Neurosci. 10.1038/s41593-019-0476-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-019-0476-2</ArticleId><ArticleId IdType="pmc">PMC6875776</ArticleId><ArticleId IdType="pubmed">31501571</ArticleId></ArticleIdList></Reference><Reference><Citation>Beagan JA, Pastuzyn ED, Fernandez LR, Guo MH, Feng K, Titus KR, Chandrashekar H, Shepherd JD, and Phillips-Cremins JE (2020). Three-dimensional genome restructuring across timescales of activity-induced neuronal gene expression. Nat. Neurosci. 10.1038/s41593-020-0634-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-020-0634-6</ArticleId><ArticleId IdType="pmc">PMC7558717</ArticleId><ArticleId IdType="pubmed">32451484</ArticleId></ArticleIdList></Reference><Reference><Citation>Marco A, Meharena HS, Dileep V, Raju RM, Davila-Velderrain J, Zhang AL, Adaikkan C, Young JZ, Gao F, Kellis M, et al. (2020). Mapping the epigenomic and transcriptomic interplay during memory formation and recall in the hippocampal engram ensemble. Nat. Neurosci, 1&#x2013;12. 10.1038/s41593-020-00717-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-020-00717-0</ArticleId><ArticleId IdType="pmc">PMC7686266</ArticleId><ArticleId IdType="pubmed">33020654</ArticleId></ArticleIdList></Reference><Reference><Citation>Dileep V, and Tsai LH (2021). Three-dimensional chromatin organization in brain function and dysfunction. Curr. Opin. Neurobiol. 69, 214&#x2013;221. 10.1016/J.CONB.2021.04.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.CONB.2021.04.006</ArticleId><ArticleId IdType="pubmed">34111830</ArticleId></ArticleIdList></Reference><Reference><Citation>Marco A (2022). Activity-dependent remodeling of genome architecture in engram cells facilitates memory formation and recall. Neural Regen. Res. 17. 10.4103/1673-5374.324834.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/1673-5374.324834</ArticleId><ArticleId IdType="pmc">PMC8552845</ArticleId><ArticleId IdType="pubmed">34558515</ArticleId></ArticleIdList></Reference><Reference><Citation>Meharena HS, Marco A, Dileep V, Lockshin ER, Akatsu GY, Mullahoo J, Watson LA, Ko T, Guerin LN, Abdurrob F, et al. (2022). Down-syndrome-induced senescence disrupts the nuclear architecture of neural progenitors. Cell Stem Cell 29, 116&#x2013;130.e7. 10.1016/J.STEM.2021.12.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.STEM.2021.12.002</ArticleId><ArticleId IdType="pmc">PMC8805993</ArticleId><ArticleId IdType="pubmed">34995493</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun JH, Zhou L, Emerson DJ, Phyo SA, Titus KR, Gong W, Gilgenast TG, Beagan JA, Davidson BL, Tassone F, et al. (2018). Disease-Associated Short Tandem Repeats Colocalize with Chromatin Domain Boundaries. Cell. 10.1016/j.cell.2018.08.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2018.08.005</ArticleId><ArticleId IdType="pmc">PMC6175607</ArticleId><ArticleId IdType="pubmed">30173918</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewis PN, Lukiw WJ, De Boni U, and Crapper McLachlan DR (1981). Changes in Chromatin Structure Associated with Alzheimer&#x2019;s Disease. J. Neurochem. 10.1111/j.1471-4159.1981.tb04670.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.1981.tb04670.x</ArticleId><ArticleId IdType="pubmed">7299396</ArticleId></ArticleIdList></Reference><Reference><Citation>Bendl J, Hauberg ME, Girdhar K, Im E, Vicari JM, Rahman S, Fernando MB, Townsley KG, Dong P, Misir R, et al. (2022). The three-dimensional landscape of cortical chromatin accessibility in Alzheimer&#x2019;s disease. Nat. Neurosci. 25. 10.1038/s41593-022-01166-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-022-01166-7</ArticleId><ArticleId IdType="pmc">PMC9581463</ArticleId><ArticleId IdType="pubmed">36171428</ArticleId></ArticleIdList></Reference><Reference><Citation>Won H, De La Torre-Ubieta L, Stein JL, Parikshak NN, Huang J, Opland CK, Gandal MJ, Sutton GJ, Hormozdiari F, Lu D, et al. (2016). Chromosome conformation elucidates regulatory relationships in developing human brain. Nature. 10.1038/nature19847.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature19847</ArticleId><ArticleId IdType="pmc">PMC5358922</ArticleId><ArticleId IdType="pubmed">27760116</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajarajan P, Borrman T, Liao W, Schrode N, Flaherty E, Casi&#xf1;o C, Powell S, Yashaswini C, LaMarca EA, Kassim B, et al. (2018). Neuron-specific signatures in the chromosomal connectome associated with schizophrenia risk. Science (80-. ). 10.1126/science.aat4311.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aat4311</ArticleId><ArticleId IdType="pmc">PMC6408958</ArticleId><ArticleId IdType="pubmed">30545851</ArticleId></ArticleIdList></Reference><Reference><Citation>Nott A, Holtman IR, Coufal NG, Schlachetzki JCM, Yu M, Hu R, Han CZ, Pena M, Xiao J, Wu Y, et al. (2019). Brain cell type&#x2013;specific enhancer&#x2013;promoter interactome maps and disease-risk association. Science (80-. ). 366, 1134&#x2013;1139. 10.1126/science.aay0793.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aay0793</ArticleId><ArticleId IdType="pmc">PMC7028213</ArticleId><ArticleId IdType="pubmed">31727856</ArticleId></ArticleIdList></Reference><Reference><Citation>Kikuchi M, Hara N, Hasegawa M, Miyashita A, Kuwano R, Ikeuchi T, and Nakaya A (2019). Enhancer variants associated with Alzheimer&#x2019;s disease affect gene expression via chromatin looping. BMC Med. Genomics. 10.1186/s12920-019-0574-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12920-019-0574-8</ArticleId><ArticleId IdType="pmc">PMC6734281</ArticleId><ArticleId IdType="pubmed">31500627</ArticleId></ArticleIdList></Reference><Reference><Citation>Javierre BM, Sewitz S, Cairns J, Wingett SW, V&#xe1;rnai C, Thiecke MJ, Freire-Pritchett P, Spivakov M, Fraser P, Burren OS, et al. (2016). Lineage-Specific Genome Architecture Links Enhancers and Non-coding Disease Variants to Target Gene Promoters. Cell. 10.1016/j.cell.2016.09.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2016.09.037</ArticleId><ArticleId IdType="pmc">PMC5123897</ArticleId><ArticleId IdType="pubmed">27863249</ArticleId></ArticleIdList></Reference><Reference><Citation>Aymard F, and Legube G (2016). A TAD closer to ATM. Mol. Cell. Oncol. 3, e1134411. 10.1080/23723556.2015.1134411.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/23723556.2015.1134411</ArticleId><ArticleId IdType="pmc">PMC4909466</ArticleId><ArticleId IdType="pubmed">27314089</ArticleId></ArticleIdList></Reference><Reference><Citation>Aymard F, Aguirrebengoa M, Guillou E, Javierre BM, Bugler B, Arnould C, Rocher V, Iacovoni JS, Biernacka A, Skrzypczak M, et al. (2017). Genome-wide mapping of long-range contacts unveils clustering of DNA double-strand breaks at damaged active genes. Nat. Struct. Mol. Biol. 24, 353&#x2013;361. 10.1038/nsmb.3387.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nsmb.3387</ArticleId><ArticleId IdType="pmc">PMC5385132</ArticleId><ArticleId IdType="pubmed">28263325</ArticleId></ArticleIdList></Reference><Reference><Citation>Aten JA, Stap J, Krawczyk PM, Van Oven CH, Hoebe RA, Essers J, and Kanaar R (2004). Dynamics of DNA Double-Strand Breaks Revealed by Clustering of Damaged Chromosome Domains. Science (80-. ). 303, 92&#x2013;95. 10.1126/science.1088845.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1088845</ArticleId><ArticleId IdType="pubmed">14704429</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanders JT, Freeman TF, Xu Y, Golloshi R, Stallard MA, Hill AM, San Martin R, Balajee AS, and McCord RP (2020). Radiation-induced DNA damage and repair effects on 3D genome organization. Nat. Commun. 2020 111 11, 1&#x2013;14. 10.1038/s41467-020-20047-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-20047-w</ArticleId><ArticleId IdType="pmc">PMC7710719</ArticleId><ArticleId IdType="pubmed">33268790</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X, Luan Y, and Yue F (2022). EagleC: A deep-learning framework for detecting a full range of structural variations from bulk and single-cell contact maps. Sci. Adv. 8. 10.1126/sciadv.abn9215.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.abn9215</ArticleId><ArticleId IdType="pmc">PMC9200291</ArticleId><ArticleId IdType="pubmed">35704579</ArticleId></ArticleIdList></Reference><Reference><Citation>Chakraborty A, and Ay F (2018). Identification of copy number variations and translocations in cancer cells from Hi-C data. Bioinformatics 34. 10.1093/bioinformatics/btx664.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btx664</ArticleId><ArticleId IdType="pmc">PMC8210825</ArticleId><ArticleId IdType="pubmed">29048467</ArticleId></ArticleIdList></Reference><Reference><Citation>Picelli S, Faridani OR, Bj&#xf6;rklund &#xc5;K, Winberg G, Sagasser S, and Sandberg R (2014). Full-length RNA-seq from single cells using Smart-seq2. Nat. Protoc. 2013 91 9, 171&#x2013;181. 10.1038/nprot.2014.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nprot.2014.006</ArticleId><ArticleId IdType="pubmed">24385147</ArticleId></ArticleIdList></Reference><Reference><Citation>Haas BJ, Dobin A, Li B, Stransky N, Pochet N, and Regev A (2019). Accuracy assessment of fusion transcript detection via read-mapping and de novo fusion transcript assembly-based methods. Genome Biol. 20, 1&#x2013;16. 10.1186/S13059-019-1842-9/FIGURES/4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/S13059-019-1842-9/FIGURES/4</ArticleId><ArticleId IdType="pmc">PMC6802306</ArticleId><ArticleId IdType="pubmed">31639029</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathys H, Boix C, Peng Z, Victor MB, Leary N, Babu S, Abdelhady G, Jiang X, Ng AP, Ghafari K, et al. (2023). Single-cell atlas of the aged human brain reveals cellular and molecular correlates of high cognitive function, dementia, and resilience to Alzheimer&#x2019;s disease pathology. Cell 186.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10601493</ArticleId><ArticleId IdType="pubmed">37774677</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva E, and Ideker T (2019). Transcriptional responses to DNA damage. DNA Repair (Amst). 79. 10.1016/j.dnarep.2019.05.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dnarep.2019.05.002</ArticleId><ArticleId IdType="pmc">PMC6570417</ArticleId><ArticleId IdType="pubmed">31102970</ArticleId></ArticleIdList></Reference><Reference><Citation>Welch GM, Boix CA, Schmauch E, Davila-Velderrain J, Victor MB, Dileep V, Bozzelli PL, Su Q, Cheng JD, Lee A, et al. (2022). Neurons burdened by DNA double-strand breaks incite microglia activation through antiviral-like signaling in neurodegeneration. Sci. Adv. 8, eabo4662.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9519048</ArticleId><ArticleId IdType="pubmed">36170369</ArticleId></ArticleIdList></Reference><Reference><Citation>Cruz JC, Tseng HC, Goldman JA, Shih H, and Tsai LH (2003). Aberrant Cdk5 activation by p25 triggers pathological events leading to neurodegeneration and neurofibrillary tangles. Neuron 40, 471&#x2013;483. 10.1016/S0896-6273(03)00627-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0896-6273(03)00627-5</ArticleId><ArticleId IdType="pubmed">14642273</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim D, Frank CL, Dobbin MM, Tsunemoto RK, Tu W, Peng PL, Guan JS, Lee BH, Moy LY, Giusti P, et al. (2008). Deregulation of HDAC1 by p25/Cdk5 in Neurotoxicity. Neuron 60, 803&#x2013;817. 10.1016/j.neuron.2008.10.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2008.10.015</ArticleId><ArticleId IdType="pmc">PMC2912147</ArticleId><ArticleId IdType="pubmed">19081376</ArticleId></ArticleIdList></Reference><Reference><Citation>Cruz JC, Kim D, Moy LY, Dobbin MM, Sun X, Bronson RT, and Tsai LH (2006). p25/cyclin-dependent kinase 5 induces production and intraneuronal accumulation of amyloid beta in vivo. J. Neurosci. 26, 10536&#x2013;10541. 10.1523/JNEUROSCI.3133-06.2006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.3133-06.2006</ArticleId><ArticleId IdType="pmc">PMC6674706</ArticleId><ArticleId IdType="pubmed">17035538</ArticleId></ArticleIdList></Reference><Reference><Citation>Trapnell C, Cacchiarelli D, Grimsby J, Pokharel P, Li S, Morse M, Lennon NJ, Livak KJ, Mikkelsen TS, and Rinn JL (2014). The dynamics and regulators of cell fate decisions are revealed by pseudotemporal ordering of single cells. Nat. Biotechnol. 2014 324 32, 381&#x2013;386. 10.1038/nbt.2859.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt.2859</ArticleId><ArticleId IdType="pmc">PMC4122333</ArticleId><ArticleId IdType="pubmed">24658644</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramsden DA, and Nussenzweig A (2021). Mechanisms driving chromosomal translocations: lost in time and space. Oncogene 40, 4263&#x2013;4270. 10.1038/S41388-021-01856-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/S41388-021-01856-9</ArticleId><ArticleId IdType="pmc">PMC8238880</ArticleId><ArticleId IdType="pubmed">34103687</ArticleId></ArticleIdList></Reference><Reference><Citation>Roukos V, Voss TC, Schmidt CK, Lee S, Wangsa D, and Misteli T (2013). Spatial dynamics of chromosome translocations in living cells. 341, 660&#x2013;664.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6324928</ArticleId><ArticleId IdType="pubmed">23929981</ArticleId></ArticleIdList></Reference><Reference><Citation>Canela A, Maman Y, Huang S. yin N., Wutz G, Tang W, Zagnoli-Vieira G, Callen E, Wong N, Day A, Peters JM, et al. (2019). Topoisomerase II-Induced Chromosome Breakage and Translocation Is Determined by Chromosome Architecture and Transcriptional Activity. Mol. Cell 75, 252&#x2013;266.e8. 10.1016/J.MOLCEL.2019.04.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.MOLCEL.2019.04.030</ArticleId><ArticleId IdType="pmc">PMC8170508</ArticleId><ArticleId IdType="pubmed">31202577</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan WX, Mirzazadeh R, Garnerone S, Scott D, Schneider MW, Kallas T, Custodio J, Wernersson E, Li Y, Gao L, et al. (2017). BLISS is a versatile and quantitative method for genome-wide profiling of DNA double-strand breaks. Nat. Commun. 8. 10.1038/ncomms15058.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms15058</ArticleId><ArticleId IdType="pmc">PMC5437291</ArticleId><ArticleId IdType="pubmed">28497783</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu YY, Tanikawa C, Ueda K, and Matsuda K (2019). INKA2, a novel p53 target that interacts with the serine/threonine kinase PAK4. Int. J. Oncol. 54, 1907&#x2013;1920. 10.3892/IJO.2019.4786.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/IJO.2019.4786</ArticleId><ArticleId IdType="pmc">PMC6521941</ArticleId><ArticleId IdType="pubmed">31081062</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai CH, Barik P, Hsieh DJY, Day CH, Ho TJ, Chen RJ, Kuo WW, Padma VV, Shibu MA, and Huang CY (2020). Inhibition of cell death-inducing p53 target 1 through miR-210-3p overexpression attenuates reactive oxygen species and apoptosis in rat adipose-derived stem cells challenged with Angiotensin II. Biochem. Biophys. Res. Commun. 532, 347&#x2013;354. 10.1016/J.BBRC.2020.07.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.BBRC.2020.07.052</ArticleId><ArticleId IdType="pubmed">32888650</ArticleId></ArticleIdList></Reference><Reference><Citation>Mijit M, Caracciolo V, Melillo A, Amicarelli F, and Giordano A (2020). Role of p53 in the Regulation of Cellular Senescence. Biomolecules 10. 10.3390/BIOM10030420.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/BIOM10030420</ArticleId><ArticleId IdType="pmc">PMC7175209</ArticleId><ArticleId IdType="pubmed">32182711</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei PC, Chang AN, Kao J, Du Z, Meyers RM, Alt FW, and Schwer B (2016). Long Neural Genes Harbor Recurrent DNA Break Clusters in Neural Stem/Progenitor Cells. Cell 164, 644&#x2013;655. 10.1016/j.cell.2015.12.039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2015.12.039</ArticleId><ArticleId IdType="pmc">PMC4752721</ArticleId><ArticleId IdType="pubmed">26871630</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellenguez C, K&#xfc;&#xe7;&#xfc;kali F, Jansen IE, Kleineidam L, Moreno-Grau S, Amin N, Naj AC, Campos-Martin R, Grenier-Boley B, Andrade V, et al. (2022). New insights into the genetic etiology of Alzheimer&#x2019;s disease and related dementias. Nat. Genet. 2022 544 54, 412&#x2013;436. 10.1038/s41588-022-01024-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-022-01024-z</ArticleId><ArticleId IdType="pmc">PMC9005347</ArticleId><ArticleId IdType="pubmed">35379992</ArticleId></ArticleIdList></Reference><Reference><Citation>Sollis E, Mosaku A, Abid A, Buniello A, Cerezo M, Gil L, Groza T, G&#xfc;ne&#x15f; O, Hall P, Hayhurst J, et al. (2023). The NHGRI-EBI GWAS Catalog: knowledgebase and deposition resource. Nucleic Acids Res. 51. 10.1093/nar/gkac1010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkac1010</ArticleId><ArticleId IdType="pmc">PMC9825413</ArticleId><ArticleId IdType="pubmed">36350656</ArticleId></ArticleIdList></Reference><Reference><Citation>Phillips-Cremins JE, Sauria MEG, Sanyal A, Gerasimova TI, Lajoie BR, Bell JSK, Ong CT, Hookway TA, Guo C, Sun Y, et al. (2013). Architectural protein subclasses shape 3D organization of genomes during lineage commitment. Cell 153, 1281&#x2013;1295. 10.1016/j.cell.2013.04.053.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2013.04.053</ArticleId><ArticleId IdType="pmc">PMC3712340</ArticleId><ArticleId IdType="pubmed">23706625</ArticleId></ArticleIdList></Reference><Reference><Citation>Rao SSP, Huang SC, Glenn St Hilaire B, Engreitz JM, Perez EM, Kieffer-Kwon KR, Sanborn AL, Johnstone SE, Bascom GD, Bochkov ID, et al. (2017). Cohesin Loss Eliminates All Loop Domains. Cell. 10.1016/j.cell.2017.09.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2017.09.026</ArticleId><ArticleId IdType="pmc">PMC5846482</ArticleId><ArticleId IdType="pubmed">28985562</ArticleId></ArticleIdList></Reference><Reference><Citation>Caron P, Aymard F, Iacovoni JS, Briois S, Canitrot Y, Bugler B, Massip L, Losada A, and Legube G (2012). Cohesin Protects Genes against &#x3b3;H2AX Induced by DNA Double-Strand Breaks. PLOS Genet. 8, e1002460. 10.1371/JOURNAL.PGEN.1002460.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/JOURNAL.PGEN.1002460</ArticleId><ArticleId IdType="pmc">PMC3261922</ArticleId><ArticleId IdType="pubmed">22275873</ArticleId></ArticleIdList></Reference><Reference><Citation>Covo S, Westmoreland JW, Gordenin DA, and Resnick MA (2010). Cohesin Is limiting for the suppression of DNA damage-induced recombination between homologous chromosomes. PLoS Genet. 6, 1&#x2013;16. 10.1371/JOURNAL.PGEN.1001006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/JOURNAL.PGEN.1001006</ArticleId><ArticleId IdType="pmc">PMC2895640</ArticleId><ArticleId IdType="pubmed">20617204</ArticleId></ArticleIdList></Reference><Reference><Citation>Gelot C, Guirouilh-Barbat J, Le Guen T, Dardillac E, Chailleux C, Canitrot Y, and Lopez BS (2016). The Cohesin Complex Prevents the End Joining of Distant DNA Double-Strand Ends. Mol. Cell 61, 15&#x2013;26. 10.1016/J.MOLCEL.2015.11.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.MOLCEL.2015.11.002</ArticleId><ArticleId IdType="pubmed">26687679</ArticleId></ArticleIdList></Reference><Reference><Citation>Hansen AS, Cattoglio C, Darzacq X, and Tjian R (2018). Recent evidence that TADs and chromatin loops are dynamic structures. Nucleus 9, 20. 10.1080/19491034.2017.1389365.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/19491034.2017.1389365</ArticleId><ArticleId IdType="pmc">PMC5990973</ArticleId><ArticleId IdType="pubmed">29077530</ArticleId></ArticleIdList></Reference><Reference><Citation>Davidson IF, Bauer B, Goetz D, Tang W, Wutz G, and Peters JM (2019). DNA loop extrusion by human cohesin. Science (80-. ). 366, 1338&#x2013;1345. 10.1126/science.aaz3418.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaz3418</ArticleId><ArticleId IdType="pubmed">31753851</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim Y, Shi Z, Zhang H, Finkelstein IJ, and Yu H (2019). Human cohesin compacts DNA by loop extrusion. Science 366, 1345&#x2013;1349. 10.1126/SCIENCE.AAZ4475.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/SCIENCE.AAZ4475</ArticleId><ArticleId IdType="pmc">PMC7387118</ArticleId><ArticleId IdType="pubmed">31780627</ArticleId></ArticleIdList></Reference><Reference><Citation>Dixon JR, Selvaraj S, Yue F, Kim A, Li Y, Shen Y, Hu M, Liu JS, and Ren B (2012). Topological Domains in Mammalian Genomes Identified by Analysis of Chromatin Interactions. Nature 485, 376. 10.1038/NATURE11082.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/NATURE11082</ArticleId><ArticleId IdType="pmc">PMC3356448</ArticleId><ArticleId IdType="pubmed">22495300</ArticleId></ArticleIdList></Reference><Reference><Citation>Nora EP, Lajoie BR, Schulz EG, Giorgetti L, Okamoto I, Servant N, Piolot T, Van Berkum NL, Meisig J, Sedat J, et al. (2012). Spatial partitioning of the regulatory landscape of the X-inactivation centre. Nat. 2012 4857398 485, 381&#x2013;385. 10.1038/nature11049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature11049</ArticleId><ArticleId IdType="pmc">PMC3555144</ArticleId><ArticleId IdType="pubmed">22495304</ArticleId></ArticleIdList></Reference><Reference><Citation>Nora EP, Goloborodko A, Valton AL, Gibcus JH, Uebersohn A, Abdennur N, Dekker J, Mirny LA, and Bruneau BG (2017). Targeted Degradation of CTCF Decouples Local Insulation of Chromosome Domains from Genomic Compartmentalization. Cell. 10.1016/j.cell.2017.05.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2017.05.004</ArticleId><ArticleId IdType="pmc">PMC5538188</ArticleId><ArticleId IdType="pubmed">28525758</ArticleId></ArticleIdList></Reference><Reference><Citation>Solovei I, Wang AS, Thanisch K, Schmidt CS, Krebs S, Zwerger M, Cohen TV, Devys D, Foisner R, Peichl L, et al. (2013). LBR and lamin A/C sequentially tether peripheral heterochromatin and inversely regulate differentiation. Cell 152, 584&#x2013;598. 10.1016/j.cell.2013.01.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2013.01.009</ArticleId><ArticleId IdType="pubmed">23374351</ArticleId></ArticleIdList></Reference><Reference><Citation>Etourneaud L, Moussa A, Rass E, Genet D, Willaume S, Chabance-Okumura C, Wanschoor P, Picotto J, Th&#xe9;z&#xe9; B, D&#xe9;pagne J, et al. (2021). Lamin B1 sequesters 53BP1 to control its recruitment to DNA damage. Sci. Adv. 7, 3799&#x2013;3826. 10.1126/SCIADV.ABB3799.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/SCIADV.ABB3799</ArticleId><ArticleId IdType="pmc">PMC8397269</ArticleId><ArticleId IdType="pubmed">34452908</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong X, James BT, Boix CA, Park Y, Galani K, Victor MB, Sun N, Hou L, Dileep V, Ho L-L, et al. (2023). Single-cell epigenomic dissection of Alzheimer&#x2019;s disease pinpoints causal variants and reveals epigenome erosion. Cell 186.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10782612</ArticleId><ArticleId IdType="pubmed">37774680</ArticleId></ArticleIdList></Reference><Reference><Citation>Rao SSP, Huntley MH, Durand NC, Stamenova EK, Bochkov ID, Robinson JT, Sanborn AL, Machol I, Omer AD, Lander ES, et al. (2014). A 3D map of the human genome at kilobase resolution reveals principles of chromatin looping. Cell. 10.1016/j.cell.2014.11.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2014.11.021</ArticleId><ArticleId IdType="pmc">PMC5635824</ArticleId><ArticleId IdType="pubmed">25497547</ArticleId></ArticleIdList></Reference><Reference><Citation>Lieberman-Aiden E, Van Berkum NL, Williams L, Imakaev M, Ragoczy T, Telling A, Amit I, Lajoie BR, Sabo PJ, Dorschner MO, et al. (2009). Comprehensive mapping of long range interactions reveals folding principles of the human genome. Science 326, 289. 10.1126/SCIENCE.1181369.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/SCIENCE.1181369</ArticleId><ArticleId IdType="pmc">PMC2858594</ArticleId><ArticleId IdType="pubmed">19815776</ArticleId></ArticleIdList></Reference><Reference><Citation>van Steensel B, and Belmont AS (2017). Lamina-Associated Domains: Links with Chromosome Architecture, Heterochromatin, and Gene Repression (NIH Public Access) 10.1016/j.cell.2017.04.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2017.04.022</ArticleId><ArticleId IdType="pmc">PMC5532494</ArticleId><ArticleId IdType="pubmed">28525751</ArticleId></ArticleIdList></Reference><Reference><Citation>Heinz S, Benner C, Spann N, Bertolino E, Lin YC, Laslo P, Cheng JX, Murre C, Singh H, and Glass CK (2010). Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol. Cell 38, 576. 10.1016/J.MOLCEL.2010.05.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.MOLCEL.2010.05.004</ArticleId><ArticleId IdType="pmc">PMC2898526</ArticleId><ArticleId IdType="pubmed">20513432</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshiyama Y, Higuchi M, Zhang B, Huang SM, Iwata N, Saido TCC, Maeda J, Suhara T, Trojanowski JQ, and Lee VMY (2007). Synapse Loss and Microglial Activation Precede Tangles in a P301S Tauopathy Mouse Model. Neuron 53. 10.1016/j.neuron.2007.01.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2007.01.010</ArticleId><ArticleId IdType="pubmed">17270732</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobbin MM, Madabhushi R, Pan L, Chen Y, Kim D, Gao J, Ahanonu B, Pao PC, Qiu Y, Zhao Y, et al. (2013). SIRT1 collaborates with ATM and HDAC1 to maintain genomic stability in neurons. 16, 1008&#x2013;1015.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4758134</ArticleId><ArticleId IdType="pubmed">23852118</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonev B, Mendelson Cohen N, Szabo Q, Fritsch L, Papadopoulos GL, Lubling Y, Xu X, Lv X, Hugnot J-PP, Tanay A, et al. (2017). Multiscale 3D Genome Rewiring during Mouse Neural Development. Cell 171, 557&#x2013;572.e24. 10.1016/j.cell.2017.09.043.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2017.09.043</ArticleId><ArticleId IdType="pmc">PMC5651218</ArticleId><ArticleId IdType="pubmed">29053968</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu B, Won H, Mah W, Park RB, Kassim B, Spiess K, Kozlenkov A, Crowley CA, Pochareddy S, Ashley-Koch AE, et al. (2021). Neuronal and glial 3D chromatin architecture informs the cellular etiology of brain disorders. Nat. Commun. 2021 121 12, 1&#x2013;13. 10.1038/s41467-021-24243-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-24243-0</ArticleId><ArticleId IdType="pmc">PMC8233376</ArticleId><ArticleId IdType="pubmed">34172755</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim JH, Rege M, Valeri J, Dunagin MC, Metzger A, Titus KR, Gilgenast TG, Gong W, Beagan JA, Raj A, et al. (2019). LADL: light-activated dynamic looping for endogenous gene expression control. Nat. Methods. 10.1038/s41592-019-0436-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41592-019-0436-5</ArticleId><ArticleId IdType="pmc">PMC6599567</ArticleId><ArticleId IdType="pubmed">31235883</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghavi-Helm Y, Klein FA, Pakozdi T, Ciglar L, Noordermeer D, Huber W, and Furlong EEM (2014). Enhancer loops appear stable during development and are associated with paused polymerase. Nat. 2014 5127512 512, 96&#x2013;100. 10.1038/nature13417.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature13417</ArticleId><ArticleId IdType="pubmed">25043061</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalocsay M, Hiller NJ, and Jentsch S (2009). Chromosome-wide Rad51 Spreading and SUMO-H2A.Z-Dependent Chromosome Fixation in Response to a Persistent DNA Double-Strand Break. Mol. Cell 33, 335&#x2013;343. 10.1016/J.MOLCEL.2009.01.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.MOLCEL.2009.01.016</ArticleId><ArticleId IdType="pubmed">19217407</ArticleId></ArticleIdList></Reference><Reference><Citation>Stefanelli G, Azam AB, Walters BJ, Brimble MA, Gettens CP, Bouchard-Cannon P, Cheng HYM, Davidoff AM, Narkaj K, Day JJ, et al. (2018). Learning and Age-Related Changes in Genome-wide H2A.Z Binding in the Mouse Hippocampus. Cell Rep. 22, 1124&#x2013;1131. 10.1016/J.CELREP.2018.01.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.CELREP.2018.01.020</ArticleId><ArticleId IdType="pmc">PMC5820781</ArticleId><ArticleId IdType="pubmed">29386101</ArticleId></ArticleIdList></Reference><Reference><Citation>Zovkic IB, Paulukaitis BS, Day JJ, Etikala DM, and Sweatt JD (2014). Histone H2A.Z subunit exchange controls consolidation of recent and remote memory. Nat. 2014 5157528 515, 582&#x2013;586. 10.1038/nature13707.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature13707</ArticleId><ArticleId IdType="pmc">PMC4768489</ArticleId><ArticleId IdType="pubmed">25219850</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang ZF, Krasikov T, Frey MR, Wang J, Matera AG, and Marzluff WF (1996). Characterization of the mouse histone gene cluster on chromosome 13: 45 histone genes in three patches spread over 1Mb. Genome Res. 6, 688&#x2013;701. 10.1101/GR.6.8.688.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/GR.6.8.688</ArticleId><ArticleId IdType="pubmed">8858344</ArticleId></ArticleIdList></Reference><Reference><Citation>Mckinnon PJ (2013). Maintaining Genome Stability in the Nervous System. Nat. Neurosci. 16, 1523. 10.1038/NN.3537.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/NN.3537</ArticleId><ArticleId IdType="pmc">PMC4112580</ArticleId><ArticleId IdType="pubmed">24165679</ArticleId></ArticleIdList></Reference><Reference><Citation>Pollina EA, Gilliam DT, Landau AT, Lin C, Pajarillo N, Davis CP, Harmin DA, Yap EL, Vogel IR, Griffith EC, et al. (2023). A NPAS4&#x2013;NuA4 complex couples synaptic activity to DNA repair. Nature 614. 10.1038/s41586-023-05711-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-023-05711-7</ArticleId><ArticleId IdType="pmc">PMC9946837</ArticleId><ArticleId IdType="pubmed">36792830</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu Q, Niu Y, Gundry M, and Zong C (2021). Single-cell damagenome profiling unveils vulnerable genes and functional pathways in human genome toward DNA damage. Sci. Adv. 7. 10.1126/sciadv.abf3329.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.abf3329</ArticleId><ArticleId IdType="pmc">PMC11060043</ArticleId><ArticleId IdType="pubmed">34215579</ArticleId></ArticleIdList></Reference><Reference><Citation>Chow HM, and Herrup K (2015). Genomic integrity and the ageing brain. Nat. Rev. Neurosci. 10.1038/nrn4020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn4020</ArticleId><ArticleId IdType="pubmed">26462757</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao Y, Sun Y, Frank KM, Dikkes P, Fujiwara Y, Seidl KJ, Sekiguchi JAM, Rathbun GA, Swat W, Wang J, et al. (1998). A critical role for DNA end-joining proteins in both lymphogenesis and neurogenesis. Cell 95, 891&#x2013;902. 10.1016/S0092-8674(00)81714-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0092-8674(00)81714-6</ArticleId><ArticleId IdType="pubmed">9875844</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimizu I, Yoshida Y, Suda M, and Minamino T (2014). DNA damage response and metabolic disease. Cell Metab. 20. 10.1016/j.cmet.2014.10.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2014.10.008</ArticleId><ArticleId IdType="pubmed">25456739</ArticleId></ArticleIdList></Reference><Reference><Citation>Schumacher B, Pothof J, Vijg J, and Hoeijmakers JHJ (2021). The central role of DNA damage in the ageing process. Nature 592. 10.1038/s41586-021-03307-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03307-7</ArticleId><ArticleId IdType="pmc">PMC9844150</ArticleId><ArticleId IdType="pubmed">33911272</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee JM, Wheeler VC, Chao MJ, Vonsattel JPG, Pinto RM, Lucente D, Abu-Elneel K, Ramos EM, Mysore JS, Gillis T, et al. (2015). Identification of Genetic Factors that Modify Clinical Onset of Huntington&#x2019;s Disease. Cell 162. 10.1016/j.cell.2015.07.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2015.07.003</ArticleId><ArticleId IdType="pmc">PMC4524551</ArticleId><ArticleId IdType="pubmed">26232222</ArticleId></ArticleIdList></Reference><Reference><Citation>Edwards PAW (2010). Fusion genes and chromosome translocations in the common epithelial cancers. J. Pathol. 220, 244&#x2013;254. 10.1002/PATH.2632.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/PATH.2632</ArticleId><ArticleId IdType="pubmed">19921709</ArticleId></ArticleIdList></Reference><Reference><Citation>Uhrig S, Ellermann J, Walther T, Burkhardt P, Fr&#xc3;&#xb6;hlich M, Hutter B, Toprak UH, Neumann O, Stenzinger A, Scholl C, et al. (2021). Accurate and efficient detection of gene fusions from RNA sequencing data. Genome Res. 31. 10.1101/GR.257246.119.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/GR.257246.119</ArticleId><ArticleId IdType="pmc">PMC7919457</ArticleId><ArticleId IdType="pubmed">33441414</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, Batut P, Chaisson M, and Gingeras TR (2013). STAR: Ultrafast universal RNA-seq aligner. Bioinformatics 29. 10.1093/bioinformatics/bts635.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/bts635</ArticleId><ArticleId IdType="pmc">PMC3530905</ArticleId><ArticleId IdType="pubmed">23104886</ArticleId></ArticleIdList></Reference><Reference><Citation>Davidson NM, Majewski IJ, and Oshlack A (2015). JAFFA: High sensitivity transcriptome-focused fusion gene detection. Genome Med. 7. 10.1186/s13073-015-0167-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13073-015-0167-x</ArticleId><ArticleId IdType="pmc">PMC4445815</ArticleId><ArticleId IdType="pubmed">26019724</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin Z, Huang W, Shen N, Li J, Wang X, Dong J, Park PJ, and Xi R (2022). Single-cell gene fusion detection by scFusion. Nat. Commun. 13. 10.1038/s41467-022-28661-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-28661-6</ArticleId><ArticleId IdType="pmc">PMC8885711</ArticleId><ArticleId IdType="pubmed">35228538</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao T, Soldatov R, Sarkar H, Kurkiewicz A, Biederstedt E, Loh PR, and Kharchenko PV (2023). Haplotype-aware analysis of somatic copy number variations from single -cell transcriptomes. Nat. Biotechnol. 41. 10.1038/s41587-022-01468-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41587-022-01468-y</ArticleId><ArticleId IdType="pmc">PMC10289836</ArticleId><ArticleId IdType="pubmed">36163550</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan J, Lee HO, Lee S, Ryu DE, Lee S, Xue C, Kim SJ, Kim K, Barkas N, Park PJ, et al. (2018). Linking transcriptional and genetic tumor heterogeneity through allele analysis of single-cell RNA-seq data. Genome Res. 28. 10.1101/gr.228080.117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gr.228080.117</ArticleId><ArticleId IdType="pmc">PMC6071640</ArticleId><ArticleId IdType="pubmed">29898899</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel AP, Tirosh I, Trombetta JJ, Shalek AK, Gillespie SM, Wakimoto H, Cahill DP, Nahed BV, Curry WT, Martuza RL, et al. (2014). Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma. Science (80-. ). 344. 10.1126/science.1254257.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1254257</ArticleId><ArticleId IdType="pmc">PMC4123637</ArticleId><ArticleId IdType="pubmed">24925914</ArticleId></ArticleIdList></Reference><Reference><Citation>Pascarella G, Hon CC, Hashimoto K, Busch A, Luginb&#xfc;hl J, Parr C, Hin Yip W, Abe K, Kratz A, Bonetti A, et al. (2022). Recombination of repeat elements generates somatic complexity in human genomes. Cell 185, 3025&#x2013;3040.e6. 10.1016/J.CELL.2022.06.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.CELL.2022.06.032</ArticleId><ArticleId IdType="pubmed">35882231</ArticleId></ArticleIdList></Reference><Reference><Citation>Jurk D, Wang C, Miwa S, Maddick M, Korolchuk V, Tsolou A, Gonos ES, Thrasivoulou C, Jill Saffrey M, Cameron K, et al. (2012). Postmitotic neurons develop a p21-dependent senescence-like phenotype driven by a DNA damage response. Aging Cell 11, 996. 10.1111/J.1474-9726.2012.00870.X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/J.1474-9726.2012.00870.X</ArticleId><ArticleId IdType="pmc">PMC3533793</ArticleId><ArticleId IdType="pubmed">22882466</ArticleId></ArticleIdList></Reference><Reference><Citation>Saez-Atienzar S, and Masliah E (2020). Cellular senescence and Alzheimer disease: the egg and the chicken scenario. Nat. Rev. Neurosci. 2020 218 21, 433&#x2013;444. 10.1038/s41583-020-0325-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41583-020-0325-z</ArticleId><ArticleId IdType="pubmed">32601397</ArticleId></ArticleIdList></Reference><Reference><Citation>Welch G, and Tsai L (2022). Mechanisms of DNA damage-mediated neurotoxicity in neurodegenerative disease. EMBO Rep. 23. 10.15252/EMBR.202154217.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/EMBR.202154217</ArticleId><ArticleId IdType="pmc">PMC9171412</ArticleId><ArticleId IdType="pubmed">35499251</ArticleId></ArticleIdList></Reference><Reference><Citation>Lodato MA, Rodin RE, Bohrson CL, Coulter ME, Barton AR, Kwon M, Sherman MA, Vitzthum CM, Luquette LJ, Yandava CN, et al. (2018). Aging and neurodegeneration are associated with increased mutations in single human neurons. Science (80-. ). 359, 555&#x2013;559. 10.1126/science.aao4426.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aao4426</ArticleId><ArticleId IdType="pmc">PMC5831169</ArticleId><ArticleId IdType="pubmed">29217584</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller MB, Yue Huang A, Kim J, Zhou Z, Kirkham SL, Maury EA, Ziegenfuss JS, Reed HC, Neil JE, Rento L, et al. (2022). Somatic genomic changes in single Alzheimer&#x2019;s disease neurons. | Nat. | 604. 10.1038/s41586-022-04640-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04640-1</ArticleId><ArticleId IdType="pmc">PMC9357465</ArticleId><ArticleId IdType="pubmed">35444284</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee MH, Siddoway B, Kaeser GE, Segota I, Rivera R, Romanow WJ, Liu CS, Park C, Kennedy G, Long T, et al. (2018). Somatic APP gene recombination in Alzheimer&#x2019;s disease and normal neurons. Nature. 10.1038/s41586-018-0718-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-018-0718-6</ArticleId><ArticleId IdType="pmc">PMC6391999</ArticleId><ArticleId IdType="pubmed">30464338</ArticleId></ArticleIdList></Reference><Reference><Citation>Kousi M, Boix C, Park YP, Mathys H, Sledzieski S, Peng Z, Bennett DA, Tsai L-H, and Kellis M (2022). Single-cell mosaicism analysis reveals cell-type-specific somatic mutational burden in Alzheimer&#x2019;s Dementia. bioRxiv, 2022.04.21.489103. 10.1101/2022.04.21.489103.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.04.21.489103</ArticleId></ArticleIdList></Reference><Reference><Citation>McConnell MJ, Moran JV, Abyzov A, Akbarian S, Bae T, Cortes-Ciriano I, Erwin JA, Fasching L, Flasch DA, Freed D, et al. (2017). Intersection of diverse neuronal genomes and neuropsychiatric disease: The Brain Somatic Mosaicism Network. Science (80-. ). 356. 10.1126/science.aal1641.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aal1641</ArticleId><ArticleId IdType="pmc">PMC5558435</ArticleId><ArticleId IdType="pubmed">28450582</ArticleId></ArticleIdList></Reference><Reference><Citation>Bedrosian TA, Quayle C, Novaresi N, and Gage FH (2018). Early life experience drives structural variation of neural genomes in mice. Science (80-. ). 10.1126/science.aah3378.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aah3378</ArticleId><ArticleId IdType="pubmed">29567711</ArticleId></ArticleIdList></Reference><Reference><Citation>De Cecco M, Ito T, Petrashen AP, Elias AE, Skvir NJ, Criscione SW, Caligiana A, Brocculi G, Adney EM, Boeke JD, et al. (2019). LINE-1 derepression in senescent cells triggers interferon and inflammaging. Nature 566, 73. 10.1038/S41586-018-0784-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/S41586-018-0784-9</ArticleId><ArticleId IdType="pmc">PMC6519963</ArticleId><ArticleId IdType="pubmed">30728521</ArticleId></ArticleIdList></Reference><Reference><Citation>Valle F. Della, Reddy P, Yamamoto M, Liu P, Saera-Vila A, Bensaddek D, Zhang H, Martinez JP, Abassi L, Celii M, et al. (2022). LINE-1 RNA causes heterochromatin erosion and is a target for amelioration of senescent phenotypes in progeroid syndromes. Sci. Transl. Med. 14. 10.1126/scitranslmed.abl6057.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.abl6057</ArticleId><ArticleId IdType="pubmed">35947677</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang JH, Hayano M, Griffin PT, Amorim JA, Bonkowski MS, Apostolides JK, Salfati EL, Blanchette M, Munding EM, Bhakta M, et al. (2023). Loss of epigenetic information as a cause of mammalian aging. Cell 186. 10.1016/j.cell.2022.12.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.12.027</ArticleId><ArticleId IdType="pmc">PMC10166133</ArticleId><ArticleId IdType="pubmed">36638792</ArticleId></ArticleIdList></Reference><Reference><Citation>Frost B, Bardai FH, and Feany MB (2016). Lamin Dysfunction Mediates Neurodegeneration in Tauopathies. Curr. Biol. 10.1016/j.cub.2015.11.039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cub.2015.11.039</ArticleId><ArticleId IdType="pmc">PMC4713335</ArticleId><ArticleId IdType="pubmed">26725200</ArticleId></ArticleIdList></Reference><Reference><Citation>Matias I, Diniz LP, Damico IV, Araujo APB, Neves L. da S., Vargas G, Leite REP, Suemoto CK, Nitrini R, Jacob-Filho W, et al. (2022). Loss of lamin-B1 and defective nuclear morphology are hallmarks of astrocyte senescence in vitro and in the aging human hippocampus. Aging Cell 21. 10.1111/ACEL.13521.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ACEL.13521</ArticleId><ArticleId IdType="pmc">PMC8761005</ArticleId><ArticleId IdType="pubmed">34894056</ArticleId></ArticleIdList></Reference><Reference><Citation>Falk M, Feodorova Y, Naumova N, Imakaev M, Lajoie BR, Leonhardt H, Joffe B, Dekker J, Fudenberg G, Solovei I, et al. (2019). Heterochromatin drives compartmentalization of inverted and conventional nuclei. Nature 570, 395&#x2013;399. 10.1038/s41586-019-1275-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-019-1275-3</ArticleId><ArticleId IdType="pmc">PMC7206897</ArticleId><ArticleId IdType="pubmed">31168090</ArticleId></ArticleIdList></Reference><Reference><Citation>Isermann A, Mann C, and R&#xfc;be CE (2020). Histone Variant H2A.J Marks Persistent DNA Damage and Triggers the Secretory Phenotype in Radiation-Induced Senescence. Int. J. Mol. Sci. 21, 1&#x2013;20. 10.3390/IJMS21239130.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/IJMS21239130</ArticleId><ArticleId IdType="pmc">PMC7729917</ArticleId><ArticleId IdType="pubmed">33266246</ArticleId></ArticleIdList></Reference><Reference><Citation>Contrepois K, Coudereau C, Benayoun BA, Schuler N, Roux PF, Bischof O, Courbeyrette R, Carvalho C, Thuret JY, Ma Z, et al. (2017). Histone variant H2A.J accumulates in senescent cells and promotes inflammatory gene expression. Nat. Commun. 2017 81 8, 1&#x2013;18. 10.1038/ncomms14995.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms14995</ArticleId><ArticleId IdType="pmc">PMC5436145</ArticleId><ArticleId IdType="pubmed">28489069</ArticleId></ArticleIdList></Reference><Reference><Citation>R&#xfc;be CE, B&#xe4;umert C, Schuler N, Isermann A, Schmal Z, Glanemann M, Mann C, and Scherthan H (2021). Human skin aging is associated with increased expression of the histone variant H2A.J in the epidermis. npj Aging Mech. Dis. 2021 71 7, 1&#x2013;11. 10.1038/s41514-021-00060-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41514-021-00060-z</ArticleId><ArticleId IdType="pmc">PMC8016850</ArticleId><ArticleId IdType="pubmed">33795696</ArticleId></ArticleIdList></Reference><Reference><Citation>Funk OH, Qalieh Y, Doyle DZ, Lam MM, and Kwan KY (2022). Postmitotic accumulation of histone variant H3.3 in new cortical neurons establishes neuronal chromatin, transcriptome, and identity. Proc. Natl. Acad. Sci. U. S. A. 119. 10.1073/pnas.2116956119.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2116956119</ArticleId><ArticleId IdType="pmc">PMC9371731</ArticleId><ArticleId IdType="pubmed">35930666</ArticleId></ArticleIdList></Reference><Reference><Citation>Chandra T, Ewels PA, Schoenfelder S, Furlan-Magaril M, Wingett SW, Kirschner K, Thuret JY, Andrews S, Fraser P, and Reik W (2015). Global reorganization of the nuclear landscape in senescent cells. Cell Rep. 10, 471&#x2013;483. 10.1016/J.CELREP.2014.12.055.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.CELREP.2014.12.055</ArticleId><ArticleId IdType="pmc">PMC4542308</ArticleId><ArticleId IdType="pubmed">25640177</ArticleId></ArticleIdList></Reference><Reference><Citation>Criscione SW, Cecco M. De, Siranosian B, Zhang Y, Kreiling JA, Sedivy JM, and Neretti N (2016). Reorganization of chromosome architecture in replicative cellular senescence. Sci. Adv. 2. 10.1126/SCIADV.1500882.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/SCIADV.1500882</ArticleId><ArticleId IdType="pmc">PMC4788486</ArticleId><ArticleId IdType="pubmed">26989773</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwasaki O, Tanizawa H, Kim KD, Kossenkov A, Nacarelli T, Tashiro S, Majumdar S, Showe LC, Zhang R, and Noma K ichi (2019). Involvement of condensin in cellular senescence through gene regulation and compartmental reorganization. Nat. Commun. 2019 101 10, 1&#x2013;20. 10.1038/s41467-019-13604-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-13604-5</ArticleId><ArticleId IdType="pmc">PMC6908677</ArticleId><ArticleId IdType="pubmed">31831736</ArticleId></ArticleIdList></Reference><Reference><Citation>Zirkel A, Nikolic M, Sofiadis K, Mallm JP, Brackley CA, Gothe H, Drechsel O, Becker C, Altm&#xfc;ller J, Josipovic N, et al. (2018). HMGB2 Loss upon Senescence Entry Disrupts Genomic Organization and Induces CTCF Clustering across Cell Types. Mol. Cell 70, 730&#x2013;744.e6. 10.1016/j.molcel.2018.03.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2018.03.030</ArticleId><ArticleId IdType="pubmed">29706538</ArticleId></ArticleIdList></Reference><Reference><Citation>Bennett DA, Buchman AS, Boyle PA, Barnes LL, Wilson RS, and Schneider JA (2018). Religious Orders Study and Rush Memory and Aging Project. J. Alzheimers. Dis. 64, S161&#x2013;S189. 10.3233/JAD-179939.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-179939</ArticleId><ArticleId IdType="pmc">PMC6380522</ArticleId><ArticleId IdType="pubmed">29865057</ArticleId></ArticleIdList></Reference><Reference><Citation>Bennett DA, Wilson RS, Schneider JA, Evans DA, Beckett LA, Aggarwal NT, Barnes LL, Fox JH, and Bach J (2002). Natural history of mild cognitive impairment in older persons. Neurology 59, 198&#x2013;205. 10.1212/WNL.59.2.198.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.59.2.198</ArticleId><ArticleId IdType="pubmed">12136057</ArticleId></ArticleIdList></Reference><Reference><Citation>Bennett DA, Schneider JA, Arvanitakis Z, Kelly JF, Aggarwal NT, Shah RC, and Wilson RS (2006). Neuropathology of older persons without cognitive impairment from two community-based studies. Neurology 66, 1837&#x2013;1844. 10.1212/01.WNL.0000219668.47116.E6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.WNL.0000219668.47116.E6</ArticleId><ArticleId IdType="pubmed">16801647</ArticleId></ArticleIdList></Reference><Reference><Citation>Bennett DA, Schneider JA, Bienias JL, Evans DA, and Wilson RS (2005). Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions. Neurology 64, 834&#x2013;841. 10.1212/01.WNL.0000152982.47274.9E.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.WNL.0000152982.47274.9E</ArticleId><ArticleId IdType="pubmed">15753419</ArticleId></ArticleIdList></Reference><Reference><Citation>Swiech L, Heidenreich M, Banerjee A, Habib N, Li Y, Trombetta J, Sur M, and Zhang F (2015). In vivo interrogation of gene function in the mammalian brain using CRISPR-Cas9. Nat. Biotechnol. 33, 102&#x2013;106. 10.1038/NBT.3055.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/NBT.3055</ArticleId><ArticleId IdType="pmc">PMC4492112</ArticleId><ArticleId IdType="pubmed">25326897</ArticleId></ArticleIdList></Reference><Reference><Citation>Lebrigand K, Magnone V, Barbry P, and Waldmann R (2020). High throughput error corrected Nanopore single cell transcriptome sequencing. Nat. Commun. 2020 111 11, 1&#x2013;8. 10.1038/s41467-020-17800-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-17800-6</ArticleId><ArticleId IdType="pmc">PMC7423900</ArticleId><ArticleId IdType="pubmed">32788667</ArticleId></ArticleIdList></Reference><Reference><Citation>Anders S, Pyl PT, and Huber W (2015). HTSeq&#x2014;a Python framework to work with high-throughput sequencing data. Bioinformatics 31, 166&#x2013;169. 10.1093/BIOINFORMATICS/BTU638.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/BIOINFORMATICS/BTU638</ArticleId><ArticleId IdType="pmc">PMC4287950</ArticleId><ArticleId IdType="pubmed">25260700</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolf FA, Angerer P, and Theis FJ (2018). SCANPY: Large-scale single-cell gene expression data analysis. Genome Biol. 19, 1&#x2013;5. 10.1186/S13059-017-1382-0/FIGURES/1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/S13059-017-1382-0/FIGURES/1</ArticleId><ArticleId IdType="pmc">PMC5802054</ArticleId><ArticleId IdType="pubmed">29409532</ArticleId></ArticleIdList></Reference><Reference><Citation>Crowell HL, Soneson C, Germain PL, Calini D, Collin L, Raposo C, Malhotra D, and Robinson MD (2020). muscat detects subpopulation-specific state transitions from multi-sample multi-condition single-cell transcriptomics data. Nat. Commun. 11. 10.1038/S41467-02019894-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/S41467-02019894-4</ArticleId><ArticleId IdType="pmc">PMC7705760</ArticleId><ArticleId IdType="pubmed">33257685</ArticleId></ArticleIdList></Reference><Reference><Citation>Langmead B, and Salzberg SL (2012). Fast gapped-read alignment with Bowtie 2. Nat. Methods 9. 10.1038/nmeth.1923.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.1923</ArticleId><ArticleId IdType="pmc">PMC3322381</ArticleId><ArticleId IdType="pubmed">22388286</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, Marth G, Abecasis G, and Durbin R (2009). The Sequence Alignment/Map format and SAMtools. Bioinformatics 25. 10.1093/bioinformatics/btp352.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btp352</ArticleId><ArticleId IdType="pmc">PMC2723002</ArticleId><ArticleId IdType="pubmed">19505943</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H (2018). Minimap2: Pairwise alignment for nucleotide sequences. Bioinformatics 34. 10.1093/bioinformatics/bty191.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/bty191</ArticleId><ArticleId IdType="pmc">PMC6137996</ArticleId><ArticleId IdType="pubmed">29750242</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H, and Durbin R (2009). Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25. 10.1093/bioinformatics/btp324.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btp324</ArticleId><ArticleId IdType="pmc">PMC2705234</ArticleId><ArticleId IdType="pubmed">19451168</ArticleId></ArticleIdList></Reference><Reference><Citation>Eden E, Navon R, Steinfeld I, Lipson D, and Yakhini Z (2009). GOrilla: A tool for discovery and visualization of enriched GO terms in ranked gene lists. BMC Bioinformatics 10, 1&#x2013;7. 10.1186/1471-2105-10-48/TABLES/1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2105-10-48/TABLES/1</ArticleId><ArticleId IdType="pmc">PMC2644678</ArticleId><ArticleId IdType="pubmed">19192299</ArticleId></ArticleIdList></Reference><Reference><Citation>Bates D, M&#xe4;chler M, Bolker BM, and Walker SC (2015). Fitting linear mixed-effects models using lme4. J. Stat. Softw. 67. 10.18637/jss.v067.i01.</Citation><ArticleIdList><ArticleId IdType="doi">10.18637/jss.v067.i01</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37774680</PMID><DateCompleted><Year>2023</Year><Month>10</Month><Day>07</Day></DateCompleted><DateRevised><Year>2024</Year><Month>11</Month><Day>14</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1097-4172</ISSN><JournalIssue CitedMedium="Internet"><Volume>186</Volume><Issue>20</Issue><PubDate><Year>2023</Year><Month>Sep</Month><Day>28</Day></PubDate></JournalIssue><Title>Cell</Title><ISOAbbreviation>Cell</ISOAbbreviation></Journal><ArticleTitle>Epigenomic dissection of Alzheimer's disease pinpoints causal variants and reveals epigenome erosion.</ArticleTitle><Pagination><StartPage>4422</StartPage><EndPage>4437.e21</EndPage><MedlinePgn>4422-4437.e21</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.cell.2023.08.040</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0092-8674(23)00974-1</ELocationID><Abstract><AbstractText>Recent work has identified dozens of non-coding loci for Alzheimer's disease (AD) risk, but their mechanisms and AD transcriptional regulatory circuitry are poorly understood. Here, we profile epigenomic and transcriptomic landscapes of 850,000 nuclei from prefrontal cortexes of 92 individuals with and without AD to build a map of the brain regulome, including epigenomic profiles, transcriptional regulators, co-accessibility modules, and peak-to-gene links in a cell-type-specific manner. We develop methods for multimodal integration and detecting regulatory modules using peak-to-gene linking. We show AD risk loci are enriched in microglial enhancers and for specific TFs including SPI1, ELF2, and RUNX1. We detect 9,628 cell-type-specific ATAC-QTL loci, which we integrate alongside peak-to-gene links to prioritize AD variant regulatory circuits. We report differential accessibility of regulatory modules in late AD in glia and in early AD in neurons. Strikingly, late-stage AD brains show global epigenome dysregulation indicative of epigenome erosion and cell identity loss.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 The Authors. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Xiong</LastName><ForeName>Xushen</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Computer Science and Artificial Intelligence Lab, Massachusetts Institute of Technology, 32 Vassar St, Cambridge, MA 02139, USA; Liangzhu Laboratory, Zhejiang University, 1369 West Wenyi Road, Hangzhou 311121, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>James</LastName><ForeName>Benjamin T</ForeName><Initials>BT</Initials><AffiliationInfo><Affiliation>Computer Science and Artificial Intelligence Lab, Massachusetts Institute of Technology, 32 Vassar St, Cambridge, MA 02139, USA; The Broad Institute of MIT and Harvard, 415 Main Street, Cambridge, MA 02142, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boix</LastName><ForeName>Carles A</ForeName><Initials>CA</Initials><AffiliationInfo><Affiliation>Computer Science and Artificial Intelligence Lab, Massachusetts Institute of Technology, 32 Vassar St, Cambridge, MA 02139, USA; The Broad Institute of MIT and Harvard, 415 Main Street, Cambridge, MA 02142, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Yongjin P</ForeName><Initials>YP</Initials><AffiliationInfo><Affiliation>Computer Science and Artificial Intelligence Lab, Massachusetts Institute of Technology, 32 Vassar St, Cambridge, MA 02139, USA; The Broad Institute of MIT and Harvard, 415 Main Street, Cambridge, MA 02142, USA; Department of Pathology and Laboratory Medicine, Department of Statistics, University of British Columbia, Vancouver, BC V6T 1Z4, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Galani</LastName><ForeName>Kyriaki</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Computer Science and Artificial Intelligence Lab, Massachusetts Institute of Technology, 32 Vassar St, Cambridge, MA 02139, USA; The Broad Institute of MIT and Harvard, 415 Main Street, Cambridge, MA 02142, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Victor</LastName><ForeName>Matheus B</ForeName><Initials>MB</Initials><AffiliationInfo><Affiliation>Picower Institute for Learning and Memory, Massachusetts Institute of Technology, Cambridge, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Na</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Computer Science and Artificial Intelligence Lab, Massachusetts Institute of Technology, 32 Vassar St, Cambridge, MA 02139, USA; The Broad Institute of MIT and Harvard, 415 Main Street, Cambridge, MA 02142, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hou</LastName><ForeName>Lei</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Computer Science and Artificial Intelligence Lab, Massachusetts Institute of Technology, 32 Vassar St, Cambridge, MA 02139, USA; The Broad Institute of MIT and Harvard, 415 Main Street, Cambridge, MA 02142, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ho</LastName><ForeName>Li-Lun</ForeName><Initials>LL</Initials><AffiliationInfo><Affiliation>Computer Science and Artificial Intelligence Lab, Massachusetts Institute of Technology, 32 Vassar St, Cambridge, MA 02139, USA; The Broad Institute of MIT and Harvard, 415 Main Street, Cambridge, MA 02142, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mantero</LastName><ForeName>Julio</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Computer Science and Artificial Intelligence Lab, Massachusetts Institute of Technology, 32 Vassar St, Cambridge, MA 02139, USA; The Broad Institute of MIT and Harvard, 415 Main Street, Cambridge, MA 02142, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scannail</LastName><ForeName>Aine Ni</ForeName><Initials>AN</Initials><AffiliationInfo><Affiliation>Picower Institute for Learning and Memory, Massachusetts Institute of Technology, Cambridge, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dileep</LastName><ForeName>Vishnu</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Picower Institute for Learning and Memory, Massachusetts Institute of Technology, Cambridge, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dong</LastName><ForeName>Weixiu</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Bioengineering, University of California, San Diego, La Jolla, CA 92093, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mathys</LastName><ForeName>Hansruedi</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Picower Institute for Learning and Memory, Massachusetts Institute of Technology, Cambridge, MA, USA; Department of Neurobiology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bennett</LastName><ForeName>David A</ForeName><Initials>DA</Initials><AffiliationInfo><Affiliation>Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, IL 60612, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsai</LastName><ForeName>Li-Huei</ForeName><Initials>LH</Initials><AffiliationInfo><Affiliation>The Broad Institute of MIT and Harvard, 415 Main Street, Cambridge, MA 02142, USA; Picower Institute for Learning and Memory, Massachusetts Institute of Technology, Cambridge, MA, USA. Electronic address: lhtsai@mit.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kellis</LastName><ForeName>Manolis</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Computer Science and Artificial Intelligence Lab, Massachusetts Institute of Technology, 32 Vassar St, Cambridge, MA 02139, USA; The Broad Institute of MIT and Harvard, 415 Main Street, Cambridge, MA 02142, USA. Electronic address: manoli@mit.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>T32 GM139790</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG074003</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>RF1 AG062377</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AG010161</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG062335</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 MH119509</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG015819</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AG072975</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 AG077227</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 DA053631</GrantID><Acronym>DA</Acronym><Agency>NIDA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>RF1 AG054012</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 AG046152</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG058002</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HG008155</GrantID><Acronym>HG</Acronym><Agency>NHGRI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 AG061356</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UG3 NS115064</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG017917</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UH3 NS115064</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS127187</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>RF1 NS129032</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG081017</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>RF1 AG057473</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 NS110453</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R56 AG067151</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG015473</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG067151</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 MH109978</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cell</MedlineTA><NlmUniqueID>0413066</NlmUniqueID><ISSNLinking>0092-8674</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Cell. 2023 Sep 28;186(20):4257-4259. doi: 10.1016/j.cell.2023.09.001.</RefSource><PMID Version="1">37774675</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="Y">Brain</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000081122" MajorTopicYN="N">Epigenome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057890" MajorTopicYN="N">Epigenomics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005786" MajorTopicYN="Y">Gene Expression Regulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055106" MajorTopicYN="N">Genome-Wide Association Study</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ATAC-QTL</Keyword><Keyword MajorTopicYN="N">Alzheimer&#x2019;s disease</Keyword><Keyword MajorTopicYN="N">GWAS</Keyword><Keyword MajorTopicYN="N">epigenome</Keyword><Keyword MajorTopicYN="N">epigenome erosion</Keyword><Keyword MajorTopicYN="N">fine-mapping</Keyword><Keyword MajorTopicYN="N">multimodal integration</Keyword><Keyword MajorTopicYN="N">peak-to-gene linking</Keyword></KeywordList><CoiStatement>Declaration of interests L.-H.T. is a member of the Scientific Advisory Boards of Cognito Therapeutics, 4M Therapeutics, Cell Signaling Technology, and Souvien Therapeutics, which have no association to the work described in this manuscript.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>9</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>4</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>8</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>10</Month><Day>6</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>9</Month><Day>30</Day><Hour>9</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>9</Month><Day>29</Day><Hour>18</Hour><Minute>16</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>28</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37774680</ArticleId><ArticleId IdType="mid">NIHMS1942150</ArticleId><ArticleId IdType="pmc">PMC10782612</ArticleId><ArticleId IdType="doi">10.1016/j.cell.2023.08.040</ArticleId><ArticleId IdType="pii">S0092-8674(23)00974-1</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Wilson RS, Boyle PA, Yu L, Barnes LL, Sytsma J, Buchman AS, Bennett DA, and Schneider JA (2015). Temporal course and pathologic basis of unawareness of memory loss in dementia. Neurology 85, 984&#x2013;991.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4567465</ArticleId><ArticleId IdType="pubmed">26311746</ArticleId></ArticleIdList></Reference><Reference><Citation>Bennett DA, Wilson RS, Schneider JA, Evans DA, Beckett LA, Aggarwal NT, Barnes LL, Fox JH, and Bach J. (2002). Natural history of mild cognitive impairment in older persons. Neurology 59, 198&#x2013;205.</Citation><ArticleIdList><ArticleId IdType="pubmed">12136057</ArticleId></ArticleIdList></Reference><Reference><Citation>Bennett DA, Schneider JA, Wilson RS, Bienias JL, and Arnold SE (2004). Neurofibrillary tangles mediate the association of amyloid load with clinical Alzheimer disease and level of cognitive function. Arch. Neurol 61, 378&#x2013;384.</Citation><ArticleIdList><ArticleId IdType="pubmed">15023815</ArticleId></ArticleIdList></Reference><Reference><Citation>Braak H, and Braak E. (1995). Staging of Alzheimer&#x2019;s disease-related neurofibrillary changes. Neurobiol. Aging 16, 271&#x2013;278; discussion 278&#x2013;284.</Citation><ArticleIdList><ArticleId IdType="pubmed">7566337</ArticleId></ArticleIdList></Reference><Reference><Citation>Querfurth HW, and LaFerla FM (2010). Alzheimer&#x2019;s disease. N. Engl. J. Med 362, 329&#x2013;344.</Citation><ArticleIdList><ArticleId IdType="pubmed">20107219</ArticleId></ArticleIdList></Reference><Reference><Citation>Ridge PG, Mukherjee S, Crane PK, Kauwe JSK, and Alzheimer&#x2019;s Disease Genetics Consortium (2013). Alzheimer&#x2019;s disease: analyzing the missing heritability. PLoS One 8, e79771.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3820606</ArticleId><ArticleId IdType="pubmed">24244562</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilson RS, Barral S, Lee JH, Leurgans SE, Foroud TM, Sweet RA, Graff-Radford N, Bird TD, Mayeux R, and Bennett DA (2011). Heritability of different forms of memory in the Late Onset Alzheimer&#x2019;s Disease Family Study. J. Alzheimers. Dis 23, 249&#x2013;255.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3130303</ArticleId><ArticleId IdType="pubmed">20930268</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellenguez C, K&#xfc;&#xe7;&#xfc;kali F, Jansen IE, Kleineidam L, Moreno-Grau S, Amin N, Naj AC, Campos-Martin R, Grenier-Boley B, Andrade V, et al. (2022). New insights into the genetic etiology of Alzheimer&#x2019;s disease and related dementias. Nat. Genet 54, 412&#x2013;436.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9005347</ArticleId><ArticleId IdType="pubmed">35379992</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwartzentruber J, Cooper S, Liu JZ, Barrio-Hernandez I, Bello E, Kumasaka N, Young AMH, Franklin RJM, Johnson T, Estrada K, et al. (2021). Genome-wide meta-analysis, fine-mapping and integrative prioritization implicate new Alzheimer&#x2019;s disease risk genes. Nat. Genet 53, 392&#x2013;402.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7610386</ArticleId><ArticleId IdType="pubmed">33589840</ArticleId></ArticleIdList></Reference><Reference><Citation>Gjoneska E, Pfenning AR, Mathys H, Quon G, Kundaje A, Tsai L-H, and Kellis M. (2015). Conserved epigenomic signals in mice and humans reveal immune basis of Alzheimer&#x2019;s disease. Nature 518, 365&#x2013;369.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4530583</ArticleId><ArticleId IdType="pubmed">25693568</ArticleId></ArticleIdList></Reference><Reference><Citation>Nott A, Holtman IR, Coufal NG, Schlachetzki JCM, Yu M, Hu R, Han CZ, Pena M, Xiao J, Wu Y, et al. (2019). Brain cell type-specific enhancer-promoter interactome maps and diseaserisk association. Science 366, 1134&#x2013;1139.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7028213</ArticleId><ArticleId IdType="pubmed">31727856</ArticleId></ArticleIdList></Reference><Reference><Citation>Mostafavi H, Spence JP, Naqvi S, and Pritchard JK (2022). Limited overlap of eQTLs and GWAS hits due to systematic differences in discovery. bioRxiv, 2022.05.07.491045. 10.1101/2022.05.07.491045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.05.07.491045</ArticleId></ArticleIdList></Reference><Reference><Citation>Connally NJ, Nazeen S, Lee D, Shi H, Stamatoyannopoulos J, Chun S, Cotsapas C, Cassa CA, and Sunyaev SR (2022). The missing link between genetic association and regulatory function. Elife 11. 10.7554/eLife.74970.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.74970</ArticleId><ArticleId IdType="pmc">PMC9842386</ArticleId><ArticleId IdType="pubmed">36515579</ArticleId></ArticleIdList></Reference><Reference><Citation>Perez RK, Gordon MG, Subramaniam M, Kim MC, Hartoularos GC, Targ S, Sun Y, Ogorodnikov A, Bueno R, Lu A, et al. (2022). Single-cell RNA-seq reveals cell type&#x2013;specific molecular and genetic associations to lupus. Science 376, eabf1970.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9297655</ArticleId><ArticleId IdType="pubmed">35389781</ArticleId></ArticleIdList></Reference><Reference><Citation>Gate RE, Cheng CS, Aiden AP, Siba A, Tabaka M, Lituiev D, Machol I, Gordon MG, Subramaniam M, Shamim M, et al. (2018). Genetic determinants of co-accessible chromatin regions in activated T cells across humans. Nat. Genet 50, 1140&#x2013;1150.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6097927</ArticleId><ArticleId IdType="pubmed">29988122</ArticleId></ArticleIdList></Reference><Reference><Citation>Kosoy R, Fullard JF, Zeng B, Bendl J, Dong P, Rahman S, Kleopoulos SP, Shao Z, Girdhar K, Humphrey J, et al. (2022). Genetics of the human microglia regulome refines Alzheimer&#x2019;s disease risk loci. Nat. Genet 54, 1145&#x2013;1154.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9388367</ArticleId><ArticleId IdType="pubmed">35931864</ArticleId></ArticleIdList></Reference><Reference><Citation>Gamazon ER, Segr&#xe8; AV, van de Bunt M, Wen X, Xi HS, Hormozdiari F, Ongen H, Konkashbaev A, Derks EM, Aguet F, et al. (2018). Using an atlas of gene regulation across 44 human tissues to inform complex disease- and trait-associated variation. Nat. Genet 50, 956&#x2013;967.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6248311</ArticleId><ArticleId IdType="pubmed">29955180</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang AC, Vest RT, Kern F, Lee DP, Agam M, Maat CA, Losada PM, Chen MB, Schaum N, Khoury N, et al. (2022). A human brain vascular atlas reveals diverse mediators of Alzheimer&#x2019;s risk. Nature. 10.1038/s41586-021-04369-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-04369-3</ArticleId><ArticleId IdType="pmc">PMC9635042</ArticleId><ArticleId IdType="pubmed">35165441</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathys H, Davila-Velderrain J, Peng Z, Gao F, Mohammadi S, Young JZ, Menon M, He L, Abdurrob F, Jiang X, et al. (2019). Single-cell transcriptomic analysis of Alzheimer&#x2019;s disease. Nature 570, 332&#x2013;337.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6865822</ArticleId><ArticleId IdType="pubmed">31042697</ArticleId></ArticleIdList></Reference><Reference><Citation>Grubman A, Chew G, Ouyang JF, Sun G, Choo XY, McLean C, Simmons RK, Buckberry S, Vargas-Landin DB, Poppe D, et al. (2019). A single-cell atlas of entorhinal cortex from individuals with Alzheimer&#x2019;s disease reveals cell-type-specific gene expression regulation. Nat. Neurosci 22, 2087&#x2013;2097.</Citation><ArticleIdList><ArticleId IdType="pubmed">31768052</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeh FL, Wang Y, Tom I, Gonzalez LC, and Sheng M. (2016). TREM2 Binds to Apolipoproteins, Including APOE and CLU/APOJ, and Thereby Facilitates Uptake of Amyloid-Beta by Microglia. Neuron 91, 328&#x2013;340.</Citation><ArticleIdList><ArticleId IdType="pubmed">27477018</ArticleId></ArticleIdList></Reference><Reference><Citation>Ulland TK, Song WM, Huang SC-C, Ulrich JD, Sergushichev A, Beatty WL, Loboda AA, Zhou Y, Cairns NJ, Kambal A, et al. (2017). TREM2 Maintains Microglial Metabolic Fitness in Alzheimer&#x2019;s Disease. Cell 170, 649&#x2013;663.e13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5573224</ArticleId><ArticleId IdType="pubmed">28802038</ArticleId></ArticleIdList></Reference><Reference><Citation>Morabito S, Miyoshi E, Michael N, Shahin S, Martini AC, Head E, Silva J, Leavy K, Perez-Rosendahl M, and Swarup V. (2021). Single-nucleus chromatin accessibility and transcriptomic characterization of Alzheimer&#x2019;s disease. Nat. Genet 53, 1143&#x2013;1155.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8766217</ArticleId><ArticleId IdType="pubmed">34239132</ArticleId></ArticleIdList></Reference><Reference><Citation>Corces MR, Shcherbina A, Kundu S, Gloudemans MJ, Fr&#xe9;sard L, Granja JM, Louie BH, Eulalio T, Shams S, Bagdatli ST, et al. (2020). Single-cell epigenomic analyses implicate candidate causal variants at inherited risk loci for Alzheimer&#x2019;s and Parkinson&#x2019;s diseases. Nat. Genet 52, 1158&#x2013;1168.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7606627</ArticleId><ArticleId IdType="pubmed">33106633</ArticleId></ArticleIdList></Reference><Reference><Citation>Bendl J, Hauberg ME, Girdhar K, Im E, Vicari JM, Rahman S, Fernando MB, Townsley KG, Dong P, Misir R, et al. (2022). The three-dimensional landscape of cortical chromatin accessibility in Alzheimer&#x2019;s disease. Nat. Neurosci 25, 1366&#x2013;1378.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9581463</ArticleId><ArticleId IdType="pubmed">36171428</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller MB, Huang AY, Kim J, Zhou Z, Kirkham SL, Maury EA, Ziegenfuss JS, Reed HC, Neil JE, Rento L, et al. (2022). Somatic genomic changes in single Alzheimer&#x2019;s disease neurons. Nature 604, 714&#x2013;722.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9357465</ArticleId><ArticleId IdType="pubmed">35444284</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang J-H, Griffin PT, Vera DL, Hayano M, Meer MV, Salfati EL, Su Q, Munding EM, Blanchette M, Bhakta M, et al. (2019). Erosion of the Epigenetic Landscape and Loss of Cellular Identity as a Cause of Aging in Mammals. bioRxiv, 808642. 10.1101/808642.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/808642</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuronal DNA double-strand breaks lead to chromosomal structural variations and 3D genome disruption in neurodegeneration Paperpile. https://paperpile.com/app/p/f3162b05-bfa3-0021-86f6-eb419a9a65d3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10697236</ArticleId><ArticleId IdType="pubmed">37774679</ArticleId></ArticleIdList></Reference><Reference><Citation>Placeholder Paperpile (Co-submitted paper in this issue). https://paperpile.com/app/p/f72bc3f2-8466-08e7-bc55-4a1344246486.</Citation></Reference><Reference><Citation>Bennett DA, Buchman AS, Boyle PA, Barnes LL, Wilson RS, and Schneider JA (2018). Religious Orders Study and Rush Memory and Aging Project. J. Alzheimers. Dis 64, S161&#x2013;S189.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6380522</ArticleId><ArticleId IdType="pubmed">29865057</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao Z-J, and Gao G. (2022). Multi-omics single-cell data integration and regulatory inference with graph-linked embedding. Nat. Biotechnol 10.1038/s41587-022-01284-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41587-022-01284-4</ArticleId><ArticleId IdType="pmc">PMC9546775</ArticleId><ArticleId IdType="pubmed">35501393</ArticleId></ArticleIdList></Reference><Reference><Citation>Hao Y, Hao S, Andersen-Nissen E, Mauck WM 3rd, Zheng S, Butler A, Lee MJ, Wilk AJ, Darby C, Zager M, et al. (2021). Integrated analysis of multimodal single-cell data. Cell 184, 3573&#x2013;3587.e29.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8238499</ArticleId><ArticleId IdType="pubmed">34062119</ArticleId></ArticleIdList></Reference><Reference><Citation>Priego N, Zhu L, Monteiro C, Mulders M, Wasilewski D, Bindeman W, Doglio L, Mart&#xed;nez L, Mart&#xed;nez-Saez E, Ram&#xf3;n Y Cajal S, et al. (2018). STAT3 labels a subpopulation of reactive astrocytes required for brain metastasis. Nat. Med 24, 1024&#x2013;1035.</Citation><ArticleIdList><ArticleId IdType="pubmed">29892069</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin Y, Li R, Zhang Z, Ren J, Song X, and Zhang G. (2020). ZBED1/DREF: A transcription factor that regulates cell proliferation. Oncol. Lett 20, 137.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7471704</ArticleId><ArticleId IdType="pubmed">32934705</ArticleId></ArticleIdList></Reference><Reference><Citation>Reed BD, Charos AE, Szekely AM, and Weissman SM (2008). Genome-wide occupancy of SREBP1 and its partners NFY and SP1 reveals novel functional roles and combinatorial regulation of distinct classes of genes. PLoS.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2478640</ArticleId><ArticleId IdType="pubmed">18654640</ArticleId></ArticleIdList></Reference><Reference><Citation>McLean CY, Bristor D, Hiller M, Clarke SL, Schaar BT, Lowe CB, Wenger AM, and Bejerano G. (2010). GREAT improves functional interpretation of cis-regulatory regions. Nat. Biotechnol 28, 495&#x2013;501.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4840234</ArticleId><ArticleId IdType="pubmed">20436461</ArticleId></ArticleIdList></Reference><Reference><Citation>Bulik-Sullivan BK, Loh P-R, Finucane HK, Ripke S, Yang J, Schizophrenia Working Group of the Psychiatric Genomics Consortium, Patterson N, Daly MJ, Price AL, and Neale BM (2015). LD Score regression distinguishes confounding from polygenicity in genome-wide association studies. Nat. Genet 47, 291&#x2013;295.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4495769</ArticleId><ArticleId IdType="pubmed">25642630</ArticleId></ArticleIdList></Reference><Reference><Citation>Kierdorf K, and Prinz M. (2013). Factors regulating microglia activation. Front. Cell. Neurosci 7, 44.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3632747</ArticleId><ArticleId IdType="pubmed">23630462</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudwarts A, Ramesha S, Gao T, Ponnusamy M, Wang S, Hansen M, Kozlova A, Bitarafan S, Kumar P, Beaulieu-Abdelahad D, et al. (2022). BIN1 is a key regulator of proinflammatory and neurodegeneration-related activation in microglia. Mol. Neurodegener 17, 33.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9077874</ArticleId><ArticleId IdType="pubmed">35526014</ArticleId></ArticleIdList></Reference><Reference><Citation>Novikova G, Kapoor M, Tcw J, Abud EM, Efthymiou AG, Chen SX, Cheng H, Fullard JF, Bendl J, Liu Y, et al. (2021). Integration of Alzheimer&#x2019;s disease genetics and myeloid genomics identifies disease risk regulatory elements and genes. Nat. Commun 12, 1610.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7955030</ArticleId><ArticleId IdType="pubmed">33712570</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou M, Xu X, Wang H, Yang G, Yang M, Zhao X, Guo H, Song J, Zheng H, Zhu Z, et al. (2020). Effect of central JAZF1 on glucose production is regulated by the PI3K-Akt-AMPK pathway. FASEB J. 34, 7058&#x2013;7074.</Citation><ArticleIdList><ArticleId IdType="pubmed">32275331</ArticleId></ArticleIdList></Reference><Reference><Citation>Manning BD, and Toker A. (2017). AKT/PKB Signaling: Navigating the Network. Cell 169, 381&#x2013;405.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5546324</ArticleId><ArticleId IdType="pubmed">28431241</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong X, Hou L, Park YP, Molinie B, GTEx Consortium, Gregory RI, and Kellis M. (2021). Genetic drivers of mA methylation in human brain, lung, heart and muscle. Nat. Genet 53, 1156&#x2013;1165.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9112289</ArticleId><ArticleId IdType="pubmed">34211177</ArticleId></ArticleIdList></Reference><Reference><Citation>Oliveira TG, and Di Paolo G. (2010). Phospholipase D in brain function and Alzheimer&#x2019;s disease. Biochim. Biophys. Acta 1801, 799.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3328196</ArticleId><ArticleId IdType="pubmed">20399893</ArticleId></ArticleIdList></Reference><Reference><Citation>Leng K, Li E, Eser R, Piergies A, Sit R, Tan M, Neff N, Li SH, Rodriguez RD, Suemoto CK, et al. (2021). Molecular characterization of selectively vulnerable neurons in Alzheimer&#x2019;s disease. Nat. Neurosci 24, 276&#x2013;287.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7854528</ArticleId><ArticleId IdType="pubmed">33432193</ArticleId></ArticleIdList></Reference><Reference><Citation>Kousi M, Boix C, Park YP, Mathys H, Sledzieski S, Peng Z, Bennett DA, Tsai L-H, and Kellis M. (2022). Single-cell mosaicism analysis reveals cell-type-specific somatic mutational burden in Alzheimer&#x2019;s Dementia. bioRxiv, 2022.04.21.489103. 10.1101/2022.04.21.489103.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.04.21.489103</ArticleId></ArticleIdList></Reference><Reference><Citation>Bertucci EM, and Parrott BB (2020). Is CpG Density the Link between Epigenetic Aging and Lifespan? Trends Genet. 36, 725&#x2013;727.</Citation><ArticleIdList><ArticleId IdType="pubmed">32624337</ArticleId></ArticleIdList></Reference><Reference><Citation>Kosan C, Heidel FH, Godmann M, and Bierhoff H. (2018). Epigenetic Erosion in Adult Stem Cells: Drivers and Passengers of Aging. Cells 7. 10.3390/cells7120237.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells7120237</ArticleId><ArticleId IdType="pmc">PMC6316114</ArticleId><ArticleId IdType="pubmed">30501028</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Z, Ji Q, Ren J, Yan P, Wu Z, Wang S, Sun L, Wang Z, Li J, Sun G, et al. (2022). Large-scale chromatin reorganization reactivates placenta-specific genes that drive cellular aging. Dev. Cell 57, 1347&#x2013;1368.e12.</Citation><ArticleIdList><ArticleId IdType="pubmed">35613614</ArticleId></ArticleIdList></Reference><Reference><Citation>Ernst J, and Kellis M. (2012). ChromHMM: automating chromatin-state discovery and characterization. Nat. Methods 9, 215&#x2013;216.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3577932</ArticleId><ArticleId IdType="pubmed">22373907</ArticleId></ArticleIdList></Reference><Reference><Citation>Roadmap Epigenomics Consortium, Kundaje A, Meuleman W, Ernst J, Bilenky M, Yen A, Heravi-Moussavi A, Kheradpour P, Zhang Z, Wang J, et al. (2015). Integrative analysis of 111 reference human epigenomes. Nature 518, 317&#x2013;330.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4530010</ArticleId><ArticleId IdType="pubmed">25693563</ArticleId></ArticleIdList></Reference><Reference><Citation>Marzi SJ, Leung SK, Ribarska T, Hannon E, Smith AR, Pishva E, Poschmann J, Moore K, Troakes C, Al-Sarraj S, et al. (2018). A histone acetylome-wide association study of Alzheimer&#x2019;s disease identifies disease-associated H3K27ac differences in the entorhinal cortex. Nat. Neurosci 21, 1618&#x2013;1627.</Citation><ArticleIdList><ArticleId IdType="pubmed">30349106</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Amaral ML, Zhu C, Grieco SF, Hou X, Lin L, Buchanan J, Tong L, Preissl S, Xu X, et al. (2022). Single-cell epigenome analysis reveals age-associated decay of heterochromatin domains in excitatory neurons in the mouse brain. Cell Res. 32, 1008&#x2013;1021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9652396</ArticleId><ArticleId IdType="pubmed">36207411</ArticleId></ArticleIdList></Reference><Reference><Citation>Caldwell AB, Liu Q, Schroth GP, Galasko DR, Yuan SH, Wagner SL, and Subramaniam S. (2020). Dedifferentiation and neuronal repression define familial Alzheimer&#x2019;s disease. Sci Adv 6. 10.1126/sciadv.aba5933.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.aba5933</ArticleId><ArticleId IdType="pmc">PMC7673760</ArticleId><ArticleId IdType="pubmed">33188013</ArticleId></ArticleIdList></Reference><Reference><Citation>Mertens J, Herdy JR, Traxler L, Schafer ST, Schlachetzki JCM, B&#xf6;hnke L, Reid DA, Lee H, Zangwill D, Fernandes DP, et al. (2021). Age-dependent instability of mature neuronal fate in induced neurons from Alzheimer&#x2019;s patients. Cell Stem Cell 28, 1533&#x2013;1548.e6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8423435</ArticleId><ArticleId IdType="pubmed">33910058</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu L, Sun T, Kobayashi K, Gao P, and Griffin JD (2002). Identification of a family of mastermind-like transcriptional coactivators for mammalian notch receptors. Mol. Cell. Biol 22, 7688&#x2013;7700.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC135662</ArticleId><ArticleId IdType="pubmed">12370315</ArticleId></ArticleIdList></Reference><Reference><Citation>Miura Y, Tam T, Ido A, Morinaga T, Miki T, Hashimoto T, and Tamaoki T. (1995). Cloning and characterization of an ATBF1 isoform that expresses in a neuronal differentiation-dependent manner. J. Biol. Chem 270, 26840&#x2013;26848.</Citation><ArticleIdList><ArticleId IdType="pubmed">7592926</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, El-Naggar S, Darling DS, Higashi Y, and Dean DC (2008). Zeb1 links epithelial-mesenchymal transition and cellular senescence. Development 135, 579&#x2013;588.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2507753</ArticleId><ArticleId IdType="pubmed">18192284</ArticleId></ArticleIdList></Reference><Reference><Citation>Speir ML, Bhaduri A, Markov NS, Moreno P, Nowakowski TJ, Papatheodorou I, Pollen AA, Raney BJ, Seninge L, Kent WJ, et al. (2021). UCSC Cell Browser: Visualize Your Single-Cell Data. Bioinformatics 37, 4578&#x2013;4580.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8652023</ArticleId><ArticleId IdType="pubmed">34244710</ArticleId></ArticleIdList></Reference><Reference><Citation>Granja JM, Corces MR, Pierce SE, Bagdatli ST, Choudhry H, Chang HY, and Greenleaf WJ (2021). ArchR is a scalable software package for integrative single-cell chromatin accessibility analysis. Nat. Genet 53, 403&#x2013;411.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8012210</ArticleId><ArticleId IdType="pubmed">33633365</ArticleId></ArticleIdList></Reference><Reference><Citation>PsychENCODE Consortium, Akbarian S, Liu C, Knowles JA, Vaccarino FM, Farnham PJ, Crawford GE, Jaffe AE, Pinto D, Dracheva S, et al. (2015). The PsychENCODE project. Nat. Neurosci 18, 1707&#x2013;1712.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4675669</ArticleId><ArticleId IdType="pubmed">26605881</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson EN, Burns TC, Hayda RA, Hospenthal DR, and Murray CK (2007). Infectious complications of open type III tibial fractures among combat casualties. Clin. Infect. Dis 45, 409&#x2013;415.</Citation><ArticleIdList><ArticleId IdType="pubmed">17638186</ArticleId></ArticleIdList></Reference><Reference><Citation>Korsunsky I, Millard N, Fan J, Slowikowski K, Zhang F, Wei K, Baglaenko Y, Brenner M, Loh P-R, and Raychaudhuri S. (2019). Fast, sensitive and accurate integration of single-cell data with Harmony. Nat. Methods 16, 1289&#x2013;1296.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6884693</ArticleId><ArticleId IdType="pubmed">31740819</ArticleId></ArticleIdList></Reference><Reference><Citation>Pola&#x144;ski K, Young MD, Miao Z, Meyer KB, Teichmann SA, and Park J-E (2019). BBKNN: fast batch alignment of single cell transcriptomes. Bioinformatics 36, 964&#x2013;965.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9883685</ArticleId><ArticleId IdType="pubmed">31400197</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolf FA, Angerer P, and Theis FJ (2018). SCANPY: large-scale single-cell gene expression data analysis. Genome Biol. 19. 10.1186/s13059-017-1382-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13059-017-1382-0</ArticleId><ArticleId IdType="pmc">PMC5802054</ArticleId><ArticleId IdType="pubmed">29409532</ArticleId></ArticleIdList></Reference><Reference><Citation>Bell AJ, and Sejnowski TJ (1997). The &#x201c;independent components&#x201d; of natural scenes are edge filters. Vision Res. 37, 3327&#x2013;3338.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2882863</ArticleId><ArticleId IdType="pubmed">9425547</ArticleId></ArticleIdList></Reference><Reference><Citation>Fulco CP, Nasser J, Jones TR, Munson G, Bergman DT, Subramanian V, Grossman SR, Anyoha R, Doughty BR, Patwardhan TA, et al. (2019). Activity-by-contact model of enhancer&#x2013;promoter regulation from thousands of CRISPR perturbations. Nat. Genet 51, 1664&#x2013;1669.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6886585</ArticleId><ArticleId IdType="pubmed">31784727</ArticleId></ArticleIdList></Reference><Reference><Citation>Risso D, Ngai J, Speed TP, and Dudoit S. (2014). Normalization of RNA-seq data using factor analysis of control genes or samples. Nat. Biotechnol 32, 896&#x2013;902.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4404308</ArticleId><ArticleId IdType="pubmed">25150836</ArticleId></ArticleIdList></Reference><Reference><Citation>He L, Davila-Velderrain J, Sumida TS, Hafler DA, Kellis M, and Kulminski AM (2021). NEBULA is a fast negative binomial mixed model for differential or co-expression analysis of large-scale multi-subject single-cell data. Commun Biol 4, 629.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8155058</ArticleId><ArticleId IdType="pubmed">34040149</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson MD, McCarthy DJ, and Smyth GK (2010). edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26, 139&#x2013;140.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2796818</ArticleId><ArticleId IdType="pubmed">19910308</ArticleId></ArticleIdList></Reference><Reference><Citation>Castro-Mondragon JA, Riudavets-Puig R, Rauluseviciute I, Berhanu Lemma R, Turchi L, Blanc-Mathieu R, Lucas J, Boddie P, Khan A, Manosalva P&#xe9;rez N, et al. (2021). JASPAR 2022: the 9th release of the open-access database of transcription factor binding profiles. Nucleic Acids Res. 50, D165&#x2013;D173.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8728201</ArticleId><ArticleId IdType="pubmed">34850907</ArticleId></ArticleIdList></Reference><Reference><Citation>Park YP, and Kellis M. (2021). CoCoA-diff: counterfactual inference for single-cell gene expression analysis. Genome Biol. 22, 228.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8369635</ArticleId><ArticleId IdType="pubmed">34404460</ArticleId></ArticleIdList></Reference><Reference><Citation>Barber RF, and Cand&#xe8;s EJ (2015). Controlling the false discovery rate via knockoffs. aos 43, 2055&#x2013;2085.</Citation></Reference><Reference><Citation>Wang Y, and Blei DM (2019). The Blessings of Multiple Causes. J. Am. Stat. Assoc 114, 1574&#x2013;1596.</Citation></Reference><Reference><Citation>Zhu Z, Fan Y, Kong Y, Lv J, and Sun F. (2021). DeepLINK: Deep learning inference using knockoffs with applications to genomics. Proc. Natl. Acad. Sci. U. S. A 118. 10.1073/pnas.2104683118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2104683118</ArticleId><ArticleId IdType="pmc">PMC8433583</ArticleId><ArticleId IdType="pubmed">34480002</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang T, Li Y, and Motsinger-Reif AA (2021). Knockoff boosted tree for model-free variable selection. Bioinformatics 37, 976&#x2013;983.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8128453</ArticleId><ArticleId IdType="pubmed">32966559</ArticleId></ArticleIdList></Reference><Reference><Citation>Candes E, Fan Y, Janson L, and Lv J. (2018). Panning for gold:&#x2019;model&#x2010;X&#x2019;knockoffs for high dimensional controlled variable selection. Journal of the Royal.</Citation></Reference><Reference><Citation>Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, and Smyth GK (2015). limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43, e47.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4402510</ArticleId><ArticleId IdType="pubmed">25605792</ArticleId></ArticleIdList></Reference><Reference><Citation>Ongen H, Buil A, Brown AA, Dermitzakis ET, and Delaneau O. (2016). Fast and efficient QTL mapper for thousands of molecular phenotypes. Bioinformatics 32, 1479&#x2013;1485.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4866519</ArticleId><ArticleId IdType="pubmed">26708335</ArticleId></ArticleIdList></Reference><Reference><Citation>Giambartolomei C, Vukcevic D, Schadt EE, Franke L, Hingorani AD, Wallace C, and Plagnol V. (2014). Bayesian test for colocalisation between pairs of genetic association studies using summary statistics. PLoS Genet. 10, e1004383.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4022491</ArticleId><ArticleId IdType="pubmed">24830394</ArticleId></ArticleIdList></Reference><Reference><Citation>Giambartolomei C, Zhenli Liu J, Zhang W, Hauberg M, Shi H, Boocock J, Pickrell J, Jaffe AE, CommonMind Consortium, Pasaniuc B, et al. (2018). A Bayesian framework for multiple trait colocalization from summary association statistics. Bioinformatics 34, 2538&#x2013;2545.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6061859</ArticleId><ArticleId IdType="pubmed">29579179</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudmant PH, Rausch T, Gardner EJ, Handsaker RE, Abyzov A, Huddleston J, Zhang Y, Ye K, Jun G, Fritz MH-Y, et al. (2015). An integrated map of structural variation in 2,504 human genomes. Nature 526, 75&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4617611</ArticleId><ArticleId IdType="pubmed">26432246</ArticleId></ArticleIdList></Reference><Reference><Citation>Phipson B, Sim CB, Porrello ER, Hewitt AW, Powell J, and Oshlack A. (2022). propeller: testing for differences in cell type proportions in single cell data. Bioinformatics 38, 4720&#x2013;4726.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9563678</ArticleId><ArticleId IdType="pubmed">36005887</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Liu T, Meyer CA, Eeckhoute J, Johnson DS, Bernstein BE, Nusbaum C, Myers RM, Brown M, Li W, et al. (2008). Model-based analysis of ChIP-Seq (MACS). Genome Biol 9, R137. 10.1186/gb-2008-9-9-r137.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/gb-2008-9-9-r137</ArticleId><ArticleId IdType="pmc">PMC2592715</ArticleId><ArticleId IdType="pubmed">18798982</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson WE, Li C, and Rabinovic A. (2007). Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics 8, 118&#x2013;127. 10.1093/biostatistics/kxj037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/biostatistics/kxj037</ArticleId><ArticleId IdType="pubmed">16632515</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan G, and Lenhard B. (2016). TFBSTools: an R/bioconductor package for transcription factor binding site analysis. Bioinformatics 32, 1555&#x2013;1556. 10.1093/bioinformatics/btw024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btw024</ArticleId><ArticleId IdType="pmc">PMC4866524</ArticleId><ArticleId IdType="pubmed">26794315</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37776854</PMID><DateCompleted><Year>2023</Year><Month>12</Month><Day>16</Day></DateCompleted><DateRevised><Year>2023</Year><Month>12</Month><Day>17</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1097-4199</ISSN><JournalIssue CitedMedium="Internet"><Volume>111</Volume><Issue>23</Issue><PubDate><Year>2023</Year><Month>Dec</Month><Day>06</Day></PubDate></JournalIssue><Title>Neuron</Title><ISOAbbreviation>Neuron</ISOAbbreviation></Journal><ArticleTitle>Molecular anatomy of adult mouse leptomeninges.</ArticleTitle><Pagination><StartPage>3745</StartPage><EndPage>3764.e7</EndPage><MedlinePgn>3745-3764.e7</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.neuron.2023.09.002</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0896-6273(23)00666-9</ELocationID><Abstract><AbstractText>Leptomeninges, consisting of the pia mater and arachnoid, form a connective tissue investment and barrier enclosure of the brain. The exact nature of leptomeningeal cells has long been debated. In this study, we identify five molecularly distinct fibroblast-like transcriptomes in cerebral leptomeninges; link them to anatomically distinct cell types of the pia, inner arachnoid, outer arachnoid barrier, and dural border layer; and contrast them to a sixth fibroblast-like transcriptome present in the choroid plexus and median eminence. Newly identified transcriptional markers enabled molecular characterization of cell types responsible for adherence of arachnoid layers to one another and for the arachnoid barrier. These markers also proved useful in identifying the molecular features of leptomeningeal development, injury, and repair that were preserved or changed after traumatic brain injury. Together, the findings highlight the value of identifying fibroblast transcriptional subsets and their cellular locations toward advancing the understanding of leptomeningeal physiology and pathology.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 The Author(s). Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pietil&#xe4;</LastName><ForeName>Riikka</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Immunology, Genetics and Pathology, Rudbeck Laboratory, Uppsala University, 75185 Uppsala, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Del Gaudio</LastName><ForeName>Francesca</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Medicine Huddinge, Karolinska Institutet, 14157 Huddinge, Sweden; Department of Cell and Molecular Biology, Karolinska Institutet, 17177 Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>He</LastName><ForeName>Liqun</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Immunology, Genetics and Pathology, Rudbeck Laboratory, Uppsala University, 75185 Uppsala, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>V&#xe1;zquez-Li&#xe9;banas</LastName><ForeName>Elisa</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Immunology, Genetics and Pathology, Rudbeck Laboratory, Uppsala University, 75185 Uppsala, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vanlandewijck</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Immunology, Genetics and Pathology, Rudbeck Laboratory, Uppsala University, 75185 Uppsala, Sweden; Department of Medicine Huddinge, Karolinska Institutet, 14157 Huddinge, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Muhl</LastName><ForeName>Lars</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Medicine Huddinge, Karolinska Institutet, 14157 Huddinge, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mocci</LastName><ForeName>Giuseppe</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Medicine Huddinge, Karolinska Institutet, 14157 Huddinge, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bj&#xf8;rnholm</LastName><ForeName>Katrine D</ForeName><Initials>KD</Initials><AffiliationInfo><Affiliation>Department of Neurobiology, Care Sciences and Society, Division of Neurogeriatrics, Center for Alzheimer Research, Karolinska Institutet, 17177 Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lindblad</LastName><ForeName>Caroline</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Clinical Neuroscience, Karolinska Institutet, 17177 Stockholm, Sweden; Department of Neurosurgery, Uppsala University Hospital, 75185 Uppsala, Sweden; Department of Medical Sciences, Uppsala University, 75185 Uppsala, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fletcher-Sandersj&#xf6;&#xf6;</LastName><ForeName>Alexander</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Clinical Neuroscience, Karolinska Institutet, 17177 Stockholm, Sweden; Department of Neurosurgery, Karolinska University Hospital, 17176 Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Svensson</LastName><ForeName>Mikael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Clinical Neuroscience, Karolinska Institutet, 17177 Stockholm, Sweden; Department of Neurology, Karolinska University Hospital, 17176 Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thelin</LastName><ForeName>Eric P</ForeName><Initials>EP</Initials><AffiliationInfo><Affiliation>Department of Clinical Neuroscience, Karolinska Institutet, 17177 Stockholm, Sweden; Department of Neurology, Karolinska University Hospital, 17176 Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Jianping</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Medicine Huddinge, Karolinska Institutet, 14157 Huddinge, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Voorden</LastName><ForeName>A Jantine</ForeName><Initials>AJ</Initials><AffiliationInfo><Affiliation>Department of Immunology, Genetics and Pathology, Rudbeck Laboratory, Uppsala University, 75185 Uppsala, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Torres</LastName><ForeName>Monica</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Immunology, Genetics and Pathology, Rudbeck Laboratory, Uppsala University, 75185 Uppsala, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Antila</LastName><ForeName>Salli</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Wihuri Research Institute and Translational Cancer Medicine Program, University of Helsinki, 00014 Helsinki, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xin</LastName><ForeName>Li</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Theodor Kocher Institute, University of Bern, 3012 Bern, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Karlstr&#xf6;m</LastName><ForeName>Helena</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Neurobiology, Care Sciences and Society, Division of Neurogeriatrics, Center for Alzheimer Research, Karolinska Institutet, 17177 Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Storm-Mathisen</LastName><ForeName>Jon</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Division of Anatomy, Department of Molecular Medicine, Institute of Basic Medical Sciences, University of Oslo, 0317 Oslo, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bergersen</LastName><ForeName>Linda Hildegard</ForeName><Initials>LH</Initials><AffiliationInfo><Affiliation>Brain and Muscle Energy Group, Institute of Oral Biology, University of Oslo, 0316 Oslo, Norway; Center for Healthy Aging, Copenhagen University, 2200 Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moggio</LastName><ForeName>Aldo</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Cell and Molecular Biology, Karolinska Institutet, 17177 Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hansson</LastName><ForeName>Emil M</ForeName><Initials>EM</Initials><AffiliationInfo><Affiliation>Department of Cell and Molecular Biology, Karolinska Institutet, 17177 Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ulvmar</LastName><ForeName>Maria H</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>Department of Medical Biochemistry and Microbiology, Uppsala University, 75123 Uppsala, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nilsson</LastName><ForeName>Per</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Neurobiology, Care Sciences and Society, Division of Neurogeriatrics, Center for Alzheimer Research, Karolinska Institutet, 17177 Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>M&#xe4;kinen</LastName><ForeName>Taija</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Immunology, Genetics and Pathology, Rudbeck Laboratory, Uppsala University, 75185 Uppsala, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Andaloussi M&#xe4;e</LastName><ForeName>Maarja</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Immunology, Genetics and Pathology, Rudbeck Laboratory, Uppsala University, 75185 Uppsala, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alitalo</LastName><ForeName>Kari</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Wihuri Research Institute and Translational Cancer Medicine Program, University of Helsinki, 00014 Helsinki, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Proulx</LastName><ForeName>Steven T</ForeName><Initials>ST</Initials><AffiliationInfo><Affiliation>Theodor Kocher Institute, University of Bern, 3012 Bern, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Engelhardt</LastName><ForeName>Britta</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Theodor Kocher Institute, University of Bern, 3012 Bern, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McDonald</LastName><ForeName>Donald M</ForeName><Initials>DM</Initials><AffiliationInfo><Affiliation>Cardiovascular Research Institute, UCSF Helen Diller Family Comprehensive Cancer Center, and Department of Anatomy, University of California, San Francisco, San Francisco, CA 94143, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lendahl</LastName><ForeName>Urban</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>Department of Cell and Molecular Biology, Karolinska Institutet, 17177 Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Andrae</LastName><ForeName>Johanna</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Immunology, Genetics and Pathology, Rudbeck Laboratory, Uppsala University, 75185 Uppsala, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Betsholtz</LastName><ForeName>Christer</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Immunology, Genetics and Pathology, Rudbeck Laboratory, Uppsala University, 75185 Uppsala, Sweden; Department of Medicine Huddinge, Karolinska Institutet, 14157 Huddinge, Sweden. Electronic address: christer.betsholtz@igp.uu.se.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>09</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Neuron</MedlineTA><NlmUniqueID>8809320</NlmUniqueID><ISSNLinking>0896-6273</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008578" MajorTopicYN="Y">Meninges</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001099" MajorTopicYN="Y">Arachnoid</DescriptorName><QualifierName UI="Q000033" MajorTopicYN="N">anatomy &amp; histology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010841" MajorTopicYN="N">Pia Mater</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002831" MajorTopicYN="N">Choroid Plexus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">arachnoid barrier</Keyword><Keyword MajorTopicYN="N">arachnoid mater</Keyword><Keyword MajorTopicYN="N">brain fibroblasts</Keyword><Keyword MajorTopicYN="N">dura mater</Keyword><Keyword MajorTopicYN="N">leptomeninges</Keyword><Keyword MajorTopicYN="N">perivascular fibroblast</Keyword><Keyword MajorTopicYN="N">pia mater</Keyword><Keyword MajorTopicYN="N">single-cell RNA sequencing</Keyword><Keyword MajorTopicYN="N">traumatic brain injury</Keyword><Keyword MajorTopicYN="N">tricellular junction</Keyword></KeywordList><CoiStatement>Declaration of interests The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>10</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>7</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>9</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>12</Month><Day>17</Day><Hour>9</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>10</Month><Day>1</Day><Hour>4</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>9</Month><Day>30</Day><Hour>18</Hour><Minute>42</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37776854</ArticleId><ArticleId IdType="doi">10.1016/j.neuron.2023.09.002</ArticleId><ArticleId IdType="pii">S0896-6273(23)00666-9</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37791598</PMID><DateCompleted><Year>2024</Year><Month>02</Month><Day>22</Day></DateCompleted><DateRevised><Year>2024</Year><Month>07</Month><Day>15</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1552-5279</ISSN><JournalIssue CitedMedium="Internet"><Volume>20</Volume><Issue>2</Issue><PubDate><Year>2024</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Alzheimer's &amp; dementia : the journal of the Alzheimer's Association</Title><ISOAbbreviation>Alzheimers Dement</ISOAbbreviation></Journal><ArticleTitle>APOE Christchurch-mimetic therapeutic antibody reduces APOE-mediated toxicity and tau phosphorylation.</ArticleTitle><Pagination><StartPage>819</StartPage><EndPage>836</EndPage><MedlinePgn>819-836</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/alz.13436</ELocationID><Abstract><AbstractText Label="INTRODUCTION">We discovered that the APOE3 Christchurch (APOE3Ch) variant may provide resistance to Alzheimer's disease (AD). This resistance may be due to reduced pathological interactions between ApoE3Ch and heparan sulfate proteoglycans (HSPGs).</AbstractText><AbstractText Label="METHODS">We developed and characterized the binding, structure, and preclinical efficacy of novel antibodies targeting human ApoE-HSPG interactions.</AbstractText><AbstractText Label="RESULTS">We found that one of these antibodies, called 7C11, preferentially bound ApoE4, a major risk factor for sporadic AD, and disrupts heparin-ApoE4 interactions. We also determined the crystal structure of a Fab fragment of 7C11 and used computer modeling to predict how it would bind to ApoE. When we tested 7C11 in mouse models, we found that it reduced recombinant ApoE-induced tau pathology in the retina of MAPT*P301S mice and curbed pTau S396 phosphorylation in brains of systemically treated APOE4 knock-in mice. Targeting ApoE-HSPG interactions using 7C11 antibody may be a promising approach to developing new therapies for AD.</AbstractText><CopyrightInformation>&#xa9; 2023 The Authors. Alzheimer's &amp; Dementia published by Wiley Periodicals LLC on behalf of Alzheimer's Association.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Marino</LastName><ForeName>Claudia</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-2332-2163</Identifier><AffiliationInfo><Affiliation>Schepens Eye Research Institute of Mass Eye and Ear and Department of Ophthalmology at Harvard Medical School, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perez-Corredor</LastName><ForeName>Paula</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Schepens Eye Research Institute of Mass Eye and Ear and Department of Ophthalmology at Harvard Medical School, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>O'Hare</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Schepens Eye Research Institute of Mass Eye and Ear and Department of Ophthalmology at Harvard Medical School, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Heuer</LastName><ForeName>Annie</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Schepens Eye Research Institute of Mass Eye and Ear and Department of Ophthalmology at Harvard Medical School, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chmielewska</LastName><ForeName>Natalia</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Schepens Eye Research Institute of Mass Eye and Ear and Department of Ophthalmology at Harvard Medical School, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gordon</LastName><ForeName>Harper</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Schepens Eye Research Institute of Mass Eye and Ear and Department of Ophthalmology at Harvard Medical School, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chandrahas</LastName><ForeName>Anita S</ForeName><Initials>AS</Initials><AffiliationInfo><Affiliation>Schepens Eye Research Institute of Mass Eye and Ear and Department of Ophthalmology at Harvard Medical School, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gonzalez-Buendia</LastName><ForeName>Lucia</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Schepens Eye Research Institute of Mass Eye and Ear and Department of Ophthalmology at Harvard Medical School, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Delgado-Tirado</LastName><ForeName>Santiago</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Schepens Eye Research Institute of Mass Eye and Ear and Department of Ophthalmology at Harvard Medical School, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Doan</LastName><ForeName>Tri H</ForeName><Initials>TH</Initials><AffiliationInfo><Affiliation>Schepens Eye Research Institute of Mass Eye and Ear and Department of Ophthalmology at Harvard Medical School, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vanderleest</LastName><ForeName>Timothy E</ForeName><Initials>TE</Initials><AffiliationInfo><Affiliation>Schepens Eye Research Institute of Mass Eye and Ear and Department of Ophthalmology at Harvard Medical School, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arevalo-Alquichire</LastName><ForeName>Said</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Schepens Eye Research Institute of Mass Eye and Ear and Department of Ophthalmology at Harvard Medical School, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Obar</LastName><ForeName>Robert A</ForeName><Initials>RA</Initials><AffiliationInfo><Affiliation>Department of Cell Biology, Harvard Medical School, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ortiz-Cordero</LastName><ForeName>Carolina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Chemistry, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Villegas</LastName><ForeName>Andres</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Grupo de Neurociencias de Antioquia, Facultad de Medicina, Universidad de Antioquia, Medell&#xed;n, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sepulveda-Falla</LastName><ForeName>Diego</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Molecular Neuropathology of Alzheimer's Disease, Institute of Neuropathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Leo A</ForeName><Initials>LA</Initials><AffiliationInfo><Affiliation>Schepens Eye Research Institute of Mass Eye and Ear and Department of Ophthalmology at Harvard Medical School, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lopera</LastName><ForeName>Francisco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Grupo de Neurociencias de Antioquia, Facultad de Medicina, Universidad de Antioquia, Medell&#xed;n, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mahley</LastName><ForeName>Robert</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Gladstone Institute of Neurological Disease, San Francisco, California, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Gladstone Institute of Cardiovascular Disease, San Francisco, California, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathology, UCSF, San Francisco, California, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, UCSF, San Francisco, California, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Cardiovascular Research Institute, UCSF, San Francisco, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Yadong</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Gladstone Institute of Neurological Disease, San Francisco, California, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Gladstone Institute of Cardiovascular Disease, San Francisco, California, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathology, UCSF, San Francisco, California, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, UCSF, San Francisco, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Quiroz</LastName><ForeName>Yakeel T</ForeName><Initials>YT</Initials><AffiliationInfo><Affiliation>Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arboleda-Velasquez</LastName><ForeName>Joseph F</ForeName><Initials>JF</Initials><AffiliationInfo><Affiliation>Schepens Eye Research Institute of Mass Eye and Ear and Department of Ophthalmology at Harvard Medical School, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 AG054671</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>RF1 NS110048</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>RF1 AG077627</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>DP5 OD019833</GrantID><Acronym>OD</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UH3 NS100121</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 EY003790</GrantID><Acronym>EY</Acronym><Agency>NEI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>10</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Alzheimers Dement</MedlineTA><NlmUniqueID>101231978</NlmUniqueID><ISSNLinking>1552-5260</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D053327">Apolipoprotein E4</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D019812">Heparan Sulfate Proteoglycans</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001057">Apolipoproteins E</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007155">Immunologic Factors</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D053318">Apolipoprotein E3</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053327" MajorTopicYN="Y">Apolipoprotein E4</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019812" MajorTopicYN="N">Heparan Sulfate Proteoglycans</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010766" MajorTopicYN="N">Phosphorylation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001057" MajorTopicYN="N">Apolipoproteins E</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007155" MajorTopicYN="N">Immunologic Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053318" MajorTopicYN="N">Apolipoprotein E3</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Alzheimer's disease</Keyword><Keyword MajorTopicYN="N">ApoE</Keyword><Keyword MajorTopicYN="N">ApoE Christchurch</Keyword><Keyword MajorTopicYN="N">Apolipoprotein E</Keyword><Keyword MajorTopicYN="N">HSPG</Keyword><Keyword MajorTopicYN="N">drug development</Keyword><Keyword MajorTopicYN="N">heparan sulfate proteoglycan</Keyword><Keyword MajorTopicYN="N">heparin</Keyword><Keyword MajorTopicYN="N">tau phosphorylation</Keyword><Keyword MajorTopicYN="N">tauopathy</Keyword><Keyword MajorTopicYN="N">therapeutic antibody</Keyword></KeywordList><CoiStatement>Drs Y. Quiroz, F. Lopera and J. Arboleda&#x2010;Velasquez are inventors on a patent filed by Mass General Brigham to leverage therapeutics inspired by the APOE Christchurch findings. Dr Y. Quiroz received grants from the National Institute on Aging, the Alzheimer's Association and Massachusetts General Hospital ECOR. Dr Y. Quiroz is and Editorial Board Member of this journal but was not involved in the peer&#x2010;review process nor had access to any information regarding its peer&#x2010;review and serves as a consultant for Biogen. Drs. J. Arboleda&#x2010;Velasquez and L. A. Kim are co&#x2010;founders of Epoch Biotech, an LLC developing resilient case&#x2010;inspired therapeutics.&#xa0;F. Lopera received consulting fees from Biogen and Tecnoquimicas. All other authors have no conflicts to disclose. Author disclosures are available in the supporting information.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>7</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>1</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>8</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>2</Month><Day>22</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>10</Month><Day>4</Day><Hour>12</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>10</Month><Day>4</Day><Hour>7</Hour><Minute>2</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>10</Month><Day>4</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37791598</ArticleId><ArticleId IdType="pmc">PMC10916992</ArticleId><ArticleId IdType="doi">10.1002/alz.13436</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Jiwaji Z, Tiwari SS, Aviles&#x2010;Reyes RX, et&#xa0;al. Reactive astrocytes acquire neuroprotective as well as deleterious signatures in response to Tau and Ass pathology. Nat Commun. 2022;13(1):135.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8748982</ArticleId><ArticleId IdType="pubmed">35013236</ArticleId></ArticleIdList></Reference><Reference><Citation>Neddens J, Temmel M, Flunkert S, et&#xa0;al. Phosphorylation of different tau sites during progression of Alzheimer's disease. Acta Neuropathol Commun. 2018;6(1):52.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6027763</ArticleId><ArticleId IdType="pubmed">29958544</ArticleId></ArticleIdList></Reference><Reference><Citation>Karlawish J, Grill JD. The approval of Aduhelm risks eroding public trust in Alzheimer research and the FDA. Nat Rev Neurol. 2021;17(9):523&#x2010;524.</Citation><ArticleIdList><ArticleId IdType="pubmed">34267383</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanzi RE. FDA approval of aduhelm paves a new path for Alzheimer's disease. ACS Chem Neurosci. 2021;12(15):2714&#x2010;2715.</Citation><ArticleIdList><ArticleId IdType="pubmed">34259498</ArticleId></ArticleIdList></Reference><Reference><Citation>Sevigny J, Chiao P, Bussi&#xe8;re T, et&#xa0;al. The antibody aducanumab reduces A&#x3b2; plaques in Alzheimer's disease. Nature. 2016;537(7618):50&#x2010;56.</Citation><ArticleIdList><ArticleId IdType="pubmed">27582220</ArticleId></ArticleIdList></Reference><Reference><Citation>van Dyck CH, Swanson CJ, Aisen P, et&#xa0;al. Lecanemab in early Alzheimer's disease. N Engl J Med. 2022.</Citation><ArticleIdList><ArticleId IdType="pubmed">36449413</ArticleId></ArticleIdList></Reference><Reference><Citation>Corder EH, Saunders AM, Risch NJ, et&#xa0;al. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nat Genet. 1994;7(2):180&#x2010;184.</Citation><ArticleIdList><ArticleId IdType="pubmed">7920638</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahley RW, Huang Y. Pathogenesis of type III hyperlipoproteinemia (dysbetalipoproteinemia). Questions, quandaries, and paradoxes. J Lipid Res. 1999;40(11):1933&#x2010;1949.</Citation><ArticleIdList><ArticleId IdType="pubmed">10552997</ArticleId></ArticleIdList></Reference><Reference><Citation>Reiman EM, Arboleda&#x2010;Velasquez JF, Quiroz YT, et&#xa0;al. Exceptionally low likelihood of Alzheimer's dementia in APOE2 homozygotes from a 5,000&#x2010;person neuropathological study. Nat Commun. 2020;11(1):667.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6997393</ArticleId><ArticleId IdType="pubmed">32015339</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu CC, Liu CC, Kanekiyo T, Xu H, Bu G. Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy. Nat Rev Neurol. 2013;9(2):106&#x2010;118.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3726719</ArticleId><ArticleId IdType="pubmed">23296339</ArticleId></ArticleIdList></Reference><Reference><Citation>Saddiki H, Fayosse A, Cognat E, et&#xa0;al. Age and the association between apolipoprotein E genotype and Alzheimer disease: a cerebrospinal fluid biomarker&#x2010;based case&#x2010;control study. PLoS Med. 2020;17(8):e1003289.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7446786</ArticleId><ArticleId IdType="pubmed">32817639</ArticleId></ArticleIdList></Reference><Reference><Citation>Cacace R, Sleegers K, Van Broeckhoven C. Molecular genetics of early&#x2010;onset Alzheimer's disease revisited. Alzheimers Dement. 2016;12(6):733&#x2010;748.</Citation><ArticleIdList><ArticleId IdType="pubmed">27016693</ArticleId></ArticleIdList></Reference><Reference><Citation>Arboleda&#x2010;Velasquez JF, Lopera F, O'Hare M, et&#xa0;al. Resistance to autosomal dominant Alzheimer's disease in an APOE3 Christchurch homozygote: a case report. Nat Med. 2019;25(11):1680&#x2010;1683.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6898984</ArticleId><ArticleId IdType="pubmed">31686034</ArticleId></ArticleIdList></Reference><Reference><Citation>Sepulveda&#x2010;Falla D, Sanchez JS, Almeida MC, et&#xa0;al. Distinct tau neuropathology and cellular profiles of an APOE3 Christchurch homozygote protected against autosomal dominant Alzheimer's dementia. Acta Neuropathol. 2022;144(3):589&#x2010;601.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9381462</ArticleId><ArticleId IdType="pubmed">35838824</ArticleId></ArticleIdList></Reference><Reference><Citation>Wardell MR, Brennan SO, Janus ED, Fraser R, Carrell RW. Apolipoprotein E2&#x2010;Christchurch (136 Arg&#x2014;&#x2010;Ser). New variant of human apolipoprotein E in a patient with type III hyperlipoproteinemia. J Clin Invest. 1987;80(2):483&#x2010;490.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC442261</ArticleId><ArticleId IdType="pubmed">3038959</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahley RW, Ji ZS. Remnant lipoprotein metabolism: key pathways involving cell&#x2010;surface heparan sulfate proteoglycans and apolipoprotein E. J Lipid Res. 1999;40(1):1&#x2010;16.</Citation><ArticleIdList><ArticleId IdType="pubmed">9869645</ArticleId></ArticleIdList></Reference><Reference><Citation>Rauch JN, Chen JJ, Sorum AW, et&#xa0;al. Tau internalization is regulated by 6&#x2010;O sulfation on heparan sulfate proteoglycans (HSPGs). Sci Rep. 2018;8(1):6382.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5913225</ArticleId><ArticleId IdType="pubmed">29686391</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu CC, Zhao N, Yamaguchi Y, et&#xa0;al. Neuronal heparan sulfates promote amyloid pathology by modulating brain amyloid&#x2010;beta clearance and aggregation in Alzheimer's disease. Sci Transl Med. 2016;8(332):332ra44.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5512541</ArticleId><ArticleId IdType="pubmed">27030596</ArticleId></ArticleIdList></Reference><Reference><Citation>Holmes BB, DeVos SL, Kfoury N, et&#xa0;al. Heparan sulfate proteoglycans mediate internalization and propagation of specific proteopathic seeds. Proc Natl Acad Sci U S A. 2013;110(33):E3138&#x2010;E3147.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3746848</ArticleId><ArticleId IdType="pubmed">23898162</ArticleId></ArticleIdList></Reference><Reference><Citation>Leveugle B, Ding W, Laurence F, et&#xa0;al. Heparin oligosaccharides that pass the blood&#x2010;brain barrier inhibit beta&#x2010;amyloid precursor protein secretion and heparin binding to beta&#x2010;amyloid peptide. J Neurochem. 1998;70(2):736&#x2010;744.</Citation><ArticleIdList><ArticleId IdType="pubmed">9453569</ArticleId></ArticleIdList></Reference><Reference><Citation>Saroja SR, Gorbachev K, Julia TCW, Goate AM, Pereira AC. Astrocyte&#x2010;secreted glypican&#x2010;4 drives APOE4&#x2010;dependent tau pathology. BioRxiv. 2021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9407658</ArticleId><ArticleId IdType="pubmed">35969759</ArticleId></ArticleIdList></Reference><Reference><Citation>Bu G. APOE targeting strategy in Alzheimer's disease: lessons learned from protective variants. Mol Neurodegener. 2022;17(1):51.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9351235</ArticleId><ArticleId IdType="pubmed">35922805</ArticleId></ArticleIdList></Reference><Reference><Citation>Jendresen CB, Cui H, Zhang X, Vlodavsky I, Nilsson LN, Li JP. Overexpression of heparanase lowers the amyloid burden in amyloid&#x2010;beta precursor protein transgenic mice. J Biol Chem. 2015;290(8):5053&#x2010;5064.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4335241</ArticleId><ArticleId IdType="pubmed">25548284</ArticleId></ArticleIdList></Reference><Reference><Citation>Leveugle B, Ding W, Buee L, Fillit HM. Interleukin&#x2010;1 and nerve growth factor induce hypersecretion and hypersulfation of neuroblastoma proteoglycans which bind beta&#x2010;amyloid. J Neuroimmunol. 1995;60(1&#x2010;2):151&#x2010;160.</Citation><ArticleIdList><ArticleId IdType="pubmed">7642743</ArticleId></ArticleIdList></Reference><Reference><Citation>Wesener DA, Wangkanont K, McBride R, et&#xa0;al. Recognition of microbial glycans by human intelectin&#x2010;1. Nat Struct Mol Biol. 2015;22(8):603&#x2010;610.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4526365</ArticleId><ArticleId IdType="pubmed">26148048</ArticleId></ArticleIdList></Reference><Reference><Citation>Day ES, Capili AD, Borysenko CW, Zafari M, Whitty A. Determining the affinity and stoichiometry of interactions between unmodified proteins in solution using Biacore. Anal Biochem. 2013;440(1):96&#x2010;107.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8627677</ArticleId><ArticleId IdType="pubmed">23711722</ArticleId></ArticleIdList></Reference><Reference><Citation>Dessau MA, Modis Y. Protein crystallization for X&#x2010;ray crystallography. J Vis Exp;2011(47).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3182643</ArticleId><ArticleId IdType="pubmed">21304455</ArticleId></ArticleIdList></Reference><Reference><Citation>Toth EA. Molecular replacement. Methods Mol Biol. 2007;364:121&#x2010;148.</Citation><ArticleIdList><ArticleId IdType="pubmed">17172763</ArticleId></ArticleIdList></Reference><Reference><Citation>Berman HM, Westbrook J, Feng Z, et&#xa0;al. The protein data bank. Nucleic Acids Res. 2000;28(1):235&#x2010;242.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC102472</ArticleId><ArticleId IdType="pubmed">10592235</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamauchi Y, Deguchi N, Takagi C, et&#xa0;al. Role of the N&#x2010; and C&#x2010;terminal domains in binding of apolipoprotein E isoforms to heparan sulfate and dermatan sulfate: a surface plasmon resonance study. Biochemistry. 2008;47(25):6702&#x2010;6710.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2844924</ArticleId><ArticleId IdType="pubmed">18507396</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou J, Tsao HK, Sheng YJ, Jiang S. Monte Carlo simulations of antibody adsorption and orientation on charged surfaces. J Chem Phys. 2004;121(2):1050&#x2010;1057.</Citation><ArticleIdList><ArticleId IdType="pubmed">15260639</ArticleId></ArticleIdList></Reference><Reference><Citation>Stopschinski BE, Holmes BB, Miller GM, et&#xa0;al. Specific glycosaminoglycan chain length and sulfation patterns are required for cell uptake of tau versus alpha&#x2010;synuclein and beta&#x2010;amyloid aggregates. J Biol Chem. 2018;293(27):10826&#x2010;10840.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6036193</ArticleId><ArticleId IdType="pubmed">29752409</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazzarino RC, Perez&#x2010;Corredor P, Vanderleest TE, et&#xa0;al. APOE3 Christchurch modulates tau phosphorylation and &#x3b2;&#x2010;catenin/Wnt/Cadherin signaling in induced pluripotent stem cell&#x2010;derived cerebral organoids from Alzheimer's cases. bioRxiv. 2023.</Citation></Reference><Reference><Citation>Jen LS, Hart AJ, Jen A, et&#xa0;al. Alzheimer's peptide kills cells of retina in vivo. Nature. 1998;392(6672):140&#x2010;141.</Citation><ArticleIdList><ArticleId IdType="pubmed">9515959</ArticleId></ArticleIdList></Reference><Reference><Citation>Koronyo&#x2010;Hamaoui M, Koronyo Y, Ljubimov AV, et&#xa0;al. Identification of amyloid plaques in retinas from Alzheimer's patients and noninvasive in vivo optical imaging of retinal plaques in a mouse model. Neuroimage. 2011;54(1):S204&#x2010;S217. Suppl.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2991559</ArticleId><ArticleId IdType="pubmed">20550967</ArticleId></ArticleIdList></Reference><Reference><Citation>Dutescu RM, Li QX, Crowston J, Masters CL, Baird PN, Culvenor JG. Amyloid precursor protein processing and retinal pathology in mouse models of Alzheimer's disease. Graefes Arch Clin Exp Ophthalmol. 2009;247(9):1213&#x2010;1221.</Citation><ArticleIdList><ArticleId IdType="pubmed">19271231</ArticleId></ArticleIdList></Reference><Reference><Citation>Schon C, Hoffmann NA, Ochs SM, et&#xa0;al. Long&#x2010;term in vivo imaging of fibrillar tau in the retina of P301S transgenic mice. PLoS One. 2012;7(12):e53547.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3534024</ArticleId><ArticleId IdType="pubmed">23300938</ArticleId></ArticleIdList></Reference><Reference><Citation>Mey J, Thanos S. Intravitreal injections of neurotrophic factors support the survival of axotomized retinal ganglion cells in adult rats in vivo. Brain Res. 1993;602(2):304&#x2010;317.</Citation><ArticleIdList><ArticleId IdType="pubmed">8448673</ArticleId></ArticleIdList></Reference><Reference><Citation>Mansour&#x2010;Robaey S, Clarke DB, Wang YC, Bray GM, Aguayo AJ. Effects of ocular injury and administration of brain&#x2010;derived neurotrophic factor on survival and regrowth of axotomized retinal ganglion cells. Proc Natl Acad Sci U S A. 1994;91(5):1632&#x2010;1636.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC43217</ArticleId><ArticleId IdType="pubmed">8127857</ArticleId></ArticleIdList></Reference><Reference><Citation>Braak H, Braak E. Evolution of the neuropathology of Alzheimer's disease. Acta Neurol Scand Suppl. 1996;165:3&#x2010;12.</Citation><ArticleIdList><ArticleId IdType="pubmed">8740983</ArticleId></ArticleIdList></Reference><Reference><Citation>Martens YA, Zhao N, Liu CC, et&#xa0;al. ApoE Cascade Hypothesis in the pathogenesis of Alzheimer's disease and related dementias. Neuron. 2022;110(8):1304&#x2010;1317.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9035117</ArticleId><ArticleId IdType="pubmed">35298921</ArticleId></ArticleIdList></Reference><Reference><Citation>Brecht WJ, Harris FM, Chang S, et&#xa0;al. Neuron&#x2010;specific apolipoprotein e4 proteolysis is associated with increased tau phosphorylation in brains of transgenic mice. J Neurosci. 2004;24(10):2527&#x2010;2534.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6729489</ArticleId><ArticleId IdType="pubmed">15014128</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao F, Hori Y, Hudry E, et&#xa0;al. Anti&#x2010;ApoE antibody given after plaque onset decreases Abeta accumulation and improves brain function in a mouse model of Abeta amyloidosis. J Neurosci. 2014;34(21):7281&#x2010;7292.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4028501</ArticleId><ArticleId IdType="pubmed">24849360</ArticleId></ArticleIdList></Reference><Reference><Citation>Gratuze M, Jiang H, Wang C, Xiong M, Bao X, Holtzman DM. APOE antibody inhibits abeta&#x2010;associated tau seeding and spreading in a mouse model. Ann Neurol. 2022;91(6):847&#x2010;852.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9285984</ArticleId><ArticleId IdType="pubmed">35285073</ArticleId></ArticleIdList></Reference><Reference><Citation>Tai LM, Ghura S, Koster KP, et&#xa0;al. APOE&#x2010;modulated A&#x3b2;&#x2010;induced neuroinflammation in Alzheimer's disease: current landscape, novel data, and future perspective. J Neurochem. 2015;133(4):465&#x2010;488.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4400246</ArticleId><ArticleId IdType="pubmed">25689586</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahley RW, Huang Y. Apolipoprotein e sets the stage: response to injury triggers neuropathology. Neuron. 2012;76(5):871&#x2010;885.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4891195</ArticleId><ArticleId IdType="pubmed">23217737</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu CC, Murray ME, Li X, et&#xa0;al. APOE3&#x2010;Jacksonville (V236E) variant reduces self&#x2010;aggregation and risk of dementia. Sci Transl Med. 2021;13(613):eabc9375.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8824726</ArticleId><ArticleId IdType="pubmed">34586832</ArticleId></ArticleIdList></Reference><Reference><Citation>Raulin AC, Kraft L, Al&#x2010;Hilaly YK, et&#xa0;al. The molecular basis for apolipoprotein E4 as the major risk factor for late&#x2010;onset Alzheimer's disease. J Mol Biol. 2019;431(12):2248&#x2010;2265.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6556554</ArticleId><ArticleId IdType="pubmed">31051176</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37812432</PMID><DateCompleted><Year>2023</Year><Month>11</Month><Day>14</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>10</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2168-6157</ISSN><JournalIssue CitedMedium="Internet"><Volume>80</Volume><Issue>11</Issue><PubDate><Year>2023</Year><Month>Nov</Month><Day>01</Day></PubDate></JournalIssue><Title>JAMA neurology</Title><ISOAbbreviation>JAMA Neurol</ISOAbbreviation></Journal><ArticleTitle>Tau Oligomer-Containing Synapse Elimination by Microglia and Astrocytes in Alzheimer Disease.</ArticleTitle><Pagination><StartPage>1209</StartPage><EndPage>1221</EndPage><MedlinePgn>1209-1221</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1001/jamaneurol.2023.3530</ELocationID><Abstract><AbstractText Label="IMPORTANCE">Factors associated with synapse loss beyond amyloid-&#x3b2; plaques and neurofibrillary tangles may more closely correlate with the emergence of cognitive deficits in Alzheimer disease (AD) and be relevant for early therapeutic intervention.</AbstractText><AbstractText Label="OBJECTIVE">To investigate whether accumulation of tau oligomers in synapses is associated with excessive synapse elimination by microglia or astrocytes and with cognitive outcomes (dementia vs no dementia [hereinafter termed resilient]) of individuals with equal burdens of AD neuropathologic changes at autopsy.</AbstractText><AbstractText Label="DESIGN, SETTING, AND PARTICIPANTS">This cross-sectional postmortem study included 40 human brains from the Massachusetts Alzheimer Disease Research Center Brain Bank with Braak III to IV stages of tau pathology but divergent antemortem cognition (dementia vs resilient) and cognitively normal controls with negligible AD neuropathologic changes. The visual cortex, a region without tau tangle deposition at Braak III to IV stages, was assessed after expansion microscopy to analyze spatial relationships of synapses with microglia and astrocytes. Participants were matched for age, sex, and apolipoprotein E status. Evidence of Lewy bodies, TDP-43 aggregates, or other lesions different from AD neuropathology were exclusion criteria. Tissue was collected from July 1998 to November 2020, and analyses were conducted from February 1, 2022, through May 31, 2023.</AbstractText><AbstractText Label="MAIN OUTCOMES AND MEASURES">Amyloid-&#x3b2; plaques, tau neuropil thread burden, synapse density, tau oligomers in synapses, and internalization of tau oligomer-tagged synapses by microglia and astrocytes were quantitated. Analyses were performed using 1-way analysis of variance for parametric variables and the Kruskal-Wallis test for nonparametric variables; between-group differences were evaluated with Holm-&#x160;&#xed;d&#xe1;k tests.</AbstractText><AbstractText Label="RESULTS">Of 40 included participants (mean [SD] age at death, 88 [8] years; 21 [52%] male), 19 had early-stage dementia with Braak stages III to IV, 13 had resilient brains with similar Braak stages III to IV, and 8 had no dementia (Braak stages 0-II). Brains with dementia but not resilient brains had substantial loss of presynaptic (43%), postsynaptic (33%), and colocalized mature synaptic elements (38%) compared with controls and significantly higher percentages of mature synapses internalized by IBA1-positive microglia (mean [SD], 13.3% [3.9%] in dementia vs 2.6% [1.9%] in resilient vs 0.9% [0.5%] in control; P&#x2009;&lt;&#x2009;.001) and by GFAP-positive astrocytes (mean [SD], 17.2% [10.9%] in dementia vs 3.7% [4.0%] in resilient vs 2.7% [1.8%] in control; P&#x2009;=&#x2009;.001). In brains with dementia but not in resilient brains, tau oligomers more often colocalized with synapses, and the proportions of tau oligomer-containing synapses inside microglia (mean [SD] for presynapses, mean [SD], 7.4% [1.8%] in dementia vs 5.1% [1.9%] resilient vs 3.7% [0.8%] control; P&#x2009;=&#x2009;.006; and for postsynapses 11.6% [3.6%] dementia vs 6.8% [1.3%] resilient vs 7.4% [2.5%] control; P&#x2009;=&#x2009;.001) and astrocytes (mean [SD] for presynapses, 7.0% [2.1%] dementia vs 4.3% [2.2%] resilient vs 4.0% [0.7%] control; P&#x2009;=&#x2009;.001; and for postsynapses, 7.9% [2.2%] dementia vs 5.3% [1.8%] resilient vs 3.0% [1.5%] control; P&#x2009;&lt;&#x2009;.001) were significantly increased compared with controls. Those changes in brains with dementia occurred in the absence of tau tangle deposition in visual cortex.</AbstractText><AbstractText Label="CONCLUSION AND RELEVANCE">The findings from this cross-sectional study suggest that microglia and astrocytes may excessively engulf synapses in brains of individuals with dementia and that the abnormal presence of tau oligomers in synapses may serve as signals for increased glial-mediated synapse elimination and early loss of brain function in AD.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Taddei</LastName><ForeName>Raquel N</ForeName><Initials>RN</Initials><AffiliationInfo><Affiliation>Neurology Department, Massachusetts General Hospital, Harvard University, Boston, Massachusetts.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Dementia Research Institute, University College London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perbet</LastName><ForeName>Romain</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Neurology Department, Massachusetts General Hospital, Harvard University, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mate de Gerando</LastName><ForeName>Anastasie</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Neurology Department, Massachusetts General Hospital, Harvard University, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wiedmer</LastName><ForeName>Anne E</ForeName><Initials>AE</Initials><AffiliationInfo><Affiliation>Neurology Department, Massachusetts General Hospital, Harvard University, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sanchez-Mico</LastName><ForeName>Maria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Neurology Department, Massachusetts General Hospital, Harvard University, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Connors Stewart</LastName><ForeName>Theresa</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>C.S. Kubik Laboratory for Neuropathology, Massachusetts General Hospital, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gaona</LastName><ForeName>Angelica</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>C.S. Kubik Laboratory for Neuropathology, Massachusetts General Hospital, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Melloni</LastName><ForeName>Alexandra</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>C.S. Kubik Laboratory for Neuropathology, Massachusetts General Hospital, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Amaral</LastName><ForeName>Ana C</ForeName><Initials>AC</Initials><AffiliationInfo><Affiliation>Neurology Department, Massachusetts General Hospital, Harvard University, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Duff</LastName><ForeName>Karen</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Neurology, Dementia Research Institute, University College London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Frosch</LastName><ForeName>Matthew P</ForeName><Initials>MP</Initials><AffiliationInfo><Affiliation>C.S. Kubik Laboratory for Neuropathology, Massachusetts General Hospital, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>G&#xf3;mez-Isla</LastName><ForeName>Teresa</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Neurology Department, Massachusetts General Hospital, Harvard University, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R56 AG069192</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JAMA Neurol</MedlineTA><NlmUniqueID>101589536</NlmUniqueID><ISSNLinking>2168-6149</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016229">Amyloid beta-Peptides</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>JAMA Neurol. 2023 Nov 1;80(11):1136-1137. doi: 10.1001/jamaneurol.2023.3539.</RefSource><PMID Version="1">37812438</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001253" MajorTopicYN="N">Astrocytes</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017628" MajorTopicYN="N">Microglia</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009457" MajorTopicYN="N">Neuroglia</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016229" MajorTopicYN="N">Amyloid beta-Peptides</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013569" MajorTopicYN="N">Synapses</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading></MeshHeadingList><CoiStatement><b>Conflict of Interest Disclosures:</b> Dr G&#xf3;mez-Isla reported receiving personal fees from Eli Lilly and Company outside the submitted work. No other disclosures were reported.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>11</Month><Day>14</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>10</Month><Day>9</Day><Hour>12</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>10</Month><Day>9</Day><Hour>11</Hour><Minute>34</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>9</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37812432</ArticleId><ArticleId IdType="pmc">PMC10562992</ArticleId><ArticleId IdType="doi">10.1001/jamaneurol.2023.3530</ArticleId><ArticleId IdType="pii">2809939</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>DeKosky ST, Scheff SW. Synapse loss in frontal cortex biopsies in Alzheimer&#x2019;s disease: correlation with cognitive severity. Ann Neurol. 1990;27(5):457-464. doi:10.1002/ana.410270502</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.410270502</ArticleId><ArticleId IdType="pubmed">2360787</ArticleId></ArticleIdList></Reference><Reference><Citation>Henstridge CM, Tzioras M, Paolicelli RC. Glial contribution to excitatory and inhibitory synapse loss in neurodegeneration. Front Cell Neurosci. 2019;13:63. doi:10.3389/fncel.2019.00063</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2019.00063</ArticleId><ArticleId IdType="pmc">PMC6399113</ArticleId><ArticleId IdType="pubmed">30863284</ArticleId></ArticleIdList></Reference><Reference><Citation>Vogels T, Murgoci AN, Hrom&#xe1;dka T. Intersection of pathological tau and microglia at the synapse. Acta Neuropathol Commun. 2019;7(1):109. doi:10.1186/s40478-019-0754-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-019-0754-y</ArticleId><ArticleId IdType="pmc">PMC6612163</ArticleId><ArticleId IdType="pubmed">31277708</ArticleId></ArticleIdList></Reference><Reference><Citation>Crystal H, Dickson D, Fuld P, et al. . Clinico-pathologic studies in dementia: nondemented subjects with pathologically confirmed Alzheimer&#x2019;s disease. Neurology. 1988;38(11):1682-1687. doi:10.1212/WNL.38.11.1682</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.38.11.1682</ArticleId><ArticleId IdType="pubmed">3185902</ArticleId></ArticleIdList></Reference><Reference><Citation>Katzman R, Terry R, DeTeresa R, et al. . Clinical, pathological, and neurochemical changes in dementia: a subgroup with preserved mental status and numerous neocortical plaques. Ann Neurol. 1988;23(2):138-144. doi:10.1002/ana.410230206</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.410230206</ArticleId><ArticleId IdType="pubmed">2897823</ArticleId></ArticleIdList></Reference><Reference><Citation>Gelber RP, Launer LJ, White LR. The Honolulu-Asia Aging Study: epidemiologic and neuropathologic research on cognitive impairment. Curr Alzheimer Res. 2012;9(6):664-672. doi:10.2174/156720512801322618</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/156720512801322618</ArticleId><ArticleId IdType="pmc">PMC4795939</ArticleId><ArticleId IdType="pubmed">22471866</ArticleId></ArticleIdList></Reference><Reference><Citation>Snowdon DA; Nun Study . Healthy aging and dementia: findings from the Nun Study. Ann Intern Med. 2003;139(5, pt 2):450-454. doi:10.7326/0003-4819-139-5_Part_2-200309021-00014</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-139-5_Part_2-200309021-00014</ArticleId><ArticleId IdType="pubmed">12965975</ArticleId></ArticleIdList></Reference><Reference><Citation>Perez-Nievas BG, Stein TD, Tai HC, et al. . Dissecting phenotypic traits linked to human resilience to Alzheimer&#x2019;s pathology. Brain. 2013;136(Pt 8):2510-2526. doi:10.1093/brain/awt171</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awt171</ArticleId><ArticleId IdType="pmc">PMC3722351</ArticleId><ArticleId IdType="pubmed">23824488</ArticleId></ArticleIdList></Reference><Reference><Citation>Barroeta-Espar I, Weinstock LD, Perez-Nievas BG, et al. . Distinct cytokine profiles in human brains resilient to Alzheimer&#x2019;s pathology. Neurobiol Dis. 2019;121:327-337. doi:10.1016/j.nbd.2018.10.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2018.10.009</ArticleId><ArticleId IdType="pmc">PMC6437670</ArticleId><ArticleId IdType="pubmed">30336198</ArticleId></ArticleIdList></Reference><Reference><Citation>Taddei RN, Sanchez-Mico MV, Bonnar O, et al. . Changes in glial cell phenotypes precede overt neurofibrillary tangle formation, correlate with markers of cortical cell damage, and predict cognitive status of individuals at Braak III-IV stages. Acta Neuropathol Commun. 2022;10(1):72. doi:10.1186/s40478-022-01370-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-022-01370-3</ArticleId><ArticleId IdType="pmc">PMC9082857</ArticleId><ArticleId IdType="pubmed">35534858</ArticleId></ArticleIdList></Reference><Reference><Citation>Paasila PJ, Davies DS, Sutherland GT, Goldsbury C. Clustering of activated microglia occurs before the formation of dystrophic neurites in the evolution of A&#x3b2; plaques in Alzheimer&#x2019;s disease. Free Neuropathol. 2020;1(0):20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8360389</ArticleId><ArticleId IdType="pubmed">34396367</ArticleId></ArticleIdList></Reference><Reference><Citation>Stevens B, Allen NJ, Vazquez LE, et al. . The classical complement cascade mediates CNS synapse elimination. Cell. 2007;131(6):1164-1178. doi:10.1016/j.cell.2007.10.036</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2007.10.036</ArticleId><ArticleId IdType="pubmed">18083105</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong S, Beja-Glasser VF, Nfonoyim BM, et al. . Complement and microglia mediate early synapse loss in Alzheimer mouse models. Science. 2016;352(6286):712-716. doi:10.1126/science.aad8373</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aad8373</ArticleId><ArticleId IdType="pmc">PMC5094372</ArticleId><ArticleId IdType="pubmed">27033548</ArticleId></ArticleIdList></Reference><Reference><Citation>Tzioras M, Daniels MJD, King D, et al. . Altered synaptic ingestion by human microglia in Alzheimer&#x2019;s disease. bioRxiv. Published online January 1, 2019:795930.</Citation></Reference><Reference><Citation>Bellenguez C, K&#xfc;&#xe7;&#xfc;kali F, Jansen I, et al. New insights into the genetic etiology of Alzheimer's disease and related dementias. Nature Genetics. 2022;54(4):412-436. doi:10.1038/s41588-022-01024-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-022-01024-z</ArticleId><ArticleId IdType="pmc">PMC9005347</ArticleId><ArticleId IdType="pubmed">35379992</ArticleId></ArticleIdList></Reference><Reference><Citation>Paasila PJ, Fok SYY, Flores-Rodriguez N, et al. . Ground state depletion microscopy as a tool for studying microglia-synapse interactions. J Neurosci Res. 2021;99(6):1515-1532. doi:10.1002/jnr.24819</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jnr.24819</ArticleId><ArticleId IdType="pmc">PMC8251743</ArticleId><ArticleId IdType="pubmed">33682204</ArticleId></ArticleIdList></Reference><Reference><Citation>Colom-Cadena M, Davies C, Sirisi S, et al. . Synaptic oligomeric tau in Alzheimer&#x2019;s disease&#x2014;a potential culprit in the spread of tau pathology through the brain. Neuron. 2023;111(14):2170-2183.e6. doi:10.1016/j.neuron.2023.04.020</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2023.04.020</ArticleId><ArticleId IdType="pubmed">37192625</ArticleId></ArticleIdList></Reference><Reference><Citation>Fein JA, Sokolow S, Miller CA, et al. . Co-localization of amyloid beta and tau pathology in Alzheimer&#x2019;s disease synaptosomes. Am J Pathol. 2008;172(6):1683-1692. doi:10.2353/ajpath.2008.070829</Citation><ArticleIdList><ArticleId IdType="doi">10.2353/ajpath.2008.070829</ArticleId><ArticleId IdType="pmc">PMC2408427</ArticleId><ArticleId IdType="pubmed">18467692</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerson J, Castillo-Carranza DL, Sengupta U, et al. . Tau oligomers derived from traumatic brain injury cause cognitive impairment and accelerate onset of pathology in Htau mice. J Neurotrauma. 2016;33(22):2034-2043. doi:10.1089/neu.2015.4262</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/neu.2015.4262</ArticleId><ArticleId IdType="pmc">PMC5116695</ArticleId><ArticleId IdType="pubmed">26729399</ArticleId></ArticleIdList></Reference><Reference><Citation>Lasagna-Reeves CA, Castillo-Carranza DL, Sengupta U, Clos AL, Jackson GR, Kayed R. Tau oligomers impair memory and induce synaptic and mitochondrial dysfunction in wild-type mice. Mol Neurodegener. 2011;6(1):39. doi:10.1186/1750-1326-6-39</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1750-1326-6-39</ArticleId><ArticleId IdType="pmc">PMC3224595</ArticleId><ArticleId IdType="pubmed">21645391</ArticleId></ArticleIdList></Reference><Reference><Citation>Niewiadomska G, Niewiadomski W, Steczkowska M, Gasiorowska A. Tau oligomers neurotoxicity. Life (Basel). 2021;11(1):28.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7824853</ArticleId><ArticleId IdType="pubmed">33418848</ArticleId></ArticleIdList></Reference><Reference><Citation>Shafiei SS, Guerrero-Mu&#xf1;oz MJ, Castillo-Carranza DL. Tau oligomers: cytotoxicity, propagation, and mitochondrial damage. Front Aging Neurosci. 2017;9:83-83. doi:10.3389/fnagi.2017.00083</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2017.00083</ArticleId><ArticleId IdType="pmc">PMC5378766</ArticleId><ArticleId IdType="pubmed">28420982</ArticleId></ArticleIdList></Reference><Reference><Citation>Guerrero-Mu&#xf1;oz MJ, Gerson J, Castillo-Carranza DL. Tau oligomers: the toxic player at synapses in Alzheimer&#x2019;s disease. Front Cell Neurosci. 2015;9:464. doi:10.3389/fncel.2015.00464</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2015.00464</ArticleId><ArticleId IdType="pmc">PMC4667007</ArticleId><ArticleId IdType="pubmed">26696824</ArticleId></ArticleIdList></Reference><Reference><Citation>Pampuscenko K, Morkuniene R, Krasauskas L, Smirnovas V, Tomita T, Borutaite V. Distinct neurotoxic effects of extracellular tau species in primary neuronal-glial cultures. Mol Neurobiol. 2021;58(2):658-667. doi:10.1007/s12035-020-02150-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-020-02150-7</ArticleId><ArticleId IdType="pubmed">33001416</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu M, Zhang M, Yin X, et al. . The role of pathological tau in synaptic dysfunction in Alzheimer&#x2019;s diseases. Transl Neurodegener. 2021;10(1):45. doi:10.1186/s40035-021-00270-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40035-021-00270-1</ArticleId><ArticleId IdType="pmc">PMC8579533</ArticleId><ArticleId IdType="pubmed">34753506</ArticleId></ArticleIdList></Reference><Reference><Citation>Wysocka A, Palasz E, Steczkowska M, Niewiadomska G. Dangerous liaisons: tau interaction with muscarinic receptors. Curr Alzheimer Res. 2020;17(3):224-237. doi:10.2174/1567205017666200424134311</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1567205017666200424134311</ArticleId><ArticleId IdType="pmc">PMC7509759</ArticleId><ArticleId IdType="pubmed">32329686</ArticleId></ArticleIdList></Reference><Reference><Citation>Bilousova T, Miller CA, Poon WW, et al. . Synaptic amyloid-&#x3b2; oligomers precede p-tau and differentiate high pathology control cases. Am J Pathol. 2016;186(1):185-198. doi:10.1016/j.ajpath.2015.09.018</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajpath.2015.09.018</ArticleId><ArticleId IdType="pmc">PMC4715217</ArticleId><ArticleId IdType="pubmed">26718979</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh A, Allen D, Fracassi A, et al. . Functional integrity of synapses in the central nervous system of cognitively intact individuals with high Alzheimer&#x2019;s disease neuropathology is associated with absence of synaptic tau oligomers. J Alzheimers Dis. 2020;78(4):1661-1678. doi:10.3233/JAD-200716</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-200716</ArticleId><ArticleId IdType="pmc">PMC7836055</ArticleId><ArticleId IdType="pubmed">33185603</ArticleId></ArticleIdList></Reference><Reference><Citation>Dejanovic B, Huntley MA, De Mazi&#xe8;re A, et al. . Changes in the synaptic proteome in tauopathy and rescue of tau-induced synapse loss by C1q antibodies. Neuron. 2018;100(6):1322-1336.e7. doi:10.1016/j.neuron.2018.10.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2018.10.014</ArticleId><ArticleId IdType="pubmed">30392797</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanchez-Mejias E, Navarro V, Jimenez S, et al. . Soluble phospho-tau from Alzheimer&#x2019;s disease hippocampus drives microglial degeneration. Acta Neuropathol. 2016;132(6):897-916. doi:10.1007/s00401-016-1630-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-016-1630-5</ArticleId><ArticleId IdType="pmc">PMC5106501</ArticleId><ArticleId IdType="pubmed">27743026</ArticleId></ArticleIdList></Reference><Reference><Citation>Romero-Molina C, Navarro V, Sanchez-Varo R, et al. . Distinct microglial responses in two transgenic murine models of tau pathology. Front Cell Neurosci. 2018;12:421. https://www.frontiersin.org/articles/10.3389/fncel.2018.00421. doi:10.3389/fncel.2018.00421
</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2018.00421</ArticleId><ArticleId IdType="doi">10.3389/fncel.2018.00421</ArticleId><ArticleId IdType="pmc">PMC6246744</ArticleId><ArticleId IdType="pubmed">30487735</ArticleId></ArticleIdList></Reference><Reference><Citation>Brelstaff JH, Mason M, Katsinelos T, et al. . Microglia become hypofunctional and release metalloproteases and tau seeds when phagocytosing live neurons with P301S tau aggregates. Sci Adv. 2021;7(43):eabg4980. doi:10.1126/sciadv.abg4980</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.abg4980</ArticleId><ArticleId IdType="pmc">PMC8528424</ArticleId><ArticleId IdType="pubmed">34669475</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen F, Tillberg PW, Boyden ES. Optical imaging: expansion microscopy. Science. 2015;347(6221):543-548. doi:10.1126/science.1260088</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1260088</ArticleId><ArticleId IdType="pmc">PMC4312537</ArticleId><ArticleId IdType="pubmed">25592419</ArticleId></ArticleIdList></Reference><Reference><Citation>Tillberg PW, Chen F, Piatkevich KD, et al. . Protein-retention expansion microscopy of cells and tissues labeled using standard fluorescent proteins and antibodies. Nat Biotechnol. 2016;34(9):987-992. doi:10.1038/nbt.3625</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt.3625</ArticleId><ArticleId IdType="pmc">PMC5068827</ArticleId><ArticleId IdType="pubmed">27376584</ArticleId></ArticleIdList></Reference><Reference><Citation>Gallagher BR, Zhao Y. Expansion microscopy: a powerful nanoscale imaging tool for neuroscientists. Neurobiol Dis. 2021;154:105362. doi:10.1016/j.nbd.2021.105362</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2021.105362</ArticleId><ArticleId IdType="pmc">PMC8600979</ArticleId><ArticleId IdType="pubmed">33813047</ArticleId></ArticleIdList></Reference><Reference><Citation>Karagiannis ED, Boyden ES. Expansion microscopy: development and neuroscience applications. Curr Opin Neurobiol. 2018;50:56-63. doi:10.1016/j.conb.2017.12.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.conb.2017.12.012</ArticleId><ArticleId IdType="pmc">PMC5984670</ArticleId><ArticleId IdType="pubmed">29316506</ArticleId></ArticleIdList></Reference><Reference><Citation>Vonsattel JPG, Del Amaya MP, Keller CE. Twenty-first century brain banking: processing brains for research: the Columbia University methods. Acta Neuropathol. 2008;115(5):509-532. doi:10.1007/s00401-007-0311-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-007-0311-9</ArticleId><ArticleId IdType="pmc">PMC2292479</ArticleId><ArticleId IdType="pubmed">17985145</ArticleId></ArticleIdList></Reference><Reference><Citation>Thal D, R&#xfc;b U, Schultz C, et al. . Sequence of A&#x3b2;-protein deposition in the human medial temporal lobe. J Neuropathol Exp Neurol. 2000;59(8):733-748.</Citation><ArticleIdList><ArticleId IdType="pubmed">10952063</ArticleId></ArticleIdList></Reference><Reference><Citation>Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 1991;82(4):239-259. doi:10.1007/BF00308809</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF00308809</ArticleId><ArticleId IdType="pubmed">1759558</ArticleId></ArticleIdList></Reference><Reference><Citation>Mirra SS, Heyman A, McKeel D, et al. . The Consortium to Establish a Registry for Alzheimer&#x2019;s Disease (CERAD): part II, standardization of the neuropathologic assessment of Alzheimer&#x2019;s disease. Neurology. 1991;41(4):479-486. doi:10.1212/WNL.41.4.479</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.41.4.479</ArticleId><ArticleId IdType="pubmed">2011243</ArticleId></ArticleIdList></Reference><Reference><Citation>Crary JF, Trojanowski JQ, Schneider JA, et al. . Primary age-related tauopathy (PART): a common pathology associated with human aging. Acta Neuropathol. 2014;128(6):755-766. doi:10.1007/s00401-014-1349-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-014-1349-0</ArticleId><ArticleId IdType="pmc">PMC4257842</ArticleId><ArticleId IdType="pubmed">25348064</ArticleId></ArticleIdList></Reference><Reference><Citation>Weintraub S, Salmon D, Mercaldo N, et al. . The Alzheimer&#x2019;s Disease Centers&#x2019; Uniform Data Set (UDS): the neuropsychologic test battery. Alzheimer Dis Assoc Disord. 2009;23(2):91-101. doi:10.1097/WAD.0b013e318191c7dd</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WAD.0b013e318191c7dd</ArticleId><ArticleId IdType="pmc">PMC2743984</ArticleId><ArticleId IdType="pubmed">19474567</ArticleId></ArticleIdList></Reference><Reference><Citation>Freifeld L, Odstrcil I, F&#xf6;rster D, et al. . Expansion microscopy of zebrafish for neuroscience and developmental biology studies. Proc Natl Acad Sci U S A. 2017;114(50):E10799-E10808. doi:10.1073/pnas.1706281114</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1706281114</ArticleId><ArticleId IdType="pmc">PMC5740639</ArticleId><ArticleId IdType="pubmed">29162696</ArticleId></ArticleIdList></Reference><Reference><Citation>Gallagher B, Zhao Y. Nanoscale imaging of synaptic connections with expansion microscopy. Discoveries (Craiova). 2019;7(3):e101-e101. doi:10.15190/d.2019.14</Citation><ArticleIdList><ArticleId IdType="doi">10.15190/d.2019.14</ArticleId><ArticleId IdType="pmc">PMC7093071</ArticleId><ArticleId IdType="pubmed">32309619</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarkar D, Kang J, Wassie AT, et al. . Expansion revealing: decrowding proteins to unmask invisible brain nanostructures. bioRxiv. Published online January 1, 2020:2020.08.29.273540. doi:10.1101/2020.08.29.273540</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.08.29.273540</ArticleId></ArticleIdList></Reference><Reference><Citation>Asano SM, Gao R, Wassie AT, Tillberg PW, Chen F, Boyden ES. Expansion microscopy: protocols for imaging proteins and RNA in cells and tissues. Curr Protoc Cell Biol. 2018;80(1):e56-e56. doi:10.1002/cpcb.56</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cpcb.56</ArticleId><ArticleId IdType="pmc">PMC6158110</ArticleId><ArticleId IdType="pubmed">30070431</ArticleId></ArticleIdList></Reference><Reference><Citation>Fogarty MJ, Hammond LA, Kanjhan R, Bellingham MC, Noakes PG. A method for the three-dimensional reconstruction of Neurobiotin&#x2122;-filled neurons and the location of their synaptic inputs. Front Neural Circuits. 2013;7:153-153. doi:10.3389/fncir.2013.00153</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncir.2013.00153</ArticleId><ArticleId IdType="pmc">PMC3787200</ArticleId><ArticleId IdType="pubmed">24101895</ArticleId></ArticleIdList></Reference><Reference><Citation>Doorn KJ, Goudriaan A, Blits-Huizinga C, et al. . Increased amoeboid microglial density in the olfactory bulb of Parkinson&#x2019;s and Alzheimer&#x2019;s patients. Brain Pathol. 2014;24(2):152-165. doi:10.1111/bpa.12088</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bpa.12088</ArticleId><ArticleId IdType="pmc">PMC8029318</ArticleId><ArticleId IdType="pubmed">24033473</ArticleId></ArticleIdList></Reference><Reference><Citation>Tai HC, Serrano-Pozo A, Hashimoto T, Frosch MP, Spires-Jones TL, Hyman BT. The synaptic accumulation of hyperphosphorylated tau oligomers in Alzheimer disease is associated with dysfunction of the ubiquitin-proteasome system. Am J Pathol. 2012;181(4):1426-1435. doi:10.1016/j.ajpath.2012.06.033</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajpath.2012.06.033</ArticleId><ArticleId IdType="pmc">PMC3463637</ArticleId><ArticleId IdType="pubmed">22867711</ArticleId></ArticleIdList></Reference><Reference><Citation>DeVos SL, Corjuc BT, Oakley DH, et al. . Synaptic tau seeding precedes tau pathology in human Alzheimer&#x2019;s disease brain. Front Neurosci. 2018;12:267. doi:10.3389/fnins.2018.00267</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2018.00267</ArticleId><ArticleId IdType="pmc">PMC5928393</ArticleId><ArticleId IdType="pubmed">29740275</ArticleId></ArticleIdList></Reference><Reference><Citation>Petry FR, Pelletier J, Bretteville A, et al. . Specificity of anti-tau antibodies when analyzing mice models of Alzheimer&#x2019;s disease: problems and solutions. PLoS One. 2014;9(5):e94251. doi:10.1371/journal.pone.0094251</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0094251</ArticleId><ArticleId IdType="pmc">PMC4008431</ArticleId><ArticleId IdType="pubmed">24788298</ArticleId></ArticleIdList></Reference><Reference><Citation>Sch&#xe4;gger H. Blue-native gels to isolate protein complexes from mitochondria. In: Pon LA, Shon EA, eds. Methods in Cell Biology. Vol 65. Academic Press; 2001:231-244, .</Citation><ArticleIdList><ArticleId IdType="pubmed">11381596</ArticleId></ArticleIdList></Reference><Reference><Citation>Pfeiffer T, Poll S, Bancelin S, et al. . Chronic 2P-STED imaging reveals high turnover of dendritic spines in the hippocampus in vivo. ELife. 2018;7:e34700.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6014725</ArticleId><ArticleId IdType="pubmed">29932052</ArticleId></ArticleIdList></Reference><Reference><Citation>S&#xfc;dhof TC. The cell biology of synapse formation. J Cell Biol. 2021;220(7):e202103052. doi:10.1083/jcb.202103052</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.202103052</ArticleId><ArticleId IdType="pmc">PMC8186004</ArticleId><ArticleId IdType="pubmed">34086051</ArticleId></ArticleIdList></Reference><Reference><Citation>Ward SM, Himmelstein DS, Lancia JK, Fu Y, Patterson KR, Binder LI. TOC1: characterization of a selective oligomeric tau antibody. J Alzheimers Dis. 2013;37(3):593-602. doi:10.3233/JAD-131235</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-131235</ArticleId><ArticleId IdType="pmc">PMC4791958</ArticleId><ArticleId IdType="pubmed">23979027</ArticleId></ArticleIdList></Reference><Reference><Citation>Patterson KR, Remmers C, Fu Y, et al. . Characterization of prefibrillar tau oligomers in vitro and in Alzheimer disease. J Biol Chem. 2011;286(26):23063-23076. doi:10.1074/jbc.M111.237974</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M111.237974</ArticleId><ArticleId IdType="pmc">PMC3123074</ArticleId><ArticleId IdType="pubmed">21550980</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung WS, Clarke LE, Wang GX, et al. . Astrocytes mediate synapse elimination through MEGF10 and MERTK pathways. Nature. 2013;504(7480):394-400. doi:10.1038/nature12776</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature12776</ArticleId><ArticleId IdType="pmc">PMC3969024</ArticleId><ArticleId IdType="pubmed">24270812</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee SY, Chung WS. The roles of astrocytic phagocytosis in maintaining homeostasis of brains. J Pharmacol Sci. 2021;145(3):223-227. doi:10.1016/j.jphs.2020.12.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jphs.2020.12.007</ArticleId><ArticleId IdType="pubmed">33602502</ArticleId></ArticleIdList></Reference><Reference><Citation>Hulshof LA, van Nuijs D, Hol EM, Middeldorp J. The role of astrocytes in synapse loss in Alzheimer&#x2019;s disease: a systematic review. Front Cell Neurosci. 2022;16:899251. https://www.frontiersin.org/articles/10.3389/fncel.2022.899251. doi:10.3389/fncel.2022.899251
</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2022.899251</ArticleId><ArticleId IdType="doi">10.3389/fncel.2022.899251</ArticleId><ArticleId IdType="pmc">PMC9244621</ArticleId><ArticleId IdType="pubmed">35783099</ArticleId></ArticleIdList></Reference><Reference><Citation>Damisah EC, Hill RA, Rai A, et al. . Astrocytes and microglia play orchestrated roles and respect phagocytic territories during neuronal corpse removal in vivo. Sci Adv. 2020;6(26):eaba3239.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7319765</ArticleId><ArticleId IdType="pubmed">32637606</ArticleId></ArticleIdList></Reference><Reference><Citation>von Bartheld CS, Bahney J, Herculano-Houzel S. The search for true numbers of neurons and glial cells in the human brain: a review of 150 years of cell counting. J Comp Neurol. 2016;524(18):3865-3895. doi:10.1002/cne.24040</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cne.24040</ArticleId><ArticleId IdType="pmc">PMC5063692</ArticleId><ArticleId IdType="pubmed">27187682</ArticleId></ArticleIdList></Reference><Reference><Citation>Perez-Catalan NA, Doe CQ, Ackerman SD. The role of astrocyte-mediated plasticity in neural circuit development and function. Neural Dev. 2021;16(1):1. doi:10.1186/s13064-020-00151-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13064-020-00151-9</ArticleId><ArticleId IdType="pmc">PMC7789420</ArticleId><ArticleId IdType="pubmed">33413602</ArticleId></ArticleIdList></Reference><Reference><Citation>Young H, Belbut B, Baeta M, Petreanu L. Laminar-specific cortico-cortical loops in mouse visual cortex. ELife. 2021;10:e59551.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7877907</ArticleId><ArticleId IdType="pubmed">33522479</ArticleId></ArticleIdList></Reference><Reference><Citation>Hage TA, Bosma-Moody A, Baker CA, et al. . Synaptic connectivity to L2/3 of primary visual cortex measured by two-photon optogenetic stimulation. ELife. 2022;11:e71103.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8824465</ArticleId><ArticleId IdType="pubmed">35060903</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xf3;mez-Isla T, Price JL, McKeel DW Jr, Morris JC, Growdon JH, Hyman BT. Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer&#x2019;s disease. J Neurosci. 1996;16(14):4491-4500. doi:10.1523/JNEUROSCI.16-14-04491.1996</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.16-14-04491.1996</ArticleId><ArticleId IdType="pmc">PMC6578866</ArticleId><ArticleId IdType="pubmed">8699259</ArticleId></ArticleIdList></Reference><Reference><Citation>Stranahan AM, Mattson MP. Selective vulnerability of neurons in layer II of the entorhinal cortex during aging and Alzheimer&#x2019;s disease. Neural Plast. 2010;2010:108190.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3039218</ArticleId><ArticleId IdType="pubmed">21331296</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohm DT, Fought AJ, Martersteck A, et al. . Accumulation of neurofibrillary tangles and activated microglia is associated with lower neuron densities in the aphasic variant of Alzheimer&#x2019;s disease. Brain Pathol. 2021;31(1):189-204. doi:10.1111/bpa.12902</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bpa.12902</ArticleId><ArticleId IdType="pmc">PMC7855834</ArticleId><ArticleId IdType="pubmed">33010092</ArticleId></ArticleIdList></Reference><Reference><Citation>Papageorgiou IE, Lewen A, Galow LV, et al. . TLR4-activated microglia require IFN-&#x3b3; to induce severe neuronal dysfunction and death in situ. Proc Natl Acad Sci U S A. 2016;113(1):212-217. doi:10.1073/pnas.1513853113</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1513853113</ArticleId><ArticleId IdType="pmc">PMC4711883</ArticleId><ArticleId IdType="pubmed">26699475</ArticleId></ArticleIdList></Reference><Reference><Citation>Au NPB, Ma CHE. Recent advances in the study of bipolar/rod-shaped microglia and their roles in neurodegeneration. Front Aging Neurosci. 2017;9:128. https://www.frontiersin.org/articles/10.3389/fnagi.2017.00128. doi:10.3389/fnagi.2017.00128
</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2017.00128</ArticleId><ArticleId IdType="doi">10.3389/fnagi.2017.00128</ArticleId><ArticleId IdType="pmc">PMC5415568</ArticleId><ArticleId IdType="pubmed">28522972</ArticleId></ArticleIdList></Reference><Reference><Citation>Mertens R, Melchert S, Gitler D, et al. . Epitope specificity of anti-synapsin autoantibodies: differential targeting of synapsin I domains. PLoS One. 2018;13(12):e0208636. doi:10.1371/journal.pone.0208636</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0208636</ArticleId><ArticleId IdType="pmc">PMC6292584</ArticleId><ArticleId IdType="pubmed">30543686</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoo KS, Lee K, Oh JY, et al. . Postsynaptic density protein 95 (PSD-95) is transported by KIF5 to dendritic regions. Mol Brain. 2019;12(1):97. doi:10.1186/s13041-019-0520-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13041-019-0520-x</ArticleId><ArticleId IdType="pmc">PMC6873588</ArticleId><ArticleId IdType="pubmed">31753031</ArticleId></ArticleIdList></Reference><Reference><Citation>Sherwood CC, Miller SB, Karl M, et al. . Invariant synapse density and neuronal connectivity scaling in primate neocortical evolution. Cereb Cortex. 2020;30(10):5604-5615. doi:10.1093/cercor/bhaa149</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cercor/bhaa149</ArticleId><ArticleId IdType="pmc">PMC8463089</ArticleId><ArticleId IdType="pubmed">32488266</ArticleId></ArticleIdList></Reference><Reference><Citation>Kubota Y, Karube F, Nomura M, Kawaguchi Y. The diversity of cortical inhibitory synapses. Front Neural Circuits. 2016;10:27. https://www.frontiersin.org/article/10.3389/fncir.2016.00027. doi:10.3389/fncir.2016.00027
</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncir.2016.00027</ArticleId><ArticleId IdType="doi">10.3389/fncir.2016.00027</ArticleId><ArticleId IdType="pmc">PMC4842771</ArticleId><ArticleId IdType="pubmed">27199670</ArticleId></ArticleIdList></Reference><Reference><Citation>Spires-Jones TL, Hyman BT. The intersection of amyloid beta and tau at synapses in Alzheimer&#x2019;s disease. Neuron. 2014;82(4):756-771. doi:10.1016/j.neuron.2014.05.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2014.05.004</ArticleId><ArticleId IdType="pmc">PMC4135182</ArticleId><ArticleId IdType="pubmed">24853936</ArticleId></ArticleIdList></Reference><Reference><Citation>Camporesi E, Nilsson J, Brinkmalm A, et al. . Fluid biomarkers for synaptic dysfunction and loss. Biomark Insights. 2020;15:1177271920950319. doi:10.1177/1177271920950319</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1177271920950319</ArticleId><ArticleId IdType="pmc">PMC7444114</ArticleId><ArticleId IdType="pubmed">32913390</ArticleId></ArticleIdList></Reference><Reference><Citation>Dom&#xed;nguez-&#xc1;lvaro M, Montero-Crespo M, Blazquez-Llorca L, Insausti R, DeFelipe J, Alonso-Nanclares L. Three-dimensional analysis of synapses in the transentorhinal cortex of Alzheimer&#x2019;s disease patients. Acta Neuropathol Commun. 2018;6(1):20-20. doi:10.1186/s40478-018-0520-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-018-0520-6</ArticleId><ArticleId IdType="pmc">PMC5834884</ArticleId><ArticleId IdType="pubmed">29499755</ArticleId></ArticleIdList></Reference><Reference><Citation>Cragg BG. The density of synapses and neurons in normal, mentally defective ageing human brains. Brain. 1975;98(1):81-90. doi:10.1093/brain/98.1.81</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/98.1.81</ArticleId><ArticleId IdType="pubmed">123474</ArticleId></ArticleIdList></Reference><Reference><Citation>Shapson-Coe A, Januszewski M, Berger DR, et al. . A connectomic study of a petascale fragment of human cerebral cortex. bioRxiv. Published online January 1, 2021:2021.05.29.446289. doi:10.1101/2021.05.29.446289</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.05.29.446289</ArticleId></ArticleIdList></Reference><Reference><Citation>Dom&#xed;nguez-&#xc1;lvaro M, Montero-Crespo M, Blazquez-Llorca L, et al. . 3D analysis of the synaptic organization in the entorhinal cortex in Alzheimer&#x2019;s disease. eNeuro. 2021;8(3):ENEURO.0504-20.2021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8225407</ArticleId><ArticleId IdType="pubmed">34039651</ArticleId></ArticleIdList></Reference><Reference><Citation>Mecca AP, Chen MK, O&#x2019;Dell RS, et al. . In vivo measurement of widespread synaptic loss in Alzheimer&#x2019;s disease with SV2A PET. Alzheimers Dement. 2020;16(7):974-982. doi:10.1002/alz.12097</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alz.12097</ArticleId><ArticleId IdType="pmc">PMC7383876</ArticleId><ArticleId IdType="pubmed">32400950</ArticleId></ArticleIdList></Reference><Reference><Citation>Colom-Cadena M, Spires-Jones T, Zetterberg H, et al. ; Synaptic Health Endpoints Working Group . The clinical promise of biomarkers of synapse damage or loss in Alzheimer&#x2019;s disease. Alzheimers Res Ther. 2020;12(1):21. doi:10.1186/s13195-020-00588-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13195-020-00588-4</ArticleId><ArticleId IdType="pmc">PMC7053087</ArticleId><ArticleId IdType="pubmed">32122400</ArticleId></ArticleIdList></Reference><Reference><Citation>Huttenlocher PR. Synaptic density in human frontal cortex&#x2014;developmental changes and effects of aging. Brain Res. 1979;163(2):195-205. doi:10.1016/0006-8993(79)90349-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0006-8993(79)90349-4</ArticleId><ArticleId IdType="pubmed">427544</ArticleId></ArticleIdList></Reference><Reference><Citation>Kopeikina KJ, Hyman BT, Spires-Jones TL. Soluble forms of tau are toxic in Alzheimer&#x2019;s disease. Transl Neurosci. 2012;3(3):223-233. doi:10.2478/s13380-012-0032-y</Citation><ArticleIdList><ArticleId IdType="doi">10.2478/s13380-012-0032-y</ArticleId><ArticleId IdType="pmc">PMC3460520</ArticleId><ArticleId IdType="pubmed">23029602</ArticleId></ArticleIdList></Reference><Reference><Citation>Bjorklund NL, Reese LC, Sadagoparamanujam VM, Ghirardi V, Woltjer RL, Taglialatela G. Absence of amyloid &#x3b2; oligomers at the postsynapse and regulated synaptic Zn2+ in cognitively intact aged individuals with Alzheimer&#x2019;s disease neuropathology. Mol Neurodegener. 2012;7(1):23. doi:10.1186/1750-1326-7-23</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1750-1326-7-23</ArticleId><ArticleId IdType="pmc">PMC3403985</ArticleId><ArticleId IdType="pubmed">22640423</ArticleId></ArticleIdList></Reference><Reference><Citation>Fritschi SK, Langer F, Kaeser SA, et al. . Highly potent soluble amyloid-&#x3b2; seeds in human Alzheimer brain but not cerebrospinal fluid. Brain. 2014;137(Pt 11):2909-2915. doi:10.1093/brain/awu255</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awu255</ArticleId><ArticleId IdType="pmc">PMC5367518</ArticleId><ArticleId IdType="pubmed">25212850</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin Y, Li F, Sonoustoun B, et al. . APOE4 exacerbates &#x3b1;-synuclein seeding activity and contributes to neurotoxicity in Alzheimer&#x2019;s disease with Lewy body pathology. Acta Neuropathol. 2022;143(6):641-662. doi:10.1007/s00401-022-02421-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-022-02421-8</ArticleId><ArticleId IdType="pmc">PMC9107450</ArticleId><ArticleId IdType="pubmed">35471463</ArticleId></ArticleIdList></Reference><Reference><Citation>de Calignon A, Spires-Jones TL, Pitstick R, Carlson GA, Hyman BT. Tangle-bearing neurons survive despite disruption of membrane integrity in a mouse model of tauopathy. J Neuropathol Exp Neurol. 2009;68(7):757-761. doi:10.1097/NEN.0b013e3181a9fc66</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/NEN.0b013e3181a9fc66</ArticleId><ArticleId IdType="pmc">PMC2756569</ArticleId><ArticleId IdType="pubmed">19535996</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37812438</PMID><DateCompleted><Year>2023</Year><Month>11</Month><Day>14</Day></DateCompleted><DateRevised><Year>2024</Year><Month>11</Month><Day>02</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2168-6157</ISSN><JournalIssue CitedMedium="Internet"><Volume>80</Volume><Issue>11</Issue><PubDate><Year>2023</Year><Month>Nov</Month><Day>01</Day></PubDate></JournalIssue><Title>JAMA neurology</Title><ISOAbbreviation>JAMA Neurol</ISOAbbreviation></Journal><ArticleTitle>Synaptic Oligomers and Glial Cells in Alzheimer Disease.</ArticleTitle><Pagination><StartPage>1136</StartPage><EndPage>1137</EndPage><MedlinePgn>1136-1137</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1001/jamaneurol.2023.3539</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Grinberg</LastName><ForeName>Lea Tenenholz</ForeName><Initials>LT</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of California, San Francisco.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathology, University of California, San Francisco.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathology, University of S&#xe3;o Paulo Medical School, Ribeir&#xe3;o Preto, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>K24 AG053435</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG060477</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG064314</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG075802</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016421">Editorial</PublicationType><PublicationType UI="D016420">Comment</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JAMA Neurol</MedlineTA><NlmUniqueID>101589536</NlmUniqueID><ISSNLinking>2168-6149</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016229">Amyloid beta-Peptides</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentOn"><RefSource>JAMA Neurol. 2023 Nov 1;80(11):1209-1221. doi: 10.1001/jamaneurol.2023.3530.</RefSource><PMID Version="1">37812432</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009457" MajorTopicYN="N">Neuroglia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016229" MajorTopicYN="N">Amyloid beta-Peptides</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013569" MajorTopicYN="N">Synapses</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>11</Month><Day>14</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>10</Month><Day>9</Day><Hour>12</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>10</Month><Day>9</Day><Hour>11</Hour><Minute>34</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>11</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37812438</ArticleId><ArticleId IdType="mid">NIHMS1964739</ArticleId><ArticleId IdType="pmc">PMC10903969</ArticleId><ArticleId IdType="doi">10.1001/jamaneurol.2023.3539</ArticleId><ArticleId IdType="pii">2809943</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Sims JR, Zimmer JA, Evans CD, et al.; TRAILBLAZER-ALZ 2 Investigators. Donanemab in Early symptomatic Alzheimer Disease: the TRAILBLAZER-ALZ 2 randomized clinical trial. JAMA. 2023;330(6):512&#x2013;527. doi:10.1001/jama.2023.13239</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2023.13239</ArticleId><ArticleId IdType="pmc">PMC10352931</ArticleId><ArticleId IdType="pubmed">37459141</ArticleId></ArticleIdList></Reference><Reference><Citation>van Dyck CH, Swanson CJ, Aisen P, et al. Lecanemab in early Alzheimer&#x2019;s disease. N Engl J Med. 2023;388(1):9&#x2013;21. doi:10.1056/NEJMoa2212948</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2212948</ArticleId><ArticleId IdType="pubmed">36449413</ArticleId></ArticleIdList></Reference><Reference><Citation>Leng F, Edison P. Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here? Nat Rev Neurol. 2021;17(3):157&#x2013;172. doi:10.1038/s41582-020-00435-v</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-020-00435-v</ArticleId><ArticleId IdType="pubmed">33318676</ArticleId></ArticleIdList></Reference><Reference><Citation>Taddei RN, Perbet R, de Gerando AM, et al. Correlation of tau oligomer&#x2013;containing synapses engulfed by microglia and astrocytes with cognition in Alzheimer disease. JAMA Neurol. Published online October 9, 2023. doi:10.1001/jamaneurol.2023.3530</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2023.3530</ArticleId><ArticleId IdType="pmc">PMC10562992</ArticleId><ArticleId IdType="pubmed">37812432</ArticleId></ArticleIdList></Reference><Reference><Citation>Arenaza-Urquijo EM, Vemuri P. Resistance vs resilience to Alzheimer disease: clarifying terminology for preclinical studies. Neurology. 2018;90)(15):695&#x2013;703. doi:10.1212/WNL.0000000000005303</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000005303</ArticleId><ArticleId IdType="pmc">PMC5894932</ArticleId><ArticleId IdType="pubmed">29592885</ArticleId></ArticleIdList></Reference><Reference><Citation>Wassie AT, Zhao Y, Boyden ES. Expansion microscopy: principles and uses in biological research. Nat Methods. 2019;16(1):33&#x2013;41. doi:10.1038/s41592-018-0219-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41592-018-0219-4</ArticleId><ArticleId IdType="pmc">PMC6373868</ArticleId><ArticleId IdType="pubmed">30573813</ArticleId></ArticleIdList></Reference><Reference><Citation>Crary JF, Trojanowski JQ, Schneider JA, et al. Primary age-related tauopathy (PART): a common pathology associated with human aging. Acta Neuropathol. 2014;128(6)755&#x2013;766. doi:10.1007/s00401-014-1349-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-014-1349-0</ArticleId><ArticleId IdType="pmc">PMC4257842</ArticleId><ArticleId IdType="pubmed">25348064</ArticleId></ArticleIdList></Reference><Reference><Citation>Terry RD, Masliah E, Salmon DP, et al. Physical basis of cognitive alterations in Alzheimer&#x2019;s disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol. 1991;30(4):572&#x2013;580. doi:10.1002/ana.410300410</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.410300410</ArticleId><ArticleId IdType="pubmed">1789684</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung WS, Welsh CA, Barres BA, Stevens B. Do glia drive synaptic and cognitive impairment in disease? Nat Neurosci. 2015;18(11):1539&#x2013;1545. doi:10.1038/nn.4142</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.4142</ArticleId><ArticleId IdType="pmc">PMC4739631</ArticleId><ArticleId IdType="pubmed">26505565</ArticleId></ArticleIdList></Reference><Reference><Citation>Lo CH, Sachs JN. The role of wild-type tau in Alzheimer&#x2019;s disease and related tauopathies. J Life Sci (Westlake Village). 2020;2(4):1&#x2013;17. doi:10.36069/JoLS/20201201</Citation><ArticleIdList><ArticleId IdType="doi">10.36069/JoLS/20201201</ArticleId><ArticleId IdType="pmc">PMC7929479</ArticleId><ArticleId IdType="pubmed">33665646</ArticleId></ArticleIdList></Reference><Reference><Citation>Lasagna-Reeves CA, Castillo-Carranza DL, Sengupta U, et al. Alzheimer brain-derived tau oligomers propagate pathology from endogenoustau. Sci Rep. 2012;2:700. doi:10.1038/srep00700</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep00700</ArticleId><ArticleId IdType="pmc">PMC3463004</ArticleId><ArticleId IdType="pubmed">23050084</ArticleId></ArticleIdList></Reference><Reference><Citation>Puangmalai N, Bhatt N, Montalbano M, et al. Internalization mechanisms of brain-derived tau oligomers from patients with Alzheimer&#x2019;s disease, progressive supranuclear palsy and dementia with Lewy bodies. Cell Death Dis. 2020;11(5):314. doi:10.1038/s41419-020-2503-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-020-2503-3</ArticleId><ArticleId IdType="pmc">PMC7198578</ArticleId><ArticleId IdType="pubmed">32366836</ArticleId></ArticleIdList></Reference><Reference><Citation>Mroczko B, Groblewska M, Litman-Zawadzka A. The role of protein misfolding and tau oligomers (TauOs) in Alzheimer&#x2019;s disease (AD). Int J Mol Sci. 2019;20)(19):4661. doi:10.3390/iims20194661</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/iims20194661</ArticleId><ArticleId IdType="pmc">PMC6802364</ArticleId><ArticleId IdType="pubmed">31547024</ArticleId></ArticleIdList></Reference><Reference><Citation>Guerrero-Mu&#xf1;oz MJ, Gerson J, Castillo-Carranza DL. Tau oligomers: the toxic player at synapses in Alzheimer&#x2019;s disease. Front Cell Neurosci. 2015;9:464. doi:10.3389/fncel.2015.00464</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2015.00464</ArticleId><ArticleId IdType="pmc">PMC4667007</ArticleId><ArticleId IdType="pubmed">26696824</ArticleId></ArticleIdList></Reference><Reference><Citation>Cline EN, Bicca MA, Viola KL, Klein WL. The amyloid-&#x3b2; oligomer hypothesis: beginning of the third decade. J Alzheimers Dis. 2018;64)(s1):S567&#x2013;S610. doi:10.3233/JAD-179941</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-179941</ArticleId><ArticleId IdType="pmc">PMC6004937</ArticleId><ArticleId IdType="pubmed">29843241</ArticleId></ArticleIdList></Reference><Reference><Citation>Lasagna-Reeves CA, Castillo-Carranza DL, Guerrero-Muoz MJ, Jackson GR, Kayed R. Preparation and characterization of neurotoxic tau oligomers. Biochemistry. 2010;49(47):10039&#x2013;10041. doi:10.1021/bi1016233</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/bi1016233</ArticleId><ArticleId IdType="pubmed">21047142</ArticleId></ArticleIdList></Reference><Reference><Citation>Meraz-R&#xed;os MA, Lira-De Le&#xf3;n KI, Campos-Pe&#xf1;a V, De Anda-Hern&#xe1;ndez MA, Mena-L&#xf3;pez R. Tau oligomers and aggregation in Alzheimer&#x2019;s disease. J Neurochem. 2010;112(6):1353&#x2013;1367. doi:10.1111/i.1471-4159.2009.06511.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/i.1471-4159.2009.06511.x</ArticleId><ArticleId IdType="pubmed">19943854</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrade-Moraes CH, Oliveira-Pinto AV, Castro-Fonseca E, et al. Cell number changes in Alzheimer&#x2019;s disease relate to dementia, not to plaques and tangles. Brain. 2013;136(Pt 12):3738&#x2013;3752. doi:10.1093/brain/awt273</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awt273</ArticleId><ArticleId IdType="pmc">PMC3859218</ArticleId><ArticleId IdType="pubmed">24136825</ArticleId></ArticleIdList></Reference><Reference><Citation>DeTure MA, Dickson DW. The neuropathological diagnosis of Alzheimer&#x2019;s disease. Mol Neurodegener. 2019;14(1). doi:10.1186/s13024-019-0333-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-019-0333-5</ArticleId><ArticleId IdType="pmc">PMC6679484</ArticleId><ArticleId IdType="pubmed">31375134</ArticleId></ArticleIdList></Reference><Reference><Citation>Leng K, Li E, Eser R, et al. Molecular characterization of selectively vulnerable neurons in Alzheimer&#x2019;s disease. Nat Neurosci. 2021;24(2):276&#x2013;287. doi:10.1038/s41593-020-00764-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-020-00764-7</ArticleId><ArticleId IdType="pmc">PMC7854528</ArticleId><ArticleId IdType="pubmed">33432193</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37824675</PMID><DateCompleted><Year>2023</Year><Month>10</Month><Day>23</Day></DateCompleted><DateRevised><Year>2023</Year><Month>10</Month><Day>27</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1095-9203</ISSN><JournalIssue CitedMedium="Internet"><Volume>382</Volume><Issue>6667</Issue><PubDate><Year>2023</Year><Month>Oct</Month><Day>13</Day></PubDate></JournalIssue><Title>Science (New York, N.Y.)</Title><ISOAbbreviation>Science</ISOAbbreviation></Journal><ArticleTitle>A quest into the human brain.</ArticleTitle><Pagination><StartPage>166</StartPage><EndPage>167</EndPage><MedlinePgn>166-167</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1126/science.adl0913</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Maroso</LastName><ForeName>Mattia</ForeName><Initials>M</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>10</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Science</MedlineTA><NlmUniqueID>0404511</NlmUniqueID><ISSNLinking>0036-8075</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="Y">Brain</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName><QualifierName UI="Q000254" MajorTopicYN="N">growth &amp; development</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>10</Month><Day>23</Day><Hour>1</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>10</Month><Day>12</Day><Hour>18</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>10</Month><Day>12</Day><Hour>14</Hour><Minute>4</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37824675</ArticleId><ArticleId IdType="doi">10.1126/science.adl0913</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37824663</PMID><DateCompleted><Year>2023</Year><Month>11</Month><Day>13</Day></DateCompleted><DateRevised><Year>2024</Year><Month>01</Month><Day>24</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1095-9203</ISSN><JournalIssue CitedMedium="Internet"><Volume>382</Volume><Issue>6667</Issue><PubDate><Year>2023</Year><Month>Oct</Month><Day>13</Day></PubDate></JournalIssue><Title>Science (New York, N.Y.)</Title><ISOAbbreviation>Science</ISOAbbreviation></Journal><ArticleTitle>Transcriptomic diversity of cell types across the adult human brain.</ArticleTitle><Pagination><StartPage>eadd7046</StartPage><MedlinePgn>eadd7046</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1126/science.add7046</ELocationID><Abstract><AbstractText>The human brain directs complex behaviors, ranging from fine motor skills to abstract intelligence, but the diversity of cell types that support these skills has not been fully described. In this work, we used single-nucleus RNA sequencing to systematically survey cells across the entire adult human brain. We sampled more than three million nuclei from approximately 100 dissections across the forebrain, midbrain, and hindbrain in three postmortem donors. Our analysis identified 461 clusters and 3313 subclusters organized largely according to developmental origins and revealing high diversity in midbrain and hindbrain neurons. Astrocytes and oligodendrocyte-lineage cells also exhibited regional diversity at multiple scales. The transcriptomic census of the entire human brain presented in this work provides a resource for understanding the molecular diversity of the human brain in health and disease.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Siletti</LastName><ForeName>Kimberly</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0001-7620-8973</Identifier><AffiliationInfo><Affiliation>Karolinska Institute, 171 77 Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Hodge</LastName><ForeName>Rebecca</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-5784-9668</Identifier><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Mossi Albiach</LastName><ForeName>Alejandro</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-7009-4901</Identifier><AffiliationInfo><Affiliation>Karolinska Institute, 171 77 Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Ka Wai</ForeName><Initials>KW</Initials><Identifier Source="ORCID">0000-0002-8578-0813</Identifier><AffiliationInfo><Affiliation>Karolinska Institute, 171 77 Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ding</LastName><ForeName>Song-Lin</ForeName><Initials>SL</Initials><Identifier Source="ORCID">0000-0002-7072-5272</Identifier><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Lijuan</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0003-1869-0372</Identifier><AffiliationInfo><Affiliation>Karolinska Institute, 171 77 Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>L&#xf6;nnerberg</LastName><ForeName>Peter</ForeName><Initials>P</Initials><Identifier Source="ORCID">0009-0009-0965-2906</Identifier><AffiliationInfo><Affiliation>Karolinska Institute, 171 77 Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bakken</LastName><ForeName>Trygve</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0003-3373-7386</Identifier><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Casper</LastName><ForeName>Tamara</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0003-1638-3651</Identifier><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Clark</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dee</LastName><ForeName>Nick</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0002-2831-9254</Identifier><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gloe</LastName><ForeName>Jessica</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0001-8343-3423</Identifier><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hirschstein</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shapovalova</LastName><ForeName>Nadiya V</ForeName><Initials>NV</Initials><Identifier Source="ORCID">0000-0002-8618-8272</Identifier><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Keene</LastName><ForeName>C Dirk</ForeName><Initials>CD</Initials><Identifier Source="ORCID">0000-0002-5291-1469</Identifier><AffiliationInfo><Affiliation>Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA 98195, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nyhus</LastName><ForeName>Julie</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-2006-8235</Identifier><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tung</LastName><ForeName>Herman</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0002-0812-3318</Identifier><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yanny</LastName><ForeName>Anna Marie</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arenas</LastName><ForeName>Ernest</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0003-0197-6577</Identifier><AffiliationInfo><Affiliation>Karolinska Institute, 171 77 Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lein</LastName><ForeName>Ed S</ForeName><Initials>ES</Initials><Identifier Source="ORCID">0000-0001-9012-6552</Identifier><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Linnarsson</LastName><ForeName>Sten</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-3491-3444</Identifier><AffiliationInfo><Affiliation>Karolinska Institute, 171 77 Stockholm, Sweden.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>10</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Science</MedlineTA><NlmUniqueID>0404511</NlmUniqueID><ISSNLinking>0036-8075</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="Y">Brain</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020869" MajorTopicYN="N">Gene Expression Profiling</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008636" MajorTopicYN="N">Mesencephalon</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009474" MajorTopicYN="N">Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016548" MajorTopicYN="N">Prosencephalon</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059467" MajorTopicYN="Y">Transcriptome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000092386" MajorTopicYN="N">Single-Cell Gene Expression Analysis</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>11</Month><Day>1</Day><Hour>12</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>10</Month><Day>12</Day><Hour>18</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>10</Month><Day>12</Day><Hour>14</Hour><Minute>4</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37824663</ArticleId><ArticleId IdType="doi">10.1126/science.add7046</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37824643</PMID><DateCompleted><Year>2023</Year><Month>11</Month><Day>13</Day></DateCompleted><DateRevised><Year>2024</Year><Month>02</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1095-9203</ISSN><JournalIssue CitedMedium="Internet"><Volume>382</Volume><Issue>6667</Issue><PubDate><Year>2023</Year><Month>Oct</Month><Day>13</Day></PubDate></JournalIssue><Title>Science (New York, N.Y.)</Title><ISOAbbreviation>Science</ISOAbbreviation></Journal><ArticleTitle>A comparative atlas of single-cell chromatin accessibility in the human brain.</ArticleTitle><Pagination><StartPage>eadf7044</StartPage><MedlinePgn>eadf7044</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1126/science.adf7044</ELocationID><Abstract><AbstractText>Recent advances in single-cell transcriptomics have illuminated the diverse neuronal and glial cell types within the human brain. However, the regulatory programs governing cell identity and function remain unclear. Using a single-nucleus assay for transposase-accessible chromatin using sequencing (snATAC-seq), we explored open chromatin landscapes across 1.1 million cells in 42 brain regions from three adults. Integrating this data unveiled 107 distinct cell types and their specific utilization of 544,735 candidate cis-regulatory DNA elements (cCREs) in the human genome. Nearly a third of the cCREs demonstrated conservation and chromatin accessibility in the mouse brain cells. We reveal strong links between specific brain cell types and neuropsychiatric disorders including schizophrenia, bipolar disorder, Alzheimer's disease (AD), and major depression, and have developed deep learning models to predict the regulatory roles of noncoding risk variants in these disorders.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Yang Eric</ForeName><Initials>YE</Initials><Identifier Source="ORCID">0000-0001-6997-6018</Identifier><AffiliationInfo><Affiliation>Department of Cellular and Molecular Medicine, University of California, San Diego, La Jolla, CA 92093, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Preissl</LastName><ForeName>Sebastian</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-8971-5616</Identifier><AffiliationInfo><Affiliation>Center for Epigenomics, University of California San Diego, School of Medicine, La Jolla, CA 92093, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miller</LastName><ForeName>Michael</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-0781-7868</Identifier><AffiliationInfo><Affiliation>Center for Epigenomics, University of California San Diego, School of Medicine, La Jolla, CA 92093, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Johnson</LastName><ForeName>Nicholas D</ForeName><Initials>ND</Initials><Identifier Source="ORCID">0000-0003-3229-6849</Identifier><AffiliationInfo><Affiliation>The Salk Institute for Biological Studies, La Jolla, CA 92037, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Zihan</ForeName><Initials>Z</Initials><Identifier Source="ORCID">0000-0002-3147-4642</Identifier><AffiliationInfo><Affiliation>Department of Computer Science and Engineering, University of California, San Diego, La Jolla, CA 92093, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiao</LastName><ForeName>Henry</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Center for Epigenomics, University of California San Diego, School of Medicine, La Jolla, CA 92093, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Chenxu</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Cellular and Molecular Medicine, University of California, San Diego, La Jolla, CA 92093, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Zhaoning</ForeName><Initials>Z</Initials><Identifier Source="ORCID">0000-0002-0290-4746</Identifier><AffiliationInfo><Affiliation>Department of Cellular and Molecular Medicine, University of California, San Diego, La Jolla, CA 92093, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xie</LastName><ForeName>Yang</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0002-7453-6786</Identifier><AffiliationInfo><Affiliation>Department of Cellular and Molecular Medicine, University of California, San Diego, La Jolla, CA 92093, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Poirion</LastName><ForeName>Olivier</ForeName><Initials>O</Initials><Identifier Source="ORCID">0000-0002-0429-7003</Identifier><AffiliationInfo><Affiliation>Center for Epigenomics, University of California San Diego, School of Medicine, La Jolla, CA 92093, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kern</LastName><ForeName>Colin</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-3249-6405</Identifier><AffiliationInfo><Affiliation>Center for Epigenomics, University of California San Diego, School of Medicine, La Jolla, CA 92093, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pinto-Duarte</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-2215-7653</Identifier><AffiliationInfo><Affiliation>The Salk Institute for Biological Studies, La Jolla, CA 92037, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tian</LastName><ForeName>Wei</ForeName><Initials>W</Initials><Identifier Source="ORCID">0000-0002-2146-1717</Identifier><AffiliationInfo><Affiliation>The Salk Institute for Biological Studies, La Jolla, CA 92037, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Siletti</LastName><ForeName>Kimberly</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0001-7620-8973</Identifier><AffiliationInfo><Affiliation>Division of Molecular Neurobiology, Department of Medical Biochemistry and Biophysics, Karolinska Institute, 171 77 Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Emerson</LastName><ForeName>Nora</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0001-7344-4487</Identifier><AffiliationInfo><Affiliation>The Salk Institute for Biological Studies, La Jolla, CA 92037, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Osteen</LastName><ForeName>Julia</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>The Salk Institute for Biological Studies, La Jolla, CA 92037, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lucero</LastName><ForeName>Jacinta</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>The Salk Institute for Biological Studies, La Jolla, CA 92037, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Lin</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Center for Epigenomics, University of California San Diego, School of Medicine, La Jolla, CA 92093, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Qian</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Center for Epigenomics, University of California San Diego, School of Medicine, La Jolla, CA 92093, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Quan</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Center for Epigenomics, University of California San Diego, School of Medicine, La Jolla, CA 92093, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zemke</LastName><ForeName>Nathan</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0002-6326-5925</Identifier><AffiliationInfo><Affiliation>Center for Epigenomics, University of California San Diego, School of Medicine, La Jolla, CA 92093, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Espinoza</LastName><ForeName>Sarah</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-8167-4709</Identifier><AffiliationInfo><Affiliation>Center for Epigenomics, University of California San Diego, School of Medicine, La Jolla, CA 92093, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yanny</LastName><ForeName>Anna Marie</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nyhus</LastName><ForeName>Julie</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-2006-8235</Identifier><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dee</LastName><ForeName>Nick</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0002-2831-9254</Identifier><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Casper</LastName><ForeName>Tamara</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0003-1638-3651</Identifier><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shapovalova</LastName><ForeName>Nadiya</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0002-8618-8272</Identifier><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hirschstein</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hodge</LastName><ForeName>Rebecca D</ForeName><Initials>RD</Initials><Identifier Source="ORCID">0000-0002-5784-9668</Identifier><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Linnarsson</LastName><ForeName>Sten</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-3491-3444</Identifier><AffiliationInfo><Affiliation>Division of Molecular Neurobiology, Department of Medical Biochemistry and Biophysics, Karolinska Institute, 171 77 Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bakken</LastName><ForeName>Trygve</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0003-3373-7386</Identifier><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Levi</LastName><ForeName>Boaz</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0002-8346-872X</Identifier><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Keene</LastName><ForeName>C Dirk</ForeName><Initials>CD</Initials><Identifier Source="ORCID">0000-0002-5291-1469</Identifier><AffiliationInfo><Affiliation>Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA 98104, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shang</LastName><ForeName>Jingbo</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-7249-4404</Identifier><AffiliationInfo><Affiliation>Department of Computer Science and Engineering, University of California, San Diego, La Jolla, CA 92093, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lein</LastName><ForeName>Ed</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0001-9012-6552</Identifier><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Allen</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-9870-7888</Identifier><AffiliationInfo><Affiliation>Center for Epigenomics, University of California San Diego, School of Medicine, La Jolla, CA 92093, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Behrens</LastName><ForeName>M Margarita</ForeName><Initials>MM</Initials><Identifier Source="ORCID">0000-0002-7168-8186</Identifier><AffiliationInfo><Affiliation>The Salk Institute for Biological Studies, La Jolla, CA 92037, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ecker</LastName><ForeName>Joseph R</ForeName><Initials>JR</Initials><Identifier Source="ORCID">0000-0001-5799-5895</Identifier><AffiliationInfo><Affiliation>The Salk Institute for Biological Studies, La Jolla, CA 92037, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Howard Hughes Medical Institute, The Salk Institute for Biological Studies, La Jolla, CA 92037, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ren</LastName><ForeName>Bing</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0002-5435-1127</Identifier><AffiliationInfo><Affiliation>Department of Cellular and Molecular Medicine, University of California, San Diego, La Jolla, CA 92093, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Epigenomics, University of California San Diego, School of Medicine, La Jolla, CA 92093, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>U01 MH114828</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U54 HG012510</GrantID><Acronym>HG</Acronym><Agency>NHGRI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 MH114812</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>S10 OD026929</GrantID><Acronym>OD</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UM1 MH130994</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>10</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Science</MedlineTA><NlmUniqueID>0404511</NlmUniqueID><ISSNLinking>0036-8075</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D002843">Chromatin</NameOfSubstance></Chemical><Chemical><RegistryNumber>9007-49-2</RegistryNumber><NameOfSubstance UI="D004247">DNA</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="Y">Brain</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002843" MajorTopicYN="Y">Chromatin</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004247" MajorTopicYN="N">DNA</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009474" MajorTopicYN="N">Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012045" MajorTopicYN="N">Regulatory Sequences, Nucleic Acid</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001271" MajorTopicYN="Y">Atlases as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059010" MajorTopicYN="N">Single-Cell Analysis</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement><b>Conflict of interst statement:</b> B.R. is a consultant of and has equity interests in Arima Genomics, Inc. B.R. is also a co-founder of Epigenome Technologies Inc. S.L. is a paid scientific advisor to Moleculent, Combigene, and the Oslo University Center of Excellence in Immunotherapy.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>11</Month><Day>1</Day><Hour>12</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>10</Month><Day>12</Day><Hour>18</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>10</Month><Day>12</Day><Hour>14</Hour><Minute>4</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>2</Month><Day>8</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37824643</ArticleId><ArticleId IdType="mid">NIHMS1959369</ArticleId><ArticleId IdType="pmc">PMC10852054</ArticleId><ArticleId IdType="doi">10.1126/science.adf7044</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Murray CJL, Atkinson C, Bhalla K, Birbeck G, Burstein R, Chou D, Dellavalle R, Danaei G, Ezzati M, Fahimi A, Flaxman D, Foreman, Gabriel S, Gakidou E, Kassebaum N, Khatibzadeh S, Lim S, Lipshultz SE, London S, Lopez, MacIntyre MF, Mokdad AH, Moran A, Moran AE, Mozaffarian D, Murphy T, Naghavi M, Pope C, Roberts T, Salomon J, Schwebel DC, Shahraz S, Sleet DA, Murray J Abraham M Ali K, Atkinson C, Bartels DH, Bhalla K, Birbeck G, Burstein R, Chen H, Criqui MH, Dahodwala, Jarlais, Ding EL, Dorsey ER, Ebel BE, Ezzati M, Fahami S Flaxman, Flaxman AD, Gonzalez-Medina D, Grant B, Hagan H, Hoffman H, Kassebaum N, Khatibzadeh S, Leasher JL, Lin J, Lipshultz SE, Lozano R, Lu Y, Mallinger L, McDermott MM, Micha R, Miller TR, Mokdad AA, Mokdad AH, Mozaffarian D, Naghavi M, Narayan KMV, Omer SB, Pelizzari PM, Phillips D, Ranganathan D, Rivara FP, Roberts T, Sampson U, Sanman E, Sapkota A, Schwebel DC, Sharaz S, Shivakoti R, Singh GM, Singh D, Tavakkoli M, Towbin JA, Wilkinson JD, Zabetian A, Murray J Abraham, Ali MK, Alvardo M, Atkinson C, Baddour LM, Benjamin EJ, Bhalla K, Birbeck G, Bolliger I, Burstein R, Carnahan E, Chou D, Chugh SS, Cohen A, Colson KE, Cooper LT, Couser W, Criqui MH, Dabhadkar KC, Dellavalle RP, Jarlais, Dicker D, Dorsey ER, Duber H, Ebel BE, Engell RE, Ezzati M, Felson DT, Finucane MM, Flaxman S, Flaxman AD, Fleming T, Foreman, Forouzanfar MH, Freedman G, Freeman MK, Gakidou E, Gillum RF, Gonzalez-Medina D, Gosselin R, Gutierrez HR, Hagan H, Havmoeller R, Hoffman H, Jacobsen KH, James SL Jasrasaria R, Jayarman S, Johns N, Kassebaum N, Khatibzadeh S, Lan Q, Leasher JL, Lim S, Lipshultz SE, London S, Lopez, Lozano R, Lu Y, Mallinger L, Meltzer M, Mensah GA, Michaud C, Miller TR, Mock C, Moffitt TE, Mokdad AA, Mokdad AH, Moran A, Naghavi M, Narayan KMV, Nelson RG, Olives C, Omer SB, Ortblad K, Ostro B, Pelizzari PM, Phillips D, Raju M, Razavi H, Ritz B, Roberts T, Sacco RL, Salomon J, Sampson U, Schwebel DC, Shahraz S, Shibuya K, Silberberg D, Singh JA, Steenland K, Taylor JA, Thurston GD, Vavilala MS, Vos T, Wagner GR, Weinstock MA, Weisskopf MG, Wulf S, Murray USB of D. Collaborators, The State of US Health, 1990&#x2013;2010: Burden of Diseases, Injuries, and Risk Factors. Jama. 310, 591&#x2013;606 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5436627</ArticleId><ArticleId IdType="pubmed">23842577</ArticleId></ArticleIdList></Reference><Reference><Citation>Buniello A, MacArthur JAL, Cerezo M, Harris LW, Hayhurst J, Malangone C, McMahon A, Morales J, Mountjoy E, Sollis E, Suveges D, Vrousgou O, Whetzel PL, Amode R, Guillen JA, Riat HS, Trevanion SJ, Hall P, Junkins H, Flicek P, Burdett T, Hindorff LA, Cunningham F, Parkinson H, The NHGRI-EBI GWAS Catalog of published genome-wide association studies, targeted arrays and summary statistics 2019. Nucleic Acids Res. 47, D1005&#x2013;D1012 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6323933</ArticleId><ArticleId IdType="pubmed">30445434</ArticleId></ArticleIdList></Reference><Reference><Citation>Claussnitzer M, Cho JH, Collins R, Cox NJ, Dermitzakis ET, Hurles ME, Kathiresan S, Kenny EE, Lindgren CM, MacArthur DG, North KN, Plon SE, Rehm HL, Risch N, Rotimi CN, Shendure J, Soranzo N, McCarthy MI, A brief history of human disease genetics. Nature. 577, 179&#x2013;189 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7405896</ArticleId><ArticleId IdType="pubmed">31915397</ArticleId></ArticleIdList></Reference><Reference><Citation>Frydas A, Wauters E, van der Zee J, Broeckhoven CV, Uncovering the impact of noncoding variants in neurodegenerative brain diseases. Trends Genet. 38, 258&#x2013;272 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34535299</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu B, Montgomery SB, Identifying causal variants and genes using functional genomics in specialized cell types and contexts. Hum Genet. 139, 95&#x2013;102 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6942616</ArticleId><ArticleId IdType="pubmed">31317254</ArticleId></ArticleIdList></Reference><Reference><Citation>Dunham I, Kundaje A, Aldred SF, Collins PJ, Davis CA, Doyle F, Epstein CB, Frietze S, Harrow J, Kaul R, Khatun J, Lajoie BR, Landt SG, Lee B-K, Pauli F, Rosenbloom KR, Sabo P, Safi A, Sanyal A, Shoresh N, Simon JM, Song L, Trinklein ND, Altshuler RC, Birney E, Brown JB, Cheng C, Djebali S, Dong X, Dunham I, Ernst J, Furey TS, Gerstein M, Giardine B, Greven M, Hardison RC, Harris RS, Herrero J, Hoffman MM, Iyer S, Kellis M, Khatun J, Kheradpour P, Kundaje A, Lassmann T, Li Q, Lin X, Marinov GK, Merkel A, Mortazavi A, Parker SCJ, Reddy TE, Rozowsky J, Schlesinger F, Thurman RE, Wang J, Ward LD, Whitfield TW, Wilder SP, Wu W, Xi HS, Yip KY, Zhuang J, Bernstein BE, Birney E, Dunham I, Green ED, Gunter C, Snyder M, Pazin MJ, Lowdon RF, Dillon LAL, Adams LB, Kelly CJ, Zhang J, Wexler JR, Green ED, Good PJ, Feingold EA, Bernstein BE, Birney E, Crawford GE, Dekker J, Elnitski L, Farnham PJ, Gerstein M, Giddings MC, Gingeras TR, Green ED, Guig&#xf3; R, Hardison RC, Hubbard TJ, Kellis M, Kent WJ, Lieb JD, Margulies EH, Myers RM, Snyder M, Stamatoyannopoulos JA, Tenenbaum SA, Weng Z, White KP, Wold B, Khatun J, Yu Y, Wrobel J, Risk BA, Gunawardena HP, Kuiper HC, Maier CW, Xie L, Chen X, Giddings MC, Bernstein BE, Epstein CB, Shoresh N, Ernst J, Kheradpour P, Mikkelsen TS, Gillespie S, Goren A, Ram O, Zhang X, Wang L, Issner R, Coyne MJ, Durham T, Ku M, Truong T, Ward LD, Altshuler RC, Eaton ML, Kellis M, Djebali S, Davis CA, Merkel A, Dobin A, Lassmann T, Mortazavi A, Tanzer A, Lagarde J, Lin W, Schlesinger F, Xue C, Marinov GK, Khatun J, Williams BA, Zaleski C, Rozowsky J, R&#xf6;der M, Kokocinski F, Abdelhamid RF, Alioto T, Antoshechkin I, Baer MT, Batut P, Bell I, Bell K, Chakrabortty S, Chen X, Chrast J, Curado J, Derrien T, Drenkow J, Dumais E, Dumais J, Duttagupta R, Fastuca M, Fejes-Toth K, Ferreira P, Foissac S, Fullwood MJ, Gao H, Gonzalez D, Gordon A, Gunawardena HP, Howald C, Jha S, Johnson R, Kapranov P, King B, Kingswood C, Li G, Luo OJ, Park E, Preall JB, Presaud K, Ribeca P, Risk BA, Robyr D, Ruan X, Sammeth M, Sandhu KS, Schaeffer L, See L-H, Shahab A, Skancke J, Suzuki AM, Takahashi H, Tilgner H, Trout D, Walters N, Wang H, Wrobel J, Yu Y, Hayashizaki Y, Harrow J, Gerstein M, Hubbard TJ, Reymond A, Antonarakis SE, Hannon GJ, Giddings MC, Ruan Y, Wold B, Carninci P, Guig&#xf3; R, Gingeras TR, Rosenbloom KR, Sloan CA, Learned K, Malladi VS, Wong MC, Barber GP, Cline MS, Dreszer TR, Heitner SG, Karolchik D, Kent WJ, Kirkup VM, Meyer LR, Long JC, Maddren M, Raney BJ, Furey TS, Song L, Grasfeder LL, Giresi PG, Lee B-K, Battenhouse A, Sheffield NC, Simon JM, Showers KA, Safi A, London D, Bhinge AA, Shestak C, Schaner MR, Kim SK, Zhang ZZ, Mieczkowski PA, Mieczkowska JO, Liu Z, McDaniell RM, Ni Y, Rashid NU, Kim MJ, Adar S, Zhang Z, Wang T, Winter D, Keefe D, Birney E, Iyer VR, Lieb JD, Crawford GE, Li G, Sandhu KS, Zheng M, Wang P, Luo OJ, Shahab A, Fullwood MJ, Ruan X, Ruan Y, Myers RM, Pauli F, Williams BA, Gertz J, Marinov GK, Reddy TE, Vielmetter J, Partridge E, Trout D, Varley KE, Gasper C, Bansal A, Pepke S, Jain P, Amrhein H, Bowling KM, Anaya M, Cross MK, King B, Muratet MA, Antoshechkin I, Newberry KM, McCue K, Nesmith AS, Fisher-Aylor KI, Pusey B, DeSalvo G, Parker SL, Balasubramanian S, Davis NS, Meadows SK, Eggleston T, Gunter C, Newberry JS, Levy SE, Absher DM, Mortazavi A, Wong WH, Wold B, Blow MJ, Visel A, Pennachio LA, Elnitski L, Margulies EH, Parker SCJ, Petrykowska HM, Abyzov A, Aken B, Barrell D, Barson G, Berry A, Bignell A, Boychenko V, Bussotti G, Chrast J, Davidson C, Derrien T, Despacio-Reyes G, Diekhans M, Ezkurdia I, Frankish A, Gilbert J, Gonzalez JM, Griffiths E, Harte R, Hendrix DA, Howald C, Hunt T, Jungreis I, Kay M, Khurana E, Kokocinski F, Leng J, Lin MF, Loveland J, Lu Z, Manthravadi D, Mariotti M, Mudge J, Mukherjee G, Notredame C, Pei B, Rodriguez JM, Saunders G, Sboner A, Searle S, Sisu C, Snow C, Steward C, Tanzer A, Tapanari E, Tress ML, van Baren MJ, Walters N, Washietl S, Wilming L, Zadissa A, Zhang Z, Brent M, Haussler D, Kellis M, Valencia A, Gerstein M, Reymond A, Guig&#xf3; R, Harrow J, Hubbard TJ, Landt SG, Frietze S, Abyzov A, Addleman N, Alexander RP, Auerbach RK, Balasubramanian S, Bettinger K, Bhardwaj N, Boyle AP, Cao AR, Cayting P, Charos A, Cheng Y, Cheng C, Eastman C, Euskirchen G, Fleming JD, Grubert F, Habegger L, Hariharan M, Harmanci A, Iyengar S, Jin VX, Karczewski KJ, Kasowski M, Lacroute P, Lam H, Lamarre-Vincent N, Leng J, Lian J, Lindahl-Allen M, Min R, Miotto B, Monahan H, Moqtaderi Z, Mu XJ, O&#x2019;Geen H, Ouyang Z, Patacsil D, Pei B, Raha D, Ramirez L, Reed B, Rozowsky J, Sboner A, Shi M, Sisu C, Slifer T, Witt H, Wu L, Xu X, Yan K-K, Yang X, Yip KY, Zhang Z, Struhl K, Weissman SM, Gerstein M, Farnham PJ, Snyder M, Tenenbaum SA, Penalva LO, Doyle F, Karmakar S, Landt SG, Bhanvadia RR, Choudhury A, Domanus M, Ma L, Moran J, Patacsil D, Slifer T, Victorsen A, Yang X, Snyder M, White KP, Auer T, Centanin L, Eichenlaub M, Gruhl F, Heermann S, Hoeckendorf B, Inoue D, Kellner T, Kirchmaier S, Mueller C, Reinhardt R, Schertel L, Schneider S, Sinn R, Wittbrodt B, Wittbrodt J, Weng Z, Whitfield TW, Wang J, Collins PJ, Aldred SF, Trinklein ND, Partridge EC, Myers RM, Dekker J, Jain G, Lajoie BR, Sanyal A, Balasundaram G, Bates DL, Byron R, Canfield TK, Diegel MJ, Dunn D, Ebersol AK, Frum T, Garg K, Gist E, Hansen RS, Boatman L, Haugen E, Humbert R, Jain G, Johnson AK, Johnson EM, Kutyavin TV, Lajoie BR, Lee K, Lotakis D, Maurano MT, Neph SJ, Neri FV, Nguyen ED, Qu H, Reynolds AP, Roach V, Rynes E, Sabo P, Sanchez ME, Sandstrom RS, Sanyal A, Shafer AO, Stergachis AB, Thomas S, Thurman RE, Vernot B, Vierstra J, Vong S, Wang H, Weaver MA, Yan Y, Zhang M, Akey JM, Bender M, Dorschner MO, Groudine M, MacCoss MJ, Navas P, Stamatoyannopoulos G, Kaul R, Dekker J, Stamatoyannopoulos JA, Dunham I, Beal K, Brazma A, Flicek P, Herrero J, Johnson N, Keefe D, Lukk M, Luscombe NM, Sobral D, Vaquerizas JM, Wilder SP, Batzoglou S, Sidow A, Hussami N, Kyriazopoulou-Panagiotopoulou S, Libbrecht MW, Schaub MA, Kundaje A, Hardison RC, Miller W, Giardine B, Harris RS, Wu W, Bickel PJ, Banfai B, Boley NP, Brown JB, Huang H, Li Q, Li JJ, Noble WS, Bilmes JA, Buske OJ, Hoffman MM, Sahu AD, Kharchenko PV, Park PJ, Baker D, Taylor J, Weng Z, Iyer S, Dong X, Greven M, Lin X, Wang J, Xi HS, Zhuang J, Gerstein M, Alexander RP, Balasubramanian S, Cheng C, Harmanci A, Lochovsky L, Min R, Mu XJ, Rozowsky J, Yan K-K, Yip KY, Birney E, An Integrated Encyclopedia of DNA Elements in the Human Genome. Nature. 489, 57&#x2013;74 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3439153</ArticleId><ArticleId IdType="pubmed">22955616</ArticleId></ArticleIdList></Reference><Reference><Citation>Kundaje A, Meuleman W, Ernst J, Bilenky M, Yen A, Heravi-Moussavi A, Kheradpour P, Zhang Z, Wang J, Ziller MJ, Amin V, Whitaker JW, Schultz MD, Ward LD, Sarkar A, Quon G, Sandstrom RS, Eaton ML, Wu Y-C, Pfenning A, Wang X, Liu MC, Coarfa C, Harris RA, Shoresh N, Epstein CB, Gjoneska E, Leung D, Xie W, Hawkins RD, Lister R, Hong C, Gascard P, Mungall AJ, Moore R, Chuah E, Tam A, Canfield TK, Hansen RS, Kaul R, Sabo PJ, Bansal MS, Carles A, Dixon JR, Farh K-H, Feizi S, Karlic R, Kim A-R, Kulkarni A, Li D, Lowdon R, Elliott G, Mercer TR, Neph SJ, Onuchic V, Polak P, Rajagopal N, Ray P, Sallari RC, Siebenthall KT, Sinnott-Armstrong NA, Stevens M, Thurman RE, Wu J, Zhang B, Zhou X, Abdennur N, Adli M, Akerman M, Barrera L, Antosiewicz-Bourget J, Ballinger T, Barnes MJ, Bates D, Bell RJA, Bennett DA, Bianco K, Bock C, Boyle P, Brinchmann J, Caballero-Campo P, Camahort R, Carrasco-Alfonso MJ, Charnecki T, Chen H, Chen Z, Cheng JB, Cho S, Chu A, Chung W-Y, Cowan C, Deng QA, Deshpande V, Diegel M, Ding B, Durham T, Echipare L, Edsall L, Flowers D, Genbacev-Krtolica O, Gifford C, Gillespie S, Giste E, Glass IA, Gnirke A, Gormley M, Gu H, Gu J, Hafler DA, Hangauer MJ, Hariharan M, Hatan M, Haugen E, He Y, Heimfeld S, Herlofsen S, Hou Z, Humbert R, Issner R, Jackson AR, Jia H, Jiang P, Johnson AK, Kadlecek T, Kamoh B, Kapidzic M, Kent J, Kim A, Kleinewietfeld M, Klugman S, Krishnan J, Kuan S, Kutyavin T, Lee A-Y, Lee K, Li J, Li N, Li Y, Ligon KL, Lin S, Lin Y, Liu J, Liu Y, Luckey CJ, Ma YP, Maire C, Marson A, Mattick JS, Mayo M, McMaster M, Metsky H, Mikkelsen T, Miller D, Miri M, Mukame E, Nagarajan RP, Neri F, Nery J, Nguyen T, O&#x2019;Geen H, Paithankar S, Papayannopoulou T, Pelizzola M, Plettner P, Propson NE, Raghuraman S, Raney BJ, Raubitschek A, Reynolds AP, Richards H, Riehle K, Rinaudo P, Robinson JF, Rockweiler NB, Rosen E, Rynes E, Schein J, Sears R, Sejnowski T, Shafer A, Shen L, Shoemaker R, Sigaroudinia M, Slukvin I, Stehling-Sun S, Stewart R, Subramanian SL, Suknuntha K, Swanson S, Tian S, Tilden H, Tsai L, Urich M, Vaughn I, Vierstra J, Vong S, Wagner U, Wang H, Wang T, Wang Y, Weiss A, Whitton H, Wildberg A, Witt H, Won K-J, Xie M, Xing X, Xu I, Xuan Z, Ye Z, Yen C, Yu P, Zhang X, Zhang X, Zhao J, Zhou Y, Zhu J, Zhu Y, Ziegler S, Beaudet AE, Boyer LA, Jager PLD, Farnham PJ, Fisher SJ, Haussler D, Jones SJM, Li W, Marra MA, McManus MT, Sunyaev S, Thomson JA, Tlsty TD, Tsai L-H, Wang W, Waterland RA, Zhang MQ, Chadwick LH, Bernstein BE, Costello JF, Ecker JR, Hirst M, Meissner A, Milosavljevic A, Ren B, Stamatoyannopoulos JA, Wang T, Kellis M, Kundaje A, Meuleman W, Ernst J, Bilenky M, Yen A, Heravi-Moussavi A, Kheradpour P, Zhang Z, Wang J, Ziller MJ, Amin V, Whitaker JW, Schultz MD, Ward LD, Sarkar A, Quon G, Sandstrom RS, Eaton ML, Wu Y-C, Pfenning AR, Wang X, Claussnitzer M, Liu Y, Coarfa C, Harris RA, Shoresh N, Epstein CB, Gjoneska E, Leung D, Xie W, Hawkins RD, Lister R, Hong C, Gascard P, Mungall AJ, Moore R, Chuah E, Tam A, Canfield TK, Hansen RS, Kaul R, Sabo PJ, Bansal MS, Carles A, Dixon JR, Farh K-H, Feizi S, Karlic R, Kim A-R, Kulkarni A, Li D, Lowdon R, Elliott G, Mercer TR, Neph SJ, Onuchic V, Polak P, Rajagopal N, Ray P, Sallari RC, Siebenthall KT, Sinnott-Armstrong NA, Stevens M, Thurman RE, Wu J, Zhang B, Zhou X, Beaudet AE, Boyer LA, Jager PLD, Farnham PJ, Fisher SJ, Haussler D, Jones SJM, Li W, Marra MA, McManus MT, Sunyaev S, Thomson JA, Tlsty TD, Tsai L-H, Wang W, Waterland RA, Zhang MQ, Chadwick LH, Bernstein BE, Costello JF, Ecker JR, Hirst M, Meissner A, Milosavljevic A, Ren B, Stamatoyannopoulos JA, Wang T, Kellis M, Integrative analysis of 111 reference human epigenomes. Nature. 518, 317&#x2013;330 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4530010</ArticleId><ArticleId IdType="pubmed">25693563</ArticleId></ArticleIdList></Reference><Reference><Citation>Hodge RD, Bakken TE, Miller JA, Smith KA, Barkan ER, Graybuck LT, Close JL, Long B, Johansen N, Penn O, Yao Z, Eggermont J, H&#xf6;llt T, Levi BP, Shehata SI, Aevermann B, Beller A, Bertagnolli D, Brouner K, Casper T, Cobbs C, Dalley R, Dee N, Ding S-L, Ellenbogen RG, Fong O, Garren E, Goldy J, Gwinn RP, Hirschstein D, Keene CD, Keshk M, Ko AL, Lathia K, Mahfouz A, Maltzer Z, McGraw M, Nguyen TN, Nyhus J, Ojemann JG, Oldre A, Parry S, Reynolds S, Rimorin C, Shapovalova NV, Somasundaram S, Szafer A, Thomsen ER, Tieu M, Quon G, Scheuermann RH, Yuste R, Sunkin SM, Lelieveldt B, Feng D, Ng L, Bernard A, Hawrylycz M, Phillips JW, Tasic B, Zeng H, Jones AR, Koch C, Lein ES, Conserved cell types with divergent features in human versus mouse cortex. Nature. 573, 61&#x2013;68 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6919571</ArticleId><ArticleId IdType="pubmed">31435019</ArticleId></ArticleIdList></Reference><Reference><Citation>Ecker JR, Geschwind DH, Kriegstein AR, Ngai J, Osten P, Polioudakis D, Regev A, Sestan N, Wickersham IR, Zeng H, The BRAIN Initiative Cell Census Consortium: Lessons Learned toward Generating a Comprehensive Brain Cell Atlas. Neuron. 96, 542&#x2013;557 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5689454</ArticleId><ArticleId IdType="pubmed">29096072</ArticleId></ArticleIdList></Reference><Reference><Citation>Eng C-HL, Lawson M, Zhu Q, Dries R, Koulena N, Takei Y, Yun J, Cronin C, Karp C, Yuan G-C, Cai L, Transcriptome-scale super-resolved imaging in tissues by RNA seqFISH+. Nature. 568, 235&#x2013;239 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6544023</ArticleId><ArticleId IdType="pubmed">30911168</ArticleId></ArticleIdList></Reference><Reference><Citation>Yao Z, Liu H, Xie F, Fischer S, Adkins RS, Aldridge AI, Ament SA, Bartlett A, Behrens MM, den Berge KV, Bertagnolli D, de B&#xe9;zieux HR, Biancalani T, Booeshaghi AS, Bravo HC, Casper T, Colantuoni C, Crabtree J, Creasy H, Crichton K, Crow M, Dee N, Dougherty EL, Doyle WI, Dudoit S, Fang R, Felix V, Fong O, Giglio M, Goldy J, Hawrylycz M, Herb BR, Hertzano R, Hou X, Hu Q, Kancherla J, Kroll M, Lathia K, Li YE, Lucero JD, Luo C, Mahurkar A, McMillen D, Nadaf NM, Nery JR, Nguyen TN, Niu S-Y, Ntranos V, Orvis J, Osteen JK, Pham T, Pinto-Duarte A, Poirion O, Preissl S, Purdom E, Rimorin C, Risso D, Rivkin AC, Smith K, Street K, Sulc J, Svensson V, Tieu M, Torkelson A, Tung H, Vaishnav ED, Vanderburg CR, van Velthoven C, Wang X, White OR, Huang ZJ, Kharchenko PV, Pachter L, Ngai J, Regev A, Tasic B, Welch JD, Gillis J, Macosko EZ, Ren B, Ecker JR, Zeng H, Mukamel EA, A transcriptomic and epigenomic cell atlas of the mouse primary motor cortex. Nature. 598, 103&#x2013;110 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8494649</ArticleId><ArticleId IdType="pubmed">34616066</ArticleId></ArticleIdList></Reference><Reference><Citation>Kepecs A, Fishell G, Interneuron cell types are fit to function. Nature. 505, 318&#x2013;326 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4349583</ArticleId><ArticleId IdType="pubmed">24429630</ArticleId></ArticleIdList></Reference><Reference><Citation>Hrvatin S, Hochbaum DR, Nagy MA, Cicconet M, Robertson K, Cheadle L, Zilionis R, Ratner A, Borges-Monroy R, Klein AM, Sabatini BL, Greenberg ME, Single-cell analysis of experience-dependent transcriptomic states in the mouse visual cortex. Nat Neurosci. 21, 120&#x2013;129 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5742025</ArticleId><ArticleId IdType="pubmed">29230054</ArticleId></ArticleIdList></Reference><Reference><Citation>Yap E-L, Greenberg ME, Activity-Regulated Transcription: Bridging the Gap between Neural Activity and Behavior. Neuron. 100, 330&#x2013;348 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6223657</ArticleId><ArticleId IdType="pubmed">30359600</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeisel A, Hochgerner H, L&#xf6;nnerberg P, Johnsson A, Memic F, van der Zwan J, H&#xe4;ring M, Braun E, Borm LE, Manno GL, Codeluppi S, Furlan A, Lee K, Skene N, Harris KD, Hjerling-Leffler J, Arenas E, Ernfors P, Marklund U, Linnarsson S, Molecular Architecture of the Mouse Nervous System. Cell. 174, 999&#x2013;1014.e22 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6086934</ArticleId><ArticleId IdType="pubmed">30096314</ArticleId></ArticleIdList></Reference><Reference><Citation>Tasic B, Yao Z, Graybuck LT, Smith KA, Nguyen TN, Bertagnolli D, Goldy J, Garren E, Economo MN, Viswanathan S, Penn O, Bakken T, Menon V, Miller J, Fong O, Hirokawa KE, Lathia K, Rimorin C, Tieu M, Larsen R, Casper T, Barkan E, Kroll M, Parry S, Shapovalova NV, Hirschstein D, Pendergraft J, Sullivan HA, Kim TK, Szafer A, Dee N, Groblewski P, Wickersham I, Cetin A, Harris JA, Levi BP, Sunkin SM, Madisen L, Daigle TL, Looger L, Bernard A, Phillips J, Lein E, Hawrylycz M, Svoboda K, Jones AR, Koch C, Zeng H, Shared and distinct transcriptomic cell types across neocortical areas. Nature. 563, 72&#x2013;78 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6456269</ArticleId><ArticleId IdType="pubmed">30382198</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang R, Xia C, Close JL, Zhang M, He J, Huang Z, Halpern AR, Long B, Miller JA, Lein ES, Zhuang X, Conservation and divergence of cortical cell organization in human and mouse revealed by MERFISH. Science. 377, 56&#x2013;62 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9262715</ArticleId><ArticleId IdType="pubmed">35771910</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen Y, Yue F, McCleary DF, Ye Z, Edsall L, Kuan S, Wagner U, Dixon J, Lee L, Lobanenkov VV, Ren B, A map of the cis-regulatory sequences in the mouse genome. Nature. 488, 116&#x2013;120 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4041622</ArticleId><ArticleId IdType="pubmed">22763441</ArticleId></ArticleIdList></Reference><Reference><Citation>Abascal F, Acosta R, Addleman NJ, Adrian J, Afzal V, Ai R, Aken B, Akiyama JA, Jammal OA, Amrhein H, Anderson SM, Andrews GR, Antoshechkin I, Ardlie KG, Armstrong J, Astley M, Banerjee B, Barkal AA, Barnes IHA, Barozzi I, Barrell D, Barson G, Bates D, Baymuradov UK, Bazile C, Beer MA, Beik S, Bender MA, Bennett R, Bouvrette LPB, Bernstein BE, Berry A, Bhaskar A, Bignell A, Blue SM, Bodine DM, Boix C, Boley N, Borrman T, Borsari B, Boyle AP, Brandsmeier LA, Breschi A, Bresnick EH, Brooks JA, Buckley M, Burge CB, Byron R, Cahill E, Cai L, Cao L, Carty M, Castanon RG, Castillo A, Chaib H, Chan ET, Chee DR, Chee S, Chen H, Chen H, Chen J-Y, Chen S, Cherry JM, Chhetri SB, Choudhary JS, Chrast J, Chung D, Clarke D, Cody NAL, Coppola CJ, Coursen J, D&#x2019;Ippolito AM, Dalton S, Danyko C, Davidson C, Davila-Velderrain J, Davis CA, Dekker J, Deran A, DeSalvo G, Despacio-Reyes G, Dewey CN, Dickel DE, Diegel M, Diekhans M, Dileep V, Ding B, Djebali S, Dobin A, Dominguez D, Donaldson S, Drenkow J, Dreszer TR, Drier Y, Duff MO, Dunn D, Eastman C, Ecker JR, Edwards MD, El-Ali N, Elhajjajy SI, Elkins K, Emili A, Epstein CB, Evans RC, Ezkurdia I, Fan K, Farnham PJ, Farrell NP, Feingold EA, Ferreira A-M, Fisher-Aylor K, Fitzgerald S, Flicek P, Foo CS, Fortier K, Frankish A, Freese P, Fu S, Fu X-D, Fu Y, Fukuda-Yuzawa Y, Fulciniti M, Funnell APW, Gabdank I, Galeev T, Gao M, Giron CG, Garvin TH, Gelboin-Burkhart CA, Georgolopoulos G, Gerstein MB, Giardine BM, Gifford DK, Gilbert DM, Gilchrist DA, Gillespie S, Gingeras TR, Gong P, Gonzalez A, Gonzalez JM, Good P, Goren A, Gorkin DU, Graveley BR, Gray M, Greenblatt JF, Griffiths E, Groudine MT, Grubert F, Gu M, Guig&#xf3; R, Guo H, Guo Y, Guo Y, Gursoy G, Gutierrez-Arcelus M, Halow J, Hardison RC, Hardy M, Hariharan M, Harmanci A, Harrington A, Harrow JL, Hashimoto TB, Hasz RD, Hatan M, Haugen E, Hayes JE, He P, He Y, Heidari N, Hendrickson D, Heuston EF, Hilton JA, Hitz BC, Hochman A, Holgren C, Hou L, Hou S, Hsiao Y-HE, Hsu S, Huang H, Hubbard TJ, Huey J, Hughes TR, Hunt T, Ibarrientos S, Issner R, Iwata M, Izuogu O, Jaakkola T, Jameel N, Jansen C, Jiang L, Jiang P, Johnson A, Johnson R, Jungreis I, Kadaba M, Kasowski M, Kasparian M, Kato M, Kaul R, Kawli T, Kay M, Keen JC, Keles S, Keller CA, Kelley D, Kellis M, Kheradpour P, Kim DS, Kirilusha A, Klein RJ, Knoechel B, Kuan S, Kulik MJ, Kumar S, Kundaje A, Kutyavin T, Lagarde J, Lajoie BR, Lambert NJ, Lazar J, Lee AY, Lee D, Lee E, Lee JW, Lee K, Leslie CS, Levy S, Li B, Li H, Li N, Li S, Li X, Li YI, Li Y, Li Y, Li Y, Lian J, Libbrecht MW, Lin S, Lin Y, Liu D, Liu J, Liu P, Liu T, Liu XS, Liu Y, Liu Y, Long M, Lou S, Loveland J, Lu A, Lu Y, L&#xe9;cuyer E, Ma L, Mackiewicz M, Mannion BJ, Mannstadt M, Manthravadi D, Marinov GK, Martin FJ, Mattei E, McCue K, McEown M, McVicker G, Meadows SK, Meissner A, Mendenhall EM, Messer CL, Meuleman W, Meyer C, Miller S, Milton MG, Mishra T, Moore DE, Moore HM, Moore JE, Moore SH, Moran J, Mortazavi A, Mudge JM, Munshi N, Murad R, Myers RM, Nandakumar V, Nandi P, Narasimha AM, Narayanan AK, Naughton H, Navarro FCP, Navas P, Nazarovs J, Nelson J, Neph S, Neri FJ, Nery JR, Nesmith AR, Newberry JS, Newberry KM, Ngo V, Nguyen R, Nguyen TB, Nguyen T, Nishida A, Noble WS, Novak CS, Novoa EM, Nu&#xf1;ez B, O&#x2019;Donnell CW, Olson S, Onate KC, Otterman E, Ozadam H, Pagan M, Palden T, Pan X, Park Y, Partridge EC, Paten B, Pauli-Behn F, Pazin MJ, Pei B, Pennacchio LA, Perez AR, Perry EH, Pervouchine DD, Phalke NN, Pham Q, Phanstiel DH, Plajzer-Frick I, Pratt GA, Pratt HE, Preissl S, Pritchard JK, Pritykin Y, Purcaro MJ, Qin Q, Quinones-Valdez G, Rabano I, Radovani E, Raj A, Rajagopal N, Ram O, Ramirez L, Ramirez RN, Rausch D, Raychaudhuri S, Raymond J, Razavi R, Reddy TE, Reimonn TM, Ren B, Reymond A, Reynolds A, Rhie SK, Rinn J, Rivera M, Rivera-Mulia JC, Roberts BS, Rodriguez JM, Rozowsky J, Ryan R, Rynes E, Salins DN, Sandstrom R, Sasaki T, Sathe S, Savic D, Scavelli A, Scheiman J, Schlaffner C, Schloss JA, Schmitges FW, See LH, Sethi A, Setty M, Shafer A, Shan S, Sharon E, Shen Q, Shen Y, Sherwood RI, Shi M, Shin S, Shoresh N, Siebenthall K, Sisu C, Slifer T, Sloan CA, Smith A, Snetkova V, Snyder MP, Spacek DV, Srinivasan S, Srivas R, Stamatoyannopoulos G, Stamatoyannopoulos JA, Stanton R, Steffan D, Stehling-Sun S, Strattan JS, Su A, Sundararaman B, Suner M-M, Syed T, Szynkarek M, Tanaka FY, Tenen D, Teng M, Thomas JA, Toffey D, Tress ML, Trout DE, Trynka G, Tsuji J, Upchurch SA, Ursu O, Uszczynska-Ratajczak B, Uziel MC, Valencia A, Biber BV, van der Velde AG, Nostrand ELV, Vaydylevich Y, Vazquez J, Victorsen A, Vielmetter J, Vierstra J, Visel A, Vlasova A, Vockley CM, Volpi S, Vong S, Wang H, Wang M, Wang Q, Wang R, Wang T, Wang W, Wang X, Wang Y, Watson NK, Wei X, Wei Z, Weisser H, Weissman SM, Welch R, Welikson RE, Weng Z, Westra H-J, Whitaker JW, White C, White KP, Wildberg A, Williams BA, Wine D, Witt HN, Wold B, Wolf M, Wright J, Xiao R, Xiao X, Xu J, Xu J, Yan K-K, Yan Y, Yang H, Yang X, Yang Y-W, Yard&#x131;mc&#x131; GG, Yee BA, Yeo GW, Young T, Yu T, Yue F, Zaleski C, Zang C, Zeng H, Zeng W, Zerbino DR, Zhai J, Zhan L, Zhan Y, Zhang B, Zhang J, Zhang J, Zhang K, Zhang L, Zhang P, Zhang Q, Zhang X-O, Zhang Y, Zhang Z, Zhao Y, Zheng Y, Zhong G, Zhou X-Q, Zhu Y, Zimmerman J, Moore JE, Purcaro MJ, Pratt HE, Epstein CB, Shoresh N, Adrian J, Kawli T, Davis CA, Dobin A, Kaul R, Halow J, Nostrand ELV, Freese P, Gorkin DU, Shen Y, He Y, Mackiewicz M, Pauli-Behn F, Williams BA, Mortazavi A, Keller CA, Zhang X-O, Elhajjajy SI, Huey J, Dickel DE, Snetkova V, Wei X, Wang X, Rivera-Mulia JC, Rozowsky J, Zhang J, Chhetri SB, Zhang J, Victorsen A, White KP, Visel A, Yeo GW, Burge CB, L&#xe9;cuyer E, Gilbert DM, Dekker J, Rinn J, Mendenhall EM, Ecker JR, Kellis M, Klein RJ, Noble WS, Kundaje A, Guig&#xf3; R, Farnham PJ, Cherry JM, Myers RM, Ren B, Graveley BR, Gerstein MB, Pennacchio LA, Snyder MP, Bernstein BE, Wold B, Hardison RC, Gingeras TR, Stamatoyannopoulos JA, Weng Z, Expanded encyclopaedias of DNA elements in the human and mouse genomes. Nature. 583, 699&#x2013;710 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7410828</ArticleId><ArticleId IdType="pubmed">32728249</ArticleId></ArticleIdList></Reference><Reference><Citation>Cusanovich DA, Hill AJ, Aghamirzaie D, Daza RM, Pliner HA, Berletch JB, Filippova GN, Huang X, Christiansen L, DeWitt WS, Lee C, Regalado SG, Read DF, Steemers FJ, Disteche CM, Trapnell C, Shendure J, A Single-Cell Atlas of In Vivo Mammalian Chromatin Accessibility. Cell. 174, 1309&#x2013;1324.e18 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6158300</ArticleId><ArticleId IdType="pubmed">30078704</ArticleId></ArticleIdList></Reference><Reference><Citation>Buenrostro JD, Wu B, Litzenburger UM, Ruff D, Gonzales ML, Snyder MP, Chang HY, Greenleaf WJ, Single-cell chromatin accessibility reveals principles of regulatory variation. Nature. 523, 486&#x2013;490 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4685948</ArticleId><ArticleId IdType="pubmed">26083756</ArticleId></ArticleIdList></Reference><Reference><Citation>Lareau CA, Duarte FM, Chew JG, Kartha VK, Burkett ZD, Kohlway AS, Pokholok D, Aryee MJ, Steemers FJ, Lebofsky R, Buenrostro JD, Droplet-based combinatorial indexing for massive-scale single-cell chromatin accessibility. Nat Biotechnol. 37, 916&#x2013;924 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10299900</ArticleId><ArticleId IdType="pubmed">31235917</ArticleId></ArticleIdList></Reference><Reference><Citation>Lake BB, Chen S, Sos BC, Fan J, Kaeser GE, Yung YC, Duong TE, Gao D, Chun J, Kharchenko PV, Zhang K, Integrative single-cell analysis of transcriptional and epigenetic states in the human adult brain. Nat Biotechnol. 36, 70&#x2013;80 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5951394</ArticleId><ArticleId IdType="pubmed">29227469</ArticleId></ArticleIdList></Reference><Reference><Citation>Preissl S, Fang R, Huang H, Zhao Y, Raviram R, Gorkin DU, Zhang Y, Sos BC, Afzal V, Dickel DE, Kuan S, Visel A, Pennacchio LA, Zhang K, Ren B, Single-nucleus analysis of accessible chromatin in developing mouse forebrain reveals cell-type-specific transcriptional regulation. Nat Neurosci. 21, 432&#x2013;439 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5862073</ArticleId><ArticleId IdType="pubmed">29434377</ArticleId></ArticleIdList></Reference><Reference><Citation>Corces MR, Shcherbina A, Kundu S, Gloudemans MJ, Fr&#xe9;sard L, Granja JM, Louie BH, Eulalio T, Shams S, Bagdatli ST, Mumbach MR, Liu B, Montine KS, Greenleaf WJ, Kundaje A, Montgomery SB, Chang HY, Montine TJ, Single-cell epigenomic analyses implicate candidate causal variants at inherited risk loci for Alzheimer&#x2019;s and Parkinson&#x2019;s diseases. Nat Genet. 52, 1158&#x2013;1168 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7606627</ArticleId><ArticleId IdType="pubmed">33106633</ArticleId></ArticleIdList></Reference><Reference><Citation>Domcke S, Hill AJ, Daza RM, Cao J, O&#x2019;Day DR, Pliner HA, Aldinger KA, Pokholok D, Zhang F, Milbank JH, Zager MA, Glass IA, Steemers FJ, Doherty D, Trapnell C, Cusanovich DA, Shendure J, A human cell atlas of fetal chromatin accessibility. Science. 370 (2020), doi:10.1126/science.aba7612.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aba7612</ArticleId><ArticleId IdType="pmc">PMC7785298</ArticleId><ArticleId IdType="pubmed">33184180</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding S-L, Royall JJ, Sunkin SM, Ng L, Facer BAC, Lesnar P, Guillozet-Bongaarts A, McMurray B, Szafer A, Dolbeare TA, Stevens A, Tirrell L, Benner T, Caldejon S, Dalley RA, Dee N, Lau C, Nyhus J, Reding M, Riley ZL, Sandman D, Shen E, van der Kouwe A, Varjabedian A, Write M, Zollei L, Dang C, Knowles JA, Koch C, Phillips JW, Sestan N, Wohnoutka P, Zielke HR, Hohmann JG, Jones AR, Bernard A, Hawrylycz MJ, Hof PR, Fischl B, Lein ES, Comprehensive cellular-resolution atlas of the adult human brain: Adult human brain atlas. J Comp Neurol. 524, Spc1&#x2013;Spc1 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5054943</ArticleId><ArticleId IdType="pubmed">27418273</ArticleId></ArticleIdList></Reference><Reference><Citation>Li YE, Preissl S, Hou X, Zhang Z, Zhang K, Qiu Y, Poirion OB, Li B, Chiou J, Liu H, Pinto-Duarte A, Kubo N, Yang X, Fang R, Wang X, Han JY, Lucero J, Yan Y, Miller M, Kuan S, Gorkin D, Gaulton KJ, Shen Y, Nunn M, Mukamel EA, Behrens MM, Ecker JR, Ren B, An atlas of gene regulatory elements in adult mouse cerebrum. Nature. 598, 129&#x2013;136 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8494637</ArticleId><ArticleId IdType="pubmed">34616068</ArticleId></ArticleIdList></Reference><Reference><Citation>Leung AW, Li JYH, The Molecular Pathway Regulating Bergmann Glia and Folia Generation in the Cerebellum. Cerebellum. 17, 42&#x2013;48 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5809181</ArticleId><ArticleId IdType="pubmed">29218544</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Liu T, Meyer CA, Eeckhoute J, Johnson DS, Bernstein BE, Nusbaum C, Myers RM, Brown M, Li W, Liu XS, Model-based analysis of ChIP-Seq (MACS). Genome Biol. 9, R137 (2008).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2592715</ArticleId><ArticleId IdType="pubmed">18798982</ArticleId></ArticleIdList></Reference><Reference><Citation>Corces MR, Granja JM, Shams S, Louie BH, Seoane JA, Zhou W, Silva TC, Groeneveld C, Wong CK, Cho SW, Satpathy AT, Mumbach MR, Hoadley KA, Robertson AG, Sheffield NC, Felau I, Castro MAA, Berman BP, Staudt LM, Zenklusen JC, Laird PW, Curtis C, Network TCGAA, Greenleaf WJ, Chang HY, Akbani R, Benz CC, Boyle EA, Broom BM, Cherniack AD, Craft B, Demchok JA, Doane AS, Elemento O, Ferguson ML, Goldman MJ, Hayes DN, He J, Hinoue T, Imielinski M, Jones SJM, Kemal A, Knijnenburg TA, Korkut A, Lin D-C, Liu Y, Mensah MKA, Mills GB, Reuter VP, Schultz A, Shen H, Smith JP, Tarnuzzer R, Trefflich S, Wang Z, Weinstein JN, Westlake LC, Xu J, Yang L, Yau C, Zhao Y, Zhu J, The chromatin accessibility landscape of primary human cancers. Science. 362 (2018), doi:10.1126/science.aav1898.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aav1898</ArticleId><ArticleId IdType="pmc">PMC6408149</ArticleId><ArticleId IdType="pubmed">30361341</ArticleId></ArticleIdList></Reference><Reference><Citation>Meuleman W, Muratov A, Rynes E, Halow J, Lee K, Bates D, Diegel M, Dunn D, Neri F, Teodosiadis A, Reynolds A, Haugen E, Nelson J, Johnson A, Frerker M, Buckley M, Sandstrom R, Vierstra J, Kaul R, Stamatoyannopoulos J, Index and biological spectrum of human DNase I hypersensitive sites. Nature. 584, 244&#x2013;251 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7422677</ArticleId><ArticleId IdType="pubmed">32728217</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang K, Hocker JD, Miller M, Hou X, Chiou J, Poirion OB, Qiu Y, Li YE, Gaulton KJ, Wang A, Preissl S, Ren B, A single-cell atlas of chromatin accessibility in the human genome. Cell. 184, 5985&#x2013;6001.e19 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8664161</ArticleId><ArticleId IdType="pubmed">34774128</ArticleId></ArticleIdList></Reference><Reference><Citation>Oproescu A-M, Han S, Schuurmans C, New Insights Into the Intricacies of Proneural Gene Regulation in the Embryonic and Adult Cerebral Cortex. Front Mol Neurosci. 14, 642016 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7917194</ArticleId><ArticleId IdType="pubmed">33658912</ArticleId></ArticleIdList></Reference><Reference><Citation>Wittstatt J, Reiprich S, K&#xfc;spert M, Crazy Little Thing Called Sox&#x2014;New Insights in Oligodendroglial Sox Protein Function. Int J Mol Sci. 20, 2713 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6600536</ArticleId><ArticleId IdType="pubmed">31159496</ArticleId></ArticleIdList></Reference><Reference><Citation>Batiuk MY, Martirosyan A, Wahis J, de Vin F, Marneffe C, Kusserow C, Koeppen J, Viana JF, Oliveira JF, Voet T, Ponting CP, Belgard TG, Holt MG, Identification of region-specific astrocyte subtypes at single cell resolution. Nat Commun. 11, 1220 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7058027</ArticleId><ArticleId IdType="pubmed">32139688</ArticleId></ArticleIdList></Reference><Reference><Citation>Marques S, Zeisel A, Codeluppi S, van Bruggen D, Falc&#xe3;o AM, Xiao L, Li H, H&#xe4;ring M, Hochgerner H, Romanov RA, Gyllborg D, Mu&#xf1;oz-Manchado AB, Manno GL, L&#xf6;nnerberg P, Floriddia EM, Rezayee F, Ernfors P, Arenas E, Hjerling-Leffler J, Harkany T, Richardson WD, Linnarsson S, Castelo-Branco G, Oligodendrocyte heterogeneity in the mouse juvenile and adult central nervous system. Science. 352, 1326&#x2013;1329 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5221728</ArticleId><ArticleId IdType="pubmed">27284195</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan Y-L, Yuan Y, Tian L, Microglial regional heterogeneity and its role in the brain. Mol Psychiatr. 25, 351&#x2013;367 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6974435</ArticleId><ArticleId IdType="pubmed">31772305</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang AC, Vest RT, Kern F, Lee DP, Agam M, Maat CA, Losada PM, Chen MB, Schaum N, Khoury N, Toland A, Calcuttawala K, Shin H, P&#xe1;lovics R, Shin A, Wang EY, Luo J, Gate D, Schulz-Schaeffer WJ, Chu P, Siegenthaler JA, McNerney MW, Keller A, Wyss-Coray T, A human brain vascular atlas reveals diverse mediators of Alzheimer&#x2019;s risk. Nature. 603, 885&#x2013;892 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9635042</ArticleId><ArticleId IdType="pubmed">35165441</ArticleId></ArticleIdList></Reference><Reference><Citation>Yue F, Cheng Y, Breschi A, Vierstra J, Wu W, Ryba T, Sandstrom R, Ma Z, Davis C, Pope BD, Shen Y, Pervouchine DD, Djebali S, Thurman RE, Kaul R, Rynes E, Kirilusha A, Marinov GK, Williams BA, Trout D, Amrhein H, Fisher-Aylor K, Antoshechkin I, DeSalvo G, See L-H, Fastuca M, Drenkow J, Zaleski C, Dobin A, Prieto P, Lagarde J, Bussotti G, Tanzer A, Denas O, Li K, Bender MA, Zhang M, Byron R, Groudine MT, McCleary D, Pham L, Ye Z, Kuan S, Edsall L, Wu Y-C, Rasmussen MD, Bansal MS, Kellis M, Keller CA, Morrissey CS, Mishra T, Jain D, Dogan N, Harris RS, Cayting P, Kawli T, Boyle AP, Euskirchen G, Kundaje A, Lin S, Lin Y, Jansen C, Malladi VS, Cline MS, Erickson DT, Kirkup VM, Learned K, Sloan CA, Rosenbloom KR, de Sousa BL, Beal K, Pignatelli M, Flicek P, Lian J, Kahveci T, Lee D, Kent WJ, Santos MR, Herrero J, Notredame C, Johnson A, Vong S, Lee K, Bates D, Neri F, Diegel M, Canfield T, Sabo PJ, Wilken MS, Reh TA, Giste E, Shafer A, Kutyavin T, Haugen E, Dunn D, Reynolds AP, Neph S, Humbert R, Hansen RS, Bruijn MD, Selleri L, Rudensky A, Josefowicz S, Samstein R, Eichler EE, Orkin SH, Levasseur D, Papayannopoulou T, Chang K-H, Skoultchi A, Gosh S, Disteche C, Treuting P, Wang Y, Weiss MJ, Blobel GA, Cao X, Zhong S, Wang T, Good PJ, Lowdon RF, Adams LB, Zhou X-Q, Pazin MJ, Feingold EA, Wold B, Taylor J, Mortazavi A, Weissman SM, Stamatoyannopoulos JA, Snyder MP, Guigo R, Gingeras TR, Gilbert DM, Hardison RC, Beer MA, Ren B, Consortium ME, A comparative encyclopedia of DNA elements in the mouse genome. Nature. 515, 355&#x2013;364 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4266106</ArticleId><ArticleId IdType="pubmed">25409824</ArticleId></ArticleIdList></Reference><Reference><Citation>Bakken TE, Jorstad NL, Hu Q, Lake BB, Tian W, Kalmbach BE, Crow M, Hodge RD, Krienen FM, Sorensen SA, Eggermont J, Yao Z, Aevermann BD, Aldridge AI, Bartlett A, Bertagnolli D, Casper T, Castanon RG, Crichton K, Daigle TL, Dalley R, Dee N, Dembrow N, Diep D, Ding S-L, Dong W, Fang R, Fischer S, Goldman M, Goldy J, Graybuck LT, Herb BR, Hou X, Kancherla J, Kroll M, Lathia K, van Lew B, Li YE, Liu CS, Liu H, Lucero JD, Mahurkar A, McMillen D, Miller JA, Moussa M, Nery JR, Nicovich PR, Niu S-Y, Orvis J, Osteen JK, Owen S, Palmer CR, Pham T, Plongthongkum N, Poirion O, Reed NM, Rimorin C, Rivkin A, Romanow WJ, Sede&#xf1;o-Cort&#xe9;s AE, Siletti K, Somasundaram S, Sulc J, Tieu M, Torkelson A, Tung H, Wang X, Xie F, Yanny AM, Zhang R, Ament SA, Behrens MM, Bravo HC, Chun J, Dobin A, Gillis J, Hertzano R, Hof PR, H&#xf6;llt T, Horwitz GD, Keene CD, Kharchenko PV, Ko AL, Lelieveldt BP, Luo C, Mukamel EA, Pinto-Duarte A, Preissl S, Regev A, Ren B, Scheuermann RH, Smith K, Spain WJ, White OR, Koch C, Hawrylycz M, Tasic B, Macosko EZ, McCarroll SA, Ting JT, Zeng H, Zhang K, Feng G, Ecker JR, Linnarsson S, Lein ES, Comparative cellular analysis of motor cortex in human, marmoset and mouse. Nature. 598, 111&#x2013;119 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8494640</ArticleId><ArticleId IdType="pubmed">34616062</ArticleId></ArticleIdList></Reference><Reference><Citation>Minnoye L, Taskiran II, Mauduit D, Fazio M, Aerschot LV, Hulselmans G, Christiaens V, Makhzami S, Seltenhammer M, Karras P, Primot A, Cadieu E, van Rooijen E, Marine J-C, Egidy G, Ghanem GE, Zon L, Wouters J, Aerts S, Genome Res, in press, doi:10.1101/gr.260844.120.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gr.260844.120</ArticleId><ArticleId IdType="pmc">PMC7706731</ArticleId><ArticleId IdType="pubmed">32732264</ArticleId></ArticleIdList></Reference><Reference><Citation>Reilly MT, Faulkner GJ, Dubnau J, Ponomarev I, Gage FH, The Role of Transposable Elements in Health and Diseases of the Central Nervous System. J Neurosci. 33, 17577&#x2013;17586 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3818539</ArticleId><ArticleId IdType="pubmed">24198348</ArticleId></ArticleIdList></Reference><Reference><Citation>Deniz &#xd6;, Ahmed M, Todd CD, Rio-Machin A, Dawson MA, Branco MR, Endogenous retroviruses are a source of enhancers with oncogenic potential in acute myeloid leukaemia. Nat Commun. 11, 3506 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7360734</ArticleId><ArticleId IdType="pubmed">32665538</ArticleId></ArticleIdList></Reference><Reference><Citation>Visel A, Minovitsky S, Dubchak I, Pennacchio LA, VISTA Enhancer Browser&#x2014;a database of tissue-specific human enhancers. Nucleic Acids Res. 35, D88&#x2013;D92 (2007).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1716724</ArticleId><ArticleId IdType="pubmed">17130149</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang F, Flanagan J, Su N, Wang L-C, Bui S, Nielson A, Wu X, Vo H-T, Ma X-J, Luo Y, RNAscope A Novel in Situ RNA Analysis Platform for Formalin-Fixed, Paraffin-Embedded Tissues. J Mol Diagnostics. 14, 22&#x2013;29 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3338343</ArticleId><ArticleId IdType="pubmed">22166544</ArticleId></ArticleIdList></Reference><Reference><Citation>Yao Z, van Velthoven CTJ, Nguyen TN, Goldy J, Sedeno-Cortes AE, Baftizadeh F, Bertagnolli D, Casper T, Chiang M, Crichton K, Ding S-L, Fong O, Garren E, Glandon A, Gouwens NW, Gray J, Graybuck LT, Hawrylycz MJ, Hirschstein D, Kroll M, Lathia K, Lee C, Levi B, McMillen D, Mok S, Pham T, Ren Q, Rimorin C, Shapovalova N, Sulc J, Sunkin SM, Tieu M, Torkelson A, Tung H, Ward K, Dee N, Smith KA, Tasic B, Zeng H, A taxonomy of transcriptomic cell types across the isocortex and hippocampal formation. Cell. 184, 3222&#x2013;3241.e26 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8195859</ArticleId><ArticleId IdType="pubmed">34004146</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghandi M, Mohammad-Noori M, Ghareghani N, Lee D, Garraway L, Beer MA, gkmSVM: an R package for gapped-kmer SVM. Bioinform Oxf Engl. 32, 2205&#x2013;7 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4937197</ArticleId><ArticleId IdType="pubmed">27153639</ArticleId></ArticleIdList></Reference><Reference><Citation>Maurano MT, Humbert R, Rynes E, Thurman RE, Haugen E, Wang H, Reynolds AP, Sandstrom R, Qu H, Brody J, Shafer A, Neri F, Lee K, Kutyavin T, Stehling-Sun S, Johnson AK, Canfield TK, Giste E, Diegel M, Bates D, Hansen RS, Neph S, Sabo PJ, Heimfeld S, Raubitschek A, Ziegler S, Cotsapas C, Sotoodehnia N, Glass I, Sunyaev SR, Kaul R, Stamatoyannopoulos JA, Systematic Localization of Common Disease-Associated Variation in Regulatory DNA. Science. 337, 1190&#x2013;1195 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3771521</ArticleId><ArticleId IdType="pubmed">22955828</ArticleId></ArticleIdList></Reference><Reference><Citation>Nelson J, Bundoc-Baronia R, Comiskey G, McGovern TF, Facing Addiction in America: The Surgeon General&#x2019;s Report on Alcohol, Drugs, and Health: A Commentary. Alcohol Treat Q. 35, 445&#x2013;454 (2017).</Citation></Reference><Reference><Citation>Kosoy R, Fullard JF, Zeng B, Bendl J, Dong P, Rahman S, Kleopoulos SP, Shao Z, Girdhar K, Humphrey J, Lopes K. de P., Charney AW, Kopell BH, Raj T, Bennett D, Kellner CP, Haroutunian V, Hoffman GE, Roussos P, Genetics of the human microglia regulome refines Alzheimer&#x2019;s disease risk loci. Nat Genet. 54, 1145&#x2013;1154 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9388367</ArticleId><ArticleId IdType="pubmed">35931864</ArticleId></ArticleIdList></Reference><Reference><Citation>Drummond E, Wisniewski T, Alzheimer&#x2019;s disease: experimental models and reality. Acta Neuropathol. 133, 155&#x2013;175 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5253109</ArticleId><ArticleId IdType="pubmed">28025715</ArticleId></ArticleIdList></Reference><Reference><Citation>Nott A, Holtman IR, Coufal NG, Schlachetzki JCM, Yu M, Hu R, Han CZ, Pena M, Xiao J, Wu Y, Keulen Z, Pasillas MP, O&#x2019;Connor C, Nickl CK, Schafer ST, Shen Z, Rissman RA, Brewer JB, Gosselin D, Gonda DD, Levy ML, Rosenfeld MG, McVicker G, Gage FH, Ren B, Glass CK, Brain cell type&#x2013;specific enhancer&#x2013;promoter interactome maps and disease-risk association. Science. 366, 1134&#x2013;1139 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7028213</ArticleId><ArticleId IdType="pubmed">31727856</ArticleId></ArticleIdList></Reference><Reference><Citation>Avsec &#x17d;, Agarwal V, Visentin D, Ledsam JR, Grabska-Barwinska A, Taylor KR, Assael Y, Jumper J, Kohli P, Kelley DR, Effective gene expression prediction from sequence by integrating long-range interactions. Nat Methods. 18, 1196&#x2013;1203 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8490152</ArticleId><ArticleId IdType="pubmed">34608324</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaswani A, Shazeer N, Parmar N, Uszkoreit J, Jones L, Gomez AN, Kaiser L, Polosukhin I, Attention Is All You Need. Arxiv (2017), doi:10.48550/arxiv.1706.03762.</Citation><ArticleIdList><ArticleId IdType="doi">10.48550/arxiv.1706.03762</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang X, Wen J, Yang H, Jones IR, Zhu X, Liu W, Li B, Clelland CD, Luo W, Wong MY, Ren X, Cui X, Song M, Liu H, Chen C, Nicolas Eng, Ravichandran M, Sun Y, Lee D, Buren EV, Jiang M-Z, Chan CSY, Ye CJ, Perera R, Gan L, Li Y, Shen Y, Characterize Alzheimer&#x2019;s disease genetic association with molecular and cellular function in Microglia. Nature Genetics, in press. doi:10.1038/s41588-023-01506-8 (2023).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-023-01506-8</ArticleId><ArticleId IdType="pmc">PMC10939305</ArticleId><ArticleId IdType="pubmed">37735198</ArticleId></ArticleIdList></Reference><Reference><Citation>Seong C, Kim HJ, Byun J-S, Kim Y, Kim D-Y, FoxO1 Controls Redox Regulation and Cellular Physiology of BV-2 Microglial Cells. Inflammation. 46, 752&#x2013;762 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">36515788</ArticleId></ArticleIdList></Reference><Reference><Citation>Villar D, Berthelot C, Aldridge S, Rayner TF, Lukk M, Pignatelli M, Park TJ, Deaville R, Erichsen JT, Jasinska AJ, Turner JMA, Bertelsen MF, Murchison EP, Flicek P, Odom DT, Enhancer Evolution across 20 Mammalian Species. Cell. 160, 554&#x2013;566 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4313353</ArticleId><ArticleId IdType="pubmed">25635462</ArticleId></ArticleIdList></Reference><Reference><Citation>van Bree EJ, Guimar&#xe3;es RLFP, Lundberg M, Blujdea ER, Rosenkrantz JL, White FTG, Poppinga J, Ferrer-Ravent&#xf3;s P, Schneider A-FE, Clayton I, Haussler D, Reinders MJT, Holstege H, Ewing AD, Moses C, Jacobs FMJ, A hidden layer of structural variation in transposable elements reveals potential genetic modifiers in human disease-risk loci. Genome Res. 32, 656&#x2013;670 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8997352</ArticleId><ArticleId IdType="pubmed">35332097</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H, Durbin R, Fast and accurate short read alignment with Burrows&#x2013;Wheeler transform. Bioinformatics. 25, 1754&#x2013;1760 (2009).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2705234</ArticleId><ArticleId IdType="pubmed">19451168</ArticleId></ArticleIdList></Reference><Reference><Citation>Ou J, Liu H, Yu J, Kelliher MA, Castilla LH, Lawson ND, Zhu LJ, ATACseqQC: a Bioconductor package for post-alignment quality assessment of ATAC-seq data. Bmc Genomics. 19, 169 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5831847</ArticleId><ArticleId IdType="pubmed">29490630</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang R, Preissl S, Li Y, Hou X, Lucero J, Wang X, Motamedi A, Shiau AK, Zhou X, Xie F, Mukamel EA, Zhang K, Zhang Y, Behrens MM, Ecker JR, Ren B, Comprehensive analysis of single cell ATAC-seq data with SnapATAC. Nat Commun. 12, 1337 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7910485</ArticleId><ArticleId IdType="pubmed">33637727</ArticleId></ArticleIdList></Reference><Reference><Citation>Frankish A, Diekhans M, Jungreis I, Lagarde J, Loveland JE, Mudge JM, Sisu C, Wright JC, Armstrong J, Barnes I, Berry A, Bignell A, Boix C, Carbonell Sala S, Cunningham F, Di Domenico T, Donaldson S, Fiddes IT, Garc&#xed;a Gir&#xf3;n C, Gonzalez JM, Grego T, Hardy M, Hourlier T, Howe KL, Hunt T, Izuogu OG, Johnson R, Martin FJ, Mart&#xed;nez L, Mohanan S, Muir P, Navarro FCP, Parker A, Pei B, Pozo F, Riera FC, Ruffier M, Schmitt BM, Stapleton E, Suner M-M, Sycheva I, Uszczynska-Ratajczak B, Wolf MY, Xu J, Yang YT, Yates A, Zerbino D, Zhang Y, Choudhary JS, Gerstein M, Guig&#xf3; R, Hubbard TJP, Kellis M, Paten B, Tress ML, Flicek P, GENCODE 2021. Nucleic Acids Res. 49, gkaa1087- (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7778937</ArticleId><ArticleId IdType="pubmed">33270111</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolock SL, Lopez R, Klein AM, Scrublet: Computational Identification of Cell Doublets in Single-Cell Transcriptomic Data. Cell Syst. 8, 281&#x2013;291.e9 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6625319</ArticleId><ArticleId IdType="pubmed">30954476</ArticleId></ArticleIdList></Reference><Reference><Citation>Benaglia T, Chauveau D, Hunter DR, Young D, mixtools : An R Package for Analyzing Finite Mixture Models. J Stat Softw. 32 (2009), doi:10.18637/jss.v032.i06.</Citation><ArticleIdList><ArticleId IdType="doi">10.18637/jss.v032.i06</ArticleId></ArticleIdList></Reference><Reference><Citation>Amemiya HM, Kundaje A, Boyle AP, The ENCODE Blacklist: Identification of Problematic Regions of the Genome. Sci Rep-uk. 9, 9354 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6597582</ArticleId><ArticleId IdType="pubmed">31249361</ArticleId></ArticleIdList></Reference><Reference><Citation>Korsunsky I, Millard N, Fan J, Slowikowski K, Zhang F, Wei K, Baglaenko Y, Brenner M, Loh P, Raychaudhuri S, Fast, sensitive and accurate integration of single-cell data with Harmony. Nat Methods. 16, 1289&#x2013;1296 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6884693</ArticleId><ArticleId IdType="pubmed">31740819</ArticleId></ArticleIdList></Reference><Reference><Citation>Hao Y, Hao S, Andersen-Nissen E, Mauck WM, Zheng S, Butler A, Lee MJ, Wilk AJ, Darby C, Zager M, Hoffman P, Stoeckius M, Papalexi E, Mimitou EP, Jain J, Srivastava A, Stuart T, Fleming LM, Yeung B, Rogers AJ, McElrath JM, Blish CA, Gottardo R, Smibert P, Satija R, Integrated analysis of multimodal single-cell data. Cell. 184, 3573&#x2013;3587.e29 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8238499</ArticleId><ArticleId IdType="pubmed">34062119</ArticleId></ArticleIdList></Reference><Reference><Citation>Traag VA, Waltman L, van Eck NJ, From Louvain to Leiden: guaranteeing well-connected communities. Sci Rep-uk. 9, 5233 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6435756</ArticleId><ArticleId IdType="pubmed">30914743</ArticleId></ArticleIdList></Reference><Reference><Citation>McInnes L, Healy J, Saul N, Gro&#xdf;berger L, UMAP: Uniform Manifold Approximation and Projection. J Open Source Softw. 3, 861 (2018).</Citation></Reference><Reference><Citation>Suzuki R, Shimodaira H, Pvclust: an R package for assessing the uncertainty in hierarchical clustering. Bioinformatics. 22, 1540&#x2013;1542 (2006).</Citation><ArticleIdList><ArticleId IdType="pubmed">16595560</ArticleId></ArticleIdList></Reference><Reference><Citation>Drost H-G, Philentropy: Information Theory and Distance Quantification with R. J Open Source Softw. 3, 765 (2018).</Citation></Reference><Reference><Citation>Quinlan AR, Hall IM, BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics. 26, 841&#x2013;842 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2832824</ArticleId><ArticleId IdType="pubmed">20110278</ArticleId></ArticleIdList></Reference><Reference><Citation>van Dijk D, Sharma R, Nainys J, Yim K, Kathail P, Carr AJ, Burdziak C, Moon KR, Chaffer CL, Pattabiraman D, Bierie B, Mazutis L, Wolf G, Krishnaswamy S, Pe&#x2019;er D, Recovering Gene Interactions from Single-Cell Data Using Data Diffusion. Cell. 174, 716&#x2013;729.e27 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6771278</ArticleId><ArticleId IdType="pubmed">29961576</ArticleId></ArticleIdList></Reference><Reference><Citation>Hodge RD, Bakken TE, Miller JA, Smith KA, Barkan ER, Graybuck LT, Close JL, Long B, Johansen N, Penn O, Yao Z, Eggermont J, H&#xf6;llt T, Levi BP, Shehata SI, Aevermann B, Beller A, Bertagnolli D, Brouner K, Casper T, Cobbs C, Dalley R, Dee N, Ding S-L, Ellenbogen RG, Fong O, Garren E, Goldy J, Gwinn RP, Hirschstein D, Keene CD, Keshk M, Ko AL, Lathia K, Mahfouz A, Maltzer Z, McGraw M, Nguyen TN, Nyhus J, Ojemann JG, Oldre A, Parry S, Reynolds S, Rimorin C, Shapovalova NV, Somasundaram S, Szafer A, Thomsen ER, Tieu M, Quon G, Scheuermann RH, Yuste R, Sunkin SM, Lelieveldt B, Feng D, Ng L, Bernard A, Hawrylycz M, Phillips JW, Tasic B, Zeng H, Jones AR, Koch C, Lein ES, Conserved cell types with divergent features in human versus mouse cortex. Nature. 573, 61&#x2013;68 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6919571</ArticleId><ArticleId IdType="pubmed">31435019</ArticleId></ArticleIdList></Reference><Reference><Citation>Li YE, Xiao M, Shi B, Yang Y-CT, Wang D, Wang F, Marcia M, Lu ZJ, Identification of high-confidence RNA regulatory elements by combinatorial classification of RNA&#x2013;protein binding sites. Genome Biol. 18, 169 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5591525</ArticleId><ArticleId IdType="pubmed">28886744</ArticleId></ArticleIdList></Reference><Reference><Citation>Pedregosa F, Varoquaux G, Gramfort A, Michel V, Thirion B, Grisel O, Blondel M, M&#xfc;ller A, Nothman J, Louppe G, Prettenhofer P, Weiss R, Dubourg V, Vanderplas J, Passos A, Cournapeau D, Brucher M, Perrot M, Duchesnay &#xc9;, Scikit-learn: Machine Learning in Python. Arxiv (2012), doi:10.48550/arxiv.1201.0490.</Citation><ArticleIdList><ArticleId IdType="doi">10.48550/arxiv.1201.0490</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoyer PO, Non-negative matrix factorization with sparseness constraints. Arxiv (2004), doi:10.48550/arxiv.cs/0408058.</Citation><ArticleIdList><ArticleId IdType="doi">10.48550/arxiv.cs/0408058</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim H, Park H, Sparse non-negative matrix factorizations via alternating non-negativity-constrained least squares for microarray data analysis. Bioinformatics. 23, 1495&#x2013;1502 (2007).</Citation><ArticleIdList><ArticleId IdType="pubmed">17483501</ArticleId></ArticleIdList></Reference><Reference><Citation>Trapnell C, Cacchiarelli D, Grimsby J, Pokharel P, Li S, Morse M, Lennon NJ, Livak KJ, Mikkelsen TS, Rinn JL, The dynamics and regulators of cell fate decisions are revealed by pseudotemporal ordering of single cells. Nat Biotechnol. 32, 381&#x2013;386 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4122333</ArticleId><ArticleId IdType="pubmed">24658644</ArticleId></ArticleIdList></Reference><Reference><Citation>Pliner HA, Packer JS, McFaline-Figueroa JL, Cusanovich DA, Daza RM, Aghamirzaie D, Srivatsan S, Qiu X, Jackson D, Minkina A, Adey AC, Steemers FJ, Shendure J, Trapnell C, Cicero Predicts cis-Regulatory DNA Interactions from Single-Cell Chromatin Accessibility Data. Mol Cell. 71, 858&#x2013;871.e8 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6582963</ArticleId><ArticleId IdType="pubmed">30078726</ArticleId></ArticleIdList></Reference><Reference><Citation>Delignette-Muller ML, Dutang C, fitdistrplus : An R Package for Fitting Distributions. J Stat Softw. 64 (2015), doi:10.18637/jss.v064.i04.</Citation><ArticleIdList><ArticleId IdType="doi">10.18637/jss.v064.i04</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu C, Zhang Y, Li YE, Lucero J, Behrens MM, Ren B, Joint profiling of histone modifications and transcriptome in single cells from mouse brain. Nat Methods. 18, 283&#x2013;292 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7954905</ArticleId><ArticleId IdType="pubmed">33589836</ArticleId></ArticleIdList></Reference><Reference><Citation>Schep AN, Wu B, Buenrostro JD, Greenleaf WJ, chromVAR: inferring transcription-factor-associated accessibility from single-cell epigenomic data. Nat Methods. 14, 975&#x2013;978 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5623146</ArticleId><ArticleId IdType="pubmed">28825706</ArticleId></ArticleIdList></Reference><Reference><Citation>Ram&#xed;rez F, Ryan DP, Gr&#xfc;ning B, Bhardwaj V, Kilpert F, Richter AS, Heyne S, D&#xfc;ndar F, Manke T, deepTools2: a next generation web server for deep-sequencing data analysis. Nucleic Acids Res. 44, W160&#x2013;5 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4987876</ArticleId><ArticleId IdType="pubmed">27079975</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaw P, Uszkoreit J, Vaswani A, Self-Attention with Relative Position Representations. Arxiv (2018), doi:10.48550/arxiv.1803.02155.</Citation><ArticleIdList><ArticleId IdType="doi">10.48550/arxiv.1803.02155</ArticleId></ArticleIdList></Reference><Reference><Citation>Shazeer N, GLU Variants Improve Transformer. Arxiv (2020), doi:10.48550/arxiv.2002.05202.</Citation><ArticleIdList><ArticleId IdType="doi">10.48550/arxiv.2002.05202</ArticleId></ArticleIdList></Reference><Reference><Citation>Heinz S, Benner C, Spann N, Bertolino E, Lin YC, Laslo P, Cheng JX, Murre C, Singh H, Glass CK, Simple Combinations of Lineage-Determining Transcription Factors Prime cis-Regulatory Elements Required for Macrophage and B Cell Identities. Mol Cell. 38, 576&#x2013;589 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2898526</ArticleId><ArticleId IdType="pubmed">20513432</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen EY, Tan CM, Kou Y, Duan Q, Wang Z, Meirelles GV, Clark NR, Ma&#x2019;ayan A, Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool. Bmc Bioinformatics. 14, 128 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3637064</ArticleId><ArticleId IdType="pubmed">23586463</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee BT, Barber GP, Benet-Pag&#xe8;s A, Casper J, Clawson H, Diekhans M, Fischer C, Gonzalez JN, Hinrichs AS, Lee CM, Muthuraman P, Nassar LR, Nguy B, Pereira T, Perez G, Raney BJ, Rosenbloom KR, Schmelter D, Speir ML, Wick BD, Zweig AS, Haussler D, Kuhn RM, Haeussler M, Kent WJ, The UCSC Genome Browser database: 2022 update. Nucleic Acids Res. 50, D1115&#x2013;D1122 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8728131</ArticleId><ArticleId IdType="pubmed">34718705</ArticleId></ArticleIdList></Reference><Reference><Citation>S. W. G. of the P. G. Consortium, Bulik-Sullivan BK, Loh P-R, Finucane HK, Ripke S, Yang J, Patterson N, Daly MJ, Price AL, Neale BM, LD Score regression distinguishes confounding from polygenicity in genome-wide association studies. Nat Genet. 47, 291&#x2013;295 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4495769</ArticleId><ArticleId IdType="pubmed">25642630</ArticleId></ArticleIdList></Reference><Reference><Citation>Hafemeister C, Satija R, Normalization and variance stabilization of single-cell RNA-seq data using regularized negative binomial regression. Genome Biol. 20, 296 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6927181</ArticleId><ArticleId IdType="pubmed">31870423</ArticleId></ArticleIdList></Reference><Reference><Citation>Barakat TS, Halbritter F, Zhang M, Rendeiro AF, Perenthaler E, Bock C, Chambers I, Functional Dissection of the Enhancer Repertoire in Human Embryonic Stem Cells. Cell Stem Cell. 23, 276&#x2013;288.e8 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6084406</ArticleId><ArticleId IdType="pubmed">30033119</ArticleId></ArticleIdList></Reference><Reference><Citation>Perdomo-Sabogal &#xc1;, Nowick K, Genetic variation in human gene regulatory factors uncovers regulatory roles in local adaptation and disease. Genome Biol Evol. 11, 2178&#x2013;2193 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6685493</ArticleId><ArticleId IdType="pubmed">31228201</ArticleId></ArticleIdList></Reference><Reference><Citation>Playfoot CJ, Duc J, Sheppard S, Dind S, Coudray A, Planet E, Trono D, Transposable elements and their KZFP controllers are drivers of transcriptional innovation in the developing human brain. Genome Res. 31, 1531&#x2013;1545 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8415367</ArticleId><ArticleId IdType="pubmed">34400477</ArticleId></ArticleIdList></Reference><Reference><Citation>&#xd6;zt&#xfc;rk Z, O&#x2019;Kane CJ, P&#xe9;rez-Moreno JJ, Axonal Endoplasmic Reticulum Dynamics and Its Roles in Neurodegeneration. Front Neurosci-switz. 14, 48 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7025499</ArticleId><ArticleId IdType="pubmed">32116502</ArticleId></ArticleIdList></Reference><Reference><Citation>Marballi KK, Gallitano AL, Immediate Early Genes Anchor a Biological Pathway of Proteins Required for Memory Formation, Long-Term Depression and Risk for Schizophrenia. Front Behav Neurosci. 12, 23 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5827560</ArticleId><ArticleId IdType="pubmed">29520222</ArticleId></ArticleIdList></Reference><Reference><Citation>Agrawal S, Baulch JE, Madan S, Salah S, Cheeks SN, Krattli RP, Subramanian VS, Acharya MM, Agrawal A, Impact of IL-21-associated peripheral and brain crosstalk on the Alzheimer&#x2019;s disease neuropathology. Cell Mol Life Sci. 79, 331 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9160131</ArticleId><ArticleId IdType="pubmed">35648273</ArticleId></ArticleIdList></Reference><Reference><Citation>Colton C, Wilt S, Gilbert D, Chernyshev O, Snell J, Dubois-Dalcq M, Species differences in the generation of reactive oxygen species by microglia. Mol Chem Neuropathol. 28, 15&#x2013;20 (1996).</Citation><ArticleIdList><ArticleId IdType="pubmed">8871937</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim YR, Kim YM, Lee J, Park J, Lee JE, Hyun Y-M, Neutrophils Return to Bloodstream Through the Brain Blood Vessel After Crosstalk With Microglia During LPS-Induced Neuroinflammation. Frontiers Cell Dev Biology. 8, 613733 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7753044</ArticleId><ArticleId IdType="pubmed">33364241</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37824674</PMID><DateCompleted><Year>2023</Year><Month>11</Month><Day>13</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>30</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1095-9203</ISSN><JournalIssue CitedMedium="Internet"><Volume>382</Volume><Issue>6667</Issue><PubDate><Year>2023</Year><Month>Oct</Month><Day>13</Day></PubDate></JournalIssue><Title>Science (New York, N.Y.)</Title><ISOAbbreviation>Science</ISOAbbreviation></Journal><ArticleTitle>Single-cell DNA methylation and 3D genome architecture in the human brain.</ArticleTitle><Pagination><StartPage>eadf5357</StartPage><MedlinePgn>eadf5357</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1126/science.adf5357</ELocationID><Abstract><AbstractText>Delineating the gene-regulatory programs underlying complex cell types is fundamental for understanding brain function in health and disease. Here, we comprehensively examined human brain cell epigenomes by probing DNA methylation and chromatin conformation at single-cell resolution in 517 thousand cells (399 thousand neurons and 118 thousand non-neurons) from 46 regions of three adult male brains. We identified 188 cell types and characterized their molecular signatures. Integrative analyses revealed concordant changes in DNA methylation, chromatin accessibility, chromatin organization, and gene expression across cell types, cortical areas, and basal ganglia structures. We further developed single-cell methylation barcodes that reliably predict brain cell types using the methylation status of select genomic sites. This multimodal epigenomic brain cell atlas provides new insights into the complexity of cell-type-specific gene regulation in adult human brains.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Tian</LastName><ForeName>Wei</ForeName><Initials>W</Initials><Identifier Source="ORCID">0000-0002-2146-1717</Identifier><AffiliationInfo><Affiliation>Genomic Analysis Laboratory, The Salk Institute for Biological Studies, La Jolla, CA 92037, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Zhou</LastName><ForeName>Jingtian</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-2060-1922</Identifier><AffiliationInfo><Affiliation>Genomic Analysis Laboratory, The Salk Institute for Biological Studies, La Jolla, CA 92037, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Bioinformatics and Systems Biology Program, University of California, San Diego, La Jolla, CA 92037, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bartlett</LastName><ForeName>Anna</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-7059-4033</Identifier><AffiliationInfo><Affiliation>Genomic Analysis Laboratory, The Salk Institute for Biological Studies, La Jolla, CA 92037, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zeng</LastName><ForeName>Qiurui</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Genomic Analysis Laboratory, The Salk Institute for Biological Studies, La Jolla, CA 92037, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Biological Sciences, University of California, San Diego, La Jolla, CA 92037, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Hanqing</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0002-5114-6048</Identifier><AffiliationInfo><Affiliation>Genomic Analysis Laboratory, The Salk Institute for Biological Studies, La Jolla, CA 92037, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Castanon</LastName><ForeName>Rosa G</ForeName><Initials>RG</Initials><Identifier Source="ORCID">0000-0003-1791-002X</Identifier><AffiliationInfo><Affiliation>Genomic Analysis Laboratory, The Salk Institute for Biological Studies, La Jolla, CA 92037, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kenworthy</LastName><ForeName>Mia</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-1704-6817</Identifier><AffiliationInfo><Affiliation>Genomic Analysis Laboratory, The Salk Institute for Biological Studies, La Jolla, CA 92037, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Altshul</LastName><ForeName>Jordan</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0001-5999-3295</Identifier><AffiliationInfo><Affiliation>Genomic Analysis Laboratory, The Salk Institute for Biological Studies, La Jolla, CA 92037, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Valadon</LastName><ForeName>Cynthia</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0003-1655-6903</Identifier><AffiliationInfo><Affiliation>Genomic Analysis Laboratory, The Salk Institute for Biological Studies, La Jolla, CA 92037, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aldridge</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-1962-8802</Identifier><AffiliationInfo><Affiliation>Genomic Analysis Laboratory, The Salk Institute for Biological Studies, La Jolla, CA 92037, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nery</LastName><ForeName>Joseph R</ForeName><Initials>JR</Initials><Identifier Source="ORCID">0000-0003-0153-5659</Identifier><AffiliationInfo><Affiliation>Genomic Analysis Laboratory, The Salk Institute for Biological Studies, La Jolla, CA 92037, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Huaming</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0001-5289-7882</Identifier><AffiliationInfo><Affiliation>Genomic Analysis Laboratory, The Salk Institute for Biological Studies, La Jolla, CA 92037, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Jiaying</ForeName><Initials>J</Initials><Identifier Source="ORCID">0009-0004-1919-1465</Identifier><AffiliationInfo><Affiliation>Genomic Analysis Laboratory, The Salk Institute for Biological Studies, La Jolla, CA 92037, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Johnson</LastName><ForeName>Nicholas D</ForeName><Initials>ND</Initials><Identifier Source="ORCID">0000-0003-3229-6849</Identifier><AffiliationInfo><Affiliation>Computational Neurobiology Laboratory, The Salk Institute for Biological Studies, La Jolla, CA 92037, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lucero</LastName><ForeName>Jacinta</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Computational Neurobiology Laboratory, The Salk Institute for Biological Studies, La Jolla, CA 92037, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Osteen</LastName><ForeName>Julia K</ForeName><Initials>JK</Initials><AffiliationInfo><Affiliation>Computational Neurobiology Laboratory, The Salk Institute for Biological Studies, La Jolla, CA 92037, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Emerson</LastName><ForeName>Nora</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0001-7344-4487</Identifier><AffiliationInfo><Affiliation>Computational Neurobiology Laboratory, The Salk Institute for Biological Studies, La Jolla, CA 92037, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rink</LastName><ForeName>Jon</ForeName><Initials>J</Initials><Identifier Source="ORCID">0009-0007-4651-0443</Identifier><AffiliationInfo><Affiliation>Computational Neurobiology Laboratory, The Salk Institute for Biological Studies, La Jolla, CA 92037, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Jasper</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-2086-1441</Identifier><AffiliationInfo><Affiliation>Computational Neurobiology Laboratory, The Salk Institute for Biological Studies, La Jolla, CA 92037, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Yang E</ForeName><Initials>YE</Initials><Identifier Source="ORCID">0000-0001-6997-6018</Identifier><AffiliationInfo><Affiliation>Ludwig Institute for Cancer Research, La Jolla, CA 92037, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Siletti</LastName><ForeName>Kimberly</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0001-7620-8973</Identifier><AffiliationInfo><Affiliation>Department of Medical Biochemistry and Biophysics, Karolinska Institutet, 171 77 Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liem</LastName><ForeName>Michelle</ForeName><Initials>M</Initials><Identifier Source="ORCID">0009-0004-0542-7166</Identifier><AffiliationInfo><Affiliation>Flow Cytometry Core Facility, The Salk Institute for Biological Studies, La Jolla, CA 92037, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Claffey</LastName><ForeName>Naomi</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Flow Cytometry Core Facility, The Salk Institute for Biological Studies, La Jolla, CA 92037, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>O'Connor</LastName><ForeName>Carolyn</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-3301-7912</Identifier><AffiliationInfo><Affiliation>Flow Cytometry Core Facility, The Salk Institute for Biological Studies, La Jolla, CA 92037, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yanny</LastName><ForeName>Anna Marie</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nyhus</LastName><ForeName>Julie</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-2006-8235</Identifier><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dee</LastName><ForeName>Nick</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0002-2831-9254</Identifier><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Casper</LastName><ForeName>Tamara</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0003-1638-3651</Identifier><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shapovalova</LastName><ForeName>Nadiya</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0002-8618-8272</Identifier><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hirschstein</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ding</LastName><ForeName>Song-Lin</ForeName><Initials>SL</Initials><Identifier Source="ORCID">0000-0002-7072-5272</Identifier><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hodge</LastName><ForeName>Rebecca</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-5784-9668</Identifier><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Levi</LastName><ForeName>Boaz P</ForeName><Initials>BP</Initials><Identifier Source="ORCID">0000-0002-8346-872X</Identifier><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Keene</LastName><ForeName>C Dirk</ForeName><Initials>CD</Initials><Identifier Source="ORCID">0000-0002-5291-1469</Identifier><AffiliationInfo><Affiliation>Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA 98195, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Linnarsson</LastName><ForeName>Sten</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-3491-3444</Identifier><AffiliationInfo><Affiliation>Department of Medical Biochemistry and Biophysics, Karolinska Institutet, 171 77 Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lein</LastName><ForeName>Ed</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0001-9012-6552</Identifier><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ren</LastName><ForeName>Bing</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0002-5435-1127</Identifier><AffiliationInfo><Affiliation>Ludwig Institute for Cancer Research, La Jolla, CA 92037, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Epigenomics, University of California, San Diego School of Medicine, La Jolla, CA 92037, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cellular and Molecular Medicine, University of California, San Diego School of Medicine, La Jolla, CA 92037, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Genomic Medicine, University of California, San Diego School of Medicine, La Jolla, CA 92037, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Moores Cancer Center, University of California, San Diego School of Medicine, La Jolla, CA 92037, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Behrens</LastName><ForeName>M Margarita</ForeName><Initials>MM</Initials><Identifier Source="ORCID">0000-0002-7168-8186</Identifier><AffiliationInfo><Affiliation>Computational Neurobiology Laboratory, The Salk Institute for Biological Studies, La Jolla, CA 92037, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ecker</LastName><ForeName>Joseph R</ForeName><Initials>JR</Initials><Identifier Source="ORCID">0000-0001-5799-5895</Identifier><AffiliationInfo><Affiliation>Genomic Analysis Laboratory, The Salk Institute for Biological Studies, La Jolla, CA 92037, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Howard Hughes Medical Institute, The Salk Institute for Biological Studies, La Jolla, CA 92037, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>U01 MH114812</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant><Grant><Acronym>HHMI</Acronym><Agency>Howard Hughes Medical Institute</Agency><Country>United States</Country></Grant><Grant><GrantID>S10 OD023689</GrantID><Acronym>OD</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 MH121282</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UM1 MH130994</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 CA014195</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>10</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Science</MedlineTA><NlmUniqueID>0404511</NlmUniqueID><ISSNLinking>0036-8075</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D002843">Chromatin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="Y">Brain</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002843" MajorTopicYN="N">Chromatin</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019175" MajorTopicYN="Y">DNA Methylation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015894" MajorTopicYN="N">Genome, Human</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059010" MajorTopicYN="N">Single-Cell Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D021621" MajorTopicYN="N">Imaging, Three-Dimensional</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D044127" MajorTopicYN="Y">Epigenesis, Genetic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001271" MajorTopicYN="N">Atlases as Topic</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement><b>Competing interests:</b> J.R.E is a member of the scientific advisor for Zymo Research In. and Ionis Pharmaceuticals. B.R. is a co-founder and consultant of Arima Genomics Inc. and co-founder of Epigenome Technologies. W.T and J.R.E have filed a provisional patent related to the findings presented in this paper. The patent application number is US provisional application No. 63/427,789 filed November 23, 2022, and assigned to Salk Institute for Biological Studies.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>11</Month><Day>1</Day><Hour>12</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>10</Month><Day>12</Day><Hour>18</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>10</Month><Day>12</Day><Hour>14</Hour><Minute>4</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>10</Month><Day>13</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37824674</ArticleId><ArticleId IdType="mid">NIHMS1929560</ArticleId><ArticleId IdType="pmc">PMC10572106</ArticleId><ArticleId IdType="doi">10.1126/science.adf5357</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Liu H, Zhou J, Tian W, Luo C, Bartlett A, Aldridge A, Lucero J, Osteen JK, Nery JR, Chen H, Rivkin A, Castanon RG, Clock B, Li YE, Hou X, Poirion OB, Preissl S, Pinto-Duarte A, O&#x2019;Connor C, Boggeman L, Fitzpatrick C, Nunn M, Mukamel EA, Zhang Z, Callaway EM, Ren B, Dixon JR, Behrens MM, Ecker JR, DNA methylation atlas of the mouse brain at single-cell resolution. Nature. 598, 120&#x2013;128 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8494641</ArticleId><ArticleId IdType="pubmed">34616061</ArticleId></ArticleIdList></Reference><Reference><Citation>Li YE, Preissl S, Hou X, Zhang Z, Zhang K, Qiu Y, Poirion OB, Li B, Chiou J, Liu H, Pinto-Duarte A, Kubo N, Yang X, Fang R, Wang X, Han JY, Lucero J, Yan Y, Miller M, Kuan S, Gorkin D, Gaulton KJ, Shen Y, Nunn M, Mukamel EA, Behrens MM, Ecker JR, Ren B, An atlas of gene regulatory elements in adult mouse cerebrum. Nature. 598, 129&#x2013;136 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8494637</ArticleId><ArticleId IdType="pubmed">34616068</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee D-S, Luo C, Zhou J, Chandran S, Rivkin A, Bartlett A, Nery JR, Fitzpatrick C, O&#x2019;Connor C, Dixon JR, Ecker JR, Simultaneous profiling of 3D genome structure and DNA methylation in single human cells. Nat. Methods. 16, 999&#x2013;1006 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6765423</ArticleId><ArticleId IdType="pubmed">31501549</ArticleId></ArticleIdList></Reference><Reference><Citation>He Y, Hariharan M, Gorkin DU, Dickel DE, Luo C, Castanon RG, Nery JR, Lee AY, Zhao Y, Huang H, Williams BA, Trout D, Amrhein H, Fang R, Chen H, Li B, Visel A, Pennacchio LA, Ren B, Ecker JR, Spatiotemporal DNA methylome dynamics of the developing mouse fetus. Nature. 583, 752&#x2013;759 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7398276</ArticleId><ArticleId IdType="pubmed">32728242</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo C, Keown CL, Kurihara L, Zhou J, He Y, Li J, Castanon R, Lucero J, Nery JR, Sandoval JP, Bui B, Sejnowski TJ, Harkins TT, Mukamel EA, Behrens MM, Ecker JR, Single-cell methylomes identify neuronal subtypes and regulatory elements in mammalian cortex. Science. 357, 600&#x2013;604 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5570439</ArticleId><ArticleId IdType="pubmed">28798132</ArticleId></ArticleIdList></Reference><Reference><Citation>de Mendoza A, Poppe D, Buckberry S, Pflueger J, Albertin CB, Daish T, Bertrand S, de la Calle-Mustienes E, G&#xf3;mez-Skarmeta JL, Nery JR, Ecker JR, Baer B, Ragsdale CW, Gr&#xfc;tzner F, Escriva H, Venkatesh B, Bogdanovic O, Lister R, The emergence of the brain non-CpG methylation system in vertebrates. Nat Ecol Evol. 5, 369&#x2013;378 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7116863</ArticleId><ArticleId IdType="pubmed">33462491</ArticleId></ArticleIdList></Reference><Reference><Citation>Lister R, Mukamel EA, Nery JR, Urich M, Puddifoot CA, Johnson ND, Lucero J, Huang Y, Dwork AJ, Schultz MD, Yu M, Tonti-Filippini J, Heyn H, Hu S, Wu JC, Rao A, Esteller M, He C, Haghighi FG, Sejnowski TJ, Behrens MM, Ecker JR, Global epigenomic reconfiguration during mammalian brain development. Science. 341, 1237905 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3785061</ArticleId><ArticleId IdType="pubmed">23828890</ArticleId></ArticleIdList></Reference><Reference><Citation>Tillotson R, Cholewa-Waclaw J, Chhatbar K, Connelly JC, Kirschner SA, Webb S, Koerner MV, Selfridge J, Kelly DA, De Sousa D, Brown K, Lyst MJ, Kriaucionis S, Bird A, Neuronal non-CG methylation is an essential target for MeCP2 function. Mol. Cell. 81, 1260&#x2013;1275.e12 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7980222</ArticleId><ArticleId IdType="pubmed">33561390</ArticleId></ArticleIdList></Reference><Reference><Citation>Dekker J, Mirny L, The 3D Genome as Moderator of Chromosomal Communication. Cell. 164, 1110&#x2013;1121 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4788811</ArticleId><ArticleId IdType="pubmed">26967279</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo C, Rivkin A, Zhou J, Sandoval JP, Kurihara L, Lucero J, Castanon R, Nery JR, Pinto-Duarte A, Bui B, Fitzpatrick C, O&#x2019;Connor C, Ruga S, Van Eden ME, Davis DA, Mash DC, Behrens MM, Ecker JR, Robust single-cell DNA methylome profiling with snmC-seq2. Nat. Commun. 9, 3824 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6147798</ArticleId><ArticleId IdType="pubmed">30237449</ArticleId></ArticleIdList></Reference><Reference><Citation>Siletti K, Hodge R, Albiach AM, Hu L, Lee KW, L&#xf6;nnerberg P, Bakken T, Ding S-L, Clark M, Casper T, Dee N, Gloe J, Dirk Keene C, Nyhus J, Tung H, Yanny AM, Arenas E, Lein ES, Linnarsson S, Transcriptomic diversity of cell types across the adult human brain. bioRxiv (2022), p. 2022.10.12.511898.</Citation><ArticleIdList><ArticleId IdType="pubmed">37824663</ArticleId></ArticleIdList></Reference><Reference><Citation>Li YE, Preissl S, Miller M, Johnson ND, Wang Z, Jiao H, Zhu C, Wang Z, Xie Y, Poirion O, Kern C, Pinto-Duarte A, Tian W, Siletti K, Emerson N, Osteen J, Lucero J, Lin L, Yang Q, Zhu Q, Espinoza S, Yanny AM, Nyhus J, Dee N, Casper T, Shapovalova N, Hirschstein D, Hodge RD, Linnarsson S, Bakken T, Levi B, Dirk Keene C, Shang J, Lein ES, Wang A, Margarita Behrens M, Ecker JR, Ren B, A comparative atlas of single-cell chromatin accessibility in the human brain. bioRxiv (2022), p. 2022.11.09.515833.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10852054</ArticleId><ArticleId IdType="pubmed">37824643</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng J, Zhou Y, Campbell SL, Le T, Li E, Sweatt JD, Silva AJ, Fan G, Dnmt1 and Dnmt3a maintain DNA methylation and regulate synaptic function in adult forebrain neurons. Nat. Neurosci. 13, 423&#x2013;430 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3060772</ArticleId><ArticleId IdType="pubmed">20228804</ArticleId></ArticleIdList></Reference><Reference><Citation>He Y, Ecker JR, Non-CG Methylation in the Human Genome. Annu. Rev. Genomics Hum. Genet. 16, 55&#x2013;77 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4729449</ArticleId><ArticleId IdType="pubmed">26077819</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou J, Ma J, Chen Y, Cheng C, Bao B, Peng J, Sejnowski TJ, Dixon JR, Ecker JR, Robust single-cell Hi-C clustering by convolution- and random-walk&#x2013;based imputation. Proceedings of the National Academy of Sciences. 116, 14011&#x2013;14018 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6628819</ArticleId><ArticleId IdType="pubmed">31235599</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan L, Ma W, Wu H, Zheng Y, Xing D, Chen R, Li X, Daley N, Deisseroth K, Xie XS, Changes in genome architecture and transcriptional dynamics progress independently of sensory experience during post-natal brain development. Cell. 184, 741&#x2013;758.e17 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33484631</ArticleId></ArticleIdList></Reference><Reference><Citation>Hodge RD, Bakken TE, Miller JA, Smith KA, Barkan ER, Graybuck LT, Close JL, Long B, Johansen N, Penn O, Yao Z, Eggermont J, H&#xf6;llt T, Levi BP, Shehata SI, Aevermann B, Beller A, Bertagnolli D, Brouner K, Casper T, Cobbs C, Dalley R, Dee N, Ding S-L, Ellenbogen RG, Fong O, Garren E, Goldy J, Gwinn RP, Hirschstein D, Keene CD, Keshk M, Ko AL, Lathia K, Mahfouz A, Maltzer Z, McGraw M, Nguyen TN, Nyhus J, Ojemann JG, Oldre A, Parry S, Reynolds S, Rimorin C, Shapovalova NV, Somasundaram S, Szafer A, Thomsen ER, Tieu M, Quon G, Scheuermann RH, Yuste R, Sunkin SM, Lelieveldt B, Feng D, Ng L, Bernard A, Hawrylycz M, Phillips JW, Tasic B, Zeng H, Jones AR, Koch C, Lein ES, Conserved cell types with divergent features in human versus mouse cortex. Nature. 573, 61&#x2013;68 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6919571</ArticleId><ArticleId IdType="pubmed">31435019</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagano T, Lubling Y, V&#xe1;rnai C, Dudley C, Leung W, Baran Y, Mendelson Cohen N, Wingett S, Fraser P, Tanay A, Cell-cycle dynamics of chromosomal organization at single-cell resolution. Nature. 547, 61&#x2013;67 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5567812</ArticleId><ArticleId IdType="pubmed">28682332</ArticleId></ArticleIdList></Reference><Reference><Citation>Buenrostro JD, Wu B, Litzenburger UM, Ruff D, Gonzales ML, Snyder MP, Chang HY, Greenleaf WJ, Single-cell chromatin accessibility reveals principles of regulatory variation. Nature. 523, 486&#x2013;490 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4685948</ArticleId><ArticleId IdType="pubmed">26083756</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang R, Zhou T, Ma J, Multiscale and integrative single-cell Hi-C analysis with Higashi. Nat. Biotechnol. 40, 254&#x2013;261 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8843812</ArticleId><ArticleId IdType="pubmed">34635838</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang R, Zhou T, Ma J, Ultrafast and interpretable single-cell 3D genome analysis with Fast-Higashi. Cell Syst. 13, 798&#x2013;807.e6 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9867958</ArticleId><ArticleId IdType="pubmed">36265466</ArticleId></ArticleIdList></Reference><Reference><Citation>Dixon JR, Selvaraj S, Yue F, Kim A, Li Y, Shen Y, Hu M, Liu JS, Ren B, Topological domains in mammalian genomes identified by analysis of chromatin interactions. Nature. 485, 376&#x2013;380 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3356448</ArticleId><ArticleId IdType="pubmed">22495300</ArticleId></ArticleIdList></Reference><Reference><Citation>Rao SSP, Huntley MH, Durand NC, Stamenova EK, Bochkov ID, Robinson JT, Sanborn AL, Machol I, Omer AD, Lander ES, Aiden EL, A 3D map of the human genome at kilobase resolution reveals principles of chromatin looping. Cell. 159, 1665&#x2013;1680 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5635824</ArticleId><ArticleId IdType="pubmed">25497547</ArticleId></ArticleIdList></Reference><Reference><Citation>Dixon JR, Jung I, Selvaraj S, Shen Y, Antosiewicz-Bourget JE, Lee AY, Ye Z, Kim A, Rajagopal N, Xie W, Diao Y, Liang J, Zhao H, Lobanenkov VV, Ecker JR, Thomson JA, Ren B, Chromatin architecture reorganization during stem cell differentiation. Nature. 518, 331&#x2013;336 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4515363</ArticleId><ArticleId IdType="pubmed">25693564</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmitt AD, Hu M, Jung I, Xu Z, Qiu Y, Tan CL, Li Y, Lin S, Lin Y, Barr CL, Ren B, A Compendium of Chromatin Contact Maps Reveals Spatially Active Regions in the Human Genome. Cell Rep. 17, 2042&#x2013;2059 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5478386</ArticleId><ArticleId IdType="pubmed">27851967</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonev B, Mendelson Cohen N, Szabo Q, Fritsch L, Papadopoulos GL, Lubling Y, Xu X, Lv X, Hugnot J-P, Tanay A, Cavalli G, Multiscale 3D Genome Rewiring during Mouse Neural Development. Cell. 171, 557&#x2013;572.e24 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5651218</ArticleId><ArticleId IdType="pubmed">29053968</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Li T, Preissl S, Amaral ML, Grinstein JD, Farah EN, Destici E, Qiu Y, Hu R, Lee AY, Chee S, Ma K, Ye Z, Zhu Q, Huang H, Fang R, Yu L, Izpisua Belmonte JC, Wu J, Evans SM, Chi NC, Ren B, Transcriptionally active HERV-H retrotransposons demarcate topologically associating domains in human pluripotent stem cells. Nat. Genet. 51, 1380&#x2013;1388 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6722002</ArticleId><ArticleId IdType="pubmed">31427791</ArticleId></ArticleIdList></Reference><Reference><Citation>Winick-Ng W, Kukalev A, Harabula I, Zea-Redondo L, Szab&#xf3; D, Meijer M, Serebreni L, Zhang Y, Bianco S, Chiariello AM, Irastorza-Azcarate I, Thieme CJ, Sparks TM, Carvalho S, Fiorillo L, Musella F, Irani E, Triglia ET, Kolodziejczyk AA, Abentung A, Apostolova G, Paul EJ, Franke V, Kempfer R, Akalin A, Teichmann SA, Dechant G, Ungless MA, Nicodemi M, Welch L, Castelo-Branco G, Pombo A, Cell-type specialization is encoded by specific chromatin topologies. Nature, 1&#x2013;8 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8612935</ArticleId><ArticleId IdType="pubmed">34789882</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiehle L, Thorn GJ, Raddatz G, Clarkson CT, Rippe K, Lyko F, Breiling A, Teif VB, DNA (de)methylation in embryonic stem cells controls CTCF-dependent chromatin boundaries. Genome Res. 29, 750&#x2013;761 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6499307</ArticleId><ArticleId IdType="pubmed">30948436</ArticleId></ArticleIdList></Reference><Reference><Citation>Noack F, Vangelisti S, Raffl G, Carido M, Diwakar J, Chong F, Bonev B, Multimodal profiling of the transcriptional regulatory landscape of the developing mouse cortex identifies Neurog2 as a key epigenome remodeler. Nat. Neurosci. 25, 154&#x2013;167 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8825286</ArticleId><ArticleId IdType="pubmed">35132236</ArticleId></ArticleIdList></Reference><Reference><Citation>Scelfo A, Barra V, Abdennur N, Spracklin G, Busato F, Salinas-Luypaert C, Bonaiti E, Velasco G, Chipont A, Gu&#xe9;rin C, Tijhuis AE, Spierings DCJ, Francastel C, Foijer F, Tost J, Mirny L, Fachinetti D, Tunable DNMT1 degradation reveals cooperation of DNMT1 and DNMT3B in regulating DNA methylation dynamics and genome organization. bioRxiv (2023), p. 2023.05.04.539406.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10876481</ArticleId><ArticleId IdType="pubmed">38376465</ArticleId></ArticleIdList></Reference><Reference><Citation>Mo A, Mukamel EA, Davis FP, Luo C, Henry GL, Picard S, Urich MA, Nery JR, Sejnowski TJ, Lister R, Eddy SR, Ecker JR, Nathans J, Epigenomic Signatures of Neuronal Diversity in the Mammalian Brain. Neuron. 86, 1369&#x2013;1384 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4499463</ArticleId><ArticleId IdType="pubmed">26087164</ArticleId></ArticleIdList></Reference><Reference><Citation>Heavner WE, Ji S, Notwell JH, Dyer ES, Tseng AM, Birgmeier J, Yoo B, Bejerano G, McConnell SK, Transcription factor expression defines subclasses of developing projection neurons highly similar to single-cell RNA-seq subtypes. Proc. Natl. Acad. Sci. U. S. A. 117, 25074&#x2013;25084 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7547209</ArticleId><ArticleId IdType="pubmed">32948690</ArticleId></ArticleIdList></Reference><Reference><Citation>Warming S, Rachel RA, Jenkins NA, Copeland NG, Zfp423 is required for normal cerebellar development. Mol. Cell. Biol. 26, 6913&#x2013;6922 (2006).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1592861</ArticleId><ArticleId IdType="pubmed">16943432</ArticleId></ArticleIdList></Reference><Reference><Citation>Casoni F, Croci L, Bosone C, D&#x2019;Ambrosio R, Badaloni A, Gaudesi D, Barili V, Sarna JR, Tessarollo L, Cremona O, Hawkes R, Warming S, Consalez GG, Zfp423/ZNF423 regulates cell cycle progression, the mode of cell division and the DNA-damage response in Purkinje neuron progenitors. Development. 144, 3686&#x2013;3697 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5675449</ArticleId><ArticleId IdType="pubmed">28893945</ArticleId></ArticleIdList></Reference><Reference><Citation>Croci L, Chung S-H, Masserdotti G, Gianola S, Bizzoca A, Gennarini G, Corradi A, Rossi F, Hawkes R, Consalez GG, A key role for the HLH transcription factor EBF2COE2,O/E-3 in Purkinje neuron migration and cerebellar cortical topography. Development. 133, 2719&#x2013;2729 (2006).</Citation><ArticleIdList><ArticleId IdType="pubmed">16774995</ArticleId></ArticleIdList></Reference><Reference><Citation>Takahashi K, Liu F-C, Oishi T, Mori T, Higo N, Hayashi M, Hirokawa K, Takahashi H, Expression of FOXP2 in the developing monkey forebrain: comparison with the expression of the genes FOXP1, PBX3, and MEIS2. J. Comp. Neurol. 509, 180&#x2013;189 (2008).</Citation><ArticleIdList><ArticleId IdType="pubmed">18461604</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaoru T, Liu F-C, Ishida M, Oishi T, Hayashi M, Kitagawa M, Shimoda K, Takahashi H, Molecular characterization of the intercalated cell masses of the amygdala: implications for the relationship with the striatum. Neuroscience. 166, 220&#x2013;230 (2010).</Citation><ArticleIdList><ArticleId IdType="pubmed">20004711</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasser J, Bergman DT, Fulco CP, Guckelberger P, Doughty BR, Patwardhan TA, Jones TR, Nguyen TH, Ulirsch JC, Lekschas F, Mualim K, Natri HM, Weeks EM, Munson G, Kane M, Kang HY, Cui A, Ray JP, Eisenhaure TM, Collins RL, Dey K, Pfister H, Price AL, Epstein CB, Kundaje A, Xavier RJ, Daly MJ, Huang H, Finucane HK, Hacohen N, Lander ES, Engreitz JM, Genome-wide enhancer maps link risk variants to disease genes. Nature. 593, 238&#x2013;243 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9153265</ArticleId><ArticleId IdType="pubmed">33828297</ArticleId></ArticleIdList></Reference><Reference><Citation>Bulik-Sullivan BK, Loh P-R, Finucane HK, Ripke S, Yang J, Schizophrenia Working Group of the Psychiatric Genomics Consortium, Patterson N, Daly MJ, Price AL, Neale BM, LD Score regression distinguishes confounding from polygenicity in genome-wide association studies. Nat. Genet. 47, 291&#x2013;295 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4495769</ArticleId><ArticleId IdType="pubmed">25642630</ArticleId></ArticleIdList></Reference><Reference><Citation>Hansen DV, Hanson JE, Sheng M, Microglia in Alzheimer&#x2019;s disease. J. Cell Biol. 217, 459&#x2013;472 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5800817</ArticleId><ArticleId IdType="pubmed">29196460</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu M, Jiang Y, Wedow R, Li Y, Brazel DM, Chen F, Datta G, Davila-Velderrain J, McGuire D, Tian C, Zhan X, 23andMe Research Team, HUNT All-In Psychiatry, Choquet H, Docherty AR, Faul JD, Foerster JR, Fritsche LG, Gabrielsen ME, Gordon SD, Haessler J, Hottenga J-J, Huang H, Jang S-K, Jansen PR, Ling Y, M&#xe4;gi R, Matoba N, McMahon G, Mulas A, Orr&#xf9; V, Palviainen T, Pandit A, Reginsson GW, Skogholt AH, Smith JA, Taylor AE, Turman C, Willemsen G, Young H, Young KA, Zajac GJM, Zhao W, Zhou W, Bjornsdottir G, Boardman JD, Boehnke M, Boomsma DI, Chen C, Cucca F, Davies GE, Eaton CB, Ehringer MA, Esko T, Fiorillo E, Gillespie NA, Gudbjartsson DF, Haller T, Harris KM, Heath AC, Hewitt JK, Hickie IB, Hokanson JE, Hopfer CJ, Hunter DJ, Iacono WG, Johnson EO, Kamatani Y, Kardia SLR, Keller MC, Kellis M, Kooperberg C, Kraft P, Krauter KS, Laakso M, Lind PA, Loukola A, Lutz SM, Madden PAF, Martin NG, McGue M, McQueen MB, Medland SE, Metspalu A, Mohlke KL, Nielsen JB, Okada Y, Peters U, Polderman TJC, Posthuma D, Reiner AP, Rice JP, Rimm E, Rose RJ, Runarsdottir V, Stallings MC, Stan&#x10d;&#xe1;kov&#xe1; A, Stefansson H, Thai KK, Tindle HA, Tyrfingsson T, Wall TL, Weir DR, Weisner C, Whitfield JB, Winsvold BS, Yin J, Zuccolo L, Bierut LJ, Hveem K, Lee JJ, Munaf&#xf2; MR, Saccone NL, Willer CJ, Cornelis MC, David SP, Hinds DA, Jorgenson E, Kaprio J, Stitzel JA, Stefansson K, Thorgeirsson TE, Abecasis G, Liu DJ, Vrieze S, Association studies of up to 1.2 million individuals yield new insights into the genetic etiology of tobacco and alcohol use. Nat. Genet. 51, 237&#x2013;244 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6358542</ArticleId><ArticleId IdType="pubmed">30643251</ArticleId></ArticleIdList></Reference><Reference><Citation>Sansom SN, Livesey FJ, Gradients in the brain: the control of the development of form and function in the cerebral cortex. Cold Spring Harb. Perspect. Biol. 1, a002519 (2009).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2742095</ArticleId><ArticleId IdType="pubmed">20066088</ArticleId></ArticleIdList></Reference><Reference><Citation>Hawrylycz MJ, Lein ES, Guillozet-Bongaarts AL, Shen EH, Ng L, Miller JA, van de Lagemaat LN, Smith KA, Ebbert A, Riley ZL, Abajian C, Beckmann CF, Bernard A, Bertagnolli D, Boe AF, Cartagena PM, Chakravarty MM, Chapin M, Chong J, Dalley RA, David Daly B, Dang C, Datta S, Dee N, Dolbeare TA, Faber V, Feng D, Fowler DR, Goldy J, Gregor BW, Haradon Z, Haynor DR, Hohmann JG, Horvath S, Howard RE, Jeromin A, Jochim JM, Kinnunen M, Lau C, Lazarz ET, Lee C, Lemon TA, Li L, Li Y, Morris JA, Overly CC, Parker PD, Parry SE, Reding M, Royall JJ, Schulkin J, Sequeira PA, Slaughterbeck CR, Smith SC, Sodt AJ, Sunkin SM, Swanson BE, Vawter MP, Williams D, Wohnoutka P, Zielke HR, Geschwind DH, Hof PR, Smith SM, Koch C, Grant SGN, Jones AR, An anatomically comprehensive atlas of the adult human brain transcriptome. Nature. 489, 391&#x2013;399 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4243026</ArticleId><ArticleId IdType="pubmed">22996553</ArticleId></ArticleIdList></Reference><Reference><Citation>Yao Z, Liu H, Xie F, Fischer S, Adkins RS, Aldridge AI, Ament SA, Bartlett A, Behrens MM, Van den Berge K, Bertagnolli D, de B&#xe9;zieux HR, Biancalani T, Booeshaghi AS, Bravo HC, Casper T, Colantuoni C, Crabtree J, Creasy H, Crichton K, Crow M, Dee N, Dougherty EL, Doyle WI, Dudoit S, Fang R, Felix V, Fong O, Giglio M, Goldy J, Hawrylycz M, Herb BR, Hertzano R, Hou X, Hu Q, Kancherla J, Kroll M, Lathia K, Li YE, Lucero JD, Luo C, Mahurkar A, McMillen D, Nadaf NM, Nery JR, Nguyen TN, Niu S-Y, Ntranos V, Orvis J, Osteen JK, Pham T, Pinto-Duarte A, Poirion O, Preissl S, Purdom E, Rimorin C, Risso D, Rivkin AC, Smith K, Street K, Sulc J, Svensson V, Tieu M, Torkelson A, Tung H, Vaishnav ED, Vanderburg CR, van Velthoven C, Wang X, White OR, Huang ZJ, Kharchenko PV, Pachter L, Ngai J, Regev A, Tasic B, Welch JD, Gillis J, Macosko EZ, Ren B, Ecker JR, Zeng H, Mukamel EA, A transcriptomic and epigenomic cell atlas of the mouse primary motor cortex. Nature. 598, 103&#x2013;110 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8494649</ArticleId><ArticleId IdType="pubmed">34616066</ArticleId></ArticleIdList></Reference><Reference><Citation>Krienen FM, Goldman M, Zhang Q, Del Rosario RCH, Florio M, Machold R, Saunders A, Levandowski K, Zaniewski H, Schuman B, Wu C, Lutservitz A, Mullally CD, Reed N, Bien E, Bortolin L, Fernandez-Otero M, Lin JD, Wysoker A, Nemesh J, Kulp D, Burns M, Tkachev V, Smith R, Walsh CA, Dimidschstein J, Rudy B, S Kean L, Berretta S, Fishell G, Feng G, McCarroll SA, Innovations present in the primate interneuron repertoire. Nature. 586, 262&#x2013;269 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7957574</ArticleId><ArticleId IdType="pubmed">32999462</ArticleId></ArticleIdList></Reference><Reference><Citation>Yao Z, van Velthoven CTJ, Nguyen TN, Goldy J, Sedeno-Cortes AE, Baftizadeh F, Bertagnolli D, Casper T, Chiang M, Crichton K, Ding S-L, Fong O, Garren E, Glandon A, Gouwens NW, Gray J, Graybuck LT, Hawrylycz MJ, Hirschstein D, Kroll M, Lathia K, Lee C, Levi B, McMillen D, Mok S, Pham T, Ren Q, Rimorin C, Shapovalova N, Sulc J, Sunkin SM, Tieu M, Torkelson A, Tung H, Ward K, Dee N, Smith KA, Tasic B, Zeng H, A taxonomy of transcriptomic cell types across the isocortex and hippocampal formation. Cell. 184, 3222&#x2013;3241.e26 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8195859</ArticleId><ArticleId IdType="pubmed">34004146</ArticleId></ArticleIdList></Reference><Reference><Citation>Tasic B, Yao Z, Graybuck LT, Smith KA, Nguyen TN, Bertagnolli D, Goldy J, Garren E, Economo MN, Viswanathan S, Penn O, Bakken T, Menon V, Miller J, Fong O, Hirokawa KE, Lathia K, Rimorin C, Tieu M, Larsen R, Casper T, Barkan E, Kroll M, Parry S, Shapovalova NV, Hirschstein D, Pendergraft J, Sullivan HA, Kim TK, Szafer A, Dee N, Groblewski P, Wickersham I, Cetin A, Harris JA, Levi BP, Sunkin SM, Madisen L, Daigle TL, Looger L, Bernard A, Phillips J, Lein E, Hawrylycz M, Svoboda K, Jones AR, Koch C, Zeng H, Shared and distinct transcriptomic cell types across neocortical areas. Nature. 563, 72&#x2013;78 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6456269</ArticleId><ArticleId IdType="pubmed">30382198</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen H, Albergante L, Hsu JY, Lareau CA, Lo Bosco G, Guan J, Zhou S, Gorban AN, Bauer DE, Aryee MJ, Langenau DM, Zinovyev A, Buenrostro JD, Yuan G-C, Pinello L, Single-cell trajectories reconstruction, exploration and mapping of omics data with STREAM. Nature Communications. 10 (2019), , doi:10.1038/s41467-019-09670-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-09670-4</ArticleId><ArticleId IdType="pmc">PMC6478907</ArticleId><ArticleId IdType="pubmed">31015418</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng J, Hsu W-H, Patterson D, Tseng C-S, Hsing H-W, Zhuang Z-H, Huang Y-T, Faedo A, Rubenstein JL, Touboul J, Chou S-J, COUP-TFI specifies the medial entorhinal cortex identity and induces differential cell adhesion to determine the integrity of its boundary with neocortex. Sci Adv. 7 (2021), doi:10.1126/sciadv.abf6808.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.abf6808</ArticleId><ArticleId IdType="pmc">PMC11057786</ArticleId><ArticleId IdType="pubmed">34215582</ArticleId></ArticleIdList></Reference><Reference><Citation>Alexander GE, DeLong MR, Strick PL, Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu. Rev. Neurosci. 9, 357&#x2013;381 (1986).</Citation><ArticleIdList><ArticleId IdType="pubmed">3085570</ArticleId></ArticleIdList></Reference><Reference><Citation>Middleton FA, Strick PL, Basal ganglia and cerebellar loops: motor and cognitive circuits. Brain Res. Brain Res. Rev. 31, 236&#x2013;250 (2000).</Citation><ArticleIdList><ArticleId IdType="pubmed">10719151</ArticleId></ArticleIdList></Reference><Reference><Citation>Bakken TE, Jorstad NL, Hu Q, Lake BB, Tian W, Kalmbach BE, Crow M, Hodge RD, Krienen FM, Sorensen SA, Eggermont J, Yao Z, Aevermann BD, Aldridge AI, Bartlett A, Bertagnolli D, Casper T, Castanon RG, Crichton K, Daigle TL, Dalley R, Dee N, Dembrow N, Diep D, Ding S-L, Dong W, Fang R, Fischer S, Goldman M, Goldy J, Graybuck LT, Herb BR, Hou X, Kancherla J, Kroll M, Lathia K, van Lew B, Li YE, Liu CS, Liu H, Lucero JD, Mahurkar A, McMillen D, Miller JA, Moussa M, Nery JR, Nicovich PR, Niu S-Y, Orvis J, Osteen JK, Owen S, Palmer CR, Pham T, Plongthongkum N, Poirion O, Reed NM, Rimorin C, Rivkin A, Romanow WJ, Sede&#xf1;o-Cort&#xe9;s AE, Siletti K, Somasundaram S, Sulc J, Tieu M, Torkelson A, Tung H, Wang X, Xie F, Yanny AM, Zhang R, Ament SA, Behrens MM, Bravo HC, Chun J, Dobin A, Gillis J, Hertzano R, Hof PR, H&#xf6;llt T, Horwitz GD, Keene CD, Kharchenko PV, Ko AL, Lelieveldt BP, Luo C, Mukamel EA, Pinto-Duarte A, Preissl S, Regev A, Ren B, Scheuermann RH, Smith K, Spain WJ, White OR, Koch C, Hawrylycz M, Tasic B, Macosko EZ, McCarroll SA, Ting JT, Zeng H, Zhang K, Feng G, Ecker JR, Linnarsson S, Lein ES, Comparative cellular analysis of motor cortex in human, marmoset and mouse. Nature. 598, 111&#x2013;119 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8494640</ArticleId><ArticleId IdType="pubmed">34616062</ArticleId></ArticleIdList></Reference><Reference><Citation>Vormstein-Schneider D, Lin JD, Pelkey KA, Chittajallu R, Guo B, Arias-Garcia MA, Allaway K, Sakopoulos S, Schneider G, Stevenson O, Vergara J, Sharma J, Zhang Q, Franken TP, Smith J, Ibrahim LA, Mastro KJ, Sabri E, Huang S, Favuzzi E, Burbridge T, Xu Q, Guo L, Vogel I, Sanchez V, Saldi GA, Gorissen BL, Yuan X, Zaghloul KA, Devinsky O, Sabatini BL, Batista-Brito R, Reynolds J, Feng G, Fu Z, McBain CJ, Fishell G, Dimidschstein J, Viral manipulation of functionally distinct interneurons in mice, non-human primates and humans. Nat. Neurosci. 23, 1629&#x2013;1636 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8015416</ArticleId><ArticleId IdType="pubmed">32807948</ArticleId></ArticleIdList></Reference><Reference><Citation>Hon GC, Rajagopal N, Shen Y, McCleary DF, Yue F, Dang MD, Ren B, Epigenetic memory at embryonic enhancers identified in DNA methylation maps from adult mouse tissues. Nat. Genet. 45, 1198&#x2013;1206 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4095776</ArticleId><ArticleId IdType="pubmed">23995138</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo C, Liu H, Xie F, Armand EJ, Siletti K, Bakken TE, Fang R, Doyle WI, Stuart T, Hodge RD, Hu L, Wang B-A, Zhang Z, Preissl S, Lee D-S, Zhou J, Niu S-Y, Castanon R, Bartlett A, Rivkin A, Wang X, Lucero J, Nery JR, Davis DA, Mash DC, Satija R, Dixon JR, Linnarsson S, Lein E, Margarita Behrens M, Ren B, Mukamel EA, Ecker JR, Single nucleus multi-omics identifies human cortical cell regulatory genome diversity. Cell Genomics. 2 (2022), p. 100107.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9004682</ArticleId><ArticleId IdType="pubmed">35419551</ArticleId></ArticleIdList></Reference><Reference><Citation>Nott A, Holtman IR, Coufal NG, Schlachetzki JCM, Yu M, Hu R, Han CZ, Pena M, Xiao J, Wu Y, Keulen Z, Pasillas MP, O&#x2019;Connor C, Nickl CK, Schafer ST, Shen Z, Rissman RA, Brewer JB, Gosselin D, Gonda DD, Levy ML, Rosenfeld MG, McVicker G, Gage FH, Ren B, Glass CK, Brain cell type-specific enhancer-promoter interactome maps and disease-risk association. Science. 366, 1134&#x2013;1139 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7028213</ArticleId><ArticleId IdType="pubmed">31727856</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu B, Won H, Mah W, Park RB, Kassim B, Spiess K, Kozlenkov A, Crowley CA, Pochareddy S, PsychENCODE Consortium, Li Y, Dracheva S, Sestan N, Akbarian S, Geschwind DH, Neuronal and glial 3D chromatin architecture informs the cellular etiology of brain disorders. Nat. Commun. 12, 3968 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8233376</ArticleId><ArticleId IdType="pubmed">34172755</ArticleId></ArticleIdList></Reference><Reference><Citation>Song M, Pebworth M-P, Yang X, Abnousi A, Fan C, Wen J, Rosen JD, Choudhary MNK, Cui X, Jones IR, Bergenholtz S, Eze UC, Juric I, Li B, Maliskova L, Lee J, Liu W, Pollen AA, Li Y, Wang T, Hu M, Kriegstein AR, Shen Y, Cell-type-specific 3D epigenomes in the developing human cortex. Nature. 587, 644&#x2013;649 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7704572</ArticleId><ArticleId IdType="pubmed">33057195</ArticleId></ArticleIdList></Reference><Reference><Citation>Horvath S, Zhang Y, Langfelder P, Kahn RS, Boks MPM, van Eijk K, van den Berg LH, Ophoff RA, Aging effects on DNA methylation modules in human brain and blood tissue. Genome Biol. 13, R97 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4053733</ArticleId><ArticleId IdType="pubmed">23034122</ArticleId></ArticleIdList></Reference><Reference><Citation>Gabbutt C, Schenck RO, Weisenberger DJ, Kimberley C, Berner A, Househam J, Lakatos E, Robertson-Tessi M, Martin I, Patel R, Clark SK, Latchford A, Barnes CP, Leedham SJ, Anderson ARA, Graham TA, Shibata D, Fluctuating methylation clocks for cell lineage tracing at high temporal resolution in human tissues. Nat. Biotechnol. 40, 720&#x2013;730 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9110299</ArticleId><ArticleId IdType="pubmed">34980912</ArticleId></ArticleIdList></Reference><Reference><Citation>Salas LA, Wiencke JK, Koestler DC, Zhang Z, Christensen BC, Kelsey KT, Tracing human stem cell lineage during development using DNA methylation. Genome Res. 28, 1285&#x2013;1295 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6120629</ArticleId><ArticleId IdType="pubmed">30072366</ArticleId></ArticleIdList></Reference><Reference><Citation>Gormally E, Caboux E, Vineis P, Hainaut P, Circulating free DNA in plasma or serum as biomarker of carcinogenesis: practical aspects and biological significance. Mutat. Res. 635, 105&#x2013;117 (2007).</Citation><ArticleIdList><ArticleId IdType="pubmed">17257890</ArticleId></ArticleIdList></Reference><Reference><Citation>Cisneros-Villanueva M, Hidalgo-P&#xe9;rez L, Rios-Romero M, Cedro-Tanda A, Ruiz-Villavicencio CA, Page K, Hastings R, Fernandez-Garcia D, Allsopp R, Fonseca-Monta&#xf1;o MA, Jimenez-Morales S, Padilla-Palma V, Shaw JA, Hidalgo-Miranda A, Cell-free DNA analysis in current cancer clinical trials: a review. Br. J. Cancer. 126, 391&#x2013;400 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8810765</ArticleId><ArticleId IdType="pubmed">35027672</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37824655</PMID><DateCompleted><Year>2023</Year><Month>11</Month><Day>13</Day></DateCompleted><DateRevised><Year>2025</Year><Month>01</Month><Day>04</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1095-9203</ISSN><JournalIssue CitedMedium="Internet"><Volume>382</Volume><Issue>6667</Issue><PubDate><Year>2023</Year><Month>Oct</Month><Day>13</Day></PubDate></JournalIssue><Title>Science (New York, N.Y.)</Title><ISOAbbreviation>Science</ISOAbbreviation></Journal><ArticleTitle>Transcriptomic cytoarchitecture reveals principles of human neocortex organization.</ArticleTitle><Pagination><StartPage>eadf6812</StartPage><MedlinePgn>eadf6812</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1126/science.adf6812</ELocationID><Abstract><AbstractText>Variation in cytoarchitecture is the basis for the histological definition of cortical areas. We used single cell transcriptomics and performed cellular characterization of the human cortex to better understand cortical areal specialization. Single-nucleus RNA-sequencing of 8 areas spanning cortical structural variation showed a highly consistent cellular makeup for 24 cell subclasses. However, proportions of excitatory neuron subclasses varied substantially, likely reflecting differences in connectivity across primary sensorimotor and association cortices. Laminar organization of astrocytes and oligodendrocytes also differed across areas. Primary visual cortex showed characteristic organization with major changes in the excitatory to inhibitory neuron ratio, expansion of layer 4 excitatory neurons, and specialized inhibitory neurons. These results lay the groundwork for a refined cellular and molecular characterization of human cortical cytoarchitecture and areal specialization.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Jorstad</LastName><ForeName>Nikolas L</ForeName><Initials>NL</Initials><Identifier Source="ORCID">0000-0001-7906-9470</Identifier><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Close</LastName><ForeName>Jennie</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0001-9234-5855</Identifier><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Johansen</LastName><ForeName>Nelson</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0002-4436-969X</Identifier><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yanny</LastName><ForeName>Anna Marie</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barkan</LastName><ForeName>Eliza R</ForeName><Initials>ER</Initials><Identifier Source="ORCID">0000-0001-7871-4327</Identifier><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Travaglini</LastName><ForeName>Kyle J</ForeName><Initials>KJ</Initials><Identifier Source="ORCID">0000-0003-3164-6448</Identifier><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bertagnolli</LastName><ForeName>Darren</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-6626-1567</Identifier><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Campos</LastName><ForeName>Jazmin</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-9384-9913</Identifier><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Casper</LastName><ForeName>Tamara</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0003-1638-3651</Identifier><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Crichton</LastName><ForeName>Kirsten</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0002-7869-1492</Identifier><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dee</LastName><ForeName>Nick</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0002-2831-9254</Identifier><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ding</LastName><ForeName>Song-Lin</ForeName><Initials>SL</Initials><Identifier Source="ORCID">0000-0002-7072-5272</Identifier><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gelfand</LastName><ForeName>Emily</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0003-2175-5894</Identifier><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goldy</LastName><ForeName>Jeff</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0001-5140-6922</Identifier><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hirschstein</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kiick</LastName><ForeName>Katelyn</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0002-1785-8092</Identifier><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kroll</LastName><ForeName>Matthew</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kunst</LastName><ForeName>Michael</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-4159-8056</Identifier><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lathia</LastName><ForeName>Kanan</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0003-0080-1951</Identifier><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Long</LastName><ForeName>Brian</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0002-7793-5969</Identifier><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martin</LastName><ForeName>Naomi</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0002-0034-1628</Identifier><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McMillen</LastName><ForeName>Delissa</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-3413-4424</Identifier><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pham</LastName><ForeName>Trangthanh</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-4738-5062</Identifier><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rimorin</LastName><ForeName>Christine</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0003-1491-8552</Identifier><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ruiz</LastName><ForeName>Augustin</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-8361-5152</Identifier><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shapovalova</LastName><ForeName>Nadiya</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0002-8618-8272</Identifier><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shehata</LastName><ForeName>Soraya</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-2909-064X</Identifier><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Siletti</LastName><ForeName>Kimberly</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0001-7620-8973</Identifier><AffiliationInfo><Affiliation>Department of Medical Biochemistry and Biophysics, Karolinska Institutet, 171 77 Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Somasundaram</LastName><ForeName>Saroja</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-3729-9849</Identifier><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sulc</LastName><ForeName>Josef</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-4928-7183</Identifier><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tieu</LastName><ForeName>Michael</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-9286-5623</Identifier><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Torkelson</LastName><ForeName>Amy</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-9465-4202</Identifier><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tung</LastName><ForeName>Herman</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0002-0812-3318</Identifier><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Callaway</LastName><ForeName>Edward M</ForeName><Initials>EM</Initials><Identifier Source="ORCID">0000-0002-6366-5267</Identifier><AffiliationInfo><Affiliation>Systems Neurobiology Laboratories, The Salk Institute for Biological Studies, La Jolla, CA 92037, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hof</LastName><ForeName>Patrick R</ForeName><Initials>PR</Initials><Identifier Source="ORCID">0000-0002-3208-1154</Identifier><AffiliationInfo><Affiliation>Nash Family Department of Neuroscience and Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Keene</LastName><ForeName>C Dirk</ForeName><Initials>CD</Initials><Identifier Source="ORCID">0000-0002-5291-1469</Identifier><AffiliationInfo><Affiliation>Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA 98195, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Levi</LastName><ForeName>Boaz P</ForeName><Initials>BP</Initials><Identifier Source="ORCID">0000-0002-8346-872X</Identifier><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Linnarsson</LastName><ForeName>Sten</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-3491-3444</Identifier><AffiliationInfo><Affiliation>Department of Medical Biochemistry and Biophysics, Karolinska Institutet, 171 77 Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mitra</LastName><ForeName>Partha P</ForeName><Initials>PP</Initials><Identifier Source="ORCID">0000-0001-8818-6804</Identifier><AffiliationInfo><Affiliation>Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, NY 11724, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smith</LastName><ForeName>Kimberly</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0002-3142-1970</Identifier><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hodge</LastName><ForeName>Rebecca D</ForeName><Initials>RD</Initials><Identifier Source="ORCID">0000-0002-5784-9668</Identifier><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bakken</LastName><ForeName>Trygve E</ForeName><Initials>TE</Initials><Identifier Source="ORCID">0000-0003-3373-7386</Identifier><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lein</LastName><ForeName>Ed S</ForeName><Initials>ES</Initials><Identifier Source="ORCID">0000-0001-9012-6552</Identifier><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>U01 MH114812</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 MH117023</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U19 MH114830</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>10</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Science</MedlineTA><NlmUniqueID>0404511</NlmUniqueID><ISSNLinking>0036-8075</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019579" MajorTopicYN="Y">Neocortex</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000648" MajorTopicYN="N">ultrastructure</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009474" MajorTopicYN="N">Neurons</DescriptorName><QualifierName UI="Q000145" MajorTopicYN="N">classification</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D059467" MajorTopicYN="N">Transcriptome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000092386" MajorTopicYN="N">Single-Cell Gene Expression Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010802" MajorTopicYN="N">Phylogeny</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement><b>Competing interests:</b> From April 11, 2022, N.L.J. is an employee of Genentech.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>11</Month><Day>1</Day><Hour>12</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>10</Month><Day>12</Day><Hour>18</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>10</Month><Day>12</Day><Hour>14</Hour><Minute>4</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>12</Month><Day>31</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37824655</ArticleId><ArticleId IdType="mid">NIHMS2041490</ArticleId><ArticleId IdType="pmc">PMC11687949</ArticleId><ArticleId IdType="doi">10.1126/science.adf6812</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>von Economo C, Koskinas GN, Triarhou LC, Atlas of cytoarchitectonics of the adult human cerebral cortex (Karger, Basil; ; New York, 1st English ed., 2008).</Citation></Reference><Reference><Citation>von Economo C, Koskinas GN, Die Cytoarchitektonik der Hirnrinde des erwachsenen Menschen.</Citation></Reference><Reference><Citation>Brodmann K, Vergleichende Lokalisationslehre der Grosshirnrinde: in ihren Prinzipien dargestellt auf Grund d. Zellenbaues (Barth, Leipzig, Repr. d. 1. Aufl. von 1909., 1985).</Citation></Reference><Reference><Citation>Vogt C, Vogt O, Allgemeine Ergebnisse unserer Hirnforschung (J.A. Barth, 1919).</Citation></Reference><Reference><Citation>Amunts K, Zilles K, Architectonic Mapping of the Human Brain beyond Brodmann. Neuron. 88, 1086&#x2013;1107 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">26687219</ArticleId></ArticleIdList></Reference><Reference><Citation>Douglas RJ, Martin KAC, Neuronal Circuits of the Neocortex. Annual Review of Neuroscience. 27, 419&#x2013;451 (2004).</Citation><ArticleIdList><ArticleId IdType="pubmed">15217339</ArticleId></ArticleIdList></Reference><Reference><Citation>Defelipe J, Markram H, Rockland K, The Neocortical Column. Frontiers in Neuroanatomy. 6 (2012) (available at https://www.frontiersin.org/articles/10.3389/fnana.2012.00022).</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnana.2012.00022</ArticleId><ArticleId IdType="pmc">PMC3383203</ArticleId><ArticleId IdType="pubmed">22745629</ArticleId></ArticleIdList></Reference><Reference><Citation>Benavides-Piccione R, Rojo C, Kastanauskaite A, DeFelipe J, Variation in Pyramidal Cell Morphology Across the Human Anterior Temporal Lobe. Cerebral Cortex. 31, 3592&#x2013;3609 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8258433</ArticleId><ArticleId IdType="pubmed">33723567</ArticleId></ArticleIdList></Reference><Reference><Citation>Elston G, Benavides-Piccione R, Elston A, Manger P, Defelipe J, Pyramidal Cells in Prefrontal Cortex of Primates: Marked Differences in Neuronal Structure Among Species. Frontiers in Neuroanatomy. 5 (2011) (available at https://www.frontiersin.org/articles/10.3389/fnana.2011.00002).</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnana.2011.00002</ArticleId><ArticleId IdType="pmc">PMC3039119</ArticleId><ArticleId IdType="pubmed">21347276</ArticleId></ArticleIdList></Reference><Reference><Citation>Luebke JI, Pyramidal Neurons Are Not Generalizable Building Blocks of Cortical Networks. Frontiers in Neuroanatomy. 11 (2017) (available at https://www.frontiersin.org/articles/10.3389/fnana.2017.00011).</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnana.2017.00011</ArticleId><ArticleId IdType="pmc">PMC5339252</ArticleId><ArticleId IdType="pubmed">28326020</ArticleId></ArticleIdList></Reference><Reference><Citation>Hodge RD, Bakken TE, Miller JA, Smith KA, Barkan ER, Graybuck LT, Close JL, Long B, Johansen N, Penn O, Yao Z, Eggermont J, H&#xf6;llt T, Levi BP, Shehata SI, Aevermann B, Beller A, Bertagnolli D, Brouner K, Casper T, Cobbs C, Dalley R, Dee N, Ding S-L, Ellenbogen RG, Fong O, Garren E, Goldy J, Gwinn RP, Hirschstein D, Keene CD, Keshk M, Ko AL, Lathia K, Mahfouz A, Maltzer Z, McGraw M, Nguyen TN, Nyhus J, Ojemann JG, Oldre A, Parry S, Reynolds S, Rimorin C, Shapovalova NV, Somasundaram S, Szafer A, Thomsen ER, Tieu M, Quon G, Scheuermann RH, Yuste R, Sunkin SM, Lelieveldt B, Feng D, Ng L, Bernard A, Hawrylycz M, Phillips JW, Tasic B, Zeng H, Jones AR, Koch C, Lein ES, Conserved cell types with divergent features in human versus mouse cortex. Nature. 573 (2019), doi:10.1038/s41586-019-1506-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-019-1506-7</ArticleId><ArticleId IdType="pmc">PMC6919571</ArticleId><ArticleId IdType="pubmed">31435019</ArticleId></ArticleIdList></Reference><Reference><Citation>Bakken TE, Jorstad NL, Hu Q, Lake BB, Tian W, Kalmbach BE, Crow M, Hodge RD, Krienen FM, Sorensen SA, Eggermont J, Yao Z, Aevermann BD, Aldridge AI, Bartlett A, Bertagnolli D, Casper T, Castanon RG, Crichton K, Daigle TL, Dalley R, Dee N, Dembrow N, Diep D, Ding S-L, Dong W, Fang R, Fischer S, Goldman M, Goldy J, Graybuck LT, Herb BR, Hou X, Kancherla J, Kroll M, Lathia K, van Lew B, Li YE, Liu CS, Liu H, Lucero JD, Mahurkar A, McMillen D, Miller JA, Moussa M, Nery JR, Nicovich PR, Niu S-Y, Orvis J, Osteen JK, Owen S, Palmer CR, Pham T, Plongthongkum N, Poirion O, Reed NM, Rimorin C, Rivkin A, Romanow WJ, Sede&#xf1;o-Cort&#xe9;s AE, Siletti K, Somasundaram S, Sulc J, Tieu M, Torkelson A, Tung H, Wang X, Xie F, Yanny AM, Zhang R, Ament SA, Behrens MM, Bravo HC, Chun J, Dobin A, Gillis J, Hertzano R, Hof PR, H&#xf6;llt T, Horwitz GD, Keene CD, Kharchenko PV, Ko AL, Lelieveldt BP, Luo C, Mukamel EA, Pinto-Duarte A, Preissl S, Regev A, Ren B, Scheuermann RH, Smith K, Spain WJ, White OR, Koch C, Hawrylycz M, Tasic B, Macosko EZ, McCarroll SA, Ting JT, Zeng H, Zhang K, Feng G, Ecker JR, Linnarsson S, Lein ES, Comparative cellular analysis of motor cortex in human, marmoset and mouse. Nature. 598 (2021), doi:10.1038/s41586-021-03465-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03465-8</ArticleId><ArticleId IdType="pmc">PMC8494640</ArticleId><ArticleId IdType="pubmed">34616062</ArticleId></ArticleIdList></Reference><Reference><Citation>BRAIN Initiative Cell Census Network (BICCN), A multimodal cell census and atlas of the mammalian primary motor cortex. Nature. 598, 86&#x2013;102 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8494634</ArticleId><ArticleId IdType="pubmed">34616075</ArticleId></ArticleIdList></Reference><Reference><Citation>Tasic B, Menon V, Nguyen TN, Kim TK, Jarsky T, Yao Z, Levi B, Gray LT, Sorensen SA, Dolbeare T, Bertagnolli D, Goldy J, Shapovalova N, Parry S, Lee C, Smith K, Bernard A, Madisen L, Sunkin SM, Hawrylycz M, Koch C, Zeng H, Adult mouse cortical cell taxonomy revealed by single cell transcriptomics. Nat Neurosci. 19, 335&#x2013;346 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4985242</ArticleId><ArticleId IdType="pubmed">26727548</ArticleId></ArticleIdList></Reference><Reference><Citation>Tasic B, Yao Z, Graybuck LT, Smith KA, Nguyen TN, Bertagnolli D, Goldy J, Garren E, Economo MN, Viswanathan S, Penn O, Bakken T, Menon V, Miller J, Fong O, Hirokawa KE, Lathia K, Rimorin C, Tieu M, Larsen R, Casper T, Barkan E, Kroll M, Parry S, Shapovalova NV, Hirschstein D, Pendergraft J, Sullivan HA, Kim TK, Szafer A, Dee N, Groblewski P, Wickersham I, Cetin A, Harris JA, Levi BP, Sunkin SM, Madisen L, Daigle TL, Looger L, Bernard A, Phillips J, Lein E, Hawrylycz M, Svoboda K, Jones AR, Koch C, Zeng H, Shared and distinct transcriptomic cell types across neocortical areas. Nature. 563, 72&#x2013;78 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6456269</ArticleId><ArticleId IdType="pubmed">30382198</ArticleId></ArticleIdList></Reference><Reference><Citation>Yao Z, Liu H, Xie F, Fischer S, Adkins RS, Aldridge AI, Ament SA, Bartlett A, Behrens MM, Van den Berge K, Bertagnolli D, de B&#xe9;zieux HR, Biancalani T, Booeshaghi AS, Bravo HC, Casper T, Colantuoni C, Crabtree J, Creasy H, Crichton K, Crow M, Dee N, Dougherty EL, Doyle WI, Dudoit S, Fang R, Felix V, Fong O, Giglio M, Goldy J, Hawrylycz M, Herb BR, Hertzano R, Hou X, Hu Q, Kancherla J, Kroll M, Lathia K, Li YE, Lucero JD, Luo C, Mahurkar A, McMillen D, Nadaf NM, Nery JR, Nguyen TN, Niu S-Y, Ntranos V, Orvis J, Osteen JK, Pham T, Pinto-Duarte A, Poirion O, Preissl S, Purdom E, Rimorin C, Risso D, Rivkin AC, Smith K, Street K, Sulc J, Svensson V, Tieu M, Torkelson A, Tung H, Vaishnav ED, Vanderburg CR, van Velthoven C, Wang X, White OR, Huang ZJ, Kharchenko PV, Pachter L, Ngai J, Regev A, Tasic B, Welch JD, Gillis J, Macosko EZ, Ren B, Ecker JR, Zeng H, Mukamel EA, A transcriptomic and epigenomic cell atlas of the mouse primary motor cortex. Nature. 598, 103&#x2013;110 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8494649</ArticleId><ArticleId IdType="pubmed">34616066</ArticleId></ArticleIdList></Reference><Reference><Citation>Yao Z, van Velthoven CTJ, Nguyen TN, Goldy J, Sedeno-Cortes AE, Baftizadeh F, Bertagnolli D, Casper T, Chiang M, Crichton K, Ding S-L, Fong O, Garren E, Glandon A, Gouwens NW, Gray J, Graybuck LT, Hawrylycz MJ, Hirschstein D, Kroll M, Lathia K, Lee C, Levi B, McMillen D, Mok S, Pham T, Ren Q, Rimorin C, Shapovalova N, Sulc J, Sunkin SM, Tieu M, Torkelson A, Tung H, Ward K, Dee N, Smith KA, Tasic B, Zeng H, A taxonomy of transcriptomic cell types across the isocortex and hippocampal formation. Cell. 184, 3222&#x2013;3241.e26 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8195859</ArticleId><ArticleId IdType="pubmed">34004146</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang M, Eichhorn SW, Zingg B, Yao Z, Cotter K, Zeng H, Dong H, Zhuang X, Spatially resolved cell atlas of the mouse primary motor cortex by MERFISH. Nature. 598, 137&#x2013;143 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8494645</ArticleId><ArticleId IdType="pubmed">34616063</ArticleId></ArticleIdList></Reference><Reference><Citation>Scala F, Kobak D, Bernabucci M, Bernaerts Y, Cadwell CR, Castro JR, Hartmanis L, Jiang X, Laturnus S, Miranda E, Mulherkar S, Tan ZH, Yao Z, Zeng H, Sandberg R, Berens P, Tolias AS, Phenotypic variation of transcriptomic cell types in mouse motor cortex. Nature. 598, 144&#x2013;150 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8113357</ArticleId><ArticleId IdType="pubmed">33184512</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding SL, Royall JJ, Sunkin SM, Ng L, Facer BAC, Lesnar P, Guillozet-Bongaarts A, McMurray B, Szafer A, Dolbeare TA, Stevens A, Tirrell L, Benner T, Caldejon S, Dalley RA, Dee N, Lau C, Nyhus J, Reding M, Riley ZL, Sandman D, Shen E, van der Kouwe A, Varjabedian A, Write M, Zollei L, Dang C, Knowles JA, Koch C, Phillips JW, Sestan N, Wohnoutka P, Zielke HR, Hohmann JG, Jones AR, Bernard A, Hawrylycz MJ, Hof PR, Fischl B, Lein ES, Comprehensive cellular-resolution atlas of the adult human brain. Journal of Comparative Neurology. 524, 3127&#x2013;3481 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5054943</ArticleId><ArticleId IdType="pubmed">27418273</ArticleId></ArticleIdList></Reference><Reference><Citation>Amunts K, Mohlberg H, Bludau S, Zilles K, Julich-Brain: A 3D probabilistic atlas of the human brain&#x2019;s cytoarchitecture. Science. 369, 988&#x2013;992 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32732281</ArticleId></ArticleIdList></Reference><Reference><Citation>Hawrylycz MJ, Lein ES, Guillozet-Bongaarts AL, Shen EH, Ng L, Miller JA, van de Lagemaat LN, Smith KA, Ebbert A, Riley ZL, Abajian C, Beckmann CF, Bernard A, Bertagnolli D, Boe AF, Cartagena PM, Chakravarty MM, Chapin M, Chong J, Dalley RA, Daly BD, Dang C, Datta S, Dee N, Dolbeare TA, Faber V, Feng D, Fowler DR, Goldy J, Gregor BW, Haradon Z, Haynor DR, Hohmann JG, Horvath S, Howard RE, Jeromin A, Jochim JM, Kinnunen M, Lau C, Lazarz ET, Lee C, Lemon TA, Li L, Li Y, Morris JA, Overly CC, Parker PD, Parry SE, Reding M, Royall JJ, Schulkin J, Sequeira PA, Slaughterbeck CR, Smith SC, Sodt AJ, Sunkin SM, Swanson BE, Vawter MP, Williams D, Wohnoutka P, Zielke HR, Geschwind DH, Hof PR, Smith SM, Koch C, Grant SGN, Jones AR, An anatomically comprehensive atlas of the adult human brain transcriptome. Nature. 489, 391&#x2013;399 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4243026</ArticleId><ArticleId IdType="pubmed">22996553</ArticleId></ArticleIdList></Reference><Reference><Citation>Yanai I, Benjamin H, Shmoish M, Chalifa-Caspi V, Shklar M, Ophir R, Bar-Even A, Horn-Saban S, Safran M, Domany E, Lancet D, Shmueli O, Genome-wide midrange transcription profiles reveal expression level relationships in human tissue specification. Bioinformatics. 21, 650&#x2013;659 (2005).</Citation><ArticleIdList><ArticleId IdType="pubmed">15388519</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller JA, Ding S-L, Sunkin SM, Smith KA, Ng L, Szafer A, Ebbert A, Riley ZL, Royall JJ, Aiona K, Arnold JM, Bennet C, Bertagnolli D, Brouner K, Butler S, Caldejon S, Carey A, Cuhaciyan C, Dalley RA, Dee N, Dolbeare TA, Facer BAC, Feng D, Fliss TP, Gee G, Goldy J, Gourley L, Gregor BW, Gu G, Howard RE, Jochim JM, Kuan CL, Lau C, Lee C-K, Lee F, Lemon TA, Lesnar P, McMurray B, Mastan N, Mosqueda N, Naluai-Cecchini T, Ngo N-K, Nyhus J, Oldre A, Olson E, Parente J, Parker PD, Parry SE, Stevens A, Pletikos M, Reding M, Roll K, Sandman D, Sarreal M, Shapouri S, Shapovalova NV, Shen EH, Sjoquist N, Slaughterbeck CR, Smith M, Sodt AJ, Williams D, Z&#xf6;llei L, Fischl B, Gerstein MB, Geschwind DH, Glass IA, Hawrylycz MJ, Hevner RF, Huang H, Jones AR, Knowles JA, Levitt P, Phillips JW, &#x160;estan N, Wohnoutka P, Dang C, Bernard A, Hohmann JG, Lein ES, Transcriptional landscape of the prenatal human brain. Nature. 508, 199&#x2013;206 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4105188</ArticleId><ArticleId IdType="pubmed">24695229</ArticleId></ArticleIdList></Reference><Reference><Citation>B&#xfc;ttner M, Ostner J, M&#xfc;ller CL, Theis FJ, Schubert B, scCODA is a Bayesian model for compositional single-cell data analysis. Nat Commun. 12, 6876 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8616929</ArticleId><ArticleId IdType="pubmed">34824236</ArticleId></ArticleIdList></Reference><Reference><Citation>Balaram P, Young NA, Kaas JH, Histological features of layers and sublayers in cortical visual areas V1 and V2 of chimpanzees, macaque monkeys, and humans. EB. 6, 5&#x2013;18 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4360995</ArticleId><ArticleId IdType="pubmed">25788835</ArticleId></ArticleIdList></Reference><Reference><Citation>Yabuta NH, Callaway EM, Functional Streams and Local Connections of Layer 4C Neurons in Primary Visual Cortex of the Macaque Monkey. J. Neurosci 18, 9489&#x2013;9499 (1998).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6792868</ArticleId><ArticleId IdType="pubmed">9801386</ArticleId></ArticleIdList></Reference><Reference><Citation>Horton JC, Hedley-Whyte ET, Wiesel TN, Mapping of cytochrome oxidase patches and ocular dominance columns in human visual cortex. Philosophical Transactions of the Royal Society of London. B, Biological Sciences. 304, 255&#x2013;272 (1997).</Citation><ArticleIdList><ArticleId IdType="pubmed">6142485</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernard A, Lubbers LS, Tanis KQ, Luo R, Podtelezhnikov AA, Finney EM, McWhorter MME, Serikawa K, Lemon T, Morgan R, Copeland C, Smith K, Cullen V, Davis-Turak J, Lee C-K, Sunkin SM, Loboda AP, Levine DM, Stone DJ, Hawrylycz MJ, Roberts CJ, Jones AR, Geschwind DH, Lein ES, Transcriptional Architecture of the Primate Neocortex. Neuron. 73, 1083&#x2013;1099 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3628746</ArticleId><ArticleId IdType="pubmed">22445337</ArticleId></ArticleIdList></Reference><Reference><Citation>Siu CR, Balsor JL, Jones DG, Murphy KM, Classic and Golli Myelin Basic Protein have distinct developmental trajectories in human visual cortex. Frontiers in Neuroscience. 9 (2015) (available at https://www.frontiersin.org/articles/10.3389/fnins.2015.00138).</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2015.00138</ArticleId><ArticleId IdType="pmc">PMC4408849</ArticleId><ArticleId IdType="pubmed">25964736</ArticleId></ArticleIdList></Reference><Reference><Citation>Nhan HL, Callaway EM, Morphology of superior colliculus- and middle temporal area-projecting neurons in primate primary visual cortex. Journal of Comparative Neurology. 520, 52&#x2013;80 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3886567</ArticleId><ArticleId IdType="pubmed">21674487</ArticleId></ArticleIdList></Reference><Reference><Citation>Fries W, Distel H, Young JZ, Large layer VI neurons of monkey striate cortex (Meynert cells) project to the superior colliculus. Proceedings of the Royal Society of London. Series B. Biological Sciences. 219, 53&#x2013;59 (1997).</Citation><ArticleIdList><ArticleId IdType="pubmed">6137827</ArticleId></ArticleIdList></Reference><Reference><Citation>Fries W, Keizer K, Kuypers HGJM, Large layer VI cells in macaque striate cortex (Meynert cells) project to both superior colliculus and prestriate visual area V5. Exp Brain Res. 58, 613&#x2013;616 (1985).</Citation><ArticleIdList><ArticleId IdType="pubmed">3839191</ArticleId></ArticleIdList></Reference><Reference><Citation>Hodge RD, Miller JA, Novotny M, Kalmbach BE, Ting JT, Bakken TE, Aevermann BD, Barkan ER, Berkowitz-Cerasano ML, Cobbs C, Diez-Fuertes F, Ding S-L, McCorrison J, Schork NJ, Shehata SI, Smith KA, Sunkin SM, Tran DN, Venepally P, Yanny AM, Steemers FJ, Phillips JW, Bernard A, Koch C, Lasken RS, Scheuermann RH, Lein ES, Transcriptomic evidence that von Economo neurons are regionally specialized extratelencephalic-projecting excitatory neurons. Nature Communications. 11 (2020), doi:10.1038/s41467-020-14952-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-14952-3</ArticleId><ArticleId IdType="pmc">PMC7054400</ArticleId><ArticleId IdType="pubmed">32127543</ArticleId></ArticleIdList></Reference><Reference><Citation>Stevens SR, van der Heijden ME, Ogawa Y, Lin T, Sillitoe RV, Rasband MN, Ankyrin-R Links Kv3.3 to the Spectrin Cytoskeleton and Is Required for Purkinje Neuron Survival. J. Neurosci 42, 2&#x2013;15 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8741159</ArticleId><ArticleId IdType="pubmed">34785580</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang AC, Vest RT, Kern F, Lee DP, Agam M, Maat CA, Losada PM, Chen MB, Schaum N, Khoury N, Toland A, Calcuttawala K, Shin H, P&#xe1;lovics R, Shin A, Wang EY, Luo J, Gate D, Schulz-Schaeffer WJ, Chu P, Siegenthaler JA, McNerney MW, Keller A, Wyss-Coray T, A human brain vascular atlas reveals diverse mediators of Alzheimer&#x2019;s risk. Nature. 603, 885&#x2013;892 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9635042</ArticleId><ArticleId IdType="pubmed">35165441</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang R, Xia C, Close JL, Zhang M, He J, Huang Z, Halpern AR, Long B, Miller JA, Lein ES, Zhuang X, Conservation and divergence of cortical cell organization in human and mouse revealed by MERFISH. Science. 377, 56&#x2013;62 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9262715</ArticleId><ArticleId IdType="pubmed">35771910</ArticleId></ArticleIdList></Reference><Reference><Citation>Glasser MF, Essen DCV, Mapping Human Cortical Areas In Vivo Based on Myelin Content as Revealed by T1- and T2-Weighted MRI. J. Neurosci 31, 11597&#x2013;11616 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3167149</ArticleId><ArticleId IdType="pubmed">21832190</ArticleId></ArticleIdList></Reference><Reference><Citation>Glasser MF, Coalson TS, Robinson EC, Hacker CD, Harwell J, Yacoub E, Ugurbil K, Andersson J, Beckmann CF, Jenkinson M, Smith SM, Van Essen DC, A multi-modal parcellation of human cerebral cortex. Nature. 536, 171&#x2013;178 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4990127</ArticleId><ArticleId IdType="pubmed">27437579</ArticleId></ArticleIdList></Reference><Reference><Citation>Siletti K, Hodge R, Albiach AM, Hu L, Lee KW, L&#xf6;nnerberg P, Bakken T, Ding S-L, Clark M, Casper T, Dee N, Gloe J, Keene CD, Nyhus J, Tung H, Yanny AM, Arenas E, Lein ES, Linnarsson S, Transcriptomic diversity of cell types across the adult human brain (2022), p. 2022.10.12.511898, doi:10.1101/2022.10.12.511898.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.10.12.511898</ArticleId><ArticleId IdType="pubmed">37824663</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeisel A, Hochgerner H, L&#xf6;nnerberg P, Johnsson A, Memic F, van der Zwan J, H&#xe4;ring M, Braun E, Borm LE, Manno GL, Codeluppi S, Furlan A, Lee K, Skene N, Harris KD, Hjerling-Leffler J, Arenas E, Ernfors P, Marklund U, Linnarsson S, Molecular Architecture of the Mouse Nervous System. Cell. 174, 999&#x2013;1014.e22 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6086934</ArticleId><ArticleId IdType="pubmed">30096314</ArticleId></ArticleIdList></Reference><Reference><Citation>Batiuk MY, Martirosyan A, Wahis J, de Vin F, Marneffe C, Kusserow C, Koeppen J, Viana JF, Oliveira JF, Voet T, Ponting CP, Belgard TG, Holt MG, Identification of region-specific astrocyte subtypes at single cell resolution. Nat Commun. 11, 1220 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7058027</ArticleId><ArticleId IdType="pubmed">32139688</ArticleId></ArticleIdList></Reference><Reference><Citation>Oberheim NA, Takano T, Han X, He W, Lin JHC, Wang F, Xu Q, Wyatt JD, Pilcher W, Ojemann JG, Ransom BR, Goldman SA, Nedergaard M, Uniquely Hominid Features of Adult Human Astrocytes. J. Neurosci 29, 3276&#x2013;3287 (2009).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2819812</ArticleId><ArticleId IdType="pubmed">19279265</ArticleId></ArticleIdList></Reference><Reference><Citation>Falcone C, McBride EL, Hopkins WD, Hof PR, Manger PR, Sherwood CC, Noctor SC, Mart&#xed;nez-Cerde&#xf1;o V, Redefining varicose projection astrocytes in primates. Glia. 70, 145&#x2013;154 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">34533866</ArticleId></ArticleIdList></Reference><Reference><Citation>Falcone C, Penna E, Hong T, Tarantal AF, Hof PR, Hopkins WD, Sherwood CC, Noctor SC, Mart&#xed;nez-Cerde&#xf1;o V, Cortical Interlaminar Astrocytes Are Generated Prenatally, Mature Postnatally, and Express Unique Markers in Human and Nonhuman Primates. Cerebral Cortex. 31, 379&#x2013;395 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7947181</ArticleId><ArticleId IdType="pubmed">32930323</ArticleId></ArticleIdList></Reference><Reference><Citation>Falcone C, Wolf-Ochoa M, Amina S, Hong T, Vakilzadeh G, Hopkins WD, Hof PR, Sherwood CC, Manger PR, Noctor SC, Mart&#xed;nez-Cerde&#xf1;o V, Cortical interlaminar astrocytes across the therian mammal radiation. Journal of Comparative Neurology. 527, 1654&#x2013;1674 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6465161</ArticleId><ArticleId IdType="pubmed">30552685</ArticleId></ArticleIdList></Reference><Reference><Citation>Berg J, Sorensen SA, Ting JT, Miller JA, Chartrand T, Buchin A, Bakken TE, Budzillo A, Dee N, Ding S-L, Gouwens NW, Hodge RD, Kalmbach B, Lee C, Lee BR, Alfiler L, Baker K, Barkan E, Beller A, Berry K, Bertagnolli D, Bickley K, Bomben J, Braun T, Brouner K, Casper T, Chong P, Crichton K, Dalley R, de Frates R, Desta T, Lee SD, D&#x2019;Orazi F, Dotson N, Egdorf T, Enstrom R, Farrell C, Feng D, Fong O, Furdan S, Galakhova AA, Gamlin C, Gary A, Glandon A, Goldy J, Gorham M, Goriounova NA, Gratiy S, Graybuck L, Gu H, Hadley K, Hansen N, Heistek TS, Henry AM, Heyer DB, Hill DJ, Hill C, Hupp M, Jarsky T, Kebede S, Keene L, Kim L, Kim M-H, Kroll M, Latimer C, Levi BP, Link KE, Mallory M, Mann R, Marshall D, Maxwell M, McGraw M, McMillen D, Melief E, Mertens EJ, Mezei L, Mihut N, Mok S, Molnar G, Mukora A, Ng L, Ngo K, Nicovich PR, Nyhus J, Olah G, Oldre A, Omstead V, Ozsvar A, Park D, Peng H, Pham T, Pom CA, Potekhina L, Rajanbabu R, Ransford S, Reid D, Rimorin C, Ruiz A, Sandman D, Sulc J, Sunkin SM, Szafer A, Szemenyei V, Thomsen ER, Tieu M, Torkelson A, Trinh J, Tung H, Wakeman W, Waleboer F, Ward K, Wilbers R, Williams G, Yao Z, Yoon J-G, Anastassiou C, Arkhipov A, Barzo P, Bernard A, Cobbs C, de Witt Hamer PC, Ellenbogen RG, Esposito L, Ferreira M, Gwinn RP, Hawrylycz MJ, Hof PR, Idema S, Jones AR, Keene CD, Ko AL, Murphy GJ, Ng L, Ojemann JG, Patel AP, Phillips JW, Silbergeld DL, Smith K, Tasic B, Yuste R, Segev I, de Kock CPJ, Mansvelder HD, Tamas G, Zeng H, Koch C, Lein ES, Human neocortical expansion involves glutamatergic neuron diversification. Nature. 598 (2021), doi:10.1038/s41586-021-03813-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03813-8</ArticleId><ArticleId IdType="pmc">PMC8494638</ArticleId><ArticleId IdType="pubmed">34616067</ArticleId></ArticleIdList></Reference><Reference><Citation>Garc&#xed;a-Cabezas M&#xc1;, Barbas H, Area 4 has layer IV in adult primates. European Journal of Neuroscience. 39, 1824&#x2013;1834 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4201116</ArticleId><ArticleId IdType="pubmed">24735460</ArticleId></ArticleIdList></Reference><Reference><Citation>Barbas H, Garc&#xed;a-Cabezas M, Motor cortex layer 4: less is more. Trends Neurosci. 38, 259&#x2013;261 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4500633</ArticleId><ArticleId IdType="pubmed">25868984</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamawaki N, Borges K, Suter BA, Harris KD, Shepherd GMG, A genuine layer 4 in motor cortex with prototypical synaptic circuit connectivity. eLife. 3, e05422 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4290446</ArticleId><ArticleId IdType="pubmed">25525751</ArticleId></ArticleIdList></Reference><Reference><Citation>Bishop KM, Rubenstein JLR, O&#x2019;Leary DDM, Distinct Actions of Emx1, Emx2, andPax6 in Regulating the Specification of Areas in the Developing Neocortex. J. Neurosci 22, 7627&#x2013;7638 (2002).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6757966</ArticleId><ArticleId IdType="pubmed">12196586</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Leary DD, Sahara S, Genetic regulation of arealization of the neocortex. Current Opinion in Neurobiology. 18, 90&#x2013;100 (2008).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2677555</ArticleId><ArticleId IdType="pubmed">18524571</ArticleId></ArticleIdList></Reference><Reference><Citation>Elston GN, Tweedale R, Rosa MGP, Cortical integration in the visual system of the macaque monkey: large-scale morphological differences in the pyramidal neurons in the occipital, parietal and temporal lobes. Proceedings of the Royal Society of London. Series B: Biological Sciences. 266, 1367&#x2013;1374 (1999).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1690073</ArticleId><ArticleId IdType="pubmed">10445291</ArticleId></ArticleIdList></Reference><Reference><Citation>Hassler R, &#x201c;Comparative Anatomy of the Central Visual Systems in Day- and Night-active Primates&#x201d; in Evolution of the Forebrain, Hassler R, Stephan H, Eds. (Springer US, Boston, MA, 1966; http://link.springer.com/10.1007/978-1-4899-6527-1_40), pp. 419&#x2013;434.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-4899-6527-1_40</ArticleId></ArticleIdList></Reference><Reference><Citation>Sohal VS, Rubenstein JLR, Excitation-inhibition balance as a framework for investigating mechanisms in neuropsychiatric disorders. Mol Psychiatry. 24, 1248&#x2013;1257 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6742424</ArticleId><ArticleId IdType="pubmed">31089192</ArticleId></ArticleIdList></Reference><Reference><Citation>Hornung J-P, De Tribolet N, Distribution of GABA-containing neurons in human frontal cortex: a quantitative immunocytochemical study. Anat Embryol. 189, 139&#x2013;145 (1994).</Citation><ArticleIdList><ArticleId IdType="pubmed">8010412</ArticleId></ArticleIdList></Reference><Reference><Citation>Beaulieu C, Kisvarday Z, Somogyi P, Cynader M, Cowey A, Quantitative Distribution of GABA-immunopositive and-immunonegative Neurons and Synapses in the Monkey Striate Cortex (Area 17). Cerebral Cortex. 2, 295&#x2013;309 (1992).</Citation><ArticleIdList><ArticleId IdType="pubmed">1330121</ArticleId></ArticleIdList></Reference><Reference><Citation>Hendry SH, Schwark HD, Jones EG, Yan J, Numbers and proportions of GABA-immunoreactive neurons in different areas of monkey cerebral cortex. J. Neurosci 7, 1503&#x2013;1519 (1987).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6568832</ArticleId><ArticleId IdType="pubmed">3033170</ArticleId></ArticleIdList></Reference><Reference><Citation>Loomba S, Straehle J, Gangadharan V, Heike N, Khalifa A, Motta A, Ju N, Sievers M, Gempt J, Meyer HS, Helmstaedter M, Connectomic comparison of mouse and human cortex. Science. 377, eabo0924 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35737810</ArticleId></ArticleIdList></Reference><Reference><Citation>Chartrand T, Dalley R, Close J, Goriounova NA, Lee BR, Mann R, Miller JA, Molnar G, Mukora A, Alfiler L, Baker K, Bakken TE, Berg J, Bertagnolli D, Braun T, Brouner K, Casper T, Csajbok EA, Dee N, Egdorf T, Enstrom R, Galakhova AA, Gary A, Gelfand E, Goldy J, Hadley K, Heistek TS, Hill D, Jorstad N, Kim L, Kocsis AK, Kruse L, Kunst M, Leon G, Long B, Mallory M, McGraw M, McMillen D, Melief EJ, Mihut N, Ng L, Nyhus J, Omstead V, Peterfi Z, Pom A, Potekhina L, Rajanbabu R, Rozsa M, Ruiz A, Sandle J, Sunkin SM, Szots I, Tieu M, Toth M, Trinh J, Vargas S, Vumbaco D, Williams G, Wilson J, Yao Z, Barzo P, Cobbs C, Ellenbogen RG, Esposito L, Ferreira M, Gouwens NW, Grannan B, Gwinn RP, Hauptman JS, Jarsky T, Keene CD, Ko AL, Koch C, Ojemann JG, Patel A, Ruzevick J, Silberberg DL, Smith K, Sorensen SA, Tasic B, Ting JT, Waters J, de Kock CPJ, Mansvelder HD, Tamas G, Zeng H, Kalmbach B, Lein ES, Morpho-electric and transcriptomic divergence of the layer 1 interneuron repertoire in human versus mouse neocortex (2022), p. 2022.10.24.511199, , doi:10.1101/2022.10.24.511199.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.10.24.511199</ArticleId><ArticleId IdType="pmc">PMC11864503</ArticleId><ArticleId IdType="pubmed">37824667</ArticleId></ArticleIdList></Reference><Reference><Citation>Aronesty E, Comparison of Sequencing Utility Programs. The Open Bioinformatics Journal. 7 (2013), doi:10.2174/1875036201307010001.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1875036201307010001</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, Batut P, Chaisson M, Gingeras TR, STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 29, 15&#x2013;21 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3530905</ArticleId><ArticleId IdType="pubmed">23104886</ArticleId></ArticleIdList></Reference><Reference><Citation>Lawrence M, Huber W, Pag&#xe8;s H, Aboyoun P, Carlson M, Gentleman R, Morgan MT, Carey VJ, Software for Computing and Annotating Genomic Ranges. PLOS Computational Biology. 9, e1003118 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3738458</ArticleId><ArticleId IdType="pubmed">23950696</ArticleId></ArticleIdList></Reference><Reference><Citation>Hafemeister C, Satija R, Normalization and variance stabilization of single-cell RNA-seq data using regularized negative binomial regression. Genome Biology. 20, 296 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6927181</ArticleId><ArticleId IdType="pubmed">31870423</ArticleId></ArticleIdList></Reference><Reference><Citation>Stuart T, Butler A, Hoffman P, Hafemeister C, Papalexi E, Mauck WM, Hao Y, Stoeckius M, Smibert P, Satija R, Comprehensive Integration of Single-Cell Data. Cell. 177, 1888&#x2013;1902.e21 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6687398</ArticleId><ArticleId IdType="pubmed">31178118</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffman GE, Schadt EE, variancePartition: interpreting drivers of variation in complex gene expression studies. BMC Bioinformatics. 17, 483 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5123296</ArticleId><ArticleId IdType="pubmed">27884101</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37824669</PMID><DateCompleted><Year>2023</Year><Month>11</Month><Day>13</Day></DateCompleted><DateRevised><Year>2025</Year><Month>01</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1095-9203</ISSN><JournalIssue CitedMedium="Internet"><Volume>382</Volume><Issue>6667</Issue><PubDate><Year>2023</Year><Month>Oct</Month><Day>13</Day></PubDate></JournalIssue><Title>Science (New York, N.Y.)</Title><ISOAbbreviation>Science</ISOAbbreviation></Journal><ArticleTitle>Signature morphoelectric properties of diverse GABAergic interneurons in the human neocortex.</ArticleTitle><Pagination><StartPage>eadf6484</StartPage><MedlinePgn>eadf6484</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1126/science.adf6484</ELocationID><Abstract><AbstractText>Human cortex transcriptomic studies have revealed a hierarchical organization of &#x3b3;-aminobutyric acid-producing (GABAergic) neurons from subclasses to a high diversity of more granular types. Rapid GABAergic neuron viral genetic labeling plus Patch-seq (patch-clamp electrophysiology plus single-cell RNA sequencing) sampling in human brain slices was used to reliably target and analyze GABAergic neuron subclasses and individual transcriptomic types. This characterization elucidated transitions between PVALB and SST subclasses, revealed morphological heterogeneity within an abundant transcriptomic type, identified multiple spatially distinct types of the primate-specialized double bouquet cells (DBCs), and shed light on cellular differences between homologous mouse and human neocortical GABAergic neuron types. These results highlight the importance of multimodal phenotypic characterization for refinement of emerging transcriptomic cell type taxonomies and for understanding conserved and specialized cellular properties of human brain cell types.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Lee</LastName><ForeName>Brian R</ForeName><Initials>BR</Initials><Identifier Source="ORCID">0000-0002-3210-5638</Identifier><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Dalley</LastName><ForeName>Rachel</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0001-7461-7845</Identifier><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miller</LastName><ForeName>Jeremy A</ForeName><Initials>JA</Initials><Identifier Source="ORCID">0000-0003-4549-588X</Identifier><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chartrand</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-7093-8681</Identifier><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Allen Institute for Neural Dynamics, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Close</LastName><ForeName>Jennie</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0001-9234-5855</Identifier><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mann</LastName><ForeName>Rusty</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-0226-2069</Identifier><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mukora</LastName><ForeName>Alice</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-8431-985X</Identifier><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ng</LastName><ForeName>Lindsay</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-4134-1608</Identifier><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alfiler</LastName><ForeName>Lauren</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0003-4847-7900</Identifier><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baker</LastName><ForeName>Katherine</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0002-5454-8026</Identifier><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bertagnolli</LastName><ForeName>Darren</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-6626-1567</Identifier><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brouner</LastName><ForeName>Krissy</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0001-5790-7154</Identifier><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Casper</LastName><ForeName>Tamara</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0003-1638-3651</Identifier><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Csajbok</LastName><ForeName>Eva</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-7089-5431</Identifier><AffiliationInfo><Affiliation>MTA-SZTE Research Group for Cortical Microcircuits, Department of Physiology, Anatomy, and Neuroscience, University of Szeged, 6726 Szeged, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Donadio</LastName><ForeName>Nicholas</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0002-6250-1148</Identifier><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Driessens</LastName><ForeName>Stan L W</ForeName><Initials>SLW</Initials><AffiliationInfo><Affiliation>Department of Integrative Neurophysiology, Center for Neurogenomics and Cognitive Research (CNCR), Vrije Universiteit, Amsterdam, 1081 HV, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Egdorf</LastName><ForeName>Tom</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0001-9059-8904</Identifier><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Enstrom</LastName><ForeName>Rachel</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0003-0100-927X</Identifier><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Galakhova</LastName><ForeName>Anna A</ForeName><Initials>AA</Initials><Identifier Source="ORCID">0000-0002-5538-0624</Identifier><AffiliationInfo><Affiliation>Department of Integrative Neurophysiology, Center for Neurogenomics and Cognitive Research (CNCR), Vrije Universiteit, Amsterdam, 1081 HV, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gary</LastName><ForeName>Amanda</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-6397-1520</Identifier><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gelfand</LastName><ForeName>Emily</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0003-2175-5894</Identifier><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goldy</LastName><ForeName>Jeff</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0001-5140-6922</Identifier><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hadley</LastName><ForeName>Kristen</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0002-4504-8724</Identifier><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Heistek</LastName><ForeName>Tim S</ForeName><Initials>TS</Initials><AffiliationInfo><Affiliation>Department of Integrative Neurophysiology, Center for Neurogenomics and Cognitive Research (CNCR), Vrije Universiteit, Amsterdam, 1081 HV, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hill</LastName><ForeName>Dijon</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0001-8879-2476</Identifier><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hou</LastName><ForeName>Wen-Hsien</ForeName><Initials>WH</Initials><AffiliationInfo><Affiliation>Department of Biomedicine, Aarhus University, 8000 Aarhus, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Johansen</LastName><ForeName>Nelson</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0002-4436-969X</Identifier><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jorstad</LastName><ForeName>Nik</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0001-7906-9470</Identifier><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Lisa</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0003-3811-8680</Identifier><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Allen Institute for Neural Dynamics, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kocsis</LastName><ForeName>Agnes Katalin</ForeName><Initials>AK</Initials><Identifier Source="ORCID">0000-0003-0810-5694</Identifier><AffiliationInfo><Affiliation>MTA-SZTE Research Group for Cortical Microcircuits, Department of Physiology, Anatomy, and Neuroscience, University of Szeged, 6726 Szeged, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kruse</LastName><ForeName>Lauren</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-3428-2443</Identifier><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kunst</LastName><ForeName>Michael</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-4159-8056</Identifier><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Le&#xf3;n</LastName><ForeName>Gabriela</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Long</LastName><ForeName>Brian</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0002-7793-5969</Identifier><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mallory</LastName><ForeName>Matthew</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-8744-3837</Identifier><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maxwell</LastName><ForeName>Michelle</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McGraw</LastName><ForeName>Medea</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-5267-489X</Identifier><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McMillen</LastName><ForeName>Delissa</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-3413-4424</Identifier><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Melief</LastName><ForeName>Erica J</ForeName><Initials>EJ</Initials><Identifier Source="ORCID">0000-0002-3570-3289</Identifier><AffiliationInfo><Affiliation>Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA 98195, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Molnar</LastName><ForeName>Gabor</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0001-7959-139X</Identifier><AffiliationInfo><Affiliation>MTA-SZTE Research Group for Cortical Microcircuits, Department of Physiology, Anatomy, and Neuroscience, University of Szeged, 6726 Szeged, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mortrud</LastName><ForeName>Marty T</ForeName><Initials>MT</Initials><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Newman</LastName><ForeName>Dakota</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nyhus</LastName><ForeName>Julie</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-2006-8235</Identifier><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Opitz-Araya</LastName><ForeName>Ximena</ForeName><Initials>X</Initials><Identifier Source="ORCID">0000-0003-4960-3622</Identifier><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ozsv&#xe1;r</LastName><ForeName>Attila</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Biomedicine, Aarhus University, 8000 Aarhus, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pham</LastName><ForeName>Trangthanh</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-4738-5062</Identifier><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pom</LastName><ForeName>Alice</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-9057-040X</Identifier><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Potekhina</LastName><ForeName>Lydia</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0001-8879-7920</Identifier><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rajanbabu</LastName><ForeName>Ram</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-7891-7578</Identifier><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ruiz</LastName><ForeName>Augustin</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-8361-5152</Identifier><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sunkin</LastName><ForeName>Susan M</ForeName><Initials>SM</Initials><Identifier Source="ORCID">0000-0001-9893-3834</Identifier><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sz&#xf6;ts</LastName><ForeName>Ildik&#xf3;</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0002-8564-4379</Identifier><AffiliationInfo><Affiliation>MTA-SZTE Research Group for Cortical Microcircuits, Department of Physiology, Anatomy, and Neuroscience, University of Szeged, 6726 Szeged, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Taskin</LastName><ForeName>Naz</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thyagarajan</LastName><ForeName>Bargavi</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0003-3871-6410</Identifier><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tieu</LastName><ForeName>Michael</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-9286-5623</Identifier><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Trinh</LastName><ForeName>Jessica</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-5064-8898</Identifier><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vargas</LastName><ForeName>Sara</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vumbaco</LastName><ForeName>David</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0001-8115-3081</Identifier><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Waleboer</LastName><ForeName>Femke</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0001-6170-5571</Identifier><AffiliationInfo><Affiliation>Department of Integrative Neurophysiology, Center for Neurogenomics and Cognitive Research (CNCR), Vrije Universiteit, Amsterdam, 1081 HV, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Walling-Bell</LastName><ForeName>Sarah</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-6995-2681</Identifier><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weed</LastName><ForeName>Natalie</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0003-0891-0327</Identifier><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Williams</LastName><ForeName>Grace</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-8463-2886</Identifier><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wilson</LastName><ForeName>Julia</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yao</LastName><ForeName>Shenqin</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-2992-4752</Identifier><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><Identifier Source="ORCID">0009-0008-1589-8059</Identifier><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barz&#xf3;</LastName><ForeName>P&#xe1;l</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0001-8717-748X</Identifier><AffiliationInfo><Affiliation>Department of Neurosurgery, University of Szeged, 6725 Szeged, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bakken</LastName><ForeName>Trygve</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0003-3373-7386</Identifier><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cobbs</LastName><ForeName>Charles</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0001-7688-4293</Identifier><AffiliationInfo><Affiliation>Swedish Neuroscience Institute, Seattle, WA 98122, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dee</LastName><ForeName>Nick</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0002-2831-9254</Identifier><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ellenbogen</LastName><ForeName>Richard G</ForeName><Initials>RG</Initials><Identifier Source="ORCID">0000-0002-3463-1009</Identifier><AffiliationInfo><Affiliation>Department of Neurological Surgery, University of Washington, Seattle, WA 98195, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Esposito</LastName><ForeName>Luke</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-3565-9126</Identifier><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ferreira</LastName><ForeName>Manuel</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurological Surgery, University of Washington, Seattle, WA 98195, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gouwens</LastName><ForeName>Nathan W</ForeName><Initials>NW</Initials><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grannan</LastName><ForeName>Benjamin</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0002-6029-2821</Identifier><AffiliationInfo><Affiliation>Department of Neurological Surgery, University of Washington, Seattle, WA 98195, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gwinn</LastName><ForeName>Ryder P</ForeName><Initials>RP</Initials><Identifier Source="ORCID">0000-0002-5849-7975</Identifier><AffiliationInfo><Affiliation>Swedish Neuroscience Institute, Seattle, WA 98122, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hauptman</LastName><ForeName>Jason S</ForeName><Initials>JS</Initials><AffiliationInfo><Affiliation>Department of Neurological Surgery, University of Washington, Seattle, WA 98195, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hodge</LastName><ForeName>Rebecca</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-5784-9668</Identifier><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jarsky</LastName><ForeName>Tim</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-4399-539X</Identifier><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Keene</LastName><ForeName>C Dirk</ForeName><Initials>CD</Initials><Identifier Source="ORCID">0000-0002-5291-1469</Identifier><AffiliationInfo><Affiliation>Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA 98195, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ko</LastName><ForeName>Andrew L</ForeName><Initials>AL</Initials><Identifier Source="ORCID">0000-0002-6253-9891</Identifier><AffiliationInfo><Affiliation>Department of Neurological Surgery, University of Washington, Seattle, WA 98195, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Korshoej</LastName><ForeName>Anders Rosendal</ForeName><Initials>AR</Initials><Identifier Source="ORCID">0000-0003-4285-8171</Identifier><AffiliationInfo><Affiliation>Department of Neurosurgery, Aarhus University Hospital, 8200 Aarhus, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Levi</LastName><ForeName>Boaz P</ForeName><Initials>BP</Initials><Identifier Source="ORCID">0000-0002-8346-872X</Identifier><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meier</LastName><ForeName>Kaare</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0001-7677-406X</Identifier><AffiliationInfo><Affiliation>Department of Neurosurgery, Aarhus University Hospital, 8200 Aarhus, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesiology, Aarhus University Hospital, 8200 Aarhus, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ojemann</LastName><ForeName>Jeffrey G</ForeName><Initials>JG</Initials><Identifier Source="ORCID">0000-0001-7580-8934</Identifier><AffiliationInfo><Affiliation>Department of Neurological Surgery, University of Washington, Seattle, WA 98195, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Patel</LastName><ForeName>Anoop</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neurological Surgery, University of Washington, Seattle, WA 98195, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ruzevick</LastName><ForeName>Jacob</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurological Surgery, University of Washington, Seattle, WA 98195, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Silbergeld</LastName><ForeName>Daniel L</ForeName><Initials>DL</Initials><AffiliationInfo><Affiliation>Department of Neurological Surgery, University of Washington, Seattle, WA 98195, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smith</LastName><ForeName>Kimberly</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0002-3142-1970</Identifier><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>S&#xf8;rensen</LastName><ForeName>Jens Christian</ForeName><Initials>JC</Initials><Identifier Source="ORCID">0000-0001-5139-7405</Identifier><AffiliationInfo><Affiliation>Department of Neurosurgery, Aarhus University Hospital, 8200 Aarhus, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Experimental Neuroscience, Aarhus University Hospital, 8200 Aarhus, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Waters</LastName><ForeName>Jack</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-2312-4183</Identifier><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Physiology and Biophysics, University of Washington, Seattle, WA 98195, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zeng</LastName><ForeName>Hongkui</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0002-0326-5878</Identifier><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Berg</LastName><ForeName>Jim</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-3300-5399</Identifier><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Allen Institute for Neural Dynamics, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Capogna</LastName><ForeName>Marco</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-2742-5485</Identifier><AffiliationInfo><Affiliation>Department of Biomedicine, Aarhus University, 8000 Aarhus, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goriounova</LastName><ForeName>Natalia A</ForeName><Initials>NA</Initials><Identifier Source="ORCID">0000-0002-5917-983X</Identifier><AffiliationInfo><Affiliation>Department of Integrative Neurophysiology, Center for Neurogenomics and Cognitive Research (CNCR), Vrije Universiteit, Amsterdam, 1081 HV, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kalmbach</LastName><ForeName>Brian</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0003-3136-8097</Identifier><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Physiology and Biophysics, University of Washington, Seattle, WA 98195, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Kock</LastName><ForeName>Christiaan P J</ForeName><Initials>CPJ</Initials><Identifier Source="ORCID">0000-0002-6697-0179</Identifier><AffiliationInfo><Affiliation>Department of Integrative Neurophysiology, Center for Neurogenomics and Cognitive Research (CNCR), Vrije Universiteit, Amsterdam, 1081 HV, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mansvelder</LastName><ForeName>Huib D</ForeName><Initials>HD</Initials><Identifier Source="ORCID">0000-0003-1365-5340</Identifier><AffiliationInfo><Affiliation>Department of Integrative Neurophysiology, Center for Neurogenomics and Cognitive Research (CNCR), Vrije Universiteit, Amsterdam, 1081 HV, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sorensen</LastName><ForeName>Staci A</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tamas</LastName><ForeName>Gabor</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-7905-6001</Identifier><AffiliationInfo><Affiliation>MTA-SZTE Research Group for Cortical Microcircuits, Department of Physiology, Anatomy, and Neuroscience, University of Szeged, 6726 Szeged, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lein</LastName><ForeName>Ed S</ForeName><Initials>ES</Initials><Identifier Source="ORCID">0000-0001-9012-6552</Identifier><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurological Surgery, University of Washington, Seattle, WA 98195, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ting</LastName><ForeName>Jonathan T</ForeName><Initials>JT</Initials><Identifier Source="ORCID">0000-0001-8266-0392</Identifier><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Physiology and Biophysics, University of Washington, Seattle, WA 98195, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 MH116247</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>RF1 MH114126</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 MH114812</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>10</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Science</MedlineTA><NlmUniqueID>0404511</NlmUniqueID><ISSNLinking>0036-8075</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>56-12-2</RegistryNumber><NameOfSubstance UI="D005680">gamma-Aminobutyric Acid</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055724" MajorTopicYN="N">Electrophysiological Phenomena</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059330" MajorTopicYN="Y">GABAergic Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005680" MajorTopicYN="N">gamma-Aminobutyric Acid</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007395" MajorTopicYN="Y">Interneurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019579" MajorTopicYN="Y">Neocortex</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018408" MajorTopicYN="N">Patch-Clamp Techniques</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>11</Month><Day>1</Day><Hour>12</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>10</Month><Day>12</Day><Hour>18</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>10</Month><Day>12</Day><Hour>14</Hour><Minute>4</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37824669</ArticleId><ArticleId IdType="doi">10.1126/science.adf6484</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37824649</PMID><DateCompleted><Year>2023</Year><Month>11</Month><Day>13</Day></DateCompleted><DateRevised><Year>2025</Year><Month>01</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1095-9203</ISSN><JournalIssue CitedMedium="Internet"><Volume>382</Volume><Issue>6667</Issue><PubDate><Year>2023</Year><Month>Oct</Month><Day>13</Day></PubDate></JournalIssue><Title>Science (New York, N.Y.)</Title><ISOAbbreviation>Science</ISOAbbreviation></Journal><ArticleTitle>Interindividual variation in human cortical cell type abundance and expression.</ArticleTitle><Pagination><StartPage>eadf2359</StartPage><MedlinePgn>eadf2359</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1126/science.adf2359</ELocationID><Abstract><AbstractText>Single-cell transcriptomic studies have identified a conserved set of neocortical cell types from small postmortem cohorts. We extended these efforts by assessing cell type variation across 75 adult individuals undergoing epilepsy and tumor surgeries. Nearly all nuclei map to one of 125 robust cell types identified in the middle temporal gyrus. However, we found interindividual variance in abundances and gene expression signatures, particularly in deep-layer glutamatergic neurons and microglia. A minority of donor variance is explainable by age, sex, ancestry, disease state, and cell state. Genomic variation was associated with expression of 150 to 250 genes for most cell types. This characterization of cellular variation provides a baseline for cell typing in health and disease.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Johansen</LastName><ForeName>Nelson</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0002-4436-969X</Identifier><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Somasundaram</LastName><ForeName>Saroja</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-3729-9849</Identifier><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Travaglini</LastName><ForeName>Kyle J</ForeName><Initials>KJ</Initials><Identifier Source="ORCID">0000-0003-3164-6448</Identifier><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yanny</LastName><ForeName>Anna Marie</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shumyatcher</LastName><ForeName>Maya</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Casper</LastName><ForeName>Tamara</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0003-1638-3651</Identifier><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cobbs</LastName><ForeName>Charles</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0001-7688-4293</Identifier><AffiliationInfo><Affiliation>Swedish Neuroscience Institute, Seattle,WA 98122, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dee</LastName><ForeName>Nick</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0002-2831-9254</Identifier><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ellenbogen</LastName><ForeName>Richard</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-3463-1009</Identifier><AffiliationInfo><Affiliation>Department of Neurological Surgery, University of Washington, Seattle, WA 98104, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ferreira</LastName><ForeName>Manuel</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurological Surgery, University of Washington, Seattle, WA 98104, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goldy</LastName><ForeName>Jeff</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0001-5140-6922</Identifier><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guzman</LastName><ForeName>Junitta</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0001-8217-9232</Identifier><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gwinn</LastName><ForeName>Ryder</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-5849-7975</Identifier><AffiliationInfo><Affiliation>Swedish Neuroscience Institute, Seattle,WA 98122, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hirschstein</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jorstad</LastName><ForeName>Nikolas L</ForeName><Initials>NL</Initials><Identifier Source="ORCID">0000-0001-7906-9470</Identifier><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Keene</LastName><ForeName>C Dirk</ForeName><Initials>CD</Initials><Identifier Source="ORCID">0000-0002-5291-1469</Identifier><AffiliationInfo><Affiliation>Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA 98104, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ko</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-6253-9891</Identifier><AffiliationInfo><Affiliation>Department of Neurological Surgery, University of Washington, Seattle, WA 98104, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Levi</LastName><ForeName>Boaz P</ForeName><Initials>BP</Initials><Identifier Source="ORCID">0000-0002-8346-872X</Identifier><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ojemann</LastName><ForeName>Jeffrey G</ForeName><Initials>JG</Initials><Identifier Source="ORCID">0000-0001-7580-8934</Identifier><AffiliationInfo><Affiliation>Department of Neurological Surgery, University of Washington, Seattle, WA 98104, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pham</LastName><ForeName>Thanh</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-4738-5062</Identifier><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shapovalova</LastName><ForeName>Nadiya</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0002-8618-8272</Identifier><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Silbergeld</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Neurological Surgery, University of Washington, Seattle, WA 98104, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sulc</LastName><ForeName>Josef</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-4928-7183</Identifier><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Torkelson</LastName><ForeName>Amy</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-9465-4202</Identifier><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tung</LastName><ForeName>Herman</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0002-0812-3318</Identifier><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smith</LastName><ForeName>Kimberly</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0002-3142-1970</Identifier><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lein</LastName><ForeName>Ed S</ForeName><Initials>ES</Initials><Identifier Source="ORCID">0000-0001-9012-6552</Identifier><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Bakken</LastName><ForeName>Trygve E</ForeName><Initials>TE</Initials><Identifier Source="ORCID">0000-0003-3373-7386</Identifier><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Hodge</LastName><ForeName>Rebecca D</ForeName><Initials>RD</Initials><Identifier Source="ORCID">0000-0002-5784-9668</Identifier><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Miller</LastName><ForeName>Jeremy A</ForeName><Initials>JA</Initials><Identifier Source="ORCID">0000-0003-4549-588X</Identifier><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>U01 MH114812</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>10</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Science</MedlineTA><NlmUniqueID>0404511</NlmUniqueID><ISSNLinking>0036-8075</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004827" MajorTopicYN="N">Epilepsy</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020869" MajorTopicYN="N">Gene Expression Profiling</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009474" MajorTopicYN="N">Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013702" MajorTopicYN="Y">Temporal Lobe</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D059467" MajorTopicYN="Y">Transcriptome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009422" MajorTopicYN="N">Nervous System Diseases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001523" MajorTopicYN="N">Mental Disorders</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>11</Month><Day>1</Day><Hour>12</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>10</Month><Day>12</Day><Hour>18</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>10</Month><Day>12</Day><Hour>14</Hour><Minute>4</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>1</Month><Day>6</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37824649</ArticleId><ArticleId IdType="mid">NIHMS2041647</ArticleId><ArticleId IdType="pmc">PMC11702338</ArticleId><ArticleId IdType="doi">10.1126/science.adf2359</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Glasser MF et al., A multi-modal parcellation of human cerebral cortex. Nature. 536, 171&#x2013;178 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4990127</ArticleId><ArticleId IdType="pubmed">27437579</ArticleId></ArticleIdList></Reference><Reference><Citation>Reardon PK et al., Normative brain size variation and brain shape diversity in humans. Science. 360, 1222&#x2013;1227 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7485526</ArticleId><ArticleId IdType="pubmed">29853553</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans AC et al., Anatomical mapping of functional activation in stereotactic coordinate space. Neuroimage. 1, 43&#x2013;53 (1992).</Citation><ArticleIdList><ArticleId IdType="pubmed">9343556</ArticleId></ArticleIdList></Reference><Reference><Citation>Llera A, Wolfers T, Mulders P and Beckmann CF, Inter-individual differences in human brain structure and morphology link to variation in demographics and behavior. eLife. 8, e44443 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6663467</ArticleId><ArticleId IdType="pubmed">31268418</ArticleId></ArticleIdList></Reference><Reference><Citation>Hibar DP et al., Common genetic variants influence human subcortical brain structures. Nature. 520, 224&#x2013;229 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4393366</ArticleId><ArticleId IdType="pubmed">25607358</ArticleId></ArticleIdList></Reference><Reference><Citation>Grasby KL et al., The genetic architecture of the human cerebral cortex. Science. 367, eaay6690 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7295264</ArticleId><ArticleId IdType="pubmed">32193296</ArticleId></ArticleIdList></Reference><Reference><Citation>Sha Z et al., The genetic architecture of structural left&#x2013;right asymmetry of the human brain. Nat Hum Behav. 5, 1226&#x2013;1239 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8455338</ArticleId><ArticleId IdType="pubmed">33723403</ArticleId></ArticleIdList></Reference><Reference><Citation>Richiardi J. et al., Correlated gene expression supports synchronous activity in brain networks. Science (New York, N.Y.). 348, 1241 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4829082</ArticleId><ArticleId IdType="pubmed">26068849</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao B. et al., Common variants contribute to intrinsic human brain functional networks. Nat Genet. 54, 508&#x2013;517 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11987081</ArticleId><ArticleId IdType="pubmed">35393594</ArticleId></ArticleIdList></Reference><Reference><Citation>Sahara S, Yanagawa Y, O&#x2019;Leary DDM and Stevens CF, The Fraction of Cortical GABAergic Neurons Is Constant from Near the Start of Cortical Neurogenesis to Adulthood. J. Neurosci 32, 4755&#x2013;4761 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3325497</ArticleId><ArticleId IdType="pubmed">22492031</ArticleId></ArticleIdList></Reference><Reference><Citation>Pakkenberg B and Gundersen HJ, Neocortical neuron number in humans: effect of sex and age. J Comp Neurol. 384, 312&#x2013;320 (1997).</Citation><ArticleIdList><ArticleId IdType="pubmed">9215725</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao B. et al., Common genetic variation influencing human white matter microstructure. Science. 372, eabf3736 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8370718</ArticleId><ArticleId IdType="pubmed">34140357</ArticleId></ArticleIdList></Reference><Reference><Citation>Tynan RJ et al., Chronic stress alters the density and morphology of microglia in a subset of stress-responsive brain regions. Brain, Behavior, and Immunity. 24, 1058&#x2013;1068 (2010).</Citation><ArticleIdList><ArticleId IdType="pubmed">20153418</ArticleId></ArticleIdList></Reference><Reference><Citation>Bakken TE et al., Comparative cellular analysis of motor cortex in human, marmoset and mouse. Nature. 598, 111&#x2013;119 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8494640</ArticleId><ArticleId IdType="pubmed">34616062</ArticleId></ArticleIdList></Reference><Reference><Citation>Hodge RD et al., Conserved cell types with divergent features in human versus mouse cortex. Nature. 573, 61&#x2013;68 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6919571</ArticleId><ArticleId IdType="pubmed">31435019</ArticleId></ArticleIdList></Reference><Reference><Citation>Tasic B. et al., Shared and distinct transcriptomic cell types across neocortical areas. Nature. 563, 72&#x2013;78 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6456269</ArticleId><ArticleId IdType="pubmed">30382198</ArticleId></ArticleIdList></Reference><Reference><Citation>Jorstad NL et al., Transcriptomic cytoarchitecture reveals principles of human neocortex organization. bioRxiv, 2022.11.06.515349 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11687949</ArticleId><ArticleId IdType="pubmed">37824655</ArticleId></ArticleIdList></Reference><Reference><Citation>Berg J. et al., Human neocortical expansion involves glutamatergic neuron diversification. Nature. 598, 151&#x2013;158 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8494638</ArticleId><ArticleId IdType="pubmed">34616067</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathys H. et al., Single-cell transcriptomic analysis of Alzheimer&#x2019;s disease. Nature. 570, 332&#x2013;337 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6865822</ArticleId><ArticleId IdType="pubmed">31042697</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitchell KJ, Innate: how the wiring of our brains shapes who we are (Princeton University Press, Princeton, 2018).</Citation></Reference><Reference><Citation>Ng B. et al., An xQTL map integrates the genetic architecture of the human brain&#x2019;s transcriptome and epigenome. Nat Neurosci. 20, 1418&#x2013;1426 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5785926</ArticleId><ArticleId IdType="pubmed">28869584</ArticleId></ArticleIdList></Reference><Reference><Citation>Bryois J. et al., Cell-type-specific cis-eQTLs in eight human brain cell types identify novel risk genes for psychiatric and neurological disorders. Nat Neurosci. 25, 1104&#x2013;1112 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35915177</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu C. et al., Probabilistic harmonization and annotation of single-cell transcriptomics data with deep generative models. Mol Syst Biol. 17, e9620 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7829634</ArticleId><ArticleId IdType="pubmed">33491336</ArticleId></ArticleIdList></Reference><Reference><Citation>Medici V. et al., Different parvalbumin and GABA expression in human epileptogenic focal cortical dysplasia. Epilepsia. 57, 1109&#x2013;1119 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">27173597</ArticleId></ArticleIdList></Reference><Reference><Citation>Pfisterer U. et al., Identification of epilepsy-associated neuronal subtypes and gene expression underlying epileptogenesis. Nat Commun. 11, 5038 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7541486</ArticleId><ArticleId IdType="pubmed">33028830</ArticleId></ArticleIdList></Reference><Reference><Citation>Cerghet M. et al., Proliferation and Death of Oligodendrocytes and Myelin Proteins Are Differentially Regulated in Male and Female Rodents. J. Neurosci 26, 1439&#x2013;1447 (2006).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6675481</ArticleId><ArticleId IdType="pubmed">16452667</ArticleId></ArticleIdList></Reference><Reference><Citation>Vanzulli I. et al., Disruption of oligodendrocyte progenitor cells is an early sign of pathology in the triple transgenic mouse model of Alzheimer&#x2019;s disease. Neurobiol Aging. 94, 130&#x2013;139 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7453384</ArticleId><ArticleId IdType="pubmed">32619874</ArticleId></ArticleIdList></Reference><Reference><Citation>Haider B, Duque A, Hasenstaub AR and McCormick DA, Neocortical Network Activity In Vivo Is Generated through a Dynamic Balance of Excitation and Inhibition. J. Neurosci 26, 4535&#x2013;4545 (2006).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6674060</ArticleId><ArticleId IdType="pubmed">16641233</ArticleId></ArticleIdList></Reference><Reference><Citation>Deco G. et al., How Local Excitation&#x2013;Inhibition Ratio Impacts the Whole Brain Dynamics. J. Neurosci 34, 7886&#x2013;7898 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4044249</ArticleId><ArticleId IdType="pubmed">24899711</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubenstein JLR and Merzenich MM, Model of autism: increased ratio of excitation/inhibition in key neural systems. Genes, Brain and Behavior. 2, 255&#x2013;267 (2003).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6748642</ArticleId><ArticleId IdType="pubmed">14606691</ArticleId></ArticleIdList></Reference><Reference><Citation>Dehghani N. et al., Dynamic Balance of Excitation and Inhibition in Human and Monkey Neocortex. Sci Rep. 6, 23176 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4793223</ArticleId><ArticleId IdType="pubmed">26980663</ArticleId></ArticleIdList></Reference><Reference><Citation>Avner P and Heard E, X-chromosome inactivation: counting, choice and initiation. Nat Rev Genet. 2, 59&#x2013;67 (2001).</Citation><ArticleIdList><ArticleId IdType="pubmed">11253071</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheng M and Greenberg ME, The regulation and function of c-fos and other immediate early genes in the nervous system. Neuron. 4, 477&#x2013;485 (1990).</Citation><ArticleIdList><ArticleId IdType="pubmed">1969743</ArticleId></ArticleIdList></Reference><Reference><Citation>Bakken TE et al., Single-nucleus and single-cell transcriptomes compared in matched cortical cell types. PLOS ONE. 13, e0209648 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6306246</ArticleId><ArticleId IdType="pubmed">30586455</ArticleId></ArticleIdList></Reference><Reference><Citation>Jorstad NL et al., Comparative transcriptomics reveals human-specific cortical features. bioRxiv. 2022.09.19.508480 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10659116</ArticleId><ArticleId IdType="pubmed">37824638</ArticleId></ArticleIdList></Reference><Reference><Citation>Hrvatin S. et al., Single-cell analysis of experience-dependent transcriptomic states in the mouse visual cortex. Nat Neurosci. 21, 120&#x2013;129 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5742025</ArticleId><ArticleId IdType="pubmed">29230054</ArticleId></ArticleIdList></Reference><Reference><Citation>Liaw A and Wiener M, Classification and Regression by randomForest. R News. 2, 18&#x2013;22 (2002).</Citation></Reference><Reference><Citation>Lappalainen T. et al., Transcriptome and genome sequencing uncovers functional variation in humans. Nature. 501, 506&#x2013;511 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3918453</ArticleId><ArticleId IdType="pubmed">24037378</ArticleId></ArticleIdList></Reference><Reference><Citation>Kedlian VR, Donertas HM and Thornton JM, The widespread increase in inter-individual variability of gene expression in the human brain with age. Aging. 11, 2253&#x2013;2280 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6520006</ArticleId><ArticleId IdType="pubmed">31003228</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffman GE and Schadt EE, variancePartition: interpreting drivers of variation in complex gene expression studies. BMC Bioinformatics. 17, 483 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5123296</ArticleId><ArticleId IdType="pubmed">27884101</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang K. et al., A single-cell atlas of chromatin accessibility in the human genome. Cell. 184, 5985&#x2013;6001.e19 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8664161</ArticleId><ArticleId IdType="pubmed">34774128</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang H. et al., Chromatin remodeling factor ARID2 suppresses hepatocellular carcinoma metastasis via DNMT1-Snail axis. Proc Natl Acad Sci U S A. 117, 4770&#x2013;4780 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7060681</ArticleId><ArticleId IdType="pubmed">32071245</ArticleId></ArticleIdList></Reference><Reference><Citation>Sieberts SK et al., Large eQTL meta-analysis reveals differing patterns between cerebral cortical and cerebellar brain regions. Sci Data. 7, 340 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7550587</ArticleId><ArticleId IdType="pubmed">33046718</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffman GE et al., CommonMind Consortium provides transcriptomic and epigenomic data for Schizophrenia and Bipolar Disorder. Sci Data. 6, 180 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6760149</ArticleId><ArticleId IdType="pubmed">31551426</ArticleId></ArticleIdList></Reference><Reference><Citation>THE GTEX CONSORTIUM et al., The Genotype-Tissue Expression (GTEx) pilot analysis: Multitissue gene regulation in humans. Science. 348, 648&#x2013;660 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4547484</ArticleId><ArticleId IdType="pubmed">25954001</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim-Hellmuth S. et al., Cell type&#x2013;specific genetic regulation of gene expression across human tissues. Science. 369, eaaz8528 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8051643</ArticleId><ArticleId IdType="pubmed">32913075</ArticleId></ArticleIdList></Reference><Reference><Citation>De Jager PL et al., Neurobiol Aging, in press, doi:10.1016/j.neurobiolaging.2011.09.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2011.09.033</ArticleId></ArticleIdList></Reference><Reference><Citation>de Jong S. et al., Common inversion polymorphism at 17q21.31 affects expression of multiple genes in tissue-specific manner. BMC Genomics. 13, 458 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3582489</ArticleId><ArticleId IdType="pubmed">22950410</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang M, He P and Bian Z, Long Noncoding RNAs in Neurodegenerative Diseases: Pathogenesis and Potential Implications as Clinical Biomarkers. Frontiers in Molecular Neuroscience. 14 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8371338</ArticleId><ArticleId IdType="pubmed">34421536</ArticleId></ArticleIdList></Reference><Reference><Citation>Rakic P, Neurons in rhesus monkey visual cortex: systematic relation between time of origin and eventual disposition. Science. 183, 425&#x2013;427 (1974).</Citation><ArticleIdList><ArticleId IdType="pubmed">4203022</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng H. et al., Morphological diversity of single neurons in molecularly defined cell types. Nature. 598, 174&#x2013;181 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8494643</ArticleId><ArticleId IdType="pubmed">34616072</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen KH, Boettiger AN, Moffitt JR, Wang S and Zhuang X, Spatially resolved, highly multiplexed RNA profiling in single cells. Science. 348, aaa6090 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4662681</ArticleId><ArticleId IdType="pubmed">25858977</ArticleId></ArticleIdList></Reference><Reference><Citation>Bycroft C. et al., The UK Biobank resource with deep phenotyping and genomic data. Nature. 562, 203&#x2013;209 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6786975</ArticleId><ArticleId IdType="pubmed">30305743</ArticleId></ArticleIdList></Reference><Reference><Citation>Johansen N and Quon G, Projecting clumped transcriptomes onto single cell atlases to achieve single cell resolution. bioRxiv. 2022.04.26.489628 (2022).</Citation></Reference><Reference><Citation>Consortium GTEx et al., Genetic effects on gene expression across human tissues. Nature. 550, 204&#x2013;213 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5776756</ArticleId><ArticleId IdType="pubmed">29022597</ArticleId></ArticleIdList></Reference><Reference><Citation>Alam A, Hana Z, Jin Z, Suen KC and Ma D, Surgery, neuroinflammation and cognitive impairment. EBioMedicine. 37, 547&#x2013;556 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6284418</ArticleId><ArticleId IdType="pubmed">30348620</ArticleId></ArticleIdList></Reference><Reference><Citation>Geirsdottir L. et al., Cross-Species Single-Cell Analysis Reveals Divergence of the Primate Microglia Program. Cell. 179, 1609&#x2013;1622.e16 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">31835035</ArticleId></ArticleIdList></Reference><Reference><Citation>Hawrylycz MJ et al., An anatomically comprehensive atlas of the adult human brain transcriptome. Nature. 489, 391&#x2013;9 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4243026</ArticleId><ArticleId IdType="pubmed">22996553</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang C-C et al., Meta-analysis of the association between variants in MAPT and neurodegenerative diseases. Oncotarget. 8, 44994&#x2013;45007 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5546535</ArticleId><ArticleId IdType="pubmed">28402959</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowles KR et al., 17q21.31 sub-haplotypes underlying H1-associated risk for Parkinson&#x2019;s disease are associated with LRRC37A/2 expression in astrocytes. Molecular Neurodegeneration. 17, 48 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9284779</ArticleId><ArticleId IdType="pubmed">35841044</ArticleId></ArticleIdList></Reference><Reference><Citation>Chanzuckerberg Initiative, CZ
CELLxGENE Discover. Retrieved (2022-05-18), from https://cellxgene.cziscience.com/ (n.d.).</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37824619</PMID><DateCompleted><Year>2023</Year><Month>11</Month><Day>01</Day></DateCompleted><DateRevised><Year>2024</Year><Month>02</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2375-2548</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><Issue>41</Issue><PubDate><Year>2023</Year><Month>Oct</Month><Day>13</Day></PubDate></JournalIssue><Title>Science advances</Title><ISOAbbreviation>Sci Adv</ISOAbbreviation></Journal><ArticleTitle>Whole human-brain mapping of single cortical neurons for profiling morphological diversity and stereotypy.</ArticleTitle><Pagination><StartPage>eadf3771</StartPage><MedlinePgn>eadf3771</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">eadf3771</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1126/sciadv.adf3771</ELocationID><Abstract><AbstractText>Quantifying neuron morphology and distribution at the whole-brain scale is essential to understand the structure and diversity of cell types. It is exceedingly challenging to reuse recent technologies of single-cell labeling and whole-brain imaging to study human brains. We propose adaptive cell tomography (ACTomography), a low-cost, high-throughput, and high-efficacy tomography approach, based on adaptive targeting of individual cells. We established a platform to inject dyes into cortical neurons in surgical tissues of 18 patients with brain tumors or other conditions and one donated fresh postmortem brain. We collected three-dimensional images of 1746 cortical neurons, of which 852 neurons were reconstructed to quantify local dendritic morphology, and mapped to standard atlases. In our data, human neurons are more diverse across brain regions than by subject age or gender. The strong stereotypy within cohorts of brain regions allows generating a statistical tensor field of neuron morphology to characterize anatomical modularity of a human brain.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Han</LastName><ForeName>Xiaofeng</ForeName><Initials>X</Initials><Identifier Source="ORCID">0000-0002-2688-3425</Identifier><AffiliationInfo><Affiliation>Institute for Brain and Intelligence, Southeast University, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guo</LastName><ForeName>Shuxia</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-8237-8936</Identifier><AffiliationInfo><Affiliation>Institute for Brain and Intelligence, Southeast University, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ji</LastName><ForeName>Nan</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0002-9001-8858</Identifier><AffiliationInfo><Affiliation>Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>China National Clinical Research Center for Neurological Diseases, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Beijing Key Laboratory of Brain Tumor, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Tian</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0003-1954-6962</Identifier><AffiliationInfo><Affiliation>Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Jian</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-3948-8184</Identifier><AffiliationInfo><Affiliation>Institute for Brain and Intelligence, Southeast University, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ye</LastName><ForeName>Xiangqiao</ForeName><Initials>X</Initials><Identifier Source="ORCID">0000-0002-9194-8213</Identifier><AffiliationInfo><Affiliation>Institute for Brain and Intelligence, Southeast University, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Yi</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0002-4775-5457</Identifier><AffiliationInfo><Affiliation>Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yun</LastName><ForeName>Zhixi</ForeName><Initials>Z</Initials><Identifier Source="ORCID">0000-0002-8226-7408</Identifier><AffiliationInfo><Affiliation>Institute for Brain and Intelligence, Southeast University, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xiong</LastName><ForeName>Feng</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0002-6927-8903</Identifier><AffiliationInfo><Affiliation>Institute for Brain and Intelligence, Southeast University, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rong</LastName><ForeName>Jing</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Institute for Brain and Intelligence, Southeast University, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Di</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0001-8426-0405</Identifier><AffiliationInfo><Affiliation>Institute for Brain and Intelligence, Southeast University, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Hui</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0002-6668-1780</Identifier><AffiliationInfo><Affiliation>Institute for Brain and Intelligence, Southeast University, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Yujin</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0001-6587-1438</Identifier><AffiliationInfo><Affiliation>Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Yue</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0001-6051-2241</Identifier><AffiliationInfo><Affiliation>China National Clinical Research Center for Neurological Diseases, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Peng</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-8567-9336</Identifier><AffiliationInfo><Affiliation>Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Wenhao</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ding</LastName><ForeName>Liya</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-1209-875X</Identifier><AffiliationInfo><Affiliation>Institute for Brain and Intelligence, Southeast University, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hawrylycz</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lein</LastName><ForeName>Ed</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0001-9012-6552</Identifier><AffiliationInfo><Affiliation>Allen Institute for Brain Science, Seattle, WA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ascoli</LastName><ForeName>Giorgio A</ForeName><Initials>GA</Initials><Identifier Source="ORCID">0000-0002-0964-676X</Identifier><AffiliationInfo><Affiliation>Center for Neural Informatics, Krasnow Institute for Advanced Studies and Bioengineering Department, College of Engineering and Computing, George Mason University, Fairfax, VA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xie</LastName><ForeName>Wei</ForeName><Initials>W</Initials><Identifier Source="ORCID">0000-0002-9179-4787</Identifier><AffiliationInfo><Affiliation>Institute for Brain and Intelligence, Southeast University, Nanjing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Key Laboratory of Developmental Genes and Human Disease, Ministry of Education, School of Life Science and Technology, Southeast University, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Lijuan</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-9548-6183</Identifier><AffiliationInfo><Affiliation>Institute for Brain and Intelligence, Southeast University, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Liwei</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0003-1919-3765</Identifier><AffiliationInfo><Affiliation>Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>China National Clinical Research Center for Neurological Diseases, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Beijing Key Laboratory of Brain Tumor, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peng</LastName><ForeName>Hanchuan</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0002-3478-3942</Identifier><AffiliationInfo><Affiliation>Institute for Brain and Intelligence, Southeast University, Nanjing, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 NS039600</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS086082</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>RF1 MH128693</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 MH114829</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>10</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Sci Adv</MedlineTA><NlmUniqueID>101653440</NlmUniqueID><ISSNLinking>2375-2548</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009474" MajorTopicYN="Y">Neurons</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001931" MajorTopicYN="Y">Brain Mapping</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D021621" MajorTopicYN="N">Imaging, Three-Dimensional</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006257" MajorTopicYN="N">Head</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>11</Month><Day>1</Day><Hour>12</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>10</Month><Day>12</Day><Hour>18</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>10</Month><Day>12</Day><Hour>14</Hour><Minute>4</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>10</Month><Day>12</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37824619</ArticleId><ArticleId IdType="pmc">PMC10569712</ArticleId><ArticleId IdType="doi">10.1126/sciadv.adf3771</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>D. Purves, G. J. Augustine, W. Hall, A.-S. LaMantia, L. White, Neurosciences (De Boeck Sup&#xe9;rieur, 2019).</Citation></Reference><Reference><Citation>Markram H., Muller E., Ramaswamy S., Reimann M. W., Abdellah M., Sanchez C. A., Ailamaki A., Alonso-Nanclares L., Antille N., Arsever S., Kahou G. A. A., Berger T. K., Bilgili A., Buncic N., Chalimourda A., Chindemi G., Courcol J. D., Delalondre F., Delattre V., Druckmann S., Dumusc R., Dynes J., Eilemann S., Gal E., Gevaert M. E., Ghobril J. P., Gidon A., Graham J. W., Gupta A., Haenel V., Hay E., Heinis T., Hernando J. B., Hines M., Kanari L., Keller D., Kenyon J., Khazen G., Kim Y., King J. G., Kisvarday Z., Kumbhar P., Lasserre S., le B&#xe9; J. V., Magalh&#xe3;es B. R. C., Merch&#xe1;n-P&#xe9;rez A., Meystre J., Morrice B. R., Muller J., Mu&#xf1;oz-C&#xe9;spedes A., Muralidhar S., Muthurasa K., Nachbaur D., Newton T. H., Nolte M., Ovcharenko A., Palacios J., Pastor L., Perin R., Ranjan R., Riachi I., Rodr&#xed;guez J. R., Riquelme J. L., R&#xf6;ssert C., Sfyrakis K., Shi Y., Shillcock J. C., Silberberg G., Silva R., Tauheed F., Telefont M., Toledo-Rodriguez M., Tr&#xe4;nkler T., van Geit W., D&#xed;az J. V., Walker R., Wang Y., Zaninetta S. M., DeFelipe J., Hill S. L., Segev I., Sch&#xfc;rmann F., Reconstruction and simulation of neocortical microcircuitry. Cell 163, 456&#x2013;492 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">26451489</ArticleId></ArticleIdList></Reference><Reference><Citation>L. Luo, Principles of Neurobiology (Garland Science, 2020).</Citation></Reference><Reference><Citation>Wen Q., Stepanyants A., Elston G. N., Grosberg A. Y., Chklovskii D. B., Maximization of the connectivity repertoire as a statistical principle governing the shapes of dendritic arbors. Proc. Natl. Acad. Sci. U.S.A. 106, 12536&#x2013;12541 (2008).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2713752</ArticleId><ArticleId IdType="pubmed">19622738</ArticleId></ArticleIdList></Reference><Reference><Citation>Oga T., Okamoto T., Fujita I., Basal dendrites of Layer-III pyramidal neurons do not scale with changes in cortical magnification factor in macaque primary visual Cortex. Frontiers in Neural Circuits 10, 74 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5030257</ArticleId><ArticleId IdType="pubmed">27708563</ArticleId></ArticleIdList></Reference><Reference><Citation>Motley S. E., Grossman Y. S., Janssen W. G. M., Baxter M. G., Rapp P. R., Dumitriu D., Morrison J. H., Selective loss of thin spines in area 7a of the primate intraparietal sulcus predicts age-related working memory impairment. J. Neurosci. 38, 10467&#x2013;10478 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6284109</ArticleId><ArticleId IdType="pubmed">30355632</ArticleId></ArticleIdList></Reference><Reference><Citation>Gouwens N. W., Sorensen S. A., Berg J., Lee C., Jarsky T., Ting J., Sunkin S. M., Feng D., Anastassiou C. A., Barkan E., Bickley K., Blesie N., Braun T., Brouner K., Budzillo A., Caldejon S., Casper T., Castelli D., Chong P., Crichton K., Cuhaciyan C., Daigle T. L., Dalley R., Dee N., Desta T., Ding S. L., Dingman S., Doperalski A., Dotson N., Egdorf T., Fisher M., de Frates R. A., Garren E., Garwood M., Gary A., Gaudreault N., Godfrey K., Gorham M., Gu H., Habel C., Hadley K., Harrington J., Harris J. A., Henry A., Hill D. J., Josephsen S., Kebede S., Kim L., Kroll M., Lee B., Lemon T., Link K. E., Liu X., Long B., Mann R., McGraw M., Mihalas S., Mukora A., Murphy G. J., Ng L., Ngo K., Nguyen T. N., Nicovich P. R., Oldre A., Park D., Parry S., Perkins J., Potekhina L., Reid D., Robertson M., Sandman D., Schroedter M., Slaughterbeck C., Soler-Llavina G., Sulc J., Szafer A., Tasic B., Taskin N., Teeter C., Thatra N., Tung H., Wakeman W., Williams G., Young R., Zhou Z., Farrell C., Peng H., Hawrylycz M. J., Lein E., Ng L., Arkhipov A., Bernard A., Phillips J. W., Zeng H., Koch C., Classification of electrophysiological and morphological neuron types in the mouse visual cortex. Nat. Neurosci. 22, 1182&#x2013;1195 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8078853</ArticleId><ArticleId IdType="pubmed">31209381</ArticleId></ArticleIdList></Reference><Reference><Citation>Marchetto M. C., Hrvoj-Mihic B., Kerman B. E., Yu D. X., Vadodaria K. C., Linker S. B., Narvaiza I., Santos R., Denli A. M., Mendes A. P. D., Oefner R., Cook J., McHenry L., Grasmick J. M., Heard K., Fredlender C., Randolph-Moore L., Kshirsagar R., Xenitopoulos R., Chou G., Hah N., Muotri A. R., Padmanabhan K., Semendeferi K., Gage F. H., Species-specific maturation profiles of human, chimpanzee and bonobo neural cells. eLife 8, e37527 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6366899</ArticleId><ArticleId IdType="pubmed">30730291</ArticleId></ArticleIdList></Reference><Reference><Citation>Wagstyl K., Larocque S., Cucurull G., Lepage C., Cohen J. P., Bludau S., Palomero-Gallagher N., Lewis L. B., Funck T., Spitzer H., Dickscheid T., Fletcher P. C., Romero A., Zilles K., Amunts K., Bengio Y., Evans A. C., BigBrain 3D atlas of cortical layers: Cortical and laminar thickness gradients diverge in sensory and motor cortices. PLoS Biol. 18, e3000678 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7159250</ArticleId><ArticleId IdType="pubmed">32243449</ArticleId></ArticleIdList></Reference><Reference><Citation>Bjerke I. E., Yates S. C., Laja A., Witter M. P., Puchades M. A., Bjaalie J. G., Leergaard T. B., Densities and numbers of calbindin and parvalbumin positive neurons across the rat and mouse brain. iScience 24, 101906 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7770605</ArticleId><ArticleId IdType="pubmed">33385111</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng H., Xie P., Liu L., Kuang X., Wang Y., Qu L., Gong H., Jiang S., Li A., Ruan Z., Ding L., Yao Z., Chen C., Chen M., Daigle T. L., Dalley R., Ding Z., Duan Y., Feiner A., He P., Hill C., Hirokawa K. E., Hong G., Huang L., Kebede S., Kuo H. C., Larsen R., Lesnar P., Li L., Li Q., Li X., Li Y., Li Y., Liu A., Lu D., Mok S., Ng L., Nguyen T. N., Ouyang Q., Pan J., Shen E., Song Y., Sunkin S. M., Tasic B., Veldman M. B., Wakeman W., Wan W., Wang P., Wang Q., Wang T., Wang Y., Xiong F., Xiong W., Xu W., Ye M., Yin L., Yu Y., Yuan J., Yuan J., Yun Z., Zeng S., Zhang S., Zhao S., Zhao Z., Zhou Z., Huang Z. J., Esposito L., Hawrylycz M. J., Sorensen S. A., Yang X. W., Zheng Y., Gu Z., Xie W., Koch C., Luo Q., Harris J. A., Wang Y., Zeng H., Morphological diversity of single neurons in molecularly defined cell types. Nature 598, 174&#x2013;181 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8494643</ArticleId><ArticleId IdType="pubmed">34616072</ArticleId></ArticleIdList></Reference><Reference><Citation>Larivi&#xe8;re S., Bayrak &#x15e;., Vos de Wael R., Benkarim O., Herholz P., Rodriguez-Cruces R., Paquola C., Hong S. J., Misic B., Evans A. C., Valk S. L., Bernhardt B. C., BrainStat: A toolbox for brain-wide statistics and multimodal feature associations. Neuroimage 266, 119807 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10715099</ArticleId><ArticleId IdType="pubmed">36513290</ArticleId></ArticleIdList></Reference><Reference><Citation>DeFelipe J., The evolution of the brain, the human nature of cortical circuits and intellectual creativity. Frontiers in neuroanatomy. 5, 29 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3098448</ArticleId><ArticleId IdType="pubmed">21647212</ArticleId></ArticleIdList></Reference><Reference><Citation>Farahany N. A., Greely H. T., Hyman S., Koch C., Grady C., Pa&#x219;ca S. P., Sestan N., Arlotta P., Bernat J. L., Ting J., Lunshof J. E., Iyer E. P. R., Hyun I., Capestany B. H., Church G. M., Huang H., Song H., The ethics of experimenting with human brain tissue. Nature 556, 429&#x2013;432 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6010307</ArticleId><ArticleId IdType="pubmed">29691509</ArticleId></ArticleIdList></Reference><Reference><Citation>Hawrylycz M. J., Lein E. S., Guillozet-Bongaarts A. L., Shen E. H., Ng L., Miller J. A., van de Lagemaat L. N., Smith K. A., Ebbert A., Riley Z. L., Abajian C., Beckmann C. F., Bernard A., Bertagnolli D., Boe A. F., Cartagena P. M., Chakravarty M. M., Chapin M., Chong J., Dalley R. A., Daly B. D., Dang C., Datta S., Dee N., Dolbeare T. A., Faber V., Feng D., Fowler D. R., Goldy J., Gregor B. W., Haradon Z., Haynor D. R., Hohmann J. G., Horvath S., Howard R. E., Jeromin A., Jochim J. M., Kinnunen M., Lau C., Lazarz E. T., Lee C., Lemon T. A., Li L., Li Y., Morris J. A., Overly C. C., Parker P. D., Parry S. E., Reding M., Royall J. J., Schulkin J., Sequeira P. A., Slaughterbeck C. R., Smith S. C., Sodt A. J., Sunkin S. M., Swanson B. E., Vawter M. P., Williams D., Wohnoutka P., Zielke H. R., Geschwind D. H., Hof P. R., Smith S. M., Koch C., Grant S. G. N., Jones A. R., An anatomically comprehensive atlas of the adult human brain transcriptome. Nature 489, 391&#x2013;399 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4243026</ArticleId><ArticleId IdType="pubmed">22996553</ArticleId></ArticleIdList></Reference><Reference><Citation>Amunts K., Lepage C., Borgeat L., Mohlberg H., Dickscheid T., Rousseau M. &#xc9;., Bludau S., Bazin P. L., Lewis L. B., Oros-Peusquens A. M., Shah N. J., Lippert T., Zilles K., Evans A. C., BigBrain: An ultrahigh-resolution 3D human brain model. Science 340, 1472&#x2013;1475 (2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">23788795</ArticleId></ArticleIdList></Reference><Reference><Citation>Boldog E., Bakken T. E., Hodge R. D., Novotny M., Aevermann B. D., Baka J., Bord&#xe9; S., Close J. L., Diez-Fuertes F., Ding S. L., Farag&#xf3; N., Kocsis &#xc1;. K., Kov&#xe1;cs B., Maltzer Z., McCorrison J. M., Miller J. A., Moln&#xe1;r G., Ol&#xe1;h G., Ozsv&#xe1;r A., R&#xf3;zsa M., Shehata S. I., Smith K. A., Sunkin S. M., Tran D. N., Venepally P., Wall A., Pusk&#xe1;s L. G., Barz&#xf3; P., Steemers F. J., Schork N. J., Scheuermann R. H., Lasken R. S., Lein E. S., Tam&#xe1;s G., Transcriptomic and morphophysiological evidence for a specialized human cortical GABAergic cell type. Nat. Neurosci. 21, 1185&#x2013;1195 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6130849</ArticleId><ArticleId IdType="pubmed">30150662</ArticleId></ArticleIdList></Reference><Reference><Citation>Long B., Zhou Z., Cetin A., Ting J., Gwinn R., Tasic B., Daigle T., Lein E., Zeng H., Saggau P., Hawrylycz M., Peng H., SmartScope2: Simultaneous imaging and reconstruction of neuronal morphology. Sci. Rep. 7, 9325 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5571186</ArticleId><ArticleId IdType="pubmed">28839271</ArticleId></ArticleIdList></Reference><Reference><Citation>Luengo-Sanchez S., Fernaud-Espinosa I., Bielza C., Benavides-Piccione R., Larra&#xf1;aga P., DeFelipe J., 3D morphology-based clustering and simulation of human pyramidal cell dendritic spines. PLoS Comput. Biol. 14, e1006221 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6060563</ArticleId><ArticleId IdType="pubmed">29897896</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalmbach B. E., Hodge R. D., Jorstad N. L., Owen S., de Frates R., Yanny A. M., Dalley R., Mallory M., Graybuck L. T., Radaelli C., Keene C. D., Gwinn R. P., Silbergeld D. L., Cobbs C., Ojemann J. G., Ko A. L., Patel A. P., Ellenbogen R. G., Bakken T. E., Daigle T. L., Dee N., Lee B. R., McGraw M., Nicovich P. R., Smith K., Sorensen S. A., Tasic B., Zeng H., Koch C., Lein E. S., Ting J. T., Signature morpho-electric, transcriptomic, and dendritic properties of human layer 5 neocortical pyramidal neurons. Neuron 109, 2914&#x2013;2927.e5 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8570452</ArticleId><ArticleId IdType="pubmed">34534454</ArticleId></ArticleIdList></Reference><Reference><Citation>Elston G. N., Benavides-Piccione R., DeFelipe J., The pyramidal cell in cognition: A comparative study in human and monkey. J. Neurosci. 21, RC163 (2001).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6763111</ArticleId><ArticleId IdType="pubmed">11511694</ArticleId></ArticleIdList></Reference><Reference><Citation>Cano-Astorga N., DeFelipe J., Alonso-Nanclares L., Three-dimensional synaptic organization of layer iii of the human temporal neocortex. Cereb. Cortex 31, 4742&#x2013;4764 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8408440</ArticleId><ArticleId IdType="pubmed">33999122</ArticleId></ArticleIdList></Reference><Reference><Citation>Hunt S., Leibner Y., Mertens E. J., Barros-Zulaica N., Kanari L., Heistek T. S., Karnani M. M., Aardse R., Wilbers R., Heyer D. B., Goriounova N. A., Verhoog M. B., Testa-Silva G., Obermayer J., Versluis T., Benavides-Piccione R., de Witt-Hamer P., Idema S., Noske D. P., Baayen J. C., Lein E. S., DeFelipe J., Markram H., Mansvelder H. D., Sch&#xfc;rmann F., Segev I., de Kock C. P. J., Strong and reliable synaptic communication between pyramidal neurons in adult human cerebral cortex. Cereb. Cortex 33, 2857&#x2013;2878 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10016070</ArticleId><ArticleId IdType="pubmed">35802476</ArticleId></ArticleIdList></Reference><Reference><Citation>Benavides-Piccione R., Rojo C., Kastanauskaite A., DeFelipe J., Variation in pyramidal cell morphology across the human anterior temporal lobe. Cereb. Cortex 31, 3592&#x2013;3609 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8258433</ArticleId><ArticleId IdType="pubmed">33723567</ArticleId></ArticleIdList></Reference><Reference><Citation>Benavides-Piccione R., Regalado-Reyes M., Fernaud-Espinosa I., Kastanauskaite A., Tapia-Gonz&#xe1;lez S., Le&#xf3;n-Espinosa G., Rojo C., Insausti R., Segev I., DeFelipe J., Differential structure of hippocampal CA1 pyramidal neurons in the human and mouse. Cereb. Cortex 30, 730&#x2013;752 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">31268532</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson K., Bones B., Robinson B., Hass C., Lee H., Ford K., Roberts T. A., Jacobs B., The morphology of supragranular pyramidal neurons in the human insular cortex: A quantitative Golgi study. Cereb. Cortex 19, 2131&#x2013;2144 (2009).</Citation><ArticleIdList><ArticleId IdType="pubmed">19126800</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayes T. L., Lewis D. A., Magnopyramidal neurons in the anterior motor speech region: Dendritic features and interhemispheric comparisons. Arch. Neurol. 53, 1277&#x2013;1283 (1996).</Citation><ArticleIdList><ArticleId IdType="pubmed">8970455</ArticleId></ArticleIdList></Reference><Reference><Citation>Warling A., Uchida R., Shin H., Dodelson C., Garcia M. E., Shea-Shumsky N. B., Svirsky S., Pothast M., Kelley H., Schumann C. M., Brzezinski C., Bauman M. D., Alexander A., McKee A. C., Stein T. D., Schall M., Jacobs B., Putative dendritic correlates of chronic traumatic encephalopathy: A preliminary quantitative Golgi exploration. J Comp Neurol 529, 1308&#x2013;1326 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8554981</ArticleId><ArticleId IdType="pubmed">32869318</ArticleId></ArticleIdList></Reference><Reference><Citation>Watson K. K., Jones T. K., Allman J. M., Dendritic architecture of the von Economo neurons. Neuroscience 141, 1107&#x2013;1112 (2006).</Citation><ArticleIdList><ArticleId IdType="pubmed">16797136</ArticleId></ArticleIdList></Reference><Reference><Citation>Lein E., Borm L. E., Linnarsson S., The promise of spatial transcriptomics for neuroscience in the era of molecular cell typing. Science 358, 64&#x2013;69 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28983044</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang R., Xia C., Close J. L., Zhang M., He J., Huang Z., Halpern A. R., Long B., Miller J. A., Lein E. S., Zhuang X., Conservation and divergence of cortical cell organization in human and mouse revealed by MERFISH. Science 377, 56&#x2013;62 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9262715</ArticleId><ArticleId IdType="pubmed">35771910</ArticleId></ArticleIdList></Reference><Reference><Citation>Cadwell C. R., Palasantza A., Jiang X., Berens P., Deng Q., Yilmaz M., Reimer J., Shen S., Bethge M., Tolias K. F., Sandberg R., Tolias A. S., Electrophysiological, transcriptomic and morphologic profiling of single neurons using Patch-seq. Nat. Biotechnol. 34, 199&#x2013;203 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4840019</ArticleId><ArticleId IdType="pubmed">26689543</ArticleId></ArticleIdList></Reference><Reference><Citation>BICCN , A multimodal cell census and atlas of the mammalian primary motor cortex. Nature 598, 86&#x2013;102 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8494634</ArticleId><ArticleId IdType="pubmed">34616075</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia C., Fan J., Emanuel G., Hao J., Zhuang X., Spatial transcriptome profiling by MERFISH reveals subcellular RNA compartmentalization and cell cycle-dependent gene expression. Proc. Natl. Acad. Sci. U.S.A. 116, 19490&#x2013;19499 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6765259</ArticleId><ArticleId IdType="pubmed">31501331</ArticleId></ArticleIdList></Reference><Reference><Citation>Long B., Li L., Knoblich U., Zeng H., Peng H., 3D image-guided automatic pipette positioning for single cell experiments in vivo. Sci. Rep. 5, 18426 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4686883</ArticleId><ArticleId IdType="pubmed">26689553</ArticleId></ArticleIdList></Reference><Reference><Citation>Akram M. A., Nanda S., Maraver P., Arma&#xf1;anzas R., Ascoli G. A., An open repository for single-cell reconstructions of the brain forest. Scientific Data 5, 1&#x2013;12 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5827689</ArticleId><ArticleId IdType="pubmed">29485626</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobs B., Schall M., Prather M., Kapler E., Driscoll L., Baca S., Jacobs J., Ford K., Wainwright M., Treml M., Regional dendritic and spine variation in human cerebral cortex: A quantitative golgi study. Cereb. Cortex 11, 558&#x2013;571 (2001).</Citation><ArticleIdList><ArticleId IdType="pubmed">11375917</ArticleId></ArticleIdList></Reference><Reference><Citation>Sholl D., Pattern discrimination and the visual cortex. J. Anat. 171, 387&#x2013;388 (1953).</Citation><ArticleIdList><ArticleId IdType="pubmed">13036904</ArticleId></ArticleIdList></Reference><Reference><Citation>Wan Y., Long F., Qu L., Xiao H., Hawrylycz M., Myers E. W., Peng H., BlastNeuron for automated comparison, retrieval and clustering of 3D neuron morphologies. Neuroinformatics 13, 487&#x2013;499 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">26036213</ArticleId></ArticleIdList></Reference><Reference><Citation>Winnubst J., Bas E., Ferreira T. A., Wu Z., Economo M. N., Edson P., Arthur B. J., Bruns C., Rokicki K., Schauder D., Olbris D. J., Murphy S. D., Ackerman D. G., Arshadi C., Baldwin P., Blake R., Elsayed A., Hasan M., Ramirez D., dos Santos B., Weldon M., Zafar A., Dudman J. T., Gerfen C. R., Hantman A. W., Korff W., Sternson S. M., Spruston N., Svoboda K., Chandrashekar J., Reconstruction of 1,000 projection neurons reveals new cell types and organization of long-range connectivity in the mouse brain. Cell 179, 268&#x2013;281.e13 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6754285</ArticleId><ArticleId IdType="pubmed">31495573</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu F., Shen Y., Ding L., Yang C. Y., Tan H., Wang H., Zhu Q., Xu R., Wu F., Xiao Y., Xu C., Li Q., Su P., Zhang L. I., Dong H. W., Desimone R., Xu F., Hu X., Lau P. M., Bi G. Q., High-throughput mapping of a whole rhesus monkey brain at micrometer resolution. Nature Biotechnol. 39, 1521&#x2013;1528 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34312500</ArticleId></ArticleIdList></Reference><Reference><Citation>Berg J., Sorensen S. A., Ting J. T., Miller J. A., Chartrand T., Buchin A., Bakken T. E., Budzillo A., Dee N., Ding S. L., Gouwens N. W., Hodge R. D., Kalmbach B., Lee C., Lee B. R., Alfiler L., Baker K., Barkan E., Beller A., Berry K., Bertagnolli D., Bickley K., Bomben J., Braun T., Brouner K., Casper T., Chong P., Crichton K., Dalley R., de Frates R., Desta T., Lee S. D., D&#x2019;Orazi F., Dotson N., Egdorf T., Enstrom R., Farrell C., Feng D., Fong O., Furdan S., Galakhova A. A., Gamlin C., Gary A., Glandon A., Goldy J., Gorham M., Goriounova N. A., Gratiy S., Graybuck L., Gu H., Hadley K., Hansen N., Heistek T. S., Henry A. M., Heyer D. B., Hill D. J., Hill C., Hupp M., Jarsky T., Kebede S., Keene L., Kim L., Kim M. H., Kroll M., Latimer C., Levi B. P., Link K. E., Mallory M., Mann R., Marshall D., Maxwell M., McGraw M., McMillen D., Melief E., Mertens E. J., Mezei L., Mihut N., Mok S., Molnar G., Mukora A., Ng L., Ngo K., Nicovich P. R., Nyhus J., Olah G., Oldre A., Omstead V., Ozsvar A., Park D., Peng H., Pham T., Pom C. A., Potekhina L., Rajanbabu R., Ransford S., Reid D., Rimorin C., Ruiz A., Sandman D., Sulc J., Sunkin S. M., Szafer A., Szemenyei V., Thomsen E. R., Tieu M., Torkelson A., Trinh J., Tung H., Wakeman W., Waleboer F., Ward K., Wilbers R., Williams G., Yao Z., Yoon J. G., Anastassiou C., Arkhipov A., Barzo P., Bernard A., Cobbs C., de Witt Hamer P. C., Ellenbogen R. G., Esposito L., Ferreira M., Gwinn R. P., Hawrylycz M. J., Hof P. R., Idema S., Jones A. R., Keene C. D., Ko A. L., Murphy G. J., Ng L., Ojemann J. G., Patel A. P., Phillips J. W., Silbergeld D. L., Smith K., Tasic B., Yuste R., Segev I., de Kock C. P. J., Mansvelder H. D., Tamas G., Zeng H., Koch C., Lein E. S., Human neocortical expansion involves glutamatergic neuron diversification. Nature 598, 151&#x2013;158 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8494638</ArticleId><ArticleId IdType="pubmed">34616067</ArticleId></ArticleIdList></Reference><Reference><Citation>Hrvoj-Mihic B., Hanson K. L., Lew C. H., Stefanacci L., Jacobs B., Bellugi U., Semendeferi K., Basal dendritic morphology of cortical pyramidal neurons in Williams syndrome: Prefrontal cortex and beyond. Front. Neurosci. 11, 419 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5554499</ArticleId><ArticleId IdType="pubmed">28848376</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobs B., Johnson N. L., Wahl D., Schall M., Maseko B. C., Lewandowski A., Raghanti M. A., Wicinski B., Butti C., Hopkins W. D., Bertelsen M. F., Walsh T., Roberts J. R., Reep R. L., Hof P. R., Sherwood C. C., Manger P. R., Corrigendum: Comparative neuronal morphology of the cerebellar cortex in afrotherians, carnivores, cetartiodactyls, and primates. Front neuroanat 8, 24 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4005950</ArticleId><ArticleId IdType="pubmed">24795574</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang B., Yin L., Zou X., Ye M., Liu Y., He T., Deng S., Jiang Y., Zheng R., Wang Y., Yang M., Lu H., Wu S., Shu Y., A subtype of inhibitory interneuron with intrinsic persistent activity in human and monkey neocortex. Cell Rep. 10, 1450&#x2013;1458 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">25753411</ArticleId></ArticleIdList></Reference><Reference><Citation>Benavides-Piccione R., Hamzei-Sichani F., Ballesteros-Y&#xe1;&#xf1;ez I., DeFelipe J., Yuste R., Dendritic size of pyramidal neurons differs among mouse cortical regions. Cereb. Cortex 16, 990&#x2013;1001 (2006).</Citation><ArticleIdList><ArticleId IdType="pubmed">16195469</ArticleId></ArticleIdList></Reference><Reference><Citation>Weber J. L., Myers E. W., Human whole-genome shotgun sequencing. Genome Res. 7, 401&#x2013;409 (1997).</Citation><ArticleIdList><ArticleId IdType="pubmed">9149936</ArticleId></ArticleIdList></Reference><Reference><Citation>Alon S., Expansion sequencing: Spatially precise in situ transcriptomics in intact biological systems. Science 371, eaax2656 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7900882</ArticleId><ArticleId IdType="pubmed">33509999</ArticleId></ArticleIdList></Reference><Reference><Citation>Graybuck L. T., Daigle T. L., Sede&#xf1;o-Cort&#xe9;s A. E., Walker M., Kalmbach B., Lenz G. H., Morin E., Nguyen T. N., Garren E., Bendrick J. L., Kim T. K., Zhou T., Mortrud M., Yao S., Siverts L.&#x2019;. A., Larsen R., Gore B. B., Szelenyi E. R., Trader C., Balaram P., van Velthoven C. T. J., Chiang M., Mich J. K., Dee N., Goldy J., Cetin A. H., Smith K., Way S. W., Esposito L., Yao Z., Gradinaru V., Sunkin S. M., Lein E., Levi B. P., Ting J. T., Zeng H., Tasic B., Enhancer viruses for combinatorial cell-subclass-specific labeling. Neuron 109, 1449&#x2013;1464.e13 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8610077</ArticleId><ArticleId IdType="pubmed">33789083</ArticleId></ArticleIdList></Reference><Reference><Citation>Bakken T. E., Jorstad N. L., Hu Q., Lake B. B., Tian W., Kalmbach B. E., Crow M., Hodge R. D., Krienen F. M., Sorensen S. A., Eggermont J., Yao Z., Aevermann B. D., Aldridge A. I., Bartlett A., Bertagnolli D., Casper T., Castanon R. G., Crichton K., Daigle T. L., Dalley R., Dee N., Dembrow N., Diep D., Ding S. L., Dong W., Fang R., Fischer S., Goldman M., Goldy J., Graybuck L. T., Herb B. R., Hou X., Kancherla J., Kroll M., Lathia K., van Lew B., Li Y. E., Liu C. S., Liu H., Lucero J. D., Mahurkar A., McMillen D., Miller J. A., Moussa M., Nery J. R., Nicovich P. R., Niu S. Y., Orvis J., Osteen J. K., Owen S., Palmer C. R., Pham T., Plongthongkum N., Poirion O., Reed N. M., Rimorin C., Rivkin A., Romanow W. J., Sede&#xf1;o-Cort&#xe9;s A. E., Siletti K., Somasundaram S., Sulc J., Tieu M., Torkelson A., Tung H., Wang X., Xie F., Yanny A. M., Zhang R., Ament S. A., Behrens M. M., Bravo H. C., Chun J., Dobin A., Gillis J., Hertzano R., Hof P. R., H&#xf6;llt T., Horwitz G. D., Keene C. D., Kharchenko P. V., Ko A. L., Lelieveldt B. P., Luo C., Mukamel E. A., Pinto-Duarte A., Preissl S., Regev A., Ren B., Scheuermann R. H., Smith K., Spain W. J., White O. R., Koch C., Hawrylycz M., Tasic B., Macosko E. Z., McCarroll S. A., Ting J. T., Zeng H., Zhang K., Feng G., Ecker J. R., Linnarsson S., Lein E. S., Comparative cellular analysis of motor cortex in human, marmoset and mouse. Nature 598, 111&#x2013;119 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8494640</ArticleId><ArticleId IdType="pubmed">34616062</ArticleId></ArticleIdList></Reference><Reference><Citation>M. H. Kim, Target cell-specific synaptic dynamics of excitatory to inhibitory neuron connections in supragranular layers of human neocortex. bioRxiv 2020-10. 2022.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10332811</ArticleId><ArticleId IdType="pubmed">37249212</ArticleId></ArticleIdList></Reference><Reference><Citation>Avants B. B., Tustison N., Song G., Advanced normalization tools (ANTS). Insight J 2, 1&#x2013;35 (2009).</Citation></Reference><Reference><Citation>Peng H., Ruan Z., Long F., Simpson J. H., Myers E. W., V3D enables real-time 3D visualization and quantitative analysis of large-scale biological image data sets. Nat Biotechnol 28, 348&#x2013;353 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2857929</ArticleId><ArticleId IdType="pubmed">20231818</ArticleId></ArticleIdList></Reference><Reference><Citation>Bria A., Iannello G., Onofri L., Peng H., TeraFly: Real-time three-dimensional visualization and annotation of terabytes of multidimensional volumetric images. Nat. Methods 13, 192&#x2013;194 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">26914202</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y., Li Q., Liu L., Zhou Z., Ruan Z., Kong L., Li Y., Wang Y., Zhong N., Chai R., Luo X., Guo Y., Hawrylycz M., Luo Q., Gu Z., Xie W., Zeng H., Peng H., TeraVR empowers precise reconstruction of complete 3-D neuronal morphology in the whole brain. Nat. Commun. 10, 1&#x2013;9 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6677772</ArticleId><ArticleId IdType="pubmed">31375678</ArticleId></ArticleIdList></Reference><Reference><Citation>Scorcioni R., Polavaram S., Ascoli G. A., L-Measure: A web-accessible tool for the analysis, comparison and search of digital reconstructions of neuronal morphologies. Nat. Protoc. 3, 866&#x2013;876 (2008).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4340709</ArticleId><ArticleId IdType="pubmed">18451794</ArticleId></ArticleIdList></Reference><Reference><Citation>Oga T., Elston G. N., Fujita I., Postnatal dendritic growth and spinogenesis of layer-V pyramidal cells differ between visual, inferotemporal, and prefrontal cortex of the macaque monkey. Front. Neurosci. 11, 118 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5347257</ArticleId><ArticleId IdType="pubmed">28348514</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding S. L., Royall J. J., Sunkin S. M., Ng L., Facer B. A. C., Lesnar P., Guillozet-Bongaarts A., McMurray B., Szafer A., Dolbeare T. A., Stevens A., Tirrell L., Benner T., Caldejon S., Dalley R. A., Dee N., Lau C., Nyhus J., Reding M., Riley Z. L., Sandman D., Shen E., van der Kouwe A., Varjabedian A., Write M., Zollei L., Dang C., Knowles J. A., Koch C., Phillips J. W., Sestan N., Wohnoutka P., Zielke H. R., Hohmann J. G., Jones A. R., Bernard A., Hawrylycz M. J., Hof P. R., Fischl B., Lein E. S., Comprehensive cellular-resolution atlas of the adult human brain. J Comp Neurol 524, 3127&#x2013;3481 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5054943</ArticleId><ArticleId IdType="pubmed">27418273</ArticleId></ArticleIdList></Reference><Reference><Citation>Louis D. N., Perry A., Wesseling P., Brat D. J., Cree I. A., Figarella-Branger D., Hawkins C., Ng H. K., Pfister S. M., Reifenberger G., Soffietti R., von Deimling A., Ellison D. W., The 2021 WHO Classification of Tumors of the Central Nervous System: A summary. Neuro Oncol. 23, 1231&#x2013;1251 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8328013</ArticleId><ArticleId IdType="pubmed">34185076</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37824657</PMID><DateCompleted><Year>2023</Year><Month>10</Month><Day>23</Day></DateCompleted><DateRevised><Year>2023</Year><Month>10</Month><Day>27</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1095-9203</ISSN><JournalIssue CitedMedium="Internet"><Volume>382</Volume><Issue>6667</Issue><PubDate><Year>2023</Year><Month>Oct</Month><Day>13</Day></PubDate></JournalIssue><Title>Science (New York, N.Y.)</Title><ISOAbbreviation>Science</ISOAbbreviation></Journal><ArticleTitle>A family portrait of human brain cells.</ArticleTitle><Pagination><StartPage>168</StartPage><EndPage>169</EndPage><MedlinePgn>168-169</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1126/science.adk4857</ELocationID><Abstract><AbstractText>A cell census provides information on the source of human brain specialization.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Weninger</LastName><ForeName>Alyssa</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Psychology and Neuroscience and Department of Nutrition, University of North Carolina Chapel Hill, Chapel Hill, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arlotta</LastName><ForeName>Paola</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>10</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Science</MedlineTA><NlmUniqueID>0404511</NlmUniqueID><ISSNLinking>0036-8075</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="Y">Brain</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName><QualifierName UI="Q000254" MajorTopicYN="N">growth &amp; development</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019070" MajorTopicYN="Y">Cell Lineage</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000092386" MajorTopicYN="N">Single-Cell Gene Expression Analysis</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>10</Month><Day>23</Day><Hour>1</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>10</Month><Day>12</Day><Hour>18</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>10</Month><Day>12</Day><Hour>14</Hour><Minute>4</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37824657</ArticleId><ArticleId IdType="doi">10.1126/science.adk4857</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37824624</PMID><DateCompleted><Year>2023</Year><Month>11</Month><Day>01</Day></DateCompleted><DateRevised><Year>2023</Year><Month>11</Month><Day>03</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2375-2548</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><Issue>41</Issue><PubDate><Year>2023</Year><Month>Oct</Month><Day>13</Day></PubDate></JournalIssue><Title>Science advances</Title><ISOAbbreviation>Sci Adv</ISOAbbreviation></Journal><ArticleTitle>Diversity of primate brain cells unraveled.</ArticleTitle><Pagination><StartPage>eadl0650</StartPage><MedlinePgn>eadl0650</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">eadl0650</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1126/sciadv.adl0650</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Komiyama</LastName><ForeName>Takaki</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Deputy Editor, Science Advances, Department of Neurobiology and Department of Neurosciences, University of California San Diego, La Jolla, CA, USA. Email: tkomiyama@ucsd.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>10</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Sci Adv</MedlineTA><NlmUniqueID>101653440</NlmUniqueID><ISSNLinking>2375-2548</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>doi: 10.1126/scitranslmed.ade1283</RefSource></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011323" MajorTopicYN="Y">Primates</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="Y">Brain</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>11</Month><Day>1</Day><Hour>12</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>10</Month><Day>12</Day><Hour>18</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>10</Month><Day>12</Day><Hour>14</Hour><Minute>4</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>10</Month><Day>12</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37824624</ArticleId><ArticleId IdType="pmc">PMC10569699</ArticleId><ArticleId IdType="doi">10.1126/sciadv.adl0650</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37794186</PMID><DateCompleted><Year>2023</Year><Month>10</Month><Day>26</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>01</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1476-4687</ISSN><JournalIssue CitedMedium="Internet"><Volume>622</Volume><Issue>7982</Issue><PubDate><Year>2023</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Nature</Title><ISOAbbreviation>Nature</ISOAbbreviation></Journal><ArticleTitle>Plasma proteomic associations with genetics and health in the UK Biobank.</ArticleTitle><Pagination><StartPage>329</StartPage><EndPage>338</EndPage><MedlinePgn>329-338</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41586-023-06592-6</ELocationID><Abstract><AbstractText>The Pharma Proteomics Project is a precompetitive biopharmaceutical consortium characterizing the plasma proteomic profiles of 54,219 UK Biobank participants. Here we provide a detailed summary of this initiative, including technical and biological validations, insights into proteomic disease signatures, and prediction modelling for various demographic and health indicators. We present comprehensive protein quantitative trait locus (pQTL) mapping of 2,923 proteins that identifies 14,287 primary genetic associations, of which 81% are previously undescribed, alongside ancestry-specific pQTL mapping in non-European individuals. The study provides an updated characterization of the genetic architecture of the plasma proteome, contextualized with projected pQTL discovery rates as sample sizes and proteomic assay coverages increase over time. We offer extensive insights into trans pQTLs across multiple biological domains, highlight genetic influences on ligand-receptor interactions and pathway perturbations across a diverse collection of cytokines and complement networks, and illustrate long-range epistatic effects of ABO blood group and FUT2 secretor status on proteins with gastrointestinal tissue-enriched expression. We demonstrate the utility of these data for drug discovery by extending the genetic proxied effects of protein targets, such as PCSK9, on additional endpoints, and disentangle specific genes and proteins perturbed at loci associated with COVID-19 susceptibility. This public-private partnership provides the scientific community with an open-access proteomics resource of considerable breadth and depth to help to elucidate the biological mechanisms underlying proteo-genomic discoveries and accelerate the development of biomarkers, predictive models and therapeutics<sup>1</sup>.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Benjamin B</ForeName><Initials>BB</Initials><Identifier Source="ORCID">0000-0001-6347-2281</Identifier><AffiliationInfo><Affiliation>Translational Sciences, Research &amp; Development, Biogen, Cambridge, MA, USA. bbsun92@outlook.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Chiou</LastName><ForeName>Joshua</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-4618-0647</Identifier><AffiliationInfo><Affiliation>Internal Medicine Research Unit, Worldwide Research, Development and Medical, Pfizer, Cambridge, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Traylor</LastName><ForeName>Matthew</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Human Genetics Centre of Excellence, Novo Nordisk Research Centre Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Benner</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Genentech, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Hsu</LastName><ForeName>Yi-Hsiang</ForeName><Initials>YH</Initials><AffiliationInfo><Affiliation>Amgen Research, Cambridge, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Richardson</LastName><ForeName>Tom G</ForeName><Initials>TG</Initials><AffiliationInfo><Affiliation>Human Genetics Centre of Excellence, Novo Nordisk Research Centre Oxford, Oxford, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Genomic Sciences, GlaxoSmithKline, Stevenage, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Surendran</LastName><ForeName>Praveen</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Genomic Sciences, GlaxoSmithKline, Stevenage, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Mahajan</LastName><ForeName>Anubha</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-5585-3420</Identifier><AffiliationInfo><Affiliation>Genentech, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Robins</LastName><ForeName>Chloe</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Genomic Sciences, GlaxoSmithKline, Collegeville, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Vasquez-Grinnell</LastName><ForeName>Steven G</ForeName><Initials>SG</Initials><AffiliationInfo><Affiliation>Bristol Myers Squibb, Princeton, NJ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Hou</LastName><ForeName>Liping</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Population Analytics, Janssen Research &amp; Development, Spring House, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Kvikstad</LastName><ForeName>Erika M</ForeName><Initials>EM</Initials><AffiliationInfo><Affiliation>Bristol Myers Squibb, Princeton, NJ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Burren</LastName><ForeName>Oliver S</ForeName><Initials>OS</Initials><AffiliationInfo><Affiliation>Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&amp;D, AstraZeneca, Cambridge, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Davitte</LastName><ForeName>Jonathan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Genomic Sciences, GlaxoSmithKline, Collegeville, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ferber</LastName><ForeName>Kyle L</ForeName><Initials>KL</Initials><AffiliationInfo><Affiliation>Biostatistics, Research and Development, Biogen, Cambridge, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gillies</LastName><ForeName>Christopher E</ForeName><Initials>CE</Initials><AffiliationInfo><Affiliation>Regeneron Genetics Center, Tarrytown, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hedman</LastName><ForeName>&#xc5;sa K</ForeName><Initials>&#xc5;K</Initials><AffiliationInfo><Affiliation>External Science and Innovation Target Sciences, Worldwide Research, Development and Medical, Pfizer, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Sile</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Human Genetics Centre of Excellence, Novo Nordisk Research Centre Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Tinchi</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0001-5098-6902</Identifier><AffiliationInfo><Affiliation>Analytics and Data Sciences, Biogen, Cambridge, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mikkilineni</LastName><ForeName>Rajesh</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Data Science Institute, Takeda Development Center Americas, Cambridge, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pendergrass</LastName><ForeName>Rion K</ForeName><Initials>RK</Initials><AffiliationInfo><Affiliation>Genentech, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pickering</LastName><ForeName>Corran</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>UK Biobank, Stockport, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prins</LastName><ForeName>Bram</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&amp;D, AstraZeneca, Cambridge, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baird</LastName><ForeName>Denis</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Translational Sciences, Research &amp; Development, Biogen, Cambridge, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Chia-Yen</ForeName><Initials>CY</Initials><AffiliationInfo><Affiliation>Translational Sciences, Research &amp; Development, Biogen, Cambridge, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ward</LastName><ForeName>Lucas D</ForeName><Initials>LD</Initials><Identifier Source="ORCID">0000-0002-8017-809X</Identifier><AffiliationInfo><Affiliation>Alnylam Human Genetics, Discovery &amp; Translational Research, Alnylam Pharmaceuticals, Cambridge, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Deaton</LastName><ForeName>Aimee M</ForeName><Initials>AM</Initials><Identifier Source="ORCID">0000-0003-0365-3077</Identifier><AffiliationInfo><Affiliation>Alnylam Human Genetics, Discovery &amp; Translational Research, Alnylam Pharmaceuticals, Cambridge, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Welsh</LastName><ForeName>Samantha</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>UK Biobank, Stockport, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Willis</LastName><ForeName>Carissa M</ForeName><Initials>CM</Initials><AffiliationInfo><Affiliation>Alnylam Human Genetics, Discovery &amp; Translational Research, Alnylam Pharmaceuticals, Cambridge, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lehner</LastName><ForeName>Nick</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Institute of Computational Biology, Helmholtz Zentrum M&#xfc;nchen, German Research Center for Environmental Health, Neuherberg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arnold</LastName><ForeName>Matthias</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-4666-0923</Identifier><AffiliationInfo><Affiliation>Institute of Computational Biology, Helmholtz Zentrum M&#xfc;nchen, German Research Center for Environmental Health, Neuherberg, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychiatry and Behavioral Sciences, Duke University, Durham, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>W&#xf6;rheide</LastName><ForeName>Maria A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Institute of Computational Biology, Helmholtz Zentrum M&#xfc;nchen, German Research Center for Environmental Health, Neuherberg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suhre</LastName><ForeName>Karsten</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0001-9638-3912</Identifier><AffiliationInfo><Affiliation>Bioinformatics Core, Weill Cornell Medicine-Qatar, Doha, Qatar.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kastenm&#xfc;ller</LastName><ForeName>Gabi</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Institute of Computational Biology, Helmholtz Zentrum M&#xfc;nchen, German Research Center for Environmental Health, Neuherberg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sethi</LastName><ForeName>Anurag</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-3295-3116</Identifier><AffiliationInfo><Affiliation>Calico Life Sciences, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cule</LastName><ForeName>Madeleine</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-7400-5643</Identifier><AffiliationInfo><Affiliation>Calico Life Sciences, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Raj</LastName><ForeName>Anil</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Calico Life Sciences, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>Alnylam Human Genetics</CollectiveName></Author><Author ValidYN="Y"><CollectiveName>AstraZeneca Genomics Initiative</CollectiveName></Author><Author ValidYN="Y"><CollectiveName>Biogen Biobank Team</CollectiveName></Author><Author ValidYN="Y"><CollectiveName>Bristol Myers Squibb</CollectiveName></Author><Author ValidYN="Y"><CollectiveName>Genentech Human Genetics</CollectiveName></Author><Author ValidYN="Y"><CollectiveName>GlaxoSmithKline Genomic Sciences</CollectiveName></Author><Author ValidYN="Y"><CollectiveName>Pfizer Integrative Biology</CollectiveName></Author><Author ValidYN="Y"><CollectiveName>Population Analytics of Janssen Data Sciences</CollectiveName></Author><Author ValidYN="Y"><CollectiveName>Regeneron Genetics Center</CollectiveName></Author><Author ValidYN="Y"><LastName>Burkitt-Gray</LastName><ForeName>Lucy</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>UK Biobank, Stockport, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Melamud</LastName><ForeName>Eugene</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-5943-6189</Identifier><AffiliationInfo><Affiliation>Calico Life Sciences, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Black</LastName><ForeName>Mary Helen</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>Population Analytics, Janssen Research &amp; Development, Spring House, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fauman</LastName><ForeName>Eric B</ForeName><Initials>EB</Initials><Identifier Source="ORCID">0000-0002-9739-0249</Identifier><AffiliationInfo><Affiliation>Internal Medicine Research Unit, Worldwide Research, Development and Medical, Pfizer, Cambridge, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Howson</LastName><ForeName>Joanna M M</ForeName><Initials>JMM</Initials><Identifier Source="ORCID">0000-0001-7618-0050</Identifier><AffiliationInfo><Affiliation>Human Genetics Centre of Excellence, Novo Nordisk Research Centre Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kang</LastName><ForeName>Hyun Min</ForeName><Initials>HM</Initials><AffiliationInfo><Affiliation>Regeneron Genetics Center, Tarrytown, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McCarthy</LastName><ForeName>Mark I</ForeName><Initials>MI</Initials><AffiliationInfo><Affiliation>Genentech, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nioi</LastName><ForeName>Paul</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Alnylam Human Genetics, Discovery &amp; Translational Research, Alnylam Pharmaceuticals, Cambridge, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Petrovski</LastName><ForeName>Slav&#xe9;</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-1527-961X</Identifier><AffiliationInfo><Affiliation>Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&amp;D, AstraZeneca, Cambridge, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, University of Melbourne, Austin Health, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scott</LastName><ForeName>Robert A</ForeName><Initials>RA</Initials><Identifier Source="ORCID">0000-0003-3634-3016</Identifier><AffiliationInfo><Affiliation>Genomic Sciences, GlaxoSmithKline, Stevenage, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smith</LastName><ForeName>Erin N</ForeName><Initials>EN</Initials><AffiliationInfo><Affiliation>Takeda Development Center Americas, San Diego, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Szalma</LastName><ForeName>S&#xe1;ndor</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-7591-3902</Identifier><AffiliationInfo><Affiliation>Takeda Development Center Americas, San Diego, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Waterworth</LastName><ForeName>Dawn M</ForeName><Initials>DM</Initials><Identifier Source="ORCID">0000-0002-9226-1317</Identifier><AffiliationInfo><Affiliation>Immunology, Janssen Research &amp; Development, Spring House, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mitnaul</LastName><ForeName>Lyndon J</ForeName><Initials>LJ</Initials><AffiliationInfo><Affiliation>Regeneron Genetics Center, Tarrytown, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Szustakowski</LastName><ForeName>Joseph D</ForeName><Initials>JD</Initials><Identifier Source="ORCID">0000-0001-7900-3973</Identifier><AffiliationInfo><Affiliation>Bristol Myers Squibb, Princeton, NJ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gibson</LastName><ForeName>Bradford W</ForeName><Initials>BW</Initials><Identifier Source="ORCID">0000-0003-3745-1940</Identifier><AffiliationInfo><Affiliation>Amgen Research, Cambridge, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miller</LastName><ForeName>Melissa R</ForeName><Initials>MR</Initials><AffiliationInfo><Affiliation>Internal Medicine Research Unit, Worldwide Research, Development and Medical, Pfizer, Cambridge, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Whelan</LastName><ForeName>Christopher D</ForeName><Initials>CD</Initials><Identifier Source="ORCID">0000-0003-0308-5583</Identifier><AffiliationInfo><Affiliation>Translational Sciences, Research &amp; Development, Biogen, Cambridge, MA, USA. christopherdwhelan@outlook.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neuroscience Data Science, Janssen Research &amp; Development, Cambridge, MA, USA. christopherdwhelan@outlook.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>10</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nature</MedlineTA><NlmUniqueID>0410462</NlmUniqueID><ISSNLinking>0028-0836</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000017">ABO Blood-Group System</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001798">Blood Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.4.1.-</RegistryNumber><NameOfSubstance UI="D005647">Fucosyltransferases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.21.-</RegistryNumber><NameOfSubstance UI="C472125">PCSK9 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.21.-</RegistryNumber><NameOfSubstance UI="D000071449">Proprotein Convertase 9</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D020543">Proteome</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000017" MajorTopicYN="N">ABO Blood-Group System</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018070" MajorTopicYN="Y">Biological Specimen Banks</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001798" MajorTopicYN="Y">Blood Proteins</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="Y">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055808" MajorTopicYN="N">Drug Discovery</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004843" MajorTopicYN="N">Epistasis, Genetic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005647" MajorTopicYN="N">Fucosyltransferases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="N">Genetic Predisposition to Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D023281" MajorTopicYN="Y">Genomics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006262" MajorTopicYN="Y">Health</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010949" MajorTopicYN="N">Plasma</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000071449" MajorTopicYN="N">Proprotein Convertase 9</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020543" MajorTopicYN="Y">Proteome</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D040901" MajorTopicYN="Y">Proteomics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055818" MajorTopicYN="N">Public-Private Sector Partnerships</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D040641" MajorTopicYN="N">Quantitative Trait Loci</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006113" MajorTopicYN="N" Type="Geographic">United Kingdom</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000097631" MajorTopicYN="N">Galactoside 2-alpha-L-fucosyltransferase</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>L.D.W., P.N., C.M.W. and A.M.D. are employees and/or stockholders of Alnylam. Y.-H.H. and B.W.G. are employees and/or stockholders of Amgen. S.P., O.S.B. and B.P. are employees and/or stockholders of AstraZeneca. B.B.S., T.L., K.L.F., D.B. and C.-Y.C. are employees and/or stockholders of Biogen. E.M.K., J.D.S. and S.G.V.-G. are employees and/or stockholders of Bristol Myers Squibb. M.C., A.R., A.S. and E.M. are employees and/or stockholders of Calico. R.K.P., M.I.M., A.M. and C.B. are employees of Genentech and holders of Roche stock. C.R., P.S., R.A.S., T.G.R. and J.D. are employees and/or stockholders of GlaxoSmithKline. M.H.B., L.H., D.M.W. and C.D.W. are employees and/or stockholders of Janssen Research &amp; Development. J.M.M.H., S.H. and M.T. are employees and/or stockholders of Novo Nordisk. &#xc5;.K.H., E.B.F., J.C. and M.R.M. are employees and/or stockholders of Pfizer. H.M.K., L.J.M. and C.E.G. are employees and/or stockholders of Regeneron. E.N.S., S.S. and R.M. are employees and/or stockholders of Takeda. L.B.-G., C.P. and S.W. are employees of the UK Biobank. The other authors declare no competing interests.</CoiStatement><InvestigatorList><Investigator ValidYN="Y"><LastName>Kang</LastName><ForeName>Hyun Ming</ForeName><Initials>HM</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>6</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>8</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>10</Month><Day>23</Day><Hour>1</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>10</Month><Day>5</Day><Hour>1</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>10</Month><Day>4</Day><Hour>23</Hour><Minute>29</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>10</Month><Day>4</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37794186</ArticleId><ArticleId IdType="pmc">PMC10567551</ArticleId><ArticleId IdType="doi">10.1038/s41586-023-06592-6</ArticleId><ArticleId IdType="pii">10.1038/s41586-023-06592-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Suhre K, McCarthy MI, Schwenk JM. Genetics meets proteomics: perspectives for large population-based studies. Nat. Rev. Genet. 2021;22:19&#x2013;37. doi: 10.1038/s41576-020-0268-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41576-020-0268-2</ArticleId><ArticleId IdType="pubmed">32860016</ArticleId></ArticleIdList></Reference><Reference><Citation>Finan, C. et al. The druggable genome and support for target identification and validation in drug development. Sci. Transl. Med.10.1126/scitranslmed.aag1166 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6321762</ArticleId><ArticleId IdType="pubmed">28356508</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt AF, et al. Genetic drug target validation using Mendelian randomisation. Nat. Commun. 2020;11:3255. doi: 10.1038/s41467-020-16969-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-16969-0</ArticleId><ArticleId IdType="pmc">PMC7320010</ArticleId><ArticleId IdType="pubmed">32591531</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen PA, Born DA, Deaton AM, Nioi P, Ward LD. Phenotypes associated with genes encoding drug targets are predictive of clinical trial side effects. Nat. Commun. 2019;10:1579. doi: 10.1038/s41467-019-09407-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-09407-3</ArticleId><ArticleId IdType="pmc">PMC6450952</ArticleId><ArticleId IdType="pubmed">30952858</ArticleId></ArticleIdList></Reference><Reference><Citation>Christiansen MK, et al. Polygenic risk score-enhanced risk stratification of coronary artery disease in patients with stable chest pain. Circ. Genom. Precis. Med. 2021;14:e003298. doi: 10.1161/CIRCGEN.120.003298.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCGEN.120.003298</ArticleId><ArticleId IdType="pubmed">34032468</ArticleId></ArticleIdList></Reference><Reference><Citation>Reay WR, Cairns MJ. Advancing the use of genome-wide association studies for drug repurposing. Nat. Rev. Genet. 2021;22:658&#x2013;671. doi: 10.1038/s41576-021-00387-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41576-021-00387-z</ArticleId><ArticleId IdType="pubmed">34302145</ArticleId></ArticleIdList></Reference><Reference><Citation>Bycroft C, et al. The UK Biobank resource with deep phenotyping and genomic data. Nature. 2018;562:203&#x2013;209. doi: 10.1038/s41586-018-0579-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-018-0579-z</ArticleId><ArticleId IdType="pmc">PMC6786975</ArticleId><ArticleId IdType="pubmed">30305743</ArticleId></ArticleIdList></Reference><Reference><Citation>Canela-Xandri O, Rawlik K, Tenesa A. An atlas of genetic associations in UK Biobank. Nat. Genet. 2018;50:1593&#x2013;1599. doi: 10.1038/s41588-018-0248-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-018-0248-z</ArticleId><ArticleId IdType="pmc">PMC6707814</ArticleId><ArticleId IdType="pubmed">30349118</ArticleId></ArticleIdList></Reference><Reference><Citation>Littlejohns TJ, et al. The UK Biobank imaging enhancement of 100,000 participants: rationale, data collection, management and future directions. Nat. Commun. 2020;11:2624. doi: 10.1038/s41467-020-15948-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-15948-9</ArticleId><ArticleId IdType="pmc">PMC7250878</ArticleId><ArticleId IdType="pubmed">32457287</ArticleId></ArticleIdList></Reference><Reference><Citation>Szustakowski JD, et al. Advancing human genetics research and drug discovery through exome sequencing of the UK Biobank. Nat. Genet. 2021;53:942&#x2013;948. doi: 10.1038/s41588-021-00885-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-021-00885-0</ArticleId><ArticleId IdType="pubmed">34183854</ArticleId></ArticleIdList></Reference><Reference><Citation>Julkunen, H., Cichonska, A., Slagboom, P. E., Wurtz, P. &amp; Nightingale Health UK Biobank Initiative. Metabolic biomarker profiling for identification of susceptibility to severe pneumonia and COVID-19 in the general population. eLife10.7554/eLife.63033 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8172246</ArticleId><ArticleId IdType="pubmed">33942721</ArticleId></ArticleIdList></Reference><Reference><Citation>Nelson MR, et al. The support of human genetic evidence for approved drug indications. Nat. Genet. 2015;47:856&#x2013;860. doi: 10.1038/ng.3314.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.3314</ArticleId><ArticleId IdType="pubmed">26121088</ArticleId></ArticleIdList></Reference><Reference><Citation>King EA, Davis JW, Degner JF. Are drug targets with genetic support twice as likely to be approved? Revised estimates of the impact of genetic support for drug mechanisms on the probability of drug approval. PLoS Genet. 2019;15:e1008489. doi: 10.1371/journal.pgen.1008489.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1008489</ArticleId><ArticleId IdType="pmc">PMC6907751</ArticleId><ArticleId IdType="pubmed">31830040</ArticleId></ArticleIdList></Reference><Reference><Citation>Fauman EB, Hyde C. An optimal variant to gene distance window derived from an empirical definition of cis and trans protein QTLs. BMC Bioinformatics. 2022;23:169. doi: 10.1186/s12859-022-04706-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12859-022-04706-x</ArticleId><ArticleId IdType="pmc">PMC9082853</ArticleId><ArticleId IdType="pubmed">35527238</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson NL, Anderson NG. The human plasma proteome: history, character, and diagnostic prospects. Mol. Cell. Proteomics. 2002;1:845&#x2013;867. doi: 10.1074/mcp.R200007-MCP200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/mcp.R200007-MCP200</ArticleId><ArticleId IdType="pubmed">12488461</ArticleId></ArticleIdList></Reference><Reference><Citation>Enroth S, Johansson A, Enroth SB, Gyllensten U. Strong effects of genetic and lifestyle factors on biomarker variation and use of personalized cutoffs. Nat. Commun. 2014;5:4684. doi: 10.1038/ncomms5684.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms5684</ArticleId><ArticleId IdType="pmc">PMC4143927</ArticleId><ArticleId IdType="pubmed">25147954</ArticleId></ArticleIdList></Reference><Reference><Citation>Emilsson V, et al. Co-regulatory networks of human serum proteins link genetics to disease. Science. 2018;361:769&#x2013;773. doi: 10.1126/science.aaq1327.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaq1327</ArticleId><ArticleId IdType="pmc">PMC6190714</ArticleId><ArticleId IdType="pubmed">30072576</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun BB, et al. Genomic atlas of the human plasma proteome. Nature. 2018;558:73&#x2013;79. doi: 10.1038/s41586-018-0175-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-018-0175-2</ArticleId><ArticleId IdType="pmc">PMC6697541</ArticleId><ArticleId IdType="pubmed">29875488</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferkingstad E, et al. Large-scale integration of the plasma proteome with genetics and disease. Nat. Genet. 2021;53:1712&#x2013;1721. doi: 10.1038/s41588-021-00978-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-021-00978-w</ArticleId><ArticleId IdType="pubmed">34857953</ArticleId></ArticleIdList></Reference><Reference><Citation>Pietzner M, et al. Mapping the proteo-genomic convergence of human diseases. Science. 2021;374:eabj1541. doi: 10.1126/science.abj1541.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abj1541</ArticleId><ArticleId IdType="pmc">PMC9904207</ArticleId><ArticleId IdType="pubmed">34648354</ArticleId></ArticleIdList></Reference><Reference><Citation>Gudjonsson A, et al. A genome-wide association study of serum proteins reveals shared loci with common diseases. Nat. Commun. 2022;13:480. doi: 10.1038/s41467-021-27850-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-27850-z</ArticleId><ArticleId IdType="pmc">PMC8789779</ArticleId><ArticleId IdType="pubmed">35078996</ArticleId></ArticleIdList></Reference><Reference><Citation>Folkersen L, et al. Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals. Nat. Metab. 2020;2:1135&#x2013;1148. doi: 10.1038/s42255-020-00287-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42255-020-00287-2</ArticleId><ArticleId IdType="pmc">PMC7611474</ArticleId><ArticleId IdType="pubmed">33067605</ArticleId></ArticleIdList></Reference><Reference><Citation>Koprulu M, et al. Proteogenomic links to human metabolic diseases. Nat. Metab. 2023;5:516&#x2013;528. doi: 10.1038/s42255-023-00753-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42255-023-00753-7</ArticleId><ArticleId IdType="pmc">PMC7614946</ArticleId><ArticleId IdType="pubmed">36823471</ArticleId></ArticleIdList></Reference><Reference><Citation>Conroy M, et al. The advantages of UK Biobank&#x2019;s open-access strategy for health research. J. Intern. Med. 2019;286:389&#x2013;397. doi: 10.1111/joim.12955.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.12955</ArticleId><ArticleId IdType="pmc">PMC6790705</ArticleId><ArticleId IdType="pubmed">31283063</ArticleId></ArticleIdList></Reference><Reference><Citation>Wik L, et al. Proximity extension assay in combination with next-generation sequencing for high-throughput proteome-wide analysis. Mol. Cell. Proteomics. 2021;20:100168. doi: 10.1016/j.mcpro.2021.100168.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mcpro.2021.100168</ArticleId><ArticleId IdType="pmc">PMC8633680</ArticleId><ArticleId IdType="pubmed">34715355</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao, Z., Jia, Y. &amp; Zhu, B. BNP and NT-proBNP as diagnostic biomarkers for cardiac dysfunction in both clinical and forensic medicine. Int. J. Mol. Sci.10.3390/ijms20081820 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6515513</ArticleId><ArticleId IdType="pubmed">31013779</ArticleId></ArticleIdList></Reference><Reference><Citation>Fry A, et al. Comparison of sociodemographic and health-related characteristics of UK Biobank participants with those of the general population. Am. J. Epidemiol. 2017;186:1026&#x2013;1034. doi: 10.1093/aje/kwx246.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/aje/kwx246</ArticleId><ArticleId IdType="pmc">PMC5860371</ArticleId><ArticleId IdType="pubmed">28641372</ArticleId></ArticleIdList></Reference><Reference><Citation>Karczewski KJ, et al. The mutational constraint spectrum quantified from variation in 141,456 humans. Nature. 2020;581:434&#x2013;443. doi: 10.1038/s41586-020-2308-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2308-7</ArticleId><ArticleId IdType="pmc">PMC7334197</ArticleId><ArticleId IdType="pubmed">32461654</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson N, et al. Quantitative proteomics screen identifies a substrate repertoire of rhomboid protease RHBDL2 in human cells and implicates it in epithelial homeostasis. Sci. Rep. 2017;7:7283. doi: 10.1038/s41598-017-07556-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-07556-3</ArticleId><ArticleId IdType="pmc">PMC5544772</ArticleId><ArticleId IdType="pubmed">28779096</ArticleId></ArticleIdList></Reference><Reference><Citation>Teshigawara S, et al. Serum vaspin concentrations are closely related to insulin resistance, and rs77060950 at SERPINA12 genetically defines distinct group with higher serum levels in Japanese population. J. Clin. Endocrinol. Metab. 2012;97:E1202&#x2013;E1207. doi: 10.1210/jc.2011-3297.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/jc.2011-3297</ArticleId><ArticleId IdType="pubmed">22539588</ArticleId></ArticleIdList></Reference><Reference><Citation>The GTEx Consortium. The GTEx Consortium atlas of genetic regulatory effects across human tissues. Science. 2020;369:1318&#x2013;1330. doi: 10.1126/science.aaz1776.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaz1776</ArticleId><ArticleId IdType="pmc">PMC7737656</ArticleId><ArticleId IdType="pubmed">32913098</ArticleId></ArticleIdList></Reference><Reference><Citation>Macdonald-Dunlop, E. et al. Mapping genetic determinants of 184 circulating proteins in 26,494 individuals to connect proteins and diseases. Preprint at medRxiv10.1101/2021.08.03.21261494 (2021).</Citation></Reference><Reference><Citation>Alanis-Lobato G, Andrade-Navarro MA, Schaefer MH. HIPPIE v2.0: enhancing meaningfulness and reliability of protein-protein interaction networks. Nucleic Acids Res. 2017;45:D408&#x2013;D414. doi: 10.1093/nar/gkw985.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkw985</ArticleId><ArticleId IdType="pmc">PMC5210659</ArticleId><ArticleId IdType="pubmed">27794551</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirk, J. A., Cheung, J. Y. &amp; Feldman, A. M. Therapeutic targeting of BAG3: considering its complexity in cancer and heart disease. J. Clin. Invest.10.1172/JCI149415 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8363278</ArticleId><ArticleId IdType="pubmed">34396980</ArticleId></ArticleIdList></Reference><Reference><Citation>Tadros R, et al. Shared genetic pathways contribute to risk of hypertrophic and dilated cardiomyopathies with opposite directions of effect. Nat. Genet. 2021;53:128&#x2013;134. doi: 10.1038/s41588-020-00762-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-020-00762-2</ArticleId><ArticleId IdType="pmc">PMC7611259</ArticleId><ArticleId IdType="pubmed">33495596</ArticleId></ArticleIdList></Reference><Reference><Citation>Villard E, et al. A genome-wide association study identifies two loci associated with heart failure due to dilated cardiomyopathy. Eur. Heart J. 2011;32:1065&#x2013;1076. doi: 10.1093/eurheartj/ehr105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehr105</ArticleId><ArticleId IdType="pmc">PMC3086901</ArticleId><ArticleId IdType="pubmed">21459883</ArticleId></ArticleIdList></Reference><Reference><Citation>Fuchs M, et al. Identification of the key structural motifs involved in HspB8/HspB6-Bag3 interaction. Biochem. J. 2009;425:245&#x2013;255. doi: 10.1042/BJ20090907.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BJ20090907</ArticleId><ArticleId IdType="pubmed">19845507</ArticleId></ArticleIdList></Reference><Reference><Citation>Perez-Bermejo, J. A. et al. Functional analysis of a common BAG3 allele associated with protection from heart failure. Nat. Cardiovasc. Res.2, 615&#x2013;628 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">39195919</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Colonna M. Interkeukin-34, a cytokine crucial for the differentiation and maintenance of tissue resident macrophages and Langerhans cells. Eur. J. Immunol. 2014;44:1575&#x2013;1581. doi: 10.1002/eji.201344365.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.201344365</ArticleId><ArticleId IdType="pmc">PMC4137395</ArticleId><ArticleId IdType="pubmed">24737461</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen MH, et al. Trans-ethnic and ancestry-specific blood-cell genetics in 746,667 individuals from 5 global populations. Cell. 2020;182:1198&#x2013;1213. doi: 10.1016/j.cell.2020.06.045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.06.045</ArticleId><ArticleId IdType="pmc">PMC7480402</ArticleId><ArticleId IdType="pubmed">32888493</ArticleId></ArticleIdList></Reference><Reference><Citation>Steri M, et al. Overexpression of the cytokine BAFF and autoimmunity risk. N. Engl. J. Med. 2017;376:1615&#x2013;1626. doi: 10.1056/NEJMoa1610528.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1610528</ArticleId><ArticleId IdType="pmc">PMC5605835</ArticleId><ArticleId IdType="pubmed">28445677</ArticleId></ArticleIdList></Reference><Reference><Citation>Astle WJ, et al. The allelic landscape of human blood cell trait variation and links to common complex disease. Cell. 2016;167:1415&#x2013;1429. doi: 10.1016/j.cell.2016.10.042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2016.10.042</ArticleId><ArticleId IdType="pmc">PMC5300907</ArticleId><ArticleId IdType="pubmed">27863252</ArticleId></ArticleIdList></Reference><Reference><Citation>Dubey AK, et al. Belimumab: first targeted biological treatment for systemic lupus erythematosus. J. Pharmacol. Pharmacother. 2011;2:317&#x2013;319. doi: 10.4103/0976-500X.85930.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/0976-500X.85930</ArticleId><ArticleId IdType="pmc">PMC3198539</ArticleId><ArticleId IdType="pubmed">22025872</ArticleId></ArticleIdList></Reference><Reference><Citation>Michalski M, et al. Primary ficolin-3 deficiency&#x2014;is it associated with increased susceptibility to infections? Immunobiology. 2015;220:711&#x2013;713. doi: 10.1016/j.imbio.2015.01.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.imbio.2015.01.003</ArticleId><ArticleId IdType="pubmed">25662573</ArticleId></ArticleIdList></Reference><Reference><Citation>Michalski M, et al. H-ficolin (ficolin-3) concentrations and FCN3 gene polymorphism in neonates. Immunobiology. 2012;217:730&#x2013;737. doi: 10.1016/j.imbio.2011.12.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.imbio.2011.12.004</ArticleId><ArticleId IdType="pubmed">22226667</ArticleId></ArticleIdList></Reference><Reference><Citation>Schlapbach LJ, et al. Congenital H-ficolin deficiency in premature infants with severe necrotising enterocolitis. Gut. 2011;60:1438&#x2013;1439. doi: 10.1136/gut.2010.226027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gut.2010.226027</ArticleId><ArticleId IdType="pubmed">20971976</ArticleId></ArticleIdList></Reference><Reference><Citation>Sokolowska A, et al. Mannan-binding lectin-associated serine protease-2 (MASP-2) deficiency in two patients with pulmonary tuberculosis and one healthy control. Cell. Mol. Immunol. 2015;12:119&#x2013;121. doi: 10.1038/cmi.2014.19.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cmi.2014.19</ArticleId><ArticleId IdType="pmc">PMC4654364</ArticleId><ArticleId IdType="pubmed">24658431</ArticleId></ArticleIdList></Reference><Reference><Citation>St Swierzko A, et al. Mannan-binding lectin-associated serine protease-2 (MASP-2) in a large cohort of neonates and its clinical associations. Mol. Immunol. 2009;46:1696&#x2013;1701. doi: 10.1016/j.molimm.2009.02.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molimm.2009.02.022</ArticleId><ArticleId IdType="pubmed">19307021</ArticleId></ArticleIdList></Reference><Reference><Citation>Stengaard-Pedersen K, et al. Inherited deficiency of mannan-binding lectin-associated serine protease 2. N. Engl. J. Med. 2003;349:554&#x2013;560. doi: 10.1056/NEJMoa022836.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa022836</ArticleId><ArticleId IdType="pubmed">12904520</ArticleId></ArticleIdList></Reference><Reference><Citation>Katz DH, et al. Proteomic profiling platforms head to head: leveraging genetics and clinical traits to compare aptamer- and antibody-based methods. Sci. Adv. 2022;8:eabm5164. doi: 10.1126/sciadv.abm5164.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.abm5164</ArticleId><ArticleId IdType="pmc">PMC9390994</ArticleId><ArticleId IdType="pubmed">35984888</ArticleId></ArticleIdList></Reference><Reference><Citation>Pietzner M, et al. Synergistic insights into human health from aptamer- and antibody-based proteomic profiling. Nat. Commun. 2021;12:6822. doi: 10.1038/s41467-021-27164-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-27164-0</ArticleId><ArticleId IdType="pmc">PMC8613205</ArticleId><ArticleId IdType="pubmed">34819519</ArticleId></ArticleIdList></Reference><Reference><Citation>Haslam DE, et al. Stability and reproducibility of proteomic profiles in epidemiological studies: comparing the Olink and SOMAscan platforms. Proteomics. 2022;22:e2100170. doi: 10.1002/pmic.202100170.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pmic.202100170</ArticleId><ArticleId IdType="pmc">PMC9923770</ArticleId><ArticleId IdType="pubmed">35598103</ArticleId></ArticleIdList></Reference><Reference><Citation>Raffield LM, et al. Comparison of proteomic assessment methods in multiple cohort studies. Proteomics. 2020;20:e1900278. doi: 10.1002/pmic.201900278.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pmic.201900278</ArticleId><ArticleId IdType="pmc">PMC7425176</ArticleId><ArticleId IdType="pubmed">32386347</ArticleId></ArticleIdList></Reference><Reference><Citation>Sirugo G, Williams SM, Tishkoff SA. The missing diversity in human genetic studies. Cell. 2019;177:26&#x2013;31. doi: 10.1016/j.cell.2019.02.048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2019.02.048</ArticleId><ArticleId IdType="pmc">PMC7380073</ArticleId><ArticleId IdType="pubmed">30901543</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J, et al. Plasma proteome analyses in individuals of European and African ancestry identify cis-pQTLs and models for proteome-wide association studies. Nat. Genet. 2022;54:593&#x2013;602. doi: 10.1038/s41588-022-01051-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-022-01051-w</ArticleId><ArticleId IdType="pmc">PMC9236177</ArticleId><ArticleId IdType="pubmed">35501419</ArticleId></ArticleIdList></Reference><Reference><Citation>Inker LA, et al. Estimating glomerular filtration rate from serum creatinine and cystatin C. N. Engl. J. Med. 2012;367:20&#x2013;29. doi: 10.1056/NEJMoa1114248.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1114248</ArticleId><ArticleId IdType="pmc">PMC4398023</ArticleId><ArticleId IdType="pubmed">22762315</ArticleId></ArticleIdList></Reference><Reference><Citation>Friedman J, Hastie T, Tibshirani R. Regularization paths for generalized linear models via coordinate descent. J. Stat. Softw. 2010;33:1&#x2013;22. doi: 10.18637/jss.v033.i01.</Citation><ArticleIdList><ArticleId IdType="doi">10.18637/jss.v033.i01</ArticleId><ArticleId IdType="pmc">PMC2929880</ArticleId><ArticleId IdType="pubmed">20808728</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuhn RM, Haussler D, Kent WJ. The UCSC genome browser and associated tools. Brief. Bioinform. 2013;14:144&#x2013;161. doi: 10.1093/bib/bbs038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bib/bbs038</ArticleId><ArticleId IdType="pmc">PMC3603215</ArticleId><ArticleId IdType="pubmed">22908213</ArticleId></ArticleIdList></Reference><Reference><Citation>Mbatchou J, et al. Computationally efficient whole-genome regression for quantitative and binary traits. Nat. Genet. 2021;53:1097&#x2013;1103. doi: 10.1038/s41588-021-00870-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-021-00870-7</ArticleId><ArticleId IdType="pubmed">34017140</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang CC, et al. Second-generation PLINK: rising to the challenge of larger and richer datasets. Gigascience. 2015;4:7. doi: 10.1186/s13742-015-0047-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13742-015-0047-8</ArticleId><ArticleId IdType="pmc">PMC4342193</ArticleId><ArticleId IdType="pubmed">25722852</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang G, Sarkar A, Carbonetto P, Stephens M. A simple new approach to variable selection in regression, with application to genetic fine mapping. J. R. Stat. Soc. B. 2020;82:1273&#x2013;1300. doi: 10.1111/rssb.12388.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/rssb.12388</ArticleId><ArticleId IdType="pmc">PMC10201948</ArticleId><ArticleId IdType="pubmed">37220626</ArticleId></ArticleIdList></Reference><Reference><Citation>Bulik-Sullivan BK, et al. LD score regression distinguishes confounding from polygenicity in genome-wide association studies. Nat. Genet. 2015;47:291&#x2013;295. doi: 10.1038/ng.3211.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.3211</ArticleId><ArticleId IdType="pmc">PMC4495769</ArticleId><ArticleId IdType="pubmed">25642630</ArticleId></ArticleIdList></Reference><Reference><Citation>Vuckovic D, et al. The polygenic and monogenic basis of blood traits and diseases. Cell. 2020;182:1214&#x2013;1231. doi: 10.1016/j.cell.2020.08.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.08.008</ArticleId><ArticleId IdType="pmc">PMC7482360</ArticleId><ArticleId IdType="pubmed">32888494</ArticleId></ArticleIdList></Reference><Reference><Citation>Foley CN, et al. A fast and efficient colocalization algorithm for identifying shared genetic risk factors across multiple traits. Nat. Commun. 2021;12:764. doi: 10.1038/s41467-020-20885-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-20885-8</ArticleId><ArticleId IdType="pmc">PMC7858636</ArticleId><ArticleId IdType="pubmed">33536417</ArticleId></ArticleIdList></Reference><Reference><Citation>Groot HE, et al. Genetically determined ABO blood group and its associations with health and disease. Arterioscler. Thromb. Vasc. Biol. 2020;40:830&#x2013;838. doi: 10.1161/ATVBAHA.119.313658.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/ATVBAHA.119.313658</ArticleId><ArticleId IdType="pubmed">31969017</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolpin BM, et al. Pancreatic cancer risk and ABO blood group alleles: results from the pancreatic cancer cohort consortium. Cancer Res. 2010;70:1015&#x2013;1023. doi: 10.1158/0008-5472.CAN-09-2993.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/0008-5472.CAN-09-2993</ArticleId><ArticleId IdType="pmc">PMC2943735</ArticleId><ArticleId IdType="pubmed">20103627</ArticleId></ArticleIdList></Reference><Reference><Citation>Pare G, et al. Novel association of ABO histo-blood group antigen with soluble ICAM-1: results of a genome-wide association study of 6,578 women. PLoS Genet. 2008;4:e1000118. doi: 10.1371/journal.pgen.1000118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1000118</ArticleId><ArticleId IdType="pmc">PMC2432033</ArticleId><ArticleId IdType="pubmed">18604267</ArticleId></ArticleIdList></Reference><Reference><Citation>Melzer D, et al. A genome-wide association study identifies protein quantitative trait loci (pQTLs) PLoS Genet. 2008;4:e1000072. doi: 10.1371/journal.pgen.1000072.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1000072</ArticleId><ArticleId IdType="pmc">PMC2362067</ArticleId><ArticleId IdType="pubmed">18464913</ArticleId></ArticleIdList></Reference><Reference><Citation>Jain A, Tuteja G. TissueEnrich: tissue-specific gene enrichment analysis. Bioinformatics. 2019;35:1966&#x2013;1967. doi: 10.1093/bioinformatics/bty890.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/bty890</ArticleId><ArticleId IdType="pmc">PMC6546155</ArticleId><ArticleId IdType="pubmed">30346488</ArticleId></ArticleIdList></Reference><Reference><Citation>Uhlen M, et al. Proteomics. tissue-based map of the human proteome. Science. 2015;347:1260419. doi: 10.1126/science.1260419.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1260419</ArticleId><ArticleId IdType="pubmed">25613900</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen Y, et al. A map of the cis-regulatory sequences in the mouse genome. Nature. 2012;488:116&#x2013;120. doi: 10.1038/nature11243.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature11243</ArticleId><ArticleId IdType="pmc">PMC4041622</ArticleId><ArticleId IdType="pubmed">22763441</ArticleId></ArticleIdList></Reference><Reference><Citation>Hemani, G. et al. The MR-Base platform supports systematic causal inference across the human phenome. eLife10.7554/eLife.34408 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5976434</ArticleId><ArticleId IdType="pubmed">29846171</ArticleId></ArticleIdList></Reference><Reference><Citation>Elsworth, B. et al. The MRC IEU OpenGWAS data infrastructure. Preprint at bioRxiv10.1101/2020.08.10.244293 (2020).</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37794183</PMID><DateCompleted><Year>2023</Year><Month>10</Month><Day>26</Day></DateCompleted><DateRevised><Year>2023</Year><Month>11</Month><Day>17</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1476-4687</ISSN><JournalIssue CitedMedium="Internet"><Volume>622</Volume><Issue>7982</Issue><PubDate><Year>2023</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Nature</Title><ISOAbbreviation>Nature</ISOAbbreviation></Journal><ArticleTitle>Rare variant associations with plasma protein levels in the UK Biobank.</ArticleTitle><Pagination><StartPage>339</StartPage><EndPage>347</EndPage><MedlinePgn>339-347</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41586-023-06547-x</ELocationID><Abstract><AbstractText>Integrating human&#xa0;genomics and proteomics can help elucidate disease mechanisms, identify clinical biomarkers and discover drug targets<sup>1-4</sup>. Because previous proteogenomic studies have focused on common variation via genome-wide association studies, the contribution of rare variants to the plasma proteome remains largely unknown. Here we identify associations between rare protein-coding variants and 2,923 plasma protein abundances measured in 49,736 UK Biobank individuals. Our variant-level exome-wide association study identified 5,433 rare genotype-protein associations, of which 81% were undetected in a previous genome-wide association study of the same cohort<sup>5</sup>. We then looked at aggregate signals using gene-level collapsing analysis, which revealed 1,962 gene-protein associations. Of the 691 gene-level signals from protein-truncating variants, 99.4% were associated with decreased protein levels. STAB1 and STAB2, encoding scavenger receptors involved in plasma protein clearance, emerged as pleiotropic loci, with 77 and 41 protein associations, respectively. We demonstrate the utility of our publicly accessible resource through several applications. These include detailing an allelic series in NLRC4, identifying potential biomarkers for a fatty liver disease-associated variant in HSD17B13 and bolstering phenome-wide association studies by integrating protein quantitative trait loci with protein-truncating variants in collapsing analyses. Finally, we uncover distinct proteomic consequences of clonal haematopoiesis (CH), including an association between TET2-CH and increased FLT3 levels. Our results highlight a considerable role for rare variation in plasma protein abundance and the value of proteogenomics in therapeutic discovery.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Dhindsa</LastName><ForeName>Ryan S</ForeName><Initials>RS</Initials><Identifier Source="ORCID">0000-0002-8965-0813</Identifier><AffiliationInfo><Affiliation>Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&amp;D, AstraZeneca, Gaithersburg, MD, US. ryan.dhindsa@astrazeneca.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Burren</LastName><ForeName>Oliver S</ForeName><Initials>OS</Initials><AffiliationInfo><Affiliation>Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&amp;D, AstraZeneca, Cambridge, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Sun</LastName><ForeName>Benjamin B</ForeName><Initials>BB</Initials><Identifier Source="ORCID">0000-0001-6347-2281</Identifier><AffiliationInfo><Affiliation>Translational Sciences, Research &amp; Development, Biogen Inc., Cambridge, MA, US.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prins</LastName><ForeName>Bram P</ForeName><Initials>BP</Initials><AffiliationInfo><Affiliation>Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&amp;D, AstraZeneca, Cambridge, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Matelska</LastName><ForeName>Dorota</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&amp;D, AstraZeneca, Cambridge, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wheeler</LastName><ForeName>Eleanor</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-8616-6444</Identifier><AffiliationInfo><Affiliation>Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&amp;D, AstraZeneca, Cambridge, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mitchell</LastName><ForeName>Jonathan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&amp;D, AstraZeneca, Cambridge, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oerton</LastName><ForeName>Erin</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-7367-4263</Identifier><AffiliationInfo><Affiliation>Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&amp;D, AstraZeneca, Cambridge, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hristova</LastName><ForeName>Ventzislava A</ForeName><Initials>VA</Initials><AffiliationInfo><Affiliation>Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&amp;D, AstraZeneca, Gaithersburg, MD, US.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smith</LastName><ForeName>Katherine R</ForeName><Initials>KR</Initials><AffiliationInfo><Affiliation>Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&amp;D, AstraZeneca, Cambridge, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carss</LastName><ForeName>Keren</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0003-4939-156X</Identifier><AffiliationInfo><Affiliation>Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&amp;D, AstraZeneca, Cambridge, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wasilewski</LastName><ForeName>Sebastian</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&amp;D, AstraZeneca, Cambridge, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Harper</LastName><ForeName>Andrew R</ForeName><Initials>AR</Initials><Identifier Source="ORCID">0000-0001-5327-0328</Identifier><AffiliationInfo><Affiliation>Clinical Development, Research and Early Development, Respiratory and Immunology (R&amp;I), BioPharmaceuticals R&amp;D, AstraZeneca, Cambridge, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Paul</LastName><ForeName>Dirk S</ForeName><Initials>DS</Initials><Identifier Source="ORCID">0000-0002-8230-0116</Identifier><AffiliationInfo><Affiliation>Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&amp;D, AstraZeneca, Cambridge, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fabre</LastName><ForeName>Margarete A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&amp;D, AstraZeneca, Cambridge, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Runz</LastName><ForeName>Heiko</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Translational Sciences, Research &amp; Development, Biogen Inc., Cambridge, MA, US.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Viollet</LastName><ForeName>Coralie</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&amp;D, AstraZeneca, Cambridge, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Challis</LastName><ForeName>Benjamin</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Translational Science and Experimental Medicine, Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&amp;D, AstraZeneca, Cambridge, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Platt</LastName><ForeName>Adam</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-3455-1789</Identifier><AffiliationInfo><Affiliation>Translational Science and Experimental Medicine, Research and Early Development, Respiratory and Immunology, BioPharmaceuticals R&amp;D, AstraZeneca, Cambridge, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>AstraZeneca Genomics Initiative</CollectiveName></Author><Author ValidYN="Y"><LastName>Vitsios</LastName><ForeName>Dimitrios</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-8939-5445</Identifier><AffiliationInfo><Affiliation>Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&amp;D, AstraZeneca, Cambridge, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ashley</LastName><ForeName>Euan A</ForeName><Initials>EA</Initials><Identifier Source="ORCID">0000-0001-9418-9577</Identifier><AffiliationInfo><Affiliation>Division of Cardiology, Department of Medicine, Stanford University, Palo Alto, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Whelan</LastName><ForeName>Christopher D</ForeName><Initials>CD</Initials><Identifier Source="ORCID">0000-0003-0308-5583</Identifier><AffiliationInfo><Affiliation>Translational Sciences, Research &amp; Development, Biogen Inc., Cambridge, MA, US.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pangalos</LastName><ForeName>Menelas N</ForeName><Initials>MN</Initials><AffiliationInfo><Affiliation>BioPharmaceuticals R&amp;D, AstraZeneca, Cambridge, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Quanli</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&amp;D, AstraZeneca, Gaithersburg, MD, US.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Petrovski</LastName><ForeName>Slav&#xe9;</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-1527-961X</Identifier><AffiliationInfo><Affiliation>Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&amp;D, AstraZeneca, Cambridge, UK. slav.petrovski@astrazeneca.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, Austin Health, University of Melbourne, Melbourne, Victoria, Australia. slav.petrovski@astrazeneca.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>10</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nature</MedlineTA><NlmUniqueID>0410462</NlmUniqueID><ISSNLinking>0028-0836</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001798">Blood Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.10.1</RegistryNumber><NameOfSubstance UI="C497970">FLT3 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.1.-.-</RegistryNumber><NameOfSubstance UI="C000626699">HSD17B13 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C435692">NLRC4 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C449926">STAB1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C449927">STAB2 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.13.11.-</RegistryNumber><NameOfSubstance UI="C541081">TET2 protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000483" MajorTopicYN="N">Alleles</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018070" MajorTopicYN="Y">Biological Specimen Banks</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001798" MajorTopicYN="Y">Blood Proteins</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059472" MajorTopicYN="N">Exome</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D056726" MajorTopicYN="Y">Genetic Association Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D023281" MajorTopicYN="Y">Genomics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006410" MajorTopicYN="N">Hematopoiesis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010949" MajorTopicYN="N">Plasma</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D040901" MajorTopicYN="Y">Proteomics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006113" MajorTopicYN="N" Type="Geographic">United Kingdom</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>R.S.D., O.S.B., B.P.P., D.&#xa0;Matelska, E.W., J.M., E.O., V.A.H., K.R.S., K.C., S.W., A.R.H., D.S.P., M.A.F., C.V., B.C., A.P., D.V., M.N.P., Q.W. and S.P. are current employees and/or stockholders of AstraZeneca. B.B.S., C.D.W. and H.R. are employees and/or stockholders of Biogen. E.A.A. is a founder of Personalis, Inc., DeepCell, Inc. and Svexa Inc.; a founding advisor of Nuevocor; a non-executive director at AstraZeneca; and an advisor to SequenceBio, Novartis, Medical Excellence Capital, Foresite Capital and Third Rock Ventures.</CoiStatement><InvestigatorList><Investigator ValidYN="Y"><LastName>&#xc5;gren</LastName><ForeName>Rasmus</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Anderson-Dring</LastName><ForeName>Lauren</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Atanur</LastName><ForeName>Santosh</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Baker</LastName><ForeName>David</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Barrett</LastName><ForeName>Carl</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Belvisi</LastName><ForeName>Maria</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bohlooly-Y</LastName><ForeName>Mohammad</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Buvall</LastName><ForeName>Lisa</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Camacho</LastName><ForeName>Niedzica</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cazares</LastName><ForeName>Lisa</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cameron-Christie</LastName><ForeName>Sophia</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chen</LastName><ForeName>Morris</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cohen</LastName><ForeName>Suzanne</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Danielson</LastName><ForeName>Regina F</ForeName><Initials>RF</Initials></Investigator><Investigator ValidYN="Y"><LastName>Das</LastName><ForeName>Shikta</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Davis</LastName><ForeName>Andrew</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Deevi</LastName><ForeName>Sri Vishnu Vardhan</ForeName><Initials>SVV</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ding</LastName><ForeName>Wei</ForeName><Initials>W</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dougherty</LastName><ForeName>Brian</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fairhurst-Hunter</LastName><ForeName>Zammy</ForeName><Initials>Z</Initials></Investigator><Investigator ValidYN="Y"><LastName>Garg</LastName><ForeName>Manik</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Georgi</LastName><ForeName>Benjamin</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rangel</LastName><ForeName>Carmen Guerrero</ForeName><Initials>CG</Initials></Investigator><Investigator ValidYN="Y"><LastName>Haefliger</LastName><ForeName>Carolina</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hammar</LastName><ForeName>M&#xe5;rten</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hanna</LastName><ForeName>Richard N</ForeName><Initials>RN</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hansen</LastName><ForeName>Pernille B L</ForeName><Initials>PBL</Initials></Investigator><Investigator ValidYN="Y"><LastName>Harrow</LastName><ForeName>Jennifer</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Henry</LastName><ForeName>Ian</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hess</LastName><ForeName>Sonja</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hollis</LastName><ForeName>Ben</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hu</LastName><ForeName>Fengyuan</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jiang</LastName><ForeName>Xiao</ForeName><Initials>X</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kundu</LastName><ForeName>Kousik</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lai</LastName><ForeName>Zhongwu</ForeName><Initials>Z</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lal</LastName><ForeName>Mark</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lassi</LastName><ForeName>Glenda</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Liang</LastName><ForeName>Yupu</ForeName><Initials>Y</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lopes</LastName><ForeName>Margarida</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lythgow</LastName><ForeName>Kieren</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>MacArthur</LastName><ForeName>Stewart</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Maisuria-Armer</LastName><ForeName>Meeta</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>March</LastName><ForeName>Ruth</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Martins</LastName><ForeName>Carla</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Megy</LastName><ForeName>Karine</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Menzies</LastName><ForeName>Rob</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Micha&#xeb;lsson</LastName><ForeName>Erik</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Middleton</LastName><ForeName>Fiona</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mowrey</LastName><ForeName>Bill</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Muthas</LastName><ForeName>Daniel</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nag</LastName><ForeName>Abhishek</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>O'Dell</LastName><ForeName>Sean</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ohne</LastName><ForeName>Yoichiro</ForeName><Initials>Y</Initials></Investigator><Investigator ValidYN="Y"><LastName>Olsson</LastName><ForeName>Henric</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>O'Neill</LastName><ForeName>Amanda</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ostridge</LastName><ForeName>Kristoffer</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pullman</LastName><ForeName>Benjamin</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rae</LastName><ForeName>William</ForeName><Initials>W</Initials></Investigator><Investigator ValidYN="Y"><LastName>Raies</LastName><ForeName>Arwa</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Reznichenko</LastName><ForeName>Anna</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ros</LastName><ForeName>Xavier Romero</ForeName><Initials>XR</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ryaboshapkina</LastName><ForeName>Maria</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sanganee</LastName><ForeName>Hitesh</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sidders</LastName><ForeName>Ben</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Snowden</LastName><ForeName>Mike</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Stankovic</LastName><ForeName>Stasa</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Stevens</LastName><ForeName>Helen</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tachmazidou</LastName><ForeName>Ioanna</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Taiy</LastName><ForeName>Haeyam</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tian</LastName><ForeName>Lifeng</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Underwood</LastName><ForeName>Christina</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Walentinsson</LastName><ForeName>Anna</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wang</LastName><ForeName>Qing-Dong</ForeName><Initials>QD</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zehir</LastName><ForeName>Ahmet</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zou</LastName><ForeName>Zoe</ForeName><Initials>Z</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>10</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>8</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>10</Month><Day>23</Day><Hour>1</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>10</Month><Day>5</Day><Hour>1</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>10</Month><Day>4</Day><Hour>23</Hour><Minute>29</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>10</Month><Day>4</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37794183</ArticleId><ArticleId IdType="pmc">PMC10567546</ArticleId><ArticleId IdType="doi">10.1038/s41586-023-06547-x</ArticleId><ArticleId IdType="pii">10.1038/s41586-023-06547-x</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Suhre K, McCarthy MI, Schwenk JM. Genetics meets proteomics: perspectives for large population-based studies. Nat. Rev. Genet. 2021;22:19&#x2013;37. doi: 10.1038/s41576-020-0268-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41576-020-0268-2</ArticleId><ArticleId IdType="pubmed">32860016</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng J, et al. Phenome-wide Mendelian randomization mapping the influence of the plasma proteome on complex diseases. Nat. Genet. 2020;52:1122&#x2013;1131. doi: 10.1038/s41588-020-0682-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-020-0682-6</ArticleId><ArticleId IdType="pmc">PMC7610464</ArticleId><ArticleId IdType="pubmed">32895551</ArticleId></ArticleIdList></Reference><Reference><Citation>Pietzner M, et al. Mapping the proteo-genomic convergence of human diseases. Science. 2021;374:eabj1541. doi: 10.1126/science.abj1541.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abj1541</ArticleId><ArticleId IdType="pmc">PMC9904207</ArticleId><ArticleId IdType="pubmed">34648354</ArticleId></ArticleIdList></Reference><Reference><Citation>Png G, et al. Mapping the serum proteome to neurological diseases using whole genome sequencing. Nat. Commun. 2021;12:7042. doi: 10.1038/s41467-021-27387-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-27387-1</ArticleId><ArticleId IdType="pmc">PMC8640022</ArticleId><ArticleId IdType="pubmed">34857772</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun, B. B. et al. Plasma proteomic associations with genetics and health in the UK Biobank. Nature10.1038/s41586-023-06592-6 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10567551</ArticleId><ArticleId IdType="pubmed">37794186</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun BB, et al. Genomic atlas of the human plasma proteome. Nature. 2018;558:73&#x2013;79. doi: 10.1038/s41586-018-0175-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-018-0175-2</ArticleId><ArticleId IdType="pmc">PMC6697541</ArticleId><ArticleId IdType="pubmed">29875488</ArticleId></ArticleIdList></Reference><Reference><Citation>Folkersen L, et al. Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals. Nat. Metab. 2020;2:1135&#x2013;1148. doi: 10.1038/s42255-020-00287-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42255-020-00287-2</ArticleId><ArticleId IdType="pmc">PMC7611474</ArticleId><ArticleId IdType="pubmed">33067605</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferkingstad E, et al. Large-scale integration of the plasma proteome with genetics and disease. Nat. Genet. 2021;53:1712&#x2013;1721. doi: 10.1038/s41588-021-00978-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-021-00978-w</ArticleId><ArticleId IdType="pubmed">34857953</ArticleId></ArticleIdList></Reference><Reference><Citation>Kierczak M, et al. Contribution of rare whole-genome sequencing variants to plasma protein levels and the missing heritability. Nat. Commun. 2022;13:2532. doi: 10.1038/s41467-022-30208-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-30208-8</ArticleId><ArticleId IdType="pmc">PMC9085767</ArticleId><ArticleId IdType="pubmed">35534486</ArticleId></ArticleIdList></Reference><Reference><Citation>Katz DH, et al. Whole genome sequence analysis of the plasma proteome in Black adults provides novel insights into cardiovascular disease. Circulation. 2022;145:357&#x2013;370. doi: 10.1161/CIRCULATIONAHA.121.055117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.121.055117</ArticleId><ArticleId IdType="pmc">PMC9158509</ArticleId><ArticleId IdType="pubmed">34814699</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Q, et al. Rare variant contribution to human disease in 281,104 UK Biobank exomes. Nature. 2021;597:527&#x2013;532. doi: 10.1038/s41586-021-03855-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03855-y</ArticleId><ArticleId IdType="pmc">PMC8458098</ArticleId><ArticleId IdType="pubmed">34375979</ArticleId></ArticleIdList></Reference><Reference><Citation>Coban-Akdemir Z, et al. Identifying genes whose mutant transcripts cause dominant disease traits by potential gain-of-function alleles. Am. J. Hum. Genet. 2018;103:171&#x2013;187. doi: 10.1016/j.ajhg.2018.06.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajhg.2018.06.009</ArticleId><ArticleId IdType="pmc">PMC6081281</ArticleId><ArticleId IdType="pubmed">30032986</ArticleId></ArticleIdList></Reference><Reference><Citation>Plenge RM, Scolnick EM, Altshuler D. Validating therapeutic targets through human genetics. Nat. Rev. Drug. Discov. 2013;12:581&#x2013;594. doi: 10.1038/nrd4051.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrd4051</ArticleId><ArticleId IdType="pubmed">23868113</ArticleId></ArticleIdList></Reference><Reference><Citation>Nag, A. et al. Human genetics uncovers MAP3K15 as an obesity-independent therapeutic target for diabetes. Sci. Adv.8, eadd5430 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9668288</ArticleId><ArticleId IdType="pubmed">36383675</ArticleId></ArticleIdList></Reference><Reference><Citation>Landrum MJ, et al. ClinVar: improving access to variant interpretations and supporting evidence. Nucleic Acids Res. 2018;46:D1062&#x2013;D1067. doi: 10.1093/nar/gkx1153.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkx1153</ArticleId><ArticleId IdType="pmc">PMC5753237</ArticleId><ArticleId IdType="pubmed">29165669</ArticleId></ArticleIdList></Reference><Reference><Citation>Ioannidis NM, et al. REVEL: an ensemble method for predicting the pathogenicity of rare missense variants. Am. J. Hum. Genet. 2016;99:877&#x2013;885. doi: 10.1016/j.ajhg.2016.08.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajhg.2016.08.016</ArticleId><ArticleId IdType="pmc">PMC5065685</ArticleId><ArticleId IdType="pubmed">27666373</ArticleId></ArticleIdList></Reference><Reference><Citation>Nag A, et al. Effects of protein-coding variants on blood metabolite measurements and clinical biomarkers in the UK Biobank. Am. J. Hum. Genet. 2023;110:487&#x2013;498. doi: 10.1016/j.ajhg.2023.02.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajhg.2023.02.002</ArticleId><ArticleId IdType="pmc">PMC10027475</ArticleId><ArticleId IdType="pubmed">36809768</ArticleId></ArticleIdList></Reference><Reference><Citation>Albert, F. W., Bloom, J. S., Siegel, J., Day, L. &amp; Kruglyak, L. Genetics of trans-regulatory variation in gene expression. eLife10.7554/eLife.35471 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6072440</ArticleId><ArticleId IdType="pubmed">30014850</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen X, Song S, Li C, Zhang J. Synonymous mutations in representative yeast genes are mostly strongly non-neutral. Nature. 2022;606:725&#x2013;731. doi: 10.1038/s41586-022-04823-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04823-w</ArticleId><ArticleId IdType="pmc">PMC9650438</ArticleId><ArticleId IdType="pubmed">35676473</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhindsa, R. S. et al. A minimal role for synonymous variation in human disease. Am. J. Hum. Genet.109, 2105&#x2013;2109 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9808499</ArticleId><ArticleId IdType="pubmed">36459978</ArticleId></ArticleIdList></Reference><Reference><Citation>Schledzewski K, et al. Deficiency of liver sinusoidal scavenger receptors stabilin-1 and -2 in mice causes glomerulofibrotic nephropathy via impaired hepatic clearance of noxious blood factors. J. Clin. Invest. 2011;121:703&#x2013;714. doi: 10.1172/JCI44740.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI44740</ArticleId><ArticleId IdType="pmc">PMC3026735</ArticleId><ArticleId IdType="pubmed">21293057</ArticleId></ArticleIdList></Reference><Reference><Citation>Manta CP, et al. Targeting of scavenger receptors Stabilin-1 and Stabilin-2 ameliorates atherosclerosis by a plasma proteome switch mediating monocyte/macrophage suppression. Circulation. 2022;146:1783&#x2013;1799. doi: 10.1161/CIRCULATIONAHA.121.058615.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.121.058615</ArticleId><ArticleId IdType="pubmed">36325910</ArticleId></ArticleIdList></Reference><Reference><Citation>Coutinho MF, Prata MJ, Alves S. Mannose-6-phosphate pathway: a review on its role in lysosomal function and dysfunction. Mol. Genet. Metab. 2012;105:542&#x2013;550. doi: 10.1016/j.ymgme.2011.12.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ymgme.2011.12.012</ArticleId><ArticleId IdType="pubmed">22266136</ArticleId></ArticleIdList></Reference><Reference><Citation>Raas-Rothschild A, et al. Molecular basis of variant pseudo-hurler polydystrophy (mucolipidosis IIIC) J. Clin. Invest. 2000;105:673&#x2013;681. doi: 10.1172/JCI5826.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI5826</ArticleId><ArticleId IdType="pmc">PMC289169</ArticleId><ArticleId IdType="pubmed">10712439</ArticleId></ArticleIdList></Reference><Reference><Citation>Ponnaiyan S, Akter F, Singh J, Winter D. Comprehensive draft of the mouse embryonic fibroblast lysosomal proteome by mass spectrometry based proteomics. Sci. Data. 2020;7:68. doi: 10.1038/s41597-020-0399-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41597-020-0399-5</ArticleId><ArticleId IdType="pmc">PMC7044164</ArticleId><ArticleId IdType="pubmed">32103020</ArticleId></ArticleIdList></Reference><Reference><Citation>Mosen, P., Sanner, A., Singh, J. &amp; Winter, D. Targeted quantification of the lysosomal proteome in complex samples. Proteomes10.3390/proteomes9010004 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7931001</ArticleId><ArticleId IdType="pubmed">33530589</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu L, Lee WS, Doray B, Kornfeld S. Engineering of GlcNAc-1-phosphotransferase for production of highly phosphorylated lysosomal enzymes for enzyme replacement therapy. Mol. Ther. Methods Clin. Dev. 2017;5:59&#x2013;65. doi: 10.1016/j.omtm.2017.03.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.omtm.2017.03.006</ArticleId><ArticleId IdType="pmc">PMC5415318</ArticleId><ArticleId IdType="pubmed">28480305</ArticleId></ArticleIdList></Reference><Reference><Citation>Harlow CE, et al. Identification and single-base gene-editing functional validation of a cis-EPO variant as a genetic predictor for EPO-increasing therapies. Am. J. Hum. Genet. 2022;109:1638&#x2013;1652. doi: 10.1016/j.ajhg.2022.08.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajhg.2022.08.004</ArticleId><ArticleId IdType="pmc">PMC9502050</ArticleId><ArticleId IdType="pubmed">36055212</ArticleId></ArticleIdList></Reference><Reference><Citation>Traynelis J, et al. Optimizing genomic medicine in epilepsy through a gene-customized approach to missense variant interpretation. Genome Res. 2017;27:1715&#x2013;1729. doi: 10.1101/gr.226589.117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gr.226589.117</ArticleId><ArticleId IdType="pmc">PMC5630035</ArticleId><ArticleId IdType="pubmed">28864458</ArticleId></ArticleIdList></Reference><Reference><Citation>Petrovski S, Goldstein DB. Unequal representation of genetic variation across ancestry groups creates healthcare inequality in the application of precision medicine. Genome Biol. 2016;17:157. doi: 10.1186/s13059-016-1016-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13059-016-1016-y</ArticleId><ArticleId IdType="pmc">PMC4944427</ArticleId><ArticleId IdType="pubmed">27418169</ArticleId></ArticleIdList></Reference><Reference><Citation>Waldmann TA, McIntire KR. Serum-&#x3b1;-fetoprotein levels in patients with ataxia-telangiectasia. Lancet. 1972;2:1112&#x2013;1115. doi: 10.1016/S0140-6736(72)92717-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(72)92717-1</ArticleId><ArticleId IdType="pubmed">4117204</ArticleId></ArticleIdList></Reference><Reference><Citation>Kretz KA, et al. Characterization of a mutation in a family with saposin B deficiency: a glycosylation site defect. Proc. Natl Acad. Sci. USA. 1990;87:2541&#x2013;2544. doi: 10.1073/pnas.87.7.2541.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.87.7.2541</ArticleId><ArticleId IdType="pmc">PMC53725</ArticleId><ArticleId IdType="pubmed">2320574</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith KR, et al. Strikingly different clinicopathological phenotypes determined by progranulin-mutation dosage. Am. J. Hum. Genet. 2012;90:1102&#x2013;1107. doi: 10.1016/j.ajhg.2012.04.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajhg.2012.04.021</ArticleId><ArticleId IdType="pmc">PMC3370276</ArticleId><ArticleId IdType="pubmed">22608501</ArticleId></ArticleIdList></Reference><Reference><Citation>Baker M, et al. Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. Nature. 2006;442:916&#x2013;919. doi: 10.1038/nature05016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature05016</ArticleId><ArticleId IdType="pubmed">16862116</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou X, Sullivan PM, Sun L, Hu F. The interaction between progranulin and prosaposin is mediated by granulins and the linker region between saposin B and C. J. Neurochem. 2017;143:236&#x2013;243. doi: 10.1111/jnc.14110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.14110</ArticleId><ArticleId IdType="pmc">PMC5630500</ArticleId><ArticleId IdType="pubmed">28640985</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicholson AM, et al. Prosaposin is a regulator of progranulin levels and oligomerization. Nat. Commun. 2016;7:11992. doi: 10.1038/ncomms11992.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms11992</ArticleId><ArticleId IdType="pmc">PMC4931318</ArticleId><ArticleId IdType="pubmed">27356620</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramilowski JA, et al. A draft network of ligand-receptor-mediated multicellular signalling in human. Nat. Commun. 2015;6:7866. doi: 10.1038/ncomms8866.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms8866</ArticleId><ArticleId IdType="pmc">PMC4525178</ArticleId><ArticleId IdType="pubmed">26198319</ArticleId></ArticleIdList></Reference><Reference><Citation>Elenbaas JS, et al. SVEP1 is an endogenous ligand for the orphan receptor PEAR1. Nat. Commun. 2023;14:850. doi: 10.1038/s41467-023-36486-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-023-36486-0</ArticleId><ArticleId IdType="pmc">PMC9932102</ArticleId><ArticleId IdType="pubmed">36792666</ArticleId></ArticleIdList></Reference><Reference><Citation>Miao EA, et al. Cytoplasmic flagellin activates caspase-1 and secretion of interleukin 1&#x3b2; via Ipaf. Nat. Immunol. 2006;7:569&#x2013;575. doi: 10.1038/ni1344.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni1344</ArticleId><ArticleId IdType="pubmed">16648853</ArticleId></ArticleIdList></Reference><Reference><Citation>Romberg N, et al. Mutation of NLRC4 causes a syndrome of enterocolitis and autoinflammation. Nat. Genet. 2014;46:1135&#x2013;1139. doi: 10.1038/ng.3066.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.3066</ArticleId><ArticleId IdType="pmc">PMC4177367</ArticleId><ArticleId IdType="pubmed">25217960</ArticleId></ArticleIdList></Reference><Reference><Citation>Wishart DS, et al. DrugBank: a comprehensive resource for in silico drug discovery and exploration. Nucleic Acids Res. 2006;34:D668&#x2013;672. doi: 10.1093/nar/gkj067.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkj067</ArticleId><ArticleId IdType="pmc">PMC1347430</ArticleId><ArticleId IdType="pubmed">16381955</ArticleId></ArticleIdList></Reference><Reference><Citation>Abul-Husn NS, et al. A protein-truncating HSD17B13 variant and protection from chronic liver disease. N. Engl. J. Med. 2018;378:1096&#x2013;1106. doi: 10.1056/NEJMoa1712191.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1712191</ArticleId><ArticleId IdType="pmc">PMC6668033</ArticleId><ArticleId IdType="pubmed">29562163</ArticleId></ArticleIdList></Reference><Reference><Citation>Abelson S, et al. Prediction of acute myeloid leukaemia risk in healthy individuals. Nature. 2018;559:400&#x2013;404. doi: 10.1038/s41586-018-0317-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-018-0317-6</ArticleId><ArticleId IdType="pmc">PMC6485381</ArticleId><ArticleId IdType="pubmed">29988082</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaiswal S, et al. Clonal hematopoiesis and risk of atherosclerotic cardiovascular disease. N. Engl. J. Med. 2017;377:111&#x2013;121. doi: 10.1056/NEJMoa1701719.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1701719</ArticleId><ArticleId IdType="pmc">PMC6717509</ArticleId><ArticleId IdType="pubmed">28636844</ArticleId></ArticleIdList></Reference><Reference><Citation>Schaefer CF, et al. PID: the Pathway Interaction Database. Nucleic Acids Res. 2009;37:D674&#x2013;679. doi: 10.1093/nar/gkn653.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkn653</ArticleId><ArticleId IdType="pmc">PMC2686461</ArticleId><ArticleId IdType="pubmed">18832364</ArticleId></ArticleIdList></Reference><Reference><Citation>Edelmann B, et al. JAK2-V617F promotes venous thrombosis through &#x3b2;1/&#x3b2;2 integrin activation. J. Clin. Invest. 2018;128:4359&#x2013;4371. doi: 10.1172/JCI90312.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI90312</ArticleId><ArticleId IdType="pmc">PMC6159978</ArticleId><ArticleId IdType="pubmed">30024857</ArticleId></ArticleIdList></Reference><Reference><Citation>Small D, et al. STK-1, the human homolog of Flk-2/Flt-3, is selectively expressed in CD34+ human bone marrow cells and is involved in the proliferation of early progenitor/stem cells. Proc. Natl Acad. Sci. USA. 1994;91:459&#x2013;463. doi: 10.1073/pnas.91.2.459.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.91.2.459</ArticleId><ArticleId IdType="pmc">PMC42968</ArticleId><ArticleId IdType="pubmed">7507245</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravandi F, et al. Outcome of patients with FLT3-mutated acute myeloid leukemia in first relapse. Leuk. Res. 2010;34:752&#x2013;756. doi: 10.1016/j.leukres.2009.10.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.leukres.2009.10.001</ArticleId><ArticleId IdType="pmc">PMC4082769</ArticleId><ArticleId IdType="pubmed">19878996</ArticleId></ArticleIdList></Reference><Reference><Citation>Perl AE, et al. Gilteritinib or chemotherapy for relapsed or refractory FLT3-mutated AML. N. Engl. J. Med. 2019;381:1728&#x2013;1740. doi: 10.1056/NEJMoa1902688.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1902688</ArticleId><ArticleId IdType="pubmed">31665578</ArticleId></ArticleIdList></Reference><Reference><Citation>Stone RM, et al. Midostaurin plus chemotherapy for acute myeloid leukemia with a FLT3 mutation. N. Engl. J. Med. 2017;377:454&#x2013;464. doi: 10.1056/NEJMoa1614359.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1614359</ArticleId><ArticleId IdType="pmc">PMC5754190</ArticleId><ArticleId IdType="pubmed">28644114</ArticleId></ArticleIdList></Reference><Reference><Citation>Collin M, Bigley V. Human dendritic cell subsets: an update. Immunology. 2018;154:3&#x2013;20. doi: 10.1111/imm.12888.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imm.12888</ArticleId><ArticleId IdType="pmc">PMC5904714</ArticleId><ArticleId IdType="pubmed">29313948</ArticleId></ArticleIdList></Reference><Reference><Citation>Colonna M, Samaridis J. Cloning of immunoglobulin-superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells. Science. 1995;268:405&#x2013;408. doi: 10.1126/science.7716543.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.7716543</ArticleId><ArticleId IdType="pubmed">7716543</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Donnell MC, Ackerman SJ, Gleich GJ, Thomas LL. Activation of basophil and mast cell histamine release by eosinophil granule major basic protein. J. Exp. Med. 1983;157:1981&#x2013;1991. doi: 10.1084/jem.157.6.1981.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.157.6.1981</ArticleId><ArticleId IdType="pmc">PMC2187055</ArticleId><ArticleId IdType="pubmed">6854212</ArticleId></ArticleIdList></Reference><Reference><Citation>Plager DA, et al. Comparative structure, proximal promoter elements, and chromosome location of the human eosinophil major basic protein genes. Genomics. 2001;71:271&#x2013;281. doi: 10.1006/geno.2000.6391.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/geno.2000.6391</ArticleId><ArticleId IdType="pubmed">11170744</ArticleId></ArticleIdList></Reference><Reference><Citation>Belizaire, R., Wong, W. J., Robinette, M. L. &amp; Ebert, B. L. Clonal haematopoiesis and dysregulation of the immune system. Nat. Rev. Immunol.10.1038/s41577-023-00843-3 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11140722</ArticleId><ArticleId IdType="pubmed">36941354</ArticleId></ArticleIdList></Reference><Reference><Citation>Frazer J, et al. Disease variant prediction with deep generative models of evolutionary data. Nature. 2021;599:91&#x2013;95. doi: 10.1038/s41586-021-04043-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-04043-8</ArticleId><ArticleId IdType="pubmed">34707284</ArticleId></ArticleIdList></Reference><Reference><Citation>Zmajkovic J, et al. A gain-of-function mutation in EPO in familial erythrocytosis. N. Engl. J. Med. 2018;378:924&#x2013;930. doi: 10.1056/NEJMoa1709064.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1709064</ArticleId><ArticleId IdType="pubmed">29514032</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudlow C, et al. UK Biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med. 2015;12:e1001779. doi: 10.1371/journal.pmed.1001779.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1001779</ArticleId><ArticleId IdType="pmc">PMC4380465</ArticleId><ArticleId IdType="pubmed">25826379</ArticleId></ArticleIdList></Reference><Reference><Citation>Bycroft C, et al. The UK Biobank resource with deep phenotyping and genomic data. Nature. 2018;562:203&#x2013;209. doi: 10.1038/s41586-018-0579-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-018-0579-z</ArticleId><ArticleId IdType="pmc">PMC6786975</ArticleId><ArticleId IdType="pubmed">30305743</ArticleId></ArticleIdList></Reference><Reference><Citation>Pedersen BS, Quinlan AR. Who&#x2019;s who? Detecting and resolving sample anomalies in human DNA sequencing studies with Peddy. Am. J. Hum. Genet. 2017;100:406&#x2013;413. doi: 10.1016/j.ajhg.2017.01.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajhg.2017.01.017</ArticleId><ArticleId IdType="pmc">PMC5339084</ArticleId><ArticleId IdType="pubmed">28190455</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Hout CV, et al. Exome sequencing and characterization of 49,960 individuals in the UK Biobank. Nature. 2020;586:749&#x2013;756. doi: 10.1038/s41586-020-2853-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2853-0</ArticleId><ArticleId IdType="pmc">PMC7759458</ArticleId><ArticleId IdType="pubmed">33087929</ArticleId></ArticleIdList></Reference><Reference><Citation>Cingolani P, et al. A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w1118; iso-2; iso-3. Fly (Austin) 2012;6:80&#x2013;92. doi: 10.4161/fly.19695.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/fly.19695</ArticleId><ArticleId IdType="pmc">PMC3679285</ArticleId><ArticleId IdType="pubmed">22728672</ArticleId></ArticleIdList></Reference><Reference><Citation>Howe KL, et al. Ensembl 2021. Nucleic Acids Res. 2021;49:D884&#x2013;D891. doi: 10.1093/nar/gkaa942.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkaa942</ArticleId><ArticleId IdType="pmc">PMC7778975</ArticleId><ArticleId IdType="pubmed">33137190</ArticleId></ArticleIdList></Reference><Reference><Citation>Karczewski KJ, et al. The mutational constraint spectrum quantified from variation in 141,456 humans. Nature. 2020;581:434&#x2013;443. doi: 10.1038/s41586-020-2308-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2308-7</ArticleId><ArticleId IdType="pmc">PMC7334197</ArticleId><ArticleId IdType="pubmed">32461654</ArticleId></ArticleIdList></Reference><Reference><Citation>Petrovski S, et al. An exome sequencing study to assess the role of rare genetic variation in pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 2017;196:82&#x2013;93. doi: 10.1164/rccm.201610-2088OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201610-2088OC</ArticleId><ArticleId IdType="pmc">PMC5519963</ArticleId><ArticleId IdType="pubmed">28099038</ArticleId></ArticleIdList></Reference><Reference><Citation>Povysil G, et al. Rare-variant collapsing analyses for complex traits: guidelines and applications. Nat. Rev. Genet. 2019;20:747&#x2013;759. doi: 10.1038/s41576-019-0177-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41576-019-0177-4</ArticleId><ArticleId IdType="pubmed">31605095</ArticleId></ArticleIdList></Reference><Reference><Citation>Cibulskis K, et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat. Biotechnol. 2013;31:213&#x2013;219. doi: 10.1038/nbt.2514.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt.2514</ArticleId><ArticleId IdType="pmc">PMC3833702</ArticleId><ArticleId IdType="pubmed">23396013</ArticleId></ArticleIdList></Reference><Reference><Citation>Jun G, et al. Detecting and estimating contamination of human DNA samples in sequencing and array-based genotype data. Am. J. Hum. Genet. 2012;91:839&#x2013;848. doi: 10.1016/j.ajhg.2012.09.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajhg.2012.09.004</ArticleId><ArticleId IdType="pmc">PMC3487130</ArticleId><ArticleId IdType="pubmed">23103226</ArticleId></ArticleIdList></Reference><Reference><Citation>Pujar S, et al. Consensus coding sequence (CCDS) database: a standardized set of human and mouse protein-coding regions supported by expert curation. Nucleic Acids Res. 2018;46:D221&#x2013;D228. doi: 10.1093/nar/gkx1031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkx1031</ArticleId><ArticleId IdType="pmc">PMC5753299</ArticleId><ArticleId IdType="pubmed">29126148</ArticleId></ArticleIdList></Reference><Reference><Citation>Manichaikul A, et al. Robust relationship inference in genome-wide association studies. Bioinformatics. 2010;26:2867&#x2013;2873. doi: 10.1093/bioinformatics/btq559.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btq559</ArticleId><ArticleId IdType="pmc">PMC3025716</ArticleId><ArticleId IdType="pubmed">20926424</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanscombe KB, Coleman JRI, Traylor M, Lewis CM. ukbtools: an R package to manage and query UK Biobank data. PLoS ONE. 2019;14:e0214311. doi: 10.1371/journal.pone.0214311.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0214311</ArticleId><ArticleId IdType="pmc">PMC6544205</ArticleId><ArticleId IdType="pubmed">31150407</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37794188</PMID><DateCompleted><Year>2023</Year><Month>10</Month><Day>26</Day></DateCompleted><DateRevised><Year>2024</Year><Month>08</Month><Day>14</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1476-4687</ISSN><JournalIssue CitedMedium="Internet"><Volume>622</Volume><Issue>7982</Issue><PubDate><Year>2023</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Nature</Title><ISOAbbreviation>Nature</ISOAbbreviation></Journal><ArticleTitle>Large-scale plasma proteomics comparisons through genetics and disease associations.</ArticleTitle><Pagination><StartPage>348</StartPage><EndPage>358</EndPage><MedlinePgn>348-358</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41586-023-06563-x</ELocationID><Abstract><AbstractText>High-throughput proteomics platforms measuring thousands of proteins in plasma combined with genomic and phenotypic information have the power to bridge the gap between the genome and diseases. Here we performed association studies of Olink Explore 3072 data generated by the UK Biobank Pharma Proteomics Project<sup>1</sup> on plasma samples from more than 50,000 UK Biobank participants with phenotypic and genotypic data, stratifying on British or Irish, African and South Asian ancestries. We compared the results with those of a SomaScan v4 study on plasma from 36,000 Icelandic people<sup>2</sup>, for 1,514 of whom Olink data were also available. We found modest correlation between the two platforms. Although cis protein quantitative trait loci were detected for a similar absolute number of assays on the two platforms (2,101 on Olink versus 2,120 on SomaScan), the proportion of assays with such supporting evidence for assay performance was higher on the Olink platform (72% versus 43%). A considerable number of proteins had genomic associations that differed between the platforms. We provide examples where differences between platforms may influence conclusions drawn from the integration of protein levels with the study of diseases. We demonstrate how leveraging the diverse ancestries of participants in the UK Biobank helps to detect novel associations and refine genomic location. Our results show the value of the information provided by the two most commonly used high-throughput proteomics platforms and demonstrate the differences between them that at times provides useful complementarity.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Eldjarn</LastName><ForeName>Grimur Hjorleifsson</ForeName><Initials>GH</Initials><Identifier Source="ORCID">0000-0002-9580-6685</Identifier><AffiliationInfo><Affiliation>deCODE Genetics/Amgen, Reykjavik, Iceland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Ferkingstad</LastName><ForeName>Egil</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0001-8090-7988</Identifier><AffiliationInfo><Affiliation>deCODE Genetics/Amgen, Reykjavik, Iceland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lund</LastName><ForeName>Sigrun H</ForeName><Initials>SH</Initials><Identifier Source="ORCID">0000-0002-3806-2296</Identifier><AffiliationInfo><Affiliation>deCODE Genetics/Amgen, Reykjavik, Iceland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Engineering and Natural Sciences, University of Iceland, Reykjavik, Iceland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Helgason</LastName><ForeName>Hannes</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>deCODE Genetics/Amgen, Reykjavik, Iceland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Engineering and Natural Sciences, University of Iceland, Reykjavik, Iceland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Magnusson</LastName><ForeName>Olafur Th</ForeName><Initials>OT</Initials><AffiliationInfo><Affiliation>deCODE Genetics/Amgen, Reykjavik, Iceland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gunnarsdottir</LastName><ForeName>Kristbjorg</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>deCODE Genetics/Amgen, Reykjavik, Iceland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Olafsdottir</LastName><ForeName>Thorunn A</ForeName><Initials>TA</Initials><Identifier Source="ORCID">0000-0001-5454-938X</Identifier><AffiliationInfo><Affiliation>deCODE Genetics/Amgen, Reykjavik, Iceland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Halldorsson</LastName><ForeName>Bjarni V</ForeName><Initials>BV</Initials><Identifier Source="ORCID">0000-0003-0756-0767</Identifier><AffiliationInfo><Affiliation>deCODE Genetics/Amgen, Reykjavik, Iceland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Technology, Reykjavik University, Reykjavik, Iceland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Olason</LastName><ForeName>Pall I</ForeName><Initials>PI</Initials><AffiliationInfo><Affiliation>deCODE Genetics/Amgen, Reykjavik, Iceland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zink</LastName><ForeName>Florian</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>deCODE Genetics/Amgen, Reykjavik, Iceland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gudjonsson</LastName><ForeName>Sigurjon A</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>deCODE Genetics/Amgen, Reykjavik, Iceland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sveinbjornsson</LastName><ForeName>Gardar</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0003-2429-9468</Identifier><AffiliationInfo><Affiliation>deCODE Genetics/Amgen, Reykjavik, Iceland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Magnusson</LastName><ForeName>Magnus I</ForeName><Initials>MI</Initials><AffiliationInfo><Affiliation>deCODE Genetics/Amgen, Reykjavik, Iceland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Helgason</LastName><ForeName>Agnar</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-8545-3767</Identifier><AffiliationInfo><Affiliation>deCODE Genetics/Amgen, Reykjavik, Iceland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anthropology, University of Iceland, Reykjavik, Iceland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oddsson</LastName><ForeName>Asmundur</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-4606-5163</Identifier><AffiliationInfo><Affiliation>deCODE Genetics/Amgen, Reykjavik, Iceland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Halldorsson</LastName><ForeName>Gisli H</ForeName><Initials>GH</Initials><Identifier Source="ORCID">0000-0001-7067-9862</Identifier><AffiliationInfo><Affiliation>deCODE Genetics/Amgen, Reykjavik, Iceland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Magnusson</LastName><ForeName>Magnus K</ForeName><Initials>MK</Initials><Identifier Source="ORCID">0000-0001-8593-4934</Identifier><AffiliationInfo><Affiliation>deCODE Genetics/Amgen, Reykjavik, Iceland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Medicine, School of Health Sciences, University of Iceland, Reykjavik, Iceland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saevarsdottir</LastName><ForeName>Saedis</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-9392-6184</Identifier><AffiliationInfo><Affiliation>deCODE Genetics/Amgen, Reykjavik, Iceland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Medicine, School of Health Sciences, University of Iceland, Reykjavik, Iceland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eiriksdottir</LastName><ForeName>Thjodbjorg</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0003-1009-7398</Identifier><AffiliationInfo><Affiliation>deCODE Genetics/Amgen, Reykjavik, Iceland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Masson</LastName><ForeName>Gisli</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>deCODE Genetics/Amgen, Reykjavik, Iceland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stefansson</LastName><ForeName>Hreinn</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>deCODE Genetics/Amgen, Reykjavik, Iceland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jonsdottir</LastName><ForeName>Ingileif</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0001-8339-150X</Identifier><AffiliationInfo><Affiliation>deCODE Genetics/Amgen, Reykjavik, Iceland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Medicine, School of Health Sciences, University of Iceland, Reykjavik, Iceland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Holm</LastName><ForeName>Hilma</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0002-9517-6636</Identifier><AffiliationInfo><Affiliation>deCODE Genetics/Amgen, Reykjavik, Iceland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rafnar</LastName><ForeName>Thorunn</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0003-0491-7046</Identifier><AffiliationInfo><Affiliation>deCODE Genetics/Amgen, Reykjavik, Iceland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Melsted</LastName><ForeName>Pall</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>deCODE Genetics/Amgen, Reykjavik, Iceland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Engineering and Natural Sciences, University of Iceland, Reykjavik, Iceland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saemundsdottir</LastName><ForeName>Jona</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>deCODE Genetics/Amgen, Reykjavik, Iceland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Norddahl</LastName><ForeName>Gudmundur L</ForeName><Initials>GL</Initials><AffiliationInfo><Affiliation>deCODE Genetics/Amgen, Reykjavik, Iceland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thorleifsson</LastName><ForeName>Gudmar</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0003-4623-9087</Identifier><AffiliationInfo><Affiliation>deCODE Genetics/Amgen, Reykjavik, Iceland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ulfarsson</LastName><ForeName>Magnus O</ForeName><Initials>MO</Initials><AffiliationInfo><Affiliation>deCODE Genetics/Amgen, Reykjavik, Iceland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Electrical and Computer Engineering, University of Iceland, Reykjavik, Iceland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gudbjartsson</LastName><ForeName>Daniel F</ForeName><Initials>DF</Initials><Identifier Source="ORCID">0000-0002-5222-9857</Identifier><AffiliationInfo><Affiliation>deCODE Genetics/Amgen, Reykjavik, Iceland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Engineering and Natural Sciences, University of Iceland, Reykjavik, Iceland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thorsteinsdottir</LastName><ForeName>Unnur</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>deCODE Genetics/Amgen, Reykjavik, Iceland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Medicine, School of Health Sciences, University of Iceland, Reykjavik, Iceland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sulem</LastName><ForeName>Patrick</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0001-7123-6123</Identifier><AffiliationInfo><Affiliation>deCODE Genetics/Amgen, Reykjavik, Iceland. patrick.sulem@decode.is.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stefansson</LastName><ForeName>Kari</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0003-1676-864X</Identifier><AffiliationInfo><Affiliation>deCODE Genetics/Amgen, Reykjavik, Iceland. kstefans@decode.is.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Medicine, School of Health Sciences, University of Iceland, Reykjavik, Iceland. kstefans@decode.is.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>10</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nature</MedlineTA><NlmUniqueID>0410462</NlmUniqueID><ISSNLinking>0028-0836</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001798">Blood Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D020543">Proteome</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="ErratumIn"><RefSource>Nature. 2024 Jun;630(8015):E3. doi: 10.1038/s41586-024-07549-z.</RefSource><PMID Version="1">38778117</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000349" MajorTopicYN="N" Type="Geographic">Africa</DescriptorName><QualifierName UI="Q000208" MajorTopicYN="N">ethnology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000095143" MajorTopicYN="N" Type="Geographic">Asia, Southern</DescriptorName><QualifierName UI="Q000208" MajorTopicYN="N">ethnology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018070" MajorTopicYN="N">Biological Specimen Banks</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001798" MajorTopicYN="Y">Blood Proteins</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D066264" MajorTopicYN="N">Datasets as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004198" MajorTopicYN="Y">Disease Susceptibility</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015894" MajorTopicYN="N">Genome, Human</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D023281" MajorTopicYN="Y">Genomics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005838" MajorTopicYN="Y">Genotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007055" MajorTopicYN="N" Type="Geographic">Iceland</DescriptorName><QualifierName UI="Q000208" MajorTopicYN="N">ethnology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007494" MajorTopicYN="N" Type="Geographic">Ireland</DescriptorName><QualifierName UI="Q000208" MajorTopicYN="N">ethnology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010641" MajorTopicYN="Y">Phenotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010949" MajorTopicYN="N">Plasma</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020543" MajorTopicYN="N">Proteome</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D040901" MajorTopicYN="Y">Proteomics</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D040641" MajorTopicYN="N">Quantitative Trait Loci</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006113" MajorTopicYN="N" Type="Geographic">United Kingdom</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>All authors are employees of deCODE Genetics, a wholly-owned subsidiary of Amgen.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>8</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>8</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>10</Month><Day>23</Day><Hour>1</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>10</Month><Day>5</Day><Hour>1</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>10</Month><Day>4</Day><Hour>23</Hour><Minute>30</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>10</Month><Day>4</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37794188</ArticleId><ArticleId IdType="pmc">PMC10567571</ArticleId><ArticleId IdType="doi">10.1038/s41586-023-06563-x</ArticleId><ArticleId IdType="pii">10.1038/s41586-023-06563-x</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Sun, B. B. et al. Plasma proteomic associations with genetics and health in the UK Biobank. Nature10.1038/s41586-023-06592-6 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10567551</ArticleId><ArticleId IdType="pubmed">37794186</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferkingstad E, et al. Large-scale integration of the plasma proteome with genetics and disease. Nat. Genet. 2021;53:1712&#x2013;1721. doi: 10.1038/s41588-021-00978-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-021-00978-w</ArticleId><ArticleId IdType="pubmed">34857953</ArticleId></ArticleIdList></Reference><Reference><Citation>Folkersen L, et al. Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals. Nat. Metab. 2020;2:1135&#x2013;1148. doi: 10.1038/s42255-020-00287-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42255-020-00287-2</ArticleId><ArticleId IdType="pmc">PMC7611474</ArticleId><ArticleId IdType="pubmed">33067605</ArticleId></ArticleIdList></Reference><Reference><Citation>Folkersen L, et al. Mapping of 79 loci for 83 plasma protein biomarkers in cardiovascular disease. PLoS Genet. 2017;13:e1006706. doi: 10.1371/journal.pgen.1006706.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1006706</ArticleId><ArticleId IdType="pmc">PMC5393901</ArticleId><ArticleId IdType="pubmed">28369058</ArticleId></ArticleIdList></Reference><Reference><Citation>Pietzner M, et al. Mapping the proteo-genomic convergence of human diseases. Science. 2021;374:eabj1541. doi: 10.1126/science.abj1541.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abj1541</ArticleId><ArticleId IdType="pmc">PMC9904207</ArticleId><ArticleId IdType="pubmed">34648354</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun BB, et al. Genomic atlas of the human plasma proteome. Nature. 2018;558:73&#x2013;79. doi: 10.1038/s41586-018-0175-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-018-0175-2</ArticleId><ArticleId IdType="pmc">PMC6697541</ArticleId><ArticleId IdType="pubmed">29875488</ArticleId></ArticleIdList></Reference><Reference><Citation>Pietzner M, et al. Synergistic insights into human health from aptamer- and antibody-based proteomic profiling. Nat. Commun. 2021;12:6822. doi: 10.1038/s41467-021-27164-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-27164-0</ArticleId><ArticleId IdType="pmc">PMC8613205</ArticleId><ArticleId IdType="pubmed">34819519</ArticleId></ArticleIdList></Reference><Reference><Citation>Kastenm&#xfc;ller G, Raffler J, Gieger C, Suhre K. Genetics of human metabolism: an update. Hum. Mol. Genet. 2015;24:R93&#x2013;R101. doi: 10.1093/hmg/ddv263.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddv263</ArticleId><ArticleId IdType="pmc">PMC4572003</ArticleId><ArticleId IdType="pubmed">26160913</ArticleId></ArticleIdList></Reference><Reference><Citation>Koprulu M, et al. Proteogenomic links to human metabolic diseases. Nat. Metab. 2023;5:516&#x2013;528. doi: 10.1038/s42255-023-00753-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42255-023-00753-7</ArticleId><ArticleId IdType="pmc">PMC7614946</ArticleId><ArticleId IdType="pubmed">36823471</ArticleId></ArticleIdList></Reference><Reference><Citation>Katz DH, et al. Proteomic profiling platforms head to head: Leveraging genetics and clinical traits to compare aptamer- and antibody-based methods. Sci. Adv. 2022;8:eabm5164. doi: 10.1126/sciadv.abm5164.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.abm5164</ArticleId><ArticleId IdType="pmc">PMC9390994</ArticleId><ArticleId IdType="pubmed">35984888</ArticleId></ArticleIdList></Reference><Reference><Citation>Raffield LM, et al. Comparison of proteomic assessment methods in multiple cohort studies. Proteomics. 2020;20:e1900278. doi: 10.1002/pmic.201900278.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pmic.201900278</ArticleId><ArticleId IdType="pmc">PMC7425176</ArticleId><ArticleId IdType="pubmed">32386347</ArticleId></ArticleIdList></Reference><Reference><Citation>Halldorsson BV, et al. The sequences of 150,119 genomes in the UK Biobank. Nature. 2022;607:732&#x2013;740. doi: 10.1038/s41586-022-04965-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04965-x</ArticleId><ArticleId IdType="pmc">PMC9329122</ArticleId><ArticleId IdType="pubmed">35859178</ArticleId></ArticleIdList></Reference><Reference><Citation>Candia J, et al. Assessment of variability in the SOMAscan assay. Sci. Rep. 2017;7:14248. doi: 10.1038/s41598-017-14755-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-14755-5</ArticleId><ArticleId IdType="pmc">PMC5660188</ArticleId><ArticleId IdType="pubmed">29079756</ArticleId></ArticleIdList></Reference><Reference><Citation>Uhl&#xe9;n M, et al. Tissue-based map of the human proteome. Science. 2015;347:1260419. doi: 10.1126/science.1260419.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1260419</ArticleId><ArticleId IdType="pubmed">25613900</ArticleId></ArticleIdList></Reference><Reference><Citation>Gorovits B, McNally J, Fiorotti C, Leung S. Protein-based matrix interferences in ligand-binding assays. Bioanalysis. 2014;6:1131&#x2013;1140. doi: 10.4155/bio.14.56.</Citation><ArticleIdList><ArticleId IdType="doi">10.4155/bio.14.56</ArticleId><ArticleId IdType="pubmed">24830897</ArticleId></ArticleIdList></Reference><Reference><Citation>Enroth S, Hallmans G, Grankvist K, Gyllensten U. Effects of long-term storage time and original sampling month on biobank plasma protein concentrations. eBioMedicine. 2016;12:309&#x2013;314. doi: 10.1016/j.ebiom.2016.08.038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2016.08.038</ArticleId><ArticleId IdType="pmc">PMC5078583</ArticleId><ArticleId IdType="pubmed">27596149</ArticleId></ArticleIdList></Reference><Reference><Citation>Koratala A, Kazory A. Natriuretic peptides as biomarkers for congestive states: the cardiorenal divergence. Dis. Markers. 2017;2017:1454986. doi: 10.1155/2017/1454986.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2017/1454986</ArticleId><ArticleId IdType="pmc">PMC5494089</ArticleId><ArticleId IdType="pubmed">28701807</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith LM, Kelleher NL. Proteoform: a single term describing protein complexity. Nat. Methods. 2013;10:186&#x2013;187. doi: 10.1038/nmeth.2369.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.2369</ArticleId><ArticleId IdType="pmc">PMC4114032</ArticleId><ArticleId IdType="pubmed">23443629</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan A, Rao MV, Veeranna, Nixon RA. Neurofilaments at a glance. J. Cell Sci. 2012;125:3257&#x2013;3263. doi: 10.1242/jcs.104729.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.104729</ArticleId><ArticleId IdType="pmc">PMC3516374</ArticleId><ArticleId IdType="pubmed">22956720</ArticleId></ArticleIdList></Reference><Reference><Citation>Teunissen CE, et al. Blood-based biomarkers for Alzheimer&#x2019;s disease: towards clinical implementation. Lancet Neurol. 2022;21:66&#x2013;77. doi: 10.1016/S1474-4422(21)00361-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(21)00361-6</ArticleId><ArticleId IdType="pubmed">34838239</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang Y, et al. Large&#x2010;scale plasma proteomic profiling identifies a high&#x2010;performance biomarker panel for Alzheimer&#x2019;s disease screening and staging. Alzheimers Dement. 2022;18:88&#x2013;102. doi: 10.1002/alz.12369.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alz.12369</ArticleId><ArticleId IdType="pmc">PMC9292367</ArticleId><ArticleId IdType="pubmed">34032364</ArticleId></ArticleIdList></Reference><Reference><Citation>Ticau S, et al. Neurofilament light chain as a biomarker of hereditary transthyretin-mediated amyloidosis. Neurology. 2021;96:e412&#x2013;e422. doi: 10.1212/WNL.0000000000011090.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000011090</ArticleId><ArticleId IdType="pmc">PMC7884985</ArticleId><ArticleId IdType="pubmed">33087494</ArticleId></ArticleIdList></Reference><Reference><Citation>Le Loupp A-G, et al. Activation of the prostaglandin D2 metabolic pathway in Crohn&#x2019;s disease: involvement of the enteric nervous system. BMC Gastroenterol. 2015;15:112. doi: 10.1186/s12876-015-0338-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12876-015-0338-7</ArticleId><ArticleId IdType="pmc">PMC4558965</ArticleId><ArticleId IdType="pubmed">26338799</ArticleId></ArticleIdList></Reference><Reference><Citation>Zamuner SR, Warrier N, Buret AG, MacNaughton WK, Wallace JL. Cyclooxygenase 2 mediates post-inflammatory colonic secretory and barrier dysfunction. Gut. 2003;52:1714&#x2013;1720. doi: 10.1136/gut.52.12.1714.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gut.52.12.1714</ArticleId><ArticleId IdType="pmc">PMC1773896</ArticleId><ArticleId IdType="pubmed">14633948</ArticleId></ArticleIdList></Reference><Reference><Citation>Larson NB, et al. Comprehensively evaluating cis-regulatory variation in the human prostate transcriptome by using gene-level allele-specific expression. Am. J. Hum. Genet. 2015;96:869&#x2013;882. doi: 10.1016/j.ajhg.2015.04.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajhg.2015.04.015</ArticleId><ArticleId IdType="pmc">PMC4457953</ArticleId><ArticleId IdType="pubmed">25983244</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J, et al. Plasma proteome analyses in individuals of European and African ancestry identify cis-pQTLs and models for proteome-wide association studies. Nat. Genet. 2022;54:593&#x2013;602. doi: 10.1038/s41588-022-01051-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-022-01051-w</ArticleId><ArticleId IdType="pmc">PMC9236177</ArticleId><ArticleId IdType="pubmed">35501419</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen JC, Boerwinkle E, Mosley TH, Hobbs HH. Sequence variations in PCSK9, low LDL, and protection against coronary heart disease. N. Engl. J. Med. 2006;354:1264&#x2013;1272. doi: 10.1056/NEJMoa054013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa054013</ArticleId><ArticleId IdType="pubmed">16554528</ArticleId></ArticleIdList></Reference><Reference><Citation>Benjannet S, Rhainds D, Hamelin J, Nassoury N, Seidah NG. The proprotein convertase (PC) PCSK9 is inactivated by furin and/or PC5/6A: functional consequences of natural mutations and post-translational modifications. J. Biol. Chem. 2006;281:30561&#x2013;30572. doi: 10.1074/jbc.M606495200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M606495200</ArticleId><ArticleId IdType="pubmed">16912035</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonarakis SE, et al. Origin of the beta S-globin gene in blacks: the contribution of recurrent mutation or gene conversion or both. Proc. Natl Acad. Sci. USA. 1984;81:853&#x2013;856. doi: 10.1073/pnas.81.3.853.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.81.3.853</ArticleId><ArticleId IdType="pmc">PMC344936</ArticleId><ArticleId IdType="pubmed">6583683</ArticleId></ArticleIdList></Reference><Reference><Citation>Gomperts E, et al. The role of carbon monoxide and heme oxygenase in the prevention of sickle cell disease vaso-occlusive crises. Am. J. Hematol. 2017;92:569&#x2013;582. doi: 10.1002/ajh.24750.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ajh.24750</ArticleId><ArticleId IdType="pmc">PMC5723421</ArticleId><ArticleId IdType="pubmed">28378932</ArticleId></ArticleIdList></Reference><Reference><Citation>1000 Genomes Project Consortium. A global reference for human genetic variation. Nature. 2015;526:68&#x2013;74. doi: 10.1038/nature15393.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature15393</ArticleId><ArticleId IdType="pmc">PMC4750478</ArticleId><ArticleId IdType="pubmed">26432245</ArticleId></ArticleIdList></Reference><Reference><Citation>Pietzner M, et al. Genetic architecture of host proteins involved in SARS-CoV-2 infection. Nat. Commun. 2020;11:6397. doi: 10.1038/s41467-020-19996-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-19996-z</ArticleId><ArticleId IdType="pmc">PMC7744536</ArticleId><ArticleId IdType="pubmed">33328453</ArticleId></ArticleIdList></Reference><Reference><Citation>Pietzner, M. et al. Genetic architecture of host proteins interacting with SARS-CoV-2. Preprint at bioRxiv10.1101/2020.07.01.182709 (2020).</Citation></Reference><Reference><Citation>Liu JZ, et al. Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations. Nat. Genet. 2015;47:979&#x2013;986. doi: 10.1038/ng.3359.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.3359</ArticleId><ArticleId IdType="pmc">PMC4881818</ArticleId><ArticleId IdType="pubmed">26192919</ArticleId></ArticleIdList></Reference><Reference><Citation>K&#xfc;hn R, L&#xf6;hler J, Rennick D, Rajewsky K, M&#xfc;ller W. Interleukin-10-deficient mice develop chronic enterocolitis. Cell. 1993;75:263&#x2013;274. doi: 10.1016/0092-8674(93)80068-P.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0092-8674(93)80068-P</ArticleId><ArticleId IdType="pubmed">8402911</ArticleId></ArticleIdList></Reference><Reference><Citation>Nambu R, et al. A systematic review of monogenic inflammatory bowel disease. Clin. Gastroenterol. Hepatol. 2022;20:E653&#x2013;E663. doi: 10.1016/j.cgh.2021.03.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cgh.2021.03.021</ArticleId><ArticleId IdType="pmc">PMC8448782</ArticleId><ArticleId IdType="pubmed">33746097</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan J, Jiang T, He D. Genetic link between rheumatoid arthritis and autoimmune liver diseases: a two-sample Mendelian randomization study. Semin. Arthritis Rheum. 2023;58:152142. doi: 10.1016/j.semarthrit.2022.152142.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semarthrit.2022.152142</ArticleId><ArticleId IdType="pubmed">36446255</ArticleId></ArticleIdList></Reference><Reference><Citation>Ono T, Hayashi M, Sasaki F, Nakashima T. RANKL biology: bone metabolism, the immune system, and beyond. Inflamm. Regen. 2020;40:2. doi: 10.1186/s41232-019-0111-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s41232-019-0111-3</ArticleId><ArticleId IdType="pmc">PMC7006158</ArticleId><ArticleId IdType="pubmed">32047573</ArticleId></ArticleIdList></Reference><Reference><Citation>Pulit SL, et al. Meta-analysis of genome-wide association studies for body fat distribution in 694 649 individuals of European ancestry. Hum. Mol. Genet. 2019;28:166&#x2013;174. doi: 10.1093/hmg/ddy327.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddy327</ArticleId><ArticleId IdType="pmc">PMC6298238</ArticleId><ArticleId IdType="pubmed">30239722</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng F, Wang Y, Kloepfer LA, Wang S, Harris RC. ErbB4 deletion predisposes to development of metabolic syndrome in mice. Am. J. Physiol. Endocrinol. Metab. 2018;315:E583&#x2013;E593. doi: 10.1152/ajpendo.00166.2018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpendo.00166.2018</ArticleId><ArticleId IdType="pmc">PMC6230712</ArticleId><ArticleId IdType="pubmed">29944391</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahajan A, et al. Fine-mapping type 2 diabetes loci to single-variant resolution using high-density imputation and islet-specific epigenome maps. Nat. Genet. 2018;50:1505&#x2013;1513. doi: 10.1038/s41588-018-0241-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-018-0241-6</ArticleId><ArticleId IdType="pmc">PMC6287706</ArticleId><ArticleId IdType="pubmed">30297969</ArticleId></ArticleIdList></Reference><Reference><Citation>Merali Z, McIntosh J, Anisman H. Role of bombesin-related peptides in the control of food intake. Neuropeptides. 1999;33:376&#x2013;386. doi: 10.1054/npep.1999.0054.</Citation><ArticleIdList><ArticleId IdType="doi">10.1054/npep.1999.0054</ArticleId><ArticleId IdType="pubmed">10657515</ArticleId></ArticleIdList></Reference><Reference><Citation>Kichaev G, et al. Leveraging polygenic functional enrichment to improve GWAS Power. Am. J. Hum. Genet. 2019;104:65&#x2013;75. doi: 10.1016/j.ajhg.2018.11.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajhg.2018.11.008</ArticleId><ArticleId IdType="pmc">PMC6323418</ArticleId><ArticleId IdType="pubmed">30595370</ArticleId></ArticleIdList></Reference><Reference><Citation>Han Y, et al. Genome-wide analysis highlights contribution of immune system pathways to the genetic architecture of asthma. Nat. Commun. 2020;11:1776. doi: 10.1038/s41467-020-15649-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-15649-3</ArticleId><ArticleId IdType="pmc">PMC7160128</ArticleId><ArticleId IdType="pubmed">32296059</ArticleId></ArticleIdList></Reference><Reference><Citation>Laza-Stanca V, et al. The role of IL-15 deficiency in the pathogenesis of virus-induced asthma exacerbations. PLoS Pathog. 2011;7:e1002114. doi: 10.1371/journal.ppat.1002114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1002114</ArticleId><ArticleId IdType="pmc">PMC3136447</ArticleId><ArticleId IdType="pubmed">21779162</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang N, et al. Reduced IL-2 response from peripheral blood mononuclear cells exposed to bacteria at 6 months of age is associated with elevated total-IgE and allergic rhinitis during the first 7 years of life. eBioMedicine. 2019;43:587&#x2013;593. doi: 10.1016/j.ebiom.2019.04.047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2019.04.047</ArticleId><ArticleId IdType="pmc">PMC6558232</ArticleId><ArticleId IdType="pubmed">31056472</ArticleId></ArticleIdList></Reference><Reference><Citation>de Leeuw C, Savage J, Bucur IG, Heskes T, Posthuma D. Understanding the assumptions underlying Mendelian randomization. Eur. J. Hum. Genet. 2022;30:653&#x2013;660. doi: 10.1038/s41431-022-01038-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41431-022-01038-5</ArticleId><ArticleId IdType="pmc">PMC9177700</ArticleId><ArticleId IdType="pubmed">35082398</ArticleId></ArticleIdList></Reference><Reference><Citation>Overton DL, Mastracci TL. Exocrine&#x2013;endocrine crosstalk: the influence of pancreatic cellular communications on organ growth, function and disease. Front. Endocrinol. 2022;13:904004. doi: 10.3389/fendo.2022.904004.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fendo.2022.904004</ArticleId><ArticleId IdType="pmc">PMC9234176</ArticleId><ArticleId IdType="pubmed">35769082</ArticleId></ArticleIdList></Reference><Reference><Citation>Szklarczyk D, et al. The STRING database in 2023: protein&#x2013;protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Res. 2022;51:D638&#x2013;D646. doi: 10.1093/nar/gkac1000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkac1000</ArticleId><ArticleId IdType="pmc">PMC9825434</ArticleId><ArticleId IdType="pubmed">36370105</ArticleId></ArticleIdList></Reference><Reference><Citation>Saevarsdottir S, et al. FLT3 stop mutation increases FLT3 ligand level and risk of autoimmune thyroid disease. Nature. 2020;584:619&#x2013;623. doi: 10.1038/s41586-020-2436-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2436-0</ArticleId><ArticleId IdType="pubmed">32581359</ArticleId></ArticleIdList></Reference><Reference><Citation>Osterlund PI, Pietil&#xe4; TE, Veckman V, Kotenko SV, Julkunen I. IFN regulatory factor family members differentially regulate the expression of type III IFN (IFN-&#x3bb;) genes. J. Immunol. 2007;179:3434&#x2013;3442. doi: 10.4049/jimmunol.179.6.3434.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.179.6.3434</ArticleId><ArticleId IdType="pubmed">17785777</ArticleId></ArticleIdList></Reference><Reference><Citation>Thareja G, et al. Differences and commonalities in the genetic architecture of protein quantitative trait loci in European and Arab populations. Hum. Mol. Genet. 2023;32:907&#x2013;916. doi: 10.1093/hmg/ddac243.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddac243</ArticleId><ArticleId IdType="pmc">PMC9990988</ArticleId><ArticleId IdType="pubmed">36168886</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu F, et al. Genome-wide genotype-serum proteome mapping provides insights into the cross-ancestry differences in cardiometabolic disease susceptibility. Nat. Commun. 2023;14:896. doi: 10.1038/s41467-023-36491-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-023-36491-3</ArticleId><ArticleId IdType="pmc">PMC9935862</ArticleId><ArticleId IdType="pubmed">36797296</ArticleId></ArticleIdList></Reference><Reference><Citation>Hansson O, et al. The genetic regulation of protein expression in cerebrospinal fluid. EMBO Mol. Med. 2023;15:e16359. doi: 10.15252/emmm.202216359.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/emmm.202216359</ArticleId><ArticleId IdType="pmc">PMC9832827</ArticleId><ArticleId IdType="pubmed">36504281</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang C, et al. Genomic atlas of the proteome from brain, CSF and plasma prioritizes proteins implicated in neurological disorders. Nat. Neurosci. 2021;24:1302&#x2013;1312. doi: 10.1038/s41593-021-00886-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-021-00886-6</ArticleId><ArticleId IdType="pmc">PMC8521603</ArticleId><ArticleId IdType="pubmed">34239129</ArticleId></ArticleIdList></Reference><Reference><Citation>Sirugo G, Williams SM, Tishkoff SA. The missing diversity in human genetic studies. Cell. 2019;177:26&#x2013;31. doi: 10.1016/j.cell.2019.02.048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2019.02.048</ArticleId><ArticleId IdType="pmc">PMC7380073</ArticleId><ArticleId IdType="pubmed">30901543</ArticleId></ArticleIdList></Reference><Reference><Citation>Bycroft C, et al. The UK Biobank resource with deep phenotyping and genomic data. Nature. 2018;562:203&#x2013;209. doi: 10.1038/s41586-018-0579-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-018-0579-z</ArticleId><ArticleId IdType="pmc">PMC6786975</ArticleId><ArticleId IdType="pubmed">30305743</ArticleId></ArticleIdList></Reference><Reference><Citation>Wik L, et al. Proximity extension assay in combination with next-generation sequencing for high-throughput proteome-wide analysis. Mol. Cell. Proteomics. 2021;20:100168. doi: 10.1016/j.mcpro.2021.100168.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mcpro.2021.100168</ArticleId><ArticleId IdType="pmc">PMC8633680</ArticleId><ArticleId IdType="pubmed">34715355</ArticleId></ArticleIdList></Reference><Reference><Citation>Assarsson E, et al. Homogenous 96-Plex PEA immunoassay exhibiting high sensitivity, specificity, and excellent scalability. PLoS ONE. 2014;9:e95192. doi: 10.1371/journal.pone.0095192.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0095192</ArticleId><ArticleId IdType="pmc">PMC3995906</ArticleId><ArticleId IdType="pubmed">24755770</ArticleId></ArticleIdList></Reference><Reference><Citation>Lundberg M, Eriksson A, Tran B, Assarsson E, Fredriksson S. Homogeneous antibody-based proximity extension assays provide sensitive and specific detection of low-abundant proteins in human blood. Nucleic Acids Res. 2011;39:e102. doi: 10.1093/nar/gkr424.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkr424</ArticleId><ArticleId IdType="pmc">PMC3159481</ArticleId><ArticleId IdType="pubmed">21646338</ArticleId></ArticleIdList></Reference><Reference><Citation>Olink Explore 1536 User Manualhttps://www.olink.com/content/uploads/2021/12/olink-explore-1536-expansion-user-manual-1.pdf (Olink Proteomics, 2021).</Citation></Reference><Reference><Citation>Gold L, et al. Aptamer-based multiplexed proteomic technology for biomarker discovery. PLoS ONE. 2010;5:e15004. doi: 10.1371/journal.pone.0015004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0015004</ArticleId><ArticleId IdType="pmc">PMC3000457</ArticleId><ArticleId IdType="pubmed">21165148</ArticleId></ArticleIdList></Reference><Reference><Citation>Rohloff JC, et al. Nucleic acid ligands with protein-like side chains: modified aptamers and their use as diagnostic and therapeutic agents. Mol. Ther. Nucleic Acids. 2014;3:e201. doi: 10.1038/mtna.2014.49.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/mtna.2014.49</ArticleId><ArticleId IdType="pmc">PMC4217074</ArticleId><ArticleId IdType="pubmed">25291143</ArticleId></ArticleIdList></Reference><Reference><Citation>SOMAscan v4 Data Standardization and File Specification Technical Notehttps://www.mcgill.ca/genepi/files/genepi/bqc19_jgh_prt_tech_note_0.pdf (SomaLogic, 2018).</Citation></Reference><Reference><Citation>Eggertsson HP, et al. Graphtyper enables population-scale genotyping using pangenome graphs. Nat. Genet. 2017;49:1654&#x2013;1660. doi: 10.1038/ng.3964.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.3964</ArticleId><ArticleId IdType="pubmed">28945251</ArticleId></ArticleIdList></Reference><Reference><Citation>Wain LV, et al. Novel insights into the genetics of smoking behaviour, lung function, and chronic obstructive pulmonary disease (UK BiLEVE): a genetic association study in UK Biobank. Lancet Respir. Med. 2015;3:769&#x2013;781. doi: 10.1016/S2213-2600(15)00283-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(15)00283-0</ArticleId><ArticleId IdType="pmc">PMC4593935</ArticleId><ArticleId IdType="pubmed">26423011</ArticleId></ArticleIdList></Reference><Reference><Citation>Welsh S, Peakman T, Sheard S, Almond R. Comparison of DNA quantification methodology used in the DNA extraction protocol for the UK Biobank cohort. BMC Genomics. 2017;18:26. doi: 10.1186/s12864-016-3391-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12864-016-3391-x</ArticleId><ArticleId IdType="pmc">PMC5217214</ArticleId><ArticleId IdType="pubmed">28056765</ArticleId></ArticleIdList></Reference><Reference><Citation>Gudbjartsson DF, et al. Large-scale whole-genome sequencing of the Icelandic population. Nat. Genet. 2015;47:435&#x2013;444. doi: 10.1038/ng.3247.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.3247</ArticleId><ArticleId IdType="pubmed">25807286</ArticleId></ArticleIdList></Reference><Reference><Citation>Kong A, et al. Detection of sharing by descent, long-range phasing and haplotype imputation. Nat. Genet. 2008;40:1068&#x2013;1075. doi: 10.1038/ng.216.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.216</ArticleId><ArticleId IdType="pmc">PMC4540081</ArticleId><ArticleId IdType="pubmed">19165921</ArticleId></ArticleIdList></Reference><Reference><Citation>The UniProt Consortium. UniProt: the universal protein knowledgebase in 2021. Nucleic Acids Res. 2021;49:D480&#x2013;D489. doi: 10.1093/nar/gkaa1100.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkaa1100</ArticleId><ArticleId IdType="pmc">PMC7778908</ArticleId><ArticleId IdType="pubmed">33237286</ArticleId></ArticleIdList></Reference><Reference><Citation>Loh P-R, et al. Efficient Bayesian mixed-model analysis increases association power in large cohorts. Nat. Genet. 2015;47:284&#x2013;290. doi: 10.1038/ng.3190.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.3190</ArticleId><ArticleId IdType="pmc">PMC4342297</ArticleId><ArticleId IdType="pubmed">25642633</ArticleId></ArticleIdList></Reference><Reference><Citation>Bulik-Sullivan BK, et al. LD score regression distinguishes confounding from polygenicity in genome-wide association studies. Nat. Genet. 2015;47:291&#x2013;295. doi: 10.1038/ng.3211.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.3211</ArticleId><ArticleId IdType="pmc">PMC4495769</ArticleId><ArticleId IdType="pubmed">25642630</ArticleId></ArticleIdList></Reference><Reference><Citation>Sham PC, Purcell SM. Statistical power and significance testing in large-scale genetic studies. Nat. Rev. Genet. 2014;15:335&#x2013;346. doi: 10.1038/nrg3706.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrg3706</ArticleId><ArticleId IdType="pubmed">24739678</ArticleId></ArticleIdList></Reference><Reference><Citation>Buniello A, et al. The NHGRI-EBI GWAS catalog of published genome-wide association studies, targeted arrays and summary statistics 2019. Nucleic Acids Res. 2019;47:D1005&#x2013;D1012. doi: 10.1093/nar/gky1120.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gky1120</ArticleId><ArticleId IdType="pmc">PMC6323933</ArticleId><ArticleId IdType="pubmed">30445434</ArticleId></ArticleIdList></Reference><Reference><Citation>Uffelmann E, et al. Genome-wide association studies. Nat. Rev. Methods Primers. 2021;1:59. doi: 10.1038/s43586-021-00056-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s43586-021-00056-9</ArticleId></ArticleIdList></Reference><Reference><Citation>Maller JB, et al. Bayesian refinement of association signals for 14 loci in 3 common diseases. Nat. Genet. 2012;44:1294&#x2013;1301. doi: 10.1038/ng.2435.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.2435</ArticleId><ArticleId IdType="pmc">PMC3791416</ArticleId><ArticleId IdType="pubmed">23104008</ArticleId></ArticleIdList></Reference><Reference><Citation>Giambartolomei C, et al. Bayesian test for colocalisation between pairs of genetic association studies using summary statistics. PLoS Genet. 2014;10:e1004383. doi: 10.1371/journal.pgen.1004383.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1004383</ArticleId><ArticleId IdType="pmc">PMC4022491</ArticleId><ArticleId IdType="pubmed">24830394</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37843849</PMID><DateCompleted><Year>2023</Year><Month>12</Month><Day>16</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>23</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2168-6157</ISSN><JournalIssue CitedMedium="Internet"><Volume>80</Volume><Issue>12</Issue><PubDate><Year>2023</Year><Month>Dec</Month><Day>01</Day></PubDate></JournalIssue><Title>JAMA neurology</Title><ISOAbbreviation>JAMA Neurol</ISOAbbreviation></Journal><ArticleTitle>Etiology of White Matter Hyperintensities in Autosomal Dominant and Sporadic Alzheimer Disease.</ArticleTitle><Pagination><StartPage>1353</StartPage><EndPage>1363</EndPage><MedlinePgn>1353-1363</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1001/jamaneurol.2023.3618</ELocationID><Abstract><AbstractText Label="IMPORTANCE">Increased white matter hyperintensity (WMH) volume is a common magnetic resonance imaging (MRI) finding in both autosomal dominant Alzheimer disease (ADAD) and late-onset Alzheimer disease (LOAD), but it remains unclear whether increased WMH along the AD continuum is reflective of AD-intrinsic processes or secondary to elevated systemic vascular risk factors.</AbstractText><AbstractText Label="OBJECTIVE">To estimate the associations of neurodegeneration and parenchymal and vessel amyloidosis with WMH accumulation and investigate whether systemic vascular risk is associated with WMH beyond these AD-intrinsic processes.</AbstractText><AbstractText Label="DESIGN, SETTING, AND PARTICIPANTS">This cohort study used data from 3 longitudinal cohort studies conducted in tertiary and community-based medical centers-the Dominantly Inherited Alzheimer Network (DIAN; February 2010 to March 2020), the Alzheimer's Disease Neuroimaging Initiative (ADNI; July 2007 to September 2021), and the Harvard Aging Brain Study (HABS; September 2010 to December 2019).</AbstractText><AbstractText Label="MAIN OUTCOME AND MEASURES">The main outcomes were the independent associations of neurodegeneration (decreases in gray matter volume), parenchymal amyloidosis (assessed by amyloid positron emission tomography), and vessel amyloidosis (evidenced by cerebral microbleeds [CMBs]) with cross-sectional and longitudinal WMH.</AbstractText><AbstractText Label="RESULTS">Data from 3960 MRI sessions among 1141 participants were included: 252 pathogenic variant carriers from DIAN (mean [SD] age, 38.4 [11.2] years; 137 [54%] female), 571 older adults from ADNI (mean [SD] age, 72.8 [7.3] years; 274 [48%] female), and 318 older adults from HABS (mean [SD] age, 72.4 [7.6] years; 194 [61%] female). Longitudinal increases in WMH volume were greater in individuals with CMBs compared with those without (DIAN: t&#x2009;=&#x2009;3.2 [P&#x2009;=&#x2009;.001]; ADNI: t&#x2009;=&#x2009;2.7 [P&#x2009;=&#x2009;.008]), associated with longitudinal decreases in gray matter volume (DIAN: t&#x2009;=&#x2009;-3.1 [P&#x2009;=&#x2009;.002]; ADNI: t&#x2009;=&#x2009;-5.6 [P&#x2009;&lt;&#x2009;.001]; HABS: t&#x2009;=&#x2009;-2.2 [P&#x2009;=&#x2009;.03]), greater in older individuals (DIAN: t&#x2009;=&#x2009;6.8 [P&#x2009;&lt;&#x2009;.001]; ADNI: t&#x2009;=&#x2009;9.1 [P&#x2009;&lt;&#x2009;.001]; HABS: t&#x2009;=&#x2009;5.4 [P&#x2009;&lt;&#x2009;.001]), and not associated with systemic vascular risk (DIAN: t&#x2009;=&#x2009;0.7 [P&#x2009;=&#x2009;.40]; ADNI: t&#x2009;=&#x2009;0.6 [P&#x2009;=&#x2009;.50]; HABS: t&#x2009;=&#x2009;1.8 [P&#x2009;=&#x2009;.06]) in individuals with ADAD and LOAD after accounting for age, gray matter volume, CMB presence, and amyloid burden. In older adults without CMBs at baseline, greater WMH volume was associated with CMB development during longitudinal follow-up (Cox proportional hazards regression model hazard ratio, 2.63; 95% CI, 1.72-4.03; P&#x2009;&lt;&#x2009;.001).</AbstractText><AbstractText Label="CONCLUSIONS AND RELEVANCE">The findings suggest that increased WMH volume in AD is associated with neurodegeneration and parenchymal and vessel amyloidosis but not with elevated systemic vascular risk. Additionally, increased WMH volume may represent an early sign of vessel amyloidosis preceding the emergence of CMBs.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Shirzadi</LastName><ForeName>Zahra</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Massachusetts General Hospital, Brigham and Women's Hospital, Harvard Medical School, Boston.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schultz</LastName><ForeName>Stephanie A</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>Massachusetts General Hospital, Brigham and Women's Hospital, Harvard Medical School, Boston.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yau</LastName><ForeName>Wai-Ying W</ForeName><Initials>WW</Initials><AffiliationInfo><Affiliation>Massachusetts General Hospital, Brigham and Women's Hospital, Harvard Medical School, Boston.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Joseph-Mathurin</LastName><ForeName>Nelly</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Washington University in St Louis School of Medicine, St Louis, Missouri.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fitzpatrick</LastName><ForeName>Colleen D</ForeName><Initials>CD</Initials><AffiliationInfo><Affiliation>Massachusetts General Hospital, Brigham and Women's Hospital, Harvard Medical School, Boston.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Levin</LastName><ForeName>Raina</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Massachusetts General Hospital, Brigham and Women's Hospital, Harvard Medical School, Boston.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kantarci</LastName><ForeName>Kejal</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Radiology, Mayo Clinic, Rochester, Minnesota.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Preboske</LastName><ForeName>Gregory M</ForeName><Initials>GM</Initials><AffiliationInfo><Affiliation>Department of Radiology, Mayo Clinic, Rochester, Minnesota.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jack</LastName><ForeName>Clifford R</ForeName><Initials>CR</Initials><Suffix>Jr</Suffix><AffiliationInfo><Affiliation>Department of Radiology, Mayo Clinic, Rochester, Minnesota.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Farlow</LastName><ForeName>Martin R</ForeName><Initials>MR</Initials><AffiliationInfo><Affiliation>Indiana Alzheimer's Disease Research Center, Indianapolis.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hassenstab</LastName><ForeName>Jason</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Washington University in St Louis School of Medicine, St Louis, Missouri.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jucker</LastName><ForeName>Mathias</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Cellular Neurology, Hertie Institute for Clinical Brain Research, University of T&#xfc;bingen, T&#xfc;bingen, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>German Center for Neurodegenerative Diseases (DZNE), T&#xfc;bingen, T&#xfc;bingen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morris</LastName><ForeName>John C</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Washington University in St Louis School of Medicine, St Louis, Missouri.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xiong</LastName><ForeName>Chengjie</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Washington University in St Louis School of Medicine, St Louis, Missouri.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Karch</LastName><ForeName>Celeste M</ForeName><Initials>CM</Initials><AffiliationInfo><Affiliation>Washington University in St Louis School of Medicine, St Louis, Missouri.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Levey</LastName><ForeName>Allan I</ForeName><Initials>AI</Initials><AffiliationInfo><Affiliation>Emory University School of Medicine, Atlanta, Georgia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gordon</LastName><ForeName>Brian A</ForeName><Initials>BA</Initials><AffiliationInfo><Affiliation>Washington University in St Louis School of Medicine, St Louis, Missouri.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schofield</LastName><ForeName>Peter R</ForeName><Initials>PR</Initials><AffiliationInfo><Affiliation>Neuroscience Research Australia, Sydney, New South Wales, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Biomedical Sciences, University of New South Wales, Sydney, New South Wales, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Salloway</LastName><ForeName>Stephen P</ForeName><Initials>SP</Initials><AffiliationInfo><Affiliation>Alpert Medical School of Brown University, Providence, Rhode Island.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perrin</LastName><ForeName>Richard J</ForeName><Initials>RJ</Initials><AffiliationInfo><Affiliation>Washington University in St Louis School of Medicine, St Louis, Missouri.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McDade</LastName><ForeName>Eric</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Washington University in St Louis School of Medicine, St Louis, Missouri.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Levin</LastName><ForeName>Johannes</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurology, Ludwig-Maximilians-Universit&#xe4;t M&#xfc;nchen, German Center for Neurodegenerative Diseases, site Munich, Munich Cluster for Systems Neurology, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cruchaga</LastName><ForeName>Carlos</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Washington University in St Louis School of Medicine, St Louis, Missouri.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Allegri</LastName><ForeName>Ricardo F</ForeName><Initials>RF</Initials><AffiliationInfo><Affiliation>Fleni Neurological Institute, Buenos Aires, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fox</LastName><ForeName>Nick C</ForeName><Initials>NC</Initials><AffiliationInfo><Affiliation>UK Dementia Research Institute, University College London, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goate</LastName><ForeName>Alison</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Washington University in St Louis School of Medicine, St Louis, Missouri.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Day</LastName><ForeName>Gregory S</ForeName><Initials>GS</Initials><AffiliationInfo><Affiliation>Department of Neurology, Mayo Clinic, Jacksonville, Florida.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koeppe</LastName><ForeName>Robert</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Radiology, University of Michigan, Ann Arbor.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chui</LastName><ForeName>Helena C</ForeName><Initials>HC</Initials><AffiliationInfo><Affiliation>Keck School of Medicine, University of Southern California, Los Angeles.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Berman</LastName><ForeName>Sarah</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Pittsburgh, Pittsburgh, Pennsylvania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mori</LastName><ForeName>Hiroshi</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Osaka Metropolitan University Medical School, Osaka, Nagaoka Sutoku University, Osaka City, Niigata, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sanchez-Valle</LastName><ForeName>Raquel</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Neurological Tissue Bank Hospital Clinic, IDIBAPS, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Jae-Hong</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rosa-Neto</LastName><ForeName>Pedro</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Montreal Neurological Institute, McGill University, Montreal, Quebec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ruthirakuhan</LastName><ForeName>Myuri</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Sunnybrook Research Institute, University of Toronto, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Che-Yuan</ForeName><Initials>CY</Initials><AffiliationInfo><Affiliation>Sunnybrook Research Institute, University of Toronto, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Swardfager</LastName><ForeName>Walter</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Sunnybrook Research Institute, University of Toronto, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Benzinger</LastName><ForeName>Tammie L S</ForeName><Initials>TLS</Initials><AffiliationInfo><Affiliation>Washington University in St Louis School of Medicine, St Louis, Missouri.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sohrabi</LastName><ForeName>Hamid R</ForeName><Initials>HR</Initials><AffiliationInfo><Affiliation>Centre for Healthy Ageing, School of Psychology, Health Future Institute, Murdoch University, Perth, Western Australia, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martins</LastName><ForeName>Ralph N</ForeName><Initials>RN</Initials><AffiliationInfo><Affiliation>School of Medical and Health Sciences, Edith Cowan University, Perth, Western Australia, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bateman</LastName><ForeName>Randall J</ForeName><Initials>RJ</Initials><AffiliationInfo><Affiliation>Washington University in St Louis School of Medicine, St Louis, Missouri.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Johnson</LastName><ForeName>Keith A</ForeName><Initials>KA</Initials><AffiliationInfo><Affiliation>Massachusetts General Hospital, Brigham and Women's Hospital, Harvard Medical School, Boston.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sperling</LastName><ForeName>Reisa A</ForeName><Initials>RA</Initials><AffiliationInfo><Affiliation>Massachusetts General Hospital, Brigham and Women's Hospital, Harvard Medical School, Boston.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Greenberg</LastName><ForeName>Steven M</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Massachusetts General Hospital, Brigham and Women's Hospital, Harvard Medical School, Boston.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schultz</LastName><ForeName>Aaron P</ForeName><Initials>AP</Initials><AffiliationInfo><Affiliation>Massachusetts General Hospital, Brigham and Women's Hospital, Harvard Medical School, Boston.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chhatwal</LastName><ForeName>Jasmeer P</ForeName><Initials>JP</Initials><AffiliationInfo><Affiliation>Massachusetts General Hospital, Brigham and Women's Hospital, Harvard Medical School, Boston.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>Dominantly Inherited Alzheimer Network and the Alzheimer&#x2019;s Disease Neuroimaging Initiative</CollectiveName></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P30 AG066444</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AG066512</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P01 AG036694</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P01 AG003991</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K01 AG080123</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AG066530</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UF1 AG032438</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AG072947</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AG072972</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AG066514</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P01 AG026276</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 AG024904</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>S10 RR023401</GrantID><Acronym>RR</Acronym><Agency>NCRR NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>RF1 AG079569</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AG072977</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P41 EB015896</GrantID><Acronym>EB</Acronym><Agency>NIBIB NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>S10 RR023043</GrantID><Acronym>RR</Acronym><Agency>NCRR NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U19 AG032438</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS092865</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>S10 RR021110</GrantID><Acronym>RR</Acronym><Agency>NCRR NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JAMA Neurol</MedlineTA><NlmUniqueID>101589536</NlmUniqueID><ISSNLinking>2168-6149</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D058227">Amyloidogenic Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D066127" MajorTopicYN="Y">White Matter</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008137" MajorTopicYN="N">Longitudinal Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008279" MajorTopicYN="N">Magnetic Resonance Imaging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000686" MajorTopicYN="Y">Amyloidosis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058227" MajorTopicYN="N">Amyloidogenic Proteins</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement><b>Conflict of Interest Disclosures:</b> Dr Shirzadi reported receiving grants from the Alzheimer Society of Canada and Health Equity Scholars Program and receiving a BrightFocus Foundation fellowship during the conduct of the study. Dr Joseph-Mathurin reported receiving grants from the Alzheimer&#x2019;s Association and the National Institute on Aging (NIA), National Institutes of Health (NIH) during the conduct of the study. Dr Kantarci reported consulting for Biogen and receiving nonfinancial support from Eli Lilly and Company outside the submitted work. Dr Hassenstab reported receiving personal fees from Eisai, Parabon NanoLabs Inc, Roche, ALZpath, and Prothena outside the submitted work. Dr Morris reported receiving grants from the NIH during the conduct of the study. Dr Karch reported receiving grants from the NIH during the conduct of the study. Dr Levey reported receiving grants from the NIA during the conduct of the study. Dr Schofield reported receiving grants from the NIH and the Anonymous Foundation, paid through Washington University in St Louis, and grants from the Roth Family Foundation during the conduct of the study. Dr Salloway reported receiving grants from Biogen, Eli Lilly and Company, Genentech, Roche, Esai, and Novartis and personal fees from Biogen, Eli Lilly and Company, Genentech, Roche, Eisai, Novartis, Acumen, Novo Nordisk, and Prothena for consulting during the conduct of the study. Dr McDade reported receiving grants from the NIA during the conduct of the study; grants from Eli Lilly and Company, Hoffmann-La Roche, and Eisai outside the submitted work; and personal fees from Alector and Eli Lilly and Company for serving on the data safety and monitoring board and from Alzamend for serving as a scientific advisor outside the submitted work. Dr J. Levin reported receiving personal fees from MODAG GmbH as compensation for work as chief marketing officer; personal fees from Biogen and Teva for lecturing; and personal fees from Eisai for advising, all outside the submitted work. Dr Allegri reported receiving grants from the NIH (subcontract, Washington University in St Louis) and from the Fleni Foundation during the conduct of the study. Dr Fox reported receiving grants from the UK National Institute for Health and Care Research (NIHR) University College London (UCL) Hospitals Biomedical Research Centre and from Rosetrees Trust during the conduct of the study; personal fees from Roche/Genentech, Biogen, Eli Lilly and Company, and Siemens paid to UCL; and nonfinancial support from Ionis for provision of research materials outside the submitted work. Dr Goate reported receiving personal fees from Genentech SAB, Muna Therapeutics SAB, and Biogen for consulting outside the submitted work. Dr Day reported receiving grants from the NIA during the conduct of the study and from the Alzheimer&#x2019;s Association and the Chan Zuckerberg Initiative; receiving personal fees from Parabon NanoLabs Inc, DynaMed (EBSCO), PeerView Media, Inc, and Continuing Education, Inc; having stock holdings in ANI Pharmaceuticals; and receiving nonfinancial support from Avid Radiopharmaceuticals (in-kind contribution of flortaucipir precursor for research) outside the submitted work. Dr Berman reported receiving grants from the NIA during the conduct of the study. Dr Benzinger reported receiving nonfinancial support from Avid Radiopharmaceuticals for radiotracers and precursors during the conduct of the study and receiving personal fees from Eli Lilly and Company, Eisai, Bristol Myers Squibb, and Biogen for consulting and grants from Siemens outside the submitted work. Dr Sohrabi reported receiving personal fees from Alector Therapeutics for serving as director of a private company (SMarT Minds Western Australia, a site for 1 of their clinical trials) and grants paid to the Health Future Institute from Track Dutch-CAA Consortium outside the submitted work. Dr Bateman reported receiving a Zenith Grant from the Alzheimer&#x2019;s Association; grants from the American Health Assistance Foundation, Glenn Foundation, Ruth K. Broad Biomedical Research Foundation, Anonymous Foundation, Merck research collaboration, Alzheimer&#x2019;s Association, Association for Frontotemporal Degeneration FTD Biomarkers Initiative, BrightFocus Foundation, Cure Alzheimer&#x2019;s Fund, Foundation for Barnes-Jewish Hospital, GHR Foundation, MetLife Foundation, Rainwater Foundation, Tau Consortium, Tau SILK Consortium (AbbVie, Biogen, Eli Lilly and Company, Novartis), and Centene; grants from Tracy Family Stable Isotope Labeling Quantitation (SILQ) Center donors Richard Frimel, David and Amy Payne, John and Linda Tracy, Pat and Jane Tracy, Tom and Catherine Tracy, and Robert Willman; and grants from the NfL Consortium (AbbVie, Biogen, Roche, UCL, and BMS). Dr Johnson reported receiving grants from the NIH during the conduct of the study. Dr Sperling reported receiving grants from the NIA during the conduct of the study and consulting for AC Immune, Acumen, Alector, Alnylam, Cytox, Genentech, Janssen, JOMDD, NervGen, Neuraly, Neurocentria, Oligomerix, Prothena, Renew, Shionogi, Vigil Neuroscience, Ionis, and Vaxxinity outside the submitted work. Dr Chhatwal reported receiving grants from the NIH and the BrightFocus Foundation during the conduct of the study and personal fees from ExpertConnect and Humana outside the submitted work. No other disclosures were reported.</CoiStatement><InvestigatorList><Investigator ValidYN="Y"><LastName>Weiner</LastName><ForeName>Michael W</ForeName><Initials>MW</Initials></Investigator><Investigator ValidYN="Y"><LastName>Aisen</LastName><ForeName>Paul</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Petersen</LastName><ForeName>Ronald</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jack</LastName><ForeName>Clifford R</ForeName><Initials>CR</Initials><Suffix>Jr</Suffix></Investigator><Investigator ValidYN="Y"><LastName>Jagust</LastName><ForeName>William</ForeName><Initials>W</Initials></Investigator><Investigator ValidYN="Y"><LastName>Trojanowki</LastName><ForeName>John Q</ForeName><Initials>JQ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Toga</LastName><ForeName>Arthur W</ForeName><Initials>AW</Initials></Investigator><Investigator ValidYN="Y"><LastName>Beckett</LastName><ForeName>Laurel</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Green</LastName><ForeName>Robert C</ForeName><Initials>RC</Initials></Investigator><Investigator ValidYN="Y"><LastName>Saykin</LastName><ForeName>Andrew J</ForeName><Initials>AJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Morris</LastName><ForeName>John C</ForeName><Initials>JC</Initials></Investigator><Investigator ValidYN="Y"><LastName>Perrin</LastName><ForeName>Richard J</ForeName><Initials>RJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Shaw</LastName><ForeName>Leslie M</ForeName><Initials>LM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Khachaturian</LastName><ForeName>Zaven</ForeName><Initials>Z</Initials></Investigator><Investigator ValidYN="Y"><LastName>Carrillo</LastName><ForeName>Maria</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Potter</LastName><ForeName>William</ForeName><Initials>W</Initials></Investigator><Investigator ValidYN="Y"><LastName>Barnes</LastName><ForeName>Lisa</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bernard</LastName><ForeName>Marie</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gonz&#xe1;lez</LastName><ForeName>Hector</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ho</LastName><ForeName>Carole</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hsiao</LastName><ForeName>John K</ForeName><Initials>JK</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jackson</LastName><ForeName>Jonathan</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Masliah</LastName><ForeName>Eliezer</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Masterman</LastName><ForeName>Donna</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Okonkwo</LastName><ForeName>Ozioma</ForeName><Initials>O</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ryan</LastName><ForeName>Laurie</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Silverberg</LastName><ForeName>Nina</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fleisher</LastName><ForeName>Adam</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sacrey</LastName><ForeName>Diana Truran</ForeName><Initials>DT</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fockler</LastName><ForeName>Juliet</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Conti</LastName><ForeName>Cat</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Veitch</LastName><ForeName>Dallas</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Neuhaus</LastName><ForeName>John</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jin</LastName><ForeName>Chengshi</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nosheny</LastName><ForeName>Rachel</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ashford</LastName><ForeName>Miriam</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Flenniken</LastName><ForeName>Derek</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kormos</LastName><ForeName>Adrienne</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Montine</LastName><ForeName>Tom</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rafii</LastName><ForeName>Michael</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Raman</LastName><ForeName>Rema</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jimenez</LastName><ForeName>Gustavo</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Donohue</LastName><ForeName>Michael</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gessert</LastName><ForeName>Devon</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Salazar</LastName><ForeName>Jennifer</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zimmerman</LastName><ForeName>Caileigh</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cabrera</LastName><ForeName>Yuliana</ForeName><Initials>Y</Initials></Investigator><Investigator ValidYN="Y"><LastName>Walter</LastName><ForeName>Sarah</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Miller</LastName><ForeName>Garrett</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Coker</LastName><ForeName>Godfrey</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Clanton</LastName><ForeName>Taylor</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hergesheimer</LastName><ForeName>Lindsey</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Smith</LastName><ForeName>Stephanie</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Adegoke</LastName><ForeName>Olusegun</ForeName><Initials>O</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mahboubi</LastName><ForeName>Payam</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Moore</LastName><ForeName>Shelley</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pizzola</LastName><ForeName>Jeremy</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Shaffer</LastName><ForeName>Elizabeth</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sloan</LastName><ForeName>Brittany</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Harvey</LastName><ForeName>Danielle</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Forghanian-Arani</LastName><ForeName>Arvin</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Borowski</LastName><ForeName>Bret</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ward</LastName><ForeName>Chad</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Schwarz</LastName><ForeName>Christopher</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jones</LastName><ForeName>David</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gunter</LastName><ForeName>Jeff</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kantarci</LastName><ForeName>Kejal</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Senjem</LastName><ForeName>Matthew</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vemuri</LastName><ForeName>Prashanthi</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Reid</LastName><ForeName>Robert</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fox</LastName><ForeName>Nick C</ForeName><Initials>NC</Initials></Investigator><Investigator ValidYN="Y"><LastName>Malone</LastName><ForeName>Ian</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Thompson</LastName><ForeName>Paul</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Thomopoulos</LastName><ForeName>Sophia I</ForeName><Initials>SI</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nir</LastName><ForeName>Talia M</ForeName><Initials>TM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jahanshad</LastName><ForeName>Neda</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>DeCarli</LastName><ForeName>Charles</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Knaack</LastName><ForeName>Alexander</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fletcher</LastName><ForeName>Evan</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tosun-Turgut</LastName><ForeName>Duygu</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chen</LastName><ForeName>Stephanie Rossi</ForeName><Initials>SR</Initials></Investigator><Investigator ValidYN="Y"><LastName>Choe</LastName><ForeName>Mark</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Crawford</LastName><ForeName>Karen</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Yushkevich</LastName><ForeName>Paul A</ForeName><Initials>PA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Das</LastName><ForeName>Sandhitsu</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Koeppe</LastName><ForeName>Robert A</ForeName><Initials>RA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Reiman</LastName><ForeName>Eric M</ForeName><Initials>EM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chen</LastName><ForeName>Kewei</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mathis</LastName><ForeName>Chet</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Landau</LastName><ForeName>Susan</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cairns</LastName><ForeName>Nigel J</ForeName><Initials>NJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Householder</LastName><ForeName>Erin</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Franklin</LastName><ForeName>Erin</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bernhardt</LastName><ForeName>Haley</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Taylor-Reinwald</LastName><ForeName>Lisa</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Korecka</LastName><ForeName>Magdalena</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Figurski</LastName><ForeName>Michael</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Neu</LastName><ForeName>Scott</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nho</LastName><ForeName>Kwangsik</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Risacher</LastName><ForeName>Shannon L</ForeName><Initials>SL</Initials></Investigator><Investigator ValidYN="Y"><LastName>Apostolova</LastName><ForeName>Liana G</ForeName><Initials>LG</Initials></Investigator><Investigator ValidYN="Y"><LastName>Shen</LastName><ForeName>Li</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Foroud</LastName><ForeName>Tatiana M</ForeName><Initials>TM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nudelman</LastName><ForeName>Kelly</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Faber</LastName><ForeName>Kelley</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wilmes</LastName><ForeName>Kristi</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Thal</LastName><ForeName>Leon</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Silbert</LastName><ForeName>Lisa C</ForeName><Initials>LC</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lind</LastName><ForeName>Betty</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Crissey</LastName><ForeName>Rachel</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kaye</LastName><ForeName>Jeffrey A</ForeName><Initials>JA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Carter</LastName><ForeName>Raina</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dolen</LastName><ForeName>Sara</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Quinn</LastName><ForeName>Joseph</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Schneider</LastName><ForeName>Lon S</ForeName><Initials>LS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pawluczyk</LastName><ForeName>Sonia</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Becerra</LastName><ForeName>Mauricio</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Teodoro</LastName><ForeName>Liberty</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dagerman</LastName><ForeName>Karen</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Spann</LastName><ForeName>Bryan M</ForeName><Initials>BM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Brewer</LastName><ForeName>James</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vanderswag</LastName><ForeName>Helen</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ziolkowski</LastName><ForeName>Jaimie</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Heidebrink</LastName><ForeName>Judith L</ForeName><Initials>JL</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zbizek-Nulph</LastName><ForeName>Lisa</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lord</LastName><ForeName>Joanne L</ForeName><Initials>JL</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mason</LastName><ForeName>Sara S</ForeName><Initials>SS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Albers</LastName><ForeName>Colleen S</ForeName><Initials>CS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Knopman</LastName><ForeName>David</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Johnson</LastName><ForeName>Kris</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Villaneuva-Meyer</LastName><ForeName>Javier</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pavlik</LastName><ForeName>Valory</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pacini</LastName><ForeName>Nathaniel</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lamb</LastName><ForeName>Ashley</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kass</LastName><ForeName>Joseph S</ForeName><Initials>JS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Doody</LastName><ForeName>Rachelle S</ForeName><Initials>RS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Shibley</LastName><ForeName>Victoria</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chowdhury</LastName><ForeName>Munir</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rountree</LastName><ForeName>Susan</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dang</LastName><ForeName>Mimi</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Stern</LastName><ForeName>Yaakov</ForeName><Initials>Y</Initials></Investigator><Investigator ValidYN="Y"><LastName>Honig</LastName><ForeName>Lawrence S</ForeName><Initials>LS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mintz</LastName><ForeName>Akiva</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ances</LastName><ForeName>Beau</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Winkfield</LastName><ForeName>David</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Carroll</LastName><ForeName>Maria</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Stobbs-Cucchi</LastName><ForeName>Georgia</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Oliver</LastName><ForeName>Angela</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Creech</LastName><ForeName>Mary L</ForeName><Initials>ML</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mintun</LastName><ForeName>Mark A</ForeName><Initials>MA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Schneider</LastName><ForeName>Stacy</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Geldmacher</LastName><ForeName>David</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Love</LastName><ForeName>Marissa Natelson</ForeName><Initials>MN</Initials></Investigator><Investigator ValidYN="Y"><LastName>Griffith</LastName><ForeName>Randall</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Clark</LastName><ForeName>David</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Brockington</LastName><ForeName>John</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Marson</LastName><ForeName>Daniel</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Grossman</LastName><ForeName>Hillel</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Goldstein</LastName><ForeName>Martin A</ForeName><Initials>MA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Greenberg</LastName><ForeName>Jonathan</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mitsis</LastName><ForeName>Effie</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Shah</LastName><ForeName>Raj C</ForeName><Initials>RC</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lamar</LastName><ForeName>Melissa</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Samuels</LastName><ForeName>Patricia</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Duara</LastName><ForeName>Ranjan</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Greig-Custo</LastName><ForeName>Maria T</ForeName><Initials>MT</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rodriguez</LastName><ForeName>Rosemarie</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Albert</LastName><ForeName>Marilyn</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Onyike</LastName><ForeName>Chiadi</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Farrington</LastName><ForeName>Leonie</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rudow</LastName><ForeName>Scott</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Brichko</LastName><ForeName>Rottislav</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kielb</LastName><ForeName>Stephanie</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Smith</LastName><ForeName>Amanda</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Raj</LastName><ForeName>Balebail Ashok</ForeName><Initials>BA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fargher</LastName><ForeName>Kristin</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sadowski</LastName><ForeName>Martin</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wisniewski</LastName><ForeName>Thomas</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Shulman</LastName><ForeName>Melanie</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Faustin</LastName><ForeName>Arline</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rao</LastName><ForeName>Julia</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Castro</LastName><ForeName>Karen M</ForeName><Initials>KM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ulysse</LastName><ForeName>Anaztasia</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chen</LastName><ForeName>Shannon</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sheikh</LastName><ForeName>Mohammed O</ForeName><Initials>MO</Initials></Investigator><Investigator ValidYN="Y"><LastName>Singleton-Garvin</LastName><ForeName>Jamika</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Doraiswamy</LastName><ForeName>P Murali</ForeName><Initials>PM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Petrella</LastName><ForeName>Jeffrey R</ForeName><Initials>JR</Initials></Investigator><Investigator ValidYN="Y"><LastName>James</LastName><ForeName>Olga</ForeName><Initials>O</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wong</LastName><ForeName>Terence Z</ForeName><Initials>TZ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Borges-Neto</LastName><ForeName>Salvador</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Karlawish</LastName><ForeName>Jason H</ForeName><Initials>JH</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wolk</LastName><ForeName>David A</ForeName><Initials>DA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vaishnavi</LastName><ForeName>Sanjeev</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Clark</LastName><ForeName>Christopher M</ForeName><Initials>CM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Arnold</LastName><ForeName>Steven E</ForeName><Initials>SE</Initials></Investigator><Investigator ValidYN="Y"><LastName>Smith</LastName><ForeName>Charles D</ForeName><Initials>CD</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jicha</LastName><ForeName>Gregory A</ForeName><Initials>GA</Initials></Investigator><Investigator ValidYN="Y"><LastName>El Khouli</LastName><ForeName>Riham</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Raslau</LastName><ForeName>Flavius D</ForeName><Initials>FD</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lopez</LastName><ForeName>Oscar L</ForeName><Initials>OL</Initials></Investigator><Investigator ValidYN="Y"><LastName>Oakley</LastName><ForeName>MaryAnn</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Simpson</LastName><ForeName>Donna M</ForeName><Initials>DM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Porsteinsson</LastName><ForeName>Anton P</ForeName><Initials>AP</Initials></Investigator><Investigator ValidYN="Y"><LastName>Martin</LastName><ForeName>Kim</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kowalski</LastName><ForeName>Nancy</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Keltz</LastName><ForeName>Melanie</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Goldstein</LastName><ForeName>Bonnie S</ForeName><Initials>BS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Makino</LastName><ForeName>Kelly M</ForeName><Initials>KM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ismail</LastName><ForeName>M Saleem</ForeName><Initials>MS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Brand</LastName><ForeName>Connie</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Thai</LastName><ForeName>Gaby</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pierce</LastName><ForeName>Aimee</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Yanez</LastName><ForeName>Beatriz</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sosa</LastName><ForeName>Elizabeth</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Witbracht</LastName><ForeName>Megan</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kelley</LastName><ForeName>Brendan</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nguyen</LastName><ForeName>Trung</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Womack</LastName><ForeName>Kyle</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mathews</LastName><ForeName>Dana</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Quiceno</LastName><ForeName>Mary</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Levey</LastName><ForeName>Allan I</ForeName><Initials>AI</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lah</LastName><ForeName>James J</ForeName><Initials>JJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hajjar</LastName><ForeName>Ihab</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cellar</LastName><ForeName>Janet S</ForeName><Initials>JS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Burns</LastName><ForeName>Jeffrey M</ForeName><Initials>JM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Swerdlow</LastName><ForeName>Russell H</ForeName><Initials>RH</Initials></Investigator><Investigator ValidYN="Y"><LastName>Brooks</LastName><ForeName>William M</ForeName><Initials>WM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Silverman</LastName><ForeName>Daniel H S</ForeName><Initials>DHS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kremen</LastName><ForeName>Sarah</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tingus</LastName><ForeName>Kathleen</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lu</LastName><ForeName>Po H</ForeName><Initials>PH</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bartzokis</LastName><ForeName>George</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Woo</LastName><ForeName>Ellen</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Teng</LastName><ForeName>Edmond</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Graff-Radford</LastName><ForeName>Neill R</ForeName><Initials>NR</Initials></Investigator><Investigator ValidYN="Y"><LastName>Parfitt</LastName><ForeName>Francine</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Poki-Walker</LastName><ForeName>Kim</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Farlow</LastName><ForeName>Martin R</ForeName><Initials>MR</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hake</LastName><ForeName>Ann Marie</ForeName><Initials>AM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Matthews</LastName><ForeName>Brandy R</ForeName><Initials>BR</Initials></Investigator><Investigator ValidYN="Y"><LastName>Brosch</LastName><ForeName>Jared R</ForeName><Initials>JR</Initials></Investigator><Investigator ValidYN="Y"><LastName>Herring</LastName><ForeName>Scott</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>van Dyck</LastName><ForeName>Christopher H</ForeName><Initials>CH</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mecca</LastName><ForeName>Adam P</ForeName><Initials>AP</Initials></Investigator><Investigator ValidYN="Y"><LastName>Good</LastName><ForeName>Susan P</ForeName><Initials>SP</Initials></Investigator><Investigator ValidYN="Y"><LastName>MacAvoy</LastName><ForeName>Martha G</ForeName><Initials>MG</Initials></Investigator><Investigator ValidYN="Y"><LastName>Carson</LastName><ForeName>Richard E</ForeName><Initials>RE</Initials></Investigator><Investigator ValidYN="Y"><LastName>Varma</LastName><ForeName>Pradeep</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chertkow</LastName><ForeName>Howard</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vaitekunis</LastName><ForeName>Susan</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hosein</LastName><ForeName>Chris</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Black</LastName><ForeName>Sandra</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Stefanovic</LastName><ForeName>Bojana</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Heyn</LastName><ForeName>Chris Chinthaka</ForeName><Initials>CC</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hsiung</LastName><ForeName>Ging-Yuek Robin</ForeName><Initials>GR</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kim</LastName><ForeName>Ellen</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mudge</LastName><ForeName>Benita</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sossi</LastName><ForeName>Vesna</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Feldman</LastName><ForeName>Howard</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Assaly</LastName><ForeName>Michele</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Finger</LastName><ForeName>Elizabeth</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pasternak</LastName><ForeName>Stephen</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rachinsky</LastName><ForeName>Irina</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kertesz</LastName><ForeName>Andrew</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Drost</LastName><ForeName>Dick</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rogers</LastName><ForeName>John</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Grant</LastName><ForeName>Ian</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Muse</LastName><ForeName>Brittanie</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rogalski</LastName><ForeName>Emily</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Robson</LastName><ForeName>Jordan</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mesulam</LastName><ForeName>M-Marsel</ForeName><Initials>MM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kerwin</LastName><ForeName>Diana</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wu</LastName><ForeName>Chuang-Kuo</ForeName><Initials>CK</Initials></Investigator><Investigator ValidYN="Y"><LastName>Johnson</LastName><ForeName>Nancy</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lipowski</LastName><ForeName>Kristine</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Weintraub</LastName><ForeName>Sandra</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bonakdarpour</LastName><ForeName>Borna</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pomara</LastName><ForeName>Nunzio</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hernando</LastName><ForeName>Raymundo</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sarrael</LastName><ForeName>Antero</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rosen</LastName><ForeName>Howard J</ForeName><Initials>HJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Miller</LastName><ForeName>Bruce L</ForeName><Initials>BL</Initials></Investigator><Investigator ValidYN="Y"><LastName>Perry</LastName><ForeName>David</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Turner</LastName><ForeName>Raymond Scott</ForeName><Initials>RS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Johnson</LastName><ForeName>Kathleen</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Reynolds</LastName><ForeName>Brigid</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>MCCann</LastName><ForeName>Kelly</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Poe</LastName><ForeName>Jessica</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sperling</LastName><ForeName>Reisa A</ForeName><Initials>RA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Johnson</LastName><ForeName>Keith A</ForeName><Initials>KA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Marshall</LastName><ForeName>Gad A</ForeName><Initials>GA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Yesavage</LastName><ForeName>Jerome</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Taylor</LastName><ForeName>Joy L</ForeName><Initials>JL</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chao</LastName><ForeName>Steven</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Coleman</LastName><ForeName>Jaila</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>White</LastName><ForeName>Jessica D</ForeName><Initials>JD</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lane</LastName><ForeName>Barton</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rosen</LastName><ForeName>Allyson</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tinklenberg</LastName><ForeName>Jared</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Belden</LastName><ForeName>Christine M</ForeName><Initials>CM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Atri</LastName><ForeName>Alireza</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Clark</LastName><ForeName>Kelly A</ForeName><Initials>KA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zamrini</LastName><ForeName>Edward</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sabbagh</LastName><ForeName>Marwan</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Killiany</LastName><ForeName>Ronald</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Stern</LastName><ForeName>Robert</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mez</LastName><ForeName>Jesse</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kowall</LastName><ForeName>Neil</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Budson</LastName><ForeName>Andrew E</ForeName><Initials>AE</Initials></Investigator><Investigator ValidYN="Y"><LastName>Obisesan</LastName><ForeName>Thomas O</ForeName><Initials>TO</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ntekim</LastName><ForeName>Oyonumo E</ForeName><Initials>OE</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wolday</LastName><ForeName>Saba</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Khan</LastName><ForeName>Javed I</ForeName><Initials>JI</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nwulia</LastName><ForeName>Evaristus</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nadarajah</LastName><ForeName>Sheeba</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lerner</LastName><ForeName>Alan</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ogrocki</LastName><ForeName>Paula</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tatsuoka</LastName><ForeName>Curtis</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fatica</LastName><ForeName>Parianne</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Maillard</LastName><ForeName>Pauline</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Olichney</LastName><ForeName>John</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Carmichael</LastName><ForeName>Owen</ForeName><Initials>O</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bates</LastName><ForeName>Vernice</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Capote</LastName><ForeName>Horacio</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rainka</LastName><ForeName>Michelle</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Borrie</LastName><ForeName>Michael</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lee</LastName><ForeName>T-Y</ForeName><Initials>TY</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bartha</LastName><ForeName>Rob</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Johnson</LastName><ForeName>Sterling</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Asthana</LastName><ForeName>Sanjay</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Carlsson</LastName><ForeName>Cynthia M</ForeName><Initials>CM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Perrin</LastName><ForeName>Allison</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Burke</LastName><ForeName>Anna</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Scharre</LastName><ForeName>Douglas W</ForeName><Initials>DW</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kataki</LastName><ForeName>Maria</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tarawneh</LastName><ForeName>Rawan</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hart</LastName><ForeName>David</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zimmerman</LastName><ForeName>Earl A</ForeName><Initials>EA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Celmins</LastName><ForeName>Dzintra</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Miller</LastName><ForeName>Delwyn D</ForeName><Initials>DD</Initials></Investigator><Investigator ValidYN="Y"><LastName>Boles Ponto</LastName><ForeName>Laura L</ForeName><Initials>LL</Initials></Investigator><Investigator ValidYN="Y"><LastName>Smith</LastName><ForeName>Karen Ekstam</ForeName><Initials>KE</Initials></Investigator><Investigator ValidYN="Y"><LastName>Koleva</LastName><ForeName>Hristina</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Shim</LastName><ForeName>Hyungsub</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nam</LastName><ForeName>Ki Won</ForeName><Initials>KW</Initials></Investigator><Investigator ValidYN="Y"><LastName>Schtulz</LastName><ForeName>Susan K</ForeName><Initials>SK</Initials></Investigator><Investigator ValidYN="Y"><LastName>Williamson</LastName><ForeName>Jeff D</ForeName><Initials>JD</Initials></Investigator><Investigator ValidYN="Y"><LastName>Craft</LastName><ForeName>Suzanne</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cleveland</LastName><ForeName>Jo</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Yang</LastName><ForeName>Mia</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sink</LastName><ForeName>Kaycee M</ForeName><Initials>KM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ott</LastName><ForeName>Brian R</ForeName><Initials>BR</Initials></Investigator><Investigator ValidYN="Y"><LastName>Drake</LastName><ForeName>Jonathan</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tremont</LastName><ForeName>Geoffrey</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Daiello</LastName><ForeName>Lori A</ForeName><Initials>LA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ritter</LastName><ForeName>Aaron</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bernick</LastName><ForeName>Charles</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Munic</LastName><ForeName>Donna</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>O'Connell</LastName><ForeName>Abigail</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mintzer</LastName><ForeName>Jacobo</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wiliams</LastName><ForeName>Arthur</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Masdeu</LastName><ForeName>Joseph</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Shi</LastName><ForeName>Jiong</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Garcia</LastName><ForeName>Angelica</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Newhouse</LastName><ForeName>Paul</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Potkin</LastName><ForeName>Steven</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Salloway</LastName><ForeName>Steven</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Malloy</LastName><ForeName>Paul</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Correia</LastName><ForeName>Stephen</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kittur</LastName><ForeName>Smita</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pearlson</LastName><ForeName>Godfrey D</ForeName><Initials>GD</Initials></Investigator><Investigator ValidYN="Y"><LastName>Blank</LastName><ForeName>Karen</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Anderson</LastName><ForeName>Karen</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Flashman</LastName><ForeName>Laura A</ForeName><Initials>LA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Seltzer</LastName><ForeName>Marc</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hynes</LastName><ForeName>Mary L</ForeName><Initials>ML</Initials></Investigator><Investigator ValidYN="Y"><LastName>Santulli</LastName><ForeName>Robert B</ForeName><Initials>RB</Initials></Investigator><Investigator ValidYN="Y"><LastName>Relkin</LastName><ForeName>Norman</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chiang</LastName><ForeName>Gloria</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lee</LastName><ForeName>Athena</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lin</LastName><ForeName>Michael</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ravdin</LastName><ForeName>Lisa</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sood</LastName><ForeName>Ajay</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Blanchard</LastName><ForeName>Kimberly S</ForeName><Initials>KS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fleischman</LastName><ForeName>Debra</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Arfanakis</LastName><ForeName>Konstantinos</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Varon</LastName><ForeName>Daniel</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Greig</LastName><ForeName>Maria T</ForeName><Initials>MT</Initials></Investigator><Investigator ValidYN="Y"><LastName>Goldstein</LastName><ForeName>Bonnie</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Martin</LastName><ForeName>Kimberly S</ForeName><Initials>KS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Reist</LastName><ForeName>Christopher</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sadowsky</LastName><ForeName>Carl</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Martinez</LastName><ForeName>Walter</ForeName><Initials>W</Initials></Investigator><Investigator ValidYN="Y"><LastName>Villena</LastName><ForeName>Teresa</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rosen</LastName><ForeName>Howard</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Marshall</LastName><ForeName>Gad</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Peskind</LastName><ForeName>Elaine R</ForeName><Initials>ER</Initials></Investigator><Investigator ValidYN="Y"><LastName>Petrie</LastName><ForeName>Eric C</ForeName><Initials>EC</Initials></Investigator><Investigator ValidYN="Y"><LastName>Li</LastName><ForeName>Gail</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Noble</LastName><ForeName>James M</ForeName><Initials>JM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Voglein</LastName><ForeName>Jonathan</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chrem Mendez</LastName><ForeName>Patricio</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Surace</LastName><ForeName>Ezequiel</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ikonomovic</LastName><ForeName>Snezana</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nadkarni</LastName><ForeName>Neelesh K</ForeName><Initials>NK</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lopera</LastName><ForeName>Francisco</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ramirez</LastName><ForeName>Laura</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Aguillon</LastName><ForeName>David</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Leon</LastName><ForeName>Yudy</ForeName><Initials>Y</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ramos</LastName><ForeName>Claudia</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Alzate</LastName><ForeName>Diana</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Baena</LastName><ForeName>Ana</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Londono</LastName><ForeName>Natalia</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Moreno</LastName><ForeName>Sonia</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Laske</LastName><ForeName>Christoph</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kuder-Buletta</LastName><ForeName>Elke</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Graber-Sultan</LastName><ForeName>Susanne</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Preische</LastName><ForeName>Oliver</ForeName><Initials>O</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hofmann</LastName><ForeName>Anna</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ikeuchi</LastName><ForeName>Takeshi</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kasuga</LastName><ForeName>Kensaku</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Niimi</LastName><ForeName>Yoshiki</ForeName><Initials>Y</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ishii</LastName><ForeName>Kenji</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Senda</LastName><ForeName>Michio</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cash</LastName><ForeName>Dave</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Roh</LastName><ForeName>Jee Hoon</ForeName><Initials>JH</Initials></Investigator><Investigator ValidYN="Y"><LastName>Riddle</LastName><ForeName>Meghan C</ForeName><Initials>MC</Initials></Investigator><Investigator ValidYN="Y"><LastName>Menard</LastName><ForeName>William</ForeName><Initials>W</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bodge</LastName><ForeName>Courtney</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Surti</LastName><ForeName>Mustafa</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Takada</LastName><ForeName>Leonel Tadao</ForeName><Initials>LT</Initials></Investigator><Investigator ValidYN="Y"><LastName>Farlow</LastName><ForeName>Martin</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sanchez-Gonzalez</LastName><ForeName>V J</ForeName><Initials>VJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Orozco-Barajas</LastName><ForeName>Maribel</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Renton</LastName><ForeName>Alan E</ForeName><Initials>AE</Initials></Investigator><Investigator ValidYN="Y"><LastName>Esposito</LastName><ForeName>Bianca T</ForeName><Initials>BT</Initials></Investigator><Investigator ValidYN="Y"><LastName>Karch</LastName><ForeName>Celeste M</ForeName><Initials>CM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Marsh</LastName><ForeName>Jacob</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fernanadez</LastName><ForeName>Victoria</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jerome</LastName><ForeName>Gina</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Herries</LastName><ForeName>Elizabeth</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Llibre-Guerra</LastName><ForeName>Jorge</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Johnson</LastName><ForeName>Erik C B</ForeName><Initials>ECB</Initials></Investigator><Investigator ValidYN="Y"><LastName>Seyfried</LastName><ForeName>Nicholas T</ForeName><Initials>NT</Initials></Investigator><Investigator ValidYN="Y"><LastName>Brooks</LastName><ForeName>William S</ForeName><Initials>WS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bechara</LastName><ForeName>Jacob A</ForeName><Initials>JA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Franklin</LastName><ForeName>Erin E</ForeName><Initials>EE</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chen</LastName><ForeName>Allison</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chen</LastName><ForeName>Charles</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Flores</LastName><ForeName>Shaney</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hantler</LastName><ForeName>Nancy</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hornbeck</LastName><ForeName>Russ</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jarman</LastName><ForeName>Steve</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Keefe</LastName><ForeName>Sarah</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Koudelis</LastName><ForeName>Deborah</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Massoumzadeh</LastName><ForeName>Parinaz</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>McCullough</LastName><ForeName>Austin</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>McKay</LastName><ForeName>Nicole</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nicklaus</LastName><ForeName>Joyce</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pulizos</LastName><ForeName>Christine</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wang</LastName><ForeName>Qing</ForeName><Initials>Q</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mishall</LastName><ForeName>Sheetal</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sabaredzovic</LastName><ForeName>Edita</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Deng</LastName><ForeName>Emily</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Candela</LastName><ForeName>Madison</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Smith</LastName><ForeName>Hunter</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hobbs</LastName><ForeName>Diana</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Scott</LastName><ForeName>Jalen</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Xiong</LastName><ForeName>Chengjie</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wang</LastName><ForeName>Peter</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Xu</LastName><ForeName>Xiong</ForeName><Initials>X</Initials></Investigator><Investigator ValidYN="Y"><LastName>Li</LastName><ForeName>Yan</ForeName><Initials>Y</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gremminger</LastName><ForeName>Emily</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ma</LastName><ForeName>Yinjiao</ForeName><Initials>Y</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bui</LastName><ForeName>Ryan</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lu</LastName><ForeName>Ruijin</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Martins</LastName><ForeName>Ralph</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sosa Ortiz</LastName><ForeName>Ana Luisa</ForeName><Initials>AL</Initials></Investigator><Investigator ValidYN="Y"><LastName>Daniels</LastName><ForeName>Alisha</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Courtney</LastName><ForeName>Laura</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mori</LastName><ForeName>Hiroshi</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Supnet-Bell PhD Csb</LastName><ForeName>Charlene</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Xu</LastName><ForeName>Jinbin</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ringman</LastName><ForeName>John</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Barthelemy</LastName><ForeName>Nicolas</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Smith</LastName><ForeName>Jennifer</ForeName><Initials>J</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>12</Month><Day>17</Day><Hour>9</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>10</Month><Day>16</Day><Hour>12</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>10</Month><Day>16</Day><Hour>11</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>16</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37843849</ArticleId><ArticleId IdType="pmc">PMC10580156</ArticleId><ArticleId IdType="doi">10.1001/jamaneurol.2023.3618</ArticleId><ArticleId IdType="pii">2810315</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Smith EE. What turns the white matter white? metabolomic clues to the origin of age-related cerebral white matter hyperintensities. Circulation. 2022;145(14):1053-1055. doi:10.1161/CIRCULATIONAHA.122.059281</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.122.059281</ArticleId><ArticleId IdType="pubmed">35377744</ArticleId></ArticleIdList></Reference><Reference><Citation>McAleese KE, Miah M, Graham S, et al. . Frontal white matter lesions in Alzheimer&#x2019;s disease are associated with both small vessel disease and AD-associated cortical pathology. Acta Neuropathol. 2021;142(6):937-950. doi:10.1007/s00401-021-02376-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-021-02376-2</ArticleId><ArticleId IdType="pmc">PMC8568857</ArticleId><ArticleId IdType="pubmed">34608542</ArticleId></ArticleIdList></Reference><Reference><Citation>McAleese KE, Walker L, Graham S, et al. . Parietal white matter lesions in Alzheimer&#x2019;s disease are associated with cortical neurodegenerative pathology, but not with small vessel disease. Acta Neuropathol. 2017;134(3):459-473. doi:10.1007/s00401-017-1738-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-017-1738-2</ArticleId><ArticleId IdType="pmc">PMC5563333</ArticleId><ArticleId IdType="pubmed">28638989</ArticleId></ArticleIdList></Reference><Reference><Citation>Ungvari Z, Toth P, Tarantini S, et al. . Hypertension-induced cognitive impairment: from pathophysiology to public health. Nat Rev Nephrol. 2021;17(10):639-654. doi:10.1038/s41581-021-00430-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41581-021-00430-6</ArticleId><ArticleId IdType="pmc">PMC8202227</ArticleId><ArticleId IdType="pubmed">34127835</ArticleId></ArticleIdList></Reference><Reference><Citation>Schoemaker D, Zanon Zotin MC, Chen K, et al. . White matter hyperintensities are a prominent feature of autosomal dominant Alzheimer&#x2019;s disease that emerge prior to dementia. Alzheimers Res Ther. 2022;14(1):89. doi:10.1186/s13195-022-01030-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13195-022-01030-7</ArticleId><ArticleId IdType="pmc">PMC9245224</ArticleId><ArticleId IdType="pubmed">35768838</ArticleId></ArticleIdList></Reference><Reference><Citation>Araque Caballero M&#xc1;, Su&#xe1;rez-Calvet M, Duering M, et al. . White matter diffusion alterations precede symptom onset in autosomal dominant Alzheimer&#x2019;s disease. Brain. 2018;141(10):3065-3080. doi:10.1093/brain/awy229</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awy229</ArticleId><ArticleId IdType="pmc">PMC6158739</ArticleId><ArticleId IdType="pubmed">30239611</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee S, Viqar F, Zimmerman ME, et al. ; Dominantly Inherited Alzheimer Network . White matter hyperintensities are a core feature of Alzheimer&#x2019;s disease: evidence from the dominantly inherited Alzheimer network. Ann Neurol. 2016;79(6):929-939. doi:10.1002/ana.24647</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.24647</ArticleId><ArticleId IdType="pmc">PMC4884146</ArticleId><ArticleId IdType="pubmed">27016429</ArticleId></ArticleIdList></Reference><Reference><Citation>McAleese KE, Firbank M, Dey M, et al. . Cortical tau load is associated with white matter hyperintensities. Acta Neuropathol Commun. 2015;3:60. doi:10.1186/s40478-015-0240-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-015-0240-0</ArticleId><ArticleId IdType="pmc">PMC4589169</ArticleId><ArticleId IdType="pubmed">26419828</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshita M, Fletcher E, Harvey D, et al. . Extent and distribution of white matter hyperintensities in normal aging, MCI, and AD. Neurology. 2006;67(12):2192-2198. doi:10.1212/01.wnl.0000249119.95747.1f</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000249119.95747.1f</ArticleId><ArticleId IdType="pmc">PMC3776588</ArticleId><ArticleId IdType="pubmed">17190943</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma R, Sekhon S, Cascella M. White matter lesions. In: StatPearls. StatPearls Publishing; 2022.</Citation></Reference><Reference><Citation>Wardlaw JM, Vald&#xe9;s Hern&#xe1;ndez MC, Mu&#xf1;oz-Maniega S. What are white matter hyperintensities made of? relevance to vascular cognitive impairment. J Am Heart Assoc. 2015;4(6):001140. doi:10.1161/JAHA.114.001140</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.114.001140</ArticleId><ArticleId IdType="pmc">PMC4599520</ArticleId><ArticleId IdType="pubmed">26104658</ArticleId></ArticleIdList></Reference><Reference><Citation>Thal DR, Ghebremedhin E, Orantes M, Wiestler OD. Vascular pathology in Alzheimer disease: correlation of cerebral amyloid angiopathy and arteriosclerosis/lipohyalinosis with cognitive decline. J Neuropathol Exp Neurol. 2003;62(12):1287-1301. doi:10.1093/jnen/62.12.1287</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jnen/62.12.1287</ArticleId><ArticleId IdType="pubmed">14692704</ArticleId></ArticleIdList></Reference><Reference><Citation>P&#xe5;lhaugen L, Sudre CH, Tecelao S, et al. . Brain amyloid and vascular risk are related to distinct white matter hyperintensity patterns. J Cereb Blood Flow Metab. 2021;41(5):1162-1174. doi:10.1177/0271678X20957604</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0271678X20957604</ArticleId><ArticleId IdType="pmc">PMC8054718</ArticleId><ArticleId IdType="pubmed">32955960</ArticleId></ArticleIdList></Reference><Reference><Citation>Caetano A, Ladeira F, Barbosa R, Calado S, Viana-Baptista M. Cerebral amyloid angiopathy&#x2014;the modified Boston criteria in clinical practice. J Neurol Sci. 2018;384:55-57. doi:10.1016/j.jns.2017.11.021</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2017.11.021</ArticleId><ArticleId IdType="pubmed">29249378</ArticleId></ArticleIdList></Reference><Reference><Citation>Shirzadi Z, Yau WW, Schultz SA, et al. ; DIAN Investigators . progressive white matter injury in preclinical Dutch cerebral amyloid angiopathy. Ann Neurol. 2022;92(3):358-363. doi:10.1002/ana.26429</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.26429</ArticleId><ArticleId IdType="pmc">PMC9391284</ArticleId><ArticleId IdType="pubmed">35670654</ArticleId></ArticleIdList></Reference><Reference><Citation>Leys D, Pruvo JP, Parent M, et al. . Could Wallerian degeneration contribute to &#x201c;leuko-araiosis&#x201d; in subjects free of any vascular disorder? J Neurol Neurosurg Psychiatry. 1991;54(1):46-50. doi:10.1136/jnnp.54.1.46</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.54.1.46</ArticleId><ArticleId IdType="pmc">PMC1014298</ArticleId><ArticleId IdType="pubmed">2010759</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris JC, Aisen PS, Bateman RJ, et al. . Developing an international network for Alzheimer research: the Dominantly Inherited Alzheimer Network. Clin Investig (Lond). 2012;2(10):975-984. doi:10.4155/cli.12.93</Citation><ArticleIdList><ArticleId IdType="doi">10.4155/cli.12.93</ArticleId><ArticleId IdType="pmc">PMC3489185</ArticleId><ArticleId IdType="pubmed">23139856</ArticleId></ArticleIdList></Reference><Reference><Citation>Mojiri Forooshani P, Biparva M, Ntiri EE, et al. . Deep Bayesian networks for uncertainty estimation and adversarial resistance of white matter hyperintensity segmentation. Hum Brain Mapp. 2022;43(7):2089-2108. doi:10.1002/hbm.25784</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hbm.25784</ArticleId><ArticleId IdType="pmc">PMC8996363</ArticleId><ArticleId IdType="pubmed">35088930</ArticleId></ArticleIdList></Reference><Reference><Citation>AICONSLab . Welcome to HyperMapp3r&#x2019;s documentation! 2020. Accessed September 2, 2023. https://hypermapp3r.readthedocs.io/en/latest/</Citation></Reference><Reference><Citation>Jenkinson M, Smith S. A global optimisation method for robust affine registration of brain images. Med Image Anal. 2001;5(2):143-156. doi:10.1016/S1361-8415(01)00036-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1361-8415(01)00036-6</ArticleId><ArticleId IdType="pubmed">11516708</ArticleId></ArticleIdList></Reference><Reference><Citation>Reuter M, Schmansky NJ, Rosas HD, Fischl B. Within-subject template estimation for unbiased longitudinal image analysis. Neuroimage. 2012;61(4):1402-1418. doi:10.1016/j.neuroimage.2012.02.084</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroimage.2012.02.084</ArticleId><ArticleId IdType="pmc">PMC3389460</ArticleId><ArticleId IdType="pubmed">22430496</ArticleId></ArticleIdList></Reference><Reference><Citation>Kantarci K, Gunter JL, Tosakulwong N, et al. ; Alzheimer&#x2019;s Disease Neuroimaging Initiative . Focal hemosiderin deposits and &#x3b2;-amyloid load in the ADNI cohort. Alzheimers Dement. 2013;9(5)(suppl):S116-S123. doi:10.1016/j.jalz.2012.10.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2012.10.011</ArticleId><ArticleId IdType="pmc">PMC3770782</ArticleId><ArticleId IdType="pubmed">23375568</ArticleId></ArticleIdList></Reference><Reference><Citation>Fotiadis P, van Rooden S, van der Grond J, et al. ; Alzheimer&#x2019;s Disease Neuroimaging Initiative . Cortical atrophy in patients with cerebral amyloid angiopathy: a case-control study. Lancet Neurol. 2016;15(8):811-819. doi:10.1016/S1474-4422(16)30030-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(16)30030-8</ArticleId><ArticleId IdType="pmc">PMC5248657</ArticleId><ArticleId IdType="pubmed">27180034</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Y, Blazey TM, Owen CJ, et al. ; Dominantly Inherited Alzheimer Network . Quantitative amyloid imaging in autosomal dominant alzheimer&#x2019;s disease: results from the DIAN study group. PLoS One. 2016;11(3):e0152082. doi:10.1371/journal.pone.0152082</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0152082</ArticleId><ArticleId IdType="pmc">PMC4807073</ArticleId><ArticleId IdType="pubmed">27010959</ArticleId></ArticleIdList></Reference><Reference><Citation>Jagust WJ, Landau SM, Koeppe RA, et al. . The Alzheimer&#x2019;s Disease Neuroimaging Initiative 2 PET Core: 2015. Alzheimers Dement. 2015;11(7):757-771. doi:10.1016/j.jalz.2015.05.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2015.05.001</ArticleId><ArticleId IdType="pmc">PMC4510459</ArticleId><ArticleId IdType="pubmed">26194311</ArticleId></ArticleIdList></Reference><Reference><Citation>Rabin JS, Schultz AP, Hedden T, et al. . Interactive associations of vascular risk and &#x3b2;-amyloid burden with cognitive decline in clinically normal elderly individuals: findings from the Harvard Aging Brain Study. JAMA Neurol. 2018;75(9):1124-1131. doi:10.1001/jamaneurol.2018.1123</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2018.1123</ArticleId><ArticleId IdType="pmc">PMC6143121</ArticleId><ArticleId IdType="pubmed">29799986</ArticleId></ArticleIdList></Reference><Reference><Citation>Alzheimer&#x2019;s Disease Neuroimaging Initiative . 2017. Accessed December 6, 2022. https://adni.loni.usc.edu/</Citation></Reference><Reference><Citation>Yau WW, Shirzadi Z, Yang HS, et al. . Tau mediates synergistic influence of vascular risk and A&#x3b2; on cognitive decline. Ann Neurol. 2022;92(5):745-755. doi:10.1002/ana.26460</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.26460</ArticleId><ArticleId IdType="pmc">PMC9650958</ArticleId><ArticleId IdType="pubmed">35880989</ArticleId></ArticleIdList></Reference><Reference><Citation>Chhatwal JP, Schultz SA, McDade E, et al. ; Dominantly Inherited Alzheimer&#x2019;s Network Investigators . Variant-dependent heterogeneity in amyloid &#x3b2; burden in autosomal dominant Alzheimer&#x2019;s disease: cross-sectional and longitudinal analyses of an observational study. Lancet Neurol. 2022;21(2):140-152. doi:10.1016/S1474-4422(21)00375-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(21)00375-6</ArticleId><ArticleId IdType="pmc">PMC8956209</ArticleId><ArticleId IdType="pubmed">35065037</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Agostino RB Sr, Vasan RS, Pencina MJ, et al. . General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation. 2008;117(6):743-753. doi:10.1161/CIRCULATIONAHA.107.699579</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.107.699579</ArticleId><ArticleId IdType="pubmed">18212285</ArticleId></ArticleIdList></Reference><Reference><Citation>Cairns NJ, Perrin RJ, Franklin EE, et al. ; Alzheimer Disease Neuroimaging Initiative; Dominantly Inherited Alzheimer Network . Neuropathologic assessment of participants in two multi-center longitudinal observational studies: the Alzheimer Disease Neuroimaging Initiative (ADNI) and the Dominantly Inherited Alzheimer Network (DIAN). Neuropathology. 2015;35(4):390-400. doi:10.1111/neup.12205</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/neup.12205</ArticleId><ArticleId IdType="pmc">PMC4521391</ArticleId><ArticleId IdType="pubmed">25964057</ArticleId></ArticleIdList></Reference><Reference><Citation>Sliz E, Shin J, Ahmad S, et al. ; NeuroCHARGE Working Group . Circulating metabolome and white matter hyperintensities in women and men. Circulation. 2022;145(14):1040-1052. doi:10.1161/CIRCULATIONAHA.121.056892</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.121.056892</ArticleId><ArticleId IdType="pmc">PMC9645366</ArticleId><ArticleId IdType="pubmed">35050683</ArticleId></ArticleIdList></Reference><Reference><Citation>Wardlaw JM, Allerhand M, Doubal FN, et al. . Vascular risk factors, large-artery atheroma, and brain white matter hyperintensities. Neurology. 2014;82(15):1331-1338. doi:10.1212/WNL.0000000000000312</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000000312</ArticleId><ArticleId IdType="pmc">PMC4001185</ArticleId><ArticleId IdType="pubmed">24623838</ArticleId></ArticleIdList></Reference><Reference><Citation>Graff-Radford J, Arenaza-Urquijo EM, Knopman DS, et al. . White matter hyperintensities: relationship to amyloid and tau burden. Brain. 2019;142(8):2483-2491. doi:10.1093/brain/awz162</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awz162</ArticleId><ArticleId IdType="pmc">PMC6658846</ArticleId><ArticleId IdType="pubmed">31199475</ArticleId></ArticleIdList></Reference><Reference><Citation>Scott MR, Hampton OL, Buckley RF, et al. . Inferior temporal tau is associated with accelerated prospective cortical thinning in clinically normal older adults. Neuroimage. 2020;220:116991. doi:10.1016/j.neuroimage.2020.116991</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroimage.2020.116991</ArticleId><ArticleId IdType="pmc">PMC7572623</ArticleId><ArticleId IdType="pubmed">32512123</ArticleId></ArticleIdList></Reference><Reference><Citation>Sepulcre J, Schultz AP, Sabuncu M, et al. . In vivo tau, amyloid, and gray matter profiles in the aging brain. J Neurosci. 2016;36(28):7364-7374. doi:10.1523/JNEUROSCI.0639-16.2016</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.0639-16.2016</ArticleId><ArticleId IdType="pmc">PMC4945661</ArticleId><ArticleId IdType="pubmed">27413148</ArticleId></ArticleIdList></Reference><Reference><Citation>Joseph-Mathurin N, Wang G, Kantarci K, et al. ; Dominantly Inherited Alzheimer Network . Longitudinal accumulation of cerebral microhemorrhages in dominantly inherited Alzheimer disease. Neurology. 2021;96(12):e1632-e1645. doi:10.1212/WNL.0000000000011542</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000011542</ArticleId><ArticleId IdType="pmc">PMC8032370</ArticleId><ArticleId IdType="pubmed">33495373</ArticleId></ArticleIdList></Reference><Reference><Citation>Marma AK, Lloyd-Jones DM. Systematic examination of the updated Framingham Heart Study general cardiovascular risk profile. Circulation. 2009;120(5):384-390. doi:10.1161/CIRCULATIONAHA.108.835470</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.108.835470</ArticleId><ArticleId IdType="pubmed">19620502</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashford MT, Raman R, Miller G, et al. ; Alzheimer&#x2019;s Disease Neuroimaging Initiative . Screening and enrollment of underrepresented ethnocultural and educational populations in the Alzheimer&#x2019;s Disease Neuroimaging Initiative (ADNI). Alzheimers Dement. 2022;18(12):2603-2613. doi:10.1002/alz.12640</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alz.12640</ArticleId><ArticleId IdType="pmc">PMC9402812</ArticleId><ArticleId IdType="pubmed">35213778</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37853914</PMID><DateCompleted><Year>2023</Year><Month>12</Month><Day>04</Day></DateCompleted><DateRevised><Year>2023</Year><Month>12</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1460-2075</ISSN><JournalIssue CitedMedium="Internet"><Volume>42</Volume><Issue>23</Issue><PubDate><Year>2023</Year><Month>Dec</Month><Day>01</Day></PubDate></JournalIssue><Title>The EMBO journal</Title><ISOAbbreviation>EMBO J</ISOAbbreviation></Journal><ArticleTitle>APP substrate ectodomain defines amyloid-&#x3b2; peptide length by restraining &#x3b3;-secretase processivity and facilitating product release.</ArticleTitle><Pagination><StartPage>e114372</StartPage><MedlinePgn>e114372</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e114372</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.15252/embj.2023114372</ELocationID><Abstract><AbstractText>Sequential proteolysis of the amyloid precursor protein (APP) by &#x3b3;-secretases generates amyloid-&#x3b2; (A&#x3b2;) peptides and defines the proportion of short-to-long A&#x3b2; peptides, which is tightly connected to Alzheimer's disease (AD) pathogenesis. Here, we study the mechanism that controls substrate processing by &#x3b3;-secretases and A&#x3b2; peptide length. We found that polar interactions established by the APP<sub>C99</sub> ectodomain (ECD), involving but not limited to its juxtamembrane region, restrain both the extent and degree of &#x3b3;-secretases processive cleavage by destabilizing enzyme-substrate interactions. We show that increasing hydrophobicity, via mutation or ligand binding, at APP<sub>C99</sub> -ECD attenuates substrate-driven product release and rescues the effects of Alzheimer's disease-associated pathogenic &#x3b3;-secretase and APP variants on A&#x3b2; length. In addition, our study reveals that APP<sub>C99</sub> -ECD facilitates the paradoxical production of longer A&#x3b2;s caused by some &#x3b3;-secretase inhibitors, which act as high-affinity competitors of the substrate. These findings assign a pivotal role to the substrate ECD in the sequential proteolysis by &#x3b3;-secretases and suggest it as a sweet&#xa0;spot for the potential design of APP-targeting compounds selectively promoting its processing by these enzymes.</AbstractText><CopyrightInformation>&#xa9; 2023 The Authors. Published under the terms of the CC BY NC ND 4.0 license.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Koch</LastName><ForeName>Matthias</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-1015-1577</Identifier><AffiliationInfo><Affiliation>VIB/KU Leuven, VIB-KU Leuven Center for Brain and Disease Research, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Enzlein</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0003-1789-4090</Identifier><AffiliationInfo><Affiliation>VIB/KU Leuven, VIB-KU Leuven Center for Brain and Disease Research, Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Mass Spectrometry and Optical Spectroscopy (CeMOS), Mannheim University of Applied Sciences, Mannheim, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Shu-Yu</ForeName><Initials>SY</Initials><Identifier Source="ORCID">0009-0009-1762-0269</Identifier><AffiliationInfo><Affiliation>Physics Department and Center of Functional Protein Assemblies, Technical University of Munich, Garching, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Petit</LastName><ForeName>Dieter</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0001-5721-8041</Identifier><AffiliationInfo><Affiliation>VIB/KU Leuven, VIB-KU Leuven Center for Brain and Disease Research, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lismont</LastName><ForeName>Sam</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>VIB/KU Leuven, VIB-KU Leuven Center for Brain and Disease Research, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zacharias</LastName><ForeName>Martin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Physics Department and Center of Functional Protein Assemblies, Technical University of Munich, Garching, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hopf</LastName><ForeName>Carsten</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Center for Mass Spectrometry and Optical Spectroscopy (CeMOS), Mannheim University of Applied Sciences, Mannheim, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Mannheim Center for Translational Neuroscience (MCTN), Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical Faculty, Heidelberg University, Heidelberg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ch&#xe1;vez-Guti&#xe9;rrez</LastName><ForeName>Luc&#xed;a</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-8239-559X</Identifier><AffiliationInfo><Affiliation>VIB/KU Leuven, VIB-KU Leuven Center for Brain and Disease Research, Leuven, Belgium.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>13FH8I05IA</GrantID><Agency>Bundesministerium f&#xfc;r Bildung und Forschung (BMBF)</Agency><Country/></Grant><Grant><GrantID>1S47020N</GrantID><Agency>Fonds Wetenschappelijk Onderzoek (FWO)</Agency><Country/></Grant><Grant><GrantID>1S23819N</GrantID><Agency>Fonds Wetenschappelijk Onderzoek (FWO)</Agency><Country/></Grant><Grant><GrantID>G0B2519N</GrantID><Agency>Fonds Wetenschappelijk Onderzoek (FWO)</Agency><Country/></Grant><Grant><GrantID>G008023N</GrantID><Agency>Fonds Wetenschappelijk Onderzoek (FWO)</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>10</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>EMBO J</MedlineTA><NlmUniqueID>8208664</NlmUniqueID><ISSNLinking>0261-4189</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016564">Amyloid beta-Protein Precursor</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016229">Amyloid beta-Peptides</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.-</RegistryNumber><NameOfSubstance UI="D053829">Amyloid Precursor Protein Secretases</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016564" MajorTopicYN="Y">Amyloid beta-Protein Precursor</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016229" MajorTopicYN="N">Amyloid beta-Peptides</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053829" MajorTopicYN="N">Amyloid Precursor Protein Secretases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D059748" MajorTopicYN="N">Proteolysis</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">amyloid precursor protein</Keyword><Keyword MajorTopicYN="N">amyloid-&#x3b2;</Keyword><Keyword MajorTopicYN="N">&#x3b3;-secretase</Keyword><Keyword MajorTopicYN="N">&#x3b3;-secretase inhibitors</Keyword><Keyword MajorTopicYN="N">&#x3b3;-secretase modulation</Keyword></KeywordList><CoiStatement>The authors declare that they have no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>9</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>4</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>9</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>12</Month><Day>4</Day><Hour>12</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>10</Month><Day>19</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>10</Month><Day>19</Day><Hour>3</Hour><Minute>59</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>10</Month><Day>18</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37853914</ArticleId><ArticleId IdType="pmc">PMC10690472</ArticleId><ArticleId IdType="doi">10.15252/embj.2023114372</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Aguayo&#x2010;Ortiz R, Guzm&#xe1;n&#x2010;Ocampo DC, Dominguez L (2019) Toward the characterization of DAPT interactions with &#x3b3;&#x2010;secretase. ChemMedChem 14: 1005&#x2013;1010</Citation><ArticleIdList><ArticleId IdType="pubmed">30925201</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersen HC (1983) Rattle: a &#x2018;velocity&#x2019; version of the shake algorithm for molecular dynamics calculations. J Comput Phys 52: 24&#x2013;34</Citation></Reference><Reference><Citation>Bai XC, Rajendra E, Yang G, Shi Y, Scheres SH (2015) Sampling the conformational space of the catalytic subunit of human gamma&#x2010;secretase. Elife 4: e11182</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4718806</ArticleId><ArticleId IdType="pubmed">26623517</ArticleId></ArticleIdList></Reference><Reference><Citation>Berendsen HJC, Postma JPM, Van Gunsteren WF, Dinola A, Haak JR (1984) Molecular dynamics with coupling to an external bath. J Chem Phys 81: 3684&#x2013;3690</Citation></Reference><Reference><Citation>Bhattarai A, Devkota S, Do HN, Wang J, Bhattarai S, Wolfe MS, Miao Y (2022) Mechanism of tripeptide trimming of amyloid &#x3b2;&#x2010;peptide 49 by &#x3b3;&#x2010;secretase. J Am Chem Soc 144: 6215&#x2013;6226</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9798850</ArticleId><ArticleId IdType="pubmed">35377629</ArticleId></ArticleIdList></Reference><Reference><Citation>Bolduc DM, Montagna DR, Seghers MC, Wolfe MS, Selkoe DJ (2016) The amyloid&#x2010;beta forming tripeptide cleavage mechanism of &#x3b3;&#x2010;secretase. Elife 5: e17578</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5134833</ArticleId><ArticleId IdType="pubmed">27580372</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown MS, Ye J, Rawson RB, Goldstein JL (2000) Regulated intramembrane proteolysis: a control mechanism conserved from bacteria to humans. Cell 100: 391&#x2013;398</Citation><ArticleIdList><ArticleId IdType="pubmed">10693756</ArticleId></ArticleIdList></Reference><Reference><Citation>Case DA, Duke RE, Walker RC, Skrynnikov NR, Cheatham TE III, Mikhailovskii O, Simmerling C, Xue Y, Roitberg A, Izmailov SA et&#xa0;al (2022) AMBER 22 reference manual. San Francisco, CA: University of California;</Citation></Reference><Reference><Citation>Ch&#xe1;vez&#x2010;Guti&#xe9;rrez L, Szaruga M (2020) Mechanisms of neurodegeneration &#x2014; insights from familial Alzheimer's disease. Semin Cell Dev Biol 105: 75&#x2013;85</Citation><ArticleIdList><ArticleId IdType="pubmed">32418657</ArticleId></ArticleIdList></Reference><Reference><Citation>Ch&#xe1;vez&#x2010;Guti&#xe9;rrez L, Bammens L, Benilova I, Vandersteen A, Benurwar M, Borgers M, Lismont S, Zhou L, Van Cleynenbreugel S, Esselmann H et&#xa0;al (2012) The mechanism of &#x3b3;&#x2010;Secretase dysfunction in familial Alzheimer disease. EMBO J 31: 2261&#x2013;2274</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3364747</ArticleId><ArticleId IdType="pubmed">22505025</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen SY, Zacharias M (2022) An internal docking site stabilizes substrate binding to &#x3b3;&#x2010;secretase: analysis by molecular dynamics simulations. Biophys J 121: 2330&#x2013;2344</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9279352</ArticleId><ArticleId IdType="pubmed">35598043</ArticleId></ArticleIdList></Reference><Reference><Citation>De Strooper B, Annaert W, Cupers P, Saftig P, Craessaerts K, Mumm JS, Schroeter EH, Schrijvers V, Wolfe MS, Ray WJ et&#xa0;al (1999) A presenilin&#x2010;1&#x2010;dependent &#x3b3;&#x2010;secretase&#x2010;like protease mediates release of notch intracellular domain. Nature 398: 518&#x2013;522</Citation><ArticleIdList><ArticleId IdType="pubmed">10206645</ArticleId></ArticleIdList></Reference><Reference><Citation>Dickson CJ, Walker RC, Gould IR (2022) Lipid21: complex lipid membrane simulations with AMBER. J Chem Theory Comput 18: 1726&#x2013;1736</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9007451</ArticleId><ArticleId IdType="pubmed">35113553</ArticleId></ArticleIdList></Reference><Reference><Citation>Franco ML, Garc&#xed;a&#x2010;Carpio I, Comaposada&#x2010;Bar&#xf3; R, Escribano&#x2010;Saiz JJ, Ch&#xe1;vez&#x2010;Guti&#xe9;rrez L, Vilar M (2021) TrkA&#x2010;mediated endocytosis of p75&#x2010;CTF prevents cholinergic neuron death upon &#x3b3;&#x2010;secretase inhibition. Life Sci Alliance 4: e202000844</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7898468</ArticleId><ArticleId IdType="pubmed">33536237</ArticleId></ArticleIdList></Reference><Reference><Citation>Funamoto S, Sasaki T, Ishihara S, Nobuhara M, Nakano M, Watanabe&#x2010;Takahashi M, Saito T, Kakuda N, Miyasaka T, Nishikawa K et&#xa0;al (2013) Substrate ectodomain is critical for substrate preference and inhibition of &#x3b3;&#x2010;secretase. Nat Commun 4: 2529</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3826621</ArticleId><ArticleId IdType="pubmed">24108142</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghosh U, Thurber KR, Yau WM, Tycko R (2021) Molecular structure of a prevalent amyloid&#x2010;&#x3b2; fibril polymorph from Alzheimer's disease brain tissue. Proc Natl Acad Sci U S A 118: e2023089118</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7848700</ArticleId><ArticleId IdType="pubmed">33431654</ArticleId></ArticleIdList></Reference><Reference><Citation>Gibb S, Strimmer K (2012) Maldiquant: A versatile R package for the analysis of mass spectrometry data. Bioinformatics 28: 2270&#x2013;2271</Citation><ArticleIdList><ArticleId IdType="pubmed">22796955</ArticleId></ArticleIdList></Reference><Reference><Citation>Goga N, Rzepiela AJ, De Vries AH, Marrink SJ, Berendsen HJC (2012) Efficient algorithms for langevin and DPD dynamics. J Chem Theory Comput 8: 3637&#x2013;3649</Citation><ArticleIdList><ArticleId IdType="pubmed">26593009</ArticleId></ArticleIdList></Reference><Reference><Citation>Gregoret LM, Sauer RT (1998) Tolerance of a protein helix to multiple alanine and valine substitutions. Fold Des 3: 119&#x2013;126</Citation><ArticleIdList><ArticleId IdType="pubmed">9565756</ArticleId></ArticleIdList></Reference><Reference><Citation>Guardia&#x2010;Laguarta C, Pera M, Clarim&#xf3;n J, Molinuevo JL, S&#xe0;nchez&#x2010;Valle R, Llad&#xf3; A, Coma M, G&#xf3;mez&#x2010;Isla T, Blesa R, Ferrer I et&#xa0;al (2010) Clinical, neuropathologic, and biochemical profile of the amyloid precursor protein I716F mutation. J Neuropathol Exp Neurol 69: 53&#x2013;59</Citation><ArticleIdList><ArticleId IdType="pubmed">20010303</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xfc;ner G, Lichtenthaler SF, Dzne D (2020) The substrate repertoire of &#x3b3;&#x2010;secretase/presenilin. Semin Cell Dev Biol 105: 27&#x2013;42</Citation><ArticleIdList><ArticleId IdType="pubmed">32616437</ArticleId></ArticleIdList></Reference><Reference><Citation>Guzm&#xe1;n&#x2010;Ocampo DC, Aguayo&#x2010;Ortiz R, Velasco&#x2010;Bolom JL, Gupta PL, Roitberg AE, Dominguez L (2023) Elucidating the protonation state of the &#x3b3;&#x2010;secretase catalytic dyad. ACS Chem Nerosci 14: 261&#x2013;269</Citation><ArticleIdList><ArticleId IdType="pubmed">36562727</ArticleId></ArticleIdList></Reference><Reference><Citation>Haass C, Hung AY, Selkoe DJ, Teplow DB (1994) Mutations associated with a locus for familial Alzheimer's disease result in alternative processing of amyloid beta&#x2010;protein precursor. J Biol Chem 269: 17741&#x2013;17748</Citation><ArticleIdList><ArticleId IdType="pubmed">8021287</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardy JA, Higgins GA (1992) Alzheimer's disease: the amyloid cascade hypothesis. Science 256: 184&#x2013;185</Citation><ArticleIdList><ArticleId IdType="pubmed">1566067</ArticleId></ArticleIdList></Reference><Reference><Citation>Hopkins CW, Le Grand S, Walker RC, Roitberg AE (2015) Long&#x2010;time&#x2010;step molecular dynamics through hydrogen mass repartitioning. J Chem Theory Comput 11: 1864&#x2013;1874</Citation><ArticleIdList><ArticleId IdType="pubmed">26574392</ArticleId></ArticleIdList></Reference><Reference><Citation>Hunter S, Brayne C (2018) Understanding the roles of mutations in the amyloid precursor protein in Alzheimer disease. Mol Psychiatry 23: 81&#x2013;93</Citation><ArticleIdList><ArticleId IdType="pubmed">29112196</ArticleId></ArticleIdList></Reference><Reference><Citation>Hur JY (2022) &#x3b3;&#x2010;Secretase in Alzheimer's disease. Exp Mol Med 54: 433&#x2013;446</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9076685</ArticleId><ArticleId IdType="pubmed">35396575</ArticleId></ArticleIdList></Reference><Reference><Citation>Jung JI, Ran Y, Cruz PE, Rosario AM, Ladd TB, Kukar TL, Koo EH, Felsenstein KM, Golde TE (2014) Complex relationships between substrate sequence and sensitivity to alterations in &#x3b3;&#x2010;secretase processivity induced by &#x3b3;&#x2010;secretase modulators. Biochemistry 53: 1947&#x2013;1957</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3985764</ArticleId><ArticleId IdType="pubmed">24620716</ArticleId></ArticleIdList></Reference><Reference><Citation>Jurisch&#x2010;Yaksi N, Sannerud R, Annaert W (2013) A fast growing spectrum of biological functions of &#x3b3;&#x2010;secretase in development and disease. Biochim Biophys Acta 1828: 2815&#x2013;2827</Citation><ArticleIdList><ArticleId IdType="pubmed">24099003</ArticleId></ArticleIdList></Reference><Reference><Citation>Kretner B, Trambauer J, Fukumori A, Mielke J, Kuhn P, Kremmer E, Giese A, Lichtenthaler SF, Haass C, Arzberger T et&#xa0;al (2016) Generation and deposition of A&#x3b2;43 by the virtually inactive presenilin&#x2010;1 L435F mutant contradicts the presenilin loss&#x2010;of&#x2010;function hypothesis of Alzheimer's disease. EMBO Mol Med 8: 458&#x2013;465</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5119496</ArticleId><ArticleId IdType="pubmed">26988102</ArticleId></ArticleIdList></Reference><Reference><Citation>Kukar TL, Ladd TB, Robertson P, Pintchovski SA, Moore B, Bann MA, Ren Z, Jansen&#x2010;West K, Malphrus K, Eggert S et&#xa0;al (2011) Lysine 624 of the amyloid precursor protein (APP) is a critical determinant of amyloid &#x3b2; peptide length: support for a sequential model of &#x3b3;&#x2010;secretase intramembrane proteolysis and regulation by the amyloid &#x3b2; precursor protein (APP) juxtamembrane region. J Biol Chem 286: 39804&#x2013;39812</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3220543</ArticleId><ArticleId IdType="pubmed">21868378</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar&#x2010;Singh S, De Jonghe C, Cruts M, Kleinert R, Wang R, Mercken M, De Strooper B, Vanderstichele H, L&#xf6;fgren A, Vanderhoeven I et&#xa0;al (2000) Nonfibrillar diffuse amyloid deposition due to a &#x3b3; 42&#x2010;secretase site mutation points to an essential role for N&#x2010;truncated A&#x3b2; 42 in Alzheimer's disease. Hum Mol Genet 9: 2589&#x2013;2598</Citation><ArticleIdList><ArticleId IdType="pubmed">11063718</ArticleId></ArticleIdList></Reference><Reference><Citation>Kyte J, Doolittle RF (1982) A simple method for displaying the hydropathic character of a protein. J Mol Biol 157: 105&#x2013;132</Citation><ArticleIdList><ArticleId IdType="pubmed">7108955</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J, Cheng X, Swails JM, Yeom MS, Eastman PK, Lemkul JA, Wei S, Buckner J, Jeong JC, Qi Y et&#xa0;al (2016) CHARMM&#x2010;GUI input generator for NAMD, GROMACS, AMBER, OpenMM, and CHARMM/OpenMM simulations using the CHARMM36 additive force field. J Chem Theory Comput 12: 405&#x2013;413</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4712441</ArticleId><ArticleId IdType="pubmed">26631602</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu CY, Ohki Y, Tomita T, Osawa S, Reed BR, Jagust W, Van Berlo V, Jin L&#x2010;W, Chui HC, Coppola G (2017) Two novel mutations in the first transmembrane domain of presenilin1 cause young&#x2010;onset Alzheimer's disease. J Alzheimers Dis 58: 1035&#x2013;1041</Citation><ArticleIdList><ArticleId IdType="pubmed">28550247</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu L, Lauro BM, He A, Lee H, Bhattarai S, Wolfe MS, Bennett DA, Karch CM, Young&#x2010;Pearse T, Selkoe DJ (2022) Identification of the A&#x3b2;37/42 peptide ratio in CSF as an improved A&#x3b2; biomarker for Alzheimer's disease. Alzheimers Dement 19: 79&#x2013;96</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9464800</ArticleId><ArticleId IdType="pubmed">35278341</ArticleId></ArticleIdList></Reference><Reference><Citation>Lomize MA, Pogozheva ID, Joo H, Mosberg HI, Lomize AL (2012) OPM database and PPM web server: resources for positioning of proteins in membranes. Nucleic Acids Res 40: D370&#x2013;D376</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3245162</ArticleId><ArticleId IdType="pubmed">21890895</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo JE, Li YM (2022) Turning the tide on Alzheimer's disease: modulation of &#x3b3;&#x2010;secretase. Cell Biosci 12: 2</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8725520</ArticleId><ArticleId IdType="pubmed">34983641</ArticleId></ArticleIdList></Reference><Reference><Citation>Maier JA, Martinez C, Kasavajhala K, Wickstrom L, Hauser KE, Simmerling C (2015) ff14SB: improving the accuracy of protein side chain and backbone parameters from ff99SB. J Chem Theory Comput 11: 3696&#x2013;3713</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4821407</ArticleId><ArticleId IdType="pubmed">26574453</ArticleId></ArticleIdList></Reference><Reference><Citation>Mark P, Nilsson L (2001) Structure and dynamics of the TIP3P, SPC, and SPC/E water models at 298 K. J Phys Chem A 105: 9954&#x2013;9960</Citation></Reference><Reference><Citation>Matsumura N, Takami M, Okochi M, Wada&#x2010;Kakuda S, Fujiwara H, Tagami S, Funamoto S, Ihara Y, Morishima&#x2010;Kawashima M (2014) &#x3b3;&#x2010;Secretase associated with lipid rafts: multiple interactive pathways in the stepwise processing of &#x3b2;&#x2010;carboxyl&#x2010;terminal fragment. J Biol Chem 289: 5109&#x2013;5121</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3931069</ArticleId><ArticleId IdType="pubmed">24375443</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller BR, McGee TD, Swails JM, Homeyer N, Gohlke H, Roitberg AE (2012) MMPBSA.py: an efficient program for end&#x2010;state free energy calculations. J Chem Theory Comput 8: 3314&#x2013;3321</Citation><ArticleIdList><ArticleId IdType="pubmed">26605738</ArticleId></ArticleIdList></Reference><Reference><Citation>Okochi M, Steiner H, Fukumori A, Tanii H, Tomita T, Tanaka T, Iwatsubo T, Kudo T, Takeda M, Haass C (2002) Presenilins mediate a dual intramembranous &#x3b3;&#x2010;secretase cleavage of Notch&#x2010;1. EMBO J 21: 5408&#x2013;5416</Citation><ArticleIdList><ArticleId IdType="pmc">PMC129073</ArticleId><ArticleId IdType="pubmed">12374741</ArticleId></ArticleIdList></Reference><Reference><Citation>Okochi M, Fukumori A, Jiang J, Itoh N, Kimura R, Steiner H, Haass C, Tagami S, Takeda M (2006) Secretion of the Notch&#x2010;1 A&#x3b2;&#x2010;like peptide during Notch signaling. J Biol Chem 281: 7890&#x2013;7898</Citation><ArticleIdList><ArticleId IdType="pubmed">16434391</ArticleId></ArticleIdList></Reference><Reference><Citation>Okochi M, Tagami S, Yanagida K, Takami M, Kodama TS, Mori K, Nakayama T, Ihara Y, Takeda M (2013) &#x3b3;&#x2010;secretase modulators and presenilin 1 mutants act differently on presenilin/&#x3b3;&#x2010;secretase function to cleave A&#x3b2;42 and A&#x3b2;43. Cell Rep 3: 42&#x2013;51</Citation><ArticleIdList><ArticleId IdType="pubmed">23291095</ArticleId></ArticleIdList></Reference><Reference><Citation>Onufriev A, Bashford D, Case DA (2004) Exploring protein native states and large&#x2010;scale conformational changes with a modified generalized born model. Proteins Struct Funct Genet 55: 383&#x2013;394</Citation><ArticleIdList><ArticleId IdType="pubmed">15048829</ArticleId></ArticleIdList></Reference><Reference><Citation>Ousson S, Saric A, Baguet A, Losberger C, Genoud S, Vilbois F, Permanne B, Hussain I, Beher D (2013) Substrate determinants in the C99 juxtamembrane domains differentially affect &#x3b3;&#x2010;secretase cleavage specificity and modulator pharmacology. J Neurochem 125: 610&#x2013;619</Citation><ArticleIdList><ArticleId IdType="pubmed">23253155</ArticleId></ArticleIdList></Reference><Reference><Citation>Pace CN, Scholtz JM (1998) A helix propensity scale based on experimental studies of peptides and proteins. Biophys J 75: 422&#x2013;427</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1299714</ArticleId><ArticleId IdType="pubmed">9649402</ArticleId></ArticleIdList></Reference><Reference><Citation>Page RM, Gutsmiedl A, Fukumori A, Winkler E, Haass C, Steiner H (2010) &#x3b2;&#x2010;Amyloid precursor protein mutants respond to &#x3b3;&#x2010;secretase modulators. J Biol Chem 285: 17798&#x2013;17810</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2878544</ArticleId><ArticleId IdType="pubmed">20348104</ArticleId></ArticleIdList></Reference><Reference><Citation>Petit D, Hitzenberger M, Lismont S, Zoltowska KM, Ryan NS, Mercken M, Bischoff F, Zacharias M, Ch&#xe1;vez&#x2010;Guti&#xe9;rrez L (2019) Extracellular interface between APP and Nicastrin regulates A&#x3b2; length and response to &#x3b3;&#x2010;secretase modulators. EMBO J 38: 1&#x2013;18</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6576158</ArticleId><ArticleId IdType="pubmed">31109937</ArticleId></ArticleIdList></Reference><Reference><Citation>Petit D, Fern&#xe1;ndez SG, Zoltowska KM, Enzlein T, Ryan NS, Connor AO, Szaruga M, Hill E, Vandenberghe R, Fox NC et&#xa0;al (2022a) A&#x3b2; profiles generated by Alzheimer's disease causing PSEN1 variants determine the pathogenicity of the mutation and predict age at disease onset. Mol Psychiatry 27: 2821&#x2013;2832</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9156411</ArticleId><ArticleId IdType="pubmed">35365805</ArticleId></ArticleIdList></Reference><Reference><Citation>Petit D, Hitzenberger M, Koch M, Lismont S, Zoltowska KM, Enzlein T, Hopf C, Zacharias M, Ch&#xe1;vez&#x2010;Guti&#xe9;rrez L (2022b) Enzyme&#x2013;substrate interface targeting by imidazole&#x2010;based &#x3b3;&#x2010;secretase modulators activates &#x3b3;&#x2010;secretase and stabilizes its interaction with APP. EMBO J 41: e111084</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9627667</ArticleId><ArticleId IdType="pubmed">36121025</ArticleId></ArticleIdList></Reference><Reference><Citation>Portelius E, Tran AJ, Andreasson U, Persson R, Brinkmann G, Zetterberg H, Blennow K, Westman&#x2010;Brinkmalm A (2007) Characterization of amyloid &#x3b2; peptides in cerebrospinal fluid by an automated immunoprecipitation procedure followed by mass spectrometry. J Proteome Res 6: 4433&#x2013;4439</Citation><ArticleIdList><ArticleId IdType="pubmed">17927230</ArticleId></ArticleIdList></Reference><Reference><Citation>Qi&#x2010;Takahara Y, Morishima&#x2010;Kawashima M, Tanimura Y, Dolios G, Hirotani N, Horikoshi Y, Kametani F, Maeda M, Saido TC, Wang R et&#xa0;al (2005) Longer forms of amyloid&#x2010;&#x3b2; protein: implications for the mechanism of intramembrane cleavage by &#x3b3;&#x2010;secretase. J Neurosci 25: 436&#x2013;445</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6725472</ArticleId><ArticleId IdType="pubmed">15647487</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren Z, Schenk D, Basi GS, Shapiro IP (2007) Amyloid &#x3b2;&#x2010;protein precursor juxtamembrane domain regulates specificity of &#x3b3;&#x2010;secretase&#x2010;dependent cleavages. J Biol Chem 282: 35350&#x2013;35360</Citation><ArticleIdList><ArticleId IdType="pubmed">17890228</ArticleId></ArticleIdList></Reference><Reference><Citation>Saito T, Suemoto T, Brouwers N, Sleegers K, Funamoto S, Mihira N, Matsuba Y, Yamada K, Nilsson P, Takano J et&#xa0;al (2011) Potent amyloidogenicity and pathogenicity of A&#x3b2; 243. Nat Neurosci 14: 1023&#x2013;1032</Citation><ArticleIdList><ArticleId IdType="pubmed">21725313</ArticleId></ArticleIdList></Reference><Reference><Citation>Salomon&#x2010;Ferrer R, G&#xf6;tz AW, Poole D, Le Grand S, Walker RC (2013) Routine microsecond molecular dynamics simulations with AMBER on GPUs. 2. Explicit solvent particle mesh ewald. J Chem Theory Comput 9: 3878&#x2013;3888</Citation><ArticleIdList><ArticleId IdType="pubmed">26592383</ArticleId></ArticleIdList></Reference><Reference><Citation>Schroeter EH, Kisslinger JA, Kopan R (1998) Notch&#x2010;1 signalling requires ligand&#x2010;induced proteolytic release of intracellular domain. Nature 393: 382&#x2013;386</Citation><ArticleIdList><ArticleId IdType="pubmed">9620803</ArticleId></ArticleIdList></Reference><Reference><Citation>Selkoe DJ, Hardy J (2016) The amyloid hypothesis of Alzheimer's disease at 25&#x2009;years. EMBO Mol Med 8: 595&#x2013;608</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4888851</ArticleId><ArticleId IdType="pubmed">27025652</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheu SY, Yang DY, Selzle HL, Schlag EW (2003) Energetics of hydrogen bonds in peptides. Proc Natl Acad Sci U S A 100: 12683&#x2013;12687</Citation><ArticleIdList><ArticleId IdType="pmc">PMC240678</ArticleId><ArticleId IdType="pubmed">14559970</ArticleId></ArticleIdList></Reference><Reference><Citation>Struhl G, Adachi A (2000) Requirements for presenilin&#x2010;dependent cleavage of notch and other transmembrane proteins. Mol Cell 6: 625&#x2013;636</Citation><ArticleIdList><ArticleId IdType="pubmed">11030342</ArticleId></ArticleIdList></Reference><Reference><Citation>Szaruga M, Veugelen S, Benurwar M, Lismont S, Sepulveda&#x2010;Falla D, Lleo A, Ryan NS, Lashley T, Fox NC, Murayama S et&#xa0;al (2015) Qualitative changes in human gamma&#x2010;secretase underlie familial Alzheimer's disease. J Exp Med 212: 2003&#x2013;2013</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4647268</ArticleId><ArticleId IdType="pubmed">26481686</ArticleId></ArticleIdList></Reference><Reference><Citation>Szaruga M, Munteanu B, Lismont S, Veugelen S, Horr&#xe9; K, Mercken M, Saido TC, Ryan NS, De Vos T, Savvides SN et&#xa0;al (2017) Alzheimer's&#x2010;causing mutations shift A&#x3b2; length by destabilizing &#x3b3;&#x2010;secretase&#x2010;A&#x3b2;n interactions. Cell 170: 443&#x2013;456</Citation><ArticleIdList><ArticleId IdType="pubmed">28753424</ArticleId></ArticleIdList></Reference><Reference><Citation>Tagami S, Yanagida K, Kodama TS, Takami M, Mizuta N, Oyama H, Nishitomi K, Chiu Y, Okamoto T, Ikeuchi T et&#xa0;al (2017) Semagacestat is a pseudo&#x2010;inhibitor of &#x3b3;&#x2010;secretase. Cell Rep 21: 259&#x2013;273</Citation><ArticleIdList><ArticleId IdType="pubmed">28978478</ArticleId></ArticleIdList></Reference><Reference><Citation>Takami M, Nagashima Y, Sano Y, Ishihara S, Morishima&#x2010;Kawashima M, Funamoto S, Ihara Y (2009) Gamma&#x2010;Secretase: successive tripeptide and tetrapeptide release from the transmembrane domain of beta&#x2010;carboxyl terminal fragment. J Neurosci 29: 13042&#x2013;13052</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6665297</ArticleId><ArticleId IdType="pubmed">19828817</ArticleId></ArticleIdList></Reference><Reference><Citation>Takeo K, Tanimura S, Shinoda T, Osawa S, Zahariev IK, Takegami N, Ishizuka&#x2010;Katsura Y, Shinya N, Takagi&#x2010;Niidome S, Tominaga A et&#xa0;al (2014) Allosteric regulation of &#x3b3;&#x2010;secretase activity by a phenylimidazole&#x2010;type &#x3b3;&#x2010;secretase modulator. Proc Natl Acad Sci U S A 111: 10544&#x2013;10549</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4115564</ArticleId><ArticleId IdType="pubmed">25009180</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian Y, Bassit B, Chau D, Li YM (2010) An APP inhibitory domain containing the Flemish mutation residue modulates &#x3b3;&#x2010;secretase activity for A&#x392; production. Nat Struct Mol Biol 17: 151&#x2013;158</Citation><ArticleIdList><ArticleId IdType="pubmed">20062056</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomidokoro Y, Rostagno A, Neubert TA, Lu Y, William Rebeck G, Frangione B, Greenberg SM, Ghiso J (2010) Iowa variant of familial Alzheimer's disease: accumulation of posttranslationally modified A&#x3b2;D23N in parenchymal and cerebrovascular amyloid deposits. Am J Pathol 176: 1841&#x2013;1854</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2843474</ArticleId><ArticleId IdType="pubmed">20228223</ArticleId></ArticleIdList></Reference><Reference><Citation>Vassar R, Bennett BD, Babu&#x2010;Khan S, Kahn S, Mendiaz EA, Denis P, Teplow DB, Ross S, Amarante P, Loeloff R (1999) &#x3b2;&#x2010;Secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science 286: 735&#x2013;741</Citation><ArticleIdList><ArticleId IdType="pubmed">10531052</ArticleId></ArticleIdList></Reference><Reference><Citation>de la Vega MP, Giedraitis V, Michno W, Kilander L, G&#xfc;ner G, Zielinski M, L&#xf6;wenmark M, Brundin RM, Danfors T, S&#xf6;derberg L et&#xa0;al (2021) The Uppsala APP deletion causes early onset autosomal dominant Alzheimer's disease by altering APP processing and increasing amyloid &#x3b2; fibril formation. Sci Transl Med 13: eabc6184</Citation><ArticleIdList><ArticleId IdType="pubmed">34380771</ArticleId></ArticleIdList></Reference><Reference><Citation>Velter AI, Bischoff FP, Berthelot D, De Cleyn M, Oehlrich D, Jaroskova L, Macdonald G, Minne G, Pieters S, Rombouts F et&#xa0;al (2014) Anilinotriazoles as potent gamma secretase modulators. Bioorg Med Chem Lett 24: 5805&#x2013;5813</Citation><ArticleIdList><ArticleId IdType="pubmed">25454273</ArticleId></ArticleIdList></Reference><Reference><Citation>Veugelen S, Saito T, Saido TC, Ch&#xe1;vez&#x2010;Guti&#xe9;rrez L, De Strooper B (2016) Familial Alzheimer's disease mutations in presenilin generate amyloidogenic A&#x3b2; peptide seeds. Neuron 90: 410&#x2013;416</Citation><ArticleIdList><ArticleId IdType="pubmed">27100199</ArticleId></ArticleIdList></Reference><Reference><Citation>Wanngren J, Ottervald J, Parpal S, Portelius E, Str&#xf6;mberg K, Borgeg&#xe5;rd T, Klintenberg R, Jur&#xe9;us A, Blomqvist J, Blennow K et&#xa0;al (2012) Second generation &#x3b3;&#x2010;secretase modulators exhibit different modulation of notch &#x3b2; and A&#x3b2; production. J Biol Chem 287: 32640&#x2013;32650</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3463353</ArticleId><ArticleId IdType="pubmed">22851182</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiltfang J, Esselmann H, Bibl M, Smirnov A, Otto M, Paul S, Schmidt B, Klafki H&#x2010;W, Maler M, Dyrks T et&#xa0;al (2002) Highly conserved and disease&#x2010;specific patterns of carboxyterminally truncated A&#x3b2; peptides 1&#x2010;37/38/39 in addition to 1&#x2010;40/42 in Alzheimer's disease and in patients with chronic neuroinflammation. J Neurochem 81: 481&#x2013;496</Citation><ArticleIdList><ArticleId IdType="pubmed">12065657</ArticleId></ArticleIdList></Reference><Reference><Citation>Yagishita S, Morishima&#x2010;Kawashima M, Tanimura Y, Ishiura S, Ihara Y (2006) DAPT&#x2010;induced intracellular accumulations of longer amyloid &#x3b2;&#x2010;proteins: further implications for the mechanism of intramembrane cleavage by &#x3b3;&#x2010;secretase. Biochemistry 45: 3952&#x2013;3960</Citation><ArticleIdList><ArticleId IdType="pubmed">16548522</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang X, Meisl G, Frohm B, Thulin E, Knowles TPJ, Linse S (2018) On the role of sidechain size and charge in the aggregation of A&#x3b2;42 with familial mutations. Proc Natl Acad Sci U S A 115: E5849&#x2013;E5858</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6042101</ArticleId><ArticleId IdType="pubmed">29895690</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang G, Zhou R, Zhou Q, Guo X, Yan C, Ke M, Lei J, Shi Y (2019) Structural basis of Notch recognition by human &#x3b3;&#x2010;secretase. Nature 565: 192&#x2013;197</Citation><ArticleIdList><ArticleId IdType="pubmed">30598546</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang G, Zhou R, Guo X, Yan C, Lei J, Shi Y (2021) Structural basis of &#x3b3;&#x2010;secretase inhibition and modulation by small molecule drugs. Cell 184: 521&#x2013;533</Citation><ArticleIdList><ArticleId IdType="pubmed">33373587</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou R, Yang G, Guo X, Zhou Q, Lei J, Shi Y (2019) Recognition of the amyloid precursor protein by human g&#x2010;secretase. Science 363: eaaw0930</Citation><ArticleIdList><ArticleId IdType="pubmed">30630874</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37857825</PMID><DateCompleted><Year>2023</Year><Month>10</Month><Day>30</Day></DateCompleted><DateRevised><Year>2025</Year><Month>04</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1529-2916</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>11</Issue><PubDate><Year>2023</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Nature immunology</Title><ISOAbbreviation>Nat Immunol</ISOAbbreviation></Journal><ArticleTitle>Cell-autonomous effects of APOE4 in restricting microglial response in brain homeostasis and Alzheimer's disease.</ArticleTitle><Pagination><StartPage>1854</StartPage><EndPage>1866</EndPage><MedlinePgn>1854-1866</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41590-023-01640-9</ELocationID><Abstract><AbstractText>Microglial involvement in Alzheimer's disease (AD) pathology has emerged as a risk-determining pathogenic event. While apolipoprotein E (APOE) is known to modify AD risk, it remains unclear how microglial apoE impacts brain cognition and AD pathology. Here, using conditional mouse models expressing apoE isoforms in microglia and central nervous system-associated macrophages (CAMs), we demonstrate a cell-autonomous effect of apoE3-mediated microglial activation and function, which are negated by apoE4. Expression of apoE3 in microglia/CAMs improves cognitive function, increases microglia surrounding amyloid plaque and reduces amyloid pathology and associated toxicity, whereas apoE4 expression either compromises or has no effects on these outcomes by impairing lipid metabolism. Single-cell transcriptomic profiling reveals increased antigen presentation and interferon pathways upon apoE3 expression. In contrast, apoE4 expression downregulates complement and lysosomal pathways, and promotes stress-related responses. Moreover, in the presence of mouse endogenous apoE, microglial apoE4 exacerbates amyloid pathology. Finally, we observed a reduction in Lgals3-positive responsive microglia surrounding amyloid plaque and an increased accumulation of lipid droplets in APOE4 human brains and induced pluripotent stem cell-derived microglia. Our findings establish critical isoform-dependent effects of microglia/CAM-expressed apoE in brain function and the development of amyloid pathology, providing new insight into how apoE4 vastly increases AD risk.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s), under exclusive licence to Springer Nature America, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Liu</LastName><ForeName>Chia-Chen</ForeName><Initials>CC</Initials><Identifier Source="ORCID">0000-0001-7203-3926</Identifier><AffiliationInfo><Affiliation>Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA. liu.chiachenjen@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neurodegenerative Diseases Research Unit, Biogen, Cambridge, MA, USA. liu.chiachenjen@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Wang</LastName><ForeName>Na</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Yuanxin</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Inoue</LastName><ForeName>Yasuteru</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shue</LastName><ForeName>Francis</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ren</LastName><ForeName>Yingxue</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Quantitative Health Sciences, Mayo Clinic, Jacksonville, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Minghui</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Genetics and Genomic Sciences, Mount Sinai Center for Transformative Disease Modeling, Icahn School of Medicine at Mount Sinai, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qiao</LastName><ForeName>Wenhui</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ikezu</LastName><ForeName>Tadafumi C</ForeName><Initials>TC</Initials><AffiliationInfo><Affiliation>Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Zonghua</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Jing</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-4520-6307</Identifier><AffiliationInfo><Affiliation>Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martens</LastName><ForeName>Yuka</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Doss</LastName><ForeName>Sydney V</ForeName><Initials>SV</Initials><Identifier Source="ORCID">0000-0002-3427-4654</Identifier><AffiliationInfo><Affiliation>Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rosenberg</LastName><ForeName>Cassandra L</ForeName><Initials>CL</Initials><AffiliationInfo><Affiliation>Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jeevaratnam</LastName><ForeName>Suren</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jia</LastName><ForeName>Lin</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Raulin</LastName><ForeName>Ana-Caroline</ForeName><Initials>AC</Initials><AffiliationInfo><Affiliation>Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qi</LastName><ForeName>Fangfang</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Neurology, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Yiyang</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alnobani</LastName><ForeName>Alla</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Knight</LastName><ForeName>Joshua</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Yixing</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Linares</LastName><ForeName>Cynthia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kurti</LastName><ForeName>Aishe</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fryer</LastName><ForeName>John D</ForeName><Initials>JD</Initials><Identifier Source="ORCID">0000-0003-3390-2994</Identifier><AffiliationInfo><Affiliation>Department of Neuroscience, Mayo Clinic, Scottsdale, AZ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Bin</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Genetics and Genomic Sciences, Mount Sinai Center for Transformative Disease Modeling, Icahn School of Medicine at Mount Sinai, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Long-Jun</ForeName><Initials>LJ</Initials><Identifier Source="ORCID">0000-0001-8019-3380</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Betty Y S</ForeName><Initials>BYS</Initials><Identifier Source="ORCID">0000-0001-6890-8355</Identifier><AffiliationInfo><Affiliation>Department of Neurosurgery, The Brain Tumor Center, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bu</LastName><ForeName>Guojun</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0003-3491-1016</Identifier><AffiliationInfo><Affiliation>Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA. gbu@ust.hk.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Life Science, The Hong Kong University of Science and Technology, Hong Kong, China. gbu@ust.hk.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>AG069701</GrantID><Agency>U.S. Department of Health &amp; Human Services | National Institutes of Health (NIH)</Agency><Country/></Grant><Grant><GrantID>AG062110</GrantID><Agency>U.S. Department of Health &amp; Human Services | National Institutes of Health (NIH)</Agency><Country/></Grant><Grant><GrantID>R37 AG027924</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U19 AG069701</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>AG027924</GrantID><Agency>U.S. Department of Health &amp; Human Services | National Institutes of Health (NIH)</Agency><Country/></Grant><Grant><GrantID>A20201542S</GrantID><Agency>BrightFocus Foundation (BrightFocus)</Agency><Country/></Grant><Grant><GrantID>RF1 AG062110</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>10</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Nat Immunol</MedlineTA><NlmUniqueID>100941354</NlmUniqueID><ISSNLinking>1529-2908</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D053318">Apolipoprotein E3</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D053327">Apolipoprotein E4</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001057">Apolipoproteins E</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053318" MajorTopicYN="N">Apolipoprotein E3</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053327" MajorTopicYN="N">Apolipoprotein E4</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001057" MajorTopicYN="Y">Apolipoproteins E</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006706" MajorTopicYN="N">Homeostasis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017628" MajorTopicYN="N">Microglia</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058225" MajorTopicYN="N">Plaque, Amyloid</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>11</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>9</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>10</Month><Day>30</Day><Hour>6</Hour><Minute>47</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>10</Month><Day>20</Day><Hour>0</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>10</Month><Day>19</Day><Hour>23</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>4</Month><Day>9</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37857825</ArticleId><ArticleId IdType="mid">NIHMS2064445</ArticleId><ArticleId IdType="pmc">PMC11980647</ArticleId><ArticleId IdType="doi">10.1038/s41590-023-01640-9</ArticleId><ArticleId IdType="pii">10.1038/s41590-023-01640-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ross CA &amp; Poirier MA Protein aggregation and neurodegenerative disease. Nat Med 10 Suppl, S10&#x2013;17, doi:10.1038/nm1066 (2004).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm1066</ArticleId><ArticleId IdType="pubmed">15272267</ArticleId></ArticleIdList></Reference><Reference><Citation>Jucker M &amp; Walker LC Pathogenic protein seeding in Alzheimer disease and other neurodegenerative disorders. Ann Neurol 70, 532&#x2013;540, doi:10.1002/ana.22615 (2011).</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.22615</ArticleId><ArticleId IdType="pmc">PMC3203752</ArticleId><ArticleId IdType="pubmed">22028219</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo T. et al. Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer's disease. Molecular neurodegeneration 15, 40, doi:10.1186/s13024-020-00391-7 (2020).</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-020-00391-7</ArticleId><ArticleId IdType="pmc">PMC7364557</ArticleId><ArticleId IdType="pubmed">32677986</ArticleId></ArticleIdList></Reference><Reference><Citation>Leng F &amp; Edison P Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here? Nature reviews. Neurology 17, 157&#x2013;172, doi:10.1038/s41582-020-00435-y (2021).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-020-00435-y</ArticleId><ArticleId IdType="pubmed">33318676</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y &amp; Colonna M Microglia in Alzheimer's disease at single-cell level. Are there common patterns in humans and mice? J Exp Med 218, doi:10.1084/jem.20202717 (2021).</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20202717</ArticleId><ArticleId IdType="pmc">PMC8302448</ArticleId><ArticleId IdType="pubmed">34292312</ArticleId></ArticleIdList></Reference><Reference><Citation>Magno L, Bunney TD, Mead E, Svensson F &amp; Bictash MN TREM2/PLCgamma2 signalling in immune cells: function, structural insight, and potential therapeutic modulation. Molecular neurodegeneration 16, 22, doi:10.1186/s13024-021-00436-5 (2021).</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-021-00436-5</ArticleId><ArticleId IdType="pmc">PMC8022522</ArticleId><ArticleId IdType="pubmed">33823896</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C. et al. Selective removal of astrocytic APOE4 strongly protects against tau-mediated neurodegeneration and decreases synaptic phagocytosis by microglia. Neuron 109, 1657&#x2013;1674 e1657, doi:10.1016/j.neuron.2021.03.024 (2021).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2021.03.024</ArticleId><ArticleId IdType="pmc">PMC8141024</ArticleId><ArticleId IdType="pubmed">33831349</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang SS et al. Microglial translational profiling reveals a convergent APOE pathway from aging, amyloid, and tau. The Journal of experimental medicine 215, 2235&#x2013;2245, doi:10.1084/jem.20180653 (2018).</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20180653</ArticleId><ArticleId IdType="pmc">PMC6122978</ArticleId><ArticleId IdType="pubmed">30082275</ArticleId></ArticleIdList></Reference><Reference><Citation>Sala Frigerio C. et al. The Major Risk Factors for Alzheimer's Disease: Age, Sex, and Genes Modulate the Microglia Response to Abeta Plaques. Cell Rep 27, 1293&#x2013;1306 e1296, doi:10.1016/j.celrep.2019.03.099 (2019).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2019.03.099</ArticleId><ArticleId IdType="pmc">PMC7340153</ArticleId><ArticleId IdType="pubmed">31018141</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu CC, Liu CC, Kanekiyo T, Xu H &amp; Bu G Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy. Nat Rev Neurol 9, 106&#x2013;118, doi:10.1038/nrneurol.2012.263 (2013).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2012.263</ArticleId><ArticleId IdType="pmc">PMC3726719</ArticleId><ArticleId IdType="pubmed">23296339</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamazaki Y, Zhao N, Caulfield TR, Liu CC &amp; Bu G Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies. Nat Rev Neurol 15, 501&#x2013;518, doi:10.1038/s41582-019-0228-7 (2019).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-019-0228-7</ArticleId><ArticleId IdType="pmc">PMC7055192</ArticleId><ArticleId IdType="pubmed">31367008</ArticleId></ArticleIdList></Reference><Reference><Citation>Raulin AC et al. ApoE in Alzheimer's disease: pathophysiology and therapeutic strategies. Molecular neurodegeneration 17, 72, doi:10.1186/s13024-022-00574-4 (2022).</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-022-00574-4</ArticleId><ArticleId IdType="pmc">PMC9644639</ArticleId><ArticleId IdType="pubmed">36348357</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez-Calle R. et al. APOE in the bullseye of neurodegenerative diseases: impact of the APOE genotype in Alzheimer's disease pathology and brain diseases. Molecular neurodegeneration 17, 62, doi:10.1186/s13024-022-00566-4 (2022).</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-022-00566-4</ArticleId><ArticleId IdType="pmc">PMC9509584</ArticleId><ArticleId IdType="pubmed">36153580</ArticleId></ArticleIdList></Reference><Reference><Citation>Spittau B. Aging Microglia-Phenotypes, Functions and Implications for Age-Related Neurodegenerative Diseases. Front Aging Neurosci 9, 194, doi:10.3389/fnagi.2017.00194 (2017).</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2017.00194</ArticleId><ArticleId IdType="pmc">PMC5469878</ArticleId><ArticleId IdType="pubmed">28659790</ArticleId></ArticleIdList></Reference><Reference><Citation>Grabert K. et al. Microglial brain region-dependent diversity and selective regional sensitivities to aging. Nat Neurosci 19, 504&#x2013;516, doi:10.1038/nn.4222 (2016).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.4222</ArticleId><ArticleId IdType="pmc">PMC4768346</ArticleId><ArticleId IdType="pubmed">26780511</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y. et al. TREM2-mediated early microglial response limits diffusion and toxicity of amyloid plaques. The Journal of experimental medicine 213, 667&#x2013;675, doi:10.1084/jem.20151948 (2016).</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20151948</ArticleId><ArticleId IdType="pmc">PMC4854736</ArticleId><ArticleId IdType="pubmed">27091843</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi Y &amp; Holtzman DM Interplay between innate immunity and Alzheimer disease: APOE and TREM2 in the spotlight. Nature reviews. Immunology 18, 759&#x2013;772, doi:10.1038/s41577-018-0051-1 (2018).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-018-0051-1</ArticleId><ArticleId IdType="pmc">PMC6425488</ArticleId><ArticleId IdType="pubmed">30140051</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi Y. et al. ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy. Nature 549, 523&#x2013;527, doi:10.1038/nature24016 (2017).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature24016</ArticleId><ArticleId IdType="pmc">PMC5641217</ArticleId><ArticleId IdType="pubmed">28959956</ArticleId></ArticleIdList></Reference><Reference><Citation>Keren-Shaul H. et al. A Unique Microglia Type Associated with Restricting Development of Alzheimer's Disease. Cell 169, 1276&#x2013;1290 e1217, doi:10.1016/j.cell.2017.05.018 (2017).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2017.05.018</ArticleId><ArticleId IdType="pubmed">28602351</ArticleId></ArticleIdList></Reference><Reference><Citation>Krasemann S. et al. The TREM2-APOE Pathway Drives the Transcriptional Phenotype of Dysfunctional Microglia in Neurodegenerative Diseases. Immunity 47, 566&#x2013;581 e569, doi:10.1016/j.immuni.2017.08.008 (2017).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2017.08.008</ArticleId><ArticleId IdType="pmc">PMC5719893</ArticleId><ArticleId IdType="pubmed">28930663</ArticleId></ArticleIdList></Reference><Reference><Citation>Ulrich JD et al. ApoE facilitates the microglial response to amyloid plaque pathology. J Exp Med 215, 1047&#x2013;1058, doi:10.1084/jem.20171265 (2018).</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20171265</ArticleId><ArticleId IdType="pmc">PMC5881464</ArticleId><ArticleId IdType="pubmed">29483128</ArticleId></ArticleIdList></Reference><Reference><Citation>Atagi Y. et al. Apolipoprotein E Is a Ligand for Triggering Receptor Expressed on Myeloid Cells 2 (TREM2). J Biol Chem 290, 26043&#x2013;26050, doi:10.1074/jbc.M115.679043 (2015).</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M115.679043</ArticleId><ArticleId IdType="pmc">PMC4646257</ArticleId><ArticleId IdType="pubmed">26374899</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyazaki S, Miyazaki T, Tashiro F, Yamato E &amp; Miyazaki J Development of a single-cassette system for spatiotemporal gene regulation in mice. Biochem Biophys Res Commun 338, 1083&#x2013;1088, doi:10.1016/j.bbrc.2005.10.054 (2005).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2005.10.054</ArticleId><ArticleId IdType="pubmed">16256950</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu CC et al. ApoE4 Accelerates Early Seeding of Amyloid Pathology. Neuron 96, 1024&#x2013;1032 e1023, doi:10.1016/j.neuron.2017.11.013 (2017).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2017.11.013</ArticleId><ArticleId IdType="pmc">PMC5948105</ArticleId><ArticleId IdType="pubmed">29216449</ArticleId></ArticleIdList></Reference><Reference><Citation>Parkhurst CN et al. Microglia promote learning-dependent synapse formation through brain-derived neurotrophic factor. Cell 155, 1596&#x2013;1609, doi:10.1016/j.cell.2013.11.030 (2013).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2013.11.030</ArticleId><ArticleId IdType="pmc">PMC4033691</ArticleId><ArticleId IdType="pubmed">24360280</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldmann T. et al. Origin, fate and dynamics of macrophages at central nervous system interfaces. Nat Immunol 17, 797&#x2013;805, doi:10.1038/ni.3423 (2016).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.3423</ArticleId><ArticleId IdType="pmc">PMC4968048</ArticleId><ArticleId IdType="pubmed">27135602</ArticleId></ArticleIdList></Reference><Reference><Citation>Masuda T. et al. Novel Hexb-based tools for studying microglia in the CNS. Nat Immunol 21, 802&#x2013;815, doi:10.1038/s41590-020-0707-4 (2020).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-020-0707-4</ArticleId><ArticleId IdType="pubmed">32541832</ArticleId></ArticleIdList></Reference><Reference><Citation>Masuda T. et al. Specification of CNS macrophage subsets occurs postnatally in defined niches. Nature 604, 740&#x2013;748, doi:10.1038/s41586-022-04596-2 (2022).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04596-2</ArticleId><ArticleId IdType="pubmed">35444273</ArticleId></ArticleIdList></Reference><Reference><Citation>Ajami B, Bennett JL, Krieger C, Tetzlaff W &amp; Rossi FM Local self-renewal can sustain CNS microglia maintenance and function throughout adult life. Nat Neurosci 10, 1538&#x2013;1543, doi:10.1038/nn2014 (2007).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn2014</ArticleId><ArticleId IdType="pubmed">18026097</ArticleId></ArticleIdList></Reference><Reference><Citation>Lawson LJ, Perry VH &amp; Gordon S Turnover of resident microglia in the normal adult mouse brain. Neuroscience 48, 405&#x2013;415, doi:10.1016/0306-4522(92)90500-2 (1992).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0306-4522(92)90500-2</ArticleId><ArticleId IdType="pubmed">1603325</ArticleId></ArticleIdList></Reference><Reference><Citation>van Furth R &amp; Cohn ZA The origin and kinetics of mononuclear phagocytes. J Exp Med 128, 415&#x2013;435, doi:10.1084/jem.128.3.415 (1968).</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.128.3.415</ArticleId><ArticleId IdType="pmc">PMC2138527</ArticleId><ArticleId IdType="pubmed">5666958</ArticleId></ArticleIdList></Reference><Reference><Citation>Fogg DK et al. A clonogenic bone marrow progenitor specific for macrophages and dendritic cells. Science 311, 83&#x2013;87, doi:10.1126/science.1117729 (2006).</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1117729</ArticleId><ArticleId IdType="pubmed">16322423</ArticleId></ArticleIdList></Reference><Reference><Citation>Jankowsky JL et al. Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase. Hum Mol Genet 13, 159&#x2013;170, doi:10.1093/hmg/ddh019 (2004).</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddh019</ArticleId><ArticleId IdType="pubmed">14645205</ArticleId></ArticleIdList></Reference><Reference><Citation>Holtzman DM et al. Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease. Proc Natl Acad Sci U S A 97, 2892&#x2013;2897, doi:10.1073/pnas.050004797 (2000).</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.050004797</ArticleId><ArticleId IdType="pmc">PMC16026</ArticleId><ArticleId IdType="pubmed">10694577</ArticleId></ArticleIdList></Reference><Reference><Citation>Pankiewicz JE et al. Blocking the apoE/Abeta interaction ameliorates Abeta-related pathology in APOE epsilon2 and epsilon4 targeted replacement Alzheimer model mice. Acta Neuropathol Commun 2, 75, doi:10.1186/s40478-014-0075-0 (2014).</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-014-0075-0</ArticleId><ArticleId IdType="pmc">PMC4174325</ArticleId><ArticleId IdType="pubmed">24972680</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharoar MG, Palko S, Ge Y, Saido TC &amp; Yan R Accumulation of saposin in dystrophic neurites is linked to impaired lysosomal functions in Alzheimer's disease brains. Mol Neurodegener 16, 45, doi:10.1186/s13024-021-00464-1 (2021).</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-021-00464-1</ArticleId><ArticleId IdType="pmc">PMC8254260</ArticleId><ArticleId IdType="pubmed">34215298</ArticleId></ArticleIdList></Reference><Reference><Citation>Boucher DM, Vijithakumar V &amp; Ouimet M Lipid Droplets as Regulators of Metabolism and Immunity. Immunometabolism 3, e210021, doi:10.20900/immunometab20210021 (2021).</Citation><ArticleIdList><ArticleId IdType="doi">10.20900/immunometab20210021</ArticleId></ArticleIdList></Reference><Reference><Citation>Marschallinger J. et al. Lipid-droplet-accumulating microglia represent a dysfunctional and proinflammatory state in the aging brain. Nat Neurosci 23, 194&#x2013;208, doi:10.1038/s41593-019-0566-1 (2020).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-019-0566-1</ArticleId><ArticleId IdType="pmc">PMC7595134</ArticleId><ArticleId IdType="pubmed">31959936</ArticleId></ArticleIdList></Reference><Reference><Citation>Sienski G. et al. APOE4 disrupts intracellular lipid homeostasis in human iPSC-derived glia. Science translational medicine 13, doi:10.1126/scitranslmed.aaz4564 (2021).</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.aaz4564</ArticleId><ArticleId IdType="pmc">PMC8218593</ArticleId><ArticleId IdType="pubmed">33658354</ArticleId></ArticleIdList></Reference><Reference><Citation>Keane L. et al. mTOR-dependent translation amplifies microglia priming in aging mice. J Clin Invest 131, doi:10.1172/JCI155208 (2021).</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI155208</ArticleId><ArticleId IdType="pmc">PMC7773382</ArticleId><ArticleId IdType="pubmed">33108356</ArticleId></ArticleIdList></Reference><Reference><Citation>Baik SH et al. A Breakdown in Metabolic Reprogramming Causes Microglia Dysfunction in Alzheimer's Disease. Cell Metab 30, 493&#x2013;507 e496, doi:10.1016/j.cmet.2019.06.005 (2019).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2019.06.005</ArticleId><ArticleId IdType="pubmed">31257151</ArticleId></ArticleIdList></Reference><Reference><Citation>Damani MR et al. Age-related alterations in the dynamic behavior of microglia. Aging Cell 10, 263&#x2013;276, doi:10.1111/j.1474-9726.2010.00660.x (2011).</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1474-9726.2010.00660.x</ArticleId><ArticleId IdType="pmc">PMC3056927</ArticleId><ArticleId IdType="pubmed">21108733</ArticleId></ArticleIdList></Reference><Reference><Citation>Davalos D. et al. ATP mediates rapid microglial response to local brain injury in vivo. Nature neuroscience 8, 752&#x2013;758, doi:10.1038/nn1472 (2005).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn1472</ArticleId><ArticleId IdType="pubmed">15895084</ArticleId></ArticleIdList></Reference><Reference><Citation>Nimmerjahn A, Kirchhoff F &amp; Helmchen F Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science 308, 1314&#x2013;1318, doi:10.1126/science.1110647 (2005).</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1110647</ArticleId><ArticleId IdType="pubmed">15831717</ArticleId></ArticleIdList></Reference><Reference><Citation>Madry C &amp; Attwell D Receptors, ion channels, and signaling mechanisms underlying microglial dynamics. J Biol Chem 290, 12443&#x2013;12450, doi:10.1074/jbc.R115.637157 (2015).</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.R115.637157</ArticleId><ArticleId IdType="pmc">PMC4432265</ArticleId><ArticleId IdType="pubmed">25855789</ArticleId></ArticleIdList></Reference><Reference><Citation>Schafer DP, Lehrman EK &amp; Stevens B The "quad-partite" synapse: microglia-synapse interactions in the developing and mature CNS. Glia 61, 24&#x2013;36, doi:10.1002/glia.22389 (2013).</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.22389</ArticleId><ArticleId IdType="pmc">PMC4082974</ArticleId><ArticleId IdType="pubmed">22829357</ArticleId></ArticleIdList></Reference><Reference><Citation>Deczkowska A. et al. Disease-Associated Microglia: A Universal Immune Sensor of Neurodegeneration. Cell 173, 1073&#x2013;1081, doi:10.1016/j.cell.2018.05.003 (2018).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2018.05.003</ArticleId><ArticleId IdType="pubmed">29775591</ArticleId></ArticleIdList></Reference><Reference><Citation>Olah M. et al. Single cell RNA sequencing of human microglia uncovers a subset associated with Alzheimer's disease. Nat Commun 11, 6129, doi:10.1038/s41467-020-19737-2 (2020).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-19737-2</ArticleId><ArticleId IdType="pmc">PMC7704703</ArticleId><ArticleId IdType="pubmed">33257666</ArticleId></ArticleIdList></Reference><Reference><Citation>Neftel C. et al. An Integrative Model of Cellular States, Plasticity, and Genetics for Glioblastoma. Cell 178, 835&#x2013;849.e821, doi:10.1016/j.cell.2019.06.024 (2019).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2019.06.024</ArticleId><ArticleId IdType="pmc">PMC6703186</ArticleId><ArticleId IdType="pubmed">31327527</ArticleId></ArticleIdList></Reference><Reference><Citation>Lau SF, Cao H, Fu AKY &amp; Ip NY Single-nucleus transcriptome analysis reveals dysregulation of angiogenic endothelial cells and neuroprotective glia in Alzheimer's disease. Proc Natl Acad Sci U S A 117, 25800&#x2013;25809, doi:10.1073/pnas.2008762117 (2020).</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2008762117</ArticleId><ArticleId IdType="pmc">PMC7568283</ArticleId><ArticleId IdType="pubmed">32989152</ArticleId></ArticleIdList></Reference><Reference><Citation>Boza-Serrano A. et al. Galectin-3, a novel endogenous TREM2 ligand, detrimentally regulates inflammatory response in Alzheimer's disease. Acta Neuropathol 138, 251&#x2013;273, doi:10.1007/s00401-019-02013-z (2019).</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-019-02013-z</ArticleId><ArticleId IdType="pmc">PMC6660511</ArticleId><ArticleId IdType="pubmed">31006066</ArticleId></ArticleIdList></Reference><Reference><Citation>Pantazis CB et al. A reference human induced pluripotent stem cell line for large-scale collaborative studies. Cell stem cell 29, 1685&#x2013;1702 e1622, doi:10.1016/j.stem.2022.11.004 (2022).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stem.2022.11.004</ArticleId><ArticleId IdType="pmc">PMC9782786</ArticleId><ArticleId IdType="pubmed">36459969</ArticleId></ArticleIdList></Reference><Reference><Citation>Querfurth H &amp; Lee HK Mammalian/mechanistic target of rapamycin (mTOR) complexes in neurodegeneration. Mol Neurodegener 16, 44, doi:10.1186/s13024-021-00428-5 (2021).</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-021-00428-5</ArticleId><ArticleId IdType="pmc">PMC8252260</ArticleId><ArticleId IdType="pubmed">34215308</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding X. et al. Loss of microglial SIRPalpha promotes synaptic pruning in preclinical models of neurodegeneration. Nat Commun 12, 2030, doi:10.1038/s41467-021-22301-1 (2021).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-22301-1</ArticleId><ArticleId IdType="pmc">PMC8016980</ArticleId><ArticleId IdType="pubmed">33795678</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong S, Dissing-Olesen L &amp; Stevens B New insights on the role of microglia in synaptic pruning in health and disease. Curr Opin Neurobiol 36, 128&#x2013;134, doi:10.1016/j.conb.2015.12.004 (2016).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.conb.2015.12.004</ArticleId><ArticleId IdType="pmc">PMC5479435</ArticleId><ArticleId IdType="pubmed">26745839</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen AT et al. APOE and TREM2 regulate amyloid-responsive microglia in Alzheimer's disease. Acta Neuropathol 140, 477&#x2013;493, doi:10.1007/s00401-020-02200-3 (2020).</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-020-02200-3</ArticleId><ArticleId IdType="pmc">PMC7520051</ArticleId><ArticleId IdType="pubmed">32840654</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi Y. et al. Microglia drive APOE-dependent neurodegeneration in a tauopathy mouse model. The Journal of experimental medicine 216, 2546&#x2013;2561, doi:10.1084/jem.20190980 (2019).</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20190980</ArticleId><ArticleId IdType="pmc">PMC6829593</ArticleId><ArticleId IdType="pubmed">31601677</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin Z. et al. APOE4 impairs the microglial response in Alzheimer's disease by inducing TGFbeta-mediated checkpoints. Nature immunology 24, 1839&#x2013;1853, doi:10.1038/s41590-023-01627-6 (2023).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-023-01627-6</ArticleId><ArticleId IdType="pmc">PMC10863749</ArticleId><ArticleId IdType="pubmed">37749326</ArticleId></ArticleIdList></Reference><Reference><Citation>Condello C, Yuan P, Schain A &amp; Grutzendler J Microglia constitute a barrier that prevents neurotoxic protofibrillar Abeta42 hotspots around plaques. Nat Commun 6, 6176, doi:10.1038/ncomms7176 (2015).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms7176</ArticleId><ArticleId IdType="pmc">PMC4311408</ArticleId><ArticleId IdType="pubmed">25630253</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y. et al. TREM2 lipid sensing sustains the microglial response in an Alzheimer's disease model. Cell 160, 1061&#x2013;1071, doi:10.1016/j.cell.2015.01.049 (2015).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2015.01.049</ArticleId><ArticleId IdType="pmc">PMC4477963</ArticleId><ArticleId IdType="pubmed">25728668</ArticleId></ArticleIdList></Reference><Reference><Citation>Parhizkar S. et al. Loss of TREM2 function increases amyloid seeding but reduces plaque-associated ApoE. Nat Neurosci 22, 191&#x2013;204, doi:10.1038/s41593-018-0296-9 (2019).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-018-0296-9</ArticleId><ArticleId IdType="pmc">PMC6417433</ArticleId><ArticleId IdType="pubmed">30617257</ArticleId></ArticleIdList></Reference><Reference><Citation>Fitz NF et al. Trem2 deficiency differentially affects phenotype and transcriptome of human APOE3 and APOE4 mice. Mol Neurodegener 15, 41, doi:10.1186/s13024-020-00394-4 (2020).</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-020-00394-4</ArticleId><ArticleId IdType="pmc">PMC7379780</ArticleId><ArticleId IdType="pubmed">32703241</ArticleId></ArticleIdList></Reference><Reference><Citation>Lanfranco MF, Sepulveda J, Kopetsky G &amp; Rebeck GW Expression and secretion of apoE isoforms in astrocytes and microglia during inflammation. Glia 69, 1478&#x2013;1493, doi:10.1002/glia.23974 (2021).</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.23974</ArticleId><ArticleId IdType="pmc">PMC8717762</ArticleId><ArticleId IdType="pubmed">33556209</ArticleId></ArticleIdList></Reference><Reference><Citation>Huynh TV et al. Lack of hepatic apoE does not influence early Abeta deposition: observations from a new APOE knock-in model. Molecular neurodegeneration 14, 37, doi:10.1186/s13024-019-0337-1 (2019).</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-019-0337-1</ArticleId><ArticleId IdType="pmc">PMC6796484</ArticleId><ArticleId IdType="pubmed">31623648</ArticleId></ArticleIdList></Reference><Reference><Citation>Martens YA et al. ApoE Cascade Hypothesis in the pathogenesis of Alzheimer's disease and related dementias. Neuron 110, 1304&#x2013;1317, doi:10.1016/j.neuron.2022.03.004 (2022).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2022.03.004</ArticleId><ArticleId IdType="pmc">PMC9035117</ArticleId><ArticleId IdType="pubmed">35298921</ArticleId></ArticleIdList></Reference><Reference><Citation>Lian H. et al. Astrocyte-Microglia Cross Talk through Complement Activation Modulates Amyloid Pathology in Mouse Models of Alzheimer's Disease. J Neurosci 36, 577&#x2013;589, doi:10.1523/JNEUROSCI.2117-15.2016 (2016).</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.2117-15.2016</ArticleId><ArticleId IdType="pmc">PMC4710776</ArticleId><ArticleId IdType="pubmed">26758846</ArticleId></ArticleIdList></Reference><Reference><Citation>Liddelow SA et al. Neurotoxic reactive astrocytes are induced by activated microglia. Nature 541, 481&#x2013;487, doi:10.1038/nature21029 (2017).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature21029</ArticleId><ArticleId IdType="pmc">PMC5404890</ArticleId><ArticleId IdType="pubmed">28099414</ArticleId></ArticleIdList></Reference><Reference><Citation>Castellano JM et al. Human apoE isoforms differentially regulate brain amyloid-beta peptide clearance. Sci Transl Med 3, 89ra57, doi:10.1126/scitranslmed.30021563/89/89ra57 [pii] (2011).</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.30021563/89/89ra57</ArticleId><ArticleId IdType="pmc">PMC3192364</ArticleId><ArticleId IdType="pubmed">21715678</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37865646</PMID><DateCompleted><Year>2023</Year><Month>11</Month><Day>01</Day></DateCompleted><DateRevised><Year>2023</Year><Month>11</Month><Day>18</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2041-1723</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Oct</Month><Day>21</Day></PubDate></JournalIssue><Title>Nature communications</Title><ISOAbbreviation>Nat Commun</ISOAbbreviation></Journal><ArticleTitle>Soluble TREM2 ameliorates tau phosphorylation and cognitive deficits through activating transgelin-2 in Alzheimer's disease.</ArticleTitle><Pagination><StartPage>6670</StartPage><MedlinePgn>6670</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">6670</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41467-023-42505-x</ELocationID><Abstract><AbstractText>Triggering receptor expressed on myeloid cells 2 (TREM2) is a transmembrane protein that is predominantly expressed by microglia in the brain. The proteolytic shedding of TREM2 results in the release of soluble TREM2 (sTREM2), which is increased in the cerebrospinal fluid of patients with Alzheimer's disease (AD). It remains unknown whether sTREM2 regulates the pathogenesis of AD. Here we identified transgelin-2 (TG2) expressed on neurons as the receptor for sTREM2. The microglia-derived sTREM2 binds to TG2, induces RhoA phosphorylation at S188, and deactivates the RhoA-ROCK-GSK3&#x3b2; pathway, ameliorating tau phosphorylation. The sTREM2 (77-89) fragment, which is the minimal active sequence of sTREM2 to activate TG2, mimics the inhibitory effect of sTREM2 on tau phosphorylation. Overexpression of sTREM2 or administration of the active peptide rescues tau pathology and behavioral defects in the tau P301S transgenic mice. Together, these findings demonstrate that the sTREM2-TG2 interaction mediates the cross-talk between microglia and neurons. sTREM2 and its active peptide may be a potential therapeutic intervention for tauopathies including AD.</AbstractText><CopyrightInformation>&#xa9; 2023. Springer Nature Limited.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Zhang</LastName><ForeName>Xingyu</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Neurology, Renmin Hospital of Wuhan University, Wuhan, 430060, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Tang</LastName><ForeName>Li</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Neurology, Renmin Hospital of Wuhan University, Wuhan, 430060, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Jiaolong</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurology, Renmin Hospital of Wuhan University, Wuhan, 430060, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meng</LastName><ForeName>Lanxia</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Neurology, Renmin Hospital of Wuhan University, Wuhan, 430060, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Jiehui</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurology, Renmin Hospital of Wuhan University, Wuhan, 430060, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Lingyan</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-3255-9736</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Renmin Hospital of Wuhan University, Wuhan, 430060, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Jiangyu</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurology, Renmin Hospital of Wuhan University, Wuhan, 430060, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xiong</LastName><ForeName>Min</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurology, Renmin Hospital of Wuhan University, Wuhan, 430060, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Zhentao</ForeName><Initials>Z</Initials><Identifier Source="ORCID">0000-0001-6708-1472</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Renmin Hospital of Wuhan University, Wuhan, 430060, China. zhentaozhang@whu.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>10</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nat Commun</MedlineTA><NlmUniqueID>101528555</NlmUniqueID><ISSNLinking>2041-1723</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C051615">transgelin</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010455">Peptides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016875">tau Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016229">Amyloid beta-Peptides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C498715">TREM2 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008562">Membrane Glycoproteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011971">Receptors, Immunologic</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010766" MajorTopicYN="N">Phosphorylation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010455" MajorTopicYN="N">Peptides</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003071" MajorTopicYN="N">Cognition</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016875" MajorTopicYN="N">tau Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016229" MajorTopicYN="N">Amyloid beta-Peptides</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008562" MajorTopicYN="N">Membrane Glycoproteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011971" MajorTopicYN="N">Receptors, Immunologic</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>11</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>10</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>11</Month><Day>1</Day><Hour>12</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>10</Month><Day>22</Day><Hour>0</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>10</Month><Day>21</Day><Hour>23</Hour><Minute>17</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>10</Month><Day>21</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37865646</ArticleId><ArticleId IdType="pmc">PMC10590452</ArticleId><ArticleId IdType="doi">10.1038/s41467-023-42505-x</ArticleId><ArticleId IdType="pii">10.1038/s41467-023-42505-x</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Long JM, Holtzman DM. Alzheimer disease: an update on pathobiology and treatment strategies. Cell. 2019;179:312&#x2013;339. doi: 10.1016/j.cell.2019.09.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2019.09.001</ArticleId><ArticleId IdType="pmc">PMC6778042</ArticleId><ArticleId IdType="pubmed">31564456</ArticleId></ArticleIdList></Reference><Reference><Citation>Dixit R, Ross JL, Goldman YE, Holzbaur ELF. Differential regulation of dynein and kinesin motor proteins by tau. Science. 2008;319:1086&#x2013;1089. doi: 10.1126/science.1152993.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1152993</ArticleId><ArticleId IdType="pmc">PMC2866193</ArticleId><ArticleId IdType="pubmed">18202255</ArticleId></ArticleIdList></Reference><Reference><Citation>Savastano A, et al. Disease-associated tau phosphorylation hinders tubulin assembly within tau condensates. Angew. Chem. Int. Ed. Engl. 2021;60:726&#x2013;730. doi: 10.1002/anie.202011157.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/anie.202011157</ArticleId><ArticleId IdType="pmc">PMC7839466</ArticleId><ArticleId IdType="pubmed">33017094</ArticleId></ArticleIdList></Reference><Reference><Citation>Despres C, et al. Identification of the Tau phosphorylation pattern that drives its aggregation. Proc. Natl. Acad. Sci. USA. 2017;114:9080&#x2013;9085. doi: 10.1073/pnas.1708448114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1708448114</ArticleId><ArticleId IdType="pmc">PMC5576827</ArticleId><ArticleId IdType="pubmed">28784767</ArticleId></ArticleIdList></Reference><Reference><Citation>Serrano-Pozo A, et al. Reactive glia not only associates with plaques but also parallels tangles in Alzheimer&#x2019;s disease. Am. J. Pathol. 2011;179:1373&#x2013;1384. doi: 10.1016/j.ajpath.2011.05.047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajpath.2011.05.047</ArticleId><ArticleId IdType="pmc">PMC3157187</ArticleId><ArticleId IdType="pubmed">21777559</ArticleId></ArticleIdList></Reference><Reference><Citation>Pascoal TA, et al. Microglial activation and tau propagate jointly across Braak stages. Nat. Med. 2021;27:1592&#x2013;1599. doi: 10.1038/s41591-021-01456-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01456-w</ArticleId><ArticleId IdType="pubmed">34446931</ArticleId></ArticleIdList></Reference><Reference><Citation>Bartels T, De Schepper S, Hong S. Microglia modulate neurodegeneration in Alzheimer&#x2019;s and Parkinson&#x2019;s diseases. Science. 2020;370:66&#x2013;69. doi: 10.1126/science.abb8587.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abb8587</ArticleId><ArticleId IdType="pubmed">33004513</ArticleId></ArticleIdList></Reference><Reference><Citation>Asai H, et al. Depletion of microglia and inhibition of exosome synthesis halt tau propagation. Nat. Neurosci. 2015;18:1584&#x2013;1593. doi: 10.1038/nn.4132.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.4132</ArticleId><ArticleId IdType="pmc">PMC4694577</ArticleId><ArticleId IdType="pubmed">26436904</ArticleId></ArticleIdList></Reference><Reference><Citation>Ising C, et al. NLRP3 inflammasome activation drives tau pathology. Nature. 2019;575:669&#x2013;673. doi: 10.1038/s41586-019-1769-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-019-1769-z</ArticleId><ArticleId IdType="pmc">PMC7324015</ArticleId><ArticleId IdType="pubmed">31748742</ArticleId></ArticleIdList></Reference><Reference><Citation>Gratuze M, et al. Activated microglia mitigate A&#x3b2;-associated tau seeding and spreading. J. Exp. Med. 2021;218:e20210542. doi: 10.1084/jem.20210542.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20210542</ArticleId><ArticleId IdType="pmc">PMC8190588</ArticleId><ArticleId IdType="pubmed">34100905</ArticleId></ArticleIdList></Reference><Reference><Citation>McAlpine CS, et al. Astrocytic interleukin-3 programs microglia and limits Alzheimer&#x2019;s disease. Nature. 2021;595:701&#x2013;706. doi: 10.1038/s41586-021-03734-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03734-6</ArticleId><ArticleId IdType="pmc">PMC8934148</ArticleId><ArticleId IdType="pubmed">34262178</ArticleId></ArticleIdList></Reference><Reference><Citation>Su&#xe1;rez-Calvet M, et al. Early increase of CSF sTREM2 in Alzheimer&#x2019;s disease is associated with tau related-neurodegeneration but not with amyloid-&#x3b2; pathology. Mol. Neurodegener. 2019;14:1. doi: 10.1186/s13024-018-0301-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-018-0301-5</ArticleId><ArticleId IdType="pmc">PMC6327425</ArticleId><ArticleId IdType="pubmed">30630532</ArticleId></ArticleIdList></Reference><Reference><Citation>Jonsson T, et al. Variant of TREM2 associated with the risk of Alzheimer&#x2019;s disease. N. Engl. J. Med. 2013;368:107&#x2013;116. doi: 10.1056/NEJMoa1211103.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1211103</ArticleId><ArticleId IdType="pmc">PMC3677583</ArticleId><ArticleId IdType="pubmed">23150908</ArticleId></ArticleIdList></Reference><Reference><Citation>Ulrich JD, Ulland TK, Colonna M, Holtzman DM. Elucidating the role of TREM2 in Alzheimer&#x2019;s disease. Neuron. 2017;94:237&#x2013;248. doi: 10.1016/j.neuron.2017.02.042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2017.02.042</ArticleId><ArticleId IdType="pubmed">28426958</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang T, et al. Silencing of TREM2 exacerbates tau pathology, neurodegenerative changes, and spatial learning deficits in P301S tau transgenic mice. Neurobiol. Aging. 2015;36:3176&#x2013;3186. doi: 10.1016/j.neurobiolaging.2015.08.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2015.08.019</ArticleId><ArticleId IdType="pubmed">26364736</ArticleId></ArticleIdList></Reference><Reference><Citation>Bemiller SM, et al. TREM2 deficiency exacerbates tau pathology through dysregulated kinase signaling in a mouse model of tauopathy. Mol. Neurodegener. 2017;12:74. doi: 10.1186/s13024-017-0216-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-017-0216-6</ArticleId><ArticleId IdType="pmc">PMC5644120</ArticleId><ArticleId IdType="pubmed">29037207</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang T, et al. TREM2 ameliorates neuronal tau pathology through suppression of microglial inflammatory response. Inflammation. 2018;41:811&#x2013;823. doi: 10.1007/s10753-018-0735-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10753-018-0735-5</ArticleId><ArticleId IdType="pubmed">29362997</ArticleId></ArticleIdList></Reference><Reference><Citation>Leyns CEG, et al. TREM2 deficiency attenuates neuroinflammation and protects against neurodegeneration in a mouse model of tauopathy. Proc. Natl Acad. Sci. USA. 2017;114:11524&#x2013;11529. doi: 10.1073/pnas.1710311114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1710311114</ArticleId><ArticleId IdType="pmc">PMC5663386</ArticleId><ArticleId IdType="pubmed">29073081</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee S-H, et al. Trem2 restrains the enhancement of tau accumulation and neurodegeneration by &#x3b2;-amyloid pathology. Neuron. 2021;109:1283&#x2013;1301.e6. doi: 10.1016/j.neuron.2021.02.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2021.02.010</ArticleId><ArticleId IdType="pubmed">33675684</ArticleId></ArticleIdList></Reference><Reference><Citation>Jain N, Lewis CA, Ulrich JD, Holtzman DM. Chronic TREM2 activation exacerbates A&#x3b2;-associated tau seeding and spreading. J. Exp. Med. 2023;220:e20220654. doi: 10.1084/jem.20220654.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20220654</ArticleId><ArticleId IdType="pmc">PMC9559604</ArticleId><ArticleId IdType="pubmed">36219197</ArticleId></ArticleIdList></Reference><Reference><Citation>Feuerbach D, et al. ADAM17 is the main sheddase for the generation of human triggering receptor expressed in myeloid cells (hTREM2) ectodomain and cleaves TREM2 after Histidine 157. Neurosci. Lett. 2017;660:109&#x2013;114. doi: 10.1016/j.neulet.2017.09.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2017.09.034</ArticleId><ArticleId IdType="pubmed">28923481</ArticleId></ArticleIdList></Reference><Reference><Citation>Wunderlich P, et al. Sequential proteolytic processing of the triggering receptor expressed on myeloid cells-2 (TREM2) protein by ectodomain shedding and &#x3b3;-secretase-dependent intramembranous cleavage. J. Biol. Chem. 2013;288:33027&#x2013;33036. doi: 10.1074/jbc.M113.517540.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M113.517540</ArticleId><ArticleId IdType="pmc">PMC3829152</ArticleId><ArticleId IdType="pubmed">24078628</ArticleId></ArticleIdList></Reference><Reference><Citation>Heslegrave A, et al. Increased cerebrospinal fluid soluble TREM2 concentration in Alzheimer&#x2019;s disease. Mol. Neurodegener. 2016;11:3. doi: 10.1186/s13024-016-0071-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-016-0071-x</ArticleId><ArticleId IdType="pmc">PMC4709982</ArticleId><ArticleId IdType="pubmed">26754172</ArticleId></ArticleIdList></Reference><Reference><Citation>Su&#xe1;rez-Calvet M, et al. sTREM2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early-stage Alzheimer&#x2019;s disease and associate with neuronal injury markers. EMBO Mol. Med. 2016;8:466&#x2013;476. doi: 10.15252/emmm.201506123.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/emmm.201506123</ArticleId><ArticleId IdType="pmc">PMC5120370</ArticleId><ArticleId IdType="pubmed">26941262</ArticleId></ArticleIdList></Reference><Reference><Citation>Ewers M, et al. Increased soluble TREM2 in cerebrospinal fluid is associated with reduced cognitive and clinical decline in Alzheimer&#x2019;s disease. Sci. Transl. Med. 2019;11:eaav6221. doi: 10.1126/scitranslmed.aav6221.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.aav6221</ArticleId><ArticleId IdType="pmc">PMC7050285</ArticleId><ArticleId IdType="pubmed">31462511</ArticleId></ArticleIdList></Reference><Reference><Citation>Morenas-Rodr&#xed;guez E, et al. Soluble TREM2 in CSF and its association with other biomarkers and cognition in autosomal-dominant Alzheimer&#x2019;s disease: a longitudinal observational study. Lancet Neurol. 2022;21:329&#x2013;341. doi: 10.1016/S1474-4422(22)00027-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(22)00027-8</ArticleId><ArticleId IdType="pmc">PMC8926925</ArticleId><ArticleId IdType="pubmed">35305339</ArticleId></ArticleIdList></Reference><Reference><Citation>Song WM, et al. Humanized TREM2 mice reveal microglia-intrinsic and -extrinsic effects of R47H polymorphism. J. Exp. Med. 2018;215:745&#x2013;760. doi: 10.1084/jem.20171529.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20171529</ArticleId><ArticleId IdType="pmc">PMC5839761</ArticleId><ArticleId IdType="pubmed">29321225</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin L-M, Ulloa L, Yang Y-Q. Transgelin-2: biochemical and clinical implications in cancer and asthma. Trends Biochem. Sci. 2019;44:885&#x2013;896. doi: 10.1016/j.tibs.2019.05.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tibs.2019.05.004</ArticleId><ArticleId IdType="pmc">PMC7023894</ArticleId><ArticleId IdType="pubmed">31256982</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin L-M, et al. Transgelin-2 as a therapeutic target for asthmatic pulmonary resistance. Sci. Transl. Med. 2018;10:eaam8604. doi: 10.1126/scitranslmed.aam8604.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.aam8604</ArticleId><ArticleId IdType="pmc">PMC6310021</ArticleId><ArticleId IdType="pubmed">29437149</ArticleId></ArticleIdList></Reference><Reference><Citation>Cap KC, et al. Distinct dual roles of p-Tyr42 RhoA GTPase in tau phosphorylation and ATP citrate lyase activation upon different A&#x3b2; concentrations. Redox Biol. 2020;32:101446. doi: 10.1016/j.redox.2020.101446.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.redox.2020.101446</ArticleId><ArticleId IdType="pmc">PMC7264465</ArticleId><ArticleId IdType="pubmed">32046944</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J, et al. Regulation of RhoA GTPase and various transcription factors in the RhoA pathway. J. Cell. Physiol. 2018;233:6381&#x2013;6392. doi: 10.1002/jcp.26487.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcp.26487</ArticleId><ArticleId IdType="pubmed">29377108</ArticleId></ArticleIdList></Reference><Reference><Citation>Forget M-A, Desrosiers RR, Gingras D, B&#xe9;liveau R. Phosphorylation states of Cdc42 and RhoA regulate their interactions with Rho GDP dissociation inhibitor and their extraction from biological membranes. Biochem. J. 2002;361:243&#x2013;254. doi: 10.1042/bj3610243.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/bj3610243</ArticleId><ArticleId IdType="pmc">PMC1222304</ArticleId><ArticleId IdType="pubmed">11772396</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang T, et al. TREM2 modifies microglial phenotype and provides neuroprotection in P301S tau transgenic mice. Neuropharmacology. 2016;105:196&#x2013;206. doi: 10.1016/j.neuropharm.2016.01.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuropharm.2016.01.028</ArticleId><ArticleId IdType="pubmed">26802771</ArticleId></ArticleIdList></Reference><Reference><Citation>Neddens J, et al. Phosphorylation of different tau sites during progression of Alzheimer&#x2019;s disease. Acta Neuropathol. Commun. 2018;6:52. doi: 10.1186/s40478-018-0557-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-018-0557-6</ArticleId><ArticleId IdType="pmc">PMC6027763</ArticleId><ArticleId IdType="pubmed">29958544</ArticleId></ArticleIdList></Reference><Reference><Citation>Bramblett GT, et al. Abnormal tau phosphorylation at Ser396 in Alzheimer&#x2019;s disease recapitulates development and contributes to reduced microtubule binding. Neuron. 1993;10:1089&#x2013;1099. doi: 10.1016/0896-6273(93)90057-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0896-6273(93)90057-X</ArticleId><ArticleId IdType="pubmed">8318230</ArticleId></ArticleIdList></Reference><Reference><Citation>Quintanilla RA, von Bernhardi R, Godoy JA, Inestrosa NC, Johnson GVW. Phosphorylated tau potentiates A&#x3b2;-induced mitochondrial damage in mature neurons. Neurobiol. Dis. 2014;71:260&#x2013;269. doi: 10.1016/j.nbd.2014.08.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2014.08.016</ArticleId><ArticleId IdType="pubmed">25134729</ArticleId></ArticleIdList></Reference><Reference><Citation>Thijssen EH, et al. Plasma phosphorylated tau 217 and phosphorylated tau 181 as biomarkers in Alzheimer&#x2019;s disease and frontotemporal lobar degeneration: a retrospective diagnostic performance study. Lancet Neurol. 2021;20:739&#x2013;752. doi: 10.1016/S1474-4422(21)00214-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(21)00214-3</ArticleId><ArticleId IdType="pmc">PMC8711249</ArticleId><ArticleId IdType="pubmed">34418401</ArticleId></ArticleIdList></Reference><Reference><Citation>Mariscal J, et al. Comprehensive palmitoyl&#x2010;proteomic analysis identifies distinct protein signatures for large and small cancer&#x2010;derived extracellular vesicles. J. Extracell. Vesicles. 2020;9:1764192. doi: 10.1080/20013078.2020.1764192.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/20013078.2020.1764192</ArticleId><ArticleId IdType="pmc">PMC7448892</ArticleId><ArticleId IdType="pubmed">32944167</ArticleId></ArticleIdList></Reference><Reference><Citation>Pradhan AJ, et al. Protein acylation by saturated very long chain fatty acids and endocytosis are involved in necroptosis. Cell Chem. Biol. 2021;28:1298&#x2013;1309.e7. doi: 10.1016/j.chembiol.2021.03.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chembiol.2021.03.012</ArticleId><ArticleId IdType="pmc">PMC8529612</ArticleId><ArticleId IdType="pubmed">33848465</ArticleId></ArticleIdList></Reference><Reference><Citation>Bausch-Fluck D, et al. A mass spectrometric-derived cell surface protein atlas. PLoS ONE. 2015;10:e0121314. doi: 10.1371/journal.pone.0121314.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0121314</ArticleId><ArticleId IdType="pmc">PMC4404347</ArticleId><ArticleId IdType="pubmed">25894527</ArticleId></ArticleIdList></Reference><Reference><Citation>Bausch-Fluck D, et al. The in silico human surfaceome. Proc. Natl. Acad. Sci. USA. 2018;115:E10988&#x2013;E10997. doi: 10.1073/pnas.1808790115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1808790115</ArticleId><ArticleId IdType="pmc">PMC6243280</ArticleId><ArticleId IdType="pubmed">30373828</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, et al. Purification and characterization of progenitor and mature human astrocytes reveals transcriptional and functional differences with mouse. Neuron. 2016;89:37&#x2013;53. doi: 10.1016/j.neuron.2015.11.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2015.11.013</ArticleId><ArticleId IdType="pmc">PMC4707064</ArticleId><ArticleId IdType="pubmed">26687838</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma K, et al. Cell type- and brain region-resolved mouse brain proteome. Nat. Neurosci. 2015;18:1819&#x2013;1831. doi: 10.1038/nn.4160.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.4160</ArticleId><ArticleId IdType="pmc">PMC7116867</ArticleId><ArticleId IdType="pubmed">26523646</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhong L, et al. Soluble TREM2 ameliorates pathological phenotypes by modulating microglial functions in an Alzheimer&#x2019;s disease model. Nat. Commun. 2019;10:1365. doi: 10.1038/s41467-019-09118-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-09118-9</ArticleId><ArticleId IdType="pmc">PMC6433910</ArticleId><ArticleId IdType="pubmed">30911003</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi E-K, et al. Regulation of RhoA GTPase and novel target proteins for ROCK. Small GTPases. 2020;11:95&#x2013;102. doi: 10.1080/21541248.2017.1364831.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21541248.2017.1364831</ArticleId><ArticleId IdType="pmc">PMC7053945</ArticleId><ArticleId IdType="pubmed">29199510</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhong L, et al. Soluble TREM2 induces inflammatory responses and enhances microglial survival. J. Exp. Med. 2017;214:597&#x2013;607. doi: 10.1084/jem.20160844.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20160844</ArticleId><ArticleId IdType="pmc">PMC5339672</ArticleId><ArticleId IdType="pubmed">28209725</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang K-J, Rasband MN. Cell surface protein-protein binding on COS-7 cells. Bio Protoc. 2015;4:e1020.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4849168</ArticleId><ArticleId IdType="pubmed">27135044</ArticleId></ArticleIdList></Reference><Reference><Citation>Susuki K, et al. Three mechanisms assemble central nervous system nodes of ranvier. Neuron. 2013;78:469&#x2013;482. doi: 10.1016/j.neuron.2013.03.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2013.03.005</ArticleId><ArticleId IdType="pmc">PMC3756512</ArticleId><ArticleId IdType="pubmed">23664614</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X, et al. Amphiphysin I cleavage by asparagine endopeptidase leads to tau hyperphosphorylation and synaptic dysfunction. eLife. 2021;10:e65301. doi: 10.7554/eLife.65301.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.65301</ArticleId><ArticleId IdType="pmc">PMC8139826</ArticleId><ArticleId IdType="pubmed">34018922</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Z, et al. Cleavage of tau by asparagine endopeptidase mediates the neurofibrillary pathology in Alzheimer&#x2019;s disease. Nat. Med. 2014;20:1254&#x2013;1262. doi: 10.1038/nm.3700.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.3700</ArticleId><ArticleId IdType="pmc">PMC4224595</ArticleId><ArticleId IdType="pubmed">25326800</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37872317</PMID><DateCompleted><Year>2023</Year><Month>10</Month><Day>30</Day></DateCompleted><DateRevised><Year>2024</Year><Month>01</Month><Day>24</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1529-2916</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>11</Issue><PubDate><Year>2023</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Nature immunology</Title><ISOAbbreviation>Nat Immunol</ISOAbbreviation></Journal><ArticleTitle>APOE set the microglia free.</ArticleTitle><Pagination><StartPage>1790</StartPage><EndPage>1791</EndPage><MedlinePgn>1790-1791</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41590-023-01651-6</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wogram</LastName><ForeName>Emile</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Institute of Neuropathology, Medical Faculty, University of Freiburg, Freiburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prinz</LastName><ForeName>Marco</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-0349-1955</Identifier><AffiliationInfo><Affiliation>Institute of Neuropathology, Medical Faculty, University of Freiburg, Freiburg, Germany. marco.prinz@uniklinik-freiburg.de.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Signalling Research Centres BIOSS and CIBSS, University of Freiburg, Freiburg, Germany. marco.prinz@uniklinik-freiburg.de.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Nat Immunol</MedlineTA><NlmUniqueID>100941354</NlmUniqueID><ISSNLinking>1529-2908</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016229">Amyloid beta-Peptides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001057">Apolipoproteins E</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016229" MajorTopicYN="Y">Amyloid beta-Peptides</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001057" MajorTopicYN="N">Apolipoproteins E</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>10</Month><Day>30</Day><Hour>6</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>10</Month><Day>24</Day><Hour>0</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>10</Month><Day>23</Day><Hour>23</Hour><Minute>34</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37872317</ArticleId><ArticleId IdType="doi">10.1038/s41590-023-01651-6</ArticleId><ArticleId IdType="pii">10.1038/s41590-023-01651-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Wu, L., Zhang, X. &amp; Zhao, L. J. Neurosci. 38, 6665&#x2013;6681 (2018).</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.2262-17.2018</ArticleId><ArticleId IdType="pubmed">29967007</ArticleId><ArticleId IdType="pmc">6067075</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu, C.-C. et al. Nat. Immunol. https://doi.org/10.1038/s41590-023-01640-9 (2023).</Citation></Reference><Reference><Citation>Yin, Z. et al. Nat. Immunol. https://doi.org/10.1038/s41590-023-01627-6 (2023).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-023-01627-6</ArticleId><ArticleId IdType="pubmed">37813965</ArticleId></ArticleIdList></Reference><Reference><Citation>Prinz, M., Masuda, T., Wheeler, M. A. &amp; Quintana, F. J. Annu. Rev. Immunol. 39, 251&#x2013;277 (2021).</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-immunol-093019-110159</ArticleId><ArticleId IdType="pubmed">33556248</ArticleId><ArticleId IdType="pmc">8085109</ArticleId></ArticleIdList></Reference><Reference><Citation>Prinz, M., Jung, S. &amp; Priller, J. Cell 179, 292&#x2013;311 (2019).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2019.08.053</ArticleId><ArticleId IdType="pubmed">31585077</ArticleId></ArticleIdList></Reference><Reference><Citation>Fullerton, S. M. et al. Am. J. Hum. Genet. 67, 881&#x2013;900 (2000).</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/303070</ArticleId><ArticleId IdType="pubmed">10986041</ArticleId><ArticleId IdType="pmc">1287893</ArticleId></ArticleIdList></Reference><Reference><Citation>Krasemann, S. et al. Immunity 47, 566&#x2013;581 e569 (2017).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2017.08.008</ArticleId><ArticleId IdType="pubmed">28930663</ArticleId><ArticleId IdType="pmc">5719893</ArticleId></ArticleIdList></Reference><Reference><Citation>Edwards, J. P., Thornton, A. M. &amp; Shevach, E. M. J. Immunol. 193, 2843&#x2013;2849 (2014).</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1401102</ArticleId><ArticleId IdType="pubmed">25127859</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldmann, T. et al. Nat. Immunol. 17, 797&#x2013;805 (2016).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.3423</ArticleId><ArticleId IdType="pubmed">27135602</ArticleId><ArticleId IdType="pmc">4968048</ArticleId></ArticleIdList></Reference><Reference><Citation>Faust, T. E. et al. Cell. Rep. 42, 113031 (2023).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2023.113031</ArticleId><ArticleId IdType="pubmed">37635351</ArticleId><ArticleId IdType="pmc">10591718</ArticleId></ArticleIdList></Reference><Reference><Citation>Komor, A. C., Kim, Y. B., Packer, M. S., Zuris, J. A. &amp; Liu, D. R. Nature 533, 420&#x2013;424 (2016).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature17946</ArticleId><ArticleId IdType="pubmed">27096365</ArticleId><ArticleId IdType="pmc">4873371</ArticleId></ArticleIdList></Reference><Reference><Citation>Simard, A. R., Soulet, D., Gowing, G., Julien, J. P. &amp; Rivest, S. Neuron 49, 489&#x2013;502 (2006).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2006.01.022</ArticleId><ArticleId IdType="pubmed">16476660</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37930695</PMID><DateCompleted><Year>2023</Year><Month>12</Month><Day>16</Day></DateCompleted><DateRevised><Year>2024</Year><Month>11</Month><Day>07</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2168-6157</ISSN><JournalIssue CitedMedium="Internet"><Volume>80</Volume><Issue>12</Issue><PubDate><Year>2023</Year><Month>Dec</Month><Day>01</Day></PubDate></JournalIssue><Title>JAMA neurology</Title><ISOAbbreviation>JAMA Neurol</ISOAbbreviation></Journal><ArticleTitle>ApoE4 and Connectivity-Mediated Spreading of Tau Pathology at Lower Amyloid Levels.</ArticleTitle><Pagination><StartPage>1295</StartPage><EndPage>1306</EndPage><MedlinePgn>1295-1306</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1001/jamaneurol.2023.4038</ELocationID><Abstract><AbstractText Label="IMPORTANCE">For the Alzheimer disease (AD) therapies to effectively attenuate clinical progression, it may be critical to intervene before the onset of amyloid-associated tau spreading, which drives neurodegeneration and cognitive decline. Time points at which amyloid-associated tau spreading accelerates may depend on individual risk factors, such as apolipoprotein E &#x3b5;4 (ApoE4) carriership, which is linked to faster disease progression; however, the association of ApoE4 with amyloid-related tau spreading is unclear.</AbstractText><AbstractText Label="OBJECTIVE">To assess if ApoE4 carriers show accelerated amyloid-related tau spreading and propose amyloid positron emission tomography (PET) thresholds at which tau spreading accelerates in ApoE4 carriers vs noncarriers.</AbstractText><AbstractText Label="DESIGN, SETTING, AND PARTICIPANTS">This cohort study including combined ApoE genotyping, amyloid PET, and longitudinal tau PET from 2 independent samples: the Alzheimer's Disease Neuroimaging Initiative (ADNI; n&#x2009;=&#x2009;237; collected from April 2015 to August 2022) and Avid-A05 (n&#x2009;=&#x2009;130; collected from December 2013 to July 2017) with a mean (SD) tau PET follow-up time of 1.9 (0.96) years in ADNI and 1.4 (0.23) years in Avid-A05. ADNI is an observational multicenter Alzheimer disease neuroimaging initiative and Avid-A05 an observational clinical trial. Participants classified as cognitively normal (152 in ADNI and 77 in Avid-A05) or mildly cognitively impaired (107 in ADNI and 53 in Avid-A05) were selected based on ApoE genotyping, amyloid-PET, and longitudinal tau PET data availability. Participants with ApoE &#x3b5;2/&#x3b5;4 genotype or classified as having dementia were excluded. Resting-state functional magnetic resonance imaging connectivity templates were based on 42 healthy participants in ADNI.</AbstractText><AbstractText Label="MAIN OUTCOMES AND MEASURES">Mediation of amyloid PET on the association between ApoE4 status and subsequent tau PET increase through Braak stage regions and interaction between ApoE4 status and amyloid PET with annual tau PET increase through Braak stage regions and connectivity-based spreading stages (tau epicenter connectivity ranked regions).</AbstractText><AbstractText Label="RESULTS">The mean (SD) age was 73.9 (7.35) years among the 237 ADNI participants and 70.2 (9.7) years among the 130 Avid-A05 participants. A total of 107 individuals in ADNI (45.1%) and 45 in Avid-A05 (34.6%) were ApoE4 carriers. Across both samples, we found that higher amyloid PET-mediated ApoE4-related tau PET increased globally (ADNI b, 0.15; 95% CI, 0.05-0.28; P&#x2009;=&#x2009;.001 and Avid-A05 b, 0.33; 95% CI, 0.14-0.54; P&#x2009;&lt;&#x2009;.001) and in earlier Braak regions. Further, we found a significant association between ApoE4 status by amyloid PET interaction and annual tau PET increases consistently through early Braak- and connectivity-based stages where amyloid-related tau accumulation was accelerated in ApoE4carriers vs noncarriers at lower centiloid thresholds, corrected for age and sex.</AbstractText><AbstractText Label="CONCLUSIONS AND RELEVANCE">The findings in this study indicate that amyloid-related tau accumulation was accelerated in ApoE4 carriers at lower amyloid levels, suggesting that ApoE4 may facilitate earlier amyloid-driven tau spreading across connected brain regions. Possible therapeutic implications might be further investigated to determine when best to prevent tau spreading and thus cognitive decline depending on ApoE4 status.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Steward</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Institute for Stroke and Dementia Research, University Hospital, Ludwig Maximilian University of Munich, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Biel</LastName><ForeName>Davina</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Institute for Stroke and Dementia Research, University Hospital, Ludwig Maximilian University of Munich, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dewenter</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Institute for Stroke and Dementia Research, University Hospital, Ludwig Maximilian University of Munich, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roemer</LastName><ForeName>Sebastian</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Institute for Stroke and Dementia Research, University Hospital, Ludwig Maximilian University of Munich, Munich, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, University Hospital, Ludwig Maximilian University of Munich, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wagner</LastName><ForeName>Fabian</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Institute for Stroke and Dementia Research, University Hospital, Ludwig Maximilian University of Munich, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dehsarvi</LastName><ForeName>Amir</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Institute for Stroke and Dementia Research, University Hospital, Ludwig Maximilian University of Munich, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rathore</LastName><ForeName>Saima</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Eli Lilly and Company, Indianapolis, Indiana.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Otero Svaldi</LastName><ForeName>Diana</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Eli Lilly and Company, Indianapolis, Indiana.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Higgins</LastName><ForeName>Ixavier</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Eli Lilly and Company, Indianapolis, Indiana.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brendel</LastName><ForeName>Matthias</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Nuclear Medicine, University Hospital, Ludwig Maximilian University of Munich, Munich, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Munich Cluster for Systems Neurology, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dichgans</LastName><ForeName>Martin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute for Stroke and Dementia Research, University Hospital, Ludwig Maximilian University of Munich, Munich, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Munich Cluster for Systems Neurology, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shcherbinin</LastName><ForeName>Sergey</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Eli Lilly and Company, Indianapolis, Indiana.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ewers</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute for Stroke and Dementia Research, University Hospital, Ludwig Maximilian University of Munich, Munich, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>German Center for Neurodegenerative Diseases, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Franzmeier</LastName><ForeName>Nicolai</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Institute for Stroke and Dementia Research, University Hospital, Ludwig Maximilian University of Munich, Munich, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Munich Cluster for Systems Neurology, Munich, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, Sweden.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JAMA Neurol</MedlineTA><NlmUniqueID>101589536</NlmUniqueID><ISSNLinking>2168-6149</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D053327">Apolipoprotein E4</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016875">tau Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000911">Antibodies, Monoclonal</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016229">Amyloid beta-Peptides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000682">Amyloid</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001057">Apolipoproteins E</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>JAMA Neurol. 2023 Dec 1;80(12):1269-1271. doi: 10.1001/jamaneurol.2023.4046.</RefSource><PMID Version="1">37930662</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053327" MajorTopicYN="N">Apolipoprotein E4</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016875" MajorTopicYN="N">tau Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000911" MajorTopicYN="N">Antibodies, Monoclonal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016229" MajorTopicYN="N">Amyloid beta-Peptides</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000682" MajorTopicYN="N">Amyloid</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001057" MajorTopicYN="N">Apolipoproteins E</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D049268" MajorTopicYN="N">Positron-Emission Tomography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060825" MajorTopicYN="Y">Cognitive Dysfunction</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005838" MajorTopicYN="N">Genotype</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement><b>Conflict of Interest Disclosures:</b> Drs Otero Svaldi and Shcherbinin report employment at stock options from Eli Lilly and Company during the conduct of the study and outside the submitted work, and have a patent pending at Eli Lilly related to this research. Dr Brendel reports personal fees from Roche, GE Healthcare, and Life Molecular Imaging as well as grants from Life Molecular Imaging and Roche outside the submitted work. Dr Ewers reports grants from ERA PerMed during the conduct of the study and grants from Eli Lilly outside the submitted work. Dr Franzmeier reports grants from Avid Radiopharmaceuticals and Hertie Network of Excellence in Clinical Neuroscience during the conduct of the study as well as grants from Bright Focus Foundation, the Alzheimer&#x2019;s Association, the Alzheimer Forschung Initiative, and the German Parkinson Society outside the submitted work. No other disclosures were reported.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>12</Month><Day>17</Day><Hour>13</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>11</Month><Day>6</Day><Hour>12</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>11</Month><Day>6</Day><Hour>11</Hour><Minute>34</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>11</Month><Day>6</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37930695</ArticleId><ArticleId IdType="pmc">PMC10628846</ArticleId><ArticleId IdType="doi">10.1001/jamaneurol.2023.4038</ArticleId><ArticleId IdType="pii">2811627</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Sch&#xf6;ll M, Lockhart SN, Schonhaut DR, et al. . PET imaging of tau deposition in the aging human brain. Neuron. 2016;89(5):971-982. doi:10.1016/j.neuron.2016.01.028</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2016.01.028</ArticleId><ArticleId IdType="pmc">PMC4779187</ArticleId><ArticleId IdType="pubmed">26938442</ArticleId></ArticleIdList></Reference><Reference><Citation>Vogel JW, Iturria-Medina Y, Strandberg OT, et al. ; Alzheimer&#x2019;s Disease Neuroimaging Initiative; Swedish BioFinder Study . Spread of pathological tau proteins through communicating neurons in human Alzheimer&#x2019;s disease. Nat Commun. 2020;11(1):2612. doi:10.1038/s41467-020-15701-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-15701-2</ArticleId><ArticleId IdType="pmc">PMC7251068</ArticleId><ArticleId IdType="pubmed">32457389</ArticleId></ArticleIdList></Reference><Reference><Citation>Franzmeier N, Dewenter A, Frontzkowski L, et al. . Patient-centered connectivity-based prediction of tau pathology spread in Alzheimer&#x2019;s disease. Sci Adv. 2020;6(48):eabd1327. doi:10.1126/sciadv.abd1327</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.abd1327</ArticleId><ArticleId IdType="pmc">PMC7695466</ArticleId><ArticleId IdType="pubmed">33246962</ArticleId></ArticleIdList></Reference><Reference><Citation>Franzmeier N, Neitzel J, Rubinski A, et al. ; Alzheimer&#x2019;s Disease Neuroimaging Initiative (ADNI) . Functional brain architecture is associated with the rate of tau accumulation in Alzheimer&#x2019;s disease. Nat Commun. 2020;11(1):347. doi:10.1038/s41467-019-14159-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-14159-1</ArticleId><ArticleId IdType="pmc">PMC6969065</ArticleId><ArticleId IdType="pubmed">31953405</ArticleId></ArticleIdList></Reference><Reference><Citation>Cope TE, Rittman T, Borchert RJ, et al. . Tau burden and the functional connectome in Alzheimer&#x2019;s disease and progressive supranuclear palsy. Brain. 2018;141(2):550-567. doi:10.1093/brain/awx347</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awx347</ArticleId><ArticleId IdType="pmc">PMC5837359</ArticleId><ArticleId IdType="pubmed">29293892</ArticleId></ArticleIdList></Reference><Reference><Citation>Adams JN, Maass A, Harrison TM, Baker SL, Jagust WJ. Cortical tau deposition follows patterns of entorhinal functional connectivity in aging. Elife. 2019;8:e49132. doi:10.7554/eLife.49132</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.49132</ArticleId><ArticleId IdType="pmc">PMC6764824</ArticleId><ArticleId IdType="pubmed">31475904</ArticleId></ArticleIdList></Reference><Reference><Citation>Jack CR Jr, Knopman DS, Jagust WJ, et al. . Hypothetical model of dynamic biomarkers of the Alzheimer&#x2019;s pathological cascade. Lancet Neurol. 2010;9(1):119-128. doi:10.1016/S1474-4422(09)70299-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(09)70299-6</ArticleId><ArticleId IdType="pmc">PMC2819840</ArticleId><ArticleId IdType="pubmed">20083042</ArticleId></ArticleIdList></Reference><Reference><Citation>Jack CR Jr, Bennett DA, Blennow K, et al. . NIA-AA Research Framework: toward a biological definition of Alzheimer&#x2019;s disease. Alzheimers Dement. 2018;14(4):535-562. doi:10.1016/j.jalz.2018.02.018</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2018.02.018</ArticleId><ArticleId IdType="pmc">PMC5958625</ArticleId><ArticleId IdType="pubmed">29653606</ArticleId></ArticleIdList></Reference><Reference><Citation>Biel D, Brendel M, Rubinski A, et al. ; Alzheimer&#x2019;s Disease Neuroimaging Initiative (ADNI) . Tau-PET and in vivo Braak-staging as prognostic markers of future cognitive decline in cognitively normal to demented individuals. Alzheimers Res Ther. 2021;13(1):137. doi:10.1186/s13195-021-00880-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13195-021-00880-x</ArticleId><ArticleId IdType="pmc">PMC8361801</ArticleId><ArticleId IdType="pubmed">34384484</ArticleId></ArticleIdList></Reference><Reference><Citation>Ossenkoppele R, Smith R, Mattsson-Carlgren N, et al. . Accuracy of tau positron emission tomography as a prognostic marker in preclinical and prodromal Alzheimer disease: a head-to-head comparison against amyloid positron emission tomography and magnetic resonance imaging. JAMA Neurol. 2021;78(8):961-971. doi:10.1001/jamaneurol.2021.1858</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2021.1858</ArticleId><ArticleId IdType="pmc">PMC8240013</ArticleId><ArticleId IdType="pubmed">34180956</ArticleId></ArticleIdList></Reference><Reference><Citation>La Joie R, Visani AV, Baker SL, et al. . Prospective longitudinal atrophy in Alzheimer&#x2019;s disease correlates with the intensity and topography of baseline tau-PET. Sci Transl Med. 2020;12(524):eaau5732. doi:10.1126/scitranslmed.aau5732</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.aau5732</ArticleId><ArticleId IdType="pmc">PMC7035952</ArticleId><ArticleId IdType="pubmed">31894103</ArticleId></ArticleIdList></Reference><Reference><Citation>Biel D, Luan Y, Brendel M, et al. ; Alzheimer&#x2019;s Disease Neuroimaging Initiative . Combining tau-PET and fMRI meta-analyses for patient-centered prediction of cognitive decline in Alzheimer&#x2019;s disease. Alzheimers Res Ther. 2022;14(1):166. doi:10.1186/s13195-022-01105-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13195-022-01105-5</ArticleId><ArticleId IdType="pmc">PMC9639286</ArticleId><ArticleId IdType="pubmed">36345046</ArticleId></ArticleIdList></Reference><Reference><Citation>Buckley RF, Mormino EC, Rabin JS, et al. . Sex differences in the association of global amyloid and regional tau deposition measured by positron emission tomography in clinically normal older adults. JAMA Neurol. 2019;76(5):542-551. doi:10.1001/jamaneurol.2018.4693</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2018.4693</ArticleId><ArticleId IdType="pmc">PMC6515599</ArticleId><ArticleId IdType="pubmed">30715078</ArticleId></ArticleIdList></Reference><Reference><Citation>Buckley RF, Scott MR, Jacobs HIL, et al. . Sex mediates relationships between regional tau pathology and cognitive decline. Ann Neurol. 2020;88(5):921-932. doi:10.1002/ana.25878</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.25878</ArticleId><ArticleId IdType="pmc">PMC7581543</ArticleId><ArticleId IdType="pubmed">32799367</ArticleId></ArticleIdList></Reference><Reference><Citation>Rabin JS, Yang HS, Schultz AP, et al. . Vascular risk and &#x3b2;-amyloid are synergistically associated with cortical tau. Ann Neurol. 2019;85(2):272-279. doi:10.1002/ana.25399</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.25399</ArticleId><ArticleId IdType="pmc">PMC6351182</ArticleId><ArticleId IdType="pubmed">30565287</ArticleId></ArticleIdList></Reference><Reference><Citation>Steward A, Biel D, Brendel M, et al. . Functional network segregation is associated with attenuated tau spreading in Alzheimer&#x2019;s disease. Alzheimers Dement.2023;19(5):2034-2046. doi:10.1002/alz.061626</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alz.061626</ArticleId><ArticleId IdType="pubmed">36433865</ArticleId></ArticleIdList></Reference><Reference><Citation>Franzmeier N, Ossenkoppele R, Brendel M, et al. . The BIN1 rs744373 Alzheimer&#x2019;s disease risk SNP is associated with faster Abeta-associated tau accumulation and cognitive decline. Alzheimers Dement. 2022;18(1):103-115. doi:10.1002/alz.055113</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alz.055113</ArticleId><ArticleId IdType="pubmed">34060233</ArticleId></ArticleIdList></Reference><Reference><Citation>Franzmeier N, Rubinski A, Neitzel J, Ewers M; Alzheimer&#x2019;s Disease Neuroimaging Initiative (ADNI) . The BIN1 rs744373 SNP is associated with increased tau-PET levels and impaired memory. Nat Commun. 2019;10(1):1766. doi:10.1038/s41467-019-09564-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-09564-5</ArticleId><ArticleId IdType="pmc">PMC6467911</ArticleId><ArticleId IdType="pubmed">30992433</ArticleId></ArticleIdList></Reference><Reference><Citation>Baek MS, Cho H, Lee HS, Lee JH, Ryu YH, Lyoo CH. Effect of APOE &#x3b5;4 genotype on amyloid-&#x3b2; and tau accumulation in Alzheimer&#x2019;s disease. Alzheimers Res Ther. 2020;12(1):140. doi:10.1186/s13195-020-00710-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13195-020-00710-6</ArticleId><ArticleId IdType="pmc">PMC7603688</ArticleId><ArticleId IdType="pubmed">33129364</ArticleId></ArticleIdList></Reference><Reference><Citation>Hersi M, Irvine B, Gupta P, Gomes J, Birkett N, Krewski D. Risk factors associated with the onset and progression of Alzheimer&#x2019;s disease: a systematic review of the evidence. Neurotoxicology. 2017;61:143-187. doi:10.1016/j.neuro.2017.03.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuro.2017.03.006</ArticleId><ArticleId IdType="pubmed">28363508</ArticleId></ArticleIdList></Reference><Reference><Citation>Benson GS, Bauer C, Hausner L, et al. . Don&#x2019;t forget about tau: the effects of ApoE4 genotype on Alzheimer&#x2019;s disease cerebrospinal fluid biomarkers in subjects with mild cognitive impairment-data from the Dementia Competence Network. J Neural Transm (Vienna). 2022;129(5-6):477-486. doi:10.1007/s00702-022-02461-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00702-022-02461-0</ArticleId><ArticleId IdType="pmc">PMC9188507</ArticleId><ArticleId IdType="pubmed">35061102</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong YJ, Kim CM, Lee JH, Sepulcre J. Correlations between APOE4 allele and regional amyloid and tau burdens in cognitively normal older individuals. Sci Rep. 2022;12(1):14307. doi:10.1038/s41598-022-18325-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-18325-2</ArticleId><ArticleId IdType="pmc">PMC9395408</ArticleId><ArticleId IdType="pubmed">35995824</ArticleId></ArticleIdList></Reference><Reference><Citation>Montal V, Diez I, Kim CM, et al. . Network tau spreading is vulnerable to the expression gradients of APOE and glutamatergic-related genes. Sci Transl Med. 2022;14(655):eabn7273. doi:10.1126/scitranslmed.abn7273</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.abn7273</ArticleId><ArticleId IdType="pmc">PMC9942690</ArticleId><ArticleId IdType="pubmed">35895837</ArticleId></ArticleIdList></Reference><Reference><Citation>Farfel JM, Yu L, De Jager PL, Schneider JA, Bennett DA. Association of APOE with tau-tangle pathology with and without &#x3b2;-amyloid. Neurobiol Aging. 2016;37:19-25. doi:10.1016/j.neurobiolaging.2015.09.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2015.09.011</ArticleId><ArticleId IdType="pmc">PMC4716785</ArticleId><ArticleId IdType="pubmed">26481403</ArticleId></ArticleIdList></Reference><Reference><Citation>Crary JF, Trojanowski JQ, Schneider JA, et al. . Primary age-related tauopathy (PART): a common pathology associated with human aging. Acta Neuropathol. 2014;128(6):755-766. doi:10.1007/s00401-014-1349-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-014-1349-0</ArticleId><ArticleId IdType="pmc">PMC4257842</ArticleId><ArticleId IdType="pubmed">25348064</ArticleId></ArticleIdList></Reference><Reference><Citation>Sando SB, Melquist S, Cannon A, et al. . APOE epsilon 4 lowers age at onset and is a high risk factor for Alzheimer&#x2019;s disease; a case control study from central Norway. BMC Neurol. 2008;8:9. doi:10.1186/1471-2377-8-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2377-8-9</ArticleId><ArticleId IdType="pmc">PMC2375917</ArticleId><ArticleId IdType="pubmed">18416843</ArticleId></ArticleIdList></Reference><Reference><Citation>van Dyck CH, Swanson CJ, Aisen P, et al. . Lecanemab in early Alzheimer&#x2019;s disease. N Engl J Med. 2023;388(1):9-21. doi:10.1056/NEJMoa2212948</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2212948</ArticleId><ArticleId IdType="pubmed">36449413</ArticleId></ArticleIdList></Reference><Reference><Citation>Ward A, Crean S, Mercaldi CJ, et al. . Prevalence of apolipoprotein E4 genotype and homozygotes (APOE e4/4) among patients diagnosed with Alzheimer&#x2019;s disease: a systematic review and meta-analysis. Neuroepidemiology. 2012;38(1):1-17. doi:10.1159/000334607</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000334607</ArticleId><ArticleId IdType="pubmed">22179327</ArticleId></ArticleIdList></Reference><Reference><Citation>Pichet Binette A, Franzmeier N, Spotorno N, et al. ; Alzheimer&#x2019;s Disease Neuroimaging Initiative . Amyloid-associated increases in soluble tau relate to tau aggregation rates and cognitive decline in early Alzheimer&#x2019;s disease. Nat Commun. 2022;13(1):6635. doi:10.1038/s41467-022-34129-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-34129-4</ArticleId><ArticleId IdType="pmc">PMC9636262</ArticleId><ArticleId IdType="pubmed">36333294</ArticleId></ArticleIdList></Reference><Reference><Citation>Hyman BT. Amyloid-dependent and amyloid-independent stages of Alzheimer disease. Arch Neurol. 2011;68(8):1062-1064. doi:10.1001/archneurol.2011.70</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneurol.2011.70</ArticleId><ArticleId IdType="pubmed">21482918</ArticleId></ArticleIdList></Reference><Reference><Citation>Meisl G, Hidari E, Allinson K, et al. . In vivo rate-determining steps of tau seed accumulation in Alzheimer&#x2019;s disease. Sci Adv. 2021;7(44):eabh1448. doi:10.1126/sciadv.abh1448</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.abh1448</ArticleId><ArticleId IdType="pmc">PMC8555892</ArticleId><ArticleId IdType="pubmed">34714685</ArticleId></ArticleIdList></Reference><Reference><Citation>Jack CR Jr, Wiste HJ, Weigand SD, et al. . Defining imaging biomarker cut points for brain aging and Alzheimer&#x2019;s disease. Alzheimers Dement. 2017;13(3):205-216. doi:10.1016/j.jalz.2016.08.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2016.08.005</ArticleId><ArticleId IdType="pmc">PMC5344738</ArticleId><ArticleId IdType="pubmed">27697430</ArticleId></ArticleIdList></Reference><Reference><Citation>Corder EH, Saunders AM, Risch NJ, et al. . Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nat Genet. 1994;7(2):180-184. doi:10.1038/ng0694-180</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng0694-180</ArticleId><ArticleId IdType="pubmed">7920638</ArticleId></ArticleIdList></Reference><Reference><Citation>Navitsky M, Joshi AD, Kennedy I, et al. . Standardization of amyloid quantitation with florbetapir standardized uptake value ratios to the Centiloid scale. Alzheimers Dement. 2018;14(12):1565-1571. doi:10.1016/j.jalz.2018.06.1353</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2018.06.1353</ArticleId><ArticleId IdType="pubmed">30006100</ArticleId></ArticleIdList></Reference><Reference><Citation>Albert MS, DeKosky ST, Dickson D, et al. . The diagnosis of mild cognitive impairment due to Alzheimer&#x2019;s disease: recommendations from the National Institute on Aging-Alzheimer&#x2019;s Association workgroups on diagnostic guidelines for Alzheimer&#x2019;s disease. Alzheimers Dement. 2011;7(3):270-279. doi:10.1016/j.jalz.2011.03.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2011.03.008</ArticleId><ArticleId IdType="pmc">PMC3312027</ArticleId><ArticleId IdType="pubmed">21514249</ArticleId></ArticleIdList></Reference><Reference><Citation>Schaefer A, Kong R, Gordon EM, et al. . Local-global parcellation of the human cerebral cortex from intrinsic functional connectivity MRI. Cereb Cortex. 2018;28(9):3095-3114. doi:10.1093/cercor/bhx179</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cercor/bhx179</ArticleId><ArticleId IdType="pmc">PMC6095216</ArticleId><ArticleId IdType="pubmed">28981612</ArticleId></ArticleIdList></Reference><Reference><Citation>Ewers M, Luan Y, Frontzkowski L, et al. ; Alzheimer&#x2019;s Disease Neuroimaging Initiative and the Dominantly Inherited Alzheimer Network . Segregation of functional networks is associated with cognitive resilience in Alzheimer&#x2019;s disease. Brain. 2021;144(7):2176-2185. doi:10.1093/brain/awab112</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awab112</ArticleId><ArticleId IdType="pmc">PMC8370409</ArticleId><ArticleId IdType="pubmed">33725114</ArticleId></ArticleIdList></Reference><Reference><Citation>de Leon MJ, Pirraglia E, Osorio RS, et al. ; Alzheimer&#x2019;s Disease Neuroimaging Initiative; National Alzheimer&#x2019;s Coordinating Center . The nonlinear relationship between cerebrospinal fluid A&#x3b2;42 and tau in preclinical Alzheimer&#x2019;s disease. PLoS One. 2018;13(2):e0191240. doi:10.1371/journal.pone.0191240</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0191240</ArticleId><ArticleId IdType="pmc">PMC5802432</ArticleId><ArticleId IdType="pubmed">29415068</ArticleId></ArticleIdList></Reference><Reference><Citation>Armstrong RA. When to use the Bonferroni correction. Ophthalmic Physiol Opt. 2014;34(5):502-508. doi:10.1111/opo.12131</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/opo.12131</ArticleId><ArticleId IdType="pubmed">24697967</ArticleId></ArticleIdList></Reference><Reference><Citation>Fleisher AS, Chen K, Liu X, et al. . Apolipoprotein E &#x3b5;4 and age effects on florbetapir positron emission tomography in healthy aging and Alzheimer disease. Neurobiol Aging. 2013;34(1):1-12. doi:10.1016/j.neurobiolaging.2012.04.017</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2012.04.017</ArticleId><ArticleId IdType="pubmed">22633529</ArticleId></ArticleIdList></Reference><Reference><Citation>Maass A, Landau S, Baker SL, et al. ; Alzheimer&#x2019;s Disease Neuroimaging Initiative . Comparison of multiple tau-PET measures as biomarkers in aging and Alzheimer&#x2019;s disease. Neuroimage. 2017;157:448-463. doi:10.1016/j.neuroimage.2017.05.058</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroimage.2017.05.058</ArticleId><ArticleId IdType="pmc">PMC5814575</ArticleId><ArticleId IdType="pubmed">28587897</ArticleId></ArticleIdList></Reference><Reference><Citation>Young CB, Johns E, Kennedy G, et al. ; Alzheimer&#x2019;s Disease Neuroimaging Initiative; A4 Study Team . APOE effects on regional tau in preclinical Alzheimer&#x2019;s disease. Mol Neurodegener. 2023;18(1):1. doi:10.1186/s13024-022-00590-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-022-00590-4</ArticleId><ArticleId IdType="pmc">PMC9811772</ArticleId><ArticleId IdType="pubmed">36597122</ArticleId></ArticleIdList></Reference><Reference><Citation>Therriault J, Benedet AL, Pascoal TA, et al. ; Alzheimer&#x2019;s Disease Neuroimaging Initiative . APOE&#x3b5;4 potentiates the relationship between amyloid-&#x3b2; and tau pathologies. Mol Psychiatry. 2021;26(10):5977-5988. doi:10.1038/s41380-020-0688-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41380-020-0688-6</ArticleId><ArticleId IdType="pmc">PMC8758492</ArticleId><ArticleId IdType="pubmed">32161362</ArticleId></ArticleIdList></Reference><Reference><Citation>La Joie R, Ayakta N, Seeley WW, et al. . Multisite study of the relationships between antemortem [11C]PIB-PET centiloid values and postmortem measures of Alzheimer&#x2019;s disease neuropathology. Alzheimers Dement. 2019;15(2):205-216. doi:10.1016/j.jalz.2018.09.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2018.09.001</ArticleId><ArticleId IdType="pmc">PMC6368897</ArticleId><ArticleId IdType="pubmed">30347188</ArticleId></ArticleIdList></Reference><Reference><Citation>Amadoru S, Dor&#xe9; V, McLean CA, et al. . Comparison of amyloid PET measured in centiloid units with neuropathological findings in Alzheimer&#x2019;s disease. Alzheimers Res Ther. 2020;12(1):22. doi:10.1186/s13195-020-00587-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13195-020-00587-5</ArticleId><ArticleId IdType="pmc">PMC7057642</ArticleId><ArticleId IdType="pubmed">32131891</ArticleId></ArticleIdList></Reference><Reference><Citation>Weigand AJ, Bangen KJ, Thomas KR, et al. ; Alzheimer&#x2019;s Disease Neuroimaging Initiative . Is tau in the absence of amyloid on the Alzheimer&#x2019;s continuum? a study of discordant PET positivity. Brain Commun. 2020;2(1):fcz046. doi:10.1093/braincomms/fcz046</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/braincomms/fcz046</ArticleId><ArticleId IdType="pmc">PMC7001143</ArticleId><ArticleId IdType="pubmed">32051933</ArticleId></ArticleIdList></Reference><Reference><Citation>Salvad&#xf3; G, Grothe MJ, Groot C, et al. ; Alzheimer&#x2019;s Disease Neuroimaging Initiative . Differential associations of APOE-&#x3b5;2 and APOE-&#x3b5;4 alleles with PET-measured amyloid-&#x3b2; and tau deposition in older individuals without dementia. Eur J Nucl Med Mol Imaging. 2021;48(7):2212-2224. doi:10.1007/s00259-021-05192-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00259-021-05192-8</ArticleId><ArticleId IdType="pmc">PMC8175302</ArticleId><ArticleId IdType="pubmed">33521872</ArticleId></ArticleIdList></Reference><Reference><Citation>Oddo S, Billings L, Kesslak JP, Cribbs DH, LaFerla FM. Abeta immunotherapy leads to clearance of early, but not late, hyperphosphorylated tau aggregates via the proteasome. Neuron. 2004;43(3):321-332. doi:10.1016/j.neuron.2004.07.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2004.07.003</ArticleId><ArticleId IdType="pubmed">15294141</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee WJ, Brown JA, Kim HR, et al. . Regional A&#x3b2;-tau interactions promote onset and acceleration of Alzheimer&#x2019;s disease tau spreading. Neuron. 2022;110(12):1932-1943. e5. doi:10.1016/j.neuron.2022.03.034</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2022.03.034</ArticleId><ArticleId IdType="pmc">PMC9233123</ArticleId><ArticleId IdType="pubmed">35443153</ArticleId></ArticleIdList></Reference><Reference><Citation>Koelewijn L, Lancaster TM, Linden D, et al. . Oscillatory hyperactivity and hyperconnectivity in young APOE-&#x3b5;4 carriers and hypoconnectivity in Alzheimer&#x2019;s disease. Elife. 2019;8:e36011. doi:10.7554/eLife.36011</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.36011</ArticleId><ArticleId IdType="pmc">PMC6491037</ArticleId><ArticleId IdType="pubmed">31038453</ArticleId></ArticleIdList></Reference><Reference><Citation>Pihlajam&#xe4;ki M, Sperling RA. Functional MRI assessment of task-induced deactivation of the default mode network in Alzheimer&#x2019;s disease and at-risk older individuals. Behav Neurol. 2009;21(1):77-91. doi:10.1155/2009/276384</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2009/276384</ArticleId><ArticleId IdType="pmc">PMC5450588</ArticleId><ArticleId IdType="pubmed">19847047</ArticleId></ArticleIdList></Reference><Reference><Citation>Stephen TL, Cacciottolo M, Balu D, et al. . APOE genotype and sex affect microglial interactions with plaques in Alzheimer&#x2019;s disease mice. Acta Neuropathol Commun. 2019;7(1):82. doi:10.1186/s40478-019-0729-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-019-0729-z</ArticleId><ArticleId IdType="pmc">PMC6528326</ArticleId><ArticleId IdType="pubmed">31113487</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodriguez GA, Tai LM, LaDu MJ, Rebeck GW. Human APOE4 increases microglia reactivity at A&#x3b2; plaques in a mouse model of A&#x3b2; deposition. J Neuroinflammation. 2014;11(1):111. doi:10.1186/1742-2094-11-111</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1742-2094-11-111</ArticleId><ArticleId IdType="pmc">PMC4077554</ArticleId><ArticleId IdType="pubmed">24948358</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu CC, Zhao N, Fu Y, et al. . ApoE4 accelerates early seeding of amyloid pathology. Neuron. 2017;96(5):1024-1032.e3. doi:10.1016/j.neuron.2017.11.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2017.11.013</ArticleId><ArticleId IdType="pmc">PMC5948105</ArticleId><ArticleId IdType="pubmed">29216449</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellaver B, Povala G, Ferreira PCL, et al. . Astrocyte reactivity influences amyloid-&#x3b2; effects on tau pathology in preclinical Alzheimer&#x2019;s disease. Nat Med. 2023;29(7):1775-1781. doi:10.1038/s41591-023-02380-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-023-02380-x</ArticleId><ArticleId IdType="pmc">PMC10353939</ArticleId><ArticleId IdType="pubmed">37248300</ArticleId></ArticleIdList></Reference><Reference><Citation>Weigand AJ, Edwards LE, Thomas KR, Bangen KJ, Bondi MW; Alzheimer&#x2019;s Disease Neuroimaging Initiative . Comprehensive characterization of elevated tau PET signal in the absence of amyloid-beta. Brain Commun. 2022;4(6):fcac272. doi:10.1093/braincomms/fcac272</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/braincomms/fcac272</ArticleId><ArticleId IdType="pmc">PMC9651027</ArticleId><ArticleId IdType="pubmed">36382220</ArticleId></ArticleIdList></Reference><Reference><Citation>Leal SL, Lockhart SN, Maass A, Bell RK, Jagust WJ. Subthreshold amyloid predicts tau deposition in aging. J Neurosci. 2018;38(19):4482-4489. doi:10.1523/JNEUROSCI.0485-18.2018</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.0485-18.2018</ArticleId><ArticleId IdType="pmc">PMC5943976</ArticleId><ArticleId IdType="pubmed">29686045</ArticleId></ArticleIdList></Reference><Reference><Citation>Therriault J, Benedet AL, Pascoal TA, et al. . Association of apolipoprotein E &#x3b5;4 with medial temporal tau independent of amyloid-&#x3b2;. JAMA Neurol. 2020;77(4):470-479. doi:10.1001/jamaneurol.2019.4421</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2019.4421</ArticleId><ArticleId IdType="pmc">PMC6990684</ArticleId><ArticleId IdType="pubmed">31860000</ArticleId></ArticleIdList></Reference><Reference><Citation>Leuzy A, Binette AP, Vogel JW, et al. ; Alzheimer&#x2019;s Disease Neuroimaging Initiative . Comparison of group-level and individualized brain regions for measuring change in longitudinal tau positron emission tomography in Alzheimer disease. JAMA Neurol. 2023;80(6):614-623. doi:10.1001/jamaneurol.2023.1067</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2023.1067</ArticleId><ArticleId IdType="pmc">PMC10167602</ArticleId><ArticleId IdType="pubmed">37155176</ArticleId></ArticleIdList></Reference><Reference><Citation>Lemoine L, Leuzy A, Chiotis K, Rodriguez-Vieitez E, Nordberg A. Tau positron emission tomography imaging in tauopathies: the added hurdle of off-target binding. Alzheimers Dement (Amst). 2018;10:232-236. doi:10.1016/j.dadm.2018.01.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dadm.2018.01.007</ArticleId><ArticleId IdType="pmc">PMC5956931</ArticleId><ArticleId IdType="pubmed">29780868</ArticleId></ArticleIdList></Reference><Reference><Citation>Lace G, Savva GM, Forster G, et al. ; MRC-CFAS . Hippocampal tau pathology is related to neuroanatomical connections: an ageing population-based study. Brain. 2009;132(Pt 5):1324-1334. doi:10.1093/brain/awp059</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awp059</ArticleId><ArticleId IdType="pubmed">19321462</ArticleId></ArticleIdList></Reference><Reference><Citation>Mu Y, Gage FH. Adult hippocampal neurogenesis and its role in Alzheimer&#x2019;s disease. Mol Neurodegener. 2011;6(1):85. doi:10.1186/1750-1326-6-85</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1750-1326-6-85</ArticleId><ArticleId IdType="pmc">PMC3261815</ArticleId><ArticleId IdType="pubmed">22192775</ArticleId></ArticleIdList></Reference><Reference><Citation>Honey CJ, Sporns O, Cammoun L, et al. . Predicting human resting-state functional connectivity from structural connectivity. Proc Natl Acad Sci U S A. 2009;106(6):2035-2040. doi:10.1073/pnas.0811168106</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0811168106</ArticleId><ArticleId IdType="pmc">PMC2634800</ArticleId><ArticleId IdType="pubmed">19188601</ArticleId></ArticleIdList></Reference><Reference><Citation>Grandjean J, Zerbi V, Balsters JH, Wenderoth N, Rudin M. Structural basis of large-scale functional connectivity in the mouse. J Neurosci. 2017;37(34):8092-8101. doi:10.1523/JNEUROSCI.0438-17.2017</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.0438-17.2017</ArticleId><ArticleId IdType="pmc">PMC6596781</ArticleId><ArticleId IdType="pubmed">28716961</ArticleId></ArticleIdList></Reference><Reference><Citation>Abhinav K, Yeh F-C, Pathak S, et al. . Advanced diffusion MRI fiber tracking in neurosurgical and neurodegenerative disorders and neuroanatomical studies: a review. Biochim Biophys Acta. 2014;1842(11):2286-2297. doi:10.1016/j.bbadis.2014.08.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2014.08.002</ArticleId><ArticleId IdType="pubmed">25127851</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothman KJ. No adjustments are needed for multiple comparisons. Epidemiology. 1990;1(1):43-46. doi:10.1097/00001648-199001000-00010</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00001648-199001000-00010</ArticleId><ArticleId IdType="pubmed">2081237</ArticleId></ArticleIdList></Reference><Reference><Citation>Naslavsky MS, Suemoto CK, Brito LA, et al. . Global and local ancestry modulate APOE association with Alzheimer&#x2019;s neuropathology and cognitive outcomes in an admixed sample. Mol Psychiatry. 2022;27(11):4800-4808. doi:10.1038/s41380-022-01729-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41380-022-01729-x</ArticleId><ArticleId IdType="pmc">PMC9734036</ArticleId><ArticleId IdType="pubmed">36071110</ArticleId></ArticleIdList></Reference><Reference><Citation>Weiner MW, Veitch DP, Aisen PS, et al. ; Alzheimer's Disease Neuroimaging Initiative . The Alzheimer's Disease Neuroimaging Initiative 3: continued innovation for clinical trial improvement. Alzheimers Dement. 2017;13(5):561-571. doi:10.1016/j.jalz.2016.10.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2016.10.006</ArticleId><ArticleId IdType="pmc">PMC5536850</ArticleId><ArticleId IdType="pubmed">27931796</ArticleId></ArticleIdList></Reference><Reference><Citation>Analysis of 18F-AV-1451 PET imaging in cognitively healthy, MCI, and AD subjects (MCI). ClinicalTrials.gov identifier: NCT02116010. Updated September 22, 2020. Accessed October 4, 2023. https://academic.oup.com/amamanualofstyle/book/27941/chapter/207563234</Citation></Reference><Reference><Citation>Pontecorvo MJ, Devous MD Sr, Navitsky M, et al. ; 18F-AV-1451-A05 investigators . Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition. Brain. 2017;140(3):748-763. doi:10.1016/j.jalz.2016.10.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2016.10.006</ArticleId><ArticleId IdType="pmc">PMC5382945</ArticleId><ArticleId IdType="pubmed">28077397</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37957317</PMID><DateCompleted><Year>2023</Year><Month>12</Month><Day>06</Day></DateCompleted><DateRevised><Year>2024</Year><Month>11</Month><Day>27</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1546-1726</ISSN><JournalIssue CitedMedium="Internet"><Volume>26</Volume><Issue>12</Issue><PubDate><Year>2023</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Nature neuroscience</Title><ISOAbbreviation>Nat Neurosci</ISOAbbreviation></Journal><ArticleTitle>The APOE-R136S mutation protects against APOE4-driven Tau pathology, neurodegeneration and neuroinflammation.</ArticleTitle><Pagination><StartPage>2104</StartPage><EndPage>2121</EndPage><MedlinePgn>2104-2121</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41593-023-01480-8</ELocationID><Abstract><AbstractText>Apolipoprotein E4 (APOE4) is the strongest genetic risk factor for late-onset Alzheimer's disease (LOAD), leading to earlier age of clinical onset and exacerbating pathologies. There is a critical need to identify protective targets. Recently, a rare APOE variant, APOE3-R136S (Christchurch), was found to protect against early-onset AD in a PSEN1-E280A carrier. In this study, we sought to determine if the R136S mutation also protects against APOE4-driven effects in LOAD. We generated tauopathy mouse and human iPSC-derived neuron models carrying human APOE4 with the homozygous or heterozygous R136S mutation. We found that the homozygous R136S mutation rescued APOE4-driven Tau pathology, neurodegeneration and neuroinflammation. The heterozygous R136S mutation partially protected against APOE4-driven neurodegeneration and neuroinflammation but not Tau pathology. Single-nucleus RNA sequencing revealed that the APOE4-R136S mutation increased disease-protective and diminished disease-associated cell populations in a gene dose-dependent manner. Thus, the APOE-R136S mutation protects against APOE4-driven AD pathologies, providing a target for therapeutic development against AD.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Nelson</LastName><ForeName>Maxine R</ForeName><Initials>MR</Initials><Identifier Source="ORCID">0000-0003-1990-5099</Identifier><AffiliationInfo><Affiliation>Gladstone Institute of Neurological Disease, Gladstone Institutes, San Francisco, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Biomedical Sciences Graduate Program, University of California, San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Peng</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Gladstone Institute of Neurological Disease, Gladstone Institutes, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Agrawal</LastName><ForeName>Ayushi</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-2940-8926</Identifier><AffiliationInfo><Affiliation>Gladstone Institute of Data Science and Biotechnology, Gladstone Institutes, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yip</LastName><ForeName>Oscar</ForeName><Initials>O</Initials><Identifier Source="ORCID">0000-0001-9096-7167</Identifier><AffiliationInfo><Affiliation>Gladstone Institute of Neurological Disease, Gladstone Institutes, San Francisco, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Biomedical Sciences Graduate Program, University of California, San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blumenfeld</LastName><ForeName>Jessica</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Gladstone Institute of Neurological Disease, Gladstone Institutes, San Francisco, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neuroscience Graduate Program, University of California, San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Traglia</LastName><ForeName>Michela</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Gladstone Institute of Data Science and Biotechnology, Gladstone Institutes, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Min Joo</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Gladstone Institute of Neurological Disease, Gladstone Institutes, San Francisco, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Biomedical Sciences Graduate Program, University of California, San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koutsodendris</LastName><ForeName>Nicole</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0002-2761-1480</Identifier><AffiliationInfo><Affiliation>Gladstone Institute of Neurological Disease, Gladstone Institutes, San Francisco, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Developmental and Stem Cell Biology Graduate Program, University of California, San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rao</LastName><ForeName>Antara</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-1269-018X</Identifier><AffiliationInfo><Affiliation>Gladstone Institute of Neurological Disease, Gladstone Institutes, San Francisco, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Developmental and Stem Cell Biology Graduate Program, University of California, San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grone</LastName><ForeName>Brian</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Gladstone Institute of Neurological Disease, Gladstone Institutes, San Francisco, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Gladstone Center for Translational Advancement, Gladstone Institutes, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hao</LastName><ForeName>Yanxia</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Gladstone Institute of Neurological Disease, Gladstone Institutes, San Francisco, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Gladstone Center for Translational Advancement, Gladstone Institutes, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yoon</LastName><ForeName>Seo Yeon</ForeName><Initials>SY</Initials><AffiliationInfo><Affiliation>Gladstone Institute of Neurological Disease, Gladstone Institutes, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Qin</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Gladstone Institute of Neurological Disease, Gladstone Institutes, San Francisco, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Gladstone Center for Translational Advancement, Gladstone Institutes, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Leon</LastName><ForeName>Samuel</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Gladstone Institute of Neurological Disease, Gladstone Institutes, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Choenyi</LastName><ForeName>Tenzing</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Gladstone Institute of Neurological Disease, Gladstone Institutes, San Francisco, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Gladstone Center for Translational Advancement, Gladstone Institutes, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thomas</LastName><ForeName>Reuben</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Gladstone Institute of Data Science and Biotechnology, Gladstone Institutes, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lopera</LastName><ForeName>Francisco</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0003-3986-1484</Identifier><AffiliationInfo><Affiliation>Grupo de Neurociencias de Antioquia de la Universidad de Antioquia, Medellin, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Quiroz</LastName><ForeName>Yakeel T</ForeName><Initials>YT</Initials><Identifier Source="ORCID">0000-0001-9714-8244</Identifier><AffiliationInfo><Affiliation>Grupo de Neurociencias de Antioquia de la Universidad de Antioquia, Medellin, Colombia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Departments of Neurology and Psychiatry, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arboleda-Velasquez</LastName><ForeName>Joseph F</ForeName><Initials>JF</Initials><AffiliationInfo><Affiliation>Schepens Eye Research Institute of Mass Eye and Ear and Department of Ophthalmology, Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reiman</LastName><ForeName>Eric M</ForeName><Initials>EM</Initials><Identifier Source="ORCID">0000-0002-0705-3696</Identifier><AffiliationInfo><Affiliation>Banner Alzheimer's Institute, Phoenix, AZ, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Arizona, Tucson, AZ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mahley</LastName><ForeName>Robert W</ForeName><Initials>RW</Initials><AffiliationInfo><Affiliation>Gladstone Institute of Neurological Disease, Gladstone Institutes, San Francisco, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathology, University of California, San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Yadong</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0002-5871-4589</Identifier><AffiliationInfo><Affiliation>Gladstone Institute of Neurological Disease, Gladstone Institutes, San Francisco, CA, USA. yadong.huang@gladstone.ucsf.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Biomedical Sciences Graduate Program, University of California, San Francisco, San Francisco, CA, USA. yadong.huang@gladstone.ucsf.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neuroscience Graduate Program, University of California, San Francisco, San Francisco, CA, USA. yadong.huang@gladstone.ucsf.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Developmental and Stem Cell Biology Graduate Program, University of California, San Francisco, San Francisco, CA, USA. yadong.huang@gladstone.ucsf.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Gladstone Center for Translational Advancement, Gladstone Institutes, San Francisco, CA, USA. yadong.huang@gladstone.ucsf.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathology, University of California, San Francisco, San Francisco, CA, USA. yadong.huang@gladstone.ucsf.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, University of California, San Francisco, San Francisco, CA, USA. yadong.huang@gladstone.ucsf.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P30 AG072980</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG071697</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P01 AG073082</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>S10 RR028962</GrantID><Acronym>RR</Acronym><Agency>NCRR NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>F31 AG074690</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>RF1 AG059751</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R56 AG056307</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>RF1 AG076647</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>F31 AG074672</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>11</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Nat Neurosci</MedlineTA><NlmUniqueID>9809671</NlmUniqueID><ISSNLinking>1097-6256</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D053318">Apolipoprotein E3</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D053327">Apolipoprotein E4</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000612345">ApoE protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000707154">Apoe protein, mouse</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053318" MajorTopicYN="N">Apolipoprotein E3</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053327" MajorTopicYN="N">Apolipoprotein E4</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000090862" MajorTopicYN="N">Neuroinflammatory Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D024801" MajorTopicYN="Y">Tauopathies</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>Y. Huang and R.W.M. are involved in establishing and managing GABAeron, Inc. Q.X. works part time at GABAeron, Inc. J.F.A.-V. is a co-inventor on a patent application describing methods and compositions for the treatment of Alzheimer&#x2019;s disease via APOE Christchurch. Other authors declare no competing financial interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>10</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>10</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>12</Month><Day>4</Day><Hour>12</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>11</Month><Day>14</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>11</Month><Day>13</Day><Hour>23</Hour><Minute>38</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>11</Month><Day>13</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37957317</ArticleId><ArticleId IdType="pmc">PMC10689245</ArticleId><ArticleId IdType="doi">10.1038/s41593-023-01480-8</ArticleId><ArticleId IdType="pii">10.1038/s41593-023-01480-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Huang Y, Mucke L. Alzheimer mechanisms and therapeutic strategies. Cell. 2012;148:1204&#x2013;1222.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3319071</ArticleId><ArticleId IdType="pubmed">22424230</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahley RW, Weisgraber KH, Huang Y. Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer&#x2019;s disease. Proc. Natl Acad. Sci. USA. 2006;103:5644&#x2013;5651.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1414631</ArticleId><ArticleId IdType="pubmed">16567625</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Y, Mahley RW. Apolipoprotein E: structure and function in lipid metabolism, neurobiology, and Alzheimer&#x2019;s diseases. Neurobiol. Dis. 2014;72PA:3&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4253862</ArticleId><ArticleId IdType="pubmed">25173806</ArticleId></ArticleIdList></Reference><Reference><Citation>Koutsodendris N, Nelson MR, Rao A, Huang Y. Apolipoprotein E and Alzheimer&#x2019;s disease: findings, hypotheses, and potential mechanisms. Annu. Rev. Pathol. 2022;17:73&#x2013;99.</Citation><ArticleIdList><ArticleId IdType="pubmed">34460318</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris FM, Brecht WJ, Xu Q, Mahley RW, Huang Y. Increased tau phosphorylation in apolipoprotein E4 transgenic mice is associated with activation of extracellular signal-regulated kinase: modulation by zinc. J. Biol. Chem. 2004;279:44795&#x2013;44801.</Citation><ArticleIdList><ArticleId IdType="pubmed">15322121</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C, et al. Gain of toxic apolipoprotein E4 effects in human iPSC-derived neurons is ameliorated by a small-molecule structure corrector. Nat. Med. 2018;24:647&#x2013;657.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5948154</ArticleId><ArticleId IdType="pubmed">29632371</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi Y, et al. ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy. Nature. 2017;549:523&#x2013;527.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5641217</ArticleId><ArticleId IdType="pubmed">28959956</ArticleId></ArticleIdList></Reference><Reference><Citation>Brecht WJ, et al. Neuron-specific apolipoprotein E4 proteolysis is associated with increased tau phosphorylation in brains of transgenic mice. J. Neurosci. 2004;24:2527&#x2013;2534.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6729489</ArticleId><ArticleId IdType="pubmed">15014128</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrews-Zwilling Y, et al. Apolipoprotein E4 causes age- and Tau-dependent impairment of GABAergic interneurons, leading to learning and memory deficits in mice. J. Neurosci. 2010;30:13707&#x2013;13717.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2988475</ArticleId><ArticleId IdType="pubmed">20943911</ArticleId></ArticleIdList></Reference><Reference><Citation>Li G, et al. GABAergic interneuron dysfunction impairs hippocampal neurogenesis in adult apolipoprotein E4 knockin mice. Cell Stem Cell. 2009;5:634&#x2013;645.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2992822</ArticleId><ArticleId IdType="pubmed">19951691</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi Y, et al. Microglia drive APOE-dependent neurodegeneration in a tauopathy mouse model. J. Exp. Med. 2019;216:2546&#x2013;2561.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6829593</ArticleId><ArticleId IdType="pubmed">31601677</ArticleId></ArticleIdList></Reference><Reference><Citation>Strittmatter WJ, et al. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc. Natl Acad. Sci. USA. 1993;90:1977&#x2013;1981.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC46003</ArticleId><ArticleId IdType="pubmed">8446617</ArticleId></ArticleIdList></Reference><Reference><Citation>Therriault J, et al. APOE&#x3b5;4 potentiates the relationship between amyloid-&#x3b2; and tau pathologies. Mol. Psychiatry. 2021;26:5977&#x2013;5988.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8758492</ArticleId><ArticleId IdType="pubmed">32161362</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin Y-T, et al. APOE4 causes widespread molecular and cellular alterations associated with Alzheimer&#x2019;s disease phenotypes in human iPSC-derived brain cell types. Neuron. 2018;98:1294.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6048952</ArticleId><ArticleId IdType="pubmed">29953873</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao J, et al. APOE4 exacerbates synapse loss and neurodegeneration in Alzheimer&#x2019;s disease patient iPSC-derived cerebral organoids. Nat. Commun. 2020;11:5540.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7608683</ArticleId><ArticleId IdType="pubmed">33139712</ArticleId></ArticleIdList></Reference><Reference><Citation>Tesseur I, et al. Expression of human apolipoprotein E4 in neurons causes hyperphosphorylation of protein tau in the brains of transgenic mice. Am. J. Pathol. 2000;156:951&#x2013;964.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1876840</ArticleId><ArticleId IdType="pubmed">10702411</ArticleId></ArticleIdList></Reference><Reference><Citation>Corder EH, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer&#x2019;s disease in late onset families. Science. 1993;261:921&#x2013;923.</Citation><ArticleIdList><ArticleId IdType="pubmed">8346443</ArticleId></ArticleIdList></Reference><Reference><Citation>Farrer LA, et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease: a meta-analysis. JAMA. 1997;278:1349&#x2013;1356.</Citation><ArticleIdList><ArticleId IdType="pubmed">9343467</ArticleId></ArticleIdList></Reference><Reference><Citation>Rebeck GW, Reiter JS, Strickland DK, Hyman BT. Apolipoprotein E in sporadic Alzheimer&#x2019;s disease: allelic variation and receptor interactions. Neuron. 1993;11:575&#x2013;580.</Citation><ArticleIdList><ArticleId IdType="pubmed">8398148</ArticleId></ArticleIdList></Reference><Reference><Citation>Ward A, et al. Prevalence of apolipoprotein E4 genotype and homozygotes (APOE e4/4) among patients diagnosed with Alzheimer&#x2019;s disease: a systematic review and meta-analysis. Neuroepidemiology. 2012;38:1&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="pubmed">22179327</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahley RW. Apolipoprotein E: from cardiovascular disease to neurodegenerative disorders. J. Mol. Med. (Berl.) 2016;94:739&#x2013;746.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4921111</ArticleId><ArticleId IdType="pubmed">27277824</ArticleId></ArticleIdList></Reference><Reference><Citation>Zalocusky KA, et al. Neuronal ApoE upregulates MHC-I expression to drive selective neurodegeneration in Alzheimer&#x2019;s disease. Nat. Neurosci. 2021;24:786&#x2013;798.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9145692</ArticleId><ArticleId IdType="pubmed">33958804</ArticleId></ArticleIdList></Reference><Reference><Citation>Gale SC, et al. APO&#x3b5;4 is associated with enhanced in vivo innate immune responses in human subjects. J. Allergy Clin. Immunol. 2014;134:127&#x2013;134.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4125509</ArticleId><ArticleId IdType="pubmed">24655576</ArticleId></ArticleIdList></Reference><Reference><Citation>Egensperger R, K&#xf6;sel S, von Eitzen U, Graeber MB. Microglial activation in Alzheimer disease: association with APOE genotype. Brain Pathol. 1998;8:439&#x2013;447.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8098510</ArticleId><ArticleId IdType="pubmed">9669695</ArticleId></ArticleIdList></Reference><Reference><Citation>Overmyer M, et al. Astrogliosis and the ApoE genotype. an immunohistochemical study of postmortem human brain tissue. Dement. Geriatr. Cogn. Disord. 1999;10:252&#x2013;257.</Citation><ArticleIdList><ArticleId IdType="pubmed">10364641</ArticleId></ArticleIdList></Reference><Reference><Citation>Minett T, et al. Microglial immunophenotype in dementia with Alzheimer&#x2019;s pathology. J. Neuroinflammation. 2016;13:135.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4890505</ArticleId><ArticleId IdType="pubmed">27256292</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Q, et al. Profile and regulation of apolipoprotein E (ApoE) expression in the CNS in mice with targeting of green fluorescent protein gene to the ApoE locus. J. Neurosci. 2006;26:4985&#x2013;4994.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6674234</ArticleId><ArticleId IdType="pubmed">16687490</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Q, et al. Intron-3 retention/splicing controls neuronal expression of apolipoprotein E in the CNS. J. Neurosci. 2008;28:1452&#x2013;1459.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6671590</ArticleId><ArticleId IdType="pubmed">18256266</ArticleId></ArticleIdList></Reference><Reference><Citation>Wetterau JR, Aggerbeck LP, Rall SC, Weisgraber KH. Human apolipoprotein E3 in aqueous solution. I. Evidence for two structural domains. J. Biol. Chem. 1988;263:6240&#x2013;6248.</Citation><ArticleIdList><ArticleId IdType="pubmed">3360781</ArticleId></ArticleIdList></Reference><Reference><Citation>Weisgraber KH. Apolipoprotein E: structure&#x2013;function relationships. Adv. Protein Chem. 1994;45:249&#x2013;302.</Citation><ArticleIdList><ArticleId IdType="pubmed">8154371</ArticleId></ArticleIdList></Reference><Reference><Citation>Weisgraber KH, Rall SC, Mahley RW. Human E apoprotein heterogeneity. Cysteine-arginine interchanges in the amino acid sequence of the apo-E isoforms. J. Biol. Chem. 1981;256:9077&#x2013;9083.</Citation><ArticleIdList><ArticleId IdType="pubmed">7263700</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahley RW, Rall SC. Apolipoprotein E: far more than a lipid transport protein. Annu. Rev. Genom. Hum. Genet. 2000;1:507&#x2013;537.</Citation><ArticleIdList><ArticleId IdType="pubmed">11701639</ArticleId></ArticleIdList></Reference><Reference><Citation>Ji Z-S, Pitas RE, Mahley RW. Differential cellular accumulation/retention of apolipoprotein E mediated by cell surface heparan sulfate proteoglycans. Apolipoproteins E3 and E2 greater than E4. J. Biol. Chem. 1998;273:13452&#x2013;13460.</Citation><ArticleIdList><ArticleId IdType="pubmed">9593678</ArticleId></ArticleIdList></Reference><Reference><Citation>Libeu CP, et al. New insights into the heparan sulfate proteoglycan-binding activity of apolipoprotein E. J. Biol. Chem. 2001;276:39138&#x2013;39144.</Citation><ArticleIdList><ArticleId IdType="pubmed">11500500</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamauchi Y, et al. Role of the N- and C-Terminal domains in binding of apolipoprotein E isoforms to heparan sulfate and dermatan sulfate: a surface plasmon resonance study. Biochemistry. 2008;47:6702&#x2013;6710.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2844924</ArticleId><ArticleId IdType="pubmed">18507396</ArticleId></ArticleIdList></Reference><Reference><Citation>Arboleda-Velasquez JF, et al. Resistance to autosomal dominant Alzheimer&#x2019;s disease in an APOE3 Christchurch homozygote: a case report. Nat. Med. 2019;25:1680&#x2013;1683.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6898984</ArticleId><ArticleId IdType="pubmed">31686034</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu C-C, et al. APOE3-Jacksonville (V236E) variant reduces self-aggregation and risk of dementia. Sci. Transl. Med. 2021;13:eabc9375.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8824726</ArticleId><ArticleId IdType="pubmed">34586832</ArticleId></ArticleIdList></Reference><Reference><Citation>Reiman EM, et al. Exceptionally low likelihood of Alzheimer&#x2019;s dementia in APOE2 homozygotes from a 5,000-person neuropathological study. Nat. Commun. 2020;11:667.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6997393</ArticleId><ArticleId IdType="pubmed">32015339</ArticleId></ArticleIdList></Reference><Reference><Citation>Medway CW, et al. ApoE variant p.V236E is associated with markedly reduced risk of Alzheimer&#x2019;s disease. Mol. Neurodegen. 2014;9:11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3995879</ArticleId><ArticleId IdType="pubmed">24607147</ArticleId></ArticleIdList></Reference><Reference><Citation>Le Guen Y, et al. Association of rare APOE missense variants V236E and R251G with risk of Alzheimer disease. JAMA Neurol. 2022;79:652&#x2013;663.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9157381</ArticleId><ArticleId IdType="pubmed">35639372</ArticleId></ArticleIdList></Reference><Reference><Citation>Quiroz YT, et al. Association between amyloid and tau accumulation in young adults with autosomal dominant Alzheimer disease. JAMA Neurol. 2018;75:548&#x2013;556.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5885174</ArticleId><ArticleId IdType="pubmed">29435558</ArticleId></ArticleIdList></Reference><Reference><Citation>Lemere CA, et al. The E280A presenilin 1 Alzheimer mutation produces increased A&#x3b2; 42 deposition and severe cerebellar pathology. Nat. Med. 1996;2:1146&#x2013;1150.</Citation><ArticleIdList><ArticleId IdType="pubmed">8837617</ArticleId></ArticleIdList></Reference><Reference><Citation>Sepulveda-Falla D, et al. Distinct tau neuropathology and cellular profiles of an APOE3 Christchurch homozygote protected against autosomal dominant Alzheimer&#x2019;s dementia. Acta Neuropathol. 2022;144:589&#x2013;601.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9381462</ArticleId><ArticleId IdType="pubmed">35838824</ArticleId></ArticleIdList></Reference><Reference><Citation>Zalocusky KA, Nelson MR, Huang Y. An Alzheimer&#x2019;s-disease-protective APOE mutation. Nat. Med. 2019;25:1648&#x2013;1649.</Citation><ArticleIdList><ArticleId IdType="pubmed">31686033</ArticleId></ArticleIdList></Reference><Reference><Citation>Wardell MR, Brennan SO, Janus ED, Fraser R, Carrell RW. Apolipoprotein E2-Christchurch (136 Arg&#x2013;Ser). New variant of human apolipoprotein E in a patient with type III hyperlipoproteinemia. J. Clin. Invest. 1987;80:483&#x2013;490.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC442261</ArticleId><ArticleId IdType="pubmed">3038959</ArticleId></ArticleIdList></Reference><Reference><Citation>Rauch JN, et al. Tau internalization is regulated by 6-O sulfation on heparan sulfate proteoglycans (HSPGs) Sci. Rep. 2018;8:6382.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5913225</ArticleId><ArticleId IdType="pubmed">29686391</ArticleId></ArticleIdList></Reference><Reference><Citation>Stopschinski BE, et al. Specific glycosaminoglycan chain length and sulfation patterns are required for cell uptake of tau vs. &#x3b1;-synuclein and &#x3b2;-amyloid aggregates. J. Biol. Chem. 2018;293:10826&#x2013;10840.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6036193</ArticleId><ArticleId IdType="pubmed">29752409</ArticleId></ArticleIdList></Reference><Reference><Citation>Holmes BB, Diamond MI. Prion-like properties of Tau protein: the importance of extracellular Tau as a therapeutic target. J. Biol. Chem. 2014;289:19855&#x2013;19861.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4106306</ArticleId><ArticleId IdType="pubmed">24860099</ArticleId></ArticleIdList></Reference><Reference><Citation>Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 1991;82:239&#x2013;259.</Citation><ArticleIdList><ArticleId IdType="pubmed">1759558</ArticleId></ArticleIdList></Reference><Reference><Citation>Congdon, E. E. &amp; Sigurdsson, E. M. Tau-targeting therapies for Alzheimer disease. Nat. Rev. Neurol.14, 399&#x2013;415 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6463489</ArticleId><ArticleId IdType="pubmed">29895964</ArticleId></ArticleIdList></Reference><Reference><Citation>Soeda Y, Takashima A. New insights into drug discovery targeting tau protein. Front. Mol. Neurosci. 2020;13:590896.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7744460</ArticleId><ArticleId IdType="pubmed">33343298</ArticleId></ArticleIdList></Reference><Reference><Citation>Bien-Ly N, Gillespie AK, Walker D, Yoon SY, Huang Y. Reducing human apolipoprotein E levels attenuates age-dependent a&#x3b2; accumulation in mutant human amyloid precursor protein transgenic mice. J. Neurosci. 2012;32:4803&#x2013;4811.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3433173</ArticleId><ArticleId IdType="pubmed">22492035</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshiyama Y, et al. Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model. Neuron. 2007;53:337&#x2013;351.</Citation><ArticleIdList><ArticleId IdType="pubmed">17270732</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaufman SK, Thomas TL, Del Tredici K, Braak H, Diamond MI. Characterization of tau prion seeding activity and strains from formaldehyde-fixed tissue. Acta Neuropathol. Commun. 2017;5:41.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5461712</ArticleId><ArticleId IdType="pubmed">28587664</ArticleId></ArticleIdList></Reference><Reference><Citation>Koutsodendris N, et al. Neuronal APOE4 removal protects against tau-mediated gliosis, neurodegeneration and myelin deficits. Nat. Aging. 2023;3:275&#x2013;296.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10154214</ArticleId><ArticleId IdType="pubmed">37118426</ArticleId></ArticleIdList></Reference><Reference><Citation>Najm R, et al. In vivo chimeric Alzheimer&#x2019;s disease modeling of apolipoprotein E4 toxicity in human neurons. Cell Rep. 2020;32:107962.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7430173</ArticleId><ArticleId IdType="pubmed">32726626</ArticleId></ArticleIdList></Reference><Reference><Citation>Holmes BB, et al. Heparan sulfate proteoglycans mediate internalization and propagation of specific proteopathic seeds. Proc. Natl Acad. Sci. USA. 2013;110:E3138&#x2013;E3147.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3746848</ArticleId><ArticleId IdType="pubmed">23898162</ArticleId></ArticleIdList></Reference><Reference><Citation>Lalazar A, et al. Site-specific mutagenesis of human apolipoprotein E. Receptor binding activity of variants with single amino acid substitutions. J. Biol. Chem. 1988;263:3542&#x2013;3545.</Citation><ArticleIdList><ArticleId IdType="pubmed">2831187</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahley RW, Huang Y. Apolipoprotein E sets the stage: response to injury triggers neuropathology. Neuron. 2012;76:871&#x2013;885.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4891195</ArticleId><ArticleId IdType="pubmed">23217737</ArticleId></ArticleIdList></Reference><Reference><Citation>Blondel VD, Guillaume J-L, Lambiotte R, Lefebvre E. Fast unfolding of communities in large networks. J. Stat. Mech. 2008;2008:P10008.</Citation></Reference><Reference><Citation>Kenigsbuch M, et al. A shared disease-associated oligodendrocyte signature among multiple CNS pathologies. Nat. Neurosci. 2022;25:876&#x2013;886.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9724210</ArticleId><ArticleId IdType="pubmed">35760863</ArticleId></ArticleIdList></Reference><Reference><Citation>Habib N, et al. Disease-associated astrocytes in Alzheimer&#x2019;s disease and aging. Nat. Neurosci. 2020;23:701&#x2013;706.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9262034</ArticleId><ArticleId IdType="pubmed">32341542</ArticleId></ArticleIdList></Reference><Reference><Citation>Keren-Shaul H, et al. A unique microglia type associated with restricting development of Alzheimer&#x2019;s disease. Cell. 2017;169:1276&#x2013;1290.</Citation><ArticleIdList><ArticleId IdType="pubmed">28602351</ArticleId></ArticleIdList></Reference><Reference><Citation>Leyns CEG, Holtzman DM. Glial contributions to neurodegeneration in tauopathies. Mol. Neurodegener. 2017;12:50.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5492997</ArticleId><ArticleId IdType="pubmed">28662669</ArticleId></ArticleIdList></Reference><Reference><Citation>Bloom GS. Amyloid-&#x3b2; and tau: the trigger and bullet in Alzheimer disease pathogenesis. JAMA Neurol. 2014;71:505&#x2013;508.</Citation><ArticleIdList><ArticleId IdType="pubmed">24493463</ArticleId></ArticleIdList></Reference><Reference><Citation>Hampel H, et al. The amyloid-&#x3b2; pathway in Alzheimer&#x2019;s disease. Mol. Psychiatry. 2021;26:5481&#x2013;5503.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8758495</ArticleId><ArticleId IdType="pubmed">34456336</ArticleId></ArticleIdList></Reference><Reference><Citation>Pereira JB, et al. Untangling the association of amyloid-&#x3b2; and tau with synaptic and axonal loss in Alzheimer&#x2019;s disease. Brain. 2021;144:310&#x2013;324.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8210638</ArticleId><ArticleId IdType="pubmed">33279949</ArticleId></ArticleIdList></Reference><Reference><Citation>Geula C, et al. Aging renders the brain vulnerable to amyloid&#x3b2;-protein neurotoxicity. Nat. Med. 1998;4:827&#x2013;831.</Citation><ArticleIdList><ArticleId IdType="pubmed">9662375</ArticleId></ArticleIdList></Reference><Reference><Citation>Heneka MT, et al. Neuroinflammation in Alzheimer&#x2019;s disease. Lancet Neurol. 2015;14:388&#x2013;405.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5909703</ArticleId><ArticleId IdType="pubmed">25792098</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang X, Potter J, Kumar S, Ravinder N, Chesnut JD. Enhanced CRISPR/Cas9-mediated precise genome editing by improved design and delivery of gRNA, Cas9 nuclease, and donor DNA. J. Biotechnol. 2017;241:136&#x2013;146.</Citation><ArticleIdList><ArticleId IdType="pubmed">27845164</ArticleId></ArticleIdList></Reference><Reference><Citation>Stemmer M, et al. CCTop: an intuitive, flexible and reliable CRISPR/Cas9 target prediction tool. PLoS ONE. 2015;10:e0124633.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4409221</ArticleId><ArticleId IdType="pubmed">25909470</ArticleId></ArticleIdList></Reference><Reference><Citation>Haeussler M, et al. Evaluation of off-target and on-target scoring algorithms and integration into the guide RNA selection tool CRISPOR. Genome Biol. 2016;17:148.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4934014</ArticleId><ArticleId IdType="pubmed">27380939</ArticleId></ArticleIdList></Reference><Reference><Citation>Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126:663&#x2013;676.</Citation><ArticleIdList><ArticleId IdType="pubmed">16904174</ArticleId></ArticleIdList></Reference><Reference><Citation>Takahashi K, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007;131:861&#x2013;872.</Citation><ArticleIdList><ArticleId IdType="pubmed">18035408</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y-H, Pruett-Miller SM. Improving single-cell cloning workflow for gene editing in human pluripotent stem cells. Stem Cell Res. 2018;31:186&#x2013;192.</Citation><ArticleIdList><ArticleId IdType="pubmed">30099335</ArticleId></ArticleIdList></Reference><Reference><Citation>Paquet D, et al. Efficient introduction of specific homozygous and heterozygous mutations using CRISPR/Cas9. Nature. 2016;533:125&#x2013;129.</Citation><ArticleIdList><ArticleId IdType="pubmed">27120160</ArticleId></ArticleIdList></Reference><Reference><Citation>Vakulskas CA, et al. A high-fidelity Cas9 mutant delivered as a ribonucleoprotein complex enables efficient gene editing in human hematopoietic stem and progenitor cells. Nat. Med. 2018;24:1216&#x2013;1224.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6107069</ArticleId><ArticleId IdType="pubmed">30082871</ArticleId></ArticleIdList></Reference><Reference><Citation>Labun K, et al. Accurate analysis of genuine CRISPR editing events with ampliCan. Genome Res. 2019;29:843&#x2013;847.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6499316</ArticleId><ArticleId IdType="pubmed">30850374</ArticleId></ArticleIdList></Reference><Reference><Citation>Cradick TJ, Qiu P, Lee CM, Fine EJ, Bao G. COSMID: a web-based tool for identifying and validating CRISPR/Cas off-target sites. Mol. Ther. Nucleic Acids. 2014;3:e214.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4272406</ArticleId><ArticleId IdType="pubmed">25462530</ArticleId></ArticleIdList></Reference><Reference><Citation>Marschallinger J, et al. Lipid-droplet-accumulating microglia represent a dysfunctional and proinflammatory state in the aging brain. Nat. Neurosci. 2020;23:194&#x2013;208.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7595134</ArticleId><ArticleId IdType="pubmed">31959936</ArticleId></ArticleIdList></Reference><Reference><Citation>Schindelin J, et al. Fiji: an open-source platform for biological-image analysis. Nat. Methods. 2012;9:676&#x2013;682.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3855844</ArticleId><ArticleId IdType="pubmed">22743772</ArticleId></ArticleIdList></Reference><Reference><Citation>Stirling DR, et al. CellProfiler 4: improvements in speed, utility and usability. BMC Bioinformatics. 2021;22:433.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8431850</ArticleId><ArticleId IdType="pubmed">34507520</ArticleId></ArticleIdList></Reference><Reference><Citation>Agarwala R, et al. Database resources of the National Center for Biotechnology Information. Nucleic Acids Res. 2016;44:D7&#x2013;D19.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4702911</ArticleId><ArticleId IdType="pubmed">26615191</ArticleId></ArticleIdList></Reference><Reference><Citation>Howe KL, et al. Ensembl 2021. Nucleic Acids Res. 2021;49:D884&#x2013;D891.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7778975</ArticleId><ArticleId IdType="pubmed">33137190</ArticleId></ArticleIdList></Reference><Reference><Citation>Frankish A, et al. GENCODE 2021. Nucleic Acids Res. 2021;49:D916&#x2013;D923.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7778937</ArticleId><ArticleId IdType="pubmed">33270111</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng GXY, et al. Massively parallel digital transcriptional profiling of single cells. Nat. Commun. 2017;8:14049.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5241818</ArticleId><ArticleId IdType="pubmed">28091601</ArticleId></ArticleIdList></Reference><Reference><Citation>Hao Y, et al. Integrated analysis of multimodal single-cell data. Cell. 2021;184:3573&#x2013;3587.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8238499</ArticleId><ArticleId IdType="pubmed">34062119</ArticleId></ArticleIdList></Reference><Reference><Citation>Hafemeister C, Satija R. Normalization and variance stabilization of single-cell RNA-seq data using regularized negative binomial regression. Genome Biol. 2019;20:296.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6927181</ArticleId><ArticleId IdType="pubmed">31870423</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahlmann-Eltze C, Huber W. glmGamPoi: fitting Gamma-Poisson generalized linear models on single cell count data. Bioinformatics. 2021;36:5701&#x2013;5702.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8023675</ArticleId><ArticleId IdType="pubmed">33295604</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu T, et al. clusterProfiler 4.0: a universal enrichment tool for interpreting omics data. Innovation (Camb.) 2021;2:100141.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8454663</ArticleId><ArticleId IdType="pubmed">34557778</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanehisa M, Sato Y, Kawashima M, Furumichi M, Tanabe M. KEGG as a reference resource for gene and protein annotation. Nucleic Acids Res. 2016;44:D457&#x2013;D462.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4702792</ArticleId><ArticleId IdType="pubmed">26476454</ArticleId></ArticleIdList></Reference><Reference><Citation>Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. Ser. B Stat. Methodol. 1995;57:289&#x2013;300.</Citation></Reference><Reference><Citation>Bates D, M&#xe4;chler M, Bolker BM, Walker SC. Fitting linear mixed-effects models using lme4. J. Stat. Soft. 2015;67:1&#x2013;48.</Citation></Reference><Reference><Citation>Shieh G, Jan S-L. Optimal sample size allocation for Welch&#x2019;s test in one-way heteroscedastic ANOVA. Behav. Res. Methods. 2015;47:374&#x2013;383.</Citation><ArticleIdList><ArticleId IdType="pubmed">24903689</ArticleId></ArticleIdList></Reference><Reference><Citation>Jan S-L, Shieh G. Sample size determinations for Welch&#x2019;s test in one-way heteroscedastic ANOVA. Br. J. Math. Stat. Psychol. 2014;67:72&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="pubmed">23316952</ArticleId></ArticleIdList></Reference><Reference><Citation>Dunnett CW. Pairwise multiple comparisons in the unequal variance case. J. Am. Stat. Assoc. 1980;75:796&#x2013;800.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37976363</PMID><DateCompleted><Year>2023</Year><Month>11</Month><Day>20</Day></DateCompleted><DateRevised><Year>2024</Year><Month>11</Month><Day>06</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2375-2548</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><Issue>46</Issue><PubDate><Year>2023</Year><Month>Nov</Month><Day>15</Day></PubDate></JournalIssue><Title>Science advances</Title><ISOAbbreviation>Sci Adv</ISOAbbreviation></Journal><ArticleTitle>Increased palmitoylation improves estrogen receptor alpha-dependent hippocampal synaptic deficits in a mouse model of synucleinopathy.</ArticleTitle><Pagination><StartPage>eadj1454</StartPage><MedlinePgn>eadj1454</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">eadj1454</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1126/sciadv.adj1454</ELocationID><Abstract><AbstractText>Parkinson's disease (PD) is characterized by conversion of soluble &#x3b1;-synuclein (&#x3b1;S) into intraneuronal aggregates and degeneration of neurons and neuronal processes. Indications that women with early-stage PD display milder neurodegenerative features suggest that female sex partially protects against &#x3b1;S pathology. We previously reported that female sex and estradiol improved &#x3b1;S homeostasis and PD-like phenotypes in E46K-amplified (3K) &#x3b1;S mice. Here, we aimed to further dissect mechanisms that drive this sex dimorphism early in disease. We observed that synaptic abnormalities were delayed in females and improved by estradiol, mediated by local estrogen receptor alpha (ER&#x3b1;). Aberrant ER&#x3b1; distribution in 3K compared to wild-type mice was paired with its decreased palmitoylation. Treatment with ML348, a de-palmitoylation inhibitor, increased ER&#x3b1; availability and soluble &#x3b1;S homeostasis, ameliorating synaptic plasticity and cognitive and motor phenotypes. Our finding that sex differences in early-disease &#x3b1;S-induced synaptic impairment in 3KL mice are in part mediated by palmitoylated ER&#x3b1; may have functional and pathogenic implications for clinical PD.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Moors</LastName><ForeName>Tim E</ForeName><Initials>TE</Initials><Identifier Source="ORCID">0000-0003-2223-9947</Identifier><AffiliationInfo><Affiliation>Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Shaomin</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-9451-2151</Identifier><AffiliationInfo><Affiliation>Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McCaffery</LastName><ForeName>Thomas D</ForeName><Initials>TD</Initials><Identifier Source="ORCID">0000-0002-7633-6008</Identifier><AffiliationInfo><Affiliation>Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ho</LastName><ForeName>Gary P H</ForeName><Initials>GPH</Initials><Identifier Source="ORCID">0000-0001-7004-8630</Identifier><AffiliationInfo><Affiliation>Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bechade</LastName><ForeName>Pascal A</ForeName><Initials>PA</Initials><AffiliationInfo><Affiliation>Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pham</LastName><ForeName>Luu N</ForeName><Initials>LN</Initials><Identifier Source="ORCID">0000-0002-7367-284X</Identifier><AffiliationInfo><Affiliation>Laboratory for Drug Discovery in Neurodegeneration, Department of Neurology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ericsson</LastName><ForeName>Maria</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-4563-3683</Identifier><AffiliationInfo><Affiliation>Electron Microscopy Laboratory, Department of Cell Biology, Harvard Medical School, Boston, MA 02115, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nuber</LastName><ForeName>Silke</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>K08 NS110876</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 NS072030</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS109510</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>RF1 NS109510</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>11</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Sci Adv</MedlineTA><NlmUniqueID>101653440</NlmUniqueID><ISSNLinking>2375-2548</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>4TI98Z838E</RegistryNumber><NameOfSubstance UI="D004958">Estradiol</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D047628">Estrogen Receptor alpha</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000654384">Esr1 protein, mouse</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004958" MajorTopicYN="N">Estradiol</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D047628" MajorTopicYN="N">Estrogen Receptor alpha</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006624" MajorTopicYN="N">Hippocampus</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D054878" MajorTopicYN="N">Lipoylation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010300" MajorTopicYN="Y">Parkinson Disease</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000080874" MajorTopicYN="Y">Synucleinopathies</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>11</Month><Day>20</Day><Hour>6</Hour><Minute>54</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>11</Month><Day>17</Day><Hour>18</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>11</Month><Day>17</Day><Hour>14</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>11</Month><Day>17</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37976363</ArticleId><ArticleId IdType="pmc">PMC10957154</ArticleId><ArticleId IdType="doi">10.1126/sciadv.adj1454</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>J.&#xa0;Oltra, C.&#xa0;Uribe, A.&#xa0;Campabadal, A.&#xa0;Inguanzo, G. C.&#xa0;Monte-Rubio, M. J.&#xa0;Marti, Y.&#xa0;Compta, F.&#xa0;Valldeoriola, C.&#xa0;Junque, B.&#xa0;Segura, Sex differences in brain and cognition in de novo Parkinson's disease. Front. Aging Neurosci. 13, 791532 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8770804</ArticleId><ArticleId IdType="pubmed">35069180</ArticleId></ArticleIdList></Reference><Reference><Citation>T. H.&#xa0;Reekes, C. I.&#xa0;Higginson, C. R.&#xa0;Ledbetter, N.&#xa0;Sathivadivel, R. M.&#xa0;Zweig, E. A.&#xa0;Disbrow, Sex specific cognitive differences in Parkinson disease. NPJ Parkinson's dis. 6, 7 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7142103</ArticleId><ArticleId IdType="pubmed">32284961</ArticleId></ArticleIdList></Reference><Reference><Citation>S. K.&#xa0;Yadav, N.&#xa0;Kathiresan, S.&#xa0;Mohan, G.&#xa0;Vasileiou, A.&#xa0;Singh, D.&#xa0;Kaura, E. R.&#xa0;Melhem, R. K.&#xa0;Gupta, E.&#xa0;Wang, F. M.&#xa0;Marincola, A.&#xa0;Borthakur, M.&#xa0;Haris, Gender-based analysis of cortical thickness and structural connectivity in Parkinson's disease. J. Neurol. 263, 2308&#x2013;2318 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5585864</ArticleId><ArticleId IdType="pubmed">27544505</ArticleId></ArticleIdList></Reference><Reference><Citation>C.&#xa0;Tremblay, N.&#xa0;Abbasi, Y.&#xa0;Zeighami, Y.&#xa0;Yau, M.&#xa0;Dadar, S.&#xa0;Rahayel, A.&#xa0;Dagher, Sex effects on brain structure in de novo Parkinson's disease: A multimodal neuroimaging study. Brain. 143, 3052&#x2013;3066 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32980872</ArticleId></ArticleIdList></Reference><Reference><Citation>C. A.&#xa0;Haaxma, B. R.&#xa0;Bloem, G. F.&#xa0;Borm, W.&#xa0;J.&#xa0;G.&#xa0;Oyen, K. L.&#xa0;Leenders, S.&#xa0;Eshuis, J.&#xa0;Booij, D. E.&#xa0;Dluzen, M. W.&#xa0;Horstink, Gender differences in Parkinson's disease. J. Neurol. Neurosurg. Psychiatry 78, 819&#x2013;824 (2007).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2117736</ArticleId><ArticleId IdType="pubmed">17098842</ArticleId></ArticleIdList></Reference><Reference><Citation>V.&#xa0;Kaasinen, J.&#xa0;Joutsa, T.&#xa0;Noponen, J.&#xa0;Johansson, M.&#xa0;Seppanen, Effects of aging and gender on striatal and extrastriatal [123I]FP-CIT binding in Parkinson's disease. Neurobiol. Aging 36, 1757&#x2013;1763 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">25697414</ArticleId></ArticleIdList></Reference><Reference><Citation>D.&#xa0;Colombo, G.&#xa0;Abbruzzese, A.&#xa0;Antonini, P.&#xa0;Barone, G.&#xa0;Bellia, F.&#xa0;Franconi, L.&#xa0;Simoni, M.&#xa0;Attar, E.&#xa0;Zagni, S.&#xa0;Haggiag, F.&#xa0;Stocchi, The "gender factor" in wearing-off among patients with Parkinson's disease: A post hoc analysis of DEEP study. ScientificWorldJournal 2015, 787451 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4320843</ArticleId><ArticleId IdType="pubmed">25685848</ArticleId></ArticleIdList></Reference><Reference><Citation>P.&#xa0;Martinelli, M.&#xa0;Contin, C.&#xa0;Scaglione, R.&#xa0;Riva, F.&#xa0;Albani, A.&#xa0;Baruzzi, Levodopa pharmacokinetics and dyskinesias: Are there sex-related differences? Neurol. Sci. 24, 192&#x2013;193 (2003).</Citation><ArticleIdList><ArticleId IdType="pubmed">14598082</ArticleId></ArticleIdList></Reference><Reference><Citation>P.&#xa0;Ragonese, M.&#xa0;D'Amelio, G.&#xa0;Salemi, P.&#xa0;Aridon, M.&#xa0;Gammino, A.&#xa0;Epifanio, L.&#xa0;Morgante, G.&#xa0;Savettieri, Risk of Parkinson disease in women: Effect of reproductive characteristics. Neurology 62, 2010&#x2013;2014 (2004).</Citation><ArticleIdList><ArticleId IdType="pubmed">15184606</ArticleId></ArticleIdList></Reference><Reference><Citation>P.&#xa0;Ragonese, M.&#xa0;D'Amelio, G.&#xa0;Callari, G.&#xa0;Salemi, L.&#xa0;Morgante, G.&#xa0;Savettieri, Age at menopause predicts age at onset of Parkinson's disease. Mov. Disord. 21, 2211&#x2013;2214 (2006).</Citation><ArticleIdList><ArticleId IdType="pubmed">17029261</ArticleId></ArticleIdList></Reference><Reference><Citation>W. A.&#xa0;Rocca, B. R.&#xa0;Grossardt, D. M.&#xa0;Maraganore, The long-term effects of oophorectomy on cognitive and motor aging are age dependent. Neurodegener. Dis. 5, 257&#x2013;260 (2008).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2768565</ArticleId><ArticleId IdType="pubmed">18322406</ArticleId></ArticleIdList></Reference><Reference><Citation>K. L.&#xa0;Tsang, S. L.&#xa0;Ho, S. K.&#xa0;Lo, Estrogen improves motor disability in parkinsonian postmenopausal women with motor fluctuations. Neurology 54, 2292&#x2013;2298 (2000).</Citation><ArticleIdList><ArticleId IdType="pubmed">10881255</ArticleId></ArticleIdList></Reference><Reference><Citation>P. J.&#xa0;Blanchet, J.&#xa0;Fang, K.&#xa0;Hyland, L. A.&#xa0;Arnold, M. M.&#xa0;Mouradian, T. N.&#xa0;Chase, Short-term effects of high-dose 17beta-estradiol in postmenopausal PD patients: A crossover study. Neurology 53, 91&#x2013;95 (1999).</Citation><ArticleIdList><ArticleId IdType="pubmed">10408542</ArticleId></ArticleIdList></Reference><Reference><Citation>R. V.&#xa0;Dye, K. J.&#xa0;Miller, E. J.&#xa0;Singer, A. J.&#xa0;Levine, Hormone replacement therapy and risk for neurodegenerative diseases. Int J Alzheimers Dis 2012, 258454 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3324889</ArticleId><ArticleId IdType="pubmed">22548198</ArticleId></ArticleIdList></Reference><Reference><Citation>J. E.&#xa0;Rossouw, G. L.&#xa0;Anderson, R. L.&#xa0;Prentice, A. Z.&#xa0;LaCroix, C.&#xa0;Kooperberg, M. L.&#xa0;Stefanick, R. D.&#xa0;Jackson, S. A.&#xa0;Beresford, B. V.&#xa0;Howard, K. C.&#xa0;Johnson, J. M.&#xa0;Kotchen, J.&#xa0;Ockene; Writing Group for the Women's Health Initiative Investigators , Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results From the Women's Health Initiative randomized controlled trial. JAMA 288, 321&#x2013;333 (2002).</Citation><ArticleIdList><ArticleId IdType="pubmed">12117397</ArticleId></ArticleIdList></Reference><Reference><Citation>M. G.&#xa0;Spillantini, R. A.&#xa0;Crowther, R.&#xa0;Jakes, M.&#xa0;Hasegawa, M.&#xa0;Goedert, alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies. Proc. Natl. Acad. Sci. U.S.A. 95, 6469&#x2013;6473 (1998).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC27806</ArticleId><ArticleId IdType="pubmed">9600990</ArticleId></ArticleIdList></Reference><Reference><Citation>D.&#xa0;Sulzer, R. H.&#xa0;Edwards, The physiological role of &#x3b1;-synuclein and its relationship to Parkinson's disease. J. Neurochem. 150, 475&#x2013;486 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6707892</ArticleId><ArticleId IdType="pubmed">31269263</ArticleId></ArticleIdList></Reference><Reference><Citation>J.&#xa0;Burre, The synaptic function of &#x3b1;-synuclein. J. Parkinsons Dis. 5, 699&#x2013;713 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4927875</ArticleId><ArticleId IdType="pubmed">26407041</ArticleId></ArticleIdList></Reference><Reference><Citation>J.&#xa0;Burre, M.&#xa0;Sharma, T. C.&#xa0;Sudhof, Cell biology and pathophysiology of &#x3b1;-synuclein. Cold Spring Harb. Perspect. Med. 8, a024091 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5519445</ArticleId><ArticleId IdType="pubmed">28108534</ArticleId></ArticleIdList></Reference><Reference><Citation>L.&#xa0;Wang, U.&#xa0;Das, D. A.&#xa0;Scott, Y.&#xa0;Tang, P. J.&#xa0;McLean, S.&#xa0;Roy, &#x3b1;-Synuclein multimers cluster synaptic vesicles and attenuate recycling. Curr. Biol. 24, 2319&#x2013;2326 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4190006</ArticleId><ArticleId IdType="pubmed">25264250</ArticleId></ArticleIdList></Reference><Reference><Citation>T.&#xa0;Logan, J.&#xa0;Bendor, C.&#xa0;Toupin, K.&#xa0;Thorn, R. H.&#xa0;Edwards, &#x3b1;-Synuclein promotes dilation of the exocytotic fusion pore. Nat. Neurosci. 20, 681&#x2013;689 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5404982</ArticleId><ArticleId IdType="pubmed">28288128</ArticleId></ArticleIdList></Reference><Reference><Citation>J. C.&#xa0;Bridi, F.&#xa0;Hirth, Mechanisms of &#x3b1;-Synuclein induced synaptopathy in Parkinson's disease. Front. Neurosci. 12, 80 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5825910</ArticleId><ArticleId IdType="pubmed">29515354</ArticleId></ArticleIdList></Reference><Reference><Citation>V.&#xa0;Ghiglieri, V.&#xa0;Calabrese, P.&#xa0;Calabresi, Alpha-synuclein: From early synaptic dysfunction to neurodegeneration. Front. Neurol. 9, 295 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5945838</ArticleId><ArticleId IdType="pubmed">29780350</ArticleId></ArticleIdList></Reference><Reference><Citation>T.&#xa0;Schirinzi, G.&#xa0;Madeo, G.&#xa0;Martella, M.&#xa0;Maltese, B.&#xa0;Picconi, P.&#xa0;Calabresi, A.&#xa0;Pisani, Early synaptic dysfunction in Parkinson's disease: Insights from animal models. Mov. Disord. 31, 802&#x2013;813 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">27193205</ArticleId></ArticleIdList></Reference><Reference><Citation>S. H.&#xa0;Shahmoradian, A. J.&#xa0;Lewis, C.&#xa0;Genoud, J.&#xa0;Hench, T. E.&#xa0;Moors, P. P.&#xa0;Navarro, D.&#xa0;Castano-Diez, G.&#xa0;Schweighauser, A.&#xa0;Graff-Meyer, K. N.&#xa0;Goldie, R.&#xa0;Sutterlin, E.&#xa0;Huisman, A.&#xa0;Ingrassia, Y.&#xa0;Gier, A.&#xa0;J.&#xa0;M.&#xa0;Rozemuller, J.&#xa0;Wang, A.&#xa0;Paepe, J.&#xa0;Erny, A.&#xa0;Staempfli, J.&#xa0;Hoernschemeyer, F.&#xa0;Grosseruschkamp, D.&#xa0;Niedieker, S. F.&#xa0;El-Mashtoly, M.&#xa0;Quadri, I.&#xa0;W.&#xa0;F. J.&#xa0;Van, V.&#xa0;Bonifati, K.&#xa0;Gerwert, B.&#xa0;Bohrmann, S.&#xa0;Frank, M.&#xa0;Britschgi, H.&#xa0;Stahlberg, W.&#xa0;D.&#xa0;J.&#xa0;Van de Berg, M. E.&#xa0;Lauer, Lewy pathology in Parkinson's disease consists of crowded organelles and lipid membranes. Nat. Neurosci. 22, 1099&#x2013;1109 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">31235907</ArticleId></ArticleIdList></Reference><Reference><Citation>A.&#xa0;McCormack, D. J.&#xa0;Keating, N.&#xa0;Chegeni, A.&#xa0;Colella, J. J.&#xa0;Wang, T.&#xa0;Chataway, Abundance of synaptic vesicle-related proteins in alpha-synuclein-containing protein inclusions suggests a targeted formation mechanism. Neurotox. Res. 35, 883&#x2013;897 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">30796693</ArticleId></ArticleIdList></Reference><Reference><Citation>H.&#xa0;Hall, S.&#xa0;Reyes, N.&#xa0;Landeck, C.&#xa0;Bye, G.&#xa0;Leanza, K.&#xa0;Double, L.&#xa0;Thompson, G.&#xa0;Halliday, D.&#xa0;Kirik, Hippocampal Lewy pathology and cholinergic dysfunction are associated with dementia in Parkinson's disease. Brain. 137, 2493&#x2013;2508 (2014).</Citation><ArticleIdList><ArticleId IdType="pubmed">25062696</ArticleId></ArticleIdList></Reference><Reference><Citation>H. I.&#xa0;Hurtig, J. Q.&#xa0;Trojanowski, J.&#xa0;Galvin, D.&#xa0;Ewbank, M. L.&#xa0;Schmidt, V. M.&#xa0;Lee, C. M.&#xa0;Clark, G.&#xa0;Glosser, M. B.&#xa0;Stern, S. M.&#xa0;Gollomp, S. E.&#xa0;Arnold, Alpha-synuclein cortical Lewy bodies correlate with dementia in Parkinson's disease. Neurology 54, 1916&#x2013;1921 (2000).</Citation><ArticleIdList><ArticleId IdType="pubmed">10822429</ArticleId></ArticleIdList></Reference><Reference><Citation>T. E.&#xa0;Moors, D.&#xa0;Mona, S.&#xa0;Luehe, G.&#xa0;Duran-Pacheco, L.&#xa0;Spycher, O.&#xa0;Mundigl, K.&#xa0;Kaluza, S.&#xa0;Huber, M. N.&#xa0;Hug, T.&#xa0;Kremer, M.&#xa0;Ritter, S.&#xa0;Dziadek, G.&#xa0;Dernick, W.&#xa0;D.&#xa0;J.&#xa0;van de Berg, M.&#xa0;Britschgi, Multi-platform quantitation of alpha-synuclein human brain proteoforms suggests disease-specific biochemical profiles of synucleinopathies. Acta Neuropathol. Commun. 10, 82 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9164351</ArticleId><ArticleId IdType="pubmed">35659116</ArticleId></ArticleIdList></Reference><Reference><Citation>W.&#xa0;Wang, A. A.&#xa0;Le, B.&#xa0;Hou, J. C.&#xa0;Lauterborn, C. D.&#xa0;Cox, E. R.&#xa0;Levin, G.&#xa0;Lynch, C. M.&#xa0;Gall, Memory-related synaptic plasticity is sexually dimorphic in rodent hippocampus. J. Neurosci. 38, 7935&#x2013;7951 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6136152</ArticleId><ArticleId IdType="pubmed">30209204</ArticleId></ArticleIdList></Reference><Reference><Citation>U.&#xa0;Dettmer, A. J.&#xa0;Newman, F.&#xa0;Soldner, E. S.&#xa0;Luth, N. C.&#xa0;Kim, V. E.&#xa0;von Saucken, J. B.&#xa0;Sanderson, R.&#xa0;Jaenisch, T.&#xa0;Bartels, D.&#xa0;Selkoe, Parkinson-causing &#x3b1;-synuclein missense mutations shift native tetramers to monomers as a mechanism for disease initiation. Nat. Commun. 6, 7314 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4490410</ArticleId><ArticleId IdType="pubmed">26076669</ArticleId></ArticleIdList></Reference><Reference><Citation>U.&#xa0;Dettmer, A. J.&#xa0;Newman, V. E.&#xa0;von Saucken, T.&#xa0;Bartels, D.&#xa0;Selkoe, KTKEGV repeat motifs are key mediators of normal &#x3b1;-synuclein tetramerization: Their mutation causes excess monomers and neurotoxicity. Proc. Natl. Acad. Sci. U.S.A. 112, 9596&#x2013;9601 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4534262</ArticleId><ArticleId IdType="pubmed">26153422</ArticleId></ArticleIdList></Reference><Reference><Citation>S.&#xa0;Nuber, M.&#xa0;Rajsombath, G.&#xa0;Minakaki, J.&#xa0;Winkler, C. P.&#xa0;Muller, M.&#xa0;Ericsson, B.&#xa0;Caldarone, U.&#xa0;Dettmer, D. J.&#xa0;Selkoe, Abrogating native &#x3b1;-synuclein tetramers in mice causes a l-DOPA-responsive motor syndrome closely resembling Parkinson's disease. Neuron 100, 75&#x2013;90.e5 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6211795</ArticleId><ArticleId IdType="pubmed">30308173</ArticleId></ArticleIdList></Reference><Reference><Citation>M. M.&#xa0;Rajsombath, A. Y.&#xa0;Nam, M.&#xa0;Ericsson, S.&#xa0;Nuber, Female sex and brain-selective estrogen benefit &#x3b1;-synuclein tetramerization and the PD-like motor syndrome in 3K transgenic mice. J. Neurosci. 39, 7628&#x2013;7640 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6750939</ArticleId><ArticleId IdType="pubmed">31405930</ArticleId></ArticleIdList></Reference><Reference><Citation>L.&#xa0;Prokai, V.&#xa0;Nguyen, S.&#xa0;Szarka, P.&#xa0;Garg, G.&#xa0;Sabnis, H. A.&#xa0;Bimonte-Nelson, K. J.&#xa0;McLaughlin, J. S.&#xa0;Talboom, C. D.&#xa0;Conrad, P. J.&#xa0;Shughrue, T. D.&#xa0;Gould, A.&#xa0;Brodie, I.&#xa0;Merchenthaler, P.&#xa0;Koulen, K.&#xa0;Prokai-Tatrai, The prodrug DHED selectively delivers 17beta-estradiol to the brain for treating estrogen-responsive disorders. Sci. Transl. Med. 7, 297ra113 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4591937</ArticleId><ArticleId IdType="pubmed">26203081</ArticleId></ArticleIdList></Reference><Reference><Citation>B.&#xa0;Liu, D. E.&#xa0;Dluzen, Oestrogen and nigrostriatal dopaminergic neurodegeneration: Animal models and clinical reports of Parkinson's disease. Clin. Exp. Pharmacol. Physiol. 34, 555&#x2013;565 (2007).</Citation><ArticleIdList><ArticleId IdType="pubmed">17581209</ArticleId></ArticleIdList></Reference><Reference><Citation>G. E.&#xa0;Gillies, S.&#xa0;McArthur, Estrogen actions in the brain and the basis for differential action in men and women: A case for sex-specific medicines. Pharmacol. Rev. 62, 155&#x2013;198 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2879914</ArticleId><ArticleId IdType="pubmed">20392807</ArticleId></ArticleIdList></Reference><Reference><Citation>G. E.&#xa0;Gillies, S.&#xa0;McArthur, Independent influences of sex steroids of systemic and central origin in a rat model of Parkinson's disease: A contribution to sex-specific neuroprotection by estrogens. Horm. Behav. 57, 23&#x2013;34 (2010).</Citation><ArticleIdList><ArticleId IdType="pubmed">19538962</ArticleId></ArticleIdList></Reference><Reference><Citation>Y.&#xa0;Hara, E. M.&#xa0;Waters, B. S.&#xa0;McEwen, J. H.&#xa0;Morrison, Estrogen effects on cognitive and synaptic health over the lifecourse. Physiol. Rev. 95, 785&#x2013;807 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4491541</ArticleId><ArticleId IdType="pubmed">26109339</ArticleId></ArticleIdList></Reference><Reference><Citation>L.&#xa0;Fonseca-Ornelas, T.&#xa0;Viennet, M.&#xa0;Rovere, H.&#xa0;Jiang, L.&#xa0;Liu, S.&#xa0;Nuber, M.&#xa0;Ericsson, H.&#xa0;Arthanari, D. J.&#xa0;Selkoe, Altered conformation of &#x3b1;-synuclein drives dysfunction of synaptic vesicles in a synaptosomal model of Parkinson's disease. Cell Rep. 36, 109333 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8552450</ArticleId><ArticleId IdType="pubmed">34233191</ArticleId></ArticleIdList></Reference><Reference><Citation>G.&#xa0;P.&#xa0;H.&#xa0;Ho, N.&#xa0;Ramalingam, T.&#xa0;Imberdis, E. C.&#xa0;Wilkie, U.&#xa0;Dettmer, D. J.&#xa0;Selkoe, Upregulation of cellular palmitoylation mitigates &#x3b1;-synuclein accumulation and neurotoxicity. Mov. Disord. 36, 348&#x2013;359 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8887921</ArticleId><ArticleId IdType="pubmed">33103814</ArticleId></ArticleIdList></Reference><Reference><Citation>A.&#xa0;Virlogeux, C.&#xa0;Scaramuzzino, S.&#xa0;Lenoir, R.&#xa0;Carpentier, M.&#xa0;Louessard, A.&#xa0;Genoux, P.&#xa0;Lino, M. V.&#xa0;Hinckelmann, A. L.&#xa0;Perrier, S.&#xa0;Humbert, F.&#xa0;Saudou, Increasing brain palmitoylation rescues behavior and neuropathology in Huntington disease mice. Sci. Adv. 7, eabb0799 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8011966</ArticleId><ArticleId IdType="pubmed">33789888</ArticleId></ArticleIdList></Reference><Reference><Citation>F. E.&#xa0;Harrison, A. H.&#xa0;Hosseini, M. P.&#xa0;McDonald, Endogenous anxiety and stress responses in water maze and Barnes maze spatial memory tasks. Behav. Brain Res. 198, 247&#x2013;251 (2009).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2663577</ArticleId><ArticleId IdType="pubmed">18996418</ArticleId></ArticleIdList></Reference><Reference><Citation>P.&#xa0;A.&#xa0;S.&#xa0;Sheppard, E.&#xa0;Choleris, L.&#xa0;A.&#xa0;M.&#xa0;Galea, Structural plasticity of the hippocampus in response to estrogens in female rodents. Mol. Brain 12, 22 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6423800</ArticleId><ArticleId IdType="pubmed">30885239</ArticleId></ArticleIdList></Reference><Reference><Citation>L. A.&#xa0;Bean, L.&#xa0;Ianov, T. C.&#xa0;Foster, Estrogen receptors, the hippocampus, and memory. Neuroscientist. 20, 534&#x2013;545 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4317255</ArticleId><ArticleId IdType="pubmed">24510074</ArticleId></ArticleIdList></Reference><Reference><Citation>T. A.&#xa0;Milner, B. S.&#xa0;McEwen, S.&#xa0;Hayashi, C. J.&#xa0;Li, L. P.&#xa0;Reagan, S. E.&#xa0;Alves, Ultrastructural evidence that hippocampal alpha estrogen receptors are located at extranuclear sites. J. Comp. Neurol. 429, 355&#x2013;371 (2001).</Citation><ArticleIdList><ArticleId IdType="pubmed">11116225</ArticleId></ArticleIdList></Reference><Reference><Citation>F.&#xa0;Acconcia, P.&#xa0;Ascenzi, G.&#xa0;Fabozzi, P.&#xa0;Visca, M.&#xa0;Marino, S-palmitoylation modulates human estrogen receptor-alpha functions. Biochem. Biophys. Res. Commun. 316, 878&#x2013;883 (2004).</Citation><ArticleIdList><ArticleId IdType="pubmed">15033483</ArticleId></ArticleIdList></Reference><Reference><Citation>M.&#xa0;Marino, P.&#xa0;Ascenzi, F.&#xa0;Acconcia, S-palmitoylation modulates estrogen receptor alpha localization and functions. Steroids 71, 298&#x2013;303 (2006).</Citation><ArticleIdList><ArticleId IdType="pubmed">16274718</ArticleId></ArticleIdList></Reference><Reference><Citation>N.&#xa0;Tabatadze, T.&#xa0;Smejkalova, C. S.&#xa0;Woolley, Distribution and posttranslational modification of synaptic ER&#x3b1; in the adult female rat hippocampus. Endocrinology 154, 819&#x2013;830 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3548183</ArticleId><ArticleId IdType="pubmed">23183182</ArticleId></ArticleIdList></Reference><Reference><Citation>P.&#xa0;La Rosa, V.&#xa0;Pesiri, G.&#xa0;Leclercq, M.&#xa0;Marino, F.&#xa0;Acconcia, Palmitoylation regulates 17&#x3b2;-estradiol-induced estrogen receptor-&#x3b1; degradation and transcriptional activity. Mol. Endocrinol. 26, 762&#x2013;774 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5417099</ArticleId><ArticleId IdType="pubmed">22446104</ArticleId></ArticleIdList></Reference><Reference><Citation>A.&#xa0;Adibekian, B. R.&#xa0;Martin, J. W.&#xa0;Chang, K. L.&#xa0;Hsu, K.&#xa0;Tsuboi, D. A.&#xa0;Bachovchin, A. E.&#xa0;Speers, S. J.&#xa0;Brown, T.&#xa0;Spicer, V.&#xa0;Fernandez-Vega, J.&#xa0;Ferguson, P. S.&#xa0;Hodder, H.&#xa0;Rosen, B. F.&#xa0;Cravatt, Confirming target engagement for reversible inhibitors in vivo by kinetically tuned activity-based probes. J. Am. Chem. Soc. 134, 10345&#x2013;10348 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3392194</ArticleId><ArticleId IdType="pubmed">22690931</ArticleId></ArticleIdList></Reference><Reference><Citation>J. I.&#xa0;Luoma, M. I.&#xa0;Boulware, P. G.&#xa0;Mermelstein, Caveolin proteins and estrogen signaling in the brain. Mol. Cell. Endocrinol. 290, 8&#x2013;13 (2008).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2565274</ArticleId><ArticleId IdType="pubmed">18502030</ArticleId></ArticleIdList></Reference><Reference><Citation>T. C.&#xa0;Foster, Role of estrogen receptor alpha and beta expression and signaling on cognitive function during aging. Hippocampus 22, 656&#x2013;669 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3704216</ArticleId><ArticleId IdType="pubmed">21538657</ArticleId></ArticleIdList></Reference><Reference><Citation>F.&#xa0;Zmuda, L. H.&#xa0;Chamberlain, Regulatory effects of post-translational modifications on zDHHC S-acyltransferases. J. Biol. Chem. 295, 14640&#x2013;14652 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7586229</ArticleId><ArticleId IdType="pubmed">32817054</ArticleId></ArticleIdList></Reference><Reference><Citation>G. E.&#xa0;Gillies, I. S.&#xa0;Pienaar, S.&#xa0;Vohra, Z.&#xa0;Qamhawi, Sex differences in Parkinson's disease. Front. Neuroendocrinol. 35, 370&#x2013;384 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4096384</ArticleId><ArticleId IdType="pubmed">24607323</ArticleId></ArticleIdList></Reference><Reference><Citation>K. L.&#xa0;Tsang, H.&#xa0;Jiang, D. B.&#xa0;Ramsden, S. L.&#xa0;Ho, The use of estrogen in the treatment of Parkinson's disease. Parkinsonism Relat. Disord. 8, 133&#x2013;137 (2001).</Citation><ArticleIdList><ArticleId IdType="pubmed">11489678</ArticleId></ArticleIdList></Reference><Reference><Citation>N.&#xa0;Thadathil, J.&#xa0;Xiao, R.&#xa0;Hori, S. E.&#xa0;Alway, M. M.&#xa0;Khan, Brain selective estrogen treatment protects dopaminergic neurons and preserves behavioral function in MPTP-induced mouse model of Parkinson's disease. J. Neuroimmune Pharmacol. 16, 667&#x2013;678 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8140060</ArticleId><ArticleId IdType="pubmed">33221984</ArticleId></ArticleIdList></Reference><Reference><Citation>M.&#xa0;D'Astous, M.&#xa0;Morissette, T.&#xa0;Di Paolo, Effect of estrogen receptor agonists treatment in MPTP mice: Evidence of neuroprotection by an ER alpha agonist. Neuropharmacology 47, 1180&#x2013;1188 (2004).</Citation><ArticleIdList><ArticleId IdType="pubmed">15567427</ArticleId></ArticleIdList></Reference><Reference><Citation>A. M.&#xa0;Baraka, A. A.&#xa0;Korish, G. A.&#xa0;Soliman, H.&#xa0;Kamal, The possible role of estrogen and selective estrogen receptor modulators in a rat model of Parkinson's disease. Life Sci. 88, 879&#x2013;885 (2011).</Citation><ArticleIdList><ArticleId IdType="pubmed">21420980</ArticleId></ArticleIdList></Reference><Reference><Citation>Y.&#xa0;Lu, G. R.&#xa0;Sareddy, J.&#xa0;Wang, R.&#xa0;Wang, Y.&#xa0;Li, Y.&#xa0;Dong, Q.&#xa0;Zhang, J.&#xa0;Liu, J. C.&#xa0;O'Connor, J.&#xa0;Xu, R. K.&#xa0;Vadlamudi, D. W.&#xa0;Brann, Neuron-derived estrogen regulates synaptic plasticity and memory. J. Neurosci. 39, 2792&#x2013;2809 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6462452</ArticleId><ArticleId IdType="pubmed">30728170</ArticleId></ArticleIdList></Reference><Reference><Citation>A.&#xa0;Pedram, M.&#xa0;Razandi, R. J.&#xa0;Deschenes, E. R.&#xa0;Levin, DHHC-7 and -21 are palmitoylacyltransferases for sex steroid receptors. Mol. Biol. Cell 23, 188&#x2013;199 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3248897</ArticleId><ArticleId IdType="pubmed">22031296</ArticleId></ArticleIdList></Reference><Reference><Citation>A.&#xa0;Pedram, M.&#xa0;Razandi, R. C.&#xa0;Sainson, J. K.&#xa0;Kim, C. C.&#xa0;Hughes, E. R.&#xa0;Levin, A conserved mechanism for steroid receptor translocation to the plasma membrane. J. Biol. Chem. 282, 22278&#x2013;22288 (2007).</Citation><ArticleIdList><ArticleId IdType="pubmed">17535799</ArticleId></ArticleIdList></Reference><Reference><Citation>S. A.&#xa0;Hart, M. A.&#xa0;Snyder, T.&#xa0;Smejkalova, C. S.&#xa0;Woolley, Estrogen mobilizes a subset of estrogen receptor-alpha-immunoreactive vesicles in inhibitory presynaptic boutons in hippocampal CA1. J. Neurosci. 27, 2102&#x2013;2111 (2007).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6673535</ArticleId><ArticleId IdType="pubmed">17314305</ArticleId></ArticleIdList></Reference><Reference><Citation>M. I.&#xa0;Boulware, J. D.&#xa0;Heisler, K. M.&#xa0;Frick, The memory-enhancing effects of hippocampal estrogen receptor activation involve metabotropic glutamate receptor signaling. J. Neurosci. 33, 15184&#x2013;15194 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6618419</ArticleId><ArticleId IdType="pubmed">24048848</ArticleId></ArticleIdList></Reference><Reference><Citation>R. D.&#xa0;Romeo, J. B.&#xa0;McCarthy, A.&#xa0;Wang, T. A.&#xa0;Milner, B. S.&#xa0;McEwen, Sex differences in hippocampal estradiol-induced N-methyl-D-aspartic acid binding and ultrastructural localization of estrogen receptor-alpha. Neuroendocrinology 81, 391&#x2013;399 (2005).</Citation><ArticleIdList><ArticleId IdType="pubmed">16276117</ArticleId></ArticleIdList></Reference><Reference><Citation>M. M.&#xa0;Adams, S. E.&#xa0;Fink, R. A.&#xa0;Shah, W. G.&#xa0;Janssen, S.&#xa0;Hayashi, T. A.&#xa0;Milner, B. S.&#xa0;McEwen, J. H.&#xa0;Morrison, Estrogen and aging affect the subcellular distribution of estrogen receptor-alpha in the hippocampus of female rats. J. Neurosci. 22, 3608&#x2013;3614 (2002).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6758372</ArticleId><ArticleId IdType="pubmed">11978836</ArticleId></ArticleIdList></Reference><Reference><Citation>R. D.&#xa0;Mehra, K.&#xa0;Sharma, C.&#xa0;Nyakas, U.&#xa0;Vij, Estrogen receptor alpha and beta immunoreactive neurons in normal adult and aged female rat hippocampus: A qualitative and quantitative study. Brain Res. 1056, 22&#x2013;35 (2005).</Citation><ArticleIdList><ArticleId IdType="pubmed">16122717</ArticleId></ArticleIdList></Reference><Reference><Citation>L.&#xa0;Fester, J.&#xa0;Prange-Kiel, L.&#xa0;Zhou, B. V.&#xa0;Blittersdorf, J.&#xa0;Bohm, H.&#xa0;Jarry, M.&#xa0;Schumacher, G. M.&#xa0;Rune, Estrogen-regulated synaptogenesis in the hippocampus: Sexual dimorphism in vivo but not in vitro. J. Steroid Biochem. Mol. Biol. 131, 24&#x2013;29 (2012).</Citation><ArticleIdList><ArticleId IdType="pubmed">22138012</ArticleId></ArticleIdList></Reference><Reference><Citation>S.&#xa0;McArthur, G. E.&#xa0;Gillies, Peripheral vs. central sex steroid hormones in experimental Parkinson&#x2019;s disease. Front Endocrinol (Lausanne) 2, 82 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3355917</ArticleId><ArticleId IdType="pubmed">22649388</ArticleId></ArticleIdList></Reference><Reference><Citation>T.&#xa0;Smejkalova, C. S.&#xa0;Woolley, Estradiol acutely potentiates hippocampal excitatory synaptic transmission through a presynaptic mechanism. J. Neurosci. 30, 16137&#x2013;16148 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3022306</ArticleId><ArticleId IdType="pubmed">21123560</ArticleId></ArticleIdList></Reference><Reference><Citation>S. R.&#xa0;Ocanas, V. A.&#xa0;Ansere, K. B.&#xa0;Tooley, N.&#xa0;Hadad, A. J.&#xa0;Chucair-Elliott, D. R.&#xa0;Stanford, S.&#xa0;Rice, B.&#xa0;Wronowski, K. D.&#xa0;Pham, J. M.&#xa0;Hoffman, S. N.&#xa0;Austad, M. B.&#xa0;Stout, W. M.&#xa0;Freeman, Differential regulation of mouse hippocampal gene expression sex differences by chromosomal content and gonadal sex. Mol. Neurobiol. 59, 4669&#x2013;4702 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9119800</ArticleId><ArticleId IdType="pubmed">35589920</ArticleId></ArticleIdList></Reference><Reference><Citation>J.&#xa0;Meitzen, J. I.&#xa0;Luoma, M. I.&#xa0;Boulware, V. L.&#xa0;Hedges, B. M.&#xa0;Peterson, K.&#xa0;Tuomela, K. A.&#xa0;Britson, P. G.&#xa0;Mermelstein, Palmitoylation of estrogen receptors is essential for neuronal membrane signaling. Endocrinology 154, 4293&#x2013;4304 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3800757</ArticleId><ArticleId IdType="pubmed">24008343</ArticleId></ArticleIdList></Reference><Reference><Citation>S.&#xa0;Nuber, A. Y.&#xa0;Nam, M. M.&#xa0;Rajsombath, H.&#xa0;Cirka, X.&#xa0;Hronowski, J.&#xa0;Wang, K.&#xa0;Hodgetts, L. S.&#xa0;Kalinichenko, C. P.&#xa0;Muller, V.&#xa0;Lambrecht, J.&#xa0;Winkler, A.&#xa0;Weihofen, T.&#xa0;Imberdis, U.&#xa0;Dettmer, S.&#xa0;Fanning, D. J.&#xa0;Selkoe, A stearoyl-coenzyme a desaturase inhibitor prevents multiple Parkinson disease phenotypes in &#x3b1;-synuclein mice. Ann. Neurol. 89, 74&#x2013;90 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7756464</ArticleId><ArticleId IdType="pubmed">32996158</ArticleId></ArticleIdList></Reference><Reference><Citation>S.&#xa0;Nuber, C. Y.&#xa0;Chung, D. F.&#xa0;Tardiff, P. A.&#xa0;Bechade, T. D.&#xa0;McCaffery, K.&#xa0;Shimanaka, J.&#xa0;Choi, B.&#xa0;Chang, W.&#xa0;Raja, E.&#xa0;Neve, C.&#xa0;Burke, X.&#xa0;Jiang, P.&#xa0;Xu, V.&#xa0;Khurana, U.&#xa0;Dettmer, S.&#xa0;Fanning, K. J.&#xa0;Rhodes, D. J.&#xa0;Selkoe, R. H.&#xa0;Scannevin, A brain-penetrant stearoyl-CoA desaturase inhibitor reverses &#x3b1;-synuclein toxicity. Neurotherapeutics 19, 1018&#x2013;1036 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9294123</ArticleId><ArticleId IdType="pubmed">35445353</ArticleId></ArticleIdList></Reference><Reference><Citation>D.&#xa0;Ebrahimi-Fakhari, L. J.&#xa0;Saidi, L.&#xa0;Wahlster, Molecular chaperones and protein folding as therapeutic targets in Parkinson's disease and other synucleinopathies. Acta Neuropathol. Commun. 1, 79 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4046681</ArticleId><ArticleId IdType="pubmed">24314025</ArticleId></ArticleIdList></Reference><Reference><Citation>S.&#xa0;Fanning, D.&#xa0;Selkoe, U.&#xa0;Dettmer, Parkinson's disease: Proteinopathy or lipidopathy? NPJ Parkinsons Dis 6, 3 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6941970</ArticleId><ArticleId IdType="pubmed">31909184</ArticleId></ArticleIdList></Reference><Reference><Citation>D.&#xa0;Scott, S.&#xa0;Roy, &#x3b1;-Synuclein inhibits intersynaptic vesicle mobility and maintains recycling-pool homeostasis. J. Neurosci. 32, 10129&#x2013;10135 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3426499</ArticleId><ArticleId IdType="pubmed">22836248</ArticleId></ArticleIdList></Reference><Reference><Citation>V. M.&#xa0;Nemani, W.&#xa0;Lu, V.&#xa0;Berge, K.&#xa0;Nakamura, B.&#xa0;Onoa, M. K.&#xa0;Lee, F. A.&#xa0;Chaudhry, R. A.&#xa0;Nicoll, R. H.&#xa0;Edwards, Increased expression of alpha-synuclein reduces neurotransmitter release by inhibiting synaptic vesicle reclustering after endocytosis. Neuron 65, 66&#x2013;79 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3119527</ArticleId><ArticleId IdType="pubmed">20152114</ArticleId></ArticleIdList></Reference><Reference><Citation>Y. E.&#xa0;Liu, W.&#xa0;Pu, Y.&#xa0;Jiang, D.&#xa0;Shi, R.&#xa0;Dackour, Y. E.&#xa0;Shi, Chaperoning of estrogen receptor and induction of mammary gland proliferation by neuronal protein synuclein gamma. Oncogene 26, 2115&#x2013;2125 (2007).</Citation><ArticleIdList><ArticleId IdType="pubmed">17016445</ArticleId></ArticleIdList></Reference><Reference><Citation>M.&#xa0;Hirohata, K.&#xa0;Ono, A.&#xa0;Morinaga, T.&#xa0;Ikeda, M.&#xa0;Yamada, Anti-aggregation and fibril-destabilizing effects of sex hormones on alpha-synuclein fibrils in vitro. Exp. Neurol. 217, 434&#x2013;439 (2009).</Citation><ArticleIdList><ArticleId IdType="pubmed">19289119</ArticleId></ArticleIdList></Reference><Reference><Citation>M. A.&#xa0;Lynch, Long-term potentiation and memory. Physiol. Rev. 84, 87&#x2013;136 (2004).</Citation><ArticleIdList><ArticleId IdType="pubmed">14715912</ArticleId></ArticleIdList></Reference><Reference><Citation>B.&#xa0;Ji, M.&#xa0;Skup, Roles of palmitoylation in structural long-term synaptic plasticity. Mol. Brain 14, 8 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7802216</ArticleId><ArticleId IdType="pubmed">33430908</ArticleId></ArticleIdList></Reference><Reference><Citation>M.&#xa0;Adlanmerini, R.&#xa0;Solinhac, A.&#xa0;Abot, A.&#xa0;Fabre, I.&#xa0;Raymond-Letron, A. L.&#xa0;Guihot, F.&#xa0;Boudou, L.&#xa0;Sautier, E.&#xa0;Vessieres, S. H.&#xa0;Kim, P.&#xa0;Liere, C.&#xa0;Fontaine, A.&#xa0;Krust, P.&#xa0;Chambon, J. A.&#xa0;Katzenellenbogen, P.&#xa0;Gourdy, P. W.&#xa0;Shaul, D.&#xa0;Henrion, J. F.&#xa0;Arnal, F.&#xa0;Lenfant, Mutation of the palmitoylation site of estrogen receptor &#x3b1; in vivo reveals tissue-specific roles for membrane versus nuclear actions. Proc. Natl. Acad. Sci. U.S.A. 111, E283&#x2013;E290 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3896153</ArticleId><ArticleId IdType="pubmed">24371309</ArticleId></ArticleIdList></Reference><Reference><Citation>A.&#xa0;Pedram, M.&#xa0;Razandi, J. K.&#xa0;Kim, F.&#xa0;O'Mahony, E. Y.&#xa0;Lee, U.&#xa0;Luderer, E. R.&#xa0;Levin, Developmental phenotype of a membrane only estrogen receptor alpha (MOER) mouse. J. Biol. Chem. 284, 3488&#x2013;3495 (2009).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2635032</ArticleId><ArticleId IdType="pubmed">19054762</ArticleId></ArticleIdList></Reference><Reference><Citation>K. R.&#xa0;Tonn Eisinger, K. M.&#xa0;Woolfrey, S. P.&#xa0;Swanson, S. A.&#xa0;Schnell, J.&#xa0;Meitzen, M.&#xa0;Dell'Acqua, P. G.&#xa0;Mermelstein, Palmitoylation of caveolin-1 is regulated by the same DHHC acyltransferases that modify steroid hormone receptors. J. Biol. Chem. 293, 15901&#x2013;15911 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6187622</ArticleId><ArticleId IdType="pubmed">30158247</ArticleId></ArticleIdList></Reference><Reference><Citation>J.&#xa0;Meitzen, K. A.&#xa0;Britson, K.&#xa0;Tuomela, P. G.&#xa0;Mermelstein, The expression of select genes necessary for membrane-associated estrogen receptor signaling differ by sex in adult rat hippocampus. Steroids 142, 21&#x2013;27 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5874170</ArticleId><ArticleId IdType="pubmed">28962849</ArticleId></ArticleIdList></Reference><Reference><Citation>G.&#xa0;P.&#xa0;H.&#xa0;Ho, B.&#xa0;Selvakumar, J.&#xa0;Mukai, L. D.&#xa0;Hester, Y.&#xa0;Wang, J. A.&#xa0;Gogos, S. H.&#xa0;Snyder, S-nitrosylation and S-palmitoylation reciprocally regulate synaptic targeting of PSD-95. Neuron 71, 131&#x2013;141 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3181141</ArticleId><ArticleId IdType="pubmed">21745643</ArticleId></ArticleIdList></Reference><Reference><Citation>J.&#xa0;Wan, A. F.&#xa0;Roth, A. O.&#xa0;Bailey, N. G.&#xa0;Davis, Palmitoylated proteins: Purification and identification. Nat. Protoc. 2, 1573&#x2013;1584 (2007).</Citation><ArticleIdList><ArticleId IdType="pubmed">17585299</ArticleId></ArticleIdList></Reference><Reference><Citation>S.&#xa0;Nuber, E.&#xa0;Petrasch-Parwez, B.&#xa0;Winner, J.&#xa0;Winkler, S.&#xa0;von Horsten, T.&#xa0;Schmidt, J.&#xa0;Boy, M.&#xa0;Kuhn, H. P.&#xa0;Nguyen, P.&#xa0;Teismann, J. B.&#xa0;Schulz, M.&#xa0;Neumann, B. J.&#xa0;Pichler, G.&#xa0;Reischl, C.&#xa0;Holzmann, I.&#xa0;Schmitt, A.&#xa0;Bornemann, W.&#xa0;Kuhn, F.&#xa0;Zimmermann, A.&#xa0;Servadio, O.&#xa0;Riess, Neurodegeneration and motor dysfunction in a conditional model of Parkinson's disease. J. Neurosci. 28, 2471&#x2013;2484 (2008).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6671187</ArticleId><ArticleId IdType="pubmed">18322092</ArticleId></ArticleIdList></Reference><Reference><Citation>S.&#xa0;Nuber, F.&#xa0;Harmuth, Z.&#xa0;Kohl, A.&#xa0;Adame, M.&#xa0;Trejo, K.&#xa0;Schonig, F.&#xa0;Zimmermann, C.&#xa0;Bauer, N.&#xa0;Casadei, C.&#xa0;Giel, C.&#xa0;Calaminus, B. J.&#xa0;Pichler, P. H.&#xa0;Jensen, C. P.&#xa0;Muller, D.&#xa0;Amato, J.&#xa0;Kornhuber, P.&#xa0;Teismann, H.&#xa0;Yamakado, R.&#xa0;Takahashi, J.&#xa0;Winkler, E.&#xa0;Masliah, O.&#xa0;Riess, A progressive dopaminergic phenotype associated with neurotoxic conversion of &#x3b1;-synuclein in BAC-transgenic rats. Brain 136, 412&#x2013;432 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3572936</ArticleId><ArticleId IdType="pubmed">23413261</ArticleId></ArticleIdList></Reference><Reference><Citation>A. J.&#xa0;Newman, D.&#xa0;Selkoe, U.&#xa0;Dettmer, A new method for quantitative immunoblotting of endogenous &#x3b1;-synuclein. PLOS ONE 8, e81314 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3835431</ArticleId><ArticleId IdType="pubmed">24278419</ArticleId></ArticleIdList></Reference><Reference><Citation>B. R.&#xa0;Lee, T.&#xa0;Kamitani, Improved immunodetection of endogenous &#x3b1;-synuclein. PLOS ONE 6, e23939 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3158774</ArticleId><ArticleId IdType="pubmed">21886844</ArticleId></ArticleIdList></Reference><Reference><Citation>J.&#xa0;Zhao, A.&#xa0;Li, M.&#xa0;Rajsombath, Y.&#xa0;Dang, D. J.&#xa0;Selkoe, S.&#xa0;Li, Soluble A&#x3b2; oligomers impair dipolar heterodendritic plasticity by activation of mGluR in the hippocampal CA1 region. iScience 6, 138&#x2013;150 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6137707</ArticleId><ArticleId IdType="pubmed">30240608</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37977120</PMID><DateCompleted><Year>2023</Year><Month>11</Month><Day>20</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>30</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1097-4164</ISSN><JournalIssue CitedMedium="Internet"><Volume>83</Volume><Issue>22</Issue><PubDate><Year>2023</Year><Month>Nov</Month><Day>16</Day></PubDate></JournalIssue><Title>Molecular cell</Title><ISOAbbreviation>Mol Cell</ISOAbbreviation></Journal><ArticleTitle>The &#x3b3;-secretase substrate proteome and its role in cell signaling regulation.</ArticleTitle><Pagination><StartPage>4106</StartPage><EndPage>4122.e10</EndPage><MedlinePgn>4106-4122.e10</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.molcel.2023.10.029</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1097-2765(23)00866-3</ELocationID><Abstract><AbstractText>&#x3b3;-Secretases mediate the regulated intramembrane proteolysis (RIP) of more than 150 integral membrane proteins. We developed an unbiased &#x3b3;-secretase substrate identification (G-SECSI) method to study to what extent these proteins are processed in parallel. We demonstrate here parallel processing of at least 85 membrane proteins in human microglia in steady-state cell culture conditions. Pharmacological inhibition of &#x3b3;-secretase caused substantial changes of human microglial transcriptomes, including the expression of genes related to the disease-associated microglia (DAM) response described in Alzheimer disease (AD). While the overall effects of &#x3b3;-secretase deficiency on transcriptomic cell states remained limited in control conditions, exposure of mouse microglia to AD-inducing amyloid plaques strongly blocked their capacity to mount this putatively protective DAM cell state. We conclude that &#x3b3;-secretase serves as a critical signaling hub integrating the effects of multiple extracellular stimuli into the overall transcriptome of the cell.</AbstractText><CopyrightInformation>Crown Copyright &#xa9; 2023. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hou</LastName><ForeName>Pengfei</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Laboratory for the Research of Neurodegenerative Diseases, VIB Center for Brain &amp; Disease Research, VIB, Leuven 3000, Belgium; Department of Neurosciences and Leuven Brain Institute, KU Leuven, Leuven 3000, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zielonka</LastName><ForeName>Magdalena</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Laboratory for the Research of Neurodegenerative Diseases, VIB Center for Brain &amp; Disease Research, VIB, Leuven 3000, Belgium; Department of Neurosciences and Leuven Brain Institute, KU Leuven, Leuven 3000, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Serneels</LastName><ForeName>Lutgarde</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Laboratory for the Research of Neurodegenerative Diseases, VIB Center for Brain &amp; Disease Research, VIB, Leuven 3000, Belgium; Department of Neurosciences and Leuven Brain Institute, KU Leuven, Leuven 3000, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martinez-Muriana</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Laboratory for the Research of Neurodegenerative Diseases, VIB Center for Brain &amp; Disease Research, VIB, Leuven 3000, Belgium; Department of Neurosciences and Leuven Brain Institute, KU Leuven, Leuven 3000, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fattorelli</LastName><ForeName>Nicola</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Laboratory for the Research of Neurodegenerative Diseases, VIB Center for Brain &amp; Disease Research, VIB, Leuven 3000, Belgium; Department of Neurosciences and Leuven Brain Institute, KU Leuven, Leuven 3000, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wolfs</LastName><ForeName>Leen</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Laboratory for the Research of Neurodegenerative Diseases, VIB Center for Brain &amp; Disease Research, VIB, Leuven 3000, Belgium; Department of Neurosciences and Leuven Brain Institute, KU Leuven, Leuven 3000, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Poovathingal</LastName><ForeName>Suresh</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurosciences and Leuven Brain Institute, KU Leuven, Leuven 3000, Belgium; Single Cell &amp; Microfluidics Expertise Unit, VIB Center for Brain &amp; Disease Research, VIB, Leuven 3000, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>T'Syen</LastName><ForeName>Dries</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Laboratory for the Research of Neurodegenerative Diseases, VIB Center for Brain &amp; Disease Research, VIB, Leuven 3000, Belgium; Department of Neurosciences and Leuven Brain Institute, KU Leuven, Leuven 3000, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Balusu</LastName><ForeName>Sriram</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Laboratory for the Research of Neurodegenerative Diseases, VIB Center for Brain &amp; Disease Research, VIB, Leuven 3000, Belgium; Department of Neurosciences and Leuven Brain Institute, KU Leuven, Leuven 3000, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Theys</LastName><ForeName>Tom</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Neurosciences, Research Group Experimental Neurosurgery and Neuroanatomy, KU Leuven, Leuven 3000, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fiers</LastName><ForeName>Mark</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Laboratory for the Research of Neurodegenerative Diseases, VIB Center for Brain &amp; Disease Research, VIB, Leuven 3000, Belgium; Department of Neurosciences and Leuven Brain Institute, KU Leuven, Leuven 3000, Belgium; Center for Human Genetics, KU Leuven, Leuven 3000, Belgium; Dementia Research Institute, Institute of Neurology, University College London, London WC1E 6BT, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mancuso</LastName><ForeName>Renzo</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Microglia and Inflammation in Neurological Disorders (MIND) Lab, VIB Center for Molecular Neurology, VIB, Antwerp 2610, Belgium; Department of Biomedical Sciences, University of Antwerp, Antwerp 2610, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Howden</LastName><ForeName>Andrew J M</ForeName><Initials>AJM</Initials><AffiliationInfo><Affiliation>Division of Cell Signaling and Immunology, School of Life Sciences, University of Dundee, Dundee DD1 4HN, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Strooper</LastName><ForeName>Bart</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Laboratory for the Research of Neurodegenerative Diseases, VIB Center for Brain &amp; Disease Research, VIB, Leuven 3000, Belgium; Department of Neurosciences and Leuven Brain Institute, KU Leuven, Leuven 3000, Belgium; Center for Human Genetics, KU Leuven, Leuven 3000, Belgium; Dementia Research Institute, Institute of Neurology, University College London, London WC1E 6BT, UK. Electronic address: bart.destrooper@kuleuven.be.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>MR/Y014847/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>11</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Mol Cell</MedlineTA><NlmUniqueID>9802571</NlmUniqueID><ISSNLinking>1097-2765</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 3.4.-</RegistryNumber><NameOfSubstance UI="D053829">Amyloid Precursor Protein Secretases</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D020543">Proteome</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008565">Membrane Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053829" MajorTopicYN="Y">Amyloid Precursor Protein Secretases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020543" MajorTopicYN="N">Proteome</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008565" MajorTopicYN="N">Membrane Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Alzheimer's disease</Keyword><Keyword MajorTopicYN="N">intramembrane proteolysis</Keyword><Keyword MajorTopicYN="N">microglia</Keyword><Keyword MajorTopicYN="N">presenilin</Keyword><Keyword MajorTopicYN="N">substrate identification</Keyword><Keyword MajorTopicYN="N">tonic signaling</Keyword><Keyword MajorTopicYN="N">&#x3b3;-secretase</Keyword></KeywordList><CoiStatement>Declaration of interests B.D.S. has been a consultant for Eli Lilly, Biogen, Janssen Pharmaceutica, Eisai, AbbVie, and other companies and is now a consultant for Eisai, Remynd, and Muna therapeutics. B.D.S. is a scientific founder of Augustine Therapeutics and a scientific founder and stockholder of Muna Therapeutics. R.M. has scientific collaborations with Alector, Nodthera, and Alchemab and has been a consultant for Sanofi.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>2</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>6</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>10</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>11</Month><Day>20</Day><Hour>6</Hour><Minute>54</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>11</Month><Day>18</Day><Hour>11</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>11</Month><Day>17</Day><Hour>18</Hour><Minute>25</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37977120</ArticleId><ArticleId IdType="doi">10.1016/j.molcel.2023.10.029</ArticleId><ArticleId IdType="pii">S1097-2765(23)00866-3</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37995685</PMID><DateCompleted><Year>2024</Year><Month>02</Month><Day>14</Day></DateCompleted><DateRevised><Year>2025</Year><Month>02</Month><Day>08</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1097-4199</ISSN><JournalIssue CitedMedium="Internet"><Volume>112</Volume><Issue>3</Issue><PubDate><Year>2024</Year><Month>Feb</Month><Day>07</Day></PubDate></JournalIssue><Title>Neuron</Title><ISOAbbreviation>Neuron</ISOAbbreviation></Journal><ArticleTitle>Amelioration of Tau and ApoE4-linked glial lipid accumulation and neurodegeneration with an LXR agonist.</ArticleTitle><Pagination><StartPage>384</StartPage><EndPage>403.e8</EndPage><MedlinePgn>384-403.e8</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.neuron.2023.10.023</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0896-6273(23)00804-8</ELocationID><Abstract><AbstractText>Apolipoprotein E (APOE) is a strong genetic risk factor for late-onset Alzheimer's disease (LOAD). APOE4 increases and APOE2 decreases risk relative to APOE3. In the P301S mouse model of tauopathy, ApoE4 increases tau pathology and neurodegeneration when compared with ApoE3 or the absence of ApoE. However, the role of ApoE isoforms and lipid metabolism in contributing to tau-mediated degeneration is unknown. We demonstrate that in P301S tau mice, ApoE4 strongly promotes glial lipid accumulation and perturbations in cholesterol metabolism and lysosomal function. Increasing lipid efflux in glia via an LXR agonist or Abca1 overexpression strongly attenuates tau pathology and neurodegeneration in P301S/ApoE4 mice. We also demonstrate reductions in reactive astrocytes and microglia, as well as changes in cholesterol biosynthesis and metabolism in glia of tauopathy mice in response to LXR activation. These data suggest that promoting efflux of glial lipids may serve as a therapeutic approach to ameliorate tau and ApoE4-linked neurodegeneration.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Litvinchuk</LastName><ForeName>Alexandra</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neurology, Hope Center for Neurological Disorders, Charles F. and Joanne Knight Alzheimer's Disease Research Center, Washington University School of Medicine, St. Louis, MO 63108, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suh</LastName><ForeName>Jung H</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Denali Therapeutics Inc., South San Francisco, CA 94080, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guo</LastName><ForeName>Jing L</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>Denali Therapeutics Inc., South San Francisco, CA 94080, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Karin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Denali Therapeutics Inc., South San Francisco, CA 94080, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Davis</LastName><ForeName>Sonnet S</ForeName><Initials>SS</Initials><AffiliationInfo><Affiliation>Denali Therapeutics Inc., South San Francisco, CA 94080, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bien-Ly</LastName><ForeName>Nga</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Denali Therapeutics Inc., South San Francisco, CA 94080, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tycksen</LastName><ForeName>Eric</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Genome Technology Access Center, McDonnell Genome Institute, St. Louis, MO 63110, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tabor</LastName><ForeName>G Travis</ForeName><Initials>GT</Initials><AffiliationInfo><Affiliation>Department of Neurology, Hope Center for Neurological Disorders, Charles F. and Joanne Knight Alzheimer's Disease Research Center, Washington University School of Medicine, St. Louis, MO 63108, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Remolina Serrano</LastName><ForeName>Javier</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurology, Hope Center for Neurological Disorders, Charles F. and Joanne Knight Alzheimer's Disease Research Center, Washington University School of Medicine, St. Louis, MO 63108, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Manis</LastName><ForeName>Melissa</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurology, Hope Center for Neurological Disorders, Charles F. and Joanne Knight Alzheimer's Disease Research Center, Washington University School of Medicine, St. Louis, MO 63108, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bao</LastName><ForeName>Xin</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Neurology, Hope Center for Neurological Disorders, Charles F. and Joanne Knight Alzheimer's Disease Research Center, Washington University School of Medicine, St. Louis, MO 63108, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Choonghee</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Neurology, Hope Center for Neurological Disorders, Charles F. and Joanne Knight Alzheimer's Disease Research Center, Washington University School of Medicine, St. Louis, MO 63108, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bosch</LastName><ForeName>Megan</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurology, Hope Center for Neurological Disorders, Charles F. and Joanne Knight Alzheimer's Disease Research Center, Washington University School of Medicine, St. Louis, MO 63108, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perez</LastName><ForeName>Enmanuel J</ForeName><Initials>EJ</Initials><AffiliationInfo><Affiliation>Department of Neurology, Hope Center for Neurological Disorders, Charles F. and Joanne Knight Alzheimer's Disease Research Center, Washington University School of Medicine, St. Louis, MO 63108, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yuede</LastName><ForeName>Carla M</ForeName><Initials>CM</Initials><AffiliationInfo><Affiliation>Department of Neurology, Hope Center for Neurological Disorders, Charles F. and Joanne Knight Alzheimer's Disease Research Center, Washington University School of Medicine, St. Louis, MO 63108, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cashikar</LastName><ForeName>Anil G</ForeName><Initials>AG</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, Hope Center for Neurological Disorders, Washington University School of Medicine, St. Louis, MO 63108, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ulrich</LastName><ForeName>Jason D</ForeName><Initials>JD</Initials><AffiliationInfo><Affiliation>Department of Neurology, Hope Center for Neurological Disorders, Charles F. and Joanne Knight Alzheimer's Disease Research Center, Washington University School of Medicine, St. Louis, MO 63108, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Di Paolo</LastName><ForeName>Gilbert</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Denali Therapeutics Inc., South San Francisco, CA 94080, USA. Electronic address: dipaolo@dnli.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Holtzman</LastName><ForeName>David M</ForeName><Initials>DM</Initials><AffiliationInfo><Affiliation>Department of Neurology, Hope Center for Neurological Disorders, Charles F. and Joanne Knight Alzheimer's Disease Research Center, Washington University School of Medicine, St. Louis, MO 63108, USA. Electronic address: holtzman@wustl.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 NS090934</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>RF1 NS090934</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG047644</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>RF1 AG047644</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U19 AG069701</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>S10 OD021629</GrantID><Acronym>OD</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R25 NS090978</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>11</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Neuron</MedlineTA><NlmUniqueID>8809320</NlmUniqueID><ISSNLinking>0896-6273</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D053327">Apolipoprotein E4</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D053318">Apolipoprotein E3</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001057">Apolipoproteins E</NameOfSubstance></Chemical><Chemical><RegistryNumber>97C5T2UQ7J</RegistryNumber><NameOfSubstance UI="D002784">Cholesterol</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Nat Rev Drug Discov. 2024 Feb;23(2):106. doi: 10.1038/d41573-024-00004-8.</RefSource><PMID Version="1">38200238</PMID></CommentsCorrections><CommentsCorrections RefType="ErratumIn"><RefSource>Neuron. 2024 Jun 19;112(12):2079. doi: 10.1016/j.neuron.2024.05.021.</RefSource><PMID Version="1">38823392</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053327" MajorTopicYN="N">Apolipoprotein E4</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053318" MajorTopicYN="N">Apolipoprotein E3</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001057" MajorTopicYN="N">Apolipoproteins E</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D024801" MajorTopicYN="Y">Tauopathies</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002784" MajorTopicYN="N">Cholesterol</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Abca1</Keyword><Keyword MajorTopicYN="N">ApoE4</Keyword><Keyword MajorTopicYN="N">LXR agonist</Keyword><Keyword MajorTopicYN="N">Tau</Keyword><Keyword MajorTopicYN="N">cholesterol metabolism</Keyword><Keyword MajorTopicYN="N">lipid</Keyword><Keyword MajorTopicYN="N">microglia</Keyword></KeywordList><CoiStatement>Declaration of interests D.M.H. is on the scientific advisory board of C2N diagnostics and has equity. D.M.H. is on the scientific advisory board of Denali Therapeutics, Genentech, and Cajal Therapeutics and consults for Asteroid Therapeutics. J.H.S., J.L.G., H.P.B., S.S.D., and G.D.P. are full-time employees and shareholders of Denali Therapeutics Inc. K.L. and N.B.-L. are former employees of Denali Therapeutics Inc.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>2</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>9</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>10</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>2</Month><Day>9</Day><Hour>12</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>11</Month><Day>24</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>11</Month><Day>23</Day><Hour>18</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>2</Month><Day>7</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37995685</ArticleId><ArticleId IdType="mid">NIHMS1941510</ArticleId><ArticleId IdType="pmc">PMC10922706</ArticleId><ArticleId IdType="doi">10.1016/j.neuron.2023.10.023</ArticleId><ArticleId IdType="pii">S0896-6273(23)00804-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Holtzman DM, Herz J, and Bu G (2012). Apolipoprotein E and apolipoprotein E receptors: Normal biology and roles in Alzheimer disease. Cold Spring Harb. Perspect. Med. 2, a006312. 10.1101/cshperspect.a006312.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a006312</ArticleId><ArticleId IdType="pmc">PMC3282491</ArticleId><ArticleId IdType="pubmed">22393530</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi Y, and Holtzman DM (2018). Interplay between innate immunity and Alzheimer disease: APOE and TREM2 in the spotlight. Nat. Rev. Immunol. 18, 759&#x2013;772. 10.1038/s41577-018-0051-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-018-0051-1</ArticleId><ArticleId IdType="pmc">PMC6425488</ArticleId><ArticleId IdType="pubmed">30140051</ArticleId></ArticleIdList></Reference><Reference><Citation>Marschallinger J, Iram T, Zardeneta M, Lee SE, Lehallier B, Haney MS, Pluvinage JV, Mathur V, Hahn O, David W, et al. (2020). Nature Neurosceince. Nat. Neurosci. 23, 194&#x2013;208. 10.1038/s41593-019-0566-1.Lipid.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-019-0566-1.Lipid</ArticleId><ArticleId IdType="pmc">PMC7595134</ArticleId><ArticleId IdType="pubmed">31959936</ArticleId></ArticleIdList></Reference><Reference><Citation>Nugent AA, Lin K, van Lengerich B, Lianoglou S, Przybyla L, Davis SS, Llapashtica C, Wang J, Kim DJ, Xia D, et al. (2020). TREM2 Regulates Microglial Cholesterol Metabolism upon Chronic Phagocytic Challenge. Neuron 105, 837&#x2013;854.e9. 10.1016/j.neuron.2019.12.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2019.12.007</ArticleId><ArticleId IdType="pubmed">31902528</ArticleId></ArticleIdList></Reference><Reference><Citation>Logan T, Simon MJ, Rana A, Cherf GM, Srivastava A, Davis SS, Low RLY, Chiu CL, Fang M, Huang F, et al. (2021). Rescue of a lysosomal storage disorder caused by Grn loss of function with a brain penetrant progranulin biologic. Cell 184, 4651&#x2013;4668.e25. 10.1016/j.cell.2021.08.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2021.08.002</ArticleId><ArticleId IdType="pmc">PMC8489356</ArticleId><ArticleId IdType="pubmed">34450028</ArticleId></ArticleIdList></Reference><Reference><Citation>TCW J, Qian L, Pipalia NH, Chao MJ, Liang SA, Shi Y, Jain BR, Bertelsen SE, Kapoor M, Marcora E, et al. (2022). Cholesterol and matrisome pathways dysregulated in astrocytes and microglia. Cell 185, 2213&#x2013;2233.e25. 10.1016/j.cell.2022.05.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.05.017</ArticleId><ArticleId IdType="pmc">PMC9340815</ArticleId><ArticleId IdType="pubmed">35750033</ArticleId></ArticleIdList></Reference><Reference><Citation>Victor MB, Leary N, Luna X, Meharena HS, Bozzelli PL, Samaan G, Murdock MH, Maydell D von, Effenberger, A.H., Cerit, O., et al. (2022). Lipid Accumulation Induced by APOE4 Impairs Microglial Surveillance of Neuronal-Network Activity. Cell Stem Cell 29, 1197&#x2013;1212. 10.1016/j.stem.2022.07.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stem.2022.07.005</ArticleId><ArticleId IdType="pmc">PMC9623845</ArticleId><ArticleId IdType="pubmed">35931030</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin YT, Seo J, Gao F, Feldman HM, Wen HL, Penney J, Cam HP, Gjoneska E, Raja WK, Cheng J, et al. (2018). APOE4 Causes Widespread Molecular and Cellular Alterations Associated with Alzheimer&#x2019;s Disease Phenotypes in Human iPSC-Derived Brain Cell Types. Neuron 98, 1141&#x2013;1154.e7. 10.1016/j.neuron.2018.05.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2018.05.008</ArticleId><ArticleId IdType="pmc">PMC6023751</ArticleId><ArticleId IdType="pubmed">29861287</ArticleId></ArticleIdList></Reference><Reference><Citation>Blanchard JW, Akay LA, Davila-Velderrain J, von Maydell D, Mathys H, Davidson SM, Effenberger A, Chen C-Y, Maner-Smith K, Hajjar I, et al. (2022). APOE4 impairs myelination via cholesterol dysregulation in oligodendrocytes. Nature 611, 769&#x2013;779. 10.1038/s41586-022-05439-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-05439-w</ArticleId><ArticleId IdType="pmc">PMC9870060</ArticleId><ArticleId IdType="pubmed">36385529</ArticleId></ArticleIdList></Reference><Reference><Citation>Cantuti-Castelvetri L, Fitzner D, Bosch-Queralt M, Weil M-T, Su M, Sen P, Ruhwedel T, Mitkovski M, Trendelenburg G, Lutjohann D, et al. (2018). Defective cholesterol clearance limits remyelination in the aged central nervous system. Science (80-. ). 688, 684&#x2013;688.</Citation><ArticleIdList><ArticleId IdType="pubmed">29301957</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewcock JW, Schlepckow K, Di Paolo G, Tahirovic S, Monroe KM, and Haass C (2020). Emerging Microglia Biology Defines Novel Therapeutic Approaches for Alzheimer&#x2019;s Disease. Neuron 108, 801&#x2013;821. 10.1016/j.neuron.2020.09.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2020.09.029</ArticleId><ArticleId IdType="pubmed">33096024</ArticleId></ArticleIdList></Reference><Reference><Citation>Romero-Molina C, Garretti F, Andrews SJ, Marcora E, and Goate AM (2022). Microglial efferocytosis: Diving into the Alzheimer&#x2019;s disease gene pool. Neuron 110, 3513&#x2013;3533. 10.1016/j.neuron.2022.10.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2022.10.015</ArticleId><ArticleId IdType="pubmed">36327897</ArticleId></ArticleIdList></Reference><Reference><Citation>Holstege H, Hulsman M, Charbonnier C, Grenier-Boley B, Quenez O, Grozeva D, van Rooij JGJ, Sims R, Ahmad S, Amin N, et al. (2022). Exome sequencing identifies rare damaging variants in ATP8B4 and ABCA1 as risk factors for Alzheimer &#x2018; s disease. Nat. Genet. 54, 1786&#x2013;1794. 10.1038/s41588-022-01208-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-022-01208-7</ArticleId><ArticleId IdType="pmc">PMC9729101</ArticleId><ArticleId IdType="pubmed">36411364</ArticleId></ArticleIdList></Reference><Reference><Citation>Brecht WJ, Harris FM, Chang S, Tesseur I, Yu GQ, Xu Q, Fish JD, Wyss-Coray T, Buttini M, Mucke L, et al. (2004). Neuron-Specific Apolipoprotein E4 Proteolysis Is Associated with Increased Tau Phosphorylation in Brains of Transgenic Mice. J. Neurosci. 24, 2527&#x2013;2534. 10.1523/JNEUROSCI.4315-03.2004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.4315-03.2004</ArticleId><ArticleId IdType="pmc">PMC6729489</ArticleId><ArticleId IdType="pubmed">15014128</ArticleId></ArticleIdList></Reference><Reference><Citation>Agosta F, Vossel KA, Miller BL, Migliaccio R, Bonasera SJ, Filippi M, Boxer AL, Karydas A, Possin KL, and Gorno-Tempini ML (2009). Apolipoprotein E &#x3b5;4 is associated with disease-specific effects on brain atrophy in Alzheimer&#x2019;s disease and frontotemporal dementia. Proc. Natl. Acad. Sci. U. S. A. 106, 2018&#x2013;2022. 10.1073/pnas.0812697106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0812697106</ArticleId><ArticleId IdType="pmc">PMC2644156</ArticleId><ArticleId IdType="pubmed">19164761</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi Y, Yamada K, Liddelow SA, Smith ST, Zhao L, Luo W, Tsai RM, Spina S, Grinberg LT, Rojas JC, et al. (2017). ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy. Nature 549, 523&#x2013;527. 10.1038/nature24016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature24016</ArticleId><ArticleId IdType="pmc">PMC5641217</ArticleId><ArticleId IdType="pubmed">28959956</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi Y, Manis M, Long J, Wang K, Sullivan PM, Serrano JR, Hoyle R, and Holtzman DM (2019). Microglia drive APOE-dependent neurodegeneration in a tauopathy mouse model. J. Exp. Med. 216, 2546&#x2013;2561. 10.1084/jem.20190980.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20190980</ArticleId><ArticleId IdType="pmc">PMC6829593</ArticleId><ArticleId IdType="pubmed">31601677</ArticleId></ArticleIdList></Reference><Reference><Citation>Gratuze M, Schlachetzki JCM, D&#x2019;Oliveira Albanus R, Jain N, Novotny B, Brase L, Rodriguez L, Mansel C, Kipnis M, O&#x2019;Brien S, et al. (2022). TREM2-independent microgliosis promotes tau-mediated neurodegeneration in the presence of ApoE4. Neuron, 1&#x2013;18. 10.1016/j.neuron.2022.10.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2022.10.022</ArticleId><ArticleId IdType="pmc">PMC9852006</ArticleId><ArticleId IdType="pubmed">36368315</ArticleId></ArticleIdList></Reference><Reference><Citation>Seo D-O, O&#x2019;Donnell D, Jain N, Ulrich JD, Herz J, Li Y, Lemieux M, Cheng J, Hu H, Serrano JR, et al. (2023). ApoE isoform- and microbiota-dependent progression of neurodegeneration in a mouse model of tauopathy. Science 379, eadd1236. 10.1126/science.add1236.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.add1236</ArticleId><ArticleId IdType="pmc">PMC9901565</ArticleId><ArticleId IdType="pubmed">36634180</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong Y, D&#x2019;Mello C, Pinsky W, Lozinski BM, Kaushik DK, Ghorbani S, Moezzi D, Brown D, Melo FC, Zandee S, et al. (2021). Oxidized phosphatidylcholines found in multiple sclerosis lesions mediate neurodegeneration and are neutralized by microglia. Nat. Neurosci. 24, 489&#x2013;503. 10.1038/s41593-021-00801-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-021-00801-z</ArticleId><ArticleId IdType="pubmed">33603230</ArticleId></ArticleIdList></Reference><Reference><Citation>Sienski G, Narayan P, Bonner JM, Kory N, Boland S, Arczewska AA, Ralvenius WT, Akay L, Lockshin E, He L, et al. (2021). APOE4 disrupts intracellular lipid homeostasis in human iPSC-derived glia. Sci. Transl. Med. 13, 1&#x2013;12. 10.1126/scitranslmed.aaz4564.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.aaz4564</ArticleId><ArticleId IdType="pmc">PMC8218593</ArticleId><ArticleId IdType="pubmed">33658354</ArticleId></ArticleIdList></Reference><Reference><Citation>Khalil M, Teunissen CE, Otto M, Piehl F, Sormani MP, Gattringer T, Barro C, Kappos L, Comabella M, Fazekas F, et al. (2018). Neurofilaments as biomarkers in neurological disorders. Nat. Rev. Neurol. 14, 577&#x2013;589. 10.1038/s41582-018-0058-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-018-0058-z</ArticleId><ArticleId IdType="pubmed">30171200</ArticleId></ArticleIdList></Reference><Reference><Citation>DeVos SL, Miller RL, Schoch KM, Holmes BB, Kebodeaux CS, Wegener AJ, Chen G, Shen T, Tran H, Nichols B, et al. (2017). Tau reduction prevents neuronal loss and reverses pathological tau deposition and seeding in mice with tauopathy. Sci. Transl. Med. 9, 1&#x2013;15. 10.1126/scitranslmed.aag0481.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.aag0481</ArticleId><ArticleId IdType="pmc">PMC5792300</ArticleId><ArticleId IdType="pubmed">28123067</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C, Xiong M, Gratuze M, Bao X, Shi Y, Andhey PS, Manis M, Schroeder C, Yin Z, Madore C, et al. (2021). Selective removal of astrocytic APOE4 strongly protects against tau-mediated neurodegeneration and decreases synaptic phagocytosis by microglia. Neuron 109, 1657&#x2013;1674.e7. 10.1016/j.neuron.2021.03.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2021.03.024</ArticleId><ArticleId IdType="pmc">PMC8141024</ArticleId><ArticleId IdType="pubmed">33831349</ArticleId></ArticleIdList></Reference><Reference><Citation>Litvinchuk A, Huynh TPV, Shi Y, Jackson RJ, Finn MB, Manis M, Francis CM, Tran AC, Sullivan PM, Ulrich JD, et al. (2021). Apolipoprotein E4 Reduction with Antisense Oligonucleotides Decreases Neurodegeneration in a Tauopathy Model. Ann. Neurol. 89, 952&#x2013;966. 10.1002/ana.26043.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.26043</ArticleId><ArticleId IdType="pmc">PMC8260038</ArticleId><ArticleId IdType="pubmed">33550655</ArticleId></ArticleIdList></Reference><Reference><Citation>Laffitte BA, Repa JJ, Joseph SB, Wilpitz DC, Kast HR, Mangelsdorf DJ, and Tontonoz P (2001). LXRs control lipid-inducible expression of the apolipoprotein E gene in macrophages and adipocytes. Proc. Natl. Acad. Sci. U. S. A. 98, 507&#x2013;512. 10.1073/pnas.98.2.507.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.98.2.507</ArticleId><ArticleId IdType="pmc">PMC14617</ArticleId><ArticleId IdType="pubmed">11149950</ArticleId></ArticleIdList></Reference><Reference><Citation>Donkin JJ, Stukas S, Hirsch-Reinshagen V, Namjoshi D, Wilkinson A, May S, Chan J, Fan J, Collins J, and Wellington CL (2010). ATP-binding cassette transporter A1 mediates the beneficial effects of the liver X receptor agonist GW3965 on object recognition memory and amyloid burden in amyloid precursor protein/presenilin 1 mice. J. Biol. Chem. 285, 34144&#x2013;34154. 10.1074/jbc.M110.108100.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M110.108100</ArticleId><ArticleId IdType="pmc">PMC2962513</ArticleId><ArticleId IdType="pubmed">20739291</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshiyama Y, Higuchi M, Zhang B, Huang SM, Iwata N, Saido T, Maeda J, Suhara T, Trojanowski JQ, and Lee VMY (2007). Synapse Loss and Microglial Activation Precede Tangles in a P301S Tauopathy Mouse Model. Neuron 53, 337&#x2013;351. 10.1016/j.neuron.2007.01.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2007.01.010</ArticleId><ArticleId IdType="pubmed">17270732</ArticleId></ArticleIdList></Reference><Reference><Citation>Litvinchuk A, Wan Y-W, Swartzlander DB, Chen F, Cole A, Propson NE, Wang Q, Zhang B, Liu Z, and Zheng H (2018). Complement C3aR Inactivation Attenuates Tau Pathology and Reverses an Immune Network Deregulated in Tauopathy Models and Alzheimer&#x2019;s Disease. Neuron, 1&#x2013;17. 10.1016/j.neuron.2018.10.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2018.10.031</ArticleId><ArticleId IdType="pmc">PMC6309202</ArticleId><ArticleId IdType="pubmed">30415998</ArticleId></ArticleIdList></Reference><Reference><Citation>Mancuso R, Fryatt G, Cleal M, Obst J, Pipi E, Monz&#xf3;n-Sandoval J, Ribe E, Winchester L, Webber C, Nevado A, et al. (2019). CSF1R inhibitor JNJ-40346527 attenuates microglial proliferation and neurodegeneration in P301S mice. Brain 142, 3243&#x2013;3264. 10.1093/brain/awz241.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awz241</ArticleId><ArticleId IdType="pmc">PMC6794948</ArticleId><ArticleId IdType="pubmed">31504240</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X, Firulyova M, Manis M, Herz J, Smirnov I, Aladyeva E, Wang C, Bao X, Finn MB, Hu H, et al. (2023). Microglia-mediated T cell infiltration drives neurodegeneration in tauopathy. Nature 615, 668&#x2013;677. 10.1038/s41586-023-05788-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-023-05788-0</ArticleId><ArticleId IdType="pmc">PMC10258627</ArticleId><ArticleId IdType="pubmed">36890231</ArticleId></ArticleIdList></Reference><Reference><Citation>Schafer DP, Lehrman EK, Kautzman AG, Koyama R, Mardinly AR, Yamasaki R, Ransohoff RM, Greenberg ME, Barres BA, and Stevens B (2012). Microglia Sculpt Postnatal Neural Circuits in an Activity and Complement-Dependent Manner. Neuron 74, 691&#x2013;705. 10.1016/j.neuron.2012.03.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2012.03.026</ArticleId><ArticleId IdType="pmc">PMC3528177</ArticleId><ArticleId IdType="pubmed">22632727</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong S, Beja-Glasser VF, Nfonoyim BM, Frouin A, Li S, Ramakrishnan S, Merry KM, Shi Q, Rosenthal A, Barres BA, et al. (2016). Complement and microglia mediate early synapse loss in Alzheimer mouse models. Science (80-. ). 352, 712&#x2013;716. 10.1126/science.aad8373.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aad8373</ArticleId><ArticleId IdType="pmc">PMC5094372</ArticleId><ArticleId IdType="pubmed">27033548</ArticleId></ArticleIdList></Reference><Reference><Citation>Krasemann S, Madore C, Cialic R, Baufeld C, Calcagno N, El Fatimy R, Beckers L, O&#x2019;Loughlin E, Xu Y, Fanek Z, et al. (2017). The TREM2-APOE Pathway Drives the Transcriptional Phenotype of Dysfunctional Microglia in Neurodegenerative Diseases. Immunity 47, 566&#x2013;581.e9. 10.1016/j.immuni.2017.08.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2017.08.008</ArticleId><ArticleId IdType="pmc">PMC5719893</ArticleId><ArticleId IdType="pubmed">28930663</ArticleId></ArticleIdList></Reference><Reference><Citation>Keren-Shaul H, Spinrad A, Weiner A, Matcovitch-Natan O, Dvir-Szternfeld R, Ulland TK, David E, Baruch K, Lara-Astaiso D, Toth B, et al. (2017). A Unique Microglia Type Associated with Restricting Development of Alzheimer&#x2019;s Disease. Cell 169, 1276&#x2013;1290.e17. 10.1016/j.cell.2017.05.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2017.05.018</ArticleId><ArticleId IdType="pubmed">28602351</ArticleId></ArticleIdList></Reference><Reference><Citation>Habib N, McCabe C, Medina S, Varshavsky M, Kitsberg D, Dvir-Szternfeld R, Green G, Dionne D, Nguyen L, Marshall JL, et al. (2020). Disease-associated astrocytes in Alzheimer&#x2019;s disease and aging. Nat. Neurosci. 23, 701&#x2013;706. 10.1038/s41593-020-0624-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-020-0624-8</ArticleId><ArticleId IdType="pmc">PMC9262034</ArticleId><ArticleId IdType="pubmed">32341542</ArticleId></ArticleIdList></Reference><Reference><Citation>Langfelder P, and Horvath S (2008). WGCNA: An R package for weighted correlation network analysis. BMC Bioinformatics 9. 10.1186/1471-2105-9-559.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2105-9-559</ArticleId><ArticleId IdType="pmc">PMC2631488</ArticleId><ArticleId IdType="pubmed">19114008</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu G, Wang LG, Han Y, and He QY (2012). ClusterProfiler: An R package for comparing biological themes among gene clusters. Omi. A J. Integr. Biol. 16, 284&#x2013;287. 10.1089/omi.2011.0118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/omi.2011.0118</ArticleId><ArticleId IdType="pmc">PMC3339379</ArticleId><ArticleId IdType="pubmed">22455463</ArticleId></ArticleIdList></Reference><Reference><Citation>Wahrle SE, Jiang H, Parsadanian M, Kim J, Li A, Knoten A, Jain S, Hirsch-Reinshagen V, Wellington CL, Bales KR, et al. (2008). Overexpression of ABCA1 reduces amyloid deposition in the PDAPP mouse model of Alzheimer disease. J. Clin. Invest. 118, 671&#x2013;682. 10.1172/JCI33622.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI33622</ArticleId><ArticleId IdType="pmc">PMC2200302</ArticleId><ArticleId IdType="pubmed">18202749</ArticleId></ArticleIdList></Reference><Reference><Citation>Miranda AM, Ashok A, Chan RB, Zhou B, Xu Y, McIntire LB, Area-Gomez E, Di Paolo G, Duff KE, Oliveira TG, et al. (2022). Effects of APOE4 allelic dosage on lipidomic signatures in the entorhinal cortex of aged mice. Transl. Psychiatry 12, 129. 10.1038/s41398-022-01881-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41398-022-01881-6</ArticleId><ArticleId IdType="pmc">PMC8964762</ArticleId><ArticleId IdType="pubmed">35351864</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia D, Lianoglou S, Sandmann T, Calvert M, Suh JH, Thomsen E, Dugas J, Pizzo ME, DeVos SL, Earr TK, et al. (2022). Novel App knock-in mouse model shows key features of amyloid pathology and reveals profound metabolic dysregulation of microglia. Mol. Neurodegener. 17, 41. 10.1186/s13024-022-00547-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-022-00547-7</ArticleId><ArticleId IdType="pmc">PMC9188195</ArticleId><ArticleId IdType="pubmed">35690868</ArticleId></ArticleIdList></Reference><Reference><Citation>Simon MJ, Logan T, DeVos SL, and Di Paolo G (2023). Lysosomal functions of progranulin and implications for treatment of frontotemporal dementia. Trends Cell Biol. 33, 324&#x2013;339. 10.1016/j.tcb.2022.09.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tcb.2022.09.006</ArticleId><ArticleId IdType="pubmed">36244875</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan RB, Oliveira TG, Cortes EP, Honig LS, Duff KE, Small SA, Wenk MR, Shui G, and Di Paolo G (2012). Comparative lipidomic analysis of mouse and human brain with Alzheimer disease. J. Biol. Chem. 287, 2678&#x2013;2688. 10.1074/jbc.M111.274142.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M111.274142</ArticleId><ArticleId IdType="pmc">PMC3268426</ArticleId><ArticleId IdType="pubmed">22134919</ArticleId></ArticleIdList></Reference><Reference><Citation>Duewell P, Kono H, Rayner KJ, Sirois CM, Vladimer G, Bauernfeind FG, Abela GS, Franchi L, Nu&#xf1;ez G, Schnurr M, et al. (2010). NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature 464, 1357&#x2013;1361. 10.1038/nature08938.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature08938</ArticleId><ArticleId IdType="pmc">PMC2946640</ArticleId><ArticleId IdType="pubmed">20428172</ArticleId></ArticleIdList></Reference><Reference><Citation>Andreone BJ, Przybyla L, Llapashtica C, Rana A, Davis SS, van Lengerich B, Lin K, Shi J, Mei Y, Astarita G, et al. (2020). Alzheimer&#x2019;s-associated PLC&#x3b3;2 is a signaling node required for both TREM2 function and the inflammatory response in human microglia. Nat. Neurosci. 23, 927&#x2013;938. 10.1038/s41593-020-0650-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-020-0650-6</ArticleId><ArticleId IdType="pubmed">32514138</ArticleId></ArticleIdList></Reference><Reference><Citation>Zelcer N, Khanlou N, Clare R, Jiang Q, Reed-Geaghan EG, Landreth GE, Vinters HV, and Tontonoz P (2007). Attenuation of neuroinflammation and Alzheimer&#x2019;s disease pathology by liver x receptors. Proc. Natl. Acad. Sci. U. S. A. 104, 10601&#x2013;10606. 10.1073/pnas.0701096104.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0701096104</ArticleId><ArticleId IdType="pmc">PMC1890560</ArticleId><ArticleId IdType="pubmed">17563384</ArticleId></ArticleIdList></Reference><Reference><Citation>Carter AY, Letronne F, Fitz NF, Mounier A, Wolfe CM, Nam KN, Reeves VL, Kamboh H, Lefterov I, and Koldamova R (2017). Liver X receptor agonist treatment significantly affects phenotype and transcriptome of APOE3 and APOE4 Abca1 haplo-deficient mice. PLoS One 12, e0172161. 10.1371/journal.pone.0172161.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0172161</ArticleId><ArticleId IdType="pmc">PMC5328633</ArticleId><ArticleId IdType="pubmed">28241068</ArticleId></ArticleIdList></Reference><Reference><Citation>Boehm-Cagan A, and Michaelson DM (2014). Reversal of apoE4-driven brain pathology and behavioral deficits by bexarotene. J. Neurosci. Off. J. Soc. Neurosci. 34, 7293&#x2013;7301. 10.1523/JNEUROSCI.5198-13.2014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.5198-13.2014</ArticleId><ArticleId IdType="pmc">PMC6608187</ArticleId><ArticleId IdType="pubmed">24849361</ArticleId></ArticleIdList></Reference><Reference><Citation>Fitz NF, Cronican A, Pham T, Fogg A, Fauq AH, Chapman R, Lefterov I, and Koldamova R (2010). Liver X receptor agonist treatment ameliorates amyloid pathology and memory deficits caused by high-fat diet in APP23 mice. J. Neurosci. 30, 6862&#x2013;6872. 10.1523/JNEUROSCI.1051-10.2010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1051-10.2010</ArticleId><ArticleId IdType="pmc">PMC2883862</ArticleId><ArticleId IdType="pubmed">20484628</ArticleId></ArticleIdList></Reference><Reference><Citation>Kratzer A, Buchebner M, Pfeifer T, Becker TM, Uray G, Miyazaki M, Miyazaki-Anzai S, Ebner B, Chandak PG, Kadam RS, et al. (2009). Synthetic LXR agonist attenuates plaque formation in apoE&#x2212;/&#x2212;mice without inducing liver steatosis and hypertriglyceridemia. J. Lipid Res. 50, 312&#x2013;326. 10.1194/jlr.M800376-JLR200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1194/jlr.M800376-JLR200</ArticleId><ArticleId IdType="pmc">PMC2636920</ArticleId><ArticleId IdType="pubmed">18812595</ArticleId></ArticleIdList></Reference><Reference><Citation>Joseph SB, Castrillo A, Laffitte BA, Mangelsdorf DJ, and Tontonoz P (2003). Reciprocal regulation of inflammation and lipid metabolism by liver X receptors. Nat. Med. 9, 213&#x2013;219. 10.1038/nm820.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm820</ArticleId><ArticleId IdType="pubmed">12524534</ArticleId></ArticleIdList></Reference><Reference><Citation>Pascual-Garc&#xed;a M, Ru&#xe9; L, Le&#xf3;n T, Julve J, Carb&#xf3; JM, Matalonga J, Auer H, Celada A, Escol&#xe0;-Gil JC, Steffensen KR, et al. (2013). Reciprocal negative cross-talk between liver X receptors (LXRs) and STAT1: effects on IFN-&#x3b3;-induced inflammatory responses and LXR-dependent gene expression. J. Immunol. 190, 6520&#x2013;6532. 10.4049/jimmunol.1201393.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1201393</ArticleId><ArticleId IdType="pubmed">23686490</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C, Fan L, Khawaja RR, Liu B, Zhan L, Kodama L, Chin M, Li Y, Le D, Zhou Y, et al. (2022). Microglial NF-&#x3ba;B drives tau spreading and toxicity in a mouse model of tauopathy. Nat. Commun. 13. 10.1038/s41467-022-29552-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-29552-6</ArticleId><ArticleId IdType="pmc">PMC9005658</ArticleId><ArticleId IdType="pubmed">35413950</ArticleId></ArticleIdList></Reference><Reference><Citation>Quintanilla R. a., Orellana DI, Gonz&#xe1;lez-Billault C, and Maccioni RB (2004). Interleukin-6 induces Alzheimer-type phosphorylation of tau protein by deregulating the cdk5/p35 pathway. Exp. Cell Res. 295, 245&#x2013;257. 10.1016/j.yexcr.2004.01.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yexcr.2004.01.002</ArticleId><ArticleId IdType="pubmed">15051507</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Liu L, Barger SW, Sue W, and Griffin T (2003). Interleukin-1 Mediates Pathological Effects of Microglia on Tau Phosphorylation and on Synaptophysin Synthesis in Cortical Neurons through a p38-MAPK Pathway. 23, 1605&#x2013;1611. 23/5/1605 [pii].</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3833596</ArticleId><ArticleId IdType="pubmed">12629164</ArticleId></ArticleIdList></Reference><Reference><Citation>Ising C, Venegas C, Zhang S, Scheiblich H, Schmidt SV, Vieira-Saecker A, Schwartz S, Albasset S, McManus RM, Tejera D, et al. (2019). NLRP3 inflammasome activation drives tau pathology. Nature 575, 669&#x2013;673. 10.1038/s41586-019-1769-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-019-1769-z</ArticleId><ArticleId IdType="pmc">PMC7324015</ArticleId><ArticleId IdType="pubmed">31748742</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Kant R, Langness VF, Herrera CM, Williams DA, Fong LK, Leestemaker Y, Steenvoorden E, Rynearson KD, Brouwers JF, Helms JB, et al. (2019). Cholesterol Metabolism Is a Druggable Axis that Independently Regulates Tau and Amyloid-&#x3b2; in iPSC-Derived Alzheimer&#x2019;s Disease Neurons. Cell Stem Cell 24, 363&#x2013;375.e9. 10.1016/j.stem.2018.12.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stem.2018.12.013</ArticleId><ArticleId IdType="pmc">PMC6414424</ArticleId><ArticleId IdType="pubmed">30686764</ArticleId></ArticleIdList></Reference><Reference><Citation>Deacon RMJ (2006). Assessing nest building in mice. Nat. Protoc. 1, 1117&#x2013;1119. 10.1038/nprot.2006.170.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nprot.2006.170</ArticleId><ArticleId IdType="pubmed">17406392</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuede CM, Wozniak DF, Creeley CE, Taylor GT, Olney JW, and Farber NB (2010). Behavioral consequences of NMDA antagonist-induced neuroapoptosis in the infant mouse brain. PLoS One 5, e11374. 10.1371/journal.pone.0011374.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0011374</ArticleId><ArticleId IdType="pmc">PMC2894063</ArticleId><ArticleId IdType="pubmed">20613880</ArticleId></ArticleIdList></Reference><Reference><Citation>Huynh TPV, Wang C, Tran AC, Tabor GT, Mahan TE, Francis CM, Finn MB, Spellman R, Manis M, Tanzi RE, et al. (2019). Lack of hepatic apoE does not influence early A&#x3b2; deposition: Observations from a new APOE knock-in model. Mol. Neurodegener. 14, 37. 10.1186/s13024-019-0337-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-019-0337-1</ArticleId><ArticleId IdType="pmc">PMC6796484</ArticleId><ArticleId IdType="pubmed">31623648</ArticleId></ArticleIdList></Reference><Reference><Citation>Rolfe AJ, Bosco DB, Broussard EN, and Ren Y (2017). In Vitro Phagocytosis of Myelin Debris by Bone Marrow-Derived Macrophages. J. Vis. Exp. 10.3791/56322.</Citation><ArticleIdList><ArticleId IdType="doi">10.3791/56322</ArticleId><ArticleId IdType="pmc">PMC5908409</ArticleId><ArticleId IdType="pubmed">29364206</ArticleId></ArticleIdList></Reference><Reference><Citation>Schafer DP, Lehrman EK, Heller CT, and Stevens B (2014). An engulfment assay: A protocol to assess interactions between CNS phagocytes and neurons. J. Vis. Exp. 88. 10.3791/51482.</Citation><ArticleIdList><ArticleId IdType="doi">10.3791/51482</ArticleId><ArticleId IdType="pmc">PMC4188069</ArticleId><ArticleId IdType="pubmed">24962472</ArticleId></ArticleIdList></Reference><Reference><Citation>Swartzlander DB, Propson NE, Roy ER, Wang B, Zheng H, Saito T, and Saido T (2018). Concurrent cell type&#x2013;specific isolation and profiling of mouse brains in inflammation and Alzheimer&#x2019;s disease. JCI Insight 3, 1&#x2013;14. 10.1172/jci.insight.121109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.121109</ArticleId><ArticleId IdType="pmc">PMC6124528</ArticleId><ArticleId IdType="pubmed">29997299</ArticleId></ArticleIdList></Reference><Reference><Citation>Finak G, McDavid A, Yajima M, Deng J, Gersuk V, Shalek AK, Slichter CK, Miller HW, McElrath MJ, Prlic M, et al. (2015). MAST: A flexible statistical framework for assessing transcriptional changes and characterizing heterogeneity in single-cell RNA sequencing data. Genome Biol. 16, 1&#x2013;13. 10.1186/s13059-015-0844-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13059-015-0844-5</ArticleId><ArticleId IdType="pmc">PMC4676162</ArticleId><ArticleId IdType="pubmed">26653891</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, Batut P, Chaisson M, and Gingeras TR (2013). STAR: Ultrafast universal RNA-seq aligner. Bioinformatics 29, 15&#x2013;21. 10.1093/bioinformatics/bts635.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/bts635</ArticleId><ArticleId IdType="pmc">PMC3530905</ArticleId><ArticleId IdType="pubmed">23104886</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao Y, Smyth GK, and Shi W (2014). FeatureCounts: An efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics 30, 923&#x2013;930. 10.1093/bioinformatics/btt656.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btt656</ArticleId><ArticleId IdType="pubmed">24227677</ArticleId></ArticleIdList></Reference><Reference><Citation>Patro R, Duggal G, Love MI, Irizarry RI, and Kinsford C (2017). Salmon: fast and bias-aware quantification of transcript expression using dual-phase inference. Nat.Methods 14, 417&#x2013;419. 10.5040/9781635577068-1566.</Citation><ArticleIdList><ArticleId IdType="doi">10.5040/9781635577068-1566</ArticleId><ArticleId IdType="pmc">PMC5600148</ArticleId><ArticleId IdType="pubmed">28263959</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L, Wang S, and Li W (2012). RSeQC: Quality control of RNA-seq experiments. Bioinformatics 28, 2184&#x2013;2185. 10.1093/bioinformatics/bts356.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/bts356</ArticleId><ArticleId IdType="pubmed">22743226</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson MD, McCarthy DJ, and Smyth GK (2009). edgeR: A Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26, 139&#x2013;140. 10.1093/bioinformatics/btp616.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btp616</ArticleId><ArticleId IdType="pmc">PMC2796818</ArticleId><ArticleId IdType="pubmed">19910308</ArticleId></ArticleIdList></Reference><Reference><Citation>Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, and Smyth GK (2015). Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43, e47. 10.1093/nar/gkv007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkv007</ArticleId><ArticleId IdType="pmc">PMC4402510</ArticleId><ArticleId IdType="pubmed">25605792</ArticleId></ArticleIdList></Reference><Reference><Citation>Leek JT, and Storey JD (2007). Capturing heterogeneity in gene expression studies by surrogate variable analysis. PLoS Genet. 3, 1724&#x2013;1735. 10.1371/journal.pgen.0030161.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.0030161</ArticleId><ArticleId IdType="pmc">PMC1994707</ArticleId><ArticleId IdType="pubmed">17907809</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo W, Friedman MS, Shedden K, Hankenson KD, and Woolf PJ (2009). GAGE: Generally applicable gene set enrichment for pathway analysis. BMC Bioinformatics 10, 1&#x2013;17. 10.1186/1471-2105-10-161.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2105-10-161</ArticleId><ArticleId IdType="pmc">PMC2696452</ArticleId><ArticleId IdType="pubmed">19473525</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao S, Guo Y, Sheng Q, and Shyr Y (2014). Advanced Heat Map and Clustering Analysis Using Heatmap3. Biomed Res. Int. 2014. 10.1155/2014/986048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2014/986048</ArticleId><ArticleId IdType="pmc">PMC4124803</ArticleId><ArticleId IdType="pubmed">25143956</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo W, and Brouwer C (2013). Pathview: An R/Bioconductor package for pathway-based data integration and visualization. Bioinformatics 29, 1830&#x2013;1831. 10.1093/bioinformatics/btt285.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btt285</ArticleId><ArticleId IdType="pmc">PMC3702256</ArticleId><ArticleId IdType="pubmed">23740750</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38030728</PMID><DateCompleted><Year>2024</Year><Month>01</Month><Day>16</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>30</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1476-4687</ISSN><JournalIssue CitedMedium="Internet"><Volume>625</Volume><Issue>7993</Issue><PubDate><Year>2024</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Nature</Title><ISOAbbreviation>Nature</ISOAbbreviation></Journal><ArticleTitle>Disease-specific tau filaments assemble via polymorphic intermediates.</ArticleTitle><Pagination><StartPage>119</StartPage><EndPage>125</EndPage><MedlinePgn>119-125</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41586-023-06788-w</ELocationID><Abstract><AbstractText>Intermediate species in the assembly of amyloid filaments are believed to play a central role in neurodegenerative diseases and may constitute important targets for therapeutic intervention<sup>1,2</sup>. However, structural information about intermediate species has been scarce and the molecular mechanisms by which amyloids assemble remain largely unknown. Here we use time-resolved cryogenic electron microscopy to study the in vitro assembly of recombinant truncated tau (amino acid residues 297-391) into paired helical filaments of Alzheimer's disease or into filaments of chronic traumatic encephalopathy<sup>3</sup>. We report the formation of a shared first intermediate amyloid&#xa0;filament, with an ordered core comprising residues 302-316. Nuclear magnetic resonance indicates that the same residues adopt rigid, &#x3b2;-strand-like conformations in monomeric tau. At later time points, the first intermediate amyloid disappears and we observe many different intermediate amyloid filaments, with structures that depend on the reaction conditions. At the end of both assembly reactions, most intermediate amyloids disappear and filaments with the same ordered cores as those from human brains remain. Our results provide structural insights into the processes of primary and secondary nucleation of amyloid assembly, with implications for the design of new therapies.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>L&#xf6;vestam</LastName><ForeName>Sofia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>MRC Laboratory of Molecular Biology, Cambridge, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>David</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-8921-5168</Identifier><AffiliationInfo><Affiliation>MRC Laboratory of Molecular Biology, Cambridge, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wagstaff</LastName><ForeName>Jane L</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>MRC Laboratory of Molecular Biology, Cambridge, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kotecha</LastName><ForeName>Abhay</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-4480-5439</Identifier><AffiliationInfo><Affiliation>Thermo Fisher Scientific, Eindhoven, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kimanius</LastName><ForeName>Dari</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>MRC Laboratory of Molecular Biology, Cambridge, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McLaughlin</LastName><ForeName>Stephen H</ForeName><Initials>SH</Initials><Identifier Source="ORCID">0000-0001-9135-6253</Identifier><AffiliationInfo><Affiliation>MRC Laboratory of Molecular Biology, Cambridge, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Murzin</LastName><ForeName>Alexey G</ForeName><Initials>AG</Initials><AffiliationInfo><Affiliation>MRC Laboratory of Molecular Biology, Cambridge, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Freund</LastName><ForeName>Stefan M V</ForeName><Initials>SMV</Initials><AffiliationInfo><Affiliation>MRC Laboratory of Molecular Biology, Cambridge, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goedert</LastName><ForeName>Michel</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-5214-7886</Identifier><AffiliationInfo><Affiliation>MRC Laboratory of Molecular Biology, Cambridge, UK. mg@mrc-lmb.cam.ac.uk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scheres</LastName><ForeName>Sjors H W</ForeName><Initials>SHW</Initials><Identifier Source="ORCID">0000-0002-0462-6540</Identifier><AffiliationInfo><Affiliation>MRC Laboratory of Molecular Biology, Cambridge, UK. scheres@mrc-lmb.cam.ac.uk.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>CC1078</GrantID><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MC_U105184291</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MC_UP_A025_1013</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>11</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nature</MedlineTA><NlmUniqueID>0410462</NlmUniqueID><ISSNLinking>0028-0836</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000682">Amyloid</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C054369">MAPT protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016875">tau Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000682" MajorTopicYN="Y">Amyloid</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000648" MajorTopicYN="N">ultrastructure</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000070627" MajorTopicYN="Y">Chronic Traumatic Encephalopathy</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020285" MajorTopicYN="N">Cryoelectron Microscopy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016874" MajorTopicYN="Y">Neurofibrillary Tangles</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000648" MajorTopicYN="N">ultrastructure</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016875" MajorTopicYN="Y">tau Proteins</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000648" MajorTopicYN="N">ultrastructure</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019906" MajorTopicYN="N">Nuclear Magnetic Resonance, Biomolecular</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011487" MajorTopicYN="N">Protein Conformation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>7</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>10</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>1</Month><Day>5</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>11</Month><Day>30</Day><Hour>0</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>11</Month><Day>29</Day><Hour>23</Hour><Minute>31</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>11</Month><Day>29</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38030728</ArticleId><ArticleId IdType="pmc">PMC10764278</ArticleId><ArticleId IdType="doi">10.1038/s41586-023-06788-w</ArticleId><ArticleId IdType="pii">10.1038/s41586-023-06788-w</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Peng C, Trojanowski JQ, Lee VM-Y. Protein transmission in neurodegenerative disease. Nat. Rev. Neurol. 2020;16:199&#x2013;212. doi: 10.1038/s41582-020-0333-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-020-0333-7</ArticleId><ArticleId IdType="pmc">PMC9242841</ArticleId><ArticleId IdType="pubmed">32203399</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilson DM, et al. Hallmarks of neurodegenerative diseases. Cell. 2023;186:693&#x2013;714. doi: 10.1016/j.cell.2022.12.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.12.032</ArticleId><ArticleId IdType="pubmed">36803602</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf6;vestam S, et al. Assembly of recombinant tau into filaments identical to those of Alzheimer&#x2019;s disease and chronic traumatic encephalopathy. Elife. 2022;11:e76494. doi: 10.7554/eLife.76494.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.76494</ArticleId><ArticleId IdType="pmc">PMC8983045</ArticleId><ArticleId IdType="pubmed">35244536</ArticleId></ArticleIdList></Reference><Reference><Citation>Arseni D, et al. TDP-43 forms amyloid filaments with a distinct fold in type A FTLD-TDP. Nature. 2023;620:898&#x2013;903. doi: 10.1038/s41586-023-06405-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-023-06405-w</ArticleId><ArticleId IdType="pmc">PMC10447236</ArticleId><ArticleId IdType="pubmed">37532939</ArticleId></ArticleIdList></Reference><Reference><Citation>Arseni D, et al. Structure of pathological TDP-43 filaments from ALS with FTLD. Nature. 2022;601:139&#x2013;143. doi: 10.1038/s41586-021-04199-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-04199-3</ArticleId><ArticleId IdType="pmc">PMC7612255</ArticleId><ArticleId IdType="pubmed">34880495</ArticleId></ArticleIdList></Reference><Reference><Citation>Falcon B, et al. Novel tau filament fold in chronic traumatic encephalopathy encloses hydrophobic molecules. Nature. 2019;568:420&#x2013;423. doi: 10.1038/s41586-019-1026-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-019-1026-5</ArticleId><ArticleId IdType="pmc">PMC6472968</ArticleId><ArticleId IdType="pubmed">30894745</ArticleId></ArticleIdList></Reference><Reference><Citation>Falcon B, et al. Structures of filaments from Pick&#x2019;s disease reveal a novel tau protein fold. Nature. 2018;561:137&#x2013;140. doi: 10.1038/s41586-018-0454-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-018-0454-y</ArticleId><ArticleId IdType="pmc">PMC6204212</ArticleId><ArticleId IdType="pubmed">30158706</ArticleId></ArticleIdList></Reference><Reference><Citation>Fitzpatrick AWP, et al. Cryo-EM structures of tau filaments from Alzheimer&#x2019;s disease. Nature. 2017;547:185&#x2013;190. doi: 10.1038/nature23002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature23002</ArticleId><ArticleId IdType="pmc">PMC5552202</ArticleId><ArticleId IdType="pubmed">28678775</ArticleId></ArticleIdList></Reference><Reference><Citation>Schweighauser M, et al. Structures of &#x3b1;-synuclein filaments from multiple system atrophy. Nature. 2020;585:464&#x2013;469. doi: 10.1038/s41586-020-2317-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2317-6</ArticleId><ArticleId IdType="pmc">PMC7116528</ArticleId><ArticleId IdType="pubmed">32461689</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi Y, et al. Structure-based classification of tauopathies. Nature. 2021;598:359&#x2013;363. doi: 10.1038/s41586-021-03911-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03911-7</ArticleId><ArticleId IdType="pmc">PMC7611841</ArticleId><ArticleId IdType="pubmed">34588692</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y, et al. Structures of &#x3b1;-synuclein filaments from human brains with Lewy pathology. Nature. 2022;610:791&#x2013;795. doi: 10.1038/s41586-022-05319-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-05319-3</ArticleId><ArticleId IdType="pmc">PMC7613749</ArticleId><ArticleId IdType="pubmed">36108674</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang W, et al. Novel tau filament fold in corticobasal degeneration. Nature. 2020;580:283&#x2013;287. doi: 10.1038/s41586-020-2043-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2043-0</ArticleId><ArticleId IdType="pmc">PMC7148158</ArticleId><ArticleId IdType="pubmed">32050258</ArticleId></ArticleIdList></Reference><Reference><Citation>Kayed R, et al. Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science. 2003;300:486&#x2013;489. doi: 10.1126/science.1079469.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1079469</ArticleId><ArticleId IdType="pubmed">12702875</ArticleId></ArticleIdList></Reference><Reference><Citation>van Dyck CH, et al. Lecanemab in early Alzheimer&#x2019;s disease. N. Engl. J. Med. 2023;388:9&#x2013;21. doi: 10.1056/NEJMoa2212948.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2212948</ArticleId><ArticleId IdType="pubmed">36449413</ArticleId></ArticleIdList></Reference><Reference><Citation>Lannfelt L, et al. Perspectives on future Alzheimer therapies: amyloid-&#x3b2; protofibrils - a new target for immunotherapy with BAN2401 in Alzheimer&#x2019;s disease. Alzheimers Res. Ther. 2014;6:16. doi: 10.1186/alzrt246.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/alzrt246</ArticleId><ArticleId IdType="pmc">PMC4054967</ArticleId><ArticleId IdType="pubmed">25031633</ArticleId></ArticleIdList></Reference><Reference><Citation>Hartley DM, et al. Protofibrillar intermediates of amyloid &#x3b2;-protein induce acute electrophysiological changes and progressive neurotoxicity in cortical neurons. J. Neurosci. 1999;19:8876&#x2013;8884. doi: 10.1523/JNEUROSCI.19-20-08876.1999.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.19-20-08876.1999</ArticleId><ArticleId IdType="pmc">PMC6782787</ArticleId><ArticleId IdType="pubmed">10516307</ArticleId></ArticleIdList></Reference><Reference><Citation>Lambert MP, et al. Diffusible, nonfibrillar ligands derived from A&#x3b2;1&#x2013;42 are potent central nervous system neurotoxins. Proc. Natl Acad. Sci. USA. 1998;95:6448&#x2013;6453. doi: 10.1073/pnas.95.11.6448.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.95.11.6448</ArticleId><ArticleId IdType="pmc">PMC27787</ArticleId><ArticleId IdType="pubmed">9600986</ArticleId></ArticleIdList></Reference><Reference><Citation>Maeda S, et al. Granular tau oligomers as intermediates of tau filaments. Biochemistry. 2007;46:3856&#x2013;3861. doi: 10.1021/bi061359o.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/bi061359o</ArticleId><ArticleId IdType="pubmed">17338548</ArticleId></ArticleIdList></Reference><Reference><Citation>Conway KA, Harper JD, Lansbury PT. Accelerated in vitro fibril formation by a mutant &#x3b1;-synuclein linked to early-onset Parkinson disease. Nat. Med. 1998;4:1318&#x2013;1320. doi: 10.1038/3311.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/3311</ArticleId><ArticleId IdType="pubmed">9809558</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y, et al. Cryo-EM structures of amyloid-&#x3b2; 42 filaments from human brains. Science. 2022;375:167&#x2013;172. doi: 10.1126/science.abm7285.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abm7285</ArticleId><ArticleId IdType="pmc">PMC7612234</ArticleId><ArticleId IdType="pubmed">35025654</ArticleId></ArticleIdList></Reference><Reference><Citation>Wischik CM, et al. Isolation of a fragment of tau derived from the core of the paired helical filament of Alzheimer disease. Proc. Natl Acad. Sci. USA. 1988;85:4506&#x2013;4510. doi: 10.1073/pnas.85.12.4506.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.85.12.4506</ArticleId><ArticleId IdType="pmc">PMC280459</ArticleId><ArticleId IdType="pubmed">3132715</ArticleId></ArticleIdList></Reference><Reference><Citation>Mukrasch MD, et al. Structural polymorphism of 441-residue Tau at single residue resolution. PLoS Biol. 2009;7:e1000034. doi: 10.1371/journal.pbio.1000034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pbio.1000034</ArticleId><ArticleId IdType="pmc">PMC2642882</ArticleId><ArticleId IdType="pubmed">19226187</ArticleId></ArticleIdList></Reference><Reference><Citation>Daebel V, et al. &#x3b2;-Sheet core of tau paired helical filaments revealed by solid-state NMR. J. Am. Chem. Soc. 2012;134:13982&#x2013;13989. doi: 10.1021/ja305470p.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/ja305470p</ArticleId><ArticleId IdType="pubmed">22862303</ArticleId></ArticleIdList></Reference><Reference><Citation>Mukrasch MD, et al. Sites of tau important for aggregation populate &#x3b2;-structure and bind to microtubules and polyanions. J. Biol. Chem. 2005;280:24978&#x2013;24986. doi: 10.1074/jbc.M501565200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M501565200</ArticleId><ArticleId IdType="pubmed">15855160</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan SN, et al. Distribution of pico- and nanosecond motions in disordered proteins from nuclear spin relaxation. Biophys. J. 2015;109:988&#x2013;999. doi: 10.1016/j.bpj.2015.06.069.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bpj.2015.06.069</ArticleId><ArticleId IdType="pmc">PMC4564687</ArticleId><ArticleId IdType="pubmed">26331256</ArticleId></ArticleIdList></Reference><Reference><Citation>Jarrett JT, Lansbury PT. Seeding &#x2018;one-dimensional crystallization&#x2019; of amyloid: a pathogenic mechanism in Alzheimer&#x2019;s disease and scrapie? Cell. 1993;73:1055&#x2013;1058. doi: 10.1016/0092-8674(93)90635-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0092-8674(93)90635-4</ArticleId><ArticleId IdType="pubmed">8513491</ArticleId></ArticleIdList></Reference><Reference><Citation>Stern AM, et al. Abundant A&#x3b2; fibrils in ultracentrifugal supernatants of aqueous extracts from Alzheimer&#x2019;s disease brains. Neuron. 2023;111:2012&#x2013;2020. doi: 10.1016/j.neuron.2023.04.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2023.04.007</ArticleId><ArticleId IdType="pmc">PMC10330525</ArticleId><ArticleId IdType="pubmed">37167969</ArticleId></ArticleIdList></Reference><Reference><Citation>Weismiller HA, et al. Structural disorder in four-repeat Tau fibrils reveals a new mechanism for barriers to cross-seeding of Tau isoforms. J. Biol. Chem. 2018;293:17336&#x2013;17348. doi: 10.1074/jbc.RA118.005316.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.RA118.005316</ArticleId><ArticleId IdType="pmc">PMC6231118</ArticleId><ArticleId IdType="pubmed">30242125</ArticleId></ArticleIdList></Reference><Reference><Citation>He S, Scheres SHW. Helical reconstruction in RELION. J. Struct. Biol. 2017;198:163&#x2013;176. doi: 10.1016/j.jsb.2017.02.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jsb.2017.02.003</ArticleId><ArticleId IdType="pmc">PMC5479445</ArticleId><ArticleId IdType="pubmed">28193500</ArticleId></ArticleIdList></Reference><Reference><Citation>Sawaya MR, et al. Atomic structures of amyloid cross-beta spines reveal varied steric zippers. Nature. 2007;447:453&#x2013;457. doi: 10.1038/nature05695.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature05695</ArticleId><ArticleId IdType="pubmed">17468747</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiltzius JJW, et al. Molecular mechanisms for protein-encoded inheritance. Nat. Struct. Mol. Biol. 2009;16:973&#x2013;978. doi: 10.1038/nsmb.1643.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nsmb.1643</ArticleId><ArticleId IdType="pmc">PMC3640378</ArticleId><ArticleId IdType="pubmed">19684598</ArticleId></ArticleIdList></Reference><Reference><Citation>Ostwald W. Studien &#xfc;ber die Bildung und Umwandlung fester K&#xf6;rper: 1. Abhandlung: &#xdc;bers&#xe4;ttigung und &#xdc;berkaltung. Z. Phys. Chem. 1897;22U:289&#x2013;330. doi: 10.1515/zpch-1897-2233.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/zpch-1897-2233</ArticleId></ArticleIdList></Reference><Reference><Citation>von Bergen M, et al. Assembly of tau protein into Alzheimer paired helical filaments depends on a local sequence motif ((306)VQIVYK(311)) forming beta structure. Proc. Natl Acad. Sci. USA. 2000;97:5129&#x2013;5134. doi: 10.1073/pnas.97.10.5129.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.97.10.5129</ArticleId><ArticleId IdType="pmc">PMC25793</ArticleId><ArticleId IdType="pubmed">10805776</ArticleId></ArticleIdList></Reference><Reference><Citation>Macdonald JA, et al. Assembly of transgenic human P301S Tau is necessary for neurodegeneration in murine spinal cord. Acta Neuropathol. Commun. 2019;7:44. doi: 10.1186/s40478-019-0695-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-019-0695-5</ArticleId><ArticleId IdType="pmc">PMC6421678</ArticleId><ArticleId IdType="pubmed">30885267</ArticleId></ArticleIdList></Reference><Reference><Citation>Falcon B, et al. Conformation determines the seeding potencies of native and recombinant Tau aggregates. J. Biol. Chem. 2015;290:1049&#x2013;1065. doi: 10.1074/jbc.M114.589309.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M114.589309</ArticleId><ArticleId IdType="pmc">PMC4294473</ArticleId><ArticleId IdType="pubmed">25406315</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie C, et al. Identification of key amino acids responsible for the distinct aggregation properties of microtubule&#x2010;associated protein 2 and tau. J. Neurochem. 2015;135:19&#x2013;26. doi: 10.1111/jnc.13228.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.13228</ArticleId><ArticleId IdType="pmc">PMC5049617</ArticleId><ArticleId IdType="pubmed">26134402</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldsbury C, Kistler J, Aebi U, Arvinte T, Cooper GJ. Watching amyloid fibrils grow by time-lapse atomic force microscopy. J. Mol. Biol. 1999;285:33&#x2013;39. doi: 10.1006/jmbi.1998.2299.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/jmbi.1998.2299</ArticleId><ArticleId IdType="pubmed">9878384</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiti F, et al. Kinetic partitioning of protein folding and aggregation. Nat. Struct. Mol. Biol. 2002;9:137&#x2013;143. doi: 10.1038/nsb752.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nsb752</ArticleId><ArticleId IdType="pubmed">11799398</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez-Escamilla A-M, Rousseau F, Schymkowitz J, Serrano L. Prediction of sequence-dependent and mutational effects on the aggregation of peptides and proteins. Nat. Biotechnol. 2004;22:1302&#x2013;1306. doi: 10.1038/nbt1012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt1012</ArticleId><ArticleId IdType="pubmed">15361882</ArticleId></ArticleIdList></Reference><Reference><Citation>Giasson BI, Murray IV, Trojanowski JQ, Lee VM. A hydrophobic stretch of 12 amino acid residues in the middle of &#x3b1;-synuclein is essential for filament assembly. J. Biol. Chem. 2001;276:2380&#x2013;2386. doi: 10.1074/jbc.M008919200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M008919200</ArticleId><ArticleId IdType="pubmed">11060312</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang L-L, et al. Structural transformation of the amyloidogenic core region of TDP-43 protein initiates its aggregation and cytoplasmic inclusion. J. Biol. Chem. 2013;288:19614&#x2013;19624. doi: 10.1074/jbc.M113.463828.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M113.463828</ArticleId><ArticleId IdType="pmc">PMC3707662</ArticleId><ArticleId IdType="pubmed">23689371</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrone FA, Hofrichter J, Sunshine HR, Eaton WA. Kinetic studies on photolysis-induced gelation of sickle cell hemoglobin suggest a new mechanism. Biophys. J. 1980;32:361&#x2013;380. doi: 10.1016/S0006-3495(80)84962-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0006-3495(80)84962-9</ArticleId><ArticleId IdType="pmc">PMC1327316</ArticleId><ArticleId IdType="pubmed">7248455</ArticleId></ArticleIdList></Reference><Reference><Citation>T&#xf6;rnquist M, et al. Secondary nucleation in amyloid formation. Chem. Commun. 2018;54:8667&#x2013;8684. doi: 10.1039/C8CC02204F.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/C8CC02204F</ArticleId><ArticleId IdType="pubmed">29978862</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang W, et al. Heparin-induced tau filaments are polymorphic and differ from those in Alzheimer&#x2019;s and Pick&#x2019;s diseases. Elife. 2019;8:e43584. doi: 10.7554/eLife.43584.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.43584</ArticleId><ArticleId IdType="pmc">PMC6375701</ArticleId><ArticleId IdType="pubmed">30720432</ArticleId></ArticleIdList></Reference><Reference><Citation>Radamaker L, et al. Cryo-EM reveals structural breaks in a patient-derived amyloid fibril from systemic AL amyloidosis. Nat. Commun. 2021;12:875. doi: 10.1038/s41467-021-21126-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-21126-2</ArticleId><ArticleId IdType="pmc">PMC7870857</ArticleId><ArticleId IdType="pubmed">33558536</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson JL, et al. TDP-43 skeins show properties of amyloid in a subset of ALS cases. Acta Neuropathol. 2013;125:121&#x2013;131. doi: 10.1007/s00401-012-1055-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-012-1055-8</ArticleId><ArticleId IdType="pmc">PMC3536927</ArticleId><ArticleId IdType="pubmed">23124365</ArticleId></ArticleIdList></Reference><Reference><Citation>LeVine H. Thioflavine T interaction with amyloid &#x3b2;-sheet structures. Amyloid. 1995;2:1&#x2013;6. doi: 10.3109/13506129509031881.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/13506129509031881</ArticleId></ArticleIdList></Reference><Reference><Citation>Prusiner SB. Prions. Proc. Natl Acad. Sci. USA. 1998;95:13363&#x2013;13383. doi: 10.1073/pnas.95.23.13363.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.95.23.13363</ArticleId><ArticleId IdType="pmc">PMC33918</ArticleId><ArticleId IdType="pubmed">9811807</ArticleId></ArticleIdList></Reference><Reference><Citation>Knowles TPJ, et al. An analytical solution to the kinetics of breakable filament assembly. Science. 2009;326:1533&#x2013;1537. doi: 10.1126/science.1178250.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1178250</ArticleId><ArticleId IdType="pubmed">20007899</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf6;vestam S, et al. Seeded assembly in vitro does not replicate the structures of &#x3b1;-synuclein filaments from multiple system atrophy. FEBS Open Bio. 2021;11:999&#x2013;1013. doi: 10.1002/2211-5463.13110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/2211-5463.13110</ArticleId><ArticleId IdType="pmc">PMC8016116</ArticleId><ArticleId IdType="pubmed">33548114</ArticleId></ArticleIdList></Reference><Reference><Citation>Tarutani A, et al. Cryo-EM structures of tau filaments from SH-SY5Y cells seeded with brain extracts from cases of Alzheimer&#x2019;s disease and corticobasal degeneration. FEBS Open Bio. 2023;13:1394&#x2013;1404. doi: 10.1002/2211-5463.13657.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/2211-5463.13657</ArticleId><ArticleId IdType="pmc">PMC10392052</ArticleId><ArticleId IdType="pubmed">37337995</ArticleId></ArticleIdList></Reference><Reference><Citation>Mirbaha H, et al. Inert and seed-competent tau monomers suggest structural origins of aggregation. eLife. 2018;7:e36584. doi: 10.7554/eLife.36584.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.36584</ArticleId><ArticleId IdType="pmc">PMC6039173</ArticleId><ArticleId IdType="pubmed">29988016</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma AM, Thomas TL, Woodard DR, Kashmer OM, Diamond MI. Tau monomer encodes strains. eLife. 2018;7:e37813. doi: 10.7554/eLife.37813.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.37813</ArticleId><ArticleId IdType="pmc">PMC6289568</ArticleId><ArticleId IdType="pubmed">30526844</ArticleId></ArticleIdList></Reference><Reference><Citation>Studier FW. Protein production by auto-induction in high density shaking cultures. Protein Expr. Purif. 2005;41:207&#x2013;234. doi: 10.1016/j.pep.2005.01.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pep.2005.01.016</ArticleId><ArticleId IdType="pubmed">15915565</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuck P. On the analysis of protein self-association by sedimentation velocity analytical ultracentrifugation. Anal. Biochem. 2003;320:104&#x2013;124. doi: 10.1016/S0003-2697(03)00289-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0003-2697(03)00289-6</ArticleId><ArticleId IdType="pubmed">12895474</ArticleId></ArticleIdList></Reference><Reference><Citation>Laue, T. M., Shah, B. D., Ridgeway, T. M. &amp; Pelletier, S. L. Computer-aided interpretation of sedimentation data for proteins. In Analytical Ultracentrifugation in Biochemistry and Polymer Science (eds Harding, S. E., Horton, J. C. &amp; Rowe, A. J.) 90&#x2013;125 (Royal Society of Chemistry, 1992).</Citation></Reference><Reference><Citation>Brautigam CA. Calculations and publication-quality illustrations for analytical ultracentrifugation data. Methods Enzymol. 2015;562:109&#x2013;133. doi: 10.1016/bs.mie.2015.05.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/bs.mie.2015.05.001</ArticleId><ArticleId IdType="pubmed">26412649</ArticleId></ArticleIdList></Reference><Reference><Citation>Delaglio F, et al. NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J. Biomol. NMR. 1995;6:277&#x2013;293. doi: 10.1007/BF00197809.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF00197809</ArticleId><ArticleId IdType="pubmed">8520220</ArticleId></ArticleIdList></Reference><Reference><Citation>Kazimierczuk K, Orekhov VY. Accelerated NMR spectroscopy by using compressed sensing. Angew. Chem. Int. Ed. Engl. 2011;50:5556&#x2013;5559. doi: 10.1002/anie.201100370.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/anie.201100370</ArticleId><ArticleId IdType="pubmed">21538743</ArticleId></ArticleIdList></Reference><Reference><Citation>Jung Y-S, Zweckstetter M. Mars - robust automatic backbone assignment of proteins. J. Biomol. NMR. 2004;30:11&#x2013;23. doi: 10.1023/B:JNMR.0000042954.99056.ad.</Citation><ArticleIdList><ArticleId IdType="doi">10.1023/B:JNMR.0000042954.99056.ad</ArticleId><ArticleId IdType="pubmed">15452431</ArticleId></ArticleIdList></Reference><Reference><Citation>Kjaergaard M, Brander S, Poulsen FM. Random coil chemical shift for intrinsically disordered proteins: effects of temperature and pH. J. Biomol. NMR. 2011;49:139&#x2013;149. doi: 10.1007/s10858-011-9472-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10858-011-9472-x</ArticleId><ArticleId IdType="pubmed">21234644</ArticleId></ArticleIdList></Reference><Reference><Citation>Kjaergaard M, Poulsen FM. Sequence correction of random coil chemical shifts: correlation between neighbor correction factors and changes in the Ramachandran distribution. J. Biomol. NMR. 2011;50:157&#x2013;165. doi: 10.1007/s10858-011-9508-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10858-011-9508-2</ArticleId><ArticleId IdType="pubmed">21604143</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwarzinger S, et al. Sequence-dependent correction of random coil NMR chemical shifts. J. Am. Chem. Soc. 2001;123:2970&#x2013;2978. doi: 10.1021/ja003760i.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/ja003760i</ArticleId><ArticleId IdType="pubmed">11457007</ArticleId></ArticleIdList></Reference><Reference><Citation>Pelupessy P, Ferrage F, Bodenhausen G. Accurate measurement of longitudinal cross-relaxation rates in nuclear magnetic resonance. J. Chem. Phys. 2007;126:134508. doi: 10.1063/1.2715583.</Citation><ArticleIdList><ArticleId IdType="doi">10.1063/1.2715583</ArticleId><ArticleId IdType="pubmed">17430048</ArticleId></ArticleIdList></Reference><Reference><Citation>Rezaei-Ghaleh N, Giller K, Becker S, Zweckstetter M. Effect of zinc binding on &#x3b2;-amyloid structure and dynamics: implications for A&#x3b2; aggregation. Biophys. J. 2011;101:1202&#x2013;1211. doi: 10.1016/j.bpj.2011.06.062.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bpj.2011.06.062</ArticleId><ArticleId IdType="pmc">PMC3164126</ArticleId><ArticleId IdType="pubmed">21889458</ArticleId></ArticleIdList></Reference><Reference><Citation>Zivanov J, et al. New tools for automated high-resolution cryo-EM structure determination in RELION-3. Elife. 2018;7:e42166. doi: 10.7554/eLife.42166.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.42166</ArticleId><ArticleId IdType="pmc">PMC6250425</ArticleId><ArticleId IdType="pubmed">30412051</ArticleId></ArticleIdList></Reference><Reference><Citation>Zivanov J, Nakane T, Scheres SHW. A Bayesian approach to beam-induced motion correction in cryo-EM single-particle analysis. IUCrJ. 2019;6:5&#x2013;17. doi: 10.1107/S205225251801463X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1107/S205225251801463X</ArticleId><ArticleId IdType="pmc">PMC6327179</ArticleId><ArticleId IdType="pubmed">30713699</ArticleId></ArticleIdList></Reference><Reference><Citation>Rohou A, Grigorieff N. CTFFIND4: fast and accurate defocus estimation from electron micrographs. J. Struct. Biol. 2015;192:216&#x2013;221. doi: 10.1016/j.jsb.2015.08.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jsb.2015.08.008</ArticleId><ArticleId IdType="pmc">PMC6760662</ArticleId><ArticleId IdType="pubmed">26278980</ArticleId></ArticleIdList></Reference><Reference><Citation>Kimanius D, Dong L, Sharov G, Nakane T, Scheres SHW. New tools for automated cryo-EM single-particle analysis in RELION-4.0. Biochem. J. 2021;478:4169&#x2013;4185. doi: 10.1042/BCJ20210708.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BCJ20210708</ArticleId><ArticleId IdType="pmc">PMC8786306</ArticleId><ArticleId IdType="pubmed">34783343</ArticleId></ArticleIdList></Reference><Reference><Citation>Bepler T, et al. Positive-unlabeled convolutional neural networks for particle picking in cryo-electron micrographs. Nat. Methods. 2019;16:1153&#x2013;1160. doi: 10.1038/s41592-019-0575-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41592-019-0575-8</ArticleId><ArticleId IdType="pmc">PMC6858545</ArticleId><ArticleId IdType="pubmed">31591578</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf6;vestam S, Scheres SHW. High-throughput cryo-EM structure determination of amyloids. Faraday Discuss. 2022;240:243&#x2013;260. doi: 10.1039/D2FD00034B.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/D2FD00034B</ArticleId><ArticleId IdType="pmc">PMC9642048</ArticleId><ArticleId IdType="pubmed">35913272</ArticleId></ArticleIdList></Reference><Reference><Citation>Pothula KR, Geraets JA, Ferber II, Schr&#xf6;der GF. Clustering polymorphs of tau and IAPP fibrils with the CHEP algorithm. Prog. Biophys. Mol. Biol. 2021;160:16&#x2013;25. doi: 10.1016/j.pbiomolbio.2020.11.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pbiomolbio.2020.11.007</ArticleId><ArticleId IdType="pubmed">33556421</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheres SHW. Amyloid structure determination in RELION-3.1. Acta Crystallogr. D. 2020;76:94&#x2013;101. doi: 10.1107/S2059798319016577.</Citation><ArticleIdList><ArticleId IdType="doi">10.1107/S2059798319016577</ArticleId><ArticleId IdType="pmc">PMC7008511</ArticleId><ArticleId IdType="pubmed">32038040</ArticleId></ArticleIdList></Reference><Reference><Citation>Kimanius, D. et al. Data-driven regularisation lowers the size barrier of cryo-EM structure determination. Preprint at bioRxiv10.1101/2023.10.23.563586 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11239489</ArticleId><ArticleId IdType="pubmed">38862790</ArticleId></ArticleIdList></Reference><Reference><Citation>Zivanov J, Nakane T, Scheres SHW. Estimation of high-order aberrations and anisotropic magnification from cryo-EM data sets in RELION-3.1. IUCrJ. 2020;7:253&#x2013;267. doi: 10.1107/S2052252520000081.</Citation><ArticleIdList><ArticleId IdType="doi">10.1107/S2052252520000081</ArticleId><ArticleId IdType="pmc">PMC7055373</ArticleId><ArticleId IdType="pubmed">32148853</ArticleId></ArticleIdList></Reference><Reference><Citation>Casa&#xf1;al A, Lohkamp B, Emsley P. Current developments in Coot for macromolecular model building of electron cryo-microscopy and crystallographic data. Protein Sci. 2020;29:1069&#x2013;1078. doi: 10.1002/pro.3791.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pro.3791</ArticleId><ArticleId IdType="pmc">PMC7096722</ArticleId><ArticleId IdType="pubmed">31730249</ArticleId></ArticleIdList></Reference><Reference><Citation>Jamali, K. et al. Automated model building and protein identification in cryo-EM maps. Preprint at bioRxiv10.1101/2023.05.16.541002 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11006616</ArticleId><ArticleId IdType="pubmed">38408488</ArticleId></ArticleIdList></Reference><Reference><Citation>Croll TI. ISOLDE: a physically realistic environment for model building into low-resolution electron-density maps. Acta Crystallogr. D. 2018;74:519&#x2013;530. doi: 10.1107/S2059798318002425.</Citation><ArticleIdList><ArticleId IdType="doi">10.1107/S2059798318002425</ArticleId><ArticleId IdType="pmc">PMC6096486</ArticleId><ArticleId IdType="pubmed">29872003</ArticleId></ArticleIdList></Reference><Reference><Citation>Pettersen EF, et al. UCSF ChimeraX: structure visualization for researchers, educators, and developers. Protein Sci. 2021;30:70&#x2013;82. doi: 10.1002/pro.3943.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pro.3943</ArticleId><ArticleId IdType="pmc">PMC7737788</ArticleId><ArticleId IdType="pubmed">32881101</ArticleId></ArticleIdList></Reference><Reference><Citation>Sawaya MR, Hughes MP, Rodriguez JA, Riek R, Eisenberg DS. The expanding amyloid family: structure, stability, function, and pathogenesis. Cell. 2021;184:4857&#x2013;4873. doi: 10.1016/j.cell.2021.08.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2021.08.013</ArticleId><ArticleId IdType="pmc">PMC8772536</ArticleId><ArticleId IdType="pubmed">34534463</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38049579</PMID><DateCompleted><Year>2024</Year><Month>01</Month><Day>10</Day></DateCompleted><DateRevised><Year>2024</Year><Month>04</Month><Day>09</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1546-1726</ISSN><JournalIssue CitedMedium="Internet"><Volume>27</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Nature neuroscience</Title><ISOAbbreviation>Nat Neurosci</ISOAbbreviation></Journal><ArticleTitle>Meningeal interleukin-17-producing T cells mediate cognitive impairment in a mouse model of salt-sensitive hypertension.</ArticleTitle><Pagination><StartPage>63</StartPage><EndPage>77</EndPage><MedlinePgn>63-77</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41593-023-01497-z</ELocationID><Abstract><AbstractText>Hypertension (HTN), a disease afflicting over one billion individuals worldwide, is a leading cause of cognitive impairment, the mechanisms of which remain poorly understood. In the present study, in a mouse model of HTN, we find that the neurovascular and cognitive dysfunction depends on interleukin (IL)-17, a cytokine elevated in individuals with HTN. However, neither circulating IL-17 nor brain angiotensin signaling can account for the dysfunction. Rather, IL-17 produced by T cells in the dura mater is the mediator released in the cerebrospinal fluid and activating IL-17 receptors on border-associated macrophages (BAMs). Accordingly, depleting BAMs, deleting IL-17 receptor A in brain macrophages or suppressing meningeal T cells rescues cognitive function without attenuating blood pressure elevation, circulating IL-17 or brain angiotensin signaling. Our data unveil a critical role of meningeal T cells and macrophage IL-17 signaling in the neurovascular and cognitive dysfunction in a mouse model of HTN.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s), under exclusive licence to Springer Nature America, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Santisteban</LastName><ForeName>Monica M</ForeName><Initials>MM</Initials><Identifier Source="ORCID">0000-0002-2836-9075</Identifier><AffiliationInfo><Affiliation>Feil Family Brain and Mind Research Institute, Weill Cornell Medicine, New York, NY, USA. monica.santisteban@vumc.org.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA. monica.santisteban@vumc.org.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schaeffer</LastName><ForeName>Samantha</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Feil Family Brain and Mind Research Institute, Weill Cornell Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Anfray</LastName><ForeName>Antoine</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Feil Family Brain and Mind Research Institute, Weill Cornell Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Faraco</LastName><ForeName>Giuseppe</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Feil Family Brain and Mind Research Institute, Weill Cornell Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brea</LastName><ForeName>David</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0003-2365-7374</Identifier><AffiliationInfo><Affiliation>Feil Family Brain and Mind Research Institute, Weill Cornell Medicine, New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neuroscience and Experimental Therapeutics, Instituto de Investigaciones Biom&#xe9;dicas de Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Gang</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Feil Family Brain and Mind Research Institute, Weill Cornell Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sobanko</LastName><ForeName>Melissa J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Feil Family Brain and Mind Research Institute, Weill Cornell Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sciortino</LastName><ForeName>Rose</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Feil Family Brain and Mind Research Institute, Weill Cornell Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Racchumi</LastName><ForeName>Gianfranco</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Feil Family Brain and Mind Research Institute, Weill Cornell Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Waisman</LastName><ForeName>Ari</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-4304-8234</Identifier><AffiliationInfo><Affiliation>Institute for Molecular Medicine, University Medical Center, Mainz, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Laibaik</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0001-7601-663X</Identifier><AffiliationInfo><Affiliation>Feil Family Brain and Mind Research Institute, Weill Cornell Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Anrather</LastName><ForeName>Josef</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-0468-9162</Identifier><AffiliationInfo><Affiliation>Feil Family Brain and Mind Research Institute, Weill Cornell Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Iadecola</LastName><ForeName>Costantino</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0001-9797-073X</Identifier><AffiliationInfo><Affiliation>Feil Family Brain and Mind Research Institute, Weill Cornell Medicine, New York, NY, USA. coi2001@med.cornell.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>K22 NS123507</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS095441</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R37 NS089323</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>12</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Nat Neurosci</MedlineTA><NlmUniqueID>9809671</NlmUniqueID><ISSNLinking>1097-6256</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D020381">Interleukin-17</NameOfSubstance></Chemical><Chemical><RegistryNumber>11128-99-7</RegistryNumber><NameOfSubstance UI="D000804">Angiotensin II</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D017673">Sodium Chloride, Dietary</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020381" MajorTopicYN="N">Interleukin-17</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000804" MajorTopicYN="N">Angiotensin II</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013601" MajorTopicYN="N">T-Lymphocytes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006973" MajorTopicYN="Y">Hypertension</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060825" MajorTopicYN="Y">Cognitive Dysfunction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017673" MajorTopicYN="N">Sodium Chloride, Dietary</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>Competing interests. C.I. is on the scientific advisory board of Broadview Ventures. All other authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>9</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>10</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>1</Month><Day>10</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>12</Month><Day>5</Day><Hour>0</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>12</Month><Day>4</Day><Hour>23</Hour><Minute>34</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>4</Month><Day>7</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38049579</ArticleId><ArticleId IdType="mid">NIHMS1980345</ArticleId><ArticleId IdType="pmc">PMC10999222</ArticleId><ArticleId IdType="doi">10.1038/s41593-023-01497-z</ArticleId><ArticleId IdType="pii">10.1038/s41593-023-01497-z</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Levine DA, Springer MV &amp; Brodtmann A Blood pressure and vascular cognitive impairment. Stroke 53, 1104&#x2013;1113 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9141568</ArticleId><ArticleId IdType="pubmed">35264009</ArticleId></ArticleIdList></Reference><Reference><Citation>Muntner P et al. Blood pressure control among us adults, 2009 to 2012 through 2017 to 2020. Hypertension 79, 1971&#x2013;1980 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9370255</ArticleId><ArticleId IdType="pubmed">35616029</ArticleId></ArticleIdList></Reference><Reference><Citation>Carey RM, Sakhuja S, Calhoun DA, Whelton PK &amp; Muntner P Prevalence of apparent treatment-resistant hypertension in the United States. Hypertension 73, 424&#x2013;431 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6693520</ArticleId><ArticleId IdType="pubmed">30580690</ArticleId></ArticleIdList></Reference><Reference><Citation>Williamson JD et al. Effect of intensive vs standard blood pressure control on probable dementia: a randomized clinical trial. JAMA 321, 553&#x2013;561 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6439590</ArticleId><ArticleId IdType="pubmed">30688979</ArticleId></ArticleIdList></Reference><Reference><Citation>Webb AJS &amp; Werring DJ New insights into cerebrovascular pathophysiology and hypertension. Stroke 53, 1054&#x2013;1064 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7615037</ArticleId><ArticleId IdType="pubmed">35255709</ArticleId></ArticleIdList></Reference><Reference><Citation>Iadecola C &amp; Gottesman RF Neurovascular and cognitive dysfunction in hypertension: epidemiology, pathobiology and treatment. Circ. Res 124, 1025&#x2013;1044 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6527115</ArticleId><ArticleId IdType="pubmed">30920929</ArticleId></ArticleIdList></Reference><Reference><Citation>Oh YS et al. National Heart, Lung, and Blood Institute Working Group report on salt in human health and sickness: building on the current scientific evidence. Hypertension 68, 281&#x2013;288 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4945367</ArticleId><ArticleId IdType="pubmed">27324228</ArticleId></ArticleIdList></Reference><Reference><Citation>Elijovich F et al. Salt sensitivity of blood pressure: a scientific statement from the American Heart Association. Hypertension 68, e7&#x2013;e46 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">27443572</ArticleId></ArticleIdList></Reference><Reference><Citation>Grobe JL et al. Angiotensinergic signaling in the brain mediates metabolic effects of deoxycorticosterone (DOCA)-salt in C57 mice. Hypertension 57, 600&#x2013;607 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3144490</ArticleId><ArticleId IdType="pubmed">21263123</ArticleId></ArticleIdList></Reference><Reference><Citation>Basting T &amp; Lazartigues E DOCA-salt hypertension: an update. Curr. Hypertens. Rep 19, 32 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6402842</ArticleId><ArticleId IdType="pubmed">28353076</ArticleId></ArticleIdList></Reference><Reference><Citation>Meade TW, Imeson JD, Gordon D &amp; Peart WS The epidemiology of plasma renin. Clin. Sci 64, 273&#x2013;280 (1983).</Citation><ArticleIdList><ArticleId IdType="pubmed">6337013</ArticleId></ArticleIdList></Reference><Reference><Citation>Alderman MH et al. Association of the renin-sodium profile with the risk of myocardial infarction in patients with hypertension. N. Engl. J. Med 324, 1098&#x2013;1104 (1991).</Citation><ArticleIdList><ArticleId IdType="pubmed">1759997</ArticleId></ArticleIdList></Reference><Reference><Citation>Madhur MS et al. Interleukin 17 promotes angiotensin II-induced hypertension and vascular dysfunction. Hypertension 55, 500&#x2013;507 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2819301</ArticleId><ArticleId IdType="pubmed">20038749</ArticleId></ArticleIdList></Reference><Reference><Citation>Yao W, Sun Y, Wang X &amp; Niu K Elevated serum level of interleukin 17 in a population with prehypertension. J. Clin. Hypertens 17, 770&#x2013;774 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8032147</ArticleId><ArticleId IdType="pubmed">26140526</ArticleId></ArticleIdList></Reference><Reference><Citation>Simundic T et al. Interleukin 17a and toll-like receptor 4 in patients with arterial hypertension. Kidney Blood Press. Res 42, 99&#x2013;108 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28359064</ArticleId></ArticleIdList></Reference><Reference><Citation>Kleinewietfeld M et al. Sodium chloride drives autoimmune disease by the induction of pathogenic Th17 cells. Nature 496, 518&#x2013;522 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3746493</ArticleId><ArticleId IdType="pubmed">23467095</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu C et al. Induction of pathogenic Th17 cells by inducible salt-sensing kinase SGK1. Nature 496, 513&#x2013;517 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3637879</ArticleId><ArticleId IdType="pubmed">23467085</ArticleId></ArticleIdList></Reference><Reference><Citation>Kierdorf K, Masuda T, Jordao MJC &amp; Prinz M Macrophages at CNS interfaces: ontogeny and function in health and disease. Nat. Rev. Neurosci 20, 547&#x2013;562 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">31358892</ArticleId></ArticleIdList></Reference><Reference><Citation>Faraco G et al. Hypertension enhances A&#x3b2;-induced neurovascular dysfunction, promotes &#x3b2;-secretase activity, and leads to amyloidogenic processing of APP. J. Cereb. Blood Flow. Metab 36, 241&#x2013;252 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4758560</ArticleId><ArticleId IdType="pubmed">25920959</ArticleId></ArticleIdList></Reference><Reference><Citation>Kopp C et al. 23Na magnetic resonance imaging-determined tissue sodium in healthy subjects and hypertensive patients. Hypertension 61, 635&#x2013;640 (2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">23339169</ArticleId></ArticleIdList></Reference><Reference><Citation>Faraco G et al. Perivascular macrophages mediate the neurovascular and cognitive dysfunction associated with hypertension. J. Clin. Invest 126, 4674&#x2013;4689 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5127678</ArticleId><ArticleId IdType="pubmed">27841763</ArticleId></ArticleIdList></Reference><Reference><Citation>Faraco G et al. Dietary salt promotes neurovascular and cognitive dysfunction through a gut-initiated Th17 response. Nat. Neurosci 21, 240&#x2013;249 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6207376</ArticleId><ArticleId IdType="pubmed">29335605</ArticleId></ArticleIdList></Reference><Reference><Citation>Toda N, Ayajiki K &amp; Okamura T Cerebral blood flow regulation by nitric oxide: recent advances. Pharm. Rev 61, 62&#x2013;97 (2009).</Citation><ArticleIdList><ArticleId IdType="pubmed">19293146</ArticleId></ArticleIdList></Reference><Reference><Citation>Iadecola C et al. The neurovasculome: key roles in brain health and cognitive impairment: a scientific statement from the American Heart Association/American Stroke Association. Stroke 54, e251&#x2013;e271 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10228567</ArticleId><ArticleId IdType="pubmed">37009740</ArticleId></ArticleIdList></Reference><Reference><Citation>Itani HA et al. Activation of human T cells in hypertension: studies of humanized mice and hypertensive humans. Hypertension 68, 123&#x2013;132 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4900908</ArticleId><ArticleId IdType="pubmed">27217403</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim S et al. Imbalance of gut microbiome and intestinal epithelial barrier dysfunction in patients with high blood pressure. Clin. Sci 132, 701&#x2013;718 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5955695</ArticleId><ArticleId IdType="pubmed">29507058</ArticleId></ArticleIdList></Reference><Reference><Citation>Esplugues E et al. Control of Th17 cells occurs in the small intestine. Nature 475, 514&#x2013;518 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3148838</ArticleId><ArticleId IdType="pubmed">21765430</ArticleId></ArticleIdList></Reference><Reference><Citation>Benakis C et al. Commensal microbiota affects ischemic stroke outcome by regulating intestinal gammadelta T cells. Nat. Med 22, 516&#x2013;523 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4860105</ArticleId><ArticleId IdType="pubmed">27019327</ArticleId></ArticleIdList></Reference><Reference><Citation>Maeda Y et al. Il-17-producing v&#x3b3;4+ &#x3b3;&#x3b4; T cells require sphingosine 1-phosphate receptor 1 for their egress from the lymph nodes under homeostatic and inflammatory conditions. J. Immunol 195, 1408&#x2013;1416 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">26170380</ArticleId></ArticleIdList></Reference><Reference><Citation>Korbelin J et al. A brain microvasculature endothelial cell-specific viral vector with the potential to treat neurovascular and neurological diseases. EMBO Mol. Med 8, 609&#x2013;625 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4888852</ArticleId><ArticleId IdType="pubmed">27137490</ArticleId></ArticleIdList></Reference><Reference><Citation>Santisteban MM et al. Endothelium-macrophage crosstalk mediates blood-brain barrier dysfunction in hypertension. Hypertension 76, 795&#x2013;807 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7429290</ArticleId><ArticleId IdType="pubmed">32654560</ArticleId></ArticleIdList></Reference><Reference><Citation>El Malki K et al. An alternative pathway of imiquimod-induced psoriasis-like skin inflammation in the absence of interleukin-17 receptor a signaling. J. Invest Dermatol 133, 441&#x2013;451 (2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">22951726</ArticleId></ArticleIdList></Reference><Reference><Citation>Schaeffer S &amp; Iadecola C Revisiting the neurovascular unit. Nat. Neurosci 24, 1198&#x2013;1209 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9462551</ArticleId><ArticleId IdType="pubmed">34354283</ArticleId></ArticleIdList></Reference><Reference><Citation>Nikolakopoulou AM et al. Endothelial LPR1 protects against neurodegeneration by blocking cyclophilin A. J. Exp. Med 218, e20202207 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7863706</ArticleId><ArticleId IdType="pubmed">33533918</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Hove H et al. A single-cell atlas of mouse brain macrophages reveals unique transcriptional identities shaped by ontogeny and tissue environment. Nat. Neurosci 22, 1021&#x2013;1035 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">31061494</ArticleId></ArticleIdList></Reference><Reference><Citation>Park L et al. Brain perivascular macrophages initiate the neurovascular dysfunction of Alzheimer abeta peptides. Circ. Res 121, 258&#x2013;269 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5522360</ArticleId><ArticleId IdType="pubmed">28515043</ArticleId></ArticleIdList></Reference><Reference><Citation>Sayd A et al. Depletion of brain perivascular macrophages regulates acute restraint stress-induced neuroinflammation and oxidative/nitrosative stress in rat frontal cortex. Eur. Neuropsychopharmacol 34, 50&#x2013;64 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32245674</ArticleId></ArticleIdList></Reference><Reference><Citation>Mendiola AS et al. Transcriptional profiling and therapeutic targeting of oxidative stress in neuroinflammation. Nat. Immunol 21, 513&#x2013;524 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7523413</ArticleId><ArticleId IdType="pubmed">32284594</ArticleId></ArticleIdList></Reference><Reference><Citation>Ivan DC, Walthert S, Berve K, Steudler J &amp; Locatelli G Dwellers and trespassers: mononuclear phagocytes at the borders of the central nervous system. Front Immunol. 11, 609921 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7973121</ArticleId><ArticleId IdType="pubmed">33746939</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia-Bonilla L et al. Role of microglial and endothelial CD36 in post-ischemic inflammasome activation and interleukin-1&#x3b2;-induced endothelial activation. Brain Behav. Immun 95, 489&#x2013;501 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8187325</ArticleId><ArticleId IdType="pubmed">33872708</ArticleId></ArticleIdList></Reference><Reference><Citation>Hohsfield LA et al. Effects of long-term and brain-wide colonization of peripheral bone marrow-derived myeloid cells in the CNS. J. Neuroinflamm 17, 279 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7504855</ArticleId><ArticleId IdType="pubmed">32951604</ArticleId></ArticleIdList></Reference><Reference><Citation>Chinnery HR, Ruitenberg MJ &amp; McMenamin PG Novel characterization of monocyte-derived cell populations in the meninges and choroid plexus and their rates of replenishment in bone marrow chimeric mice. J. Neuropathol. Exp. Neurol 69, 896&#x2013;909 (2010).</Citation><ArticleIdList><ArticleId IdType="pubmed">20720507</ArticleId></ArticleIdList></Reference><Reference><Citation>Pietrowski E et al. Pro-inflammatory effects of interleukin-17a on vascular smooth muscle cells involve NAD(P)H-oxidase derived reactive oxygen species. J. Vasc. Res 48, 52&#x2013;58 (2011).</Citation><ArticleIdList><ArticleId IdType="pubmed">20606471</ArticleId></ArticleIdList></Reference><Reference><Citation>Alves de Lima K et al. Meningeal &#x3b3;&#x3b4; T cells regulate anxiety-like behavior via IL-17a signaling in neurons. Nat. Immunol 21, 1421&#x2013;1429 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8496952</ArticleId><ArticleId IdType="pubmed">32929273</ArticleId></ArticleIdList></Reference><Reference><Citation>Ribeiro M et al. Meningeal &#x3b3;&#x3b4; T cell-derived IL-17 controls synaptic plasticity and short-term memory. Sci. Immunol 4, eaay5199 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6894940</ArticleId><ArticleId IdType="pubmed">31604844</ArticleId></ArticleIdList></Reference><Reference><Citation>Rustenhoven J et al. Functional characterization of the dural sinuses as a neuroimmune interface. Cell 184, 1000&#x2013;1016.e1027 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8487654</ArticleId><ArticleId IdType="pubmed">33508229</ArticleId></ArticleIdList></Reference><Reference><Citation>Ranieri E, Netti GS &amp; Gigante M CTL ELISPOT assay and T cell detection. Methods Mol. Biol 2325, 65&#x2013;77 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34053051</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones HE, Abrams KA &amp; Siegenthaler JA Techniques for visualizing fibroblast-vessel interactions in the developing and adult CNS. Neurophotonics 9, 021911 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8983066</ArticleId><ArticleId IdType="pubmed">35402637</ArticleId></ArticleIdList></Reference><Reference><Citation>Derk J et al. Formation and function of the meningeal arachnoid barrier around the developing mouse brain. Dev. Cell 58, 635&#x2013;644.e4 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10231667</ArticleId><ArticleId IdType="pubmed">36996816</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y et al. Mucosal-associated invariant T cells restrict reactive oxidative damage and preserve meningeal barrier integrity and cognitive function. Nat. Immunol 23, 1714&#x2013;1725 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10202031</ArticleId><ArticleId IdType="pubmed">36411380</ArticleId></ArticleIdList></Reference><Reference><Citation>Prinz I, Silva-Santos B &amp; Pennington DJ Functional development of &#x3b3;&#x3b4; T cells. Eur. J. Immunol 43, 1988&#x2013;1994 (2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">23928962</ArticleId></ArticleIdList></Reference><Reference><Citation>Gray EE et al. Deficiency in IL-17-committed v&#x3b3;4+ &#x3b3;&#x3b4; T cells in a spontaneous Sox13-mutant CD45.1+ congenic mouse substrain provides protection from dermatitis. Nat. Immunol 14, 584&#x2013;592 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3660499</ArticleId><ArticleId IdType="pubmed">23624556</ArticleId></ArticleIdList></Reference><Reference><Citation>McKenzie DR et al. lL-17-producing &#x3b3;&#x3b4; T cells switch migratory patterns between resting and activated states. Nat. Commun 8, 15632 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5465362</ArticleId><ArticleId IdType="pubmed">28580944</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandala S et al. Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists. Science 296, 346&#x2013;349 (2002).</Citation><ArticleIdList><ArticleId IdType="pubmed">11923495</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiba K et al. FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats. J. Immunol 160, 5037&#x2013;5044 (1998).</Citation><ArticleIdList><ArticleId IdType="pubmed">9590253</ArticleId></ArticleIdList></Reference><Reference><Citation>Enosawa S, Suzuki S, Kakefuda T, Li XK &amp; Amemiya H Induction of selective cell death targeting on mature T-lymphocytes in rats by a novel immunosuppressant, FTY720. Immunopharmacology 34, 171&#x2013;179 (1996).</Citation><ArticleIdList><ArticleId IdType="pubmed">8886861</ArticleId></ArticleIdList></Reference><Reference><Citation>Krebs CF et al. Autoimmune renal disease is exacerbated by S1P-receptor-1-dependent intestinal Th17 cell migration to the kidney. Immunity 45, 1078&#x2013;1092 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6381450</ArticleId><ArticleId IdType="pubmed">27851911</ArticleId></ArticleIdList></Reference><Reference><Citation>De Silva TM, Modrick ML, Grobe JL &amp; Faraci FM Activation of the central renin-angiotensin system causes local cerebrovascular dysfunction. Stroke 52, 2404&#x2013;2413 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8262118</ArticleId><ArticleId IdType="pubmed">34107734</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu X &amp; Crowley SD The immune system in hypertension: a Lost Shaker of Salt 2021 Lewis K. Dahl Memorial Lecture. Hypertension 79, 1339&#x2013;1347 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9248984</ArticleId><ArticleId IdType="pubmed">35545942</ArticleId></ArticleIdList></Reference><Reference><Citation>Norlander AE, Madhur MS &amp; Harrison DG The immunology of hypertension. J. Exp. Med 215, 21&#x2013;33 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5748862</ArticleId><ArticleId IdType="pubmed">29247045</ArticleId></ArticleIdList></Reference><Reference><Citation>Drummond GR, Vinh A, Guzik TJ &amp; Sobey CG Immune mechanisms of hypertension. Nat. Rev. Immunol 19, 517&#x2013;532 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">30992524</ArticleId></ArticleIdList></Reference><Reference><Citation>Higaki A, Mahmoud AUM, Paradis P &amp; Schiffrin EL Role of interleukin-23/interleukin-17 axis in T-cell mediated actions in hypertension. Cardiovasc Res. 117, 1274&#x2013;1283 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32870976</ArticleId></ArticleIdList></Reference><Reference><Citation>Louveau A et al. CNS lymphatic drainage and neuroinflammation are regulated by meningeal lymphatic vasculature. Nat. Neurosci 21, 1380&#x2013;1391 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6214619</ArticleId><ArticleId IdType="pubmed">30224810</ArticleId></ArticleIdList></Reference><Reference><Citation>Gorelick PB et al. Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 42, 2672&#x2013;2713 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3778669</ArticleId><ArticleId IdType="pubmed">21778438</ArticleId></ArticleIdList></Reference><Reference><Citation>Cortes-Canteli M &amp; Iadecola C Alzheimer&#x2019;s disease and vascular aging: JACC focus seminar. J. Am. Coll. Cardiol 75, 942&#x2013;951 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8046164</ArticleId><ArticleId IdType="pubmed">32130930</ArticleId></ArticleIdList></Reference><Reference><Citation>Brigas HC et al. IL-17 triggers the onset of cognitive and synaptic deficits in early stages of Alzheimer&#x2019;s disease. Cell Rep. 36, 109574 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34469732</ArticleId></ArticleIdList></Reference><Reference><Citation>Rouch L et al. Antihypertensive drugs, prevention of cognitive decline and dementia: a systematic review of observational studies, randomized controlled trials and meta-analyses, with discussion of potential mechanisms. CNS Drugs 29, 113&#x2013;130 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">25700645</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding J et al. Antihypertensive medications and risk for incident dementia and Alzheimer&#x2019;s disease: a meta-analysis of individual participant data from prospective cohort studies. Lancet Neurol. 19, 61&#x2013;70 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7391421</ArticleId><ArticleId IdType="pubmed">31706889</ArticleId></ArticleIdList></Reference><Reference><Citation>James PA et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA 311, 507&#x2013;520 (2014).</Citation><ArticleIdList><ArticleId IdType="pubmed">24352797</ArticleId></ArticleIdList></Reference><Reference><Citation>Harrison DG, Coffman TM &amp; Wilcox CS Pathophysiology of hypertension: the mosaic theory and beyond. Circ. Res 128, 847&#x2013;863 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8023760</ArticleId><ArticleId IdType="pubmed">33793328</ArticleId></ArticleIdList></Reference><Reference><Citation>Ridker PM et al. Antiinflammatory therapy with canakinumab for atherosclerotic disease. N. Engl. J. Med 377, 1119&#x2013;1131 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28845751</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma T, Wang F, Xu S &amp; Huang JH Meningeal immunity: structure, function and a potential therapeutic target of neurodegenerative diseases. Brain Behav. Immun 93, 264&#x2013;276 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33548498</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayashi S, Lewis P, Pevny L &amp; McMahon AP Efficient gene modulation in mouse epiblast using a Sox2Cre transgenic mouse strain. Mech. Dev 119, S97&#x2013;S101 (2002).</Citation><ArticleIdList><ArticleId IdType="pubmed">14516668</ArticleId></ArticleIdList></Reference><Reference><Citation>Belanger KM et al. Greater T regulatory cells in females attenuate DOCA-salt-induced increases in blood pressure versus males. Hypertension 75, 1615&#x2013;1623 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7225054</ArticleId><ArticleId IdType="pubmed">32336228</ArticleId></ArticleIdList></Reference><Reference><Citation>Korvela M et al. Quantification of 10 elements in human cerebrospinal fluid from chronic pain patients with and without spinal cord stimulation. J. Trace Elem. Med. Biol 37, 1&#x2013;7 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">27473826</ArticleId></ArticleIdList></Reference><Reference><Citation>Bischoff K, Lamm C, Erb HN &amp; Hillebrandt JR The effects of formalin fixation and tissue embedding of bovine liver on copper, iron, and zinc analysis. J. Vet. Diagn. Invest 20, 220&#x2013;224 (2008).</Citation><ArticleIdList><ArticleId IdType="pubmed">18319437</ArticleId></ArticleIdList></Reference><Reference><Citation>Capone C et al. The cerebrovascular dysfunction induced by slow pressor doses of angiotensin ii precedes the development of hypertension. Am. J. Physiol. Heart Circ. Physiol 300, H397&#x2013;H407 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3023263</ArticleId><ArticleId IdType="pubmed">20971763</ArticleId></ArticleIdList></Reference><Reference><Citation>Kober F et al. High-resolution myocardial perfusion mapping in small animals in vivo by spin-labeling gradient-echo imaging. Magn. Reson. Med 51, 62&#x2013;67 (2004).</Citation><ArticleIdList><ArticleId IdType="pubmed">14705046</ArticleId></ArticleIdList></Reference><Reference><Citation>Deacon RM Assessing nest building in mice. Nat. Protoc 1, 1117&#x2013;1119 (2006).</Citation><ArticleIdList><ArticleId IdType="pubmed">17406392</ArticleId></ArticleIdList></Reference><Reference><Citation>Faraco G et al. Dietary salt promotes cognitive impairment through tau phosphorylation. Nature 574, 686&#x2013;690 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7380655</ArticleId><ArticleId IdType="pubmed">31645758</ArticleId></ArticleIdList></Reference><Reference><Citation>Brea D et al. Stroke affects intestinal immune cell trafficking to the central nervous system. Brain Behav. Immun 96, 295&#x2013;302 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8672365</ArticleId><ArticleId IdType="pubmed">33989742</ArticleId></ArticleIdList></Reference><Reference><Citation>Louveau A, Filiano A &amp; Kipnis J Meningeal whole mount preparation and characterization of neural cells by flow cytometry. Curr. Protoc. Immunol 121, e50 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6040815</ArticleId><ArticleId IdType="pubmed">30008983</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldmann T et al. Origin, fate and dynamics of macrophages at central nervous system interfaces. Nat. Immunol 17, 797&#x2013;805 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4968048</ArticleId><ArticleId IdType="pubmed">27135602</ArticleId></ArticleIdList></Reference><Reference><Citation>Borst K &amp; Prinz M Deciphering the heterogeneity of myeloid cells during neuroinflammation in the single-cell era. Brain Pathol. 30, 1192&#x2013;1207 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8018048</ArticleId><ArticleId IdType="pubmed">33058309</ArticleId></ArticleIdList></Reference><Reference><Citation>Mendes NF &amp; Velloso LA Perivascular macrophages in high-fat diet-induced hypothalamic inflammation. J. Neuroinflamm 19, 136 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9185933</ArticleId><ArticleId IdType="pubmed">35681242</ArticleId></ArticleIdList></Reference><Reference><Citation>Park L et al. Scavenger receptor CD36 is essential for the cerebrovascular oxidative stress and neurovascular dysfunction induced by amyloid-beta. Proc. Natl Acad. Sci. USA 108, 5063&#x2013;5068 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3064396</ArticleId><ArticleId IdType="pubmed">21383152</ArticleId></ArticleIdList></Reference><Reference><Citation>Rudick RA, Zirretta DK &amp; Herndon RM Clearance of albumin from mouse subarachnoid space: a measure of CSF bulk flow. J. Neurosci. Methods 6, 253&#x2013;259 (1982).</Citation><ArticleIdList><ArticleId IdType="pubmed">7144238</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim NK et al. An improved method for collection of cerebrospinal fluid from anesthetized mice. J. Vis. Exp 19, 56774 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5931779</ArticleId><ArticleId IdType="pubmed">29608146</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakamoto H et al. Angiotensin-(1&#x2013;7) and nitric oxide interaction in renovascular hypertension. Hypertension 25, 796&#x2013;802 (1995).</Citation><ArticleIdList><ArticleId IdType="pubmed">7536715</ArticleId></ArticleIdList></Reference><Reference><Citation>Park L et al. Tau induces PSD95-neuronal nos uncoupling and neurovascular dysfunction independent of neurodegeneration. Nat. Neurosci 23, 1079&#x2013;1089 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7896353</ArticleId><ArticleId IdType="pubmed">32778793</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38086389</PMID><DateCompleted><Year>2024</Year><Month>01</Month><Day>29</Day></DateCompleted><DateRevised><Year>2025</Year><Month>04</Month><Day>03</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1097-4172</ISSN><JournalIssue CitedMedium="Internet"><Volume>187</Volume><Issue>2</Issue><PubDate><Year>2024</Year><Month>Jan</Month><Day>18</Day></PubDate></JournalIssue><Title>Cell</Title><ISOAbbreviation>Cell</ISOAbbreviation></Journal><ArticleTitle>APOE3ch alters microglial response and suppresses A&#x3b2;-induced tau seeding and spread.</ArticleTitle><Pagination><StartPage>428</StartPage><EndPage>445.e20</EndPage><MedlinePgn>428-445.e20</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.cell.2023.11.029</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0092-8674(23)01315-6</ELocationID><Abstract><AbstractText>A recent case report described an individual who was a homozygous carrier of the APOE3 Christchurch (APOE3ch) mutation and resistant to autosomal dominant Alzheimer's Disease (AD) caused by a PSEN1-E280A mutation. Whether APOE3ch contributed to the protective effect remains unclear. We generated a humanized APOE3ch knock-in mouse and crossed it to an amyloid-&#x3b2; (A&#x3b2;) plaque-depositing model. We injected AD-tau brain extract to investigate tau seeding and spreading in the presence or absence of amyloid. Similar to the case report, APOE3ch expression resulted in peripheral dyslipidemia and a marked reduction in plaque-associated tau pathology. Additionally, we observed decreased amyloid response and enhanced microglial response around plaques. We also demonstrate increased myeloid cell phagocytosis and degradation of tau aggregates linked to weaker APOE3ch binding to heparin sulfate proteoglycans. APOE3ch influences the microglial response to A&#x3b2; plaques, which suppresses A&#x3b2;-induced tau seeding and spreading. The results reveal new possibilities to target A&#x3b2;-induced tauopathy.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Yun</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Neurology, Washington University School of Medicine, St. Louis, MO 63110, USA; Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Song</LastName><ForeName>Sihui</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurology, Washington University School of Medicine, St. Louis, MO 63110, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Parhizkar</LastName><ForeName>Samira</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurology, Washington University School of Medicine, St. Louis, MO 63110, USA; Hope Center for Neurological Disorders, Washington University School of Medicine, St. Louis, MO 63110, USA; Knight Alzheimer's Disease Research Center, Washington University School of Medicine, St. Louis, MO 63110, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lord</LastName><ForeName>Jennifer</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurology, Washington University School of Medicine, St. Louis, MO 63110, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Yiyang</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Neurology, Washington University School of Medicine, St. Louis, MO 63110, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Strickland</LastName><ForeName>Michael R</ForeName><Initials>MR</Initials><AffiliationInfo><Affiliation>Department of Neurology, Washington University School of Medicine, St. Louis, MO 63110, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Chanung</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Neurology, Washington University School of Medicine, St. Louis, MO 63110, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Jiyu</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurology, Washington University School of Medicine, St. Louis, MO 63110, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tabor</LastName><ForeName>G Travis</ForeName><Initials>GT</Initials><AffiliationInfo><Affiliation>Department of Neurology, Washington University School of Medicine, St. Louis, MO 63110, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Hong</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Neurology, Washington University School of Medicine, St. Louis, MO 63110, USA; Hope Center for Neurological Disorders, Washington University School of Medicine, St. Louis, MO 63110, USA; Knight Alzheimer's Disease Research Center, Washington University School of Medicine, St. Louis, MO 63110, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Kevin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Neurology, Washington University School of Medicine, St. Louis, MO 63110, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Davis</LastName><ForeName>Albert A</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>Department of Neurology, Washington University School of Medicine, St. Louis, MO 63110, USA; Hope Center for Neurological Disorders, Washington University School of Medicine, St. Louis, MO 63110, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yuede</LastName><ForeName>Carla M</ForeName><Initials>CM</Initials><AffiliationInfo><Affiliation>Department of Neurology, Washington University School of Medicine, St. Louis, MO 63110, USA; Hope Center for Neurological Disorders, Washington University School of Medicine, St. Louis, MO 63110, USA; Knight Alzheimer's Disease Research Center, Washington University School of Medicine, St. Louis, MO 63110, USA; Department of Psychiatry, Washington University School of Medicine, St. Louis, MO 63110, USA; Department of Neuroscience, Washington University School of Medicine, St. Louis, MO 63110, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Colonna</LastName><ForeName>Marco</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA; Hope Center for Neurological Disorders, Washington University School of Medicine, St. Louis, MO 63110, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ulrich</LastName><ForeName>Jason D</ForeName><Initials>JD</Initials><AffiliationInfo><Affiliation>Department of Neurology, Washington University School of Medicine, St. Louis, MO 63110, USA; Hope Center for Neurological Disorders, Washington University School of Medicine, St. Louis, MO 63110, USA; Knight Alzheimer's Disease Research Center, Washington University School of Medicine, St. Louis, MO 63110, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Holtzman</LastName><ForeName>David M</ForeName><Initials>DM</Initials><AffiliationInfo><Affiliation>Department of Neurology, Washington University School of Medicine, St. Louis, MO 63110, USA; Hope Center for Neurological Disorders, Washington University School of Medicine, St. Louis, MO 63110, USA; Knight Alzheimer's Disease Research Center, Washington University School of Medicine, St. Louis, MO 63110, USA. Electronic address: holtzman@wustl.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P30 AG066444</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>RF1 NS090934</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K08 NS101118</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P01 AG003991</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>RF1 AG047644</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U19 AG069701</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 DK056341</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P01 AG026276</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>12</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cell</MedlineTA><NlmUniqueID>0413066</NlmUniqueID><ISSNLinking>0092-8674</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016229">Amyloid beta-Peptides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D058227">Amyloidogenic Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D053318">Apolipoprotein E3</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016875">tau Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016229" MajorTopicYN="Y">Amyloid beta-Peptides</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058227" MajorTopicYN="N">Amyloidogenic Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053318" MajorTopicYN="Y">Apolipoprotein E3</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017628" MajorTopicYN="N">Microglia</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058225" MajorTopicYN="N">Plaque, Amyloid</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016875" MajorTopicYN="Y">tau Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094143" MajorTopicYN="N">Case Reports as Topic</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>Declaration of interests D.M.H. is an inventor on a patent licensed by Washington University to C2N Diagnostics on the therapeutic use of anti-tau antibodies. D.M.H. co-founded and is on the scientific advisory board of C2N Diagnostics. D.M.H. is on the scientific advisory board of Denali, Genentech, and Cajal Neuroscience and consults for Asteroid, and is on the Advisory Board for Cell. M.C. is a member of Vigil Neuro scientific advisory board (SAB), is consultant for Cell Signaling Technology and NGM Bio. The rest of the authors have no conflict of interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>7</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>10</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>11</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>1</Month><Day>22</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>12</Month><Day>13</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>12</Month><Day>12</Day><Hour>18</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>1</Month><Day>18</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38086389</ArticleId><ArticleId IdType="mid">NIHMS1949274</ArticleId><ArticleId IdType="pmc">PMC10842861</ArticleId><ArticleId IdType="doi">10.1016/j.cell.2023.11.029</ArticleId><ArticleId IdType="pii">S0092-8674(23)01315-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Harper LC
2022. 
Alzheimer&#x2019;s Association Facts and Figures. https://www.alz.org/alzheimers-dementia/facts-figures.</Citation></Reference><Reference><Citation>Long JM, and Holtzman DM (2019). Alzheimer Disease: An Update on Pathobiology and Treatment Strategies. Cell 179, 312&#x2013;339. 10.1016/j.cell.2019.09.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2019.09.001</ArticleId><ArticleId IdType="pmc">PMC6778042</ArticleId><ArticleId IdType="pubmed">31564456</ArticleId></ArticleIdList></Reference><Reference><Citation>Self WK, and Holtzman DM (2023). Emerging diagnostics and therapeutics for Alzheimer disease. Nat. Med. 29, 2187&#x2013;2199. 10.1038/s41591-023-02505-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-023-02505-2</ArticleId><ArticleId IdType="pubmed">37667136</ArticleId></ArticleIdList></Reference><Reference><Citation>Bateman RJ, Aisen PS, De Strooper B, Fox NC, Lemere CA, Ringman JM, Salloway S, Sperling RA, Windisch M, and Xiong C (2011). Autosomal-dominant Alzheimer&#x2019;s disease: a review and proposal for the prevention of Alzheimer&#x2019;s disease. Alzheimers. Res. Ther. 3, 1. 10.1186/alzrt59.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/alzrt59</ArticleId><ArticleId IdType="pmc">PMC3109410</ArticleId><ArticleId IdType="pubmed">21211070</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryman DC, Acosta-Baena N, Aisen PS, Bird T, Danek A, Fox NC, Goate A, Frommelt P, Ghetti B, Langbaum JBS, et al. (2014). Symptom onset in autosomal dominant Alzheimer disease: a systematic review and meta-analysis. Neurology 83, 253&#x2013;260. 10.1212/WNL.0000000000000596.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000000596</ArticleId><ArticleId IdType="pmc">PMC4117367</ArticleId><ArticleId IdType="pubmed">24928124</ArticleId></ArticleIdList></Reference><Reference><Citation>Martens YA, Zhao N, Liu C-C, Kanekiyo T, Yang AJ, Goate AM, Holtzman DM, and Bu G (2022). ApoE Cascade Hypothesis in the pathogenesis of Alzheimer&#x2019;s disease and related dementias. Neuron 110, 1304&#x2013;1317. 10.1016/j.neuron.2022.03.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2022.03.004</ArticleId><ArticleId IdType="pmc">PMC9035117</ArticleId><ArticleId IdType="pubmed">35298921</ArticleId></ArticleIdList></Reference><Reference><Citation>Arboleda-Velasquez JF, Lopera F, O&#x2019;Hare M, Delgado-Tirado S, Marino C, Chmielewska N, Saez-Torres KL, Amarnani D, Schultz AP, Sperling RA, et al. (2019). Resistance to autosomal dominant Alzheimer&#x2019;s disease in an APOE3 Christchurch homozygote: a case report. Nat. Med. 25, 1680&#x2013;1683. 10.1038/s41591-019-0611-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-019-0611-3</ArticleId><ArticleId IdType="pmc">PMC6898984</ArticleId><ArticleId IdType="pubmed">31686034</ArticleId></ArticleIdList></Reference><Reference><Citation>Sepulveda-Falla D, Sanchez JS, Almeida MC, Boassa D, Acosta-Uribe J, Vila-Castelar C, Ramirez-Gomez L, Baena A, Aguillon D, Villalba-Moreno ND, et al. (2022). Distinct tau neuropathology and cellular profiles of an APOE3 Christchurch homozygote protected against autosomal dominant Alzheimer&#x2019;s dementia. Acta Neuropathol. 144, 589&#x2013;601. 10.1007/s00401-022-02467-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-022-02467-8</ArticleId><ArticleId IdType="pmc">PMC9381462</ArticleId><ArticleId IdType="pubmed">35838824</ArticleId></ArticleIdList></Reference><Reference><Citation>Wardell MR, Brennan SO, Janus ED, Fraser R, and Carrell RW (1987). Apolipoprotein E2-Christchurch (136 Arg----Ser). New variant of human apolipoprotein E in a patient with type III hyperlipoproteinemia. J. Clin. Invest. 80, 483&#x2013;490. 10.1172/JCI113096.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI113096</ArticleId><ArticleId IdType="pmc">PMC442261</ArticleId><ArticleId IdType="pubmed">3038959</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahley RW, Huang Y, and Rall SC Jr, (1999). Pathogenesis of type III hyperlipoproteinemia (dysbetalipoproteinemia). Questions, quandaries, and paradoxes. J. Lipid Res. 40, 1933&#x2013;1949.</Citation><ArticleIdList><ArticleId IdType="pubmed">10552997</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahley RW (1988). Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 240, 622&#x2013;630. 10.1126/science.3283935.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.3283935</ArticleId><ArticleId IdType="pubmed">3283935</ArticleId></ArticleIdList></Reference><Reference><Citation>Lalazar A, Weisgraber KH, Rall SC Jr, Giladi H., Innerarity TL., Levanon AZ., Boyles JK., Amit B., Gorecki M., and Mahley RW. (1988). Site-specific mutagenesis of human apolipoprotein E. Receptor binding activity of variants with single amino acid substitutions. J. Biol. Chem. 263, 3542&#x2013;3545.</Citation><ArticleIdList><ArticleId IdType="pubmed">2831187</ArticleId></ArticleIdList></Reference><Reference><Citation>Mah D, Zhu Y, Su G, Zhao J, Canning A, Gibson J, Song X, Stancanelli E, Xu Y, Zhang F, et al. (2023). Apolipoprotein E Recognizes Alzheimer&#x2019;s Disease Associated 3-O Sulfation of Heparan Sulfate. Angew. Chem. Int. Ed Engl. 62, e202212636. 10.1002/anie.202212636.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/anie.202212636</ArticleId><ArticleId IdType="pmc">PMC10430763</ArticleId><ArticleId IdType="pubmed">37014788</ArticleId></ArticleIdList></Reference><Reference><Citation>Radde R, Bolmont T, Kaeser SA, Coomaraswamy J, Lindau D, Stoltze L, Calhoun ME, J&#xe4;ggi F, Wolburg H, Gengler S, et al. (2006). Abeta42-driven cerebral amyloidosis in transgenic mice reveals early and robust pathology. EMBO Rep. 7, 940&#x2013;946. 10.1038/sj.embor.7400784.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.embor.7400784</ArticleId><ArticleId IdType="pmc">PMC1559665</ArticleId><ArticleId IdType="pubmed">16906128</ArticleId></ArticleIdList></Reference><Reference><Citation>Palmisano BT, Zhu L, Eckel RH, and Stafford JM (2018). Sex differences in lipid and lipoprotein metabolism. Mol Metab 15, 45&#x2013;55. 10.1016/j.molmet.2018.05.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molmet.2018.05.008</ArticleId><ArticleId IdType="pmc">PMC6066747</ArticleId><ArticleId IdType="pubmed">29858147</ArticleId></ArticleIdList></Reference><Reference><Citation>He Z, Guo JL, McBride JD, Narasimhan S, Kim H, Changolkar L, Zhang B, Gathagan RJ, Yue C, Dengler C, et al. (2018). Amyloid-&#x3b2; plaques enhance Alzheimer&#x2019;s brain tau-seeded pathologies by facilitating neuritic plaque tau aggregation. Nat. Med. 24, 29&#x2013;38. 10.1038/nm.4443.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.4443</ArticleId><ArticleId IdType="pmc">PMC5760353</ArticleId><ArticleId IdType="pubmed">29200205</ArticleId></ArticleIdList></Reference><Reference><Citation>Leyns CEG, Gratuze M, Narasimhan S, Jain N, Koscal LJ, Jiang H, Manis M, Colonna M, Lee VMY, Ulrich JD, et al. (2019). TREM2 function impedes tau seeding in neuritic plaques. Nat. Neurosci. 22, 1217&#x2013;1222. 10.1038/s41593-019-0433-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-019-0433-0</ArticleId><ArticleId IdType="pmc">PMC6660358</ArticleId><ArticleId IdType="pubmed">31235932</ArticleId></ArticleIdList></Reference><Reference><Citation>Gratuze M, Chen Y, Parhizkar S, Jain N, Strickland MR, Serrano JR, Colonna M, Ulrich JD, and Holtzman DM (2021). Activated microglia mitigate A&#x3b2;-associated tau seeding and spreading. J. Exp. Med. 218. 10.1084/jem.20210542.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20210542</ArticleId><ArticleId IdType="pmc">PMC8190588</ArticleId><ArticleId IdType="pubmed">34100905</ArticleId></ArticleIdList></Reference><Reference><Citation>Horie K, Salvad&#xf3; G, Barth&#xe9;lemy NR, Janelidze S, Li Y, He Y, Saef B, Chen CD, Jiang H, Strandberg O, et al. (2023). CSF MTBR-tau243 is a specific biomarker of tau tangle pathology in Alzheimer&#x2019;s disease. Nat. Med. 29, 1954&#x2013;1963. 10.1038/s41591-023-02443-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-023-02443-z</ArticleId><ArticleId IdType="pmc">PMC10427417</ArticleId><ArticleId IdType="pubmed">37443334</ArticleId></ArticleIdList></Reference><Reference><Citation>Garai K, Verghese PB, Baban B, Holtzman DM, and Frieden C (2014). The binding of apolipoprotein E to oligomers and fibrils of amyloid-&#x3b2; alters the kinetics of amyloid aggregation. Biochemistry 53, 6323&#x2013;6331. 10.1021/bi5008172.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/bi5008172</ArticleId><ArticleId IdType="pmc">PMC4196732</ArticleId><ArticleId IdType="pubmed">25207746</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Ulland TK, Ulrich JD, Song W, Tzaferis JA, Hole JT, Yuan P, Mahan TE, Shi Y, Gilfillan S, et al. (2016). TREM2-mediated early microglial response limits diffusion and toxicity of amyloid plaques. J. Exp. Med. 213, 667&#x2013;675. 10.1084/jem.20151948.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20151948</ArticleId><ArticleId IdType="pmc">PMC4854736</ArticleId><ArticleId IdType="pubmed">27091843</ArticleId></ArticleIdList></Reference><Reference><Citation>Spires-Jones TL, and Hyman BT (2014). The intersection of amyloid beta and tau at synapses in Alzheimer&#x2019;s disease. Neuron 82, 756&#x2013;771. 10.1016/j.neuron.2014.05.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2014.05.004</ArticleId><ArticleId IdType="pmc">PMC4135182</ArticleId><ArticleId IdType="pubmed">24853936</ArticleId></ArticleIdList></Reference><Reference><Citation>Jain N, Lewis CA, Ulrich JD, and Holtzman DM (2023). Chronic TREM2 activation exacerbates A&#x3b2;-associated tau seeding and spreading. J. Exp. Med. 220. 10.1084/jem.20220654.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20220654</ArticleId><ArticleId IdType="pmc">PMC9559604</ArticleId><ArticleId IdType="pubmed">36219197</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed Z, Cooper J, Murray TK, Garn K, McNaughton E, Clarke H, Parhizkar S, Ward MA, Cavallini A, Jackson S, et al. (2014). A novel in vivo model of tau propagation with rapid and progressive neurofibrillary tangle pathology: the pattern of spread is determined by connectivity, not proximity. Acta Neuropathol. 127, 667&#x2013;683. 10.1007/s00401-014-1254-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-014-1254-6</ArticleId><ArticleId IdType="pmc">PMC4252866</ArticleId><ArticleId IdType="pubmed">24531916</ArticleId></ArticleIdList></Reference><Reference><Citation>Stine WB, Jungbauer L, Yu C, and LaDu MJ (2011). Preparing synthetic A&#x3b2; in different aggregation states. Methods Mol. Biol. 670, 13&#x2013;32. 10.1007/978-1-60761-744-0_2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-60761-744-0</ArticleId><ArticleId IdType="pmc">PMC3752843</ArticleId><ArticleId IdType="pubmed">20967580</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S, Sudan R, Peng V, Zhou Y, Du S, Yuede CM, Lei T, Hou J, Cai Z, Cella M, et al. (2022). TREM2 drives microglia response to amyloid-&#x3b2; via SYK-dependent and -independent pathways. Cell 185, 4153&#x2013;4169.e19. 10.1016/j.cell.2022.09.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.09.033</ArticleId><ArticleId IdType="pmc">PMC9625082</ArticleId><ArticleId IdType="pubmed">36306735</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanekiyo T, Zhang J, Liu Q, Liu C-C, Zhang L, and Bu G (2011). Heparan sulphate proteoglycan and the low-density lipoprotein receptor-related protein 1 constitute major pathways for neuronal amyloid-beta uptake. J. Neurosci. 31, 1644&#x2013;1651. 10.1523/JNEUROSCI.5491-10.2011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.5491-10.2011</ArticleId><ArticleId IdType="pmc">PMC3272839</ArticleId><ArticleId IdType="pubmed">21289173</ArticleId></ArticleIdList></Reference><Reference><Citation>Holmes BB, DeVos SL, Kfoury N, Li M, Jacks R, Yanamandra K, Ouidja MO, Brodsky FM, Marasa J, Bagchi DP, et al. (2013). Heparan sulfate proteoglycans mediate internalization and propagation of specific proteopathic seeds. Proc. Natl. Acad. Sci. U. S. A. 110, E3138&#x2013;E3147. 10.1073/pnas.1301440110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1301440110</ArticleId><ArticleId IdType="pmc">PMC3746848</ArticleId><ArticleId IdType="pubmed">23898162</ArticleId></ArticleIdList></Reference><Reference><Citation>Shinohara M, Tachibana M, Kanekiyo T, and Bu G (2017). Role of LRP1 in the pathogenesis of Alzheimer&#x2019;s disease: evidence from clinical and preclinical studies. J. Lipid Res. 58, 1267&#x2013;1281. 10.1194/jlr.R075796.</Citation><ArticleIdList><ArticleId IdType="doi">10.1194/jlr.R075796</ArticleId><ArticleId IdType="pmc">PMC5496044</ArticleId><ArticleId IdType="pubmed">28381441</ArticleId></ArticleIdList></Reference><Reference><Citation>Tachibana M, Holm M-L, Liu C-C, Shinohara M, Aikawa T, Oue H, Yamazaki Y, Martens YA, Murray ME, Sullivan PM, et al. (2019). APOE4-mediated amyloid-&#x3b2; pathology depends on its neuronal receptor LRP1. J. Clin. Invest. 129, 1272&#x2013;1277. 10.1172/JCI124853.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI124853</ArticleId><ArticleId IdType="pmc">PMC6391135</ArticleId><ArticleId IdType="pubmed">30741718</ArticleId></ArticleIdList></Reference><Reference><Citation>Rauch JN, Luna G, Guzman E, Audouard M, Challis C, Sibih YE, Leshuk C, Hernandez I, Wegmann S, Hyman BT, et al. (2020). LRP1 is a master regulator of tau uptake and spread. Nature 580, 381&#x2013;385. 10.1038/s41586-020-2156-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2156-5</ArticleId><ArticleId IdType="pmc">PMC7687380</ArticleId><ArticleId IdType="pubmed">32296178</ArticleId></ArticleIdList></Reference><Reference><Citation>Asai H, Ikezu S, Tsunoda S, Medalla M, Luebke J, Haydar T, Wolozin B, Butovsky O, K&#xfc;gler S, and Ikezu T (2015). Depletion of microglia and inhibition of exosome synthesis halt tau propagation. Nat. Neurosci. 18, 1584&#x2013;1593. 10.1038/nn.4132.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.4132</ArticleId><ArticleId IdType="pmc">PMC4694577</ArticleId><ArticleId IdType="pubmed">26436904</ArticleId></ArticleIdList></Reference><Reference><Citation>Colonna M, and Wang Y (2016). TREM2 variants: new keys to decipher Alzheimer disease pathogenesis. Nat. Rev. Neurosci. 17, 201&#x2013;207. 10.1038/nrn.2016.7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn.2016.7</ArticleId><ArticleId IdType="pubmed">26911435</ArticleId></ArticleIdList></Reference><Reference><Citation>Belloy ME, Andrews SJ, Le Guen Y, Cuccaro M, Farrer LA, Napolioni V, and Greicius MD (2023). APOE Genotype and Alzheimer Disease Risk Across Age, Sex, and Population Ancestry. JAMA Neurol. 10.1001/jamaneurol.2023.3599.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2023.3599</ArticleId><ArticleId IdType="pmc">PMC10628838</ArticleId><ArticleId IdType="pubmed">37930705</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu C-C, Murray ME, Li X, Zhao N, Wang N, Heckman MG, Shue F, Martens Y, Li Y, Raulin A-C, et al. (2021). APOE3-Jacksonville (V236E) variant reduces self-aggregation and risk of dementia. Sci. Transl. Med. 13, eabc9375. 10.1126/scitranslmed.abc9375.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.abc9375</ArticleId><ArticleId IdType="pmc">PMC8824726</ArticleId><ArticleId IdType="pubmed">34586832</ArticleId></ArticleIdList></Reference><Reference><Citation>Pocovi M, Cenarro A, Civeir F, Myers RH, Casao E, Esteban M, and Ordovas JM (1996). Incomplete dominance of type III hyperlipoproteinemia is associated with the rare apolipoprotein E2 (Arg136&#x2192; Ser) variant in multigenerational pedigree studies. Atherosclerosis 122, 33&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pubmed">8724110</ArticleId></ArticleIdList></Reference><Reference><Citation>Linton MF, Gish R, Hubl ST, B&#xfc;tler E, Esquivel C, Bry WI, Boyles JK, Wardell MR, and Young SG (1991). Phenotypes of apolipoprotein B and apolipoprotein E after liver transplantation. J. Clin. Invest. 88, 270&#x2013;281. 10.1172/JCI115288.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI115288</ArticleId><ArticleId IdType="pmc">PMC296029</ArticleId><ArticleId IdType="pubmed">2056122</ArticleId></ArticleIdList></Reference><Reference><Citation>Wildsmith KR, Basak JM, Patterson BW, Pyatkivskyy Y, Kim J, Yarasheski KE, Wang JX, Mawuenyega KG, Jiang H, Parsadanian M, et al. (2012). In vivo human apolipoprotein E isoform fractional turnover rates in the CNS. PLoS One 7, e38013. 10.1371/journal.pone.0038013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0038013</ArticleId><ArticleId IdType="pmc">PMC3366983</ArticleId><ArticleId IdType="pubmed">22675504</ArticleId></ArticleIdList></Reference><Reference><Citation>Ondrejcak T, Klyubin I, Hu N-W, O&#x2019;Malley TT, Corbett GT, Winters R, Perkinton MS, Billinton A, Prenderville JA, Walsh DM, et al. (2023). Tau and Amyloid &#x3b2; Protein in Patient-Derived Aqueous Brain Extracts Act Concomitantly to Disrupt Long-Term Potentiation in Vivo. J. Neurosci. 43, 5870&#x2013;5879. 10.1523/JNEUROSCI.0082-23.2023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.0082-23.2023</ArticleId><ArticleId IdType="pmc">PMC10423043</ArticleId><ArticleId IdType="pubmed">37491315</ArticleId></ArticleIdList></Reference><Reference><Citation>Keren-Shaul H, Spinrad A, Weiner A, Matcovitch-Natan O, Dvir-Szternfeld R, Ulland TK, David E, Baruch K, Lara-Astaiso D, Toth B, et al. (2017). A Unique Microglia Type Associated with Restricting Development of Alzheimer&#x2019;s Disease. Cell 169, 1276&#x2013;1290.e17. 10.1016/j.cell.2017.05.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2017.05.018</ArticleId><ArticleId IdType="pubmed">28602351</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y, and Colonna M (2021). Microglia in Alzheimer&#x2019;s disease at single-cell level. Are there common patterns in humans and mice? J. Exp. Med. 218. 10.1084/jem.20202717.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20202717</ArticleId><ArticleId IdType="pmc">PMC8302448</ArticleId><ArticleId IdType="pubmed">34292312</ArticleId></ArticleIdList></Reference><Reference><Citation>Huynh T-PV, Wang C, Tran AC, Tabor GT, Mahan TE, Francis CM, Finn MB, Spellman R, Manis M, Tanzi RE, et al. (2019). Lack of hepatic apoE does not influence early A&#x3b2; deposition: observations from a new APOE knock-in model. Mol. Neurodegener. 14, 37. 10.1186/s13024-019-0337-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-019-0337-1</ArticleId><ArticleId IdType="pmc">PMC6796484</ArticleId><ArticleId IdType="pubmed">31623648</ArticleId></ArticleIdList></Reference><Reference><Citation>Wozniak DF, Diggs-Andrews KA, Conyers S, Yuede CM, Dearborn JT, Brown JA, Tokuda K, Izumi Y, Zorumski CF, and Gutmann DH (2013). Motivational disturbances and effects of L-dopa administration in neurofibromatosis-1 model mice. PLoS One 8, e66024. 10.1371/journal.pone.0066024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0066024</ArticleId><ArticleId IdType="pmc">PMC3677926</ArticleId><ArticleId IdType="pubmed">23762458</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X, Firulyova M, Manis M, Herz J, Smirnov I, Aladyeva E, Wang C, Bao X, Finn MB, Hu H, et al. (2023). Microglia-mediated T cell infiltration drives neurodegeneration in tauopathy. Nature 615, 668&#x2013;677. 10.1038/s41586-023-05788-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-023-05788-0</ArticleId><ArticleId IdType="pmc">PMC10258627</ArticleId><ArticleId IdType="pubmed">36890231</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuede CM, Wozniak DF, Creeley CE, Taylor GT, Olney JW, and Farber NB (2010). Behavioral consequences of NMDA antagonist-induced neuroapoptosis in the infant mouse brain. PLoS One 5, e11374. 10.1371/journal.pone.0011374.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0011374</ArticleId><ArticleId IdType="pmc">PMC2894063</ArticleId><ArticleId IdType="pubmed">20613880</ArticleId></ArticleIdList></Reference><Reference><Citation>Parhizkar S, Gent G, Chen Y, Rensing N, Gratuze M, Strout G, Sviben S, Tycksen E, Zhang Q, Gilmore PE, et al. (2023). Sleep deprivation exacerbates microglial reactivity and A&#x3b2; deposition in a TREM2-dependent manner in mice. Sci. Transl. Med. 15, eade6285. 10.1126/scitranslmed.ade6285.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.ade6285</ArticleId><ArticleId IdType="pmc">PMC10449561</ArticleId><ArticleId IdType="pubmed">37099634</ArticleId></ArticleIdList></Reference><Reference><Citation>Garber DW, Kulkarni KR, and Anantharamaiah GM (2000). A sensitive and convenient method for lipoprotein profile analysis of individual mouse plasma samples. J. Lipid Res. 41, 1020&#x2013;1026.</Citation><ArticleIdList><ArticleId IdType="pubmed">10828095</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo JL, Narasimhan S, Changolkar L, He Z, Stieber A, Zhang B, Gathagan RJ, Iba M, McBride JD, Trojanowski JQ, et al. (2016). Unique pathological tau conformers from Alzheimer&#x2019;s brains transmit tau pathology in nontransgenic mice. J. Exp. Med. 213, 2635&#x2013;2654. 10.1084/jem.20160833.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20160833</ArticleId><ArticleId IdType="pmc">PMC5110027</ArticleId><ArticleId IdType="pubmed">27810929</ArticleId></ArticleIdList></Reference><Reference><Citation>Garai K, and Frieden C (2013). Quantitative analysis of the time course of A&#x3b2; oligomerization and subsequent growth steps using tetramethylrhodamine-labeled A&#x3b2;. Proc. Natl. Acad. Sci. U. S. A. 110, 3321&#x2013;3326. 10.1073/pnas.1222478110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1222478110</ArticleId><ArticleId IdType="pmc">PMC3587211</ArticleId><ArticleId IdType="pubmed">23401512</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>